Citrus Sinensis ID: 003932
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 785 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SXB8 | 842 | G-type lectin S-receptor- | yes | no | 0.484 | 0.451 | 0.481 | 2e-95 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.490 | 0.451 | 0.477 | 1e-94 | |
| O64780 | 814 | G-type lectin S-receptor- | no | no | 0.472 | 0.455 | 0.467 | 3e-94 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.388 | 0.358 | 0.545 | 4e-94 | |
| Q9T058 | 849 | G-type lectin S-receptor- | no | no | 0.485 | 0.448 | 0.462 | 2e-93 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.422 | 0.496 | 0.498 | 3e-93 | |
| Q9SYA0 | 804 | G-type lectin S-receptor- | no | no | 0.470 | 0.458 | 0.461 | 5e-93 | |
| O64776 | 792 | G-type lectin S-receptor- | no | no | 0.490 | 0.486 | 0.449 | 5e-93 | |
| O64777 | 806 | G-type lectin S-receptor- | no | no | 0.485 | 0.472 | 0.461 | 6e-93 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.429 | 0.411 | 0.505 | 6e-93 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 350 bits (898), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 187/388 (48%), Positives = 251/388 (64%), Gaps = 8/388 (2%)
Query: 401 AALTLLLGCCAYKYNQMKRLNLIEEDSAKASNTRA---NNETEAGDFNRNVPNLRVYSLA 457
AA+ +LL C YK KR ++ SA+ R ++ E+ + L ++
Sbjct: 460 AAVCVLLACRKYK----KRPAPAKDRSAELMFKRMEALTSDNESASNQIKLKELPLFEFQ 515
Query: 458 DIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL 517
+ +T+ FS+RNKLG+GG+GPVYKG LP G+ IAVK+LS+ S QG EE NEV++ +KL
Sbjct: 516 VLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKL 575
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
QH NL+++LG CI+ EERML+YEYMP KSLD YLFDP+++ ILDWK R +I+EGI +GLL
Sbjct: 576 QHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLL 635
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
YL SRL IIHRDLK SNILL E + PKISDFG+ARIF E NT +VVGT GY+ P
Sbjct: 636 YLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRVVGTYGYMSP 695
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697
EYA +G +S KSDVFS GV+ L+IISG+R S NL++L +A++LW G+ D
Sbjct: 696 EYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLAD 755
Query: 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQVD 757
+ D+ ++ +C+ I LLCVQE NDRP++ V ML E ++ PK+PAF +
Sbjct: 756 PAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLADPKQPAFIVRRG 815
Query: 758 EIGIELLSTTNLEKCSAYDVSFSEVVAR 785
E S + +K S DVS + V R
Sbjct: 816 ASEAE-SSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 193/404 (47%), Positives = 262/404 (64%), Gaps = 19/404 (4%)
Query: 391 LSIALISTAAAALTLLLGCCAYKYNQMKRLNL----IEEDSAKASNTRANNE-TEAGDFN 445
L I + T+AA L +L +Y + Q +++N I + R E E+G F
Sbjct: 449 LIIVVTFTSAAILVVLSSTASYVFLQRRKVNKELGSIPRGVHLCDSERHIKELIESGRFK 508
Query: 446 RN------VPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT 499
++ VP+ + L I AT FS NKLG+GG+GPVYKG+ P + IAVK+LS+
Sbjct: 509 QDDSQGIDVPS---FELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKRLSRC 565
Query: 500 STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLI 559
S QG EEFKNEV+L AKLQH NL+R+LG+C+ EE++L+YEYMP+KSLD ++FD RKL
Sbjct: 566 SGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFD--RKLC 623
Query: 560 --LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617
LDWK R +II GI +GLLYL + SRL IIHRDLK SNILL E M PKISDFG+ARIF
Sbjct: 624 QRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFG 683
Query: 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 677
NT +VVGT GY+ PEYA +G++S KSDVFSFGV++++ ISGKR + ++L
Sbjct: 684 GSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSL 743
Query: 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737
S+L HA++LWK +G+E +D L + ++CL + LLCVQE+PNDRP+M V ML
Sbjct: 744 SLLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFML 803
Query: 738 -KNETTNINTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSFS 780
+E + TPK+PAF + + S+T E CS +++ +
Sbjct: 804 GSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTIT 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64780|Y1614_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61400 OS=Arabidopsis thaliana GN=At1g61400 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 347 bits (889), Expect = 3e-94, Method: Compositional matrix adjust.
Identities = 180/385 (46%), Positives = 252/385 (65%), Gaps = 14/385 (3%)
Query: 370 AQKDSITSASVDKDEHSSNRRLSIALISTAAAALTLLLGCCAYKY--NQMKRLNLIEEDS 427
A + S + + E N+R + T + L ++LG A+ + ++++ LI ED+
Sbjct: 413 AAGGELLSIRLARSELDVNKRKKTIIAITVSLTLFVILGFTAFGFWRRRVEQNALISEDA 472
Query: 428 AKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPC 487
+ N+ + D VP L + + I+ AT FS+ NKLG GG+G VYKG L
Sbjct: 473 WR-------NDLQTQD----VPGLEYFEMNTIQTATNNFSLSNKLGHGGFGSVYKGKLQD 521
Query: 488 GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547
G IAVK+LS +S QG +EF NE++L +KLQH NL+RVLG C++ E++LIYE+M NKSL
Sbjct: 522 GREIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYEFMKNKSL 581
Query: 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKI 607
D ++FD ++L +DW KR II+GI +GLLYL SRL IIHRDLKVSNILL E M PKI
Sbjct: 582 DTFVFDSKKRLEIDWPKRFDIIQGIARGLLYLHRDSRLRIIHRDLKVSNILLDEKMNPKI 641
Query: 608 SDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
SDFG+AR+F ++ T +VVGT+GY+ PEYA GV+S KSD++SFGVLLL+IISG+++
Sbjct: 642 SDFGLARMFHGTEYQDKTRRVVGTLGYMSPEYAWAGVFSEKSDIYSFGVLLLEIISGEKI 701
Query: 668 SMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDR 727
S E ++L +A+E W G +GV +D L D P ++ RC++I LLCVQ P DR
Sbjct: 702 SRFSYGEEGKTLLAYAWECWCGARGVNLLDQALGDSCHPYEVGRCVQIGLLCVQYQPADR 761
Query: 728 PSMLEVSSMLKNETTNINTPKKPAF 752
P+ LE+ SML T+++ PK+P F
Sbjct: 762 PNTLELLSMLTT-TSDLPLPKQPTF 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 346 bits (888), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 169/310 (54%), Positives = 229/310 (73%), Gaps = 5/310 (1%)
Query: 447 NVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEE 506
N L+++S + AT+ FS NKLGEGG+GPVYKG L GE +A+K+LS S QG E
Sbjct: 508 NNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVE 567
Query: 507 FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
FKNE ML AKLQH NL+++LG C++ +E+MLIYEYMPNKSLD +LFDP+RK++LDWK R
Sbjct: 568 FKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRF 627
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
I+EGI QGLLYL +YSRL +IHRD+K NILL E M PKISDFGMARIF + + NT+
Sbjct: 628 RIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTK 687
Query: 627 QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN-LSILEHAYE 685
+V GT GY+ PEY +G++S KSDVFSFGVL+L+II G++ + +E L+++ H +
Sbjct: 688 RVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWN 747
Query: 686 LWKGGKGVEFVDSFLDDR--NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743
L+K + E +D L D +P +++RC+++ALLCVQ+N +DRPSML+V SM+ + N
Sbjct: 748 LFKENRVREVIDPSLGDSAVENP-QVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNN 806
Query: 744 -INTPKKPAF 752
++ PK+PAF
Sbjct: 807 ALSLPKEPAF 816
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9T058|Y4119_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g11900 OS=Arabidopsis thaliana GN=At4g11900 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 344 bits (882), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 183/396 (46%), Positives = 256/396 (64%), Gaps = 15/396 (3%)
Query: 361 HDWLLSQAAAQKDSITSASVDKDEHSSNRRLSIALIS---TAAAALTLLLGCCAYKYNQM 417
H + L A++ +I++A+ K EHS + + + L+ A AA + L CC +
Sbjct: 440 HTFFLRLASS---NISTANNRKTEHSKGKSIVLPLVLASLVATAACFVGLYCCISSRIRR 496
Query: 418 KRLNLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGY 477
K+ E+ S + E G + N+ +L DI AT FS + KLGEGG+
Sbjct: 497 KKKQRDEKHSREL--------LEGGLIDDAGENMCYLNLHDIMVATNSFSRKKKLGEGGF 548
Query: 478 GPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537
GPVYKG LP G +A+K+LSK S+QG EFKNEV+L KLQH NL+R+LG+C++ +E++L
Sbjct: 549 GPVYKGKLPNGMEVAIKRLSKKSSQGLTEFKNEVVLIIKLQHKNLVRLLGYCVEGDEKLL 608
Query: 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNI 597
IYEYM NKSLD LFD ++ LDW+ R+ I+ G T+GL YL EYSRL IIHRDLK SNI
Sbjct: 609 IYEYMSNKSLDGLLFDSLKSRELDWETRMKIVNGTTRGLQYLHEYSRLRIIHRDLKASNI 668
Query: 598 LLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVL 657
LL + M PKISDFG ARIF + ++++T+++VGT GY+ PEYA GV S KSD++SFGVL
Sbjct: 669 LLDDEMNPKISDFGTARIFGCKQIDDSTQRIVGTFGYMSPEYALGGVISEKSDIYSFGVL 728
Query: 658 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIAL 717
LL+IISGK+ + ++ S++ + +E W KGV +D + S + MRC+ IAL
Sbjct: 729 LLEIISGKKATRFVHNDQKHSLIAYEWESWCETKGVSIIDEPMCCSYSLEEAMRCIHIAL 788
Query: 718 LCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFS 753
LCVQ++P DRP + ++ ML N+ T + PK+P FS
Sbjct: 789 LCVQDHPKDRPMISQIVYMLSNDNT-LPIPKQPTFS 823
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 343 bits (880), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 168/337 (49%), Positives = 234/337 (69%), Gaps = 5/337 (1%)
Query: 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVML 513
+S IEAAT++FS N +G GG+G VY+G L G +AVK+LSKTS QG EEFKNE +L
Sbjct: 333 FSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVL 392
Query: 514 TAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGIT 573
+KLQH NL+R+LGFC++ EE++L+YE++PNKSLD +LFDP ++ LDW +R +II GI
Sbjct: 393 VSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIA 452
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633
+G+LYL + SRLTIIHRDLK SNILL M PKI+DFGMARIF + + NT ++ GT G
Sbjct: 453 RGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFG 512
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS-ILEHAYELWKGGKG 692
Y+ PEYA +G +S KSDV+SFGVL+L+IISGK+ S I+++ S ++ HA+ LW+ G
Sbjct: 513 YMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSP 572
Query: 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAF 752
+E VD + + + RC+ IALLCVQE+P DRP + + ML + TT ++ P+ P F
Sbjct: 573 LELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPGF 632
Query: 753 ---SKQVDEIGIELLSTTNLE-KCSAYDVSFSEVVAR 785
+ +++ G+E +T+ S D S +E R
Sbjct: 633 CLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SYA0|Y1150_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61500 OS=Arabidopsis thaliana GN=At1g61500 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 5e-93, Method: Compositional matrix adjust.
Identities = 175/379 (46%), Positives = 251/379 (66%), Gaps = 10/379 (2%)
Query: 375 ITSASVDKDEHSSNRRLSIALISTAAAALTLLLGCCAYKYNQMKRLNLIEEDSAKASNTR 434
+ S + + E N+R + S + L ++LG A+ + + E A S
Sbjct: 409 LLSIRLARSELDGNKRKKTIVASIVSLTLFMILGFTAFGVWRCRV-----EHIAHISKDA 463
Query: 435 ANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVK 494
N+ + D VP L + + I+ AT FS+ NKLG+GG+G VYKG L G+ IAVK
Sbjct: 464 WKNDLKPQD----VPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVK 519
Query: 495 KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDP 554
+LS +S QG EEF NE++L +KLQH NL+RVLG CI+ EE++LIYE+M NKSLD +LFD
Sbjct: 520 RLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDS 579
Query: 555 IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614
++L +DW KR II+GI +GLLYL SRL +IHRDLKVSNILL E M PKISDFG+AR
Sbjct: 580 RKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLAR 639
Query: 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN 674
++ ++NT +VVGT+GY+ PEYA G++S KSD++SFGVL+L+IISG+++S
Sbjct: 640 MYQGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGV 699
Query: 675 ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS 734
E +++ +A+E W +G++ +D L D P ++ RC++I LLCVQ P DRP+ LE+
Sbjct: 700 EGKTLIAYAWESWSEYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELL 759
Query: 735 SMLKNETTNINTPKKPAFS 753
+ML T+++ +PK+P F+
Sbjct: 760 AMLTT-TSDLPSPKQPTFA 777
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64776|Y1144_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61440 OS=Arabidopsis thaliana GN=At1g61440 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 5e-93, Method: Compositional matrix adjust.
Identities = 182/405 (44%), Positives = 261/405 (64%), Gaps = 20/405 (4%)
Query: 349 LGYYAWQVSFDDHDWLLSQAAAQKDSITSASVDKDEHSSNRRLSIALISTAAAALTLLLG 408
+G W S D D + A + SI A + D H R+++I + ST + L ++LG
Sbjct: 380 IGCLMW--SKDLMDTMQFSAGGEILSIRLAHSELDVH--KRKMTI-VASTVSLTLFVILG 434
Query: 409 CCAYKYNQMKRLNLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSI 468
+ + + N ++ A ++ ++ ++VP L + + I+ AT FS+
Sbjct: 435 FATFGFWR----NRVKHHDAWRNDLQS----------QDVPGLEFFEMNTIQTATSNFSL 480
Query: 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGF 528
NKLG GG+G VYKG L G IAVK+LS +S QG +EF NE++L +KLQH NL+RVLG
Sbjct: 481 SNKLGHGGFGSVYKGKLQDGREIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGC 540
Query: 529 CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTII 588
C++ +E++LIYE+M NKSLD ++F ++L LDW KR II+GI +GLLYL SRL +I
Sbjct: 541 CVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLRVI 600
Query: 589 HRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTK 648
HRDLKVSNILL E M PKISDFG+AR+F ++ T +VVGT+GY+ PEYA GV+S K
Sbjct: 601 HRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTRRVVGTLGYMSPEYAWTGVFSEK 660
Query: 649 SDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCK 708
SD++SFGVLLL+IISG+++S E ++L + +E W +GV +D LDD + P +
Sbjct: 661 SDIYSFGVLLLEIISGEKISRFSYGEEGKALLAYVWECWCETRGVNLLDQALDDSSHPAE 720
Query: 709 LMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFS 753
+ RC++I LLCVQ P DRP+ LE+ SML T+++ PK+P F+
Sbjct: 721 VGRCVQIGLLCVQHQPADRPNTLELLSMLTT-TSDLPLPKQPTFA 764
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64777|Y1643_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61430 OS=Arabidopsis thaliana GN=At1g61430 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 6e-93, Method: Compositional matrix adjust.
Identities = 182/394 (46%), Positives = 252/394 (63%), Gaps = 13/394 (3%)
Query: 362 DWLLSQAAAQKDSITSASVDKDEHSSNRRLSIALISTAAAALTLLLGCCAYKYNQMKRLN 421
D + ++ + + S + + E N+R + ST + L ++ G A+ + + +
Sbjct: 394 DLMDTRQFSAAGELLSIRLARSELDVNKRKMTIVASTVSLTLFVIFGFAAFGFWRCR--- 450
Query: 422 LIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVY 481
E +A SN N ++ D VP L + + I+ AT FS+ NKLG GG+G VY
Sbjct: 451 --VEHNAHISNDAWRNFLQSQD----VPGLEFFEMNAIQTATNNFSLSNKLGPGGFGSVY 504
Query: 482 K---GVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538
K G L G IAVK+LS +S QG +EF NE++L +KLQH NL+RVLG C++ E++LI
Sbjct: 505 KARNGKLQDGREIAVKRLSSSSGQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGTEKLLI 564
Query: 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598
Y ++ NKSLD ++FD +KL LDW KR IIEGI +GLLYL SRL +IHRDLKVSNIL
Sbjct: 565 YGFLKNKSLDTFVFDARKKLELDWPKRFEIIEGIARGLLYLHRDSRLRVIHRDLKVSNIL 624
Query: 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658
L E M PKISDFG+AR+F +E T +VVGT+GY+ PEYA GV+S KSD++SFGVLL
Sbjct: 625 LDEKMNPKISDFGLARMFQGTQYQEKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLL 684
Query: 659 LQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALL 718
L+IISGK++S E ++L +A+E W + V F+D L D + P ++ RC++I LL
Sbjct: 685 LEIISGKKISSFSYGEEGKALLAYAWECWCETREVNFLDQALADSSHPSEVGRCVQIGLL 744
Query: 719 CVQENPNDRPSMLEVSSMLKNETTNINTPKKPAF 752
CVQ P DRP+ LE+ SML T+++ PKKP F
Sbjct: 745 CVQHEPADRPNTLELLSMLTT-TSDLPLPKKPTF 777
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 6e-93, Method: Compositional matrix adjust.
Identities = 179/354 (50%), Positives = 240/354 (67%), Gaps = 17/354 (4%)
Query: 403 LTLLLGCCAYKYNQMKRLNLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAA 462
L+L G + ++ L + K + ++NNE L+++S + +A
Sbjct: 445 LSLRFGSTIDQEMLLRELGIDRSCIHKRNERKSNNE------------LQIFSFESVVSA 492
Query: 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
T+ FS NKLGEGG+GPVYKG L GE +A+K+LS S QG EFKNE +L AKLQH NL
Sbjct: 493 TDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNL 552
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
++VLG CI+ +E+MLIYEYM NKSLD +LFDP+RK +LDW R I+EGI QGLLYL +Y
Sbjct: 553 VQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKY 612
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK 642
SRL +IHRD+K SNILL E M PKISDFG+ARIF E NT++V GT GY+ PEY +
Sbjct: 613 SRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEETRANTKRVAGTFGYMSPEYFRE 672
Query: 643 GVYSTKSDVFSFGVLLLQIISGKR-LSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701
G++S KSDVFSFGVL+L+II G++ S + L+++ H + L+K K E +D L
Sbjct: 673 GLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLEGPLNLIVHVWNLFKENKIREVIDLSLR 732
Query: 702 DR--NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN-INTPKKPAF 752
D + P +++RC+++ALLCVQEN DRPSML+V SM+ E N ++ PK+PAF
Sbjct: 733 DSALDYP-QVLRCVQVALLCVQENAEDRPSMLDVVSMIYGEGNNALSLPKEPAF 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 785 | ||||||
| 224142425 | 763 | predicted protein [Populus trichocarpa] | 0.968 | 0.996 | 0.567 | 0.0 | |
| 356558668 | 909 | PREDICTED: uncharacterized protein LOC10 | 0.941 | 0.812 | 0.559 | 0.0 | |
| 359484771 | 781 | PREDICTED: G-type lectin S-receptor-like | 0.938 | 0.943 | 0.522 | 0.0 | |
| 359497026 | 738 | PREDICTED: G-type lectin S-receptor-like | 0.913 | 0.971 | 0.507 | 0.0 | |
| 296088199 | 1130 | unnamed protein product [Vitis vinifera] | 0.924 | 0.642 | 0.489 | 0.0 | |
| 255565055 | 721 | conserved hypothetical protein [Ricinus | 0.914 | 0.995 | 0.495 | 0.0 | |
| 5814093 | 739 | receptor-like kinase CHRK1 [Nicotiana ta | 0.912 | 0.968 | 0.457 | 1e-180 | |
| 296084604 | 580 | unnamed protein product [Vitis vinifera] | 0.715 | 0.968 | 0.541 | 1e-173 | |
| 147787796 | 658 | hypothetical protein VITISV_036051 [Viti | 0.828 | 0.987 | 0.445 | 1e-171 | |
| 255565053 | 445 | conserved hypothetical protein [Ricinus | 0.564 | 0.995 | 0.490 | 1e-122 |
| >gi|224142425|ref|XP_002324558.1| predicted protein [Populus trichocarpa] gi|222865992|gb|EEF03123.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2152), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/788 (56%), Positives = 555/788 (70%), Gaps = 28/788 (3%)
Query: 1 MAS-IIISIIFHTLLYSELHPAKAKPWIRVGYLNLSEVSTISGINYDLFTHLICSSADIN 59
MAS I I I+FH L +LH AKA+ WI+ GY IS IN L+THLIC+ A +N
Sbjct: 1 MASRITIIILFHVFLSLKLHTAKAQAWIKAGYWFSGSDLPISDINSTLYTHLICAFAGLN 60
Query: 60 STTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKS 119
S++Y LS+S SD+ + F +TVK+KNPSITT+LSIG G NYS S+MV NS++RKS
Sbjct: 61 SSSYHLSISS-SDDQFFSAFTNTVKQKNPSITTLLSIGGGS-ANYSTLSAMVGNSTYRKS 118
Query: 120 FIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLI 179
FID SI+IAR YGF+GLDF+W + NTS +M ++G LF+EWR AA L+ + S+ + LI
Sbjct: 119 FIDDSIKIARHYGFQGLDFSWVSANTSDNMDSMGTLFEEWR-AAIALERRKSSLSE--LI 175
Query: 180 LTARFRYSP--PANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFAR 237
LTA +YSP + S+ ++SI++NLNW H + YY P FTA AALY S
Sbjct: 176 LTAAVQYSPRLDSGSFPIDSIRKNLNWTHVLAFDYYMPTWAKFTAAFAALYDPDSDV--- 232
Query: 238 STDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKI 297
+TD + AWI GL A KLV+ LPFYGYAW L ++ IGA A GPA+ + G ++YK I
Sbjct: 233 NTDFGIAAWINGGLPASKLVLGLPFYGYAWKLANLNESAIGAPATGPAVTEDGDLSYKDI 292
Query: 298 KNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVS 357
N+ KT G V +YNSTY VNY G W FD V+ VR K++YAKEK LLGY W+VS
Sbjct: 293 NNYFKTNG-RVNPIYNSTYVVNYGIVGPAWISFDGVDVVRTKVSYAKEKALLGYVVWEVS 351
Query: 358 FDDHDWLLSQAAAQKDSITSASVDKDEHSSNRRLSIALISTAAAALTLLLGCCAYKYNQM 417
+DD+ W+LSQA K E R+ I +++T AA + +LLG Y
Sbjct: 352 YDDN-WVLSQAGVDL---------KHEGRPKSRILIIILTTTAAVI-ILLGLAFYFIR-- 398
Query: 418 KRLNLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGY 477
N I + +K + + NN AGDF+ N P+L VYSLADIE AT++F+ NKLGEGG+
Sbjct: 399 ---NRILKSKSKETKLKVNNAAAAGDFDSNNPDLIVYSLADIEKATDQFAFENKLGEGGF 455
Query: 478 GPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537
GPVYKGVLP G+ IAVKKLSK+STQGF+EFKNEVMLTAKLQHVNL++VLGFC++ EE++L
Sbjct: 456 GPVYKGVLPGGQEIAVKKLSKSSTQGFDEFKNEVMLTAKLQHVNLVKVLGFCVEREEKVL 515
Query: 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNI 597
IYEYMP KSLD YLFDPIR+ +LDWK+R IIEGITQGLLYLQEYSRLTIIHRDLK SNI
Sbjct: 516 IYEYMPKKSLDSYLFDPIRRYLLDWKRREEIIEGITQGLLYLQEYSRLTIIHRDLKASNI 575
Query: 598 LLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVL 657
LL MKPKISDFGMARIF K+ E NT ++VGT GY+PPEY GVYS KSDV+SFG++
Sbjct: 576 LLDGDMKPKISDFGMARIFTKDEQEANTSRLVGTYGYVPPEYVRNGVYSIKSDVYSFGIV 635
Query: 658 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIAL 717
LL IISGK+ L G +E LS+LE+AYELWK GKG+E +D LDD S CKL++CL+IAL
Sbjct: 636 LLHIISGKKNGSLYGSDETLSLLEYAYELWKDGKGMEIMDPSLDDTLSSCKLIKCLQIAL 695
Query: 718 LCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDV 777
LCVQENP DRPSMLEVSSMLKNET + PK+PAFS + DE +++ CS D
Sbjct: 696 LCVQENPIDRPSMLEVSSMLKNETAIVTIPKRPAFSVKTDEDDKNRPDQLHIKICSVDDA 755
Query: 778 SFSEVVAR 785
+ S+VV R
Sbjct: 756 TISQVVGR 763
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558668|ref|XP_003547625.1| PREDICTED: uncharacterized protein LOC100787480 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/786 (55%), Positives = 554/786 (70%), Gaps = 47/786 (5%)
Query: 5 IISIIFHTLLYSELHPAKAKPWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQ 64
I ++F LL E P KA+ W++ GY +S IN L+THLIC+ A++NS+TY+
Sbjct: 7 IALVLFEFLLCQEFEPLKAQTWLQAGYWYSGSGFPVSDINSALYTHLICAFAELNSSTYE 66
Query: 65 LSLSLPSDENQIAKFADTVKKKNPSITTILSI--GQGKDTNYSIYSSMVRNSSHRKSFID 122
L +S P DE + F TVK+KNPSITT+LSI G G DT + S MV S RK FI
Sbjct: 67 LYVS-PEDEQSFSSFTTTVKQKNPSITTLLSIAGGNGNDT---VLSLMVSKDSSRKYFIQ 122
Query: 123 SSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTA 182
SSIRIARLYGF+GLD +W P T +DM N+G LF+EWR AA A +ST+ +LILTA
Sbjct: 123 SSIRIARLYGFQGLDLSWV-PETISDMNNMGRLFEEWRAAAKSEAANDSTQ---VLILTA 178
Query: 183 RFRYSPPANS--YLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTD 240
+ P +S Y + SIQ NLNW+H +T Y+ P NFTA AALY S + +TD
Sbjct: 179 AVHFRPGLDSASYPVESIQNNLNWVHILTYDYHMPQLANFTAAHAALYDPSS---SVNTD 235
Query: 241 QVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNH 300
+K WI G++A KLV+ LPFYGYAW L PEDN IGA+A GPA+ SG + YK IK +
Sbjct: 236 NGIKEWIGSGVTASKLVLGLPFYGYAWNLRNPEDNAIGASATGPAIGKSGAMNYKDIKAY 295
Query: 301 IKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
I+ YG V+ YN+TY VNYFS G+ W G+DDVE V+ K++YA+E +LLGY WQV +DD
Sbjct: 296 IQRYGGHVK--YNATYVVNYFSNGSTWIGYDDVEVVKMKVSYARENKLLGYAVWQVPYDD 353
Query: 361 HDWLLSQAAAQKDSITSASVDKDEHSSNRRLSIALISTAAAALTLLLGCCAYKYNQMKRL 420
+W+LS AAA+ VD++ +S R L I LI TA + + LLG Y ++R
Sbjct: 354 -NWVLSSAAAEH-------VDQNGRNSWRLLVIILIITAMSVI--LLGILIY---YLRR- 399
Query: 421 NLIEEDSAKASNTRANNETEAGD-FNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGP 479
R T+A F+ N P+L+V+S +DIE AT RFSI NK+G+GGYGP
Sbjct: 400 -------------RFPKSTDASRLFHSNAPDLQVFSFSDIEQATNRFSIENKVGQGGYGP 446
Query: 480 VYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539
VYKG+L + +AVKKLSK STQGFEEFKNEVMLTA+LQHVNL+R+LGF ID E++ML+Y
Sbjct: 447 VYKGILSNRQEVAVKKLSKASTQGFEEFKNEVMLTARLQHVNLVRLLGFYIDGEQQMLVY 506
Query: 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599
EYMPNKSLD YLFDPIR+ +LDW+KR++IIEGITQGLLYLQEYSRLTIIHRD+K SNILL
Sbjct: 507 EYMPNKSLDSYLFDPIRRYLLDWRKRIYIIEGITQGLLYLQEYSRLTIIHRDIKASNILL 566
Query: 600 GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLL 659
MKPKISDFGMARIF K+ LE NT ++VGT GY+ PEYA KG+YSTKSDV+SFGVLLL
Sbjct: 567 DNEMKPKISDFGMARIFRKDELEANTSKIVGTYGYVSPEYAMKGLYSTKSDVYSFGVLLL 626
Query: 660 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLC 719
QI+SG+R + G +ENL+++E+AYELWK GKG+EF D LDD +S CKL+RC++IALLC
Sbjct: 627 QIVSGRRTACFYGEHENLNLMEYAYELWKEGKGMEFADPSLDDSHSTCKLLRCMQIALLC 686
Query: 720 VQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSF 779
VQE+ NDRP++ E+SSMLK++T I P+KPAFS DE + EKCS D +
Sbjct: 687 VQEDANDRPTVKEISSMLKSDTILI-IPQKPAFSINRDEKKPNKF-IMHEEKCSINDATI 744
Query: 780 SEVVAR 785
S+VVAR
Sbjct: 745 SQVVAR 750
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484771|ref|XP_003633158.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/790 (52%), Positives = 527/790 (66%), Gaps = 53/790 (6%)
Query: 21 AKAKPWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFA 80
+ + WI+ GY S I I LFTHL+C+ ADIN TTYQLS+S S+E+ + F
Sbjct: 20 SHGETWIKAGYWYAGSESPIPDIKSGLFTHLLCAFADINPTTYQLSIS-SSEEHYFSTFT 78
Query: 81 DTVKKKNPSITTILSI--GQG--------KDTNYSIYSSMVRNSSHRKSFIDSSIRIARL 130
D VK++NPS+ T+LSI GQG + N S+ S MVR S+RKSFI+S+++ ARL
Sbjct: 79 DIVKRRNPSVVTLLSIWGGQGPTGLSILGERVNSSMVSLMVRQPSYRKSFIESAMKTARL 138
Query: 131 YGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPP- 189
YGF GLD W PNT +DM N+G L DE R AA KL+++NS + + LILT Y P
Sbjct: 139 YGFHGLDLFWLWPNTESDMKNMGALLDELR-AAVKLESRNSGK--APLILTMAVHYVPTL 195
Query: 190 -ANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIE 248
+ SY + +IQRNL+W H YY P NFT AALY +S STD ++ WI
Sbjct: 196 YSVSYHIEAIQRNLDWAHIPAYDYYLPSRVNFTHAHAALYDPLSNV---STDFGIREWIS 252
Query: 249 RGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDV 308
+G A KLV+ LP++GYAWTLV P NGIGA +G A+ G ++YK IK +++YG
Sbjct: 253 KGFPASKLVLGLPYHGYAWTLVNPNHNGIGAPTSGIAMTADGSMSYKYIKWFLRSYG--A 310
Query: 309 QVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQA 368
MYN+TY VNY + GT W GFDDV+A+RAKI+YAKEK+LLGY +QVS DD +W LSQA
Sbjct: 311 TSMYNATYVVNYVTIGTTWIGFDDVQAIRAKISYAKEKKLLGYNVFQVSNDD-NWALSQA 369
Query: 369 AAQKDSITSASVDKDEHSSNRRLSIALISTAAAALTLLLG---CCAYKYNQMKRL---NL 422
A D + H + L I ++ A L L+ G CC + +K + NL
Sbjct: 370 AQDDDKV---------HHKKQELLIKIL-VPIAVLILVAGSIMCCYSRSRVLKAIGTRNL 419
Query: 423 ----IEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYG 478
+ E +K+S +FN N PNLRV+S A+I+ AT FS NKLGEGG+G
Sbjct: 420 GKISLHEVGSKSSGVE--------NFNSNAPNLRVFSFAEIKEATNNFSFENKLGEGGFG 471
Query: 479 PVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538
PVYKG GE +AVK+LSKTS QG EEFKNEV LTAKLQHVNL+R+ GFC + EE+MLI
Sbjct: 472 PVYKGKSQKGEEMAVKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLI 531
Query: 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598
YEYMPNKSLD YLFDP R+ LDW KR+ IIEGITQGLLYLQEYS TIIHRDLK SNIL
Sbjct: 532 YEYMPNKSLDFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNIL 591
Query: 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658
L MKPKISDFG+AR F K+ E +T ++VGT GY+PPEY +G+YS K DV+SFGVLL
Sbjct: 592 LDSEMKPKISDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLL 651
Query: 659 LQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALL 718
LQIIS +R S G+++NL++LE+AYELWK G+G+ F+D LDD +S CKLM C+++ALL
Sbjct: 652 LQIISSRRNSCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALL 711
Query: 719 CVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQVDEIGIELLSTTNLEK---CSAY 775
C+QENP+ RP+MLEVSSMLK+ET + P +PAFS + +E + + T + S
Sbjct: 712 CIQENPDHRPTMLEVSSMLKSETAAMPAPLRPAFSIKSNEDKLSVNDATTSSQQNILSVN 771
Query: 776 DVSFSEVVAR 785
D + S++V R
Sbjct: 772 DATISDLVPR 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497026|ref|XP_003635401.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1869), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/758 (50%), Positives = 513/758 (67%), Gaps = 41/758 (5%)
Query: 3 SIIISIIFHTLLYSELHPAKAKPWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTT 62
++++ I FH L + ++ W++ GY S + IN LFTHL+C+ A ++ +
Sbjct: 7 ALLLFIAFHFRL------SNSQTWVKAGYWYSGNESPVPDINSALFTHLLCAFAWLDPSA 60
Query: 63 YQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFID 122
YQ+ +S PSDE A F + VKK+NPSI T+LSI GK+ + + +SSM+ S+RKSFI+
Sbjct: 61 YQIYIS-PSDEQYFATFTNIVKKRNPSIITLLSIWAGKNDS-TKFSSMISQPSYRKSFIE 118
Query: 123 SSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTA 182
SSI+ ARLYGF+GLD + P T ++ N+G+LFDEWR A +++++ QS LILT
Sbjct: 119 SSIKTARLYGFQGLDLSGYWPRTVSNTINMGILFDEWRAA---VNSESRDPSQSPLILTL 175
Query: 183 RFRYSPPANS--YLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTD 240
Y P S Y ++SI+RN++W+H YY P S NFT AALY +S +TD
Sbjct: 176 EVHYLPTLGSVSYEVDSIRRNMDWVHVAAYDYYLPSSVNFTHAHAALYDPVS---RVNTD 232
Query: 241 QVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNH 300
+ WI RGL A KLV+ L ++GYAWTL+ P++NGIGA A+G A+ G V+YK IK
Sbjct: 233 FGIGEWIGRGLPAGKLVLGLAYHGYAWTLLNPKENGIGAPASGLAMTPDGSVSYKYIKWF 292
Query: 301 IKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
I++Y + +YN+TY VNY S G W G+DDVEA+R K++YAKEK LLGY W+VS D+
Sbjct: 293 IRSY--ECASVYNATYVVNYCSFGATWIGYDDVEAIRTKVSYAKEKGLLGYNVWEVSHDE 350
Query: 361 HDWLLSQAAAQKDSITSASVDKDEHSSNRRLSIALISTAAAALTLLLGCCAYKYNQMKRL 420
+W+LS AA +D +DE + R L I L+ A L + +
Sbjct: 351 -NWVLSLAAQGED--------QDEGNKQRLLVIILLPIAIVVLLV------------SSI 389
Query: 421 NLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPV 480
+ + K+ + + + N + PNL+V+S + I+ AT FS N+LGEGG+GPV
Sbjct: 390 MFMMQTRPKSLPIKLGSNISSA--NSDDPNLQVFSFSTIKVATNNFSSENRLGEGGFGPV 447
Query: 481 YKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540
YKG LP G+ IAVK+LSKTS QG EEFKNEV LTA LQHVNL+++LGFC EE+MLIYE
Sbjct: 448 YKGKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYE 507
Query: 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG 600
MPNKSLD YLFDP R+ LDW KR+ IIEGITQGLLYLQEYS TIIHRDLK SNILL
Sbjct: 508 CMPNKSLDFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLD 567
Query: 601 EAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQ 660
MKPKISDFG+AR F K+ E +T ++VGT GY+PPEY +G+YS K DV+SFGVLLLQ
Sbjct: 568 SEMKPKISDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQ 627
Query: 661 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCV 720
IIS +R S G+++NL++LE+AYELWK G+G+ F+D LDD +S CKLM C+++ALLC+
Sbjct: 628 IISSRRNSCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCI 687
Query: 721 QENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQVDE 758
QENP+ RP+MLEVSSMLK+ET + P +PAFS + +E
Sbjct: 688 QENPDHRPTMLEVSSMLKSETAAMPAPLRPAFSIKSNE 725
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088199|emb|CBI35714.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1865), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/786 (48%), Positives = 516/786 (65%), Gaps = 60/786 (7%)
Query: 3 SIIISIIFHTLLYSELHPAKAKPWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTT 62
++++ I FH L + ++ W++ GY S + IN LFTHL+C+ A ++ +
Sbjct: 402 ALLLFIAFHFRL------SNSQTWVKAGYWYSGNESPVPDINSALFTHLLCAFAWLDPSA 455
Query: 63 YQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFID 122
YQ+ +S PSDE A F + VKK+NPSI T+LSI GK+ + + +SSM+ S+RKSFI+
Sbjct: 456 YQIYIS-PSDEQYFATFTNIVKKRNPSIITLLSIWAGKNDS-TKFSSMISQPSYRKSFIE 513
Query: 123 SSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTA 182
SSI+ ARLYGF+GLD + P T ++ N+G+LFDEWR A +++++ QS LILT
Sbjct: 514 SSIKTARLYGFQGLDLSGYWPRTVSNTINMGILFDEWRAA---VNSESRDPSQSPLILTL 570
Query: 183 RFRYSPPANS--YLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTD 240
Y P S Y ++SI+RN++W+H YY P
Sbjct: 571 EVHYLPTLGSVSYEVDSIRRNMDWVHVAAYDYYLPSR----------------------- 607
Query: 241 QVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNH 300
L A KLV+ L ++GYAWTL+ P++NGIGA A+G A+ G V+YK IK
Sbjct: 608 ----------LPAGKLVLGLAYHGYAWTLLNPKENGIGAPASGLAMTPDGSVSYKYIKWF 657
Query: 301 IKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
I++Y + +YN+TY VNY S G W G+DDVEA+R K++YAKEK LLGY W+VS D+
Sbjct: 658 IRSY--ECASVYNATYVVNYCSFGATWIGYDDVEAIRTKVSYAKEKGLLGYNVWEVSHDE 715
Query: 361 HDWLLSQAAAQKDSITSASVDKDEHSSNRRLSIALISTAAAALTLL-LGCCAYKYNQMKR 419
+W+LS AA +D +DE + R L I L+ A L + + C +K +
Sbjct: 716 -NWVLSLAAQGED--------QDEGNKQRLLVIILLPIAIVVLLVSSIMCHRWKGRLIFN 766
Query: 420 LNLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGP 479
+ ++ + K+ + + + N + PNL+V+S + I+ AT FS N+LGEGG+GP
Sbjct: 767 IKVMMQTRPKSLPIKLGSNISSA--NSDDPNLQVFSFSTIKVATNNFSSENRLGEGGFGP 824
Query: 480 VYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539
VYKG LP G+ IAVK+LSKTS QG EEFKNEV LTA LQHVNL+++LGFC EE+MLIY
Sbjct: 825 VYKGKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIY 884
Query: 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599
E MPNKSLD YLFDP +++LDW KR+HIIEGITQGLLYLQEYSRL IIHRDLK SNILL
Sbjct: 885 ECMPNKSLDFYLFDPEGQVLLDWGKRIHIIEGITQGLLYLQEYSRLRIIHRDLKASNILL 944
Query: 600 GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLL 659
MKPKI+DFG+ARIF K+ E NT ++VGT GY+ PEY KG YS KSDV+SFGVLLL
Sbjct: 945 DGEMKPKIADFGIARIFQKDENEANTGRIVGTYGYVSPEYVQKGTYSVKSDVYSFGVLLL 1004
Query: 660 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLC 719
QIISGK+ + G+++NL +LE+AYELWK GK +EF+D LDD S CKL RC+++ALLC
Sbjct: 1005 QIISGKKNTCFYGLDQNLHLLEYAYELWKDGKSMEFMDPSLDDACSSCKLTRCMQVALLC 1064
Query: 720 VQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSF 779
VQENP DRPS+LEV SM+KNET I TP++PAF+ + DE+ + S + E S +
Sbjct: 1065 VQENPADRPSVLEVDSMIKNETAAIATPRRPAFAAKRDEVEADGKSASGHEIGSVNVTTI 1124
Query: 780 SEVVAR 785
S+V+ R
Sbjct: 1125 SQVLPR 1130
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565055|ref|XP_002523520.1| conserved hypothetical protein [Ricinus communis] gi|223537227|gb|EEF38859.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/765 (49%), Positives = 494/765 (64%), Gaps = 47/765 (6%)
Query: 23 AKPWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADT 82
AKPWI+ Y + S S +N LFTH+ A I+++TYQLS S+E ++ F T
Sbjct: 2 AKPWIKAAYYDSSGNLPASSVNSALFTHIYYGFAGIDNSTYQLSYPF-SNEQDVSTFTAT 60
Query: 83 VKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTA 142
+K+KNPSI T+LSIG NYS +S+MV S+RK+FI SSI+IAR YGF GLD AW
Sbjct: 61 LKRKNPSIITLLSIGLAY-RNYSTFSTMVSQPSYRKAFIRSSIKIARRYGFHGLDLAWLW 119
Query: 143 PNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPAN-SYLLNSIQRN 201
PNTS DM N+G+L +EWR AA +++NS+ Q +L + +R N ++ + SI+RN
Sbjct: 120 PNTSFDMKNVGVLLEEWR-AAVNSESRNSSEPQIILTMMT-YRLPVIGNLTFPVESIERN 177
Query: 202 LNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLP 261
LNW++ +T Y+ P+ T AALY SG +TD ++AW+ERGL KLV+ LP
Sbjct: 178 LNWVNILTFDYHLPLKERATGNHAALYDP-SGHV--NTDFCVRAWLERGLPPSKLVLGLP 234
Query: 262 FYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYF 321
++GYAWTLV P DN +GA ++GP L G + YK I++ I YG V YN+TY VNYF
Sbjct: 235 YHGYAWTLVNPNDNSVGAPSSGPDLTMDGSIGYKMIQSVISGYGYGVASTYNATYAVNYF 294
Query: 322 STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAAAQKDSITSASVD 381
+ T W FDDVEA+R KI+YA K LLGY+ +Q++ DD DW LS+AA V
Sbjct: 295 TIRTTWINFDDVEAIRTKISYAVTKGLLGYFVFQLANDD-DWKLSRAAY--------GVG 345
Query: 382 KDEHSSNRRLSIALISTAAAALTLLLGCCAYKYNQMKRLNLIEEDSAKASNTRANNETEA 441
DE ++ I L+ L L Y + ++ TE
Sbjct: 346 NDEKKKKSQIIIVLVPIVVVILLLFAPASYY---------------IRCRTLKSRGNTEF 390
Query: 442 GDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST 501
G+ VP+ + L + +N P +G LP G+ IAVK+LSKTS
Sbjct: 391 GE----VPS---FELGQPITVVNEYPDQN-------APNLQGKLPRGQEIAVKRLSKTSN 436
Query: 502 QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILD 561
QG +EFKNE+ LTAKLQHVNL+R+LG+C + +E+MLIYEYMPNKSLD YLFD R+L L+
Sbjct: 437 QGLKEFKNELKLTAKLQHVNLVRLLGYCTERKEKMLIYEYMPNKSLDFYLFDQKRRLELN 496
Query: 562 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621
W+KRVHIIEGI QGLLYLQEYS LTIIH+D+K SNILL MKPKISDFGMARIF KE+
Sbjct: 497 WEKRVHIIEGIAQGLLYLQEYSNLTIIHKDIKSSNILLDSNMKPKISDFGMARIFQKENH 556
Query: 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 681
E NT Q+VGT GY+PPEY +GVYSTK DV+SFGVLLLQIISGK+ + G + NL++LE
Sbjct: 557 EANTCQIVGTYGYVPPEYVKRGVYSTKYDVYSFGVLLLQIISGKKNTCYYGSHVNLNLLE 616
Query: 682 HAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741
+AYE W+ G G EF+D LDD +S CKL+RCL++ LLCVQE+P DRPS+L++ SMLKNE
Sbjct: 617 YAYEFWETGNGKEFLDPVLDDSHSTCKLLRCLQVGLLCVQESPIDRPSILQICSMLKNEN 676
Query: 742 TNINTPKKPAFS-KQVDEIGIELLSTTNLEKCSAYDVSFSEVVAR 785
I +PK+PAFS DEI + +T+ + S S SE++ R
Sbjct: 677 DIIVSPKRPAFSVTSNDEIEKNVSKSTSQDVGSVNSASLSELLPR 721
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|5814093|gb|AAD52097.1|AF088885_1 receptor-like kinase CHRK1 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1645), Expect = e-180, Method: Compositional matrix adjust.
Identities = 351/768 (45%), Positives = 491/768 (63%), Gaps = 52/768 (6%)
Query: 21 AKAKPWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFA 80
+ A WI+ G+ + I +FTH+ + A IN+++++L +S SDE I+ F+
Sbjct: 21 SDATAWIKSGFWYAGSEFPVPEIPSTMFTHIHFAFAYINASSFELYVS-HSDEPYISTFS 79
Query: 81 DTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAW 140
+TVK+KNPS+ T+LSI G+D + + ++ M S RKSFI +SI+ AR YGF+GLD
Sbjct: 80 NTVKQKNPSVITLLSIWGGRDESPNFFA-MTSQFSRRKSFITTSIKTARQYGFQGLDLIG 138
Query: 141 TAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANS--YLLNSI 198
PNT +M N+ +EWR A + TR LILT YSP +S Y +++I
Sbjct: 139 VNPNTDANMTNMRSFIEEWRTAINSESKSSGTRT---LILTMGAYYSPMLDSMSYPIDTI 195
Query: 199 QRNLNWIH-AVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLV 257
RN +W+H A+ Y+P S +TD +K WI+RGL A+K+V
Sbjct: 196 IRNFDWVHLKAYAALYDPTS------------------KLNTDYGIKEWIKRGLPANKIV 237
Query: 258 MCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYE 317
+ L ++GYAWTLV P+ N + A G A+ G ++Y+ IK ++K+YG V +YNST+
Sbjct: 238 LGLAYHGYAWTLVNPKHNTVRTPARGLAITQDGSISYRYIKQYMKSYG--VTPVYNSTFV 295
Query: 318 VNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAAAQKDSITS 377
VNY + G+ W G+DDVEA+R K++YAK+K LLG+ A+Q+ DD +W LS+ A ++
Sbjct: 296 VNYVTIGSFWIGYDDVEAIRTKVSYAKDKGLLGFAAFQIPSDDVNWELSKTAQDEE---- 351
Query: 378 ASVDKDEHSSNRRLSIALISTAAAALTLLLGCCAYKYNQMKRLNLIEEDSAKASNTRANN 437
++D+ SNRRL L+ T + L + ++++ + ++ R N
Sbjct: 352 ---EEDQSGSNRRLLAILLPTLTLTILL----------LSTIVFILKKKTLRSEGIRELN 398
Query: 438 ETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLS 497
E G NL+V+ I+AAT+ FSI+NKLGEGG+GPVYKG L G+ IA+K+LS
Sbjct: 399 ERAIGH------NLKVFKFDKIKAATDNFSIKNKLGEGGFGPVYKGRLSDGQEIAIKRLS 452
Query: 498 KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRK 557
S QG EEF+NEV L +KLQHVN++++ G C + EE++LIYEYMPNKSLD YL+DP++
Sbjct: 453 AYSKQGVEEFQNEVTLASKLQHVNVLQLQGCCTEREEKILIYEYMPNKSLDFYLYDPVQS 512
Query: 558 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617
L LDW+ RV IIEG+TQGLLYLQEYS T+IHRDLK SNILL + MKPKISDFG+A++F
Sbjct: 513 LQLDWETRVRIIEGVTQGLLYLQEYSAFTVIHRDLKASNILLDDEMKPKISDFGIAKLFQ 572
Query: 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 677
K+ E NT ++VGT G +PPEY +G+YS K DV+SFGVLLLQI+ K+ S GI +L
Sbjct: 573 KDEKEANTGRIVGTYGCVPPEYVKRGLYSRKYDVYSFGVLLLQILGEKKNSSEYGIKNDL 632
Query: 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737
++LE+AYELW+ G GV+F+D L D + K +R ++ ALLCVQE DRPSMLEV SML
Sbjct: 633 NLLEYAYELWEKGNGVDFLDLSLQDDSRIGKQLRYMQAALLCVQEKWEDRPSMLEVYSML 692
Query: 738 KNETTNINTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSFSEVVAR 785
KNET + PK PAFSK D E L T +L CS ++ S+++AR
Sbjct: 693 KNETEVLPNPKVPAFSKNKDNDTQETLVTPDL-TCSDNSLTISQLIAR 739
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084604|emb|CBI25625.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1582), Expect = e-173, Method: Compositional matrix adjust.
Identities = 325/600 (54%), Positives = 409/600 (68%), Gaps = 38/600 (6%)
Query: 192 SYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGL 251
SY + +IQRNL+W H YY P NFT AALY +S STD ++ WI +G
Sbjct: 13 SYHIEAIQRNLDWAHIPAYDYYLPSRVNFTHAHAALYDPLSNV---STDFGIREWISKGF 69
Query: 252 SADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVM 311
A KLV+ LP++GYAWTLV P NGIGA +G A+ G ++YK IK +++YG M
Sbjct: 70 PASKLVLGLPYHGYAWTLVNPNHNGIGAPTSGIAMTADGSMSYKYIKWFLRSYG--ATSM 127
Query: 312 YNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAAAQ 371
YN+TY VNY + GT W GFDDV+A+RAKI+YAKEK+LLGY +QVS DD +W LSQAA
Sbjct: 128 YNATYVVNYVTIGTTWIGFDDVQAIRAKISYAKEKKLLGYNVFQVSNDD-NWALSQAAQD 186
Query: 372 KDSITSASVDKDEHSSNRRLSIALISTAAAALTLLLG---CCAYKYNQMKRLNLIEEDSA 428
D + H + L I ++ A L L+ G CC Y++ + L I S
Sbjct: 187 DDKV---------HHKKQELLIKIL-VPIAVLILVAGSIMCC---YSRSRVLKAIGNFSV 233
Query: 429 KASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCG 488
+ +FN N PNLRV+S A+I+ AT FS NKLGEGG+GPVYKG G
Sbjct: 234 E-------------NFNSNAPNLRVFSFAEIKEATNNFSFENKLGEGGFGPVYKGKSQKG 280
Query: 489 EVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLD 548
E +AVK+LSKTS QG EEFKNEV LTAKLQHVNL+R+ GFC + EE+MLIYEYMPNKSLD
Sbjct: 281 EEMAVKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSLD 340
Query: 549 CYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKIS 608
YLFDP R+ LDW KR+ IIEGITQGLLYLQEYS TIIHRDLK SNILL MKPKIS
Sbjct: 341 FYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKIS 400
Query: 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLS 668
DFG+AR F K+ E +T ++VGT GY+PPEY +G+YS K DV+SFGVLLLQIIS +R S
Sbjct: 401 DFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIISSRRNS 460
Query: 669 MLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRP 728
G+++NL++LE+AYELWK G+G+ F+D LDD +S CKLM C+++ALLC+QENP+ RP
Sbjct: 461 CTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCIQENPDHRP 520
Query: 729 SMLEVSSMLKNETTNINTPKKPAFSKQVDEIGIELLSTTNLEK---CSAYDVSFSEVVAR 785
+MLEVSSMLK+ET + P +PAFS + +E + + T + S D + S++V R
Sbjct: 521 TMLEVSSMLKSETAAMPAPLRPAFSIKSNEDKLSVNDATTSSQQNILSVNDATISDLVPR 580
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147787796|emb|CAN60684.1| hypothetical protein VITISV_036051 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1565), Expect = e-171, Method: Compositional matrix adjust.
Identities = 350/785 (44%), Positives = 453/785 (57%), Gaps = 135/785 (17%)
Query: 3 SIIISIIFHTLLYSELHPAKAKPWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTT 62
++++ I FH L + ++ W++ GY S + IN LFTHL+C+ A ++S+T
Sbjct: 7 ALLLFIAFHFRL------SNSQTWVKAGYWYSGNESPVPDINSALFTHLLCAFAWLDSST 60
Query: 63 YQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFID 122
YQ+ +S PSDE A F + VKK+NPSITT+LSI GK+ + + +SSM+ SHRKSFI+
Sbjct: 61 YQIYIS-PSDEQYFATFTNIVKKRNPSITTLLSIWAGKNDSTN-FSSMISQPSHRKSFIE 118
Query: 123 SSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTA 182
SSI+ ARLYGF+GLD + P T ++ N+G+LFDEWR A +++++ QS LILT
Sbjct: 119 SSIKTARLYGFQGLDLSGYWPRTVSNTINMGILFDEWRAA---VNSESRDPSQSPLILTL 175
Query: 183 RFRYSPPANS--YLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTD 240
+ P S Y ++SI+RNL+W+H YY P S NFT AALY D
Sbjct: 176 KVHCLPTLESVSYEVDSIRRNLDWVHVAAYDYYLPSSVNFTHAHAALY-----------D 224
Query: 241 QVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNH 300
+ W E G +G W
Sbjct: 225 PRVTGW-EAGFG----------FGVPWVC------------------------------- 242
Query: 301 IKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
+ T P + +++ S G W G+DDVEA+R K++YAKEK LLGY+ W+VS D+
Sbjct: 243 MDTLEPQGKWYWSTC-----ISFGATWIGYDDVEAIRTKVSYAKEKGLLGYFVWEVSHDE 297
Query: 361 HDWLLSQAAAQKDSITSASVDKDEHSSNRRLSIALISTAAAALTLLLGCCAYKYNQMKRL 420
+W+LS AA +D +DE + R L+I L+ A L L K
Sbjct: 298 -NWVLSLAAQDED--------QDEGNKQRLLAIILLPIAIVVLLTTLKSLPIKL------ 342
Query: 421 NLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPV 480
SN + N + PNL+V+S I+ AT FS NKLGEGG+GPV
Sbjct: 343 ---------GSNISSANSDD--------PNLQVFSFTTIKVATNNFSSENKLGEGGFGPV 385
Query: 481 YKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540
YKG LP G+ IAVK+LSKTS QG EEFKNEV LTA LQHVNL+++LGFC EE+MLIYE
Sbjct: 386 YKGKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYE 445
Query: 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG 600
MP SLD YLFDP +++LDW KR+HIIEGITQGLLYLQEYSRL IIHRDLK SNILL
Sbjct: 446 CMPXXSLDFYLFDPEGQVLLDWGKRIHIIEGITQGLLYLQEYSRLRIIHRDLKASNILLD 505
Query: 601 EAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQ 660
MKPKI+DFG+ARIF K+ E NT ++VGT GY+ PEY KG YS KSD
Sbjct: 506 GEMKPKIADFGIARIFQKDENEANTGRIVGTYGYVSPEYVQKGTYSVKSD---------- 555
Query: 661 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCV 720
AYELWK GK +EF+D LDD S CKL RC+++ALLCV
Sbjct: 556 ----------------------AYELWKDGKSMEFMDPSLDDACSSCKLTRCMQVALLCV 593
Query: 721 QENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSFS 780
QENP DRPSMLEV SM+KNET I P++PAF+ + DE+ + S + E S + S
Sbjct: 594 QENPADRPSMLEVDSMIKNETAAIAIPRRPAFAXKRDEVEADGKSASGHEIGSVNVTTIS 653
Query: 781 EVVAR 785
+V+ R
Sbjct: 654 QVLPR 658
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565053|ref|XP_002523519.1| conserved hypothetical protein [Ricinus communis] gi|223537226|gb|EEF38858.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 445 bits (1144), Expect = e-122, Method: Compositional matrix adjust.
Identities = 260/530 (49%), Positives = 313/530 (59%), Gaps = 87/530 (16%)
Query: 110 MVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAK 169
MV NS++R+SFIDSSIR ARLYGF+GLD +W + NTS +M N+ LF EWR AA + +
Sbjct: 1 MVSNSTYRRSFIDSSIRRARLYGFQGLDLSWGSANTSDNMANLDTLFQEWR-AAVASEMR 59
Query: 170 NSTRQQSLLILTARFRYSPPANSYLL--NSIQRNLNWIHAVTASYYEPVSTNFTAPPAAL 227
NS+ S LILTA YSP NS L +SIQRNLNW A+ Y+P ST
Sbjct: 60 NSS--MSELILTASVHYSPELNSISLPADSIQRNLNWFTHAHAALYDPRST--------- 108
Query: 228 YGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALY 287
+TD + AW+ +GL A LV+ PFYGYAWTL +N IGA A GPA+
Sbjct: 109 ---------VNTDFGVGAWMNKGLIASTLVLSWPFYGYAWTLANSNNNSIGAPATGPAIT 159
Query: 288 DSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKR 347
++G + IKN I+ VNY + G+ W F DVEAVR K++YAKEK+
Sbjct: 160 ETGAMRCNDIKNFIQQ-------------SVNYCANGSTWICFHDVEAVRTKVSYAKEKK 206
Query: 348 LLGYYAWQVSFDDHDWLLSQAAAQKDSITSASVDKDEHSSNRRLSIALISTAAAALTLLL 407
LLGY W VS DD +W LSQAA +D + + L I L +TAAA L LL+
Sbjct: 207 LLGYVVWHVSNDD-NWELSQAAQLEDV-------QGQEKQPPSLVIILTTTAAAVL-LLI 257
Query: 408 GCCAYKYNQMKRLNLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFS 467
G Y ++R + +K S + AG F N
Sbjct: 258 GFMLY----IRRKRTLR---SKVSKLETDEAATAGYFGSN-------------------- 290
Query: 468 IRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLG 527
GVL GE IAVKKLS TS QG EEFKNEVMLTAKLQHV L RVLG
Sbjct: 291 ---------------GVLVGGEEIAVKKLSNTSAQGSEEFKNEVMLTAKLQHVFLARVLG 335
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
FCID EE+MLIYEYMPNKSLD YLFDPIR+ LDW KRV I EG+TQGLLYLQEYSR+T+
Sbjct: 336 FCIDREEQMLIYEYMPNKSLDYYLFDPIRRCTLDWTKRVEISEGVTQGLLYLQEYSRMTV 395
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
IHRDLK S IL +K KIS+ GM RIF KE E NT+++VGT+G +PP
Sbjct: 396 IHRDLKASKILFDNDLKAKISNIGMTRIFTKEGPEANTDRIVGTLGVVPP 445
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 785 | ||||||
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.431 | 0.398 | 0.514 | 4.1e-88 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.442 | 0.518 | 0.487 | 4.4e-88 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.389 | 0.380 | 0.524 | 5.7e-86 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.410 | 0.399 | 0.498 | 5.7e-86 | |
| TAIR|locus:2197724 | 806 | AT1G61430 [Arabidopsis thalian | 0.411 | 0.400 | 0.519 | 7.2e-86 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.410 | 0.379 | 0.518 | 1.8e-85 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.448 | 0.415 | 0.511 | 3.8e-85 | |
| TAIR|locus:2121706 | 690 | CRK21 "cysteine-rich RLK (RECE | 0.445 | 0.507 | 0.481 | 8.2e-85 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.392 | 0.388 | 0.524 | 2.1e-84 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.401 | 0.392 | 0.512 | 2.1e-84 |
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
Identities = 178/346 (51%), Positives = 244/346 (70%)
Query: 446 RNVPN-LRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGF 504
RN N L+++S + AT+ FS NKLGEGG+GPVYKG L GE +A+K+LS S QG
Sbjct: 506 RNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGL 565
Query: 505 EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKK 564
EFKNE ML AKLQH NL+++LG C++ +E+MLIYEYMPNKSLD +LFDP+RK++LDWK
Sbjct: 566 VEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKL 625
Query: 565 RVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
R I+EGI QGLLYL +YSRL +IHRD+K NILL E M PKISDFGMARIF + + N
Sbjct: 626 RFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKAN 685
Query: 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN-LSILEHA 683
T++V GT GY+ PEY +G++S KSDVFSFGVL+L+II G++ + +E L+++ H
Sbjct: 686 TKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHV 745
Query: 684 YELWKGGKGVEFVDSFLDDR--NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741
+ L+K + E +D L D +P +++RC+++ALLCVQ+N +DRPSML+V SM+ +
Sbjct: 746 WNLFKENRVREVIDPSLGDSAVENP-QVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDG 804
Query: 742 TN-INTPKKPAFSKQVDEIGIEL-LSTTNLEKCSAYDVSFSEVVAR 785
N ++ PK+PAF E+ + +E SA V+ + + AR
Sbjct: 805 NNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 862 (308.5 bits), Expect = 4.4e-88, Sum P(2) = 4.4e-88
Identities = 172/353 (48%), Positives = 241/353 (68%)
Query: 438 ETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLS 497
E +A D +L+ +S IEAAT++FS N +G GG+G VY+G L G +AVK+LS
Sbjct: 318 EVQATDEITTTHSLQ-FSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLS 376
Query: 498 KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRK 557
KTS QG EEFKNE +L +KLQH NL+R+LGFC++ EE++L+YE++PNKSLD +LFDP ++
Sbjct: 377 KTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQ 436
Query: 558 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617
LDW +R +II GI +G+LYL + SRLTIIHRDLK SNILL M PKI+DFGMARIF
Sbjct: 437 GELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFG 496
Query: 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 677
+ + NT ++ GT GY+ PEYA +G +S KSDV+SFGVL+L+IISGK+ S I+++
Sbjct: 497 VDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSG 556
Query: 678 S-ILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736
S ++ HA+ LW+ G +E VD + + + RC+ IALLCVQE+P DRP + + M
Sbjct: 557 SNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMM 616
Query: 737 LKNETTNINTPKKPAF---SKQVDEIGIELLSTTNLE-KCSAYDVSFSEVVAR 785
L + TT ++ P+ P F + +++ G+E +T+ S D S +E R
Sbjct: 617 LTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 841 (301.1 bits), Expect = 5.7e-86, Sum P(2) = 5.7e-86
Identities = 162/309 (52%), Positives = 228/309 (73%)
Query: 446 RNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFE 505
++VP L + + I+ AT FS+ NKLG+GG+G VYKG L G+ IAVK+LS +S QG E
Sbjct: 471 QDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKE 530
Query: 506 EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR 565
EF NE++L +KLQH NL+RVLG CI+ EE++LIYE+M NKSLD +LFD ++L +DW KR
Sbjct: 531 EFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKR 590
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625
II+GI +GLLYL SRL +IHRDLKVSNILL E M PKISDFG+AR++ ++NT
Sbjct: 591 FDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNT 650
Query: 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLC-GINENLSILEHAY 684
+VVGT+GY+ PEYA G++S KSD++SFGVL+L+IISG+++S G+ E +++ +A+
Sbjct: 651 RRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGV-EGKTLIAYAW 709
Query: 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744
E W +G++ +D L D P ++ RC++I LLCVQ P DRP+ LE+ +ML T+++
Sbjct: 710 ESWSEYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTT-TSDL 768
Query: 745 NTPKKPAFS 753
+PK+P F+
Sbjct: 769 PSPKQPTFA 777
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 5.7e-86, Sum P(2) = 5.7e-86
Identities = 162/325 (49%), Positives = 230/325 (70%)
Query: 446 RNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFE 505
++VP L + + I+ AT FSI NKLG+GG+GPVYKG L G+ IAVK+LS +S QG E
Sbjct: 474 QDVPGLDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKE 533
Query: 506 EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR 565
EF NE++L +KLQH NL+R+LG CI+ EE++LIYE+M N SLD +LFD ++L +DW KR
Sbjct: 534 EFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKR 593
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625
+ II+GI +G+ YL S L +IHRDLKVSNILL E M PKISDFG+AR++ ++NT
Sbjct: 594 LDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNT 653
Query: 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685
+VVGT+GY+ PEYA G++S KSD++SFGVL+L+IISG+++S E +++ +A+E
Sbjct: 654 RRVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKTLIAYAWE 713
Query: 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNIN 745
W G++ +D + D P ++ RC++I LLCVQ P DRP+ LE+ SML T+++
Sbjct: 714 SWCDTGGIDLLDKDVADSCRPLEVERCVQIGLLCVQHQPADRPNTLELLSMLTT-TSDLP 772
Query: 746 TPKKPAF--SKQVDEIGIELLSTTN 768
P++P F ++ D+ E L T N
Sbjct: 773 PPEQPTFVVHRRDDKSSSEDLITVN 797
|
|
| TAIR|locus:2197724 AT1G61430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 835 (299.0 bits), Expect = 7.2e-86, Sum P(2) = 7.2e-86
Identities = 172/331 (51%), Positives = 226/331 (68%)
Query: 425 EDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYK-- 482
E +A SN N ++ D VP L + + I+ AT FS+ NKLG GG+G VYK
Sbjct: 452 EHNAHISNDAWRNFLQSQD----VPGLEFFEMNAIQTATNNFSLSNKLGPGGFGSVYKAR 507
Query: 483 -GVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541
G L G IAVK+LS +S QG +EF NE++L +KLQH NL+RVLG C++ E++LIY +
Sbjct: 508 NGKLQDGREIAVKRLSSSSGQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYGF 567
Query: 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE 601
+ NKSLD ++FD +KL LDW KR IIEGI +GLLYL SRL +IHRDLKVSNILL E
Sbjct: 568 LKNKSLDTFVFDARKKLELDWPKRFEIIEGIARGLLYLHRDSRLRVIHRDLKVSNILLDE 627
Query: 602 AMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQI 661
M PKISDFG+AR+F +E T +VVGT+GY+ PEYA GV+S KSD++SFGVLLL+I
Sbjct: 628 KMNPKISDFGLARMFQGTQYQEKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEI 687
Query: 662 ISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQ 721
ISGK++S E ++L +A+E W + V F+D L D + P ++ RC++I LLCVQ
Sbjct: 688 ISGKKISSFSYGEEGKALLAYAWECWCETREVNFLDQALADSSHPSEVGRCVQIGLLCVQ 747
Query: 722 ENPNDRPSMLEVSSMLKNETTNINTPKKPAF 752
P DRP+ LE+ SML T+++ PKKP F
Sbjct: 748 HEPADRPNTLELLSMLTT-TSDLPLPKKPTF 777
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 855 (306.0 bits), Expect = 1.8e-85, P = 1.8e-85
Identities = 170/328 (51%), Positives = 231/328 (70%)
Query: 451 LRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNE 510
L+VYSL I AT FS NKLGEGG+GPVY G LP GE +AVK+L + S QG EEFKNE
Sbjct: 515 LKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNE 574
Query: 511 VMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIE 570
V+L AKLQH NL+R+LG CI EE++L+YEYMPNKSLD +LF+P ++ +LDWKKR IIE
Sbjct: 575 VILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIE 634
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG 630
GI +GLLYL SRL ++HRDLK SNILL MKPKISDFGMAR+F + + NT +VVG
Sbjct: 635 GIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVG 694
Query: 631 TIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR-LSMLCGINENLSILEHAYELWKG 689
T GY+ PEYA +G++S KSDV+ FGVL+L+II+GKR +S C ++L+I +A+ W
Sbjct: 695 TFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCH-EDSLNIAGYAWRQWNE 753
Query: 690 GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKK 749
E +D + S +++RC+ IALLCVQ++ ++RP + V ML N+++++ P+
Sbjct: 754 DNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRP 813
Query: 750 PAFSKQVDEIGIELLSTTNLEKCSAYDV 777
P + G E+ S+ + EK ++ +
Sbjct: 814 PTLMLR----GREIESSKSSEKDRSHSI 837
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 852 (305.0 bits), Expect = 3.8e-85, P = 3.8e-85
Identities = 185/362 (51%), Positives = 241/362 (66%)
Query: 429 KASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCG 488
KAS + + E + D+ +P + +LA AT FS NKLG+GG+G VYKG+L G
Sbjct: 491 KASRSYTSKENKT-DY-LELPLMEWKALA---MATNNFSTDNKLGQGGFGIVYKGMLLDG 545
Query: 489 EVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLD 548
+ IAVK+LSK S+QG +EF NEV L AKLQH+NL+R+LG C+D E+MLIYEY+ N SLD
Sbjct: 546 KEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLD 605
Query: 549 CYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKIS 608
+LFD R L+W+KR II GI +GLLYL + SR IIHRDLK SN+LL + M PKIS
Sbjct: 606 SHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKIS 665
Query: 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLS 668
DFGMARIF +E E NT +VVGT GY+ PEYA G++S KSDVFSFGVLLL+IISGKR
Sbjct: 666 DFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNK 725
Query: 669 MLCGINENLSILEHAYELWKGGKGVEFVDSF-LDDRNS--PC-KLMRCLEIALLCVQENP 724
N +L++L + WK GK +E VD +D +S P +++RC++I LLCVQE
Sbjct: 726 GFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERA 785
Query: 725 NDRPSMLEVSSMLKNETTNINTPKKPAFSKQVDEIGIELLSTTNLE-KCSAYDVSFSEVV 783
DRP M V ML +ETT I PK+P F + ++ S+T + +C+ V+ S +
Sbjct: 786 EDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVID 845
Query: 784 AR 785
AR
Sbjct: 846 AR 847
|
|
| TAIR|locus:2121706 CRK21 "cysteine-rich RLK (RECEPTOR-like protein kinase) 21" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 8.2e-85, Sum P(2) = 8.2e-85
Identities = 173/359 (48%), Positives = 235/359 (65%)
Query: 435 ANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVK 494
A+ + D + +LR + I+AAT F NKLG GG+G VYKG+ P G +A K
Sbjct: 333 ASPDDATDDLTASSGSLR-FDFRAIKAATSNFHKSNKLGHGGFGAVYKGMFPNGTEVAAK 391
Query: 495 KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDP 554
+LSK S QG EFKNEV+L A+LQH NL+ +LGF ++ EE++L+YE++PNKSLD +LFDP
Sbjct: 392 RLSKPSDQGEPEFKNEVLLVARLQHKNLVGLLGFSVEGEEKILVYEFVPNKSLDHFLFDP 451
Query: 555 IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614
I+++ LDW +R +IIEGIT+G+LYL + SRLTIIHRDLK SNILL M PKI+DFG+AR
Sbjct: 452 IKRVQLDWPRRHNIIEGITRGILYLHQDSRLTIIHRDLKASNILLDAEMNPKIADFGLAR 511
Query: 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN 674
F E NT +VVGT GY+PPEY G +STKSDV+SFGVL+L+II GK+ S I+
Sbjct: 512 NFRVNQTEANTGRVVGTFGYMPPEYVANGQFSTKSDVYSFGVLILEIIGGKKNSSFHQID 571
Query: 675 ENLS-ILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
++S ++ H + L G +E VD + + +++RC+ I LLCVQENP+DRPSM +
Sbjct: 572 GSVSNLVTHVWRLRNNGSLLELVDPAIGENYDKDEVIRCIHIGLLCVQENPDDRPSMSTI 631
Query: 734 SSMLKNETTNINTPKKPAF----SKQVDEIGIELL---STTNLEKCSAYDVSFSEVVAR 785
ML N + + P+ P F + + + LL ST+ CS D S + V R
Sbjct: 632 FRMLTNVSITLPVPQPPGFFFRERSEPNPLAERLLPGPSTSMSFTCSVDDASITSVRPR 690
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 845 (302.5 bits), Expect = 2.1e-84, P = 2.1e-84
Identities = 162/309 (52%), Positives = 222/309 (71%)
Query: 445 NRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGF 504
+++VP L + + I+ AT FS+ NKLG GG+G VYKG L G IAVK+LS +S QG
Sbjct: 457 SQDVPGLEFFEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDGREIAVKRLSSSSEQGK 516
Query: 505 EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKK 564
+EF NE++L +KLQH NL+RVLG C++ +E++LIYE+M NKSLD ++F ++L LDW K
Sbjct: 517 QEFMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPK 576
Query: 565 RVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
R II+GI +GLLYL SRL +IHRDLKVSNILL E M PKISDFG+AR+F ++
Sbjct: 577 RFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDK 636
Query: 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 684
T +VVGT+GY+ PEYA GV+S KSD++SFGVLLL+IISG+++S E ++L + +
Sbjct: 637 TRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEKISRFSYGEEGKALLAYVW 696
Query: 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744
E W +GV +D LDD + P ++ RC++I LLCVQ P DRP+ LE+ SML T+++
Sbjct: 697 ECWCETRGVNLLDQALDDSSHPAEVGRCVQIGLLCVQHQPADRPNTLELLSMLTT-TSDL 755
Query: 745 NTPKKPAFS 753
PK+P F+
Sbjct: 756 PLPKQPTFA 764
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 845 (302.5 bits), Expect = 2.1e-84, P = 2.1e-84
Identities = 162/316 (51%), Positives = 225/316 (71%)
Query: 445 NRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGF 504
+ +V L + + IE AT FS+ NKLG+GG+GPVYKG L G+ IAVK+LS +S QG
Sbjct: 468 SEDVSGLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGK 527
Query: 505 EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKK 564
EEF NE++L +KLQH+NL+R+LG CI+ EER+L+YE+M NKSLD ++FD +++ +DW K
Sbjct: 528 EEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPK 587
Query: 565 RVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
R II+GI +GLLYL SRL IIHRD+KVSNILL + M PKISDFG+AR++ ++N
Sbjct: 588 RFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDN 647
Query: 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 684
T ++VGT+GY+ PEYA GV+S KSD +SFGVLLL++ISG+++S E ++L +A+
Sbjct: 648 TRRIVGTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKISRFSYDKERKNLLAYAW 707
Query: 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744
E W GV F+D D P ++ RC++I LLCVQ P DRP+ LE+ SML T+++
Sbjct: 708 ESWCENGGVGFLDKDATDSCHPSEVGRCVQIGLLCVQHQPADRPNTLELLSMLTT-TSDL 766
Query: 745 NTPKKPAFSKQVDEIG 760
PK+P F+ + G
Sbjct: 767 PLPKEPTFAVHTSDDG 782
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 3.2.1.14 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 785 | |||
| cd02879 | 299 | cd02879, GH18_plant_chitinase_class_V, The class V | 2e-94 | |
| smart00636 | 334 | smart00636, Glyco_18, Glyco_18 domain | 3e-63 | |
| pfam00704 | 325 | pfam00704, Glyco_hydro_18, Glycosyl hydrolases fam | 2e-58 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-43 | |
| cd02872 | 362 | cd02872, GH18_chitolectin_chitotriosidase, This co | 2e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-23 | |
| cd02873 | 413 | cd02873, GH18_IDGF, The IDGF's (imaginal disc grow | 4e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-18 | |
| COG3325 | 441 | COG3325, ChiA, Chitinase [Carbohydrate transport a | 4e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-18 | |
| cd06548 | 322 | cd06548, GH18_chitinase, The GH18 (glycosyl hydrol | 8e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-14 | |
| cd00598 | 210 | cd00598, GH18_chitinase-like, The GH18 (glycosyl h | 4e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd02874 | 313 | cd02874, GH18_CFLE_spore_hydrolase, Cortical fragm | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| COG3858 | 423 | COG3858, COG3858, Predicted glycosyl hydrolase [Ge | 2e-04 | |
| cd06545 | 253 | cd06545, GH18_3CO4_chitinase, The Bacteroides thet | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 |
| >gnl|CDD|119358 cd02879, GH18_plant_chitinase_class_V, The class V plant chitinases have a glycosyl hydrolase family 18 (GH18) domain, but lack the chitin-binding domain present in other GH18 enzymes | Back alignment and domain information |
|---|
Score = 296 bits (760), Expect = 2e-94
Identities = 133/348 (38%), Positives = 197/348 (56%), Gaps = 57/348 (16%)
Query: 25 PWIRVGY-LNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTV 83
++ GY SE S I+ LFTHL + AD++ +TY++ +S PSDE++ + F +TV
Sbjct: 2 TIVKGGYWPAWSEEFPPSNIDSSLFTHLFYAFADLDPSTYEVVIS-PSDESEFSTFTETV 60
Query: 84 KKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAP 143
K+KNPS+ T+LSIG G ++ S +++M + + RK+FI+SSI++AR YGF GLD W P
Sbjct: 61 KRKNPSVKTLLSIG-GGGSDSSAFAAMASDPTARKAFINSSIKVARKYGFDGLDLDWEFP 119
Query: 144 NTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSP------PANSYLLNS 197
++ +M N G L +EWR AA K +A++S R L+LTA +SP + SY + +
Sbjct: 120 SSQVEMENFGKLLEEWR-AAVKDEARSSGRPP--LLLTAAVYFSPILFLSDDSVSYPIEA 176
Query: 198 IQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLV 257
I +NL+W++ + YY +N T P AALY S STD +K+WI+ G+ A KLV
Sbjct: 177 INKNLDWVNVMAYDYYGSWESNTTGPAAALYDPNSN---VSTDYGIKSWIKAGVPAKKLV 233
Query: 258 MCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYE 317
+ LP YG AWTL Y++T
Sbjct: 234 LGLPLYGRAWTL------------------------------------------YDTTTV 251
Query: 318 VNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLL 365
+Y GT W G+DDV+++ K+ YAK+K LLGY+AW V +DD++WL
Sbjct: 252 SSYVYAGTTWIGYDDVQSIAVKVKYAKQKGLLGYFAWAVGYDDNNWLS 299
|
The GH18 domain of the class V chitinases has endochitinase activity in some cases and no catalytic activity in others. Included in this family is a lectin found in black locust (Robinia pseudoacacia) bark, which binds chitin but lacks chitinase activity. Also included is a chitinase-related receptor-like kinase (CHRK1) from tobacco (Nicotiana tabacum), with an N-terminal GH18 domain and a C-terminal kinase domain, which is thought to be part of a plant signaling pathway. The GH18 domain of CHRK1 is expressed extracellularly where it binds chitin but lacks chitinase activity. Length = 299 |
| >gnl|CDD|214753 smart00636, Glyco_18, Glyco_18 domain | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 3e-63
Identities = 95/333 (28%), Positives = 147/333 (44%), Gaps = 27/333 (8%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98
+ I TH+I + A+I+ +D + +KKKNP + +LSIG
Sbjct: 17 PVDDIPASKLTHIIYAFANIDPDGTVTIGDEWADIGNFGQLKA-LKKKNPGLKVLLSIG- 74
Query: 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAP-NTSTDMFNIGLLFD 157
G T +SSM+ + + RK FIDS + + YGF G+D W P D N L
Sbjct: 75 G-WTESDNFSSMLSDPASRKKFIDSIVSFLKKYGFDGIDIDWEYPGGRGDDRENYTALLK 133
Query: 158 EWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYL---LNSIQRNLNWIHAVTASYYE 214
E R LD + + + +LT P L +I + L++I+ +T ++
Sbjct: 134 ELR---EALDKEGAEGKG--YLLTIAVPAGPDKIDKGYGDLPAIAKYLDFINLMTYDFHG 188
Query: 215 PVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPED 274
S N T A LY + D +K ++ +G+ KLV+ +PFYG WTLV +
Sbjct: 189 AWS-NPTGHNAPLYAGPGDPEKYNVDYAVKYYLCKGVPPSKLVLGIPFYGRGWTLVDGSN 247
Query: 275 NGIGAAAAGPA-----LYDSGLVTYKKIKNHI---KTYGPDVQVMYNSTYEVNYFSTGTV 326
NG GA GPA ++ G+V Y++I + Y + Y Y
Sbjct: 248 NGPGAPFTGPATGGPGTWEGGVVDYREICKLLGATVVYDDTAKAPY------AYNPGTGQ 301
Query: 327 WFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFD 359
W +DD +++AK Y K+K L G W++ D
Sbjct: 302 WVSYDDPRSIKAKADYVKDKGLGGVMIWELDAD 334
|
Length = 334 |
| >gnl|CDD|216071 pfam00704, Glyco_hydro_18, Glycosyl hydrolases family 18 | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-58
Identities = 93/326 (28%), Positives = 149/326 (45%), Gaps = 23/326 (7%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQ---IAKFADTVKKKNPSITTILS 95
+ I D TH+I + A+I+ + + D+ + D K +NP + +LS
Sbjct: 18 PLDDIPTDKLTHIIYAFANIDGNGTFGNNADTEDDGLKGCFEQLKDLKKCQNPGVKVLLS 77
Query: 96 IGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAP-NTSTDMFNIGL 154
IG G T +S + + + RK+F DS I + YGF G+D W P D N
Sbjct: 78 IG-G-WTFSGGFSLLASDDAKRKTFADSIIDFLKKYGFDGIDIDWEYPGGKGDDKDNYTA 135
Query: 155 LFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYL-LNSIQRNLNWIHAVTASYY 213
L E R A K +L+A P + I + L++I+ +T ++
Sbjct: 136 LLKELRAALKKEAKAG-------YLLSAAVPAGPDKIDGSDIAKIGKYLDFINLMTYDFH 188
Query: 214 EPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPE 273
N T P A LY ++ D ++ +++ G+ A KLV+ +PFYG WTLV
Sbjct: 189 GWS--NITGPNAPLYDGSW----QNVDYAVQYYLKAGVPASKLVLGIPFYGRGWTLVNGS 242
Query: 274 DNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDV 333
NG GA A GP ++ G+++YK+I +K+ Y+ T + Y G + +DD
Sbjct: 243 GNGGGAPAPGPGTWEGGILSYKEICALLKSGAGPG---YDDTAKAPYIYKGKQFVSYDDP 299
Query: 334 EAVRAKIAYAKEKRLLGYYAWQVSFD 359
+++AK Y K+K L G W + D
Sbjct: 300 RSIKAKAKYVKDKGLGGVMIWSLDQD 325
|
Length = 325 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 7e-48
Identities = 86/282 (30%), Positives = 126/282 (44%), Gaps = 45/282 (15%)
Query: 471 KLGEGGYGPVYKGVL-----PCGEVIAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIR 524
KLGEG +G VYKG L +AVK L + S Q EEF E + KL H N+++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
+LG C + E ++ EYM L YL K L + I +G+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYL---ES 120
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PEY 639
IHRDL N L+GE + KISDFG++R + + G +P PE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR------DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699
+G +++KSDV+SFGVLL +I + + + G E + +
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTL------------------GEQPYPGMSNEEVL-EY 215
Query: 700 LDDRNSPCKLMRC----LEIALLCVQENPNDRPSMLEVSSML 737
L + + C ++ L C E+P DRP+ E+ +L
Sbjct: 216 LKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-47
Identities = 90/282 (31%), Positives = 127/282 (45%), Gaps = 44/282 (15%)
Query: 471 KLGEGGYGPVYKGVL-----PCGEVIAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIR 524
KLGEG +G VYKG L +AVK L + S Q EEF E + KL H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
+LG C + E M++ EYMP L YL R L + I +G+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYL---ES 121
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PEY 639
IHRDL N L+GE + KISDFG++R + + G +P PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR------DLYDDDYYKVKGGKLPIRWMAPES 175
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699
+G +++KSDV+SFGVLL +I + E + G E + +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTL------------------GEEPYPGMSNAEVL-EY 216
Query: 700 LDDRNSPCKLMRC----LEIALLCVQENPNDRPSMLEVSSML 737
L K C ++ L C E+P DRP+ E+ +L
Sbjct: 217 LKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-45
Identities = 93/293 (31%), Positives = 132/293 (45%), Gaps = 55/293 (18%)
Query: 470 NKLGEGGYGPVYKGVL--PCGEVI--AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIR 524
KLGEG +G VYKG L G+ AVK L + S + ++F E + KL H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYL------FDPIRKLILDWKKRVHIIEGITQGLLY 578
+LG C + E L+ EYM L YL F K L K + I +G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-- 636
L + +HRDL N L+GE + KISDFG++R + ++ T G +P
Sbjct: 121 L---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172
Query: 637 ---PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI-NENLS---ILEHAYELWKG 689
PE G++++KSDV+SFGVLL +I + L LS +LE+
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFT------LGATPYPGLSNEEVLEY------- 219
Query: 690 GKGVEFVDSFLDDRNSPCKLMRCL----EIALLCVQENPNDRPSMLEVSSMLK 738
L K C E+ L C Q +P DRP+ E+ L+
Sbjct: 220 ----------LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 3e-45
Identities = 86/282 (30%), Positives = 124/282 (43%), Gaps = 44/282 (15%)
Query: 471 KLGEGGYGPVYKGVL------PCGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLI 523
KLGEG +G VYKG L +V AVK L + ++ + EEF E + KL H N++
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
R+LG C E ++ EYMP L +L KL L + + I +G+ YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL--LQMALQIAKGMEYL---E 119
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PE 638
+HRDL N L+ E + KISDFG++R + E+ G +P PE
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSR-----DIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698
G +++KSDV+SFGVLL +I + + G E ++
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQP------------------YPGMSNEEVLEL 216
Query: 699 FLDDRNSPCKLMRCLEIA---LLCVQENPNDRPSMLEVSSML 737
D P E+ L C +P DRP+ E+ L
Sbjct: 217 LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 3e-45
Identities = 83/268 (30%), Positives = 126/268 (47%), Gaps = 24/268 (8%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLG 527
KLG G +G VYK G+++AVK L K S + + + E+ + +L H N++R++
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
D + L+ EY L YL R L + I I +GL YL I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE-YATKGVYS 646
IHRDLK NILL E KI+DFG+A+ K S + VGT Y+ PE Y
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 647 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSP 706
K DV+S GV+L ++++GK I + L ++ G +EF + +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRR-----ILGPPLEFDEPKWSSGSEE 232
Query: 707 CK-LMRCLEIALLCVQENPNDRPSMLEV 733
K L++ C+ ++P+ RP+ E+
Sbjct: 233 AKDLIKK------CLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 74/204 (36%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFC 529
LGEGG+G VY G+ +A+K + K S+ EE E+ + KL H N++++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 530 IDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 589
D L+ EY SL L + KL D R I+ I +GL YL IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILR--ILLQILEGLEYLHSNG---IIH 115
Query: 590 RDLKVSNILLGEA-MKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE-YATKGVYST 647
RDLK NILL K K++DFG++++ + T +VGT Y+ PE KG YS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 648 KSDVFSFGVLLLQIISGKRLSMLC 671
KSD++S GV+L ++ K L
Sbjct: 174 KSDIWSLGVILYELPELKDLIRKM 197
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 75/273 (27%), Positives = 117/273 (42%), Gaps = 30/273 (10%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLI 523
+ I KLGEG +G VY G+++A+K + K + E E+ + KL+H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKL-ILDWKKRVHIIEGITQGLLYLQEY 582
R+ D ++ L+ EY L FD ++K L + + I L YL
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDL----FDLLKKRGRLSEDEARFYLRQILSALEYLHS- 115
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK 642
I+HRDLK NILL E K++DFG+AR VGT Y+ PE
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLG 170
Query: 643 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702
Y D++S GV+L ++++GK G ++ L + + K GK D
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP--FPGDDQLLELFK------KIGKPKPPFPPPEWD 222
Query: 703 RNSPCK--LMRCLEIALLCVQENPNDRPSMLEV 733
+ K + + L +P R + E
Sbjct: 223 ISPEAKDLIRKLLVK-------DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|119351 cd02872, GH18_chitolectin_chitotriosidase, This conserved domain family includes a large number of catalytically inactive chitinase-like lectins (chitolectins) including YKL-39, YKL-40 (HCGP39), YM1, oviductin, and AMCase (acidic mammalian chitinase), as well as catalytically active chitotriosidases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-40
Identities = 95/339 (28%), Positives = 154/339 (45%), Gaps = 32/339 (9%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSL--SLPSDENQIAKFADTVKKKNPSITTILSI 96
I+ L TH+I + A +N + L D +F +K+KNP++ T+L+I
Sbjct: 19 VPENIDPFLCTHIIYAFAGLNPDGNIIILDEWNDIDLGLYERFNA-LKEKNPNLKTLLAI 77
Query: 97 GQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAP----NTSTDMFNI 152
G + + +S+M + +RK+FI S+I R YGF GLD W P D N
Sbjct: 78 GGWNFGS-AKFSAMAASPENRKTFIKSAIAFLRKYGFDGLDLDWEYPGQRGGPPEDKENF 136
Query: 153 GLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPA--NSYLLNSIQRNLNWIHAVTA 210
L E R A + + L+LTA +Y + I + L++I+ +T
Sbjct: 137 VTLLKELREA---FEPEAPR-----LLLTAAVSAGKETIDAAYDIPEISKYLDFINVMTY 188
Query: 211 SY---YEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAW 267
+ +E V T +P A + + D +K W+ +G +KLV+ +P YG ++
Sbjct: 189 DFHGSWEGV-TGHNSPLYAGSADTGDQKYLNVDYAIKYWLSKGAPPEKLVLGIPTYGRSF 247
Query: 268 TLVKPEDNGIGAAAAGPA-----LYDSGLVTYKKIKNHI-KTYGPDVQVMYNSTYEVNYF 321
TL P + G+GA A+GP ++G + Y I + V+++ +V Y
Sbjct: 248 TLASPSNTGVGAPASGPGTAGPYTREAGFLAY----YEICEFLKSGWTVVWDDEQKVPYA 303
Query: 322 STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
G W G+DD E++ K+ Y K K L G W + DD
Sbjct: 304 YKGNQWVGYDDEESIALKVQYLKSKGLGGAMVWSIDLDD 342
|
The conserved domain is an eight-stranded alpha/beta barrel fold belonging to the family 18 glycosyl hydrolases. The fold has a pronounced active-site cleft at the C-terminal end of the beta-barrel. The chitolectins lack a key active site glutamate (the proton donor required for hydrolytic activity) but retain highly conserved residues involved in oligosaccharide binding. Chitotriosidase is a chitinolytic enzyme expressed in maturing macrophages, which suggests that it plays a part in antimicrobial defense. Chitotriosidase hydrolyzes chitotriose, as well as colloidal chitin to yield chitobiose and is therefore considered an exochitinase. Chitotriosidase occurs in two major forms, the large form being converted to the small form by either RNA or post-translational processing. Although the small form, containing the chitinase domain alone, is sufficient for the chitinolytic activity, the additional C-terminal chitin-binding domain of the large form plays a role in processing colloidal chitin. The chitotriosidase gene is nonessential in humans, as about 35% of the population are heterozygous and 6% homozygous for an inactivated form of the gene. HCGP39 is a 39-kDa human cartilage glycoprotein thought to play a role in connective tissue remodeling and defense against pathogens. Length = 362 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 80/280 (28%), Positives = 120/280 (42%), Gaps = 45/280 (16%)
Query: 465 RFSIRNKLGEGGYGPVYKGVLPC-GEVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVN 521
++ LG G +G VY + GE++AVK LS S + E + E+ + + LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 522 LIRVLGFCIDSEERML-IY-EYMPNKSLDCYL--FDP-----IRKLILDWKKRVHIIEGI 572
++R G D E+ L I+ EY+ SL L F IRK I
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ----------I 110
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
+GL YL I+HRD+K +NIL+ K++DFG A+ E T V GT
Sbjct: 111 LEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR-LSMLCGINENLSILEHAYELWKGGK 691
++ PE Y +D++S G ++++ +GK S L N L+K G
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL----GNPMAA-----LYKIGS 218
Query: 692 GVEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPS 729
E + + K L +CL +P RP+
Sbjct: 219 SGE-PPEIPEHLSEEAKDFLRKCLRR-------DPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 70/281 (24%), Positives = 119/281 (42%), Gaps = 55/281 (19%)
Query: 466 FSIRNKLGEGGYGPVYKG-VLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIR 524
F I K+G+GG+G VYK G+ +A+K + S + E+ NE+ + K +H N+++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV------HIIEGITQGLLY 578
G + +E ++ E+ SL + L+ + + ++ + + +GL Y
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSL--------KDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
L IIHRD+K +NILL + K+ DFG++ + VGT ++ PE
Sbjct: 114 LHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPE 167
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGK---------RLSMLCGINENLSILEHAYELWKG 689
Y K+D++S G+ +++ GK + N L
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-------GPPGLRNP 220
Query: 690 GK-GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729
K EF D FL C+Q+NP RP+
Sbjct: 221 EKWSDEFKD-FLK----------------KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 70/211 (33%), Positives = 111/211 (52%), Gaps = 20/211 (9%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH 519
E E F++ KLG G +G V++G+ +A+K L ++F+ EV +L+H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
+LI + C E +I E M SL +L P + +L + + + +G+ YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYL 120
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES--LEENTEQVVGTIGYIP- 636
+E + IHRDL NIL+GE + K++DFG+AR+ KE L + + IP
Sbjct: 121 EEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKK--------IPY 168
Query: 637 ----PEYATKGVYSTKSDVFSFGVLLLQIIS 663
PE A+ G +STKSDV+SFG+LL ++ +
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 86/273 (31%), Positives = 131/273 (47%), Gaps = 33/273 (12%)
Query: 464 ERFSIR--NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
+R SI+ KLG G +G V++G+ +AVK L K T ++F E + KL+H
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPK 62
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYL-FDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
LI++ C E ++ E M SL YL R L L + + + + G+ YL+
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLE 120
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
+ IHRDL N+L+GE K++DFG+AR+ KE + E E I + PE A
Sbjct: 121 AQN---YIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAA 176
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN-ENLSILEHAYELWKGGKGVEFVDSF 699
+S KSDV+SFG+LL +I++ R+ N E L ++ Y +
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM------------- 223
Query: 700 LDDRNSPCKL---MRCLEIALLCVQENPNDRPS 729
PC +I L C +E+P+DRP+
Sbjct: 224 ------PCPPGCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 472 LGEGGYGPVYKG--VLPCGE----VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIR 524
LGEG +G VYKG P +A+K L + + +EF+ E L + LQH N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYLF-------------DPIRKLILDWKKRVHIIEG 571
+LG C + +++EY+ + L +L D K LD +HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
I G+ YL S +HRDL N L+GE + KISDFG++R + +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
+ ++PPE G ++T+SD++SFGV+L +I S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 87/281 (30%), Positives = 137/281 (48%), Gaps = 36/281 (12%)
Query: 467 SIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRV 525
++++KLG G YG VY+GV +AVK L K T EEF E + +++H NL+++
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 526 LGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL 585
LG C +I E+M +L YL + R+ ++ +++ I+ + YL+ +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLE---KK 123
Query: 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT--IGYIPPEYATKG 643
IHRDL N L+GE K++DFG++R+ ++ T I + PE
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYN 180
Query: 644 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703
+S KSDV++FGVLL +I + +S GI+ L YEL + G + +R
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT-YGMSPYPGID-----LSQVYELLEKG--------YRMER 226
Query: 704 NSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
C +LMR C Q NP+DRPS E+ +
Sbjct: 227 PEGCPPKVYELMRA------CWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 27/212 (12%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVN 521
+ + + +G G +G VYKG+ L G+ +A+K++S + + E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHI--------IEGIT 573
+++ +G S+ +I EY N SL R++I KK + +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL--------RQII---KKFGPFPESLVAVYVYQVL 109
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633
QGL YL E +IHRD+K +NIL + K++DFG+A S ++ + VVGT
Sbjct: 110 QGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPY 164
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
++ PE ST SD++S G ++++++G
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 64/206 (31%), Positives = 112/206 (54%), Gaps = 21/206 (10%)
Query: 472 LGEGGYGPVYKGV-LPCGEVI----AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRV 525
LG G +G VYKGV +P GE + A+K L +TS + +E +E + A + H +++R+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 526 LGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKL----ILDWKKRVHIIEGITQGLLYLQE 581
LG C+ S + LI + MP L Y+ + + +L+W + I +G+ YL+E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT 641
++HRDL N+L+ KI+DFG+A++ + E + E I ++ E
Sbjct: 128 KR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 642 KGVYSTKSDVFSFGVLLLQIIS-GKR 666
+Y+ KSDV+S+GV + ++++ G +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 86/271 (31%), Positives = 130/271 (47%), Gaps = 31/271 (11%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
E + KLG G +G V+ G +AVK L K T E F E + KL+H L+
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEY 582
++ C + E ++ EYM SL +L +KL L + V + I +G+ YL+
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE-- 120
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT---IGYIPPEY 639
IHRDL NIL+GE + KI+DFG+AR+ E E + G I + PE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTARE--GAKFPIKWTAPEA 175
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN-ENLSILEHAYELWKGGKGVEFVDS 698
A G ++ KSDV+SFG+LL +I++ R+ N E L +E Y + +
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---------- 225
Query: 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729
N P +L ++ L C ++P +RP+
Sbjct: 226 ---PPNCPEELY---DLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 39/278 (14%)
Query: 471 KLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFC 529
K+G+G +G VYKGVL +AVK T +F E + + H N+++++G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 530 IDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 589
+ + ++ E +P SL +L +L + KK + + G+ YL+ S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLE--SK-NCIH 116
Query: 590 RDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE--QVVGTIGYIP-----PEYATK 642
RDL N L+GE KISDFGM+R EE V + IP PE
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-------EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 643 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702
G Y+++SDV+S+G+LL + S + Y + E ++S
Sbjct: 170 GRYTSESDVWSYGILLWETFSLG---------------DTPYPGMSNQQTRERIES--GY 212
Query: 703 RNSPCKLM--RCLEIALLCVQENPNDRPSMLEVSSMLK 738
R +L + L C +P +RPS E+ + L+
Sbjct: 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 77/270 (28%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 472 LGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID 531
LG G +G V+ G +A+K + + ++F E + KL H NL+++ G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 591
++ EYM N L YL + RK L + + + + + + YL+ IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 592 LKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT---IGYIPPEYATKGVYSTK 648
L N L+GE K+SDFG+AR L++ GT + + PPE +S+K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYV----LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 649 SDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS-FLDDRNSPC 707
SDV+SFGVL+ ++ S ++ YE + + VE V + + R
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP---------------YERFSNSEVVESVSAGYRLYRPKLA 226
Query: 708 KLMRCLEIALLCVQENPNDRPSMLEVSSML 737
I C E P DRP+ ++ S L
Sbjct: 227 P-TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 87/281 (30%), Positives = 137/281 (48%), Gaps = 24/281 (8%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH 519
E E + KLG G +G V+ G +A+K L K + E F E L +LQH
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQH 60
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
L+R L + E +I EYM N SL +L P + L K + + I +G+ ++
Sbjct: 61 PRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFI 118
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
+ R IHRDL+ +NIL+ E + KI+DFG+AR+ +++ E I + PE
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEA 174
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN-ENLSILEHAYELWKGGKGVEFVDS 698
G ++ KSDV+SFG+LL +I++ R+ N E + LE Y + +
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR---------- 224
Query: 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
N P +L E+ LC +E P +RP+ + S+L++
Sbjct: 225 ---PDNCPEELY---ELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 3e-27
Identities = 78/306 (25%), Positives = 122/306 (39%), Gaps = 23/306 (7%)
Query: 466 FSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSK--TSTQGFEE-FKNEVMLTAKLQH-VN 521
+ I KLGEG +G VY +++A+K L+K S E F E+ + A L H N
Sbjct: 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
++++ F D L+ EY+ SL+ L RK L + + I+ I L YL
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL-- 117
Query: 582 YSRLTIIHRDLKVSNILLGE-AMKPKISDFGMARIFAKESLEENTEQ----VVGTIGYIP 636
IIHRD+K NILL K+ DFG+A++ + VGT GY+
Sbjct: 118 -HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 637 PEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLC-GINENLSILEHAYELWKGGKG 692
PE S+ SD++S G+ L ++++G + L+ EL
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-----P 231
Query: 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAF 752
+ S L N ++ + ++P +R S S +
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291
Query: 753 SKQVDE 758
K D
Sbjct: 292 LKPDDS 297
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 472 LGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID 531
+G+G +G V G G+ +AVK L ST + F E + L+H NL+++LG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 591
++ EYM SL YL R +I +++ + +G+ YL+E + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVI-TLAQQLGFALDVCEGMEYLEEKN---FVHRD 127
Query: 592 LKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT--IGYIPPEYATKGVYSTKS 649
L N+L+ E + K+SDFG+A+ E + Q G + + PE + +STKS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 650 DVFSFGVLLLQIISGKR 666
DV+SFG+LL +I S R
Sbjct: 181 DVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 76/293 (25%), Positives = 135/293 (46%), Gaps = 50/293 (17%)
Query: 472 LGEGGYGPVYKG----VLPCGE--VIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIR 524
LGEG +G V+ G + P + ++AVK L +T++ + F+ E L QH N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLI---------LDWKKRVHIIEGIT 573
G C + + ++++EYM + L+ +L P + L + + I I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR-IFAKESLEENTEQVVGT- 631
G++YL + +HRDL N L+G + KI DFGM+R ++ + +V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY-----RVGGHT 184
Query: 632 ---IGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELW 687
I ++PPE ++T+SDV+SFGV+L +I + GK+ + E
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ-----------PWYGLSNE-- 231
Query: 688 KGGKGVEFVDS-FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ +E + L R C +I L C + +P R ++ ++ L+
Sbjct: 232 ---EVIECITQGRLLQRPRTCPSEVY-DIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 32/284 (11%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTSTQGFEE-FKNEVM 512
E + ++ LG G +G VY+G+ +AVK L ++ ++ E F E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 513 LTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFD----PIRKLILDWKKRVHI 568
+ +K H N++R++G + R ++ E M L +L + P R L K +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 569 IEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENT 625
+ +G YL+E IHRD+ N LL G KI+DFGMAR + S
Sbjct: 122 ARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685
+ + I ++PPE G++++K+DV+SFGVLL +I S + N+ E
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VME 232
Query: 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729
GG ++ + P + R I C Q P DRP+
Sbjct: 233 FVTGGGRLDP------PKGCPGPVYR---IMTDCWQHTPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 84/286 (29%), Positives = 140/286 (48%), Gaps = 37/286 (12%)
Query: 472 LGEGGYGPVYKG----VLPCGE---VIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLI 523
LG G +G VY+G +L G +AVK L K +T Q +EF E L + H N++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDP----IRKLILDWKKRVHIIEGITQGLLYL 579
++LG C+ +E + +I E M L YL D +L K+ + I + +G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKP-----KISDFGMARIFAKESLEENTEQVVGTIGY 634
+ ++ IHRDL N L+ E KI DFG+AR K + + + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 635 IPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGV 693
+ PE G ++T+SDV+SFGVL+ +I++ G++ +N N +L+H GG+
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ--PYPALN-NQEVLQHVTA---GGR-- 231
Query: 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
N P K+ + + C ++P++RP+ + +L+N
Sbjct: 232 -----LQKPENCPDKIYQLM---TNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 86/288 (29%), Positives = 124/288 (43%), Gaps = 53/288 (18%)
Query: 470 NKLGEGGYGPVYKGVLP-----CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNL 522
+LGEG +G V GE +AVK L S Q +F+ E+ + L H N+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 523 IRVLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
++ G C R LI EY+P+ SL YL + ++ K+ + I +G+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE-QVVGTIGYIP--- 636
IHRDL NIL+ KISDFG+A++ L E+ + V G P
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKV-----LPEDKDYYYVKEPGESPIFW 178
Query: 637 --PEYATKGVYSTKSDVFSFGVLLLQIISGKRLS--------MLCGINENLSILEHAYEL 686
PE +S+ SDV+SFGV L ++ + S + GI + I+ EL
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 687 WKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPS 729
K G+ + R C LM+ LC + P DRPS
Sbjct: 239 LKEGERL--------PRPPSCPDEVYDLMK------LCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 87/284 (30%), Positives = 140/284 (49%), Gaps = 30/284 (10%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH 519
E E + KLG G +G V+ G +AVK L K T E F E + KL+H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRH 60
Query: 520 VNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
L+++ + + SEE + ++ EYM SL +L D + L V + + G+ Y
Sbjct: 61 DKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAY 117
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG-TIGYIPP 637
++ R+ IHRDL+ +NIL+G+ + KI+DFG+AR+ E E Q I + P
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN--ENLSILEHAYELWKGGKGVEF 695
E A G ++ KSDV+SFG+LL ++++ R+ G+N E L +E Y +
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPY-PGMNNREVLEQVERGYRMPCPQ----- 226
Query: 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ P L E+ L C +++P +RP+ + S L++
Sbjct: 227 --------DCPISLH---ELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 49/288 (17%)
Query: 467 SIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHV 520
+I +G G +G V +G L +A+K L S+ +F E + + H
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKE-IDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHP 65
Query: 521 NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
N+IR+ G S M+I EYM N SLD +L + K + V ++ GI G+ YL
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT--VGQLVGMLRGIASGMKYL- 122
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI-GYIP--- 636
S + +HRDL NIL+ + K+SDFG++R E++E T G IP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL------EDSEATYTTKGGKIPIRW 174
Query: 637 --PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGV 693
PE +++ SDV+SFG+++ +++S G+R Y
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER----------------PYWDMSNQ--- 215
Query: 694 EFVDSFLDDRNSPCKLMRC----LEIALLCVQENPNDRPSMLEVSSML 737
+ + + D P M C ++ L C Q++ N+RP+ ++ S L
Sbjct: 216 DVIKAVEDGYRLP-PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 31/219 (14%)
Query: 472 LGEGGYGPVYK----GVLPCGE--VIAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIR 524
+G+G +G V++ G+LP ++AVK L + S +F+ E L A+ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYLFD-------------------PIRKLILDWKKR 565
+LG C + L++EYM L+ +L + L L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR-IFAKESLEEN 624
+ I + + G+ YL E +HRDL N L+GE M KI+DFG++R I++ + + +
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
+ I ++PPE Y+T+SDV+++GV+L +I S
Sbjct: 190 ENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 74/265 (27%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 471 KLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGF---EEFKNEVMLTAKLQHVNLIRVLG 527
++G G +G V+ G +A+K T +G E+F E + KL H L+++ G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIK----TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
C + L++E+M + L YL ++ + + + + +G+ YL+ + +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT---IGYIPPEYATKGV 644
IHRDL N L+GE K+SDFGM R L++ GT + + PE +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFV----LDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 645 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704
YS+KSDV+SFGVL+ ++ S + EN S E + G + R
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPY-----ENRSNSEVVETINAGFR-------LYKPRL 225
Query: 705 SPCKLMRCLEIALLCVQENPNDRPS 729
+ + E+ C +E P DRPS
Sbjct: 226 ASQSVY---ELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 85/286 (29%), Positives = 134/286 (46%), Gaps = 33/286 (11%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH 519
E E + KLG G +G V+ G +AVK L K T + F E L LQH
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQH 60
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSL-DCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
L+R+ E +I EYM SL D D K++L K + I +G+ Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAY 118
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT----EQVVGTIGY 634
++ R IHRDL+ +N+L+ E++ KI+DFG+AR+ +E+N E I +
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARV-----IEDNEYTAREGAKFPIKW 170
Query: 635 IPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN-LSILEHAYELWKGGKGV 693
PE G ++ KSDV+SFG+LL +I++ ++ N + +S L+ Y + +
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR----- 225
Query: 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
N P +L +I C +E +RP+ + S+L +
Sbjct: 226 --------MENCPDELY---DIMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 84/307 (27%), Positives = 139/307 (45%), Gaps = 58/307 (18%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGV---LPCGEV---IAVKKLSKTSTQGFE-EFKNE-- 510
E E+ ++ +LG+G +G VY+G+ + GE +A+K +++ ++ EF NE
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 511 VMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL------------FDPI-RK 557
VM HV +R+LG + +++ E M L YL P +
Sbjct: 62 VMKEFNCHHV--VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 558 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR-IF 616
+ E I G+ YL +HRDL N ++ E + KI DFGM R I+
Sbjct: 120 KFIQM-----AAE-IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY 170
Query: 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 676
+ + + ++ + ++ PE GV++TKSDV+SFGV+L ++
Sbjct: 171 ETDYYRKGGKGLL-PVRWMAPESLKDGVFTTKSDVWSFGVVLWEM--------------- 214
Query: 677 LSILEHAYELWKGGKGVEFVDSFLDDR---NSP-CKLMRCLEIALLCVQENPNDRPSMLE 732
++ E Y+ G E V F+ D + P + LE+ +C Q NP RP+ LE
Sbjct: 215 ATLAEQPYQ----GLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLE 270
Query: 733 VSSMLKN 739
+ S LK+
Sbjct: 271 IVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 49/284 (17%)
Query: 472 LGEGGYGPVYKGVLPC---------GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
LG+G +G V C GEV+AVKKL ++ + +F+ E+ + LQH N+
Sbjct: 12 LGKGNFGSVEL----CRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 523 IRVLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
++ G C + R L+ EY+P SL YL + LD +K + I +G+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLG 125
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE-QVVGTIGYIP--- 636
+HRDL NIL+ + KI DFG+ ++ L ++ E V G P
Sbjct: 126 S---KRYVHRDLATRNILVESENRVKIGDFGLTKV-----LPQDKEYYKVREPGESPIFW 177
Query: 637 --PEYATKGVYSTKSDVFSFGVLLLQII---------SGKRLSMLCGINENLSILEHAYE 685
PE T+ +S SDV+SFGV+L ++ + + M+ + I+ H E
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729
L K + C I C +P+ RPS
Sbjct: 238 LLKNNGRLPAPPG--------CP-AEIYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 471 KLGEGGYGPVY----KGVLPCGE--VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIR 524
+LGEG +G V+ +LP + ++AVK L + S ++F+ E L LQH +++R
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLI----------LDWKKRVHIIEGI 572
G C + ++++EYM + L+ +L P K++ L + + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
G++YL + L +HRDL N L+G+ + KI DFGM+R + + I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKR 666
++PPE ++T+SD++SFGV+L +I + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 74/287 (25%), Positives = 117/287 (40%), Gaps = 57/287 (19%)
Query: 466 FSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLI 523
LG+G G VYK P G++ A+KK+ + F + E+ + ++
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGIT--------QG 575
+ G E ++ EYM SL L KK I E + +G
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLL-----------KKVGKIPEPVLAYIARQILKG 111
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
L YL +++ IIHRD+K SN+L+ + KI+DFG++++ + NT VGT+ Y+
Sbjct: 112 LDYL--HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYM 167
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKR----------LSMLCGINENLSILEHAYE 685
PE YS +D++S G+ LL+ GK ++ I +
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-----GPPPS 222
Query: 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLE 732
L EF D F+ C+Q++P RPS E
Sbjct: 223 LPAEEFSPEFRD-FIS----------------ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 82/285 (28%), Positives = 122/285 (42%), Gaps = 46/285 (16%)
Query: 470 NKLGEGGYGPVYKGV--LPCGEVI--AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIR 524
+LG G +G V KGV + G+ + AVK L + G +EF E + A+L H ++R
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
++G C E ML+ E P L YL + D K+ H + G+ YL+
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH---QVAMGMAYLESKH- 115
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT--IGYIPPEYATK 642
+HRDL N+LL + KISDFGM+R S + G + + PE
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-DYYRATTAGRWPLKWYAPECINY 172
Query: 643 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702
G +S+KSDV+S+GV L E S Y KG + + ++S
Sbjct: 173 GKFSSKSDVWSYGVTLW---------------EAFSYGAKPYGEMKGAEVIAMLES---- 213
Query: 703 RNSPCKLMRCLE--------IALLCVQENPNDRPSMLEVSSMLKN 739
+ + E I L C + P DRP+ E+ S +
Sbjct: 214 ----GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 75/233 (32%), Positives = 120/233 (51%), Gaps = 28/233 (12%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFE-EFKNEVMLTAKLQHVNL 522
+ ++GEG YG VYK GE++A+KK+ + +GF E+ L KL+H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 523 IRVLGFCIDSEER---MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
+R+ S+ + +++EYM + L L P K K ++ + +GL YL
Sbjct: 61 VRLKEIVT-SKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK--CYMKQLLEGLQYL 116
Query: 580 QEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
I+HRD+K SNIL+ G K++DFG+AR + K + + T +V+ T+ Y P
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVL---KLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 637 PEY---ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686
PE AT+ Y + D++S G +L ++ GK + G E L LE +EL
Sbjct: 170 PELLLGATR--YGPEVDMWSVGCILAELFLGK--PIFQGSTE-LEQLEKIFEL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 79/289 (27%), Positives = 136/289 (47%), Gaps = 36/289 (12%)
Query: 468 IRNKLGEGGYGPVYKGVL--PCGE----VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
++ +LGEG +G V+ C E ++AVK L S ++F E L LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLI--------LDWKKRVHIIEG 571
+++ G C++ + ++++EYM + L+ +L P L+ L + +HI +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
I G++YL +HRDL N L+GE + KI DFGM+R +
Sbjct: 129 IAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGG 690
I ++PPE ++T+SDV+S GV+L +I + GK+ NE + + L +
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR-- 243
Query: 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
R P ++ ++ L C Q P+ R ++ E+ S+L+N
Sbjct: 244 -----------PRTCPKEVY---DLMLGCWQREPHMRLNIKEIHSLLQN 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 468 IRNKLGEGGYGPVY----KGVLPCGE--VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
++ +LGEG +G V+ + P + ++AVK L + ++F+ E L LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLILDWKKR-----------VHI 568
+++ G C D + ++++EYM + L+ +L P +++D + R +HI
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 569 IEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV 628
I G++YL +HRDL N L+G + KI DFGM+R
Sbjct: 129 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 629 VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKR 666
+ I ++PPE ++T+SDV+SFGV+L +I + GK+
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 86/287 (29%), Positives = 141/287 (49%), Gaps = 36/287 (12%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH 519
E E + KLG+G +G V+ G +A+K L K T E F E + KL+H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRH 60
Query: 520 VNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
L+ + + + SEE + ++ E+M SL +L + K L + V + I G+ Y
Sbjct: 61 DKLVPL--YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAY 117
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG-TIGYIPP 637
++ R+ IHRDL+ +NIL+G+ + KI+DFG+AR+ E E Q I + P
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN-ENLSILEHAYELWKGGKGVEFV 696
E A G ++ KSDV+SFG+LL ++++ R+ +N E L +E Y +
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---------- 222
Query: 697 DSFLDDRNSPCKLMRC----LEIALLCVQENPNDRPSMLEVSSMLKN 739
PC C E+ LC +++P++RP+ + S L++
Sbjct: 223 ---------PCP-QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 84/290 (28%), Positives = 139/290 (47%), Gaps = 36/290 (12%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH 519
E E + KLG+G +G V+ G +A+K L K T E F E + KL+H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 60
Query: 520 VNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
L+++ + + SEE + ++ EYM SL +L + K L + V + I G+ Y
Sbjct: 61 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAY 117
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG-TIGYIPP 637
++ R+ +HRDL+ +NIL+GE + K++DFG+AR+ E E Q I + P
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN-ENLSILEHAYELWKGGKGVEFV 696
E A G ++ KSDV+SFG+LL ++ + R+ +N E L +E Y +
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------- 222
Query: 697 DSFLDDRNSPCKLMRC----LEIALLCVQENPNDRPSMLEVSSMLKNETT 742
PC C ++ C ++ P +RP+ + + L++ T
Sbjct: 223 ---------PCP-PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 80/290 (27%), Positives = 110/290 (37%), Gaps = 59/290 (20%)
Query: 471 KLGEGGYGPVYKG--VLPCGEVI--AVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRV 525
KLG+G +G V +G G+VI AVK L ++F E + L H NLIR+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 526 LGFCIDSEERMLIYEYMPNKSL------DCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
G + M++ E P SL D I L D+ I G+ YL
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTL-CDYA------VQIANGMRYL 113
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT------IG 633
E R IHRDL NILL K KI DFG+ R +L +N + V
Sbjct: 114 -ESKRF--IHRDLAARNILLASDDKVKIGDFGLMR-----ALPQNEDHYVMEEHLKVPFA 165
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693
+ PE +S SDV+ FGV L ++ + + E W G G
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFT------------------YGEEPWAGLSGS 207
Query: 694 EFVDSFLDDRNS------PCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737
+ + D+ + L C NP DRP+ + L
Sbjct: 208 QILKKI--DKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 78/298 (26%), Positives = 134/298 (44%), Gaps = 52/298 (17%)
Query: 472 LGEGGYGPVYKGV------LPCGEVIAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIR 524
LGEG +G V K +AVK L + ++ + +E L ++ H ++I+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKL----------------------ILDW 562
+ G C +LI EY SL +L + RK+ L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRES-RKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 563 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR-IFAKESL 621
+ I++G+ YL E + ++HRDL N+L+ E K KISDFG++R ++ ++S
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL- 680
+ ++ + + ++ E +Y+T+SDV+SFGVLL +I++ G N I
Sbjct: 184 VKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-------LGGNPYPGIAP 235
Query: 681 EHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738
E + L K G +E R C + L C ++ P+ RP+ ++S L+
Sbjct: 236 ERLFNLLKTGYRME--------RPENCS-EEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|119352 cd02873, GH18_IDGF, The IDGF's (imaginal disc growth factors) are a family of growth factors identified in insects that include at least five members, some of which are encoded by genes in a tight cluster | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 92/375 (24%), Positives = 155/375 (41%), Gaps = 76/375 (20%)
Query: 49 THLICSSADINSTTYQL-SLSLPSD-ENQIAKFADTVKKKNPSITTILSIGQGKDTNYSI 106
THL+ A I++ TY++ SL+ D + + ++K+K P + +LS+G +DT+
Sbjct: 32 THLVYGYAGIDADTYKIKSLNEDLDLDKSHYRAITSLKRKYPHLKVLLSVGGDRDTDEEG 91
Query: 107 ----YSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAP------------------- 143
Y ++ +S R +FI+S+ + + YGF GLD AW P
Sbjct: 92 ENEKYLLLLESSESRNAFINSAHSLLKTYGFDGLDLAWQFPKNKPKKVRGTFGSAWHSFK 151
Query: 144 NTSTDMFNIGLLFDEWRIAATKL--DAKNSTRQQSLLILTARFRYSPPANS---YLLNSI 198
T + E + T L + KN+ R L+LT P NS + + +I
Sbjct: 152 KLFTGDSVVDEKAAEHKEQFTALVRELKNALR-PDGLLLT--LTVLPHVNSTWYFDVPAI 208
Query: 199 QRNLNWIHAVTASY----YEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSAD 254
N+++++ T + P ++TAP LY +K W+ +G A
Sbjct: 209 ANNVDFVNLATFDFLTPERNPEEADYTAPIYELYERNPHHNVDYQ---VKYWLNQGTPAS 265
Query: 255 KLVMCLPFYGYAWTLVKPEDNGI----------GAAAAGPALYDSGLVTYKKI------K 298
KL + + YG AW L K D+GI G AGP GL+++ +I
Sbjct: 266 KLNLGIATYGRAWKLTK--DSGITGVPPVLETDGPGPAGPQTKTPGLLSWPEICSKLPNP 323
Query: 299 NHIKTYGPDVQVMYNSTYEVNYFSTGT-------------VWFGFDDVEAVRAKIAYAKE 345
++K ++ + + T G+ +W ++D + K YAK
Sbjct: 324 ANLKGADAPLRKVGDPTKR-----FGSYAYRPADENGEHGIWVSYEDPDTAANKAGYAKA 378
Query: 346 KRLLGYYAWQVSFDD 360
K L G + +S DD
Sbjct: 379 KGLGGVALFDLSLDD 393
|
The IDGF's have an eight-stranded alpha/beta barrel fold and are related to the glycosyl hydrolase family 18 (GH18) chitinases, but they have an amino acid substitution known to abolish chitinase catalytic activity. IDGFs may have evolved from chitinases to gain new functions as growth factors, interacting with cell surface glycoproteins involved in growth-promoting processes. Length = 413 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 81/315 (25%), Positives = 135/315 (42%), Gaps = 54/315 (17%)
Query: 460 EAATERFSIRNKLGEGGYGPVY----------------KGVLPCGEV-IAVKKLSKTSTQ 502
E + + KLGEG +G V+ + V +AVK L ++
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 503 -GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL--------FD 553
E+F EV + ++L N+ R+LG C +I EYM N L+ +L
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 554 PIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613
L + +++ I G+ YL+ L +HRDL N L+G+ KI+DFGM+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 614 RIFAKESLEENTEQVVGT----IGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSM 669
R + +V G I ++ E G ++TKSDV++FGV L +I++
Sbjct: 178 R----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT------ 227
Query: 670 LCGIN--ENLS---ILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENP 724
LC E+L+ ++E+A ++ ++ N P E+ L C + +
Sbjct: 228 LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPR---PPNCP---KDIYELMLECWRRDE 281
Query: 725 NDRPSMLEVSSMLKN 739
DRP+ E+ L+
Sbjct: 282 EDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 471 KLGEGGYGPVYKG--VLPC---GEVIAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIR 524
+LGE +G +YKG LP +++A+K L + Q + EF+ E L A+L H N++
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYLF--------------DPIRKLILDWKKRVHIIE 570
+LG + +++EY+ L +L D K LD +HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR-IFAKESLEENTEQVV 629
I G+ YL + +H+DL NIL+GE + KISD G++R I++ + + ++
Sbjct: 132 QIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
I ++PPE G +S+ SD++SFGV+L +I S
Sbjct: 189 -PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 81/291 (27%), Positives = 133/291 (45%), Gaps = 44/291 (15%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH 519
E E + KLG G +G V+ +AVK + K + E F E + LQH
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 60
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFD------PIRKLILDWKKRVHIIEGIT 573
L++ L + E +I E+M SL +L P+ KLI D+ + I
Sbjct: 61 DKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-DFSAQ------IA 112
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT----EQVV 629
+G+ ++++ + IHRDL+ +NIL+ ++ KI+DFG+AR+ +E+N E
Sbjct: 113 EGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV-----IEDNEYTAREGAK 164
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN-ENLSILEHAYELWK 688
I + PE G ++ KSDV+SFG+LL++I++ R+ N E + LE Y +
Sbjct: 165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-- 222
Query: 689 GGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
R C I + C + P +RP+ + S+L +
Sbjct: 223 -------------PRPENCP-EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVN 521
++ I ++G+G +G VY G++ +K+ LS S + E+ NEV + KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 522 LIRVLGFCIDS--EERML--IYEYMPNKSLDCYLFDPIRKLILDWKKRVH------IIEG 571
+I+ +S E+ L + EY L + I KK I++
Sbjct: 61 IIK----YYESFEEKGKLCIVMEYADGGDLS--------QKIKKQKKEGKPFPEEQILDW 108
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ---V 628
Q L L+ I+HRD+K NI L K+ DFG++++ L + V
Sbjct: 109 FVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-----LSSTVDLAKTV 163
Query: 629 VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
VGT Y+ PE Y+ KSD++S G +L ++ + K
Sbjct: 164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 83/300 (27%), Positives = 135/300 (45%), Gaps = 44/300 (14%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEV-------IAVKKLSKT-STQGFEEFKNEV 511
E A E+ ++ +LG+G +G VY+G+ G V +A+K +++ S + EF NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAK-GVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 512 MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILD---------- 561
+ + +++R+LG + ++I E M L YL R L +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPP 116
Query: 562 -WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620
KK + + I G+ YL +HRDL N ++ E KI DFGM R +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 680
+ + + ++ PE GV++T SDV+SFGV+L +I ++
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA---------------TLA 218
Query: 681 EHAYELWKGGKGVEFV-DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
E Y+ + + FV + L D+ C M E+ +C Q NP RPS LE+ S +K
Sbjct: 219 EQPYQGMSNEQVLRFVMEGGLLDKPDNCPDM-LFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 79/298 (26%), Positives = 138/298 (46%), Gaps = 38/298 (12%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGV---LPCGEV---IAVKKLSKT-STQGFEEFKNE-- 510
E + E+ ++ +LG+G +G VY+G + GE +AVK ++++ S + EF NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 511 VMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLF-------DPIRKLILDWK 563
VM HV +R+LG + +++ E M + L YL + + +
Sbjct: 62 VMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 564 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623
+ + + I G+ YL +HRDL N ++ KI DFGM R +
Sbjct: 120 EMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176
Query: 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA 683
+ + + ++ PE GV++T SD++SFGV+L +I S+ E
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQP 221
Query: 684 YELWKGGKGVEFV-DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740
Y+ + ++FV D D+ C R ++ +C Q NP RP+ LE+ ++LK++
Sbjct: 222 YQGLSNEQVLKFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 472 LGEGGYGPVY----KGVLPCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIR 524
LG+G +G V K G++ A+K L K + E E + +++ H +++
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 525 VLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
L + +EE++ L+ EY P L +L + + + I L YL
Sbjct: 58 -LHYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARF--YAAEIVLALEYLH--- 110
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG 643
L II+RDLK NILL K++DFG+A+ + E T GT Y+ PE
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--GSRTNTFCGTPEYLAPEVLLGK 168
Query: 644 VYSTKSDVFSFGVLLLQIISGK 665
Y D +S GVLL ++++GK
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 72/290 (24%), Positives = 127/290 (43%), Gaps = 47/290 (16%)
Query: 472 LGEGGYGPVYKGVLPCGEV----IAVK--KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRV 525
LGEG +G V +G L + +AVK KL + EEF +E H N++++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 526 LGFCIDSEER------MLIYEYMPNKSLDCYLFD----------PIRKLILDWKKRVHII 569
+G C ++ M+I +M + L +L P++ L+ +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK-------FM 119
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
I G+ YL S IHRDL N +L E M ++DFG+++
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG 689
+ +I E VY++KSDV++FGV + +I + + + G+ EN I Y+ +
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT-RGQTPYPGV-ENHEI----YDYLRH 230
Query: 690 GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
G ++ + LD+ ++ C + +P DRP+ ++ +L+N
Sbjct: 231 GNRLKQPEDCLDE---------LYDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 72/265 (27%), Positives = 127/265 (47%), Gaps = 32/265 (12%)
Query: 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLS------KTSTQGFEEFKNEVMLTAKLQHVNLI 523
LG+G YG VY G+ G++IAVK++ + + +E+ + EV L L+HVN++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
+ LG C+D + E++P S+ L F P+ + + + I G+ YL
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHN 120
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL----EENTEQVVGTIGYIPP 637
++HRD+K +N++L K+ DFG AR A L + + GT ++ P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGK-------RLSMLCGINENLSILEHAYELWKGG 690
E + Y KSD++S G + ++ +GK RL+ + I + ++ + +
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237
Query: 691 KGVEFVDSFL----DDRNSPCKLMR 711
++FV S L +R S +L+R
Sbjct: 238 -AIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 466 FSIRNKLGEGGYGPVYKGVLPC-GEVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNL 522
F I NK+G+G +G V+K V V A+K+ LSK + + EE +E + AKL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGI----TQGLLY 578
IR +D + ++ EY N L KL+ + R + + Q LL
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDL--------HKLLKMQRGRPLPEDQVWRFFIQILLG 113
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
L I+HRD+K N+ L KI D G+A++ + + NT +VGT Y+ PE
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGK 665
Y+ KSDV++ GV+L + +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 5e-21
Identities = 64/202 (31%), Positives = 114/202 (56%), Gaps = 20/202 (9%)
Query: 472 LGEGGYGPVYKGV-LPCGEVI----AVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRV 525
LG G +G VYKG+ +P GE + A+K L++T+ + EF +E ++ A + H +L+R+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 526 LGFCIDSEERMLIYEYMPNKSLDCYLF---DPI-RKLILDWKKRVHIIEGITQGLLYLQE 581
LG C+ S L+ + MP+ L Y+ D I +L+L+W + I +G++YL+E
Sbjct: 75 LGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT 641
++HRDL N+L+ KI+DFG+AR+ + E N + I ++ E
Sbjct: 128 RR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 642 KGVYSTKSDVFSFGVLLLQIIS 663
++ +SDV+S+GV + ++++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-21
Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 32/212 (15%)
Query: 472 LGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEE-----FKNEVMLTAKLQHVNLIRVL 526
+G G +G V++G+L V KT G+ E F +E + + H N+IR+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 527 GFCIDSEERMLIYEYMPNKSLDCYL------FDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
G + M+I EYM N +LD YL F + V ++ GI G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY--------QLVGMLRGIAAGMKYL- 123
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP---- 636
S + +HRDL NIL+ ++ K+SDFG++R+ E E T G G IP
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSG--GKIPIRWT 177
Query: 637 -PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR 666
PE +++ SDV+SFG+++ +++S G+R
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 33/282 (11%)
Query: 472 LGEGGYGPVYKGVLPCGE------VIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIR 524
LG G +G V+ E ++ VK L KT + + EF+ E+ + KL H N++R
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYL------FDPIRKLILDWKKRVHIIEGITQGLLY 578
+LG C ++E +I EY L +L + ++ L K++V + I G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR-IFAKESLEENTEQVVGTIGYIPP 637
L S +HRDL N L+ + K+S +++ ++ E + + + ++ P
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR--NALIPLRWLAP 187
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697
E + +STKSDV+SFGVL+ ++ + L +E +L + GK V
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRL----QAGKLELPVP 241
Query: 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
P +L + + C NP DRPS E+ S L
Sbjct: 242 E-----GCPSRLYK---LMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
E + K+GEG G VYK G+ +A+KK+ Q E NE+++ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSL-DCYLFDPIRKLILDWKKRVHIIEG--------I 572
++ + +E ++ EYM SL D I+ V + E +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTD----------IITQNF-VRMNEPQIAYVCREV 125
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
QGL YL +IHRD+K NILL + K++DFG A KE + N+ VVGT
Sbjct: 126 LQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTP 180
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
++ PE + Y K D++S G++ +++ G
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 69/230 (30%), Positives = 113/230 (49%), Gaps = 33/230 (14%)
Query: 458 DIEAATERFSIRNKLGEGGYGPVYKGVL---PCGE---VIAVKKLS-KTSTQGFEEFKNE 510
+I +T RF +LGE +G VYKG L GE +A+K L K EEFK+E
Sbjct: 1 EINLSTVRF--MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 511 VMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLF-------------DPIRK 557
M+ ++LQH N++ +LG + +I+ Y + L +L D K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 558 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617
L+ VHI+ I G+ +L + ++H+DL N+L+ + + KISD G+ R
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFR--- 172
Query: 618 KESLEENTEQVVGT----IGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
E + +++G I ++ PE G +S SD++S+GV+L ++ S
Sbjct: 173 -EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 84/313 (26%), Positives = 137/313 (43%), Gaps = 54/313 (17%)
Query: 464 ERFSIRNKLGEGGYGPVY------KGVLPCGE-----------VIAVKKLSKTSTQGFE- 505
+ KLGEG +G V+ LP + ++AVK L + +
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 506 EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-------------- 551
+F EV + ++L+ N+IR+LG C+D + +I EYM N L+ +L
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 552 FDPIRK--LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISD 609
P + + +H+ I G+ YL S L +HRDL N L+GE + KI+D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 610 FGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSM 669
FGM+R + V I ++ E G ++T SDV++FGV L +I+ M
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL------M 235
Query: 670 LC-----GINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENP 724
LC G + ++E+A E ++ ++ R PC E+ L C +
Sbjct: 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYL-----FRPPPCP-QGLYELMLQCWSRDC 289
Query: 725 NDRPSMLEVSSML 737
+RPS ++ + L
Sbjct: 290 RERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 469 RNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVM---LTAKLQHVNLIR 524
+LG G G V K + P G+++AVK + + K + + K ++
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVG 63
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYL---FDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
G ++ + + EYM SLD L I + IL K I + +GL YL
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERIL--GK---IAVAVLKGLTYL-- 116
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF----AKESLEENTEQVVGTIGYIPP 637
+ + IIHRD+K SNIL+ + K+ DFG++ AK VGT Y+ P
Sbjct: 117 HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF--------VGTSSYMAP 168
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGK 665
E YS KSD++S G+ L+++ +G+
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 471 KLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI 530
+LG G +G V+ G +A+K +++ + E+F E + KL H L+++ G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 531 DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 590
+ ++ E+M N L YL R+ L + + + + +G+ YL+ R + IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHR 124
Query: 591 DLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT---IGYIPPEYATKGVYST 647
DL N L+ K+SDFGM R L++ G + + PPE YS+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 648 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707
KSDV+SFGVL+ ++ + ++ E S E + +G R
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPF-----EKKSNYEVVEMISRG------------FRLYRP 223
Query: 708 KL--MRCLEIALLCVQENPNDRPSMLEV 733
KL M E+ C E P RP+ E+
Sbjct: 224 KLASMTVYEVMYSCWHEKPEGRPTFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 85/299 (28%), Positives = 138/299 (46%), Gaps = 56/299 (18%)
Query: 459 IEAATERFSIRNKLGEGGYGPVYKGVL--PCGEVIAVKKLSKTSTQGFEE-----FKNEV 511
I+A+ I +G G +G V G L P I V KT G+ E F +E
Sbjct: 1 IDAS--CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVA--IKTLKAGYTEKQRRDFLSEA 56
Query: 512 MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLILDWKKRVHII 569
+ + H N+I + G S+ M++ EYM N SLD +L D +I + V ++
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI----QLVGML 112
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
GI G+ YL S + +HRDL NIL+ + K+SDFG++R+ LE++ E
Sbjct: 113 RGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEAAY 164
Query: 630 GTI-GYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEH 682
T G IP PE +++ SDV+S+G+++ +++S G+R + + +E
Sbjct: 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE 224
Query: 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRC----LEIALLCVQENPNDRPSMLEVSSML 737
Y L +P M C ++ L C Q++ N+RP ++ S+L
Sbjct: 225 GYRL-----------------PAP---MDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-20
Identities = 81/311 (26%), Positives = 135/311 (43%), Gaps = 50/311 (16%)
Query: 460 EAATERFSIRNKLGEGGYGPVY----KGVLP-------------CGEVIAVKKL-SKTST 501
E +R + + KLGEG +G V+ +G+ ++AVK L +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 502 QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLF------DPI 555
+F E+ + ++L+ N+IR+L CI S+ +I EYM N L+ +L
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 556 R--KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613
+ + + + + + I G+ YL S L +HRDL N L+G+ KI+DFGM+
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI 673
R + V I ++ E G ++T SDV++FGV L +I++ LC
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT------LCK- 230
Query: 674 NENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMR---CLE----IALLCVQENPND 726
E Y + +E F D+ L + C + + L C + N +
Sbjct: 231 -------EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKE 283
Query: 727 RPSMLEVSSML 737
RPS E+ + L
Sbjct: 284 RPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 35/277 (12%)
Query: 465 RFSIRNKLGEGGYGPVYK-GVLPCGEVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVN 521
F + KLG+G YG VYK L + A+K+ L S + E+ NE+ + A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLI---LDWKKRVHIIEGITQGL 576
+I +D + ++ EY P L + RKLI W+ + ++ G
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----- 115
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
LQ I+HRDLK +NILL KI D G++++ K + +GT Y+
Sbjct: 116 --LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMA 169
Query: 637 PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696
PE YS KSD++S G LL ++ + ++ + GK
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA-------PPFEARSMQDLRYKVQRGKYPPIP 222
Query: 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
+ D + + M +Q P RP+ ++
Sbjct: 223 PIYSQDLQNFIRSM---------LQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 7e-20
Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 48/224 (21%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKK---------LSKTSTQGFEEFKNEVMLTA 515
+ KLGEG YG VYK GE++A+KK + T+ + E+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLK 53
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGIT-- 573
+L+H N++++L + L++EY D L +K + KR +
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC-----DMDL----KKYL---DKRPGPLSPNLIK 101
Query: 574 -------QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
+GL Y +S I+HRDLK NIL+ K++DFG+AR F L T
Sbjct: 102 SIMYQLLRGLAYC--HSHR-ILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTH 157
Query: 627 QVVGTIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGKRL 667
+VV T+ Y PE + YST D++S G + ++I+GK L
Sbjct: 158 EVV-TLWYRAPEILLGSKH--YSTAVDIWSVGCIFAEMITGKPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
E F I KLGEG YG VYK + G+V+A+K + + +E E+ + + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYI 60
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
++ G + + ++ EY S+ + K L ++ I+ +GL YL
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNK-TLTEEEIAAILYQTLKGLEYLH-- 116
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK 642
IHRD+K NILL E + K++DFG++ + NT V+GT ++ PE +
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQE 173
Query: 643 GVYSTKSDVFSFGVLLLQIISGK 665
Y+ K+D++S G+ +++ GK
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 9e-20
Identities = 74/302 (24%), Positives = 130/302 (43%), Gaps = 49/302 (16%)
Query: 460 EAATERFSIRNKLGEGGYGPVY----KGVL-----PCGE------VIAVKKL-SKTSTQG 503
E ++ ++ KLGEG +G V+ +G+ E ++AVK L + +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 504 FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFD-PIRKLI--- 559
+F E+ + ++L++ N+IR+LG C+ + +I EYM N L+ +L I
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 560 -----LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614
+ +++ I G+ YL + L +HRDL N L+G KI+DFGM+R
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN 674
+ V I ++ E G ++T SDV++FGV L ++ + LC
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT------LCK-- 229
Query: 675 ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMR-------CLEIALLCVQENPNDR 727
E Y L + +E F ++ L + ++ + C + DR
Sbjct: 230 ------EQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDR 283
Query: 728 PS 729
P+
Sbjct: 284 PT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 472 LGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCI 530
LG+G +G V+KG L +AVK + Q + +F +E + + H N+++++G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 531 DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 590
+ ++ E +P +L +K L K+ V G+ YL+ + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 591 DLKVSNILLGEAMKPKISDFGMAR-----IFAKESLEENTEQVVGTIGYIPPEYATKGVY 645
DL N L+GE KISDFGM+R I++ L++ I + PE G Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI------PIKWTAPEALNYGRY 171
Query: 646 STKSDVFSFGVLLLQIIS 663
S++SDV+S+G+LL + S
Sbjct: 172 SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 30/216 (13%)
Query: 468 IRNKLGEGGYGPVYKGVL-PCGE---VIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNL 522
I +G G +G V +G L G+ +A+K L T + +F +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYL------FDPIRKLILDWKKRVHIIEGITQGL 576
I + G S M+I E+M N +LD +L F I + V ++ GI G+
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI--------QLVGMLRGIAAGM 119
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
YL E + +HRDL NIL+ + K+SDFG++R ++ + +G G IP
Sbjct: 120 KYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIP 174
Query: 637 -----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR 666
PE +++ SDV+S+G+++ +++S G+R
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVK--KLSKTSTQGFEEFKNEVMLTAKLQHVN 521
R+ NK+G G +G VY V L GE++AVK ++ + +E +E+ + L+H N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIR-KLILDWK-KRVHIIEGITQGLLYL 579
L++ G + E+ + EY +L + + ILD RV+ ++ + +GL YL
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQ-LLEGLAYL 115
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ--VVGTIGYIPP 637
+ I+HRD+K +NI L K+ DFG A + E + GT Y+ P
Sbjct: 116 HSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 638 EYATKGVYSTK---SDVFSFGVLLLQIISGKR 666
E T G +D++S G ++L++ +GKR
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST------QGFEEFKNEVMLTAKLQHVNLI 523
++LGEG G V K L +I K T Q E + + + ++
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSCKSPYIV 62
Query: 524 RVLGFCIDSEERML--IYEYMPNKSLDCYLFDPIRKLILDWKKRV--HIIEGITQGLLYL 579
+ G +D + EY SLD ++ ++K ++V I E + +GL YL
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
IIHRD+K SNILL + K+ DFG+ + E + GT Y+ PE
Sbjct: 122 HSRK---IIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAGTFTGTSFYMAPER 174
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGK 665
YS SDV+S G+ LL++ +
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 472 LGEGGYGPVY--KGVLPCGEVI----AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRV 525
+G G +G V+ + VI V++++K + NE + L H N+I
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 526 LGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL 585
++ + M++ EY P +L Y+ L LD I+ Q LL L
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDT---ILHFFVQILLALHHVHTK 120
Query: 586 TIIHRDLKVSNILLGE-AMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV 644
I+HRDLK NILL + M KI DFG+++I + +S VVGT YI PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKP 177
Query: 645 YSTKSDVFSFGVLLLQIISGKR 666
Y+ KSD+++ G +L ++ S KR
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
E + + ++G G YG VYK + GE++A+K + FE + E+ + + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLD---CYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
+ G + ++ ++ EY SL P+ +L + ++ +GL YL
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQI-----AYVCRETLKGLAYL 117
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
E + IHRD+K +NILL E K++DFG++ + + +GT ++ PE
Sbjct: 118 HETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEV 172
Query: 640 A---TKGVYSTKSDVFSFGV 656
A KG Y K D+++ G+
Sbjct: 173 AAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 45/275 (16%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLS-----KTSTQGFEEFKNEVMLTAKLQHVNLIRV 525
LG G +G VY+G+ L G+ AVK++S +T + ++ + E+ L +KLQH N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 526 LGFCIDSEERMLIY-EYMPNKSLDCYL--FDPIRK-LILDWKKRVHIIEGITQGLLYLQE 581
LG E+ + I+ E +P SL L + + +I + ++ I GL YL
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYL-- 118
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY-A 640
+ R +HRD+K +NIL+ K++DFGMA+ + S + G+ ++ PE A
Sbjct: 119 HDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIA 174
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---VEFVD 697
+G Y +D++S G +L++ +GK S LE ++K G+ D
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK---------PPWSQLEGVAAVFKIGRSKELPPIPD 225
Query: 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLE 732
D+ + L C+Q +P+ RP+ E
Sbjct: 226 HLSDEAK---------DFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 69/278 (24%), Positives = 123/278 (44%), Gaps = 46/278 (16%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHV 520
E F++ +G+G +G VYK + +V+A+K L + + E+ + E+ ++ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 521 NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
+ + G + + +I EY S D ++ LD I+ + GL YL
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
E + IHRD+K +NILL E K++DFG++ + NT VGT ++ PE
Sbjct: 116 EEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVI 170
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGK---------RLSMLCGINENLSILEHAYELWKGGK 691
+ Y K+D++S G+ +++ G+ R+ L N S+ + + K K
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFS--KPFK 228
Query: 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729
+FV LC+ ++P +RPS
Sbjct: 229 --DFVS--------------------LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFK-NEVMLTAKLQHVNLIRVLG 527
K+GEG YG VYK GE++A+KK+ + ++G + E+ L +L H N+I++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
+ L++E+M D Y R+ L + + QGL + + I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---I 119
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE-YATKGVYS 646
+HRDLK N+L+ K++DFG+AR F T VV T Y PE YS
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYS 177
Query: 647 TKSDVFSFGVLLLQIISGKRL 667
T D++S G + +++S + L
Sbjct: 178 TPVDIWSVGCIFAELLSRRPL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 29/213 (13%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKK--LSKTSTQGFEE--------FKNEVMLTAKLQHV 520
+G+G YG VY + + GE++AVK+ L T + ++E+ L H+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 521 NLIRVLGFCIDSEERMLIY-EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
N+++ LGF +EE + I+ EY+P S+ L R + + E + +GL YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYL 124
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR----IFAKESLEENTEQVVGTIGYI 635
I+HRDLK N+L+ KISDFG+++ I+ + + + Q G++ ++
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYD--NDQNMSMQ--GSVFWM 177
Query: 636 PPE--YATKGVYSTKSDVFSFGVLLLQIISGKR 666
PE ++ YS K D++S G ++L++ +G+R
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 9/198 (4%)
Query: 472 LGEGGYGPVYKGVLPCGEV-IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI 530
LG+G YG VY +V IA+K++ + ++ + E+ L + L+H N+++ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 531 DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 590
++ + E +P SL L L + + + + I +GL YL + I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHR 132
Query: 591 DLKVSNILLGE-AMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV--YST 647
D+K N+L+ + KISDFG ++ A + TE GT+ Y+ PE KG Y
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 648 KSDVFSFGVLLLQIISGK 665
+D++S G ++++ +GK
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 48/290 (16%)
Query: 472 LGEGGYGPVYKGVLPCGEVI---AVK--KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVL 526
LGEG +G V +G L + I AVK K++ + E+F +E + + H N++R++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 527 GFCIDSEER------MLIYEYMPNKSL----------DCYLFDPIRKLILDWKKRVHIIE 570
G C+ + E ++I +M + L DC + P + L V +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML-------VKFMT 119
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG 630
I G+ YL S + IHRDL N +L E M ++DFG+++
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 631 TIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690
+ +I E VY+TKSDV+SFGV + +I + + + G+ EN I Y+ + G
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT-RGQTPYPGV-ENSEI----YDYLRQG 230
Query: 691 KGVEFVDSFLDDRNSPCKLMRCL-EIALLCVQENPNDRPSMLEVSSMLKN 739
++ P + L + C NP DRPS + L+
Sbjct: 231 NRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 32/214 (14%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKK--LSKTSTQG-------FEEFKNEVMLTAKLQHVN 521
+G G +G VY G+ GE++AVK+ L S + E+ L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKS----LDCY--LFDPIRKLILDWKKRVHIIEGITQG 575
+++ LG +D++ + EY+P S L+ Y + + + + + I +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---------NFVRQILKG 118
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL----EENTEQVVGT 631
L YL ++R IIHRD+K +NIL+ KISDFG+++ SL + G+
Sbjct: 119 LNYL--HNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
+ ++ PE + Y+ K+D++S G L++++++GK
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS--KTSTQGFEEFKNEVMLTAKLQHVNL 522
+ + +G+G +G V K G+++ K++ + + ++ +EV + +L+H N+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCY-----LFDPIRKLILDWKKRV--HIIEGI-TQ 574
+R ID + +Y M Y L I+K + +K + I I TQ
Sbjct: 62 VRYYDRIIDRSNQ-TLYIVME------YCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQ 113
Query: 575 GLLYLQE-----YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
LL L E T++HRDLK +NI L K+ DFG+A+I +S T V
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YV 171
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
GT Y+ PE Y KSD++S G L+ ++ +
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
+ + +G+G +G V G G +AVK + +T + F E + +L+H NL+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 524 RVLGFCIDSEERMLIY-EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
++LG ++ + + I EYM SL YL R +L + + + + YL+
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK 642
+ +HRDL N+L+ E K+SDFG+ + + S ++T ++ + + PE +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALRE 173
Query: 643 GVYSTKSDVFSFGVLLLQIISGKRL 667
+STKSDV+SFG+LL +I S R+
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFK--------NEVML 513
F I K+G+G + VYK + L G V+A+KK+ Q FE E+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-----QIFEMMDAKARQDCLKEIDL 55
Query: 514 TAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGIT 573
+L H N+I+ L I++ E ++ E L ++I +KK+ +I T
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDL--------SRMIKHFKKQKRLIPERT 107
Query: 574 QGLLYLQEYSRLT------IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627
++Q S L I+HRD+K +N+ + K+ D G+ R F+ ++ ++
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-- 165
Query: 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658
+VGT Y+ PE + Y+ KSD++S G LL
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 68/236 (28%), Positives = 95/236 (40%), Gaps = 33/236 (13%)
Query: 466 FSIRNKLGEGGYGPVYKGVLPC-GEVIAVKKLSK---TSTQGFEEFKNE-VMLTAKLQHV 520
F +GEG + V + A+K L K + + K E +LT H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 521 NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKL-ILDWKKRVHIIEGITQGLLYL 579
+I++ D E + EY PN L IRK LD K I L YL
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGEL----LQYIRKYGSLDEKCTRFYAAEILLALEYL 118
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV----------- 628
IIHRDLK NILL + M KI+DFG A++ S E+ +
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 629 -------VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 677
VGT Y+ PE + SD+++ G ++ Q+++GK G NE L
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK--PPFRGSNEYL 229
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|225862 COG3325, ChiA, Chitinase [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-18
Identities = 84/377 (22%), Positives = 140/377 (37%), Gaps = 63/377 (16%)
Query: 40 ISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFAD--------------TVKK 85
++ INY I S + +L N D +K
Sbjct: 65 LTHINYAFLD--INSDGKSIESWVADEAALYGVPNIEGVELDPWSDPLKGHFGALFDLKA 122
Query: 86 KNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT 145
P + T++SIG D+ +S M + + R++F S++ R YGF G+D W P +
Sbjct: 123 TYPDLKTLISIGGWSDSGG--FSDMAADDASRENFAKSAVEFMRTYGFDGVDIDWEYPGS 180
Query: 146 STDMFNIG---------LLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYL-- 194
D N G LL E R KLD + + A +P + L
Sbjct: 181 GGDAGNCGRPKDKANYVLLLQELR---KKLDKAGVEDGRHYQLTIA----APASKDKLEG 233
Query: 195 --LNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSI------SGRFARSTDQVLKAW 246
I + +++I+ +T ++ + AALYG+ +G F + W
Sbjct: 234 LNHAEIAQYVDYINIMTYDFHGAWN-ETLGHHAALYGTPKDPPLANGGFYVDAEVDGIDW 292
Query: 247 IERGLSAD----KLVMCLPFYGYAWTLVKPEDNGI------GAAAAGPAL--YDSGLVTY 294
+E G + D KLV+ +PFYG W V G G +G +++G
Sbjct: 293 LEEGFAGDVPPSKLVLGMPFYGRGWNGVDGGSLGTCPGLYQGLDNSGIPKGTWEAGNGDK 352
Query: 295 KKIKNHI----KTYGPDVQVMYNSTYEVNYF--STGTVWFGFDDVEAVRAKIAYAKEKRL 348
K + + ++ + Y V+ +DD +V+AK Y + L
Sbjct: 353 DYGKAYDLDANNAGKNGYERYWDDVAKAPYLYNPEKGVFISYDDPRSVKAKAEYVADNNL 412
Query: 349 LGYYAWQVSFDDHDWLL 365
G W++S D++ LL
Sbjct: 413 GGMMFWEISGDENGVLL 429
|
Length = 441 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHV---NLIRVL 526
+G G YG VY+G +P G V+A+K ++ T + + EV L ++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 527 GFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLI----LDWKKRVHIIEGITQGLLYLQEY 582
G + +I EY S +R L+ + K II + L Y+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGS--------VRTLMKAGPIAEKYISVIIREVLVALKYIH-- 118
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK 642
++ +IHRD+K +NIL+ K+ DFG+A + + S + +T VGT ++ PE T+
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITE 175
Query: 643 GV-YSTKSDVFSFGVLLLQIISG 664
G Y TK+D++S G+ + ++ +G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|119365 cd06548, GH18_chitinase, The GH18 (glycosyl hydrolases, family 18) type II chitinases hydrolyze chitin, an abundant polymer of N-acetylglucosamine and have been identified in bacteria, fungi, insects, plants, viruses, and protozoan parasites | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 8e-18
Identities = 80/349 (22%), Positives = 125/349 (35%), Gaps = 79/349 (22%)
Query: 43 INYDLFTHLICSSADINS--TTYQLSLSLPSDENQIAKFADTV---------------KK 85
I D TH+ + ADI+ + Q K+
Sbjct: 21 IPADKLTHINYAFADIDGDGGVVTSDDEAADEAAQSVDGGADTDDQPLKGNFGQLRKLKQ 80
Query: 86 KNPSITTILSIGQ-GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPN 144
KNP + +LSIG +S + R F DS++ R YGF G+D W P
Sbjct: 81 KNPHLKILLSIGGWTWSGGFS---DAAATEASRAKFADSAVDFIRKYGFDGIDIDWEYPG 137
Query: 145 T---------STDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYL- 194
+ D N LL E R LDA + + L+ A +P L
Sbjct: 138 SGGAPGNVARPEDKENFTLLLKELR---EALDALGAETGRKYLLTIA----APAGPDKLD 190
Query: 195 ---LNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFAR-STDQVLKAWIERG 250
+ I + L++I+ +T ++ S N T + LY S + S D + ++ G
Sbjct: 191 KLEVAEIAKYLDFINLMTYDFHGAWS-NTTGHHSNLYASPADPPGGYSVDAAVNYYLSAG 249
Query: 251 LSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQV 310
+ +KLV+ +PFYG WT + A P LY+
Sbjct: 250 VPPEKLVLGVPFYGRGWTGYTRYWD---EVAKAPYLYN---------------------- 284
Query: 311 MYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFD 359
+ + +DD +++AK Y K+K L G W++S D
Sbjct: 285 -----------PSTKTFISYDDPRSIKAKADYVKDKGLGGVMFWELSGD 322
|
The structure of this domain is an eight-stranded alpha/beta barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. Length = 322 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 75/280 (26%), Positives = 128/280 (45%), Gaps = 34/280 (12%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
++ ++ +GEG +G V +G G+ +AVK + T + F E + KL H NL+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLV 62
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
R+LG I ++ E M +L +L R L+ + + + +G+ YL+
Sbjct: 63 RLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALV-SVIQLLQFSLDVAEGMEYLESKK 120
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG 643
++HRDL NIL+ E K+SDFG+AR+ S+ + ++ + + PE
Sbjct: 121 ---LVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHK 172
Query: 644 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELW--KGGKGVEFVDSFL 700
+S+KSDV+S+GVLL ++ S G+ + E +E Y + +G +V
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV---- 228
Query: 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740
LM C + P RPS ++ L+ E
Sbjct: 229 --------LMTS------CWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 75/275 (27%), Positives = 130/275 (47%), Gaps = 34/275 (12%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLS----KTSTQG--FEEFKNEVMLTAKLQHVNLIR 524
LG G + Y+ + G ++AVK+++ +S Q E + E+ L A+L H ++IR
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
+LG + L E+M S+ L + ++ ++ ++ E + +GL YL E
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 583 SRLTIIHRDLKVSNILL-GEAMKPKISDFGMA-RIFAK-ESLEENTEQVVGTIGYIPPEY 639
IIHRD+K +N+L+ + +I+DFG A R+ AK E Q++GTI ++ PE
Sbjct: 123 Q---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699
Y DV+S G +++++ + K E S H ++K + S
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK----PPWNAEKHS--NHLALIFK-------IASA 226
Query: 700 LDDRNSPCKLMRCL-EIALLCVQENPNDRPSMLEV 733
+ P L L ++ L C++ P DRP E+
Sbjct: 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 80/275 (29%), Positives = 125/275 (45%), Gaps = 42/275 (15%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---EVMLTAKLQHVN 521
FS ++G G +G VY + EV+A+KK+S + Q E++++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
I+ G + L+ EY + D + K L + + G QGL YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY-- 639
++ +IHRD+K NILL E K+ DFG A I A + VGT ++ PE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVIL 184
Query: 640 -ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE----LWKGGKGVE 694
+G Y K DV+S G+ +++ +R L +N +S L H + + G E
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNA-MSALYHIAQNESPALQSGHWSE 241
Query: 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729
+ +F+D C+Q+ P DRP+
Sbjct: 242 YFRNFVDS----------------CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-17
Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 48/282 (17%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS---KTSTQGFEEFKNEVMLTAKLQHVN 521
F+ ++G G +G VY + EV+A+KK+S K S + +++ EV +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
I G + L+ EY + D + K L + I G QGL YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY-- 639
+ +IHRD+K NILL E + K++DFG A S+ VGT ++ PE
Sbjct: 144 H---NMIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 640 -ATKGVYSTKSDVFSFGVLLLQIISGK-------RLSMLCGINENLSILEHAYELWKGGK 691
+G Y K DV+S G+ +++ K +S L I +N S + E W
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE-WS--- 250
Query: 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
++ +F+D C+Q+ P DRP+ E+
Sbjct: 251 --DYFRNFVDS----------------CLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 52/215 (24%), Positives = 110/215 (51%), Gaps = 10/215 (4%)
Query: 452 RVYSLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNE 510
++ ++ I ++++ K+G+G G V+ + + G+ +A+K+++ E NE
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE 66
Query: 511 VMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIE 570
+++ +L++ N++ L + +E ++ EY+ SL D + + +D + +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG 630
Q L +L +IHRD+K N+LLG K++DFG E + +T +VG
Sbjct: 123 ECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 631 TIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
T ++ PE T+ Y K D++S G++ ++++ G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNL 522
+ + +G G VY + LP E +A+K+ L K T +E + EV ++ H N+
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNV 61
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
++ + +E L+ Y+ SL + + LD +++ + +GL YL
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK----ESLEENTEQVVGTIGYIPPE 638
+ IHRD+K NILLGE KI+DFG++ A T VGT ++ PE
Sbjct: 122 GQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT--FVGTPCWMAPE 176
Query: 639 YATKGV-YSTKSDVFSFGVLLLQIISGK 665
+ Y K+D++SFG+ +++ +G
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 53/215 (24%), Positives = 109/215 (50%), Gaps = 10/215 (4%)
Query: 452 RVYSLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNE 510
++ ++ + ++++ K+G+G G VY + + G+ +A+K+++ E NE
Sbjct: 7 KLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINE 66
Query: 511 VMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIE 570
+++ + +H N++ L + +E ++ EY+ SL D + + +D + +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG 630
Q L +L +IHRD+K NILLG K++DFG E + +T +VG
Sbjct: 123 ECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 631 TIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
T ++ PE T+ Y K D++S G++ ++++ G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 41/219 (18%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN-----EVMLTAKLQ 518
R+ KLGEG Y VYK G ++A+KK+ + ++ N E+ L +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 519 HVNLIRVLG-FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG------ 571
H N+I +L F S L++E+M + K+I D K + +
Sbjct: 61 HPNIIGLLDVFGHKSNIN-LVFEFMETD---------LEKVIKD--KSIVLTPADIKSYM 108
Query: 572 --ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
+GL YL I+HRDLK +N+L+ K++DFG+AR F + + T QVV
Sbjct: 109 LMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RKMTHQVV 164
Query: 630 GTIGYIPPEY---ATKGVYSTKSDVFSFGV----LLLQI 661
T Y PE A Y D++S G LLL++
Sbjct: 165 -TRWYRAPELLFGARH--YGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 57/204 (27%), Positives = 107/204 (52%), Gaps = 24/204 (11%)
Query: 472 LGEGGYGPVYKGV-LPCGEVI----AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRV 525
LG G +G V+KG+ +P G+ I A+K + ++ Q F+E + ++ L H ++R+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 526 LGFCIDSEERMLIYEYMPNKSLDCYL------FDPIRKLILDWKKRVHIIEGITQGLLYL 579
LG C + + L+ + P SL ++ DP + +L+W + I +G+ YL
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQ------IAKGMYYL 125
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
+E+ ++HR+L NILL +I+DFG+A + + + + I ++ E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 640 ATKGVYSTKSDVFSFGVLLLQIIS 663
G Y+ +SDV+S+GV + +++S
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 28/206 (13%)
Query: 472 LGEGGYGPVYKGV-LPCGEVI----AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRV 525
LG G +G VYKG+ +P GE + A+K+L + TS + +E +E + A + + ++ R+
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 526 LGFCIDSEERMLIYEYMPNKSLDCYLFDPIR--------KLILDWKKRVHIIEGITQGLL 577
LG C+ S + LI + MP C L D +R + +L+W + I +G+
Sbjct: 75 LGICLTSTVQ-LITQLMP---FGC-LLDYVREHKDNIGSQYLLNWCVQ------IAKGMN 123
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
YL+E ++HRDL N+L+ KI+DFG+A++ + E + E I ++
Sbjct: 124 YLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIIS 663
E +Y+ +SDV+S+GV + ++++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 78/230 (33%), Positives = 111/230 (48%), Gaps = 50/230 (21%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVML 513
++ I KLG+G YG V+K + EV+A+KK+ F+ F+N E+M
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59
Query: 514 TAKL-QHVNLIRVLGFCIDSEERMLIY---EYMPNKSLDCYLFDPIRKLILDWKKRVHII 569
+L H N++++L I +E IY EYM + L IR IL + VH
Sbjct: 60 LQELGDHPNIVKLLNV-IKAENDKDIYLVFEYM-----ETDLHAVIRANIL---EDVHKR 110
Query: 570 EGITQGLLYLQEY--SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627
+ Q LL +Y S +IHRDLK SNILL + K++DFG+AR + E E
Sbjct: 111 YIMYQ-LLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENP 167
Query: 628 V----VGTIGYIPPE------YATKGVYSTKSDVFSFGVLLLQIISGKRL 667
V V T Y PE TKGV D++S G +L +++ GK L
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLGKPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 5e-17
Identities = 53/215 (24%), Positives = 109/215 (50%), Gaps = 10/215 (4%)
Query: 452 RVYSLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNE 510
++ S+ + ++++ K+G+G G VY + + G+ +A+K+++ E NE
Sbjct: 7 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE 66
Query: 511 VMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIE 570
+++ + ++ N++ L + +E ++ EY+ SL D + + +D + +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG 630
Q L +L +IHRD+K NILLG K++DFG E + +T +VG
Sbjct: 123 ECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 631 TIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
T ++ PE T+ Y K D++S G++ ++++ G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 90/310 (29%), Positives = 144/310 (46%), Gaps = 69/310 (22%)
Query: 472 LGEGGYGPVYKGVLPCGEV---IAVKKLSKTSTQG-FEEFKNEVMLTAKL-QHVNLIRVL 526
+GEG +G V K + + A+K++ + +++ +F E+ + KL H N+I +L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 527 GFCIDSEERMLIY---EYMPNKSLDCYL-------FDPIRKL------ILDWKKRVHIIE 570
G C E R +Y EY P+ +L +L DP + L ++ +H
Sbjct: 75 GAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR---IFAKESLEENTEQ 627
+ +G+ YL S+ IHRDL NIL+GE KI+DFG++R ++ K+
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-------- 180
Query: 628 VVGTIGYIPP-----EYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN--ENLSIL 680
T+G +P E VY+T SDV+S+GVLL +I+S + CG+ E L
Sbjct: 181 ---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-TPYCGMTCAELYEKL 236
Query: 681 EHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS----MLEVSSM 736
Y L K L+ + LMR C +E P +RPS ++ ++ M
Sbjct: 237 PQGYRLEKP----------LNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNRM 280
Query: 737 LKNETTNINT 746
L+ T +NT
Sbjct: 281 LEERKTYVNT 290
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 66/203 (32%), Positives = 110/203 (54%), Gaps = 15/203 (7%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFK-NEVMLTAKLQHVNLIRVLGF 528
KLGEG Y VYKG GE++A+K++ + +G E+ L +L+H N++R L
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVR-LHD 65
Query: 529 CIDSEER-MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
I +E + ML++EYM +K L Y+ + LD + +G+ + E +
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---V 121
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT--EQVVGTIGYIPPEYATKG-V 644
+HRDLK N+L+ + + K++DFG+AR F + NT +VV T+ Y P+
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVLLGSRT 177
Query: 645 YSTKSDVFSFGVLLLQIISGKRL 667
YST D++S G ++ ++I+G+ L
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVN 521
E F+ ++G+G +G VYKG+ EV+A+K + + + E+ + E+ + ++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKS-LDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
+ R G + + +I EY+ S LD P+ + + I+ I +GL YL
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLH 118
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
+ IHRD+K +N+LL E K++DFG+A ++ NT VGT ++ PE
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGK 665
+ Y K+D++S G+ +++ G+
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 79/278 (28%), Positives = 121/278 (43%), Gaps = 48/278 (17%)
Query: 470 NKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---EVMLTAKLQHVNLIRV 525
+++G G +G VY EV+AVKK+S + Q E++++ EV +L+H N I
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 526 LGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL 585
G + L+ EY + D + K L + I G QGL YL ++
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY---ATK 642
+IHRD+K NILL E + K++DFG A S VGT ++ PE +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDE 194
Query: 643 GVYSTKSDVFSFGVLLLQIISGK-------RLSMLCGINENLSILEHAYELWKGGKGVEF 695
G Y K DV+S G+ +++ K +S L I +N S + E +G F
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG--F 252
Query: 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
VD C+Q+ P +RP+ E+
Sbjct: 253 VD--------------------YCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 85/300 (28%), Positives = 128/300 (42%), Gaps = 57/300 (19%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGV---LPCGE---VIAVKKLSKTSTQGFEEFKNEV-- 511
E +R ++ LGEG +G V K L +AVK L +T+ ++ + V
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSE 65
Query: 512 MLTAKL--QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-----------FDPIRKL 558
M K+ +H N+I +LG C ++ EY + +L +L D R
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 559 I--LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616
L K V + +G+ +L S+ IHRDL N+L+ E KI+DFG+AR
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLA--SK-KCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 617 AKESLEENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS--GKRLSM 669
T T G +P PE VY+ +SDV+SFGVLL +I + G S
Sbjct: 183 HHIDYYRKT-----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG---SP 234
Query: 670 LCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729
GI +E ++L K G +E +N +L + C E P+ RP+
Sbjct: 235 YPGIP-----VEELFKLLKEGYRME------KPQNCTQELYH---LMRDCWHEVPSQRPT 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-17
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 471 KLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI 530
+LG G +G V G +A+K + K + +EF E + KL H L+++ G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 531 DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 590
++ EYM N L YL + ++ + + + + + +G+ YL+ IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESKQ---FIHR 124
Query: 591 DLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT---IGYIPPEYATKGVYST 647
DL N L+ + K+SDFG++R L++ VG+ + + PPE +S+
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 648 KSDVFSFGVLLLQIIS-GK 665
KSDV++FGVL+ ++ S GK
Sbjct: 181 KSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 52/215 (24%), Positives = 107/215 (49%), Gaps = 10/215 (4%)
Query: 452 RVYSLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNE 510
++ S+ + ++++ K+G+G G VY + + G+ +A+++++ E NE
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 511 VMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIE 570
+++ + ++ N++ L + +E ++ EY+ SL D + + +D + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 123
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG 630
Q L +L +IHRD+K NILLG K++DFG E + +VG
Sbjct: 124 ECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVG 178
Query: 631 TIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
T ++ PE T+ Y K D++S G++ +++I G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 84/299 (28%), Positives = 127/299 (42%), Gaps = 58/299 (19%)
Query: 450 NLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS---KTSTQGFE 505
+ + L + + F+ ++G G +G VY + EV+A+KK+S K S + ++
Sbjct: 1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ 60
Query: 506 EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILD-WKK 564
+ EV +L+H N I G + L+ EY + D IL+ KK
Sbjct: 61 DIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASD----------ILEVHKK 110
Query: 565 RVH------IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618
+ I G QGL YL + R IHRD+K NILL E K++DFG A
Sbjct: 111 PLQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA----- 162
Query: 619 ESLEENTEQVVGTIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
SL VGT ++ PE +G Y K DV+S G+ +++ +R L +N
Sbjct: 163 -SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNA 219
Query: 676 NLSILEHAYE-----LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729
+S L H + L F + F+D C+Q+ P DRPS
Sbjct: 220 -MSALYHIAQNDSPTLSSNDWSDYFRN-FVD----------------SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKL---SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLG 527
LG G G V K +P G V+A K + +K+S + ++ E+ + + + ++ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSFYG 70
Query: 528 FCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL 585
++ + E+M SLD PI IL I + +GL YL Y+
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVH 123
Query: 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVY 645
I+HRD+K SNIL+ + K+ DFG++ E + + VGT Y+ PE G Y
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKY 179
Query: 646 STKSDVFSFGVLLLQIISGK 665
+ KSDV+S G+ ++++ GK
Sbjct: 180 TVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 471 KLGEGGYGPVYKGVLPC-------GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
K+GEG G V C G +AVK + Q E NEV++ QH N++
Sbjct: 28 KIGEGSTGIV------CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVV 81
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
+ + EE ++ E++ +L D + + L+ ++ + E + Q L YL
Sbjct: 82 EMYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG 137
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG 643
+IHRD+K +ILL + K+SDFG +K+ + + +VGT ++ PE ++
Sbjct: 138 ---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRT 192
Query: 644 VYSTKSDVFSFGVLLLQIISGK 665
Y T+ D++S G+++++++ G+
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 17/204 (8%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFK-NEVMLTAKLQHVNLIRVLG 527
K+GEG YG VYK GEV+A+KK+ T T+G E+ L +L H N++++L
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 528 FCIDSEERM-LIYEYMPNKSLDCYL-FDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL 585
I +E ++ L++E++ ++ L ++ P+ + L K + + QGL + +
Sbjct: 67 -VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSY--LFQLLQGLAFCHSHR-- 120
Query: 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE--YATKG 643
++HRDLK N+L+ K++DFG+AR F + T +VV T+ Y PE K
Sbjct: 121 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGCK- 176
Query: 644 VYSTKSDVFSFGVLLLQIISGKRL 667
YST D++S G + ++++ + L
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 73/301 (24%), Positives = 127/301 (42%), Gaps = 64/301 (21%)
Query: 466 FSIRNKLGEGGYGPVYK--------GVLPCGEV----IAVKKLSKTSTQGFEEFKNEV-M 512
+++ LG G +G VYK +L E+ A K + + + +EV +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 513 LTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVH----- 567
+ +L+H N++R ++++ ++ + + P+ + K++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGA--------PLGEHFNSLKEKKQRFTEE 113
Query: 568 ----IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623
I + L YL + R I+HRDL +NI+LGE K I+DFG+A+ ++ E
Sbjct: 114 RIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPES 168
Query: 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQII-------SGKRLSMLCGINEN 676
VVGTI Y PE Y K+DV++FG +L Q+ S LS+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA------ 222
Query: 677 LSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736
I+E YE G E V + + C+ + RP +++VS+M
Sbjct: 223 TKIVEAVYEPLPEGMYSEDV-TDVITS---------------CLTPDAEARPDIIQVSAM 266
Query: 737 L 737
+
Sbjct: 267 I 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 36/220 (16%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN--EVMLTAKLQ-HVNLIRVL 526
+LG+G +G VY GE++A+KK+ K +EE N EV KL H N++++
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 527 GFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV-------HIIEGITQGLLYL 579
+++E ++EYM + L+ +L+ D K + II I QGL ++
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLY----QLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN---TEQVVGTIGYIP 636
+ HRDLK N+L+ KI+DFG+AR + T+ V T Y
Sbjct: 116 H---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRA 166
Query: 637 PEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
PE + YS+ D+++ G ++ ++ + + L G +E
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPL--FPGSSE 204
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 63/222 (28%), Positives = 109/222 (49%), Gaps = 21/222 (9%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFE-EFKNEVMLTAK 516
+ ++F I ++GEG YG VYK GE++A+KK+ +GF E+ + +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 517 LQHVNLIRVLGFCIDSEERM----------LIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
L H N++ + D ++ + L++EYM D L + ++ + +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSED- 116
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
HI + Q L L + +HRD+K SNILL + K++DFG+AR++ E T
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 627 QVVGTIGYIPPEYAT-KGVYSTKSDVFSFGVLLLQIISGKRL 667
+V+ T+ Y PPE + Y DV+S G +L ++ + K +
Sbjct: 177 KVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 472 LGEGGYGPVYKGVL--PCGEVI--AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVL 526
+G+G +G VY G L G+ I AVK L++ T + E+F E ++ H N++ +L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 527 GFCIDSE-ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL 585
G C+ SE +++ YM + L ++ + K + + +G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASKK-- 118
Query: 586 TIIHRDLKVSNILLGEAMKPKISDFGMAR-IFAKESLE-ENTEQVVGTIGYIPPEYATKG 643
+HRDL N +L E+ K++DFG+AR I+ KE N + ++ E
Sbjct: 119 -FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 644 VYSTKSDVFSFGVLLLQIIS 663
++TKSDV+SFGVLL ++++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 465 RFSIRNKLGEGGYGPVYK-GVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAK----LQH 519
R+ I ++GEG +G V+K GE +A+KK+ + N+ + K QH
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQH 58
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
++++L +L+ EYMP+ L L D R L K + + +G+ Y+
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYM 115
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE- 638
I+HRDLK +N+L+ KI+DFG+AR+F++E + Q V T Y PE
Sbjct: 116 HA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPEL 171
Query: 639 -YATKGVYSTKSDVFSFGVLLLQIISG 664
Y + Y D+++ G + ++++G
Sbjct: 172 LYGARK-YDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 38/280 (13%)
Query: 471 KLGEGGYGPVYKGVL---PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAK-LQHVN---LI 523
+LG G +G V KG+ + +AVK L + K+E++ A +Q ++ ++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
R++G C ++E ML+ E L+ +L K + + K ++ ++ G+ YL+E +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFLQK--NKHVTE-KNITELVHQVSMGMKYLEETN 115
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT----IGYIPPEY 639
+HRDL N+LL KISDFG+++ +EN + + + PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKAL---GADENYYKAKTHGKWPVKWYAPEC 169
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699
+S+KSDV+SFGVL+ E S + Y+ KG + + ++S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMW---------------EAFSYGQKPYKGMKGNEVTQMIESG 214
Query: 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
++ LC ++RP V L+N
Sbjct: 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-16
Identities = 53/204 (25%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVN 521
E F+ ++G+G +G V+KG+ +V+A+K + + + E+ + E+ + ++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
+ + G + + +I EY+ S D +R D + +++ I +GL YL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT 641
+ IHRD+K +N+LL E K++DFG+A ++ NT VGT ++ PE
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 642 KGVYSTKSDVFSFGVLLLQIISGK 665
+ Y +K+D++S G+ +++ G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 471 KLGEGGYGPVYKGVLPCGEV-IAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGF 528
++G G +G V+ G L +AVK +T + +F E + + H N++R++G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 529 CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTII 588
C + ++ E + +L +L + K+ + ++E G+ YL+ I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV--KELIQMVENAAAGMEYLESKH---CI 116
Query: 589 HRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PEYATKG 643
HRDL N L+ E KISDFGM+R E+ G + IP PE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 644 VYSTKSDVFSFGVLLLQIIS 663
YS++SDV+SFG+LL + S
Sbjct: 172 RYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 59/222 (26%), Positives = 84/222 (37%), Gaps = 47/222 (21%)
Query: 466 FSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQH-- 519
F + +G+G +G V ++ A+K ++K NE + +L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 520 -VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG------- 571
VNL F D E + YL + L+L R H+ +
Sbjct: 62 LVNLWY--SFQ-DEE--------------NMYL---VVDLLLGGDLRYHLSQKVKFSEEQ 101
Query: 572 -------ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
I L YL IIHRD+K NILL E I+DF +A +
Sbjct: 102 VKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTL 155
Query: 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
T GT GY+ PE + YS D +S GV + + GKR
Sbjct: 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVN 521
R+ + +GEG YG V P G +A+KK+S Q F + E+ + + +H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 522 LIRVLGF-CIDSEERM----LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHI---IEGIT 573
+I +L S E ++ E M D Y + L D HI + I
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSND-----HIQYFLYQIL 116
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV---VG 630
+GL Y+ + ++HRDLK SN+LL KI DFG+ARI E ++T + V
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH--DHTGFLTEYVA 171
Query: 631 TIGYIPPE--YATKGVYSTKSDVFSFGVLLLQIISGKRL 667
T Y PE +KG Y+ D++S G +L +++S + L
Sbjct: 172 TRWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 475 GGYGPVY---KGVLPCGEVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQHVNLIRVLGF 528
G YG V+ K G++ A+K + K ++ E + ++ Q +++ L +
Sbjct: 4 GAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK-LYY 60
Query: 529 CIDSEERM-LIYEYMPNKSLDCY-LFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLT 586
++ + L+ EY+P D L + + L D + I I L YL
Sbjct: 61 SFQGKKNLYLVMEYLPGG--DLASLLENVGSLDEDVAR--IYIAEIVLALEYLH---SNG 113
Query: 587 IIHRDLKVSNILLGEAMKPKISDFG------MARIFAKESLEENTEQVVGTIGYIPPEYA 640
IIHRDLK NIL+ K++DFG + R E+ +++VGT YI PE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 641 TKGVYSTKSDVFSFGVLLLQIISG 664
+S D +S G +L + + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 54/204 (26%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVN 521
E F+ K+G+G +G V+KG+ +V+A+K + + + E+ + E+ + ++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
+ + G + + +I EY+ S D + LD + I+ I +GL YL
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT 641
+ IHRD+K +N+LL E + K++DFG+A ++ N VGT ++ PE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIK 174
Query: 642 KGVYSTKSDVFSFGVLLLQIISGK 665
+ Y +K+D++S G+ +++ G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 472 LGEGGYGPVYKGVLPC--------GEVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNL 522
LGEG +G V L C GE++AVK L + Q +K E+ + L H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 523 IRVLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL- 579
++ G C + + LI EY+P SL YL P KL L + + + I +G+ YL
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNL--AQLLLFAQQICEGMAYLH 124
Query: 580 -QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL----EENTEQVVGTIGY 634
Q Y IHRDL N+LL KI DFG+A+ + E+ + V +
Sbjct: 125 SQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FW 176
Query: 635 IPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
E + +S SDV+SFGV L ++++
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 59/251 (23%), Positives = 108/251 (43%), Gaps = 40/251 (15%)
Query: 496 LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI 555
L++ S + + NE+++ + LQH N+I +D ++ EY +L +D I
Sbjct: 35 LTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL----YDKI 90
Query: 556 ---RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612
+ + + + + + I + Y+ + I+HRD+K NI L +A K+ DFG+
Sbjct: 91 VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGI 147
Query: 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR------ 666
++I E E VVGT Y+ PE Y+ KSD+++ G +L ++++ KR
Sbjct: 148 SKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205
Query: 667 LSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPND 726
L + I++ Y E + L+ +Q++P
Sbjct: 206 PLNLV-----VKIVQGNYTPVVSVYSSELI-----------SLVHS------LLQQDPEK 243
Query: 727 RPSMLEVSSML 737
RP+ EV
Sbjct: 244 RPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 46/229 (20%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEV---IAVKKLSKTSTQG-FEEFKNEVMLTAKL-Q 518
E + +GEG +G V + ++ + A+K L + +++ +F E+ + KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 519 HVNLIRVLGFCIDSEERMLIY---EYMPNKSLDCYL-------FDPI------RKLILDW 562
H N+I +LG C E R +Y EY P +L +L DP L
Sbjct: 62 HPNIINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 563 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR---IFAKE 619
++ + + G+ YL E IHRDL N+L+GE + KI+DFG++R ++ K+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 620 SLEENTEQVVGTIGYIPP-----EYATKGVYSTKSDVFSFGVLLLQIIS 663
T+G +P E VY+TKSDV+SFGVLL +I+S
Sbjct: 176 -----------TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 41/200 (20%)
Query: 465 RFSIRNKLGEGGYGPVYKGVL---PCGEVIAVKKL--SKTSTQGFEEFK-NEVMLTAKLQ 518
++ I +G G YG VYK G+ A+KK K G + E+ L +L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 519 HVNLIRVLGFCIDSEERM--LIYEYMPNKSLDCYLFDPIRKLILDW---KKRVHIIEG-- 571
H N++ ++ ++ ++ L+++Y + I+ + KRV I
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQ----------IIKFHRQAKRVSIPPSMV 110
Query: 572 ------ITQGLLYLQEYSRLTIIHRDLKVSNILL-GEAM---KPKISDFGMARIFA---K 618
I G+ YL ++HRDLK +NIL+ GE KI D G+AR+F K
Sbjct: 111 KSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 619 ESLEENTEQVVGTIGYIPPE 638
+ + VV TI Y PE
Sbjct: 168 PLADLD--PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 19/197 (9%)
Query: 470 NKLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFK-NEVMLTAKLQ---HVNLI 523
++GEG YG VYK L G +A+KK+ S +G E+ L +L+ H N++
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 524 RVLGFC--IDSEERM---LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
R+L C ++ + L++E++ ++ L YL K L + ++ + +G+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
L + I+HRDLK NIL+ + KI+DFG+ARI++ E T VV T+ Y PE
Sbjct: 123 LHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVV-TLWYRAPE 176
Query: 639 YATKGVYSTKSDVFSFG 655
+ Y+T D++S G
Sbjct: 177 VLLQSSYATPVDMWSVG 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 40/218 (18%)
Query: 472 LGEGGYGPVYKGVLPCGEV---IAVKKLSKTSTQG-FEEFKNEVMLTAKL-QHVNLIRVL 526
+GEG +G V K + + A+K++ + +++ +F E+ + KL H N+I +L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 527 GFCIDSEERMLIYEYMPNKSLDCYL-------FDPI------RKLILDWKKRVHIIEGIT 573
G C L EY P+ +L +L DP L ++ +H +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR---IFAKESLEENTEQVVG 630
+G+ YL + IHRDL NIL+GE KI+DFG++R ++ K+
Sbjct: 123 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK----------- 168
Query: 631 TIGYIPP-----EYATKGVYSTKSDVFSFGVLLLQIIS 663
T+G +P E VY+T SDV+S+GVLL +I+S
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 464 ERFSIRNKLGEGGYGPVYKG-VLPCGEVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQ 518
++ + +GEG YG V K GE++A+KK K S + E+ K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLR 58
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL------FDP--IRKLILDWKKRVHIIE 570
H N++ + L++EY+ L+ L P +R I W+
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYI--WQ------- 108
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG 630
+ Q + Y IIHRD+K NIL+ E+ K+ DFG AR T+ V
Sbjct: 109 -LLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA- 163
Query: 631 TIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRL 667
T Y PE Y DV++ G ++ +++ G+ L
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 58/202 (28%), Positives = 108/202 (53%), Gaps = 20/202 (9%)
Query: 472 LGEGGYGPVYKGV-LPCGEVI----AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRV 525
LG G +G VYKG+ +P GE + A+K L + TS + +E +E + A + + R+
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 526 LGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKL----ILDWKKRVHIIEGITQGLLYLQE 581
LG C+ S + L+ + MP L Y+ + ++ +L+W + I +G+ YL+E
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT 641
+ ++HRDL N+L+ KI+DFG+AR+ + E + + I ++ E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 642 KGVYSTKSDVFSFGVLLLQIIS 663
++ +SDV+S+GV + ++++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 471 KLGEGGYGPVYKGVLP-CGEVIAVKKLS-KTSTQGFE-EFKNEVMLTAKLQ---HVNLIR 524
++G G YG VYK P G +A+K + +T+ G EV L +L+ H N++R
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 525 VLGFC----IDSEERM-LIYEYMPNKSLDCYLFD-PIRKLILDWKKRVHIIEGITQGLLY 578
++ C D E ++ L++E++ ++ L YL P L + K ++ +GL +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDF 123
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
L I+HRDLK NIL+ + K++DFG+ARI+ S + VV T+ Y PE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPE 177
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
+ Y+T D++S G + ++ +R + CG +E
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 472 LGEGGYGPVYK-GVLPCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLG 527
LG+GG+G V V G++ A KKL K +G + NE + K+ I L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 528 FCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLT 586
+ ++++ + L+ M L ++++ + + + + I GL +L +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLH---QRR 115
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYS 646
I++RDLK N+LL + +ISD G+A + GT GY+ PE VY
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYD 172
Query: 647 TKSDVFSFGVLLLQIISGK 665
D F+ G L ++I+G+
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 464 ERFSIRNKLGEGGYGPVYKG-VLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
K+GEG G V G +AVKK+ Q E NEV++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
+ + + +E ++ E++ +L D + ++ ++ + + + L +L
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK 642
+IHRD+K +ILL + K+SDFG +KE + +VGT ++ PE ++
Sbjct: 135 G---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISR 189
Query: 643 GVYSTKSDVFSFGVLLLQIISGK 665
Y T+ D++S G+++++++ G+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 471 KLGEGGYGPV-YKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFC 529
K+GEG G V V G+++AVKK+ Q E NEV++ QH N++ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 530 IDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 589
+ +E ++ E++ +L D + ++ ++ + + + L L +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 590 RDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKS 649
RD+K +ILL + K+SDFG +KE + +VGT ++ PE ++ Y +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 650 DVFSFGVLLLQIISGK 665
D++S G+++++++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 460 EAATERFSIRNKLGEGGYGPVYK----GVLPCGEVI--AVKKLSKTSTQGFEE-FKNEVM 512
E S LG G +G V + G+ V+ AVK L T+ E +E+
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 513 LTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCY--LFDPIRK---LILDWKKRV 566
+ + L H N++ +LG C ++I EY CY L + +R+ L + +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYC------CYGDLLNFLRRKRESFLTLEDLL 144
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
+ +G+ +L + IHRDL N+LL KI DFG+AR + + ++
Sbjct: 145 SFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNY 197
Query: 627 QVVGT----IGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
V G + ++ PE VY+ +SDV+S+G+LL +I S
Sbjct: 198 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 50/228 (21%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN--------EVMLT 514
+ + N++ EG YG VY+ GE++A+KKL E+ K E+ +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK------MEKEKEGFPITSLREINIL 58
Query: 515 AKLQHVNLIR----VLGFCIDSEERMLIY---EYMPN--KSL-----DCYLFDPIRKLIL 560
KLQH N++ V+G +D IY EY+ + KSL +L ++ L+L
Sbjct: 59 LKLQHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML 113
Query: 561 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620
++ G+ +L + I+HRDLK SN+LL KI DFG+AR +
Sbjct: 114 ------QLLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SP 159
Query: 621 LEENTEQVVGTIGYIPPE-YATKGVYSTKSDVFSFGVLLLQIISGKRL 667
L+ T+ VV T+ Y PE YST D++S G + ++++ K L
Sbjct: 160 LKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|119349 cd00598, GH18_chitinase-like, The GH18 (glycosyl hydrolase, family 18) type II chitinases hydrolyze chitin, an abundant polymer of beta-1,4-linked N-acetylglucosamine (GlcNAc) which is a major component of the cell wall of fungi and the exoskeleton of arthropods | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 42/192 (21%), Positives = 77/192 (40%), Gaps = 29/192 (15%)
Query: 29 VGYLNLSEVSTISG---INYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKK 85
+ Y + I L TH+I + A+I+S S+E +
Sbjct: 2 ICYYDGWSSGRGPDPTDIPLSLCTHIIYAFAEISSDGSLNLFGDKSEEPLKGALE-ELAS 60
Query: 86 KNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT 145
K P + ++SIG S ++ + + R +F +S + + YGF G+D W P
Sbjct: 61 KKPGLKVLISIGGW---TDSSPFTLASDPASRAAFANSLVSFLKTYGFDGVDIDWEYPGA 117
Query: 146 S--TDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPAN------SYLLNS 197
+ +D N L E R + L A N +LT + PA+ +Y + +
Sbjct: 118 ADNSDRENFITLLRELR---SALGAAN-------YLLTI----AVPASYFDLGYAYDVPA 163
Query: 198 IQRNLNWIHAVT 209
I +++++ +T
Sbjct: 164 IGDYVDFVNVMT 175
|
Chitinases have been identified in viruses, bacteria, fungi, protozoan parasites, insects, and plants. The structure of the GH18 domain is an eight-stranded beta/alpha barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. The GH18 family includes chitotriosidase, chitobiase, hevamine, zymocin-alpha, narbonin, SI-CLP (stabilin-1 interacting chitinase-like protein), IDGF (imaginal disc growth factor), CFLE (cortical fragment-lytic enzyme) spore hydrolase, the type III and type V plant chitinases, the endo-beta-N-acetylglucosaminidases, and the chitolectins. The GH85 (glycosyl hydrolase, family 85) ENGases (endo-beta-N-acetylglucosaminidases) are closely related to the GH18 chitinases and are included in this alignment model. Length = 210 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 459 IEAATERFSIRNKLGEGGYGPVYKGV--LPCGEVIAVK-KLSKTSTQG--FEEFKNEVML 513
E E ++ +GEG +G VY+GV P E IAV K K T E+F E +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 514 TAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGIT 573
+ H ++++++G + ++ E P L YL + K LD + ++
Sbjct: 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLS 117
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT-- 631
L YL+ +HRD+ N+L+ K+ DFG++R ES + + G
Sbjct: 118 TALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS---KGKLP 171
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
I ++ PE +++ SDV+ FGV + +I+
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTSTQGFEE-----FKNEVMLT 514
+R ++ + L EG +G ++ G+L P E KT E E L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEV---FVKTVKDHASEIQVTLLLQESCLL 62
Query: 515 AKLQHVNLIRVLGFCI-DSEERMLIYEYMPNKSLDCYLFDPIRKLI-------LDWKKRV 566
L H N++ +L CI D E ++Y YM +L +L +L L ++ V
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC--RLGEANNPQALSTQQLV 120
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR-IFAKE--SLEE 623
H+ I G+ YL + +IH+D+ N ++ E ++ KI+D ++R +F + L +
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
N + + ++ E YS+ SDV+SFGVLL ++++
Sbjct: 178 NENR---PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 12/202 (5%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLSKTST-QGFEEFK-NEVMLTAKLQHVNLIRVLG 527
K+GEG YG VYKG G+++A+KK+ S +G E+ L +LQH N++ +
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKL-ILDWKKRVHIIEGITQGLLYLQEYSRLT 586
+ LI+E++ + L YL D + K +D + + I QG+L+ +SR
Sbjct: 67 VLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC--HSR-R 121
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV-Y 645
++HRDLK N+L+ K++DFG+AR F + T +VV T+ Y PE Y
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLLGSPRY 179
Query: 646 STKSDVFSFGVLLLQIISGKRL 667
ST D++S G + ++ + K L
Sbjct: 180 STPVDIWSIGTIFAEMATKKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 60/218 (27%), Positives = 109/218 (50%), Gaps = 38/218 (17%)
Query: 471 KLGEGGYGPVYKG--VLPCGEVIAVKKLS-KTSTQGFE-EFKNEVMLTAKLQ---HVNLI 523
++GEG YG V+K + G +A+K++ +T +G EV + L+ H N++
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 524 RVLGFCI----DSEERM-LIYEYMPNKSLDCYLF---DP------IRKLILDWKKRVHII 569
R+ C D E ++ L++E++ ++ L YL +P I+ ++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-------- 118
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
+ +GL +L + ++HRDLK NIL+ + + K++DFG+ARI+ S + VV
Sbjct: 119 --LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 170
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
T+ Y PE + Y+T D++S G + ++ K L
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 470 NKLGEGGYGPVYKGVLPCGE-VIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLG 527
+KLGEG Y VYKG + ++A+K++ +G EV L L+H N++ +
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
+ L++EY+ +K L YL D I ++ + + + +GL Y R +
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQ-LLRGLNYCH---RRKV 125
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV-YS 646
+HRDLK N+L+ E + K++DFG+AR AK + V T+ Y PP+ YS
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 647 TKSDVFSFGVLLLQIISGKRL 667
T+ D++ G + ++ +G+ L
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 19/201 (9%)
Query: 472 LGEGGYGPVYK-GVLPCGEVIAVKKLSKTS--TQGFEE-FKNEVMLTAKLQHVNLIRVLG 527
LG GG+G V V A+K + K G +E +E + + H ++++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKL-ILDWKKRVHIIEGITQGLLYLQEYSRLT 586
D + ++ EY L + +R + D I + YL
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYL---HNRG 113
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKE-SLEENTEQVVGTIGYIPPEY-ATKGV 644
II+RDLK N+LL K+ DFG FAK+ + T GT Y+ PE KG
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFG----FAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168
Query: 645 YSTKSDVFSFGVLLLQIISGK 665
Y D +S G+LL ++++G+
Sbjct: 169 YDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 19/205 (9%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFK-NEVMLTAKLQHVNLIRVLG 527
K+GEG YG VYK GE++A+KK+ +T +G E+ L +L H N++R+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 528 FCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILD---WKKRVHIIEGITQGLLYLQEYS 583
+ SE ++ L++E++ + L Y+ D LD K ++ + QG+ Y +S
Sbjct: 66 V-VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLY---QLLQGIAYC--HS 117
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG 643
++HRDLK N+L+ K++DFG+AR F + T +VV T+ Y PE
Sbjct: 118 H-RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGS 174
Query: 644 -VYSTKSDVFSFGVLLLQIISGKRL 667
YST D++S G + ++++ + L
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 470 NKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLG 527
N++G G G VYK + P G + A+K + + E+ + + H N+++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
+ E ++ E+M SL+ I D + + I G+ YL R I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAYLH---RRHI 189
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA----TKG 643
+HRD+K SN+L+ A KI+DFG++RI A+ N+ VGTI Y+ PE G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLNHG 247
Query: 644 VYSTKS-DVFSFGVLLLQIISGK 665
Y + D++S GV +L+ G+
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 470 NKLGEGGYGPVYKGVLPCGE-VIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLG 527
KLGEG Y V+KG E ++A+K++ +G EV L L+H N++ +
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
+ L++EY+ +K L Y+ D ++ ++ + + I +GL Y R +
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQ-ILRGLAYCH---RRKV 125
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT-KGVYS 646
+HRDLK N+L+ E + K++DFG+AR AK + V T+ Y PP+ YS
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 647 TKSDVFSFGVLLLQIISGKRL 667
T+ D++ G + ++ SG+ L
Sbjct: 184 TQIDMWGVGCIFFEMASGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 55/198 (27%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 472 LGEGGYGPVYK-GVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN--LIRVLGF 528
LG+GG+G V V G++ A KKL K + K ++ L+ VN I L +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 529 CIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
+S+ + L+ M L ++++ + + L+ ++ +H IT G+L+L + I
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYST 647
++RD+K N+LL + ++SD G+A + K+ + Q GT GY+ PE + YS
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA-VELKDG--KTITQRAGTNGYMAPEILKEEPYSY 173
Query: 648 KSDVFSFGVLLLQIISGK 665
D F+ G + ++++G+
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 52/196 (26%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 471 KLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFC 529
K+GEG G V G+ +AVKK+ Q E NEV++ H N++ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 530 IDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 589
+ +E ++ E++ +L D + ++ ++ + + + L YL +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 590 RDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKS 649
RD+K +ILL + K+SDFG +KE + + +VGT ++ PE ++ Y T+
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSLVGTPYWMAPEVISRLPYGTEV 199
Query: 650 DVFSFGVLLLQIISGK 665
D++S G++++++I G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 464 ERF--SIRNKLGEGGYGPV----YKGVLP----CGEVIAVKKLS-KTSTQGFEEFKNEVM 512
+RF IR+ LGEG +G V Y P GE +AVK L ++ + K E+
Sbjct: 3 KRFLKRIRD-LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 58
Query: 513 LTAKLQHVNLIRVLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIE 570
+ L H N+++ G C + LI E++P+ SL YL P K ++ K+++
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAV 116
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV- 629
I +G+ YL SR +HRDL N+L+ + KI DFG+ + ++E + E
Sbjct: 117 QICKGMDYLG--SR-QYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEYYTV 168
Query: 630 -----GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
+ + PE + + SDV+SFGV L ++++
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 78/288 (27%), Positives = 120/288 (41%), Gaps = 49/288 (17%)
Query: 465 RFSIRNKLGEGGYGPVY--KGVLPCGE-VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
R+ I K+GEG +G +Y K VI L+K + E K EV+L AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSL-------DCYLFDPIRKLILDWKKRVHIIEGITQ 574
++ ++ ++ EY L LF IL W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS--EDQILSWFVQ------ISL 112
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFGMARIFAKESLEENTEQVVGTIG 633
GL ++ + I+HRD+K NI L + M K+ DFG+AR E VGT
Sbjct: 113 GLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--ELAYTCVGTPY 167
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693
Y+ PE Y+ K+D++S G +L + L L+H +E G
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYE----------------LCTLKHPFE---GNNLH 208
Query: 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQ---ENPNDRPSMLEVSSMLK 738
+ V +P ++ L Q +P DRPS ++S+LK
Sbjct: 209 QLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPS---ITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKK-----LSKTSTQGFEEFKNEVMLTAKLQHVNLIRV 525
LG+G +G VY + G +AVK+ S + + + E+ L LQH +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 526 LGFCIDSEERMLIY-EYMPNKSLDCYL--FDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
G C+ +E + I+ EYMP S+ L + + + + R I +G+ YL
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH-- 121
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMA-RIFAKESLEENTEQVVGTIGYIPPEYAT 641
I+HRD+K +NIL A K+ DFG + R+ S + V GT ++ PE +
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 642 KGVYSTKSDVFSFGVLLLQIISGK 665
Y K+DV+S G ++++++ K
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 26/230 (11%)
Query: 457 ADIEAATERFSIRNKLGEGGYGPVYK----GVLPCGE----VIAVKKLSKTST-QGFEEF 507
E +R + LGEG +G V + G+ +AVK L +T + +
Sbjct: 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL 64
Query: 508 KNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-----------FDPI 555
+E+ L + +H N+I +LG C +I EY +L +L FD
Sbjct: 65 ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124
Query: 556 R--KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613
+ + L +K V + +G+ YL+ SR IHRDL N+L+ E KI+DFG+A
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
R + T + ++ PE VY+ +SDV+SFG+L+ +I +
Sbjct: 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 66/283 (23%), Positives = 123/283 (43%), Gaps = 40/283 (14%)
Query: 467 SIRNKLGEGGYGPVYKGVL--PCGE--VIAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVN 521
I LG G +G + +G L P +A+ L + S + F E + + H N
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
++R+ G M++ EYM N +LD +L +L+ + + ++ G+ G+ YL E
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA--GQLMGMLPGLASGMKYLSE 125
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG------YI 635
+ +H+ L +L+ + KIS F + E+ +E + T+ +
Sbjct: 126 ---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSEAIYTTMSGKSPVLWA 175
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVE 694
PE +S+ SDV+SFG+++ +++S G+R + + +E + L
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA------ 229
Query: 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737
RN P L + + L C Q+ +RP ++ S+L
Sbjct: 230 -------PRNCPNLLHQLM---LDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 469 RNKLGEGGYGPVYKG-VLPCGEVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVL 526
+ LG G G VYK L ++AVK + T + + +E+ + K +I
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 527 G-FCIDSEERMLI-YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGIT----QGLLYLQ 580
G F + E R+ I E+M SLD Y K H++ I +GL YL
Sbjct: 66 GAFFV--ENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLW 112
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
L I+HRD+K SN+L+ + K+ DFG++ + + + VGT Y+ PE
Sbjct: 113 S---LKILHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERI 165
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGK 665
+ Y SDV+S G+ +++ G+
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 68/229 (29%), Positives = 106/229 (46%), Gaps = 64/229 (27%)
Query: 470 NKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN--------EVMLTAKLQHV 520
N++GEG YG VY+ GE++A+KK+ + ++ E+ L L+H
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVR------MDNERDGIPISSLREITLLLNLRHP 66
Query: 521 NLIR----VLGFCIDSEERMLIYEY-----------MPN----KSLDCYLFDPIRKLILD 561
N++ V+G +DS L+ EY MP + C + +R
Sbjct: 67 NIVELKEVVVGKHLDS--IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLR----- 119
Query: 562 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621
GL YL E IIHRDLKVSN+LL + KI+DFG+AR + +
Sbjct: 120 -------------GLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA- 162
Query: 622 EENTEQVVGTIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGKRL 667
+ T +VV T+ Y PE T Y+T D+++ G +L ++++ K L
Sbjct: 163 KPMTPKVV-TLWYRAPELLLGCTT--YTTAIDMWAVGCILAELLAHKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 55/205 (26%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
E F + ++G G YG VYK + GE+ A+K + + F + E+++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSL-DCY-LFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
+ G + ++ + E+ SL D Y + P+ + + + R + QGL YL
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGM-ARIFAKESLEENTEQVVGTIGYIPPEY 639
+ +HRD+K +NILL + K++DFG+ A+I A + + +GT ++ PE
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIA---KRKSFIGTPYWMAPEV 177
Query: 640 AT---KGVYSTKSDVFSFGVLLLQI 661
A KG Y+ D+++ G+ +++
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS---KTSTQGFEEFKNEVMLTAKLQHVN 521
F I K+G G + VY+ L + +A+KK+ + ++ E+ L +L H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLILD---WKKRVHIIEGITQGL 576
+I+ L I+ E ++ E L + F ++LI + WK V + +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH-- 121
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
+SR ++HRD+K +N+ + K+ D G+ R F+ ++ ++ +VGT Y+
Sbjct: 122 ----MHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174
Query: 637 PEYATKGVYSTKSDVFSFGVLLLQI 661
PE + Y+ KSD++S G LL ++
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFK-NEVMLTAKLQHVNLIRVLG 527
K+GEG YG V+K E++A+K++ +G E+ L +L+H N++R+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGIT----QGLLYLQEYS 583
++ L++EY ++ L Y FD I I++ +GL + ++
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-----DPEIVKSFMFQLLKGLAFCHSHN 119
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE--YAT 641
++HRDLK N+L+ + + K++DFG+AR F + E V T+ Y PP+ +
Sbjct: 120 ---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGA 174
Query: 642 KGVYSTKSDVFSFGVLLLQIISGKR 666
K YST D++S G + ++ + R
Sbjct: 175 KL-YSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 30/223 (13%)
Query: 462 ATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QH 519
T F + +GEG YG VYK G+++A+K + + EE K E + K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNH 62
Query: 520 VNLIRVLGF------CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV------H 567
N+ G + ++ L+ E S+ D ++ L KR+ +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT----DLVKGL-RKKGKRLKEEWIAY 117
Query: 568 IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627
I+ +GL YL E +IHRD+K NILL + + K+ DFG++ NT
Sbjct: 118 ILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-- 172
Query: 628 VVGTIGYIPPE-----YATKGVYSTKSDVFSFGVLLLQIISGK 665
+GT ++ PE Y +SDV+S G+ +++ GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 31/283 (10%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS---KTSTQGFEEFKNEVMLTAKLQHVN 521
F I K+G G + VY+ L G +A+KK+ + + E+ L +L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLILD---WKKRVHIIEGITQGL 576
+I+ I+ E ++ E L + F ++LI + WK V +
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA----- 118
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
L+ ++HRD+K +N+ + K+ D G+ R F+ ++ ++ +VGT Y+
Sbjct: 119 --LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174
Query: 637 PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696
PE + Y+ KSD++S G LL ++ + + S G NL Y L K + ++
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNL------YSLCKKIEQCDYP 226
Query: 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
D + + ++ +C+ +P RP + V + K
Sbjct: 227 PLPSDHYSEELR-----QLVNMCINPDPEKRPDITYVYDVAKR 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 61/286 (21%)
Query: 462 ATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKK-LSKTSTQGFE-EFKNEVMLTAKLQ 518
+ I KLGEG +G VYK + G V+A+KK L GF E+ + KL+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 519 HVNLIRVLGFCID-----SEERMLIYEYMP--NKSLDCYLFDPIRKLILDWKKRVH---- 567
H N++ ++ ++ +R +Y P + L L +P V
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP----------SVKLTES 115
Query: 568 ----IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF------- 616
+ + +G+ YL E I+HRD+K +NIL+ KI+DFG+AR +
Sbjct: 116 QIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 617 ---AKESLEENTEQVVGTIGYIPPEY-ATKGVYSTKSDVFSFGVLLLQIISGK------- 665
+ T VV T Y PPE + Y+T D++ G + ++ + +
Sbjct: 173 KGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231
Query: 666 ---RLSM---LCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNS 705
+L + LCG + E + W+ G E V SF + +
Sbjct: 232 DIDQLHLIFKLCG-----TPTEETWPGWRSLPGCEGVHSFTNYPRT 272
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 470 NKLGEGGYGPVYKGVLPCGEVIA---VKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRV 525
+++G G +G V G G A VK+L ++T F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 526 LGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV--HIIEGITQGLLYLQEYS 583
LG CI+S +L+ E+ P L YL + +K V + + GLL+L
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT-- 641
+ IH DL + N L + KI D+G+A E + + ++ PE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 642 ----KGVYSTK-SDVFSFGVLLLQI 661
TK S+++S GV + ++
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 64/289 (22%)
Query: 471 KLGEGGYGPVYKGVL----PCGEVIAVKKL--SKTSTQGFEEFKNEVMLTAKLQHVNLIR 524
K+GEG +G K +L G+ +K++ SK S + EE + EV + + ++H N+++
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKL------------ILDWKKRVHIIEGI 572
+ EE +Y M C D +K+ ILDW
Sbjct: 64 ---YQESFEENGNLYIVMDY----CEGGDLYKKINAQRGVLFPEDQILDW---------F 107
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
Q L L+ I+HRD+K NI L + K+ DFG+AR+ S E +GT
Sbjct: 108 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTP 165
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692
Y+ PE Y+ KSD+++ G +L ++ + L+HA+E G
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCT----------------LKHAFE---AGNM 206
Query: 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQ---ENPNDRPSMLEVSSMLK 738
V + P ++ L Q NP DRPS V+S+L+
Sbjct: 207 KNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPS---VNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIR 524
+ + ++G G YG VYK L GE+ AVK + F + E+ + + +H N++
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 525 VLGFCIDSEERMLIYEYMPNKSL-DCY-LFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
G + E+ + EY SL D Y + P+ +L + + R + QGL YL
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSK 125
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGM-ARIFAKESLEENTEQVVGTIGYIPPEYAT 641
++ HRD+K +NILL + K++DFG+ A+I A + + +GT ++ PE A
Sbjct: 126 GKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIA---KRKSFIGTPYWMAPEVAA 179
Query: 642 ---KGVYSTKSDVFSFGVLLLQI 661
G Y+ D+++ G+ +++
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 65/232 (28%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 465 RFSIRNKLGEGGYGPVY-----KGV----LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTA 515
R+ ++ +LG+G +G VY K V L + I V +L+ T + E L +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLS 57
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKK--RVHIIEGIT 573
KL H +++ ++ + +I EY + LDC + +L K + E
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC----KLEELKHTGKTLSENQVCEWFI 113
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633
Q LL + + I+HRDLK NI L + KI DFG++R+ T GT
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT--FTGTPY 170
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685
Y+ PE Y +KSD++S G +L + M C L HA+E
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYE--------MCC--------LAHAFE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 466 FSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQH 519
F++ LG+G +G V + L + +AVK L S+ EEF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 520 VNLIRVLGFCIDSEER------MLIYEYMPNKSLDCYLF------DPIRKLILDWKKRVH 567
N+I+++G + S + M+I +M + L +L +P L + V
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVR 117
Query: 568 IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR-IFAKESLEENTE 626
+ I G+ YL S IHRDL N +L E M ++DFG+++ I++ + +
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 627 QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
+ + ++ E VY+T SDV++FGV + +I++
Sbjct: 175 SKL-PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 26/227 (11%)
Query: 460 EAATERFSIRNKLGEGGYGPVY--------KGVLPCGEVIAVKKLSKTSTQ-GFEEFKNE 510
E + ++ ++ LGEG +G V K +AVK L +T+ + +E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 511 V-MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-----------FDPIR-- 556
+ M+ +H N+I +LG C +I EY +L YL +D R
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 557 KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616
+ +K V + +G+ YL + IHRDL N+L+ E KI+DFG+AR
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
+ T + ++ PE VY+ +SDV+SFGVL+ +I +
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 63/274 (22%), Positives = 126/274 (45%), Gaps = 23/274 (8%)
Query: 470 NKLGEGGYGPVYKGVLPCGEV-IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGF 528
N + G G YKG + VK+++ ++ +E+ KLQH N+++++G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGL 751
Query: 529 CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTII 588
C + LI+EY+ K+L L + L W++R I GI + L +L ++
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 589 HRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTK 648
+L I++ +P + R+ L +T+ + + Y+ PE + K
Sbjct: 806 VGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AYVAPETRETKDITEK 858
Query: 649 SDVFSFGVLLLQIISGKRLS-MLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707
SD++ FG++L+++++GK + G++ SI+E A + ++D + S
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHG--SIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916
Query: 708 K--LMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ ++ + +AL C +P RP +V L++
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 64/231 (27%), Positives = 114/231 (49%), Gaps = 19/231 (8%)
Query: 461 AATERFSIRNKLGEGGYGPVYKGVLPC-GEVIAVKKLSKTSTQG--FEEFKNEVMLTAKL 517
AAT ++ KLGEG Y VYKG+ G+++A+K +S + +G F + E L L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGL 60
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
+H N++ + E ++EYM + L Y+ L + R+ + + + +GL
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGL-HPYNVRLFMFQ-LLRGLA 117
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
Y+ I+HRDLK N+L+ + K++DFG+AR AK + V T+ Y PP
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPP 172
Query: 638 EYATKGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687
+ YS+ D++ G + ++++ G+ G++ + E ++W
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPA--FPGVS---DVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 67/232 (28%), Positives = 99/232 (42%), Gaps = 55/232 (23%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVMLT 514
R+ + +G G YG V V G +A+KK+S F + E+ L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLL 53
Query: 515 AKLQHVNLIRVLG-FCIDSEERM----LIYEYMPNKSLDCYLFDPIRKLI-----LDWKK 564
L+H N+I +L S E ++ E M D + K+I L
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELME---TDLH------KVIKSPQPLTDDH 104
Query: 565 RVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
+ + I +GL YL + +IHRDLK SNIL+ KI DFG+AR + E+
Sbjct: 105 IQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
Query: 625 --TEQVVGTIGYIPPE-------YATKGVYSTKSDVFSFGVLLLQIISGKRL 667
TE VV T Y PE Y TK + D++S G + ++++ K L
Sbjct: 162 FLTEYVV-TRWYRAPELLLSSSRY-TKAI-----DIWSVGCIFAELLTRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 11/214 (5%)
Query: 470 NKLGEGGYGPVYKGVLPCGE-VIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLG 527
+KLGEG Y V+KG E ++A+K++ +G EV L L+H N++ +
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
L++EY+ + L YL D L+ ++ + + + +GL Y + I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCHKRK---I 124
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV-YS 646
+HRDLK N+L+ E + K++DFG+AR AK + V T+ Y PP+ YS
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 647 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 680
T D++ G +L ++ +G+ + + E L ++
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 26/227 (11%)
Query: 460 EAATERFSIRNKLGEGGYGPVY--------KGVLPCGEVIAVKKLSKTST-QGFEEFKNE 510
E + R ++ LGEG +G V K +AVK L +T + + +E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 511 V-MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-----------FDPIR-- 556
+ M+ +H N+I +LG C ++ EY +L YL FD +
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 557 KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616
+ L +K V + +G+ YL + IHRDL N+L+ E KI+DFG+AR
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
+ T + ++ PE VY+ +SDV+SFGVLL +I +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 26/227 (11%)
Query: 460 EAATERFSIRNKLGEGGYGPVY--------KGVLPCGEVIAVKKL-SKTSTQGFEEFKNE 510
E +R + LGEG +G V K +AVK L S + + + +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 511 V-MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-----------FDP--IR 556
+ M+ +H N+I +LG C +I EY +L YL ++P +
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 557 KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616
+ L +K V + +G+ YL + IHRDL N+L+ E KI+DFG+AR
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
+ T + ++ PE +Y+ +SDV+SFGVLL +I +
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-12
Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 49/237 (20%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQ 518
+R+ I +G+GG G VY P C +A+KK+ + K E + A L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLI 60
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMP---NKSLDCYLFDPIRKLILDWKKRVH-------- 567
H ++ V C D + +Y MP +L L +K L K +
Sbjct: 61 HPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAF 115
Query: 568 --IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625
I I + Y+ +S+ ++HRDLK NILLG + I D+G A K+ LEE
Sbjct: 116 LSIFHKICATIEYV--HSK-GVLHRDLKPDNILLGLFGEVVILDWGAAI--FKK-LEEED 169
Query: 626 E-------------------QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
++VGT Y+ PE S +D+++ GV+L Q+++
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 33/213 (15%)
Query: 472 LGEGGYGPVYKGVL----------PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
LG+G + +YKGVL P EV V K+ + + F L ++L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
L+++ G C+ E M + EY+ LD +L + L WK + + + + L YL++
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 582 YSRLTIIHRDLKVSNILL---GEAMKP----KISDFGMAR-IFAKESLEENTEQVVGTIG 633
++H ++ NIL+ G K+SD G+ + ++E E I
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER-------IP 169
Query: 634 YIPPEYATKGVYSTKS--DVFSFGVLLLQIISG 664
+I PE G S D +SFG LL+I S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 466 FSIRNKLGEGGYGPVY----KGVLPCGEVIAVKKLSKTS----TQGFEEFKNEVMLTAKL 517
F + LG G YG V+ G G++ A+K L K + + E + E + +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 518 QHVNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
+ + L + ++ ++ LI +Y+ L +L+ R+ + + RV+I E +
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIV---- 115
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
L L +L II+RD+K+ NILL ++DFG+++ F E EE GTI Y+
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-EERAYSFCGTIEYMA 174
Query: 637 PEYATKGV--YSTKSDVFSFGVLLLQIISG 664
PE G + D +S GVL ++++G
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 464 ERFSIRNKLGEGGYGPVYK------GVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL 517
E + I +LG+G +G VYK G L +VI K S + E++ E+ + A
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATC 66
Query: 518 QHVNLIRVLG-FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
H ++++LG F D + ++I E+ P ++D + + R L + ++ +I Q L
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVI--CRQML 120
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
LQ + IIHRDLK N+LL K++DFG++ K +L+ + +GT ++
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK-TLQRR-DSFIGTPYWMA 178
Query: 637 PEYA-----TKGVYSTKSDVFSFGVLLLQI 661
PE Y K+D++S G+ L+++
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 9e-12
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 471 KLGEGGYGPVYKGVLPC-GEVIAVKKLSKTSTQG--FEEFKNEVMLTAKLQHVNLIRVLG 527
KLGEG Y VYKG G+++A+K + +G F + E L L+H N++ +
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL-QEYSRLT 586
E L++EY+ C D + ++ + + + +GL Y+ Q Y
Sbjct: 71 IIHTKETLTLVFEYVHTDL--CQYMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY---- 123
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV-Y 645
I+HRDLK N+L+ + + K++DFG+AR AK V T+ Y PP+ Y
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 646 STKSDVFSFGVLLLQIISG 664
ST D++ G + +++I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 28/217 (12%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFK-NEVMLTAKLQHV 520
+++ K+GEG YG VYK E IA+KK+ + +G E+ L ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 521 NLIRVLGFCIDSEERM-LIYEYMP---NKSLDCYLFDPIRKLILDWKKRVHIIEG----I 572
N++R L + SE+R+ L++EY+ K +D P D+ K +I+ I
Sbjct: 62 NIVR-LQDVVHSEKRLYLVFEYLDLDLKKHMDS---SP------DFAKNPRLIKTYLYQI 111
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP-KISDFGMARIFAKESLEENTEQVVGT 631
+G+ Y + ++HRDLK N+L+ K++DFG+AR F + T +VV T
Sbjct: 112 LRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-T 166
Query: 632 IGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRL 667
+ Y PE YST D++S G + ++++ K L
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPL 203
|
Length = 294 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 471 KLGEGGYGPVYKGVLPCGEV---IAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVL 526
+LG G +G V KGV + +A+K L ++ +E E + +L + ++R++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 527 GFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLT 586
G C ++E ML+ E L+ +L +K + V ++ ++ G+ YL+ +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PEYAT 641
+HRDL N+LL KISDFG+++ +++ + G P PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGA----DDSYYKARSAGKWPLKWYAPECIN 171
Query: 642 KGVYSTKSDVFSFGVLLLQIIS 663
+S++SDV+S+G+ + + S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|119353 cd02874, GH18_CFLE_spore_hydrolase, Cortical fragment-lytic enzyme (CFLE) is a peptidoglycan hydrolase involved in bacterial endospore germination | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 69/344 (20%), Positives = 123/344 (35%), Gaps = 102/344 (29%)
Query: 61 TTYQL----SLSLPSDENQIAKFADTVKKKN----PSITTILSIGQGKDTNYSIYSSMVR 112
Y + +L+ DE I + K++ IT + + + + +++
Sbjct: 32 FWYGVDADGTLTGLPDERLI----EAAKRRGVKPLLVITNL----TNGNFDSELAHAVLS 83
Query: 113 NSSHRKSFIDSSIRIARLYGFRGL--DFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKN 170
N R+ I++ + +A+ YG+ G+ DF P + + L R + +L
Sbjct: 84 NPEARQRLINNILALAKKYGYDGVNIDFENVPP-EDREAYT-QFL----RELSDRL---- 133
Query: 171 STRQQSLLILTARFRYSPPANSYLLNSIQRNLNWI-------HAVTASY-----YEPVST 218
+ TA P S + NW + Y+
Sbjct: 134 --HPAGYTLSTA----VVPKTS-----ADQFGNWSGAYDYAAIGKIVDFVVLMTYD---- 178
Query: 219 NFTA--PPAALYGSISGRFARSTDQVLKAWIERGLS-------ADKLVMCLPFYGYAWTL 269
PP G ++ W+ER L +K+++ +P YGY WTL
Sbjct: 179 WHWRGGPP----GPVAPI----------GWVERVLQYAVTQIPREKILLGIPLYGYDWTL 224
Query: 270 VKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFS------- 322
P G A+ ++ ++ N K YG ++Q Y+ + +F
Sbjct: 225 --PYKKGGKAST----------ISPQQAINLAKRYGAEIQ--YDEEAQSPFFRYVDEQGR 270
Query: 323 TGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSF-DDHDWLL 365
VWF +D +++AK AKE L G W++ D +WLL
Sbjct: 271 RHEVWF--EDARSLQAKFELAKEYGLRGVSYWRLGLEDPQNWLL 312
|
CFLE is expressed as an inactive preprotein (called SleB) in the forespore compartment of sporulating cells. SleB translocates across the forespore inner membrane and is deposited as a mature enzyme in the cortex layer of the spore. As part of a sensory mechanism capable of initiating germination, CFLE degrades a spore-specific peptidoglycan constituent called muramic-acid delta-lactam that comprises the outer cortex. CFLE has a C-terminal glycosyl hydrolase family 18 (GH18) catalytic domain as well as two N-terminal LysM peptidoglycan-binding domains. In addition to SleB, this family includes YaaH, YdhD, and YvbX from Bacillus subtilis. Length = 313 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 56/202 (27%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 472 LGEGGYGPVY--KGVLP--CGEVIAVKKLSKTSTQGFEEF--KNEVMLTAKLQHVNLIRV 525
LG+G +G V+ + + G++ A+K L K + + + K E + A++ H +++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK- 62
Query: 526 LGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
L + +E ++ LI +++ L F + K ++ ++ V + + L L
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LAELALALDHLHS 116
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL--EENTEQVVGTIGYIPPEYATK 642
L II+RDLK NILL E K++DFG+ +KES+ E+ GT+ Y+ PE +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 643 GVYSTKSDVFSFGVLLLQIISG 664
++ +D +SFGVL+ ++++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 23/206 (11%)
Query: 471 KLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQG--FEEFKNEVMLTAKLQHVNLIRVLG 527
KLGEG Y VYKG G+++A+K++ +G F + E L L+H N++ L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69
Query: 528 FCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLT 586
I +++ + L++EY+ + L Y+ D L + + +GL Y +
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCH---QRR 123
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT--EQVVGTIGYIPPEY---AT 641
++HRDLK N+L+ E + K++DFG+AR AK S+ T +VV T+ Y PP+ +T
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR--AK-SVPSKTYSNEVV-TLWYRPPDVLLGST 179
Query: 642 KGVYSTKSDVFSFGVLLLQIISGKRL 667
+ YST D++ G + ++ +G+ L
Sbjct: 180 E--YSTSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 64/248 (25%), Positives = 112/248 (45%), Gaps = 50/248 (20%)
Query: 463 TERFSIRNK-LGEGGYGPVYKGV-LPCGEVIAVKK--LSKTSTQGFEEFKN--------- 509
+ER+ + LGEG YG V K G+++A+KK + + S ++ +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 510 ---EVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN---KSLDCYLFDPIRKLILDWK 563
E+ + +++H N++ ++ ++ + L+ + M + K +D RK+ L
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD-------RKIRLTES 119
Query: 564 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL-- 621
+ I+ I GL L ++ +HRDL +NI + KI+DFG+AR +
Sbjct: 120 QVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 622 -----------EENTEQVVGTIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGKRL 667
EE T +VV T+ Y PE A K Y D++S G + ++++GK L
Sbjct: 177 TLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEK--YHFAVDMWSVGCIFAELLTGKPL 233
Query: 668 SMLCGINE 675
G NE
Sbjct: 234 --FPGENE 239
|
Length = 335 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 53/160 (33%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE--NTEQVV 629
I GL +L E II+RDLK+ N+LL KI+DFGM KE + T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMC----KEGILGGVTTSTFC 157
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL---SILEH--AY 684
GT YI PE + Y D ++ GVLL ++++G+ S G +E+ SILE Y
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ--SPFEGDDEDELFQSILEDEVRY 215
Query: 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENP 724
W + + SFL +P K + CL ++ +P
Sbjct: 216 PRWLSKEAKSILKSFL--TKNPEKRLGCLPTGEQDIKGHP 253
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVM-LTAKLQHV---NLIRVL 526
LG G YG V K +P G ++AVK++ +T +E K +M L ++ V +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR--ATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 527 GFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV------HIIEGITQGLLYLQ 580
G + + E M + SLD + K + D + I I + L YL
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE-- 638
+L++IHRD+K SN+L+ + K+ DFG++ +S+ + + G Y+ PE
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTID--AGCKPYMAPERI 175
Query: 639 ---YATKGVYSTKSDVFSFGVLLLQIISGK 665
KG Y KSDV+S G+ ++++ +G+
Sbjct: 176 NPELNQKG-YDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 510 EVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHII 569
E ML + H ++IR+ + ++ +P+ S D Y + R L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
+ I +GL YL IIHRD+K NI + + + I D G A+ + +
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
GT+ PE + Y++K+D++S G++L ++++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 49/206 (23%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVN 521
+ + I +LG+G +G VYK + A K+ + S + E+F E+ + ++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 522 LIRVL-GFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
++ + + +++ +LI E+ +LD + + + + + + R + + + L +L
Sbjct: 64 IVGLYEAYFYENKLWILI-EFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH 120
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
+ +IHRDLK NILL K++DFG++ + +T +GT ++ PE
Sbjct: 121 SHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVV 175
Query: 641 -----TKGVYSTKSDVFSFGVLLLQI 661
Y K+D++S G+ L+++
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 465 RFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSK-----TSTQGFEEFKNEVMLTAKLQH 519
++++ +GEG +G + +L K K S+ E+ + E +L AK++H
Sbjct: 1 QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKL-----ILDWKKRVHIIEGITQ 574
N++ ++ EY L + KL IL W Q
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---------FVQ 108
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
L +Q ++HRD+K NI L + K K+ DFG AR+ T VGT Y
Sbjct: 109 MCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYY 166
Query: 635 IPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
+PPE Y+ KSD++S G +L ++ + K
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 65/233 (27%), Positives = 106/233 (45%), Gaps = 35/233 (15%)
Query: 455 SLADIEAATER-----FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFK 508
SL DI+ + R F + +G G YG VYKG + G++ A+K + T + EE K
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIK 60
Query: 509 NEV-MLTAKLQHVNLIRVLGFCI------DSEERMLIYEYMPNKSLDCYLFDPIRK---- 557
E+ ML H N+ G I ++ L+ E+ S+ D ++
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT----DLVKNTKGN 116
Query: 558 -LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616
L DW +I I +GL +L + +IHRD+K N+LL E + K+ DFG++
Sbjct: 117 ALKEDWI--AYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171
Query: 617 AKESLEENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISG 664
+ NT +GT ++ PE Y +SD++S G+ +++ G
Sbjct: 172 DRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKL-----SKTSTQGFEEFKNEVMLTAKLQHVNLIRV 525
LG+G +G VY G +AVK++ S +++ + E+ L L H +++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 526 LGFCIDSEERML--IYEYMPNKSLDCYLFDPIRKL-ILDWKKRVHIIEGITQGLLYLQEY 582
G D ER L E+MP S+ D ++ L I +G+ YL
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE-ENTEQVVGTIGYIPPEYAT 641
I+HRD+K +NIL K+ DFG ++ L + V GT ++ PE +
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 642 KGVYSTKSDVFSFGVLLLQIISGK 665
Y K+D++S G ++++++ K
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNL 522
E + I +LG+G +G VYK V+A K+ T S + E++ E+ + A H N+
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHII-EGITQGLLYLQE 581
+++L ++ E+ ++D + + R L + ++ ++ + + L YL E
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHE 121
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE-ENTEQVVGTIGYIPPEY- 639
IIHRDLK NIL K++DFG++ AK + + + +GT ++ PE
Sbjct: 122 NK---IIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 640 ----ATKGVYSTKSDVFSFGVLLLQI 661
+ Y K+DV+S G+ L+++
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNLI 523
F + +G G YG VYKG + G++ A+K + T + EE K E+ ML H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 524 RVLGFCIDS------EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
G I ++ L+ E+ S+ L + L + +I I +GL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
+L ++ +IHRD+K N+LL E + K+ DFG++ + NT +GT ++ P
Sbjct: 126 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAP 180
Query: 638 EYAT-----KGVYSTKSDVFSFGVLLLQIISG 664
E Y KSD++S G+ +++ G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 33/79 (41%), Positives = 49/79 (62%), Gaps = 5/79 (6%)
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV-Y 645
+++RDLK +NILL E +ISD G+A F+K+ + VGT GY+ PE KGV Y
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAY 173
Query: 646 STKSDVFSFGVLLLQIISG 664
+ +D FS G +L +++ G
Sbjct: 174 DSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPC-----GEVIAVKKLSKTSTQGFEEFKN----EVMLT 514
E++ +GEG YG V K C G+++A+KK ++ + K E+ +
Sbjct: 1 EKYENLGLVGEGSYGMVMK----CKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRML 54
Query: 515 AKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
+L+H NL+ ++ + L++E++ + LD P LD + + I +
Sbjct: 55 KQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILR 111
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
G+ + ++ IIHRD+K NIL+ ++ K+ DFG AR A + E V T Y
Sbjct: 112 GIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEVYTDYVATRWY 166
Query: 635 IPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRL 667
PE Y D+++ G L+ ++++G+ L
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQ 518
ER++ ++G G YG V + GE +A+KKLS+ E F E+ L +Q
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQ 72
Query: 519 HVNLIRVLGFCIDS---EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
H N+I +L + +E Y MP D I L K +++ + G
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
L Y+ IIHRDLK N+ + E + KI DFG+AR + E T VV T Y
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV-TRWYR 181
Query: 636 PPEYATKGVYSTKS-DVFSFGVLLLQIISGKRL 667
PE ++ ++ D++S G ++ ++++GK L
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTL 214
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 41/134 (30%), Positives = 66/134 (49%), Gaps = 25/134 (18%)
Query: 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599
E+M SLD L ++ + ++ I + +GL YL+E + I+HRD+K SNIL+
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISI--AVLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 600 GEAMKPKISDFG--------MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDV 651
+ K+ DFG MA F VGT Y+ PE Y+ +SD+
Sbjct: 134 NSRGEIKLCDFGVSGQLIDSMANSF------------VGTRSYMSPERLQGTHYTVQSDI 181
Query: 652 FSFGVLLLQIISGK 665
+S G+ L+++ G+
Sbjct: 182 WSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEV-IAVKKLSKTSTQGFEEFKN---EVMLTAKLQH 519
+R+ + +G G YG V +A+KKLS+ Q K E+ L + H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHMDH 73
Query: 520 VNLIRVLG-FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
N+I +L F S Y+ + L + ++ L ++ I +GL Y
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKY 133
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
+ IIHRDLK SNI + E + KI DFG+AR ++ V T Y PE
Sbjct: 134 IHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 185
Query: 639 YA-TKGVYSTKSDVFSFGVLLLQIISGKRL 667
Y+ D++S G ++ ++++GK L
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTL 215
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 466 FSIRNKLGEGGYGPVY----KGVLPCGEVIAVKKLSKTSTQGFEEFK---NE--VMLTAK 516
F I ++G+GGYG V+ K GE++A+K++ K+ E + E ++ T K
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKK-RVHIIEGITQG 575
L+++L D E L EY+P L +L R ++ E
Sbjct: 60 --SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMF--- 111
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
+ L IHRDLK N L+ + K++DFG+ +K + VVG+ Y+
Sbjct: 112 -EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGL----SKGIVTY-ANSVVGSPDYM 165
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISG 664
PE Y D +S G +L + + G
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 466 FSIRNKLGEGGYGPVY----KGVLPCGEVIAVKKLSKTS----TQGFEEFKNEVMLTAKL 517
F + LG G YG V+ G++ A+K L K + + E + E + +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 518 QHVNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
+ + L + +E ++ LI +Y+ + +L+ R + + R + E I
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEII---- 115
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
L L+ +L I++RD+K+ NILL ++DFG+++ F E +E T GTI Y+
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYMA 174
Query: 637 PEYA-TKGVYSTKSDVFSFGVLLLQIISG 664
PE KG + D +S G+L+ ++++G
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 8/99 (8%)
Query: 575 GLLYLQ-------EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627
GLL++Q +S+ +IHRD+K +NILL K+ DFG ++++A ++
Sbjct: 146 GLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204
Query: 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
GT Y+ PE + YS K+D+FS GVLL ++++ KR
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 34/76 (44%), Positives = 43/76 (56%)
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYST 647
IHRDL NILL E KI DFG+AR K+ + ++ PE VY+T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 648 KSDVFSFGVLLLQIIS 663
+SDV+SFGVLL +I S
Sbjct: 255 QSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKL-----SKTSTQGFEEFKNEVMLTAKLQHVNLIRV 525
LG+G +G VY + G +A K++ S +++ + E+ L LQH +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 526 LGFCIDSEERML--IYEYMPNKSLDCYL--FDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
G D E+ L EYMP S+ L + + + + R I+EG++ YL
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-QILEGMS----YLHS 124
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE-ENTEQVVGTIGYIPPEYA 640
I+HRD+K +NIL A K+ DFG ++ + V GT ++ PE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGK 665
+ Y K+DV+S G ++++++ K
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 476 GYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE- 534
G +G C +IA K K ++ + +NE++ +L H N++++ EE
Sbjct: 181 GVNSTNQGKPKCERLIA--KRVKAGSRAAIQLENEILALGRLNHENILKI-------EEI 231
Query: 535 -RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIE--GITQGLLYLQEY--SRLTIIH 589
R YM + D L+ + DWK R + + I + LL EY + +IH
Sbjct: 232 LRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-LIH 290
Query: 590 RDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKS 649
RD+K+ NI L K + DFG A F KE E VGT+ PE Y +
Sbjct: 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEIT 349
Query: 650 DVFSFGVLLLQIISGKRLSMLCGINEN 676
D++S G++LL ++S C I +
Sbjct: 350 DIWSCGLILLDMLSHD----FCPIGDG 372
|
Length = 501 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 470 NKLGEGGYGPVYKGVL--PCGEVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVNLIRVL 526
++LG+G YG VYK VL P G +A+K++ + F + E+ + K ++
Sbjct: 7 DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 527 G-FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL 585
G F I+ M + EYM SLD + + I + +GL +L+E
Sbjct: 66 GAFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122
Query: 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY------ 639
IIHRD+K +N+L+ + K+ DFG++ + N +G Y+ PE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKSGGP 178
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGK 665
Y+ +SDV+S G+ +L++ G+
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 472 LGEGGYGPVYK-GVLPCGEVIAVKKLSKTSTQGFEEFKNEVM-LTAK--LQHVNLIRV-- 525
LG+GG+G V V G++ A KKL K + ++ K E M L K L+ VN V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 526 LGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
L + ++++ + L+ M L ++++ + D ++ V IT GL L R
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLH---R 120
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV 644
I++RDLK NILL + +ISD G+A + E E VGT+GY+ PE
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEG--ETIRGRVGTVGYMAPEVVKNER 177
Query: 645 YSTKSDVFSFGVLLLQIISGK 665
Y+ D + G L+ ++I GK
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKL-----SKTSTQGFEEFKNEVMLTAKLQHVNLIRV 525
LG G +G VY G +AVK++ S+ +++ + E+ L L+H +++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 526 LGFCIDSEERML--IYEYMPNKSLDCYLFDPIRKL-ILDWKKRVHIIEGITQGLLYLQEY 582
G D EE+ L EYMP S+ D ++ L I QG+ YL
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMA-RIFAKESLEENTEQVVGTIGYIPPEYAT 641
I+HRD+K +NIL A K+ DFG + RI + V GT ++ PE +
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 642 KGVYSTKSDVFSFGVLLLQIISGK 665
Y K+DV+S ++++++ K
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKG-VLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ 518
A ++G G G VYK G V+AVK++ +T + EE K +M L
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILM---DLD 65
Query: 519 HV-------NLIRVLGFCIDSEERMLIYEYMPN--KSLDCYLFDPIRKLILDWKKRVHII 569
V +++ G+ I + + E M L + PI + IL +
Sbjct: 66 VVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMT 120
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
I + L YL+E + +IHRD+K SNILL + K+ DFG++ +S + T
Sbjct: 121 VAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDS-KAKTRS-A 175
Query: 630 GTIGYIPPEYAT----KGVYSTKSDVFSFGVLLLQIISGK 665
G Y+ PE Y ++DV+S G+ L+++ +G+
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 55/280 (19%)
Query: 472 LGEGGYGPVYKG----VLPCGEV----IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
LG+G + ++KG V GE+ + +K L K+ E F + ++L H +L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
G C+ +E +++ EY+ SLD YL + + WK + + + + L +L++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDKG 120
Query: 584 RLTIIHRDLKVSNILLG--EAMKP------KISDFGMA-RIFAKESLEENTEQVVGTIGY 634
+ H ++ N+LL E K K+SD G++ + KE L E I +
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER-------IPW 170
Query: 635 IPPE-YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693
+PPE S +D +SFG L +I G ++ LS L+ +L
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEI--------FSGGDKPLSALDSQKKL------- 215
Query: 694 EFVDSFLDDRNS-PCKLMRCLEIALL---CVQENPNDRPS 729
F +DR+ P + E+A L C+ P+ RPS
Sbjct: 216 ----QFYEDRHQLPAP--KWTELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH 519
E + F ++LG G G V K +I +KL + +N+++ ++ H
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLH 58
Query: 520 -VNLIRVLGF---CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
N ++GF E + E+M SLD L + +++ + +V I + +G
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSI--AVLRG 115
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
L YL+E + I+HRD+K SNIL+ + K+ DFG++ + ++ VGT Y+
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYM 169
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
PE YS +SD++S G+ L+++ G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
T+ +L L+ +++RDLK +NILL E +ISD G+A F+K+ + VGT
Sbjct: 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 159
Query: 633 GYIPPEYATKGV-YSTKSDVFSFGVLLLQIISG 664
GY+ PE KG Y + +D FS G +L +++ G
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 34/76 (44%), Positives = 43/76 (56%)
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYST 647
IHRDL NILL E KI DFG+AR K+ + ++ PE VY+T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 648 KSDVFSFGVLLLQIIS 663
+SDV+SFGVLL +I S
Sbjct: 256 QSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 472 LGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFK----NEVMLTAKLQHVNLIRVL 526
LG+G +G V+ L + A+K L K ++ + + +L+ +H L +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 527 GFCIDSEERMLIYEYMPNKSL-----DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
E + EY+ L C+ FD R + I GL +L
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------IICGLQFLHS 114
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL--EENTEQVVGTIGYIPPEY 639
I++RDLK+ NILL KI+DFGM KE++ + T GT YI PE
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGM----CKENMLGDAKTCTFCGTPDYIAPEI 167
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
Y+T D +SFGVLL +++ G+ S G +E
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQ--SPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 41/116 (35%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVV 629
I GL +L II+RDLK+ N++L KI+DFGM KE++ T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM----CKENIFGGKTTRTFC 162
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN---LSILEH 682
GT YI PE Y D ++FGVLL ++++G+ G +E+ SI+EH
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--PPFDGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 24/230 (10%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKK-LSKTSTQG-----FEEFKNEVMLTAKLQHVNLI 523
K+GEG YG VYK G+++A+KK + +G E ML+ + V L+
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 524 RVLGFCIDSEERM--LIYEYMPN---KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
V + + L++EY+ + K +D P R L K + + +G+ +
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS--FMYQLLKGVAH 125
Query: 579 LQEYSRLTIIHRDLKVSNILLGEA-MKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
+ ++HRDLK N+L+ + KI+D G+ R F+ ++ T ++V T+ Y P
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYRAP 180
Query: 638 EYATKGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686
E YST D++S G + ++ + L G +E L L H ++L
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL--FPGDSE-LQQLLHIFKL 227
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 75/264 (28%), Positives = 111/264 (42%), Gaps = 53/264 (20%)
Query: 472 LGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAK------LQHVNLIR 524
LG+G +G V L G + AVK L K ++ E +T K H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 525 VLGFCIDSEERML-IYEYMPNKSL-----DCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
L C + +R+ + E++ L FD R R + E IT L++
Sbjct: 61 -LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-------RFYAAE-ITSALMF 111
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTIGYIP 636
L + II+RDLK+ N+LL K++DFGM KE + T GT YI
Sbjct: 112 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM----CKEGIFNGKTTSTFCGTPDYIA 164
Query: 637 PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG------INEN---LSIL--EHAYE 685
PE + +Y D ++ GVLL + MLCG NE+ +IL E Y
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYE--------MLCGHAPFEAENEDDLFEAILNDEVVYP 216
Query: 686 LWKGGKGVEFVDSFLDDRNSPCKL 709
W V+ + +F+ +N +L
Sbjct: 217 TWLSQDAVDILKAFM-TKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 472 LGEGGYGPVYK-GVLPCGEVIAVKKLSKTSTQGFEEFKNEVM-LTAK--LQHVN--LIRV 525
LG+GG+G V V G++ A KKL K + ++ K E M L K L+ VN +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 526 LGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
L + ++++ + L+ M L +++ + + + + V I GL ++ +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGL---EDLHQ 120
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV 644
I++RDLK NILL + +ISD G+A + E + + VGT+GY+ PE
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEG--QTIKGRVGTVGYMAPEVVKNER 177
Query: 645 YSTKSDVFSFGVLLLQIISGK 665
Y+ D ++ G LL ++I+G+
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 472 LGEGGYGPVYK-GVLPCGEVIAVKKLSKTSTQGFEEFKNEVM-LTAK--LQHVN--LIRV 525
LG+GG+G V V G++ A KKL K + ++ K E M L K L+ VN +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 526 LGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
L + ++++ + L+ M L ++++ + D ++ + + GL LQ R
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---R 120
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV 644
I++RDLK NILL + +ISD G+A + E VGT+GY+ PE
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETVRGRVGTVGYMAPEVINNEK 177
Query: 645 YSTKSDVFSFGVLLLQIISGK 665
Y+ D + G L+ ++I G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK------TSTQGFEEFKNEVMLTA 515
T R+ +G G +G V G+ +A+KK+ K + + + E K L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LLK 64
Query: 516 KLQHVNLIRVLGFCID-SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
L+H N+I + I E+ + E + P+ K + + + I +
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-----FLYQILR 119
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
GL Y+ ++HRDLK SNIL+ E KI DFG+ARI + V T Y
Sbjct: 120 GLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYY 171
Query: 635 IPPEYA-TKGVYSTKSDVFSFGVLLLQIISGKRL 667
PE T Y + D++S G + +++ GK L
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 472 LGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLG 527
LG+GG+G V + G++ A KKL+K +G+E E + AK+ H I L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 528 FCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLI-LDWKKRVHIIEGITQGLLYLQEYSRL 585
+ ++ + L+ M L ++++ + + I GL +L +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVY 645
II+RDLK N+LL +ISD G+A + K+ + T+ GT G++ PE Y
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLA-VELKDG-QSKTKGYAGTPGFMAPELLQGEEY 174
Query: 646 STKSDVFSFGVLLLQIISGK 665
D F+ GV L ++I+ +
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH 519
E + F ++LG G G V+K +I +KL + +N+++ ++ H
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLH 58
Query: 520 -VNLIRVLGF---CIDSEERMLIYEYMPNKSLDCYLFDP--IRKLILDWKKRVHIIEGIT 573
N ++GF E + E+M SLD L I + IL K + +I+G+T
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLT 117
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633
YL+E + I+HRD+K SNIL+ + K+ DFG++ + ++ VGT
Sbjct: 118 ----YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 167
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
Y+ PE YS +SD++S G+ L+++ G+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPC-----GEVIAVKKLSKTSTQGFEEFKN-------EV 511
E++ +K+GEG YG V+K C G+++A+KK ++ E+ E+
Sbjct: 1 EKYEKLSKIGEGSYGVVFK----CRNRETGQIVAIKKFVES-----EDDPVIKKIALREI 51
Query: 512 MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR---VHI 568
+ +L+H NL+ ++ + L++EY + L+ L+ R H+
Sbjct: 52 RMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLN----------ELEKNPRGVPEHL 101
Query: 569 IEGIT-QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627
I+ I Q L + + IHRD+K NIL+ + + K+ DFG ARI ++
Sbjct: 102 IKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP--GDDYTD 159
Query: 628 VVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRL 667
V T Y PE Y DV++ G + ++++G+ L
Sbjct: 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 4e-09
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 21/206 (10%)
Query: 466 FSIRNKLGEGGYGPV----YKGVLPCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQ 518
F LG G +G V +K G+ A+K LSK + E NE + ++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H L+ + G D L+ EY+P L + R + + + L Y
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEPVA-RFYAAQ-VVLALEY 116
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
L L I++RDLK N+LL KI+DFG FAK ++ T + GT Y+ PE
Sbjct: 117 LH---SLDIVYRDLKPENLLLDSDGYIKITDFG----FAKR-VKGRTYTLCGTPEYLAPE 168
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISG 664
Y D ++ G+L+ ++++G
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 33/76 (43%), Positives = 42/76 (55%)
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYST 647
IHRDL NILL E KI DFG+AR K+ + ++ PE VY+
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 648 KSDVFSFGVLLLQIIS 663
+SDV+SFGVLL +I S
Sbjct: 261 QSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 41/116 (35%), Positives = 62/116 (53%), Gaps = 14/116 (12%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE--NTEQVV 629
I GL +L II+RDLK+ N++L KI+DFGM KE++ + T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM----CKENMWDGVTTKTFC 162
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN---LSILEH 682
GT YI PE Y D ++FGVLL ++++G+ + G +E+ SI+EH
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVV 629
I+ GL +L II+RDLK+ N++L KI+DFGM KE + + T
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGM----CKEHMVDGVTTRTFC 162
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
GT YI PE Y D +++GVLL ++++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI 530
LG G G V+ V C + +AVKK+ T Q + E+ + +L H N+++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 531 DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL----- 585
S + + Y I + ++ ++E QG L +E++RL
Sbjct: 73 PSGSDLTEDVGSLTELNSVY----IVQEYMETDLAN-VLE---QGPL-SEEHARLFMYQL 123
Query: 586 ----------TIIHRDLKVSNILLG-EAMKPKISDFGMARIFAKE-SLEENTEQVVGTIG 633
++HRDLK +N+ + E + KI DFG+ARI S + + + T
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 634 YIPPEYATKGVYSTKS-DVFSFGVLLLQIISGKRL 667
Y P TK+ D+++ G + ++++GK L
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 55/187 (29%), Positives = 95/187 (50%), Gaps = 29/187 (15%)
Query: 470 NKLGEGGYGPVYKGV-LPCGEVIAVKK-LSKTSTQGFEEFK-NEVMLTAKLQHVNLIRVL 526
K+G+G +G V+K +++A+KK L + +GF E+ + L+H N++ ++
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 527 GFCIDSEERM---------LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
C ++ L++E+ + L L + K L K+V ++ + GL
Sbjct: 78 EIC-RTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLLNGLY 133
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN------TEQVVGT 631
Y+ R I+HRD+K +NIL+ + K++DFG+AR F SL +N T +VV T
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAF---SLSKNSKPNRYTNRVV-T 186
Query: 632 IGYIPPE 638
+ Y PPE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 31/79 (39%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYS 646
II+RDLK+ N+LL + KI+DFGM + + E GT YI PE Y+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 647 TKSDVFSFGVLLLQIISGK 665
D +SFGVLL +++ G+
Sbjct: 175 ESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT--EQVV 629
+ +GL Y+ + +IHRDLK SN+L+ E + +I DFGMAR + E + V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 630 GTIGYIPPEYA-TKGVYSTKSDVFSFGVLLLQIISGKRL 667
T Y PE + Y+T D++S G + +++ ++L
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 466 FSIRNKLGEGGYGPVY--KGVL--PCGEVIAVKKLSKTS----TQGFEEFKNEVMLTAKL 517
F + LG G YG V+ + V G++ A+K L K + + E + E + +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 518 QHVNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
+ + L + ++ ++ LI +Y+ L +L R ++ V I G + +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSG--EIV 115
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
L L+ +L II+RD+K+ NILL ++DFG+++ F ++ +E GTI Y+
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTIEYMA 174
Query: 637 PEYATKGV--YSTKSDVFSFGVLLLQIISG 664
P+ G + D +S GVL+ ++++G
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 471 KLGEGGYGPVYKGVLPCG---EVIAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVL 526
++G G +G V G + G + VK+L S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 527 GFCIDSEERMLIYEYMPNKSLDCYLFDPIRK---LILDWKKRVHIIEGITQGLLYLQEYS 583
G C + +L+ E+ P L YL RK + D + I GLL+L
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG 643
+ IH DL + N LL + KI D+G++ KE +Q+ + +I PE +
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE- 176
Query: 644 VY--------STKSDVFSFGVLLLQI 661
V+ + +S+V+S GV + ++
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 34/212 (16%)
Query: 472 LGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQH-VNLIRVLGF 528
+G G +G V K + P G ++AVK++ T + + ++ + + +++ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 529 CIDSEERMLIYEYMPNKSLD-CYLFDPIRKLILDWKKRVHIIEGI--------TQGLLYL 579
+ + E M + SLD Y K + + + I E I + L YL
Sbjct: 72 LFREGDCWICMELM-DISLDKFY------KYVYE-VLKSVIPEEILGKIAVATVKALNYL 123
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV--VGTIGYIPP 637
+E L IIHRD+K SNILL K+ DFG++ L ++ + G Y+ P
Sbjct: 124 KE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAP 176
Query: 638 E----YATKGVYSTKSDVFSFGVLLLQIISGK 665
E A G Y +SDV+S G+ L ++ +GK
Sbjct: 177 ERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 32/212 (15%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN------EVMLTAKLQHVNLIR 524
+G G YG V E +A+KK++ F+ + E+ L L H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA----FDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 525 VLGFCIDSEERM------LIYEYMPNKSLDCYLFDPIRK---LILDWKKRVHIIEGITQG 575
+ + R ++YE M D L IR L D + + + + +G
Sbjct: 69 IKD-IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQ--YFLYQLLRG 120
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
L Y+ + ++HRDLK SN+LL KI DFG+AR E + TE VV
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRA 176
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
P Y+T DV+S G + +++ K L
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTIG 633
L L+ + II+RDLK NILL K++DFG+ KES+ E T GTI
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL----CKESIHEGTVTHTFCGTIE 165
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
Y+ PE + + D +S G L+ +++G
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 465 RFSIRNKLGEGGYGPVYKGVLPC-----GEVIAVKKLSKTSTQGFEEFKN----EVMLTA 515
+F + +GEG YG V K C E++A+KK ++ EE K E+ +
Sbjct: 2 KFEVLGVVGEGAYGVVLK----CRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLR 55
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
L+ N++ + + L++EY+ L+ L + + + K R +I + I
Sbjct: 56 TLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKA- 112
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
+ + I+HRD+K N+L+ K+ DFG AR + E N + V T Y
Sbjct: 113 ---IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYR 168
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
PE Y D++S G +L ++ G+ L
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 475 GGYGPVY--KGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN----LIRVLGF 528
G +G VY K G+ A+K L K+ + N V + + + L +
Sbjct: 7 GAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVAKLYY 64
Query: 529 CIDSEERM-LIYEYMPNKSLDC-YLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLT 586
S++ + L+ EY+ DC L + L DW K+ I + +L +++ +
Sbjct: 65 SFQSKDYLYLVMEYLNGG--DCASLIKTLGGLPEDWAKQY-----IAEVVLGVEDLHQRG 117
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYS 646
IIHRD+K N+L+ + K++DFG++R ++ VGT Y+ PE GV
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPE-TILGVGD 170
Query: 647 TK-SDVFSFGVLLLQIISGKR 666
K SD +S G ++ + + G
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 472 LGEGGYGPVY----KGVLPCGEVIAVKKLSKTSTQGFEEF------KNEVMLTAKLQHVN 521
LG+G +G V KG EV A+K L K ++ K + L AK H
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPF 57
Query: 522 LIRVLGFCIDSEERML-IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
L L C +++R+ + EY+ L +F R D + +T L++L
Sbjct: 58 LTA-LHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTIGYIPPE 638
+ +I+RDLK+ NILL K++DFGM KE + T GT YI PE
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGM----CKEGILNGVTTTTFCGTPDYIAPE 166
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGK 665
+ Y D ++ GVL+ ++++G+
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 472 LGEGGYGPVYK-GVLPCGEVIAVKKLSKTSTQGFEEFKNEVM-LTAK--LQHVN--LIRV 525
LG+GG+G V V G++ A K+L K + ++ K E M L K L+ VN +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEK---KRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 526 LGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
L + ++++ + L+ M L ++++ + + ++ + I GL L R
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLH---R 120
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMA-RIFAKESLEENTEQVVGTIGYIPPEYATKG 643
++RDLK NILL + +ISD G+A +I ES+ VGT+GY+ PE
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQ 176
Query: 644 VYSTKSDVFSFGVLLLQIISGK 665
Y+ D + G L+ ++I G+
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 470 NKLGEGGYGPVYKG-VLPCGEVIAVKKLSKTSTQGFEEFKN--EVMLTAKLQ-HVNLIRV 525
K+GEG + V K G+ A+K + K + E+ N E+ +L H N++R+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 526 LGFCIDSEER--MLIYEYMPNKSLDCYLFDPI--RKLILDWKKRVHIIEGITQGLLYLQE 581
+ D + L++E M D L++ I RK L K+ + + + L ++
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR-IFAKESLEENTEQVVGTIGYIPPE-Y 639
R I HRD+K NIL+ + + K++DFG R I++K E + T Y PE
Sbjct: 118 --RNGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTE----YISTRWYRAPECL 170
Query: 640 ATKGVYSTKSDVFSFGVLLLQIIS 663
T G Y K D+++ G + +I+S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK--TSTQGFEEFKNEVMLTAKLQHV 520
ER+ + +G G YG V G +AVKKLS+ S + E+ L ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 521 NLIRVLGFCIDSEERMLIYEYMPNKSL----DCYLFDPI-----------RKLILDWKKR 565
N+I +L + P +SL D YL + +KL D +
Sbjct: 77 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ- 123
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625
+I I +GL Y+ IIHRDLK SN+ + E + KI DFG+AR ++
Sbjct: 124 -FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEM 174
Query: 626 EQVVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRL 667
V T Y PE + Y+ D++S G ++ ++++G+ L
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 217
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 60/244 (24%), Positives = 93/244 (38%), Gaps = 61/244 (25%)
Query: 464 ERFSIRNKLGEGGYGPVY--KGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
+ F + +G G +G V+ + G+V A+K L K+ +++ ++ HV
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDT-GQVYAMKVLRKS----------DMIKRNQIAHVR 49
Query: 522 LIR-VLGFCI------------DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWK-KRVH 567
R +L D E L+ EYMP L L IRK + + R +
Sbjct: 50 AERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFY 106
Query: 568 IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA-------------- 613
I E + L L +L IHRD+K NIL+ K++DFG+
Sbjct: 107 IAELV----LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 614 -------------RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQ 660
R + VGT YI PE Y + D +S GV+L +
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
Query: 661 IISG 664
++ G
Sbjct: 223 MLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 472 LGEGGYGPV----YKGVLPCGEVIAVKKLSK---TSTQGFEEFKNE--VMLTA-KLQHVN 521
LG G +G V YK GE+ A+K L K + E E + TA +H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 522 LIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
L+ + C +E+ + + EY L + I + + V + GL YL
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMH----IHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL--EENTEQVVGTIGYIPPE 638
E I++RDLK+ N+LL KI+DFG+ KE + + T GT ++ PE
Sbjct: 119 ENK---IVYRDLKLDNLLLDTEGFVKIADFGL----CKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISG 664
T+ Y+ D + GVL+ +++ G
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 70/238 (29%), Positives = 105/238 (44%), Gaps = 26/238 (10%)
Query: 442 GDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS 500
G F N L + SL D T+ + I +G+G YG VYK G + AVK L S
Sbjct: 3 GLFPYNSSMLGLESLGD---PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS 59
Query: 501 TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERM-----LIYEYMPNKSLDCYLFDP 554
EE + E + L H N+++ G +++ + L+ E S+
Sbjct: 60 DVD-EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVT-----E 113
Query: 555 IRKLILDWKKRVH--IIEGITQG-LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611
+ K +L +R+ +I I G LL LQ IIHRD+K +NILL K+ DFG
Sbjct: 114 LVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173
Query: 612 MARIFAKESLEENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISG 664
++ L NT VGT ++ PE Y + DV+S G+ +++ G
Sbjct: 174 VSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLG 527
+G G +G V+ A+K ++ + + NE + ++ H +IR+
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 528 FCIDSEERML--IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL 585
F + ++R L + EY+P L YL + + + E I L YL
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASE-IVCALEYLHS---K 120
Query: 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE-YATKGV 644
I++RDLK NILL + K++DFG FAK+ L + T + GT Y+ PE +KG
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFG----FAKK-LRDRTWTLCGTPEYLAPEVIQSKG- 174
Query: 645 YSTKSDVFSFGVLLLQIISGK 665
++ D ++ G+L+ +++ G
Sbjct: 175 HNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 498 KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML-IYEYMPNKSLDCYLFDPIR 556
+T FE+ N L L C +E R+ + EY+ L +F R
Sbjct: 43 QTEKHVFEQASNHPFLVG----------LHSCFQTESRLFFVIEYVNGGDL---MFHMQR 89
Query: 557 KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616
+ L + I+ L YL E II+RDLK+ N+LL K++D+GM
Sbjct: 90 QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM---- 142
Query: 617 AKESLE--ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN 674
KE L + T GT YI PE Y D ++ GVL+ ++++G+ + G +
Sbjct: 143 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202
Query: 675 EN 676
+N
Sbjct: 203 DN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 472 LGEGGYGPV----YKGVLPCGEVIAVKKLS--KTSTQGFEEFKNEVMLTAKLQHVNLIR- 524
+G+G YG V ++ G+ +KKL+ S + + + E L ++L+H N++
Sbjct: 8 VGKGSYGEVSLVRHRTD---GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 525 -------------VLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG 571
V+GFC E +Y + + +++W +
Sbjct: 65 RESWEGEDGLLYIVMGFC----EGGDLYHKLKEQKGKLLP----ENQVVEWFVQ------ 110
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
I L YL E I+HRDLK N+ L K+ D G+AR+ E+ + ++GT
Sbjct: 111 IAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGT 165
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
Y+ PE + Y+ KSDV++ G + ++ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 513 LTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGI 572
L +++ H++L V G C+ E +++ E++ + LD L ++ + WK + + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITVAQQL 126
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNIL-----LGEAMKP--KISDFGMARIFAKESLEENT 625
L YL++ + ++H ++ NIL L E P K+SD G++ F S EE
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 626 EQVVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQI 661
E+ I +I PE G ST +D +SFG LL+I
Sbjct: 182 ER----IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 13/97 (13%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
+ QG+ +L + IHRD+ N+LL + KI DFG+AR + ++ VV
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272
Query: 632 IGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS 663
+P PE VY+ +SDV+S+G+LL +I S
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 28/76 (36%), Positives = 43/76 (56%)
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYST 647
+HRDL N+LL + KI DFG+AR +S + + ++ PE +Y+T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 648 KSDVFSFGVLLLQIIS 663
SDV+S+G+LL +I S
Sbjct: 319 LSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 38/223 (17%)
Query: 465 RFSIRNKLGEGGYGPV----YKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV 520
R+ + +LG+G YG V E +A+KK++ F +++ L+ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSE-EETVAIKKITNV-------FSKKILAKRALREL 52
Query: 521 NLIRVLG------FCIDSEERMLIYEYMPNKSLDCY--LFDPIRKLILDWKKRV---HII 569
L+R D M I L Y L + I+ + + H
Sbjct: 53 KLLRHFRGHKNITCLYD----MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQ 108
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV- 628
I Q L L+ ++HRDLK N+L+ + KI DFG+AR F+ E+ EN +
Sbjct: 109 SFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS-ENPGENAGFMT 167
Query: 629 --VGTIGYIPPE----YATKGVYSTKSDVFSFGVLLLQIISGK 665
V T Y PE + + Y+ DV+S G +L +++ K
Sbjct: 168 EYVATRWYRAPEIMLSFQS---YTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 28/76 (36%), Positives = 44/76 (57%)
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYST 647
+HRDL N+L+ E KI DFG+AR ++S + + ++ PE +Y+T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 648 KSDVFSFGVLLLQIIS 663
SDV+SFG+LL +I +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
I +GL YL I+HRD+K N+L+ KI DFG+AR+ + + T++VV T
Sbjct: 112 ILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167
Query: 632 IGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRL 667
Y PE Y++ D++S G + +++ + L
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRIL 204
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK--TSTQGFEEFKNEVMLTAKLQHV 520
+R+ ++G G YG V + G +A+KKL + S + E+ L ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 521 NLIRVLG-FCIDS--EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVH-IIEGITQGL 576
N+I +L F D + Y MP D KL D R+ ++ + +GL
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED---RIQFLVYQMLKGL 131
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
Y+ IIHRDLK N+ + E + KI DFG+AR ++ E T VV T Y
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVV-TRWYRA 183
Query: 637 PEYATKGVYSTKS-DVFSFGVLLLQIISGKRL 667
PE ++ T++ D++S G ++ ++++GK L
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 31/81 (38%), Positives = 45/81 (55%), Gaps = 6/81 (7%)
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL--EENTEQVVGTIGYIPPEYATKGV 644
II+RDLK+ N++L KI+DFGM KE++ + GT YI PE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGM----CKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 645 YSTKSDVFSFGVLLLQIISGK 665
Y+ D +SFGVLL +++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 32/81 (39%), Positives = 43/81 (53%), Gaps = 10/81 (12%)
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PEYATK 642
IHRDL NILL KI DFG+AR + ++ VV +P PE
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGNARLPVKWMAPESIFN 290
Query: 643 GVYSTKSDVFSFGVLLLQIIS 663
VY+ +SDV+S+G+LL +I S
Sbjct: 291 CVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 30/93 (32%), Positives = 50/93 (53%)
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633
Q +L L E ++HRDLK +NI L K+ DFG ++ ++ + GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
Y+ PE + YS K+D++S GV+L ++++ R
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 16/102 (15%)
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI-------------FAKESLE 622
L YL Y I+HRDLK N+L+ K++DFG+++I K++ E
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
+QV GT YI PE + Y D ++ G++L + + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE--ENTEQVV 629
I+ L +L E II+RDLK+ N+LL K++D+GM KE + + T
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM----CKEGIRPGDTTSTFC 157
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 676
GT YI PE Y D ++ GVL+ ++++G+ + G+++N
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 38/201 (18%)
Query: 488 GEVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML-IYEYMP 543
G +A+K L + + F+ E L A+L H N++ +L + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 544 NKSLDCYLFDPIRKLILDWKKRVHIIEG----ITQGLLYLQEYSRLT------IIHRDLK 593
++L + V +G G L LQ L I+HRDLK
Sbjct: 63 GRTL----------------REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLK 106
Query: 594 VSNILL---GEAMKPKISDFGMARIF--AKESLEEN---TEQVVGTIGYIPPEYATKGVY 645
NI++ G K+ DFG+ + +++ T +V+GT Y PE
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
Query: 646 STKSDVFSFGVLLLQIISGKR 666
+ SD++++G++ L+ ++G+R
Sbjct: 167 TPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 472 LGEGGYGPV---YKGVLPCGEVIAVKKLSK------TSTQGFEEFKNEVMLTAKLQHVNL 522
+G G G V Y V G+ +A+KKLS+ + + + E +M H N+
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELV--LMKLVN--HKNI 77
Query: 523 IRVLG-FCIDS--EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
I +L F EE +Y M + +D L I ++ LD ++ +++ + G+ +L
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVM--ELMDANLCQVI-QMDLDHERMSYLLYQMLCGIKHL 134
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
IIHRDLK SNI++ KI DFG+AR + T VV T Y PE
Sbjct: 135 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVV-TRYYRAPEV 188
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRL 667
Y D++S G ++ ++I G L
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMIRGTVL 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 471 KLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFK-NEVMLTAKLQHVNLIRVLGFC 529
K+G G YG VYK G+ L + G E+ L +L+H N+I +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 530 IDSEERM--LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY-----LQEY 582
+ +R L+++Y + F K KK V + G+ + LLY +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 583 SRLTIIHRDLKVSNIL-LGEAM---KPKISDFGMARIFAKESLE--ENTEQVVGTIGYIP 636
++HRDLK +NIL +GE + KI+D G AR+F L+ + + VV T Y
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWYRA 183
Query: 637 PEYATKGVYSTKS-DVFSFGVLLLQIISGK 665
PE + TK+ D+++ G + ++++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 2/93 (2%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
+ L L+ + +I+RDLK NILL + DFG+ ++ K+ + T GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGT 156
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
Y+ PE Y+ D ++ GVLL ++++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 529 CIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
C + R+ L+ EY+ L +F R+ L + I L +L E I
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---I 117
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE--ENTEQVVGTIGYIPPEYATKGVY 645
I+RDLK+ N+LL K++D+GM KE L + T GT YI PE Y
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGM----CKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 646 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686
D ++ GVL+ ++++G+ + N +++ ++ +++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 464 ERFSIRNKLGEGGYGPV---YKGVLPCGEVIAVKKLSK---TSTQGFEEFKNEVMLTAKL 517
+R+ +G G G V + VL G +AVKKLS+ T ++ V+L +
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKC-V 77
Query: 518 QHVNLIRVLGFCIDS---EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
H N+I +L EE +Y M + +D L I + LD ++ +++ +
Sbjct: 78 NHKNIISLLNVFTPQKSLEEFQDVYLVM--ELMDANLCQVIH-MELDHERMSYLLYQMLC 134
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
G+ +L IIHRDLK SNI++ KI DFG+AR + T VV T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVV-TRYY 188
Query: 635 IPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
PE Y D++S G ++ +++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 472 LGEGGYGPVYKGVLPC-GEVIAVKKLSKTSTQGFEEFKNEVM-----LTAKLQHVNLIRV 525
+G+G +G V G AVK L K + +E +N +M L L+H L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG- 60
Query: 526 LGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
L + + E++ + +Y+ L +L + L+ + R + E + + YL
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS--- 114
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL--EENTEQVVGTIGYIPPEYATK 642
L II+RDLK NILL ++DFG+ KE + EE T GT Y+ PE K
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGL----CKEGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 643 GVYSTKSDVFSFGVLLLQIISG 664
Y D + G +L +++ G
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 40/237 (16%)
Query: 450 NLRVYSLADIE-AATERFSIRNKLGEGGYGPV---YKGVLPCGEVIAVKKLSK---TSTQ 502
N + D +R+ +G G G V Y +L +A+KKLS+ T
Sbjct: 9 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTH 66
Query: 503 GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL----DCY----LFDP 554
++ E++L + H N+I +L + P KSL D Y L D
Sbjct: 67 AKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDA 113
Query: 555 ----IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610
+ ++ LD ++ +++ + G+ +L IIHRDLK SNI++ KI DF
Sbjct: 114 NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 170
Query: 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
G+AR + V T Y PE Y D++S G ++ ++I G L
Sbjct: 171 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 18/194 (9%)
Query: 480 VYKGVLPCGEVI--AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM- 536
+YKG+ EVI KK K + +NE+ ++ N++++ GF ID + +
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 537 ---LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 593
LI EY L L ++ L +K ++ + +GL L +Y+ +++L
Sbjct: 96 RLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 594 VSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK--GVYSTKSDV 651
+ L+ E K KI G+ +I + + V + Y + Y+ K D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKN-----VNFMVYFSYKMLNDIFSEYTIKDDI 205
Query: 652 FSFGVLLLQIISGK 665
+S GV+L +I +GK
Sbjct: 206 YSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 33/212 (15%)
Query: 466 FSIRNKLGEGGYGPV----YKGVLPCGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQ 518
F + LG G +G V +KG GE A+K L K + + E + +L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 519 H---VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIR---KLILDWKKRVHIIEGI 572
H VN++ F D + E++ L F +R + D K H +
Sbjct: 77 HPFIVNMMC--SF-QDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH--AEL 127
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
YL II+RDLK N+LL K++DFG FAK+ + + T + GT
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFG----FAKK-VPDRTFTLCGTP 179
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
Y+ PE + D ++ GVLL + I+G
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 13/209 (6%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK--TSTQGFEEFKNEVMLTAKLQHV 520
ER+ +G G YG V + +AVKKLS+ S E+ L ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 521 NLIRVLGFCIDSEERMLIYE-YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
N+I +L + E Y+ + L + ++ L + +I + +GL Y+
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
IIHRDLK SN+ + E + +I DFG+AR ++ V T Y PE
Sbjct: 135 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEI 186
Query: 640 ATKGV-YSTKSDVFSFGVLLLQIISGKRL 667
+ Y+ D++S G ++ +++ GK L
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKAL 215
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE---FKNEVMLTAKLQHVN 521
F +++ +G G +G V G++ A+K + K+ E F+ E + +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
+ ++ D + L+ EY P L L L + E + Q YL E
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDL----------LSLLNRYEDQFDEDMAQ--FYLAE 110
Query: 582 YS-------RLTIIHRDLKVSNILLGEAMKPKISDFG-MARIFAKESLEENTEQVVGTIG 633
++ +HRD+K N+L+ K++DFG AR+ A + + N++ VGT
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV--NSKLPVGTPD 168
Query: 634 YIPPEYAT------KGVYSTKSDVFSFGVLLLQIISGK 665
YI PE T KG Y + D +S GV+ ++I G+
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 63/266 (23%), Positives = 101/266 (37%), Gaps = 44/266 (16%)
Query: 422 LIEEDSAKASNTRANNETEAGDFNRNVPNL-RVYSLADIEAATE-RFSIRNKLGEGGYGP 479
L + D + +E S +D + +++I + L G G
Sbjct: 48 LGDSDDVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGE 107
Query: 480 VY----KGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535
V+ G +VI VK ++ T G E+ + + H +I
Sbjct: 108 VFVCTKHGDEQRKKVI-VKAVTGGKTPG-----REIDILKTISHRAIIN----------- 150
Query: 536 MLIYEYMPNKSLDCY--------LFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLT 586
LI+ Y KS C LF + R L ++ + I + + L YL
Sbjct: 151 -LIHAYR-WKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--- 205
Query: 587 IIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV---VGTIGYIPPEYATKG 643
IIHRD+K NI L E + DFG A K +T Q GT+ PE
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDTPQCYGWSGTLETNSPELLALD 262
Query: 644 VYSTKSDVFSFGVLLLQIISGKRLSM 669
Y K+D++S G++L + +S K +++
Sbjct: 263 PYCAKTDIWSAGLVLFE-MSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 61/250 (24%), Positives = 103/250 (41%), Gaps = 58/250 (23%)
Query: 458 DIEAATERFSIRNKLGEGGYGPVY------KGVLPCGEVIAVKKLSKTSTQGFEEFKNEV 511
D E+ + + K+G G +G V+ C + I+ + L + + EV
Sbjct: 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS---QLVIEV 63
Query: 512 MLTAKLQHVNLIRVLGFCIDSEERML--IYEYMPNKSLD-----CY-LFDPIRKLILDWK 563
+ +L+H N++R + ++ + L + E+ L CY +F I +
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE------ 117
Query: 564 KRVHIIEGITQGLLYLQEYSR--------LTIIHRDLKVSNILLGEAMK----------- 604
H I IT+ LL+ Y ++HRDLK NI L ++
Sbjct: 118 ---HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 605 ------PKISDFGMARIFAKESLEENTEQVVGTIGYIPPE---YATKGVYSTKSDVFSFG 655
KI DFG+++ ES+ VGT Y PE + TK Y KSD+++ G
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKS-YDDKSDMWALG 230
Query: 656 VLLLQIISGK 665
++ ++ SGK
Sbjct: 231 CIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 40/243 (16%)
Query: 445 NRNVPNLR------VYSLADIEAATERFSIRNKLGEGGYGPV----YKGVLPCGEVIAVK 494
N+N+ N V + ++ E + + +G G +G V +K +V A+K
Sbjct: 18 NKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMK 74
Query: 495 KLSK-----TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--IYEYMPNKSL 547
LSK S F + ++M A V V FC +++ L + EYMP L
Sbjct: 75 LLSKFEMIKRSDSAFFWEERDIMAFANSPWV----VQLFCAFQDDKYLYMVMEYMPGGDL 130
Query: 548 DCYL--FDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP 605
+ +D K W K + +L L + +IHRD+K N+LL +
Sbjct: 131 VNLMSNYDVPEK----WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181
Query: 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEY----ATKGVYSTKSDVFSFGVLLLQI 661
K++DFG + + + VGT YI PE G Y + D +S GV L ++
Sbjct: 182 KLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240
Query: 662 ISG 664
+ G
Sbjct: 241 LVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 63/241 (26%), Positives = 101/241 (41%), Gaps = 36/241 (14%)
Query: 445 NRNVPNL------RVYSLADIEAATERFSIRNKLGEGGYGPV----YKGVLPCGEVIAVK 494
N+N+ N + + D+ E + + +G G +G V +K +V A+K
Sbjct: 18 NKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMK 74
Query: 495 KLSK-----TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDC 549
LSK S F + ++M A V +++ D ++ EYMP L
Sbjct: 75 LLSKFEMIKRSDSAFFWEERDIMAFANSPWV--VQLFYAFQDDRYLYMVMEYMPGGDLVN 132
Query: 550 YL--FDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKI 607
+ +D K W R + E + L L + IHRD+K N+LL ++ K+
Sbjct: 133 LMSNYDVPEK----WA-RFYTAEVV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183
Query: 608 SDFGMARIFAKESLEENTEQVVGTIGYIPPEY----ATKGVYSTKSDVFSFGVLLLQIIS 663
+DFG KE + + VGT YI PE G Y + D +S GV L +++
Sbjct: 184 ADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242
Query: 664 G 664
G
Sbjct: 243 G 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 472 LGEGGYGPVYKGVLPCGEVI-AVKKLSKTSTQGFEEFKNEV----MLTAKLQHVNLIRVL 526
+G+G +G V E AVK L K + +E K+ + +L ++H L+ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-L 61
Query: 527 GFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL 585
F + +++ + +Y+ L +L + L+ + R + E I L YL L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---L 115
Query: 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTIGYIPPEYATKG 643
I++RDLK NILL ++DFG+ KE++E N T GT Y+ PE K
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGL----CKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 644 VYSTKSDVFSFGVLLLQIISG 664
Y D + G +L +++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 464 ERFSIRNKLGEGGYGPV---YKGVLPCGEVIAVKKLSK---TSTQGFEEFKNEVMLTAKL 517
+R+ +G G G V Y VL +A+KKLS+ T ++ E++L +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 73
Query: 518 QHVNLIRVLGFCIDS---EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
H N+I +L EE +Y M + +D L I ++ LD ++ +++ +
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVM--ELMDANLCQVI-QMELDHERMSYLLYQMLC 130
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
G+ +L IIHRDLK SNI++ KI DFG+AR + T VV T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVV-TRYY 184
Query: 635 IPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
PE Y D++S G ++ +++ K L
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 10/157 (6%)
Query: 510 EVMLTAKLQHVNLIRVLG-FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHI 568
E + + H ++I++ G F + +++ Y + L CYL I D + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDI---LAI 187
Query: 569 IEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV 628
+ + + YL E IIHRD+K NI + + DFG A F +
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGW 243
Query: 629 VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
GTI PE + Y D++S G++L ++ +
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 43/205 (20%), Positives = 82/205 (40%), Gaps = 36/205 (17%)
Query: 472 LGEGGYGPVYKGVLPCGEVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFC 529
+ + K P ++AVKK L S + + + E++ + +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 530 IDSEERMLIYEYMPNKS----LDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRL 585
I E ++ M S L + + + +L + I++ + L Y+
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI-----AFILKDVLNALDYIH---SK 120
Query: 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV- 644
IHR +K S+ILL K +S + K ++VV + P+ + K +
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG---KRQRVV----HDFPKSSVKNLP 173
Query: 645 -------------YSTKSDVFSFGV 656
Y+ KSD++S G+
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 471 KLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFK-NEVMLTAKLQHVNLIRVLGFC 529
K+G G YG VYK G+ L + G E+ L +L+H N+I +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 530 IDSEERM--LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY-----LQEY 582
+ +R L+++Y + F K KK + + + + LLY +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 583 SRLTIIHRDLKVSNIL-LGEAM---KPKISDFGMARIFAKESLE--ENTEQVVGTIGYIP 636
++HRDLK +NIL +GE + KI+D G AR+F L+ + + VV T Y
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWYRA 183
Query: 637 PEYATKGVYSTKS-DVFSFGVLLLQIISGK 665
PE + TK+ D+++ G + ++++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN------EVMLTAKL 517
R+ I+ +G+G YG V + GE +A+KK++ FE + E+ L L
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV----FEHVSDATRILREIKLLRLL 56
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
+H +++ + + R Y+ + ++ L I+ D H + Q L
Sbjct: 57 RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHHQFFLYQLLR 114
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI-FAKESLEENTEQVVGTIGYIP 636
L+ + HRDLK NIL K KI DFG+AR+ F V T Y
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 637 PE----YATKGVYSTKSDVFSFGVLLLQIISGKRL 667
PE + +K Y+ D++S G + ++++GK L
Sbjct: 175 PELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
I + +L L+ + I++RDLK NILL + DFG+++ A + + T GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGT 159
Query: 632 IGYIPPE--YATKGVYSTKSDVFSFGVLLLQIISG 664
Y+ PE KG Y+ D +S GVL+ ++ G
Sbjct: 160 TEYLAPEVLLDEKG-YTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633
Q +L + L I++RDLK N+LL + K++DFG A++ ++ T + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPE 193
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
YI PE + +D ++ G+ + +I+ G
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 463 TERFSIRNKLGEGGYGPVYKGVL--PCGEVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQH 519
++ + I +G+G YG V+K VL G AVK L EE + E +L A H
Sbjct: 17 SDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDH 74
Query: 520 VNLIRVLGF-----CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVH--IIEGI 572
N+++ G + ++ L+ E S+ + K L +R+ II I
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT-----DLVKGFLKRGERMEEPIIAYI 129
Query: 573 T-QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
+ L+ LQ IHRD+K +NILL K+ DFG++ L NT VGT
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187
Query: 632 IGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISG 664
++ PE Y + DV+S G+ +++ G
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 9/95 (9%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVV 629
I L YL L II+RDLK NILL ++DFG+ KE +E + T
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGL----CKEGIEHSKTTSTFC 157
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
GT Y+ PE K Y D + G +L +++ G
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 471 KLGEGGYGPVYKGVLPCGEVIA---VKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVL 526
++G G +G V + +A VK+L + S++ EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 527 GFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR-VHIIE------GITQGLLYL 579
G C+++ +L++EY L YL W +R ++ I G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
+ +H DL + N L + K+ D+G+ KE E + + ++ PE
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172
Query: 640 ATK---GVYSTK----SDVFSFGVLLLQI 661
+ G+ + + S+V++ GV L ++
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
I L YL +S +++RDLK+ N++L + KI+DFG+ + K+ T GT
Sbjct: 104 IVSALDYL--HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 159
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
Y+ PE Y D + GV++ +++ G+
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 33/118 (27%), Positives = 54/118 (45%), Gaps = 13/118 (11%)
Query: 551 LFDPIRK-LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP-KIS 608
LFD ++K L + II + + L L ++ IIH D+K+ N+L A +
Sbjct: 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152
Query: 609 DFGMARIFAKESLEENTEQVV-GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
D+G+ +I T GT+ Y PE Y D ++ GVL ++++GK
Sbjct: 153 DYGLCKI-------IGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 44/171 (25%), Positives = 68/171 (39%), Gaps = 44/171 (25%)
Query: 531 DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKK-RVHIIEGITQGLLYLQEYSRLTIIH 589
D LI EY+P + L ++K ++ R +I E I L + +L IH
Sbjct: 72 DENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETI----LAIDSIHKLGYIH 124
Query: 590 RDLKVSNILLGEAMKPKISDFGM------------ARIFAK-------------ESLEEN 624
RD+K N+LL K+SDFG+ RI + S +
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 625 TE-----------QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
E VGT YI PE + Y+ + D +S GV++ +++ G
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA-RIFAKESLEENTEQVVG 630
+ + +L + +L +HRD+K N+LL + +++DFG R+ A +++ N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165
Query: 631 TIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGK 665
T YI PE KG Y + D +S GV + +++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|226376 COG3858, COG3858, Predicted glycosyl hydrolase [General function prediction only] | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 33/137 (24%), Positives = 53/137 (38%), Gaps = 30/137 (21%)
Query: 246 WIERGL-------SADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIK 298
W+ + + A+K++M +P YGY WTL + G A A P D +
Sbjct: 298 WVRKVIEYALTVIPAEKVMMGIPLYGYDWTL-PYDPLGYLARAISP---DEAIDI----- 348
Query: 299 NHIKTYGPDVQVMYNSTYEVNYFSTG-------TVWFGFDDVEAVRAKIAYAKEKRLLGY 351
Y +Q Y++T + +F VW F+D + + K+ KE L G
Sbjct: 349 --ANRYNATIQ--YDATSQSPFFYYVDKEGRYHEVW--FEDARSFQTKLDLIKEYGLRGV 402
Query: 352 YAWQVSFDDHD-WLLSQ 367
W + +D W
Sbjct: 403 SYWVLGQEDPRNWTYLP 419
|
Length = 423 |
| >gnl|CDD|119362 cd06545, GH18_3CO4_chitinase, The Bacteroides thetaiotaomicron protein represented by pdb structure 3CO4 is an uncharacterized bacterial member of the family 18 glycosyl hydrolases with homologs found in Flavobacterium, Stigmatella, and Pseudomonas | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 55/258 (21%), Positives = 93/258 (36%), Gaps = 51/258 (19%)
Query: 29 VGYLNLS--EVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKK 86
VGYL + I++ TH+ + A+ ++ L+ +++ +
Sbjct: 2 VGYLPNYDDLNALSPTIDFSKLTHINLAFANPDANGT---LNANPVRSELNSVVNAAHAH 58
Query: 87 NPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT- 145
N I L+ G +++ + + + RK+ +D I Y G+D P+
Sbjct: 59 NVKILISLAGGSP-----PEFTAALNDPAKRKALVDKIINYVVSYNLDGIDVDLEGPDVT 113
Query: 146 --STDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLN 203
+F L L + +LTA A S N
Sbjct: 114 FGDYLVFIRAL--------YAALKKEG-------KLLTA-------AVS------SWNGG 145
Query: 204 WIHAVTASYYEPV---STNFTAPPAALYGSISGRFARSTDQVLKAWIERGL-SADKLVMC 259
+ T +Y++ + S + T P + + + L W ERGL S DKLV+
Sbjct: 146 AVSDSTLAYFDFINIMSYDATGPWWGDNPGQHSSYDDAVND-LNYWNERGLASKDKLVLG 204
Query: 260 LPFYGYAWTLVKPEDNGI 277
LPFYGY + NGI
Sbjct: 205 LPFYGYGFYY-----NGI 217
|
Length = 253 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 29/147 (19%), Positives = 52/147 (35%), Gaps = 15/147 (10%)
Query: 471 KLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI--RVLGF 528
L G VY + + +K + + EV + L L +VL
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKG--ADREREVAILQLLARKGLPVPKVLAS 61
Query: 529 CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTII 588
L+ E++ ++LD + +++ I E + + L L + L +
Sbjct: 62 GESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 589 HRDLKVSNILLGEAMKPKISDFGMARI 615
H DL NIL+ + I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE--NTEQVV 629
I L YL +++RDLK+ N++L + KI+DFG+ KE + + +
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGL----CKEGISDGATMKTFC 156
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
GT Y+ PE Y D + GV++ +++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 32/104 (30%), Positives = 48/104 (46%), Gaps = 10/104 (9%)
Query: 563 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE--S 620
+ R + E I L YL + I++RDLK NILL ++DFG+ KE +
Sbjct: 97 RARFYAAE-IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGL----CKEGIA 148
Query: 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
+ T GT Y+ PE K Y D + G +L +++ G
Sbjct: 149 QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 472 LGEGGYGPVYKGVL----PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN--LIRV 525
LG+G +G V +L G A+K L K +E + V + LQ+ +
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 526 LGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
L + + +R+ + EY L +L ++ + + R + E I L YL +SR
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL--HSR 114
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL--EENTEQVVGTIGYIPPEYATK 642
+++RD+K+ N++L + KI+DFG+ KE + + GT Y+ PE
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGL----CKEGISDGATMKTFCGTPEYLAPEVLED 169
Query: 643 GVYSTKSDVFSFGVLLLQIISGK 665
Y D + GV++ +++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 472 LGEGGYGPVYKGVL----PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN--LIRV 525
LG+G +G V +L G+ A+K L K +E + + + L++ +
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 526 LGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584
L + +++R+ + EY+ L F R+ + + I L YL
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE--NTEQVVGTIGYIPPEYATK 642
I++RDLK+ N++L + KI+DFG+ KE + + + GT Y+ PE
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGL----CKEGITDAATMKTFCGTPEYLAPEVLED 169
Query: 643 GVYSTKSDVFSFGVLLLQIISGK 665
Y D + GV++ +++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 5/81 (6%)
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY----ATKG 643
IHRD+K N+LL ++ K++DFG + + VGT YI PE G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 644 VYSTKSDVFSFGVLLLQIISG 664
Y + D +S GV L +++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 54/202 (26%), Positives = 80/202 (39%), Gaps = 42/202 (20%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTSTQGFEEFKNE-VMLT--- 514
+ F + KLGEG +G VYK L +KK T E + NE V
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK--ATEYGAVEIWMNERVRRACPN 189
Query: 515 --AKLQHVNLIRVLGFCIDSEERMLIYEY---------MPNK----SLDCYLFDPIRKLI 559
A + L V +E L++ Y M +K +++ YL ++ L
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 560 LDWKKRVHIIEGITQGLLY-LQEYSRLTIIHRDLKVSNILLGEAMKP-KISDFGMARIFA 617
++ II+ I + +L+ L I+HRD+K NI+ E KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA---- 303
Query: 618 KESLEENTEQVVGTIGYIPPEY 639
+ VG I YIP E+
Sbjct: 304 -------ADLRVG-INYIPKEF 317
|
Length = 566 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 33/126 (26%), Positives = 53/126 (42%), Gaps = 33/126 (26%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK------------- 618
I + +L + +L IHRD+K N+LL K+SDFG+ K
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 619 ----------------ESLEENTEQV----VGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658
E+ ++N Q+ VGT YI PE + Y+ D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 659 LQIISG 664
+++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 33/126 (26%), Positives = 52/126 (41%), Gaps = 33/126 (26%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK------------- 618
I + +L + +L IHRD+K N+LL K+SDFG+ K
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 619 ----------------ESLEENTEQV----VGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658
E+ + N Q+ VGT YI PE + Y+ D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 659 LQIISG 664
+++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ---V 628
+ + ++ + +L +HRD+K NIL+ +++DFG + +E+ T Q
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL----KLMEDGTVQSSVA 163
Query: 629 VGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGK 665
VGT YI PE KG Y + D +S GV + +++ G+
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 23/215 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKK-------LSKTSTQGFEEFKNEVMLTAK 516
+ F I +G G +G V + E I K L + T F E +N V++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERN-VLVNGD 59
Query: 517 LQHVNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
Q I L + E + L+ +Y L L +L D R +I E +
Sbjct: 60 CQ---WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYIAEMV--- 112
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
L + +L +HRD+K N+LL +++DFG ++ +++ VGT YI
Sbjct: 113 -LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS-VAVGTPDYI 170
Query: 636 PPEYATK-----GVYSTKSDVFSFGVLLLQIISGK 665
PE G Y + D +S GV + +++ G+
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 785 | |||
| cd02879 | 299 | GH18_plant_chitinase_class_V The class V plant chi | 100.0 | |
| cd02873 | 413 | GH18_IDGF The IDGF's (imaginal disc growth factors | 100.0 | |
| COG3325 | 441 | ChiA Chitinase [Carbohydrate transport and metabol | 100.0 | |
| KOG2806 | 432 | consensus Chitinase [Carbohydrate transport and me | 100.0 | |
| cd02872 | 362 | GH18_chitolectin_chitotriosidase This conserved do | 100.0 | |
| cd02878 | 345 | GH18_zymocin_alpha Zymocin, alpha subunit. Zymocin | 100.0 | |
| smart00636 | 334 | Glyco_18 Glycosyl hydrolase family 18. | 100.0 | |
| cd06548 | 322 | GH18_chitinase The GH18 (glycosyl hydrolases, fami | 100.0 | |
| PF00704 | 343 | Glyco_hydro_18: Glycosyl hydrolases family 18; Int | 100.0 | |
| cd02876 | 318 | GH18_SI-CLP Stabilin-1 interacting chitinase-like | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd02875 | 358 | GH18_chitobiase Chitobiase (also known as di-N-ace | 100.0 | |
| cd02874 | 313 | GH18_CFLE_spore_hydrolase Cortical fragment-lytic | 100.0 | |
| cd06545 | 253 | GH18_3CO4_chitinase The Bacteroides thetaiotaomicr | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06549 | 298 | GH18_trifunctional GH18 domain of an uncharacteriz | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd00598 | 210 | GH18_chitinase-like The GH18 (glycosyl hydrolase, | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06544 | 253 | GH18_narbonin Narbonin is a plant 2S protein from | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd06546 | 256 | GH18_CTS3_chitinase GH18 domain of CTS3 (chitinase | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| COG3858 | 423 | Predicted glycosyl hydrolase [General function pre | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd02871 | 312 | GH18_chitinase_D-like GH18 domain of Chitinase D ( | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| cd06542 | 255 | GH18_EndoS-like Endo-beta-N-acetylglucosaminidases | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG2091 | 392 | consensus Predicted member of glycosyl hydrolase f | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd02877 | 280 | GH18_hevamine_XipI_class_III This conserved domain | 99.86 | |
| cd06543 | 294 | GH18_PF-ChiA-like PF-ChiA is an uncharacterized ch | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| COG3469 | 332 | Chitinase [Carbohydrate transport and metabolism] | 99.68 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.94 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| KOG4701 | 568 | consensus Chitinase [Cell wall/membrane/envelope b | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.79 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.31 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.3 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.23 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.2 | |
| cd06547 | 339 | GH85_ENGase Endo-beta-N-acetylglucosaminidase (ENG | 98.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.07 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.97 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.91 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.78 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.75 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.66 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.62 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.59 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.56 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.5 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.48 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.46 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.45 | |
| PF02638 | 311 | DUF187: Glycosyl hydrolase like GH101; InterPro: I | 97.41 | |
| PF03644 | 311 | Glyco_hydro_85: Glycosyl hydrolase family 85 ; Int | 97.4 |
| >cd02879 GH18_plant_chitinase_class_V The class V plant chitinases have a glycosyl hydrolase family 18 (GH18) domain, but lack the chitin-binding domain present in other GH18 enzymes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-63 Score=520.99 Aligned_cols=291 Identities=42% Similarity=0.778 Sum_probs=251.7
Q ss_pred CcEEEEEecCCC-CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCCC
Q 003932 25 PWIRVGYLNLSE-VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTN 103 (785)
Q Consensus 25 ~~~~vgY~~~~~-~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~ 103 (785)
+-+++|||++|. .+.+++||+++||||+|+|+.++++++.+...+ .+...+..+.+.+|+++|++|+|+|||||+. +
T Consensus 2 ~~~~~~Y~~~w~~~~~~~~i~~~~~THi~yaf~~~~~~~~~~~~~~-~~~~~~~~~~~~~k~~~~~lkvlisiGG~~~-~ 79 (299)
T cd02879 2 TIVKGGYWPAWSEEFPPSNIDSSLFTHLFYAFADLDPSTYEVVISP-SDESEFSTFTETVKRKNPSVKTLLSIGGGGS-D 79 (299)
T ss_pred CeEEEEEECCCCCCCChhHCCcccCCEEEEEEEEecCCCCEEeecc-ccHHHHHHHHHHHHHhCCCCeEEEEEeCCCC-C
Confidence 347899999997 889999999999999999999999887777664 3455677777789999999999999999875 3
Q ss_pred cccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEee
Q 003932 104 YSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTAR 183 (785)
Q Consensus 104 ~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~ 183 (785)
+..|+.+++++++|++||+++++++++|||||||||||||+.++|++||+.|+++||++|+..... ..+.+..++++++
T Consensus 80 s~~fs~~~~~~~~R~~fi~siv~~l~~~~fDGidiDWE~P~~~~d~~n~~~ll~elr~~l~~~~~~-~~~~~~~ls~av~ 158 (299)
T cd02879 80 SSAFAAMASDPTARKAFINSSIKVARKYGFDGLDLDWEFPSSQVEMENFGKLLEEWRAAVKDEARS-SGRPPLLLTAAVY 158 (299)
T ss_pred CchhhHHhCCHHHHHHHHHHHHHHHHHhCCCceeecccCCCChhHHHHHHHHHHHHHHHHHHHhhc-cCCCcEEEEeecc
Confidence 456999999999999999999999999999999999999988899999999999999999864322 2223455555554
Q ss_pred cccCC----CCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeec
Q 003932 184 FRYSP----PANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMC 259 (785)
Q Consensus 184 ~~~~~----~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~KlvlG 259 (785)
+.... ....|++++|.++||||||||||+||+|....++|+|||+.... ..+++.+|++|++.|+|++||+||
T Consensus 159 ~~~~~~~~~~~~~yd~~~l~~~vD~i~vMtYD~~g~~~~~~~~~~a~l~~~~~---~~~~~~~v~~~~~~g~p~~KlvlG 235 (299)
T cd02879 159 FSPILFLSDDSVSYPIEAINKNLDWVNVMAYDYYGSWESNTTGPAAALYDPNS---NVSTDYGIKSWIKAGVPAKKLVLG 235 (299)
T ss_pred cchhhccccccccCCHHHHHhhCCEEEEEeecccCCCCCCCCCCCCcCCCCCC---CCCHHHHHHHHHHcCCCHHHEEEE
Confidence 43322 34578999999999999999999999998777899999996542 468999999999999999999999
Q ss_pred cccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHHHH
Q 003932 260 LPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAK 339 (785)
Q Consensus 260 ip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~~K 339 (785)
||||||+|++ ||+.+..+|.+.+++||+|||++|++.|
T Consensus 236 vp~YGr~~~~------------------------------------------~D~~~~~~y~~~~~~wi~ydd~~Si~~K 273 (299)
T cd02879 236 LPLYGRAWTL------------------------------------------YDTTTVSSYVYAGTTWIGYDDVQSIAVK 273 (299)
T ss_pred eccccccccc------------------------------------------cCCCcceEEEEECCEEEEeCCHHHHHHH
Confidence 9999999963 6777778898888999999999999999
Q ss_pred HhhhcccCccceEeeeccccchhh
Q 003932 340 IAYAKEKRLLGYYAWQVSFDDHDW 363 (785)
Q Consensus 340 ~~~~~~~glgG~~~W~l~~Dd~~~ 363 (785)
++||+++||||+|+|++++||.++
T Consensus 274 ~~~a~~~~lgGv~~W~l~~Dd~~~ 297 (299)
T cd02879 274 VKYAKQKGLLGYFAWAVGYDDNNW 297 (299)
T ss_pred HHHHHhCCCCeEEEEEeecCCccc
Confidence 999999999999999999999775
|
The GH18 domain of the class V chitinases has endochitinase activity in some cases and no catalytic activity in others. Included in this family is a lectin found in black locust (Robinia pseudoacacia) bark, which binds chitin but lacks chitinase activity. Also included is a chitinase-related receptor-like kinase (CHRK1) from tobacco (Nicotiana tabacum), with an N-terminal GH18 domain and a C-terminal kinase domain, which is thought to be part of a plant signaling pathway. The GH18 domain of CHRK1 is expressed extracellularly where it binds chitin but lacks chitinase activity. |
| >cd02873 GH18_IDGF The IDGF's (imaginal disc growth factors) are a family of growth factors identified in insects that include at least five members, some of which are encoded by genes in a tight cluster | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-62 Score=535.10 Aligned_cols=325 Identities=25% Similarity=0.415 Sum_probs=263.5
Q ss_pred EEEEecCCC-------CCCcCCCCCCC--CceEEEEEEEeeCCccEEecCCCccHH--HHHHHHHHHHhcCCCceEEEEe
Q 003932 28 RVGYLNLSE-------VSTISGINYDL--FTHLICSSADINSTTYQLSLSLPSDEN--QIAKFADTVKKKNPSITTILSI 96 (785)
Q Consensus 28 ~vgY~~~~~-------~~~~~~i~~~~--~Thi~~~f~~~~~~~~~~~~~~~~~~~--~~~~~~~~~k~~~p~lkv~~si 96 (785)
+||||..|. .+.+++||..+ ||||+|+|+.++++++.+...+++.+. .....+..+|++||++|||+||
T Consensus 2 vvcyy~~~a~~r~~~~~~~~~~i~~~~~~~THl~yaf~~i~~~~~~~~~~~~~~~~~~~~~~~~~~lk~~~p~lKvllSi 81 (413)
T cd02873 2 LVCYYDSKSYLREGLAKMSLEDLEPALQFCTHLVYGYAGIDADTYKIKSLNEDLDLDKSHYRAITSLKRKYPHLKVLLSV 81 (413)
T ss_pred EEEEecchhhcCCCCCeeCHHHcCCccccCCeEEEEEEEEeCCCCEEEecCcccchhhhHHHHHHHHHhhCCCCeEEEee
Confidence 689998763 44689999876 999999999999988777776554431 2334445599999999999999
Q ss_pred cCCCCCC----cccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC---------------------------
Q 003932 97 GQGKDTN----YSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT--------------------------- 145 (785)
Q Consensus 97 gG~~~~~----~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~--------------------------- 145 (785)
|||+.+. +..|+.+++++++|++||+++++|+++|+|||||||||||+.
T Consensus 82 GGw~~~~~~~~s~~fs~~~~~~~~R~~Fi~siv~~l~~~~fDGidiDWEyP~~~~~~~~g~~~~~~~~~~~~~~g~~~~~ 161 (413)
T cd02873 82 GGDRDTDEEGENEKYLLLLESSESRNAFINSAHSLLKTYGFDGLDLAWQFPKNKPKKVRGTFGSAWHSFKKLFTGDSVVD 161 (413)
T ss_pred cCCCCCCCcccchhhHHHhCCHHHHHHHHHHHHHHHHHcCCCCeEeeeeCCCCcccccccccchhhhhhhcccccccccC
Confidence 9997643 457999999999999999999999999999999999999952
Q ss_pred ---CCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCC-CC
Q 003932 146 ---STDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTN-FT 221 (785)
Q Consensus 146 ---~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~-~~ 221 (785)
++|++||+.|+++||++|++. +..+++++++... ....||+++|+++|||||||||||||+|+.+ .+
T Consensus 162 ~~~~~d~~nf~~Ll~elr~~l~~~--------~~~ls~av~~~~~-~~~~~d~~~l~~~vD~inlMtYD~~g~~~~~~~~ 232 (413)
T cd02873 162 EKAAEHKEQFTALVRELKNALRPD--------GLLLTLTVLPHVN-STWYFDVPAIANNVDFVNLATFDFLTPERNPEEA 232 (413)
T ss_pred CCChhHHHHHHHHHHHHHHHhccc--------CcEEEEEecCCch-hccccCHHHHhhcCCEEEEEEecccCCCCCCCcc
Confidence 357899999999999999752 3456665543322 2345899999999999999999999998754 68
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeeccccccceeeecCCCC-CC-------CCCCCCCCccccCcccc
Q 003932 222 APPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPED-NG-------IGAAAAGPALYDSGLVT 293 (785)
Q Consensus 222 g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~-~~-------~~~~~~g~~~~~~g~~~ 293 (785)
+++|||+.........+++.+|++|++.|+|++||+||||||||.|+++++.. .+ .|....|+.+.++|.++
T Consensus 233 ~~~apL~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~w~l~~~~~~~g~~~~~~~~g~~~~G~~~~~~g~l~ 312 (413)
T cd02873 233 DYTAPIYELYERNPHHNVDYQVKYWLNQGTPASKLNLGIATYGRAWKLTKDSGITGVPPVLETDGPGPAGPQTKTPGLLS 312 (413)
T ss_pred CcCCccCCCccccccccHHHHHHHHHHcCCCHHHeEEEEecceeeeEccCCCCCcCCCCCccCCCCCCCCCCcCCCcccc
Confidence 99999997643333569999999999999999999999999999999876432 11 23334567778899999
Q ss_pred HHHHHhhhhhcC------CCeEEEecccee-eeeee-------cCCEEEEeCCHHHHHHHHhhhcccCccceEeeecccc
Q 003932 294 YKKIKNHIKTYG------PDVQVMYNSTYE-VNYFS-------TGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFD 359 (785)
Q Consensus 294 y~~i~~~~~~~~------~~~~~~~d~~~~-~~y~~-------~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~D 359 (785)
|.|||..+...+ ..++..||.... .+|.+ .+++||+|||++|++.|++||+++||||+|+|++++|
T Consensus 313 y~ei~~~~~~~~~~~g~~~~~~~~~d~~~~~~~y~y~~~d~~~~~~~wvsydd~~Si~~K~~y~~~~gLgGv~~W~l~~D 392 (413)
T cd02873 313 WPEICSKLPNPANLKGADAPLRKVGDPTKRFGSYAYRPADENGEHGIWVSYEDPDTAANKAGYAKAKGLGGVALFDLSLD 392 (413)
T ss_pred HHHHHHhhccCccccccccceeEeecccccccceEEeccccCCCCCeEEEeCCHHHHHHHHHHHHhCCCceEEEEeeecC
Confidence 999998765321 235667887765 36664 2357999999999999999999999999999999999
Q ss_pred ch
Q 003932 360 DH 361 (785)
Q Consensus 360 d~ 361 (785)
|.
T Consensus 393 D~ 394 (413)
T cd02873 393 DF 394 (413)
T ss_pred cC
Confidence 95
|
The IDGF's have an eight-stranded alpha/beta barrel fold and are related to the glycosyl hydrolase family 18 (GH18) chitinases, but they have an amino acid substitution known to abolish chitinase catalytic activity. IDGFs may have evolved from chitinases to gain new functions as growth factors, interacting with cell surface glycoproteins involved in growth-promoting processes. |
| >COG3325 ChiA Chitinase [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-62 Score=494.61 Aligned_cols=343 Identities=22% Similarity=0.306 Sum_probs=263.9
Q ss_pred CCCCCcEEEEEecCCC-----CCCcCCCCCCCCceEEEEEEEeeCCccE------------------EecCCCcc--HHH
Q 003932 21 AKAKPWIRVGYLNLSE-----VSTISGINYDLFTHLICSSADINSTTYQ------------------LSLSLPSD--ENQ 75 (785)
Q Consensus 21 ~~~~~~~~vgY~~~~~-----~~~~~~i~~~~~Thi~~~f~~~~~~~~~------------------~~~~~~~~--~~~ 75 (785)
....++++||||++|. .+.+.+||++++|||+|||+.|+.+|.. ....++|. ...
T Consensus 33 ~~d~~~rvvgYY~sWs~~d~~~y~~~DIp~~qlTHInYAF~~I~~~g~~~~~~~~~~~~~~~~~~~~~~e~dp~~~~~~G 112 (441)
T COG3325 33 TSDDQFKVVGYYTSWSQYDRQDYFPGDIPLDQLTHINYAFLDINSDGKSIESWVADEAALYGVPNIEGVELDPWSDPLKG 112 (441)
T ss_pred CCCCCceEEEEecccccCCCcccccccCCHHHhceeeEEEEEecCCCCccccccccchhhccccCcCceeeccccccccc
Confidence 3456689999999885 4578999999999999999999988832 11123333 233
Q ss_pred HHHHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCC---------CC
Q 003932 76 IAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPN---------TS 146 (785)
Q Consensus 76 ~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~---------~~ 146 (785)
...++..+|+++|++|+++|||||..|+. |+.|+++.++|++|++|+|+||++|+|||||||||||+ .+
T Consensus 113 ~~~~L~~lk~~~~d~k~l~SIGGWs~S~~--F~~~aad~a~re~Fa~saVe~~r~~~FDGVDIDWEYP~~~~~~~~~~~~ 190 (441)
T COG3325 113 HFGALFDLKATYPDLKTLISIGGWSDSGG--FSDMAADDASRENFAKSAVEFMRTYGFDGVDIDWEYPGSGGDAGNCGRP 190 (441)
T ss_pred hHHHHHHHhhhCCCceEEEeecccccCCC--cchhhcCHHHHHHHHHHHHHHHHhcCCCceeeccccCCCCCCCCCCCCc
Confidence 45667779999999999999999988877 99999999999999999999999999999999999994 34
Q ss_pred CCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCC
Q 003932 147 TDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAA 226 (785)
Q Consensus 147 ~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~ap 226 (785)
.+.+||+.|+++||++|+..+.... +++.|++++++... .....+..+++++|||||+|||||||+|. ..+|||||
T Consensus 191 ~d~~ny~~Ll~eLR~~LD~a~~edg--r~Y~LTiA~~as~~-~l~~~~~~~~~~~vDyiNiMTYDf~G~Wn-~~~Gh~a~ 266 (441)
T COG3325 191 KDKANYVLLLQELRKKLDKAGVEDG--RHYQLTIAAPASKD-KLEGLNHAEIAQYVDYINIMTYDFHGAWN-ETLGHHAA 266 (441)
T ss_pred ccHHHHHHHHHHHHHHHhhcccccC--ceEEEEEecCCchh-hhhcccHHHHHHHHhhhheeeeecccccc-cccccccc
Confidence 6889999999999999987654322 35566666665544 33478899999999999999999999986 56999999
Q ss_pred CCCCCCCCCC----CCH------HHHHHHHHHcCCCCCceeeccccccceeeecCCCCCC----CCCCCC--C--Ccccc
Q 003932 227 LYGSISGRFA----RST------DQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNG----IGAAAA--G--PALYD 288 (785)
Q Consensus 227 l~~~~~~~~~----~~~------~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~----~~~~~~--g--~~~~~ 288 (785)
||+.+.++.. +.+ ...++...+.++||+|||||+|||||+|..++....+ ...... | .+++.
T Consensus 267 Ly~~~~d~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~klvlG~p~YgRgw~~v~~~~~~~~~~~~q~~~n~g~~~Gtw~ 346 (441)
T COG3325 267 LYGTPKDPPLANGGFYVDAEVDGIDWLEEGFAGDVPPSKLVLGMPFYGRGWNGVDGGSLGTCPGLYQGLDNSGIPKGTWE 346 (441)
T ss_pred cccCCCCCccccCCeeEEEEechhHHHHhhhccCCCCceEEeeccccccccccccCcccCCCCCcccccCCCCCCCCccc
Confidence 9986655431 112 2345556667899999999999999999998765532 111111 1 12222
Q ss_pred CccccHHHH----HhhhhhcCCCeEEEeccceeeeeee--cCCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchh
Q 003932 289 SGLVTYKKI----KNHIKTYGPDVQVMYNSTYEVNYFS--TGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362 (785)
Q Consensus 289 ~g~~~y~~i----~~~~~~~~~~~~~~~d~~~~~~y~~--~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~ 362 (785)
.+...+... ....+...+++.+.||+.+.+||++ .++.||||||++||++|++||+++||||+|+|++++|- +
T Consensus 347 a~n~~~~~~~~~~l~~n~~~~~g~~~~~d~~a~apyL~n~~~~vFiSyDd~rSvkaK~eYv~~n~LGG~m~We~sgD~-n 425 (441)
T COG3325 347 AGNGDKDYGKAYDLDANNAGKNGYERYWDDVAKAPYLYNPEKGVFISYDDPRSVKAKAEYVADNNLGGMMFWEISGDE-N 425 (441)
T ss_pred ccccCccchhhccccccccCCCCeeEecccccccceeecCCCCeEEEccCCcchhhHHHHHhhcCccceEEEEecCCc-c
Confidence 222222111 1112233578999999999999995 56799999999999999999999999999999999994 4
Q ss_pred hhhhhhhh
Q 003932 363 WLLSQAAA 370 (785)
Q Consensus 363 ~~l~~~~~ 370 (785)
..|.+++.
T Consensus 426 ~~llna~~ 433 (441)
T COG3325 426 GVLLNAVN 433 (441)
T ss_pred hhHHHHhh
Confidence 55666654
|
|
| >KOG2806 consensus Chitinase [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-61 Score=524.44 Aligned_cols=342 Identities=25% Similarity=0.446 Sum_probs=285.6
Q ss_pred CCCCCcEEEEEecCCC-CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCC
Q 003932 21 AKAKPWIRVGYLNLSE-VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQG 99 (785)
Q Consensus 21 ~~~~~~~~vgY~~~~~-~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~ 99 (785)
...+.+..+|||..+. ...+++++.++|||++|+|+.++.++..+ +........+..+.+.+|.+||++|+|+|||||
T Consensus 53 ~~~c~~~~~~~~~~~~~~~~~~~~~~~~~TH~vfafa~~~~~~~~~-~~~~~~~~~f~~~~~~~k~~n~~vK~llSIGG~ 131 (432)
T KOG2806|consen 53 NTVCEKSIVGYYPSRIGPETLEDQDPLKCTHLVYAFAKMKRVGYVV-FCGARTMNRFSSYNQTAKSSNPTVKVMISIGGS 131 (432)
T ss_pred cccccceeEEEeCCCCCCCCccccChhhcCcceEEEeeecccccEE-eccchhhhhhHHHHHHHHhhCCCceEEEEecCC
Confidence 3446677899999888 88999999999999999999999998444 443444567778888899999999999999998
Q ss_pred CCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCC-CCCCchhHHHHHHHHHHHhhhhhhhcccccceeE
Q 003932 100 KDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPN-TSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLL 178 (785)
Q Consensus 100 ~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~-~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~ 178 (785)
. .++..|+.|++|++.|+.||+|+++|+++|+|||||||||||+ .+.|+.+|..|++|||++|.+..... .+...++
T Consensus 132 ~-~ns~~fs~~~s~~~~r~~FI~Sii~fl~~~~fDGvDL~We~P~~~~~d~~~~~~~i~elr~~~~~~~~~~-~~~~~~l 209 (432)
T KOG2806|consen 132 H-GNSGLFSLVLSDRMIRAKFIESVVSFIKDYGFDGVDLAWEWPLFTPSDQLEFSRFIQELRSAFARETLKS-PDTAKVL 209 (432)
T ss_pred C-CCccchhhhhcChHHHHHHHHHHHHHHHHcCCCceeeeeECCCCchhhHHHHHHHHHHHHHHHHHHhhcc-CCcccee
Confidence 3 3344599999999999999999999999999999999999997 67899999999999999998754322 2222233
Q ss_pred EEEeecccC-CCCccccHHHHHhccceeeeeeccCCCccCCC-CCCCCCCCCCCCC-CCCCCCHHHHHHHHHHcCCCCCc
Q 003932 179 ILTARFRYS-PPANSYLLNSIQRNLNWIHAVTASYYEPVSTN-FTAPPAALYGSIS-GRFARSTDQVLKAWIERGLSADK 255 (785)
Q Consensus 179 ~~~~~~~~~-~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~-~~g~~apl~~~~~-~~~~~~~~~~v~~~~~~gvp~~K 255 (785)
+.++..+.. ....+||+++|.+++||||||+|||||+|+++ .+||+||||+... ....++++.++++|++.|.||+|
T Consensus 210 ~~~v~~~~~~~~~~~ydi~~i~~~~DfiNi~syDf~gpw~~~~~tGp~aPl~~~~~~~~~~~Nvd~~~ky~~~~~~~~~K 289 (432)
T KOG2806|consen 210 EAVVADSKQSAYSDGYDYENLSKYVDFINIMSYDYYGPWSLPCFTGPPSPLYKGPSMTNPKMNVDSLLKYWTEKGLPPSK 289 (432)
T ss_pred eeccccCccchhhccCCHHHHHhhCCeEEEecccccCCCcCCCcCCCCcccCCCCcccccCcchhhhHHHHhhcCCCchh
Confidence 333333322 46778999999999999999999999999874 7999999998754 34467999999999999999999
Q ss_pred eeeccccccceeeecCCCCCCCCCCC-----CCC-ccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeec--CCEE
Q 003932 256 LVMCLPFYGYAWTLVKPEDNGIGAAA-----AGP-ALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFST--GTVW 327 (785)
Q Consensus 256 lvlGip~YG~~~~~~~~~~~~~~~~~-----~g~-~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~--~~~~ 327 (785)
++||||||||.|++++...+ .+.+. .++ ....+|.++|.|||+.....+ ...||+.+.+||.++ +++|
T Consensus 290 l~~gip~yg~~w~~~~~~~~-~~~~~~~~~~~~~~~~~~~g~ls~~ei~~~~~~~~---~~~~d~~~~~~Y~~~~~~~~w 365 (432)
T KOG2806|consen 290 LVLALPFYGRSWQLLEDSRS-SAAPPFGQAAPVSMRSKGGGYMSYPEICERKINTG---VTHWDEETQTPYLYNIPYDQW 365 (432)
T ss_pred eEEEEecceehhhhcCCcCC-CCCccCCCcccCccccccCceeeHHHHHHHhcccC---CceecCCceeeeEEecCCCeE
Confidence 99999999999999886554 33222 233 344789999999999644322 789999999999998 9999
Q ss_pred EEeCCHHHHHHHHhhhcccCccceEeeeccccchhhhhhhhh
Q 003932 328 FGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAA 369 (785)
Q Consensus 328 i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~~~l~~~~ 369 (785)
|+|||++|++.|++||+++||||+|+|++|+||....++.++
T Consensus 366 vtyen~~Si~~K~~Yvk~~~lGGv~iW~vd~DD~~~~~~~~~ 407 (432)
T KOG2806|consen 366 VTYENERSIHIKADYAKDEGLGGVAIWNIDQDDESGSLLNAA 407 (432)
T ss_pred EecCCHHHHHHHHHHHHhcCCceEEEEeccCCCCCCcccccc
Confidence 999999999999999999999999999999999888766643
|
|
| >cd02872 GH18_chitolectin_chitotriosidase This conserved domain family includes a large number of catalytically inactive chitinase-like lectins (chitolectins) including YKL-39, YKL-40 (HCGP39), YM1, oviductin, and AMCase (acidic mammalian chitinase), as well as catalytically active chitotriosidases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-61 Score=519.96 Aligned_cols=323 Identities=28% Similarity=0.466 Sum_probs=273.0
Q ss_pred EEEEecCCC-------CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCcc--HHHHHHHHHHHHhcCCCceEEEEecC
Q 003932 28 RVGYLNLSE-------VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSD--ENQIAKFADTVKKKNPSITTILSIGQ 98 (785)
Q Consensus 28 ~vgY~~~~~-------~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~--~~~~~~~~~~~k~~~p~lkv~~sigG 98 (785)
+||||++|. .+.+++||+++||||+|+|+.++++|. +...+++. .....+.+.++|++||++||++||||
T Consensus 1 v~~y~~~w~~~~~~~~~~~~~~i~~~~~Thv~y~f~~i~~~g~-~~~~~~~~d~~~~~~~~~~~lk~~~p~lkvlisiGG 79 (362)
T cd02872 1 VVCYFTNWAQYRPGNGKFVPENIDPFLCTHIIYAFAGLNPDGN-IIILDEWNDIDLGLYERFNALKEKNPNLKTLLAIGG 79 (362)
T ss_pred CEEEECcchhcCCCCCCcChhHCCcccCCEEEEeeEEECCCCC-EEecCchhhhhhhHHHHHHHHHhhCCCceEEEEEcC
Confidence 489998874 357899999999999999999999874 44444443 33444445569999999999999998
Q ss_pred CCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC----CCCchhHHHHHHHHHHHhhhhhhhccccc
Q 003932 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT----STDMFNIGLLFDEWRIAATKLDAKNSTRQ 174 (785)
Q Consensus 99 ~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~----~~d~~~~~~ll~~lr~~l~~~~~~~~~~~ 174 (785)
|..+ +..|+.+++++++|++||+++++++++|||||||||||||+. ++|+++|+.|+++||++|++.+ +
T Consensus 80 ~~~~-~~~f~~~~~~~~~r~~fi~~iv~~l~~~~~DGidiDwE~p~~~~~~~~d~~~~~~ll~~lr~~l~~~~------~ 152 (362)
T cd02872 80 WNFG-SAKFSAMAASPENRKTFIKSAIAFLRKYGFDGLDLDWEYPGQRGGPPEDKENFVTLLKELREAFEPEA------P 152 (362)
T ss_pred CCCC-cchhHHHhCCHHHHHHHHHHHHHHHHHcCCCCeeeeeeccccCCCCHHHHHHHHHHHHHHHHHHHhhC------c
Confidence 8753 336999999999999999999999999999999999999964 5789999999999999997632 2
Q ss_pred ceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHcCC
Q 003932 175 QSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGR---FARSTDQVLKAWIERGL 251 (785)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~---~~~~~~~~v~~~~~~gv 251 (785)
+..+++++++........||+++|.+++||||||+||++++|. ..+|++|||+..+... ...+++.+|++|++.|+
T Consensus 153 ~~~ls~av~~~~~~~~~~~d~~~l~~~vD~v~vmtYD~~~~~~-~~~g~~spl~~~~~~~~~~~~~~v~~~v~~~~~~gv 231 (362)
T cd02872 153 RLLLTAAVSAGKETIDAAYDIPEISKYLDFINVMTYDFHGSWE-GVTGHNSPLYAGSADTGDQKYLNVDYAIKYWLSKGA 231 (362)
T ss_pred CeEEEEEecCChHHHhhcCCHHHHhhhcceEEEecccCCCCCC-CCCCCCCCCCCCCCCccccccccHHHHHHHHHHcCC
Confidence 4556666655443334579999999999999999999999986 4699999999765432 35689999999999999
Q ss_pred CCCceeeccccccceeeecCCCCCCCCCCCCCC-----ccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCE
Q 003932 252 SADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGP-----ALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTV 326 (785)
Q Consensus 252 p~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~-----~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~ 326 (785)
|++||+||||||||.|+++++.+++.|++..|+ .+.+.|.++|.|||+.+ . .++...||+.+.+||.+.+++
T Consensus 232 p~~KlvlGlp~YG~~~~~~~~~~~~~g~~~~g~~~~g~~~~~~g~~~y~ei~~~~-~--~~~~~~~D~~~~~~y~~~~~~ 308 (362)
T cd02872 232 PPEKLVLGIPTYGRSFTLASPSNTGVGAPASGPGTAGPYTREAGFLAYYEICEFL-K--SGWTVVWDDEQKVPYAYKGNQ 308 (362)
T ss_pred CHHHeEeccccccceeeecCCccCCCCCccCCCCCCCCCcCCCccchHHHHHHhh-c--CCcEEEEeCCcceeEEEECCE
Confidence 999999999999999999887777777766543 45678999999999876 3 458999999999999988999
Q ss_pred EEEeCCHHHHHHHHhhhcccCccceEeeeccccchh
Q 003932 327 WFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362 (785)
Q Consensus 327 ~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~ 362 (785)
||+|||++|++.|++||+++||||+|+|++++||..
T Consensus 309 ~v~ydd~~Si~~K~~~~~~~~lgGv~iW~l~~DD~~ 344 (362)
T cd02872 309 WVGYDDEESIALKVQYLKSKGLGGAMVWSIDLDDFR 344 (362)
T ss_pred EEEeCCHHHHHHHHHHHHhCCCceEEEEeeecCcCC
Confidence 999999999999999999999999999999999954
|
The conserved domain is an eight-stranded alpha/beta barrel fold belonging to the family 18 glycosyl hydrolases. The fold has a pronounced active-site cleft at the C-terminal end of the beta-barrel. The chitolectins lack a key active site glutamate (the proton donor required for hydrolytic activity) but retain highly conserved residues involved in oligosaccharide binding. Chitotriosidase is a chitinolytic enzyme expressed in maturing macrophages, which suggests that it plays a part in antimicrobial defense. Chitotriosidase hydrolyzes chitotriose, as well as colloidal chitin to yield chitobiose and is therefore considered an exochitinase. Chitotriosidase occurs in two major forms, the la |
| >cd02878 GH18_zymocin_alpha Zymocin, alpha subunit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-59 Score=500.28 Aligned_cols=312 Identities=17% Similarity=0.290 Sum_probs=249.7
Q ss_pred EEEEEecCCC------CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCC
Q 003932 27 IRVGYLNLSE------VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGK 100 (785)
Q Consensus 27 ~~vgY~~~~~------~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~ 100 (785)
++||||++|. .+.+++||+++||||+|+|+.++++| ++...+ ....+.++.+ +| ++|||+|||||+
T Consensus 1 ~~v~Y~~~w~~~r~~~~~~~~~i~~~~~THi~yaf~~~~~~g-~l~~~~--~~~~~~~~~~-~k----~lkvllsiGG~~ 72 (345)
T cd02878 1 KNIAYFEAYNLDRPCLNMDVTQIDTSKYTHIHFAFANITSDF-SVDVSS--VQEQFSDFKK-LK----GVKKILSFGGWD 72 (345)
T ss_pred CEEEEEChhhcCCCCCCCCHhHCCcccCCEEEEEeEeecCCC-eEeecc--cHHHHHHHHh-hc----CcEEEEEEeCCC
Confidence 3699999884 46799999999999999999999887 665542 3344444432 33 299999999998
Q ss_pred CCCc----ccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC----------CCCchhHHHHHHHHHHHhhhh
Q 003932 101 DTNY----SIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT----------STDMFNIGLLFDEWRIAATKL 166 (785)
Q Consensus 101 ~~~~----~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~----------~~d~~~~~~ll~~lr~~l~~~ 166 (785)
.++. ..|+.++ ++++|++||+++++++++|||||||||||||+. ++|+++|+.|+++||++|++
T Consensus 73 ~s~~~~~~~~f~~~~-~~~~R~~Fi~si~~~~~~~~fDGidiDwE~P~~~~~~~~~~~~~~d~~n~~~ll~elr~~l~~- 150 (345)
T cd02878 73 FSTSPSTYQIFRDAV-KPANRDTFANNVVNFVNKYNLDGVDFDWEYPGAPDIPGIPAGDPDDGKNYLEFLKLLKSKLPS- 150 (345)
T ss_pred CCCCCccchhhHhhc-CHHHHHHHHHHHHHHHHHcCCCceeecccCCcccCCCCCCCCChHHHHHHHHHHHHHHHHhCc-
Confidence 6553 2588888 999999999999999999999999999999953 35889999999999999964
Q ss_pred hhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCC---CC-CCCCHHHH
Q 003932 167 DAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSIS---GR-FARSTDQV 242 (785)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~---~~-~~~~~~~~ 242 (785)
+..+++++++.. .....|+++++.+++|||||||||+||+|... +++++|...... .. ...+++.+
T Consensus 151 --------~~~ls~a~~~~~-~~~~~yd~~~l~~~vD~i~vMtYD~~g~w~~~-~~~~~p~~p~~~~~~~~~~~~~~~~~ 220 (345)
T cd02878 151 --------GKSLSIAAPASY-WYLKGFPIKDMAKYVDYIVYMTYDLHGQWDYG-NKWASPGCPAGNCLRSHVNKTETLDA 220 (345)
T ss_pred --------CcEEEEEcCCCh-hhhcCCcHHHHHhhCcEEEEEeecccCCcCcc-CCcCCCCCCcccccccCCCchhHHHH
Confidence 445666554432 22356999999999999999999999999743 444544221110 00 11258899
Q ss_pred HHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCCCCc--------cccCccccHHHHHhhhhhcCCCeEEEecc
Q 003932 243 LKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPA--------LYDSGLVTYKKIKNHIKTYGPDVQVMYNS 314 (785)
Q Consensus 243 v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~--------~~~~g~~~y~~i~~~~~~~~~~~~~~~d~ 314 (785)
|++|++.|+|++||+||||||||.|+++++.++++++|..|++ +...|.+.|.+||..+... .++...||.
T Consensus 221 v~~~~~~Gvp~~KlvlGip~YGr~~~l~~~~~~~~~~p~~g~~~~~~~g~~~~~~g~~~~~e~~~~~~~~-~~~~~~~d~ 299 (345)
T cd02878 221 LSMITKAGVPSNKVVVGVASYGRSFKMADPGCTGPGCTFTGPGSGAEAGRCTCTAGYGAISEIEIIDISK-SKNKRWYDT 299 (345)
T ss_pred HHHHHHcCCCHHHeEEeeccccceeeccCCCCCCCCCcccCCCCCCCCCCCCCchhhhhHHHHHHHHhcc-CCCcEEEec
Confidence 9999999999999999999999999999999888888887663 2344556669998754332 358999999
Q ss_pred ceeeeee-ecCCEEEEeCCHHHHHHHHhhhcccCccceEeeecccc
Q 003932 315 TYEVNYF-STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFD 359 (785)
Q Consensus 315 ~~~~~y~-~~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~D 359 (785)
.+.+||. +++++||+|||++|++.|++||+++||||+|+|+||+|
T Consensus 300 ~~~~~y~~~~~~~wv~ydd~~Si~~K~~y~~~~~LgGv~~W~ld~~ 345 (345)
T cd02878 300 DSDSDILVYDDDQWVAYMSPATKAARIEWYKGLNFGGTSDWAVDLQ 345 (345)
T ss_pred CCCccEEEEcCCEEEEcCCHHHHHHHHHHHHhCCCceEEEeeccCC
Confidence 9999987 56779999999999999999999999999999999987
|
Zymocin is a heterotrimeric enzyme that inhibits yeast cell cycle progression. The zymocin alpha subunit has a chitinase activity that is essential for holoenzyme action from the cell exterior while the gamma subunit contains the intracellular toxin responsible for G1 phase cell cycle arrest. The zymocin alpha and beta subunits are thought to act from the cell's exterior by docking to the cell wall-associated chitin, thus mediating gamma-toxin translocation. The alpha subunit has an eight-stranded TIM barrel fold similar to that of family 18 glycosyl hydrolases such as hevamine, chitolectin, and chitobiase. |
| >smart00636 Glyco_18 Glycosyl hydrolase family 18 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-58 Score=496.58 Aligned_cols=320 Identities=30% Similarity=0.509 Sum_probs=270.9
Q ss_pred EEEEEecCCCC----CCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccH-HHHHHHHHHHHhcCCCceEEEEecCCCC
Q 003932 27 IRVGYLNLSEV----STISGINYDLFTHLICSSADINSTTYQLSLSLPSDE-NQIAKFADTVKKKNPSITTILSIGQGKD 101 (785)
Q Consensus 27 ~~vgY~~~~~~----~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~k~~~p~lkv~~sigG~~~ 101 (785)
+++|||++|.. ++++++|.++||||+|+|+.++++| .+.+.++..+ ..+.. +..+|+++|++|+|+|||||+.
T Consensus 1 ~~~~Y~~~w~~~~~~~~~~~~~~~~~thv~~~~~~~~~~g-~~~~~~~~~~~~~~~~-~~~l~~~~~~~kvl~svgg~~~ 78 (334)
T smart00636 1 RVVGYFTNWGVYGRNFPVDDIPASKLTHIIYAFANIDPDG-TVTIGDEWADIGNFGQ-LKALKKKNPGLKVLLSIGGWTE 78 (334)
T ss_pred CEEEEECchhccCCCCChhHCCcccCcEEEEeeeeeCCCC-CEeeCCcchhhhhHHH-HHHHHHhCCCCEEEEEEeCCCC
Confidence 36999999873 7899999999999999999999976 6666654444 23444 5558999999999999999876
Q ss_pred CCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCC-CCchhHHHHHHHHHHHhhhhhhhcccccceeEEE
Q 003932 102 TNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTS-TDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLIL 180 (785)
Q Consensus 102 ~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~-~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~ 180 (785)
+ ..|+.+++++++|++||+++++++++|+|||||||||+|+.. .++++|+.|+++||++|++.. . ..++..+++
T Consensus 79 s--~~f~~~~~~~~~r~~fi~~i~~~~~~~~~DGidiDwE~~~~~~~d~~~~~~ll~~lr~~l~~~~--~-~~~~~~lsi 153 (334)
T smart00636 79 S--DNFSSMLSDPASRKKFIDSIVSFLKKYGFDGIDIDWEYPGARGDDRENYTALLKELREALDKEG--A-EGKGYLLTI 153 (334)
T ss_pred C--cchhHHHCCHHHHHHHHHHHHHHHHHcCCCeEEECCcCCCCCccHHHHHHHHHHHHHHHHHHhc--c-cCCceEEEE
Confidence 3 559999999999999999999999999999999999999654 688999999999999997641 1 133566666
Q ss_pred EeecccCCCCcccc-HHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeec
Q 003932 181 TARFRYSPPANSYL-LNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMC 259 (785)
Q Consensus 181 ~~~~~~~~~~~~~~-~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~KlvlG 259 (785)
++++........|+ ++++.+++|||++|+||+|++|++ .+||+|||+.........+++.+|++|++.|+|++||+||
T Consensus 154 ~v~~~~~~~~~~~~~~~~l~~~vD~v~vm~YD~~~~~~~-~~g~~spl~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlG 232 (334)
T smart00636 154 AVPAGPDKIDKGYGDLPAIAKYLDFINLMTYDFHGAWSN-PTGHNAPLYAGPGDPEKYNVDYAVKYYLCKGVPPSKLVLG 232 (334)
T ss_pred EecCChHHHHhhhhhHHHHHhhCcEEEEeeeccCCCCCC-CCCCCCcCCCCCCCCCCccHHHHHHHHHHcCCCHHHeEEe
Confidence 66654433334588 599999999999999999999864 6999999998665445668999999999999999999999
Q ss_pred cccccceeeecCCCCCCCCCCCCCC-----ccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeec-C-CEEEEeCC
Q 003932 260 LPFYGYAWTLVKPEDNGIGAAAAGP-----ALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFST-G-TVWFGFDD 332 (785)
Q Consensus 260 ip~YG~~~~~~~~~~~~~~~~~~g~-----~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~-~-~~~i~ydd 332 (785)
||||||.|++.++..++++++..|+ .+...|.++|.+||+.. ++...||+.+.++|.+. + ++||+|||
T Consensus 233 ip~YG~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~y~ei~~~~-----~~~~~~d~~~~~~y~~~~~~~~~v~ydd 307 (334)
T smart00636 233 IPFYGRGWTLVDGSNNGPGAPFTGPATGGPGTWEGGVVDYREICKLL-----GATVVWDDTAKAPYAYNPGTGQWVSYDD 307 (334)
T ss_pred eccccCccccCCCCcCCCCCcccCCCCCCCCCCcccchhHHHHHhhc-----CcEEEEcCCCceeEEEECCCCEEEEcCC
Confidence 9999999999888777777776554 44578899999999874 48899999998999865 3 59999999
Q ss_pred HHHHHHHHhhhcccCccceEeeecccc
Q 003932 333 VEAVRAKIAYAKEKRLLGYYAWQVSFD 359 (785)
Q Consensus 333 ~~Si~~K~~~~~~~glgG~~~W~l~~D 359 (785)
++|++.|++||+++||||+|+|+|++|
T Consensus 308 ~~Si~~K~~~~~~~~lgGv~iW~l~~D 334 (334)
T smart00636 308 PRSIKAKADYVKDKGLGGVMIWELDAD 334 (334)
T ss_pred HHHHHHHHHHHHhCCCCeEEEEeecCC
Confidence 999999999999999999999999997
|
|
| >cd06548 GH18_chitinase The GH18 (glycosyl hydrolases, family 18) type II chitinases hydrolyze chitin, an abundant polymer of N-acetylglucosamine and have been identified in bacteria, fungi, insects, plants, viruses, and protozoan parasites | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-58 Score=490.23 Aligned_cols=287 Identities=28% Similarity=0.437 Sum_probs=240.5
Q ss_pred EEEEecCCCCCC----cC-CCCCCCCceEEEEEEEeeCCccEEecCCCc------------------cHHHHHHHHHHHH
Q 003932 28 RVGYLNLSEVST----IS-GINYDLFTHLICSSADINSTTYQLSLSLPS------------------DENQIAKFADTVK 84 (785)
Q Consensus 28 ~vgY~~~~~~~~----~~-~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~k 84 (785)
++|||++|..+. +. +||+++||||+|+|+.++++|..+...+.+ ....+.+ +..+|
T Consensus 1 v~~Y~~~W~~~~~~~~~~~~i~~~~~THl~yaf~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~lk 79 (322)
T cd06548 1 VVGYFTNWGIYGRNYFVTDDIPADKLTHINYAFADIDGDGGVVTSDDEAADEAAQSVDGGADTDDQPLKGNFGQ-LRKLK 79 (322)
T ss_pred CEEEeCCCcccCCCCCcccCCChhHCcEEEEEeeeEcCCCCeEccChhhhhhccccCCcccccCCccchhHHHH-HHHHH
Confidence 489999997553 34 599999999999999999998655433221 1223444 44599
Q ss_pred hcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC---------CCCchhHHHH
Q 003932 85 KKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT---------STDMFNIGLL 155 (785)
Q Consensus 85 ~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~---------~~d~~~~~~l 155 (785)
++||++|||+|||||+.+ ..|+.++++++.|++||+++++++++|+|||||||||||+. ++|+++|+.|
T Consensus 80 ~~~p~lkvl~siGG~~~s--~~f~~~~~~~~~r~~Fi~siv~~l~~~~fDGidiDwE~p~~~~~~~~~~~~~d~~~~~~l 157 (322)
T cd06548 80 QKNPHLKILLSIGGWTWS--GGFSDAAATEASRAKFADSAVDFIRKYGFDGIDIDWEYPGSGGAPGNVARPEDKENFTLL 157 (322)
T ss_pred HhCCCCEEEEEEeCCCCC--CCchhHhCCHHHHHHHHHHHHHHHHhcCCCeEEECCcCCCCCCCCCCCCChhHHHHHHHH
Confidence 999999999999998765 45999999999999999999999999999999999999965 5789999999
Q ss_pred HHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCC-C
Q 003932 156 FDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISG-R 234 (785)
Q Consensus 156 l~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~-~ 234 (785)
|++||++|+..+.. ..++..+++++++... ....+++++|.++|||||+|||||||+|+ ..+||+|||++.+.. .
T Consensus 158 l~~Lr~~l~~~~~~--~~~~~~Ls~av~~~~~-~~~~~~~~~l~~~vD~vnlMtYD~~g~w~-~~~g~~spL~~~~~~~~ 233 (322)
T cd06548 158 LKELREALDALGAE--TGRKYLLTIAAPAGPD-KLDKLEVAEIAKYLDFINLMTYDFHGAWS-NTTGHHSNLYASPADPP 233 (322)
T ss_pred HHHHHHHHHHhhhc--cCCceEEEEEccCCHH-HHhcCCHHHHhhcCCEEEEEEeeccCCCC-CCCCCCCCCCCCCCCCC
Confidence 99999999875432 1224556665544332 23457899999999999999999999987 569999999976543 2
Q ss_pred CCCCHHHHHHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEecc
Q 003932 235 FARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNS 314 (785)
Q Consensus 235 ~~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~ 314 (785)
...+++.+|++|++.|+|++||+||||||||.|++ +...||+
T Consensus 234 ~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~~~~--------------------------------------~~~~~D~ 275 (322)
T cd06548 234 GGYSVDAAVNYYLSAGVPPEKLVLGVPFYGRGWTG--------------------------------------YTRYWDE 275 (322)
T ss_pred CCccHHHHHHHHHHcCCCHHHeEEEecccccccCC--------------------------------------cEEEEcC
Confidence 35689999999999999999999999999999963 5778999
Q ss_pred ceeeeeeecC--CEEEEeCCHHHHHHHHhhhcccCccceEeeecccc
Q 003932 315 TYEVNYFSTG--TVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFD 359 (785)
Q Consensus 315 ~~~~~y~~~~--~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~D 359 (785)
.+.+||.+++ ++||+|||++||+.|++||+++||||+|+|++++|
T Consensus 276 ~~~~~y~~~~~~~~~v~ydd~~Si~~K~~~a~~~~LgGv~~W~l~~D 322 (322)
T cd06548 276 VAKAPYLYNPSTKTFISYDDPRSIKAKADYVKDKGLGGVMFWELSGD 322 (322)
T ss_pred CcceeEEEeCCCCeEEEeCCHHHHHHHHHHHHhcCCccEEEEeccCC
Confidence 9999999766 89999999999999999999999999999999997
|
The structure of this domain is an eight-stranded alpha/beta barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. |
| >PF00704 Glyco_hydro_18: Glycosyl hydrolases family 18; InterPro: IPR001223 O-Glycosyl hydrolases 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=450.23 Aligned_cols=326 Identities=27% Similarity=0.445 Sum_probs=266.6
Q ss_pred cEEEEEecCCCC-----CCcCCCCCCCCceEEEEEEEeeCCccEEe----cCCCccHHHHHHHHHHHHhcCCCceEEEEe
Q 003932 26 WIRVGYLNLSEV-----STISGINYDLFTHLICSSADINSTTYQLS----LSLPSDENQIAKFADTVKKKNPSITTILSI 96 (785)
Q Consensus 26 ~~~vgY~~~~~~-----~~~~~i~~~~~Thi~~~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~k~~~p~lkv~~si 96 (785)
++++|||.+|.. +.++++++++||||+|+|+.++.++.... .............+..+|+++|++||++||
T Consensus 1 ~~vv~Y~~~~~~~~~~~~~~~~i~~~~~t~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kvllsi 80 (343)
T PF00704_consen 1 KRVVGYYSNWNSYRPGSYKIEDIPWSKCTHIVYAFAGIDPNGNLNYPWNFDDDNDGDSSGFKNLKELKAKNPGVKVLLSI 80 (343)
T ss_dssp BEEEEEEEGGGGSSTGCSHGGGSHTTTESEEEEEEEEEETTTTEEEGTTTECSSTTHHHHHHHHHHHHHHHTT-EEEEEE
T ss_pred CEEEEEECCcCCCCCCCCCHHHCCcccCCEEEEEeeeecCCCceecccccccccCccccchhHHHHHHhhccCceEEEEe
Confidence 478999998853 56889999999999999999999985532 122233444445556689999999999999
Q ss_pred cCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCC---CCchhHHHHHHHHHHHhhhhhhhcccc
Q 003932 97 GQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTS---TDMFNIGLLFDEWRIAATKLDAKNSTR 173 (785)
Q Consensus 97 gG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~---~d~~~~~~ll~~lr~~l~~~~~~~~~~ 173 (785)
|||+.+. ..|+.++++++.|++||+++++++++|||||||||||+|+.. .++.+|..|+++||++|++.....
T Consensus 81 gg~~~~~-~~~~~~~~~~~~r~~f~~~i~~~l~~y~~DGidiD~e~~~~~~~~~~~~~~~~~l~~L~~~l~~~~~~~--- 156 (343)
T PF00704_consen 81 GGWGMSS-DGFSQLLSNPAKRQNFINNIVSFLKKYGFDGIDIDWEYPSSSGDPQDKDNYTAFLKELRKALKRANRSG--- 156 (343)
T ss_dssp EETTSSH-HHHHHHHHSHHHHHHHHHHHHHHHHHHT-SEEEEEESSTTSTSSTTHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred ccccccc-cccccccccHHHHHHHHHhhhhhhcccCcceeeeeeeeccccccchhhhhhhhhhhhhhhhhccccccc---
Confidence 9886654 259999999999999999999999999999999999999653 589999999999999998753322
Q ss_pred cceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCC
Q 003932 174 QQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSA 253 (785)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~ 253 (785)
++..+++++++... ....++++++.+++|||++|+||++++|.+ .++|++|+++...+....+++.++++|+..|+|+
T Consensus 157 ~~~~ls~a~p~~~~-~~~~~~~~~l~~~vD~v~~m~yD~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~v~~~~~~g~p~ 234 (343)
T PF00704_consen 157 KGYILSVAVPPSPD-YYDKYDYKELAQYVDYVNLMTYDYHGPWSD-VTGPNAPLYDSSWDSNYYSVDSAVQYWIKAGVPP 234 (343)
T ss_dssp STSEEEEEEECSHH-HHTTHHHHHHHTTSSEEEEETTSSSSTTSS-BETTSSSSSHTTTSGTSSSHHHHHHHHHHTTSTG
T ss_pred ceeEEeeccccccc-cccccccccccccccccccccccCCCCccc-ccccccccccCCccCCCceeeeehhhhccccCCh
Confidence 24566666555443 233458999999999999999999998876 7999999997654334568999999999999999
Q ss_pred CceeeccccccceeeecCCCCCCCCCCC---CCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecC--CEEE
Q 003932 254 DKLVMCLPFYGYAWTLVKPEDNGIGAAA---AGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTG--TVWF 328 (785)
Q Consensus 254 ~KlvlGip~YG~~~~~~~~~~~~~~~~~---~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~--~~~i 328 (785)
+||+||+|+||+.|++.+...+....+. .+..+..+|.++|.++|...+++ ++...||+.+..+|.... ++||
T Consensus 235 ~Kl~lglp~yg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~~~~~~y~~~~~~~~~i 312 (343)
T PF00704_consen 235 SKLVLGLPFYGRSWTLVNGSPNGPWGPAYWSPGKGTKNAGILSYYELCALLKSN--GYTVQWDDTAQAPYAYNDDKKHWI 312 (343)
T ss_dssp GGEEEEEESEEEEEESSSSTTSTTTBBEESEETTTTSBTTEEEHHHHHHHTHHT--TEEEEEETTTTEEEEEETTTTEEE
T ss_pred hheeecCCcccccceecCCcCCCCCCcccccccccccCCCccccccchhhcccC--CcceEEeecccceEEEecCCCeEE
Confidence 9999999999999999877666554432 45667889999999999987643 488899999999998766 7999
Q ss_pred EeCCHHHHHHHHhhhcccCccceEeeecccc
Q 003932 329 GFDDVEAVRAKIAYAKEKRLLGYYAWQVSFD 359 (785)
Q Consensus 329 ~ydd~~Si~~K~~~~~~~glgG~~~W~l~~D 359 (785)
+|||++|++.|++|++++||||+|+|+|++|
T Consensus 313 ~~e~~~Si~~K~~~v~~~glgGv~~W~l~~D 343 (343)
T PF00704_consen 313 SYEDPRSIKAKMDYVKEKGLGGVAIWSLDQD 343 (343)
T ss_dssp EE--HHHHHHHHHHHHHTT-SEEEEETGGGS
T ss_pred EeCCHHHHHHHHHHHHhCCCCEEEEEecCCC
Confidence 9999999999999999999999999999998
|
2.1. from EC are a widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a non-carbohydrate moiety. A classification system for glycosyl hydrolases, based on sequence similarity, has led to the definition of 85 different families [, ]. This classification is available on the CAZy (CArbohydrate-Active EnZymes) web site. Some members of this family, GH18 from CAZY, belong to the chitinase class II group which includes chitinase, chitodextrinase and the killer toxin of Kluyveromyces lactis. The chitinases hydrolyse chitin oligosaccharides. The family also includes various glycoproteins from mammals; cartilage glycoprotein and the oviduct-specific glycoproteins are two examples.; GO: 0004553 hydrolase activity, hydrolyzing O-glycosyl compounds, 0005975 carbohydrate metabolic process; PDB: 1ITX_A 3ALG_A 3ALF_A 1NAR_A 3QOK_A 3G6L_A 3G6M_A 2DT1_A 2B31_A 2O92_A .... |
| >cd02876 GH18_SI-CLP Stabilin-1 interacting chitinase-like protein (SI-CLP) is a eukaryotic chitinase-like protein of unknown function that interacts with the endocytic/sorting transmembrane receptor stabilin-1 and is secreted from the lysosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=442.01 Aligned_cols=292 Identities=16% Similarity=0.196 Sum_probs=233.6
Q ss_pred EEEEEecCCC--CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEE--EEecCCCCC
Q 003932 27 IRVGYLNLSE--VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTI--LSIGQGKDT 102 (785)
Q Consensus 27 ~~vgY~~~~~--~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~--~sigG~~~~ 102 (785)
.++|||++|. .+.+.+++.++||||+|+|+.++++|+.+......+. + ...+..+|+++|++||+ +++|||..
T Consensus 4 ~~~~y~~~W~~~~~~~~~~~~~~lthv~~~f~~i~~~g~~~~~~~~~~~-~-~~~~~~lk~~~~~lkvlp~i~~gg~~~- 80 (318)
T cd02876 4 PVLGYVTPWNSHGYDVAKKFAAKFTHVSPVWLQIKRKGNKFVIEGTHDI-D-KGWIEEVRKANKNIKILPRVLFEGWSY- 80 (318)
T ss_pred ceEEEEcCcCccchHHHHHHhccCCEecceEEEEecCCCeeeeecCcch-h-hHHHHHHHhhCCCcEEEeEEEECCCCH-
Confidence 3689999986 4578889999999999999999988865544432121 1 22455689999999999 66788753
Q ss_pred CcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeee-ccCCCC---CCCchhHHHHHHHHHHHhhhhhhhcccccceeE
Q 003932 103 NYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFA-WTAPNT---STDMFNIGLLFDEWRIAATKLDAKNSTRQQSLL 178 (785)
Q Consensus 103 ~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiD-wE~p~~---~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~ 178 (785)
..|+.+++|+++|++||+++++++++||||||||| ||||+. ++++++|+.|+++||++|++. +..+
T Consensus 81 --~~f~~~~~~~~~R~~fi~s~~~~~~~~~~DGidiD~we~p~~~~~~~d~~~~~~~l~el~~~l~~~--------~~~l 150 (318)
T cd02876 81 --QDLQSLLNDEQEREKLIKLLVTTAKKNHFDGIVLEVWSQLAAYGVPDKRKELIQLVIHLGETLHSA--------NLKL 150 (318)
T ss_pred --HHHHHHHcCHHHHHHHHHHHHHHHHHcCCCcEEEechhhhcccCCHHHHHHHHHHHHHHHHHHhhc--------CCEE
Confidence 35999999999999999999999999999999999 999954 358999999999999999763 3455
Q ss_pred EEEeecccCC-----CCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcC-CC
Q 003932 179 ILTARFRYSP-----PANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERG-LS 252 (785)
Q Consensus 179 ~~~~~~~~~~-----~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~g-vp 252 (785)
++++++.... ....||+++|++++|||||||||+||+ +.+||+||++ +++.++++|++.| +|
T Consensus 151 ~~~v~~~~~~~~~~~~~~~~d~~~l~~~vD~v~lMtYD~~~~---~~~g~~apl~---------~v~~~v~~~~~~~~vp 218 (318)
T cd02876 151 ILVIPPPREKGNQNGLFTRKDFEKLAPHVDGFSLMTYDYSSP---QRPGPNAPLS---------WVRSCLELLLPESGKK 218 (318)
T ss_pred EEEEcCccccccccccccccCHHHHHhhccEEEEEeeccCCC---CCCCCCCCcH---------HHHHHHHHHHhcCCCC
Confidence 6655544322 234689999999999999999999986 4699999997 8999999999987 99
Q ss_pred CCceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeee-eeecC---CEEE
Q 003932 253 ADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVN-YFSTG---TVWF 328 (785)
Q Consensus 253 ~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~-y~~~~---~~~i 328 (785)
++||+||||||||.|++.+ .+.+..+ ..|.+++. .. +++..||+.+..+ |.+.+ ++||
T Consensus 219 ~~KlvlGip~YG~~w~~~~-----~~~~~~~--------~~~~~~~~---~~--~~~~~~d~~~~~~~~~y~~~~~~~~v 280 (318)
T cd02876 219 RAKILLGLNFYGNDYTLPG-----GGGAITG--------SEYLKLLK---SN--KPKLQWDEKSAEHFFEYKNKGGKHAV 280 (318)
T ss_pred HHHeEEeccccccccccCC-----CCceeeh--------HHHHHHHH---hc--CCCceeccCCCcceEEEecCCCcEEE
Confidence 9999999999999998643 1111111 23444444 22 3678999986665 44433 7999
Q ss_pred EeCCHHHHHHHHhhhcccCccceEeeeccccchh
Q 003932 329 GFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362 (785)
Q Consensus 329 ~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~ 362 (785)
+|||++|++.|++||+++|| |+|+|+|+++++.
T Consensus 281 ~ydd~~Si~~K~~~a~~~~l-Gv~~W~lg~~~~~ 313 (318)
T cd02876 281 FYPTLKSIQLRLDLAKELGT-GISIWELGQGLDY 313 (318)
T ss_pred EeCCHHHHHHHHHHHHHcCC-cEEEEcccCCchH
Confidence 99999999999999999999 9999999999755
|
SI-CLP has a glycosyl hydrolase family 18 (GH18) domain but lacks a chitin-binding domain. The catalytic amino acids of the GH18 domain are not conserved in SI-CLP, similar to the chitolectins YKL-39, YKL-40, and YM1/2. Human SI-CLP is sorted to late endosomes and secretory lysosomes in alternatively activated macrophages. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=429.16 Aligned_cols=289 Identities=43% Similarity=0.718 Sum_probs=254.0
Q ss_pred CccccChHHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEE
Q 003932 450 NLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFC 529 (785)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 529 (785)
..+.|++.++..+|++|...++||+|+||.||+|.+.++..||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999998899999988765443145699999999999999999999999
Q ss_pred ecCC-ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeec
Q 003932 530 IDSE-ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKIS 608 (785)
Q Consensus 530 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 608 (785)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 499999999999999999875443 78999999999999999999999888889999999999999999999999
Q ss_pred cccceeeecccccccccccc-cccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 609 DFGMARIFAKESLEENTEQV-VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+...........+++|....+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999664331 1111112 79999999999999999999999999999999999998887655555556899999999
Q ss_pred hCCccccccccccC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 688 KGGKGVEFVDSFLD-DRNSP-CKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 688 ~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
..+...+++|+.+. ..... .....+..++.+|++.+|.+||+|.||++.|+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999986 44443 57788999999999999999999999999996653
|
|
| >cd02875 GH18_chitobiase Chitobiase (also known as di-N-acetylchitobiase) is a lysosomal glycosidase that hydrolyzes the reducing-end N-acetylglucosamine from the chitobiose core of oligosaccharides during the ordered degradation of asparagine-linked glycoproteins in eukaryotes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=417.46 Aligned_cols=293 Identities=16% Similarity=0.216 Sum_probs=225.7
Q ss_pred CCcEEEEEecCCCCCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCCC
Q 003932 24 KPWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTN 103 (785)
Q Consensus 24 ~~~~~vgY~~~~~~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~ 103 (785)
..+.++||.... ......|++.+|||..+ + ..++ ..+..+|++ ++||+++.+ .
T Consensus 34 ~~~~~~~~~~~~--~~~~~~~~~~~tti~~~-------~-------~~~~----~~~~~A~~~--~v~v~~~~~-~---- 86 (358)
T cd02875 34 PRFEFLVFSVNS--TNYPNYDWSKVTTIAIF-------G-------DIDD----ELLCYAHSK--GVRLVLKGD-V---- 86 (358)
T ss_pred CceEEEEEEeCC--CcCcccccccceEEEec-------C-------CCCH----HHHHHHHHc--CCEEEEECc-c----
Confidence 347789998543 45678899999999976 1 1122 233334544 699998733 1
Q ss_pred cccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC--CCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEE
Q 003932 104 YSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT--STDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILT 181 (785)
Q Consensus 104 ~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~--~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~ 181 (785)
+ ...++|+++|++||+++++++++|||||||||||||+. +.++++|+.|+++||++|++.+ .+..++++
T Consensus 87 ~---~~~l~~~~~R~~fi~siv~~~~~~gfDGIdIDwE~p~~~~~~d~~~~t~llkelr~~l~~~~------~~~~Lsva 157 (358)
T cd02875 87 P---LEQISNPTYRTQWIQQKVELAKSQFMDGINIDIEQPITKGSPEYYALTELVKETTKAFKKEN------PGYQISFD 157 (358)
T ss_pred C---HHHcCCHHHHHHHHHHHHHHHHHhCCCeEEEcccCCCCCCcchHHHHHHHHHHHHHHHhhcC------CCcEEEEE
Confidence 1 24588999999999999999999999999999999963 4689999999999999997631 24556666
Q ss_pred eecccCCCC-ccccHHHHHhccceeeeeeccCCCc-cC-CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCceee
Q 003932 182 ARFRYSPPA-NSYLLNSIQRNLNWIHAVTASYYEP-VS-TNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVM 258 (785)
Q Consensus 182 ~~~~~~~~~-~~~~~~~l~~~~D~v~vm~yd~~~~-~~-~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~Klvl 258 (785)
++..+.... ..||+++|++++|||||||||+|++ |. ...+||+||+. +++.+|++|+..|+|++||+|
T Consensus 158 v~~~p~~~~~~~yd~~~l~~~vD~v~lMtYD~h~~~w~~~~~~g~~ap~~---------~v~~~v~~~~~~gvp~~KLvL 228 (358)
T cd02875 158 VAWSPSCIDKRCYDYTGIADASDFLVVMDYDEQSQIWGKECIAGANSPYS---------QTLSGYNNFTKLGIDPKKLVM 228 (358)
T ss_pred EecCcccccccccCHHHHHhhCCEeeEEeecccCCCCCCCCCCCCCCCch---------hHHHHHHHHHHcCCCHHHeEE
Confidence 654433222 3499999999999999999999985 54 34688999976 889999999999999999999
Q ss_pred ccccccceeeecCCC-CC----CCCCCCCCCc-cc-cCccccHHHHHhhhhhcCCCeEEEeccceeeeeee-c---CC-E
Q 003932 259 CLPFYGYAWTLVKPE-DN----GIGAAAAGPA-LY-DSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFS-T---GT-V 326 (785)
Q Consensus 259 Gip~YG~~~~~~~~~-~~----~~~~~~~g~~-~~-~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~-~---~~-~ 326 (785)
|||||||+|++.++. .. ..+.+..|+. +. .++.++|.+|++.++.. ++...||+.+++||+. . +. +
T Consensus 229 Gip~YGr~w~~~~~~~~~~~~~~~~~p~~g~~~~~~~g~~i~Y~ei~~~~~~~--~~~~~wD~~~~~py~~y~d~~g~~~ 306 (358)
T cd02875 229 GLPWYGYDYPCLNGNLEDVVCTIPKVPFRGANCSDAAGRQIPYSEIMKQINSS--IGGRLWDSEQKSPFYNYKDKQGNLH 306 (358)
T ss_pred EeCCCCCceeCCCCcccCcccCCCCCCcCCCCCcCCCCCccCHHHHHHHHhcC--CCceeeccccccceEEEecCCCcEE
Confidence 999999999976543 11 1122222221 11 33578999999977643 3678899999999873 2 32 7
Q ss_pred EEEeCCHHHHHHHHhhhcccCccceEeeeccccchhh
Q 003932 327 WFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDW 363 (785)
Q Consensus 327 ~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~~ 363 (785)
||||||++|++.|++||+++||||+|+|++|+||...
T Consensus 307 ~V~ydD~~Si~~K~~~a~~~gL~Gv~iW~ld~dD~~g 343 (358)
T cd02875 307 QVWYDNPQSLSIKVAYAKNLGLKGIGMWNGDLLDYSG 343 (358)
T ss_pred EEEeCCHHHHHHHHHHHHhCCCCeEEEEeccccccCC
Confidence 9999999999999999999999999999999999654
|
Chitobiase can only do so if the asparagine that joins the oligosaccharide to protein is previously removed by a glycosylasparaginase. Chitobiase is therefore the final step in the lysosomal degradation of the protein/carbohydrate linkage component of asparagine-linked glycoproteins. The catalytic domain of chitobiase is an eight-stranded alpha/beta barrel fold similar to that of other family 18 glycosyl hydrolases such as hevamine and chitotriosidase. |
| >cd02874 GH18_CFLE_spore_hydrolase Cortical fragment-lytic enzyme (CFLE) is a peptidoglycan hydrolase involved in bacterial endospore germination | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=413.95 Aligned_cols=294 Identities=18% Similarity=0.303 Sum_probs=236.8
Q ss_pred EEEEEecCCCCC--CcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCC--C
Q 003932 27 IRVGYLNLSEVS--TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKD--T 102 (785)
Q Consensus 27 ~~vgY~~~~~~~--~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~--~ 102 (785)
.++|||++|+.. ....-..+++|||++.++.++++|. +... .. ..++..+|++ ++||+++||||.. +
T Consensus 3 ~~~g~~~~~~~~~~~~~~~~~~~lt~v~p~w~~~~~~g~-~~~~---~~---~~~~~~a~~~--~~kv~~~i~~~~~~~~ 73 (313)
T cd02874 3 EVLGYYTPRNGSDYESLRANAPYLTYIAPFWYGVDADGT-LTGL---PD---ERLIEAAKRR--GVKPLLVITNLTNGNF 73 (313)
T ss_pred eEEEEEecCCCchHHHHHHhcCCCCEEEEEEEEEcCCCC-CCCC---CC---HHHHHHHHHC--CCeEEEEEecCCCCCC
Confidence 478999988764 4444467899999999999999873 3221 11 3455556665 6999999998753 4
Q ss_pred CcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEe
Q 003932 103 NYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTA 182 (785)
Q Consensus 103 ~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~ 182 (785)
++..|+.+++++++|++||+++++++++|||||||||||+| .++++++|+.|+++||++|++. +..+++++
T Consensus 74 ~~~~~~~~l~~~~~r~~fi~~iv~~l~~~~~DGidiDwE~~-~~~d~~~~~~fl~~lr~~l~~~--------~~~lsv~~ 144 (313)
T cd02874 74 DSELAHAVLSNPEARQRLINNILALAKKYGYDGVNIDFENV-PPEDREAYTQFLRELSDRLHPA--------GYTLSTAV 144 (313)
T ss_pred CHHHHHHHhcCHHHHHHHHHHHHHHHHHhCCCcEEEecccC-CHHHHHHHHHHHHHHHHHhhhc--------CcEEEEEe
Confidence 55678999999999999999999999999999999999999 5689999999999999999752 34555555
Q ss_pred ecccCC-----CCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCcee
Q 003932 183 RFRYSP-----PANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLV 257 (785)
Q Consensus 183 ~~~~~~-----~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~Klv 257 (785)
.+.... ....|+++++++++|||++|+||+|++|+ .+||+||+. +++..+++++ .|+|++||+
T Consensus 145 ~p~~~~~~~~~~~~~~~~~~l~~~vD~v~lm~YD~~~~~~--~~gp~a~~~---------~~~~~~~~~~-~gvp~~Klv 212 (313)
T cd02874 145 VPKTSADQFGNWSGAYDYAAIGKIVDFVVLMTYDWHWRGG--PPGPVAPIG---------WVERVLQYAV-TQIPREKIL 212 (313)
T ss_pred cCccccccccccccccCHHHHHhhCCEEEEEEeccCCCCC--CCCccCChH---------HHHHHHHHHH-hcCCHHHEE
Confidence 443321 23578999999999999999999999863 589999986 6788887666 799999999
Q ss_pred eccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeee-----cCCEEEEeCC
Q 003932 258 MCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFS-----TGTVWFGFDD 332 (785)
Q Consensus 258 lGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~-----~~~~~i~ydd 332 (785)
||||+|||.|++.++. ....+.++|.++++.+.+.+ +...||+.+.+||.. ...+||+|||
T Consensus 213 lGip~YG~~w~~~~~~------------~~~~~~~~~~~~~~~~~~~~--~~~~~d~~~~~~~~~y~~~~g~~~~v~y~d 278 (313)
T cd02874 213 LGIPLYGYDWTLPYKK------------GGKASTISPQQAINLAKRYG--AEIQYDEEAQSPFFRYVDEQGRRHEVWFED 278 (313)
T ss_pred EeecccccccccCCCC------------CcCccccCHHHHHHHHHHcC--CCeEECcccCCCcEEEEeCCCCEEEEEeCc
Confidence 9999999999865411 11245678888888777644 788999999998762 2358999999
Q ss_pred HHHHHHHHhhhcccCccceEeeeccccchh-hh
Q 003932 333 VEAVRAKIAYAKEKRLLGYYAWQVSFDDHD-WL 364 (785)
Q Consensus 333 ~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~-~~ 364 (785)
++|++.|++|++++||||+++|+|++||+. |.
T Consensus 279 ~~Si~~K~~~~~~~~lgGv~iW~lg~dD~~~w~ 311 (313)
T cd02874 279 ARSLQAKFELAKEYGLRGVSYWRLGLEDPQNWL 311 (313)
T ss_pred HHHHHHHHHHHHHcCCCeEEEEECCCCCccccc
Confidence 999999999999999999999999999964 64
|
CFLE is expressed as an inactive preprotein (called SleB) in the forespore compartment of sporulating cells. SleB translocates across the forespore inner membrane and is deposited as a mature enzyme in the cortex layer of the spore. As part of a sensory mechanism capable of initiating germination, CFLE degrades a spore-specific peptidoglycan constituent called muramic-acid delta-lactam that comprises the outer cortex. CFLE has a C-terminal glycosyl hydrolase family 18 (GH18) catalytic domain as well as two N-terminal LysM peptidoglycan-binding domains. In addition to SleB, this family includes YaaH, YdhD, and YvbX from Bacillus subtilis. |
| >cd06545 GH18_3CO4_chitinase The Bacteroides thetaiotaomicron protein represented by pdb structure 3CO4 is an uncharacterized bacterial member of the family 18 glycosyl hydrolases with homologs found in Flavobacterium, Stigmatella, and Pseudomonas | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=378.41 Aligned_cols=241 Identities=22% Similarity=0.379 Sum_probs=200.8
Q ss_pred EEEEecCCCCCC--cCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCCCcc
Q 003932 28 RVGYLNLSEVST--ISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNYS 105 (785)
Q Consensus 28 ~vgY~~~~~~~~--~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~ 105 (785)
+||||++|+... ++++|.++||||+|+|+.++++| .+...+. ...+..++..+|+ +++||++|||||..+
T Consensus 1 vigyy~~w~~~~~~~~~~~~~~lThv~~~f~~i~~~G-~l~~~~~--~~~~~~~~~~~~~--~~~kvl~sigg~~~~--- 72 (253)
T cd06545 1 VVGYLPNYDDLNALSPTIDFSKLTHINLAFANPDANG-TLNANPV--RSELNSVVNAAHA--HNVKILISLAGGSPP--- 72 (253)
T ss_pred CEEEeCCcccccCCcccCChhhCCeEEEEEEEECCCC-eEEecCc--HHHHHHHHHHHHh--CCCEEEEEEcCCCCC---
Confidence 589999998765 89999999999999999999988 5655532 2344555555554 479999999987542
Q ss_pred cchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecc
Q 003932 106 IYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFR 185 (785)
Q Consensus 106 ~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~ 185 (785)
.|+.+++++++|++||+++++++++|+|||||||||+|+.. +++|..|+++||++|++. +..+++++++.
T Consensus 73 ~~~~~~~~~~~r~~fi~~lv~~~~~~~~DGIdiDwE~~~~~--~~~~~~fv~~Lr~~l~~~--------~~~lt~av~~~ 142 (253)
T cd06545 73 EFTAALNDPAKRKALVDKIINYVVSYNLDGIDVDLEGPDVT--FGDYLVFIRALYAALKKE--------GKLLTAAVSSW 142 (253)
T ss_pred cchhhhcCHHHHHHHHHHHHHHHHHhCCCceeEEeeccCcc--HhHHHHHHHHHHHHHhhc--------CcEEEEEccCc
Confidence 27789999999999999999999999999999999999643 789999999999999752 33444444322
Q ss_pred cCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCC-CCCceeecccccc
Q 003932 186 YSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGL-SADKLVMCLPFYG 264 (785)
Q Consensus 186 ~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gv-p~~KlvlGip~YG 264 (785)
. ..+...++.+++||||||+||++|+|....+||++|+. +++.++++|+..|+ |++||+||+|+||
T Consensus 143 ~----~~~~~~~~~~~vD~i~vMtYD~~g~~~~~~~g~~a~~~---------~~~~~v~~~~~~g~ip~~KlvlGlp~YG 209 (253)
T cd06545 143 N----GGAVSDSTLAYFDFINIMSYDATGPWWGDNPGQHSSYD---------DAVNDLNYWNERGLASKDKLVLGLPFYG 209 (253)
T ss_pred c----cccccHHHHhhCCEEEEEcCcCCCCCCCCCCCCCCchH---------hHHHHHHHHHHcCCCCHHHEEEEeCCcc
Confidence 1 12234678899999999999999999766789999976 78999999999998 9999999999999
Q ss_pred ceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHHHHHhhhc
Q 003932 265 YAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAK 344 (785)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~~K~~~~~ 344 (785)
|.| +|+.+.+++.|++|++
T Consensus 210 ~~w-------------------------------------------------------------~~~~~~~~~~~~~~~~ 228 (253)
T cd06545 210 YGF-------------------------------------------------------------YYNGIPTIRNKVAFAK 228 (253)
T ss_pred ccc-------------------------------------------------------------cCCCHHHHHHHHHHHH
Confidence 988 2788889999999999
Q ss_pred ccCccceEeeeccccch
Q 003932 345 EKRLLGYYAWQVSFDDH 361 (785)
Q Consensus 345 ~~glgG~~~W~l~~Dd~ 361 (785)
++ +||+|+|++++|..
T Consensus 229 ~~-~gG~~~w~~~~d~~ 244 (253)
T cd06545 229 QN-YGGVMIWELSQDAS 244 (253)
T ss_pred Hh-cCeEEEEeccCCCC
Confidence 99 99999999999973
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=366.71 Aligned_cols=252 Identities=26% Similarity=0.324 Sum_probs=206.9
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc-cEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-RMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~ 541 (785)
+++.++.||+|..|+||+++++ +++.+|+|++... .....+++.+|++++++.+||+||.++|.|.+... ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3456688999999999999965 7889999999543 45567789999999999999999999999999984 9999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
|.+|||+.++... +.+++...-+|+.++++||.|||+.. +||||||||+|||++..|+|||||||.+..+.+.
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999998543 45899999999999999999999733 4999999999999999999999999999877544
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
....++||..|||||.+.+..|+.++||||||+.++|+.+|+-|+..... ......+.. .....+....+.+
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll-~~Iv~~ppP~lP~---- 304 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELL-CAIVDEPPPRLPE---- 304 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHH-HHHhcCCCCCCCc----
Confidence 34568999999999999999999999999999999999999999876411 111112111 1111111111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ..+.++..++..||++||.+||+++|+++
T Consensus 305 -~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 305 -G---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -c---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 24558999999999999999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=381.49 Aligned_cols=260 Identities=32% Similarity=0.489 Sum_probs=213.0
Q ss_pred CCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCC-ccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 541 (785)
.+.+.+.||+|+||+||+|.+.....||+|++..... ...+.|.+|+.+|.+++|||||+++|+|.+.. .+++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 3445567999999999999998555599999986532 22568999999999999999999999999887 79999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-ceeeccccceeeecccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFGMARIFAKES 620 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~ 620 (785)
|++|+|..+++.. ....+++..+++++.|||+||.|||++.. ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999764 45679999999999999999999998863 99999999999999998 99999999998765332
Q ss_pred cccccccccccCCcccccccC--CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYAT--KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.......||..|||||++. ...|+.|+||||||++||||+||+.||..... .+........+..
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~R------ 264 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLR------ 264 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC------
Confidence 2333468999999999999 56899999999999999999999999975432 2222222222221
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
...+..+...+..++.+||+.||.+||++.+++..|+......
T Consensus 265 ---p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 265 ---PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ---CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 2222225567889999999999999999999999999765433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=380.59 Aligned_cols=247 Identities=30% Similarity=0.441 Sum_probs=212.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.+|...+.||+|+|+.||.++. .+|+.||+|++.+. .....+.+.+|+++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 88999999999874 3345667889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|+|++++|..++. ++..+++..++.+..||+.||.|||+++ |+|||||..|+||+++.+|||+|||+|..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999885 5667999999999999999999999986 999999999999999999999999999988654
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
. +.....|||+.|.|||++.....+..+||||+|||+|-||.|++||+.....+. ....+...
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-------y~~Ik~~~-------- 234 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-------YNKIKLNE-------- 234 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-------HHHHHhcC--------
Confidence 3 344568999999999999999999999999999999999999999975433222 22221111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...+.....+..+||.++|+.||.+|||+++|+.
T Consensus 235 --Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 --YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112233446788999999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=383.21 Aligned_cols=261 Identities=31% Similarity=0.478 Sum_probs=215.4
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
+...+.+.+++.||+|-||.||+|.++....||+|.+..... ..+.|.+|+++|++|+|+|||+++|+|..++.++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 334455677789999999999999999777999999976533 3367889999999999999999999999988999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||+.|+|.++|.. ..+..+...+.+.++.|||+||+||+++. +|||||.++||||+++..+||+|||||+...+.
T Consensus 281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999999976 34566889999999999999999999886 999999999999999999999999999955443
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.+ .......-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+. ...+..+..
T Consensus 357 ~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-------~~~le~GyR------ 422 (468)
T KOG0197|consen 357 EY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-------LELLERGYR------ 422 (468)
T ss_pred ce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-------HHHHhccCc------
Confidence 22 22333344679999999999999999999999999999998 8888754332222 222222221
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
-..+..++.++.+|+..||+.+|++|||++.+...|+....
T Consensus 423 ---lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 423 ---LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 12234466789999999999999999999999999988654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=361.16 Aligned_cols=204 Identities=30% Similarity=0.475 Sum_probs=182.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
..+|.+.+.||+|+|++||+|++ .++..||||.+.+. .....+.+..|+.+|+.++|||||.+++++..++.++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45788889999999999999995 46789999999877 5666677899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC------Cceeeccccce
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA------MKPKISDFGMA 613 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~------~~~kl~Dfg~a 613 (785)
|||.||+|..+++. +..+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999964 346999999999999999999999987 9999999999999865 45899999999
Q ss_pred eeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCC
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~ 675 (785)
+.+.+.. .....+|++.|||||+++.++|+.|+|+||+|++||+|++|+.||......+
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 9987543 3456899999999999999999999999999999999999999998655433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=396.95 Aligned_cols=261 Identities=31% Similarity=0.492 Sum_probs=222.3
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCChh-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCc
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 534 (785)
.+.+....+.||+|.||.||+|... ....||||.++..... ..++|++|++++..++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 4566777899999999999999842 3456999999876554 77899999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCcc-----------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIR-----------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM 603 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 603 (785)
.+||+|||..|+|.+||..... ...++..+.+.||.|||.||.||-+++ +|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 9999999999999999963211 334889999999999999999999887 99999999999999999
Q ss_pred ceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHH
Q 003932 604 KPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEH 682 (785)
Q Consensus 604 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~ 682 (785)
.|||+|||+++.+...++.+......-.++|||||.+..+++|++||||||||+|||+++ |+.|+.....++
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------- 713 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------- 713 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence 999999999998877766665545556789999999999999999999999999999998 999987655433
Q ss_pred HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 683 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
+......++... .+..++.++++|+..||+.+|++||+++||-..|+...
T Consensus 714 VIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 714 VIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 334444444322 23445678999999999999999999999999998754
|
|
| >cd06549 GH18_trifunctional GH18 domain of an uncharacterized family of bacterial proteins, which share a common three-domain architecture: an N-terminal glycosyl hydrolase family 18 (GH18) domain, a glycosyl transferase family 2 domain, and a C-terminal polysaccharide deacetylase domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=368.56 Aligned_cols=288 Identities=14% Similarity=0.138 Sum_probs=217.9
Q ss_pred EEEEecCCCCCCcC--CCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCCCcc
Q 003932 28 RVGYLNLSEVSTIS--GINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNYS 105 (785)
Q Consensus 28 ~vgY~~~~~~~~~~--~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~ 105 (785)
++|||..|+....+ ....+.+|||+..+..+...++.+... .+. .....+.++|+++|.++++.+++|++. ++.
T Consensus 2 ~l~~~~~w~~~s~~sl~~~~~~l~~vsP~W~~~~~~~g~l~~~--~d~-~~~~~~~~~k~~~~~l~~~~~~~~~~~-~~~ 77 (298)
T cd06549 2 ALAFYTPWDDASFASLKRHAPRLDWLVPEWLNLTGPEGRIDVF--VDP-QGVAIIAAAKAHPKVLPLVQNISGGAW-DGK 77 (298)
T ss_pred eeEEEecCChhhHHHHHHhhccCCEEeceeEEEecCCCceecc--CCh-HHHHHHHHHHcCCceeEEEEecCCCCC-CHH
Confidence 68999988654322 233568999999999998433355432 222 223345568888899999999997654 344
Q ss_pred cchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecc
Q 003932 106 IYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFR 185 (785)
Q Consensus 106 ~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~ 185 (785)
.|+.++++++.|++||+++++++++|||||||||||++ .++|+++|+.|+++||++|++. +..+++++++.
T Consensus 78 ~~~~~l~~~~~R~~fi~~iv~~~~~~~~dGidiD~E~~-~~~d~~~~~~fl~eL~~~l~~~--------~~~lsv~v~~~ 148 (298)
T cd06549 78 NIARLLADPSARAKFIANIAAYLERNQADGIVLDFEEL-PADDLPKYVAFLSELRRRLPAQ--------GKQLTVTVPAD 148 (298)
T ss_pred HHHHHhcCHHHHHHHHHHHHHHHHHhCCCCEEEecCCC-ChhHHHHHHHHHHHHHHHhhhc--------CcEEEEEecCC
Confidence 69999999999999999999999999999999999998 6689999999999999999763 34566665443
Q ss_pred cCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeeccccccc
Q 003932 186 YSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGY 265 (785)
Q Consensus 186 ~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~KlvlGip~YG~ 265 (785)
...||++++.+++|+|+||+||+|++++ .+||.+|.. +++..+++. ..|+|++||+||||+|||
T Consensus 149 ----~~~~d~~~l~~~~D~v~lMtYD~~~~~~--~~gp~a~~~---------~~~~~~~~~-~~~vp~~KlvlGip~YG~ 212 (298)
T cd06549 149 ----EADWNLKALARNADKLILMAYDEHYQGG--APGPIASQD---------WFESNLAQA-VKKLPPEKLIVALGSYGY 212 (298)
T ss_pred ----CCCCCHHHHHHhCCEEEEEEeccCCCCC--CCCCCCChh---------hHHHHHHHH-HhCCCHHHEEEEecccCc
Confidence 2358999999999999999999997653 467777654 667777664 468999999999999999
Q ss_pred eeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeee-eee-c--C-CEEEEeCCHHHHHHHH
Q 003932 266 AWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVN-YFS-T--G-TVWFGFDDVEAVRAKI 340 (785)
Q Consensus 266 ~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~-y~~-~--~-~~~i~ydd~~Si~~K~ 340 (785)
.|++... + ...+..+....+...+ ....||+....+ |.+ + + .++|||||.+|++.|+
T Consensus 213 ~w~~~~~-----~-----------~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~g~~h~Vw~~d~~Sl~~K~ 274 (298)
T cd06549 213 DWTKGGN-----T-----------KAISSEAAWLLAAHAS--AAVKFDDKASNATYFFYDDEGVSHEVWMLDAVTLFNQL 274 (298)
T ss_pred cccCCCC-----C-----------cccCHHHHHHHHHHcC--CcceecccccCCceEEEcCCCcEEEEEeccHHHHHHHH
Confidence 9976321 0 1122333333333333 455676655544 333 2 2 4799999999999999
Q ss_pred hhhcccCccceEeeeccccchh
Q 003932 341 AYAKEKRLLGYYAWQVSFDDHD 362 (785)
Q Consensus 341 ~~~~~~glgG~~~W~l~~Dd~~ 362 (785)
++|+++||||+++|+|++||+.
T Consensus 275 ~~a~~~~l~Gva~W~lg~ed~~ 296 (298)
T cd06549 275 KAVQRLGPAGVALWRLGSEDPG 296 (298)
T ss_pred HHHHHcCCCcEEEEeccCCCCC
Confidence 9999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=359.37 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=203.0
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCCh-------hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTST-------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 534 (785)
.+.|.+.+.||+|+||.|-+|. ..+++.||||++.+... .......+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4568888999999999999998 56899999999986421 122345799999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC---Cceeecccc
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA---MKPKISDFG 611 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfg 611 (785)
.||||||+.||.|.+.+- ....+.+.....++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999884 3445677777889999999999999997 9999999999999766 789999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHh
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK 688 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 688 (785)
+|+...+. ......|||+.|.|||++.+.. +..++|+||+||+||-+|+|.+||...-... ++. ++..
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~----eQI~ 395 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK----EQIL 395 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH----HHHh
Confidence 99986543 4567789999999999998764 3358899999999999999999997432221 122 2222
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 689 GGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 689 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.++... .........++..++|.+||..||++|||+.|+++
T Consensus 396 ~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222111 01112234567899999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=344.06 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=209.1
Q ss_pred cCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEE-EEecCC-ccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLG-FCIDSE-ERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-~~~lv 538 (785)
.+|+++++||+|+||+||++. ..+|..+|.|.+.-. +.+..+.+..|+.+|++|+|||||++++ .+.+.. .++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468889999999999999998 568999999998743 4566778899999999999999999998 444444 48999
Q ss_pred EEecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 539 YEYMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYLQEYSR-LTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
||+|..|+|...+... ..+..++++.+++++.|++.||.++|+.-+ ..|+||||||.||+|+.+|.|||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999988542 235679999999999999999999998432 23999999999999999999999999999987
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... .......+||+.||+||.+.+.+|+.||||||+||++|||+.-++||...+ ..+-. +....+....
T Consensus 179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~-~KI~qgd~~~-- 247 (375)
T KOG0591|consen 179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLC-KKIEQGDYPP-- 247 (375)
T ss_pred cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHH-HHHHcCCCCC--
Confidence 644 234556899999999999999999999999999999999999999997541 12111 1222221111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
-+....+..+.+||..|+..||..||+...+++.+..
T Consensus 248 ------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 ------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1123456689999999999999999996666555554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=350.12 Aligned_cols=242 Identities=25% Similarity=0.356 Sum_probs=202.7
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|+++++||+|+||.||.++ .++++.+|+|++++.. ..+.+....|..+|.+++||.||++...|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999998 4578999999998763 34556788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
+||+.||.|..+|. +...+++..+..++..|+.||.|||+.+ ||||||||+|||||.+|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999984 4556889988899999999999999987 99999999999999999999999999986433
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. ...+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.... .+....++.
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-------~~~I~~~k~------ 242 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-------YDKILKGKL------ 242 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-------HHHHhcCcC------
Confidence 2 2345568999999999999999999999999999999999999999975442221 111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRP 728 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 728 (785)
...+.-...+..+++.+.|+.||++|-
T Consensus 243 ---~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 ---PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 011111344788999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=333.50 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=204.9
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
+.|+.+.++|+|+||.||+++. ++|+.||||++.... +.-.+-..+|+++|++++|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4578889999999999999995 579999999997653 3334456799999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
||+..-|.++-+ ....++.....+++.|+++|+.|+|++. +|||||||+|||++.+|.+||||||+|+.+...
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 998766655432 2234788899999999999999999886 999999999999999999999999999987632
Q ss_pred cccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHH--------HHHHHhCCc
Q 003932 621 LEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGGK 691 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~ 691 (785)
....+..+.|.+|+|||.+.+ .+|+..+|||++||++.||++|.+.|.....-+....+.. ....+..+.
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 234566788999999999988 6899999999999999999999999876544333222221 122222221
Q ss_pred cc---ccc---ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GV---EFV---DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~---~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. .+. +...-+..-+.....+.+++..||+.||.+|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 111 100011112223446889999999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.26 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=209.8
Q ss_pred HhcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 536 (785)
...+|.+++.||+|+|++|++|+ ..+++.||||++.+.- ....+-+..|-..|.+| .||.|++|+..|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34679999999999999999999 5579999999997752 23334567888999999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+|+||+++|+|.++|.. -+.+++.....++.+|+.||+|||++| ||||||||+|||||++++++|+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999964 356889999999999999999999987 999999999999999999999999999988
Q ss_pred cccccc---------ccc--ccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH
Q 003932 617 AKESLE---------ENT--EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 617 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 685 (785)
.+.... ... ..++||..|.+||++.....+..+|||+|||+||+|+.|++||...++.-. .+....
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli---FqkI~~ 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI---FQKIQA 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH---HHHHHH
Confidence 643221 111 458999999999999999999999999999999999999999975543221 111111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
+.-.+++..++.+.+|+.+.|..||++|+|.+||.+.
T Consensus 302 --------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 --------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1122233334578899999999999999999999765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=368.45 Aligned_cols=264 Identities=27% Similarity=0.421 Sum_probs=218.9
Q ss_pred cCCCcceeeceeCcEEEEEEEeCC----CcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPC----GEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
....+.++||.|.||.|++|+++. ...||||.++... ...+.+|..|..+|.+++||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 445677999999999999999642 3469999998653 45567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
.|||++|+|+.||+.+ ...+++.+...++++||.||.||.+.+ +|||||..+|||++.+..+|++|||+++.+.+
T Consensus 709 TEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999754 355899999999999999999999886 99999999999999999999999999998765
Q ss_pred ccccc-ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 619 ESLEE-NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 619 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
..... .+..-.-+.+|.|||.+...+++.+|||||||+|+||.++ |.+|+-.....+.+..++..
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g------------- 850 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG------------- 850 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc-------------
Confidence 43111 1111223579999999999999999999999999999886 99997654433333222221
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPK 748 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 748 (785)
.+-..+.+++..|.+|+..|||+|-.+||.+.||+..|++.+.+..+-+
T Consensus 851 ---yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 851 ---YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred ---cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 2223455678899999999999999999999999999999987765543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.89 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=205.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC--ccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 540 (785)
.++...+.||+|+||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|.....+ .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777899999999999999954 48999999987664444677899999999999999999999855444 5899999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-CCceeeccccceeeecc-
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFGMARIFAK- 618 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~- 618 (785)
|+++|+|.+++..... .+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965432 5999999999999999999999886 999999999999999 79999999999987653
Q ss_pred cccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
...........||+.|||||++..+ ....++|||||||++.||+||++||... ....+.............
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~--- 243 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPE--- 243 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCC---
Confidence 1112234457899999999999963 3445999999999999999999999753 122233333332221111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.+...+....+++.+|++.||++|||+.++++..--
T Consensus 244 ------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 244 ------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 122234578899999999999999999999976543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=333.35 Aligned_cols=262 Identities=21% Similarity=0.316 Sum_probs=209.8
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.+.|++.+.||.|..++||+|+ .+.++.||||++.-.. ..+.+.+.+|+..|+.++||||++++..|..++.+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4679999999999999999999 5678999999997542 3346889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
||.+||+.+++...... .+++..+..|++++++||.|||.+| .||||||+.||||+++|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999998754433 3899999999999999999999987 9999999999999999999999999887765443
Q ss_pred cccc--cccccccCCcccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 621 LEEN--TEQVVGTIGYIPPEYATK--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 621 ~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.... ...++||++|||||++.. ..|+.|+||||||++..||.+|..||....+.. -....+.+.. ....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~p-p~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQNDP-PTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCCC-CCcc
Confidence 2221 156789999999999654 469999999999999999999999986443211 1111111111 1111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
-..+...........+.+++..||+.||.+|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 112222222334458899999999999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.44 Aligned_cols=271 Identities=28% Similarity=0.443 Sum_probs=220.1
Q ss_pred cChHHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec
Q 003932 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID 531 (785)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 531 (785)
.+..+++...+.+.+.+.||+|+||+||+|++. | .||||++... ..+..+.|++|+..+++-+|.||+-++|+|.+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 455788888889999999999999999999986 3 4899999865 34567889999999999999999999999998
Q ss_pred CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
... .+|+.+|+|.+|..+|+.. +..++..+.+.|++||++||.|||.+. |||||||+.||+|.++++|||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 877 9999999999999999753 356889999999999999999999886 9999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHh
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATK---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK 688 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 688 (785)
++..-..-..........|...|||||+++. .+|+..+||||||||+|||+||..|+........+ |.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi---------fm 604 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII---------FM 604 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE---------EE
Confidence 9976443333334455678899999999975 46899999999999999999999999733322221 11
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 689 GGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 689 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
-++..-..+.... ...++.++.+|+..||..++++||.+.+|+..|+......
T Consensus 605 VGrG~l~pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 605 VGRGYLMPDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ecccccCccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 2222111221111 1223457889999999999999999999999998876533
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=339.88 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=206.1
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 537 (785)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|+++... ........+||.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3567888999999999999999 6789999999998764 33334567899999999999999999998876 68999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|+|||+. +|.-++.. ....+++.++..++.||+.||.|||..+ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999976 67666643 2346899999999999999999999987 9999999999999999999999999999876
Q ss_pred ccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc---
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV--- 693 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 693 (785)
.... ...+..+-|..|+|||++.|. .|+...|+||.||||.||+.|++.+....+.+. +...+++.......
T Consensus 270 ~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ---l~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 270 PSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ---LHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH---HHHHHHHhCCCChhccc
Confidence 5543 235566789999999999885 699999999999999999999998876544332 23333332221110
Q ss_pred --ccc-----cc------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 694 --EFV-----DS------FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 694 --~~~-----~~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+. .+ .+.+. ....+...++|+..+|..||.+|.|+.++++.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111 00 01100 11123467889999999999999999999753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=345.19 Aligned_cols=262 Identities=25% Similarity=0.337 Sum_probs=209.0
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHH--HHHHHHHHHcCC-CCceeeEEEEEecCC-ccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE--FKNEVMLTAKLQ-HVNLIRVLGFCIDSE-ERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 537 (785)
-++|.++++||.|.||.||+|+ ..++..||||++++.... +++ -.+|+..|++|+ ||||+++.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4689999999999999999999 567899999999765433 233 357999999998 999999999999887 9999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|||||+ .+|.+++.++ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+||.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999994 5899999764 677999999999999999999999987 9999999999999999999999999999865
Q ss_pred ccccccccccccccCCcccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc---
Q 003932 618 KESLEENTEQVVGTIGYIPPEYAT-KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV--- 693 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 693 (785)
.. ...+..+.|.+|+|||++. ...|+.+.|||++|||++|+.+-++.|...++-+.+..+..+ +......
T Consensus 162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V---LGtP~~~~~~ 235 (538)
T KOG0661|consen 162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV---LGTPDKDSWP 235 (538)
T ss_pred cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH---hCCCccccch
Confidence 33 4566788999999999774 567999999999999999999999998765544333222211 1111111
Q ss_pred ---------cccccccCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 694 ---------EFVDSFLDDRN----SPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 694 ---------~~~~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
.+.-+...... .+....++.+++.+|+++||.+|||++|.++.-
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11111111111 122456789999999999999999999998764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=339.95 Aligned_cols=267 Identities=25% Similarity=0.399 Sum_probs=218.4
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
-+.....+.++||+|-||.|.++....+..||||+++... ...+.+|.+|+++|.+|+||||++++|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3456788899999999999999998878999999998764 345588999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||++|+|..++..+.... +......+|+.||+.||+||.+.. +|||||.++|+|++.++++||+|||+++.+...
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999997653322 455677889999999999999874 999999999999999999999999999987766
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.+.+.....+-+++|||||.+..++++.++|||+||+++||+++ ...|+..... .+.++..-.++........
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~-- 765 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVV-- 765 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCccee--
Confidence 66655555667899999999999999999999999999999875 5566653221 1223333233222221111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
-..++.++..+++++..||..|-++||+++++...|.+.
T Consensus 766 ----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 ----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 123445567889999999999999999999999998865
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.69 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=210.4
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
...|...++||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||+++..+...+.+++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3567777899999999999998 556889999999877666667789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
|++|+|.+.+ ....+++.++..|++.+++||+|||..+ |+|||||++|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999998887 3445899999999999999999999987 99999999999999999999999999988765432
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.....+||++|||||+.....|++|.||||||++++||+-|.+||...++.. ..+.....+. ..
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyLIa~ng~--------P~ 488 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGT--------PK 488 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH------HHHHHhhcCC--------CC
Confidence 3445789999999999999999999999999999999999999986422211 1111111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
-.........+.+++.+||+.||.+||++.|+|+
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1223344568999999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=340.79 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=206.6
Q ss_pred HhcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
..++|+++++||+|+||.||+|+ ..+|..+|+|++++... ...+.++.|-.+|...++|+||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999 55799999999998753 455667889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||++||++..+|. +...|++......+.+++.|+..||+.+ ||||||||+|+|||..|++||+|||++.-+.
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999984 5667999999999999999999999987 9999999999999999999999999985432
Q ss_pred cc----------------------ccc-----cc------------------cccccccCCcccccccCCCCCCChhhHH
Q 003932 618 KE----------------------SLE-----EN------------------TEQVVGTIGYIPPEYATKGVYSTKSDVF 652 (785)
Q Consensus 618 ~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 652 (785)
.. ... .. ....+||+.|+|||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 00 0135799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC---
Q 003932 653 SFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS--- 729 (785)
Q Consensus 653 SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs--- 729 (785)
|||||+||||.|.+||....+.+....+......+.... ......+..+||.+|+. ||++|-.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-------------~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-------------EVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-------------cCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999999987665554333322222221111 11122578899999999 9999975
Q ss_pred HHHHHH
Q 003932 730 MLEVSS 735 (785)
Q Consensus 730 ~~evl~ 735 (785)
++||.+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 666654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=376.79 Aligned_cols=264 Identities=28% Similarity=0.500 Sum_probs=216.3
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC--CCc----EEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP--CGE----VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 534 (785)
...+.++...||+|.||.||.|... .+. .||+|.+.+. +.++..+|.+|..+|+.++|||||+++|+|.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3566788899999999999999843 233 4899999875 45677889999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCc----cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 535 RMLIYEYMPNKSLDCYLFDPI----RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
.++++|||++|+|..+|++.. ....++..+.+.++.|||+|+.||++++ +|||||..+|+||+....|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 999999999999999997642 2456899999999999999999999987 999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhC
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKG 689 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 689 (785)
|||+.+....+.+....-.-...|||||.+..+.++.|+|||||||+|||++| |..|+......+. ......+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~g 920 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEG 920 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhC
Confidence 99996655444433333334578999999999999999999999999999998 8888764332221 1112222
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 690 GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 690 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
++ -..+..++..+++|+.+||+.+|++||++..|++++..+...+
T Consensus 921 gR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 921 GR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred Cc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 21 1234455678899999999999999999999999988775443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=349.96 Aligned_cols=262 Identities=28% Similarity=0.423 Sum_probs=204.3
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCC
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE 533 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 533 (785)
..++|++.++||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++++ +||||++++++|....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 457899999999999999999973 235679999997543 33456788999999999 8999999999987654
Q ss_pred -ccEEEEEecCCCChhhhhcCCcc--------------------------------------------------------
Q 003932 534 -ERMLIYEYMPNKSLDCYLFDPIR-------------------------------------------------------- 556 (785)
Q Consensus 534 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 556 (785)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999988854211
Q ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccccccccCC
Q 003932 557 ---KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633 (785)
Q Consensus 557 ---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 633 (785)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134778889999999999999999876 99999999999999999999999999986543221112223345678
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHH
Q 003932 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRC 712 (785)
Q Consensus 634 y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 712 (785)
|+|||++.+..++.++|||||||++|||++ |..|+......+ ........+.... .+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMR---------APENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCC---------CCCCCCHHH
Confidence 999999999999999999999999999997 999986433211 1111111111111 111234578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 713 LEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 713 ~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.+++.+||+.||++|||+.|+++.|++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=308.57 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=206.6
Q ss_pred cCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChh--hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQ--GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.+|..+++||+|.||.||+|+ ..+|+.||||++...... ......+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999 568999999999754321 22356789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
||+ .+|...+.+ +...+....+..++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 589888865 3456888999999999999999999987 9999999999999999999999999999986543
Q ss_pred cccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc------
Q 003932 621 LEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV------ 693 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 693 (785)
. .....+-|..|+|||.+.|. .|+..+||||.|||+.||+-|.+.+..... ++......+.+......
T Consensus 156 ~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD---idQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 R--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD---IDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred c--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch---HHHHHHHHHHcCCCCcccCcccc
Confidence 2 23334779999999988875 599999999999999999999887764332 22333333333222111
Q ss_pred cccc---------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 694 EFVD---------SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 694 ~~~~---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
.+.| +.++. .-+.......+|+..|+..||.+|++++|+++.=
T Consensus 231 ~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 1111 11111 2223345679999999999999999999998754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=313.30 Aligned_cols=236 Identities=26% Similarity=0.328 Sum_probs=200.1
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|+.++.||.|+||.|.+++.+ +|..+|+|++.+.. ....+...+|..+|+.+.||+++++.+.|.+...++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888999999999999999954 68889999998764 344566788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||++||.|.++|+. ...++++.+..++.+|+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 99999999999964 345889999999999999999999987 99999999999999999999999999998542
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.+-..|||+.|+|||++....++.++|.|||||++|||+.|.+||...+. +...+ ....++
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~----KI~~~~-------- 257 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYE----KILEGK-------- 257 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHH----HHHhCc--------
Confidence 35568999999999999999999999999999999999999999986544 11221 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCC
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDR 727 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~R 727 (785)
-.++......+.+|+...|+.|-.+|
T Consensus 258 --v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 --VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11222334478889999999999999
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.06 Aligned_cols=244 Identities=29% Similarity=0.395 Sum_probs=201.0
Q ss_pred CcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCC
Q 003932 467 SIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKS 546 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 546 (785)
..++-||.|+.|.||+|++. ++.||||+++... ..+|+-|++|+|+||+.|.|+|......|||||||+.|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 44578999999999999988 7889999885322 347888999999999999999999999999999999999
Q ss_pred hhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccc
Q 003932 547 LDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626 (785)
Q Consensus 547 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 626 (785)
|...|.. ...++......+..+||.||.|||.+. |||||||+-||||+.+..|||+|||-++.....+ ..-
T Consensus 199 L~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkM 269 (904)
T KOG4721|consen 199 LYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKM 269 (904)
T ss_pred HHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhh
Confidence 9999954 345777888999999999999999986 9999999999999999999999999988764431 223
Q ss_pred cccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCH
Q 003932 627 QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSP 706 (785)
Q Consensus 627 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 706 (785)
.++||..|||||++++.+.++|+|||||||||||||||..|+...+....+ |.-+. ..|.---+.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---------wGVGs------NsL~LpvPs 334 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---------WGVGS------NSLHLPVPS 334 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---------EeccC------CcccccCcc
Confidence 478999999999999999999999999999999999999998754332211 11111 011111233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 707 CKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 707 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.++..+.-|+++||+..|..||++++++..|+-...
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 455678889999999999999999999999986543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=338.02 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=204.5
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC----Ch-hhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCc
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT----ST-QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEE 534 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 534 (785)
..++|.+.+.||+|+||.|++|.. .+++.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 356899999999999999999984 56899999977654 11 23456778999999998 9999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-Cceeeccccce
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDFGMA 613 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a 613 (785)
.++||||+.+|+|.+++.+ ...+.+.....+++|++.|++|||+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 455888999999999999999999987 9999999999999999 99999999999
Q ss_pred eeecccccccccccccccCCcccccccCCCC-CC-ChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGV-YS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..... .........+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~l~~ki~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PNLYRKIRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HHHHHHHhcCC
Confidence 8763 1234566789999999999999987 75 789999999999999999999975221 11111111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS 734 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 734 (785)
..+.. ... ..++..|+.+||..||.+|+++.+|+
T Consensus 240 -~~~p~-----~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 -FKIPS-----YLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -ccCCC-----CcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11111 110 45788999999999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.76 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=207.9
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|.+.+.||+|+||.||||+. .+.+.||+|.+.+.. .++.+.+.+|+++++.++||||+.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4788889999999999999994 468899999998764 3456778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+.| +|..+|. ....+++..+..++.+++.||.|||+.. |+|||+||+|||++.++.+|++|||+|+.+...
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9976 9999995 3456999999999999999999999986 999999999999999999999999999987543
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
....+...||+.|||||+..+.+|+..+|+||+||++|||++|++||.... +.+-+.....+.
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~---------- 216 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDP---------- 216 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCC----------
Confidence 234566789999999999999999999999999999999999999996432 111121211111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
-..+......+.+++...|++||.+|.+-.+++.
T Consensus 217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 0112244557889999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=320.63 Aligned_cols=267 Identities=25% Similarity=0.349 Sum_probs=205.9
Q ss_pred CCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHc--CCCCceeeEEEEEecCC----ccEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDSE----ERMLI 538 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv 538 (785)
..++.++||+|.||.||+|++. ++.||||++... +.+.|++|.++.+. ++|+||++++++-.... ..+||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3456688999999999999987 689999999654 44678888888776 48999999999876554 78999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc------CCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY------SRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
++|.+.|||.++|. ...++|....+|+..+++||+|||+. ++++|+|||||++||||..|+++.|+|||+
T Consensus 287 t~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999994 45699999999999999999999974 446799999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCC-C-----CChhhHHHHHHHHHHHHcCCCCCcccCC----------CCc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGV-Y-----STKSDVFSFGVLLLQIISGKRLSMLCGI----------NEN 676 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwSlGvvl~elltG~~p~~~~~~----------~~~ 676 (785)
|..+.+..........+||.+|||||++.+.- + -.+.||||+|.|||||++...-...... -..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99988665555556679999999999998753 2 2479999999999999986543321000 011
Q ss_pred ccHHHHHHHHHhCC-ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 677 LSILEHAYELWKGG-KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 677 ~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
...++......... ....+.+..... ..+..+.+.+..||..||+.|.|+.=+-+++.+....
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11222222222222 223333333322 2345789999999999999999999999988876543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=333.36 Aligned_cols=265 Identities=28% Similarity=0.428 Sum_probs=203.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-----------------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceee
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-----------------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIR 524 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 524 (785)
.++|.+.++||+|+||.||+|... .+..||+|.+.... ......+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 357889999999999999999743 23469999987653 344567899999999999999999
Q ss_pred EEEEEecCCccEEEEEecCCCChhhhhcCCc----------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 003932 525 VLGFCIDSEERMLIYEYMPNKSLDCYLFDPI----------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTII 588 (785)
Q Consensus 525 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 588 (785)
+++++.+.+..++||||+++|+|.+++.... ....+++..+.+++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999998884321 1134678889999999999999999886 99
Q ss_pred EecccCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcC--CC
Q 003932 589 HRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG--KR 666 (785)
Q Consensus 589 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG--~~ 666 (785)
||||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999876443222222334567899999999988999999999999999999974 45
Q ss_pred CCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 667 LSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 667 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
|+...... .................. ...++..+..+.+++.+||+.||++|||+.||.+.|++
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 55432211 122222222211111000 01112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=303.50 Aligned_cols=265 Identities=25% Similarity=0.290 Sum_probs=212.3
Q ss_pred HhcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC-----cc
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ER 535 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 535 (785)
..++|.+.++||+|||+-||+++ ..+++.+|+|++.....++.+..++|++..++++|||++++++++..+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999999 6678999999998887778888999999999999999999999876543 48
Q ss_pred EEEEEecCCCChhhhhcCCcc-ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIR-KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
|++++|...|||.+.+..... ...+++.+.+.|+.++++||++||+.. +++.||||||.|||+.+++.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999998865433 347999999999999999999999985 479999999999999999999999999987
Q ss_pred eeccccccc-------ccccccccCCcccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHH
Q 003932 615 IFAKESLEE-------NTEQVVGTIGYIPPEYATK---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 615 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 684 (785)
...-.-... .......|..|+|||.+.- ...++++|||||||+||+|+.|..||+..-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 653221111 1123457999999998854 4578999999999999999999999863111
Q ss_pred HHHhCCccc-cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 685 ELWKGGKGV-EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 685 ~~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.++... -+....+.-......++.+.+++.+|++.||.+||++.+++..++...
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 111111111112225678999999999999999999999999998753
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=329.52 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=205.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..|...+.||+|+||.||+|.. .+++.||+|++.-. ...+.+.+++|+.++.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3567778999999999999994 57899999999754 345667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
|.+|++.+.|.. ...+++..+.-+++++..||.|||.++ .+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999998843 333477778889999999999999986 99999999999999999999999999988765533
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
. ...++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+....-++ .+-.-+.+.
T Consensus 167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~ 232 (467)
T KOG0201|consen 167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLD 232 (467)
T ss_pred c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCccc
Confidence 3 26789999999999999889999999999999999999999998654331111000 001111222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+ .....+.+++..||++||+.||++.++++
T Consensus 233 ~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 G----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred c----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2 33457899999999999999999999975
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.20 Aligned_cols=268 Identities=29% Similarity=0.405 Sum_probs=213.4
Q ss_pred HHHHHHhcCCCcceeeceeCcEEEEEEEeCC--C--cE-EEEEEcCC---CChhhHHHHHHHHHHHHcCCCCceeeEEEE
Q 003932 457 ADIEAATERFSIRNKLGEGGYGPVYKGVLPC--G--EV-IAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGF 528 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 528 (785)
..|+...++..+.++||+|.||.||+|.+.. + .. ||+|.... .......++.+|.++|++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455556677778999999999999998542 2 23 89999885 245677889999999999999999999999
Q ss_pred EecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeec
Q 003932 529 CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKIS 608 (785)
Q Consensus 529 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 608 (785)
+.....+++|||+|.||+|.++|.... ..++..+++.++.+.|.||+|||+.. ++||||..+|+|++.++.+||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence 999999999999999999999996532 25899999999999999999999986 9999999999999999999999
Q ss_pred cccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHH
Q 003932 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
|||+++.... +........-+..|+|||.+....++.++|||||||++||+++ |..|+...... +-..+..
T Consensus 305 DFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~ 376 (474)
T KOG0194|consen 305 DFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIV 376 (474)
T ss_pred ccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHH
Confidence 9999876431 1111112234679999999999999999999999999999998 88887643321 1111111
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCC
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINT 746 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 746 (785)
..+... ..+...+..+..++.+||..+|++||+|.++.+.|+........
T Consensus 377 ~~~~r~---------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 377 KNGYRM---------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred hcCccC---------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 222111 12223455788899999999999999999999999987665544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.03 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=206.7
Q ss_pred cCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.-|++++.||.|+.|.|-+|+ ..+|+..|||++.+.. ......+.+|+-+|+.+.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 347788999999999999999 4689999999998752 222345789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|-|.++|. +++.+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||||..-.++
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999984 5667999999999999999999999987 999999999999999999999999999875443
Q ss_pred ccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
......||++.|.|||+++|.+| +.++||||.|||||.||||+.||...+ + .......+.+. .++.
T Consensus 166 ---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----i---r~LLlKV~~G~-f~MP-- 232 (786)
T KOG0588|consen 166 ---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----I---RVLLLKVQRGV-FEMP-- 232 (786)
T ss_pred ---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----H---HHHHHHHHcCc-ccCC--
Confidence 44567899999999999999987 478999999999999999999997322 1 11112222221 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
...+.++.+|+.+|+..||.+|.|++||++.
T Consensus 233 -------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 233 -------SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1223478899999999999999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.90 Aligned_cols=260 Identities=21% Similarity=0.290 Sum_probs=203.7
Q ss_pred CccccChHHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhh---HHHHHHHHHHHHcCCCCceeeEE
Q 003932 450 NLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQHVNLIRVL 526 (785)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~ 526 (785)
+++.++..++ +......||+|+++.||+|... |+.||||++....... .+.+.+|+.++++++||||++++
T Consensus 11 ~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDI-----DKYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHc-----CCCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 3444455554 2233368999999999999985 8899999998653322 46788999999999999999999
Q ss_pred EEEec----CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC
Q 003932 527 GFCID----SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA 602 (785)
Q Consensus 527 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 602 (785)
+++.+ ....++||||+++|+|.+++.. ...+++.....++.+++.||.|||+.. +++||||||+|||++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN 159 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC
Confidence 99876 3467899999999999999854 345888999999999999999999752 37899999999999999
Q ss_pred CceeeccccceeeecccccccccccccccCCcccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHH
Q 003932 603 MKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 680 (785)
Q Consensus 603 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~ 680 (785)
+.+||+|||+++.+... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .
T Consensus 160 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~- 230 (283)
T PHA02988 160 YKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---I- 230 (283)
T ss_pred CcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---H-
Confidence 99999999998764322 123467899999999976 679999999999999999999999996432111 1
Q ss_pred HHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 681 EHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.......+... ..+...+..+.+++.+||+.||++|||++|+++.|+..
T Consensus 231 --~~~i~~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 231 --YDLIINKNNSL---------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred --HHHHHhcCCCC---------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11111111111 11112345789999999999999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=342.97 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=204.7
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS 532 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 532 (785)
...++|++.+.||+|+||.||+|+. .++..||||++.... ....+.+.+|+.+++.+ +||||++++++|...
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3456799999999999999999963 245689999997542 33456788999999999 899999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCcc--------------------------------------------------------
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIR-------------------------------------------------------- 556 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 556 (785)
...++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999988853211
Q ss_pred ----------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 557 ----------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 557 ----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 124788899999999999999999876 9999999999999999999999999998764332
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.........++..|+|||.+.+..++.++|||||||++|||++ |..|+....... ...+....+....
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~----- 337 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRML----- 337 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccCC-----
Confidence 2111222345678999999999999999999999999999998 888875322111 1112222211100
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.+...+.++.+|+.+||+.||++||++.||++.|++.
T Consensus 338 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 ----SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111234788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.51 Aligned_cols=248 Identities=23% Similarity=0.392 Sum_probs=209.9
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
..+|++.+.||+|.||.|-+|. ...|+.||||.+++.. .++.-.+.+|+++|..|+||||+.++.+|.+.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4579999999999999999998 4689999999998764 34455688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||..+|.|.+++. .+..+++.....+++||..|+.|+|.+. ++|||||.+|||||.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999995 4556999999999999999999999886 99999999999999999999999999988754
Q ss_pred cccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
. +..+.+||++.|.+||++.+.+| .+.+|-|||||+||-|+.|..||...+.. ...++...+...
T Consensus 206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYr---- 271 (668)
T KOG0611|consen 206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYR---- 271 (668)
T ss_pred c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhccccc----
Confidence 4 45677999999999999999987 57899999999999999999999754321 122223222211
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
.+..+....-||++||..||.+|.|+.+|....
T Consensus 272 -------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 -------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111223455699999999999999999997654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=325.09 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=199.6
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.|+..+.||+|+||.||+|.. .+++.||+|++.+.. ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999985 578999999987542 2223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998877542 2335889999999999999999999886 9999999999999999999999999998753321
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... ...........
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------- 221 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ--------- 221 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc---------
Confidence 223456899999999999999999999999999999999999999754322211 11111111100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 735 (785)
..........+.+|+.+||+.||.+||+ ++++++
T Consensus 222 -~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 -EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111123447889999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.11 Aligned_cols=244 Identities=24% Similarity=0.336 Sum_probs=205.0
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCcc
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 535 (785)
...++|.++++||+|+||.|+++..+ +++.+|||++++.. ..+.+..+.|.+++... +||.+++++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999954 68899999998863 45677888899998877 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+.||++..+. ....+++.++..++..++.||+|||+++ ||+||||.+|||||.+|.+||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999954333 4466999999999999999999999987 99999999999999999999999999986
Q ss_pred ecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
.-. ....+.+++||+.|||||++.+..|+..+|.|||||+|||||.|..||...++.+....+. .
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------~------- 582 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------N------- 582 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh------c-------
Confidence 432 2345678999999999999999999999999999999999999999998665544322110 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSM 730 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 730 (785)
| +..++...+.+...++.++|.++|++|-.+
T Consensus 583 -d---~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 -D---EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -C---CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 0 112233445678899999999999999866
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.36 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=204.4
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS 532 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 532 (785)
...++|++.+.||+|+||.||+|+. .++..||+|++.... ....+.+.+|+.+++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3456799999999999999999873 233579999997643 33456788999999999 899999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCc---------------------------------------------------------
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPI--------------------------------------------------------- 555 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 555 (785)
...++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999998874321
Q ss_pred ----------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccc
Q 003932 556 ----------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625 (785)
Q Consensus 556 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 625 (785)
....+++..+.+++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 0124788889999999999999999876 999999999999999999999999999865433211112
Q ss_pred ccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 626 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ............ ..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~~~---------~~ 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGYQM---------SR 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcccCc---------cC
Confidence 22335678999999998999999999999999999997 999986432211 011111111100 00
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
+...+.++.+++.+||+.||++||++.+|++.|++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111235788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=298.24 Aligned_cols=249 Identities=28% Similarity=0.403 Sum_probs=206.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++++.||+|-||.||.|+. +++-.||+|++.+.. .+-.+++.+|+++-..|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35789999999999999999995 467789999997753 22345788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
+||.++|+|...|.+. ....+++.....++.|+|.||.|+|... ++||||||+|+|++..+.+||+|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999643 3445888888999999999999999875 9999999999999999999999999987632
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.......|||..|.+||...+...+..+|+|++|++.||++.|.+||......+....+ .. .++.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI-------~k---~~~~-- 240 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI-------RK---VDLK-- 240 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH-------HH---cccc--
Confidence 22344679999999999999999999999999999999999999999755432221111 11 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+........++|..|+..+|.+|.+..|++..
T Consensus 241 -----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 -----FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 122334478899999999999999999998753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=328.58 Aligned_cols=263 Identities=23% Similarity=0.289 Sum_probs=203.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999954 68889999987642 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999853 335888999999999999999999854 4999999999999999999999999998765322
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc---------
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK--------- 691 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 691 (785)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+......+....... .......
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPR 232 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCcc
Confidence 22345689999999999999999999999999999999999999854321110000000 0000000
Q ss_pred --------------------ccccccccc----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 692 --------------------GVEFVDSFL----DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 692 --------------------~~~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
..+..+... ..........++.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 000111234578999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=322.90 Aligned_cols=257 Identities=30% Similarity=0.507 Sum_probs=206.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeCC------CcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPC------GEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
++|++.+.||+|+||.||+|.... ...+++|.+.... ......+.+|+..+++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998532 2579999987543 334567899999999999999999999999989999
Q ss_pred EEEEecCCCChhhhhcCCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC
Q 003932 537 LIYEYMPNKSLDCYLFDPIR-------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM 603 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 603 (785)
++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854211 145788999999999999999999986 99999999999999999
Q ss_pred ceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHH
Q 003932 604 KPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEH 682 (785)
Q Consensus 604 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~ 682 (785)
.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999987543332223334456889999999998899999999999999999998 999886432211
Q ss_pred HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 683 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
........... ..+...+.++.+|+.+||+.||.+||+++||++.|++
T Consensus 235 ~~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11112211111 1122344688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.28 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=203.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChh-hH-HHHHHHHHHHHcCCCCceeeEEEEEecC--CccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQ-GF-EEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 537 (785)
.+.|+.++.|++|+||.||+|+. .+++.||+|+++..... .+ -.-.+||.+|.+++|||||.+..+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 45688899999999999999994 57899999999765321 11 1347899999999999999999987754 47999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|||||+. +|..++.... ..+...+...+..|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999965 8888886533 45778888899999999999999987 9999999999999999999999999999876
Q ss_pred ccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc---cc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK---GV 693 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 693 (785)
.. ....+..+-|..|+|||++.+. .|++..|+||+|||+.||+++++.+...++-+.+ ....+.+.... +.
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl---~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL---DKIFKLLGTPSEAIWP 303 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH---HHHHHHhCCCccccCC
Confidence 54 3445667789999999999885 5999999999999999999999988765543332 33333222211 11
Q ss_pred cc--------------cccccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 694 EF--------------VDSFLDDRNSPC-KLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 694 ~~--------------~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+ .-..++..+... ..+.-.+|+..+|..||.+|.|++|.++.
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 001111111111 23456789999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.87 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=201.1
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--------------hhhHHHHHHHHHHHHcCCCCceee
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--------------TQGFEEFKNEVMLTAKLQHVNLIR 524 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~ 524 (785)
....++|++.+.||+|.||.|-+|+. .+++.||+|++.+.. ....+...+|+.+|++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 44567899999999999999999994 468999999997642 122457889999999999999999
Q ss_pred EEEEEecC--CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC
Q 003932 525 VLGFCIDS--EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA 602 (785)
Q Consensus 525 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 602 (785)
|+.+..+. +.+|||+|||..|.+... ......+...++++++++++.||+|||.++ ||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 99998754 579999999998877432 222333899999999999999999999987 9999999999999999
Q ss_pred Cceeeccccceeeeccccc---ccccccccccCCcccccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCcccCCCC
Q 003932 603 MKPKISDFGMARIFAKESL---EENTEQVVGTIGYIPPEYATKGV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675 (785)
Q Consensus 603 ~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltG~~p~~~~~~~~ 675 (785)
|+|||+|||.+........ .......+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||......+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 9999999999987633211 12234478999999999887733 3568999999999999999999996432211
Q ss_pred cccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 676 NLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
..... +...+.-...++.-+.+.+||.++|++||++|.+..+|....
T Consensus 327 -------l~~KI--------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 327 -------LFDKI--------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -------HHHHH--------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11111 111111111223456788999999999999999999997654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.74 Aligned_cols=251 Identities=35% Similarity=0.531 Sum_probs=194.4
Q ss_pred CcceeeceeCcEEEEEEEeC-----CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 467 SIRNKLGEGGYGPVYKGVLP-----CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++.+.||.|.||.||+|.+. .+..|+||.+... .....+.+.+|++.+++++||||++++|+|...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999965 3577999999654 33457889999999999999999999999998888999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++|+|.++|... ....+++..+..|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999654 2356899999999999999999999986 9999999999999999999999999998763322
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.............|+|||.+.+..++.++||||||+++|||++ |+.|+.... ..+.. .....+.....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~-~~~~~~~~~~~---- 226 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEII-EKLKQGQRLPI---- 226 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHH-HHHHTTEETTS----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc-cccccccccee----
Confidence 2222333456789999999999889999999999999999999 677764321 11111 22222222111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
+...+..+.+++.+||+.+|++||+++++++.|
T Consensus 227 -----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 -----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112344688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=319.05 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=203.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
..+|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++......++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999743 35689999997653 3344578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998542 245889999999999999999999886 9999999999999999999999999876532
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ .......+...
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~--- 227 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRL--- 227 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---
Confidence 2111 11112335678999999999999999999999999999875 999986432211 11111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
..+...+..+.+++.+||+.+|.+||++++|.+.|++.
T Consensus 228 ------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11222345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.15 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=203.0
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999964 58899999997542 234456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999853 345888999999999999999999886 99999999999999999999999999876432
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ... ..+.. . +...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~i-~~~~~--~---~~~~ 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENL-KYWKE--T---LQRP 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH---HHH-Hhccc--c---ccCC
Confidence 233467899999999999999999999999999999999999998643322211 111 11110 0 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
...........++.+++.+||+.+|.+||+++++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000011234578899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=322.05 Aligned_cols=258 Identities=28% Similarity=0.473 Sum_probs=206.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCChh-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|.+.+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888899999999999999853 2478999999765443 456889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCc-----------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc
Q 003932 536 MLIYEYMPNKSLDCYLFDPI-----------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK 604 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 604 (785)
++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986432 2345788999999999999999999886 999999999999999999
Q ss_pred eeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHH
Q 003932 605 PKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHA 683 (785)
Q Consensus 605 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 683 (785)
++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ .
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~ 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------V 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------H
Confidence 99999999986543322222233446788999999999999999999999999999998 999986432211 1
Q ss_pred HHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 684 YELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 684 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
......+.... .....+..+.+++.+||+.||++||++.|+++.|++
T Consensus 234 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111111111 111234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=327.62 Aligned_cols=245 Identities=22% Similarity=0.247 Sum_probs=198.9
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999954 68899999986532 233456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998853 345888999999999999999999886 999999999999999999999999998765322
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+......+ .. ....... ..
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~----~~i~~~~-~~----- 216 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IY----EKILAGK-LE----- 216 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCC-cC-----
Confidence 223568999999999999999999999999999999999999986432111 11 1111111 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSSM 736 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 736 (785)
.+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 217 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 ----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11112346889999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=308.41 Aligned_cols=279 Identities=24% Similarity=0.318 Sum_probs=209.2
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCC--CChhhHHHHHHHHHHHHcCCCCceeeEEEEEec-----CC
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSK--TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-----SE 533 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 533 (785)
....|..++.||+|+||.|+.+.. .+|+.||+|++.. ......++..+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345667689999999999999984 5789999999984 345566778899999999999999999998865 35
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
..|+|+|+| +.+|...++. ...++......+..||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 789999999 6688888843 334888899999999999999999876 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH--------H
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------Y 684 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~ 684 (785)
+...........+..+.|..|.|||++.. ..|+...||||.|||+.||++|++.|...+.-..+.++... .
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98765433344566788999999997754 67999999999999999999999998765543333222111 1
Q ss_pred HHHhCCccccccccccCCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccCCCCCC
Q 003932 685 ELWKGGKGVEFVDSFLDDRN------SPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNETTNINTP 747 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~ 747 (785)
...........+.+...... -+......++|+.+||..||.+|+|++|.++. |......-..|
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 11111111111111000000 01122367899999999999999999999863 44443333334
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=366.55 Aligned_cols=262 Identities=23% Similarity=0.405 Sum_probs=209.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
...+...+.||+|+||.||+|+. .++..||+|++...... ...|++.+++++||||++++++|.+....++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45677888999999999999995 57899999998654322 23468889999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++|+|.++++ .++|..+.+++.|+++||+|||..++++|+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999984 27899999999999999999997766779999999999999999888775 555433211
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.....+|..|+|||++.+..++.++|||||||++|||+||+.|+.... .......+|.............+++.+.
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCcccc
Confidence 122367899999999999999999999999999999999999985322 2233455555444444333344454443
Q ss_pred CC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 702 DR--NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 702 ~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.. ....+..++.+++.+||+.||++||+|+|+++.|++...
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 22 234556678899999999999999999999999998754
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=319.21 Aligned_cols=256 Identities=30% Similarity=0.478 Sum_probs=210.0
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+..+|++.++||.|+||.||+|....++.+++|.+..........+.+|+.+++.++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678999999999999999999877899999999877665667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996532 345889999999999999999999886 99999999999999999999999999976543221
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+......+ .. .......
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~----~~~~~~~--------- 221 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VY----DQITAGY--------- 221 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HH----HHHHhCC---------
Confidence 1 123345678999999998889999999999999999998 888885432111 11 1111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
........+..+.+++.+||+.||.+|||++++++.|++
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 011112334578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=317.40 Aligned_cols=255 Identities=28% Similarity=0.430 Sum_probs=206.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.++|++.++||+|++|.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 467899999999999999999987788899999865433 3567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 999999988543 2345788899999999999999999876 99999999999999999999999999987643221
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......++..|+|||.+.+..++.++|||||||++|+|++ |+.|+......+ ...........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~-------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRM-------- 223 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence 11222345678999999998889999999999999999998 998885432111 11111111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
......+..+.+++.+||+.+|++||+++++.+.|++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111233478899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.99 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=210.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
++|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+..+++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999732 345689999877666666789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc
Q 003932 538 IYEYMPNKSLDCYLFDPI-------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK 604 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 604 (785)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985422 1234889999999999999999999886 999999999999999999
Q ss_pred eeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHH
Q 003932 605 PKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHA 683 (785)
Q Consensus 605 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 683 (785)
++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543322222334456789999999999999999999999999999998 999875432211 1
Q ss_pred HHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 684 YELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 684 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
......+..... ....+..+.+++.+||+.+|++||+++++++.|++....
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111222211111 112345788999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=334.87 Aligned_cols=263 Identities=26% Similarity=0.388 Sum_probs=205.9
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCC-CCceeeEEEEEecC
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDS 532 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 532 (785)
...++|.++++||+|+||.||+|... .+..||||++.... ....+.+.+|+.+++++. ||||++++++|.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34678999999999999999999842 23469999997543 334567899999999996 99999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCcc--------------------------------------------------------
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIR-------------------------------------------------------- 556 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 556 (785)
...++||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999988754210
Q ss_pred -------------------------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE
Q 003932 557 -------------------------------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599 (785)
Q Consensus 557 -------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 599 (785)
...+++..+..++.|+++||.|||+.+ ++||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 124778888999999999999999876 9999999999999
Q ss_pred cCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCccc
Q 003932 600 GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLS 678 (785)
Q Consensus 600 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 678 (785)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--- 347 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--- 347 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---
Confidence 9999999999999987543322222233456788999999999899999999999999999997 888875322111
Q ss_pred HHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 679 ILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
........+... ......+..+.+++.+||+.||++||++.+|.+.|++..
T Consensus 348 ---~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 ---TFYNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHHHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111111111100 011223457889999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.69 Aligned_cols=261 Identities=29% Similarity=0.480 Sum_probs=208.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
..+|.+.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788999999999999999974 234568999998776666678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCc----------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCcee
Q 003932 537 LIYEYMPNKSLDCYLFDPI----------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPK 606 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 606 (785)
+||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999885321 1235899999999999999999999886 99999999999999999999
Q ss_pred eccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHH
Q 003932 607 ISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 685 (785)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 999999986543322222233445778999999999999999999999999999998 888875432111 111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
....+..... ....+..+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 234 ~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 234 CITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111111110 11123478999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.98 Aligned_cols=252 Identities=19% Similarity=0.207 Sum_probs=203.3
Q ss_pred CCCcceeeceeCcEEEEEEEeC-C-CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-C-GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999843 3 6778889876655555567888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 543 PNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 543 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999998875432 2446888999999999999999999876 99999999999999999999999999987654322
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .+........ ....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~-~~~~------- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYG-KYDP------- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-CCCC-------
Confidence 2233456799999999999999999999999999999999999999864321 1111111111 1000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+......+.+++.+||+.||++||++.+++.
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122347889999999999999999999864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.64 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=206.0
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..++|++.+.||+|++|.||+|...+++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 3567899999999999999999987778899999876532 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.... ...+++..+..++.|++.|+.+||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999985432 345889999999999999999999886 99999999999999999999999999987653221
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
. .......+..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ............
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~------- 223 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGYRM------- 223 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC-------
Confidence 1 1112223458999999999999999999999999999999 88887532211 111111111100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
......+..+.+++.+||+.+|++||++.++++.|++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0112234578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=338.95 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=209.4
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCC-cEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEE-Eec------C
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCG-EVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGF-CID------S 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~ 532 (785)
...++++.+.|.+|||+.||+|+...+ ..||+|++-..+....+.+.+|+++|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345778899999999999999996655 999999998888888899999999999996 9999999993 221 1
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
-+.+|.||||++|+|-+++..+.... |++.++++|+.++++|+++||... ++|||||||-+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 35789999999999999997654444 999999999999999999999984 6899999999999999999999999999
Q ss_pred eeeecccccccc-------cccccccCCccccccc---CCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHH
Q 003932 613 ARIFAKESLEEN-------TEQVVGTIGYIPPEYA---TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH 682 (785)
Q Consensus 613 a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 682 (785)
+........... .-...-|+.|+|||.+ .+...++|+|||+|||+||-|+....||+..+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI------ 266 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI------ 266 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE------
Confidence 875332211000 0012368999999966 677899999999999999999999999986543221
Q ss_pred HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 683 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
++....--..+.....+.+||..||+.||.+||++-+++..+-..
T Consensus 267 -------------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 267 -------------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred -------------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 111111112245677899999999999999999999999888664
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.75 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=203.5
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE 533 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 533 (785)
...++|++.+.||+|+||.||+|... .+..+|+|++.... .....++.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34678999999999999999998743 34679999986542 334456889999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCcc-------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCcee
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIR-------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPK 606 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 606 (785)
..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999998854221 234678889999999999999999876 99999999999999999999
Q ss_pred eccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHH
Q 003932 607 ISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 685 (785)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~ 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLR 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH
Confidence 999999876543322222222345778999999999889999999999999999999 67777533211 1111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.......... +...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 233 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111111 11223478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=322.18 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=200.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|++.+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36899999999999999999964 67889999987542 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|++++++..+.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765542 2345888999999999999999999886 9999999999999999999999999998754322
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH--------HHHHhCCcc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKG 692 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 692 (785)
........|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+... ...+.....
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 11223456899999999999988999999999999999999999998653321111111000 000000000
Q ss_pred -ccccccccCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 -VEFVDSFLDD------RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 -~~~~~~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.....+.... ......+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 001112346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.33 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=201.7
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
++|++.+.||+|+||.||++....+..+|+|.+..... ..+.+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45888899999999999999988778899999865432 23578899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999988542 235889999999999999999999886 999999999999999999999999998765332211
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .... ....+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~----~i~~~~~~~-------- 221 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVE----MISRGFRLY-------- 221 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCCCC--------
Confidence 1122345678999999998889999999999999999999 88887533211 1111 111111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
.+......+.+++.+||+.+|++||++.++++.|.
T Consensus 222 -~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 -RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112347899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.28 Aligned_cols=264 Identities=24% Similarity=0.359 Sum_probs=197.8
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.++||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999854 68899999987543 22334677899999999999999999999988899999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 975 888877432 334788899999999999999999886 9999999999999999999999999997643221
Q ss_pred ccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHH-----HHHhCCcccc-
Q 003932 622 EENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKGVE- 694 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~- 694 (785)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.... ..|......+
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 12233567899999998875 568999999999999999999999986543322211111000 0011000000
Q ss_pred c---cccccCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 F---VDSFLDDRN----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 ~---~~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+ ..+...... .+....++.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 000000000 0112346789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=330.16 Aligned_cols=241 Identities=20% Similarity=0.258 Sum_probs=195.0
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCC
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
+.||+|+||.||++.. .+++.||+|++.+.. ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478899999997542 234456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccc
Q 003932 546 SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625 (785)
Q Consensus 546 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 625 (785)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 99888853 346889999999999999999999886 999999999999999999999999998753221 1223
Q ss_pred ccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCC
Q 003932 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNS 705 (785)
Q Consensus 626 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 705 (785)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... . ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~-~---------~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEE-I---------RFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCC-C---------CCC
Confidence 44679999999999999999999999999999999999999986432111 111111111 0 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 706 PCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 706 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
.....++.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12345788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=330.77 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=198.9
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56899999999999999999954 68899999986532 233456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999988853 345788888999999999999999986 999999999999999999999999999875332
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......+. ..+
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~-~~~~i~~~~-~~~---- 234 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FR-IYEKILAGR-LKF---- 234 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HH-HHHHHhcCC-cCC----
Confidence 2235789999999999999999999999999999999999999864221 11 111111111 010
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSSM 736 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 736 (785)
+......+.+++.+||+.||.+||+ +++++..
T Consensus 235 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 -----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1112346789999999999999997 5777643
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=324.77 Aligned_cols=199 Identities=26% Similarity=0.336 Sum_probs=173.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||++... ++..+|+|++... .....+.+.+|++++++++|+||++++++|...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999965 6788999988754 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|.+++.. ...+++.....++.|++.||.|||+.+ +++||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999853 345788999999999999999999753 4999999999999999999999999998754322
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSML 670 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~ 670 (785)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22335689999999999998999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=325.02 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=210.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc-cEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-RMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 539 (785)
++|..++++|+|+||.+++++.+ +++.+++|.++-.. ....+...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999854 57789999997553 3334467889999999999999999999998888 99999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
+||+||+|.+.+... +...+++.++..++.|++.|+.|||+.+ |+|||||+.|||++.++.|||+|||+|+.+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999998653 3567999999999999999999999876 999999999999999999999999999988655
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
. ......+||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+... ++....+.
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~~------------- 221 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINRG------------- 221 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhhc-------------
Confidence 3 23456789999999999999999999999999999999999999987544332 22211111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.-...+.....++..++..||+.+|..||++.+++..
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 0111233345688999999999999999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.45 Aligned_cols=257 Identities=25% Similarity=0.323 Sum_probs=193.1
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC-----ccEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLI 538 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 538 (785)
.|.-.+++|.|+||.||.|+. .+++.||||+.-...+- -.+|+++|++++|||||++..+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466679999999999999995 45789999998655331 246999999999999999999887432 34589
Q ss_pred EEecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-Cceeeccccceeee
Q 003932 539 YEYMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDFGMARIF 616 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~~ 616 (785)
|||||. +|.+.++.. ..+..++...+.-+..||.+||.|||+.+ |+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 787777532 12445777778889999999999999965 9999999999999965 99999999999988
Q ss_pred cccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc---
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG--- 692 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 692 (785)
.... .......|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|......+.. .+ ..+.+.....
T Consensus 177 ~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL--~e-Iik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL--VE-IIKVLGTPTREDI 250 (364)
T ss_pred ccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH--HH-HHHHhCCCCHHHH
Confidence 6542 22445679999999998875 6999999999999999999999988754332222 21 1122211110
Q ss_pred -------ccccccccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 -------VEFVDSFLDDR-----NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 -------~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+...+.+... .......+..+++.++|+.+|.+|.++.|++.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 01111111111 22334457899999999999999999999864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.17 Aligned_cols=262 Identities=29% Similarity=0.440 Sum_probs=204.0
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC-
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS- 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 532 (785)
..++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4568999999999999999999632 34789999997543 33445678899999999 899999999988654
Q ss_pred CccEEEEEecCCCChhhhhcCCcc--------------------------------------------------------
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIR-------------------------------------------------------- 556 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 556 (785)
...+++|||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999988753211
Q ss_pred --ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccccccccCCc
Q 003932 557 --KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634 (785)
Q Consensus 557 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 634 (785)
...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.++|+|||+++.+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 125789999999999999999999876 999999999999999999999999999876433222222334567789
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHH
Q 003932 635 IPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCL 713 (785)
Q Consensus 635 ~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 713 (785)
+|||++.+..++.++|||||||++|||++ |+.|+......+ ............ ..+.....++.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRM---------RAPEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCC---------CCCccCCHHHH
Confidence 99999999999999999999999999998 998886422211 111111111111 01112335788
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 714 EIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 714 ~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
+++.+||+.+|++||++.|+++.|++..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.33 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=203.5
Q ss_pred cCCCcceeeceeCcEEEEEEEe-----CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
++|++.+.||+|+||.||+|.. ..+..+++|.+.... ......+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999973 245789999997543 3444678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCc--------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC
Q 003932 538 IYEYMPNKSLDCYLFDPI--------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM 603 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 603 (785)
||||+++++|.+++.... ....+++...+.++.|++.||.|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999884321 1234788899999999999999999886 99999999999999999
Q ss_pred ceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHH
Q 003932 604 KPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEH 682 (785)
Q Consensus 604 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~ 682 (785)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------E 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 999999999987543322222333446778999999998889999999999999999998 88887543211 1
Q ss_pred HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 683 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
............ .....+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111110 111223478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.47 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=201.8
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
++|.+.+.||+|+||.||+|....+..+|+|.+..... ..+.+.+|+.++++++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 46888999999999999999877667799999875433 33678999999999999999999999998889999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+|+|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99999988543 225889999999999999999999886 999999999999999999999999998865433211
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ ...........
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~--------- 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRL--------- 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCC---------
Confidence 1112335678999999998889999999999999999998 988875432211 11111111110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
......+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011112457899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.79 Aligned_cols=264 Identities=28% Similarity=0.438 Sum_probs=218.3
Q ss_pred HHHHHHhcCCCcceeeceeCcEEEEEEEeCC-CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 457 ADIEAATERFSIRNKLGEGGYGPVYKGVLPC-GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
++|+....+.....+||-|.||.||.|.++. .-.||||.++... -..++|..|..+|+.++|||+|+++|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4566666777888999999999999999764 5579999997654 4568999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
|||+|||..|+|.++|++.. +..++....+.++.||+.||.||...+ +|||||..+|+|+.++..||++|||++++
T Consensus 339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999997653 345777788999999999999999876 99999999999999999999999999999
Q ss_pred ecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
+....+... ..-.-.+.|.|||.+..+.++.|+|||+|||+|||+.| |..|+...+. ..++.++..+-.
T Consensus 415 MtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~LLEkgyR-- 484 (1157)
T KOG4278|consen 415 MTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGLLEKGYR-- 484 (1157)
T ss_pred hcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHHHhcccc--
Confidence 865543221 11223678999999999999999999999999999997 8888764332 233444433322
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
-..+..+++.+++|++.||+++|.+||++.|+.+.|+....
T Consensus 485 -------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 485 -------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 22344566789999999999999999999999999987654
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.61 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=204.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.++|++.+.||+|+||.||+|... +...+|+|.+.... ......+.+|+.++++++||||+++++++......++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357889999999999999999864 24579999987643 3345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
+|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998542 236889999999999999999999876 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .............
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~-- 228 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAVEDGYRLP-- 228 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCCCCC--
Confidence 2211111222345678999999999999999999999999999998 98887532211 1111111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.....+..+.+++.+||+.+|++||++.|+++.|+..
T Consensus 229 -------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=315.50 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=204.8
Q ss_pred cCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
++|.+.++||+|+||.||++.. .++..+++|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 5678889999999999999963 2356799999887776667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCcc------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCce
Q 003932 538 IYEYMPNKSLDCYLFDPIR------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP 605 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 605 (785)
+|||+++++|.+++..... ...+++..+..++.|++.|++|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 134789999999999999999999886 9999999999999999999
Q ss_pred eeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHH
Q 003932 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 606 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 684 (785)
+|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~---- 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI---- 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH----
Confidence 9999999976543322122223345678999999999999999999999999999998 888875332211 11
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.......... .+...+..+.+++.+||+.||.+||++.||++.|+.
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111111110 111223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=313.55 Aligned_cols=255 Identities=30% Similarity=0.477 Sum_probs=204.5
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.+|.+.+.||+|++|.||+|... .++.+++|++.... ...+++.+|++++++++|+||+++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999954 58889999987543 33567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999988543 2345889999999999999999999876 999999999999999999999999999875433211
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
......++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ...........
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~--------- 223 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKGYR--------- 223 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCC---------
Confidence 1112234568999999999999999999999999999998 88887532211 11122211111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111122345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=340.48 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=204.0
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC----
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE---- 533 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 533 (785)
...++|.+.+.||+|+||.||+|.. .+++.||||++... .......+.+|+..+..++|+|+++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999984 57899999998654 3344567889999999999999999888765332
Q ss_pred ----ccEEEEEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeec
Q 003932 534 ----ERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKIS 608 (785)
Q Consensus 534 ----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 608 (785)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3679999999999999886432 2346889999999999999999999886 9999999999999999999999
Q ss_pred cccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHh
Q 003932 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK 688 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 688 (785)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~- 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTL- 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh-
Confidence 99999876543222333456799999999999999999999999999999999999999864221 11111111
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 689 GGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 689 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+... ..+...+..+.+++.+||+.||.+||++.++++.
T Consensus 259 ~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11110 0112234578899999999999999999999763
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=322.77 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=201.5
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCc----EEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGE----VIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.+|++.+.||+|+||.||+|++. ++. .||+|++.... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999843 333 38999987543 34456788999999999999999999999764 5789
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988643 335788999999999999999999886 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ ...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--- 230 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL--- 230 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCCC---
Confidence 3322111222334678999999999999999999999999999998 999885322111 11111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
...+.....+.+++.+||+.+|.+||++.+++..|.....
T Consensus 231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0011223468899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=316.69 Aligned_cols=263 Identities=24% Similarity=0.300 Sum_probs=196.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999964 688999999875432 223456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+. ++|.+++.. ....++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 577776643 2345788899999999999999999986 9999999999999999999999999987543221
Q ss_pred cccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc------
Q 003932 621 LEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV------ 693 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 693 (785)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..................
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence 12234568899999998865 4588999999999999999999999864321 111111111111110000
Q ss_pred ---cccccccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 ---EFVDSFLDDRNS---------PCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 ---~~~~~~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
............ ......+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000 001235779999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.06 Aligned_cols=241 Identities=20% Similarity=0.259 Sum_probs=193.6
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCC
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 46899999999754 2234456778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccc
Q 003932 546 SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625 (785)
Q Consensus 546 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 625 (785)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcc
Confidence 99888743 345889999999999999999999886 999999999999999999999999998753221 1122
Q ss_pred ccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCC
Q 003932 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNS 705 (785)
Q Consensus 626 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 705 (785)
....||..|+|||++.+..++.++|||||||++|||++|+.|+....... ......... . ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~~-~---------~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEE-I---------RFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCC-C---------CCC
Confidence 34578999999999999999999999999999999999999986432211 111111110 0 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 706 PCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 706 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
......+.+++.+||+.||.+|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 12234788999999999999998 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.19 Aligned_cols=245 Identities=20% Similarity=0.253 Sum_probs=198.7
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-C-CcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-C-GEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
++|++.+.||+|+||.||+|... . +..||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46899999999999999999843 2 368999998643 223445688899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999998853 345889999999999999999999986 99999999999999999999999999986532
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ......... ..
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~-~~~~i~~~~-~~---- 246 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------L-IYQKILEGI-IY---- 246 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------H-HHHHHhcCC-CC----
Confidence 2 23457899999999999988999999999999999999999998643211 1 111111111 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSSM 736 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 736 (785)
.+......+.+++.+||+.||.+|+ +++++++.
T Consensus 247 -----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 -----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111234678999999999999995 89888764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=326.55 Aligned_cols=259 Identities=19% Similarity=0.206 Sum_probs=194.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..+|++.+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 36799999999999999999995 4688999997532 3467899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+. ++|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 85 688777743 345889999999999999999999886 9999999999999999999999999987533221
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCC-c---ccHHHHHHHHHhCCc------
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE-N---LSILEHAYELWKGGK------ 691 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~-~---~~~~~~~~~~~~~~~------ 691 (785)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+......+ . ...+...........
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 112334579999999999999999999999999999999999998765322111 0 001111111000000
Q ss_pred c----cccc-------ccccCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 G----VEFV-------DSFLDDRN----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~----~~~~-------~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. .... ........ ....+.++.+|+.+||+.||++|||++|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000 00000000 0123457889999999999999999999984
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.14 Aligned_cols=265 Identities=25% Similarity=0.318 Sum_probs=203.2
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChh--hHHHHHHHHHHHHcCCCCc-eeeEEEEEecCC-----
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQ--GFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSE----- 533 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 533 (785)
...|..+++||+|.||+||+|+ ..+|+.||+|+++-.... ......+|+.++++++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3457777889999999999999 457899999999865331 2345678999999999999 999999998877
Q ss_pred -ccEEEEEecCCCChhhhhcCCccc-cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 534 -ERMLIYEYMPNKSLDCYLFDPIRK-LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 534 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
.+++|+||+ ..+|..++...... ..++...+..+..||++||+|||+++ |+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 788999999 55898888653321 34677889999999999999999987 9999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
+|+.+.-. .+..+..++|..|+|||++.+. .|+...||||+||++.||+++++.|..... ........+.....
T Consensus 166 lAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTP 240 (323)
T ss_pred hHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCC
Confidence 99965422 2235567889999999999887 699999999999999999999988875443 22223333322221
Q ss_pred c---ccc---cccc--ccCCCC-CHHH-------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 691 K---GVE---FVDS--FLDDRN-SPCK-------LMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 691 ~---~~~---~~~~--~l~~~~-~~~~-------~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
. +.. ..+. ...... .... .....+++.+||+.+|.+|.|++.+++.
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 111 1111 111111 1111 1367899999999999999999999886
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=323.55 Aligned_cols=265 Identities=23% Similarity=0.358 Sum_probs=194.8
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC-----ccE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERM 536 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 536 (785)
+|++.++||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999995 46899999998743 2233456889999999999999999999886432 479
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+||||+. ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688887743 345889999999999999999999986 999999999999999999999999999764
Q ss_pred ccccc-ccccccccccCCcccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHH--------HHH
Q 003932 617 AKESL-EENTEQVVGTIGYIPPEYATK--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYE 685 (785)
Q Consensus 617 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~ 685 (785)
..... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.. ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 112234578999999999876 6789999999999999999999999864332111100000 000
Q ss_pred HHhCCccccccccccCCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 686 LWKGGKGVEFVDSFLDDRN------SPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+......+.......... .+.....+.+++.+||+.||++|||++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000000 01123467899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.60 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=202.6
Q ss_pred cCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
.+|.+.+.||+|+||.||+|... .+..||+|++..... ...+.+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35777899999999999999853 247899999976543 23456889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCC-------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC
Q 003932 537 LIYEYMPNKSLDCYLFDP-------------IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM 603 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 603 (785)
+++||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999887421 11235788889999999999999999886 99999999999999999
Q ss_pred ceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHH
Q 003932 604 KPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEH 682 (785)
Q Consensus 604 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~ 682 (785)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... +
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------H-
Confidence 999999999886543322222233456789999999988889999999999999999998 77777532211 1
Q ss_pred HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 683 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
............ .....+..+.+++.+||+.+|.+||++++|++.|+.
T Consensus 235 ~~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111121211111 112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=305.02 Aligned_cols=254 Identities=22% Similarity=0.276 Sum_probs=207.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.+.|++++.||+|.-|+||++... ++..+|+|++.+... +...+.+.|-++|+.++||.++.|++.+..+...|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 356788899999999999999965 468899999987643 3445677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
||||+||+|..+++.. ....+++..+..++..++-||+|||-.| ||.|||||+||||.++|++.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999888653 4566899999999999999999999987 99999999999999999999999998864311
Q ss_pred c--------------------------------ccc----------------------cccccccccCCcccccccCCCC
Q 003932 619 E--------------------------------SLE----------------------ENTEQVVGTIGYIPPEYATKGV 644 (785)
Q Consensus 619 ~--------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~ 644 (785)
. ... .....++||-.|+|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 000 0112467999999999999999
Q ss_pred CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCC
Q 003932 645 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENP 724 (785)
Q Consensus 645 ~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP 724 (785)
.+.++|+|+|||+|||||.|..||...+..+.+..+- . ....+. ..+..+..+.+||++.|.+||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv------~--~~l~Fp-------~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV------G--QPLKFP-------EEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh------c--CCCcCC-------CCCcchhHHHHHHHHHhccCh
Confidence 9999999999999999999999998766555432221 1 011111 112345578999999999999
Q ss_pred CCCCC----HHHHHH
Q 003932 725 NDRPS----MLEVSS 735 (785)
Q Consensus 725 ~~RPs----~~evl~ 735 (785)
++|.. +.||.+
T Consensus 377 ~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhccccchHHhhc
Confidence 99998 888865
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=309.34 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=195.7
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999985 468899999886543 34456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccccc
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 627 (785)
.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9988532 335789999999999999999999886 99999999999999999999999999876433211111111
Q ss_pred ccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCH
Q 003932 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSP 706 (785)
Q Consensus 628 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 706 (785)
...+..|+|||.+.+..++.++|||||||++|||++ |..|+...... ........... ...+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~~~---------~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQGVR---------LPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCC---------CCCcc
Confidence 223467999999999899999999999999999998 88777532211 11111111100 01112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 707 CKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 707 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
..+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.04 Aligned_cols=241 Identities=20% Similarity=0.256 Sum_probs=191.9
Q ss_pred eceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 472 LGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 472 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
||+|+||.||+|... +++.||+|++.+. .......+.+|+.++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999954 6889999998653 233445678899999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccccc
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 627 (785)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 988853 345889999999999999999999886 9999999999999999999999999987532221 22334
Q ss_pred ccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHH
Q 003932 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707 (785)
Q Consensus 628 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 707 (785)
..||..|+|||++.+..++.++|||||||++|||++|+.||..... .+....... .. . ..+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-~~-~---------~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-EP-L---------RFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-CC-C---------CCCCc
Confidence 6799999999999999999999999999999999999999864321 111111111 11 0 11112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 708 KLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 708 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
....+.+++.+||+.||.+||++.++.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 334788999999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.14 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=207.6
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEec
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID 531 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 531 (785)
....++|++.+.||+|+||.||++... ....+|+|.+... .......+.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344567899999999999999999853 2367999998764 234456688999999999 89999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCC-------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDP-------------IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
....+++|||+++|+|..++... .....+++..++.++.|++.||.|||+.+ ++||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999998532 12346889999999999999999999876 999999999999
Q ss_pred EcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcc
Q 003932 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENL 677 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~ 677 (785)
+++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--- 241 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---
Confidence 99999999999999987654322222222345678999999998899999999999999999997 88887532211
Q ss_pred cHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
............ ..+......+.+++.+||+.||++|||+.|+++.|++..
T Consensus 242 ----~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ----ELFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111222111111 111223457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=316.80 Aligned_cols=265 Identities=25% Similarity=0.437 Sum_probs=201.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCC---------------CcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPC---------------GEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVL 526 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 526 (785)
.++|++.+.||+|+||.||++.... ...||+|.++.. .......+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987532 235899999764 333456789999999999999999999
Q ss_pred EEEecCCccEEEEEecCCCChhhhhcCCc---------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCE
Q 003932 527 GFCIDSEERMLIYEYMPNKSLDCYLFDPI---------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNI 597 (785)
Q Consensus 527 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Ni 597 (785)
+++......++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999885321 1124688899999999999999999886 99999999999
Q ss_pred EEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCcccCCCC
Q 003932 598 LLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGINE 675 (785)
Q Consensus 598 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--G~~p~~~~~~~~ 675 (785)
++++++.+||+|||++................++..|+|||.+.+..++.++|||||||+++||++ |..|+......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999876543322222223345778999999998889999999999999999998 445554322111
Q ss_pred cccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 676 NLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.+......+......... ...+..+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 241 ---~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 ---VIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111111100000 0111234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=325.01 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=193.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++|+||+++++++......++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3566778999999999999985 468999999986543 33446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++|+|.... ...+..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999985432 2456778889999999999999886 9999999999999999999999999998754321
Q ss_pred ccccccccccCCcccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATK-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.......||..|+|||.+.. ...+.++|||||||++|||++|+.||......+...... .......
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~---- 293 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC----AICMSQP---- 293 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----HHhccCC----
Confidence 12234578999999998743 234568999999999999999999987332222111111 0000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.........++.+++.+||+.||++||++.|+++.
T Consensus 294 -----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112234578999999999999999999999874
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.54 Aligned_cols=242 Identities=20% Similarity=0.255 Sum_probs=194.8
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCC
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
+.||+|+||.||++.. .+++.||+|++.+. .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46899999999754 2234457788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccc
Q 003932 546 SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625 (785)
Q Consensus 546 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 625 (785)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence 99888743 345889999999999999999999886 999999999999999999999999998753221 1123
Q ss_pred ccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCC
Q 003932 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNS 705 (785)
Q Consensus 626 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 705 (785)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... . ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~-~---------~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMED-I---------KFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-------HHHHhccCC-c---------cCC
Confidence 34579999999999999999999999999999999999999986432211 111111100 0 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003932 706 PCKLMRCLEIALLCVQENPNDRP-----SMLEVSSM 736 (785)
Q Consensus 706 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 736 (785)
......+.+++.+||+.||++|| ++.|+++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12334688999999999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=317.34 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=193.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe--CCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcC---CCCceeeEEEEEe-----c
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL--PCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKL---QHVNLIRVLGFCI-----D 531 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 531 (785)
.+|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3689999999999999999985 2467899999865421 2223456677776665 6999999999985 2
Q ss_pred CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
....++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 68888885432 334889999999999999999999886 9999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
+++..... .......||..|+|||.+.+..++.++|||||||++|||++|++||......+. +...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCC
Confidence 99875432 223445689999999999988999999999999999999999999875432221 111111110000
Q ss_pred ccc------ccccccCCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVE------FVDSFLDDR-------NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~------~~~~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
... .....+... ..+.....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 000000000 00122346789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=309.95 Aligned_cols=254 Identities=29% Similarity=0.467 Sum_probs=202.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.++|++.+.||+|+||.||+|....+..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457899999999999999999987788899999876433 2457899999999999999999999875 45689999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||++++++.++|+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence 999999998643 2345789999999999999999999886 99999999999999999999999999987543221
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... + ...........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~-------- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------E-VLEQVERGYRM-------- 222 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC--------
Confidence 11122335678999999988889999999999999999999 88888542211 1 11111111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
......+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112234578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=309.32 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=200.7
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
.+|++.+.||+|+||.||+|...++..+|+|.+.+... ....+.+|+.++++++|+||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35788899999999999999987777899999865432 23567889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 99999988543 235889999999999999999999886 999999999999999999999999998765432111
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ .. ....... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~---------~~ 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV----ESVSAGY---------RL 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH----HHHHcCC---------cC
Confidence 1111223457999999999999999999999999999999 788875432211 11 1111110 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
..+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 111223557899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=312.81 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=201.0
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCc----EEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGE----VIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.+|++.+.||+|+||.||+|... +++ .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999853 344 47888876443 2344677888889999999999999998864 56789
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 345889999999999999999999876 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
............++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... .......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~- 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLAQ- 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCCC-
Confidence 4322222334557788999999998899999999999999999998 998885432111 1122222211110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.......+.+++.+||+.||++|||+.|+++.|.....
T Consensus 233 --------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 --------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 01123467889999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=323.15 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=197.1
Q ss_pred CCCcceeeceeCcEEEEEEEe----CCCcEEEEEEcCCCC----hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCcc
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTS----TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 535 (785)
+|++.+.||+|+||.||+++. .+++.||+|++.+.. ....+.+..|+.+++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999874 357899999986532 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999988853 345889999999999999999999886 99999999999999999999999999876
Q ss_pred ecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
+..... .......||..|+|||++.+. .++.++|||||||++|||++|+.||...........+ ........
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~~~--- 227 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV---SRRILKCD--- 227 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH---HHHHhcCC---
Confidence 533221 122345799999999999875 4788999999999999999999998654332221111 11111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
. .........+.+++.+||+.||++|| +++++++
T Consensus 228 ---~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 ---P----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---C----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 11112334678999999999999999 6677765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.56 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=203.1
Q ss_pred CCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
+|++.+.||+|+||.||+|+.. ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999842 23568899887553 3445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCc---------------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCC
Q 003932 538 IYEYMPNKSLDCYLFDPI---------------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSN 596 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~N 596 (785)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1134788999999999999999999876 9999999999
Q ss_pred EEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCC
Q 003932 597 ILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINE 675 (785)
Q Consensus 597 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~ 675 (785)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999976533222111223345678999999988889999999999999999998 98888533211
Q ss_pred cccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 676 NLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
........... .......+.++.+++.+||+.+|++||++.|+++.|++..
T Consensus 237 ------~~~~~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 ------RLFNLLKTGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ------HHHHHHhCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11111111110 0111223357889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=314.12 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=206.8
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCC-----CcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec-CCc
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPC-----GEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEE 534 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 534 (785)
..++|++.+.||+|+||.||+|.... +..|++|++... .....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35689999999999999999999654 678999998754 33445678899999999999999999998876 467
Q ss_pred cEEEEEecCCCChhhhhcCCccc-----cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecc
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRK-----LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISD 609 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 609 (785)
.++++||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543222 46889999999999999999999876 99999999999999999999999
Q ss_pred ccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHh
Q 003932 610 FGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWK 688 (785)
Q Consensus 610 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 688 (785)
||+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.|+...... ... ....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMA----AYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHH----HHHH
Confidence 999986543322222223346778999999998889999999999999999999 99988543211 111 1111
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 689 GGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 689 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
..... ......+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus 234 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11100 011112357889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=315.04 Aligned_cols=262 Identities=25% Similarity=0.435 Sum_probs=204.6
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE 533 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 533 (785)
...++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999742 24579999986543 233446788999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCc-------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCcee
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPI-------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPK 606 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 606 (785)
..++||||+++|+|.+++.... .....++..+..++.|++.||.|||+.+ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999985421 1234567788999999999999999886 99999999999999999999
Q ss_pred eccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHH
Q 003932 607 ISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 685 (785)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-------~~~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------QVLK 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence 999999886543322222222345678999999998899999999999999999998 67777532211 1111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
....+.... .....+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus 233 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111111111 01122357899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=314.79 Aligned_cols=263 Identities=29% Similarity=0.443 Sum_probs=201.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 536 (785)
.+|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999974 35788999999877666677899999999999999999999987543 4678
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998542 335889999999999999999999886 999999999999999999999999999876
Q ss_pred cccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCC--------c-ccHHHHHHHH
Q 003932 617 AKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE--------N-LSILEHAYEL 686 (785)
Q Consensus 617 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~--------~-~~~~~~~~~~ 686 (785)
...... .......++..|+|||.+.+..++.++|||||||++|||++|..++....... . ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 432211 11111223456999999998899999999999999999999876643211100 0 0000000111
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
..... ........+..+.+++.+||+.+|++|||+.||++.|+..
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11100 0011122345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=328.02 Aligned_cols=265 Identities=26% Similarity=0.388 Sum_probs=206.4
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCC-CCceeeEEEEEe
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCI 530 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 530 (785)
++...++|.+.+.||+|+||.||+|++. .++.||+|++.... ....+.+.+|+.++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4445567889999999999999999843 34679999997653 233457889999999997 999999999999
Q ss_pred cCCccEEEEEecCCCChhhhhcCCcc------------------------------------------------------
Q 003932 531 DSEERMLIYEYMPNKSLDCYLFDPIR------------------------------------------------------ 556 (785)
Q Consensus 531 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 556 (785)
.....++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999998864211
Q ss_pred -----------------------------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCC
Q 003932 557 -----------------------------------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVS 595 (785)
Q Consensus 557 -----------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~ 595 (785)
...+++.....++.||+.||.|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 124677788999999999999999875 999999999
Q ss_pred CEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCC
Q 003932 596 NILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGIN 674 (785)
Q Consensus 596 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~ 674 (785)
|||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986533221111223356788999999998889999999999999999998 88887543211
Q ss_pred CcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 675 ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
+ ........+... ..+......+.+++.+||+.+|.+||+++||++.|++..
T Consensus 349 ~------~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E------QFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H------HHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 111111111111 011123457899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.65 Aligned_cols=265 Identities=27% Similarity=0.426 Sum_probs=205.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCC-----------------CcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceee
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPC-----------------GEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIR 524 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 524 (785)
..+|++.+.||+|+||.||+|.... +..+|+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999987432 2458999987653 344567889999999999999999
Q ss_pred EEEEEecCCccEEEEEecCCCChhhhhcCCc--------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCC
Q 003932 525 VLGFCIDSEERMLIYEYMPNKSLDCYLFDPI--------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSN 596 (785)
Q Consensus 525 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~N 596 (785)
+++++......+++|||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986432 1125899999999999999999999876 9999999999
Q ss_pred EEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCcccCCC
Q 003932 597 ILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGIN 674 (785)
Q Consensus 597 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--G~~p~~~~~~~ 674 (785)
|+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999987544332222334456788999999998889999999999999999998 5566543221
Q ss_pred CcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 675 ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
..........+......... ......+.++.+++.+||+.||++|||+.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11222222211111111111 0111233578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.52 Aligned_cols=251 Identities=25% Similarity=0.300 Sum_probs=199.5
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
+|++.++||+|+||.||++.. .+++.||+|++..... .....+.+|+.++++++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999995 4688999999875422 223456789999999999999999999999899999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++|+|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887542 2345899999999999999999999986 9999999999999999999999999988653221
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ...........
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------- 221 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ--------- 221 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc---------
Confidence 123346899999999999989999999999999999999999999743322111 11111111100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
.......+..+.+++.+||+.||++|| +++++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 111222345788999999999999999 7888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.52 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=201.0
Q ss_pred CCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc-----
Q 003932 466 FSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE----- 534 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 534 (785)
|.+.+.||+|+||.||+|... .+..+|+|++... .....+.+.+|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999853 2467999998754 23445678999999999999999999998876554
Q ss_pred -cEEEEEecCCCChhhhhcCCc---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 535 -RMLIYEYMPNKSLDCYLFDPI---RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 535 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
.++++||+++|+|..++.... ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999998885421 2346889999999999999999999876 999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhC
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKG 689 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 689 (785)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~----~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIY----DYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHc
Confidence 99987654332222222345678999999988889999999999999999999 88887532211 111 11111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 690 GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 690 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
+.... .+...+..+.+++.+||+.||++||++.|+++.|++.
T Consensus 231 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 1122345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=322.96 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=203.1
Q ss_pred CCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-C-----CceeeEEEEEecCCccEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-H-----VNLIRVLGFCIDSEERML 537 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 537 (785)
+|.+.+.||+|+||.|.+|. ..+++.||||++++. ..-..+-..|+.+|..|+ | -|+|+++++|...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 89999999999999999999 557999999999765 334456678999999997 4 389999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC--Cceeeccccceee
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA--MKPKISDFGMARI 615 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--~~~kl~Dfg~a~~ 615 (785)
|+|.+ .-+|.++|..+. ...++...+..|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.++.
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99998 569999997653 445899999999999999999999886 9999999999999754 3799999999987
Q ss_pred ecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH--------HH--
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YE-- 685 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~-- 685 (785)
.... ....+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|...++.+.+..+... ..
T Consensus 341 ~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 5433 22567789999999999999999999999999999999999888765554433322211 00
Q ss_pred -----HHhC-Ccccccccc------------------ccCCC------------CCHHHHHHHHHHHHHccccCCCCCCC
Q 003932 686 -----LWKG-GKGVEFVDS------------------FLDDR------------NSPCKLMRCLEIALLCVQENPNDRPS 729 (785)
Q Consensus 686 -----~~~~-~~~~~~~~~------------------~l~~~------------~~~~~~~~l~~li~~cl~~dP~~RPs 729 (785)
.+.. ......... ..... ...+....+.+++.+||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 1111 000000000 00000 01123446899999999999999999
Q ss_pred HHHHHHH
Q 003932 730 MLEVSSM 736 (785)
Q Consensus 730 ~~evl~~ 736 (785)
..|.++.
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999763
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.00 Aligned_cols=258 Identities=29% Similarity=0.460 Sum_probs=202.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|.+.+.||+|++|.||+|... .+..|++|.+.... ......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467899999999999999999864 35678999887543 33345688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCcc----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC---ceeec
Q 003932 536 MLIYEYMPNKSLDCYLFDPIR----KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM---KPKIS 608 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~ 608 (785)
++||||+++++|.+++..... ...+++..+++++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999998854321 235899999999999999999999886 99999999999998755 59999
Q ss_pred cccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHH
Q 003932 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+ .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VMEFV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHH
Confidence 9999987643222222222334568999999998999999999999999999997 888876432211 11111
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
...... ..+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 235 TGGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111111 1112224578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.82 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=198.1
Q ss_pred CCcceeeceeCcEEEEEEEeCC-Cc--EEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------Cc
Q 003932 466 FSIRNKLGEGGYGPVYKGVLPC-GE--VIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EE 534 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 534 (785)
|.+.+.||+|+||.||+|+... +. .+|+|.+... .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999643 32 5899988754 344566788999999999999999999987532 25
Q ss_pred cEEEEEecCCCChhhhhcCC---ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 535 RMLIYEYMPNKSLDCYLFDP---IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
.+++|||+++|+|..++... .....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998887321 12345889999999999999999999876 9999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... ........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcC
Confidence 9987643322112223345778999999999999999999999999999999 78887532211 111222222
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 691 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.... .....+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 1112344688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=321.78 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=192.4
Q ss_pred CCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHH---HcCCCCceeeEEEEEecCCccEEE
Q 003932 466 FSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLT---AKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
|++.+.||+|+||.||+|.. .+++.||+|++.+.. ....+.+.+|+.++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67789999999999999985 468999999997542 22344566666554 566899999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|..++. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988774 245899999999999999999999886 99999999999999999999999999875322
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. ........|+..|+|||.+.+..++.++|||||||++|||++|+.||......+ .. ........
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~-~~i~~~~~------ 218 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VF-DSIVNDEV------ 218 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCCC------
Confidence 1 122334678999999999999999999999999999999999999986432211 11 11111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
..+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 219 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01112234678999999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.80 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=205.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|.+.+.||+|+||.||+|... .+..+|+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467899999999999999999853 23679999987543 34455788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCcc-------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeec
Q 003932 536 MLIYEYMPNKSLDCYLFDPIR-------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKIS 608 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 608 (785)
++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999854221 234788899999999999999999876 9999999999999999999999
Q ss_pred cccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHH
Q 003932 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ ..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHH
Confidence 9999886544332222333456789999999988889999999999999999998 888875322111 11122
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
..+..... +...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 21111111 11124578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.46 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=202.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.++|++.++||+|+||.||+|...+...+|+|++..... ..+.+.+|++++++++|+||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 457999999999999999999977667799999976433 3357889999999999999999999874 45689999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.++.+.....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 999999998642 2335788999999999999999999876 99999999999999999999999999987643321
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......++..|+|||...+..++.++|||||||++|||++ |+.|+......+ ..........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~~--------- 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR--------- 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCCC---------
Confidence 11123346678999999998899999999999999999999 777775332111 1111111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.......+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011123345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.71 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=215.4
Q ss_pred HHHHHhcCCCcceeeceeCcEEEEEEEeC---CCc--EEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec
Q 003932 458 DIEAATERFSIRNKLGEGGYGPVYKGVLP---CGE--VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID 531 (785)
Q Consensus 458 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 531 (785)
+.+..++...+.++||.|-||.||+|..- .|+ .||||..+.. .....+.|..|..+|+.++||||++++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 34455667788899999999999999842 233 4899999874 45667889999999999999999999999974
Q ss_pred CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
...++|||.++-|.|..+|.. +...++......++.||+.+|+|||+.. +|||||..+|||+.....|||+|||
T Consensus 463 -~P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred -cceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccc
Confidence 578999999999999999964 4556888999999999999999999875 9999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
+++.+....+.+.. ...-++.|||||.+.-.+++.++|||.|||++||+++ |..||......+.+-.++
T Consensus 537 LSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE--------- 606 (974)
T KOG4257|consen 537 LSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE--------- 606 (974)
T ss_pred hhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec---------
Confidence 99998776655443 3344778999999999999999999999999999986 999998655444332221
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 691 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
..-+-..++.++..++.|+.+||..+|.+||.+.|+...|..+
T Consensus 607 -------nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 607 -------NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred -------CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 1111223445677899999999999999999999998888654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=313.60 Aligned_cols=267 Identities=24% Similarity=0.314 Sum_probs=199.8
Q ss_pred CCcceeeceeCcEEEEEEEe-----CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccEE
Q 003932 466 FSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERML 537 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 537 (785)
|++.+.||+|+||+||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988652 357789999987653 23456788999999999999999999988754 35789
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998843 34899999999999999999999886 9999999999999999999999999998764
Q ss_pred cccccc-ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEE-NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .................+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence 322111 1122345667999999998889999999999999999999999875432110 00000000000000000111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
+.......+...+..+.+++.+||+.+|++|||++++++.|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111223346899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd00598 GH18_chitinase-like The GH18 (glycosyl hydrolase, family 18) type II chitinases hydrolyze chitin, an abundant polymer of beta-1,4-linked N-acetylglucosamine (GlcNAc) which is a major component of the cell wall of fungi and the exoskeleton of arthropods | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.93 Aligned_cols=205 Identities=26% Similarity=0.432 Sum_probs=169.7
Q ss_pred EEEEecCCCCCC---cCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCCCc
Q 003932 28 RVGYLNLSEVST---ISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNY 104 (785)
Q Consensus 28 ~vgY~~~~~~~~---~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~ 104 (785)
+||||..|.... +..++.++||||+|+|+.+++++........ ........++.+|+++|++||++|||||.....
T Consensus 1 vv~y~~~w~~~~~~~~~~~~~~~~thvi~~f~~v~~~~~~~~~~~~-~~~~~~~~i~~l~~~~~g~kv~~sigg~~~~~~ 79 (210)
T cd00598 1 VICYYDGWSSGRGPDPTDIPLSLCTHIIYAFAEISSDGSLNLFGDK-SEEPLKGALEELASKKPGLKVLISIGGWTDSSP 79 (210)
T ss_pred CEEEEccccccCCCChhhCCcccCCEEEEeeEEECCCCCEecccCc-ccHHHHHHHHHHHHhCCCCEEEEEEcCCCCCCC
Confidence 489999987654 4889999999999999999998854432222 223344556668888899999999998876544
Q ss_pred ccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCC--CchhHHHHHHHHHHHhhhhhhhcccccceeEEEEe
Q 003932 105 SIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTST--DMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTA 182 (785)
Q Consensus 105 ~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~--d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~ 182 (785)
| .++++++.|++|++++++++++|+|||||||||+|.... ++++|+.|+++||++|++. +..+++++
T Consensus 80 --~-~~~~~~~~~~~f~~~~~~~v~~~~~DGidiD~E~~~~~~~~~~~~~~~ll~~lr~~l~~~--------~~~ls~a~ 148 (210)
T cd00598 80 --F-TLASDPASRAAFANSLVSFLKTYGFDGVDIDWEYPGAADNSDRENFITLLRELRSALGAA--------NYLLTIAV 148 (210)
T ss_pred --c-hhhcCHHHHHHHHHHHHHHHHHcCCCceEEeeeCCCCcCccHHHHHHHHHHHHHHHhccc--------CcEEEEEe
Confidence 4 889999999999999999999999999999999996544 5899999999999999752 44556655
Q ss_pred ecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeecccc
Q 003932 183 RFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPF 262 (785)
Q Consensus 183 ~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~KlvlGip~ 262 (785)
++........|++.++.+++||+++|+|| |++|+|+
T Consensus 149 ~~~~~~~~~~~~~~~l~~~vD~v~vm~Yd--------------------------------------------l~~g~~~ 184 (210)
T cd00598 149 PASYFDLGYAYDVPAIGDYVDFVNVMTYD--------------------------------------------LVLGVPF 184 (210)
T ss_pred cCChHHhhccCCHHHHHhhCCEEEEeeec--------------------------------------------ccccchh
Confidence 54443333348999999999999999999 8899999
Q ss_pred ccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHHHHHhh
Q 003932 263 YGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAY 342 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~~K~~~ 342 (785)
| |++.|++|
T Consensus 185 ~-----------------------------------------------------------------------s~~~k~~~ 193 (210)
T cd00598 185 Y-----------------------------------------------------------------------SLGAKAKY 193 (210)
T ss_pred h-----------------------------------------------------------------------hHHHHHHH
Confidence 8 89999999
Q ss_pred hcccCccceEeeecccc
Q 003932 343 AKEKRLLGYYAWQVSFD 359 (785)
Q Consensus 343 ~~~~glgG~~~W~l~~D 359 (785)
++++++||+|+|++++|
T Consensus 194 ~~~~~~gGv~~w~~~~d 210 (210)
T cd00598 194 AKQKGLGGVMIWELDQD 210 (210)
T ss_pred HHHcCCceEEEEeccCC
Confidence 99999999999999987
|
Chitinases have been identified in viruses, bacteria, fungi, protozoan parasites, insects, and plants. The structure of the GH18 domain is an eight-stranded beta/alpha barrel with a pronounced active-site cleft at the C-terminal end of the beta-barrel. The GH18 family includes chitotriosidase, chitobiase, hevamine, zymocin-alpha, narbonin, SI-CLP (stabilin-1 interacting chitinase-like protein), IDGF (imaginal disc growth factor), CFLE (cortical fragment-lytic enzyme) spore hydrolase, the type III and type V plant chitinases, the endo-beta-N-acetylglucosaminidases, and the chitolectins. The GH85 (glycosyl hydrolase, family 85) ENGases (endo-beta-N-acetylglucosaminidases) are closely related to the GH18 chitinases and are inclu |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=328.22 Aligned_cols=253 Identities=20% Similarity=0.271 Sum_probs=195.7
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.|++++.||+|+||+||+|+. .+++.||+|++.+.. ....+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999984 568899999997542 2344578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998853 345788888999999999999999876 9999999999999999999999999975431100
Q ss_pred c---------------------------------------------ccccccccccCCcccccccCCCCCCChhhHHHHH
Q 003932 621 L---------------------------------------------EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFG 655 (785)
Q Consensus 621 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 655 (785)
. .......+||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999998899999999999
Q ss_pred HHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHH
Q 003932 656 VLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALL--CVQENPNDRPSMLEV 733 (785)
Q Consensus 656 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ev 733 (785)
|++|||++|+.||......+ ............... .......++.+++.+ |+..+|..||++.|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~~-------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE------TQLKVINWENTLHIP-------PQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH------HHHHHHccccccCCC-------CCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999996533211 111111100001100 011123467778877 556666679999999
Q ss_pred HHH
Q 003932 734 SSM 736 (785)
Q Consensus 734 l~~ 736 (785)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=306.04 Aligned_cols=259 Identities=21% Similarity=0.330 Sum_probs=206.6
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.+++.++||||+++++++......++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4789999999999999999995 46889999987643 2334456889999999999999999999999889999999
Q ss_pred EecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 540 EYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
||+++++|.+++.... ....++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988874322 2345788999999999999999999876 99999999999999999999999999887643
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ....... ......
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~-~~~~~~------ 225 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK-IEQCDY------ 225 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-HhcCCC------
Confidence 22 1122346888999999999888999999999999999999999998532211 1111111 111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...........+.+++.+||+.+|++||++.++++.|++.
T Consensus 226 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 --PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0111123345789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.64 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=198.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.++||+|+||.||+|.. .+++.+|+|++... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999984 56889999998654 334446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996542 3678888999999999999999886 999999999999999999999999999765332
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.|+.......................... +
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~- 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----L- 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----C-
Confidence 22345789999999999999999999999999999999999999864322211111111111111111000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.......++.+++.+||+.+|.+||+++|+++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011123468899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.21 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=205.7
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS 532 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 532 (785)
...++|.+.+.||+|+||.||++.. ..+..+|+|++.... ....+.+.+|+.+++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3446799999999999999999973 134579999987653 34456789999999999 799999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
...+++|||+++|+|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999985422 233899999999999999999999886 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ ........+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCC
Confidence 876543221111222345778999999999999999999999999999998 998875432211 1111111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
... .....+..+.+++.+||+.+|++||++.|+++.|++.
T Consensus 262 ~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 0111234788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.39 Aligned_cols=265 Identities=27% Similarity=0.394 Sum_probs=207.1
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeC--------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEe
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLP--------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCI 530 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 530 (785)
....+|++.+.||+|+||.||+|... ....+|+|.+.... ....+++.+|+.+++++ +|+||++++++|.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 33457899999999999999999732 12368999887543 34456789999999999 8999999999999
Q ss_pred cCCccEEEEEecCCCChhhhhcCCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCE
Q 003932 531 DSEERMLIYEYMPNKSLDCYLFDPI-------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNI 597 (785)
Q Consensus 531 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Ni 597 (785)
.....++++||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence 9999999999999999999985421 1235788999999999999999999886 99999999999
Q ss_pred EEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCc
Q 003932 598 LLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINEN 676 (785)
Q Consensus 598 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~ 676 (785)
|++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 999999999999999987643322222222334568999999999999999999999999999998 7887753321
Q ss_pred ccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 677 LSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
+............. ........+.+++.+||+.+|.+||++.|+++.|+......
T Consensus 243 ----~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 ----EELFKLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ----HHHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11112222211111 11123347889999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=329.00 Aligned_cols=254 Identities=21% Similarity=0.272 Sum_probs=200.2
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
..++|++.+.||+|+||.||+++. .+++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 356899999999999999999985 46889999998653 22333457789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 34788888899999999999999886 9999999999999999999999999998754
Q ss_pred ccccccccccccccCCcccccccCCC----CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKG----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
.... ......+||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~ 266 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSL 266 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcC
Confidence 3221 122345799999999988653 3788999999999999999999998643321 1111111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPND--RPSMLEVSSM 736 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 736 (785)
.+.+ ....+..+.+++.+||+.+|.+ ||++.|+++.
T Consensus 267 ~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111 1123457889999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=321.20 Aligned_cols=241 Identities=25% Similarity=0.334 Sum_probs=193.0
Q ss_pred eeeceeCcEEEEEEEe----CCCcEEEEEEcCCCC----hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 470 NKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+.||+|+||.||++.. ..++.||+|++.+.. ......+.+|+.++++++||||+++++++......++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999984 357889999987532 22334577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.. ...+.+..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999988843 345778888899999999999999886 9999999999999999999999999987543221
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+.. .
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~-~~~~-~------- 218 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKIL-KGKL-N------- 218 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHH-cCCC-C-------
Confidence 1223457899999999999988999999999999999999999998643211 1111111 1110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
.+......+.+++.+||+.+|++|| ++.++++
T Consensus 219 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 --LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1112234688999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=325.20 Aligned_cols=202 Identities=24% Similarity=0.335 Sum_probs=173.6
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||+||+|.. .+++.||+|++.+.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999985 468899999997542 233456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999998853 345889999999999999999999886 999999999999999999999999998754321
Q ss_pred ccc---------------------------------cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCC
Q 003932 620 SLE---------------------------------ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666 (785)
Q Consensus 620 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~ 666 (785)
... ......+||..|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCccc
Q 003932 667 LSMLC 671 (785)
Q Consensus 667 p~~~~ 671 (785)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.66 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=202.5
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|.+.+.||+|+||.||+|... +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36899999999999999999954 68999999997542 234457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 46889999999999999999999976 999999999999999999999999999865433
Q ss_pred c---------------------------cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccC
Q 003932 620 S---------------------------LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672 (785)
Q Consensus 620 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~ 672 (785)
. .........||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011234568999999999999999999999999999999999999986543
Q ss_pred CCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 003932 673 INENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS-MLEVSSM 736 (785)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 736 (785)
... ............... .....+..+.+++.+|++ ||.+||+ ++|+++.
T Consensus 235 ~~~------~~~~i~~~~~~~~~p-------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE------TYNKIINWKESLRFP-------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH------HHHHHhccCCcccCC-------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211 111111100000000 011134578899999998 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.31 Aligned_cols=265 Identities=26% Similarity=0.443 Sum_probs=202.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-----------------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceee
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-----------------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIR 524 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 524 (785)
.++|++.+.||+|+||.||++... ++..+|+|++.... ......+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998532 23468999997543 344567899999999999999999
Q ss_pred EEEEEecCCccEEEEEecCCCChhhhhcCCcc--------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCC
Q 003932 525 VLGFCIDSEERMLIYEYMPNKSLDCYLFDPIR--------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSN 596 (785)
Q Consensus 525 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~N 596 (785)
+++++......+++|||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999998864321 124778899999999999999999886 9999999999
Q ss_pred EEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCcccCCC
Q 003932 597 ILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGIN 674 (785)
Q Consensus 597 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt--G~~p~~~~~~~ 674 (785)
||++.++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999886543322222222344678999999888889999999999999999998 66676533221
Q ss_pred CcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 675 ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
+ ........+......... ......+..+.+++.+||+.||++||++.||++.|++
T Consensus 241 ~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q---VIENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 111111111111100000 0011233578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.90 Aligned_cols=248 Identities=20% Similarity=0.313 Sum_probs=194.7
Q ss_pred eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
++||+|+||.||+|... +++.||+|++.+.. ....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999854 68899999997542 23345678899999888 799999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 999888743 345899999999999999999999886 999999999999999999999999998742211 122
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCc--ccHHHHHHHHHhCCccccccccccCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN--LSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...+..+. ............... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~-------- 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-IR-------- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-CC--------
Confidence 3346789999999999999999999999999999999999999975433221 111112222221111 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPS------MLEVSS 735 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 735 (785)
.+......+.+++.+||+.||.+||+ ++++++
T Consensus 224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11122346889999999999999997 567753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.77 Aligned_cols=240 Identities=24% Similarity=0.307 Sum_probs=188.7
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHc-CCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAK-LQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|..++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 467889999987532 2233445566666665 4899999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999888853 335888999999999999999999976 9999999999999999999999999997643221 22
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...+..+ ......... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~----------~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILNDR----------PHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC----------CCC
Confidence 344679999999999999999999999999999999999999986432211 111111110 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSML-EVS 734 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 734 (785)
+......+.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112234678999999999999999875 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.42 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=205.1
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCChh
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLD 548 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 548 (785)
-+||+|.||+||-|+. .+...+|||.+........+-+.+|+.+.++|+|.|||+++|.|.+....-+.||-+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 4799999999999995 456779999998877777778999999999999999999999999999999999999999999
Q ss_pred hhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-CCCceeeccccceeeeccccccccccc
Q 003932 549 CYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG-EAMKPKISDFGMARIFAKESLEENTEQ 627 (785)
Q Consensus 549 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 627 (785)
++|...-..-.-.+.++-.+.+||++||.|||+++ |||||||-+|||++ -.|.+||+|||-++.+. .....+..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCccccc
Confidence 99965333333477888889999999999999997 99999999999997 57899999999998764 23456677
Q ss_pred ccccCCcccccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCC
Q 003932 628 VVGTIGYIPPEYATKGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNS 705 (785)
Q Consensus 628 ~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 705 (785)
+.||..|||||++..++ |+..+|||||||++.||.||++||...+.... .+++-+ + .......+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVG----m--yKvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVG----M--YKVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhc----c--eecCCCCc
Confidence 88999999999998764 89999999999999999999999976553321 111111 0 01123345
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 706 PCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 706 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.....+...+|.+|+.+||.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 556678899999999999999999999975
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=319.96 Aligned_cols=241 Identities=23% Similarity=0.276 Sum_probs=191.8
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCC-ceeeEEEEEecCCccEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHV-NLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 539 (785)
+|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999854 5788999998753 223445677899999999765 5888999999889999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999888843 345788999999999999999999886 999999999999999999999999998753211
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
........||..|+|||++.+..++.++|||||||++|||++|+.||......+ .. .......
T Consensus 155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~----~~i~~~~-------- 217 (324)
T cd05587 155 --GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LF----QSIMEHN-------- 217 (324)
T ss_pred --CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH----HHHHcCC--------
Confidence 112334578999999999999999999999999999999999999986432111 11 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSM 730 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 730 (785)
...+......+.+++.+||+.||.+||+.
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 --VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01111223468899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.45 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=204.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC--------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP--------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS 532 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 532 (785)
.++|.+.+.||+|+||.||++... +...+|+|.+.... ......+.+|+.+++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999742 23469999997642 34456788899999999 799999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIR-------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 599 (785)
...++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999864321 134888999999999999999999876 9999999999999
Q ss_pred cCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCccc
Q 003932 600 GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLS 678 (785)
Q Consensus 600 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 678 (785)
+.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 9999999999999876543221111222234568999999999889999999999999999998 8888753221
Q ss_pred HHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 679 ILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
+............+ .+......+.+++.+||+.+|++||++.++++.|+...
T Consensus 249 --~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 --EELFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred --HHHHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11111222111111 11123457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.46 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=206.3
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe--------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEe
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL--------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCI 530 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 530 (785)
...++|.+.+.||+|+||.||+|+. ..+..+|+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3356788999999999999999973 124579999987542 34456788999999999 8999999999999
Q ss_pred cCCccEEEEEecCCCChhhhhcCCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCE
Q 003932 531 DSEERMLIYEYMPNKSLDCYLFDPIR-------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNI 597 (785)
Q Consensus 531 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Ni 597 (785)
.....+++|||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999864321 235788899999999999999999886 99999999999
Q ss_pred EEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCc
Q 003932 598 LLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINEN 676 (785)
Q Consensus 598 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~ 676 (785)
+++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 999999999999999987644322222223345678999999998889999999999999999998 7777643221
Q ss_pred ccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 677 LSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.............. .....+..+.+++.+||+.+|++||++.|+++.|++..
T Consensus 246 ----~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 246 ----EELFKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred ----HHHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 11111222211111 11223457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.80 Aligned_cols=255 Identities=31% Similarity=0.487 Sum_probs=204.2
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..++|++.++||+|+||.||+|...+++.+|+|.+..... ..+.+.+|+.++++++|+||+++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3567899999999999999999988889999999876543 3467889999999999999999999874 4578999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999988543 2345888999999999999999999876 99999999999999999999999999977543221
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ .. ..........
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~------ 223 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VI----QNLERGYRMP------ 223 (260)
T ss_pred -ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HH----HHHHcCCCCC------
Confidence 11122345678999999998889999999999999999999 999986432111 11 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.....+.++.+++.+||+.+|++||+++++++.|++
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 ---RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111123478999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=288.58 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=201.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--------hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--------TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS 532 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 532 (785)
-..|.-.+.||.|..+.|.++.. .+++.+|+|++.... ..-.+.-..|+.+|+++ .||+|+.+.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677778999999999998874 578889999985421 12234556799999998 799999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
...++|+|.|+.|.|.++|. ....++++...+|++|+..|++|||... ||||||||+|||++++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999994 4567999999999999999999999875 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCC------CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATK------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 686 (785)
++.+.++ +.....|||++|+|||.+.. ..|+..+|+|++||++|.||.|.+||.-.. ..-..++
T Consensus 170 a~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ 239 (411)
T KOG0599|consen 170 ACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRM 239 (411)
T ss_pred eeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHH
Confidence 9987655 45667899999999998854 358889999999999999999999984210 0011122
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...++ .++- .....+......+||.+||+.||.+|.|++|+++
T Consensus 240 ImeGk-yqF~-----speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGK-YQFR-----SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhcc-cccC-----CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 22221 1111 1112233456789999999999999999999864
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.53 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=201.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.++|++.+.||+|++|.||+|....+..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 356889999999999999999977667899999865432 3456889999999999999999999875 45689999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence 999999998643 2334789999999999999999999876 99999999999999999999999999987543221
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ .. .........
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~-------- 222 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VL----EQVERGYRM-------- 222 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCC--------
Confidence 11122345678999999998899999999999999999999 888875422111 11 111111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
..+...+..+.+++.+||+.||++||+++++++.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112234578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=328.20 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=198.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3689999999999999999995 468899999997532 233456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998853 345899999999999999999999986 999999999999999999999999998764321
Q ss_pred cccc------------------------------------ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc
Q 003932 620 SLEE------------------------------------NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663 (785)
Q Consensus 620 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt 663 (785)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 003932 664 GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS---MLEVSS 735 (785)
Q Consensus 664 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 735 (785)
|+.||......+ ................ .......+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~~~------~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQE------TYRKIINWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHH------HHHHHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999986432211 1111111111111110 01123467889999997 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.42 Aligned_cols=243 Identities=20% Similarity=0.250 Sum_probs=193.5
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCC
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
+.||+|+||.||++.. .+++.||+|++.+. .......+.+|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 46889999999754 2233456778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccc
Q 003932 546 SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625 (785)
Q Consensus 546 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 625 (785)
+|..++.. ...+++..+..++.||+.||.|||+.. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~--~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM 153 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence 99888743 345889999999999999999999731 49999999999999999999999999987532221 122
Q ss_pred ccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCC
Q 003932 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNS 705 (785)
Q Consensus 626 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 705 (785)
....||..|+|||++.+..++.++|||||||++|||++|+.||....... ......... .. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~-~~---------~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEE-IR---------FP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCC-CC---------CC
Confidence 34579999999999999999999999999999999999999986432211 111111110 00 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003932 706 PCKLMRCLEIALLCVQENPNDRP-----SMLEVSSM 736 (785)
Q Consensus 706 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 736 (785)
......+.+++.+||+.||++|+ ++.++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 12234688999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.16 Aligned_cols=258 Identities=28% Similarity=0.481 Sum_probs=204.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|++.+.||+|+||.||+|... ++..+|+|++.... ......+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 46789999987653 33456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCc-------------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCC
Q 003932 536 MLIYEYMPNKSLDCYLFDPI-------------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSN 596 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~N 596 (785)
+++|||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1234788899999999999999999876 9999999999
Q ss_pred EEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCC
Q 003932 597 ILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINE 675 (785)
Q Consensus 597 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~ 675 (785)
|+++.++.++|+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999876543322222222344678999999998899999999999999999997 87777532211
Q ss_pred cccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 676 NLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
........+.... .....+.++.+++.+||+.+|.+|||+.|+++.|++
T Consensus 240 ------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ------EVIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1112222221111 011234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=331.62 Aligned_cols=259 Identities=19% Similarity=0.286 Sum_probs=190.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--------C
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--------E 533 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 533 (785)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+.++++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 46799999999999999999995 468899999886542 2335799999999999999999876432 1
Q ss_pred ccEEEEEecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-ceeecccc
Q 003932 534 ERMLIYEYMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFG 611 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg 611 (785)
.+++||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 36689999975 666655321 23456889999999999999999999886 99999999999999664 79999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
+++.+... .......||+.|+|||++.+. .++.++|||||||++|||++|++||......+. +..........
T Consensus 217 la~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~i~~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ---LVRIIQVLGTP 290 (440)
T ss_pred cchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCC
Confidence 99865432 122335689999999988764 689999999999999999999999864332221 11111111100
Q ss_pred cc----------cc-----ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 691 KG----------VE-----FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 691 ~~----------~~-----~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. .+ .....+....+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 00 00000000011122357889999999999999999999973
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.68 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=201.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCc----EEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGE----VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
..+|++.++||+|+||.||+|.. .+++ .||+|++... .....+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35688899999999999999984 3444 4899998754 33445678899999999999999999999875 4578
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+++||+++|+|.+++... ...+++..++.++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999988542 345889999999999999999999886 999999999999999999999999999876
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
.............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~- 231 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGERLP- 231 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC-
Confidence 43222111222345678999999998899999999999999999998 888875322111 111121111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.....+..+.+++.+||+.||++||++.++++.|+...
T Consensus 232 --------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 232 --------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11123447889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.63 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=199.8
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688999999999999999985 468899999997542 234456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998542 245889999999999999999999986 999999999999999999999999999876433
Q ss_pred ccccccccccccCCcccccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYAT------KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
... ......||..|+|||++. ...++.++|||||||++|||++|+.||...... .............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCcc
Confidence 211 223356899999999986 456789999999999999999999998643221 1111111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+. ..+.....+.+++..||+ +|.+||++.++++
T Consensus 229 ~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111 111234568889999998 9999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.12 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=205.7
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC--------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEec
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP--------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID 531 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 531 (785)
..++|.+.+.||+|+||.||+|+.. ....+|+|.+.... ......+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467899999999999999999731 24568999987543 34456788999999999 69999999999998
Q ss_pred CCccEEEEEecCCCChhhhhcCCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPI-------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
....+++|||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 889999999999999999985422 1245889999999999999999999876 999999999999
Q ss_pred EcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcc
Q 003932 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENL 677 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~ 677 (785)
++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999986543222222222234567999999998889999999999999999999 88887533211
Q ss_pred cHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
.............. ....+..+.+++.+||+.+|++||++.|+++.|++....
T Consensus 244 ----~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 ----ELFKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ----HHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11111222111111 112234788999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.74 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=201.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++.+.||+|+||.||+|+. .+++.+|+|++..........+.+|+.++++++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999995 56889999999765555556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999998853 345789999999999999999999876 9999999999999999999999999998764321
Q ss_pred ccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.......++..|+|||.+. ...++.++|||||||++|||++|+.|+......+... . .... .....
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~~~~---~~~~~ 229 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MSKS---NFQPP 229 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-eecC---CCCCC
Confidence 1123356888999999874 3457889999999999999999999875332111100 0 0000 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
... .....+..+.+++.+||+.+|++||+++++++.|
T Consensus 230 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 010 0112345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.36 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=193.8
Q ss_pred eceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 472 LGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 472 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
||+|+||+||++.. .+++.+|+|++.+... ...+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999985 4688999999875422 2335677899999999999999999999999999999999999999
Q ss_pred hhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccc
Q 003932 548 DCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626 (785)
Q Consensus 548 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 626 (785)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..+.... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 88775322 3456899999999999999999999886 9999999999999999999999999997654332 1233
Q ss_pred cccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCH
Q 003932 627 QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSP 706 (785)
Q Consensus 627 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 706 (785)
...||..|+|||.+.+..++.++|||||||++|||++|+.||...+..... ........... .....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~----------~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS----------VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC----------CCCcc
Confidence 457899999999999999999999999999999999999998643321110 01111100000 01112
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 707 CKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 707 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
..+..+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2345788999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.33 Aligned_cols=243 Identities=21% Similarity=0.306 Sum_probs=190.8
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|.. .+++.+|+|++.+. .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 46789999999764 223445677888888776 899999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence 999887743 345889999999999999999999886 999999999999999999999999998753221 112
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCc--ccHHHHHHHHHhCCccccccccccCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN--LSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ .....+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-------- 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-------- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C--------
Confidence 3346789999999999999999999999999999999999999864332221 1111222222211110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSM 730 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 730 (785)
.+......+.+++.+||+.||++||++
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111223467899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=325.54 Aligned_cols=255 Identities=20% Similarity=0.262 Sum_probs=198.8
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
...++|++.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999954 6889999998642 2223455788999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998843 34788899999999999999999886 999999999999999999999999999876
Q ss_pred cccccccccccccccCCcccccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
..... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ............
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~ 265 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNS 265 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcc
Confidence 43221 1223467999999999987643 788999999999999999999999643221 111111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPND--RPSMLEVSSM 736 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 736 (785)
..+.. .......+.+++..|++.++.+ ||++.|+++.
T Consensus 266 ~~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LNFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111 1122346778999999865544 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=327.92 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=196.0
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|.+.+.||+|+||.||++.. .+++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688999999999999999984 478899999986532 233456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998853 345788889999999999999999886 999999999999999999999999998643211
Q ss_pred ccc------------c---------------------------------ccccccccCCcccccccCCCCCCChhhHHHH
Q 003932 620 SLE------------E---------------------------------NTEQVVGTIGYIPPEYATKGVYSTKSDVFSF 654 (785)
Q Consensus 620 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 654 (785)
... . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012469999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCC---CCHH
Q 003932 655 GVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDR---PSML 731 (785)
Q Consensus 655 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ 731 (785)
||++|||++|+.||......+ . ............+.+ ......++.+++.+|++ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~---~---~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE---T---YRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH---H---HHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999986432211 1 111111111111111 01123467889999998 66665 5999
Q ss_pred HHHHH
Q 003932 732 EVSSM 736 (785)
Q Consensus 732 evl~~ 736 (785)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=304.45 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=194.9
Q ss_pred eeceeCcEEEEEEEe---CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCC
Q 003932 471 KLGEGGYGPVYKGVL---PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
.||+|+||.||+|.. .++..+|+|++.... ....+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 357889999986543 334567889999999999999999999885 45678999999999
Q ss_pred ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc-cc
Q 003932 546 SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE-EN 624 (785)
Q Consensus 546 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~ 624 (785)
+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99998843 335889999999999999999999886 999999999999999999999999999875432211 11
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 703 (785)
.....++..|+|||.+....++.++|||||||++|||++ |+.|+......+ . ......+....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~i~~~~~~~--------- 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V----TQMIESGERME--------- 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHCCCCCC---------
Confidence 122234578999999988889999999999999999998 999986432211 1 11122211111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 704 NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 704 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.+...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1112345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=305.35 Aligned_cols=256 Identities=30% Similarity=0.485 Sum_probs=205.6
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..++|.+.+.||+|+||.||+|..++++.+++|.+..... ..+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4568999999999999999999987778899999875433 346789999999999999999999999988899999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.... ...+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999986532 245889999999999999999999886 99999999999999999999999999887643211
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......++..|+|||.+.+..++.++||||||++++||++ |+.|+...... ... ........
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~-------- 222 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVL----EQVERGYR-------- 222 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC--------
Confidence 11122234568999999998889999999999999999998 99888532211 111 11111100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.......+..+.+++.+||+.+|++||+++++.+.|++
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011124578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.08 Aligned_cols=241 Identities=23% Similarity=0.281 Sum_probs=191.7
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 539 (785)
+|++.+.||+|+||.||+|... +++.||+|++.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999854 57899999987542 22334566777887777 5899999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999888743 345888999999999999999999886 999999999999999999999999998754321
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+....... .. ........
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~----~~i~~~~~------- 218 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF----QSIMEHNV------- 218 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCCC-------
Confidence 1 12334578999999999999999999999999999999999999986432211 11 11111110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSM 730 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 730 (785)
..+.....++.+++.+||+.+|.+|++.
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111233478899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=290.99 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=202.2
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.++|++.+.||+|.|+.|+++. ..+|+.+|+|++... +....+.+.+|+.+.+.|+||||+++.....+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4578888999999999999998 457889999988643 3457788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---CCceeeccccceeee
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---AMKPKISDFGMARIF 616 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg~a~~~ 616 (785)
|+|.|++|..-+- .+...++..+-..++||+++|.|+|..+ |||||+||+|++|-+ .--+||+|||++..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999965542 3356778888899999999999999986 999999999999953 345899999999987
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
..+ ...-..+||+.|||||++...+|+..+|||+.||+||-||.|.+||...... ..++....+. .++
T Consensus 164 ~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~-yd~- 231 (355)
T KOG0033|consen 164 NDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGA-YDY- 231 (355)
T ss_pred CCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccc-cCC-
Confidence 632 2334578999999999999999999999999999999999999999743221 1222222221 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.....+...++..+|+++||..||.+|.|+.|.+.
T Consensus 232 ----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 ----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11112233457889999999999999999999864
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.74 Aligned_cols=243 Identities=20% Similarity=0.282 Sum_probs=192.7
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|.. .+++.+|+|++.+.. ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 467899999997642 23445678899998888 699999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence 999887743 345899999999999999999999986 999999999999999999999999998753221 122
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
....+||..|+|||++.+..++.++|||||||++|||++|+.||....................... .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~---------~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-IR---------I 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-CC---------C
Confidence 3346799999999999999999999999999999999999999965433332222222222222111 00 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSM 730 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~ 730 (785)
+...+..+.+++.+||+.||.+||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11123467899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.73 Aligned_cols=261 Identities=21% Similarity=0.281 Sum_probs=201.7
Q ss_pred hHHHHHHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec
Q 003932 456 LADIEAATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID 531 (785)
Q Consensus 456 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 531 (785)
+.++....++|++.+.||+|+||.||++... +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445556689999999999999999999954 6889999998643 22334457789999999999999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
....++||||+++|+|.+++.. ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999998843 34788888999999999999999886 9999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
+++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ........
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~ 260 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM 260 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 9987643221 1223467999999999987543 78899999999999999999999964322 11111111
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPND--RPSMLEVSSML 737 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 737 (785)
.......+.+ .......+.+++..||+.++.+ ||+++|+++..
T Consensus 261 ~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111111111 1123446788999999844443 77999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.83 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=196.6
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC-----ccE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERM 536 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 536 (785)
+|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999995 47899999998653 2334567889999999999999999999998766 789
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+|+||+. ++|...+.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 577776632 345889999999999999999999886 999999999999999999999999999865
Q ss_pred cccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHH-------------
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH------------- 682 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~------------- 682 (785)
..... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+..
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 43221 122334678999999998874 478999999999999999999999865432221111100
Q ss_pred ---HHHHHhC-CccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 683 ---AYELWKG-GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 683 ---~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
....+.. ........... ........++.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000 00000000000 0011124578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=311.62 Aligned_cols=257 Identities=29% Similarity=0.433 Sum_probs=200.1
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CC--cEEEEEEcCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CG--EVIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 538 (785)
++|++.+.||+|+||.||+|... ++ ..+++|.+... .....+.+.+|+.+++++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 47889999999999999999854 33 34788888743 334456788999999999 799999999999998999999
Q ss_pred EEecCCCChhhhhcCCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCce
Q 003932 539 YEYMPNKSLDCYLFDPI-------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP 605 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 605 (785)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1135888999999999999999999876 9999999999999999999
Q ss_pred eeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHH
Q 003932 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 606 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 684 (785)
||+|||++...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+ ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LY 228 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 99999998642211 01111223557999999998889999999999999999997 999885332111 11
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
......... ......+..+.+++.+||+.+|.+||+++++++.|++...
T Consensus 229 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 229 EKLPQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111100 1111233578899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.57 Aligned_cols=236 Identities=24% Similarity=0.319 Sum_probs=188.8
Q ss_pred eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|... +++.||+|++.+.. ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 68899999987532 23345667788888776 799999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence 999888853 345889999999999999999999886 999999999999999999999999998753221 112
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC----------CC
Confidence 334578999999999999999999999999999999999999986433211 1111111110 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSM 730 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~ 730 (785)
+......+.+++.+||+.||.+||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11123478899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.57 Aligned_cols=241 Identities=24% Similarity=0.321 Sum_probs=189.7
Q ss_pred eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHc-CCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAK-LQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 57899999987542 2233456667777775 4899999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999988853 345788999999999999999999886 9999999999999999999999999987532211 12
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
.....||..|+|||++.+..++.++|||||||++|||++|+.|+......+ .. ....... .. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~----~~i~~~~------~~----~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LF----QSIRMDN------PC----Y 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCC------CC----C
Confidence 234568999999999999999999999999999999999999986432211 11 1111111 00 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSML-EVSS 735 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 735 (785)
+......+.+++.+||+.||++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111234678999999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.54 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=207.9
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|++|.||+|... +++.+|+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999965 7899999988642 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 540 EYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
||+++++|..++.... ....+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999998885422 2345889999999999999999999886 99999999999999999999999999876543
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.|+.... ....... .....+..
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~-~~~~~~~~------ 225 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLC-KKIEKCDY------ 225 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHH-hhhhcCCC------
Confidence 221 1223467889999999998889999999999999999999999985332 1111111 11111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 226 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 --PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0111113345788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=305.96 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=192.9
Q ss_pred eceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 472 LGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 472 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
||+|+||.||++.. .+++.+|+|++..... .....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 4689999999864321 2233456799999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccccc
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 627 (785)
..++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8887543 2334888999999999999999999876 9999999999999999999999999988754321 2223
Q ss_pred ccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHH
Q 003932 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707 (785)
Q Consensus 628 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 707 (785)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+........ ..+........ . +.. ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~-~----~~~-----~~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED-E----VKF-----EHQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc-c----ccc-----cccc
Confidence 4689999999999998899999999999999999999999864322111 11111111110 0 000 0112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 708 KLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 708 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
...++.+++.+||+.||++||+++|+++.+.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 2446889999999999999999988764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.81 Aligned_cols=242 Identities=23% Similarity=0.300 Sum_probs=192.3
Q ss_pred eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
++||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999854 57899999987542 23345567788888866 799999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999888743 345888999999999999999999986 9999999999999999999999999987643221 12
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+ .. ..... .. . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~---~~i~~-~~---~-------~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LF---ESILH-DD---V-------LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HH---HHHHc-CC---C-------CC
Confidence 334578999999999999999999999999999999999999996433211 11 11111 11 0 00
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRP-------SMLEVSSM 736 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 736 (785)
+......+.+++.+||+.||++|| +++++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111234688999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=302.63 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=204.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.++|++.+.||+|+||.||+|... ++.+|+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999876 78899999976644 4577899999999999999999999999889999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 9999999985432 235899999999999999999999886 9999999999999999999999999998753221
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.....+..|+|||.+.+..++.++||||||++++||++ |+.|+......+ ............
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------- 219 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRME------- 219 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCC-------
Confidence 12334678999999998889999999999999999997 998875432111 111111111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 --APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111224578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=304.27 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=200.6
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-----hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
++|.+.+.||+|++|.||+|.. .+++.+++|.+.... ......+.+|+.++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999985 468999999986542 1234568889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988853 345788889999999999999999886 9999999999999999999999999987654
Q ss_pred ccccccc-cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEEN-TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~---- 225 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTN---- 225 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccCCC----
Confidence 3211111 1335678899999999999999999999999999999999999753211 1111111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
...+......+.+++.+||+.+|++|||+.|+++.
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01112234468899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=300.33 Aligned_cols=247 Identities=28% Similarity=0.390 Sum_probs=197.1
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCChh
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLD 548 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 548 (785)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999987888999999876543 33346889999999999999999999999999999999999999999
Q ss_pred hhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccccc
Q 003932 549 CYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV 628 (785)
Q Consensus 549 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 628 (785)
+++... ...+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence 988542 235789999999999999999999876 99999999999999999999999999876433211 111122
Q ss_pred cccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHH
Q 003932 629 VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707 (785)
Q Consensus 629 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 707 (785)
.++..|+|||++.+..++.++||||||+++|||++ |..|+....... ........... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRM---------SCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCC
Confidence 34567999999998889999999999999999998 888885332111 11111111111 11112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 708 KLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 708 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
.+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=311.16 Aligned_cols=264 Identities=23% Similarity=0.295 Sum_probs=200.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.+.||+|+||.||++... ++..+|+|.+... ......++.+|++++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999854 6788999988654 233445688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.. ...+++..+..++.|+++||.|||+.. +++||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 999999999853 245788999999999999999999742 4999999999999999999999999998754322
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc---------
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG--------- 692 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 692 (785)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+........................
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 123456889999999998888999999999999999999999998533211110000000000000000
Q ss_pred --------ccccccccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 693 --------VEFVDSFLD----DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 693 --------~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+..+.... ..........+.+++.+||+.+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00011134468899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=327.66 Aligned_cols=252 Identities=20% Similarity=0.264 Sum_probs=195.2
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
+|++++.||+|+||.||+|+. .+++.||+|++.+.. ......+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 689999999999999999994 468899999986532 2234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999853 345788888999999999999999886 9999999999999999999999999975321000
Q ss_pred -----------------------------------------cccccccccccCCcccccccCCCCCCChhhHHHHHHHHH
Q 003932 621 -----------------------------------------LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLL 659 (785)
Q Consensus 621 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ 659 (785)
........+||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000012347999999999999999999999999999999
Q ss_pred HHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 003932 660 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRP---SMLEVSSM 736 (785)
Q Consensus 660 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~ 736 (785)
||++|+.||......+. .............. ........+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 236 ell~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET------QLKVINWETTLHIP-------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH------HHHHhccCccccCC-------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999965432111 11111100000000 01112345677888876 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.98 Aligned_cols=238 Identities=22% Similarity=0.298 Sum_probs=191.2
Q ss_pred eeeceeCcEEEEEEEe----CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 470 NKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
+.||+|+||.||+++. .+++.+|+|++.+.. ......+.+|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 357899999997542 2234456789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999988843 345899999999999999999999886 9999999999999999999999999987643221 1
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 703 (785)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+...... ........ .. ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~-~~-~~--------- 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILK-AK-LG--------- 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHc-CC-CC---------
Confidence 233457899999999999888999999999999999999999998643211 11111111 11 00
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003932 704 NSPCKLMRCLEIALLCVQENPNDRPSMLE 732 (785)
Q Consensus 704 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 732 (785)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11122346789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.07 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=193.7
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
+|+++++||+|+||.||+|+. .+++.+|+|++.+.. ......+.+|+.++++++|+||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999985 468899999997542 2344578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998853 245788888999999999999999886 9999999999999999999999999975331100
Q ss_pred c---------------------------------------------ccccccccccCCcccccccCCCCCCChhhHHHHH
Q 003932 621 L---------------------------------------------EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFG 655 (785)
Q Consensus 621 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 655 (785)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001234689999999999999999999999999
Q ss_pred HHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHH
Q 003932 656 VLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS---MLE 732 (785)
Q Consensus 656 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~e 732 (785)
|++|||++|+.||......+ ............... .......++.+++.+|+ .+|.+|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p-------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLE------TQMKVINWQTSLHIP-------PQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHH------HHHHHHccCCCcCCC-------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 99999999999996432211 111111111111110 01112345677777765 49999997 777
Q ss_pred HHH
Q 003932 733 VSS 735 (785)
Q Consensus 733 vl~ 735 (785)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.93 Aligned_cols=252 Identities=31% Similarity=0.478 Sum_probs=199.7
Q ss_pred CCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHH--HHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 466 FSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFE--EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
|++.+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999965 5678999999877544332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++. ....+++..+..++.|+++||.+||+.+ ++|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999985 3456899999999999999999999986 99999999999999999999999999876411 12
Q ss_pred cccccccccCCcccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYAT-KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......++..|+|||.+. +..++.++||||||+++++|++|..|+......+...... ..... .......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~----~~~~~~~- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKR----PLPSSSQ- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHT----HHHHHTT-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccc----ccccccc-
Confidence 3344567899999999998 8889999999999999999999999987541111111111 11100 0000000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........+.+++.+||+.||++||++.++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001258899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=303.60 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=202.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CC---cEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CG---EVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.+|+..+.||+|+||.||+|... ++ ..+++|.+.... ....+.+..|+.++++++|+|++++.+++......++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999854 23 379999987552 34456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998542 345889999999999999999999886 99999999999999999999999999886543
Q ss_pred ccccccc-ccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 619 ESLEENT-EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 619 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
....... .....+..|+|||.+.+..++.++|||||||++|||++ |+.|+...... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~~~~~i~~~~~---- 228 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAINDGFR---- 228 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhcCCC----
Confidence 2211111 11223457999999998889999999999999999997 99998543211 11111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.......+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 229 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 -----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.44 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=210.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 537 (785)
...|++.+.||+|.||.||+++.+ +|+.+|+|.+.+... ...+.+.+|+.+|+++. ||||+.+++.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467899999999999999999965 599999999987643 24468899999999998 9999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC----Cceeeccccce
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA----MKPKISDFGMA 613 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~~kl~Dfg~a 613 (785)
|||++.||.|.+.+... .+++.....++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999988654 3899999999999999999999986 9999999999999643 57999999999
Q ss_pred eeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.......... ....+..
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~- 255 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF- 255 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence 98765 345667899999999999999999999999999999999999999997544333211 1111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
+ +.....+.......+++..|+..||.+|+|+.++++.
T Consensus 256 ~-----f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 D-----FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C-----CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 1222233345678899999999999999999999984
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=308.51 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=202.5
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.+|++.+.||+|++|.||+|.. .+++.+++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5789999999999999999984 468899999998765555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-- 170 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--
Confidence 99999998842 34788999999999999999999886 9999999999999999999999999987643321
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... .......... .. +
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~-~~-----~-- 236 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-PE-----L-- 236 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCC-CC-----C--
Confidence 11233468899999999998889999999999999999999999986432211 1111111110 00 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.........+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011223356889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=312.84 Aligned_cols=240 Identities=25% Similarity=0.321 Sum_probs=189.3
Q ss_pred eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|... +++.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999954 68899999997532 22344566777777654 899999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++..... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 999888843 345788999999999999999999886 999999999999999999999999998753211 122
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....... .. ....... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~----~~~~~~~------~~~---- 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LF----ESIRVDT------PHY---- 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCC------CCC----
Confidence 334678999999999999999999999999999999999999986432111 11 1111110 001
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSML-EVS 734 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 734 (785)
+......+.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111234678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=305.41 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=201.1
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CC---cEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CG---EVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.+|++.+.||+|+||.||+|... ++ ..||+|.+... .......+..|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35788899999999999999854 23 36999998764 344556899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988542 345889999999999999999999886 99999999999999999999999999876543
Q ss_pred cccccccc-ccc--ccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 619 ESLEENTE-QVV--GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 619 ~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
........ ... .+..|+|||.+.+..++.++|||||||++|||++ |..|+...... ... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~----~~i~~~~~-- 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVI----NAIEQDYR-- 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHH----HHHHcCCc--
Confidence 22111111 111 2457999999999999999999999999999886 99888543211 111 11111100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.......+..+.+++.+||+.+|.+||++.+++..|++.
T Consensus 230 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 -------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=301.52 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=194.6
Q ss_pred eeceeCcEEEEEEEeC---CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCC
Q 003932 471 KLGEGGYGPVYKGVLP---CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKS 546 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 546 (785)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 35579999987653 333467889999999999999999999885 457899999999999
Q ss_pred hhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc-ccc
Q 003932 547 LDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE-ENT 625 (785)
Q Consensus 547 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~ 625 (785)
|.+++.. ....+++..+.+++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......... ...
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998853 2346899999999999999999999886 999999999999999999999999998765332111 111
Q ss_pred ccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 626 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
....++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ .......+... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRL---------DC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---------CC
Confidence 12233578999999998889999999999999999996 999886432211 11222221111 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
+...+.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=302.03 Aligned_cols=250 Identities=26% Similarity=0.343 Sum_probs=202.7
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|.+.+.||+|++|.||+|.. .+++.+++|.+... .....+.+.+|++++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999995 46889999998643 344566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2346889999999999999999999876 99999999999999999999999999887644321
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
......|+..|+|||++.+..++.++|||||||+++||++|+.|+...... ..... ...+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~-------- 219 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILK-IIRGVFP-------- 219 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHcCCCC--------
Confidence 123346788999999999999999999999999999999999998643311 11111 1111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.70 Aligned_cols=241 Identities=25% Similarity=0.307 Sum_probs=192.6
Q ss_pred eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|... +++.||+|++.+.. ......+..|..+++.+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999854 57899999997542 23445677888888887 799999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999888743 335899999999999999999999886 9999999999999999999999999987532211 12
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
....+|+..|+|||++.+..++.++|||||||++|||++|+.||....... .......... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV----------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----------CC
Confidence 234568999999999999999999999999999999999999986432111 1111111110 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSM-----LEVSS 735 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 735 (785)
+......+.+++.+||+.||++||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11223478899999999999999999 88765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=303.84 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=202.5
Q ss_pred cCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.+|++.+.||+|+||.||+|... .+..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999853 23479999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998542 245789999999999999999999886 99999999999999999999999999987643
Q ss_pred ccccc-ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 619 ESLEE-NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 619 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
..... ......++..|+|||.+.+..++.++|||||||++||+++ |+.|+......+ .. ....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~----~~~~~~~--~~- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI----KAIEEGY--RL- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH----HHHhCCC--cC-
Confidence 22111 1112233568999999998889999999999999999886 999886432211 11 1111111 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
......+..+.+++.+||+.+|.+||++.++++.|++.
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=336.28 Aligned_cols=261 Identities=24% Similarity=0.295 Sum_probs=201.9
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999954 68999999997542 233457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCc--------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 540 EYMPNKSLDCYLFDPI--------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
||+++|+|.+++.... .....++..++.++.||++||+|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1223566788899999999999999886 9999999999999999999999999
Q ss_pred ceeeeccccc----------------ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCC
Q 003932 612 MARIFAKESL----------------EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675 (785)
Q Consensus 612 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~ 675 (785)
+++....... .......+||+.|+|||++.+..++.++|||||||++|||+||+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001123469999999999999999999999999999999999999986422111
Q ss_pred cccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhccc
Q 003932 676 NLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRP-SMLEVSSMLKNET 741 (785)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 741 (785)
. ... ..... ... .......+..+.+++.+||+.||++|| +++++.+.|+...
T Consensus 239 i----~~~-~~i~~--P~~-------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 I----SYR-DVILS--PIE-------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred h----hhh-hhccC--hhh-------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 000 00000 000 000112334678899999999999996 6777777776653
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=303.20 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=206.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|++|.||++.. .+++.+++|.+... ......++.+|+.+++.++|+||+++++++......+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999994 57899999988653 2334467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 540 EYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999885322 2346899999999999999999999886 99999999999999999999999999876543
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ..... .......
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~------- 224 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQCD------- 224 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHh-hhhhcCC-------
Confidence 22 1123346889999999999988999999999999999999999998532211 11111 1111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
............+.+++.+||+.+|++|||+.+|++.+++.
T Consensus 225 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00111123445788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=323.30 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=207.3
Q ss_pred CcceeeceeCcEEEEEEEe-CCCc----EEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 467 SIRNKLGEGGYGPVYKGVL-PCGE----VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
...++||+|+||+||+|.+ ..++ +||+|++... ..+...++.+|+-+|.+++|||+++++|+|..+. +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4458999999999999984 3343 5899998765 4456678999999999999999999999998765 889999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
||+.|+|.++++. .+..+..+..+.+..|||+||.|||++. ++||||..+|||+.+-..+||.|||+++.+....
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999975 4456888999999999999999999875 9999999999999999999999999999887654
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
..-......-.+.|||-|.++...++.++|||||||++|||+| |..|+......+.. +.++.+.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~ge-------- 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEKGE-------- 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhccc--------
Confidence 4333334445678999999999999999999999999999998 88888654433322 2222221
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
+-..++.+...+..++.+||..|+..||+++++...+.+-.
T Consensus 918 -RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 -RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 12234455668899999999999999999999988876543
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.59 Aligned_cols=250 Identities=33% Similarity=0.512 Sum_probs=202.6
Q ss_pred eeeceeCcEEEEEEEeCC----CcEEEEEEcCCCChh-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLPC----GEVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|.... +..+++|.+...... ..+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 788999999876443 367889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCcc------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 545 KSLDCYLFDPIR------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 545 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
++|.+++..... ...+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865321 366899999999999999999999876 99999999999999999999999999987654
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
...........++..|+|||.+....++.++|||||||++|||++ |..|+...... ............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------EVLEYLRKGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC----
Confidence 332222334567889999999998889999999999999999999 68888644211 111111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
......+..+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111222457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=303.61 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=191.4
Q ss_pred eeeceeCcEEEEEEEeC---CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCC
Q 003932 470 NKLGEGGYGPVYKGVLP---CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
+.||+|+||.||+|... ++..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999854 34679999987653 233457888999999999999999999999989999999999999
Q ss_pred ChhhhhcCCc--cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 546 SLDCYLFDPI--RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 546 sL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+|.+++.... .....++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986422 1234567788899999999999999886 9999999999999999999999999987543322222
Q ss_pred ccccccccCCcccccccCCC-------CCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 624 NTEQVVGTIGYIPPEYATKG-------VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
......++..|+|||++.+. .++.++||||||+++|||++ |+.|+......+. ... ... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hhh-cccCCC
Confidence 22334577889999988642 35789999999999999996 9999864322111 110 011 111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
..+.+.. .....+.+++..|+ .+|++|||++||+..|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 12335778999998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=302.89 Aligned_cols=249 Identities=29% Similarity=0.411 Sum_probs=198.7
Q ss_pred eeeceeCcEEEEEEEeCC--C--cEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLPC--G--EVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
++||+|++|.||+|.+.. + ..+|+|.+..... ...+.+.+|+.++++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998542 3 3689999987655 566789999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc-c
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE-E 623 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 623 (785)
++|.+++..... ..+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865332 46899999999999999999999886 999999999999999999999999999876432111 1
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ ... .........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~~~~~~--------- 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---KIDKEGERL--------- 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHhcCCcC---------
Confidence 1223456789999999999899999999999999999998 999985332211 111 111111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
......+..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.28 Aligned_cols=261 Identities=28% Similarity=0.408 Sum_probs=200.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC-C
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS-E 533 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 533 (785)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999973 346789999997543 33455688999999999 689999999988654 4
Q ss_pred ccEEEEEecCCCChhhhhcCCcc---------------------------------------------------------
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIR--------------------------------------------------------- 556 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 556 (785)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999988853210
Q ss_pred -------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccccccc
Q 003932 557 -------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629 (785)
Q Consensus 557 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 629 (785)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123678888999999999999999886 9999999999999999999999999987653322111122234
Q ss_pred ccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHH
Q 003932 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCK 708 (785)
Q Consensus 630 gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 708 (785)
++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ........+..... +...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~---------~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA---------PDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCC---------CCCC
Confidence 5678999999998899999999999999999997 888875432111 11111111111111 1112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 709 LMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 709 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
...+.+++..||+.+|++||++.||++.|+...
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 346889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=301.36 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=198.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEe-cCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI-DSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 542 (785)
++|.+.+.||+|+||.||++... +..+++|.+..... .+.+.+|+.++++++|+|++++++++. ..+..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47889999999999999999866 77899999865432 357889999999999999999999765 456789999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--- 155 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 155 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc---
Confidence 9999999886432 335889999999999999999999876 999999999999999999999999998764322
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.....++..|+|||++.+..++.++|||||||++|||++ |+.|+..... .+ .......+....
T Consensus 156 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~~~------- 219 (256)
T cd05082 156 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KD-VVPRVEKGYKMD------- 219 (256)
T ss_pred --CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHhcCCCCC-------
Confidence 122334568999999999899999999999999999997 8888753221 11 111111111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.....+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=320.73 Aligned_cols=261 Identities=20% Similarity=0.216 Sum_probs=200.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC---CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP---CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
..+|.+.+.||+|+||.||++... .+..|++|.+... ....+|++++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999743 4578999988653 23467999999999999999999999889999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|++. ++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++.....
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 67877773 3456899999999999999999999886 999999999999999999999999999876544
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc---
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV--- 696 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 696 (785)
..........||..|+|||++.+..++.++|||||||++|||++|+.|+...........+....+....... ++.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~-~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL-EFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc-ccCCcc
Confidence 3333334567999999999999999999999999999999999999998754433222222222221111000 000
Q ss_pred -----------ccccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 697 -----------DSFLDDRNS-------PCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 697 -----------~~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
....+.... ......+.+++.+||+.||++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0113467889999999999999999999865
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.56 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=206.6
Q ss_pred cCCCcceeeceeCcEEEEEEEeC--CCc--EEEEEEcCCCChh-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP--CGE--VIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
++..+.++||+|+||.|++|.+. +|+ .||||.++..... ....|.+|+.+|.+|+|+|+++|||+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34566789999999999999864 343 5899999876544 67789999999999999999999999987 788999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
+|.++.|||.+.|++ ..+..+.......++.|||.||.||..++ +|||||..+|+||-....|||+|||+.+.+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999977 45667888999999999999999999886 99999999999999999999999999998764
Q ss_pred ccc-ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 619 ESL-EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 619 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... ........-...|+|||.++...++.++|||+|||++|||+| |..||..+.....+ +.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------Hhc
Confidence 322 122222334678999999999999999999999999999998 78888765432221 112
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS 734 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 734 (785)
|..-+-..++.+++.+++++..||..+|.+|||+..|.
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 22122234566788999999999999999999999996
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=300.14 Aligned_cols=248 Identities=29% Similarity=0.428 Sum_probs=197.7
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcCCCChh-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCChh
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLD 548 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 548 (785)
++||+|++|.||++....++.|++|++...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999766899999998765433 5567899999999999999999999999999999999999999999
Q ss_pred hhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccccc
Q 003932 549 CYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV 628 (785)
Q Consensus 549 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 628 (785)
+++... ...+++..+..++.+++.+|.|||+.+ ++||||+|+||+++.++.++|+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988542 235788999999999999999999886 999999999999999999999999998765422211111222
Q ss_pred cccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHH
Q 003932 629 VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707 (785)
Q Consensus 629 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 707 (785)
..+..|+|||.+.+..++.++|||||||++|||++ |..|+....... .......... ...+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGYR---------MPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCCC---------CCCCcc
Confidence 34567999999998899999999999999999999 777775432211 1111111100 011122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 708 KLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 708 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
.+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.05 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=212.2
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChh--hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQ--GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.-|.+.+.||+|-|..|-+|++ -+|..||||++.+.... ....+.+|++.|+.++|||||++|.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3477789999999999999984 47999999999887433 34568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE-cCCCceeeccccceeeeccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL-GEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill-~~~~~~kl~Dfg~a~~~~~~ 619 (785)
.-.+|+|.+|+-.+. ..+.+....+++.||+.|+.|+|+.| +|||||||+||.+ ..-|-|||+|||++..+.++
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999996543 34788888999999999999999998 9999999999866 56789999999999887655
Q ss_pred ccccccccccccCCcccccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
+.....||+..|-|||++.+..|+ +++||||||||||-|++|++||+..+..+.+..+. |-
T Consensus 173 ---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm---------------DC 234 (864)
T KOG4717|consen 173 ---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM---------------DC 234 (864)
T ss_pred ---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh---------------cc
Confidence 345678999999999999999886 57999999999999999999998766555433221 10
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccCCC
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNETTNI 744 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~ 744 (785)
+...+.....+|.+||..||..||++|.+.+||.. .|+.....+
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 11223345668999999999999999999999964 455544333
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=297.80 Aligned_cols=272 Identities=22% Similarity=0.318 Sum_probs=206.9
Q ss_pred hHHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHc--CCCCceeeEEEEEecCC
Q 003932 456 LADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDSE 533 (785)
Q Consensus 456 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~ 533 (785)
+--.....++..+.+.||+|.||.||+|.+. |+.||||++..... +.+.+|.++++. |+|+||+.+++.-..++
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 3334455678999999999999999999998 89999999976543 355667777765 59999999998865443
Q ss_pred ----ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeEEecccCCCEEEcCCCc
Q 003932 534 ----ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE-----YSRLTIIHRDLKVSNILLGEAMK 604 (785)
Q Consensus 534 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~Dikp~Nill~~~~~ 604 (785)
.++||.+|.+.|||.+||. +..++....++++..+|.||++||. ++.+.|.|||||+.|||+..++.
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 6889999999999999993 4568999999999999999999996 46778999999999999999999
Q ss_pred eeeccccceeeecccc--cccccccccccCCcccccccCCCC----C--CChhhHHHHHHHHHHHHcC----------CC
Q 003932 605 PKISDFGMARIFAKES--LEENTEQVVGTIGYIPPEYATKGV----Y--STKSDVFSFGVLLLQIISG----------KR 666 (785)
Q Consensus 605 ~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlGvvl~elltG----------~~ 666 (785)
+.|+|+|+|....... ........+||.+|||||++...- + -..+||||||.|+||+... +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 9999999998765432 122345578999999999986532 1 2469999999999998752 24
Q ss_pred CCcccCCCCcccHHHHHHHHHhCCcccccccccc-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 667 LSMLCGINENLSILEHAYELWKGGKGVEFVDSFL-DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 667 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
||...-+.+ ...+...+..--. .+.+.+ ....+.+.+..+.++++.||..||.-|-|+=.+.+.|.+..
T Consensus 435 Pyyd~Vp~D--Ps~eeMrkVVCv~----~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 435 PYYDVVPSD--PSFEEMRKVVCVQ----KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CcccCCCCC--CCHHHHhcceeec----ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 554332222 1222222221111 111111 23345566778999999999999999999999999988764
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.79 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=203.7
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..++|++.+.||+|+||.||++....+..+++|.+.... ...+.+.+|+.++++++|+||+++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 456899999999999999999997777889999887543 334678899999999999999999999887 778999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999998543 2345788899999999999999999876 99999999999999999999999999976543221
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......++..|+|||.+....++.++|||||||++|++++ |+.|+......+ .. ..........
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~~------ 223 (260)
T cd05073 158 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VI----RALERGYRMP------ 223 (260)
T ss_pred -ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHhCCCCCC------
Confidence 11222345678999999998889999999999999999998 888885432111 11 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.....+..+.+++.+||+.+|++||++.++.+.|++
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111233578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.92 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=197.6
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++++++|+|++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367789999999999999985 468899999987542 2223456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999888542 2235888999999999999999999876 9999999999999999999999999987643221
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ...........
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~~--------- 221 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVQ--------- 221 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhhh---------
Confidence 122346899999999999999999999999999999999999999643221111 11111111000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 735 (785)
..........+.+++.+||+.||++||| ++|+++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0011122346789999999999999999 778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.90 Aligned_cols=263 Identities=23% Similarity=0.364 Sum_probs=202.0
Q ss_pred cCCCcceeeceeCcEEEEEEEe-----CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--Ccc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EER 535 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 535 (785)
+.|++++.||+|+||.||++.. .++..||+|.+.... ......+.+|+.++++++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578889999999999999973 357889999987553 34456789999999999999999999998775 568
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999988532 235889999999999999999999886 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCC--------CCcccHHHHHHHH
Q 003932 616 FAKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI--------NENLSILEHAYEL 686 (785)
Q Consensus 616 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~--------~~~~~~~~~~~~~ 686 (785)
+...... .......++..|+|||.+.+..++.++|||||||++|||++++.|...... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6432211 122334567789999999988899999999999999999998765422100 0000011111111
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...+... ......+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111110 01112345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=320.11 Aligned_cols=262 Identities=18% Similarity=0.189 Sum_probs=195.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++......++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999964 578899996432 2456899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+. ++|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 94 6887777432 235899999999999999999999886 99999999999999999999999999987643322
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCc-ccHHHHHHHHHhCCc--cccccc-
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN-LSILEHAYELWKGGK--GVEFVD- 697 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~- 697 (785)
........||..|+|||++.+..++.++|||||||+||||++|..++........ ........+...... ..++..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 2222345799999999999999999999999999999999998876543221110 000010111111000 000000
Q ss_pred -------c-------ccCCC-CC------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 698 -------S-------FLDDR-NS------PCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 698 -------~-------~l~~~-~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
. ..... .. ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00000 00 0112367889999999999999999999864
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.30 Aligned_cols=240 Identities=20% Similarity=0.346 Sum_probs=188.2
Q ss_pred eeeceeCcEEEEEEEeCC-------------CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 470 NKLGEGGYGPVYKGVLPC-------------GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
+.||+|+||.||+|.... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998431 2358899887665555567888999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc-------eeecc
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK-------PKISD 609 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-------~kl~D 609 (785)
+||||+++|+|..++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888753 2345889999999999999999999876 999999999999987664 89999
Q ss_pred ccceeeecccccccccccccccCCcccccccC-CCCCCChhhHHHHHHHHHHHH-cCCCCCcccCCCCcccHHHHHHHHH
Q 003932 610 FGMARIFAKESLEENTEQVVGTIGYIPPEYAT-KGVYSTKSDVFSFGVLLLQII-SGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 610 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
||++..... .....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+ .....
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~ 222 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFY 222 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHH
Confidence 999865421 12345788999999887 466899999999999999998 5777765322111 11111
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
.... . ........+.+|+.+||+.||.+||++.+|++.|+
T Consensus 223 ~~~~--~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC--M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc--c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 0 01112346889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=312.67 Aligned_cols=264 Identities=26% Similarity=0.393 Sum_probs=197.1
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|.+.+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|+.++++++|+||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56899999999999999999854 678899999875432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 975 777776432 335788899999999999999999886 9999999999999999999999999987643221
Q ss_pred ccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHH-----HHHhCCcc-cc
Q 003932 622 EENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKG-VE 694 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~ 694 (785)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.... ..|..... .+
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 12223467899999998865 458899999999999999999999987544332222111110 00000000 00
Q ss_pred ccccccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 FVDSFLDD-------RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 ~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..+..... ...+.....+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 000112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.27 Aligned_cols=237 Identities=22% Similarity=0.269 Sum_probs=186.7
Q ss_pred eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHH-HHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|+.. +++.||+|++.+.. ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999954 68999999987532 122234445544 56789999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 999888853 345888999999999999999999886 999999999999999999999999998753221 122
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... +....... .. .. +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-~~-~~-----~---- 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILN-KP-LR-----L---- 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHc-CC-CC-----C----
Confidence 33457899999999999999999999999999999999999998643211 11111111 11 00 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSML 731 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 731 (785)
.+.....+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112245788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.59 Aligned_cols=248 Identities=30% Similarity=0.452 Sum_probs=195.4
Q ss_pred eeeceeCcEEEEEEEeC-C---CcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP-C---GEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
++||+|+||.||+|... . +..+|+|.+..... ...+.+.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999742 2 36899999986543 34567889999999999999999999876 4568999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc-c
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE-E 623 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 623 (785)
++|.+++... ..+++..+..++.|++.+|+|||..+ ++||||||+|||++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 35889999999999999999999886 999999999999999999999999999876433211 1
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... .. ...........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~----~~~~~~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EV----IAMLESGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHcCCcCC--------
Confidence 1112224568999999999999999999999999999998 99988543211 11 11111111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.....+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=298.91 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=188.7
Q ss_pred eeceeCcEEEEEEEeC---CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCC
Q 003932 471 KLGEGGYGPVYKGVLP---CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKS 546 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 546 (785)
.||+|+||.||+|... ....+++|.+.... ......+.+|+..++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5999999999999743 24568889876543 3334568899999999999999999999999999999999999999
Q ss_pred hhhhhcCCcc--ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 547 LDCYLFDPIR--KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 547 L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865322 233567788899999999999999886 99999999999999999999999999875433222122
Q ss_pred cccccccCCcccccccCC-------CCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 625 TEQVVGTIGYIPPEYATK-------GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.....++..|+|||++.. ..++.++|||||||++|||++ |..|+......+ ........ ......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~-~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVRE-QDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhc-cCccCC
Confidence 233446778999998743 356889999999999999999 777775332111 11111111 111222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
.+.+. ......+.+++..|| .||++|||++||++.|.
T Consensus 232 ~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22111 123346677888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.69 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=200.0
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
+.+++++.....||+|+||.||+|.. .++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34455666668999999999999984 46788999998877666677899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-CCceeeccccceeeec
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFGMARIFA 617 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~a~~~~ 617 (785)
+||+++++|.+++.........+...+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999864322222378888899999999999999876 999999999999986 6799999999987653
Q ss_pred ccccccccccccccCCcccccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
... .......++..|+|||.+.... ++.++||||||+++|+|++|+.|+....... ...+......
T Consensus 161 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~------- 228 (268)
T cd06624 161 GIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK------- 228 (268)
T ss_pred cCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-------
Confidence 221 1222345788999999986643 7889999999999999999999986432111 0000000000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.....+......+.+++.+||+.+|++|||+.|+++
T Consensus 229 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 001111223457889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.46 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=203.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..+|++.+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46899999999999999999995 57899999999766555556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 999999998842 34788899999999999999999876 9999999999999999999999999987654322
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.|+.......... .....+.. .
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~~~--------~ 234 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTP--------E 234 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCCCC--------C
Confidence 11233468889999999999889999999999999999999999986433211100 00000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..........+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011223346788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.65 Aligned_cols=250 Identities=23% Similarity=0.289 Sum_probs=196.6
Q ss_pred CCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 466 FSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
|+..+.||+|+||+||+|.. .+++.+|+|.+..... .....+.+|++++++++|+|++++.+.+...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67778999999999999985 4688999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-- 155 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--
Confidence 9999998887542 2335899999999999999999999886 999999999999999999999999998764322
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ............
T Consensus 156 -~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~---------- 221 (285)
T cd05632 156 -ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE---------- 221 (285)
T ss_pred -CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc----------
Confidence 112335689999999999998999999999999999999999999864322111 111111111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 735 (785)
..........+.+|+..||+.||++||+ +.+++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0011122346788999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.17 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=201.1
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+......+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999854 6889999998643 3345567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++... ....++......++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 999998887532 2345788999999999999999999886 9999999999999999999999999998764321
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
.......++..|+|||++.+..++.++|+||||+++|+|++|+.|+...... ...... ..+....
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~-------- 219 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKV-CQGSYKP-------- 219 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHH-hcCCCCC--------
Confidence 1223356888999999999988999999999999999999999998642211 111111 1111110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+......+.+++.+||+.||++||++.+++..
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111233468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.21 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=200.8
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
.+|++.+.||+|+||.||++....++.+++|.+..... ....+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999977678899999875433 23578899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+++|.+++... ...+++..+..++.+++.+++|||+.+ ++||||||+||+++.++.++|+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999888542 235788999999999999999999886 999999999999999999999999998865432211
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .......+. ....
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~----- 222 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGF--RLYK----- 222 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCC--CCCC-----
Confidence 1122335678999999998889999999999999999998 888875322111 111111110 0010
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 223 --~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 --PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.24 Aligned_cols=239 Identities=24% Similarity=0.361 Sum_probs=186.3
Q ss_pred eeceeCcEEEEEEEeCC-------------------------CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeE
Q 003932 471 KLGEGGYGPVYKGVLPC-------------------------GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRV 525 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 525 (785)
+||+|+||.||+|.... ...|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13488999876555555678889999999999999999
Q ss_pred EEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC--
Q 003932 526 LGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-- 603 (785)
Q Consensus 526 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-- 603 (785)
+++|.+....++||||+++|+|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988854 2345788999999999999999999876 99999999999998644
Q ss_pred -----ceeeccccceeeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHH-cCCCCCcccCCCCc
Q 003932 604 -----KPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQII-SGKRLSMLCGINEN 676 (785)
Q Consensus 604 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~ell-tG~~p~~~~~~~~~ 676 (785)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+......+.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999987643211 22356788999998875 56899999999999999995 68888764322111
Q ss_pred ccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 677 LSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
. ....... . + +......+.+++.+||+.+|++||++.++++.|.
T Consensus 231 ----~---~~~~~~~--~-----~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ----E---RFYEKKH--R-----L----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ----H---HHHHhcc--C-----C----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 1111100 0 0 0111236889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.02 Aligned_cols=243 Identities=20% Similarity=0.252 Sum_probs=188.1
Q ss_pred eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHH-HHHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|+.. +++.+|+|++.+.. ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999954 57889999987532 12222334443 456788999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+.+.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 999988853 344778888889999999999999986 999999999999999999999999998754221 122
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ... ..... . . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~~~-~-~---------~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD---NILNK-P-L---------QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHH---HHHhC-C-c---------CC
Confidence 344679999999999999999999999999999999999999986432211 111 11111 0 0 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
.+.....+.+++.+||+.||.+||++.+.+..+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 112334688999999999999999987544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=310.84 Aligned_cols=245 Identities=30% Similarity=0.412 Sum_probs=200.2
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
..|.-++.||.|+||.||.|+. .+.+.||||++.-. ....+..+.+|+..|++++|||++.+.|+|......+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3466678899999999999994 46789999999754 4456778999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||| -||-.+++. ..+.++.+..+..|+.+.++||+|||++. .||||||..||||++.|.|||+|||.|....+
T Consensus 106 EYC-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHH-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 999 457777763 23556888899999999999999999986 89999999999999999999999999876543
Q ss_pred ccccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
...++||++|||||++. .+.|+-++||||||+++.||...++|....+ .....+- ...+..
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALYH-IAQNes---- 242 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYH-IAQNES---- 242 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHHH-HHhcCC----
Confidence 45689999999999875 4679999999999999999999998865321 1111111 111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+.+ ........+++++..||++-|.+|||.++++.
T Consensus 243 -PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 -PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 111 14456778999999999999999999998864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=294.08 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=207.9
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
+-|.++++||+|+||.||++.+ .+|+.+|+|++.... +.+++.+|+.+|++++.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3478889999999999999985 579999999987653 4578899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
..|+..+.++. ++..+.+..+..+++.-+.||+|||... -+|||||..||||+.+|.+||+|||.+-.+.....
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 99999999854 5677999999999999999999999985 79999999999999999999999999977654322
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc--ccc
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD--SFL 700 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l 700 (785)
......||+.|||||++..-.|+.++||||||++..||..|++|+....+-. ..-.+. +..
T Consensus 185 -KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIFMIPT~PPP 247 (502)
T KOG0574|consen 185 -KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIFMIPTKPPP 247 (502)
T ss_pred -hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeEeccCCCCC
Confidence 2345789999999999999999999999999999999999999986322111 111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.-..++..+.++-+++++||-++|++|-|+-++++.
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 122345567789999999999999999999998764
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.00 Aligned_cols=261 Identities=25% Similarity=0.333 Sum_probs=196.5
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|++.+.||+|++|.||+|+.. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999954 68899999986542 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
++ ++|.+++........+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 688888754434456899999999999999999999876 9999999999999999999999999987653221
Q ss_pred ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhC--------Ccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG--------GKG 692 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~ 692 (785)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.|+......+. .......+.. ...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ---LFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCChhhhhcchh
Confidence 122234568899999988764 478999999999999999999998864321110 0000000000 000
Q ss_pred c--------cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 V--------EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 ~--------~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ......+. ........++.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000000 001112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.27 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=200.5
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++++.||+|+||.||++... ++..+|+|.+... .......+.+|+.++++++|+||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999965 7899999988654 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|..++........+++..+..++.|++.||.|||+.. +++||||||+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999988865333346899999999999999999999742 4999999999999999999999999998765322
Q ss_pred ccccccccccCCcccccccCCCC------CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGV------YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||........ . ...........
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~-~~~~~~~~~~~--- 227 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---F-AQLSAIVDGDP--- 227 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---H-HHHHHHhhcCC---
Confidence 223345788999999986543 47899999999999999999999864321111 1 11111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..........+.+++.+||+.+|++||++.+++.
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1112224557889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=312.80 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=191.0
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 539 (785)
+|++.+.||+|+||.||+|.. .+++.||+|++.+.. ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999985 468899999987542 233456778888888885 577888999999889999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988843 345889999999999999999999886 999999999999999999999999998754222
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
. .......||..|+|||++.+..++.++|||||||++|||++|+.|+...... .... .... ...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~---~i~~-~~~------- 218 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQ---SIME-HNV------- 218 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHHh-CCC-------
Confidence 1 1223456899999999999999999999999999999999999998643211 1111 1111 110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSM 730 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 730 (785)
..+......+.+++.+||+.+|.+|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111223467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.80 Aligned_cols=249 Identities=26% Similarity=0.451 Sum_probs=198.3
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChh---------hHHHHHHHHHHHHcCCCCceeeEEEEEecCCc
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQ---------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 534 (785)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999985 45788999988654221 23467889999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 245788889999999999999999876 9999999999999999999999999988
Q ss_pred eecccccc----cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 615 IFAKESLE----ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 615 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
........ .......|+..|+|||.+.+..++.++|||||||++|+|++|+.|+...... ........ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIGE-N 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHhc-c
Confidence 76422111 1112345788999999999988999999999999999999999998643211 11111111 0
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 691 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ........+..+.+++.+||+.||.+||++.|+++
T Consensus 228 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 A---------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred C---------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 01111223457889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.97 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=202.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCc----EEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGE----VIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.+|++.+.||+|+||.||+|... +++ .+|+|.+.... ......+.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888899999999999999853 232 58999887654 3445678899999999999999999999987 78899
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|+||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998643 334889999999999999999999875 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
............++..|+|||.+....++.++|||||||++|||++ |+.|+......+ ...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~--- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERL--- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCC---
Confidence 3221111122234568999999988889999999999999999998 999986432111 11111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
..+......+.+++.+||..+|++||++.++++.|++..
T Consensus 231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 011112346889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=336.80 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=201.5
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--Cc
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EE 534 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 534 (785)
.....+|.+++.||+|+||.||+|.. .++..+|+|++... .......+..|+.++++++||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34457899999999999999999995 45778999988653 233456788999999999999999999988643 46
Q ss_pred cEEEEEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeEEecccCCCEEEcC--------
Q 003932 535 RMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSR----LTIIHRDLKVSNILLGE-------- 601 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~Dikp~Nill~~-------- 601 (785)
++|||||+++|+|..+|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999885422 23468999999999999999999998542 35999999999999964
Q ss_pred ---------CCceeeccccceeeecccccccccccccccCCcccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCcc
Q 003932 602 ---------AMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK--GVYSTKSDVFSFGVLLLQIISGKRLSML 670 (785)
Q Consensus 602 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltG~~p~~~ 670 (785)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2348999999998654322 2234578999999999864 4588999999999999999999999863
Q ss_pred cCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHHhcc
Q 003932 671 CGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS--SMLKNE 740 (785)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl--~~L~~~ 740 (785)
... ............. . .....+..+.+||..||+.+|.+||++.|++ ..+...
T Consensus 246 ~~~------~~qli~~lk~~p~--l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANN------FSQLISELKRGPD--L--------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCc------HHHHHHHHhcCCC--C--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 221 1111111111110 0 0111235788999999999999999999998 455544
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.65 Aligned_cols=255 Identities=18% Similarity=0.246 Sum_probs=195.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||+++. .+++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999995 46889999998652 2233456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999988532 345888999999999999999999886 999999999999999999999999998765432
Q ss_pred ccccccccccccCCcccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATK-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+.............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~ 228 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQ 228 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCccc
Confidence 21 11223468999999999863 4578899999999999999999999864321 111111111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPN--DRPSMLEVSSM 736 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 736 (785)
+.. .....+..+.+++.+|+..+++ .||+++++++.
T Consensus 229 ~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111 0111344678888887765443 37899888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.41 Aligned_cols=253 Identities=22% Similarity=0.344 Sum_probs=200.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|.+.+.||+|+||.||+|+. .+++.+|+|.+..........+.+|+.+++.++||||+++++.+......++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35788889999999999999985 46889999998766555556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999998843 345889999999999999999999886 9999999999999999999999999987654321
Q ss_pred ccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.......|+..|+|||.+. ...++.++|||||||++|+|++|+.|+........ .......... ..
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~~~----~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSNFQ----PP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccCCC----CC
Confidence 1223456899999999874 45688999999999999999999998754322111 0000000000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.... ....+..+.+++.+||+.+|++||+++++++
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0100 0112346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.83 Aligned_cols=258 Identities=29% Similarity=0.428 Sum_probs=200.1
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCc--EEEEEEcCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGE--VIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 538 (785)
++|++.+.||+|+||.||+|... ++. .+++|.+... .......+.+|+.++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888999999999999999854 343 4678777643 234456788999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCce
Q 003932 539 YEYMPNKSLDCYLFDPI-------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP 605 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 605 (785)
|||+++++|.+++.... ....+++..++.++.|++.|++|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235789999999999999999999876 9999999999999999999
Q ss_pred eeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHH
Q 003932 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 606 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 684 (785)
||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..|+......+ ..
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 233 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HH
Confidence 99999998642111 11111234567999999988889999999999999999998 999885332111 11
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
.......... .....+..+.+++.+||+.+|++||++.++++.|++....
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 234 EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111110000 0111234688999999999999999999999999875433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.01 Aligned_cols=263 Identities=22% Similarity=0.272 Sum_probs=195.4
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC-----
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----- 533 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 533 (785)
..++|++.+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999985 46889999998653 2334556789999999999999999999986443
Q ss_pred -ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 534 -ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 534 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
..++||||+.+ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 5555442 23778888999999999999999986 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHH------------
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL------------ 680 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~------------ 680 (785)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+..+.....
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 8754322 1223457899999999999999999999999999999999999999754321110000
Q ss_pred H----HHHHHHhCCcc------ccccccccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 681 E----HAYELWKGGKG------VEFVDSFLD---DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 681 ~----~~~~~~~~~~~------~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
. ........... .+....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000000000 000000000 00111123468899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=301.44 Aligned_cols=263 Identities=29% Similarity=0.419 Sum_probs=204.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-----CCcEEEEEEcCCCChh-hHHHHHHHHHHHHcCCCCceeeEEEEEec--CCcc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-----CGEVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEER 535 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 535 (785)
+.|++.+.||+|+||.||+|... ++..+|+|++...... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999843 3678999999866443 45789999999999999999999999887 5578
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998543 235899999999999999999999886 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcc--------cHHHHHHHH
Q 003932 616 FAKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--------SILEHAYEL 686 (785)
Q Consensus 616 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~--------~~~~~~~~~ 686 (785)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532111 1111234456799999999889999999999999999999999887532211100 011111111
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
..... ........+.++.+++.+||+.+|++||++.||+++|+++
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 0111122335788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=300.88 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=200.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
+.|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|+.++++++|+||+++++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999964 58899999998777666778899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|..++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++...... .
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~ 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--L 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--c
Confidence 999998877432 345889999999999999999999876 999999999999999999999999998764322 1
Q ss_pred cccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 623 ENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.......++..|+|||.+. ...++.++|||||||++|||++|+.|+..... ....... ........
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~-~~~~~~~~-- 235 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKI-AKSEPPTL-- 235 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHH-hcCCCccC--
Confidence 1223456788999999885 34467899999999999999999999854321 1111111 11110000
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.........+.+++.+||+.+|++||++.++++
T Consensus 236 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 -----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011123346889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.49 Aligned_cols=240 Identities=22% Similarity=0.264 Sum_probs=188.0
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHH-HHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|.. .+++.+|+|++.+.. ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 468999999987542 223344555554 56778999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 999888743 345889999999999999999999886 999999999999999999999999998753221 122
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+ .......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~~------~~---- 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKPL------VL---- 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCCc------cC----
Confidence 344679999999999999999999999999999999999999986432111 1111111110 00
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSMLEVS 734 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl 734 (785)
.+.....+.+++.+|++.+|.+||++++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 112234678899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=300.20 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=198.6
Q ss_pred CCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 466 FSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+|++++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999965 5778899998776666677889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
++|..++.. ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999887753 2345889999999999999999999986 9999999999999999999999999987643221 12
Q ss_pred cccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 625 TEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.....++..|+|||++. +..++.++|||||||++|||++|+.|+..... .......... ......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~-~~~~~~--- 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKS-EPPTLA--- 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhc-CCCCCC---
Confidence 23456889999999884 34577899999999999999999998754221 1111111111 100000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.....+..+.+++.+||+.||.+||++.++++.
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 ----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011223578899999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=299.54 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=199.2
Q ss_pred CCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCC------hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTS------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
+|.+.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998788999999886432 12335688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999853 235788999999999999999999876 99999999999999999999999999876432
Q ss_pred cc----cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 619 ES----LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 619 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
.. .........++..|+|||.+.+..++.++|||||||++|+|++|+.|+....... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~-- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYIGAHRGL-- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHhhhccCC--
Confidence 11 1112233568899999999999889999999999999999999999986432111 11110000000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+ .........+.+++.+||+.+|.+||++.|+++
T Consensus 227 --~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 --MP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 111123457889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.61 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=201.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCC----CcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPC----GEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.++|.+.+.||+|+||.||+|.... ...+++|...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999998532 3468999987654 4556688999999999999999999998875 56789
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998542 235899999999999999999999876 9999999999999999999999999998754
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
...... .....++..|+|||.+....++.++||||||+++|||++ |+.||......+ . . ..........
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~-~~~~~~~~~~-- 228 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---V---I-GRIENGERLP-- 228 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---H---H-HHHHcCCcCC--
Confidence 332111 112334568999999988889999999999999999996 999986433211 1 1 1111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.....+..+.+++.+|+..+|.+|||+.++++.|++.
T Consensus 229 -------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 229 -------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=302.06 Aligned_cols=249 Identities=23% Similarity=0.396 Sum_probs=202.0
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.+|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4689999999999999999984 578999999997665555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|..++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999988842 34889999999999999999999886 99999999999999999999999999876543221
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......++..|+|||.+.+..++.++|||||||++|+|++|+.|+...... ........... .. +
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~~~~~-~~-----~-- 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGT-PE-----L-- 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCC-cc-----c--
Confidence 122346888999999999888999999999999999999999998643221 11111111110 00 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.........+.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011122346888999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.22 Aligned_cols=197 Identities=25% Similarity=0.374 Sum_probs=159.1
Q ss_pred ceeeceeCcEEEEEEEeC---CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEec--CCccEEEEEecC
Q 003932 469 RNKLGEGGYGPVYKGVLP---CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLIYEYMP 543 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 543 (785)
.++||+|+||.||+|+.. +++.+|+|.+..... ...+.+|+.++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999853 467899999875432 2456789999999999999999998864 346789999985
Q ss_pred CCChhhhhcCC------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE----cCCCceeeccccce
Q 003932 544 NKSLDCYLFDP------IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL----GEAMKPKISDFGMA 613 (785)
Q Consensus 544 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~Dfg~a 613 (785)
++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4777666321 11235888999999999999999999886 9999999999999 45678999999999
Q ss_pred eeeccccc-ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCccc
Q 003932 614 RIFAKESL-EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLC 671 (785)
Q Consensus 614 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~ 671 (785)
+.+..... ........||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643211 1123346789999999998774 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.84 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=191.1
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcC---CCCceeeEEEEEecC-----C
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDS-----E 533 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 533 (785)
+|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588899999999999999985 4688999999875321 1223455677666655 799999999988642 3
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
..+++|||+++ +|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999974 787777542 2344889999999999999999999886 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
+..... .......+|..|+|||++.+..++.++|||||||++|||++|++|+......+ ...............
T Consensus 156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 865432 12233567899999999999899999999999999999999999985432211 111111111100000
Q ss_pred ------cccccccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 ------EFVDSFLDD-------RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 ------~~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......... ...+.....+.+++.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 001123346789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.17 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=201.6
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.+.||.|++|.||+|+.. +++.+++|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999954 68899999987553 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999998853 26889999999999999999999876 9999999999999999999999999998765432
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.|+....... .. .......... +.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~-~~~~~~~~~~-----~~ 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VL-FLIPKNNPPS-----LE 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HH-HHhhhcCCCC-----Cc
Confidence 12234567889999999999889999999999999999999999986432111 01 1111111101 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. ..+..+.+++.+||+.+|++||+++++++
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 03446889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.88 Aligned_cols=251 Identities=30% Similarity=0.493 Sum_probs=196.8
Q ss_pred eeeceeCcEEEEEEEeCC-------CcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 470 NKLGEGGYGPVYKGVLPC-------GEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+.||+|+||.||+|+... +..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998532 2578999886543 24456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCc----cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-----ceeeccccc
Q 003932 542 MPNKSLDCYLFDPI----RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-----KPKISDFGM 612 (785)
Q Consensus 542 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-----~~kl~Dfg~ 612 (785)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986422 2234788999999999999999999876 99999999999999877 899999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
+................++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... .... .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~----~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVL----QHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHH----HHHhcCC
Confidence 876543322222223345778999999999999999999999999999998 9988753221 1111 1111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.. ......+..+.+++.+||+.+|++||++.++++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 1112234578899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=319.98 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=194.6
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688999999999999999985 468899999997532 233456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998853 345889999999999999999999886 999999999999999999999999998754321
Q ss_pred ccc---------------------------------cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCC
Q 003932 620 SLE---------------------------------ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666 (785)
Q Consensus 620 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~ 666 (785)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 000 00113479999999999999999999999999999999999999
Q ss_pred CCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 003932 667 LSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS---MLEVSS 735 (785)
Q Consensus 667 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 735 (785)
||........ ............+.. ......++.+++.+|+. ||.+|++ +.|+++
T Consensus 235 Pf~~~~~~~~------~~~i~~~~~~~~~p~-------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQET------YRKVMNWKETLVFPP-------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHHH------HHHHHcCCCceecCC-------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9864332111 111111000011110 00123467778888764 9999996 555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.18 Aligned_cols=247 Identities=26% Similarity=0.449 Sum_probs=197.7
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
.+|++.+.||+|+||.||++.. .++.+|+|.+.... ..+.+.+|+.++++++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688999999999999999975 47789999986543 235788999999999999999999998754 5799999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999986432 335789999999999999999999876 999999999999999999999999998764321
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......+..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ .......+...
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~--------- 216 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRM--------- 216 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCC---------
Confidence 112234568999999998899999999999999999997 898886432211 11111111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
......+..+.+++.+||+.+|++||+++++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=297.44 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=201.8
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
++|++.+.||+|+||.||+|... +++.+++|.+..... .+++.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57889999999999999999965 478999999875533 578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 99999998853 2346899999999999999999999886 9999999999999999999999999988754332
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ... ... ... .. .
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~~-~~~-~~~----~~--~ 219 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IFM-IPN-KPP----PT--L 219 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hhh-hcc-CCC----CC--C
Confidence 122334578899999999998999999999999999999999999864322110 000 000 000 00 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.........+.+++.+||+.||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 011223357889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=296.21 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=202.9
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|+..+.||+|+||.||.++. .+++.+++|.+... .......+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999984 46888999988654 344456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999886432 345889999999999999999999876 99999999999999999999999999987644321
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... +...... .+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~~~------ 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV-QGNYTPV------ 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-cCCCCCC------
Confidence 223456899999999999888899999999999999999999988542211 1111111 1111000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
....+..+.+++.+||+.+|.+||++.++++.+
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 122244688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.49 Aligned_cols=249 Identities=29% Similarity=0.434 Sum_probs=193.5
Q ss_pred eeeceeCcEEEEEEEeC-CCc--EEEEEEcCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP-CGE--VIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|+.. ++. .+++|.+... .....+.+.+|+++++++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999964 343 4688888753 334456788999999999 899999999999999999999999999
Q ss_pred CChhhhhcCCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 545 KSLDCYLFDPI-------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 545 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985422 1234789999999999999999999876 9999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... .........
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEKLPQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------HHHHHHhCC
Confidence 98532211 11111233567999999988889999999999999999997 99988532211 111111111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 691 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...+ ........+.+++.+||+.+|.+|||+.+++..|++.
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1111 1111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.30 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=197.2
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC------
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS------ 532 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 532 (785)
.+.+.|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+..|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3566788999999999999999985 468889999986553 3345778899999998 799999999998753
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999988642 2345889999999999999999999886 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
+....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+...... .......
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~~~ 229 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIP 229 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHHHh
Confidence 88653321 2233456899999999886 345788999999999999999999998532211 1111111
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. .... + .....+..+.+++.+||+.+|.+|||+.|+++
T Consensus 230 ~~-~~~~-----~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RN-PAPR-----L---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cC-CCCC-----C---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11 0000 0 11122346889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=296.98 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=203.8
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
++|++.+.||+|+||.||+|.. .+++.+++|.+........+.+.+|+.++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5789999999999999999985 457889999998766556778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 999999988542 245889999999999999999999876 9999999999999999999999999987654321
Q ss_pred cccccccccCCcccccccCCC---CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 623 ENTEQVVGTIGYIPPEYATKG---VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.|+....... ......... .....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~~~~~~~~~----~~~~~ 225 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------ALFLISKSN----FPPPK 225 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcc----CCCcc
Confidence 112335678899999999877 78999999999999999999999986432111 111111110 00000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+ ......+.++.+++.+||+.+|.+|||+.+++.
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 112234567899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.77 Aligned_cols=237 Identities=21% Similarity=0.280 Sum_probs=185.5
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHH-HHHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
++||+|+||.||+|+. .+++.||+|++.+.. ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999995 468899999987532 12233444554 467889999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 999887743 345788888999999999999999876 999999999999999999999999998753221 112
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||...+.. ........ .. . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-~~-~---------~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILH-KP-L---------QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhc-CC-C---------CC
Confidence 33457899999999999989999999999999999999999998643211 11111111 10 0 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSML 731 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 731 (785)
+......+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112334688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.24 Aligned_cols=192 Identities=24% Similarity=0.360 Sum_probs=163.6
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999954 5778999986443 23468999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
++. ++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 995 678777743 2345899999999999999999999886 999999999999999999999999998753221
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLS 668 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~ 668 (785)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999866554
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.77 Aligned_cols=257 Identities=27% Similarity=0.388 Sum_probs=202.1
Q ss_pred cCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCChh-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
++|++.+.||+|+||.||+|+.. ..+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999853 3467999988765433 4567899999999999999999999999989999
Q ss_pred EEEEecCCCChhhhhcCCccc------cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 537 LIYEYMPNKSLDCYLFDPIRK------LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
+||||+++|+|.+++...... ..+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643321 25899999999999999999999886 999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhC
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKG 689 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 689 (785)
|++........ .......++..|+|||.+.+...+.++||||||+++|+|++ |..|+...... ... .....
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~----~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVL----NRLQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHH----HHHHc
Confidence 99875432211 12223456778999999988888999999999999999998 77777432111 111 11111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 690 GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 690 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.... .......+..+.+++.+||+.+|.+||++.|+++.|.+
T Consensus 234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 1110 00111234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.80 Aligned_cols=263 Identities=23% Similarity=0.261 Sum_probs=195.4
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------ 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 532 (785)
..++|++.+.||+|+||.||++.. ..++.+|+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999985 46889999999754 233445678899999999999999999988643
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
...++||||+++ +|...+. ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346899999965 5655552 23788889999999999999999886 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHH-----------
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE----------- 681 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~----------- 681 (785)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9764322 12234578999999999999999999999999999999999999986433211100000
Q ss_pred -----HHHHHHhCCcc-ccc------ccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 682 -----HAYELWKGGKG-VEF------VDSFL--DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 682 -----~~~~~~~~~~~-~~~------~~~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
........... ... .+... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000 000 00000 000111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.60 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=196.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999854 67899999987542 22334677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
++ ++|..++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 97 5888877542 335788999999999999999999886 9999999999999999999999999987643221
Q ss_pred ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc---cccc--
Q 003932 622 EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK---GVEF-- 695 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 695 (785)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+. ............ ....
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhc
Confidence 112234568899999988654 578899999999999999999999865432211 111111110000 0000
Q ss_pred ----cccccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 696 ----VDSFLDD-------RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 696 ----~~~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....... ...+.....+.+|+.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 001112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=301.64 Aligned_cols=240 Identities=23% Similarity=0.387 Sum_probs=188.1
Q ss_pred eeeceeCcEEEEEEEeCC--------CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 470 NKLGEGGYGPVYKGVLPC--------GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++|||++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998531 234888888766555567788999999999999999999999998999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc--------eeeccccce
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK--------PKISDFGMA 613 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--------~kl~Dfg~a 613 (785)
+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998643 235788999999999999999999886 999999999999987765 589999987
Q ss_pred eeecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCC-CCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
..... .....++..|+|||++.+. .++.++|||||||++|||++|. .|+...... .. .......
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~-~~~~~~~- 221 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KK-LQFYEDR- 221 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HH-HHHHHcc-
Confidence 65422 2234678899999999874 5789999999999999999995 444321111 10 1111110
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
.. .+......+.+++.+||+.||++|||++++++.|+
T Consensus 222 -~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -HQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -cc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 11112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.01 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=203.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||+||++.. .+++.+|+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35688889999999999999985 468889999886543 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|..++.. ...+++.....++.+++.+|.|||+.+ +++||||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999988743 345889999999999999999999743 4999999999999999999999999998654322
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCc-----ccHHHHHHHHHhCCccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN-----LSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 695 (785)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.|+......+. .............. .
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 230 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-P--- 230 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-C---
Confidence 12235689999999999888899999999999999999999999875433211 11111111111110 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
........+..+.+++.+||+.||.+|||+.|+++..
T Consensus 231 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 -----PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -----CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000111345788999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.79 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=188.1
Q ss_pred eeceeCcEEEEEEEeCC---CcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCC
Q 003932 471 KLGEGGYGPVYKGVLPC---GEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKS 546 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 546 (785)
.||+|+||.||+|...+ ...+++|.+.... ....+.+.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 59999999999997432 2356777766443 3455688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcc-ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccc
Q 003932 547 LDCYLFDPIR-KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625 (785)
Q Consensus 547 L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 625 (785)
|.+++..... ....++.....++.||++||+|||+.+ ++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999864321 234667778899999999999999876 999999999999999999999999997643222111222
Q ss_pred ccccccCCcccccccCC-------CCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 626 EQVVGTIGYIPPEYATK-------GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 626 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
....++..|+|||++.. ..++.++|||||||++|||++ |..|+..... .+....... .......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccCC
Confidence 34567889999998753 235789999999999999997 4556643221 111111111 11122222
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
+.+.. .....+.+++..|| .+|.+||++++|++.|.
T Consensus 232 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22221 23346788999999 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=297.22 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=191.5
Q ss_pred eeeceeCcEEEEEEEeC----CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec-CCccEEEEEecC
Q 003932 470 NKLGEGGYGPVYKGVLP----CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLIYEYMP 543 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 543 (785)
+.||+|+||.||+|... ....+|+|.+... .....+.+.+|+.+++.++||||+++++++.. ....++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999842 2457999998643 34456678899999999999999999998764 456889999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+|+|.+++... ....++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998542 234677888899999999999999876 9999999999999999999999999987653321111
Q ss_pred --ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCC-CCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 624 --NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 624 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
......++..|+|||.+.+..++.++|||||||++|||++|. +|+.... ........... ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~-~~~~------ 222 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQG-RRLL------ 222 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcC-CCCC------
Confidence 112234577899999998888999999999999999999964 4443211 11111111111 1000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.....+..+.+++.+||+.+|++||++.|+++.|++..
T Consensus 223 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 ---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01112347889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=297.90 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=201.5
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999854 68899999987543 34556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 999999998842 34788889999999999999999876 9999999999999999999999999998764332
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......++..|+|||.+.+..++.++|+|||||++|||++|+.|+......... ...... ..
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~---------~~ 218 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKN---------NP 218 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhhhcC---------CC
Confidence 1223346788999999999888999999999999999999999998643221100 000000 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.......+..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12223455678899999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=297.26 Aligned_cols=238 Identities=24% Similarity=0.398 Sum_probs=187.4
Q ss_pred eeeceeCcEEEEEEEeCCCc-----------EEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 470 NKLGEGGYGPVYKGVLPCGE-----------VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
+.||+|+||.||+|...... .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999965322 4778877654333 5778899999999999999999999988 778999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-------ceeecccc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-------KPKISDFG 611 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-------~~kl~Dfg 611 (785)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+|||++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986432 25889999999999999999999876 99999999999999887 79999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCC--CCCChhhHHHHHHHHHHHHcC-CCCCcccCCCCcccHHHHHHHHHh
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKG--VYSTKSDVFSFGVLLLQIISG-KRLSMLCGINENLSILEHAYELWK 688 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 688 (785)
++..... .....++..|+|||.+.+. .++.++|||||||++|||++| ..|+......+ . ...+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~-~~~~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------K-ERFYQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------H-HHHHh
Confidence 9876432 2234567789999999877 789999999999999999994 66654332111 0 11111
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 689 GGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 689 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
..... .......+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHRL-----------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCCC-----------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11000 0001157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.15 Aligned_cols=256 Identities=26% Similarity=0.463 Sum_probs=199.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCc----EEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGE----VIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.+|+..+.||+|+||.||+|... ++. .+|+|.+.... .....++.+|+.++++++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778899999999999999853 343 57899887543 23344688999999999999999999998754 5679
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
++||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999988542 335788999999999999999999886 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
............++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... ..............
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~-- 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGERLP-- 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCCC--
Confidence 3322112223345778999999999999999999999999999997 8888753221 11112222111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
........+.+++..||..+|++||+++++++.|+...
T Consensus 232 -------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 232 -------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112346889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=324.06 Aligned_cols=269 Identities=19% Similarity=0.264 Sum_probs=192.9
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC------CceeeEEEEEec
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH------VNLIRVLGFCID 531 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 531 (785)
+....++|++.++||+|+||.||+|.. ..++.||||+++.... ....+..|+.+++.++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 344568899999999999999999985 4678899999965322 23445667777776654 458889988875
Q ss_pred C-CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-------
Q 003932 532 S-EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM------- 603 (785)
Q Consensus 532 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~------- 603 (785)
. ...++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+.. +||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccc
Confidence 4 4688999988 7788777743 345889999999999999999999741 399999999999998765
Q ss_pred ---------ceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCC
Q 003932 604 ---------KPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN 674 (785)
Q Consensus 604 ---------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~ 674 (785)
.+||+|||.+.... ......+||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999875421 2233467999999999999999999999999999999999999999754432
Q ss_pred CcccHHHHHH----HHHhCC----ccccccc------cc---------cCCCC--CHHHHHHHHHHHHHccccCCCCCCC
Q 003932 675 ENLSILEHAY----ELWKGG----KGVEFVD------SF---------LDDRN--SPCKLMRCLEIALLCVQENPNDRPS 729 (785)
Q Consensus 675 ~~~~~~~~~~----~~~~~~----~~~~~~~------~~---------l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs 729 (785)
+....+.... ..|... ...++.+ .. ..... .......+.+|+.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 2211111110 000000 0000000 00 00000 0011245789999999999999999
Q ss_pred HHHHHH--HHhc
Q 003932 730 MLEVSS--MLKN 739 (785)
Q Consensus 730 ~~evl~--~L~~ 739 (785)
++|+++ .|.+
T Consensus 432 a~e~L~Hp~~~~ 443 (467)
T PTZ00284 432 ARQMTTHPYVLK 443 (467)
T ss_pred HHHHhcCccccc
Confidence 999986 4444
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.54 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=198.5
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466778899999999999985 457889999987543 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++.. ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 99999988742 35788999999999999999999876 9999999999999999999999999987654321
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
.......++..|+|||.+.+..++.++|||||||++|||++|+.|+........ . ........ .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~----~~~~~~~~---------~ 219 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L----FLIPKNSP---------P 219 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H----hhhhcCCC---------C
Confidence 112234678899999999998899999999999999999999999753321110 0 01111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......+..+.+++.+||+.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111123456889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.04 Aligned_cols=260 Identities=23% Similarity=0.265 Sum_probs=195.2
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------ 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 532 (785)
..++|.+.+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999985 46888999999754 233445678899999999999999999987543
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999965 6666552 23778889999999999999999886 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHh----
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK---- 688 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---- 688 (785)
++..... .......+|..|+|||++.+..++.++|||||||++|||++|+.||......+. .........
T Consensus 173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCP 246 (364)
T ss_pred ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence 9764332 122345789999999999999999999999999999999999999864332111 111100000
Q ss_pred --------------CCcc--c-----ccccccc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 689 --------------GGKG--V-----EFVDSFL---DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 689 --------------~~~~--~-----~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.... . ......+ ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0 0000000 000011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=298.61 Aligned_cols=253 Identities=21% Similarity=0.344 Sum_probs=202.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++.+.||.|++|.||++... ++..+|+|.+........+.+..|+.++++++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457899999999999999999964 6889999999876666667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999988542 245889999999999999999999986 9999999999999999999999999987643221
Q ss_pred ccccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 622 EENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.......++..|+|||.+. ...++.++|||||||++|||++|+.|+...... ...... .......
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~-- 227 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKI-LKSEPPT-- 227 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHH-hcCCCCC--
Confidence 1223456889999999875 345778999999999999999999998643211 111111 1111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
+ ..+......+.+++.+||+.+|.+||++.++++.
T Consensus 228 ---~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 ---L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 0111233468899999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=297.41 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=199.8
Q ss_pred CCCcceeeceeCcEEEEEEEeCC--CcEEEEEEcCCC----------ChhhHHHHHHHHHHHHc-CCCCceeeEEEEEec
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLPC--GEVIAVKKLSKT----------STQGFEEFKNEVMLTAK-LQHVNLIRVLGFCID 531 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 531 (785)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999653 688999987532 22234456778887765 799999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
....+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+.. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998887432 22346888999999999999999999632 4999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..... ....
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~-~~~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATK-IVEA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHH-Hhhc
Confidence 9998754332 233456889999999999888999999999999999999999998533211 11111 1111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 691 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
... +. ........+.+++.+||+.||++||++.|+..++++
T Consensus 229 ~~~----~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VYE----PL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCC----cC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 100 00 011223578899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.37 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=199.2
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-CccEEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLIYE 540 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 540 (785)
+|++.+.||+|++|.||++... +++.+|+|++... .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999954 5788999998653 234456788999999999999999999887643 45789999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|.+++... ....+++.++..++.+++.|+.+||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888643 2345899999999999999999999886 9999999999999999999999999998764321
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......++..|+|||.+.+..++.++|||||||++++|++|+.|+..... ......... +...
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~-~~~~------- 220 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIE-GKLP------- 220 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-cCCC-------
Confidence 122345688999999999999999999999999999999999998753221 111111111 1110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.........+.+++.+||+.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1112234578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.57 Aligned_cols=258 Identities=25% Similarity=0.295 Sum_probs=194.0
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------ 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 532 (785)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999984 568899999987542 22345677899999999999999999887533
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
...+++++++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 788887763 335889999999999999999999886 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
++..... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+ ............
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~- 235 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTP- 235 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCC-
Confidence 9865322 234568999999999877 568999999999999999999999986432211 111111100000
Q ss_pred cccccc-----------cccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 692 GVEFVD-----------SFLDDRNS-------PCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 692 ~~~~~~-----------~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
..+... ..+..... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000000 0012357799999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=295.60 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=199.4
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-----hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999965 78999999986543 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999853 235788999999999999999999886 99999999999999999999999999887543
Q ss_pred cccccccccccccCCcccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.. ......++..|+|||.+.... ++.++|+|||||++|+|++|+.|+..... .............
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~----- 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKEL----- 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccC-----
Confidence 32 223456888999999987776 89999999999999999999999864321 1111111110110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111123457889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.28 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=203.9
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.+.||.|+||+||+|.. .++..+++|++.... ......+.+|+..++.++|+|++++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4689999999999999999994 467889999987543 23556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++........+++.....++.|++.||.+||+.+ ++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865333346889999999999999999999876 99999999999999999999999999876654322
Q ss_pred c--cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 622 E--ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 622 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. .......|+..|+|||.+... .++.++|+|||||++|||++|+.|+....... ...+...... . ...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~~-~-~~~- 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQNDP-P-SLE- 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCCC-C-CcC-
Confidence 2 122334688999999998776 78999999999999999999999986432211 1111111110 0 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........+..+.+++.+||+.||++||++.++++
T Consensus 229 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 --TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00011123457889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.16 Aligned_cols=199 Identities=18% Similarity=0.275 Sum_probs=164.7
Q ss_pred cceeecee--CcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 468 IRNKLGEG--GYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 468 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
++++||+| +|++||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7899999985 578999999997542 333456788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999885432 234889999999999999999999876 999999999999999999999999865443211110
Q ss_pred -----cccccccccCCcccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCcc
Q 003932 623 -----ENTEQVVGTIGYIPPEYATK--GVYSTKSDVFSFGVLLLQIISGKRLSML 670 (785)
Q Consensus 623 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltG~~p~~~ 670 (785)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01122356778999999976 4588999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=300.25 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=198.6
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999965 58899999986442 2233567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|..++.. ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988877632 335899999999999999999999976 9999999999999999999999999998764432
Q ss_pred cccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH--------HHHHhCCc
Q 003932 621 LEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGK 691 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 691 (785)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ ...+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999876 45789999999999999999999998643322211111100 00000000
Q ss_pred ccc-ccccccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVE-FVDSFLDDRN-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~-~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
... ...+...... .+.....+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 0000000000 0112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.66 Aligned_cols=195 Identities=26% Similarity=0.393 Sum_probs=157.9
Q ss_pred eeeceeCcEEEEEEEeC---CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEec--CCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP---CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 544 (785)
.+||+|+||.||+|+.. ++..+|+|.+..... ...+.+|+.++++++||||+++++++.. ....++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 68999999999999854 457899999875432 2457789999999999999999998854 4567899999865
Q ss_pred CChhhhhcCC------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE----cCCCceeecccccee
Q 003932 545 KSLDCYLFDP------IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL----GEAMKPKISDFGMAR 614 (785)
Q Consensus 545 gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~Dfg~a~ 614 (785)
+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 12235888999999999999999999886 9999999999999 566799999999998
Q ss_pred eecccccc-cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcc
Q 003932 615 IFAKESLE-ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSML 670 (785)
Q Consensus 615 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~ 670 (785)
........ .......+|..|+|||.+.+. .++.++|||||||++|||+||++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76433211 122345789999999998764 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.36 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=193.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-----hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--Ccc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EER 535 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 535 (785)
.+|+..+.||+|+||.||+|.. .+++.+++|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999985 468899999886432 23345688899999999999999999988753 567
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998853 234788899999999999999999876 99999999999999999999999999876
Q ss_pred eccccc-ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 616 FAKESL-EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 616 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.|+..... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~--- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT--- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC---
Confidence 532211 1112234578899999999998899999999999999999999999863211 111111111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+......+.+++ +||..+|++||+++||++
T Consensus 227 ------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0111122233556666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06544 GH18_narbonin Narbonin is a plant 2S protein from the globulin fraction of narbon bean (Vicia narbonensis L | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=284.45 Aligned_cols=205 Identities=14% Similarity=0.113 Sum_probs=145.6
Q ss_pred CCCCcCCCCCCC--CceEEEEEE-EeeCC----ccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCCCcccch
Q 003932 36 EVSTISGINYDL--FTHLICSSA-DINST----TYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYS 108 (785)
Q Consensus 36 ~~~~~~~i~~~~--~Thi~~~f~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs 108 (785)
....+++||.+. ||||+|||+ ..+.. ++.+... +.++....+.+..+|++||++|||+|||||+...+..+.
T Consensus 11 ~~~~~~dip~~~~~~thii~aFa~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~lK~~~p~lKvllSiGG~~~~~~~~~~ 89 (253)
T cd06544 11 NGVTFSDVPINPKVEFHFILSFAIDYDTESNPTNGKFNPY-WDTENLTPEAVKSIKAQHPNVKVVISIGGRGVQNNPTPF 89 (253)
T ss_pred CCccccccCCCCCeeEEEEEEeeeecccccCCCCCccccc-cCccccCHHHHHHHHHhCCCcEEEEEeCCCCCCCCcccc
Confidence 345799999998 999999999 44331 2233222 222333455666799999999999999999875433333
Q ss_pred hhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCC
Q 003932 109 SMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSP 188 (785)
Q Consensus 109 ~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (785)
...+....|++||+|+++++++|||||||||||||. .|+++|+.|+++||++|++. + .+++++..+...
T Consensus 90 ~~~~~~~~~~~fv~S~~~~l~~~~fDGiDiDwE~~~--~d~~~f~~ll~~l~~~l~~~--------~-~lt~a~vap~~~ 158 (253)
T cd06544 90 DPSNVDSWVSNAVSSLTSIIQTYNLDGIDIDYEHFP--ADPDTFVECIGQLITELKNN--------G-VIKVASIAPSED 158 (253)
T ss_pred CchhhhhHHHHHHHHHHHHHHHhCCCceeeecccCC--cCHHHHHHHHHHHHHHhhhc--------C-CeEEEEecCCcc
Confidence 344555566777999999999999999999999993 67999999999999999752 2 333333222222
Q ss_pred CCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeeccccccceee
Q 003932 189 PANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWT 268 (785)
Q Consensus 189 ~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~ 268 (785)
....+.++.+.+++|+|++|+||+++.+.. . . ........+.|. .++|++||++|+|+|++.|.
T Consensus 159 ~~~~~y~~~~~~~~d~id~~~~qfy~~~~~---~--~----------~~~~~~~~~~~~-~~~p~~Kv~lGl~a~~~~~~ 222 (253)
T cd06544 159 AEQSHYLALYNAYGDYIDYVNYQFYNYGVP---T--T----------VAKYVEFYDEVA-NNYPGKKVLASFSTDGEDGA 222 (253)
T ss_pred ccccccHHHHHHhhCceeEEEhhhhCCCCC---C--C----------HHHHHHHHHHHH-hCCCcccEEEEEecCCCccC
Confidence 214556889999999999999999876431 1 0 001223344444 47999999999999998873
|
) cotyledons with unknown function. Narbonin has a glycosyl hydrolase family 18 (GH18) domain without the conserved catalytic residues and with no known enzymatic activity. Narbonin amounts to up to 3% of the total seed globulins of mature seeds and was thought to be a storage protein but was found to degrade too slowly during germination. This family also includes the VfNOD32 nodulin from Vicia faba. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=297.19 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=197.7
Q ss_pred CCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC------
Q 003932 466 FSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ 533 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 533 (785)
|.+.+.||+|+||.||+|... +++.+|+|++... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999843 4688999998754 2344567889999999999999999999886542
Q ss_pred ccEEEEEecCCCChhhhhcCCc---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPI---RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
..++++||+++|+|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988764211 2235788999999999999999999876 999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhC
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKG 689 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 689 (785)
|+++...............++..|++||.+.+..++.++|||||||++|||++ |++|+...... . .......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~----~~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---E----IYNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---H----HHHHHHc
Confidence 99886543322222223345678999999998889999999999999999999 88887532211 1 1111111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 690 GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 690 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
..... .....+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 231 ~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 1112345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=300.58 Aligned_cols=262 Identities=21% Similarity=0.286 Sum_probs=200.9
Q ss_pred ChHHHHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEe--
Q 003932 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCI-- 530 (785)
Q Consensus 455 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 530 (785)
.++.+....++|++.+.||+|+||.||++.. .+++.+|+|++..... ....+.+|+.+++++ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3455566778999999999999999999985 4678999998865332 235678899999999 6999999999884
Q ss_pred ---cCCccEEEEEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCcee
Q 003932 531 ---DSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPK 606 (785)
Q Consensus 531 ---~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 606 (785)
.....++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 3456899999999999998875322 2345788899999999999999999876 99999999999999999999
Q ss_pred eccccceeeecccccccccccccccCCcccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHH
Q 003932 607 ISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 681 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 681 (785)
|+|||+++....... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.|+.......
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------ 236 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------ 236 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------
Confidence 999999887643221 2233468999999998853 447889999999999999999999986432111
Q ss_pred HHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 682 HAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.... ........... +......+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~-~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 ALFK-IPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHhh-ccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0101 00110000000 11123468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=296.85 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=198.1
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh----------hhHHHHHHHHHHHHcCCCCceeeEEEEEecCC
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST----------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE 533 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 533 (785)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+..... ...+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477789999999999999984 4688999998864211 12345788999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988543 45888999999999999999999876 999999999999999999999999998
Q ss_pred eeecccccccccccccccCCcccccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
................++..|+|||.+.... ++.++|+||||+++|||++|..|+..... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhcccc
Confidence 7653322112223456889999999987654 78999999999999999999999853211 111111111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
...+. .......+..+.+++.+||+.+|.+||++.++++.
T Consensus 230 ~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIP-----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCC-----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111 11112234578899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.32 Aligned_cols=251 Identities=33% Similarity=0.534 Sum_probs=199.2
Q ss_pred CCcceeeceeCcEEEEEEEeCC-----CcEEEEEEcCCCChh-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 466 FSIRNKLGEGGYGPVYKGVLPC-----GEVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
+++.+.||.|+||.||+++... +..+|+|++...... ..+.+..|+.+++.++|+||+++++++.+....+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999643 378999999765443 5678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++++|.+++..... ..+++..+..++.|++.+|++||+.+ ++||||+|+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854221 12899999999999999999999886 999999999999999999999999999876543
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
...... ...++..|+|||.+.+..++.++||||||+++++|++ |+.|+..... .... ..........
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~----~~~~~~~~~~---- 224 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVL----EYLKKGYRLP---- 224 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHhcCCCCC----
Confidence 221111 2336789999999988889999999999999999998 7777653211 1111 1111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
.....+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 225 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111345788999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.52 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=198.6
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCC--CChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSK--TSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 538 (785)
....|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+..|.+| .|.+|+++++|-..+..+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3567999999999999999999987778888888753 3455567799999999999 599999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||- .-+|..+|...... ...| .+..+..|++.++.++|+++ |||.||||.|+|+-. |.+||+|||.|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9975 56898888653322 2223 66778899999999999987 999999999999965 5899999999998877
Q ss_pred cccccccccccccCCcccccccCCCC-----------CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGV-----------YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
....-.....+||..||+||.+.... .++++||||||||||+|+.|+.||... ..........-
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl~aI~ 586 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKLHAIT 586 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHHHhhc
Confidence 76665666789999999999885432 567999999999999999999998521 11111111111
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
..+...++.+- . ...++++++..||+.||++||++.|+++.
T Consensus 587 ~P~~~Iefp~~-----~---~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 587 DPNHEIEFPDI-----P---ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CCCccccccCC-----C---CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11111222211 1 11238999999999999999999999863
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.70 Aligned_cols=255 Identities=19% Similarity=0.240 Sum_probs=195.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.++||+|+||.||++... +++.+|+|++.+.. ......+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999954 57889999986432 223345788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 245888899999999999999999886 999999999999999999999999998765332
Q ss_pred ccccccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+.............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~ 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQ 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCcccc
Confidence 11 1223357999999999886 34578999999999999999999999864321 111111111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPND--RPSMLEVSSM 736 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 736 (785)
+.. ........+.+++.+|+..++++ ||++.|+++.
T Consensus 229 ~p~------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPA------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCC------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 110 01122456788999988655444 6889988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.48 Aligned_cols=248 Identities=24% Similarity=0.289 Sum_probs=201.5
Q ss_pred cCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
+.|..-++||+|+||.||-++ ..+|+.+|.|++.+... .......+|..+|++++.+.||.+-..+...+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 457777999999999999998 55899999999976532 22334678999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
..|.||+|.-+|++... +.+++.+++.++.+|+.||++||... ||.||+||+|||||+.|+++|+|+|+|..+...
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999987644 66999999999999999999999886 999999999999999999999999999987654
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
......+||.+|||||++.+..|+...|.|||||+||||+.|+.||...........++ +.... .
T Consensus 341 ---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---rr~~~-~-------- 405 (591)
T KOG0986|consen 341 ---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---RRTLE-D-------- 405 (591)
T ss_pred ---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---HHHhc-c--------
Confidence 33445689999999999999999999999999999999999999986433221110111 10000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSML 731 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 731 (785)
....+...+++...+....|++||++|...+
T Consensus 406 -~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 406 -PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1122333445778888899999999997443
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=293.66 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=200.4
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|++.+.||+|+||.||++.. .+++.+++|.+... .....+++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999984 46889999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 9999999888542 2234788999999999999999999876 9999999999999999999999999998754322
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......|+..|+|||.+.+..++.++|+|||||++++|++|+.|+..... .+....... +....
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~~~------- 220 (256)
T cd08218 156 -ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIR-GSYPP------- 220 (256)
T ss_pred -hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhc-CCCCC-------
Confidence 112234578899999999988899999999999999999999999863221 111111111 11100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........+.+++.+||+.+|.+||++.++++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11123447889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.81 Aligned_cols=255 Identities=18% Similarity=0.221 Sum_probs=195.8
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999954 6788999998653 2233445788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 245788899999999999999999886 999999999999999999999999999875432
Q ss_pred ccccccccccccCCcccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATK-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
.. .......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 228 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQ 228 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCccc
Confidence 21 11223569999999998875 45788999999999999999999998643211 11111111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPND--RPSMLEVSSM 736 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 736 (785)
+. ......+.++.+++.+|++..+++ |++++++++.
T Consensus 229 ~p------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FP------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CC------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 10 001122457888999999866544 4578877653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.33 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=198.7
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
.|.....||+|+||.||++.. .++..+|+|.+........+.+.+|+..+++++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344457799999999999985 4688999999876655566778899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+++|.+++.. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~ 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence 9999988732 34788999999999999999999886 9999999999999999999999999987543221 1
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 703 (785)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ... ..... ....+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~----~~~~~-----~~~~~~~- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMR----RIRDN-----LPPRVKD- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhc-----CCCcccc-
Confidence 2233568899999999988889999999999999999999999986422111 111 11110 0111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 704 NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 704 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.......+.+++.+||+.||++|||++|+++.
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11123467889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=291.60 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=205.0
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
+|++.+.||+|++|.||+|+.. +++.+++|++..... ...+.+.+|+..+.+++|+|++++++++......++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6888899999999999999965 589999999877644 44577899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
++++|.+++... ..+++..+..++.|+++++.|||+ .+ ++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 999999998532 568999999999999999999998 76 99999999999999999999999999987643321
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+............ ..........
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~------- 222 (264)
T cd06623 156 --QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QAICDGPPPS------- 222 (264)
T ss_pred --cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HHHhcCCCCC-------
Confidence 122456788999999999999999999999999999999999998655431211111 1111111100
Q ss_pred CCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 702 DRNSPC-KLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 702 ~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.... .+..+.+++.+||+.+|++||++.|+++.
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 --LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 34578999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.15 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=195.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-----hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--Ccc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EER 535 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 535 (785)
.+|++.+.||+|+||.||+|.. .+++.|++|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999985 468899999885321 23345788899999999999999999988764 457
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
+++|||+++++|.+++.. ...+++.....++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998853 234788888999999999999999886 99999999999999999999999999876
Q ss_pred ecccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 616 FAKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 616 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.|+..... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~--- 226 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPT--- 226 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHHHHHhcCCC---
Confidence 5322111 122334688999999999988899999999999999999999999853211 111111111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+......+.+++.+|+. +|++||+++|+++
T Consensus 227 ------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 ------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111223344567889999995 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=299.75 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=202.4
Q ss_pred cChHHHHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEec
Q 003932 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID 531 (785)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 531 (785)
+...++..+.++|.+.+.||+|+||.||++.. .+++.+|+|++..... ....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45556666788999999999999999999995 4688999999865432 235677899999998 89999999999875
Q ss_pred C-----CccEEEEEecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCce
Q 003932 532 S-----EERMLIYEYMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP 605 (785)
Q Consensus 532 ~-----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 605 (785)
. ...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3579999999999999887532 12345889999999999999999999876 9999999999999999999
Q ss_pred eeccccceeeecccccccccccccccCCcccccccCCCC-----CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHH
Q 003932 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV-----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 680 (785)
Q Consensus 606 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~ 680 (785)
+|+|||++........ ......|+..|+|||.+.... ++.++|||||||++|||++|+.|+......
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------ 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------ 239 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence 9999999876543221 122346788999999886543 688999999999999999999998643211
Q ss_pred HHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 681 EHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...... ......... ........+.+++.+||+.+|++||++.|+++
T Consensus 240 ~~~~~~-~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 KTLFKI-PRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHH-hcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 111111110 11123346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=300.86 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=197.8
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|++.+.||+|+||.||+|... +++.+|+|++..... ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999964 588999999865432 234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|..+... ...+++..+..++.|++++|.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877632 234889999999999999999999876 9999999999999999999999999988754332
Q ss_pred cccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHh-----------
Q 003932 621 LEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK----------- 688 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~----------- 688 (785)
.......++..|+|||.+.+ ..++.++||||||+++|||++|++|+......+ ..........
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhc
Confidence 22233567889999998876 347889999999999999999998885432111 1111110000
Q ss_pred CCccc-cccccccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 689 GGKGV-EFVDSFLDD-----RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 689 ~~~~~-~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..... ......... ...+..+..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 000000000 001123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.30 Aligned_cols=260 Identities=26% Similarity=0.325 Sum_probs=200.8
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 539 (785)
++|+..+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||++++++|... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3678889999999999999996 4688899999875432 3456789999999999999999999998654 3689999
Q ss_pred EecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 540 EYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
||+++++|.+++.... ....+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988764321 2345788999999999999999999876 99999999999999999999999999875432
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. ......++..|+|||.+.+..++.++|||||||++|+|++|+.|+....... ....+. .............+.
T Consensus 158 ~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~ 231 (287)
T cd06621 158 S----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIEL-LSYIVNMPNPELKDE 231 (287)
T ss_pred c----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHH-HHHHhcCCchhhccC
Confidence 2 1123457889999999999999999999999999999999999987543211 111111 111111111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. .........+.+++.+||+.+|.+|||+.|+++
T Consensus 232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 -P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 001123567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.03 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=200.6
Q ss_pred ChHHHHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEec-
Q 003932 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID- 531 (785)
Q Consensus 455 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 531 (785)
++.++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4555566778999999999999999999995 468899999986543 3345678899999988 79999999999853
Q ss_pred -----CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCcee
Q 003932 532 -----SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPK 606 (785)
Q Consensus 532 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 606 (785)
....+++|||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 35679999999999999988542 2345788888999999999999999886 99999999999999999999
Q ss_pred eccccceeeecccccccccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHH
Q 003932 607 ISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 681 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 681 (785)
|+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.|+.........
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~---- 235 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---- 235 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----
Confidence 99999987643221 1223456889999999876 345788999999999999999999998643221110
Q ss_pred HHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 682 HAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.... ..... .......+..+.+++.+||+.||.+||++.|+++
T Consensus 236 --~~~~-~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 --FLIP-RNPPP--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hhHh-hCCCC--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 00000 0011123457899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.50 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=200.3
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC------hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
+|+..+.||+|++|.||++.. .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999984 568899999987543 1234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-ceeeccccceeee
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFGMARIF 616 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~ 616 (785)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998853 345788999999999999999999886 99999999999998776 5999999998776
Q ss_pred cccccc--cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 617 AKESLE--ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 617 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
...... .......++..|+|||.+.+..++.++||||+|+++++|++|+.|+........ ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~---- 227 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASAT---- 227 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccC----
Confidence 433111 112234678899999999888899999999999999999999999864322111 11111111000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.....+......+.+++.+||+.+|.+||++.|++.
T Consensus 228 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 -----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011122334467889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=291.28 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=199.1
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|++.+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|||++++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578899999999999999985 468889999987542 34456788999999999999999999999988999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-Cceeeccccceeeecccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDFGMARIFAKES 620 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~ 620 (785)
+++++|.+++... ....+++..+..++.+++++|.|||+.+ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998543 2345789999999999999999999886 9999999999999855 457999999998764321
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... .. ..... ......
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~---~~~~~-~~~~~~----- 221 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LV---LKIMS-GTFAPI----- 221 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HH---HHHHh-cCCCCC-----
Confidence 2223567889999999998889999999999999999999999985432211 11 11111 110011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.......+.+++.+||+.+|.+|||+.|+++
T Consensus 222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1113446889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.56 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=202.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|.+.+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36899999999999999999984 46788999998765555556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 34788899999999999999999886 99999999999999999999999999876543321
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... ........ .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~~--------~ 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTP--------E 234 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCCC--------C
Confidence 2233468889999999988889999999999999999999999986433211110 00000000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
..........+.+++.+||+.+|++||++.+++..
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111234468899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.61 Aligned_cols=261 Identities=25% Similarity=0.302 Sum_probs=197.7
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChh-----hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQ-----GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
+|++.+.||+|++|.||+|... +++.|++|++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999954 6889999999765322 234567899999999999999999999998999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985432 36899999999999999999999886 99999999999999999999999999987643
Q ss_pred cccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc------
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK------ 691 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 691 (785)
.. .......++..|+|||.+.+ ..++.++|||||||++|||++|.+|+......+ .............
T Consensus 155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhh
Confidence 32 12223346788999998865 457899999999999999999977765332211 1111111110000
Q ss_pred ---cccccccccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 692 ---GVEFVDSFLDDR-----NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 692 ---~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
............ ........+.+++.+||+.+|++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 011224578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=286.95 Aligned_cols=265 Identities=22% Similarity=0.321 Sum_probs=217.4
Q ss_pred hHHHHHHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEE
Q 003932 456 LADIEAATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGF 528 (785)
Q Consensus 456 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 528 (785)
..++....+++++..++-+|.||.||.|.+. +.+.|-+|.+... +.-....+..|..++..+.|||++.+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4456667788999999999999999999643 2344667766543 33344567888888889999999999999
Q ss_pred EecC-CccEEEEEecCCCChhhhhc-----CCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC
Q 003932 529 CIDS-EERMLIYEYMPNKSLDCYLF-----DPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA 602 (785)
Q Consensus 529 ~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 602 (785)
+... ...+.++.++.-|+|..+|. +......++..+...++.|++.|++|||.++ +||.||..+|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8754 57889999999999999997 4445566888899999999999999999987 9999999999999999
Q ss_pred CceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHH
Q 003932 603 MKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILE 681 (785)
Q Consensus 603 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~ 681 (785)
.+|||+|=.+++.+.+.++....+....+..||+||.+....|+..+|||||||+||||+| |+.|+...++.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 9999999999999988888777777778899999999999999999999999999999998 888886544332
Q ss_pred HHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 682 HAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
...+++++... ..+-.++.++..++.-||...|++||+++|+..-|.+
T Consensus 507 -m~~ylkdGyRl---------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 507 -MEHYLKDGYRL---------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -HHHHHhcccee---------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 22233333221 1223355689999999999999999999999988865
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.74 Aligned_cols=257 Identities=20% Similarity=0.231 Sum_probs=200.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999954 57889999987653 233456789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999853 245888999999999999999999876 999999999999999999999999998642110
Q ss_pred cc-------------ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH
Q 003932 620 SL-------------EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686 (785)
Q Consensus 620 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 686 (785)
.. ........++..|+|||.+.+..++.++|||||||++|||++|+.|+...... +.. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~-~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELF-GQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HH
Confidence 00 00111245788999999998888999999999999999999999998632211 111 11
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
..... .... ......+..+.+++.+||+.+|++||++.++.+.|+..
T Consensus 228 ~~~~~---~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 228 VISDD---IEWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHhcc---cCCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11110 0000 00112344688999999999999999988787777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.74 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=199.9
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|++.+.||+|++|.||+|.. .+++.+++|++.... ....+.+.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 578899999999999999995 468899999987654 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+ +++|.+++... ...+++..+..++.||+++|.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999988542 245899999999999999999999886 99999999999999999999999999887643321
Q ss_pred ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc------cc
Q 003932 622 EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG------VE 694 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 694 (785)
.......++..|+|||.+.+. .++.++|||||||+++||++|++|+..... ................ .+
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence 123345688999999988654 468999999999999999999777653321 1111111111111000 00
Q ss_pred cc--cc-ccC-C------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 695 FV--DS-FLD-D------RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 695 ~~--~~-~l~-~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.. .. ... . ...+.....+.+++.+||+.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00 000 0 0001223678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.76 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=194.1
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|++.+.||+|+||.||+|... +|+.+|+|++..... .....+.+|+.++++++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999954 688999999865321 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 97 5777766432 345899999999999999999999886 9999999999999999999999999987653221
Q ss_pred ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc------cc
Q 003932 622 EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG------VE 694 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 694 (785)
.......++..|+|||.+.+. .++.++|||||||++|||++|..|+....... .......+....... ..
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhh
Confidence 122234578899999988765 47899999999999999999998864322111 111111111100000 00
Q ss_pred cccc----ccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 FVDS----FLDD-----RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 ~~~~----~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..+. .... ...+.....+.+++.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 0000 011123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=292.91 Aligned_cols=252 Identities=26% Similarity=0.326 Sum_probs=201.0
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
+|+..+.||+|++|.||++... +++.+++|++.... ....+++.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5778899999999999999965 68899999987653 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
++++|.+++.... ..+++.....++.|++.+|.|||+ .+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 9999999885432 568889999999999999999998 65 9999999999999999999999999987653221
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ....+..... .........
T Consensus 156 ---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~----- 225 (265)
T cd06605 156 ---AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYI-VNEPPPRLP----- 225 (265)
T ss_pred ---hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHH-hcCCCCCCC-----
Confidence 112567889999999999999999999999999999999999986432211 1111111111 111111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.......+.+++.+||..||.+|||+.+++.
T Consensus 226 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 ---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0113456889999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=292.33 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=199.2
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
-|++.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788999999999999985 468899999986543 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|..++.. ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999988842 35789999999999999999999876 99999999999999999999999999876543221
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......++..|+|||.+.+..++.++|+|||||++|+|++|..|+....... .. ........ .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~-~~~~~~~~---------~ 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VL-FLIPKNNP---------P 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HH-HHHhcCCC---------C
Confidence 1223467889999999988889999999999999999999999985322111 11 11111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
......+..+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1112234578899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=294.73 Aligned_cols=244 Identities=24% Similarity=0.302 Sum_probs=198.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999954 68899999986532 234466889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++++|.+++.. ...++...+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999998853 345889999999999999999999876 999999999999999999999999998775432
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.....++..|+|||.+.+...+.++||||||+++|+|++|+.|+..... .........+.. .
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~----- 216 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKV-R----- 216 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCc-c-----
Confidence 2334688999999999888889999999999999999999999864331 111111111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
.+......+.+++.+||+.||.+|| +++|+++
T Consensus 217 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 ----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111245788999999999999999 6677753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=299.36 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=195.4
Q ss_pred CCCcceeeceeCcEEEEEEEeC---CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP---CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERM 536 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 536 (785)
+|++.+.||+|++|.||+|... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999954 47899999998732 33345678899999999999999999999988 7899
Q ss_pred EEEEecCCCChhhhhcCCc--cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC----CCceeeccc
Q 003932 537 LIYEYMPNKSLDCYLFDPI--RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE----AMKPKISDF 610 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~----~~~~kl~Df 610 (785)
+||||+++ +|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5655553221 1236888999999999999999999886 999999999999999 999999999
Q ss_pred cceeeeccccc-ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcc------cHHHH
Q 003932 611 GMARIFAKESL-EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL------SILEH 682 (785)
Q Consensus 611 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~------~~~~~ 682 (785)
|++..+..... ........++..|+|||.+.+. .++.++|||||||+++||++|+.|+......... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987543321 1122345678999999988764 5789999999999999999999998654332200 00011
Q ss_pred HHHHHhCC------------ccccccccccCCCCC----H-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 683 AYELWKGG------------KGVEFVDSFLDDRNS----P-------CKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 683 ~~~~~~~~------------~~~~~~~~~l~~~~~----~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+... ......+........ . .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111000 000000000000000 0 22346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.87 Aligned_cols=240 Identities=23% Similarity=0.300 Sum_probs=184.1
Q ss_pred eceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcC---CCCceeeEEEEEecCCccEEEEEecCC
Q 003932 472 LGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---QGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 472 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
||+|+||.||+|+. .+++.||+|++.+... ........|..++.++ +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999985 4689999999865321 2223344566666554 699999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.++|+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCC
Confidence 999888743 345889999999999999999999886 999999999999999999999999998753221 122
Q ss_pred cccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCC
Q 003932 625 TEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 703 (785)
....+||..|+|||.+.+. .++.++|||||||++|||++|+.||...... ........+. ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~-~~~~~------ 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGK-VRFPK------ 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCC-CCCCC------
Confidence 3346799999999998765 4789999999999999999999998643211 1111111111 01110
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 003932 704 NSPCKLMRCLEIALLCVQENPNDRPS----MLEVSS 735 (785)
Q Consensus 704 ~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 735 (785)
......+.+++.+||+.||.+||+ +.++++
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112346788999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.97 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=200.0
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|++.+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999964 68899999987532 3334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|++++.+..+... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777665532 334889999999999999999999886 9999999999999999999999999988765432
Q ss_pred cccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhC----------
Q 003932 621 LEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG---------- 689 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------- 689 (785)
. .......++..|+|||++.+. .++.++||||||+++|+|++|+.|+......+ ........+..
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcc
Confidence 1 122335678899999999888 78999999999999999999999886432211 11111110000
Q ss_pred -Cccc---ccccc----ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 690 -GKGV---EFVDS----FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 690 -~~~~---~~~~~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.... +.... .+........+..+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 00000 0000111122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.92 Aligned_cols=253 Identities=24% Similarity=0.286 Sum_probs=200.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999954 589999999976532 24556889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+.+++|.+++... ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 2346899999999999999999999886 999999999999999999999999998754321
Q ss_pred ccc---------------------------cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccC
Q 003932 620 SLE---------------------------ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672 (785)
Q Consensus 620 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~ 672 (785)
... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123467889999999999889999999999999999999999986433
Q ss_pred CCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 003932 673 INENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS----MLEVSS 735 (785)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 735 (785)
.... ........ ... ......+..+.+++.+||+.||++||+ +.|++.
T Consensus 237 ~~~~------~~~~~~~~--~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET------FSNILKKE--VTF-------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH------HHHHhcCC--ccC-------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2111 11111110 000 001113457899999999999999999 777766
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.57 Aligned_cols=262 Identities=26% Similarity=0.353 Sum_probs=194.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57899999999999999999964 688999999875432 2224567899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+.+ +|.+++... ...+++.....++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 157 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS- 157 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence 974 898887542 235788999999999999999999886 9999999999999999999999999987542211
Q ss_pred ccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc-------
Q 003932 622 EENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV------- 693 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 693 (785)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .................
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhh
Confidence 11122346789999998876 45889999999999999999999998643211 11111111111100000
Q ss_pred --cccccc--------cCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 --EFVDSF--------LDDR-NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 --~~~~~~--------l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...... +... ........+.+++.+||+.+|.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0000 00111246789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=274.13 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=194.6
Q ss_pred CCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEEEEec
Q 003932 466 FSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.+.+..||.|+.|.|++++.. +|...|||.+++. +..+.+++...++++.+.+ +|+||+.+|+|......++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 345677999999999999954 6899999999876 4556667778888777664 899999999999999999999998
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
. .-++.+|.. ...++++...-++...++.||.||.++| +|+|||+||+|||+|+.|++||||||++-.+.+..
T Consensus 174 s-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 174 S-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred H-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 3 344555532 2345888888889999999999999987 69999999999999999999999999998776542
Q ss_pred cccccccccCCcccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 623 ENTEQVVGTIGYIPPEYATK---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
..+...|-+.|||||.+.- ..|+-++||||||+.|+||.||+-|+..+..+- ...... +. ... +.
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltkv---ln-~eP-----P~ 314 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTKV---LN-EEP-----PL 314 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHHH---Hh-cCC-----CC
Confidence 2334568899999998864 458899999999999999999999998755322 112111 11 111 12
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
+.... ..+..+.+++..||++|+.+||...++++.
T Consensus 315 L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22111 134578899999999999999999998753
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=296.52 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred cceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCC
Q 003932 468 IRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKS 546 (785)
Q Consensus 468 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 546 (785)
....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++......++++||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999854 688999999876544455678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccc
Q 003932 547 LDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626 (785)
Q Consensus 547 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 626 (785)
|..++. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....... ....
T Consensus 105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 175 (297)
T cd06659 105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK 175 (297)
T ss_pred HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence 988773 235789999999999999999999886 9999999999999999999999999987543321 1223
Q ss_pred cccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCH
Q 003932 627 QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSP 706 (785)
Q Consensus 627 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 706 (785)
...++..|+|||.+.+..++.++|||||||++|||++|+.|+...... ... .......... .. ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~-~~~~~~~~~~-----~~--~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAM-KRLRDSPPPK-----LK--NAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHhccCCCC-----cc--ccC
Confidence 356889999999999888999999999999999999999998632211 111 1111111000 00 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 707 CKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 707 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.....+.+++.+||+.+|++||++.++++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 123467899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=292.05 Aligned_cols=247 Identities=27% Similarity=0.425 Sum_probs=197.4
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCC---CCceeeEEEEEecCCccEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 539 (785)
.|++.+.||+|+||.||+|.. .+++.+++|.+... .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999995 56889999998754 3344567889999999986 999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988843 25889999999999999999999886 999999999999999999999999999876543
Q ss_pred ccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. .......|+..|+|||.+.++ .++.++|||||||++|+|++|+.|+....... .. ........ +
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~-~~~~~~~~-----~ 220 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AM-MLIPKSKP-----P 220 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hh-hccccCCC-----C
Confidence 2 122334688999999988654 47899999999999999999999986432111 00 00000000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+... ..+..+.+++.+||+.||++||++.|++.
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 01110 13347889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.04 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=200.1
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|++.+.||+|+||.||+|.. .+++.+++|.+..... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578889999999999999985 4688999999876544 3567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998853 234788899999999999999999886 99999999999999999999999999887644322
Q ss_pred ccc--cccccccCCcccccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 622 EEN--TEQVVGTIGYIPPEYATKGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 622 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... .....++..|+|||.+.+.. ++.++||||||++++||++|+.|+...... ........ ......
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~~~~-- 226 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVG-AGHKPP-- 226 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHh-cCCCCC--
Confidence 111 12356788999999998776 889999999999999999999998643211 11111111 011000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+.. .......+.+++.+||+.+|.+||++.|++.
T Consensus 227 ---~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 ---IPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 1112446789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=281.74 Aligned_cols=241 Identities=21% Similarity=0.269 Sum_probs=199.1
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
-++|..+++||+|.||.|.+++ ..+++.+|+|++++.- ..+...-..|-++|+..+||.+..+...|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3678999999999999999999 4579999999998763 34445567899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||..||.|.-+|. +...+++.+....-..|+.||.|||+.. ||.||||.+|.|||.+|++||+|||+++.-.
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999987773 4556888888888899999999999875 9999999999999999999999999997532
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.....+..+|||+.|+|||++....|+..+|.|.+||++|||++|+.||...+......++- ..
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-------~e-------- 383 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-------ME-------- 383 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-------hh--------
Confidence 23345667899999999999999999999999999999999999999998654433222211 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRP 728 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 728 (785)
.-.++.....+...|+...|.+||.+|.
T Consensus 384 --d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 --DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 0112222334677899999999999995
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.90 Aligned_cols=251 Identities=20% Similarity=0.328 Sum_probs=202.8
Q ss_pred CCCcceeeceeCcEEEEEEEeCC-CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLPC-GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
.|.++..||.|+||.||+|+.+. +-.-|.|++........+.+.-||++|..++||+||++++.|+-.+.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45677789999999999999653 44457888887778888899999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
||-.+..+... ...+++.++.-++.|++.||.|||+.. |||||||..|||++-+|.++|+|||.+..... ...
T Consensus 113 GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ 185 (1187)
T ss_pred CchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence 99998887543 346899999999999999999999885 99999999999999999999999999865322 223
Q ss_pred ccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 624 NTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
..+.+.||++|||||+.. ..+|+.++||||||++|.||..+.+|....++. .+.-.........++
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-------RVllKiaKSePPTLl-- 256 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEPPTLL-- 256 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-------HHHHHHhhcCCCccc--
Confidence 456789999999999775 457999999999999999999999886533221 111111111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+......+.+++..||.+||..||++.++++.
T Consensus 257 -----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 -----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 122345578899999999999999999999763
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=296.12 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=196.9
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 538 (785)
++|++.+.||+|+||.||+|... +++.+++|.+..... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999965 688999999975432 2223567899999999999999999998877 889999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
+||+. ++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 4888887542 235899999999999999999999886 99999999999999999999999999987643
Q ss_pred cccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhC--------
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG-------- 689 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------- 689 (785)
.. .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+......+ ........+..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID---QLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchHHHHH
Confidence 31 122334578899999988765 46899999999999999999999986433211 11111111100
Q ss_pred ---------CccccccccccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 690 ---------GKGVEFVDSFLDDRNSPC-KLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 690 ---------~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..........+....... ....+.+++.+||+.+|++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000001111111111 2456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=284.19 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=203.8
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLIY 539 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 539 (785)
+|.+.+.||+|++|.||+|... +++.+++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999965 688999999876542 4567889999999999999999999999988 8899999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++++|.+++... ..+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998542 26899999999999999999999976 999999999999999999999999999876544
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
..........++..|+|||.+.+...+.++||||||+++++|++|+.|+.... ...............
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~------- 222 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP------- 222 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC-------
Confidence 32111334568899999999998889999999999999999999999986543 111111111110010
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 --~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 --PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111222457899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=290.13 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=200.8
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec--CCccEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLIY 539 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 539 (785)
+|++.+.||.|+||.||++.. .+++.+|+|.+... .....+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999984 46788999998653 33445678899999999999999999998764 34678999
Q ss_pred EecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 540 EYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYS--RLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
||+++++|.+++.... ....+++..+..++.||+.||.|||..+ ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999885421 2456899999999999999999999443 345999999999999999999999999999876
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
..... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+..... .............
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~--- 228 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLASKIKEGKFR--- 228 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHHHHhcCCCC---
Confidence 44321 12335689999999999998899999999999999999999999864321 1111111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.........+.+++.+||+.+|++||++.+|++.
T Consensus 229 ------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=292.39 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=198.9
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCC------
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE------ 533 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 533 (785)
.+++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999964 578899999876543 346789999999999 7999999999997654
Q ss_pred ccEEEEEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998885422 2356889999999999999999999876 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATK-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
+....... .......++..|+|||.+.. ..++.++|||||||++++|++|+.|+....... ......
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKIP 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHhh
Confidence 87654321 22234568899999998754 346789999999999999999999986322111 111111
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ..... + .........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~-~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 R-NPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-cCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11000 0 011123457889999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=293.80 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=192.0
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHH-HHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVML-TAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|++.+.||+|+||.||++... +++.||+|++.... ......+..|+.. ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36889999999999999999954 68999999987643 2223345556654 566789999999999999999999999
Q ss_pred ecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 541 YMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 541 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|++ |+|.+++... .....+++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6887776432 23356899999999999999999999862 3999999999999999999999999998765322
Q ss_pred ccccccccccccCCcccccccCC----CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATK----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
.......++..|+|||.+.+ ..++.++|+|||||++|||++|+.|+..... . .+........ .....
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~---~~~~~~~~~~-~~~~~ 228 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--P---FQQLKQVVEE-PSPQL 228 (283)
T ss_pred ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--C---HHHHHHHHhc-CCCCC
Confidence 11223457889999998865 4468899999999999999999999853211 1 1111111111 10111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.....+..+.+++.+||+.+|.+||++.++++
T Consensus 229 --------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 --------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01123457889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=292.24 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=193.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
+.+|.+.+.||+|+||.||+|.. .+++.+++|++..... .....+.+|+.+++.++|+||+++++++......++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46799999999999999999985 4688999999875432 223456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+. ++|..++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 6776665432 234678888899999999999999886 9999999999999999999999999987643221
Q ss_pred cccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc--------
Q 003932 621 LEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK-------- 691 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 691 (785)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.|+...... ...............
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 158 --QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred --CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhh
Confidence 112234578899999998764 5788999999999999999999998643211 111111111000000
Q ss_pred -cccccccccCCC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 -GVEFVDSFLDDR---------NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 -~~~~~~~~l~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
............ ........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 00011346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=294.75 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=195.2
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|+..+.||.|++|.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999854 68899999987542 22335688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 95 6888877543 2345889999999999999999999876 9999999999999999999999999987653221
Q ss_pred ccccccccccCCcccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc--------
Q 003932 622 EENTEQVVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG-------- 692 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 692 (785)
.......++..|+|||.+.+.. ++.++|||||||++|||+||+.|+......+ ..............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCChhhhhhhhH
Confidence 1122335688999999887654 6889999999999999999999986433211 11111111000000
Q ss_pred --------ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 --------VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 --------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.......+.. ..+.....+.+++.+||+.||.+|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 01112346789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=292.08 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=198.2
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344557999999999999985 4688999999876555555678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+++|.+++.. ..+++..+..++.|++.+|+|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~ 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--P 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--c
Confidence 9999998853 35788999999999999999999886 9999999999999999999999999876543221 1
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 703 (785)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+..... ....... ..... ..+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~-~~~~~-----~~~~~- 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRI-RDNLP-----PKLKN- 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHH-HhcCC-----CCCcc-
Confidence 12234688999999999988899999999999999999999999854221 1111111 11110 00100
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 704 NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 704 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1113347899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=284.39 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=202.7
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999965 688999999987665566788999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+++|.+++... ...+++..+..++.|++.+|.+||..+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999988542 246899999999999999999999875 99999999999999999999999999887654321
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 703 (785)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... ........ ........
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~------ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT-NGPPGLRN------ 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-cCCCCcCc------
Confidence 33456889999999999888999999999999999999999998643211 11111111 11111110
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 704 NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 704 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.......+.+++.+||+.||++|||+.|+++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111357889999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=292.37 Aligned_cols=260 Identities=27% Similarity=0.360 Sum_probs=196.6
Q ss_pred CCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccEEEEE
Q 003932 466 FSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLIYE 540 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 540 (785)
|++.+.||+|++|.||+|... +++.+|+|++.... ......+.+|++++++++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567899999999999999955 58899999998663 33345678899999999999999999999887 78999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++ +|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888877432 246899999999999999999999876 9999999999999999999999999998764432
Q ss_pred cccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc-----
Q 003932 621 LEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE----- 694 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 694 (785)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ................
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence 1 12233456788999998765 457899999999999999999999986443221 1111111111000000
Q ss_pred ------------ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 ------------FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 ------------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.....+........+..+.+++.+||+.+|.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000001112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=292.11 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=197.9
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
+|++.+.||+|++|.||+|+.. +++.||+|++..... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999964 688999999876532 23456778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++ +|.+++........+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 85 88887755443456899999999999999999999876 9999999999999999999999999987543221
Q ss_pred cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc--------cc
Q 003932 623 ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK--------GV 693 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 693 (785)
.......++..|++||.+.+. .++.++|||||||++|+|++|+.|+......+ ............. ..
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcC
Confidence 112234568899999988664 57899999999999999999999986443221 1111111111000 00
Q ss_pred cccccccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 EFVDSFLD-------DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 ~~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........ ....+.....+.+++.+|++.||.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0001122346789999999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.02 Aligned_cols=263 Identities=23% Similarity=0.277 Sum_probs=196.1
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------ 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 532 (785)
..++|++.+.||+|+||.||+|.. .+++.||+|++.+. .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357899999999999999999995 47899999998653 233445677899999999999999999988643
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35699999995 577776632 2788889999999999999999886 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHH------------
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL------------ 680 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~------------ 680 (785)
++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.|+...+.......+
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98754321 123346788999999999999999999999999999999999998643321110000
Q ss_pred ---HHHHHHHhCCcc-------cccccccc----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 681 ---EHAYELWKGGKG-------VEFVDSFL----DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 681 ---~~~~~~~~~~~~-------~~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
......+..... .+.....+ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 00000000 000011234568899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.93 Aligned_cols=270 Identities=24% Similarity=0.310 Sum_probs=198.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-----Ccc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 535 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999984 468899999986432 23345678899999999999999999887644 357
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++++||+.+ +|..++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999964 7776663 345889999999999999999999886 99999999999999999999999999987
Q ss_pred eccccccc-ccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc--
Q 003932 616 FAKESLEE-NTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK-- 691 (785)
Q Consensus 616 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 691 (785)
........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.|+....... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 54322111 1233568899999998754 568899999999999999999999985432111 1111111110000
Q ss_pred ---------cccccccccCC-C-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccCC
Q 003932 692 ---------GVEFVDSFLDD-R-----NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNETTN 743 (785)
Q Consensus 692 ---------~~~~~~~~l~~-~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~ 743 (785)
..+........ . ..+.....+.+++.+||+.+|++|||+.|+++. |+.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00000000000 0 001123468899999999999999999999886 6665443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.42 Aligned_cols=246 Identities=29% Similarity=0.392 Sum_probs=194.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
+.|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++.++|.+....++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888899999999999999854 68899999986432 234457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 566666532 2335889999999999999999999876 999999999999999999999999998764322
Q ss_pred ccccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+..... ....... ......
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~-~~~~~~--- 232 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHI-AQNDSP--- 232 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHH-hcCCCC---
Confidence 2346788999999874 35688999999999999999999999753221 1111111 111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
..........+.+++.+||+.+|++||++.+++..
T Consensus 233 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 -----TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00112234578999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=313.58 Aligned_cols=269 Identities=22% Similarity=0.283 Sum_probs=186.4
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeCC--CcEEEEE------------------EcCCCChhhHHHHHHHHHHHHcCCCC
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLPC--GEVIAVK------------------KLSKTSTQGFEEFKNEVMLTAKLQHV 520 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ 520 (785)
...++|++++.||+|+||+||++.... +...+.| .+. ........+.+|+.++++++|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987431 2222222 111 1122345688999999999999
Q ss_pred ceeeEEEEEecCCccEEEEEecCCCChhhhhcCCcc--ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 521 NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIR--KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 521 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
||+++++++......++|+|++. ++|..++..... ...........++.||+.||.|||+.+ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999985 566666643211 122345667789999999999999886 999999999999
Q ss_pred EcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCccc
Q 003932 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS 678 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~ 678 (785)
++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..++..........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999987643321 12234579999999999999999999999999999999999875433222111111
Q ss_pred HHHHHHHHHhCCccccccc----------cc-cCC--CCCH------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 679 ILEHAYELWKGGKGVEFVD----------SF-LDD--RNSP------CKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~----------~~-l~~--~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+......+.. ...++.+ .. +.. ...+ .....+.+++.+||+.||++|||+.|+++.
T Consensus 379 ~~~~~~~~~~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhccc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111111000 0000000 00 000 0000 012356778999999999999999999863
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=290.69 Aligned_cols=247 Identities=23% Similarity=0.285 Sum_probs=200.0
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
+|++.+.||.|+||.||+|... +++.+++|++.+.. ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999964 68899999997542 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|..++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988432 46889999999999999999999886 9999999999999999999999999987654332
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+....... ...........
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~---------- 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQETA---------- 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhccc----------
Confidence 2234567889999999998889999999999999999999999987543221 11111111100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSM--LEVS 734 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 734 (785)
....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011112233578899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.34 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=202.1
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
..+.|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|++++++++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999965 688899999976554 45678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999986432 36899999999999999999999875 9999999999999999999999999886543221
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.|+...... ........ ......
T Consensus 171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~----- 236 (286)
T cd06614 171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITT-KGIPPL----- 236 (286)
T ss_pred --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-cCCCCC-----
Confidence 1122345788999999999888999999999999999999999997532211 11111111 110000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......+..+.+++.+||+.+|.+||++.++++
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011113457889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=287.40 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=198.5
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|.+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999954 57889999986542 23445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc-eeeccccceeeecccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK-PKISDFGMARIFAKES 620 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-~kl~Dfg~a~~~~~~~ 620 (785)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988542 2235789999999999999999999886 999999999999998864 6999999987654322
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......|+..|+|||.+.+..++.++|+||||++++||++|+.|+..... ......... ....
T Consensus 157 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~------- 220 (257)
T cd08225 157 --ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYFA------- 220 (257)
T ss_pred --ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccCC-------
Confidence 122234688899999999888899999999999999999999999853321 111111111 1110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...+.....+.+++.+||+.+|++|||+.|+++
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011122347889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.14 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=194.4
Q ss_pred ceeeceeCcEEEEEEEeC-CCcEEEEEEc--CC--CChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc--cEEEEEe
Q 003932 469 RNKLGEGGYGPVYKGVLP-CGEVIAVKKL--SK--TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE--RMLIYEY 541 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~--~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 541 (785)
.++||+|+|-+||+|... +|-.||=-.+ ++ ......+.|..|+.+|+.|+||||++++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 368999999999999854 4555542222 11 234556789999999999999999999999987765 6789999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-CCceeeccccceeeecccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFGMARIFAKES 620 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~ 620 (785)
|..|+|..|+.+. ...+.+....|++||++||.|||++. ++|||||||-+||+|+. -|.|||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 9999999998643 34778899999999999999999975 68999999999999985 589999999999876543
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
......||+.|||||... ..|+..+||||||++++||+|+.-|+..+.... ..++....+....-+..
T Consensus 200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A------QIYKKV~SGiKP~sl~k-- 267 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA------QIYKKVTSGIKPAALSK-- 267 (632)
T ss_pred ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH------HHHHHHHcCCCHHHhhc--
Confidence 233478999999999887 779999999999999999999999998765432 12233333322222111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 739 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 739 (785)
.. .+++.++|.+|+.. .++|||+.|++. +|..
T Consensus 268 --V~----dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 268 --VK----DPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred --cC----CHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 11 23788999999999 999999999985 4444
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.55 Aligned_cols=257 Identities=27% Similarity=0.355 Sum_probs=199.9
Q ss_pred CCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------CccEE
Q 003932 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERML 537 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 537 (785)
+...+.||+|+||.||+|+ ..+|+.||||.+++.. ....+...+|+++|++++|+|||++++.-... ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445789999999999999 5689999999998753 34556778999999999999999999976543 35689
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc--CCC--ceeeccccce
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG--EAM--KPKISDFGMA 613 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~--~~kl~Dfg~a 613 (785)
|||||.+|||...|....+...+++...+.++.+++.||.|||+++ |+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888888999999999999999999999886 99999999999984 334 3699999999
Q ss_pred eeecccccccccccccccCCcccccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYAT-KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
+.+.+.. .....+||..|++||... .+.|+..+|.|||||++|++.||..||.......+...+.|....-+....
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9876653 566789999999999998 488999999999999999999999999876655433333333222211111
Q ss_pred ccccccc----------c--CCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003932 693 VEFVDSF----------L--DDRNSPCKLMRCLEIALLCVQENPNDRP 728 (785)
Q Consensus 693 ~~~~~~~----------l--~~~~~~~~~~~l~~li~~cl~~dP~~RP 728 (785)
.-..... + ....+......+-..+..+|..+|++|-
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111100 0 1111233344566677778888888887
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=288.18 Aligned_cols=258 Identities=17% Similarity=0.176 Sum_probs=182.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCC----CcEEEEEEcCCCChhh-H----------HHHHHHHHHHHcCCCCceeeEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPC----GEVIAVKKLSKTSTQG-F----------EEFKNEVMLTAKLQHVNLIRVLG 527 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~niv~l~~ 527 (785)
.++|.+.++||+|+||.||+|...+ +..+++|+........ . .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999999643 3456666543222110 0 01123334556678999999999
Q ss_pred EEecCC----ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC
Q 003932 528 FCIDSE----ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM 603 (785)
Q Consensus 528 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 603 (785)
++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 766443 3367777663 355555432 223567888899999999999999876 99999999999999999
Q ss_pred ceeeccccceeeecccccc-----cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCccc
Q 003932 604 KPKISDFGMARIFAKESLE-----ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS 678 (785)
Q Consensus 604 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~ 678 (785)
.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+++||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999876432111 11223469999999999999999999999999999999999999997553322111
Q ss_pred HHHH--HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 679 ILEH--AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 679 ~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
.... .......+. +. .+..+..+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~~~~~~~~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEGK--------IK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhhh--------hc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1000 011111110 00 1112357889999999999999999999998874
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.63 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=193.3
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|...+.||+|+||.||++.. .+++.+|+|++.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 456678899999999999985 468899999987543 334557889999999996 99999999999998999999999
Q ss_pred cCCCChhhhhcC--CccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 542 MPNKSLDCYLFD--PIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 542 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
+.. ++.++... ......+++..+..++.+++.||+|||+.. +++||||||+||+++.++.++|+|||+++.+...
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55443311 112356889999999999999999999752 4999999999999999999999999998764332
Q ss_pred ccccccccccccCCcccccccCCC---CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKG---VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
. ......|+..|+|||.+.+. .++.++|||||||++|||++|+.|+.... ...+........ ..
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~-~~---- 228 (288)
T cd06616 162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG-DP---- 228 (288)
T ss_pred C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC-CC----
Confidence 1 11233578899999998776 68999999999999999999999986432 111111111111 10
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
+.+........+..+.+++.+||+.+|++|||+.+|+..
T Consensus 229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 -PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112245578999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.08 Aligned_cols=263 Identities=23% Similarity=0.292 Sum_probs=193.5
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCc-----
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEE----- 534 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 534 (785)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36889999999999999999954 688999999865422 23356788999999995 6999999999886655
Q ss_pred cEEEEEecCCCChhhhhcCCcc--ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-CCceeecccc
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIR--KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFG 611 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg 611 (785)
.++||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78877754322 245799999999999999999999886 999999999999998 8999999999
Q ss_pred ceeeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
++..+.... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..|+....... ............
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ---QLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHhCCC
Confidence 987653221 11223356788999998865 457899999999999999999999886432211 111111111110
Q ss_pred cccc------ccc----cccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 691 KGVE------FVD----SFLD----DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 691 ~~~~------~~~----~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.... ... .... ....+....++.+++.+||+.||.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 000 0000 0001123457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=282.46 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=193.6
Q ss_pred eceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 472 LGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 472 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
||.|++|.||+++.. +++.+++|++.+.. ....+.+.+|+.++++++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999964 58899999987543 23446788999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccccc
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 627 (785)
.+++.. ...++...+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999853 234888999999999999999999876 9999999999999999999999999998764332 2223
Q ss_pred ccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHH
Q 003932 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707 (785)
Q Consensus 628 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 707 (785)
..++..|++||.+.+..++.++|+||||+++|+|++|..|+...... ............... ..+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~---------~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNGKL---------EFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCCCC---------CCCcc
Confidence 46788999999998888999999999999999999999998654321 111111111111111 11111
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003932 708 KLMRCLEIALLCVQENPNDRPS-----MLEVSS 735 (785)
Q Consensus 708 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 735 (785)
....+.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2457899999999999999999 667665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.70 Aligned_cols=263 Identities=26% Similarity=0.351 Sum_probs=194.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 537 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45789999999999999999995 4689999999864322 2223456899999999999999999998755 46899
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 4787777532 245889999999999999999999986 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc-----
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK----- 691 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 691 (785)
... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+......+ .............
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWP 234 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhch
Confidence 321 11222345788999998866 457899999999999999999999986433222 1111111111000
Q ss_pred ---c------ccccccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 692 ---G------VEFVDSFLDD--RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 692 ---~------~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
. .......... .........+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000000000 0001124467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=287.16 Aligned_cols=242 Identities=24% Similarity=0.288 Sum_probs=185.2
Q ss_pred eeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---hhHHHHHHHHHH---HHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 471 KLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---QGFEEFKNEVML---TAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
.||+|+||.||++.. .+++.+|+|.+.+... .....+.+|..+ +...+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 4688999999865421 112223444433 334479999999999998899999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---- 150 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence 9999988853 345899999999999999999999886 999999999999999999999999998764322
Q ss_pred ccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ........ ...
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~----------~~~ 216 (279)
T cd05633 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT----------VNV 216 (279)
T ss_pred CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc----------CCc
Confidence 1223468999999998864 56899999999999999999999998644322211 11111000 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSSM 736 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 736 (785)
..+......+.+++.+||+.||.+|| +++|+++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11222345788999999999999999 59888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=287.56 Aligned_cols=244 Identities=23% Similarity=0.275 Sum_probs=190.3
Q ss_pred eceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 472 LGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 472 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
||+|+||+||++.. .+++.+++|.+.... ......+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 468899999987542 22334567899999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccccc
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 627 (785)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 998864322 35889999999999999999999886 999999999999999999999999998765331 12233
Q ss_pred ccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHH
Q 003932 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707 (785)
Q Consensus 628 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 707 (785)
..++..|+|||.+.+..++.++|||||||++++|++|+.|+...........+ ..... .. .......
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~-~~---------~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRRTL-EM---------AVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhccc-cc---------cccCCcc
Confidence 45788999999998888999999999999999999999998643321111100 00000 00 0011112
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 708 KLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 708 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
....+.+++.+||+.||.+|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 345788999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.38 Aligned_cols=260 Identities=24% Similarity=0.329 Sum_probs=194.2
Q ss_pred CCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 466 FSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
|++.+.||.|++|.||+|.. .+++.||+|++.... ....+.+.+|++++++++|+|++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56789999999999999985 468999999987543 223356788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
+ ++|.+++.... ...+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 5 68988875422 235899999999999999999999875 9999999999999999999999999987643221
Q ss_pred cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc---------c
Q 003932 623 ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK---------G 692 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 692 (785)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+....... ......+...... .
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID---QLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHHhhhhhhc
Confidence 112233568899999988664 57899999999999999999999986432211 1111111000000 0
Q ss_pred ccccccccC------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 VEFVDSFLD------DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 ~~~~~~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+....... ....+.....+.+++.+||+.+|.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0001122357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=326.50 Aligned_cols=253 Identities=27% Similarity=0.374 Sum_probs=203.2
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
+-++.....||.|.||.||-|. .++|...|+|-+.... ......+.+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4567778899999999999999 5678999999887543 334456789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||.+|+|.+++. .....++.....+..|++.|+.|||++| ||||||||.||+|+.+|.+|++|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999984 3344667777778899999999999997 999999999999999999999999999988654
Q ss_pred c--cccccccccccCCcccccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH-HhCCccc
Q 003932 620 S--LEENTEQVVGTIGYIPPEYATKGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL-WKGGKGV 693 (785)
Q Consensus 620 ~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 693 (785)
. .........||+.|||||++.+.. -..++||||+|||+.||.||++||...+. +|+..+ ...+...
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHKP 1460 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCCC
Confidence 2 122344578999999999997643 45789999999999999999999975432 122111 1122222
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
.+ +.....+-.+++..||+.||++|.++.|+++.=
T Consensus 1461 q~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1461 QI---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CC---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 22 222344667899999999999999998887653
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=283.49 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=196.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC-----ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--Ccc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT-----STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EER 535 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 535 (785)
.+|.+.+.||+|+||.||+|.. .+++.+++|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999985 46889999987532 223456788999999999999999999998764 457
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988853 234788899999999999999999886 99999999999999999999999999986
Q ss_pred ecccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 616 FAKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 616 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
....... .......++..|+|||.+.+..++.++|||||||+++||++|+.|+..... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~--- 226 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPT--- 226 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCC---
Confidence 5321111 112235688999999999988899999999999999999999999864321 111111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+......+.+++.+||+ +|.+||++.+++.
T Consensus 227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111222344578899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=288.49 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=190.7
Q ss_pred CCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCC-CCceeeEEEEEecC--CccEEEEE
Q 003932 466 FSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDS--EERMLIYE 540 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 540 (785)
|++.+.||+|+||.||+|.. .+++.+|+|++.... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999985 468899999987642 222233457888888885 99999999999987 88999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|++ ++|.+.+... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5777776432 346899999999999999999999886 999999999999999 999999999998654321
Q ss_pred cccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH-----------h
Q 003932 621 LEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW-----------K 688 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-----------~ 688 (785)
......++..|+|||.+.. ..++.++|||||||++|||++|+.|+...+..+ .+....... .
T Consensus 154 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 ---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred ---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 1223457889999997654 557889999999999999999999986533221 111111111 0
Q ss_pred CCccccccccccCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 689 GGKGVEFVDSFLDDR----NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 689 ~~~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.........+..... ..+..+..+.+++.+||+.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000000 01123568899999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.46 Aligned_cols=267 Identities=20% Similarity=0.353 Sum_probs=192.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc-----
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE----- 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 534 (785)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||++++++|.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999954 68899999886432 1222345689999999999999999999876543
Q ss_pred ---cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 535 ---RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 535 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
.++||||+. ++|...+.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 499999996 477777643 2235899999999999999999999886 9999999999999999999999999
Q ss_pred ceeeecccccc--cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH---
Q 003932 612 MARIFAKESLE--ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE--- 685 (785)
Q Consensus 612 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~--- 685 (785)
++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99866432211 112234578899999988765 378899999999999999999998864332111111111000
Q ss_pred --HHhCCccccccccc-cCCC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 686 --LWKGGKGVEFVDSF-LDDR---------NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 686 --~~~~~~~~~~~~~~-l~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+.........+.. .... ........+.+++.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000000 0000 00001235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.63 Aligned_cols=244 Identities=22% Similarity=0.327 Sum_probs=195.2
Q ss_pred ceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 469 RNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
..+||+|+||.||++.. .+++.+|+|++..........+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999985 46899999998765555566788999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccccc
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 627 (785)
.+++.. ..+++.....++.|++.+|+|||+.+ ++||||+|+||+++.++.++|+|||++....... .....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence 887732 34788999999999999999999886 9999999999999999999999999987653321 11233
Q ss_pred ccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHH
Q 003932 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707 (785)
Q Consensus 628 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 707 (785)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....... ... ....... ..+.. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~----~~~~~~~-----~~~~~--~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----MIRDNLP-----PKLKN--LHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhhCC-----cccCC--ccc
Confidence 567899999999988889999999999999999999999986322111 111 1111000 00000 111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 708 KLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 708 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2346788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=281.06 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=201.3
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|++.+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++++++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999854 678999999987653 4567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++... ..+++..+..++.|++.+|.+||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988532 46899999999999999999999886 99999999999999999999999999987654321
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
......++..|+|||...+..++.++||||||+++++|++|+.|+..... ............
T Consensus 155 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~---------- 216 (254)
T cd06627 155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIVQDDH---------- 216 (254)
T ss_pred --cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhccCC----------
Confidence 12335678899999999888889999999999999999999998853221 111111111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0111122457889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=290.72 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=196.5
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC----
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE---- 533 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 533 (785)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999964 58899999987542 223346778999999999999999999987654
Q ss_pred ------ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceee
Q 003932 534 ------ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKI 607 (785)
Q Consensus 534 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 607 (785)
..++|+||+++ +|..++... ...+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999976 666666432 345899999999999999999999886 999999999999999999999
Q ss_pred ccccceeeecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH
Q 003932 608 SDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686 (785)
Q Consensus 608 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 686 (785)
+|||++........ .......++..|+|||.+.+. .++.++|||||||+++||++|+.|+..... ..........
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRL 233 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Confidence 99999987643321 112223457789999988654 578999999999999999999998864322 1122222221
Q ss_pred HhCCcccc---c--------cc------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 687 WKGGKGVE---F--------VD------SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 687 ~~~~~~~~---~--------~~------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........ + .+ ...... ....+..+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111000 0 00 000000 0112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.87 Aligned_cols=266 Identities=21% Similarity=0.314 Sum_probs=196.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEec----CCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 535 (785)
.++|++.+.||+|++|.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36899999999999999999995 468999999987542 2334567789999999999999999988753 3467
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 688888743 344899999999999999999999876 99999999999999999999999999987
Q ss_pred eccccccc--ccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH--------H
Q 003932 616 FAKESLEE--NTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------Y 684 (785)
Q Consensus 616 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~ 684 (785)
........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 64332111 1223578899999998865 45889999999999999999999998643322111110000 0
Q ss_pred HHHhCCccccccccccCC-C-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 685 ELWKGGKGVEFVDSFLDD-R-----NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~-~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.........+........ . ..+..+..+.+++.+||+.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000000000000 0 01123457899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=290.26 Aligned_cols=249 Identities=28% Similarity=0.382 Sum_probs=195.6
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.|...+.||+|+||.||+++. .++..+|+|++.... ......+.+|++++++++|+|++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 477788999999999999995 468899999987432 2334578889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++ +|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9974 77666643 2345889999999999999999999886 99999999999999999999999999865322
Q ss_pred cccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.....++..|+|||.+. ...++.++|||||||++|||++|+.|+...... ...........
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~------ 241 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES------ 241 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccC------
Confidence 22346788999999874 456889999999999999999999987542111 11111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...........+.+++.+||+.+|.+||++.++++.+-..
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0011122345688999999999999999999999866544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=280.25 Aligned_cols=249 Identities=21% Similarity=0.249 Sum_probs=190.5
Q ss_pred HHHHHHhcCCCcceee--ceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC
Q 003932 457 ADIEAATERFSIRNKL--GEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS 532 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 532 (785)
.+.....++|++.+.+ |+|+||.||++.. .++..+|+|.+........ |+.....+ +|+||+++++.+...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444445677777776 9999999999995 4688899999865432211 22222222 799999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-ceeecccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFG 611 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg 611 (785)
+..++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++ .++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999998532 36899999999999999999999886 99999999999999998 99999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
++...... ....++..|+|||++.+..++.++||||||+++|||++|+.|+......+ .......... ..
T Consensus 156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---~~ 225 (267)
T PHA03390 156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ---QK 225 (267)
T ss_pred cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh---cc
Confidence 98765322 22457889999999999899999999999999999999999987332211 1111111111 00
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS-MLEVSS 735 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 735 (785)
.. .........+.+++.+||+.+|.+||+ ++|+++
T Consensus 226 ~~---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 KL---------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cC---------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 011123457889999999999999996 688873
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=283.82 Aligned_cols=245 Identities=18% Similarity=0.234 Sum_probs=188.7
Q ss_pred eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---hhHHHHHHHHHH-HHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---QGFEEFKNEVML-TAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|.. .+++.||+|.+.+... .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999985 4688999999876432 222234445444 4455899999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999998853 245888999999999999999999876 99999999999999999999999999875432
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+....... .......... .. ....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-~~-----~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRI-NW-----PEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhccc-CC-----CCcc
Confidence 223457889999999998889999999999999999999999986432111 1111111110 00 0011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
....+..+.+++.+||+.+|++||++.++.+.|.-
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11234578899999999999999988777665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=278.48 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=203.3
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|.+.+.||.|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999954 688999999976533 4556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 542 MPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 542 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886432 1356899999999999999999999886 9999999999999999999999999998764432
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......|+..|+|||.+.+..++.++||||+|+++++|++|+.|+...... . ............
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~------ 222 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------E-LALKILKGQYPP------ 222 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------H-HHHHHhcCCCCC------
Confidence 1223356888999999999888999999999999999999999998543211 1 111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+......+.+++.+||+.+|++||++.|+++
T Consensus 223 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 ---IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11123347889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=288.51 Aligned_cols=259 Identities=25% Similarity=0.311 Sum_probs=197.7
Q ss_pred CCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 466 FSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
|++.+.||+|++|.||+|... +++.+++|++..... .....+.+|+.++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999854 688999999875432 24467888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++ +|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 887777442 246889999999999999999999886 9999999999999999999999999998765432
Q ss_pred cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc---------
Q 003932 623 ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG--------- 692 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 692 (785)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+...+..+ ........+.....
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhh
Confidence 122234578899999998876 78999999999999999999999886433211 11111111111000
Q ss_pred -----cccccccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 -----VEFVDSFL--DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 -----~~~~~~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........ .....+..+..+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000 00011223567899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.60 Aligned_cols=263 Identities=27% Similarity=0.383 Sum_probs=195.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC--CccE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS--EERM 536 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~ 536 (785)
.++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 567899999999999999999964 6889999988643 233345677899999999 999999999988643 3679
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 588887743 25788899999999999999999876 999999999999999999999999999876
Q ss_pred cccccc---cccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHh----
Q 003932 617 AKESLE---ENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK---- 688 (785)
Q Consensus 617 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---- 688 (785)
...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.|+......+. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~ 234 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPSA 234 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 433221 12234568899999998765 4578899999999999999999999854322111 111000000
Q ss_pred -------CCccccccccccCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 689 -------GGKGVEFVDSFLDD------RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 689 -------~~~~~~~~~~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
......+++..... ...+.....+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 0011124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=298.13 Aligned_cols=265 Identities=24% Similarity=0.326 Sum_probs=196.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-----Cc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 534 (785)
.++|.+.+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35789999999999999999984 46899999998753 223345677899999999999999999987644 34
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 688877743 345889999999999999999999886 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhC----
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG---- 689 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 689 (785)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.|+........ ..........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChH
Confidence 654321 22233467889999998765 4688999999999999999999999864321111 1111110000
Q ss_pred -------CccccccccccCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhc
Q 003932 690 -------GKGVEFVDSFLDD------RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKN 739 (785)
Q Consensus 690 -------~~~~~~~~~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 739 (785)
............. ...+..+..+.+++.+||+.+|++|||++|+++. |+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000000000000 0011234578899999999999999999999876 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.84 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=204.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
...|.+.+.||+|.|+.|.+|+. .++..||+|.+.+.. ....+.+.+|+++|..++|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45788999999999999999994 478999999998763 334455889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+.+|.+.+++..+.+ ..+.....++.|+.++++|||++. |||||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999965443 445778889999999999999886 999999999999999999999999999987643
Q ss_pred ccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
...+..+|++.|.|||++.+..| ++++|+||+|++||-|++|..||......+.... .+..
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r------vl~g--------- 270 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR------VLRG--------- 270 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch------heee---------
Confidence 45677899999999999999875 5799999999999999999999975443221110 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+ ..+.....++.++++++|-.+|.+|++++++.+
T Consensus 271 k~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 271 KY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 00 011112336778999999999999999999854
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=283.62 Aligned_cols=249 Identities=27% Similarity=0.348 Sum_probs=201.6
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|++.+.||+|++|.||++.. .+++.+++|.+.... ......+.+|+.++++++|+||+++.+++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999984 467899999987542 33455678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 542 MPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 542 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999885422 2356889999999999999999999886 999999999999999999999999998776443
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
......++..|+|||.+.+..++.++|+||||+++|||++|+.|+......+ ...........
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 219 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKYP------- 219 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCCC-------
Confidence 2223457889999999999889999999999999999999999986432111 11111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.........+.+++.+||+.+|++||++.|+++.
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112344578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=291.06 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=190.1
Q ss_pred eeecee--CcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEG--GYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+| +||+||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++......++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 8999999995 47899999998753 233456788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc-
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE- 623 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 623 (785)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999886432 234888999999999999999999876 9999999999999999999999998654322111100
Q ss_pred ----ccccccccCCcccccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC-------
Q 003932 624 ----NTEQVVGTIGYIPPEYATKG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG------- 690 (785)
Q Consensus 624 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------- 690 (785)
......++..|+|||++.+. .++.++|||||||++|||++|+.|+........ ........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~ 233 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCccc
Confidence 01112345679999999764 478999999999999999999999864321110 00000000
Q ss_pred -----------------------------ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 691 -----------------------------KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 691 -----------------------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.........+...........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000001111111112334567899999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=287.53 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=193.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|++.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999954 688999999865422 233567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-CCceeeccccceeeeccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFGMARIFAKE 619 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~~ 619 (785)
|++ ++|.+++... ....+++.....++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 5777766432 2233578888899999999999999876 999999999999985 567999999999764322
Q ss_pred ccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc-----
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV----- 693 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 693 (785)
........++..|+|||.+.+. .++.++|||||||++|+|++|+.|+......+ ...............
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 --VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred --ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhcccc
Confidence 1112234578899999988764 57899999999999999999999986432211 111111111100000
Q ss_pred -cccc---c--ccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 -EFVD---S--FLDD----RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 -~~~~---~--~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...+ . .... ...+.....+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0 0000 001122346889999999999999999999986
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=285.51 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=195.9
Q ss_pred eceeCcEEEEEEEeC-CCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 472 LGEGGYGPVYKGVLP-CGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 472 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
||+|+||.||++... +++.+++|++..... ...+.+.+|++++++++|+||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 589999999976533 4456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc------
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL------ 621 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~------ 621 (785)
.+++... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988542 35899999999999999999999886 99999999999999999999999999876433211
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
........++..|+|||.+.....+.++||||||++++||++|+.|+......+ . ......+. .....
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~-~~~~~~~~-~~~~~---- 222 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------I-FQNILNGK-IEWPE---- 222 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHhcCC-cCCCc----
Confidence 112234567889999999988889999999999999999999999986432111 1 11111111 00000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
....+..+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 223 ---DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ---cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00024578899999999999999999777776664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=286.57 Aligned_cols=261 Identities=20% Similarity=0.238 Sum_probs=191.0
Q ss_pred cceeeceeCcEEEEEEEeCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCC
Q 003932 468 IRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 468 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
+.+.+|.|+++.|+++.. +++.+|+|++... .....+.+.+|+.++++++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445555666666666555 5899999998754 3445668999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc---
Q 003932 546 SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE--- 622 (785)
Q Consensus 546 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--- 622 (785)
+|.+++.... ...+++.....++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||.+.........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999986432 234788899999999999999999886 999999999999999999999999998765432211
Q ss_pred --cccccccccCCcccccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH----HhCCc---
Q 003932 623 --ENTEQVVGTIGYIPPEYATKG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL----WKGGK--- 691 (785)
Q Consensus 623 --~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~~~--- 691 (785)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ...+..... +....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence 112334577889999998763 58899999999999999999999986432111 111110000 00000
Q ss_pred ----ccc----cccc----ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 ----GVE----FVDS----FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ----~~~----~~~~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
... ..+. .............+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 0000 0001111223456889999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=285.77 Aligned_cols=256 Identities=22% Similarity=0.301 Sum_probs=199.1
Q ss_pred CCCcceeeceeCcEEEEEEEe----CCCcEEEEEEcCCCC----hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCcc
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTS----TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 535 (785)
+|++.+.||+|++|.||+++. .+++.+|+|.+.+.. ....+.+.+|+.+++++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999974 356789999987532 22335678899999999 599999999999988999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+++++|.+++.. ...+++.....++.|++++|.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988853 245788999999999999999999876 99999999999999999999999999876
Q ss_pred ecccccccccccccccCCcccccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
+..... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..|+...+.... ............
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~--- 228 (288)
T cd05583 155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSK--- 228 (288)
T ss_pred cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccC---
Confidence 543321 1122346889999999987765 78899999999999999999999864322111 111111111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...+......+.+++.+||+.+|++|||+.++.+.|+-.
T Consensus 229 --------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 011112334688999999999999999999998887763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=289.56 Aligned_cols=263 Identities=25% Similarity=0.313 Sum_probs=195.0
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEec-CCccE
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERM 536 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 536 (785)
..+++|++.+.||.|+||.||+|.. .+++.+|+|++.+.. ....+.+.+|+.++++++||||+++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3567899999999999999999984 478999999886432 2334567889999999999999999999875 45788
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+++||+ +++|..++. ...++......++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568887773 234778888899999999999999886 999999999999999999999999998753
Q ss_pred cccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHH--------HHHHH
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELW 687 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~ 687 (785)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|+.............. ....+
T Consensus 159 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 22 1223457889999998766 5689999999999999999999998864322111000000 00000
Q ss_pred hCCccccccccccC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 688 KGGKGVEFVDSFLD-DRNS-----PCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 688 ~~~~~~~~~~~~l~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
......+++..... ...+ +.....+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00011111110000 0000 1123578899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=295.34 Aligned_cols=266 Identities=25% Similarity=0.317 Sum_probs=202.0
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC-----ccE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERM 536 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 536 (785)
+|++.+.||+|++|.||+|+.. +++.+++|++.... ....+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999954 58899999987653 344567889999999999999999999988765 789
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
++|||++ ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 578887743 236899999999999999999999886 999999999999999999999999999876
Q ss_pred cccccc-cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHh------
Q 003932 617 AKESLE-ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK------ 688 (785)
Q Consensus 617 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~------ 688 (785)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+. .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhH
Confidence 543210 122334678899999999887 789999999999999999999999865442211 111111100
Q ss_pred -----CCccccccccccCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 003932 689 -----GGKGVEFVDSFLDDR------NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNE 740 (785)
Q Consensus 689 -----~~~~~~~~~~~l~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 740 (785)
.......+....... ..+.....+.+++.+||+.+|.+||+++++++. |++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000000000 001124568899999999999999999999873 5553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=267.85 Aligned_cols=273 Identities=23% Similarity=0.281 Sum_probs=198.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CC----CcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEec-CCc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PC----GEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 534 (785)
...|+....||+|.||.||+|.. ++ .+.+|+|+++.... ..-....+|+.+++.++|||++.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 35788999999999999999962 22 23689999976521 112345789999999999999999999987 678
Q ss_pred cEEEEEecCCCChhhhhcC--CccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC----Cceeec
Q 003932 535 RMLIYEYMPNKSLDCYLFD--PIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA----MKPKIS 608 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~~kl~ 608 (785)
.+|++||.+. +|...++- ......++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999965 67666642 223457888999999999999999999998 9999999999999877 999999
Q ss_pred cccceeeecccccc-cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCC------CcccHH
Q 003932 609 DFGMARIFAKESLE-ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGIN------ENLSIL 680 (785)
Q Consensus 609 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~------~~~~~~ 680 (785)
|||+++.+...-.. -..+..+-|+.|+|||++.|. .|+++.|||+.|||+.||+|-.+.|...... -....+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999987543211 124456789999999999885 5999999999999999999988877542221 111122
Q ss_pred HHHHHHHhCCccccccc------------cccCCCCCHH-----------HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 681 EHAYELWKGGKGVEFVD------------SFLDDRNSPC-----------KLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 681 ~~~~~~~~~~~~~~~~~------------~~l~~~~~~~-----------~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
......+.-.......+ .+-....... .....++|+.++|+.||-+|.|+++.++..
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 22222221111100000 0000000010 011367899999999999999999998754
Q ss_pred hc
Q 003932 738 KN 739 (785)
Q Consensus 738 ~~ 739 (785)
--
T Consensus 339 yF 340 (438)
T KOG0666|consen 339 YF 340 (438)
T ss_pred cc
Confidence 33
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=310.01 Aligned_cols=264 Identities=27% Similarity=0.400 Sum_probs=210.8
Q ss_pred HHHHHhcCCCcceeeceeCcEEEEEEEeC----C----CcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEE
Q 003932 458 DIEAATERFSIRNKLGEGGYGPVYKGVLP----C----GEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLG 527 (785)
Q Consensus 458 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 527 (785)
.++...++..+.+.||+|.||.|++|... . ...||||.+.... ..+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 35555666777889999999999999732 1 3569999998653 35667899999999998 6999999999
Q ss_pred EEecCCccEEEEEecCCCChhhhhcCCc-----c------c--cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccC
Q 003932 528 FCIDSEERMLIYEYMPNKSLDCYLFDPI-----R------K--LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKV 594 (785)
Q Consensus 528 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp 594 (785)
+|.+....++|+||+..|+|..+|+... . . ..++....+.++.|||.||+||++.. +|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999997543 0 0 24889999999999999999999876 99999999
Q ss_pred CCEEEcCCCceeeccccceeeeccccccccccccc--ccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCccc
Q 003932 595 SNILLGEAMKPKISDFGMARIFAKESLEENTEQVV--GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLC 671 (785)
Q Consensus 595 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~ 671 (785)
+|||+.++..+||+|||+++...+....... ... -...|||||.+....|+.++||||||++|||++| |..|+...
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999999999999975443332211 111 2456999999999999999999999999999998 77777542
Q ss_pred CCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 672 GINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.. .....+..+.+..++.. ..+..+++++++.||+.+|++||++.++.+.|+..
T Consensus 526 ~~------~~~l~~~l~~G~r~~~P---------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 PP------TEELLEFLKEGNRMEQP---------EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred Cc------HHHHHHHHhcCCCCCCC---------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 12223344444433322 22356889999999999999999999999999984
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=283.88 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=193.6
Q ss_pred CCCcceeeceeCcEEEEEEEe----CCCcEEEEEEcCCCCh----hhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCcc
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTST----QGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 535 (785)
+|++.+.||+|+||.||++.. .+|+.||+|++..... ...+.+.+|+.+++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 3688999999875322 2345678899999999 599999999999988889
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998853 345788899999999999999999876 99999999999999999999999999876
Q ss_pred ecccccccccccccccCCcccccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
...... .......|+..|+|||.+... .++.++||||||+++|+|++|+.|+...+.... .............
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~-- 229 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEP-- 229 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccCC--
Confidence 543221 122235688999999998753 467899999999999999999999864322111 1111111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
..+......+.+++.+||+.||++|| ++.+++.
T Consensus 230 ---------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 ---------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01112334678999999999999997 5566643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=286.30 Aligned_cols=249 Identities=27% Similarity=0.338 Sum_probs=200.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 538 (785)
++|.+.+.||+|++|.||+|... +++.+++|++.+. .....+.+.+|+.++++++ |+||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36889999999999999999954 6899999998753 2233467888999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
||++++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998853 336899999999999999999999886 99999999999999999999999999887643
Q ss_pred cccc------------------cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHH
Q 003932 619 ESLE------------------ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 680 (785)
Q Consensus 619 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~ 680 (785)
.... .......++..|+|||.+....++.++||||||+++++|++|+.|+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------ 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------
Confidence 3211 1123346788999999998888999999999999999999999998644311
Q ss_pred HHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 003932 681 EHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSM----LEVSS 735 (785)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 735 (785)
......... ....+...+..+.+++.+||+.+|.+||++ +++++
T Consensus 229 ~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKILKL-----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHhc-----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111110 011112224578899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=283.30 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=192.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.++|++.+.||+|++|.||+|... +++.+|||++.... ......+..|+.++.+. .|+||+++++++......+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 356888999999999999999976 48899999997543 23344566677766666 5999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+. ++|..++... ...+++..+..++.|++.||+|||+.. +++||||+|+||++++++.++|+|||++..+...
T Consensus 94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 4676665432 236889999999999999999999742 4999999999999999999999999998765432
Q ss_pred ccccccccccccCCcccccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
. ......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+...... .+......... ....
T Consensus 169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~ 239 (296)
T cd06618 169 K---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPSL 239 (296)
T ss_pred C---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCCC
Confidence 1 112235778999999987654 788999999999999999999998532111 11111111111 0000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
. .......++.+++.+||+.||++||++.++++.
T Consensus 240 ~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 P-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 011234578999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=313.81 Aligned_cols=260 Identities=21% Similarity=0.260 Sum_probs=208.0
Q ss_pred ChHHHHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEe
Q 003932 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCI 530 (785)
Q Consensus 455 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 530 (785)
...++....++|.++++||+|+||.|.+++. .+++.||+|++.+. .......|.+|-++|.--+.+.|++++..|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 4556666788999999999999999999995 47889999999873 3445567999999999999999999999999
Q ss_pred cCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 531 DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 531 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
+...+|+|||||+||+|-.+|... ..+++..+..++..|+-||.-||+.| +|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999998542 25888888889999999999999987 999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATK-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 685 (785)
|.+-.+...+. ......+|||.|.+||++.. +.|++.+|.||+||++|||+.|..||......+....+.
T Consensus 220 GsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm---- 294 (1317)
T KOG0612|consen 220 GSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM---- 294 (1317)
T ss_pred hhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh----
Confidence 99887764432 23455789999999998842 568999999999999999999999997543222221111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS---MLEVSS 735 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 735 (785)
.-.....+++ ....+++..+||++.+. +|..|.. ++++..
T Consensus 295 --~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 --NHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred --chhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1111122221 12245577788888776 7888887 888754
|
|
| >cd06546 GH18_CTS3_chitinase GH18 domain of CTS3 (chitinase 3), an uncharacterized protein from the human fungal pathogen Coccidioides posadasii | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-31 Score=267.85 Aligned_cols=197 Identities=15% Similarity=0.195 Sum_probs=143.8
Q ss_pred EEEEEecCCCCC--------CcCCCCCCCCceEEEEEEEeeCCccEEecCCCccH----HHHHHHHHHHHhcCCCceEEE
Q 003932 27 IRVGYLNLSEVS--------TISGINYDLFTHLICSSADINSTTYQLSLSLPSDE----NQIAKFADTVKKKNPSITTIL 94 (785)
Q Consensus 27 ~~vgY~~~~~~~--------~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~----~~~~~~~~~~k~~~p~lkv~~ 94 (785)
++||||..|... ++..+++.+||||+|+|+.++++| .+.+.+.+.+ ..+.+.++.+| ++++|||+
T Consensus 1 r~v~y~~~~~~~~~~~~~~~~~~~~~~~~~THvi~af~~i~~~G-~l~~~d~~~~~~~~~~~~~~i~~~~--~~g~KVll 77 (256)
T cd06546 1 RLVIYYQTTHPSNGDPISSLLLVTEKGIALTHLIVAALHINDDG-NIHLNDHPPDHPRFTTLWTELAILQ--SSGVKVMG 77 (256)
T ss_pred CEEEEEccEECCCCCcccccccccCCCCCCceEEEEEEEECCCC-eEEECCCCCCcchhhHHHHHHHHHH--hCCCEEEE
Confidence 378999776321 234567889999999999999987 6766654321 13344444454 57899999
Q ss_pred EecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhccccc
Q 003932 95 SIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQ 174 (785)
Q Consensus 95 sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~ 174 (785)
|||||.. +. |+.++++++.|++|++++++++++|+|||||||||||+ +..+|..|+++||+++.+
T Consensus 78 SiGG~~~-~~--fs~~a~~~~~r~~f~~s~~~~~~~~~~DGiDiDwE~p~---~~~~~~~ll~~Lr~~~~~--------- 142 (256)
T cd06546 78 MLGGAAP-GS--FSRLDDDDEDFERYYGQLRDMIRRRGLDGLDLDVEEPM---SLDGIIRLIDRLRSDFGP--------- 142 (256)
T ss_pred EECCCCC-CC--cccccCCHHHHHHHHHHHHHHHHHhCCCceEEeeecCC---CHhHHHHHHHHHHHHhCC---------
Confidence 9999864 23 98888999999999999999999999999999999994 457999999999998743
Q ss_pred ceeEEEEeeccc----CCCCccccHHHHH----hccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q 003932 175 QSLLILTARFRY----SPPANSYLLNSIQ----RNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAW 246 (785)
Q Consensus 175 ~~~~~~~~~~~~----~~~~~~~~~~~l~----~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~ 246 (785)
+..+++++.... ......+++.++. .++||+|+|.||.+|... + ......|
T Consensus 143 ~~~lT~Ap~~~~~~~g~~~~~~~~~~~l~~~~~~~~Df~nvQfYn~~g~~~--------------------~-~~~~~~~ 201 (256)
T cd06546 143 DFIITLAPVASALTGGEANLSGFDYRELEQARGDKIDFYNAQFYNGFGSMS--------------------S-PSDYDAI 201 (256)
T ss_pred CcEEEECCccccccCCcccccccCHHHHHHhhCCceeEEEEcCcCCCCCcc--------------------C-HHHHHHH
Confidence 444444332221 1123456777665 499999999999654311 0 1123446
Q ss_pred HHcCCCCCceeecccc
Q 003932 247 IERGLSADKLVMCLPF 262 (785)
Q Consensus 247 ~~~gvp~~KlvlGip~ 262 (785)
++.|+|++||++|+|.
T Consensus 202 ~~~~~~~~Kv~iGlpa 217 (256)
T cd06546 202 VAQGWDPERIVIGLLT 217 (256)
T ss_pred HHcCCCcccEEEEEec
Confidence 6779999999999985
|
CTS3 has a chitinase-like glycosyl hydrolase family 18 (GH18) domain; and has homologs in bacteria as well as fungi. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=282.45 Aligned_cols=259 Identities=27% Similarity=0.370 Sum_probs=192.5
Q ss_pred CCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcC---CCCceeeEEEEEecCCc-----
Q 003932 466 FSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEE----- 534 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 534 (785)
|++.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999965 488999999975422 2233456677776655 69999999999987776
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.+++|||++ ++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 47888775422 235899999999999999999999886 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
...... ......++..|+|||.+.+..++.++|||||||++|||++|++|+......+ ................
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHh
Confidence 764331 1223457889999999999999999999999999999999998876433221 1111111111000000
Q ss_pred cc------ccccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 FV------DSFLDD-------RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 ~~------~~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. ...... ...+.....+.+++.+||+.||.+||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 000000 001122456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=291.16 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=195.3
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC-----
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----- 533 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 533 (785)
..++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999984 468999999986432 223456789999999999999999999887543
Q ss_pred -ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 534 -ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 534 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
..++||||+ +++|..++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999998 778887773 235889999999999999999999886 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH------
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE------ 685 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~------ 685 (785)
+...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.|+....... .......
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 236 (343)
T cd07880 165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD---QLMEIMKVTGTPS 236 (343)
T ss_pred ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCC
Confidence 8764321 223457889999998876 458899999999999999999999986432211 1100000
Q ss_pred -----HHhCCccccccccc--cCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHHhcc
Q 003932 686 -----LWKGGKGVEFVDSF--LDD----RNSPCKLMRCLEIALLCVQENPNDRPSMLEVS--SMLKNE 740 (785)
Q Consensus 686 -----~~~~~~~~~~~~~~--l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl--~~L~~~ 740 (785)
.+............ ... ...+.....+.+++.+|++.||++|||+.+++ ..++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000000000000 000 00011233678999999999999999999998 445443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=288.54 Aligned_cols=261 Identities=24% Similarity=0.326 Sum_probs=192.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC------
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ 533 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 533 (785)
..+|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36899999999999999999995 468999999987532 222346788999999999999999999987543
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 665554 224788999999999999999999886 999999999999999999999999998
Q ss_pred eeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH-----
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW----- 687 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~----- 687 (785)
+.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .........
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP 236 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 75422 1223467889999999876 468899999999999999999999986432211 111111100
Q ss_pred ------hCCccccccc---cccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 003932 688 ------KGGKGVEFVD---SFLDDRN---SPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNE 740 (785)
Q Consensus 688 ------~~~~~~~~~~---~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 740 (785)
.......... ....... .+.....+.+++.+||+.||++||+++|++.. ++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000000 0000000 01123467899999999999999999999843 6554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=285.35 Aligned_cols=250 Identities=29% Similarity=0.370 Sum_probs=195.0
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
..|...+.||+|++|.||+|+. .+++.+++|.+... ......++.+|+.+++.++|+|++++.+++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3477778999999999999995 46788999998642 2334456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+. |+|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 577766643 2345788999999999999999999876 999999999999999999999999998765322
Q ss_pred ccccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
....++..|+|||.+. ...++.++|||||||++|||++|+.|+...... ..... .......
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~--- 232 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNESP--- 232 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHH-HhhcCCC---
Confidence 2345788999999874 356788999999999999999999987532111 11111 1111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
..........+.+++.+||+.+|++||++.+++...-..
T Consensus 233 -----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 233 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred -----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 011122345688999999999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=296.33 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=191.9
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC----------
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS---------- 532 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 532 (785)
.+|.+.+.||.|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6799999999999999999985 46889999998776656667788999999999999999999776543
Q ss_pred ----CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-CCCceee
Q 003932 533 ----EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG-EAMKPKI 607 (785)
Q Consensus 533 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl 607 (785)
...++||||++ ++|.+++. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++ +++.++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 34789999997 58877773 234888999999999999999999886 99999999999997 4567899
Q ss_pred ccccceeeeccccccc-ccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH--
Q 003932 608 SDFGMARIFAKESLEE-NTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-- 683 (785)
Q Consensus 608 ~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-- 683 (785)
+|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998653321111 1123357889999997654 56788999999999999999999998643321110000000
Q ss_pred ------HHHHhCCccccccccccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 684 ------YELWKGGKGVEFVDSFLDDRN-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 684 ------~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..................... .+....++.+++.+||+.||.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000000000000000 0112346889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=280.14 Aligned_cols=241 Identities=25% Similarity=0.286 Sum_probs=184.8
Q ss_pred eeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---hhHHHHHHHH---HHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 471 KLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---QGFEEFKNEV---MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
.||+|+||.||++.. .+++.||+|.+.+... .....+..|. ..++...||||+++.+++......++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4688999999876422 1111233333 34445689999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..+...
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 9999888743 346899999999999999999999876 999999999999999999999999998754322
Q ss_pred ccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......|+..|+|||.+.++ .++.++||||+||++|||++|+.|+......... ......... ..
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~------~~---- 216 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTM------AV---- 216 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----HHHHHhhcc------CC----
Confidence 12234689999999998754 6899999999999999999999998653221111 111111000 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
..+...+..+.+++.+||+.+|.+|| ++.++++
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 01111245788999999999999999 8999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=290.03 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=194.1
Q ss_pred cCCC-cceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhh--------------HHHHHHHHHHHHcCCCCceeeEEE
Q 003932 464 ERFS-IRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQG--------------FEEFKNEVMLTAKLQHVNLIRVLG 527 (785)
Q Consensus 464 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 527 (785)
++|. +.+.||+|+||.||+|... +++.||+|++....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3554 4577999999999999954 68899999986542211 124678999999999999999999
Q ss_pred EEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceee
Q 003932 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKI 607 (785)
Q Consensus 528 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 607 (785)
++...+..++||||+. |+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 688888743 345889999999999999999999876 999999999999999999999
Q ss_pred ccccceeeeccccc------------ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCC
Q 003932 608 SDFGMARIFAKESL------------EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGIN 674 (785)
Q Consensus 608 ~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~ 674 (785)
+|||++........ ........++..|+|||.+.+. .++.++|||||||++|||++|+.|+...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999987642111 1111223467889999998764 4689999999999999999999998644322
Q ss_pred CcccHHHHHHHHHhCCccccccc-----------cccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 675 ENLSILEHAYELWKGGKGVEFVD-----------SFLDD---RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+ ................... ..... .........+.+++.+||+.+|++||+++|++.
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 1222222111111000000 00000 000112356889999999999999999999985
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=293.31 Aligned_cols=265 Identities=23% Similarity=0.273 Sum_probs=196.2
Q ss_pred hHHHHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC
Q 003932 456 LADIEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS 532 (785)
Q Consensus 456 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 532 (785)
..++...+++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345566779999999999999999999984 578899999987542 22345678899999999999999999987643
Q ss_pred ------CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCcee
Q 003932 533 ------EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPK 606 (785)
Q Consensus 533 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 606 (785)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467788876 7888877732 34889999999999999999999886 99999999999999999999
Q ss_pred eccccceeeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH
Q 003932 607 ISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 685 (785)
|+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+....... .......
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~ 232 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILR 232 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 999999876422 2233467889999998866 568899999999999999999999985432211 1111111
Q ss_pred HHhC-----------Cccccc---cccccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 686 LWKG-----------GKGVEF---VDSFLDDR---NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 686 ~~~~-----------~~~~~~---~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.... ...... +....... ........+.+++.+||+.||.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 000000 00000000 000123467899999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=306.12 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=187.4
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEec-------
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID------- 531 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 531 (785)
....+|+.++.||+|+||.||+++.+ +|+.||||+++-.. ......+.+|+..+.+|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45678999999999999999999955 79999999998653 3445568899999999999999998753210
Q ss_pred --------------------------------------------------------------------------------
Q 003932 532 -------------------------------------------------------------------------------- 531 (785)
Q Consensus 532 -------------------------------------------------------------------------------- 531 (785)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHH
Q 003932 532 ------------------------S--------EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579 (785)
Q Consensus 532 ------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L 579 (785)
+ ..+||-||||+..+|.+++.++.... .....++++++|+.||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0 12467788998888888775432211 3566789999999999999
Q ss_pred hhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec---c-------------cccccccccccccCCcccccccCCC
Q 003932 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA---K-------------ESLEENTEQVVGTIGYIPPEYATKG 643 (785)
Q Consensus 580 H~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~---~-------------~~~~~~~~~~~gt~~y~aPE~~~~~ 643 (785)
|+.+ ||||||||.||+|+++..|||+|||+|.... . .......+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9987 9999999999999999999999999998721 0 0011123457899999999999775
Q ss_pred C---CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHcc
Q 003932 644 V---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCV 720 (785)
Q Consensus 644 ~---~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl 720 (785)
. |+.|+|+|||||||+||+.- |... .+ ... ....++.+..... . .+.......-..+|++++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~yP---F~Ts--ME---Ra~-iL~~LR~g~iP~~--~----~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLYP---FGTS--ME---RAS-ILTNLRKGSIPEP--A----DFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhcc---CCch--HH---HHH-HHHhcccCCCCCC--c----ccccccchHHHHHHHHHh
Confidence 4 99999999999999999863 3211 11 111 1222233332222 1 111112223457999999
Q ss_pred ccCCCCCCCHHHHHH
Q 003932 721 QENPNDRPSMLEVSS 735 (785)
Q Consensus 721 ~~dP~~RPs~~evl~ 735 (785)
+.||++|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=281.40 Aligned_cols=262 Identities=23% Similarity=0.291 Sum_probs=193.4
Q ss_pred CCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEEEEec
Q 003932 466 FSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
|++.+.||+|++|.||+|+.. +++.+++|++..... .......+|+..+++++ |+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567899999999999999964 578899999875432 22234457899999998 999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
+|+|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 889988875432 246899999999999999999999886 9999999999999999999999999998654321
Q ss_pred cccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHH----------HHHHHHhCCc
Q 003932 623 ENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE----------HAYELWKGGK 691 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~----------~~~~~~~~~~ 691 (785)
......++..|+|||.+.. ..++.++|+||||++++||++|+.|+......+...... +.........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2233467889999998754 457899999999999999999998886443221110000 0000000000
Q ss_pred cccccccccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVEFVDSFLDD---RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+...... ...+.....+.+++.+||+.+|++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000 000011356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=285.46 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=191.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChh--hHHHHHHHHHHHHcCCCCceeeEEEEEecCC------
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQ--GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ 533 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 533 (785)
.++|++.+.||+|+||.||+|... +++.+|+|++...... ....+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999954 6889999998654221 2245678999999999999999999875443
Q ss_pred --ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 534 --ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 534 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
..++|+||+.+ +|...+.. ....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46899999965 56665543 2346899999999999999999999886 9999999999999999999999999
Q ss_pred ceeeecccccc---------cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHH
Q 003932 612 MARIFAKESLE---------ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 681 (785)
Q Consensus 612 ~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 681 (785)
+++........ .......++..|+|||.+.+. .++.++|||||||++|||++|++|+....... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 99765432211 111234578889999987654 57899999999999999999999986433211 111
Q ss_pred HHHHHHhCCcc---------ccccccccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 682 HAYELWKGGKG---------VEFVDSFLDDRNS-------PCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 682 ~~~~~~~~~~~---------~~~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........... ....+........ ......+.+++.+||+.||.+|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111110000 0000000000000 111246889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=282.89 Aligned_cols=244 Identities=29% Similarity=0.400 Sum_probs=191.1
Q ss_pred CCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 466 FSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
|...+.||+|+||.||+|+. .+++.+++|++.... ......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999985 468899999986532 23445688899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+. |+|.+++.. ....+++..+..++.|++.++.|||+.+ ++||||+|+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 567666643 2345889999999999999999999886 9999999999999999999999999976422
Q ss_pred ccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
......|+..|+|||++. ...++.++|||||||++|||++|..|+...... ......... .....
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~-~~~~~--- 240 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-DSPTL--- 240 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhc-CCCCC---
Confidence 122456888999999984 456888999999999999999999987543211 111111111 10000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
........+.+++.+||+.+|.+||++.+++..
T Consensus 241 -----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111123468889999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=264.48 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=199.1
Q ss_pred eeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 470 NKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
+.||+|+|+.|--++ ..++..+|||++.+.....+.++.+|++++.++ .|+||++++++|.++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 789999999999988 678999999999998877888899999999998 599999999999999999999999999999
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc---eeeccccceeeecccc----
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK---PKISDFGMARIFAKES---- 620 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Dfg~a~~~~~~~---- 620 (785)
..++. .+..+++..+.++..+|+.||.+||..+ |.|||+||+|||..+... +||+||.+..-+....
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 88885 4456899999999999999999999987 999999999999976554 7999999876542211
Q ss_pred -cccccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCC-----Cccc--HHH-HHHHH
Q 003932 621 -LEENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN-----ENLS--ILE-HAYEL 686 (785)
Q Consensus 621 -~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~-----~~~~--~~~-~~~~~ 686 (785)
.......++|+..|||||+.. ...|+.++|.||||||||-||+|.+||...... ..-. ..+ ....-
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 112234578999999999663 245899999999999999999999999753221 1111 111 11111
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..++. .++.+. .....+.+..+++...+..++.+|-++.+++.
T Consensus 318 IQEGk-YeFPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGK-YEFPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccC-CcCChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22221 223221 11223456778999999999999999999876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=267.67 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=192.8
Q ss_pred cceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecCC
Q 003932 468 IRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST-QGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 468 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
-+..||.|+||+|++-.+ ++|+..|||+++.... .+.+++..|.+...+- ++||||+++|.+..+..+++.||.| .
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence 346799999999999884 5799999999987654 5567788888766554 7999999999999999999999999 4
Q ss_pred CChhhhhcC--CccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 545 KSLDCYLFD--PIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 545 gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
.||+.+... ......+++...-.|....+.||.||.... .|||||+||+||||+..|.+||||||.+-.+..+-
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-- 222 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-- 222 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH--
Confidence 577655421 113455888888888889999999998865 69999999999999999999999999987654331
Q ss_pred cccccccccCCcccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 623 ENTEQVVGTIGYIPPEYATK--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
..+.-.|-..|||||.+.. ..|+-+|||||||++|+|+.||+-|+...+ +..+....... +....+..
T Consensus 223 -AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~-gdpp~l~~--- 292 (361)
T KOG1006|consen 223 -AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVI-GDPPILLF--- 292 (361)
T ss_pred -HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHc-CCCCeecC---
Confidence 1223467789999998864 348999999999999999999999986432 22332222222 22211111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
+.........+..++..||.+|-+.||...+++++
T Consensus 293 -~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 -DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11222344578899999999999999999998753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=263.48 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=196.4
Q ss_pred hcCCCcc-eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC----Ccc
Q 003932 463 TERFSIR-NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS----EER 535 (785)
Q Consensus 463 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~ 535 (785)
+++|.+. ++||-|-.|.|..+.. .+++.+|+|++.... ..++|+++.-+. .|||||.+++++.+. ..+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4556554 6799999999999984 478999999996542 346788776665 699999999998653 457
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---CCceeeccccc
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---AMKPKISDFGM 612 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg~ 612 (785)
.+|||.|+||.|.+.+.++ ....+++.++..|..||+.|+.|||+.. |.||||||+|+|... |..+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 7999999999999888654 3456999999999999999999999875 999999999999974 55799999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
|+.-.. .......+-|++|.|||++...+|+..+|+||+||++|-||+|.+||..........-. .+.... ..
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM---k~rI~~-gq 283 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KRRIRT-GQ 283 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH---HhHhhc-cC
Confidence 986432 23455678899999999999999999999999999999999999999754332211111 111111 11
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.++.+ ....+.++...++|+.+|..+|.+|.|+.|+..
T Consensus 284 y~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 YEFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 12221 123345677889999999999999999999975
|
|
| >COG3858 Predicted glycosyl hydrolase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=271.52 Aligned_cols=250 Identities=18% Similarity=0.271 Sum_probs=192.7
Q ss_pred HHhcCCCceEEEEecC--CCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHH
Q 003932 83 VKKKNPSITTILSIGQ--GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWR 160 (785)
Q Consensus 83 ~k~~~p~lkv~~sigG--~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr 160 (785)
.++++...-+.+|=++ ..+++...++.++.++..++++++++++.++.+|+.||.||+|.. .+.|++.|+.|++++|
T Consensus 156 ~~~~~i~~~~~iSN~~~~~~~f~~ela~~lL~net~~~~~i~~ii~~l~~~Gyrgv~iDfE~v-~~~DR~~yt~flR~~r 234 (423)
T COG3858 156 AQCRKIKPVPGISNGTRPGANFGGELAQLLLNNETAKNRLINNIITLLDARGYRGVNIDFENV-GPGDRELYTDFLRQVR 234 (423)
T ss_pred hhhcccceeEEEecCCccccccchHHHHHHHhcHHHHHHHHHHHHHHHHhcCcccEEechhhC-CHHHHHHHHHHHHHHH
Confidence 4444433344455554 344555567999999999999999999999999999999999988 5699999999999999
Q ss_pred HHhhhhhhhcccccceeEEEEeecccC-----CCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC
Q 003932 161 IAATKLDAKNSTRQQSLLILTARFRYS-----PPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF 235 (785)
Q Consensus 161 ~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~ 235 (785)
++|++. +..+++++++... .+.+.||+..+++.+|||.+||||.|.+| +.+|+.||..
T Consensus 235 ~~l~~~--------G~~~siAvaakt~~~~~G~W~~~~dy~a~Gkiad~v~lMtYd~h~~g--G~PG~vA~i~------- 297 (423)
T COG3858 235 DALHSG--------GYTVSIAVAAKTSDLQVGSWHGAYDYVALGKIADFVILMTYDWHYSG--GPPGPVASIG------- 297 (423)
T ss_pred HHhccC--------CeEEEEEecCCCCCCcCccccchhhhhhhceeeeEEEEEEeccCcCC--CCCCcccCch-------
Confidence 999873 4566666665442 24567999999999999999999988665 5689999876
Q ss_pred CCCHHHHHHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccc
Q 003932 236 ARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNST 315 (785)
Q Consensus 236 ~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~ 315 (785)
+++..+++-+. -+|++||+||||+||++|++.... .|....+ .+..+-....++ ...+..||..
T Consensus 298 --~vr~~ieya~T-~iP~~Kv~mGip~YGYDW~~~y~~---~g~~~~a--------~~~~~~i~ia~~--y~A~Iq~D~~ 361 (423)
T COG3858 298 --WVRKVIEYALT-VIPAEKVMMGIPLYGYDWTLPYDP---LGYLARA--------ISPDEAIDIANR--YNATIQYDAT 361 (423)
T ss_pred --hHhhhhhhhhe-ecchHHeEEccccccccccCCCCC---Ccceeee--------cCcchhhhhhcc--cCCccCcCcc
Confidence 78888877666 699999999999999999864322 1111111 222221111222 2367789999
Q ss_pred eeeeeee----cC-CEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchh-hhhh
Q 003932 316 YEVNYFS----TG-TVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD-WLLS 366 (785)
Q Consensus 316 ~~~~y~~----~~-~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~-~~l~ 366 (785)
++.||++ ++ +++|||||.+|+..|.+++|++||.||++|.|++.|+. |+.+
T Consensus 362 ~qsp~F~y~D~eg~~h~VWfeD~~s~~~k~~lik~ygl~GVs~W~Lg~e~p~~w~~l 418 (423)
T COG3858 362 SQSPFFYYVDKEGRYHEVWFEDARSFQTKLDLIKEYGLRGVSYWVLGQEDPRNWTYL 418 (423)
T ss_pred ccCceEEEEcCCCceEEEEcCchHHHHHHHHHHHHcCCceEEEEEecCcchhHHhhc
Confidence 9999883 34 68999999999999999999999999999999999954 6554
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=289.28 Aligned_cols=257 Identities=25% Similarity=0.328 Sum_probs=193.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc-----
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE----- 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 534 (785)
.++|++.+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 568999999999999999999964 6789999998653 22334567789999999999999999987765544
Q ss_pred -cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 535 -RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 535 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 6789888743 45899999999999999999999886 999999999999999999999999998
Q ss_pred eeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC--
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG-- 690 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 690 (785)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.|+....... .+..........
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~ 237 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDE 237 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCH
Confidence 765322 233467889999998865 367899999999999999999999986432211 111111110000
Q ss_pred ---------ccccccccccCCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 691 ---------KGVEFVDSFLDDRN------SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 691 ---------~~~~~~~~~l~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....++........ .......+.+++.+||+.+|++|||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000000 0012457889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=279.62 Aligned_cols=259 Identities=27% Similarity=0.338 Sum_probs=196.8
Q ss_pred CCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 466 FSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
|++.+.||+|++|.||+|+.. +++.+++|++.... ....+.+..|+.++++++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 58999999998653 333456788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
+ ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-- 152 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-- 152 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc--
Confidence 7 58998885421 45899999999999999999999986 9999999999999999999999999987654321
Q ss_pred cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc--------cc
Q 003932 623 ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK--------GV 693 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 693 (785)
.......++..|+|||.+.+. .++.++|||||||+++||++|+.|+...... .............. ..
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhccc
Confidence 122234457789999998776 7899999999999999999999888543321 11111111111000 00
Q ss_pred cccccccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 EFVDSFLDD-------RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 ~~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...+..... ...+.....+.+++.+||+.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 001112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=284.83 Aligned_cols=260 Identities=24% Similarity=0.298 Sum_probs=189.2
Q ss_pred CCCcceeeceeCcEEEEEEEeC-C--CcEEEEEEcCCCC--hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC----Cc
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-C--GEVIAVKKLSKTS--TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS----EE 534 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 534 (785)
+|++.+.||+|+||.||++... . +..+|+|++.... ....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999954 3 6789999987532 22345678899999999 599999999875432 45
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++++||+. ++|...+.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888885 688887743 345889999999999999999999886 9999999999999999999999999998
Q ss_pred eecccccc--cccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH----
Q 003932 615 IFAKESLE--ENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW---- 687 (785)
Q Consensus 615 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---- 687 (785)
.+...... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.|+...+... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 76432211 11233568999999998765 468999999999999999999999886433111 111110000
Q ss_pred -------hCCccccccc---cccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003932 688 -------KGGKGVEFVD---SFLD---DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS 734 (785)
Q Consensus 688 -------~~~~~~~~~~---~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 734 (785)
.......... .... ....+.....+.+++.+||+.||++|||+.|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 0000 000011234788999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=277.00 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=192.4
Q ss_pred CCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC-----ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT-----STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
+|.+.+.||+|+||.||++... .+..+++|.+... ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999854 3444555555432 122334567789999999999999999999988999999
Q ss_pred EEecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 539 YEYMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
+||+++++|..++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887532 23356899999999999999999999876 999999999999975 569999999987754
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.... .......... +.
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~~------ 221 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-GP------ 221 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-CC------
Confidence 322 12233457889999999988889999999999999999999999875321 1111111111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........+.++.+++.+||+.+|++||++.|+++
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01112234457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=241.62 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=196.6
Q ss_pred CCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+|...++||+|.||+||+|+ .++++.||+|+++-.. ..--....+|+-+++.++|+|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667899999999999999 5578899999997543 22234568899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
|. .+|..+... -+..++......++.|+++||.++|+++ +.|||+||+|.|++.+|.+||+|||+++.++-..
T Consensus 83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 94 467766532 3456888999999999999999999986 9999999999999999999999999998765331
Q ss_pred ccccccccccCCcccccccCCCC-CCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCC---c---cc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGG---K---GV 693 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~---~---~~ 693 (785)
+.....+-|..|.+|.++.+.+ |++..|+||-||++.|+.. |++.|...+..+.. ....+.+... . ..
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql---krif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL---KRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH---HHHHHHhCCCccccCCccc
Confidence 2233445689999999998864 8999999999999999986 77666654444332 2222322221 1 11
Q ss_pred cccccccCCCCCHHH---------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 694 EFVDSFLDDRNSPCK---------LMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~---------~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+.|......++... ...=.+++...+.-+|.+|.++++.++.
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 233322222222111 1122678888888899999999998764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=288.43 Aligned_cols=239 Identities=24% Similarity=0.347 Sum_probs=190.5
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++.|.+...+|.|+|+.|-.+. ..+++..++|++.+... +..+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 3456777789999999999988 45788899999977622 235566555554 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE-cCCCceeeccccceeeeccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL-GEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill-~~~~~~kl~Dfg~a~~~~~~ 619 (785)
.+.++-|.+.+.. .. .....+..|+.+|+.++.|||++| +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~---~~-~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---KP-EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---cc-hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999987666532 22 222677789999999999999987 9999999999999 69999999999999875443
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
....+-|..|.|||++....|++++||||||++||+||+|+.|+...... .. ......
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~----------- 527 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQ----------- 527 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhc-----------
Confidence 33456688999999999999999999999999999999999998754433 11 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......+.+....+|+.+||+.||.+||+|.++..
T Consensus 528 -~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 -MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 12222445567889999999999999999999964
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=270.62 Aligned_cols=236 Identities=26% Similarity=0.326 Sum_probs=190.3
Q ss_pred eceeCcEEEEEEEeC-CCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 472 LGEGGYGPVYKGVLP-CGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 472 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
||+|+||.||++... +++.+++|++..... .....+..|+.++++++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999954 588999999876532 2445788999999999999999999999999999999999999999
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccccccc
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 627 (785)
.+++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9988532 35889999999999999999999875 9999999999999999999999999988754331 12334
Q ss_pred ccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHH
Q 003932 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707 (785)
Q Consensus 628 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 707 (785)
..++..|+|||.+.+...+.++|+||||+++|+|++|+.|+..... ..... .. .... . ..+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~-~~~~-~---------~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KI-LKDP-L---------RFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HH-hcCC-C---------CCCCC
Confidence 5678899999999988899999999999999999999999854321 11111 11 1110 0 11111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHH
Q 003932 708 KLMRCLEIALLCVQENPNDRPSMLE 732 (785)
Q Consensus 708 ~~~~l~~li~~cl~~dP~~RPs~~e 732 (785)
.+..+.+++.+||+.||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2457889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=270.07 Aligned_cols=241 Identities=24% Similarity=0.286 Sum_probs=193.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 537 (785)
..+|.++.+||+|+||.|-+|..+ +.+.+|||++++.- ..+.+.-..|-++|... +-|.+++++.+++.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457899999999999999999854 56789999998762 23444556677787766 46789999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+.||+|--++.. -..+.+..+..++..||-||-+||+.+ ||.||||.+|||||.+|++||+|||+++.-.
T Consensus 428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999766643 334667788889999999999999987 9999999999999999999999999987532
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
-. ...+..++||+.|+|||++...+|+.++|.|||||+||||+.|++||...++.+....+. ..
T Consensus 502 ~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~---eh----------- 565 (683)
T KOG0696|consen 502 FD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM---EH----------- 565 (683)
T ss_pred cC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---Hc-----------
Confidence 11 234567899999999999999999999999999999999999999998655443222111 10
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRP 728 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 728 (785)
.-.++...+.+...+....|.+.|.+|.
T Consensus 566 ---nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ---NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1123334455777888899999999995
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=286.64 Aligned_cols=259 Identities=23% Similarity=0.333 Sum_probs=207.3
Q ss_pred HHHHHHhcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEec---
Q 003932 457 ADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID--- 531 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 531 (785)
+.+...++.|++.+.||.|.+|.||+++ .++++..|+|+....... .+++..|.++++.+ .|||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3333456789999999999999999999 557888899998765433 36678889999887 69999999999873
Q ss_pred --CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecc
Q 003932 532 --SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISD 609 (785)
Q Consensus 532 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 609 (785)
++.++||||||.+||..+++..-. ...+.|..+..|++.++.||.+||..+ ++|||||-.|||++.++.|||+|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 468999999999999999986644 566899999999999999999999987 99999999999999999999999
Q ss_pred ccceeeecccccccccccccccCCcccccccCCC-----CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHH
Q 003932 610 FGMARIFAKESLEENTEQVVGTIGYIPPEYATKG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 610 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 684 (785)
||++..+... ........||+.|||||++... .|+.++|+||||++..||--|.+|+...-+. .
T Consensus 167 FGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------r 235 (953)
T KOG0587|consen 167 FGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------R 235 (953)
T ss_pred eeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------h
Confidence 9999887543 2334567899999999999654 3778999999999999999999987532110 1
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.++.-.+ .+...-..+.....++.++|..||.+|-.+||++.++++.
T Consensus 236 aLF~IpR-----NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ALFLIPR-----NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhccCCC-----CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111111 1112223345667789999999999999999999998753
|
|
| >cd02871 GH18_chitinase_D-like GH18 domain of Chitinase D (ChiD) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=267.55 Aligned_cols=211 Identities=17% Similarity=0.249 Sum_probs=146.1
Q ss_pred cEEEEEecCCCCC------CcCCCCCCCCceEEEEEEEeeCCcc-EEec-----CCCccHHHHHHHHHHHHhcCCCceEE
Q 003932 26 WIRVGYLNLSEVS------TISGINYDLFTHLICSSADINSTTY-QLSL-----SLPSDENQIAKFADTVKKKNPSITTI 93 (785)
Q Consensus 26 ~~~vgY~~~~~~~------~~~~i~~~~~Thi~~~f~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~k~~~p~lkv~ 93 (785)
++++|||.+|... +++.+ ++.||||+|+|+.++.++. .+.+ ........+.+.++.+|++ ++|||
T Consensus 1 k~~vgY~~~w~~~~~~~~~~~~~~-~~~yt~i~~AF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~q~~--G~KVl 77 (312)
T cd02871 1 KVLVGYWHNWDNGAGSGRQDLDDV-PSKYNVINVAFAEPTSDGGGEVTFNNGSSPGGYSPAEFKADIKALQAK--GKKVL 77 (312)
T ss_pred CeEEEecCcccCCCCCCCCCcccC-CCCCCEEEEcceeecCCCceeEeecccCCcccCChHHHHHHHHHHHHC--CCEEE
Confidence 4789999988543 24444 5899999999999987652 2221 1223345667777767775 59999
Q ss_pred EEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCC----CCchhHHHHHHHHHHHhhhhhhh
Q 003932 94 LSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTS----TDMFNIGLLFDEWRIAATKLDAK 169 (785)
Q Consensus 94 ~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~----~d~~~~~~ll~~lr~~l~~~~~~ 169 (785)
+|||||..+ ..+++++.|++|++++++++++|+|||||||||+|... +++++|..|+++||+++..
T Consensus 78 lSiGG~~~~------~~~~~~~~~~~fa~sl~~~~~~~g~DGiDiD~E~~~~~~~~~~~~~~~~~~lk~lr~~~~~---- 147 (312)
T cd02871 78 ISIGGANGH------VDLNHTAQEDNFVDSIVAIIKEYGFDGLDIDLESGSNPLNATPVITNLISALKQLKDHYGP---- 147 (312)
T ss_pred EEEeCCCCc------cccCCHHHHHHHHHHHHHHHHHhCCCeEEEecccCCccCCcHHHHHHHHHHHHHHHHHcCC----
Confidence 999988642 23778899999999999999999999999999999543 3679999999999988743
Q ss_pred cccccceeEEEEeecccCC--------CCccc--cHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCH
Q 003932 170 NSTRQQSLLILTARFRYSP--------PANSY--LLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARST 239 (785)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~ 239 (785)
++.+++++..+... ....| .+.++.+++||||+|.||.++.+. +...-+. ......
T Consensus 148 -----~~~lT~AP~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~D~invqfYn~~~~~~-----~~~~~~~----~~~~~~ 213 (312)
T cd02871 148 -----NFILTMAPETPYVQGGYAAYGGIWGAYLPLIDNLRDDLTWLNVQYYNSGGMGG-----CDGQSYS----QGTADF 213 (312)
T ss_pred -----CeEEEECCCcccccCcccccccCCcchhHHHHHhhhheeEEEEeeccCCCccc-----ccccCCc----cchhHH
Confidence 44555543322211 11234 367888999999999999765431 1111010 001123
Q ss_pred HHHHHHHHHcC-----------CCCCceeeccccc
Q 003932 240 DQVLKAWIERG-----------LSADKLVMCLPFY 263 (785)
Q Consensus 240 ~~~v~~~~~~g-----------vp~~KlvlGip~Y 263 (785)
..++..++..| +|++||++|+|+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~p~~Kv~iG~pa~ 248 (312)
T cd02871 214 LVALADMLLTGFPIAGNDRFPPLPADKVVIGLPAS 248 (312)
T ss_pred HHHHHHHHHcCCCccCCcccccCChhhEEEeccCC
Confidence 33444445555 8999999999974
|
ChiD, a chitinase found in Bacillus circulans, hydrolyzes the 1,4-beta-linkages of N-acetylglucosamine in chitin and chitodextrins. The domain architecture of ChiD includes a catalytic glycosyl hydrolase family 18 (GH18) domain, a chitin-binding domain, and a fibronectin type III domain. The chitin-binding and fibronectin type III domains are located either N-terminal or C-terminal to the catalytic domain. This family includes exochitinase Chi36 from Bacillus cereus. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=269.77 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=198.5
Q ss_pred HhcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC-------hhhHHHHHHHHHHHHcCCCCceeeEEEEEe-cC
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS-------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCI-DS 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~ 532 (785)
..++|-++.+||+|+|+.||+|. +...+.||||+-.-.. ..-.+...+|.++.+.|+||.||++++++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 45789999999999999999999 4557889999864321 111234568999999999999999999986 56
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc---CCCceeecc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG---EAMKPKISD 609 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~D 609 (785)
+.+|-|+|||+|.+|+-+|.. ...++++.+..|+.||+.||.||.+. .++|||-||||.||||- .-|.+||+|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 688999999999999999953 45688999999999999999999987 46899999999999995 457899999
Q ss_pred ccceeeeccccccc-----ccccccccCCcccccccCCC----CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHH
Q 003932 610 FGMARIFAKESLEE-----NTEQVVGTIGYIPPEYATKG----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 680 (785)
Q Consensus 610 fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~ 680 (785)
||+++.+...++.. .+....||.+|++||++.-+ ..+.|+||||.|||+|.++.|+.||.-....
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ------ 690 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ------ 690 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH------
Confidence 99999987665442 24557899999999988543 4788999999999999999999999632211
Q ss_pred HHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003932 681 EHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS 734 (785)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 734 (785)
.+.+..+.+.....-.+. ..+-...+...+|++||+.--++|....++.
T Consensus 691 ---QdILqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 ---QDILQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---HHHHhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 112222222211111111 1122234677899999999999998877764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=300.61 Aligned_cols=145 Identities=26% Similarity=0.362 Sum_probs=129.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|.+.++||+|+||.||+|... +++.||+|++.... ......+..|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999965 68899999997542 233467888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
||+.+++|..++.. ...+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998853 235788889999999999999999875 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=264.40 Aligned_cols=220 Identities=17% Similarity=0.144 Sum_probs=174.1
Q ss_pred eCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCChhhhhcC
Q 003932 475 GGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFD 553 (785)
Q Consensus 475 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 553 (785)
|.+|.||+++. .+++.+|+|++.... .+..|...+....||||+++++++.+....+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 468899999997653 223455555566799999999999999999999999999999988853
Q ss_pred CccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccccccccCC
Q 003932 554 PIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633 (785)
Q Consensus 554 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 633 (785)
...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 234889999999999999999999876 999999999999999999999999987654332 122345678
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHH
Q 003932 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCL 713 (785)
Q Consensus 634 y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 713 (785)
|+|||.+.+..++.++||||+|+++|||++|+.|+...... ....... ..+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~~~~---------~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTHTTL---------NIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccccccc---------CCcccCCHHHH
Confidence 99999998888999999999999999999999876422110 0000000 01111234688
Q ss_pred HHHHHccccCCCCCCCHH
Q 003932 714 EIALLCVQENPNDRPSML 731 (785)
Q Consensus 714 ~li~~cl~~dP~~RPs~~ 731 (785)
+++.+||+.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=268.06 Aligned_cols=261 Identities=20% Similarity=0.291 Sum_probs=200.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC--C----ceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH--V----NLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~ 535 (785)
+.+|.+...+|+|.||.|..+.. ..+..||||+++... .-.+..+-|+++++++.+ | .++.+.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 68999999999999999999984 357889999996543 334566789999999942 2 377888889889999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC--------------
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-------------- 601 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-------------- 601 (785)
|+|+|.+ |-|+.++|..+ .-.+++...+..|+.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 66999999764 3456889999999999999999999987 999999999999932
Q ss_pred ------CCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCC
Q 003932 602 ------AMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675 (785)
Q Consensus 602 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~ 675 (785)
+..+||+|||.|..-.+. ....+.|..|.|||++.+-.++.++||||+||||.||.+|...|+.....+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 345899999999864322 355788999999999999999999999999999999999999988766444
Q ss_pred cccHHHHH--------------HHHHhCCccccccccccCC----------------CCCHHHHHHHHHHHHHccccCCC
Q 003932 676 NLSILEHA--------------YELWKGGKGVEFVDSFLDD----------------RNSPCKLMRCLEIALLCVQENPN 725 (785)
Q Consensus 676 ~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~----------------~~~~~~~~~l~~li~~cl~~dP~ 725 (785)
.+.+.+.. .+.+..++ .+..+..... .....+..+|.+|+..||..||.
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~r-ldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGR-LDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhccc-ccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 33222221 11111111 1100000000 01122345799999999999999
Q ss_pred CCCCHHHHHH
Q 003932 726 DRPSMLEVSS 735 (785)
Q Consensus 726 ~RPs~~evl~ 735 (785)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999985
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=274.62 Aligned_cols=244 Identities=26% Similarity=0.338 Sum_probs=195.3
Q ss_pred ceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCC
Q 003932 469 RNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
.++||+|.||+||-|+. ++|+.||||++.+. ..+...++++|+.+|+++.||.||.+...|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 37899999999999984 57999999999764 3344478999999999999999999999999999999999999655
Q ss_pred ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC---Cceeeccccceeeecccccc
Q 003932 546 SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA---MKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 546 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~ 622 (785)
-|.-.|. .....+++.....++.||+.||.|||.+. |+|+||||+||||.+. -++||||||+|+.+.+.+.
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 4544442 24556888888889999999999999885 9999999999999754 4799999999999876643
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
....+||+.|+|||+++.+.|...-|+||.||++|--|+|.-||.... +....++.+.-++ ..
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMy-------------Pp 785 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMY-------------PP 785 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhcccccc-------------CC
Confidence 345789999999999999999999999999999999999999986321 1112222221111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+..+.....++||...||..-.+|-|..+-+.
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 222334457788999999999999998877643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=275.36 Aligned_cols=207 Identities=24% Similarity=0.354 Sum_probs=177.1
Q ss_pred cCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.-|..++.||-|+||+|.+++ .++...+|+|.+++.+ +......+.|-++|...+.+.||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 458888999999999999998 5667789999998864 334456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc-
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK- 618 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~- 618 (785)
+|++||++-.+| .+...+++..+..++..+..|++++|..| +|||||||+|||||.+|++||+|||++.-+.-
T Consensus 709 dYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 999999998888 35567888888888889999999999987 99999999999999999999999999864421
Q ss_pred --------ccccc-------------------------------ccccccccCCcccccccCCCCCCChhhHHHHHHHHH
Q 003932 619 --------ESLEE-------------------------------NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLL 659 (785)
Q Consensus 619 --------~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ 659 (785)
.+..+ .....+||..|+|||++....++..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00000 002357999999999999999999999999999999
Q ss_pred HHHcCCCCCcccCCCCc
Q 003932 660 QIISGKRLSMLCGINEN 676 (785)
Q Consensus 660 elltG~~p~~~~~~~~~ 676 (785)
||+.|++||......+.
T Consensus 863 em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHhhCCCCccCCCCCcc
Confidence 99999999987665543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=276.83 Aligned_cols=247 Identities=21% Similarity=0.260 Sum_probs=203.1
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCc-EEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGE-VIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.+++.+..||-|+||.|=++..++.. .+|+|++++. .....+.+..|-.+|.+++.|.||++|-.|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667788999999999999866444 3889988765 3344566788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|-|-||.|...|.+ +..++..+...++.++.+|++|||.++ ||.|||||+|++|+.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999964 445788888889999999999999887 999999999999999999999999999987644
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
..+-.+|||+.|.|||++.+...+.++|.||||+++||||+|.+||...++-....++-.....+ ++.
T Consensus 574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------~~P--- 641 (732)
T KOG0614|consen 574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------EFP--- 641 (732)
T ss_pred ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------hcc---
Confidence 45667899999999999999999999999999999999999999998766544444443332222 222
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVS 734 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl 734 (785)
........+|+++.+..+|.+|.. +.+|.
T Consensus 642 ------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIk 675 (732)
T KOG0614|consen 642 ------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIK 675 (732)
T ss_pred ------cccchhHHHHHHHHHhcCcHhhhccccCChHHHH
Confidence 112235667999999999999975 55554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=251.83 Aligned_cols=248 Identities=20% Similarity=0.307 Sum_probs=196.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 537 (785)
..+|.++.+||+|+|..|..+++ ++.+.+|+|++++. ..++..-.+.|..+..+. +||.+|-+..+|..++.+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 45789999999999999999995 46788999999764 334455677788777776 79999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|.||++||+|--++ ++...++++.+..+...|+-||.|||+.+ ||.||||.+|||+|.+|++||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999996555 45556899999999999999999999987 9999999999999999999999999987632
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcc-cHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL-SILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 696 (785)
.. ...+..++||+.|.|||++++..|...+|.|+|||+++||+.|+.||...+..... ..-....+...+.. ..
T Consensus 403 ~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-ir-- 477 (593)
T KOG0695|consen 403 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-IR-- 477 (593)
T ss_pred CC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-cc--
Confidence 22 23466789999999999999999999999999999999999999999876643222 12222222221111 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRP 728 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 728 (785)
.+...+.....++..-|++||.+|.
T Consensus 478 -------iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 -------IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -------ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1112223455688889999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-32 Score=254.75 Aligned_cols=268 Identities=20% Similarity=0.372 Sum_probs=194.7
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecC--------
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-------- 532 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 532 (785)
..|+.+.+||+|.||.||+|+. ++++.||+|++...+. .--....+|+++|+.|+|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3466678999999999999994 4678889887654221 1123457899999999999999999888632
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
..+++||++|+. +|.-+|.+. ...++...+.++..++..||.|+|... |+|||+|+.|+|++.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347899999965 777777542 345888899999999999999999876 99999999999999999999999999
Q ss_pred eeeecccc--cccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH-----H
Q 003932 613 ARIFAKES--LEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-----Y 684 (785)
Q Consensus 613 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-----~ 684 (785)
++.+.... .....+..+-|..|++||.+.+. .|+++.|||.-|||+.||++|.+.+........+.++... .
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98764332 22234445669999999988774 6999999999999999999999887655444333333222 1
Q ss_pred HHHhCCccccccccc----c-CCCC--CHHH------HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 685 ELWKGGKGVEFVDSF----L-DDRN--SPCK------LMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~----l-~~~~--~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
..|.+-...++..+. + .... .+.. .....+|+..++..||.+|+.+.+++..-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 112111111111111 1 0000 0111 12567899999999999999999987643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=285.50 Aligned_cols=259 Identities=21% Similarity=0.201 Sum_probs=165.9
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC-C----CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEE------Ee
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP-C----GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGF------CI 530 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 530 (785)
..++|++.+.||+|+||.||+|+.. + +..||+|++...... +...+| .++...+.++..+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3578999999999999999999964 4 688999998653321 111111 1112222222221111 24
Q ss_pred cCCccEEEEEecCCCChhhhhcCCccc-----------------cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeccc
Q 003932 531 DSEERMLIYEYMPNKSLDCYLFDPIRK-----------------LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 593 (785)
Q Consensus 531 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 593 (785)
.....++|+||+++++|.+++...... .......+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999888542110 01122345679999999999999876 9999999
Q ss_pred CCCEEEcC-CCceeeccccceeeecccccccccccccccCCcccccccCCC----------------------CCCChhh
Q 003932 594 VSNILLGE-AMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG----------------------VYSTKSD 650 (785)
Q Consensus 594 p~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 650 (785)
|+|||++. ++.+||+|||+++.+.... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 6899999999998654321 1223446789999999965332 2345679
Q ss_pred HHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc-cccccccccCCCCCHH----------HHHHHHHHHHHc
Q 003932 651 VFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK-GVEFVDSFLDDRNSPC----------KLMRCLEIALLC 719 (785)
Q Consensus 651 vwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~----------~~~~l~~li~~c 719 (785)
||||||+||||+++..+... + ... ....+.... ........+......+ ......+|+.+|
T Consensus 362 VwSlGviL~el~~~~~~~~~----~---~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS----N---LIQ-FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch----H---HHH-HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 99999999999997654321 0 000 011111000 0000000000000000 112345899999
Q ss_pred cccCCCCCCCHHHHHHH
Q 003932 720 VQENPNDRPSMLEVSSM 736 (785)
Q Consensus 720 l~~dP~~RPs~~evl~~ 736 (785)
|+.||++|||++|+++.
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=279.60 Aligned_cols=245 Identities=26% Similarity=0.353 Sum_probs=185.8
Q ss_pred CCcceeeceeCcEE-EEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecC
Q 003932 466 FSIRNKLGEGGYGP-VYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 466 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
|.-.+++|.|+.|+ ||+|... ++.||||++.... ..-..+|+..|+.- +|||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44457799999876 7899987 8899999985432 23557899999887 6999999999999999999999999
Q ss_pred CCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---C--Cceeeccccceeeec
Q 003932 544 NKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---A--MKPKISDFGMARIFA 617 (785)
Q Consensus 544 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~--~~~kl~Dfg~a~~~~ 617 (785)
..+|.+++.... ......-...+.+..|++.||++||+.+ ||||||||+||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 569999996531 1111111445778899999999999976 999999999999975 2 578999999999875
Q ss_pred cccc-ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 618 KESL-EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG-KRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 618 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
.... -.......||-+|+|||++....-+..+||||||||+|+.++| .+||...- ++.............
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--------~R~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--------ERQANILTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--------HhhhhhhcCccceee
Confidence 4322 2235567899999999999998888899999999999999985 88986321 111111222211111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS 734 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 734 (785)
+. . ..++ +..+||.+|++++|..||++.+|+
T Consensus 735 L~----~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 LE----P--LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ec----c--CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11 1 1111 677899999999999999999995
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=252.36 Aligned_cols=238 Identities=26% Similarity=0.305 Sum_probs=191.2
Q ss_pred CcEEEEEEEeC-CCcEEEEEEcCCCChhh-HHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCChhhhhcC
Q 003932 476 GYGPVYKGVLP-CGEVIAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFD 553 (785)
Q Consensus 476 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 553 (785)
+||.||+|... +++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999998765444 67899999999999999999999999998999999999999999998854
Q ss_pred CccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccccccccCC
Q 003932 554 PIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633 (785)
Q Consensus 554 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 633 (785)
.. .+++..+..++.++++++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 22 2788999999999999999999886 9999999999999999999999999998765432 2334567889
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHH
Q 003932 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCL 713 (785)
Q Consensus 634 y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 713 (785)
|++||.+.+..++.++||||||+++++|++|..|+...... .............. .. ........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~-~~------~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPF-PP------PEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCC-cc------ccccCCHHHH
Confidence 99999999888999999999999999999999988542111 11111111111100 00 0000334788
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 003932 714 EIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 714 ~li~~cl~~dP~~RPs~~evl~ 735 (785)
+++.+||..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=273.47 Aligned_cols=264 Identities=21% Similarity=0.266 Sum_probs=178.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-----------------CCCcEEEEEEcCCCChhhHHH--------------HHHHH
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-----------------PCGEVIAVKKLSKTSTQGFEE--------------FKNEV 511 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~ 511 (785)
.++|++.++||+|+||.||+|.. ..++.||||++........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999963 235679999986543322222 33466
Q ss_pred HHHHcCCCCce-----eeEEEEEec--------CCccEEEEEecCCCChhhhhcCCcc---------------------c
Q 003932 512 MLTAKLQHVNL-----IRVLGFCID--------SEERMLIYEYMPNKSLDCYLFDPIR---------------------K 557 (785)
Q Consensus 512 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~ 557 (785)
.++.+++|.++ ++++++|.. ....+|||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 667777653 3468999999999999998864211 1
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccc
Q 003932 558 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637 (785)
Q Consensus 558 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 637 (785)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 23467788899999999999999876 99999999999999999999999999976533211 111223347899999
Q ss_pred cccCCCCC----------------------CChhhHHHHHHHHHHHHcCCC-CCcccCC-CCcccHHHHHHHHHhCCccc
Q 003932 638 EYATKGVY----------------------STKSDVFSFGVLLLQIISGKR-LSMLCGI-NENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 638 E~~~~~~~----------------------~~~~DvwSlGvvl~elltG~~-p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 693 (785)
|.+..... ..+.||||+||++++|++|.. |+..... .............|......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98754321 134799999999999999875 4432110 01000011111111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENP---NDRPSMLEVSS 735 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 735 (785)
.. + -...........+++.+||..+| .+|+|++|+++
T Consensus 460 ~~-~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KY-D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CC-C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 10 0 00011123467889999999766 68999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=230.43 Aligned_cols=207 Identities=24% Similarity=0.318 Sum_probs=168.9
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCcc
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 535 (785)
++...+...-++.||+|++|.|-+-++ .+|...|+|+++.. +.+..++..+|+++..+. .+|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344445566678899999999988884 57999999999865 345556778888876655 799999999999999999
Q ss_pred EEEEEecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 536 MLIYEYMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
++.||.| ..||+.+.... .....+++...-+|+..+.+||.|||++- .++|||+||+|||++.+|+||+||||.+-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 55887665332 23556888889999999999999999865 69999999999999999999999999998
Q ss_pred eecccccccccccccccCCcccccccCC----CCCCChhhHHHHHHHHHHHHcCCCCCccc
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATK----GVYSTKSDVFSFGVLLLQIISGKRLSMLC 671 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvvl~elltG~~p~~~~ 671 (785)
.+.++-. .+.-.|-..|||||.+.. ..|+-|+||||||+.+.||.+++.|+...
T Consensus 198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 7654321 122356789999998854 36899999999999999999999998654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=240.90 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=192.0
Q ss_pred cceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-----CccEEEE
Q 003932 468 IRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLIY 539 (785)
Q Consensus 468 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ 539 (785)
-.+.||-|.||.||.+.. .+|+.|++|++..- +....+.+.+|+.+|.-.+|.|++..++...-. .+.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 346799999999999985 47899999998754 334556788999999999999999988876533 2567888
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|.| ..+|...+- ....++...+.-+..||++||.|||+.+ |.||||||.|.|++.+..+||+|||+++.....
T Consensus 137 ELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 888 457776663 3445666677778999999999999876 999999999999999999999999999975443
Q ss_pred ccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH--------HHHHhCC
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGG 690 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 690 (785)
. ....+..+-|.+|+|||++.+. .|+...||||.||++.||+..+..|...++-+..+++... .+.-.++
T Consensus 210 ~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 D-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred h-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 2 3344455678999999999885 5999999999999999999988888765543333322111 1111111
Q ss_pred cccccccc--------ccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 691 KGVEFVDS--------FLDD-RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 691 ~~~~~~~~--------~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
-...++.. .+.. ......-.+...+.++++..||.+|.+..+.+..+..
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 00011110 0000 0011122355678889999999999999998876644
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=228.10 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=192.1
Q ss_pred HhcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCC--ccEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSE--ERML 537 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l 537 (785)
..++|++.+++|+|-++.||.|. ..+++.++||+++... .+.+.+|+.+|+.|. ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35789999999999999999998 4567889999996543 357889999999996 999999999987654 5679
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-Cceeeccccceeee
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDFGMARIF 616 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~~ 616 (785)
|+||+.+.+...+. +.++...+...+.+++.||.|+|+.| |+|||+||.|+++|.. -.++|+|+|+|..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876554 34677788889999999999999987 9999999999999954 57999999999987
Q ss_pred cccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH--------HHHH
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELW 687 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~ 687 (785)
.+... ....+.+..|.-||++.. ..|+.+-|+|||||+|..|+..+.||.-...+ ..+++..+ ...+
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHH
Confidence 65432 223456778999998866 45889999999999999999999998532211 11122111 1111
Q ss_pred hCCcc------ccccc--------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 688 KGGKG------VEFVD--------SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 688 ~~~~~------~~~~~--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..-.. ..++. .++.....-....+.++++...|..|.++|||++|...
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11000 00000 01111111112357889999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-26 Score=229.16 Aligned_cols=211 Identities=34% Similarity=0.539 Sum_probs=182.4
Q ss_pred eceeCcEEEEEEEeC-CCcEEEEEEcCCCChh-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCChhh
Q 003932 472 LGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDC 549 (785)
Q Consensus 472 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 549 (785)
||+|++|.||++... +++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4889999999766442 34678999999999999999999999999899999999999999999
Q ss_pred hhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-CCceeeccccceeeecccccccccccc
Q 003932 550 YLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFGMARIFAKESLEENTEQV 628 (785)
Q Consensus 550 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 628 (785)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 885421 35889999999999999999999886 999999999999999 89999999999987644321 12334
Q ss_pred cccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHH
Q 003932 629 VGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC 707 (785)
Q Consensus 629 ~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 707 (785)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999887 788999999999999998
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 708 KLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 708 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3677899999999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-28 Score=250.96 Aligned_cols=207 Identities=22% Similarity=0.260 Sum_probs=173.9
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC------CceeeEEEEEec
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH------VNLIRVLGFCID 531 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 531 (785)
-+....+|.+....|+|-|++|..|.. ..|..||||++++...- .+.=+.|+++|++|+. -|+++++..|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 445678999999999999999999984 35779999999876322 2344679999999953 478999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-Cceeeccc
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDF 610 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Df 610 (785)
.+++|||+|-+ ..+|.+.|.....+..|....+..++.|+.-||..|..++ |+|.||||.|||+++. ..+|||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 99999999987 5689999987777778889999999999999999999886 9999999999999865 56899999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCC
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN 674 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~ 674 (785)
|.|....... .+.+.-+..|.|||++.|-+|+...|+||.||+||||.||+..|.....+
T Consensus 582 GSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 582 GSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred cccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 9998764432 22234467899999999999999999999999999999999988754433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=235.57 Aligned_cols=132 Identities=22% Similarity=0.291 Sum_probs=110.1
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-----C---CceeeEEEEEec--
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-----H---VNLIRVLGFCID-- 531 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 531 (785)
..+|.+.++||-|-|++||++. ....+.||+|+.+.. ..-.+.-..||++|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3789999999999999999998 456788999998543 334456778999999883 3 369999999874
Q ss_pred --CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE
Q 003932 532 --SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599 (785)
Q Consensus 532 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 599 (785)
+.++|||+|++ |.+|..++..... .-++...+.+|++||+.||.|||... +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 46899999999 7788777754333 34899999999999999999999976 79999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-27 Score=228.71 Aligned_cols=260 Identities=24% Similarity=0.257 Sum_probs=190.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------Cc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EE 534 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 534 (785)
.+|.-++.+|.|.- .|..+.. -.+++||+|++... .....+...+|...+..++|+||++++.++.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46667778888887 6666653 35889999998654 233445678899999999999999999998743 36
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.|+|||+| ..+|...+. ..++-.++..|..|++.|++|||+.+ |+||||||+||++..++.+||.|||+++
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 78999999 568877764 23667888899999999999999987 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccH---------------
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSI--------------- 679 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~--------------- 679 (785)
.-... -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+..|.....-+....
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 64332 244567789999999999998899999999999999999999988763221110000
Q ss_pred -HHHHHHHHhCCc-------cccccccccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 680 -LEHAYELWKGGK-------GVEFVDSFLDD--RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 680 -~~~~~~~~~~~~-------~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
...+........ ...+.|..... ..++.......+++.+||-.||++|.+++++++.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000001111000 00111111110 0111223457889999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=253.06 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=202.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|+++..+|.|.||.||+++. .+++..|+|+++-.......-++.|+-+++.++|+||+.++|.+.....+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46799999999999999999994 57889999999877777778889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
|.+|+|.+.-+ ....+++.++..+++...+||.|||+.+ -+|||||-.|||+++.|.+|++|||.+-.+...-
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence 99999988764 4567899999999999999999999987 7999999999999999999999999987654321
Q ss_pred ccccccccccCCccccccc---CCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYA---TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.....+.||++|||||+. +.+.|..++|||++|+...||-.-++|....-+ .+ + .++...... -.+
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr-~-l~LmTkS~~--qpp 235 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MR-A-LFLMTKSGF--QPP 235 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HH-H-HHHhhccCC--CCC
Confidence 223457899999999966 456689999999999999999777766432111 11 1 111111111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+++ .....+.+.++++.|+.++|++||+++.+++
T Consensus 236 ~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1221 2234557889999999999999999987653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=245.11 Aligned_cols=196 Identities=24% Similarity=0.366 Sum_probs=167.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChh--------hHHHHHHHHHHHHcCC---CCceeeEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQ--------GFEEFKNEVMLTAKLQ---HVNLIRVLGFCID 531 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 531 (785)
.+|..++.+|+|+||.|++|.++ +...|++|.+.+.+.- ..-.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999965 4667899998775321 1112456999999997 9999999999999
Q ss_pred CCccEEEEEec-CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 532 SEERMLIYEYM-PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 532 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
.+..||+||-. ++-+|.+++. .++.+++.....|+.|++.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999965 4567888873 4567999999999999999999999987 999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCc
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSM 669 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~ 669 (785)
|.+.....+ ..+.++||..|.|||++.|.+| ...-|||++|++||.++....|+.
T Consensus 715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765433 4567899999999999999886 567899999999999998888874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=223.80 Aligned_cols=199 Identities=34% Similarity=0.497 Sum_probs=171.4
Q ss_pred CCcceeeceeCcEEEEEEEeCC-CcEEEEEEcCCCChh-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 466 FSIRNKLGEGGYGPVYKGVLPC-GEVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
|.+.+.||+|++|.||++.... ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999664 889999999876554 56788999999999999999999999998899999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+++|.+++..... .+++.....++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AA 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cc
Confidence 9999998854221 1788999999999999999999886 9999999999999999999999999998765432 01
Q ss_pred ccccccccCCccccccc-CCCCCCChhhHHHHHHHHHHHHcCCCCCcc
Q 003932 624 NTEQVVGTIGYIPPEYA-TKGVYSTKSDVFSFGVLLLQIISGKRLSML 670 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltG~~p~~~ 670 (785)
......++..|++||.+ ....++.++||||||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678899999998 666788899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-25 Score=224.03 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=193.7
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 536 (785)
..+.|..+++||+|.|++||++.+. ..+.||+|.+...+.. ..+.+|+++|..+ .+.||+++.+++...+...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 4467889999999999999999843 4678999999776543 4688999999999 5999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-CCceeeccccceee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFGMARI 615 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~a~~ 615 (785)
+|+||++.....+++.. ++...+...++.+..||+++|..| ||||||||+|+|.+. .+.-.|.|||+|..
T Consensus 112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence 99999999998888742 667888899999999999999987 999999999999984 56779999999973
Q ss_pred ecccc------c----------------------------cc--------ccccccccCCcccccccCCC-CCCChhhHH
Q 003932 616 FAKES------L----------------------------EE--------NTEQVVGTIGYIPPEYATKG-VYSTKSDVF 652 (785)
Q Consensus 616 ~~~~~------~----------------------------~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw 652 (785)
..... . .. ......||++|.|||++... .-++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21100 0 00 00124699999999988764 478899999
Q ss_pred HHHHHHHHHHcCCCCCcccCCCCcccHHHHH-----------HH------HHhCCc---ccc------cc--ccc-----
Q 003932 653 SFGVLLLQIISGKRLSMLCGINENLSILEHA-----------YE------LWKGGK---GVE------FV--DSF----- 699 (785)
Q Consensus 653 SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-----------~~------~~~~~~---~~~------~~--~~~----- 699 (785)
|.|||++.+++++.||......- ..+.+.+ .. .|.... ..+ -+ ...
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999986433211 1111100 00 111000 000 00 000
Q ss_pred ---cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 700 ---LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 700 ---l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.........+..+++++.+|+..||.+|.|++|.+..
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011112223478999999999999999999999753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-25 Score=209.71 Aligned_cols=253 Identities=19% Similarity=0.316 Sum_probs=186.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEE-EecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGF-CIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 539 (785)
.+.|.+.+.||+|.||.+-++.++ +...+++|-+..... ...+|.+|...--.| .|.||+.-+++ |...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467999999999999999999965 567889998876533 346788887665555 58999987764 45556777899
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc--CCCceeeccccceeeec
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG--EAMKPKISDFGMARIFA 617 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Dfg~a~~~~ 617 (785)
||+|.|+|.+-+.. ..+.+....+++.|++.|+.|+|+.. +||||||.+|||+- +..++||||||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999877633 34677888899999999999999875 99999999999993 34589999999987643
Q ss_pred ccccccccccccccCCcccccccCCC-----CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
.. .....-+..|.+||..... ...+.+|||.||++++.++||+.||......+ ..-+.+..|.....
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKRKN 246 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcccC
Confidence 21 1223346789999976442 25678999999999999999999998433222 22334455555554
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 737 (785)
....+.+- ...+.+..+.++-|..+|++|--..++..+.
T Consensus 247 ~~~P~~F~------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PALPKKFN------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccCchhhc------ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 44333221 1234677888899999999995555554443
|
|
| >cd06542 GH18_EndoS-like Endo-beta-N-acetylglucosaminidases are bacterial chitinases that hydrolyze the chitin core of various asparagine (N)-linked glycans and glycoproteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=214.66 Aligned_cols=229 Identities=13% Similarity=0.092 Sum_probs=162.7
Q ss_pred EEEEEecCCCC------CCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCC
Q 003932 27 IRVGYLNLSEV------STISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGK 100 (785)
Q Consensus 27 ~~vgY~~~~~~------~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~ 100 (785)
+.+|||.+|.. ..+.++| +.+++|++.++.++.++... ...........+..+|++ ++||++|||||.
T Consensus 2 ~~~~y~~~~~~~~~~~~~~l~~~p-ds~D~v~lf~~~~~~~~~~~---~~~~~~~~~~~i~~l~~k--G~KVl~sigg~~ 75 (255)
T cd06542 2 ISFGYFEVWDDKGASLQESLLNLP-DSVDMVSLFAANINLDAATA---VQFLLTNKETYIRPLQAK--GTKVLLSILGNH 75 (255)
T ss_pred eEEEEEEecCCcCcccccccccCC-CcceEEEEcccccCcccccc---hhhhhHHHHHHHHHHhhC--CCEEEEEECCCC
Confidence 56899999875 5777886 66888888555554332110 112234455666667665 699999999887
Q ss_pred CCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC------CCCchhHHHHHHHHHHHhhhhhhhccccc
Q 003932 101 DTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT------STDMFNIGLLFDEWRIAATKLDAKNSTRQ 174 (785)
Q Consensus 101 ~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~------~~d~~~~~~ll~~lr~~l~~~~~~~~~~~ 174 (785)
.... | ....+++.|++|++++++++++|||||||||||+|.. +.+.++|..|+++||+++.. .
T Consensus 76 ~~~~--~-~~~~~~~~~~~fa~~l~~~v~~yglDGiDiD~E~~~~~~~~~~~~~~~~~~~lv~~Lr~~~~~--------~ 144 (255)
T cd06542 76 LGAG--F-ANNLSDAAAKAYAKAIVDTVDKYGLDGVDFDDEYSGYGKNGTSQPSNEAFVRLIKELRKYMGP--------T 144 (255)
T ss_pred CCCC--c-cccCCHHHHHHHHHHHHHHHHHhCCCceEEeeeecccCCCCCCcchHHHHHHHHHHHHHHhCc--------C
Confidence 5443 4 3467889999999999999999999999999999854 24778999999999998853 1
Q ss_pred ceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCC
Q 003932 175 QSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSAD 254 (785)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~ 254 (785)
+++++++..+..... +.+++.+++||+++|+||-++. . .+. .+ .-...|+|++
T Consensus 145 ~kllt~~~~~~~~~~----~~~~~~~~vDyv~~~~y~~~~~---~-~~~---~~----------------~~~~~g~~~~ 197 (255)
T cd06542 145 DKLLTIDGYGQALSN----DGEEVSPYVDYVIYQYYGSSSS---S-TQR---NW----------------NTNSPKIPPE 197 (255)
T ss_pred CcEEEEEecCCchhc----CHHHHHHhCCEEEeeccCCCCc---c-CCc---cc----------------ccccCCCCHH
Confidence 445555554332211 7899999999999999984321 1 111 01 1124589999
Q ss_pred ceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHH
Q 003932 255 KLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVE 334 (785)
Q Consensus 255 KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~ 334 (785)
|+++|++|++...+ .+..
T Consensus 198 k~i~~~~~~~~~~~--------------------------------------------------------------~~~~ 215 (255)
T cd06542 198 KMVYTESFEEENGG--------------------------------------------------------------NSGS 215 (255)
T ss_pred HceeeeeeecccCC--------------------------------------------------------------Ccch
Confidence 99999999864220 1224
Q ss_pred HHHHHHhhhccc-CccceEeeeccccch
Q 003932 335 AVRAKIAYAKEK-RLLGYYAWQVSFDDH 361 (785)
Q Consensus 335 Si~~K~~~~~~~-glgG~~~W~l~~Dd~ 361 (785)
++...++|+.+. +.||+|+|.++.|..
T Consensus 216 ~~~~~A~~~~~~~~~gG~~~y~~~~dy~ 243 (255)
T cd06542 216 SAEQYARWTPAKGGKGGIGTYALDRDYY 243 (255)
T ss_pred hHHHHHhcCcccCceEEEEEEecCCCcc
Confidence 566667777777 899999999999864
|
The endo-beta-N-acetylglucosaminidases have a glycosyl hydrolase family 18 (GH18) catalytic domain. Some members also have an additional C-terminal glycosyl hydrolase family 20 (GH20) domain while others have an N-terminal domain of unknown function (pfam08522). Members of this family include endo-beta-N-acetylglucosaminidase S (EndoS) from Streptococcus pyogenes, EndoF1, EndoF2, EndoF3, and EndoH from Flavobacterium meningosepticum, and EndoE from Enterococcus faecalis. EndoS is a secreted endoglycosidase from Streptococcus pyogenes that specifically hydrolyzes the glycan on human IgG between two core N-acetylglucosamine residues. EndoE is a secreted endoglycosidase, encoded by the ndoE gene in Enterococcus faecalis, that hydrolyzes the glycan on human RNase B. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=259.08 Aligned_cols=195 Identities=18% Similarity=0.199 Sum_probs=136.8
Q ss_pred CCC-CceeeEEEEE-------ecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 003932 517 LQH-VNLIRVLGFC-------IDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTII 588 (785)
Q Consensus 517 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 588 (785)
++| .||++++++| ......++++|++ +++|.++|... ...+++..+..++.||++||.|||+++ |+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 445 5777777776 2334567788887 66999999542 345899999999999999999999886 99
Q ss_pred EecccCCCEEEcC-------------------CCceeeccccceeeeccccc--------------ccccccccccCCcc
Q 003932 589 HRDLKVSNILLGE-------------------AMKPKISDFGMARIFAKESL--------------EENTEQVVGTIGYI 635 (785)
Q Consensus 589 H~Dikp~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~ 635 (785)
||||||+||||+. ++.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566777777654221000 00011235788999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHH
Q 003932 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEI 715 (785)
Q Consensus 636 aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 715 (785)
|||++.+..++.++|||||||+||||++|..|+.... ..... .... ...+. ..........+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~----~~~~----~~~~~-----~~~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSS----LRHR----VLPPQ-----ILLNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHH----HHHh----hcChh-----hhhcCHHHHHH
Confidence 9999999999999999999999999999887753210 00100 0000 00000 00112345678
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 003932 716 ALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 716 i~~cl~~dP~~RPs~~evl~ 735 (785)
+.+||+.+|.+||++.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 88999999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=201.37 Aligned_cols=167 Identities=19% Similarity=0.096 Sum_probs=124.4
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
|||.+++... ...+++..+..++.|++.||.|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 6888888532 345899999999999999999999874 999999999999999 9998875432
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
...||..|+|||++.+..++.++|||||||++|||++|+.|+...... ............... .. ....
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~----~~---~~~~ 131 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADD----PR---DRSN 131 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCC----cc---cccc
Confidence 125789999999999999999999999999999999999998533211 111111111111000 00 0001
Q ss_pred CHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 705 SPCKLM--RCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 705 ~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...... .+.+++.+||+.+|.+||++.|+++.+...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 111222 589999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=215.80 Aligned_cols=276 Identities=20% Similarity=0.221 Sum_probs=201.1
Q ss_pred CCCcceeeceeCcEEEEEEEeCCC--cEEEEEEcCCCChhhHHHHHHHHHHHHcCCC----CceeeEEEEE-ecCCccEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLPCG--EVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH----VNLIRVLGFC-IDSEERML 537 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 537 (785)
+|.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 4788888776533322367788888888863 5888888888 46678899
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-----Cceeeccccc
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-----MKPKISDFGM 612 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-----~~~kl~Dfg~ 612 (785)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889998775443 567999999999999999999999987 9999999999999865 4689999999
Q ss_pred ee--eeccccc-----ccc-cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHH
Q 003932 613 AR--IFAKESL-----EEN-TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 613 a~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 684 (785)
++ .+..... .+. .....||..|+++..+.+...+++.|+||++.++.|++.|..||...........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 4322211 111 234569999999999999999999999999999999999999986543322211111111
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCCccccc
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQVD 757 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~ 757 (785)
... .... .....+..+.++...+-..+...+|....+...|+.............+.|...
T Consensus 254 ~~~-------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~ 314 (322)
T KOG1164|consen 254 RKL-------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVK 314 (322)
T ss_pred hhh-------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccc
Confidence 110 0000 111223345555555556899999999999999887655443444344444443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-24 Score=202.38 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=190.7
Q ss_pred CCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 466 FSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
..+..+|.+...|..|+|++. |..+++|++... ....-+.|.+|.-.|+.+.||||++++|.|.....+.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 455677899999999999998 445667776543 22233578899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEE-ecccCCCEEEcCCCceeec--cccceeeecccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH-RDLKVSNILLGEAMKPKIS--DFGMARIFAKES 620 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH-~Dikp~Nill~~~~~~kl~--Dfg~a~~~~~~~ 620 (785)
.|||...|++. .....+..+..+++.++++|++|||+..+ ++- --|.+..|++|++.+.+|+ |--++.
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsf------ 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSF------ 341 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeee------
Confidence 99999999874 34557788999999999999999999863 443 4689999999999988875 322211
Q ss_pred cccccccccccCCcccccccCCCCCC---ChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYS---TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
+.. ...-.+.||+||.++..+.+ ..+|+|||+++||||.|...||....+-+ ..+++.-
T Consensus 342 -qe~--gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---------------cgmkial 403 (448)
T KOG0195|consen 342 -QEV--GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---------------CGMKIAL 403 (448)
T ss_pred -ecc--ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---------------hhhhhhh
Confidence 111 12346799999999876643 57999999999999999999997544322 1122222
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
+.++-..++.....+.+|+.-|...||.+||.+..|+-+|+.-
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 3344455555666788999999999999999999999888763
|
|
| >KOG2091 consensus Predicted member of glycosyl hydrolase family 18 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=192.26 Aligned_cols=291 Identities=14% Similarity=0.130 Sum_probs=214.1
Q ss_pred cEEEEEecCCC--CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCCC
Q 003932 26 WIRVGYLNLSE--VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTN 103 (785)
Q Consensus 26 ~~~vgY~~~~~--~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~ 103 (785)
.-+.||.++|+ .|+++.|-.++.|||.--+..+...|..+......+. -...+++++++++++++++-+= .....
T Consensus 79 ~~vLayVTPWNs~Gydvakifaskft~iSPVW~ql~~qgs~~~v~G~hdi--d~gwiralRk~~~~l~ivPR~~-fd~~~ 155 (392)
T KOG2091|consen 79 GTVLAYVTPWNSHGYDVAKIFASKFTYISPVWLQLKDQGSDVGVYGKHDI--DPGWIRALRKSGKDLHIVPRFY-FDEFT 155 (392)
T ss_pred CceEEEecCcCccchhHHHHHhcccceecchheeehhcCcceEEeecccC--ChHHHHHHHHhCCCceeeceeh-hhhcc
Confidence 34589999986 7899999999999999999888766544433322221 1234556899999999988776 34455
Q ss_pred cccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeecc--CCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEE
Q 003932 104 YSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWT--APNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILT 181 (785)
Q Consensus 104 ~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE--~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~ 181 (785)
+..|..++.+++-|++..+.++++++++||||+.|+-- +.+...| .....|++.|..++++. +...+.+
T Consensus 156 ~~d~ke~l~ke~l~ekv~~tlv~~ck~~~fdGlVlevwsq~a~~i~d-~~al~~v~hl~k~Lhkq--------~l~~iLv 226 (392)
T KOG2091|consen 156 SADLKEFLVKEALREKVGQTLVNFCKKHGFDGLVLEVWSQLADVIAD-KDALELVEHLGKALHKQ--------ELQAILV 226 (392)
T ss_pred chHHHHHhhhHHHHHHHHHHHHHHHHHcCCCeeeHHHHHHHHHHHhh-hHHHHHHHHHHHHHHHh--------heEEEEE
Confidence 66789999999999999999999999999999999852 1122233 23345677777777642 3334444
Q ss_pred eecccCCCC------ccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCc
Q 003932 182 ARFRYSPPA------NSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADK 255 (785)
Q Consensus 182 ~~~~~~~~~------~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~K 255 (785)
++++..... ..-++..|.+.+|.+.+|||||.++. -+|++||++ +++.++....-...-+.|
T Consensus 227 vPp~~~~e~~~~~~ft~ee~~~L~~~~d~fsLmTYd~s~~~---~pg~nap~~---------wi~~~l~~l~~~s~~r~K 294 (392)
T KOG2091|consen 227 VPPVIEEENGQLKFFTPEEFSKLVAVYDGFSLMTYDYSLVQ---GPGPNAPLE---------WIRHCLHHLGGSSAKRPK 294 (392)
T ss_pred eCCCCcCCCCCcCcCCHHHHHHHHHhhhheeEEEeeccccc---CCCCCCCHH---------HHHHHHHHhCCccccccc
Confidence 444322221 12357889999999999999997642 389999988 889998876655566789
Q ss_pred eeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeee-----ecCCEEEEe
Q 003932 256 LVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYF-----STGTVWFGF 330 (785)
Q Consensus 256 lvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~-----~~~~~~i~y 330 (785)
+.+|+-|||..|...+ | .+.++-......++... ....||+.+...++ .++++-|.|
T Consensus 295 iLlGlNFYG~d~~~gd----g------------~~~IT~~rYL~lLk~~k--~~~~~Dees~EH~f~~k~n~~gkhivfy 356 (392)
T KOG2091|consen 295 ILLGLNFYGNDFNLGD----G------------GEAITAKRYLQLLKGEK--SVFKFDEESKEHFFEYKRNDDGKHIVFY 356 (392)
T ss_pred eeEeeeccccccccCC----C------------CCceeHHHHHHHHhccC--cceeeccccchhheeeeccCCCceEEEe
Confidence 9999999999996411 1 12344455555555433 67789999998776 245899999
Q ss_pred CCHHHHHHHHhhhcccCccceEeeecccc
Q 003932 331 DDVEAVRAKIAYAKEKRLLGYYAWQVSFD 359 (785)
Q Consensus 331 dd~~Si~~K~~~~~~~glgG~~~W~l~~D 359 (785)
.+-.|+..+.++|++.|. |++||++++-
T Consensus 357 PTL~Sl~~Ri~lA~~~gv-gISIWe~GqG 384 (392)
T KOG2091|consen 357 PTLTSLELRIELARELGV-GISIWEYGQG 384 (392)
T ss_pred cchHhHHHHHHHHHHhCC-ceEeeeccCc
Confidence 999999999999999995 9999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=194.04 Aligned_cols=266 Identities=18% Similarity=0.227 Sum_probs=199.3
Q ss_pred cCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
-.|.++++||+|+||.++.|+ +-+++.||||.-...+ +..++..|.+..+.| ..++|..++.+-..+.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 478999999999999999998 5679999999875543 335788899999988 578999999888888888999998
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-----Cceeeccccceeee
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-----MKPKISDFGMARIF 616 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-----~~~kl~Dfg~a~~~ 616 (785)
+ |-||.++..- ....++.+++..+|.|++.-++|+|+++ +|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 8899887743 3445899999999999999999999987 9999999999999743 35899999999987
Q ss_pred cccccccc-----cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 617 AKESLEEN-----TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 617 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
.+...... .....||.+||+=....+.+-+.+.|+-|||-+++..|-|..||.......+-...+. +.+.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK----IGe~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK----IGETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH----hcccc
Confidence 65433221 2345799999999999999999999999999999999999999986554443222221 11111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCC
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINT 746 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 746 (785)
..--+.. |... . +.++..-+.-.-..+..+-|..+-+...+.........
T Consensus 256 r~T~i~~-Lc~g-~---P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 256 RSTPIEV-LCEG-F---PEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred ccCCHHH-HHhc-C---HHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 1111111 1111 1 22333333334456888889988887777665544433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-22 Score=208.90 Aligned_cols=168 Identities=17% Similarity=0.189 Sum_probs=129.9
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEeC--CCcEEEEEEcCCC-----ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVLP--CGEVIAVKKLSKT-----STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS 532 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 532 (785)
.....+|.+.+.||+|+||+||+|+.. +++.+|||++... .....+.+.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 344578999999999999999999854 5777899987533 12234568999999999999999853322 2
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecc-cCCCEEEcCCCceeecccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL-KVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di-kp~Nill~~~~~~kl~Dfg 611 (785)
...++||||+++++|.. +. . .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++++||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 46799999999999962 21 1 01 1467889999999999986 999999 9999999999999999999
Q ss_pred ceeeecccccccc------cccccccCCcccccccCCC
Q 003932 612 MARIFAKESLEEN------TEQVVGTIGYIPPEYATKG 643 (785)
Q Consensus 612 ~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 643 (785)
+++.+........ .....+++.|+|||.+.-.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9998754332111 1346788899999988643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=191.30 Aligned_cols=266 Identities=18% Similarity=0.243 Sum_probs=201.9
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC-CceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 540 (785)
..+|.++++||.|+||.+|.|. ..+|+.||+|+-+..... .++..|..+.+.|++ ..|..+..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 5679999999999999999998 567999999998665433 467789999999975 688888888888889999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---CCceeeccccceeeec
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---AMKPKISDFGMARIFA 617 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg~a~~~~ 617 (785)
.+ |-||.+++.- ....++.++.+-++.|++.-++|+|..+ ++||||||+|+|..- -.++.|+|||+++.+.
T Consensus 92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 8899887742 3345888999999999999999999887 999999999999963 3468999999998875
Q ss_pred cccccc-----ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 618 KESLEE-----NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 618 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
+..... ......||.+|.+-....+..-+.+.|+-|+|.+|..+.-|..||.........+..+.. .+.+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI----~EkK~ 241 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI----SEKKM 241 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH----HHhhc
Confidence 432221 234567999999998888888899999999999999999999999865443322222222 11111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNIN 745 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 745 (785)
. ..-..+... .+.++.-.+.=|-..-.++-|...-+.+.++-+...+.
T Consensus 242 s-~~ie~LC~G----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 242 S-TPIEVLCKG----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred C-CCHHHHhCC----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 1 111112122 23456667777888888899988877777766554443
|
|
| >cd02877 GH18_hevamine_XipI_class_III This conserved domain family includes xylanase inhibitor Xip-I, and the class III plant chitinases such as hevamine, concanavalin B, and PPL2, all of which have a glycosyl hydrolase family 18 (GH18) domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-20 Score=189.44 Aligned_cols=201 Identities=15% Similarity=0.102 Sum_probs=130.1
Q ss_pred EEEEecCCC-CCCcCCC-CCCCCceEEEEEEEeeCCcc--EEecCCCccH------HHHHHHHHHHHhcCCCceEEEEec
Q 003932 28 RVGYLNLSE-VSTISGI-NYDLFTHLICSSADINSTTY--QLSLSLPSDE------NQIAKFADTVKKKNPSITTILSIG 97 (785)
Q Consensus 28 ~vgY~~~~~-~~~~~~i-~~~~~Thi~~~f~~~~~~~~--~~~~~~~~~~------~~~~~~~~~~k~~~p~lkv~~sig 97 (785)
++.||-... ..+++.. +...++-|+++|+..-.+++ .+.+...-.. .++...++.++++ ++|||+|||
T Consensus 3 v~vyWGq~~~~~~L~~~C~~~~~dii~i~Fl~~~~~~~~p~~n~~~~c~~~~~~~c~~~~~dI~~cq~~--G~KVlLSIG 80 (280)
T cd02877 3 IAVYWGQNSDEGSLREYCDTGNYDIVNISFLNVFGSGGTPGLNFAGHCGGSTYPNCPQLGADIKHCQSK--GKKVLLSIG 80 (280)
T ss_pred eEEECCCCCCCCCHHHHhCCCCccEEEEEeEcccCCCCCcccCccccCcccccccchhHHHHHHHHHHC--CCEEEEEcc
Confidence 567873322 3344433 33468999999997665432 2333322111 3677777766654 699999999
Q ss_pred CCCCCCcccchhhhcChhhhHHHHHHHHHHH------------HHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhh
Q 003932 98 QGKDTNYSIYSSMVRNSSHRKSFIDSSIRIA------------RLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATK 165 (785)
Q Consensus 98 G~~~~~~~~fs~~~~~~~~r~~fi~si~~~~------------~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~ 165 (785)
||+.+.+ | ++++.|++|++++.++. .+++|||||||||+|.. .+|..|+++||+.+..
T Consensus 81 G~~~~~~--~----~s~~~a~~Fa~~l~~~~~~~~~~~~~rp~g~~~lDGiD~D~E~~~~----~~~~~l~~~LR~~~~~ 150 (280)
T cd02877 81 GAGGSYS--L----SSDADAKDFADYLWNAFGGGTDSGVPRPFGDAVVDGFDFDIEHGSP----ENYDALAKRLRSLFAS 150 (280)
T ss_pred CCCCCcC--C----CCHHHHHHHHHHHHHHhCCccccccccccccccccceEEecccCCc----cCHHHHHHHHHHHhhc
Confidence 9876533 3 78899999999998775 26789999999999953 6899999999998864
Q ss_pred hhhhcccccceeEEEEeecccCCCCccccHHHHHh-ccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q 003932 166 LDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQR-NLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLK 244 (785)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~ 244 (785)
.. .+++.+++++..+ ....+....+.. ++||||+|.||..+- .+. .+. ........+
T Consensus 151 ~~-----~~~~~LTaAPq~~---~~d~~~~~~i~~~~~D~i~vqfYn~~~c--------~~~-~~~-----~~~~~~~~~ 208 (280)
T cd02877 151 DP-----SKKYYLTAAPQCP---YPDASLGDAIATGLFDFIFVQFYNNPCC--------SYA-SGN-----ASGFNFNWD 208 (280)
T ss_pred cc-----CCceEEEeccccC---CcchhHHHHHccCccCEEEEEEecCccc--------ccc-ccc-----cchhhhHHH
Confidence 21 1234444433221 233355556664 999999999995321 000 000 012334566
Q ss_pred HHHHcCCCC---Cceeeccccc
Q 003932 245 AWIERGLSA---DKLVMCLPFY 263 (785)
Q Consensus 245 ~~~~~gvp~---~KlvlGip~Y 263 (785)
.|... ++. .||+||+|..
T Consensus 209 ~w~~~-~~~~~~~kv~lGlpas 229 (280)
T cd02877 209 TWTSW-AKATSNAKVFLGLPAS 229 (280)
T ss_pred HHHHh-cccCCCceEEEecccC
Confidence 67764 665 8999999975
|
Hevamine is a class III endochitinase that hydrolyzes the linear polysaccharide chains of chitin and peptidoglycan and is important for defense against pathogenic bacteria and fungi. PPL2 (Parkia platycephala lectin 2) is a class III chitinase from Parkia platycephala seeds that hydrolyzes beta(1-4) glycosidic bonds linking 2-acetoamido-2-deoxy-beta-D-glucopyranose units in chitin. |
| >cd06543 GH18_PF-ChiA-like PF-ChiA is an uncharacterized chitinase found in the hyperthermophilic archaeon Pyrococcus furiosus with a glycosyl hydrolase family 18 (GH18) catalytic domain as well as a cellulose-binding domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=193.81 Aligned_cols=151 Identities=11% Similarity=0.064 Sum_probs=113.9
Q ss_pred CCCCceEEEEEEEeeCCccEEecCCCc--c-HHHHHHHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHH
Q 003932 45 YDLFTHLICSSADINSTTYQLSLSLPS--D-ENQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFI 121 (785)
Q Consensus 45 ~~~~Thi~~~f~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi 121 (785)
-..|+|++++|+....++ ........ + ...+.+.+..+|+++ +||++|||||.+.. | ..+...|++|+
T Consensus 23 ~~g~~~v~lAFi~~~~~~-~~~w~g~~~~~~~~~~~~~i~~lk~~G--~kViiS~GG~~g~~---~---~~~~~~~~~~~ 93 (294)
T cd06543 23 ATGVKAFTLAFIVASGGC-KPAWGGSYPLDQGGWIKSDIAALRAAG--GDVIVSFGGASGTP---L---ATSCTSADQLA 93 (294)
T ss_pred HcCCCEEEEEEEEcCCCC-cccCCCCCCcccchhHHHHHHHHHHcC--CeEEEEecCCCCCc---c---ccCcccHHHHH
Confidence 358999999999887554 44443221 1 345566677799886 89999999987532 3 33788999999
Q ss_pred HHHHHHHHHcCCceeeeeccCCCCCCCc---hhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCC-CCccccHHH
Q 003932 122 DSSIRIARLYGFRGLDFAWTAPNTSTDM---FNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSP-PANSYLLNS 197 (785)
Q Consensus 122 ~si~~~~~~y~~DGiDiDwE~p~~~~d~---~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 197 (785)
+++.+++++|+|||||||||+|. ..++ +++..+|++|++++. ...++++++..+.. ...++++.+
T Consensus 94 ~a~~~~i~~y~~dgiDfDiE~~~-~~d~~~~~~~~~al~~Lq~~~p----------~l~vs~Tlp~~p~gl~~~g~~~l~ 162 (294)
T cd06543 94 AAYQKVIDAYGLTHLDFDIEGGA-LTDTAAIDRRAQALALLQKEYP----------DLKISFTLPVLPTGLTPDGLNVLE 162 (294)
T ss_pred HHHHHHHHHhCCCeEEEeccCCc-cccchhHHHHHHHHHHHHHHCC----------CcEEEEecCCCCCCCChhHHHHHH
Confidence 99999999999999999999995 4554 788888999987763 44566666554432 235677888
Q ss_pred HHh----ccceeeeeeccCCCc
Q 003932 198 IQR----NLNWIHAVTASYYEP 215 (785)
Q Consensus 198 l~~----~~D~v~vm~yd~~~~ 215 (785)
.+. .+|+||+|+|||+++
T Consensus 163 ~a~~~Gv~~d~VNiMtmDyg~~ 184 (294)
T cd06543 163 AAAANGVDLDTVNIMTMDYGSS 184 (294)
T ss_pred HHHHcCCCcceeeeeeecCCCC
Confidence 888 899999999998753
|
Members of this domain family are found not only in archaea but also in eukaryotes and prokaryotes. PF-ChiA exhibits hydrolytic activity toward both colloidal and crystalline (beta/alpha) chitins at high temperature. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-19 Score=193.07 Aligned_cols=262 Identities=28% Similarity=0.359 Sum_probs=196.3
Q ss_pred CCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChh---hHHHHHHHHHHHHcCCCC-ceeeEEEEEecCCccEEEEEe
Q 003932 466 FSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQ---GFEEFKNEVMLTAKLQHV-NLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 541 (785)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++...+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999976 77899998765332 366789999999999988 799999999777778999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-ceeeccccceeeecccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFGMARIFAKES 620 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~ 620 (785)
+.++++.+++........++......+..|++.++.|+|..+ ++|||+||+||+++..+ .++++|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999866643211126888999999999999999999987 99999999999999988 79999999998655432
Q ss_pred ccc----ccccccccCCcccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 621 LEE----NTEQVVGTIGYIPPEYATK---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 621 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..|+...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 221 2456789999999999988 57889999999999999999999995543321 0011111111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467889999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-21 Score=219.80 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=183.6
Q ss_pred CcceeeceeCcEEEEEEEe-CCCcEEEEEEcC----CC-Ch-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 467 SIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLS----KT-ST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~----~~-~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
...+++|.|.+|.|+.... ...+..+.|.++ .. .. .....+..|+-+-..+.|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3457899999998877763 233444444433 11 11 11112556777778889999988777766665555569
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||++ +|..++.. ...+....+..++.|+..|+.|||+.+ +.|||+|++|++++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99888843 235777888899999999999999997 999999999999999999999999999887554
Q ss_pred ccc--cccccccccCCcccccccCCCCCCC-hhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 620 SLE--ENTEQVVGTIGYIPPEYATKGVYST-KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 620 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... ......+|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+... . ...........
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~-----~~~~~~~~~~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K-----TNNYSDQRNIF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-h-----hhccccccccc
Confidence 333 3455678999999999999999876 4899999999999999999997655444321 0 00000000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. -........+.+...++.++|+.||.+|.|+++|++
T Consensus 548 ~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 E--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 000011223446788999999999999999999974
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-21 Score=215.86 Aligned_cols=250 Identities=18% Similarity=0.212 Sum_probs=180.5
Q ss_pred CCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh----hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST----QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++...+.||++.|=.|.+|+.+.|. |+||++-+..+ ....+..+|++ ...++|||.+++.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777899999999999999988776 89999876642 23334444555 556699999998887766777888988
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec-c-
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA-K- 618 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~-~- 618 (785)
|+.. +|.+.| ..++.+...+...|+.|++.||.-+|..+ |+|||||.+|||++.-.-+.|+||..-+... +
T Consensus 102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 8854 776666 34566788888899999999999999887 9999999999999999999999997654321 1
Q ss_pred ---cccccccccccccCCcccccccCCC----------C-CCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHH
Q 003932 619 ---ESLEENTEQVVGTIGYIPPEYATKG----------V-YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHA 683 (785)
Q Consensus 619 ---~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 683 (785)
.++.-..+......+|.|||.+... . .+++.||||+||+++||++ |++||... ..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----------QL 244 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----------QL 244 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----------HH
Confidence 1111112233445689999977431 2 6789999999999999997 78877521 11
Q ss_pred HHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 684 YELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 684 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
..+-. +. .......++... ...+++++..|++.||.+|-++++.++.-++
T Consensus 245 ~aYr~-~~-~~~~e~~Le~Ie----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 245 LAYRS-GN-ADDPEQLLEKIE----DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HhHhc-cC-ccCHHHHHHhCc----CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 11111 11 111111111111 1268899999999999999999999987443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.4e-20 Score=180.35 Aligned_cols=170 Identities=13% Similarity=0.130 Sum_probs=131.0
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhH---HH------HHHHHHHHHcCCCCceeeEEEEEecC
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGF---EE------FKNEVMLTAKLQHVNLIRVLGFCIDS 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 532 (785)
...+|...++||.|+||.||++.. ++..+|+|.++....... .. +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999765 477899999975432221 22 67899999999999999998886533
Q ss_pred --------CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc
Q 003932 533 --------EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK 604 (785)
Q Consensus 533 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 604 (785)
...+|+|||++|.+|.++.. ++. ....+++.++..||..+ ++|||++|+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977631 222 24558999999999886 99999999999999988
Q ss_pred eeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHH
Q 003932 605 PKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQI 661 (785)
Q Consensus 605 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~el 661 (785)
++|+|||......... .. ..+.....+..++|+||||+.+.-+
T Consensus 173 i~liDfg~~~~~~e~~---a~-----------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 173 LRIIDLSGKRCTAQRK---AK-----------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEEEECCCcccccchh---hH-----------HHHHHHhHhcccccccceeEeehHH
Confidence 9999999876542111 00 0133444566789999999998755
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-19 Score=175.26 Aligned_cols=139 Identities=17% Similarity=0.154 Sum_probs=106.9
Q ss_pred ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChh--h-------H-----------------HHHHHHHHHHHcCCCCce
Q 003932 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQ--G-------F-----------------EEFKNEVMLTAKLQHVNL 522 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 522 (785)
.+.||+|++|.||+|...+|+.||+|+++..... . . .....|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999999754211 0 0 122359999999987776
Q ss_pred eeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEecccCCCEEEcC
Q 003932 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL-QEYSRLTIIHRDLKVSNILLGE 601 (785)
Q Consensus 523 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dikp~Nill~~ 601 (785)
.....+.. ...++||||++++++...+. ....++......++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 43332222 23489999999887754432 224578899999999999999999 5665 99999999999998
Q ss_pred CCceeeccccceeee
Q 003932 602 AMKPKISDFGMARIF 616 (785)
Q Consensus 602 ~~~~kl~Dfg~a~~~ 616 (785)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.3e-19 Score=189.66 Aligned_cols=219 Identities=26% Similarity=0.376 Sum_probs=164.1
Q ss_pred HHcCCCCceeeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEeccc
Q 003932 514 TAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 593 (785)
Q Consensus 514 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 593 (785)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-...+.++|+.||.|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568999999999999999999999999999999999965 3456889999999999999999999763 23999999
Q ss_pred CCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCC-------CCChhhHHHHHHHHHHHHcCCC
Q 003932 594 VSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV-------YSTKSDVFSFGVLLLQIISGKR 666 (785)
Q Consensus 594 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvvl~elltG~~ 666 (785)
+.|+++|..+.+||+|||+.................-..-|.|||.++... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987764211111111222456799999997742 4678999999999999999999
Q ss_pred CCcccCCCCcc-cHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 667 LSMLCGINENL-SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 667 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
||......... .++... ...+ ...+.+.+.... .....+..++..||..+|.+||+++++-..++.....
T Consensus 157 ~~~~~~~~~~~~eii~~~---~~~~--~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRV---KKGG--SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHHH---HhcC--CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99764443332 122221 1111 111111111110 2233688999999999999999999999999886543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=169.41 Aligned_cols=140 Identities=19% Similarity=0.222 Sum_probs=110.0
Q ss_pred ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChh--------------------------hHHHHHHHHHHHHcCCCCce
Q 003932 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQ--------------------------GFEEFKNEVMLTAKLQHVNL 522 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 522 (785)
...||+|++|.||+|...+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999778999999998764211 01224578999999999987
Q ss_pred eeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecccCCCEEEcC
Q 003932 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKVSNILLGE 601 (785)
Q Consensus 523 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~ 601 (785)
.....+... ..++||||++++++..... ....++......++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 3489999999886543321 22346778889999999999999998 65 99999999999999
Q ss_pred CCceeeccccceeeec
Q 003932 602 AMKPKISDFGMARIFA 617 (785)
Q Consensus 602 ~~~~kl~Dfg~a~~~~ 617 (785)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-18 Score=172.33 Aligned_cols=234 Identities=18% Similarity=0.240 Sum_probs=148.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCC----------CceeeEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQH----------VNLIRVLGFC 529 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~ 529 (785)
..+...+.||.|+++.||.++.. +++.+|+|++.... ....+++++|.-....+.+ -.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 34566789999999999999964 68999999986432 3456677777655544322 1222222211
Q ss_pred e------------cCC-----ccEEEEEecCCCChhhhhcC---Cc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 003932 530 I------------DSE-----ERMLIYEYMPNKSLDCYLFD---PI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTII 588 (785)
Q Consensus 530 ~------------~~~-----~~~lv~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 588 (785)
. +.+ ..+++|+-+ .++|..++.. .. ....+....++.+..|+++.+++||+.+ ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 111 235677776 6688777532 11 1223445667778899999999999997 99
Q ss_pred EecccCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCC--------CCCCChhhHHHHHHHHHH
Q 003932 589 HRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK--------GVYSTKSDVFSFGVLLLQ 660 (785)
Q Consensus 589 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvvl~e 660 (785)
|+||+|+|++++.+|.+.|+||+.....+.... ....+..|.+||.... ..++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999999998776433211 1233578999996643 247889999999999999
Q ss_pred HHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 003932 661 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDR 727 (785)
Q Consensus 661 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 727 (785)
|+||+.|+........... .+. .+...++.+..||..+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-------------------~f~--~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-------------------DFS--RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-------------------GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-------------------cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999875432211100 111 122566788999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-17 Score=160.99 Aligned_cols=189 Identities=16% Similarity=0.127 Sum_probs=140.4
Q ss_pred CcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChh----hHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEEEEe
Q 003932 467 SIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQ----GFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.+...|++|+||+|+.+.. .+..++.+.+.....- ....+.+|+++|++|. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999998766 4777887777654331 1225789999999995 5789999886 356999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecc-cCCCEEEcCCCceeeccccceeeecccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL-KVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di-kp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
+.|.+|...+. . ....++.|++++|.++|..+ |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998864331 0 11357788999999999987 999999 7999999999999999999998654332
Q ss_pred cc------cc-----cccccccCCcccccccCCC-CCC-ChhhHHHHHHHHHHHHcCCCCCcccCC
Q 003932 621 LE------EN-----TEQVVGTIGYIPPEYATKG-VYS-TKSDVFSFGVLLLQIISGKRLSMLCGI 673 (785)
Q Consensus 621 ~~------~~-----~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvvl~elltG~~p~~~~~~ 673 (785)
.. +. ......++.|++|+...-- ..+ ...+.++-|+-+|.++|++.+....++
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 10 00 0112357788888754432 233 578999999999999999988765444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-18 Score=201.01 Aligned_cols=201 Identities=20% Similarity=0.255 Sum_probs=161.8
Q ss_pred HHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC---CCceeeEEEEEecCC
Q 003932 457 ADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSE 533 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 533 (785)
.+.+...+.|.+.+.||+|+||.||+|...+|+.||+|+-.....-+ |.--.+++.+|+ -+-|.++..++.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 45566678999999999999999999997779999999987765432 222233444444 234445555555567
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-------CCCcee
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG-------EAMKPK 606 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-------~~~~~k 606 (785)
..+||+||.+.|+|.+++. ....+++.....++.|+++.+..||..+ |||+||||+|+||. ++--++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 7899999999999999985 4567899999999999999999999987 99999999999994 234589
Q ss_pred eccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCC
Q 003932 607 ISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~ 666 (785)
|+|||.+-.+..-.........++|-.+-.+|...|.+.+.++|.|.|+.+++-||.|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999877654333334556788999999999999999999999999999999999984
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-19 Score=192.23 Aligned_cols=232 Identities=22% Similarity=0.277 Sum_probs=177.7
Q ss_pred eeceeCcEEEEEEE----eCCCcEEEEEEcCCCChh--hHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEEEEecC
Q 003932 471 KLGEGGYGPVYKGV----LPCGEVIAVKKLSKTSTQ--GFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
.+|+|+||.|+++. .+.+..+|+|++.+.... .......|..++...+ ||.++++...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 345778999998765321 1124556788888886 9999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+|.|...+.. ...+++.........++-++.++|+.+ ++|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9999877743 344666666677778899999999987 99999999999999999999999999987543321
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 703 (785)
.+||..|||||++. .....+|.||||++++||+||..|+.. + ......+ ..-.
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~------~~~~Il~-----------~~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D------TMKRILK-----------AELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H------HHHHHhh-----------hccC
Confidence 28999999999998 457889999999999999999999864 1 1111111 0112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHH
Q 003932 704 NSPCKLMRCLEIALLCVQENPNDRPSM--LEVSSML 737 (785)
Q Consensus 704 ~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~L 737 (785)
.+.........++..++..+|..|--. ..+.++.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 233445567788888999999999755 3444444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=160.40 Aligned_cols=135 Identities=20% Similarity=0.215 Sum_probs=103.7
Q ss_pred cceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-----CCCceeeEEEEEecCC---c-cEEE
Q 003932 468 IRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-----QHVNLIRVLGFCIDSE---E-RMLI 538 (785)
Q Consensus 468 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lv 538 (785)
-.+.||+|+||.||. .-.++. .+||++........+.+.+|+.+++++ .||||++++|++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 347899999999996 323333 479988765444557789999999999 5799999999998764 2 3378
Q ss_pred EEe--cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEEecccCCCEEEcC----CCceeecccc
Q 003932 539 YEY--MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL-LYLQEYSRLTIIHRDLKVSNILLGE----AMKPKISDFG 611 (785)
Q Consensus 539 ~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dikp~Nill~~----~~~~kl~Dfg 611 (785)
+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +++++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 6689999999542 24444 34567777777 9999987 999999999999974 3479999944
Q ss_pred ce
Q 003932 612 MA 613 (785)
Q Consensus 612 ~a 613 (785)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >COG3469 Chitinase [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-15 Score=142.59 Aligned_cols=180 Identities=13% Similarity=0.188 Sum_probs=115.4
Q ss_pred CCCCCCCcEEEEEecCCCCC--------CcCCCC----CCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhc
Q 003932 19 HPAKAKPWIRVGYLNLSEVS--------TISGIN----YDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKK 86 (785)
Q Consensus 19 ~~~~~~~~~~vgY~~~~~~~--------~~~~i~----~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~ 86 (785)
....++.++.||||.+|..- +..+|. +..+..+..+|..-..+=.+..+. ...+.++++.+.+|.++
T Consensus 19 vm~~~~~KvLvGyWHnw~sgaaDgyq~gs~adial~d~~~~ynvv~V~Fmk~~g~iptf~P~-~~~daeFr~~v~aLnae 97 (332)
T COG3469 19 VMPDISNKVLVGYWHNWKSGAADGYQQGSSADIALADTPRNYNVVTVSFMKGAGDIPTFKPY-NDPDAEFRAQVGALNAE 97 (332)
T ss_pred hccccccceEEEeeecccccccccccccceeeeEeccCCcccceEEEEEeecCCCCcccCcC-CCCHHHHHHHHHHhhcc
Confidence 34445667999999988321 111211 234556666665333221111111 12346777777777666
Q ss_pred CCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCC-CCch-hHHHHHHHHHHHhh
Q 003932 87 NPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTS-TDMF-NIGLLFDEWRIAAT 164 (785)
Q Consensus 87 ~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~-~d~~-~~~~ll~~lr~~l~ 164 (785)
. --|++|+||....- --.....+.|+++|++++++|||||+|||.|.-... .|.+ -...++|.+++.-+
T Consensus 98 G--kavllsLGGAdghI-------eL~~~qE~~fv~eiirlietyGFDGLDiDLEq~ai~~~dnq~v~p~alk~vk~hyk 168 (332)
T COG3469 98 G--KAVLLSLGGADGHI-------ELKAGQEQAFVNEIIRLIETYGFDGLDIDLEQSAILAADNQTVIPAALKAVKDHYK 168 (332)
T ss_pred C--cEEEEEccCccceE-------EeccchHHHHHHHHHHHHHHhCCCccccchhhhhhhhcCCeeehHHHHHHHHHHHH
Confidence 3 67889999764421 122334679999999999999999999999965321 2322 55667777776655
Q ss_pred hhhhhcccccceeEEEEeecccCCCCcccc--HHHHHhccceeeeeeccCCC
Q 003932 165 KLDAKNSTRQQSLLILTARFRYSPPANSYL--LNSIQRNLNWIHAVTASYYE 214 (785)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~D~v~vm~yd~~~ 214 (785)
. ..+++.++++...++-...+.|- +.++..+.|||+.+-|+--|
T Consensus 169 ~------~Gk~f~itMAPEfPYl~~~gaY~pyin~l~~~yD~i~pQlYNqGG 214 (332)
T COG3469 169 N------QGKNFFITMAPEFPYLQGWGAYIPYINELRDYYDFIAPQLYNQGG 214 (332)
T ss_pred h------cCCceEEEecCCCceecCCcccchHHHHHhhHHhhhhHHHhcCCC
Confidence 4 33477777777777655555553 78899999999999998543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=159.24 Aligned_cols=198 Identities=21% Similarity=0.248 Sum_probs=136.1
Q ss_pred CCCceeeEEEEEec---------------------------CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHH
Q 003932 518 QHVNLIRVLGFCID---------------------------SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIE 570 (785)
Q Consensus 518 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 570 (785)
+|||||+++++|.+ ...+|+||...+ -+|..++.. ...+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 68999998887653 235678888764 478888743 2345566677889
Q ss_pred HHHHHHHHHhhcCCCCeEEecccCCCEEEc--CCC--ceeeccccceeeecccccccc----cccccccCCcccccccCC
Q 003932 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLG--EAM--KPKISDFGMARIFAKESLEEN----TEQVVGTIGYIPPEYATK 642 (785)
Q Consensus 571 ~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~--~~kl~Dfg~a~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~ 642 (785)
|+++|+.|||.++ |.|||+|++|||+. +++ .+.|+|||++---......-. .-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999987 99999999999994 333 478999998754332211111 112347788999998865
Q ss_pred CC------CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHH
Q 003932 643 GV------YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIA 716 (785)
Q Consensus 643 ~~------~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li 716 (785)
.+ --.|+|.|+.|.+.||+++...||...++.. .+...+...+ + ...+...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~q-------------L-Palp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQ-------------L-PALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhh-------------C-CCCcccCChHHHHHH
Confidence 33 1358999999999999999999998644321 1111111110 0 011222344678899
Q ss_pred HHccccCCCCCCCHHHHHHHHh
Q 003932 717 LLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 717 ~~cl~~dP~~RPs~~evl~~L~ 738 (785)
...|+.||++|++..-....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999876655554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.8e-16 Score=157.23 Aligned_cols=143 Identities=17% Similarity=0.169 Sum_probs=111.0
Q ss_pred cCCCcceeeceeCcEEEEEEE--eCCCcEEEEEEcCCCChh------------------------hHHHHHHHHHHHHcC
Q 003932 464 ERFSIRNKLGEGGYGPVYKGV--LPCGEVIAVKKLSKTSTQ------------------------GFEEFKNEVMLTAKL 517 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 517 (785)
..|.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 458899999999999999998 567999999998753210 012356899999999
Q ss_pred CCC--ceeeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCC
Q 003932 518 QHV--NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVS 595 (785)
Q Consensus 518 ~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~ 595 (785)
.+. .+.++++. ...++||||+++++|...... ...........++.|++.++.+||+.+ +++||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 753 34455543 235899999999888665422 233555667889999999999999875 3999999999
Q ss_pred CEEEcCCCceeeccccceeee
Q 003932 596 NILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 596 Nill~~~~~~kl~Dfg~a~~~ 616 (785)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.6e-16 Score=154.07 Aligned_cols=134 Identities=20% Similarity=0.285 Sum_probs=111.3
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST--------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|+.++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 467789998654321 1123577899999999999988777777777888999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++|++|.+++... .. .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887431 11 77889999999999999886 99999999999999 78999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.7e-17 Score=171.96 Aligned_cols=175 Identities=25% Similarity=0.339 Sum_probs=129.4
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
.+++.|++|...+|.++|..+......++.....++.|++.++.| . +.+|||+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999766556667888899999999999999 3 3899999999999999999999999998
Q ss_pred eeecccc----cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCcccCCCCcccHHHHHHHHHh
Q 003932 614 RIFAKES----LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG-KRLSMLCGINENLSILEHAYELWK 688 (785)
Q Consensus 614 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 688 (785)
....... .....+...||..||+||.+.+..|+.|+||||||++|+||+.- ...++. .....-+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence 8765443 11123456799999999999999999999999999999999872 221111 01111111
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 003932 689 GGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733 (785)
Q Consensus 689 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 733 (785)
.+... ...+.+. +.-..++.+++.+.|.+||++.+.
T Consensus 474 ~g~ip---~~~~~d~------p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIP---PEFLQDY------PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCC---hHHhhcC------cHHHHHHHHhcCCCcccCchHHHH
Confidence 11111 0111111 123468999999999999954443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=150.89 Aligned_cols=139 Identities=20% Similarity=0.197 Sum_probs=108.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh----------------------hhHHHHHHHHHHHHcCCCC
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST----------------------QGFEEFKNEVMLTAKLQHV 520 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~ 520 (785)
...|.+.+.||+|+||.||++...+|+.+|||+++.... ........|+.++..+.|+
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 334788899999999999999987899999998764321 0112356788888888777
Q ss_pred --ceeeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 521 --NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 521 --niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
.+...++. ...++||||+++++|...... .....++.+++.++.++|+.+ ++||||+|+||+
T Consensus 94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nil 157 (198)
T cd05144 94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNIL 157 (198)
T ss_pred CCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEE
Confidence 44444442 456899999999998765420 234578889999999999876 999999999999
Q ss_pred EcCCCceeeccccceeeec
Q 003932 599 LGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~ 617 (785)
+++++.++|+|||++....
T Consensus 158 l~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EcCCCcEEEEECCccccCC
Confidence 9999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.6e-16 Score=173.38 Aligned_cols=242 Identities=20% Similarity=0.252 Sum_probs=157.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.+|+.++.|..|++|.||.+++. +.+.+|+ ++++...- +++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li----lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI----LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccchh----hhc---cccccCCccee-------------------
Confidence 57888999999999999999865 4567788 44433211 011 22222333333
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc-
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL- 621 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~- 621 (785)
|+-...+.. .+.++.. ++.+++|||+.+ |+|||+||+|.+++.-|++|++|||+++..-....
T Consensus 136 --gDc~tllk~---~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKN---IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhccc---CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 343333422 1223332 267899999987 99999999999999999999999999875421100
Q ss_pred -----------cc-ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhC
Q 003932 622 -----------EE-NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG 689 (785)
Q Consensus 622 -----------~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 689 (785)
.+ .....+||+.|.|||++....|...+|+|++|+++||.+-|+.||.....++.+..+-.....|.+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 01 123458999999999999999999999999999999999999999865544433222211111111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHHhcccCCCCCC----CCCCCcccccccccc
Q 003932 690 GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSML-EVSSMLKNETTNINTP----KKPAFSKQVDEIGIE 762 (785)
Q Consensus 690 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~L~~~~~~~~~~----~~~~~~~~~~~~~~~ 762 (785)
+ ......+..+++.+.|+.+|..|--.. ++.-.=+.....++.. .+..|+.+++.++..
T Consensus 280 ~--------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddt 343 (1205)
T KOG0606|consen 280 E--------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDT 343 (1205)
T ss_pred c--------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccc
Confidence 1 222334778899999999999996333 3322223333334332 245566666666543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-15 Score=149.87 Aligned_cols=130 Identities=22% Similarity=0.331 Sum_probs=104.6
Q ss_pred eeceeCcEEEEEEEeCCCcEEEEEEcCCCC--h------hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 471 KLGEGGYGPVYKGVLPCGEVIAVKKLSKTS--T------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.||+|++|.||+|... +..+++|+..... . ...+++.+|++++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999854 6789999865421 1 11245778999999998887655555555667789999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
+|++|.+++.... . .++.+++++|.+||+.+ ++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988773211 0 78899999999999886 99999999999999 88999999999765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.5e-15 Score=170.38 Aligned_cols=136 Identities=21% Similarity=0.310 Sum_probs=110.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEc-CCC-C------hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKL-SKT-S------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
..|...+.||+|+||.||+|...... +++|+. .+. . ....+.+.+|++++++++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44566789999999999999876443 344432 221 1 11234678999999999999998888888777788
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988773 34678999999999999886 9999999999999 678999999999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.5e-14 Score=133.21 Aligned_cols=135 Identities=21% Similarity=0.181 Sum_probs=114.4
Q ss_pred cceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC--CceeeEEEEEecCCccEEEEEecCCC
Q 003932 468 IRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH--VNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 468 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999764 7899999876543 4578899999999976 58999998888778899999999988
Q ss_pred ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 546 SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 546 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++..+ +......++.++++++.+||.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4566677889999999999987656799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.8e-14 Score=139.15 Aligned_cols=137 Identities=20% Similarity=0.217 Sum_probs=97.9
Q ss_pred ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChh--hHHH----------------------HHHHHHHHHcCCCC--ce
Q 003932 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQ--GFEE----------------------FKNEVMLTAKLQHV--NL 522 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni 522 (785)
.+.||+|+||.||+|...+++.||||+++..... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999998754211 1111 13456666665443 24
Q ss_pred eeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecccCCCEEEcC
Q 003932 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKVSNILLGE 601 (785)
Q Consensus 523 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~ 601 (785)
.+.+++ ...++||||++++++...... ..... .....++.+++.++.++|. .+ ++||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~---~~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK---DVRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhh---hhhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 246899999999654321111 00011 5567899999999999998 54 99999999999999
Q ss_pred CCceeeccccceeeec
Q 003932 602 AMKPKISDFGMARIFA 617 (785)
Q Consensus 602 ~~~~kl~Dfg~a~~~~ 617 (785)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.6e-15 Score=170.51 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=187.6
Q ss_pred cCCCcceeeceeCcEEEEEEEe--CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL--PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 538 (785)
..|.+.+.||+|+|+.|-.... .....+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 3567778899999999988874 334567777776553 223334556777777776 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEEecccCCCEEEcCCC-ceeeccccceeee
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ-EYSRLTIIHRDLKVSNILLGEAM-KPKISDFGMARIF 616 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~ 616 (785)
.+|..++++...+... .....+....-..+.|+..++.|+| ..+ +.||||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998777311 1113444556678899999999999 665 99999999999999999 9999999999987
Q ss_pred cc-cccccccccccc-cCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 617 AK-ESLEENTEQVVG-TIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 617 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ...|...+..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------~~~~~~~~~~ 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------YSSWKSNKGR 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc------ceeecccccc
Confidence 76 444445556778 9999999999884 4567899999999999999999998754433210 0111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS 734 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 734 (785)
...............++.+++..+|..|.+.+++.
T Consensus 250 ------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 ------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 00011111223566788899999999999988874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.6e-13 Score=137.71 Aligned_cols=134 Identities=20% Similarity=0.216 Sum_probs=102.7
Q ss_pred eeec-eeCcEEEEEEEeCCCcEEEEEEcCCCC-------------hhhHHHHHHHHHHHHcCCCCce--eeEEEEEecCC
Q 003932 470 NKLG-EGGYGPVYKGVLPCGEVIAVKKLSKTS-------------TQGFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSE 533 (785)
Q Consensus 470 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 533 (785)
..|| .|+.|+||.+... +..++||.+.... ......+.+|+.++.+++|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8888999998876 6778999885321 1223457889999999998875 66777654332
Q ss_pred ----ccEEEEEecCC-CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeec
Q 003932 534 ----ERMLIYEYMPN-KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKIS 608 (785)
Q Consensus 534 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 608 (785)
..++|||++++ .+|.+++.. ..++.. .+.+++.++.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 22599999997 688887743 234433 3568999999999987 9999999999999999999999
Q ss_pred cccceee
Q 003932 609 DFGMARI 615 (785)
Q Consensus 609 Dfg~a~~ 615 (785)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998865
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=4e-12 Score=140.24 Aligned_cols=141 Identities=21% Similarity=0.207 Sum_probs=97.7
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHH----------------------------------------HHHH
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFE----------------------------------------EFKN 509 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 509 (785)
+.||.|++|+||+|++.+|+.||||+.+........ .|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 679999999999999989999999998654211100 1334
Q ss_pred HHHHHHcC----CCCceeeEEEEEe-cCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHH-HHHHHhhcC
Q 003932 510 EVMLTAKL----QHVNLIRVLGFCI-DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ-GLLYLQEYS 583 (785)
Q Consensus 510 E~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~ 583 (785)
|...+.++ +|.+-+.+-.++. .....+|||||++|++|.++..... ... .+..++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 55444444 2333233323332 2346799999999999987763211 111 23456666665 467778765
Q ss_pred CCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 584 ~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
++|+|++|.||+++.+++++++|||++..+.+
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-12 Score=128.43 Aligned_cols=203 Identities=21% Similarity=0.204 Sum_probs=137.7
Q ss_pred HHHHcCCCCceeeEEEEEecC-----CccEEEEEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 003932 512 MLTAKLQHVNLIRVLGFCIDS-----EERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRL 585 (785)
Q Consensus 512 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 585 (785)
.-+-++-|.|||+++.|+.+. ....++.|||..|+|..+|++.. ....+......+++-||..||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 445566899999999987654 35678999999999999996532 2445778888999999999999999984 6
Q ss_pred CeEEecccCCCEEEcCCCceeeccccceeeeccc---ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHH
Q 003932 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE---SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQII 662 (785)
Q Consensus 586 ~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ell 662 (785)
+|+|+++..+-|++..+|-+|++----. ..... ..........+-++|.+||.-.....+..+|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8999999999999999998887531111 00000 0000111223567899999887777888999999999999998
Q ss_pred cCCCCCccc-CCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 663 SGKRLSMLC-GINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 663 tG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
-|..-.... ........+..+ ....... .=..++..|++..|+.||+|++++..
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~---------i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANV---------IIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhhh---------eeeccCc-----------cccCcCcccccCCCCCCcchhhhhcC
Confidence 776421110 000000000000 0000000 11247788999999999999998653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.4e-12 Score=134.88 Aligned_cols=249 Identities=22% Similarity=0.247 Sum_probs=176.9
Q ss_pred cCCCcceeece--eCcEEEEEEEe---CCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCcc
Q 003932 464 ERFSIRNKLGE--GGYGPVYKGVL---PCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 464 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 535 (785)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-..... .....=.+|+....++ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35667789999 99999999986 3577889988433221 2222224566666666 589999988888888999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEEecccCCCEEEcCC-Cceeeccc
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ----GLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDF 610 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Df 610 (785)
++-+|++ +.+|..+.+.. ...++.........+..+ ||.++|... ++|-|+||.||++..+ ..++++||
T Consensus 194 fiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 9999998 47787776542 233666677777788888 999999876 9999999999999999 88999999
Q ss_pred cceeeeccccccccc---ccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 611 GMARIFAKESLEENT---EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 611 g~a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
|+...+......... ....|...|++||...+ .++..+|||++|.+.++..+|..+....-. . .|
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~----------~W 335 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN-S----------SW 335 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-C----------Cc
Confidence 999988765433222 12357889999997764 478899999999999999888765432100 1 01
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...+...+.+.. ......++..++.++++.+|..|++.+.+..
T Consensus 336 ~~~r~~~ip~e~-----~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 SQLRQGYIPLEF-----CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccccCchhh-----hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111111111 1112234556889999999999998887753
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.8e-11 Score=115.73 Aligned_cols=131 Identities=19% Similarity=0.152 Sum_probs=97.0
Q ss_pred ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCcee-eEEEEEecCCccEEEEEecCCCCh
Q 003932 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI-RVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
.+.|+.|.++.||++... ++.+++|....... ....+..|+..++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999876 77899999865432 123467889999888655544 444443 3346899999999887
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS--RLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
.... . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 0 11235678999999999875 23469999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.8e-10 Score=123.49 Aligned_cols=167 Identities=16% Similarity=0.188 Sum_probs=126.4
Q ss_pred eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHH
Q 003932 485 LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKK 564 (785)
Q Consensus 485 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 564 (785)
..++.+|.|...........+...+-++.|+.++||||++++..+..+...|+|+|.+ ..|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 4467788888877665544556778889999999999999999999999999999987 456666633 22455
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCC
Q 003932 565 RVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV 644 (785)
Q Consensus 565 ~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 644 (785)
....+.||+.||.+||+.+ +++|++|.-..|+++..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 5667889999999999766 699999999999999999999999998866432211 111222233566776554332
Q ss_pred CCChhhHHHHHHHHHHHHcCC
Q 003932 645 YSTKSDVFSFGVLLLQIISGK 665 (785)
Q Consensus 645 ~~~~~DvwSlGvvl~elltG~ 665 (785)
-..|.|-|||+++|++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999994
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-10 Score=127.92 Aligned_cols=147 Identities=19% Similarity=0.169 Sum_probs=93.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCC-CcEEEEEEcCCCChh----------------------------------hHHH-
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPC-GEVIAVKKLSKTSTQ----------------------------------GFEE- 506 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~- 506 (785)
-..|+. +.||+|++|+||+|++.+ |+.||||+.++.-.. -.+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999876 999999999754210 0111
Q ss_pred -----HHHHHHHHHcC----CCCceeeEEEEEec-CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHH-
Q 003932 507 -----FKNEVMLTAKL----QHVNLIRVLGFCID-SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG- 575 (785)
Q Consensus 507 -----~~~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~- 575 (785)
+.+|...+.++ .+.+.+.+-.++.+ ....+|||||+.|+.+.++-.- .....+.. .++...++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~---~la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMK---LLAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHH---HHHHHHHHHH
Confidence 33344444443 24444444444433 4567899999999999764211 11111111 122221111
Q ss_pred HHHHhhcCCCCeEEecccCCCEEEcCCC----ceeeccccceeeecc
Q 003932 576 LLYLQEYSRLTIIHRDLKVSNILLGEAM----KPKISDFGMARIFAK 618 (785)
Q Consensus 576 l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfg~a~~~~~ 618 (785)
+.-+... +++|+|++|.||+++.++ +++++|||+...+.+
T Consensus 273 ~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 1222333 499999999999999888 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.4e-09 Score=103.63 Aligned_cols=136 Identities=15% Similarity=0.119 Sum_probs=98.0
Q ss_pred eeeceeCcEEEEEEEeCC-------CcEEEEEEcCCCC----------------------hhhHHHHH----HHHHHHHc
Q 003932 470 NKLGEGGYGPVYKGVLPC-------GEVIAVKKLSKTS----------------------TQGFEEFK----NEVMLTAK 516 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~ 516 (785)
..||.|--+.||.|...+ +..+|||+.+... ....+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998542 4789999975321 01122333 79999998
Q ss_pred CCC--CceeeEEEEEecCCccEEEEEecCCCChhh-hhcCCccccCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEEecc
Q 003932 517 LQH--VNLIRVLGFCIDSEERMLIYEYMPNKSLDC-YLFDPIRKLILDWKKRVHIIEGITQGLLYL-QEYSRLTIIHRDL 592 (785)
Q Consensus 517 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Di 592 (785)
+.. -++..++++ ...++||||+.++.+.. .+. ...++......+..+++.+|..| |..+ +|||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 456666654 46789999997654422 221 22344556677888999999998 6665 999999
Q ss_pred cCCCEEEcCCCceeeccccceeeec
Q 003932 593 KVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 593 kp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
++.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.1e-09 Score=108.47 Aligned_cols=142 Identities=18% Similarity=0.269 Sum_probs=109.1
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCC--CceeeEEEEEecCC---ccEEEEEecC
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQH--VNLIRVLGFCIDSE---ERMLIYEYMP 543 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 543 (785)
+.|+.|..+.||++...+|+.+++|....... .....+..|.++++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999877668899999865432 134567889999999875 34577777766542 5689999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS---------------------------------------- 583 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 583 (785)
+.++...+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765421 23666777788888888888888521
Q ss_pred -------------CCCeEEecccCCCEEEcC--CCceeeccccceee
Q 003932 584 -------------RLTIIHRDLKVSNILLGE--AMKPKISDFGMARI 615 (785)
Q Consensus 584 -------------~~~ivH~Dikp~Nill~~--~~~~kl~Dfg~a~~ 615 (785)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7e-09 Score=95.90 Aligned_cols=143 Identities=23% Similarity=0.316 Sum_probs=105.5
Q ss_pred cceeeceeCcEEEEEEEeCCCcEEEEEE-cCCCC-------hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 468 IRNKLGEGGYGPVYKGVLPCGEVIAVKK-LSKTS-------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 468 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.+..|-+|+-+.|+++... |+.+.||. +.+.- .-...+.++|++.+.++.--.|....-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999887 66666664 33321 112345678999999987667666666677778889999
Q ss_pred EecCC-CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC---ceeeccccceee
Q 003932 540 EYMPN-KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM---KPKISDFGMARI 615 (785)
Q Consensus 540 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~Dfg~a~~ 615 (785)
||+++ .++.+++.........+ .....++..|-+.+.-||..+ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 36777775433332222 333678888999999999987 99999999999997554 358999999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.7e-10 Score=120.68 Aligned_cols=251 Identities=20% Similarity=0.198 Sum_probs=174.8
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEe--CCCcEEEEEEcCCCChhhHHHH--HHHHHHHHcC-CCCceeeEEEEEecCCc
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVL--PCGEVIAVKKLSKTSTQGFEEF--KNEVMLTAKL-QHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~~~~~~~~~ 534 (785)
.....+|.++..||.|.|+.|+.... .++..|++|.+.+.......++ ..|+.+...+ .|.+++.....+..-..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34467899999999999999999873 4677899998876543332222 3455555555 58888887777777777
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-Cceeeccccce
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDFGMA 613 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a 613 (785)
.++--|||+++++...+ .....++...++++..|++.++.++|+.. ++|+|++|+||++..+ +..+++|||++
T Consensus 341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 88999999999886555 23345677778889999999999999776 9999999999999876 78899999998
Q ss_pred eeecccccccccccccccCCc-ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 614 RIFAKESLEENTEQVVGTIGY-IPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
..+.-. .......+..| .+|+......+..+.|++|||.-+.|.++|.+....... +
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------------~----- 472 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------------S----- 472 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------c-----
Confidence 643211 11111223344 366666777788999999999999999998764321110 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
..+...... ..+.....+..+...+...++..||.+.++....+.+
T Consensus 473 ~~i~~~~~p--~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 473 LTIRSGDTP--NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred eeeeccccc--CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 000000000 0111224566677888899999999999887665543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.5e-09 Score=96.77 Aligned_cols=131 Identities=21% Similarity=0.302 Sum_probs=98.0
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcC-CCC--h-----hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLS-KTS--T-----QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..+++|+-+.+|.+.+. |..+++|.=. +.- + -..+...+|..++.+++--.|....=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999765 4445555432 221 1 1223466799999988766665555566677888999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888432 2456667777888899887 99999999999998765 99999999864
|
|
| >KOG4701 consensus Chitinase [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.6e-07 Score=92.15 Aligned_cols=105 Identities=13% Similarity=0.093 Sum_probs=68.5
Q ss_pred CCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHH----------cCCceeeeeccCCCCCCCchhHHHHHH
Q 003932 88 PSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARL----------YGFRGLDFAWTAPNTSTDMFNIGLLFD 157 (785)
Q Consensus 88 p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~----------y~~DGiDiDwE~p~~~~d~~~~~~ll~ 157 (785)
.++|||+|+||+.+.= .+.+.+..+.|++.+-+..-. -=+||+|+|.|.. ....|.+|-+
T Consensus 102 ~GiKVlLSLGG~~GnY------s~~~d~dA~~fA~~LWn~Fg~G~~S~RPfg~AVvDGfDF~IE~g----~~~~ysaLA~ 171 (568)
T KOG4701|consen 102 NGIKVLLSLGGYNGNY------SLNNDDDATNFAFQLWNIFGSGEDSYRPFGKAVVDGFDFEIEKG----TNTAYSALAK 171 (568)
T ss_pred cCeEEEEeccCcccce------eeccchhHHHHHHHHHHHhcCCccccCcccchhccceeeeeecC----CcchHHHHHH
Confidence 3799999999765422 267778888999998776432 1189999999954 3456888999
Q ss_pred HHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHH-hccceeeeeecc
Q 003932 158 EWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQ-RNLNWIHAVTAS 211 (785)
Q Consensus 158 ~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~D~v~vm~yd 211 (785)
.||+.|.. +.+.+++.+++-.+.+.. .--..|. +..||+.++-|+
T Consensus 172 ~L~~~Fa~-------~~r~yYLsaAPQCP~PD~--~~G~aL~~~~fDf~~IQFYN 217 (568)
T KOG4701|consen 172 RLLEIFAS-------DPRRYYLSAAPQCPVPDH--TLGKALSENSFDFLSIQFYN 217 (568)
T ss_pred HHHHHHcc-------CCceEEeccCCCCCCCch--hhhhhhhccccceEEEEeec
Confidence 99988854 223444444433322211 1112222 458999999987
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.3e-07 Score=98.02 Aligned_cols=266 Identities=14% Similarity=0.069 Sum_probs=158.3
Q ss_pred CcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEE----Ee--c-CCccEEE
Q 003932 467 SIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGF----CI--D-SEERMLI 538 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~~--~-~~~~~lv 538 (785)
.....||+|+.+.+|-.-. -.-.+.|+..........+. +..|... .||-+-.-+.+ .. + .....+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3457899999999996431 12246688776654332222 2223222 45533221111 11 1 1225677
Q ss_pred EEecCCCCh-hhhhc---CCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 539 YEYMPNKSL-DCYLF---DPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 539 ~e~~~~gsL-~~~l~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
|..+++.-= ..++. +++..+...|.-.+++++.++.+.+.||..| .+-+|+.++|+|+.+++.|.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 777765421 22221 1233456889999999999999999999987 8889999999999999999999855433
Q ss_pred eecccccccccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcC-CCCCcccCCC-CcccHHH--HHHH
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISG-KRLSMLCGIN-ENLSILE--HAYE 685 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG-~~p~~~~~~~-~~~~~~~--~~~~ 685 (785)
... ........+|...|.+||.-. +..-+...|.|.||+++++||.| ++|+...... +...-.+ ...-
T Consensus 166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 321 223345578999999999654 33456789999999999999986 8998642210 0000011 0000
Q ss_pred HHhCCc-cccccccccCCCCCHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHhcccCC
Q 003932 686 LWKGGK-GVEFVDSFLDDRNSPCKLMRCLEIALLCVQEN--PNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 686 ~~~~~~-~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~~ 743 (785)
.+.... ...-..+.....+....+..+..+..+|+... +.-|||++..+..|.....+
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 000000 00000011111122223446777888898643 56899999887777654433
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.6e-07 Score=99.99 Aligned_cols=168 Identities=21% Similarity=0.300 Sum_probs=126.6
Q ss_pred cEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEe----cCCccEEEEEecCC-CChhhh
Q 003932 477 YGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI----DSEERMLIYEYMPN-KSLDCY 550 (785)
Q Consensus 477 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~ 550 (785)
-.+.|++.. .+|..|++|++.............-+++++++.|.|+|++..++. ....+++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 467899984 479999999995443332223344578889999999999999876 34578899999886 466665
Q ss_pred hcCC------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 551 LFDP------------IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 551 l~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
-+.. ......++...+.++.|+..||.++|+.| +..+=|.+.+||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5432 22345788999999999999999999987 88899999999999999999988887665543
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCC
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~ 666 (785)
.. . |.+.+. .+-|.=-||.+++.|.||..
T Consensus 446 d~--------------~--~~le~~---Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP--------------T--EPLESQ---QQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC--------------C--cchhHH---hhhhHHHHHHHHHHHhhccc
Confidence 32 0 111111 35699999999999999964
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.6e-09 Score=123.49 Aligned_cols=251 Identities=17% Similarity=0.175 Sum_probs=163.2
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
...+.+.+.+-+-+|+++.++.+.- ..+...+.|...... ....+....+-.++-..++|-++...--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3456788888899999999998873 234344444433221 111222222222222234465665544445567889
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
|+++|..+++|...|+... ..+.......+..+.+.+++||... +.|+|++|.|.+...++..++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999998886543 2333334445556788899999764 899999999999999999999999844322
Q ss_pred ccc----------------cc---------c----cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCC
Q 003932 617 AKE----------------SL---------E----ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667 (785)
Q Consensus 617 ~~~----------------~~---------~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p 667 (785)
.-- .. . .......+|..|.+||.+.+......+|.|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00 0 011235689999999999999999999999999999999999999
Q ss_pred CcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 003932 668 SMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSML 731 (785)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 731 (785)
+.......... -..... .... ........+...++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~f~-------ni~~~~-~~~p------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFE-------NILNRD-IPWP------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhh-------ccccCC-CCCC------CCccccChhhhhhhhhhhccCchhccCcc
Confidence 87543322211 000000 0000 01112233566788888889999998776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-07 Score=91.52 Aligned_cols=125 Identities=26% Similarity=0.283 Sum_probs=80.8
Q ss_pred EEEEEEeCCCcEEEEEEcCCCC--------------h------------hhHHHHHHHHHHHHcCCCC--ceeeEEEEEe
Q 003932 479 PVYKGVLPCGEVIAVKKLSKTS--------------T------------QGFEEFKNEVMLTAKLQHV--NLIRVLGFCI 530 (785)
Q Consensus 479 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 530 (785)
.||.|...++..+|+|+.+... . ......++|.+.|.++... ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999975321 0 0122467899999999766 466666552
Q ss_pred cCCccEEEEEecC--CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEEecccCCCEEEcCCCceee
Q 003932 531 DSEERMLIYEYMP--NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY-LQEYSRLTIIHRDLKVSNILLGEAMKPKI 607 (785)
Q Consensus 531 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dikp~Nill~~~~~~kl 607 (785)
...+||||++ |..+..+.... ++......++.+++..+.. +|..+ ++|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 55554433211 1123345566777775555 46665 9999999999999988 9999
Q ss_pred ccccceeee
Q 003932 608 SDFGMARIF 616 (785)
Q Consensus 608 ~Dfg~a~~~ 616 (785)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.1e-07 Score=95.47 Aligned_cols=141 Identities=20% Similarity=0.138 Sum_probs=97.4
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcCCCChh-hH----------HHHHHHHHHHHcCCCCc--eeeEEEEEec-----
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQ-GF----------EEFKNEVMLTAKLQHVN--LIRVLGFCID----- 531 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 531 (785)
+.+-.-....|++.... |+.+.||+....... .. ..+.+|...+.+|...+ .++++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 34443344456666554 778999977543311 01 13678888888875433 3344445432
Q ss_pred CCccEEEEEecCCC-ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-------CC
Q 003932 532 SEERMLIYEYMPNK-SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-------AM 603 (785)
Q Consensus 532 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-------~~ 603 (785)
....++|+|++++. +|.+++.... ....+......++.+++..+.-||..+ |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23478999999886 7888874321 223455667789999999999999987 999999999999975 46
Q ss_pred ceeeccccceee
Q 003932 604 KPKISDFGMARI 615 (785)
Q Consensus 604 ~~kl~Dfg~a~~ 615 (785)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.2e-07 Score=89.34 Aligned_cols=135 Identities=23% Similarity=0.235 Sum_probs=95.6
Q ss_pred CCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh----------------------hhHHHHHHHHHHHHcCCCC--c
Q 003932 466 FSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST----------------------QGFEEFKNEVMLTAKLQHV--N 521 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 521 (785)
..+.++||-|--+.||.|....|.++|||.=+.... ..+...++|.+.|++|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999997432110 1122357899999998655 6
Q ss_pred eeeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC
Q 003932 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE 601 (785)
Q Consensus 522 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~ 601 (785)
+.+.+++ +.-.+|||+++|-.|...- ++....-.++..|++-+.-+-..| |||+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7776664 4567999999886664322 122222334444444444443444 999999999999999
Q ss_pred CCceeeccccceee
Q 003932 602 AMKPKISDFGMARI 615 (785)
Q Consensus 602 ~~~~kl~Dfg~a~~ 615 (785)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.2e-08 Score=110.30 Aligned_cols=153 Identities=18% Similarity=0.187 Sum_probs=105.0
Q ss_pred HHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc-------cccccccCCcccccccCCC
Q 003932 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN-------TEQVVGTIGYIPPEYATKG 643 (785)
Q Consensus 571 ~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 643 (785)
+++.|+.|+|... ++||++|.|++|.++.++.+||+.|+.+........... .........|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4558999999764 799999999999999999999999998866543211111 1112356789999999998
Q ss_pred CCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHcccc
Q 003932 644 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQE 722 (785)
Q Consensus 644 ~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~ 722 (785)
..+.++|+||+||++|-+.. |+..+...+...... ......+- -....+...+.++.+=+.+++..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----~~~~~~~~--------~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----FSRNLLNA--------GAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhh-----hhhccccc--------ccccccccCcHHHHHHHHHHhcC
Confidence 88999999999999999984 554443322211111 11100000 00111233455788889999999
Q ss_pred CCCCCCCHHHHHHHHh
Q 003932 723 NPNDRPSMLEVSSMLK 738 (785)
Q Consensus 723 dP~~RPs~~evl~~L~ 738 (785)
++..||++.++....-
T Consensus 252 ~~~~rp~~~~l~~~~f 267 (700)
T KOG2137|consen 252 DSAVRPTLDLLLSIPF 267 (700)
T ss_pred CcccCcchhhhhcccc
Confidence 9999998888765443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.5e-06 Score=82.80 Aligned_cols=139 Identities=18% Similarity=0.203 Sum_probs=86.0
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCc--eeeEEEEEecCCccEEEEEecCCCC-
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN--LIRVLGFCIDSEERMLIYEYMPNKS- 546 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 546 (785)
..||+|..+.||+.. +..+++|...... ......+|.++++.+..-+ +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 579999999999842 4567889886543 2245688999998886443 4677888777777889999998863
Q ss_pred hhhhh---------------------cCCccccCCCHHHHH-HHHHH----------HHH-HHHHHhhc-CCCCeEEecc
Q 003932 547 LDCYL---------------------FDPIRKLILDWKKRV-HIIEG----------ITQ-GLLYLQEY-SRLTIIHRDL 592 (785)
Q Consensus 547 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~~----------i~~-~l~~LH~~-~~~~ivH~Di 592 (785)
+...+ |.. ........... .+..+ +.+ ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~-~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHST-KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCC-CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 110 00001111100 00000 001 12222211 2235799999
Q ss_pred cCCCEEEcCCCceeeccccceee
Q 003932 593 KVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 593 kp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.1e-06 Score=83.20 Aligned_cols=105 Identities=22% Similarity=0.238 Sum_probs=80.7
Q ss_pred HHHHHHHHHHHcCCCC--ceeeEEEEEecCC----ccEEEEEecCCC-ChhhhhcCCccccCCCHHHHHHHHHHHHHHHH
Q 003932 505 EEFKNEVMLTAKLQHV--NLIRVLGFCIDSE----ERMLIYEYMPNK-SLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577 (785)
Q Consensus 505 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 577 (785)
....+|...+..|... .+.+.+++..... ..++|+|++++. +|.+++..... .+......++.+++..+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 3567788877777433 3455666655432 357999999874 78888853211 555677889999999999
Q ss_pred HHhhcCCCCeEEecccCCCEEEcCCC---ceeeccccceee
Q 003932 578 YLQEYSRLTIIHRDLKVSNILLGEAM---KPKISDFGMARI 615 (785)
Q Consensus 578 ~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~Dfg~a~~ 615 (785)
-||..+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999987 99999999999999887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.2e-06 Score=92.40 Aligned_cols=140 Identities=19% Similarity=0.255 Sum_probs=91.9
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhh------------------------------HH----------HHHH
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQG------------------------------FE----------EFKN 509 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 509 (785)
+-|+.++-|+||+|++.+|+.||||+.+..-... .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999986542110 01 1333
Q ss_pred HHHHHHcC----C-CCceeeEEEEEec-CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHH-HHHHhhc
Q 003932 510 EVMLTAKL----Q-HVNLIRVLGFCID-SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG-LLYLQEY 582 (785)
Q Consensus 510 E~~~l~~l----~-h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l~~LH~~ 582 (785)
|..-+.++ + .+++ .+=.++++ .....|+|||++|-.+.+..... ....+.+ .++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k---~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRK---ELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHH---HHHHHHHHHHHHHHHhc
Confidence 44444443 2 2333 33333433 56789999999999888774211 1223422 233333332 2222222
Q ss_pred CCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 583 ~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
++.|.|.+|.||+++.+|++.+.|||+...+.+
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 499999999999999999999999999887654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.3e-05 Score=77.92 Aligned_cols=139 Identities=14% Similarity=0.089 Sum_probs=100.0
Q ss_pred eceeCcEEEEEEEeCCCcEEEEEEcCCCC------hhhHHHHHHHHHHHHcCCCC--ceeeEEEEEecC----CccEEEE
Q 003932 472 LGEGGYGPVYKGVLPCGEVIAVKKLSKTS------TQGFEEFKNEVMLTAKLQHV--NLIRVLGFCIDS----EERMLIY 539 (785)
Q Consensus 472 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~ 539 (785)
-|+||-+-|+..... |+.+-+|+-.+.. +.....|.+|+..+++|... .+.++....... ...+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 356888889887766 4468888875221 33456899999999988533 344444222211 2367999
Q ss_pred EecCC-CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc--eeeccccceee
Q 003932 540 EYMPN-KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK--PKISDFGMARI 615 (785)
Q Consensus 540 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~ 615 (785)
|-+.+ -+|.+++.+.. ....+...+..++.++++.+.-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 57877774321 223566777899999999999999987 999999999999986667 99999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.7e-05 Score=77.32 Aligned_cols=138 Identities=16% Similarity=0.141 Sum_probs=92.0
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHH---------HHHHHHHHcC---CCCceeeEEEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEF---------KNEVMLTAKL---QHVNLIRVLGFC 529 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l---~h~niv~l~~~~ 529 (785)
...+|...+++-......|.+-..+ |+.+++|..+.......+.| .+.+..+.++ .......++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4578888888888888888777766 68899999876543322222 2233333333 222333333332
Q ss_pred ec-----CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc
Q 003932 530 ID-----SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK 604 (785)
Q Consensus 530 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 604 (785)
.. ....+|+|||++|..|.++.. ++. .++..+.+++.-||..| +.|+|..|.|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 21 234568999999988865431 222 24456778899999987 9999999999999865 4
Q ss_pred eeeccccceee
Q 003932 605 PKISDFGMARI 615 (785)
Q Consensus 605 ~kl~Dfg~a~~ 615 (785)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd06547 GH85_ENGase Endo-beta-N-acetylglucosaminidase (ENGase) hydrolyzes the N-N'-diacetylchitobiosyl core of N-glycosylproteins | Back alignment and domain information |
|---|
Probab=98.15 E-value=7.7e-06 Score=86.48 Aligned_cols=82 Identities=7% Similarity=0.114 Sum_probs=67.5
Q ss_pred HHHhcCCCceEEEEecCCCCCCcccchhhhcC-hhhhHHHHHHHHHHHHHcCCceeeeeccCCC-CCCCchhHHHHHHHH
Q 003932 82 TVKKKNPSITTILSIGQGKDTNYSIYSSMVRN-SSHRKSFIDSSIRIARLYGFRGLDFAWTAPN-TSTDMFNIGLLFDEW 159 (785)
Q Consensus 82 ~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~-~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~-~~~d~~~~~~ll~~l 159 (785)
++|++ ++||+-.|-=-+..+...+..++.+ ++.|..+|+.++++++.|||||+.||+|... ..++++++..|+++|
T Consensus 54 aAHkn--GV~Vlgti~~e~~~~~~~~~~lL~~~~~~~~~~a~kLv~lak~yGfDGw~iN~E~~~~~~~~~~~l~~F~~~L 131 (339)
T cd06547 54 AAHRN--GVPVLGTFIFEWTGQVEWLEDFLKKDEDGSFPVADKLVEVAKYYGFDGWLINIETELGDAEKAKRLIAFLRYL 131 (339)
T ss_pred HHHhc--CCeEEEEEEecCCCchHHHHHHhccCcccchHHHHHHHHHHHHhCCCceEeeeeccCCcHHHHHHHHHHHHHH
Confidence 36666 5999977751111123457888888 9999999999999999999999999999986 578999999999999
Q ss_pred HHHhhh
Q 003932 160 RIAATK 165 (785)
Q Consensus 160 r~~l~~ 165 (785)
++++++
T Consensus 132 ~~~~~~ 137 (339)
T cd06547 132 KAKLHE 137 (339)
T ss_pred HHHHhh
Confidence 999876
|
The beta-1,4-glycosyl bond located between two N-acetylglucosamine residues is hydrolyzed such that N-acetylglucosamine 1 remains with the protein and N-acetylglucosamine 2 forms the reducing end of the released glycan. ENGase is a key enzyme in the processing of free oligosaccharides in the cytosol of eukaryotes. Oligosaccharides formed in the lumen of the endoplasmic reticulum are transported into the cytosol where they are catabolized by cytosolic ENGases and other enzymes, possibly to maximize the reutilization of the component sugars. ENGases have an eight-stranded alpha/beta barrel topology and are classified as a family 85 glycosyl hydrolase (GH85) domain. The GH85 ENGases are sequence-similar to the family 18 glycosyl hydrolases, also known as GH18 chitinases. An ENGase-like protein is also found in bacteria and is included in this alignment mod |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=4e-05 Score=77.82 Aligned_cols=144 Identities=23% Similarity=0.207 Sum_probs=85.2
Q ss_pred ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCC--ceeeEEEEEecC---CccEEEEEecC
Q 003932 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV--NLIRVLGFCIDS---EERMLIYEYMP 543 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 543 (785)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.++... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999876 68999997654 3456777888888887433 356666644332 34689999999
Q ss_pred CCChhh----------------hh---cCC-ccccCCCH-H--------HHHHH------------HHHHHH-HHHHHhh
Q 003932 544 NKSLDC----------------YL---FDP-IRKLILDW-K--------KRVHI------------IEGITQ-GLLYLQE 581 (785)
Q Consensus 544 ~gsL~~----------------~l---~~~-~~~~~l~~-~--------~~~~i------------~~~i~~-~l~~LH~ 581 (785)
+.++.. .+ +.. ........ . ..... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 011 00000010 0 00000 111222 3333332
Q ss_pred c----CCCCeEEecccCCCEEEc-CCCceeeccccceee
Q 003932 582 Y----SRLTIIHRDLKVSNILLG-EAMKPKISDFGMARI 615 (785)
Q Consensus 582 ~----~~~~ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~ 615 (785)
. ....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 345699999999999999 666778999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.2e-05 Score=75.39 Aligned_cols=152 Identities=20% Similarity=0.233 Sum_probs=98.5
Q ss_pred ChHHHHHHhcCCCccee---eceeCcEEEEEEEeCCCcEEEEEEcCCCChh-------------------hH-----HHH
Q 003932 455 SLADIEAATERFSIRNK---LGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQ-------------------GF-----EEF 507 (785)
Q Consensus 455 ~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~-----~~~ 507 (785)
++..+.....+..+.+. |+.|--+.||+|...++..+|+|+++..... .. ...
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34445455555555444 5566678899998878999999998643211 00 113
Q ss_pred HHHHHHHHcCC--CCceeeEEEEEecCCccEEEEEecCCCCh-hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003932 508 KNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLIYEYMPNKSL-DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584 (785)
Q Consensus 508 ~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 584 (785)
.+|..-|+++. +-.+.+.+.+. ...|||||+....+ .-.|. ...+.......+..++++.+.-|-...
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 46777777773 34455555543 45799999965421 11121 122223356667777877777776533
Q ss_pred CCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 585 ~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
++||+||+.-|||+. ++.+.|+|||-|....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 499999999999999 8899999999886543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.97 E-value=5.8e-05 Score=77.34 Aligned_cols=141 Identities=16% Similarity=0.142 Sum_probs=85.6
Q ss_pred eeceeCc-EEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEEEEecCCCChh
Q 003932 471 KLGEGGY-GPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLIYEYMPNKSLD 548 (785)
Q Consensus 471 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 548 (785)
.|-.|.. ..||+.... +..+++|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444544 788998765 4678889886543 235677888888773 445667777776666789999999998876
Q ss_pred hhhc-------------------CCcc-ccCCC--HHHHHHHHH--------------------HHHHHHHHHhh----c
Q 003932 549 CYLF-------------------DPIR-KLILD--WKKRVHIIE--------------------GITQGLLYLQE----Y 582 (785)
Q Consensus 549 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~i~~~l~~LH~----~ 582 (785)
.... .... ..... ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 1000 00010 000000000 01111222211 1
Q ss_pred CCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 583 ~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.91 E-value=5.2e-05 Score=73.67 Aligned_cols=105 Identities=22% Similarity=0.200 Sum_probs=82.4
Q ss_pred HHHHHHHHcCCC-CceeeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 003932 508 KNEVMLTAKLQH-VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLT 586 (785)
Q Consensus 508 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 586 (785)
.+|.-+++.+.+ +++++++|+| ..++|.||.+.+++...-.....-...+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888866 6999999999 34789999987766422101112234789999999999999999999865445
Q ss_pred eEEecccCCCEEEcCCCceeeccccceeee
Q 003932 587 IIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 587 ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999998876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=9.9e-05 Score=82.00 Aligned_cols=142 Identities=18% Similarity=0.232 Sum_probs=89.4
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhh-------------------------------HH------HHHHHHH
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQG-------------------------------FE------EFKNEVM 512 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~ 512 (785)
+.||.-+.|.||+|++++|+.||||+-+..-... .+ .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999976532110 00 1333433
Q ss_pred HHHc----CCCCc---eeeEEEEEec-CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003932 513 LTAK----LQHVN---LIRVLGFCID-SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSR 584 (785)
Q Consensus 513 ~l~~----l~h~n---iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 584 (785)
-..+ +.|-+ -|.+=.++++ .....|+||||+|..+.+.-.- ....++.. .++..+.++.. +..-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~---~i~~~l~~~~~--~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPH---DILNKLVEAYL--EQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHH---HHHHHHHHHHH--HHHHh
Confidence 3322 34544 1112223322 3578999999999988766421 22234444 33444444322 22112
Q ss_pred CCeEEecccCCCEEEcC----CCceeeccccceeeecc
Q 003932 585 LTIIHRDLKVSNILLGE----AMKPKISDFGMARIFAK 618 (785)
Q Consensus 585 ~~ivH~Dikp~Nill~~----~~~~kl~Dfg~a~~~~~ 618 (785)
.+++|+|=.|.||+++. ++.+.+-|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 25999999999999984 67899999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00027 Score=85.22 Aligned_cols=79 Identities=19% Similarity=0.349 Sum_probs=58.2
Q ss_pred ceeeceeCcEEEEEEEeCCC---cEEEEEEcCCCC-hhhHHHHHHHHHHHHcCC-CCce--eeEEEEEecC---CccEEE
Q 003932 469 RNKLGEGGYGPVYKGVLPCG---EVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQ-HVNL--IRVLGFCIDS---EERMLI 538 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 538 (785)
.+.|+.|.++.+|+.....+ ..+++|+..... ......+.+|.++++.+. |.++ .+++.+|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47789999999999876543 467888765432 123356789999999985 6654 7888888765 367899
Q ss_pred EEecCCCCh
Q 003932 539 YEYMPNKSL 547 (785)
Q Consensus 539 ~e~~~~gsL 547 (785)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=2.9e-06 Score=92.74 Aligned_cols=187 Identities=18% Similarity=0.152 Sum_probs=129.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCc-eeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~ 542 (785)
.-+.....+++++++.++|.+--..+....+.+... ....-++++|.+++||| .+..++-+..+....++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 334444668899999999987332333345554333 34456889999999999 666666666677888999999
Q ss_pred CCC-ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 543 PNK-SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 543 ~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
..+ +-.... ......+...+...+.+.-.+++++||+.. =+|+| ||+..+ +..+..||+....+....
T Consensus 317 s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 317 STGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred cCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence 877 221111 011112333344455556677888888763 48888 777665 688999999887665432
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLS 668 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~ 668 (785)
......+++.++|||+...+.+....|+|++|+-..++--|-+|-
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234567899999999999999999999999998777777776653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00028 Score=71.73 Aligned_cols=73 Identities=15% Similarity=0.214 Sum_probs=46.4
Q ss_pred eeeceeCcE-EEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCC---ceeeEEEEEecCC---ccEEEEEec
Q 003932 470 NKLGEGGYG-PVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV---NLIRVLGFCIDSE---ERMLIYEYM 542 (785)
Q Consensus 470 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~e~~ 542 (785)
+.|+.|+.. .||+. +..+++|..+... ....+.+|.+++..+... .+..+++.....+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567767666 48875 2357788765422 234788899999887532 3444554433322 348899999
Q ss_pred CCCChh
Q 003932 543 PNKSLD 548 (785)
Q Consensus 543 ~~gsL~ 548 (785)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 998774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00055 Score=66.83 Aligned_cols=128 Identities=20% Similarity=0.272 Sum_probs=88.5
Q ss_pred ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCC----------------hhhHHHHHHHHHHHHcCC------CCceeeEE
Q 003932 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTS----------------TQGFEEFKNEVMLTAKLQ------HVNLIRVL 526 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 526 (785)
...||+|+.=.||. ++.....+||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 36799999998886 4555667889887655 123455667776666555 78899999
Q ss_pred EEEecCCccEEEEEecCC--C----ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc
Q 003932 527 GFCIDSEERMLIYEYMPN--K----SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG 600 (785)
Q Consensus 527 ~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~ 600 (785)
|+...+....+|+|.+.+ | +|.+++. ...++. ...+ .+-+-..||-+++ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999899999998643 2 4566663 233444 3333 3334455666665 99999999999996
Q ss_pred CCC----ceeecc
Q 003932 601 EAM----KPKISD 609 (785)
Q Consensus 601 ~~~----~~kl~D 609 (785)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 332 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00095 Score=70.28 Aligned_cols=78 Identities=18% Similarity=0.112 Sum_probs=56.7
Q ss_pred CcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC---CceeeEEEEEecC---CccEEEEE
Q 003932 467 SIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH---VNLIRVLGFCIDS---EERMLIYE 540 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e 540 (785)
.-.+.||.|..+.||.....+++ +++|..+.... ...+..|...++.+.. ..+.+++++|... +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFST--PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEeccccc--chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 33467999999999998766554 56677433111 2478889999988843 4678888887543 56899999
Q ss_pred ecCCCCh
Q 003932 541 YMPNKSL 547 (785)
Q Consensus 541 ~~~~gsL 547 (785)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0005 Score=69.92 Aligned_cols=75 Identities=16% Similarity=0.237 Sum_probs=49.5
Q ss_pred ceeeceeCcEEEEEEEeCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCce-eeEEEEEecCCccEEEEEecCCC
Q 003932 469 RNKLGEGGYGPVYKGVLPC--GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 545 (785)
.+.|..|-...+|+....+ ++.+++|+....... .-...+|+.+++.+...++ .++++.+. -.++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3568888889999998664 678889987653222 1233468888888754333 44444332 24899999987
Q ss_pred Chh
Q 003932 546 SLD 548 (785)
Q Consensus 546 sL~ 548 (785)
++.
T Consensus 78 ~l~ 80 (235)
T cd05157 78 TLE 80 (235)
T ss_pred cCC
Confidence 763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00096 Score=64.51 Aligned_cols=136 Identities=23% Similarity=0.371 Sum_probs=91.0
Q ss_pred CCCccccChHHHHHHhcCCCcceeeceeCc-EEEEEEEeCCCcEEEEEEcCC---CCh------------------hhHH
Q 003932 448 VPNLRVYSLADIEAATERFSIRNKLGEGGY-GPVYKGVLPCGEVIAVKKLSK---TST------------------QGFE 505 (785)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~ 505 (785)
.|.+..|... ..+++.++.||.|.. |.||++... |+.+|+|.+.. ... ....
T Consensus 26 gPKL~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~ 99 (207)
T PF13095_consen 26 GPKLEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYAD 99 (207)
T ss_pred CCCcCCcCCC-----CCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcC
Confidence 4455556552 278999999999999 999999987 77999999322 100 1122
Q ss_pred HHHHHHHHHHcCC---CCce--eeEEEEEecC------------------CccEEEEEecCCCChhhhhcCCccccCCCH
Q 003932 506 EFKNEVMLTAKLQ---HVNL--IRVLGFCIDS------------------EERMLIYEYMPNKSLDCYLFDPIRKLILDW 562 (785)
Q Consensus 506 ~~~~E~~~l~~l~---h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~ 562 (785)
.|..|.+...+|+ +.++ ++.+||..-. ....||.||++... .+..
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~ 167 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI 167 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch
Confidence 4677877777664 5566 8999987422 11246777665432 1222
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 563 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 563 ~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
+-+.+|.+-+..+|..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 168 ----~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 ----RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ----hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 23345566677788776 999999999986 4588999854
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0005 Score=64.13 Aligned_cols=129 Identities=21% Similarity=0.245 Sum_probs=85.9
Q ss_pred CcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceee-EEEEEecCCccEEEEEecCCC
Q 003932 467 SIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIR-VLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g 545 (785)
...+.|++|.+|.||+|.+. |..+|+|+-+..++ ...+..|.++|..+.-.++-+ ++.+- .-++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 44578999999999999987 56889998766543 467899999999987766544 44432 234559999998
Q ss_pred ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccC-CCEEEcCCCceeeccccceee
Q 003932 546 SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKV-SNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 546 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp-~Nill~~~~~~kl~Dfg~a~~ 615 (785)
.|.+.-.. .+-+.... +++.---|... +|-|+.|.- ...++-.+..+.|+||.-|+.
T Consensus 98 ~L~~~~~~------~~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIG------GDRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhc------ccHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88665421 12233333 33332333333 488888864 444444444999999998864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00045 Score=71.31 Aligned_cols=139 Identities=16% Similarity=0.103 Sum_probs=78.8
Q ss_pred eeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCce-eeEEEEEecCCccEEEEEecCCCChhh
Q 003932 471 KLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLIYEYMPNKSLDC 549 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 549 (785)
.+..|-.+.+|+.... ++.+++|..........-...+|..+++.+...++ .+++..+. -++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHP-GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEeC-CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 3556778889988744 66788887654322210134678888888854333 33444432 379999999877642
Q ss_pred h-----------------hcCCc-cccCCCHHHH-HHHHHH---------HHHHHHHHhhc-----CCCCeEEecccCCC
Q 003932 550 Y-----------------LFDPI-RKLILDWKKR-VHIIEG---------ITQGLLYLQEY-----SRLTIIHRDLKVSN 596 (785)
Q Consensus 550 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------i~~~l~~LH~~-----~~~~ivH~Dikp~N 596 (785)
. +|... ....++.... .....+ +...+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11110 0111121111 111111 11112222211 12358999999999
Q ss_pred EEEcCCCceeeccccceee
Q 003932 597 ILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 597 ill~~~~~~kl~Dfg~a~~ 615 (785)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0011 Score=78.21 Aligned_cols=200 Identities=21% Similarity=0.205 Sum_probs=136.1
Q ss_pred HHHHHHHHHHHHcCCCCceeeEEEEEecCCccE----EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHH
Q 003932 504 FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM----LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579 (785)
Q Consensus 504 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L 579 (785)
......|+..+.+..|+|++.++.|........ +..+++..-++...+.. -...+....+.+..++..||.|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHH
Confidence 334456778888889999999999877654333 44567888788777743 34577888888999999999999
Q ss_pred hhcCCCCeEEecccCC---CEEEcCCCceeec--cccceeeecccccccccccccccCCcccccccCCCCCCC--hhhHH
Q 003932 580 QEYSRLTIIHRDLKVS---NILLGEAMKPKIS--DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYST--KSDVF 652 (785)
Q Consensus 580 H~~~~~~ivH~Dikp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dvw 652 (785)
|+.. ..|.-+..+ +.-.+.++.+.++ ||+.+..+.... .......+..+.+||......+.. ..|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHH
Confidence 9874 555555554 5555667777777 888877654332 122233456778888887766554 47999
Q ss_pred HHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003932 653 SFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLE 732 (785)
Q Consensus 653 SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 732 (785)
++|..+..+..|..+...... +...+... .. ..+.....+|+.-++++|+++.+
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~----------------------~~~~l~~~-~~---~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAV----------------------PVSLLDVL-ST---SELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHHHHHhhhhhcCcccccccc----------------------hhhhhccc-cc---hhhhhhhhhhcchhhhhccchhh
Confidence 999999999988754321110 00001110 00 04566788999999999999999
Q ss_pred HHHHHh
Q 003932 733 VSSMLK 738 (785)
Q Consensus 733 vl~~L~ 738 (785)
++...-
T Consensus 431 ll~~~f 436 (1351)
T KOG1035|consen 431 LLTHPF 436 (1351)
T ss_pred hhhchh
Confidence 987543
|
|
| >PF02638 DUF187: Glycosyl hydrolase like GH101; InterPro: IPR003790 This entry describes proteins of unknown function | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00082 Score=70.77 Aligned_cols=130 Identities=15% Similarity=0.139 Sum_probs=84.4
Q ss_pred cChhhhHHHHHHHHHHHHHcCCceeeee-ccCCC-----------------------CCCC-------chhHHHHHHHHH
Q 003932 112 RNSSHRKSFIDSSIRIARLYGFRGLDFA-WTAPN-----------------------TSTD-------MFNIGLLFDEWR 160 (785)
Q Consensus 112 ~~~~~r~~fi~si~~~~~~y~~DGiDiD-wE~p~-----------------------~~~d-------~~~~~~ll~~lr 160 (785)
..|+.|+-.++-+.+++++|.+|||.|| .-||. .+.| +++...|+++++
T Consensus 134 ~~PeVr~~i~~~v~Eiv~~YdvDGIhlDdy~yp~~~~g~~~~~~~~y~~~~g~~~~~~~~d~~W~~WRr~~I~~~V~~i~ 213 (311)
T PF02638_consen 134 GHPEVRDYIIDIVKEIVKNYDVDGIHLDDYFYPPPSFGYDFPDVAAYEKYTGKDPFSSPEDDAWTQWRRDNINNFVKRIY 213 (311)
T ss_pred CCHHHHHHHHHHHHHHHhcCCCCeEEecccccccccCCCCCccHHHHHHhcCcCCCCCccchHHHHHHHHHHHHHHHHHH
Confidence 4678899999999999999999999999 45641 1234 678888999999
Q ss_pred HHhhhhhhhcccccceeEEEEeecccCCC--CccccHHHHH--hccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCC
Q 003932 161 IAATKLDAKNSTRQQSLLILTARFRYSPP--ANSYLLNSIQ--RNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFA 236 (785)
Q Consensus 161 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~--~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~ 236 (785)
+++++.. +...+.+++....... ....|..... .++|++..|.|-.. .... .
T Consensus 214 ~~ik~~k------P~v~~sisp~g~~~~~y~~~~qD~~~W~~~G~iD~i~Pq~Y~~~------~~~~------------~ 269 (311)
T PF02638_consen 214 DAIKAIK------PWVKFSISPFGIWNSAYDDYYQDWRNWLKEGYIDYIVPQIYWSD------FSHF------------T 269 (311)
T ss_pred HHHHHhC------CCCeEEEEeecchhhhhhheeccHHHHHhcCCccEEEeeecccc------cchh------------H
Confidence 9988753 2323333332222111 1223444443 67999999999530 0110 1
Q ss_pred CCHHHHHHHHHHcCCCC-Cceeeccccccc
Q 003932 237 RSTDQVLKAWIERGLSA-DKLVMCLPFYGY 265 (785)
Q Consensus 237 ~~~~~~v~~~~~~gvp~-~KlvlGip~YG~ 265 (785)
...+..+..|.+.-.+. -+|.+|+.+|-.
T Consensus 270 ~~~~~~~~~w~~~~~~~~v~ly~G~~~y~~ 299 (311)
T PF02638_consen 270 APYEQLAKWWAKQVKPTNVHLYIGLALYKV 299 (311)
T ss_pred HHHHHHHHHHHHhhcCCCceEEEccCcCCC
Confidence 14567777777654443 489999999864
|
|
| >PF03644 Glyco_hydro_85: Glycosyl hydrolase family 85 ; InterPro: IPR005201 O-Glycosyl hydrolases 3 | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00022 Score=74.72 Aligned_cols=148 Identities=15% Similarity=0.200 Sum_probs=88.1
Q ss_pred HHHHhcCCCceEEEEecCCCCCCcccchhhhc-ChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCC-CCchhHHHHHHH
Q 003932 81 DTVKKKNPSITTILSIGQGKDTNYSIYSSMVR-NSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTS-TDMFNIGLLFDE 158 (785)
Q Consensus 81 ~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~-~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~-~d~~~~~~ll~~ 158 (785)
.++|++ ++||+=.|-=.+..+...+..++. ++.....+|+.++++++.|||||.-|+||.+... .+..++..|+++
T Consensus 49 daAHrn--GV~vLGTiife~~~~~~~~~~ll~~~~~g~~~~A~kLi~ia~~yGFDGw~iN~E~~~~~~~~~~~l~~F~~~ 126 (311)
T PF03644_consen 49 DAAHRN--GVKVLGTIIFEWGGGAEWCEELLEKDEDGSFPYADKLIEIAKYYGFDGWLINIETPLSGPEDAENLIDFLKY 126 (311)
T ss_dssp HHHHHT--T--EEEEEEEEEE--HHHHHHHT---TTS--HHHHHHHHHHHHHT--EEEEEEEESSTTGGGHHHHHHHHHH
T ss_pred HHHHhc--CceEEEEEEecCCchHHHHHHHHcCCcccccHHHHHHHHHHHHcCCCceEEEecccCCchhHHHHHHHHHHH
Confidence 446665 599875543111122345788888 8888999999999999999999999999988655 688999999999
Q ss_pred HHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccC-----CCccCCCCCCCCCCCCCCCCC
Q 003932 159 WRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASY-----YEPVSTNFTAPPAALYGSISG 233 (785)
Q Consensus 159 lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~-----~~~~~~~~~g~~apl~~~~~~ 233 (785)
|++++++ .. .. .||-||= ...|.+.....+.+....++.
T Consensus 127 l~~~~~~-~~------~~-----------------------------~v~WYDs~t~~G~l~~qn~Ln~~N~~f~~~~d~ 170 (311)
T PF03644_consen 127 LRKEAHE-NP------GS-----------------------------EVIWYDSVTNSGRLSWQNELNDKNKPFFDVCDG 170 (311)
T ss_dssp HHHHHHH-T-------T------------------------------EEEEES-B-SSSSB---SSS-TTTGGGBES-SE
T ss_pred HHHHhhc-CC------Cc-----------------------------EEEEeecCCcCCccchHHHHHhhCcchhhhcce
Confidence 9988764 10 11 2222221 112333333333333222211
Q ss_pred CC------CCCHHHHHHHHHHcCCCCCceeeccccccce
Q 003932 234 RF------ARSTDQVLKAWIERGLSADKLVMCLPFYGYA 266 (785)
Q Consensus 234 ~~------~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~ 266 (785)
.. ..++..+++.....|.+|.+|.+||=..||.
T Consensus 171 iFlNY~W~~~~l~~s~~~A~~~~~~~~~vy~GiDv~grg 209 (311)
T PF03644_consen 171 IFLNYNWNPDSLESSVANAKSRGRDPYDVYAGIDVFGRG 209 (311)
T ss_dssp EEE-S--SHHHHHHHHHHHHHHTS-GGGEEEEEEHHHHT
T ss_pred eeEecCCCcccHHHHHHHHHHcCCCHHHEEEEEEEEcCC
Confidence 00 1145677777788899999999999999987
|
2.1. from EC are a widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a non-carbohydrate moiety. A classification system for glycosyl hydrolases, based on sequence similarity, has led to the definition of 85 different families [, ]. This classification is available on the CAZy (CArbohydrate-Active EnZymes) web site. This group of endo-beta-N-acetylglucosaminidases belong to the glycoside hydrolase family 85 (GH85 from CAZY). These enzymes work on a broad spectrum of substrates.; GO: 0033925 mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity, 0005737 cytoplasm; PDB: 2W92_A 2W91_A 2VTF_B 3FHQ_B 3FHA_D 3GDB_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 785 | ||||
| 3aqu_A | 356 | Crystal Structure Of A Class V Chitinase From Arabi | 4e-60 | ||
| 3alg_A | 353 | Crystal Structure Of Class V Chitinase (E115q Mutan | 5e-60 | ||
| 3alf_A | 353 | Crystal Structure Of Class V Chitinase From Nicotia | 6e-60 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-36 | ||
| 1guv_A | 366 | Structure Of Human Chitotriosidase Length = 366 | 1e-27 | ||
| 1hki_A | 365 | Crystal Structure Of Human Chitinase In Complex Wit | 3e-27 | ||
| 1lg1_A | 365 | Crystal Structure Of Human Chitotriosidase In Compl | 3e-27 | ||
| 1hkk_A | 364 | High Resoultion Crystal Structure Of Human Chitinas | 3e-27 | ||
| 1waw_A | 445 | Specificity And Affinity Of Natural Product Cyclope | 4e-27 | ||
| 4ay1_A | 365 | Human Ykl-39 Is A Pseudo-Chitinase With Retained Ch | 3e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-23 | ||
| 3fxy_A | 395 | Acidic Mammalian Chinase, Catalytic Domain Length = | 3e-23 | ||
| 2ybt_A | 381 | Crystal Structure Of Human Acidic Chitinase In Comp | 3e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-23 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-22 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-22 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-22 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-22 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-22 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-22 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-22 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-22 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-22 | ||
| 1hjv_A | 362 | Crystal Structure Of Hcgp-39 In Complex With Chitin | 3e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-22 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-22 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-22 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-22 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-22 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-22 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-22 | ||
| 1e9l_A | 377 | The Crystal Structure Of Novel Mammalian Lectin Ym1 | 9e-22 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-22 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-21 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-21 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-21 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-21 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-19 | ||
| 1sr0_A | 361 | Crystal Structure Of Signalling Protein From Sheep( | 1e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 1ljy_A | 361 | Crystal Structure Of A Novel Regulatory 40 Kda Mamm | 3e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-19 | ||
| 1xhg_A | 361 | Crystal Structure Of A 40 Kda Signalling Protein Fr | 4e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-19 | ||
| 2pi6_A | 361 | Crystal Structure Of The Sheep Signalling Glycoprot | 5e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-19 | ||
| 1syt_A | 361 | Crystal Structure Of Signalling Protein From Goat S | 8e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-18 | ||
| 2esc_A | 361 | Crystal Structure Of A 40 Kda Protective Signalling | 1e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 1owq_A | 361 | Crystal Structure Of A 40 Kda Signalling Protein (S | 1e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 1tfv_A | 361 | Crystal Structure Of A Buffalo Signaling Glycoprote | 2e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-18 | ||
| 1zbv_A | 361 | Crystal Structure Of The Goat Signalling Protein (S | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 1itx_A | 419 | Catalytic Domain Of Chitinase A1 From Bacillus Circ | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-12 | ||
| 3g6l_A | 406 | The Crystal Structure Of A Chitinase Crchi1 From Th | 7e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 1jnd_A | 420 | Crystal Structure Of Imaginal Disc Growth Factor-2 | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-10 | ||
| 1eib_A | 540 | Crystal Structure Of Chitinase A Mutant D313a Compl | 6e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-10 | ||
| 1rd6_A | 563 | Crystal Structure Of S. Marcescens Chitinase A Muta | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-10 | ||
| 2wly_A | 548 | Chitinase A From Serratia Marcescens Atcc990 In Com | 7e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-10 | ||
| 2wk2_A | 540 | Chitinase A From Serratia Marcescens Atcc990 In Com | 9e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 1d2k_A | 392 | C. Immitis Chitinase 1 At 2.2 Angstroms Resolution | 1e-09 | ||
| 1ll7_A | 392 | Structure Of The E171q Mutant Of C. Immitis Chitina | 1e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 1ll6_A | 392 | Structure Of The D169n Mutant Of C. Immitis Chitina | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 1k9t_A | 540 | Chitinase A Complexed With Tetra-N-Acetylchitotrios | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 1ehn_A | 540 | Crystal Structure Of Chitinase A Mutant E315q Compl | 3e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 1ffr_A | 540 | Crystal Structure Of Chitinase A Mutant Y390f Compl | 3e-09 | ||
| 1edq_A | 540 | Crystal Structure Of Chitinase A From S. Marcescens | 3e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-09 | ||
| 1ctn_A | 540 | Crystal Structure Of A Bacterial Chitinase At 2.3 A | 3e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-09 | ||
| 1nh6_A | 540 | Structure Of S. Marcescens Chitinase A, E315l, Comp | 3e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 1w9p_A | 433 | Specificity And Affinity Of Natural Product Cyclope | 5e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-09 | ||
| 1wno_A | 395 | Crystal Structure Of A Native Chitinase From Asperg | 7e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-08 | ||
| 3ars_A | 584 | Crystal Structure Analysis Of Chitinase A From Vibr | 4e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 1ur9_A | 499 | Interactions Of A Family 18 Chitinase With The Desi | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 1ogb_A | 499 | Chitinase B From Serratia Marcescens Mutant D142n L | 1e-07 | ||
| 1e6n_B | 499 | Chitinase B From Serratia Marcescens Inactive Mutan | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 1e15_A | 499 | Chitinase B From Serratia Marcescens Length = 499 | 1e-07 | ||
| 1h0g_A | 499 | Complex Of A Chitinase With The Natural Product Cyc | 1e-07 | ||
| 1e6z_A | 498 | Chitinase B From Serratia Marcescens Wildtype In Co | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 3b9a_A | 584 | Crystal Structure Of Vibrio Harveyi Chitinase A Com | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3b8s_A | 584 | Crystal Structure Of Wild-Type Chitinase A From Vib | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 1goi_A | 499 | Crystal Structure Of The D140n Mutant Of Chitinase | 4e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-06 | ||
| 1kfw_A | 435 | Structure Of Catalytic Domain Of Psychrophilic Chit | 9e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-05 |
| >pdb|3AQU|A Chain A, Crystal Structure Of A Class V Chitinase From Arabidopsis Thaliana Length = 356 | Back alignment and structure |
|
| >pdb|3ALG|A Chain A, Crystal Structure Of Class V Chitinase (E115q Mutant) From Nicotiana Tobaccum In Complex With Nag4 Length = 353 | Back alignment and structure |
|
| >pdb|3ALF|A Chain A, Crystal Structure Of Class V Chitinase From Nicotiana Tobaccum Length = 353 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1GUV|A Chain A, Structure Of Human Chitotriosidase Length = 366 | Back alignment and structure |
|
| >pdb|1HKI|A Chain A, Crystal Structure Of Human Chitinase In Complex With Glucoallosamidin B Length = 365 | Back alignment and structure |
|
| >pdb|1LG1|A Chain A, Crystal Structure Of Human Chitotriosidase In Complex With Chitobiose Length = 365 | Back alignment and structure |
|
| >pdb|1HKK|A Chain A, High Resoultion Crystal Structure Of Human Chitinase In Complex With Allosamidin Length = 364 | Back alignment and structure |
|
| >pdb|1WAW|A Chain A, Specificity And Affinity Of Natural Product Cyclopentapeptide Inhibitor Argadin Against Human Chitinase Length = 445 | Back alignment and structure |
|
| >pdb|4AY1|A Chain A, Human Ykl-39 Is A Pseudo-Chitinase With Retained Chitooligosaccharide Binding Properties Length = 365 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3FXY|A Chain A, Acidic Mammalian Chinase, Catalytic Domain Length = 395 | Back alignment and structure |
|
| >pdb|2YBT|A Chain A, Crystal Structure Of Human Acidic Chitinase In Complex With Bisdionin C Length = 381 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1HJV|A Chain A, Crystal Structure Of Hcgp-39 In Complex With Chitin Tetramer Length = 362 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1E9L|A Chain A, The Crystal Structure Of Novel Mammalian Lectin Ym1 Suggests A Saccharide Binding Site Length = 377 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1SR0|A Chain A, Crystal Structure Of Signalling Protein From Sheep(Sps-40) At 3.0a Resolution Using Crystal Grown In The Presence Of Polysaccharides Length = 361 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LJY|A Chain A, Crystal Structure Of A Novel Regulatory 40 Kda Mammary Gland Protein (Mgp-40) Secreted During Involution Length = 361 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XHG|A Chain A, Crystal Structure Of A 40 Kda Signalling Protein From Porcine (spp-40) At 2.89a Resolution Length = 361 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PI6|A Chain A, Crystal Structure Of The Sheep Signalling Glycoprotein (Sps-40) Complex With 2-Methyl-2-4-Pentanediol At 1.65a Resolution Reveals Specific Binding Characteristics Of Sps-40 Length = 361 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1SYT|A Chain A, Crystal Structure Of Signalling Protein From Goat Spg-40 In The Presense Of N,n',n''-triacetyl-chitotriose At 2.6a Resolution Length = 361 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ESC|A Chain A, Crystal Structure Of A 40 Kda Protective Signalling Protein From Bovine (Spc-40) At 2.1 A Resolution Length = 361 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1OWQ|A Chain A, Crystal Structure Of A 40 Kda Signalling Protein (Spc-40) Secreted During Involution Length = 361 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1TFV|A Chain A, Crystal Structure Of A Buffalo Signaling Glycoprotein (Spb-40) Secreted During Involution Length = 361 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1ZBV|A Chain A, Crystal Structure Of The Goat Signalling Protein (Spg-40) Complexed With A Designed Peptide Trp-Pro-Trp At 3.2a Resolution Length = 361 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ITX|A Chain A, Catalytic Domain Of Chitinase A1 From Bacillus Circulans Wl-12 Length = 419 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G6L|A Chain A, The Crystal Structure Of A Chitinase Crchi1 From The Nematophagous Fungus Clonostachys Rosea Length = 406 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1JND|A Chain A, Crystal Structure Of Imaginal Disc Growth Factor-2 Length = 420 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1EIB|A Chain A, Crystal Structure Of Chitinase A Mutant D313a Complexed With Octa-N- Acetylchitooctaose (Nag)8 Length = 540 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1RD6|A Chain A, Crystal Structure Of S. Marcescens Chitinase A Mutant W167a Length = 563 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WLY|A Chain A, Chitinase A From Serratia Marcescens Atcc990 In Complex With Chitotrio-Thiazoline. Length = 548 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WK2|A Chain A, Chitinase A From Serratia Marcescens Atcc990 In Complex With Chitotrio-Thiazoline Dithioamide Length = 540 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1D2K|A Chain A, C. Immitis Chitinase 1 At 2.2 Angstroms Resolution Length = 392 | Back alignment and structure |
|
| >pdb|1LL7|A Chain A, Structure Of The E171q Mutant Of C. Immitis Chitinase 1 Length = 392 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1LL6|A Chain A, Structure Of The D169n Mutant Of C. Immitis Chitinase 1 Length = 392 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1K9T|A Chain A, Chitinase A Complexed With Tetra-N-Acetylchitotriose Length = 540 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1EHN|A Chain A, Crystal Structure Of Chitinase A Mutant E315q Complexed With Octa-N- Acetylchitooctaose (Nag)8 Length = 540 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1FFR|A Chain A, Crystal Structure Of Chitinase A Mutant Y390f Complexed With Hexa-n- Acetylchitohexaose (nag)6 Length = 540 | Back alignment and structure |
|
| >pdb|1EDQ|A Chain A, Crystal Structure Of Chitinase A From S. Marcescens At 1.55 Angstroms Length = 540 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1CTN|A Chain A, Crystal Structure Of A Bacterial Chitinase At 2.3 Angstroms Resolution Length = 540 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1NH6|A Chain A, Structure Of S. Marcescens Chitinase A, E315l, Complex With Hexasaccharide Length = 540 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1W9P|A Chain A, Specificity And Affinity Of Natural Product Cyclopentapeptide Inhibitors Against Aspergillus Fumigatus, Human And Bacterial Chitinasefra Length = 433 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1WNO|A Chain A, Crystal Structure Of A Native Chitinase From Aspergillus Fumigatus Yj- 407 Length = 395 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3ARS|A Chain A, Crystal Structure Analysis Of Chitinase A From Vibrio Harveyi With Novel Inhibitors - Apo Structure Of Mutant W275g Length = 584 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UR9|A Chain A, Interactions Of A Family 18 Chitinase With The Designed Inhibitor Hm508, And Its Degradation Product, Chitobiono-Delta-Lactone Length = 499 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OGB|A Chain A, Chitinase B From Serratia Marcescens Mutant D142n Length = 499 | Back alignment and structure |
|
| >pdb|1E6N|B Chain B, Chitinase B From Serratia Marcescens Inactive Mutant E144q In Complex With N-Acetylglucosamine-Pentamer Length = 499 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1E15|A Chain A, Chitinase B From Serratia Marcescens Length = 499 | Back alignment and structure |
|
| >pdb|1H0G|A Chain A, Complex Of A Chitinase With The Natural Product Cyclopentapeptide Argadin From Clonostachys Length = 499 | Back alignment and structure |
|
| >pdb|1E6Z|A Chain A, Chitinase B From Serratia Marcescens Wildtype In Complex With Catalytic Intermediate Length = 498 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3B9A|A Chain A, Crystal Structure Of Vibrio Harveyi Chitinase A Complexed With Hexasaccharide Length = 584 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3B8S|A Chain A, Crystal Structure Of Wild-Type Chitinase A From Vibrio Harveyi Length = 584 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GOI|A Chain A, Crystal Structure Of The D140n Mutant Of Chitinase B From Serratia Marcescens At 1.45 A Resolution Length = 499 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1KFW|A Chain A, Structure Of Catalytic Domain Of Psychrophilic Chitinase B From Arthrobacter Tad20 Length = 435 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 365 bits (939), Expect = e-120
Identities = 115/295 (38%), Positives = 177/295 (60%), Gaps = 5/295 (1%)
Query: 450 NLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFE-EFK 508
L+ +SL +++ A++ FS +N LG GG+G VYKG L G ++AVK+L + TQG E +F+
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 509 NEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIR-KLILDWKKRVH 567
EV + + H NL+R+ GFC+ ER+L+Y YM N S+ L + + LDW KR
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 568 IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627
I G +GL YL ++ IIHRD+K +NILL E + + DFG+A++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-A 194
Query: 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI--NENLSILEHAYE 685
V GTIG+I PEY + G S K+DVF +GV+LL++I+G+R L + ++++ +L+
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740
L K K VD L ++ + +++ALLC Q +P +RP M EV ML+ +
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 359 bits (925), Expect = e-119
Identities = 107/314 (34%), Positives = 160/314 (50%), Gaps = 19/314 (6%)
Query: 440 EAGDFNRNVPNLRVYSLADIEAATERFS------IRNKLGEGGYGPVYKGVLPCGEVIAV 493
E + +S +++ T F NK+GEGG+G VYKG + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAV 59
Query: 494 KKLSK----TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDC 549
KKL+ T+ + ++F E+ + AK QH NL+ +LGF D ++ L+Y YMPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 550 YLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISD 609
L L W R I +G G+ +L E IHRD+K +NILL EA KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 610 FGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSM 669
FG+AR K + T ++VGT Y+ PE G + KSD++SFGV+LL+II+G
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 670 LCGINENLSILEHAYELWKGGKGVE-FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRP 728
+ L L+ E+ K +E ++D ++D +S + +A C+ E N RP
Sbjct: 236 EHREPQLL--LDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRP 292
Query: 729 SMLEVSSMLKNETT 742
+ +V +L+ T
Sbjct: 293 DIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-108
Identities = 107/313 (34%), Positives = 172/313 (54%), Gaps = 5/313 (1%)
Query: 427 SAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLP 486
S + T + N+ + + + L D+E AT F + +G G +G VYKGVL
Sbjct: 3 SKYSKATNSINDALSSSYLVPFES-YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 487 CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKS 546
G +A+K+ + S+QG EEF+ E+ + +H +L+ ++GFC + E +LIY+YM N +
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 547 LDCYLFDPIR-KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP 605
L +L+ + + W++R+ I G +GL YL + IIHRD+K NILL E P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
KI+DFG+++ + + V GT+GYI PEY KG + KSDV+SFGV+L +++ +
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 666 RLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPN 725
+ E +++ E A E G+ + VD L D+ P L + + A+ C+ +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 726 DRPSMLEVSSMLK 738
DRPSM +V L+
Sbjct: 299 DRPSMGDVLWKLE 311
|
| >3aqu_A AT4G19810; stress response, TIM barrel, hydrolase, chitin; HET: FLC; 2.01A {Arabidopsis thaliana} Length = 356 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 3e-84
Identities = 132/358 (36%), Positives = 208/358 (58%), Gaps = 12/358 (3%)
Query: 24 KPWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTV 83
+ ++ Y + ++ I+ LFTHL C+ AD+NS T Q+++S +++ + + F TV
Sbjct: 2 QTVVKASYWFPASEFPVTDIDSSLFTHLFCAFADLNSQTNQVTVS-SANQPKFSTFTQTV 60
Query: 84 KKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAP 143
+++NPS+ T+LSIG G + + Y+SM N + RKSFIDSSIR+AR YGF GLD W P
Sbjct: 61 QRRNPSVKTLLSIG-GGIADKTAYASMASNPTSRKSFIDSSIRVARSYGFHGLDLDWEYP 119
Query: 144 NTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPP--ANSYLLNSIQRN 201
+++T+M N G L EWR A + A+ S+ + L+L A YS + Y ++++ +
Sbjct: 120 SSATEMTNFGTLLREWRSA---VVAEASSSGKPRLLLAAAVFYSNNYYSVLYPVSAVASS 176
Query: 202 LNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLP 261
L+W++ + +Y P + T PPAAL+ + S D ++WI+ GL A K V+ P
Sbjct: 177 LDWVNLMAYDFYGPGWSRVTGPPAALFDPSNAGP--SGDAGTRSWIQAGLPAKKAVLGFP 234
Query: 262 FYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYF 321
+YGYAW L + A G A+ G + Y +I+ I G +YNST +Y
Sbjct: 235 YYGYAWRLTNANSHSYYAPTTGAAISPDGSIGYGQIRKFIVDNG--ATTVYNSTVVGDYC 292
Query: 322 STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAAAQKDSITSAS 379
GT W G+DD +++ K+ YAK++ LLGY++W V DD + LS+AA+Q T+A+
Sbjct: 293 YAGTNWIGYDDNQSIVTKVRYAKQRGLLGYFSWHVGADD-NSGLSRAASQAWDATTAT 349
|
| >3alf_A Chitinase, class V; hydrolase; 1.20A {Nicotiana tabacum} PDB: 3alg_A* Length = 353 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 2e-83
Identities = 131/349 (37%), Positives = 194/349 (55%), Gaps = 16/349 (4%)
Query: 27 IRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKK 86
++ GY ++ I+ LFTHL C+ AD+N QL +S P +++ +F TV++K
Sbjct: 4 VKGGYWFKDSGLALNNIDSTLFTHLFCAFADLNPQLNQLIIS-PENQDSFRQFTSTVQRK 62
Query: 87 NPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTS 146
NPS+ T LSI G N + Y M R + RKSFIDSSIR+AR GF GLD W P ++
Sbjct: 63 NPSVKTFLSIA-GGRANSTAYGIMARQPNSRKSFIDSSIRLARQLGFHGLDLDWEYPLSA 121
Query: 147 TDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPAN--SYLLNSIQRNLNW 204
DM N+G L +EWR A ++ + ++ L+LTA SP N +Y + S+ RNL+W
Sbjct: 122 ADMTNLGTLLNEWRTA---INTEARNSGRAALLLTAAVSNSPRVNGLNYPVESLARNLDW 178
Query: 205 IHAVTASYYEPV-STNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFY 263
I+ + +Y P S + T A L+ S + AWI+ G+ KLV+ +PFY
Sbjct: 179 INLMAYDFYGPNWSPSQTNSHAQLFDP-VNHV--SGSDGINAWIQAGVPTKKLVLGIPFY 235
Query: 264 GYAWTLVKPEDNGIGAAAAGPAL---YDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNY 320
GYAW LV +G+ A AAG + D G +TY +I+++I +YN+T +Y
Sbjct: 236 GYAWRLVNANIHGLRAPAAGKSNVGAVDDGSMTYNRIRDYIVESR--ATTVYNATIVGDY 293
Query: 321 FSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAA 369
+G+ W +DD + VR K+ Y K + LLGY+AW V+ D + L A+
Sbjct: 294 CYSGSNWISYDDTQTVRNKVNYVKGRGLLGYFAWHVAGDQNWGLSRTAS 342
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 1e-79
Identities = 68/314 (21%), Positives = 116/314 (36%), Gaps = 30/314 (9%)
Query: 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLT 514
++ + + G +G V+K E +AVK Q ++ + EV
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-NEYEVYSL 72
Query: 515 AKLQHVNLIRVLGFCIDSE----ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIE 570
++H N+++ +G + LI + SL +L + ++ W + HI E
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAE 128
Query: 571 GITQGLLYL-------QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623
+ +GL YL ++ + I HRD+K N+LL + I+DFG+A F
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 624 NTEQVVGTIGYIPPEYATKGV-----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS 678
+T VGT Y+ PE + + D+++ G++L ++ S + L
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 679 ILEHAYELWKGGKGVEFVDS-----FLDDRNSPCKLMRCL-EIALLCVQENPNDRPSMLE 732
E + E V L D M L E C + R S
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 733 VSSMLKN--ETTNI 744
V + TNI
Sbjct: 309 VGERITQMQRLTNI 322
|
| >4ay1_A Chitinase-3-like protein 2; chilectin, lectin, chitooligosaccharide, pseudochitinase, HY; HET: NAG; 1.95A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 7e-68
Identities = 86/355 (24%), Positives = 149/355 (41%), Gaps = 26/355 (7%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98
T I+ L +HLI S A I + + E + + +++K KNP + +LSIG
Sbjct: 22 TPENIDPFLCSHLIYSFASIENNKVIIK---DKSEVMLYQTINSLKTKNPKLKILLSIG- 77
Query: 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDE 158
G + MV +S+ R FI+S I R + F GLD +W P + + +L E
Sbjct: 78 GYLFGSKGFHPMVDSSTSRLEFINSIILFLRNHNFDGLDVSWIYP-DQKENTHFTVLIHE 136
Query: 159 WRIAATKLDAKNSTRQQSLLILTARFRYSPP--ANSYLLNSIQRNLNWIHAVTASYYEP- 215
A + + L+LTA NSY + + ++L++I+ ++ ++
Sbjct: 137 LAEA---FQKDFTKSTKERLLLTAGVSAGRQMIDNSYQVEKLAKDLDFINLLSFDFHGSW 193
Query: 216 VSTNFTAPPAALYGSISGRFAR---STDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKP 272
T + L R + + + WI +G+ ++K+VM +P YG+++TL
Sbjct: 194 EKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYWIHKGMPSEKVVMGIPTYGHSFTLASA 253
Query: 273 EDNGIGAAAAGPAL-----YDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVW 327
+ +GA A+GP SG + Y +I +K + +V Y G W
Sbjct: 254 -ETTVGAPASGPGAAGPITESSGFLAYYEICQFLKGAK----ITRLQDQQVPYAVKGNQW 308
Query: 328 FGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAAAQKDSITSASVDK 382
G+DDV+++ K+ + K L G W + DD + A
Sbjct: 309 VGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDDFTGKS--CNQGPYPLVQAVKRS 361
|
| >3fy1_A Amcase, TSA1902, acidic mammalian chitinase; structure, crystallography, asthma,inhibitor, chitin degradation, methylallosamidin; HET: NA1 NAA AMI; 1.70A {Homo sapiens} PDB: 3fxy_A* 3rm4_A* 3rm8_A* 3rm9_A* 3rme_A* 2ybt_A* 2ybu_A* Length = 395 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 4e-66
Identities = 87/358 (24%), Positives = 151/358 (42%), Gaps = 27/358 (7%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98
IN L THLI + A + + + ++ + + + +K KN + T+L+IG
Sbjct: 21 MPDDINPCLCTHLIYAFAGMQNNEITT---IEWNDVTLYQAFNGLKNKNSQLKTLLAIG- 76
Query: 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPN----TSTDMFNIGL 154
G + + +++MV +R++FI S I+ R Y F GLDF W P D +
Sbjct: 77 GWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTV 136
Query: 155 LFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPP--ANSYLLNSIQRNLNWIHAVTASY 212
L E R A + + + L++TA + Y + + + L++IH +T
Sbjct: 137 LVQEMREA---FEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQYLDYIHVMTYDL 193
Query: 213 YEPVSTNFTAPPAALYGS---ISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTL 269
+ +T + LY + D V+ W + G A+KL++ P YG+ + L
Sbjct: 194 HGSWE-GYTGENSPLYKYPTDTGSNAYLNVDYVMNYWKDNGAPAEKLIVGFPTYGHNFIL 252
Query: 270 VKPEDNGIGAAAAGPAL-----YDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTG 324
P + GIGA +G +SG+ Y +I +K +++ EV Y G
Sbjct: 253 SNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLK---NGATQGWDAPQEVPYAYQG 309
Query: 325 TVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAAAQKDSITSASVDK 382
VW G+D+V++ K + K + G W + DD + K + S
Sbjct: 310 NVWVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDDFTG--TFCNQGKFPLISTLKKA 365
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 8e-66
Identities = 71/333 (21%), Positives = 115/333 (34%), Gaps = 45/333 (13%)
Query: 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLT 514
+ ++ + + +G G YG VYKG L +AVK S + Q F K +
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRV 61
Query: 515 AKLQHVNLIRVLGFCI-----DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHII 569
++H N+ R + E +L+ EY PN SL YL DW +
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLA 117
Query: 570 EGITQGLLYL------QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623
+T+GL YL ++ + I HRDL N+L+ ISDFG++ L
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 624 NTEQ------VVGTIGYIPPEYATKGV-------YSTKSDVFSFGVLLLQIISGKRLSML 670
E+ VGTI Y+ PE V + D+++ G++ +I
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 671 CGINENLSILEHAYELWKGGKG-----VEFVD------SFLDDRNSPCKLMRCL-EIALL 718
+ A++ G V F + +R L E
Sbjct: 238 GESVPEYQM---AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 719 CVQENPNDRPSMLEVSSMLKNETTNINTPKKPA 751
C ++ R + + K +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >1vf8_A YM1, secretory protein; chitinase, CHI-lectin, structural plasticity, functional versatility, immune system; 1.31A {Mus musculus} SCOP: c.1.8.5 d.26.3.1 PDB: 1e9l_A Length = 377 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-65
Identities = 82/336 (24%), Positives = 147/336 (43%), Gaps = 25/336 (7%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98
I+ L THLI + A + + ++ + D +K KN + T+L+IG
Sbjct: 21 KPGNIDPCLCTHLIYAFAGMQNNE--ITYTHEQDLRDYEALNG-LKDKNTELKTLLAIG- 76
Query: 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAW----TAPNTSTDMFNIGL 154
G + +S+MV +R+ FI S IR R Y F GL+ W + + D +
Sbjct: 77 GWKFGPAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNLDWQYPGSRGSPPKDKHLFSV 136
Query: 155 LFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPA--NSYLLNSIQRNLNWIHAVTASY 212
L E R A + ++ + L+LT+ + Y + + ++L++I +T
Sbjct: 137 LVKEMRKA---FEEESVEKDIPRLLLTSTGAGIIDVIKSGYKIPELSQSLDYIQVMTYDL 193
Query: 213 YEPVSTNFTAPPAALYGS---ISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTL 269
++P +T + LY S I + D ++ W + G +++KL++ P YG+ + L
Sbjct: 194 HDP-KDGYTGENSPLYKSPYDIGKSADLNVDSIISYWKDHGAASEKLIVGFPAYGHTFIL 252
Query: 270 VKPEDNGIGAAAAGPAL-----YDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTG 324
P GIGA +SGL+ Y ++ + ++++ EV Y G
Sbjct: 253 SDPSKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFLN---EGATEVWDAPQEVPYAYQG 309
Query: 325 TVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
W G+D+V + + K + K+ L G W + DD
Sbjct: 310 NEWVGYDNVRSFKLKAQWLKDNNLGGAVVWPLDMDD 345
|
| >1wb0_A Chitinase 1, chitotriosidase 1; cyclopentapeptide inhibitors, chitinase inhibitors, carbohyd metabolism, chitin degradation, chitin-binding; HET: VR0 MEA; 1.65A {Homo sapiens} SCOP: c.1.8.5 d.26.3.1 PDB: 1waw_A* 1guv_A 1lg2_A 1lg1_A 1lq0_A 1hki_A* 1hkj_A* 1hkm_A* 1hkk_A* Length = 445 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 7e-63
Identities = 82/339 (24%), Positives = 153/339 (45%), Gaps = 33/339 (9%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98
++ L THLI + A + + + ++ + + + +KK NP + T+L+IG
Sbjct: 21 LPKDLDPSLCTHLIYAFAGMTNHQLSTT---EWNDETLYQEFNGLKKMNPKLKTLLAIG- 76
Query: 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAP----NTSTDMFNIGL 154
G + ++ MV +++R++F++S+IR R Y F GLD W P + + D
Sbjct: 77 GWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTT 136
Query: 155 LFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYL-----LNSIQRNLNWIHAVT 209
L + A + T + L+L+A P +Y+ ++ I +NL++++ +
Sbjct: 137 LVQDLANA---FQQEAQTSGKERLLLSA---AVPAGQTYVDAGYEVDKIAQNLDFVNLMA 190
Query: 210 ---ASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYA 266
+E V T +P + + D ++ W+++G A KL++ +P YG +
Sbjct: 191 YDFHGSWEKV-TGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRS 249
Query: 267 WTLVKPEDNGIGAAAAGPAL-----YDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYF 321
+TL D +GA A G + G++ Y ++ + +V Y
Sbjct: 250 FTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSW-----KGATKQRIQDQKVPYI 304
Query: 322 STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
W GFDDVE+ + K++Y K+K L G W + DD
Sbjct: 305 FRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDD 343
|
| >2pi6_A Chitinase-3-like protein 1; complex, signaling protein; HET: NAG MAN; 1.65A {Ovis aries} SCOP: c.1.8.5 d.26.3.1 PDB: 2dpe_A* 1sr0_A* 1zl1_A* 1zbk_A* 2dsu_A* 2dsv_A* 2dsw_A* 2fdm_A* 2g41_A* 2g8z_A* 2dt1_A* 1zbv_A* 1zu8_A* 2aos_A* 2b31_A* 1zbw_A* 2dt0_A* 2dsz_A* 2dt2_A* 2dt3_A* ... Length = 361 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-60
Identities = 80/332 (24%), Positives = 140/332 (42%), Gaps = 26/332 (7%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98
I+ L TH+I + A+I++ + +D +K +NP + T+LS+G
Sbjct: 21 FPDAIDPFLCTHVIYTFANISNNE--IDTWEWNDVTLYDTLNT-LKNRNPKLKTLLSVG- 76
Query: 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDE 158
G + +S + + R++FI S R +GF GLD AW P D ++ L E
Sbjct: 77 GWNFGPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYP-GRRDKRHLTTLVKE 135
Query: 159 WRIAATKLDAKNSTRQQSLLILTARFRYSPP--ANSYLLNSIQRNLNWIHAVTASY-YEP 215
+ + + LL L+A Y + I R+L++I +T Y +
Sbjct: 136 MKAE---FIREAQAGTEQLL-LSAAVSAGKIAIDRGYDIAQISRHLDFISLLT--YDFHG 189
Query: 216 VSTNFTAPPAALYGSISGRFAR--STDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPE 273
+ L+ +R + D + + G A+KLVM +P +G ++TL
Sbjct: 190 AWRQTVGHHSPLFRGNEDASSRFSNADYAVSYMLRLGAPANKLVMGIPTFGRSFTLASS- 248
Query: 274 DNGIGAAAAGPAL-----YDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWF 328
+GA +GP + + G++ Y +I + + +V Y + G W
Sbjct: 249 KTDVGAPVSGPGIPGRFTKEKGILAYYEICDFLHGAT----THRFRDQQVPYATKGNQWV 304
Query: 329 GFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
+DD E+V+ K Y K ++L G W + DD
Sbjct: 305 AYDDQESVKNKARYLKNRQLAGAMVWALDLDD 336
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-55
Identities = 66/297 (22%), Positives = 125/297 (42%), Gaps = 41/297 (13%)
Query: 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKL--SKTSTQGFEEFKNEVM 512
D++ +I+ K+G G +G V++ G +AVK L + EF EV
Sbjct: 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 513 LTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGI 572
+ +L+H N++ +G ++ EY+ SL L + LD ++R+ + +
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
+G+ YL I+HR+LK N+L+ + K+ DFG++R+ K S +++ GT
Sbjct: 147 AKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTP 203
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR----------LSMLCGINENLSILEH 682
++ PE + KSDV+SFGV+L ++ + ++ ++ + + L I +
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
++ C P RPS + +L+
Sbjct: 264 LNPQVA-------------------AIIE------GCWTNEPWKRPSFATIMDLLRP 295
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 8e-55
Identities = 72/293 (24%), Positives = 115/293 (39%), Gaps = 40/293 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
LG+G +G K GEV+ +K+L + + F EV + L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
++ +G + I EY+ +L + + W +RV + I G+ YL
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYL--- 124
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ------------VVG 630
+ IIHRDL N L+ E ++DFG+AR+ E + + VVG
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 631 TIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690
++ PE Y K DVFSFG++L +II + + + L
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN------ADPDYLPRTMDFGL---- 234
Query: 691 KGVEFVDSFLDDRNSPCKLMRC----LEIALLCVQENPNDRPSMLEVSSMLKN 739
V FLD C I + C +P RPS +++ L+
Sbjct: 235 ----NVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-54
Identities = 78/281 (27%), Positives = 139/281 (49%), Gaps = 24/281 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVN 521
+ ++ ++G G +G VYKG G+V AVK L+ T + Q + FKNEV + K +HVN
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
++ +G+ + ++ ++ SL +L K + KK + I +G+ YL
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDYLH- 137
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE--- 638
+IIHRDLK +NI L E KI DFG+A ++ S EQ+ G+I ++ PE
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698
YS +SDV++FG++L ++++G+ N++ + G+G D
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQII--EMVGRGSLSPDL 247
Query: 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
N P ++ + C+++ ++RPS + + ++
Sbjct: 248 SKVRSNCPKRM---KRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-53
Identities = 63/282 (22%), Positives = 116/282 (41%), Gaps = 35/282 (12%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
+ + +G G +G V K + +A+K++ S + + F E+ +++ H N++
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
++ G C++ L+ EY SL L + +QG+ YL
Sbjct: 65 KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 584 RLTIIHRDLKVSNILLGEAMK-PKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK 642
+IHRDLK N+LL KI DFG A ++ + G+ ++ PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEG 177
Query: 643 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV-----EFVD 697
YS K DVFS+G++L ++I+ ++ + + W G + +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPF------DEIGGPAFRIM-WAVHNGTRPPLIKNLP 230
Query: 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ LM C ++P+ RPSM E+ ++ +
Sbjct: 231 KPI------ESLMTR------CWSKDPSQRPSMEEIVKIMTH 260
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 56/294 (19%)
Query: 468 IRNKLGEGGYGPVYKGVLPCGEVIAVKKL----SKTSTQGFEEFKNEVMLTAKLQHVNLI 523
+ +G GG+G VY+ G+ +AVK + +Q E + E L A L+H N+I
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
+ G C+ L+ E+ L+ L + V+ I +G+ YL + +
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 584 RLTIIHRDLKVSNILLGEAMKP--------KISDFGMARIFAKESLEENTEQVVGTIGYI 635
+ IIHRDLK SNIL+ + ++ KI+DFG+AR + + + G ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWM 181
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKR-------LSMLCGINEN---LSILEHAYE 685
PE ++S SDV+S+GVLL ++++G+ L++ G+ N L I E
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241
Query: 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ KLM C +P+ RPS + L
Sbjct: 242 PFA-------------------KLME------DCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-51
Identities = 66/296 (22%), Positives = 126/296 (42%), Gaps = 48/296 (16%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPC-GEVIAVKKLSKTSTQG-------FEEFKNEVMLTA 515
++G+GG+G V+KG L V+A+K L ++G F+EF+ EV + +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
L H N++++ G ++ E++P L L D + + W ++ ++ I G
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEA-----MKPKISDFGMARIFAKESLEENTEQVVG 630
+ Y+Q I+HRDL+ NI L + K++DFG+++ + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLG 188
Query: 631 TIGYIPPE--YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK 688
++ PE A + Y+ K+D +SF ++L I++G+ + S + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF------DEYSYGKIKFINMI 242
Query: 689 GGKGV-----EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+G+ E L ++ LC +P RP + L
Sbjct: 243 REEGLRPTIPEDCPPRL------RNVIE------LCWSGDPKKRPHFSYIVKELSE 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 66/306 (21%), Positives = 126/306 (41%), Gaps = 39/306 (12%)
Query: 449 PNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKL--SKTSTQGFEE 506
+ L + + E+ I +G+G +G VY G GEV A++ + + + +
Sbjct: 18 ASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKA 75
Query: 507 FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
FK EVM + +H N++ +G C+ +I ++L + D K++LD K
Sbjct: 76 FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTR 133
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
I + I +G+ YL +++ I+H+DLK N+ K I+DFG+ I +
Sbjct: 134 QIAQEIVKGMGYL--HAK-GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRRED 189
Query: 627 Q---VVGTIGYIPPE---------YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN 674
+ G + ++ PE K +S SDVF+ G + ++ + +
Sbjct: 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF------ 243
Query: 675 ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC-KLMRCLEIALLCVQENPNDRPSMLEV 733
+ +++ G K + K + +I L C +RP+ ++
Sbjct: 244 KTQPAEAIIWQMGTGMK--------PNLSQIGMGKEIS--DILLFCWAFEQEERPTFTKL 293
Query: 734 SSMLKN 739
ML+
Sbjct: 294 MDMLEK 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-49
Identities = 61/283 (21%), Positives = 108/283 (38%), Gaps = 38/283 (13%)
Query: 467 SIRNKLGEGGYGPVYKGVLPCGEVIAVKKL--SKTSTQGFEEFKNEVMLTAKLQHVNLIR 524
+ KL E G ++KG G I VK L ST+ +F E H N++
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 525 VLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
VLG C LI +MP SL L + ++D + V + +G+ +L
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE---Y 639
L I L ++++ E M +IS + F + ++ PE
Sbjct: 131 EPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-------RMYAPAWVAPEALQK 182
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF---V 696
+ +D++SF VLL ++++ + +LS +E ++ G +
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPF------ADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ KLM+ +C+ E+P RP + +L+
Sbjct: 237 SPHV------SKLMK------ICMNEDPAKRPKFDMIVPILEK 267
|
| >1jnd_A Imaginal DISC growth factor-2; IDGF, chitinase, insulin recep heparin, hormone-growth factor complex; HET: NAG BMA MAN; 1.30A {Drosophila melanogaster} SCOP: c.1.8.5 d.26.3.1 PDB: 1jne_A* Length = 420 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-46
Identities = 67/376 (17%), Positives = 132/376 (35%), Gaps = 61/376 (16%)
Query: 43 INYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFAD--TVKKKNPSITTILSIGQGK 100
I +HL+ A + Q + + +F++ ++K+K P + +LS+G
Sbjct: 28 IALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSEVTSLKRKYPHLKVLLSVGGDH 87
Query: 101 DTNY---SIYSSMVRNSSHRKS-FIDSSIRIARLYGFRGLDFAW-----------TAPNT 145
D + + Y ++ R+ FI S+ + + YGF GLD A+
Sbjct: 88 DIDPDHPNKYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAYQFPKNKPRKVHGDLGL 147
Query: 146 STDMFNIGLLFDEWRIAATKLDAKNSTR---------QQSLLILT----ARFRYSPPANS 192
+ D L + T + +L+ +
Sbjct: 148 AWKSIKKLFTGDFIVDPHAALHKEQFTALVRDVKDSLRADGFLLSLTVLPNVNST---WY 204
Query: 193 YLLNSIQRNLNWIHAVT----ASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIE 248
+ + ++ +++++ T P +++AP GS + D ++ W+
Sbjct: 205 FDIPALNGLVDFVNLATFDFLTPARNPEEADYSAPIYHPDGSKDRLAHLNADFQVEYWLS 264
Query: 249 RGLSADKLVMCLPFYGYAWTLVKPEDNG--------IGAAAAGPALYDSGLVTYKKIKNH 300
+G ++K+ + + YG AW L K G A G GL++Y +I
Sbjct: 265 QGFPSNKINLGVATYGNAWKLTKDSGLEGVPVVPETSGPAPEGFQSQKPGLLSYAEICGK 324
Query: 301 IK--------------TYGPDVQVMYNSTYEV--NYFSTGTVWFGFDDVEAVRAKIAYAK 344
+ D + + T +W +DD ++ K AYA+
Sbjct: 325 LSNPQNQFLKGNESPLRRVSDPTKRFGGIAYRPVDGQITEGIWVSYDDPDSASNKAAYAR 384
Query: 345 EKRLLGYYAWQVSFDD 360
K L G + +S+DD
Sbjct: 385 VKNLGGVALFDLSYDD 400
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-45
Identities = 70/290 (24%), Positives = 110/290 (37%), Gaps = 46/290 (15%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEV-IAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVN 521
E + ++G G +G V+ G L +AVK +F E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
++R++G C + ++ E + +L +L + K + ++ G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYL-- 229
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP----- 636
IHRDL N L+ E KISDFGM+R + G + +P
Sbjct: 230 -ESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-----EADGVYAASGGLRQVPVKWTA 283
Query: 637 PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEF 695
PE G YS++SDV+SFG+LL + S G Y + EF
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGAS----------------PYPNLSNQQTREF 327
Query: 696 VDS-FLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
V+ C +LM C P RPS + L++
Sbjct: 328 VEKGGRLPCPELCPDAVFRLM------EQCWAYEPGQRPSFSTIYQELQS 371
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 70/308 (22%), Positives = 112/308 (36%), Gaps = 56/308 (18%)
Query: 468 IRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNE--VMLTAKLQHVNLIRV 525
+ ++G+G YG V+ G GE +AVK T + E + T ++H N++
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGF 96
Query: 526 LGFCIDSEER----MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL-- 579
+ I LI +Y N SL +D ++ LD K + + GL +L
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 580 ---QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ--VVGTIGY 634
+ I HRDLK NIL+ + I+D G+A F ++ E + VGT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 635 IPPE------YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK 688
+PPE +D++SFG++L ++ C + + Y
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR------CVSGGIVEEYQLPYHDLV 266
Query: 689 GGKGV--EFVDSFLDDRNSP---------------CKLMRCLEIALLCVQENPNDRPSML 731
+ + + P KLM C NP R + L
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT------ECWAHNPASRLTAL 320
Query: 732 EVSSMLKN 739
V L
Sbjct: 321 RVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-45
Identities = 67/308 (21%), Positives = 121/308 (39%), Gaps = 56/308 (18%)
Query: 468 IRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNE--VMLTAKLQHVNLIRV 525
+ +G+G YG V++G GE +AVK S ++ + + E + T L+H N++
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 526 LGFCIDSE----ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL-- 579
+ + S + LI Y SL +D ++ LD + I+ I GL +L
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 580 ---QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ--VVGTIGY 634
+ I HRDLK NIL+ + + I+D G+A + ++ + + + VGT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 635 IPPE------YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK 688
+ PE + D+++FG++L ++ N + + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR------MVSNGIVEDYKPPFYDVV 237
Query: 689 GG--------KGV-------EFVDSFLDDRNSP--CKLMRCLEIALLCVQENPNDRPSML 731
K V + + D KLM+ C +NP+ R + L
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK------ECWYQNPSARLTAL 291
Query: 732 EVSSMLKN 739
+ L
Sbjct: 292 RIKKTLTK 299
|
| >1w9p_A Chitinase; peptide inhibitors, argifin, argadin, glycosidase, hydrolase; 1.7A {Aspergillus fumigatus} SCOP: c.1.8.5 d.26.3.1 PDB: 1w9u_A* 1w9v_A* 2a3a_A* 2a3b_A* 2a3c_A* 2a3e_A* 2iuz_A* 3ch9_A 3chc_A* 3chd_A* 3che_A* 3chf_A* 1wno_A* Length = 433 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-44
Identities = 68/347 (19%), Positives = 128/347 (36%), Gaps = 49/347 (14%)
Query: 43 INYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTV-----------------KK 85
+ + TH++ + A++ T ++ ++ + + D+ KK
Sbjct: 64 LPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCIKQLYLLKK 123
Query: 86 KNPSITTILSIGQGKDTNYS-IYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPN 144
+N ++ +LSIG YS ++ + RK+F +++++ + GF GLD W P
Sbjct: 124 QNRNLKVLLSIGGW---TYSPNFAPAASTDAGRKNFAKTAVKLLQDLGFDGLDIDWEYPE 180
Query: 145 TSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPA-----NSYLLNSIQ 199
+ LL E R A A N+ Q +LT + PA L +
Sbjct: 181 NDQQANDFVLLLKEVRTALDSYSAANAGGQH--FLLTV----ASPAGPDKIKVLHLKDMD 234
Query: 200 RNLNWIHAVTASYYEPVSTNFTAPPAALYGS--ISGRFARSTDQVLKAWIERGLSADKLV 257
+ L++ + + Y S + + A +Y +T L + G+ A+K+V
Sbjct: 235 QQLDFWNLMAYDYAGSFS-SLSGHQANVYNDTSNPLSTPFNTQTALDLYRAGGVPANKIV 293
Query: 258 MCLPFYGYAWTLVKPEDNGIGAAAAGPALY--DSGLVTYKKIKNHIKTYGPDVQVMYNST 315
+ +P YG ++ +G G G ++G+ YK +
Sbjct: 294 LGMPLYGRSFANT----DGPGKPYNGVGQGSWENGVWDYKALPQ------AGATEHVLPD 343
Query: 316 YEVNYF--STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
+Y +T +D+ + K Y K L G W S D
Sbjct: 344 IMASYSYDATNKFLISYDNPQVANLKSGYIKSLGLGGAMWWDSSSDK 390
|
| >1ll7_A Chitinase 1; beta-alpha barrel, hydrolase; 2.00A {Coccidioides immitis} SCOP: c.1.8.5 d.26.3.1 PDB: 1d2k_A 1ll4_A* 1ll6_A Length = 392 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-43
Identities = 74/347 (21%), Positives = 136/347 (39%), Gaps = 50/347 (14%)
Query: 43 INYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTV-----------------KK 85
+ D FTH++ + A+I + ++ LS + D KK
Sbjct: 24 LKADQFTHILYAFANIRPS-GEVYLSDTWADTDKHYPGDKWDEPGNNVYGCIKQMYLLKK 82
Query: 86 KNPSITTILSIGQGKDTNYS-IYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPN 144
N ++ T+LSIG YS + + RK F D+S+++ + GF G+D W P
Sbjct: 83 NNRNLKTLLSIGGW---TYSPNFKTPASTEEGRKKFADTSLKLMKDLGFDGIDIDWQYPE 139
Query: 145 TSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPA-----NSYLLNSIQ 199
+ LL R A AK+ ++ +LT + PA N L +
Sbjct: 140 DEKQANDFVLLLKACREALDAYSAKHPNGKK--FLLTI----ASPAGPQNYNKLKLAEMD 193
Query: 200 RNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFAR--STDQVLKAWIERGLSADKLV 257
+ L++ + + + + + ++ S + + S+D+ +K +I+ G+ A+K+V
Sbjct: 194 KYLDFWNLMAYDFSGSWD-KVSGHMSNVFPSTTKPESTPFSSDKAVKDYIKAGVPANKIV 252
Query: 258 MCLPFYGYAWTLVKPEDNGIGAAAAGPALY--DSGLVTYKKIKNHIKTYGPDVQVMYNST 315
+ +P YG A+ +GIG + G ++G+ YK + QV
Sbjct: 253 LGMPLYGRAFAST----DGIGTSFNGVGGGSWENGVWDYKDMPQ------QGAQVTELED 302
Query: 316 YEVNYF--STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
+Y +D V+ K Y + + G W+ S D
Sbjct: 303 IAASYSYDKNKRYLISYDTVKIAGKKAEYITKNGMGGGMWWESSSDK 349
|
| >3g6m_A Chitinase, crchi1; inhibitor, caffeine, glycosidase, hydrolas hydrolase inhibitor complex; HET: CFF; 1.65A {Bionectria ochroleuca} PDB: 3g6l_A* Length = 406 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-43
Identities = 71/351 (20%), Positives = 127/351 (36%), Gaps = 46/351 (13%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTV--------------- 83
+ + H++ S ++ + + + D+
Sbjct: 38 QPADLQASKILHVLYSFMNLRVD-GTVYSGDTYADLEKHYSDDSWNDIGTNAYGCVKQLY 96
Query: 84 --KKKNPSITTILSIGQGKDTNYS-IYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAW 140
KK N S+ +LSIG +S + + + R +F +++ + +GF G+D W
Sbjct: 97 KLKKANRSLKIMLSIGGW---TWSTNFPAAASTEATRATFAKTAVEFMKDWGFDGIDVDW 153
Query: 141 TAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPA-----NSYLL 195
P + TD N+ LL R A + L+ + PA N L
Sbjct: 154 EYPASETDANNMVLLLQRVRQELDSYSATYANGYH--FQLSI----AAPAGPSHYNVLKL 207
Query: 196 NSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGS--ISGRFARSTDQVLKAWIERGLSA 253
+ L+ I+ + Y + + LY S ST + A+I G+ A
Sbjct: 208 AQLGSVLDNINLMAYDYAGSWD-SVSGHQTNLYPSTSNPSSTPFSTKAAVDAYIAAGVPA 266
Query: 254 DKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYN 313
K+++ +P YG A+ + G + G ++SG+ YK + V+ +
Sbjct: 267 SKIILGMPIYGRAFVGT--DGPGKPYSTIGEGSWESGIWDYKVLPK------AGATVITD 318
Query: 314 STYEVNYF--STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362
S Y S+ +D + VR K++YAK L G W+ S D
Sbjct: 319 SAAGATYSYDSSSRTMISYDTPDMVRTKVSYAKGLGLGGSMFWEASADKTG 369
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 8e-43
Identities = 61/300 (20%), Positives = 114/300 (38%), Gaps = 40/300 (13%)
Query: 468 IRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLG 527
++ +G+G +G V++G GE +AVK S + + + E+ T L+H N++ +
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIA 103
Query: 528 FCIDSE----ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL---- 579
+ L+ +Y + SL FD + + + + + + GL +L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 580 -QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ--VVGTIGYIP 636
+ I HRDLK NIL+ + I+D G+A + + VGT Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 637 PE------YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690
PE ++D+++ G++ +I C I + Y
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARR------CSIGGIHEDYQLPYYDLVPS 273
Query: 691 K-GVEFVDSF---------LDDRNSPCKLMRCL-EIALLCVQENPNDRPSMLEVSSMLKN 739
VE + + +R C+ +R + +I C N R + L + L
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >1itx_A Chitinase A1, glycosyl hydrolase; alpha-beta (TIM) barrel; 1.10A {Bacillus circulans} SCOP: c.1.8.5 d.26.3.1 Length = 419 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-43
Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 40/314 (12%)
Query: 84 KKKNPSITTILSIGQGKDTNYSI-YSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAW-- 140
K+ NP++ TI+S+G G +S +S + ++ R+ F +S++ R Y F G+D W
Sbjct: 117 KQTNPNLKTIISVG-G--WTWSNRFSDVAATAATREVFANSAVDFLRKYNFDGVDLDWEY 173
Query: 141 -----TAPNTS--TDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPA--- 190
N+ D N LL + R KLDA + + L+ A A
Sbjct: 174 PVSGGLDGNSKRPEDKQNYTLLLSKIR---EKLDAAGAVDGKKYLLTIA-----SGASAT 225
Query: 191 --NSYLLNSIQRNLNWIHAVTASYY---EPVSTNFTAP----PAALYGSISGRFARSTDQ 241
+ L I ++WI+ +T + + + + AP PAA + +
Sbjct: 226 YAANTELAKIAAIVDWINIMTYDFNGAWQKI-SAHNAPLNYDPAASAAGVPDANTFNVAA 284
Query: 242 VLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPAL---YDSGLVTYKKIK 298
+ ++ G+ A KLV+ +PFYG W NG G + +++G + ++
Sbjct: 285 GAQGHLDAGVPAAKLVLGVPFYGRGWDGCAQAGNGQYQTCTGGSSVGTWEAGSFDFYDLE 344
Query: 299 NHIKTYGPDVQVMYNSTYEVNYF--STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQV 356
+ +N T +V Y ++ + +DD E+V K AY K K L G W++
Sbjct: 345 ANYIN-KNGYTRYWNDTAKVPYLYNASNKRFISYDDAESVGYKTAYIKSKGLGGAMFWEL 403
Query: 357 SFDDHDWLLSQAAA 370
S D + L ++ A
Sbjct: 404 SGDRNKTLQNKLKA 417
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 69/319 (21%), Positives = 121/319 (37%), Gaps = 56/319 (17%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP-----CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ 518
++LG+G +G V G ++AVK+L + +F+ E+ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 519 HVNLIRVLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
+++ G + L+ EY+P+ L +L + LD + + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
YL +HRDL NIL+ KI+DFG+A++ + VV G P
Sbjct: 141 EYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP----LDKDYYVVREPGQSP 193
Query: 637 -----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691
PE + ++S +SDV+SFGV+L ++ + C +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCDKS------------CSPSA 235
Query: 692 GVEFVDSFLDDRNSPCKLMRCLE-----------------IALLCVQENPNDRPSMLEVS 734
+ D + +L+ LE + LC +P DRPS +
Sbjct: 236 EFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALG 295
Query: 735 SMLKNETTNINTPKKPAFS 753
L + + AF+
Sbjct: 296 PQLDMLWSGSRGCETHAFT 314
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 80/304 (26%), Positives = 124/304 (40%), Gaps = 41/304 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP-----CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ 518
+LG+G +G V GEV+AVKKL ++ + +F+ E+ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 519 HVNLIRVLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
H N+++ G C + R LI EY+P SL YL K +D K + I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ-VVGTIGYI 635
YL IHRDL NIL+ + KI DFG+ ++ L ++ E V G
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEFFKVKEPGES 179
Query: 636 P-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690
P PE T+ +S SDV+SFGV+L ++ + S I
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 691 KGVEFVDSFLDDRNSPC---------KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741
+E + ++ P +M C N N RPS +++ +
Sbjct: 240 HLIELLK---NNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQIR 290
Query: 742 TNIN 745
N+
Sbjct: 291 DNMA 294
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 74/301 (24%), Positives = 113/301 (37%), Gaps = 49/301 (16%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKL-SKTSTQGFEEFKNEVMLTAKL 517
LGEG +G V GE++AVK L + Q +K E+ + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 518 QHVNLIRVLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
H ++I+ G C D+ L+ EY+P SL YL + + + + + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ-VVGTIGY 634
+ YL IHRDL N+LL KI DFG+A+ + E E V G
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA-----VPEGHEYYRVREDGD 198
Query: 635 IP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWK 688
P PE + + SDV+SFGV L ++++ L +
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ------ 252
Query: 689 GGKGVEFVDSFLDD-------RNSPC---KLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738
G V + L+ P LM C + + RP+ + +LK
Sbjct: 253 GQMTVLRLTELLERGERLPRPDKCPAEVYHLM------KNCWETEASFRPTFENLIPILK 306
Query: 739 N 739
Sbjct: 307 T 307
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 78/298 (26%), Positives = 121/298 (40%), Gaps = 41/298 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP-----CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ 518
+LG+G +G V GEV+AVKKL ++ + +F+ E+ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 519 HVNLIRVLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
H N+++ G C + R LI EY+P SL YL K +D K + I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ-VVGTIGYI 635
YL IHRDL NIL+ + KI DFG+ ++ L ++ E V G
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEYYKVKEPGES 210
Query: 636 P-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690
P PE T+ +S SDV+SFGV+L ++ + S I
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG---QM 267
Query: 691 KGVEFVDSFLDDRNSPC---------KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
++ ++ P +M C N N RPS +++ +
Sbjct: 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 77/310 (24%), Positives = 131/310 (42%), Gaps = 68/310 (21%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGE------VIAVKKLSKTSTQGFEEFKNEVMLTAKL 517
++ +LGEG +G V+ ++AVK L + S ++F+ E L L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL------------FDPIRKLILDWKKR 565
QH +++R G C + ++++EYM + L+ +L + + L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625
+ + + G++YL + L +HRDL N L+G+ + KI DFGM+R +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTD 212
Query: 626 EQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGINE 675
VG +P PE ++T+SDV+SFGV+L +I + GK+ LS N
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-----NT 267
Query: 676 N-LSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPS 729
+ + EL +R C +MR C Q P R S
Sbjct: 268 EAIDCITQGREL---------------ERPRACPPEVYAIMR------GCWQREPQQRHS 306
Query: 730 MLEVSSMLKN 739
+ +V + L+
Sbjct: 307 IKDVHARLQA 316
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 70/304 (23%), Positives = 124/304 (40%), Gaps = 42/304 (13%)
Query: 446 RNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFE 505
+N P+ E + + +LG G +G V G +A+K + K + +
Sbjct: 6 KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSED 64
Query: 506 EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR 565
EF E + L H L+++ G C +I EYM N L YL + + ++
Sbjct: 65 EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQL 122
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625
+ + + + + + YL +HRDL N L+ + K+SDFG++R L++
Sbjct: 123 LEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEY 175
Query: 626 EQVVGT---IGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILE 681
VG+ + + PPE +S+KSD+++FGVL+ +I S GK
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM--------------- 220
Query: 682 HAYELWKGGKGVEFVDS-FLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSS 735
YE + + E + R +M C E ++RP+ + S
Sbjct: 221 -PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM------YSCWHEKADERPTFKILLS 273
Query: 736 MLKN 739
+ +
Sbjct: 274 NILD 277
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 82/311 (26%), Positives = 134/311 (43%), Gaps = 58/311 (18%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEV-IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
++++KLG G YG VY+GV + +AVK L K T EEF E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
+++LG C +I E+M +L YL + + + +++ I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----P 637
+ IHRDL N L+GE K++DFG++R+ P P
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFPIKWTAP 181
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKG 692
E +S KSDV++FGVLL +I + G + +++ +LE Y +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLEKDYRM------ 231
Query: 693 VEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTP 747
+R C +LM C Q NP+DRPS E+ +
Sbjct: 232 ---------ERPEGCPEKVYELM------RACWQWNPSDRPSFAEIHQAFETMFQE---- 272
Query: 748 KKPAFSKQVDE 758
+ S +V++
Sbjct: 273 --SSISDEVEK 281
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 77/311 (24%), Positives = 127/311 (40%), Gaps = 69/311 (22%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL----PCGEVI--AVKKLSKTSTQGFEEFKNEVMLTAKL 517
++ +LGEG +G V+ P + + AVK L + ++F+ E L L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-------------FDPIRKLILDWKK 564
QH ++++ G C D + ++++EYM + L+ +L K L +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 565 RVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
+HI I G++YL + +HRDL N L+G + KI DFGM+R +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYST 186
Query: 625 TEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGIN 674
VG +P PE ++T+SDV+SFGV+L +I + GK+ LS N
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-----N 241
Query: 675 EN-LSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRP 728
+ + L +R C +M C Q P R
Sbjct: 242 TEVIECITQGRVL---------------ERPRVCPKEVYDVML------GCWQREPQQRL 280
Query: 729 SMLEVSSMLKN 739
++ E+ +L
Sbjct: 281 NIKEIYKILHA 291
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 77/312 (24%), Positives = 127/312 (40%), Gaps = 70/312 (22%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL----PCGEVI--AVKKLSKTST-QGFEEFKNEVMLTAK 516
+LGE +G VYKG L P + A+K L + EEF++E ML A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-------------FDPIRKLILDWK 563
LQH N++ +LG + +I+ Y + L +L D K L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 564 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623
VH++ I G+ YL S ++H+DL N+L+ + + KISD G+ R +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE-----VYA 180
Query: 624 NTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGI 673
+ +P PE G +S SD++S+GV+L ++ S G + S
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----- 235
Query: 674 NEN-LSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDR 727
N++ + ++ + L C LM + C E P+ R
Sbjct: 236 NQDVVEMIRNRQVL---------------PCPDDCPAWVYALM------IECWNEFPSRR 274
Query: 728 PSMLEVSSMLKN 739
P ++ S L+
Sbjct: 275 PRFKDIHSRLRA 286
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 73/290 (25%), Positives = 122/290 (42%), Gaps = 42/290 (14%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
+ ++G G +G V+ G + +A+K + + E+F E + KL H L+
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
++ G C++ L+ E+M + L YL + + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYL---E 121
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT---IGYIPPEYA 640
+IHRDL N L+GE K+SDFGM R L++ GT + + PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSSTGTKFPVKWASPEVF 177
Query: 641 TKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS- 698
+ YS+KSDV+SFGVL+ ++ S GK YE + VE + +
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKI----------------PYENRSNSEVVEDISTG 221
Query: 699 FLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743
F + ++M C +E P DRP+ + L +
Sbjct: 222 FRLYKPRLASTHVYQIM------NHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-41
Identities = 85/306 (27%), Positives = 135/306 (44%), Gaps = 50/306 (16%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL--PCGEVI--AVKKLSKTST-QGFEEFKNEVMLTAKLQ 518
SI +G G +G V G L P + I A+K L T + +F E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H N+IR+ G S+ M++ EYM N SLD +L + + V ++ GI G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKY 162
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY-IP- 636
L S + +HRDL NIL+ + K+SDFG+ R+ LE++ E T G IP
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV-----LEDDPEAAYTTRGGKIPI 214
Query: 637 ----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGK 691
PE +++ SDV+S+G++L +++S G+R Y
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER----------------PYWEMSNQD 258
Query: 692 GVEFVDS-FLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNIN 745
++ VD + C +LM L C Q++ N+RP ++ S+L N
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILDKLIRNPG 312
Query: 746 TPKKPA 751
+ K
Sbjct: 313 SLKIIT 318
|
| >3qok_A Putative chitinase II; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, glycosyl hydrolases family 18; 2.60A {Klebsiella pneumoniae subsp} Length = 420 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-40
Identities = 64/387 (16%), Positives = 122/387 (31%), Gaps = 78/387 (20%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTV------------KKK 86
I ++ THL S I + + + D + + + +K+
Sbjct: 45 DIDKLDVRQITHLNYSFGLIYNDEKDETNAALKDPAHLHEIWLSPKVQADLQKLPALRKQ 104
Query: 87 NPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTS 146
NP + +LS+G G +S + R FI S+ +I + YG G+D W P
Sbjct: 105 NPDLKVLLSVG-G--WGARGFSGAAATAESRAVFIRSAQKIIQQYGLDGIDLDWEFPVNG 161
Query: 147 TDMFNIG---------LLFDEWRIAATKLDAKNSTRQQSLLILTA-----RFRYSPPANS 192
L R A + + ++T +
Sbjct: 162 AWGLVASQPADRDNFTALLKSLREA---VGEQ--------KLVTIAVGANAESPK---SW 207
Query: 193 YLLNSIQRNLNWIHAVTASYYEPVSTNFTAP--PAALYGSISGRFARSTDQVLKAWIERG 250
+ ++ LN+I+ +T F + ++ + +++ S D V+ ++ G
Sbjct: 208 VDVKAVAPVLNYINLMTYDMAYGT-QYFNSNLYDSSHWPTVAAADKYSADFVVNNYLAAG 266
Query: 251 LSADKLVMCLPFYG----------YAWTLVKPEDNGIGAAAAGPAL-----------YDS 289
L ++ + + FYG WT ++N + GP
Sbjct: 267 LKPSQMNLGIGFYGRVPKRAVEPGIDWTKADAQNNPVTQPYFGPQQIALFASLGYDLSKD 326
Query: 290 GLVTYKKIKNHIKTYG---------PDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKI 340
V Y I + + +V + + +++ +V K
Sbjct: 327 TYVKYNDIVGKLLNDPQKRFTEHWDDEAKVPW--LSVQSAEGKPLFALSYENPRSVAIKA 384
Query: 341 AYAKEKRLLGYYAWQVSFDDHDWLLSQ 367
Y K K L G W+ DD + L Q
Sbjct: 385 DYIKAKGLAGAMFWEYGADDQNQLARQ 411
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 70/298 (23%), Positives = 119/298 (39%), Gaps = 45/298 (15%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP-----CGEVIAVKKL-SKTSTQGFEEFKNEVMLTAKL 517
LGEG +G V GE +AVK L ++ + K E+ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 518 QHVNLIRVLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
H N+++ G C + LI E++P+ SL YL P K ++ K+++ I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ-VVGTIGY 634
+ YL +HRDL N+L+ + KI DFG+ + +E + E V
Sbjct: 139 MDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----IETDKEYYTVKDDRD 190
Query: 635 IP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWK 688
P PE + + SDV+SFGV L ++++ S + L ++ +
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS--PMALFLKMIGPTHGQMT 248
Query: 689 GGKGVEFVDSFLDDRNSPC---------KLMRCLEIALLCVQENPNDRPSMLEVSSML 737
+ V + + + PC +LM C + P++R S +
Sbjct: 249 VTRLVNTLK---EGKRLPCPPNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGF 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 74/306 (24%), Positives = 136/306 (44%), Gaps = 49/306 (16%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL--PCGEV---IAVKKLSK-TSTQGFEEFKNEVMLTAKL 517
+ + +G G +G VYKG+L G+ +A+K L + + +F E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
H N+IR+ G + M+I EYM N +LD +L + + + + V ++ GI G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLRGIAAGMK 161
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP- 636
YL + + +HRDL NIL+ + K+SDFG++R+ + T G IP
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG----GKIPI 214
Query: 637 ----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGK 691
PE + +++ SDV+SFG+++ ++++ G+R Y +
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER----------------PYWELSNHE 258
Query: 692 GVEFVDS-FLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNIN 745
++ ++ F C +LM + C Q+ RP ++ S+L +
Sbjct: 259 VMKAINDGFRLPTPMDCPSAIYQLM------MQCWQQERARRPKFADIVSILDKLIRAPD 312
Query: 746 TPKKPA 751
+ K A
Sbjct: 313 SLKTLA 318
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-40
Identities = 79/302 (26%), Positives = 138/302 (45%), Gaps = 40/302 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEV-IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
++++KLG G YG VY+GV + +AVK L + + + EEF E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 278
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
+++LG C +I E+M +L YL + + + +++ I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK 642
+ IHR+L N L+GE K++DFG++R+ ++ + I + PE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 643 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701
+S KSDV++FGVLL +I + G +++ +LE Y +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--------------- 438
Query: 702 DRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQV 756
+R C +LM C Q NP+DRPS E+ + + S +V
Sbjct: 439 ERPEGCPEKVYELM------RACWQWNPSDRPSFAEIHQAFETMFQE------SSISDEV 486
Query: 757 DE 758
++
Sbjct: 487 EK 488
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 75/305 (24%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL--PCGEVI--AVKKL-SKTSTQGFEEFKNEVMLTAKLQ 518
R I +G G G V G L P + A+K L + + + +F +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H N+IR+ G M++ EYM N SLD +L + + + V ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRY 166
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-- 636
L S L +HRDL N+L+ + K+SDFG++R+ + T G IP
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG----GKIPIR 219
Query: 637 ---PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKG 692
PE +S+ SDV+SFGV++ ++++ G+R Y
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER----------------PYWNMTNRDV 263
Query: 693 VEFVDS-FLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINT 746
+ V+ + C +LM L C ++ RP ++ S+L + +
Sbjct: 264 ISSVEEGYRLPAPMGCPHALHQLM------LDCWHKDRAQRPRFSQIVSVLDALIRSPES 317
Query: 747 PKKPA 751
+ A
Sbjct: 318 LRATA 322
|
| >1edq_A Chitinase A; beta-alpha (TIM) barrel, hydrolase; 1.55A {Serratia marcescens} SCOP: b.1.18.2 c.1.8.5 d.26.3.1 PDB: 1ffq_A* 1ffr_A* 1ehn_A* 1ctn_A 1k9t_A* 1eib_A* 2wlz_A* 2wly_A* 2wm0_A* 2wk2_A* 1nh6_A* 1x6l_A 1rd6_A 1x6n_A* Length = 540 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-40
Identities = 65/300 (21%), Positives = 114/300 (38%), Gaps = 33/300 (11%)
Query: 84 KKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYG-FRGLDFAWTA 142
K+ +P + + SIG S + + R F+ S + + F G+D W
Sbjct: 237 KQAHPDLKILPSIGGW---TLSDPFFFMGDKVKRDRFVGSVKEFLQTWKFFDGVDIDWEF 293
Query: 143 PNTSTDMFNIG---------LLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSY 193
P N+G LL E R LD + + + +A
Sbjct: 294 PGGKGANPNLGSPQDGETYVLLMKELR---AMLDQLSVETGRKYELTSA----ISAGKDK 346
Query: 194 L----LNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSIS-GRFARSTDQVLKAWIE 248
+ N Q +++ I ++ +Y AL A +T + A +
Sbjct: 347 IDKVAYNVAQNSMDHIFLMSYDFYGAFDLKNLGHQTALNAPAWKPDTAYTTVNGVNALLA 406
Query: 249 RGLSADKLVMCLPFYGYAWTLVKPEDNGIG----AAAAGPALYDSGLVTYKKIKNHIKTY 304
+G+ K+V+ YG WT V N I A +++G+V Y++I +
Sbjct: 407 QGVKPGKIVVGTAMYGRGWTGVNGYQNNIPFTGTATGPVKGTWENGIVDYRQIAGQFMS- 465
Query: 305 GPDVQVMYNSTYEVNYF--STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362
+ Q Y++T E Y + FDD +V+AK Y +K+L G ++W++ D+ D
Sbjct: 466 -GEWQYTYDATAEAPYVFKPSTGDLITFDDARSVQAKGKYVLDKQLGGLFSWEIDADNGD 524
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 73/286 (25%), Positives = 118/286 (41%), Gaps = 42/286 (14%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
E ++ +LG G +G V G +AVK + K + +EF E KL H L+
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
+ G C ++ EY+ N L YL + L + + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP--SQLLEMCYDVCEGMAFL---E 121
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT---IGYIPPEYA 640
IHRDL N L+ + K+SDFGM R L++ VGT + + PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSAPEVF 177
Query: 641 TKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS- 698
YS+KSDV++FG+L+ ++ S GK Y+L+ + V V
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKM----------------PYDLYTNSEVVLKVSQG 221
Query: 699 FLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
R ++M C E P RP+ ++ S ++
Sbjct: 222 HRLYRPHLASDTIYQIM------YSCWHELPEKRPTFQQLLSSIEP 261
|
| >1kfw_A Chitinase B; TIM barrel, hydrolase; 1.74A {Arthrobacter SP} SCOP: c.1.8.5 d.26.3.1 Length = 435 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-40
Identities = 62/319 (19%), Positives = 111/319 (34%), Gaps = 49/319 (15%)
Query: 84 KKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYG----------- 132
K KNP + ++S+G + +S + R+ + S I +
Sbjct: 112 KAKNPKLKVMISLGGWTWSKN--FSKAAATEASRQKLVSSCIDLYIKGNLPNFEGRGGAG 169
Query: 133 -----FRGLDFAW-----------TAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQS 176
F G+D W +T D N L E+R +LDA ST +
Sbjct: 170 AAAGIFDGIDIDWEWPGTNSGLAGNGVDTVNDRANFKALLAEFR---KQLDAYGSTNNKK 226
Query: 177 LLILTA----RFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGS-- 230
++ A + + ++L++ + + T A LY
Sbjct: 227 YVLSAFLPANPADID--AGGWDDPANFKSLDFGSIQGYDLHGAWNPTLTGHQANLYDDPA 284
Query: 231 --ISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYD 288
+ S D+ +K ++ G+ +L + L YG WT K A P Y+
Sbjct: 285 DPRAPSKKFSADKAVKKYLAAGIDPKQLGLGLAAYGRGWTGAKNVSPWGPATDGAPGTYE 344
Query: 289 SGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRL 348
+ Y K+K + Y++ + GT W+ +D++ + K Y K L
Sbjct: 345 TANEDYDKLKTLGTDH-------YDAATGSAWRYDGTQWWSYDNIATTKQKTDYIVSKGL 397
Query: 349 LGYYAWQVSFDDHDWLLSQ 367
G W++S D + L+
Sbjct: 398 GGGMWWELSGDRNGELVGA 416
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-39
Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 44/299 (14%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
E + KLG+G +G V+ G +A+K L K T E F E + KL+H L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
++ + E ++ EYM SL +L K L + V + I G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---E 297
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PE 638
R+ +HRDL+ +NIL+GE + K++DFG+AR L E+ E P PE
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLAR------LIEDNEYTARQGAKFPIKWTAPE 351
Query: 639 YATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697
A G ++ KSDV+SFG+LL ++ + G+ E L +E Y +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------- 400
Query: 698 SFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPA 751
C LM C ++ P +RP+ + + L++ T+ +P
Sbjct: 401 ----PCPPECPESLHDLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-39
Identities = 71/289 (24%), Positives = 125/289 (43%), Gaps = 44/289 (15%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
+ + +G+G +G V G +V AVK + +T + F E + +L+H NL+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 524 RVLGFCIDSEER-MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
++LG ++ + ++ EYM SL YL R + L + + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL--- 305
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY--IPPEYA 640
+HRDL N+L+ E K+SDFG+ + E ++ Q G + PE
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEAL 358
Query: 641 TKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699
+ +STKSDV+SFG+LL +I S G+ + + + +E Y++
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM------------- 405
Query: 700 LDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743
D C +M C + RP+ L++ L++ T+
Sbjct: 406 --DAPDGCPPAVYDVM------KNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1goi_A Chitinase B; chitin degradation, hydrolase, glycosidase; 1.45A {Serratia marcescens} SCOP: b.72.2.1 c.1.8.5 d.26.3.1 PDB: 1o6i_A* 1e6r_A* 1e15_A 1gpf_A* 1ur8_A* 1w1p_A* 1w1t_A* 1w1v_A* 1w1y_A* 1e6p_A 1e6n_A 1h0g_A* 1h0i_A* 1ogb_A 1ogg_A* 1e6z_A* 1ur9_A* Length = 499 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-39
Identities = 79/388 (20%), Positives = 148/388 (38%), Gaps = 75/388 (19%)
Query: 37 VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQ----IAKFADTVKKKNPSITT 92
VS I+ TH+ S DINS + + +++ + + + +K NPS+
Sbjct: 33 VSNITPAKAKQLTHINFSFLDINSNL-ECAWDPATNDAKARDVVNRLTA-LKAHNPSLRI 90
Query: 93 ILSIG-----QGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTST 147
+ SIG +++ Y + V+ + R F S +RI + YGF G++ W P +
Sbjct: 91 MFSIGGWYYSNDLGVSHANYVNAVKTPASRAKFAQSCVRIMKDYGFDGVNIDWEYPQ-AA 149
Query: 148 DMFNIGLLFDEWRIAATKLDA--KNSTRQQSLLILTARFRYSPPANSYL------LNSIQ 199
++ E R T L+ RQ LT +L L I
Sbjct: 150 EVDGFIAALQEIR---TLLNQQTITDGRQALPYQLTI---AGAGGAFFLSRYYSKLAQIV 203
Query: 200 RNLNWIHAVTASYYEPVSTNFTAPPAALYGS-------------------------ISGR 234
L++I+ +T P T AAL+G
Sbjct: 204 APLDYINLMTYDLAGPWE-KVTNHQAALFGDAAGPTFYNALREANLGWSWEELTRAFPSP 262
Query: 235 FARSTDQVLKA-WIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPA-------- 285
F+ + D ++ + G+ + K+VM +PFYG A+ V + G ++ + P
Sbjct: 263 FSLTVDAAVQQHLMMEGVPSAKIVMGVPFYGRAFKGVSGGNGGQYSSHSTPGEDPYPSTD 322
Query: 286 -----------LYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYF--STGTVWFGFDD 332
D + +Y++++ ++ Q ++N + Y + ++ +DD
Sbjct: 323 YWLVGCEECVRDKDPRIASYRQLEQMLQG-NYGYQRLWNDKTKTPYLYHAQNGLFVTYDD 381
Query: 333 VEAVRAKIAYAKEKRLLGYYAWQVSFDD 360
E+ + K Y K+++L G W + D+
Sbjct: 382 AESFKYKAKYIKQQQLGGVMFWHLGQDN 409
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 2e-39
Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 44/299 (14%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
E + KLG+G +G V+ G +A+K L K T E F E + KL+H L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
++ + E ++ EYM SL +L K L + V + I G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---E 380
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PE 638
R+ +HRDL+ +NIL+GE + K++DFG+AR L E+ E P PE
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLAR------LIEDNEYTARQGAKFPIKWTAPE 434
Query: 639 YATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697
A G ++ KSDV+SFG+LL ++ + G+ E L +E Y +
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------- 483
Query: 698 SFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPA 751
C LM C ++ P +RP+ + + L++ T+ +P
Sbjct: 484 ----PCPPECPESLHDLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 77/316 (24%), Positives = 124/316 (39%), Gaps = 60/316 (18%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGE------VIAVKKLSKTST-QGFEEFKNEVMLTAK 516
+ ++ LG G +G VY+G + +AVK L + + Q +F E ++ +K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL----FDPIRKLILDWKKRVHIIEGI 572
H N++R +G + S R ++ E M L +L P + L +H+ I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVV 629
G YL IHRD+ N LL G KI DFGMAR + +
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRK 201
Query: 630 GTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGINEN-LS 678
G +P PE +G++++K+D +SFGVLL +I S G S N+ L
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLE 256
Query: 679 ILEHAYELWKGGKGVEFVDSFLDDRNSP---CKLMRCLEIALLCVQENPNDRPSMLEVSS 735
+ + +N P ++M C Q P DRP+ +
Sbjct: 257 FVTSGGRMDP-------------PKNCPGPVYRIMT------QCWQHQPEDRPNFAIILE 297
Query: 736 MLKNETTNINTPKKPA 751
++ T + +
Sbjct: 298 RIEYCTQDPDVINTAL 313
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 71/293 (24%), Positives = 128/293 (43%), Gaps = 52/293 (17%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
+ + +G+G +G V G +V AVK + +T + F E + +L+H NL+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 524 RVLGFCIDSEER-MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
++LG ++ + ++ EYM SL YL + +L + + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT--IGYIPPEYA 640
+HRDL N+L+ E K+SDFG+ + E ++ Q G + + PE
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEAL 186
Query: 641 TKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGVEF 695
+ +STKSDV+SFG+LL +I S G+ + + + + +E Y++
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRVEKGYKM--------- 233
Query: 696 VDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743
D C ++M C + RPS L++ L++ T+
Sbjct: 234 ------DAPDGCPPAVYEVM------KNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 46/303 (15%)
Query: 468 IRNKLGEGGYGPVYKGVL--PCGEV-IAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLI 523
+LG G +G V +GV ++ +A+K L + T EE E + +L + ++
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
R++G C +E ML+ E L +L ++ ++ ++ G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYL---E 127
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PE 638
+HRDL N+LL KISDFG+++ +++ + G P PE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG----ADDSYYTARSAGKWPLKWYAPE 183
Query: 639 YATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697
+S++SDV+S+GV + + +S G++ Y+ KG + + F++
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK----------------PYKKMKGPEVMAFIE 227
Query: 698 SFLDDR-NSPCKLMRCL----EIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAF 752
R P C + C DRP L V ++ ++ + +
Sbjct: 228 Q--GKRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282
Query: 753 SKQ 755
Sbjct: 283 HHH 285
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 77/320 (24%), Positives = 122/320 (38%), Gaps = 68/320 (21%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGE------VIAVKKLSKTST-QGFEEFKNEVMLTAK 516
+ ++ LG G +G VY+G + +AVK L + + Q +F E ++ +K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL----FDPIRKLILDWKKRVHIIEGI 572
H N++R +G + S R ++ E M L +L P + L +H+ I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVV 629
G YL IHRD+ N LL G KI DFGMAR +
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRK 242
Query: 630 GTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGINEN-LS 678
G +P PE +G++++K+D +SFGVLL +I S G S N+ L
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLE 297
Query: 679 ILEHAYELWKGGKGVEFVDSFLDDRNSP--C-----KLMRCLEIALLCVQENPNDRPSML 731
+ + P C ++M C Q P DRP+
Sbjct: 298 FVTSGGRMDP-----------------PKNCPGPVYRIMT------QCWQHQPEDRPNFA 334
Query: 732 EVSSMLKNETTNINTPKKPA 751
+ ++ T + +
Sbjct: 335 IILERIEYCTQDPDVINTAL 354
|
| >3fnd_A Chitinase; TIM-barrel, structural genomics, PSI-2, P structure initiative, NEW YORK SGX research center for STRU genomics, nysgxrc; 1.90A {Bacteroides thetaiotaomicron} PDB: 3co4_A Length = 312 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 55/338 (16%), Positives = 108/338 (31%), Gaps = 61/338 (18%)
Query: 29 VGYLNLSEVS---TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKK 85
+GYL L + I + TH+ S A + + +L++ +I +
Sbjct: 7 IGYLALDDWEFESLFPTIEWKYLTHINASFARVKADG---TLNINPVRKRIESVRE--TA 61
Query: 86 KNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT 145
++ ++S+ + + +++ + + RK I I + Y G D + +
Sbjct: 62 HKHNVKILISLAKN---SPGEFTTAINDPKARKELIQQIIAFTKEYKLDGFDIDYEEYDN 118
Query: 146 STDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWI 205
N L R AK +++T ++ ++I
Sbjct: 119 WDK--NFPSLLVFARGL---YLAKEKN-----MLMTC---AVNSRWLNYGTEWEQYFDYI 165
Query: 206 HAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIER-GLSADKLVMCLPFYG 264
+ ++ T+ A+ + LK W E+ S K+V LPFYG
Sbjct: 166 NLMSYDRG--AFTDKPVQHASYD---------DFVKDLKYWNEQCRASKSKIVGGLPFYG 214
Query: 265 YAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTG 324
Y+W GA + SG++ + + K
Sbjct: 215 YSWEESLQ-----GAVDDVRGIRYSGILKHLGNEAADK--------------------DN 249
Query: 325 TVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362
++ + K + KE G WQ+ D H+
Sbjct: 250 IGKTYYNGRPTIANKCKFIKENDYAGVMIWQLFQDAHN 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 80/308 (25%), Positives = 126/308 (40%), Gaps = 66/308 (21%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTSTQG-FEEFKNEVMLTAK 516
E+ ++ +LG+G +G VY+GV +A+K +++ ++ EF NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-------FDPIRKLILDWKKRVHII 569
+++R+LG + ++I E M L YL + K + +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
I G+ YL + +HRDL N ++ E KI DFGM R + E
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRK 196
Query: 630 GTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI-------NENL 677
G G +P PE GV++T SDV+SFGV+L +I + L + L
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVL 250
Query: 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLE 732
+ L D+ C +LMR +C Q NP RPS LE
Sbjct: 251 RFVMEGGLL---------------DKPDNCPDMLFELMR------MCWQYNPKMRPSFLE 289
Query: 733 VSSMLKNE 740
+ S +K E
Sbjct: 290 IISSIKEE 297
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 69/309 (22%), Positives = 118/309 (38%), Gaps = 58/309 (18%)
Query: 455 SLADIEAATERFSIR--NKLGEGGYGPVYKGVLPCGE----VIAVKKLSK-TSTQGFEEF 507
+ D+ ER +G+G +G VY G A+K LS+ T Q E F
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF 69
Query: 508 KNEVMLTAKLQHVNLIRVLGFCIDSEER-MLIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
E +L L H N++ ++G + E ++ YM + L ++ P R + K +
Sbjct: 70 LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLI 127
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
+ +G+ YL + +HRDL N +L E+ K++DFG+AR E
Sbjct: 128 SFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD---REYYS 181
Query: 627 QVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGINEN 676
+P E ++TKSDV+SFGVLL ++++ G + +
Sbjct: 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-----PFD 236
Query: 677 -LSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSM 730
L L + C ++M C + +P RP+
Sbjct: 237 LTHFLAQGRRL---------------PQPEYCPDSLYQVM------QQCWEADPAVRPTF 275
Query: 731 LEVSSMLKN 739
+ ++
Sbjct: 276 RVLVGEVEQ 284
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 60/303 (19%), Positives = 105/303 (34%), Gaps = 65/303 (21%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL--------PCGEVIAVKKLSKTSTQGFEEFKNEVMLTA 515
E LG+G + ++KGV + +K L K E F + +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
KL H +L+ G C+ +E +L+ E++ SLD YL + + WK + + + +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAA 125
Query: 576 LLYLQEYSRLTIIHRDLKVSNILL--------GEAMKPKISDFGMARIFAKESLEENTEQ 627
+ +L T+IH ++ NILL G K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 628 VVGTIGYIP-----PE-YATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSIL 680
I PE + +D +SFG L +I S G +
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK-------------- 217
Query: 681 EHAYELWKGGKGVEFVDS-FLDDRNSPC---KLMRCLEIALLCVQENPNDRPSMLEVSSM 736
+ ++F + L+ C+ P+ RPS +
Sbjct: 218 --PLSALDSQRKLQFYEDRHQLPAPKAAELANLI------NNCMDYEPDHRPSFRAIIRD 269
Query: 737 LKN 739
L +
Sbjct: 270 LNS 272
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 51/293 (17%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL--PCGEVI--AVKKLSK-TSTQGFEEFKNEVMLTAKLQ 518
E + LGEG +G VY+GV GE I AVK K + E+F +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H ++++++G + E +I E P L YL L + V I + + Y
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAY 128
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-- 636
L + +HRD+ V NIL+ K+ DFG++R E+ + ++ +P
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYI------EDEDYYKASVTRLPIK 179
Query: 637 ---PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKG 692
PE ++T SDV+ F V + +I+S GK+ + +
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ----------------PFFWLENKDV 223
Query: 693 VEFVDS-FLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ ++ + C LM C +P+DRP E+ L +
Sbjct: 224 IGVLEKGDRLPKPDLCPPVLYTLM------TRCWDYDPSDRPRFTELVCSLSD 270
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 65/291 (22%), Positives = 123/291 (42%), Gaps = 49/291 (16%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL-PCGE----VIAVKKLSKTSTQG-FEEFKNEVMLTAKL 517
F LG G +G VYKG+ P GE +A+K+L + ++ +E +E + A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
+ ++ R+LG C+ LI + MP L Y+ + + + ++ I +G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMN 131
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP- 636
YL++ ++HRDL N+L+ KI+DFG+A++ L ++ G +P
Sbjct: 132 YLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL-----LGAEEKEYHAEGGKVPI 183
Query: 637 ----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGK 691
E +Y+ +SDV+S+GV + ++++ G + Y+ +
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----------------PYDGIPASE 227
Query: 692 GVEFVDSFLDDR-NSPCKLMRCL----EIALLCVQENPNDRPSMLEVSSML 737
++ +R P C I C + + RP E+
Sbjct: 228 ISSILEK--GERLPQP---PICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 60/297 (20%), Positives = 112/297 (37%), Gaps = 51/297 (17%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL--PCGEVI--AVKKLSK-TSTQGFEEFKNEVMLTAKLQ 518
ER + +GEG +G V++G+ P + A+K TS E+F E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H ++++++G + +I E L +L L L + ++ L Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAY 131
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-- 636
L +HRD+ N+L+ K+ DFG++R E++ + G +P
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIK 182
Query: 637 ---PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKG 692
PE +++ SDV+ FGV + +I+ G + ++ K
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVK----------------PFQGVKNNDV 226
Query: 693 VEFVDS-FLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743
+ +++ C LM C +P+ RP E+ + L
Sbjct: 227 IGRIENGERLPMPPNCPPTLYSLM------TKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 70/304 (23%), Positives = 122/304 (40%), Gaps = 58/304 (19%)
Query: 459 IEAATERFSIRNKLGEGGYGPVYKGVLPCGE----VIAVKKLSKTSTQG-FEEFKNEVML 513
I ++ +G G +G VY G L + AVK L++ + G +F E ++
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 514 TAKLQHVNLIRVLGFCIDSEE-RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGI 572
H N++ +LG C+ SE +++ YM + L ++ + + K + +
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQV 137
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR-IFAKESLEENTEQVVGT 631
+G+ YL +HRDL N +L E K++DFG+AR ++ KE + + T
Sbjct: 138 AKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK----T 190
Query: 632 IGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGINEN-LSIL 680
+P E ++TKSDV+SFGVLL ++++ G ++ + L
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYL 245
Query: 681 EHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSS 735
L + C ++M L C RPS E+ S
Sbjct: 246 LQGRRL---------------LQPEYCPDPLYEVM------LKCWHPKAEMRPSFSELVS 284
Query: 736 MLKN 739
+
Sbjct: 285 RISA 288
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 76/315 (24%), Positives = 124/315 (39%), Gaps = 62/315 (19%)
Query: 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGE----VIAVK--KLSKTSTQGFEEF 507
L D+ + LGEG +G V +G L + +AVK KL +S + EEF
Sbjct: 24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF 83
Query: 508 KNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLIYEYMPNKSLDCYL---FDPIRKLI 559
+E H N+IR+LG CI+ + M+I +M L YL
Sbjct: 84 LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143
Query: 560 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619
+ + + + I G+ YL S +HRDL N +L + M ++DFG+++
Sbjct: 144 IPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----- 195
Query: 620 SLEENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSM 669
+ G I +P E VY++KSDV++FGV + +I + G +
Sbjct: 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255
Query: 670 LCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENP 724
+E L H + L + C ++M C + +P
Sbjct: 256 ----HEMYDYLLHGHRL---------------KQPEDCLDELYEIMYS------CWRTDP 290
Query: 725 NDRPSMLEVSSMLKN 739
DRP+ + L+
Sbjct: 291 LDRPTFSVLRLQLEK 305
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-38
Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 52/289 (17%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
E + KLG G +G V+ +AVK + K + E F E + LQH L+
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
++ E +I E+M SL +L K + I +G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PE 638
+ IHRDL+ +NIL+ ++ KI+DFG+AR+ E+ E P PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVI------EDNEYTAREGAKFPIKWTAPE 355
Query: 639 YATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGV 693
G ++ KSDV+SFG+LL++I++ G+ +S E + LE Y +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEVIRALERGYRM------- 404
Query: 694 EFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSML 737
R C +M + C + P +RP+ + S+L
Sbjct: 405 --------PRPENCPEELYNIM------MRCWKNRPEERPTFEYIQSVL 439
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVI----AVKKL-SKTSTQGFEEFKNEVMLTAKL 517
LG G +G V+KGV P GE I +K + K+ Q F+ + ++ L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
H +++R+LG C L+ +Y+P SL ++ L + ++ I +G+
Sbjct: 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMY 129
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP- 636
YL ++HR+L N+LL + +++DFG+A + L + +Q++ + P
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADL-----LPPDDKQLLYSEAKTPI 181
Query: 637 ----PEYATKGVYSTKSDVFSFGVLLLQIIS 663
E G Y+ +SDV+S+GV + ++++
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 83/291 (28%), Positives = 130/291 (44%), Gaps = 52/291 (17%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
E + +LG G +G V+ G +AVK L K + + F E L +LQH L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
R+ E +I EYM N SL +L P + L K + + I +G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PE 638
IHRDL+ +NIL+ + + KI+DFG+AR+ E+ E P PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI------EDNEYTAREGAKFPIKWTAPE 180
Query: 639 YATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGV 693
G ++ KSDV+SFG+LL +I++ G+ ++ E + LE Y +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQNLERGYRM------- 229
Query: 694 EFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
R C +LM LC +E P DRP+ + S+L++
Sbjct: 230 --------VRPDNCPEELYQLM------RLCWKERPEDRPTFDYLRSVLED 266
|
| >3oa5_A CHI1; TIM barrel, hydrolase; HET: 2PE; 1.74A {Yersinia} PDB: 4a5q_A Length = 574 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-38
Identities = 48/359 (13%), Positives = 114/359 (31%), Gaps = 52/359 (14%)
Query: 43 INYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDT 102
+ + + C + + + + F + + + + LSIG G
Sbjct: 192 PDGAVLASINCGFTKWEAGDANERYNQEKAKGLLGGFRL-LHEADKELEFSLSIG-G--W 247
Query: 103 NYSI-YSSMVRNSSHRKSFIDSSIRIARLYG-FRGLDFAW--------TAPNTSTDMFNI 152
+ S +S + ++ R +F++ + + F LD W PN+ D N
Sbjct: 248 SMSGLFSEIAKDEILRTNFVEGIKDFFQRFPMFSHLDIDWEYPGSIGAGNPNSPDDGANF 307
Query: 153 GLLFDEWRIAATKLDAKNSTRQQSLLILTA-----RFRYSPPANSYLLNSIQRNLNWIHA 207
+L + A + ++ + + + + + I+
Sbjct: 308 AILIQQITDA---KISNL-------KGISIASSADPAKI---DAANIPALMDAGVTGINL 354
Query: 208 VTASYYEPVSTNFTAPPAALYGSISGRFAR-STDQVLKAWIER-GLSADKLVMCLPFYGY 265
+T ++ + +Y S +++ S D + I+ + + + Y
Sbjct: 355 MTYDFFTLGD-GKLSHHTNIYRDPSDVYSKYSIDDAVTHLIDEKKVDPKAIFIGYAGYTR 413
Query: 266 AWTLVKPEDNGI-GAAAAGPAL--------YDSGLVTYKKIKNHIKTYG-----PDVQVM 311
+ A G ++ ++ + I H + +++
Sbjct: 414 NAKNATITTSIPSEEALKGTYTDANQTLGSFEYSVLEWTDIICHYMDFEKGEGRNGYKLV 473
Query: 312 YNSTYEVNYF--STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQA 368
++ + +Y V+ D +VR K Y K+K L G + W D+ L + A
Sbjct: 474 HDKVAKADYLYSEATKVFISLDTPRSVRDKGRYVKDKGLGGLFIWSGDQDNGI-LTNAA 531
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-38
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 22/212 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL--PCGEVI--AVKKL---SKTSTQGFEEFKNEVMLTAK 516
+ + KLG+G +G V +G P G+ + AVK L + + ++F EV
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
L H NLIR+ G + + ++ E P SL L +L + +G+
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGM 134
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
YL IHRDL N+LL KI DFG+ R + + V+ +P
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL----PQNDDHYVMQEHRKVP 187
Query: 637 -----PEYATKGVYSTKSDVFSFGVLLLQIIS 663
PE +S SD + FGV L ++ +
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 71/333 (21%), Positives = 123/333 (36%), Gaps = 61/333 (18%)
Query: 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGE----VIAVK--KLSKTSTQGFEEF 507
L D+ ++F++ LG+G +G V + L + +AVK K ++ EEF
Sbjct: 13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF 72
Query: 508 KNEVMLTAKLQHVNLIRVLGFCIDSEER------MLIYEYMPNKSLDCYLFD---PIRKL 558
E + H ++ +++G + S + M+I +M + L +L
Sbjct: 73 LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 559 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618
L + V + I G+ YL S IHRDL N +L E M ++DFG++R
Sbjct: 133 NLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR---- 185
Query: 619 ESLEENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSML--C 671
+ G +P E +Y+ SDV++FGV + +I++
Sbjct: 186 -KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT---RGQTPYA 241
Query: 672 GIN--ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENP 724
GI E + L L + C LM C +P
Sbjct: 242 GIENAEIYNYLIGGNRL---------------KQPPECMEEVYDLMYQ------CWSADP 280
Query: 725 NDRPSMLEVSSMLKNETTNINTPKKPAFSKQVD 757
RPS + L+N +++ ++
Sbjct: 281 KQRPSFTCLRMELENILGHLSVLSTSQDPLYIN 313
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 73/300 (24%), Positives = 123/300 (41%), Gaps = 49/300 (16%)
Query: 464 ERFSIRNK-LGEGGYGPVYKGVLPCGEV---IAVK--KLSKTSTQGFEEFKNEVMLTAKL 517
+ ++ +K LG G +G V KG +V +AVK K +E E + +L
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
+ ++R++G C ++E ML+ E L+ YL + K + ++ ++ G+
Sbjct: 76 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMK 131
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP- 636
YL +HRDL N+LL KISDFG+++ + T G P
Sbjct: 132 YL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPV 184
Query: 637 ----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGK 691
PE +S+KSDV+SFGVL+ + S G++ Y KG +
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK----------------PYRGMKGSE 228
Query: 692 GVEFVDSFLDDR-NSPCKLMRCL----EIALLCVQENPNDRPSMLEVSSMLKNETTNINT 746
++ +R P C ++ LC + +RP V L+N ++
Sbjct: 229 VTAMLEK--GERMGCP---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 68/305 (22%), Positives = 119/305 (39%), Gaps = 60/305 (19%)
Query: 459 IEAATERFSIRNKLGEGGYGPVYKGVLPCGE----VIAVKKLSKTSTQG-FEEFKNEVML 513
I ++ +G G +G VY G L + AVK L++ + G +F E ++
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143
Query: 514 TAKLQHVNLIRVLGFCIDSEE-RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGI 572
H N++ +LG C+ SE +++ YM + L ++ + + K + +
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQV 201
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV--G 630
+G+ +L +HRDL N +L E K++DFG+AR + + V
Sbjct: 202 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEFDSVHNK 253
Query: 631 TIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKR----LSMLCGINEN-LSI 679
T +P E ++TKSDV+SFGVLL ++++ G ++ +
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVY 308
Query: 680 LEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLEVS 734
L L + C ++M L C RPS E+
Sbjct: 309 LLQGRRL---------------LQPEYCPDPLYEVM------LKCWHPKAEMRPSFSELV 347
Query: 735 SMLKN 739
S +
Sbjct: 348 SRISA 352
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 87/325 (26%), Positives = 136/325 (41%), Gaps = 69/325 (21%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEV---IAVKKLSKTSTQG-FEEFKNEVMLTAKL-Q 518
++ +GEG +G V K + + A+K++ + +++ +F E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-------------FDPIRKLILDWKKR 565
H N+I +LG C L EY P+ +L +L L ++
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625
+H + +G+ YL S+ IHRDL NIL+GE KI+DFG++R
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 193
Query: 626 EQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGIN--ENL 677
V T+G +P E VY+T SDV+S+GVLL +I+S G CG+ E
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELY 251
Query: 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPNDRPSMLE 732
L Y L ++ C LMR C +E P +RPS +
Sbjct: 252 EKLPQGYRL---------------EKPLNCDDEVYDLMR------QCWREKPYERPSFAQ 290
Query: 733 VSS----MLKNETTNINTPKKPAFS 753
+ ML+ T +NT F+
Sbjct: 291 ILVSLNRMLEERKTYVNTTLYEKFT 315
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 73/321 (22%), Positives = 119/321 (37%), Gaps = 80/321 (24%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL----PCGEVI--AVKKLSKTST-QGFEEFKNEVMLTAK 516
+GEG +G V++ P AVK L + ++ +F+ E L A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL---------------------FDPI 555
+ N++++LG C + L++EYM L+ +L
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 556 RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615
L +++ I + G+ YL S +HRDL N L+GE M KI+DFG++R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR- 222
Query: 616 FAKESLEENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSML 670
++ IP PE Y+T+SDV+++GV+L +I S
Sbjct: 223 ----NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------Y 272
Query: 671 CGI------NEN-LSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALL 718
+E + + L C LMR L
Sbjct: 273 GLQPYYGMAHEEVIYYVRDGNIL---------------ACPENCPLELYNLMR------L 311
Query: 719 CVQENPNDRPSMLEVSSMLKN 739
C + P DRPS + +L+
Sbjct: 312 CWSKLPADRPSFCSIHRILQR 332
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL--PCGEV---IAVKKL-SKTSTQGFEEFKNEVMLTAKL 517
F LG G +G VYKG+ +V +A+K+L TS + +E +E + A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
+ ++ R+LG C+ + LI + MP L Y+ + K + + ++ I +G+
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP- 636
YL++ ++HRDL N+L+ KI+DFG+A++ L ++ G +P
Sbjct: 132 YLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL-----LGAEEKEYHAEGGKVPI 183
Query: 637 ----PEYATKGVYSTKSDVFSFGVLLLQIIS 663
E +Y+ +SDV+S+GV + ++++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 74/313 (23%), Positives = 124/313 (39%), Gaps = 69/313 (22%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL------PCGEVI--AVKKL-SKTSTQGFEEFKNEVMLT 514
++ ++ LGEG +G V E + AVK L + + + +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 515 AKL-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-------------FDPIRKLIL 560
+ +H N+I +LG C +I EY +L YL + + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 561 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620
+K V + +G+ YL + IHRDL N+L+ E KI+DFG+AR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----D 206
Query: 621 LEENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSML--CGI 673
+ T G +P PE VY+ +SDV+SFGVL+ +I + L GI
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT---LGGSPYPGI 263
Query: 674 N--ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPND 726
E +L+ + + D+ + C +MR C P+
Sbjct: 264 PVEELFKLLKEGHRM---------------DKPANCTNELYMMMR------DCWHAVPSQ 302
Query: 727 RPSMLEVSSMLKN 739
RP+ ++ L
Sbjct: 303 RPTFKQLVEDLDR 315
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 71/313 (22%), Positives = 115/313 (36%), Gaps = 69/313 (22%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKL-SKTSTQGFEEFKNEVMLTAK 516
+R + LG G +G V + +AVK L + +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 517 L-QHVNLIRVLGFCIDSEE-RMLIYEYMPNKSLDCYL-------------FDPIRKLILD 561
+ H+N++ +LG C M+I E+ +L YL + + K L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 562 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621
+ + + +G+ +L + IHRDL NILL E KI DFG+AR +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DI 198
Query: 622 EENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSML--CGIN 674
++ + V +P PE VY+ +SDV+SFGVLL +I S L G+
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---LGASPYPGVK 255
Query: 675 EN---LSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPND 726
+ L+ + + M C P+
Sbjct: 256 IDEEFCRRLKEGTRM---------------RAPDYTTPEMYQTML------DCWHGEPSQ 294
Query: 727 RPSMLEVSSMLKN 739
RP+ E+ L N
Sbjct: 295 RPTFSELVEHLGN 307
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-36
Identities = 74/313 (23%), Positives = 124/313 (39%), Gaps = 69/313 (22%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP------CGEVI--AVKKL-SKTSTQGFEEFKNEVMLT 514
++ ++ LGEG +G V E + AVK L + + + +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 515 AKL-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-------------FDPIRKLIL 560
+ +H N+I +LG C +I EY +L YL + + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 561 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620
+K V + +G+ YL + IHRDL N+L+ E KI+DFG+AR
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD----- 252
Query: 621 LEENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSML--CGI 673
+ T G +P PE VY+ +SDV+SFGVL+ +I + L GI
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT---LGGSPYPGI 309
Query: 674 --NENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPND 726
E +L+ + + D+ + C +MR C P+
Sbjct: 310 PVEELFKLLKEGHRM---------------DKPANCTNELYMMMRD------CWHAVPSQ 348
Query: 727 RPSMLEVSSMLKN 739
RP+ ++ L
Sbjct: 349 RPTFKQLVEDLDR 361
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-36
Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 52/307 (16%)
Query: 468 IRNKLGEGGYGPVYKGVL-PCGEVI--AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLI 523
+LG G +G V +GV + I A+K L T EE E + +L + ++
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
R++G C +E ML+ E L +L ++ ++ ++ G+ YL
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYL---E 453
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PE 638
+HR+L N+LL KISDFG+++ +++ + G P PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG----ADDSYYTARSAGKWPLKWYAPE 509
Query: 639 YATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697
+S++SDV+S+GV + + +S G++ Y+ KG + + F++
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQK----------------PYKKMKGPEVMAFIE 553
Query: 698 SFLDDRNSP---C-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKK 749
R C LM C DRP L V ++ ++ + +
Sbjct: 554 Q--GKRMECPPECPPELYALM------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605
Query: 750 PAFSKQV 756
+ +V
Sbjct: 606 GGSALEV 612
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-36
Identities = 67/344 (19%), Positives = 129/344 (37%), Gaps = 51/344 (14%)
Query: 417 MKRLNLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGG 476
+ +L E+ ++ + + + + S D E ER + +GEG
Sbjct: 343 IPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQ 402
Query: 477 YGPVYKGVL--PCGEVI--AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID 531
+G V++G+ P + A+K + TS E+F E + + H ++++++G +
Sbjct: 403 FGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462
Query: 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 591
+I E L +L RK LD + ++ L YL +HRD
Sbjct: 463 -NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYL---ESKRFVHRD 516
Query: 592 LKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP-----PEYATKGVYS 646
+ N+L+ K+ DFG++R E++ + G +P PE ++
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 647 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS-FLDDRN 704
+ SDV+ FGV + +I+ G + ++ K + +++
Sbjct: 571 SASDVWMFGVCMWEILMHGVK----------------PFQGVKNNDVIGRIENGERLPMP 614
Query: 705 SPC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743
C LM C +P+ RP E+ + L
Sbjct: 615 PNCPPTLYSLM------TKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 78/318 (24%), Positives = 130/318 (40%), Gaps = 74/318 (23%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGE------VIAVKKLSKTSTQG-FEEFKNEVMLTAK 516
+ + LGEG +G V K + +AVK L + ++ + +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL---------------------FDPI 555
+ H ++I++ G C +LI EY SL +L D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 556 RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615
+ L + I+QG+ YL + + ++HRDL NIL+ E K KISDFG++R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 616 FAKESLEENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSML 670
+ E V + G IP E +Y+T+SDV+SFGVLL +I++ L
Sbjct: 199 ----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---LGGN 251
Query: 671 --CGIN--ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQ 721
GI ++L+ + + +R C +LM C +
Sbjct: 252 PYPGIPPERLFNLLKTGHRM---------------ERPDNCSEEMYRLMLQ------CWK 290
Query: 722 ENPNDRPSMLEVSSMLKN 739
+ P+ RP ++S L+
Sbjct: 291 QEPDKRPVFADISKDLEK 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 67/313 (21%), Positives = 120/313 (38%), Gaps = 68/313 (21%)
Query: 464 ERFSIRNKLGEGGYGPVYKG----VLPCGEVI--AVKKL-SKTSTQGFEEFKNEVMLTAK 516
R S LG G +G V + ++ + AVK L E +E+ + +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 517 L-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL---------------FDPIRKLIL 560
L H+N++ +LG C ++I EY L +L +L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 561 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620
D + + + +G+ +L + IHRDL NILL KI DFG+AR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD----- 194
Query: 621 LEENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGIN 674
++ ++ VV +P PE VY+ +SDV+S+G+ L ++ S G S G+
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS--SPYPGMP 252
Query: 675 EN---LSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPND 726
+ +++ + + +M+ C +P
Sbjct: 253 VDSKFYKMIKEGFRM---------------LSPEHAPAEMYDIMK------TCWDADPLK 291
Query: 727 RPSMLEVSSMLKN 739
RP+ ++ +++
Sbjct: 292 RPTFKQIVQLIEK 304
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 76/313 (24%), Positives = 120/313 (38%), Gaps = 69/313 (22%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP--------CGEVIAVKKL-SKTSTQGFEEFKNEVMLT 514
+R + LGEG +G V +AVK L S + + + +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 515 AKL-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-------------FDPIRKLIL 560
+ +H N+I +LG C +I EY +L YL + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 561 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620
K V + +G+ YL + IHRDL N+L+ E KI+DFG+AR
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD----- 240
Query: 621 LEENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSML--CGI 673
+ T G +P PE +Y+ +SDV+SFGVLL +I + L G+
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---LGGSPYPGV 297
Query: 674 N--ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPND 726
E +L+ + + D+ S C +MR C P+
Sbjct: 298 PVEELFKLLKEGHRM---------------DKPSNCTNELYMMMR------DCWHAVPSQ 336
Query: 727 RPSMLEVSSMLKN 739
RP+ ++ L
Sbjct: 337 RPTFKQLVEDLDR 349
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 70/317 (22%), Positives = 117/317 (36%), Gaps = 72/317 (22%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV---LPCGE---VIAVKKL-SKTSTQGFEEFKNEVMLTAK 516
LG G +G V + L + +AVK L S E +E+ + +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 517 L-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-----------FDPIRKLILDWKK 564
L QH N++ +LG C ++I EY L +L I +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 565 RVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
+H + QG+ +L + IHRD+ N+LL KI DFG+AR +S
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---- 218
Query: 625 TEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-------GKRLSMLCG 672
+V +P PE VY+ +SDV+S+G+LL +I S G
Sbjct: 219 -NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL------ 271
Query: 673 INEN-LSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQENPND 726
+N +++ Y++ + + +M+ C P
Sbjct: 272 VNSKFYKLVKDGYQM---------------AQPAFAPKNIYSIMQ------ACWALEPTH 310
Query: 727 RPSMLEVSSMLKNETTN 743
RP+ ++ S L+ +
Sbjct: 311 RPTFQQICSFLQEQAQE 327
|
| >3cz8_A Putative sporulation-specific glycosylase YDHD; structural genomics, uncharacterized protein, protein struct initiative, PSI-2; 2.20A {Bacillus subtilis subsp} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 58/356 (16%), Positives = 120/356 (33%), Gaps = 60/356 (16%)
Query: 25 PWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTV- 83
G L S N DL LI A +S+ + + + + D
Sbjct: 4 SNYIAGTL-----SFYVLRNPDLDRELINDYAPYSSSISIFEYHIAPNGDIANQLNDAAA 58
Query: 84 -----KKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDF 138
+++ + TI ++ + I ++ N + R + +++ + G+ G+
Sbjct: 59 IETTWQRRVTPLATITNLT-SGGFSTEIVHQVLNNPTARTNLVNNIYDLVSTRGYGGVTI 117
Query: 139 AWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTA-----RFRYSPPANSY 193
+ + + D + R L A +LT P Y
Sbjct: 118 DFEQVS-AADRDLFTGFLRQLRDR---LQAGG-------YVLTIAVPAKTSDNIPWLRGY 166
Query: 194 LLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSA 253
I +N++ + Y + + P A + + ++ I + +
Sbjct: 167 DYGGIGAVVNYMFIMA--YDWHHAGSEPGPVAPIT---------EIRRTIEFTI-AQVPS 214
Query: 254 DKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYN 313
K+++ +P YGY W + P G A+A ++ + Y +Q Y+
Sbjct: 215 RKIIIGVPLYGYDWII--PYQPGTVASA----------ISNQNAIERAMRYQAPIQ--YS 260
Query: 314 STYEVNYFS-----TGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDD-HDW 363
+ Y+ +F T F+ V ++ K+ +E RL AWQ++ + H
Sbjct: 261 AEYQSPFFRYSDQQGRTHEVWFEGVRSMSRKMQIVREYRLQAIGAWQLTLAEGHHH 316
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 68/293 (23%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVN 521
+SI ++G GG V++ + ++ A+K ++ Q + ++NE+ KLQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 522 L--IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
IR+ + I + ++ E N L+ +L +K +D +R + + + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE- 638
++ I+H DLK +N L+ + M K+ DFG+A ++ + VGT+ Y+PPE
Sbjct: 144 HQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 639 ----------YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG------INENLSILEH 682
+K S KSDV+S G +L M G I +S L
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYY--------MTYGKTPFQQIINQISKLHA 251
Query: 683 AYELWKGGKGVEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV 733
E F D + L CL + +P R S+ E+
Sbjct: 252 -----IIDPNHEI--EFPDIPEKDLQDVLKCCL-------KRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 68/293 (23%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVN 521
+SI ++G GG V++ + ++ A+K ++ Q + ++NE+ KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 522 L--IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
IR+ + I + ++ E N L+ +L +K +D +R + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE- 638
++ I+H DLK +N L+ + M K+ DFG+A ++ + VGT+ Y+PPE
Sbjct: 125 HQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 639 ----------YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG------INENLSILEH 682
+K S KSDV+S G +L M G I +S L
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYY--------MTYGKTPFQQIINQISKLHA 232
Query: 683 AYELWKGGKGVEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV 733
E F D + L CL + +P R S+ E+
Sbjct: 233 -----IIDPNHEI--EFPDIPEKDLQDVLKCCL-------KRDPKQRISIPEL 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 73/326 (22%), Positives = 125/326 (38%), Gaps = 73/326 (22%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL----PCGEVI--AVKKL-SKTSTQGFEEFKNEVMLTAK 516
E LG G +G V G I AVK L K + E +E+ + +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 517 L-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL--------------------FDPI 555
L H N++ +LG C S LI+EY L YL +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 556 RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615
+L ++ + + +G+ +L + +HRDL N+L+ KI DFG+AR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR- 220
Query: 616 FAKESLEENTEQVVGTIGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSM 669
+ ++ VV +P PE +G+Y+ KSDV+S+G+LL +I S G +
Sbjct: 221 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--NP 274
Query: 670 LCGINEN---LSILEHAYELWKGGKGVEFVDSFLDDRNSPC-----KLMRCLEIALLCVQ 721
GI + ++++ +++ D+ +M+ C
Sbjct: 275 YPGIPVDANFYKLIQNGFKM---------------DQPFYATEEIYIIMQ------SCWA 313
Query: 722 ENPNDRPSMLEVSSMLKNETTNINTP 747
+ RPS ++S L + +
Sbjct: 314 FDSRKRPSFPNLTSFLGCQLADAEEA 339
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-33
Identities = 67/293 (22%), Positives = 120/293 (40%), Gaps = 53/293 (18%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVN 521
+SI ++G GG V++ + ++ A+K ++ Q + ++NE+ KLQ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 522 L--IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
IR+ + I + ++ E N L+ +L +K +D +R + + + + +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE- 638
++ I+H DLK +N L+ + M K+ DFG+A ++ + VG + Y+PPE
Sbjct: 172 HQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 639 ----------YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG------INENLSILEH 682
+K S KSDV+S G +L M G I +S L
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYY--------MTYGKTPFQQIINQISKLHA 279
Query: 683 AYELWKGGKGVEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV 733
E F D + L CL + +P R S+ E+
Sbjct: 280 -----IIDPNHEI--EFPDIPEKDLQDVLKCCL-------KRDPKQRISIPEL 318
|
| >3arx_A Chitinase A; TIM barrel, inhibitor complex, glycosidase, hydrolase, hydro hydrolase inhibitor complex; HET: POY; 1.16A {Vibrio harveyi} PDB: 3aro_A* 3arp_A* 3arr_A* 3arv_A* 3arw_A* 3arq_A* 3ary_A* 3arz_A* 3b8s_A 3b9e_A 3b9a_A* 3b9d_A 3as2_A* 3ars_A* 3art_A* 3as0_A* 3as1_A* 3aru_A* 3as3_A* Length = 584 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 67/331 (20%), Positives = 122/331 (36%), Gaps = 64/331 (19%)
Query: 84 KKKNPSITTILSIGQGKDTNYS-IYSSMVRNSSHRKSFIDSSIRIARLYGFR-GLDFAWT 141
K++NP + I SIG G S + V + +R +F+ S + + + F G+D W
Sbjct: 239 KQRNPDLKIIPSIG-G--WTLSDPFYDFV-DKKNRDTFVASVKKFLKTWKFYDGVDIDWE 294
Query: 142 APNTSTDMFNIG----------LLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPAN 191
P + G L E R LD + ++ + +A
Sbjct: 295 FPGGGGAAADKGDPVNDGPAYIALMRELR---VMLDELEAETGRTYELTSA----IGVGY 347
Query: 192 SYL----LNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFAR---------- 237
+ + +++I A+T +Y + N ALY R +
Sbjct: 348 DKIEDVDYADAVQYMDYIFAMTYDFYGGWN-NVPGHQTALYCGSFMRPGQCDGGGVDENG 406
Query: 238 --------STDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPED------------NGI 277
+ D ++ + +G+ A+KLV+ YG W V P+ G
Sbjct: 407 EPYKGPAYTADNGIQLLLAQGVPANKLVLGTAMYGRGWEGVTPDTLTDPNDPMTGTATGK 466
Query: 278 GAAAAGPALYDSGLVTYKKIKNHIKTYG----PDVQVMYNSTYEVNYF--STGTVWFGFD 331
+ +++ G++ YK IK+ + + Y++ E + + FD
Sbjct: 467 LKGSTAQGVWEDGVIDYKGIKSFMLGANNTGINGFEYGYDAQAEAPWVWNRSTGELITFD 526
Query: 332 DVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362
D +V AK YAK L G ++W++ D+ D
Sbjct: 527 DHRSVLAKGNYAKSLGLAGLFSWEIDADNGD 557
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 60/317 (18%), Positives = 119/317 (37%), Gaps = 49/317 (15%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVN 521
F LG GG+G V++ A+K++ E+ EV AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 522 LIRVLGFCID---------SEERMLIY---EYMPNKSLDCYLFDPIRKLILDWKKRVHII 569
++R ++ S ++ +Y + ++L ++ + +HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV- 628
I + + +L ++HRDLK SNI K+ DFG+ ++ E+
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 629 ---------VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSI 679
VGT Y+ PE YS K D+FS G++L + +L + +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE--------LLYPFSTQMER 233
Query: 680 LEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ ++ +F F +++ + +P +RP + + ++N
Sbjct: 234 VRTLTDVRNL----KFPPLFTQKYPCEYVMVQ------DMLSPSPMERPEAINI---IEN 280
Query: 740 ET-TNINTPKKPAFSKQ 755
+++ P K ++
Sbjct: 281 AVFEDLDFPGKTVLRQR 297
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 69/297 (23%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
F +G GG+G V+K G+ +K++ + E+ + EV AKL HVN+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLF---------DPIRKLILDWKKR-------V 566
+ G + ++S LF + + I + +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGT-LEQWIEKRRGEKLDKVLAL 125
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
+ E IT+G+ Y+ +I+RDLK SNI L + + KI DFG+ +
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RT 179
Query: 627 QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686
+ GT+ Y+ PE + Y + D+++ G++L EL
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLIL-------------------------AEL 214
Query: 687 WKGGKGVEFVDSFLDDRNSPCKLMRCL----------EIALLCVQENPNDRPSMLEV 733
+ + L + + + + P DRP+ E+
Sbjct: 215 LHVCD------TAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 67/300 (22%), Positives = 113/300 (37%), Gaps = 52/300 (17%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
F LG+G +G V K A+KK+ T + +EVML A L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 522 LIRVLGFCIDSEERML----------IY---EYMPNKSLDCYLFDPI--RKLILDWKKRV 566
++R ++ + ++ EY N +L +D I L +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
+ I + L Y+ IIHRDLK NI + E+ KI DFG+A+ + +
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 627 Q------------VVGTIGYIPPE-YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI 673
+GT Y+ E G Y+ K D++S G++ + M+
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE--------MIYPF 228
Query: 674 NENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
+ + + + + +EF F D++ K +I L + +PN RP +
Sbjct: 229 STGME-RVNILKKLRSVS-IEFPPDFDDNKMKVEK-----KIIRLLIDHDPNKRPGARTL 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 463 TERFS-IRNKLGEGGYGPVYKGV-LPCGEVIAVK--KLSKTSTQGFEEFKNEVMLTAKLQ 518
RF ++G G + VYKG+ +A + K + + FK E + LQ
Sbjct: 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 519 HVNLIRVLGFCIDSEERM----LIYEYMPNKSLDCYL--FDPIR-KLILDWKKRVHIIEG 571
H N++R + + L+ E M + +L YL F ++ K++ W ++
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ------ 137
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILL----GEAMKPKISDFGMARIFAKESLEENTEQ 627
I +GL +L IIHRDLK NI + G KI D G+A + +
Sbjct: 138 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSV---KIGDLGLATLKRASF----AKA 189
Query: 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687
V+GT ++ PE + Y DV++FG+ +L++ + + C +N + +
Sbjct: 190 VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSEC---QNAAQIYR----- 240
Query: 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729
+ GV+ + D P EI C+++N ++R S
Sbjct: 241 RVTSGVK--PASFDKVAIPE----VKEIIEGCIRQNKDERYS 276
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHV 520
E++ K+GEG +G G +K+ +S+ S++ EE + EV + A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 521 NLIRVLGFCIDSEERMLIYEYMPNKSLDCYL----FDPIR-KLILDWKKRVHIIEGITQG 575
N+++ ++ ++ +Y L + + ILDW ++ I
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW-----FVQ-ICLA 137
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
L ++ + I+HRD+K NI L + ++ DFG+AR+ +GT Y+
Sbjct: 138 LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYL 192
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
PE Y+ KSD+++ G +L ++ + K
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 47/214 (21%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKL---SKTSTQGFEEFKNEVMLTAKLQH 519
F I K+G G + VY+ L G +A+KK+ + + E+ L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRK-------LILDWKKRVHIIEGI 572
N+I+ I+ E ++ E L + ++ + + ++ +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY-----FVQ-L 145
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
L ++ ++HRD+K +N+ + K+ D G+ R F+ ++ ++ +VGT
Sbjct: 146 CSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 200
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
Y+ PE + Y+ KSD++S G LL ++ + +
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 24/222 (10%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAK 516
+ E + + +G G YG K G+++ K+L + + +EV L +
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 517 LQHVNLIRVLGFCIDSEERML--IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG--- 571
L+H N++R ID L + EY L I K K+R ++ E
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL----ASVITKGT---KERQYLDEEFVL 114
Query: 572 -----ITQGLLYL--QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
+T L + T++HRDLK +N+ L K+ DFG+ARI ++
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
T VGT Y+ PE + Y+ KSD++S G LL ++ +
Sbjct: 175 T--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-29
Identities = 62/283 (21%), Positives = 103/283 (36%), Gaps = 40/283 (14%)
Query: 465 RFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNLI 523
F ++ LG G G + + +AVK++ + F EV +L +H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI--RKLILDWKKRVHIIEGITQGLLYLQE 581
R D + + + E L + + + + + +++ T GL +L
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-----ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 582 YSRLTIIHRDLKVSNILLGE-----AMKPKISDFGMARIF-AKESLEENTEQVVGTIGYI 635
L I+HRDLK NIL+ +K ISDFG+ + V GT G+I
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 636 PPEY---ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692
PE K + D+FS G + +IS + +IL A L
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL------ 247
Query: 693 VEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV 733
+ + + + + +P RPS V
Sbjct: 248 --DCLHPEKHEDVIARELIEKMI-------AMDPQKRPSAKHV 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 29/277 (10%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ 518
+ + R LG+G YG VY G L IA+K++ + ++ + E+ L L+
Sbjct: 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK 77
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H N+++ LG ++ + E +P SL L L + + + I +GL Y
Sbjct: 78 HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
L + I+HRD+K N+L+ KISDFG ++ A + T GT+ Y+ P
Sbjct: 138 LHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAP 192
Query: 638 EYATKGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695
E KG Y +D++S G ++++ +GK + E + + +++ E
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAM---FKVGMFKVHPEI 247
Query: 696 VDSFLDDRNSP-CK--LMRCLEIALLCVQENPNDRPS 729
+S S K +++C E +P+ R
Sbjct: 248 PESM-----SAEAKAFILKCFEP-------DPDKRAC 272
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 13/208 (6%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVK--KLSKTSTQGFEE-FKNEVMLTAKLQH 519
ER+ I +KLG GG VY +A+K + + + F+ EV +++L H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
N++ ++ + + L+ EY+ +L Y+ L ++ I G+
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGI--- 124
Query: 580 QEYS-RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
+++ + I+HRD+K NIL+ KI DFG+A+ ++ SL + T V+GT+ Y PE
Sbjct: 125 -KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPE 182
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGKR 666
A +D++S G++L +++ G+
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 29/222 (13%)
Query: 458 DIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAK 516
+ + + KLGEGG+ V L G A+K++ Q EE + E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 517 LQHVNLIRVLGFCIDSEERM----LIYEYMPNKSLDCYLFDPIRKLILDWKKR------V 566
H N++R++ +C+ L+ + +L ++ I +L D +
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIERL-KDKGNFLTEDQIL 137
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE------- 619
++ GI +GL + HRDLK +NILLG+ +P + D G
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 620 SLEENTEQVVGTIGYIPPE---YATKGVYSTKSDVFSFGVLL 658
++ TI Y PE + V ++DV+S G +L
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 24/219 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVN 521
+ + + LG+G V++G G++ A+K + S + E + KL H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 522 LIRVLGFCIDSEERMLIY---EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
++++ + E+ P SL L +P L + + ++ + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKP----KISDFGMARIFAKESLEENTEQVVGTIGY 634
L+E I+HR++K NI+ K++DFG AR + + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEY 181
Query: 635 IPPEYATKGV--------YSTKSDVFSFGVLLLQIISGK 665
+ P+ + V Y D++S GV +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS--TQGFEE-FKNEVMLTAKLQH 519
R+ LG+GG+ ++ EV A K + K+ E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 520 VNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRV------HIIEGI 572
+++ G + + + ++ E +SL + ++ +K + + + I
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQI 150
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
G YL R +IHRDLK+ N+ L E ++ KI DFG+A + + + GT
Sbjct: 151 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTP 205
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
YI PE +K +S + DV+S G ++ ++ GK
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS--TQGFEE-FKNEVMLTAKLQH 519
R+ LG+GG+ ++ EV A K + K+ E E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 520 VNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRV------HIIEGI 572
+++ G + + + ++ E +SL + ++ +K + + + I
Sbjct: 75 QHVVGFHG-FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQI 124
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
G YL R +IHRDLK+ N+ L E ++ KI DFG+A + + + GT
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTP 179
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
YI PE +K +S + DV+S G ++ ++ GK
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3bxw_B Chitinase domain-containing protein 1; TIM barrel, lysosome, secreted, hydrolase; 2.70A {Homo sapiens} Length = 393 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 39/367 (10%), Positives = 107/367 (29%), Gaps = 44/367 (11%)
Query: 8 IIFHTLLYSELHPAKAKPWIRVGYLNLSEVS--TISGINYDLFTHLICSSADINSTTYQL 65
++ H S + +GY+ ++ + FT + + +
Sbjct: 61 VLEHRSYCSAKARDRHFAGDVLGYVTPWNSHGYDVTKVFGSKFTQISPVWLQLKRRG-RE 119
Query: 66 SLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSI 125
+ + + V+K + + + D Y + +++ + + + +
Sbjct: 120 MFEVTGLHDVDQGWMRAVRKHAKGLHIVPRLLFE-DWTYDDFRNVLDSEDEIEELSKTVV 178
Query: 126 RIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFR 185
++A+ F G S + + A L +
Sbjct: 179 QVAKNQHFDGFVVEVWNQLLSQKRVGLIHMLTHLAEA---LHQARLLALLVIPPAITPGT 235
Query: 186 YSPPANS-YLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLK 244
+ + L+ +T Y+ + + P A L ++
Sbjct: 236 DQLGMFTHKEFEQLAPVLDGFSLMT---YDYSTAHQPGPNAPLS---------WVRACVQ 283
Query: 245 AWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTY 304
+ K+++ L FYG + K V + +K +
Sbjct: 284 VLDPKSKWRSKILLGLNFYGMDYATSKDA---------------REPVVGARYIQTLKDH 328
Query: 305 GPDVQVMYNSTYEVNYFS-----TGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFD 359
P + ++S ++F +G + +++++ ++ A+E +G W++
Sbjct: 329 RPRMV--WDSQASEHFFEYKKSRSGRHVVFYPTLKSLQVRLELARELG-VGVSIWELGQG 385
Query: 360 DHD-WLL 365
+ L
Sbjct: 386 LDYFYDL 392
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQ--GFEE-FKNEVMLTAKLQH 519
E F I LG+G +G VY ++A+K L K + G E + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKL-ILDWKKRVHIIEGITQGLLY 578
N++R+ G+ D+ LI EY P ++ + ++KL D ++ I + L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSY 124
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
+IHRD+K N+LLG A + KI+DFG ++ + + GT+ Y+PPE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPE 177
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGK 665
++ K D++S GVL + + GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 24/219 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVN 521
+ + + LG+G V++G G++ A+K + S + E + KL H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 522 LIRVLGFCIDSEERMLIY---EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
++++ + E+ P SL L +P L + + ++ + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKP----KISDFGMARIFAKESLEENTEQVVGTIGY 634
L+E I+HR++K NI+ K++DFG AR + + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEY 181
Query: 635 IPPEYATKGV--------YSTKSDVFSFGVLLLQIISGK 665
+ P+ + V Y D++S GV +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-27
Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 34/292 (11%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNL 522
+ ++ +LG GG+G V + + GE +A+K+ + + E + E+ + KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 523 IRVLGFCIDSEERM-------LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
+ D +++ L EY L YL L ++ I+
Sbjct: 75 VS-AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 576 LLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
L YL E IIHRDLK NI+L + + KI D G A+ + L + VGT+
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTL 187
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR------LSMLCGINENLSILEHAYEL 686
Y+ PE + Y+ D +SFG L + I+G R + EH
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIAL-----LCVQENPNDRPSMLEV 733
V+F P L L L + + R + +
Sbjct: 248 DDLTGAVKFSSVLPT----PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 28/242 (11%), Positives = 74/242 (30%), Gaps = 24/242 (9%)
Query: 443 DFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGV------LPCGEVIAVKKL 496
++ +P ++ + + + ++ + + LGEG + VY+ + +K
Sbjct: 46 EWQCKLPAIKPKT--EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ 103
Query: 497 SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL--FDP 554
+ F + ++ + +L+ E +L + +
Sbjct: 104 KPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKN 163
Query: 555 IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP--------- 605
+ ++ + + + + + IIH D+K N +LG
Sbjct: 164 TPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220
Query: 606 --KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS 663
+ D G + T G+ E + ++ + D F + ++
Sbjct: 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
Query: 664 GK 665
G
Sbjct: 281 GT 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS--TQGFEE-FKNEVMLTAKLQH 519
E F + N LG+G + VY+ + G +A+K + K + G + +NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIR---KLILDWKKRVHIIEGITQGL 576
+++ + + DS L+ E N + ++ K + + R H + I G+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQIITGM 125
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
LYL + I+HRDL +SN+LL M KI+DFG+A + T + GT YI
Sbjct: 126 LYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYIS 180
Query: 637 PEYATKGVYSTKSDVFSFGVLLLQIISGK 665
PE AT+ + +SDV+S G + ++ G+
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 41/357 (11%), Positives = 90/357 (25%), Gaps = 60/357 (16%)
Query: 415 NQMKRLNLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGE 474
+ + L + A A + +N V SL + + L
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAE-TTVDSLLS--QGERKLKLVEPLRV 72
Query: 475 GGYGPVYKGV-LPCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFC- 529
G V+ + E A+K + S E A+L +
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 530 -------------------IDSEERMLIYEY---MPNKSLD-CYLFDPIRKLI-----LD 561
++ + Y MP S+D LF + +
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 562 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621
+ + + LQ ++H N+ + + + D +
Sbjct: 193 ILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW-----KV 244
Query: 622 EENTEQVVGTIGYIPPEY--ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI---NEN 676
+ Y P E+ A+ ++ + + G+ + + + C
Sbjct: 245 GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR--------VWCLFLPFGLV 296
Query: 677 LSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
++ +++ +F P + + L + R LE
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG-RFLNF--DRRRRLLPLEA 350
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 52/204 (25%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
++++ K+G+G G VY + + G+ +A+++++ E NE+++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
++ L + +E ++ EY+ SL D + + +D + + Q L +L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT 641
+IHRD+K NILLG K++DFG E + +T +VGT ++ PE T
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 642 KGVYSTKSDVFSFGVLLLQIISGK 665
+ Y K D++S G++ +++I G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 54/204 (26%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
K+GEG G V G +AVK + Q E NEV++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
++ + + EE ++ E++ +L D + ++ L+ ++ + E + Q L YL
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT 641
+IHRD+K +ILL + K+SDFG +K+ + + +VGT ++ PE +
Sbjct: 160 QG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 642 KGVYSTKSDVFSFGVLLLQIISGK 665
+ +Y+T+ D++S G+++++++ G+
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3sim_A Protein, family 18 chitinase; family 18 plant chitinase, TIM barrel, chitin binding, glyco hydrolase, hydrolase; 2.10A {Crocus vernus} Length = 275 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 38/249 (15%), Positives = 76/249 (30%), Gaps = 24/249 (9%)
Query: 43 INYDLFT-HLICS-------SADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTIL 94
IN + + S S+ ST + ++ S + + +K +P++ +
Sbjct: 22 INPHITKFQFVLSFAVDYTASSPHTSTNGKFNVFWDSSILGPDQISA-IKSSHPNVRVAV 80
Query: 95 SIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGL 154
S+G + ++ S + + S RI + Y G+D + +TD
Sbjct: 81 SLGGASVGSNTVQFQAASVDSWVSNAVTSLTRIIQRYNLDGIDIDYEHFQ-NTDKNTFAE 139
Query: 155 LFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYE 214
L +I A P + Y L N I+ + +
Sbjct: 140 CIGRLITT---LKKNG-------VISFASISPFPSVDEYYLALFNEYKNAINHINYQFKA 189
Query: 215 PVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPED 274
S+ Y + + ++ + G L + F+ A +L
Sbjct: 190 YDSSTSVDKFLGYYNNAASKYKGGN---VLISFSTGPHPGGLPVDKGFFDAATSLKNKGK 246
Query: 275 -NGIGAAAA 282
+GI A
Sbjct: 247 LHGIAVWTA 255
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQH 519
+E + KLG G YG V A+K + KT ST + EV + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPIRKLILDWKKR------VHIIE 570
N++++ F D L+ E LFD I + + II+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMEC-------YKGGELFDEIIH-----RMKFNEVDAAVIIK 143
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQ 627
+ G+ YL + I+HRDLK N+LL + KI DFG++ +F ++ ++
Sbjct: 144 QVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN---QKKMKE 197
Query: 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
+GT YI PE + Y K DV+S GV+L +++G
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKG---VLPCGEVIAVK--KLSKTSTQGFEE-FKNEVMLTAKL 517
+R+ + LG GG V+ +AVK + F F+ E A L
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 518 QHVNLIRVLGFCIDSEERMLIY----EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGIT 573
H ++ V + EY+ +L + + + K+ + +I
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADAC 126
Query: 574 QGLLYLQEYS-RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE-NTEQVVGT 631
Q L +S + IIHRD+K +NI++ K+ DFG+AR A T V+GT
Sbjct: 127 QAL----NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
Y+ PE A +SDV+S G +L ++++G+
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 61/303 (20%), Positives = 102/303 (33%), Gaps = 57/303 (18%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNL 522
LG G G V G +AVK++ + E+ +LT H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRK--------LILDWKKRVHIIEGITQ 574
IR + E + L D + + + ++ I
Sbjct: 72 IRYYCSETTDRFLYIALELC-----NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILL-------------GEAMKPKISDFGMARIFA--KE 619
G+ +L L IIHRDLK NIL+ E ++ ISDFG+ + +
Sbjct: 127 GVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 620 SLEENTEQVVGTIGYIPPE-------YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
S N GT G+ PE TK + D+FS G + I+S +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 673 INENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSM 730
+ +I+ + L E + + + ++ +P RP+
Sbjct: 244 YSRESNIIRGIFSL------DEMKCLHDRSLIAEATDLISQMIDH-------DPLKRPTA 290
Query: 731 LEV 733
++V
Sbjct: 291 MKV 293
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 68/237 (28%), Positives = 103/237 (43%), Gaps = 37/237 (15%)
Query: 443 DFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT-- 499
+ + +Y ER++I LG+G +G V K + AVK ++K
Sbjct: 4 HHHHSSGRENLYFQGTFA---ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60
Query: 500 STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPIR 556
+ EV L KL H N++++ DS ++ E LFD I
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL-------YTGGELFDEII 113
Query: 557 KLILDWKKR------VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKI 607
K +KR II+ + G+ Y+ + I+HRDLK NILL + KI
Sbjct: 114 K-----RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKI 165
Query: 608 SDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
DFG++ F + + +GT YI PE +G Y K DV+S GV+L ++SG
Sbjct: 166 IDFGLSTCFQQ---NTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQ 518
++R+ + LG+G +G V G+ AVK +SK E EV L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPIRKLILDWKKR------VHII 569
H N++++ F D L+ E LFD I +KR II
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEV-------YTGGELFDEIIS-----RKRFSEVDAARII 132
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTE 626
+ G+ Y+ + I+HRDLK N+LL + +I DFG++ F + +
Sbjct: 133 RQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMK 186
Query: 627 QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
+GT YI PE G Y K DV+S GV+L ++SG
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-26
Identities = 54/245 (22%), Positives = 98/245 (40%), Gaps = 26/245 (10%)
Query: 424 EEDSAKASNTRANNETEAGD--FNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVY 481
+ K + N+ + + + + VP + + + I +LG G +G V+
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVY---DYYDILEELGSGAFGVVH 68
Query: 482 KGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540
+ V G V K ++ KNE+ + +L H LI + D E +LI E
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128
Query: 541 YMPNKSLDCY---LFDPI--RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVS 595
+ LFD I + + ++ + +GL ++ E +I+H D+K
Sbjct: 129 F-------LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPE 178
Query: 596 NILLG--EAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFS 653
NI+ +A KI DFG+A +E + T + PE + +D+++
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWA 235
Query: 654 FGVLL 658
GVL
Sbjct: 236 IGVLG 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 68/323 (21%), Positives = 110/323 (34%), Gaps = 52/323 (16%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNL 522
R +R L EGG+ VY+ + G A+K+L + EV KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 523 IRVLGFCIDSEERM-------LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
++ +E L+ + L +L + L + I +
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF----------AKESLEENT 625
+ ++ + IIHRDLKV N+LL K+ DFG A + +L E
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 626 EQVVGTIGYIPPE---YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI-----NENL 677
T Y PE + K D+++ G +L + L
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL--------YLLCFRQHPFEDGAKL 259
Query: 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSML 737
I+ Y + D L A+L Q NP +R S+ EV L
Sbjct: 260 RIVNGKYSIPP------------HDTQYTV--FHSLIRAML--QVNPEERLSIAEVVHQL 303
Query: 738 KNETTNINTPKKPAFSKQVDEIG 760
+ N K ++ +++ G
Sbjct: 304 QEIAAARNVNPKSPITELLEQNG 326
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 67/278 (24%), Positives = 109/278 (39%), Gaps = 20/278 (7%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQG-FEEFKNEVMLTAKL 517
E + F ++LG G G V+K P G V+A K + + E+ + +
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 518 QHVNLIRVLG-FCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLILDWKKRVHIIEGITQ 574
++ G F D E + + E+M SLD L I + IL + + +
Sbjct: 89 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAVIK 142
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
GL YL + I+HRD+K SNIL+ + K+ DFG++ +S+ N+ VGT Y
Sbjct: 143 GLTYL--REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSM-ANS--FVGTRSY 196
Query: 635 IPPEYATKGVYSTKSDVFSFGVLLLQIISGK---RLSMLCGINENLSILEHAYELWKGGK 691
+ PE YS +SD++S G+ L+++ G+ + +
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729
M E+ V E P PS
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 61/347 (17%), Positives = 113/347 (32%), Gaps = 92/347 (26%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVN 521
F +G GG+G V++ A+K++ E+ EV AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 522 LIRVLGFCI-----------------------------------------DSEERMLIYE 540
++R + D
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 541 YMPNKSLDCYLF------------DPIRK----LILDWKKRVHIIEGITQGLLYLQEYSR 584
+ S YL+ D + + + +HI I + + +L
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL---HS 182
Query: 585 LTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV----------VGTIGY 634
++HRDLK SNI K+ DFG+ ++ E+ VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 635 IPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694
+ PE YS K D+FS G++L +++ M E + I+ ++ +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIIT---DVRNL----K 290
Query: 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV--SSMLKN 739
F F +++ + +P +RP ++ +++ +N
Sbjct: 291 FPLLFTQKYPQEHMMVQ------DMLSPSPTERPEATDIIENAIFEN 331
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 55/205 (26%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQG-FEEFKNEVMLTAKLQHV 520
E F+ K+G+G +G V+KG+ +V+A+K + + E+ + E+ + ++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 521 NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
+ + G + + +I EY+ S D + LD + I+ I +GL YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
IHRD+K +N+LL E + K++DFG+A ++ NT VGT ++ PE
Sbjct: 137 SEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGK 665
+ Y +K+D++S G+ +++ G+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGE 216
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 42/218 (19%), Positives = 83/218 (38%), Gaps = 22/218 (10%)
Query: 457 ADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTA 515
+ + + ++G G +G V++ G AVKK+ + E++ A
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIR-KLILDWKKRVHIIEGI 572
L ++ + G + + E + SL + + L + +
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL------YYLGQA 159
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDFGMARIFAKESLEENTEQ---V 628
+GL YL I+H D+K N+LL + + DFG A + L ++ +
Sbjct: 160 LEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 629 VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
GT ++ PE K D++S ++L +++G
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 53/235 (22%), Positives = 96/235 (40%), Gaps = 30/235 (12%)
Query: 443 DFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPC-GEVIAVKKLSKTST 501
+ + +Y I+ + F + KLG G +G V+ G +K ++K +
Sbjct: 4 HHHHSSGRENLYFQGTID---DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60
Query: 502 QG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPIRK 557
Q E+ + E+ + L H N+I++ D ++ E C L + I
Sbjct: 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET-------CEGGELLERIVS 113
Query: 558 LILDW-----KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISD 609
+++ + L Y ++H+DLK NIL KI D
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 610 FGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
FG+A +F +E++ GT Y+ PE K + K D++S GV++ +++G
Sbjct: 171 FGLAELFKS---DEHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 49/216 (22%), Positives = 79/216 (36%), Gaps = 30/216 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKL-QH 519
+ F ++LG G YG V+K G + AVK+ + EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRK--------LILDWKKRVHIIEG 571
+R+ + L E L + + + +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-----GPSLQQHCEAWGASLPEAQVWGY-----LRD- 165
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
L +L ++H D+K +NI LG + K+ DFG+ E G
Sbjct: 166 TLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGD 219
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
Y+ PE +G Y T +DVFS G+ +L++ L
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-25
Identities = 40/211 (18%), Positives = 80/211 (37%), Gaps = 26/211 (12%)
Query: 465 RFSIRNKLGEGGYGPVYKG---VLPCGEVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHV 520
++ ++ + GG G +Y + G + +K L + + E A++ H
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 521 NLIRVL--GFCIDSEERMLIY---EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
+++++ D + Y EY+ +SL L + + + I
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPA 194
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
L YL + +++ DLK NI+L E + K+ D G + + GT G+
Sbjct: 195 LSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINS-FGYLYGTPGFQ 244
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
PE G + +D+++ G L +
Sbjct: 245 APEIVRTGP-TVATDIYTVGRTLAALTLDLP 274
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-25
Identities = 48/251 (19%), Positives = 96/251 (38%), Gaps = 23/251 (9%)
Query: 418 KRLNLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAA--TERFSIRNKLGEG 475
+R ++ K + + ++ ++ +I+ + + I +LG G
Sbjct: 109 RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTG 168
Query: 476 GYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 534
+G V++ G A K + E + E+ + L+H L+ + D E
Sbjct: 169 AFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228
Query: 535 RMLIYEYMPNKSLDCY---LFDPI--RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 589
++IYE+ LF+ + + + V + + +GL ++ E +H
Sbjct: 229 MVMIYEF-------MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVH 278
Query: 590 RDLKVSNILLGEAMKP--KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYST 647
DLK NI+ K+ DFG+ +++ + GT + PE A
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 648 KSDVFSFGVLL 658
+D++S GVL
Sbjct: 336 YTDMWSVGVLS 346
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 32/215 (14%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
+ +++ N +G G +G V V A KK+ K + + FK E+ + L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPIRKLILDWKKR------VHIIEGI 572
+IR+ D+ + L+ E C LF+ + K+ I++ +
Sbjct: 68 IIRLYETFEDNTDIYLVMEL-------CTGGELFERVVH-----KRVFRESDAARIMKDV 115
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVV 629
+ Y + L + HRDLK N L K+ DFG+A F + V
Sbjct: 116 LSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKV 169
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
GT Y+ P+ +G+Y + D +S GV++ ++ G
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 46/209 (22%), Positives = 88/209 (42%), Gaps = 17/209 (8%)
Query: 465 RFSIRNKLGEGGYGPVYKG---VLPCGEVIAVKKLSK--TSTQGFEE-FKNEVMLTAKLQ 518
+ +R +G GG G VY+ V ++A+K +S+ +S F + E +LQ
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ 92
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
+++ + F + + + L L L + V I+ I L
Sbjct: 93 EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSAL-- 147
Query: 579 LQEYS-RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
+ + HRD+K NIL+ + DFG+A E L + VGT+ Y+ P
Sbjct: 148 --DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAP 204
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGKR 666
E ++ + ++D+++ +L + ++G
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 68/214 (31%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQG--FEEFKNEVMLTAKLQH 519
ER++I LG+G +G V K + AVK ++K S + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR------VHIIEGIT 573
N++++ DS ++ E LFD I K +KR II+ +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIK-----RKRFSEHDAARIIKQVF 131
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVG 630
G+ Y+ + I+HRDLK NILL + KI DFG++ F + + +G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIG 185
Query: 631 TIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664
T YI PE +G Y K DV+S GV+L ++SG
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
+ F LG G + V+ G++ A+K + K+ +NE+ + K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQ 580
++ + + L+ + + LFD I + + K +I+ + + YL
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVS----GGELFDRILERGVYTEKDASLVIQQVLSAVKYLH 123
Query: 581 EYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
E I+HRDLK N+L E K I+DFG++++ + GT GY+ P
Sbjct: 124 E---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYVAP 176
Query: 638 EYATKGVYSTKSDVFSFGVLL 658
E + YS D +S GV+
Sbjct: 177 EVLAQKPYSKAVDCWSIGVIT 197
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEE-FKNEVMLTAKLQH 519
+ F I LG+G +G VY ++A+K L K+ +G E + E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV------HIIEGIT 573
N++R+ + D + L+ E+ P L + ++K R +E +
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQK-----HGRFDEQRSATFMEELA 124
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633
L Y +IHRD+K N+L+G + KI+DFG ++ + + GT+
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRTMCGTLD 177
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
Y+PPE + K D++ GVL + + G
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 78/321 (24%), Positives = 125/321 (38%), Gaps = 70/321 (21%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK-------------TSTQGFEEFK 508
E + KLG G YG V A+K + K + EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 509 NEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPIRKLILDWKKR 565
NE+ L L H N+I++ D + L+ E+ LF+ I + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF-------YEGGELFEQIIN-----RHK 142
Query: 566 ------VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIF 616
+I++ I G+ YL + I+HRD+K NILL + KI DFG++ F
Sbjct: 143 FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG---- 672
+K + +GT YI PE K Y+ K DV+S GV++ +LCG
Sbjct: 200 SK---DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYI--------LLCGYPPF 247
Query: 673 INENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCK-LMRCLEIALLCVQENPNDRPSML 731
+N + + + GK F + + + K L++ +L + N R +
Sbjct: 248 GGQNDQDI---IKKVEKGK-YYFDFNDWKNISDEAKELIKL----MLTY--DYNKRCTAE 297
Query: 732 EVSSM--LKNETTNINTPKKP 750
E + +K NIN +
Sbjct: 298 EALNSRWIKKYANNINKSDQK 318
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
E F + KLGEG YG VYK + G+++A+K++ +E E+ + + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSL-DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
+++ G + + ++ EY S+ D +R L + I++ +GL YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
IHRD+K NILL K++DFG+A + NT V+GT ++ PE
Sbjct: 143 FMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGK 665
+ Y+ +D++S G+ +++ GK
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 459 IEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVM----L 513
+E + +LG G YG V K +P G+++AVK++ T +E K +M
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDIS 59
Query: 514 TAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV------H 567
+ + G + + E M + SLD + K ++D + +
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGK 113
Query: 568 IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ 627
I I + L +L +S+L++IHRD+K SN+L+ + K+ DFG++ + ++
Sbjct: 114 IAVSIVKALEHL--HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD-DVAKDI-- 168
Query: 628 VVGTIGYIPPE----YATKGVYSTKSDVFSFGVLLLQIISGK 665
G Y+ PE + YS KSD++S G+ ++++ +
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 463 TERFSIRNKLGEGGYGPVYKGVLPC-----GEVIAVKKLSKTSTQG------FEEFKNEV 511
+ + I +LG G + V K C G A K + K ++ EE + EV
Sbjct: 11 EDFYDIGEELGSGQFAIVKK----CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 512 MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIE 570
+ ++ H N+I + + + +LI E + L FD + +K L ++ I+
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIK 122
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP----KISDFGMARIFAKESLEENTE 626
I G+ YL I H DLK NI+L + P K+ DFG+A +
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFK 176
Query: 627 QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658
+ GT ++ PE ++D++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 466 FSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIR 524
S LG G +G V+K G +A K + + EE KNE+ + +L H NLI+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 525 VLGFCIDSEERMLIYEYMPNKSLDCY---LFDPI--RKLILDWKKRVHIIEGITQGLLYL 579
+ + +L+ EY LFD I L + ++ I +G+ ++
Sbjct: 151 LYDAFESKNDIVLVMEY-------VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 580 QEYSRLTIIHRDLKVSNILLG--EAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
+ + I+H DLK NIL +A + KI DFG+AR + E + GT ++ P
Sbjct: 204 HQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTPEFLAP 257
Query: 638 EYATKGVYSTKSDVFSFGVLL 658
E S +D++S GV+
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIA 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 46/210 (21%), Positives = 82/210 (39%), Gaps = 23/210 (10%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVK-----KLSKTSTQGFEEFKNEVMLTAK 516
+ + + +G+G + V + + G+ AVK K + + E+ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI--RKLILDW---KKRVHIIEG 571
L+H +++ +L +++E+M L I R H +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQV 628
I + L Y + IIHRD+K +LL + K+ FG+A +
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGR 193
Query: 629 VGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658
VGT ++ PE + Y DV+ GV+L
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKN--------EVMLTA 515
E++ K+GEG YG VYK G ++A+K++ + E+ L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
+L H N++ ++ L++E+M K L L + L K + + +G
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIK--IYLYQLLRG 131
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
+ + ++ I+HRDLK N+L+ K++DFG+AR F + T +VV T+ Y
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVV-TLWYR 186
Query: 636 PPEY---ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
P+ + K YST D++S G + ++I+GK L G+ +
Sbjct: 187 APDVLMGSKK--YSTSVDIWSIGCIFAEMITGKPL--FPGVTD 225
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGF------EEFKNEVMLTA 515
+ + I +LG G + V K G A K + K ++ EE + EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQ 574
++ H N+I + + + +LI E + L FD + +K L ++ I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILL----GEAMKPKISDFGMARIFAKESLEENTEQVVG 630
G+ YL I H DLK NI+L K+ DFG+A + + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFG 180
Query: 631 TIGYIPPEYATKGVYSTKSDVFSFGVLL 658
T ++ PE ++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 29/223 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKN--------EVMLTA 515
E++ K+GEG YG VYK GE A+KK+ E+ E+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
+L+H N++++ + +L++E++ + L L L K + + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAK--SFLLQLLNG 112
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
+ Y + ++HRDLK N+L+ + KI+DFG+AR F + + T ++V T+ Y
Sbjct: 113 IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIV-TLWYR 167
Query: 636 PPEY---ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
P+ + K YST D++S G + ++++G L G++E
Sbjct: 168 APDVLMGSKK--YSTTIDIWSVGCIFAEMVNGTPL--FPGVSE 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 459 IEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVM----L 513
+A ++G G G V+K G VIAVK++ ++ + EE K +M +
Sbjct: 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVV 77
Query: 514 TAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL--FDPIRKLILDWKKRVHIIEG 571
+++ G I + + + E M + PI + IL +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL-----GKMTVA 132
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
I + L YL + +IHRD+K SNILL E + K+ DFG++ ++ G
Sbjct: 133 IVKALYYL--KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-DKAKDRS--AGC 187
Query: 632 IGYIPPE-----YATKGVYSTKSDVFSFGVLLLQIISGK 665
Y+ PE TK Y ++DV+S G+ L+++ +G+
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 67/329 (20%), Positives = 112/329 (34%), Gaps = 83/329 (25%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVK-----KLSKTSTQGFEEFKNEVMLTAK 516
+++ ++ +G+G YG V + + A+K K+ + + + E K EV L K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV---------- 566
L H N+ R+ D + L+ E L D + I D +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 567 -------------------------------HIIEGITQGLLYLQEYSRLTIIHRDLKVS 595
+I+ I L YL I HRD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197
Query: 596 NILLG--EAMKPKISDFGMARIFAKESLEENTE--QVVGTIGYIPPE--YATKGVYSTKS 649
N L ++ + K+ DFG+++ F K + E GT ++ PE T Y K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 650 DVFSFGVLLLQIISGKRLSMLCGI----NENLSILEHAYELWKGGKGVEFVDSFLDDRNS 705
D +S GVLL +L G N + K + F + + +
Sbjct: 258 DAWSAGVLL--------HLLLMGAVPFPGVNDADT---ISQVLNKK-LCFENPNYNVLSP 305
Query: 706 PCK-LMRCLEIALLCVQENPNDRPSMLEV 733
+ L+ LL N ++R +
Sbjct: 306 LARDLLSN----LLNR--NVDERFDAMRA 328
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 22/204 (10%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
E++ I LG G +G V++ V + K + K E+ + +H N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPI--RKLILDWKKRVHIIEGITQGL 576
++ + EE ++I+E+ +F+ I L+ ++ V + + + L
Sbjct: 63 ILHLHESFESMEELVMIFEF-------ISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 577 LYLQEYSRLTIIHRDLKVSNILLG--EAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
+L I H D++ NI+ + KI +FG AR +N + Y
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEY 169
Query: 635 IPPEYATKGVYSTKSDVFSFGVLL 658
PE V ST +D++S G L+
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 50/233 (21%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT-----------------STQGFEE 506
+ I L +G + + + A+KK K+ +++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 507 FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-----FDPIRKLILD 561
FKNE+ + +++ + G + +E +IYEYM N S+ + D +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 562 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621
+ II+ + Y+ ++ I HRD+K SNIL+ + + K+SDFG + + +
Sbjct: 150 IQVIKCIIKSVLNSFSYI--HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 622 EENTEQVVGTIGYIPPE-YATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCG 672
+ GT ++PPE ++ + Y+ K D++S G+ L M
Sbjct: 208 K--G--SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL--------YVMFYN 248
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 31/217 (14%)
Query: 457 ADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQG------FEEFKN 509
+ +E + + + +LG G + V K G+ A K + K EE +
Sbjct: 1 SMVE---DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 57
Query: 510 EVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPI-RKLILDWKKR 565
EV + +++H N+I + + + +LI E LFD + K L +
Sbjct: 58 EVNILREIRHPNIITLHDIFENKTDVVLILEL-------VSGGELFDFLAEKESLTEDEA 110
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP----KISDFGMARIFAKESL 621
++ I G+ YL I H DLK NI+L + P K+ DFG+A
Sbjct: 111 TQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-- 165
Query: 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658
+ + GT ++ PE ++D++S GV+
Sbjct: 166 -NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
E + I +LG+G +G VYK G + A K + S + E++ E+ + A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKL--ILDWKKRVHIIEGITQGLLYL 579
++++LG + ++ E+ P ++D + +L L + + + + L +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY----- 634
IIHRDLK N+L+ +++DFG++ K + ++ +GT Y
Sbjct: 134 HSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT-PYWMAPE 187
Query: 635 -IPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
+ E Y K+D++S G+ L+++ +
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 6e-23
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 28/204 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN--------EVMLT 514
+++ K+GEG YG V+K E++A+K++ ++ E+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 515 AKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
+L+H N++R+ ++ L++E+ + L Y L + K + + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVK--SFLFQLLK 112
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
GL + + ++HRDLK N+L+ + K+++FG+AR F + + +VV T+ Y
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVV-TLWY 167
Query: 635 IPPEY---ATKGVYSTKSDVFSFG 655
PP+ A YST D++S G
Sbjct: 168 RPPDVLFGAKL--YSTSIDMWSAG 189
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQH 519
++ + ++ +LG+G + V + V G A K ++ S + F++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLY 578
N++R+ + L+++ + L F+ I + H I+ I + + Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 579 LQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
I+HR+LK N+LL + K++DFG+A E GT GY+
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYL 174
Query: 636 PPEYATKGVYSTKSDVFSFGVLL 658
PE K YS D+++ GV+L
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVIL 197
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 35/226 (15%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE--------FKNEVML 513
+ + + LG G G V + +A++ +SK + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 514 TAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGI 572
KL H +I++ F D+E+ ++ E M L FD + L +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 248
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP---KISDFGMARIFAKESLEENTEQVV 629
+ YL E IIHRDLK N+LL + KI+DFG ++I + SL +
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 302
Query: 630 GTIGYIPPE---YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
GT Y+ PE Y+ D +S GV+L L G
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL--------FICLSG 340
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 28/211 (13%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGF------EEFKNEVMLTA 515
+ + +LG G + V K G A K + K T+ E+ + EV +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPI-RKLILDWKKRVHIIEG 571
++QH N+I + + + +LI E LFD + K L ++ ++
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILEL-------VAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP----KISDFGMARIFAKESLEENTEQ 627
I G+ YL L I H DLK NI+L + P KI DFG+A +
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKN 176
Query: 628 VVGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658
+ GT ++ PE ++D++S GV+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQ 518
+ FS ++G G +G VY + EV+A+KK+S + Q +++ EV KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H N I+ G + L+ EY + D + K L + + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 169
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
L ++ +IHRD+K NILL E K+ DFG A I A N+ VGT ++ PE
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANS--FVGTPYWMAPE 220
Query: 639 ---YATKGVYSTKSDVFSFGVLLLQIISGK 665
+G Y K DV+S G+ +++ K
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 458 DIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE-FKN----EV 511
D+++ +R+ + LGEG + VYK +++A+KK+ ++ E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 512 MLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG 571
L +L H N+I +L L++++M L+ + D L K +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIK--AYMLM 120
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
QGL YL ++ I+HRDLK +N+LL E K++DFG+A+ F T QVV T
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVV-T 175
Query: 632 IGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGK 665
Y PE A Y D+++ G +L +++
Sbjct: 176 RWYRAPELLFGARM--YGVGVDMWAVGCILAELLLRV 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQH 519
++ + ++ +LG+G + V + V G A K ++ S + F++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLY 578
N++R+ + L+++ + L F+ I + H I+ I + + Y
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 143
Query: 579 LQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
I+HR+LK N+LL + K++DFG+A E GT GY+
Sbjct: 144 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYL 197
Query: 636 PPEYATKGVYSTKSDVFSFGVLL 658
PE K YS D+++ GV+L
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVIL 220
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 2e-22
Identities = 27/247 (10%), Positives = 66/247 (26%), Gaps = 51/247 (20%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHV 520
LG+ + GE V T + ++ K EV+ L+ +
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 521 ----------------NLIRVLGFC------IDSEERMLIYEYMPNKSLDCYLFDPIRKL 558
+L++ +D + ++ + + L L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 559 I--------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610
+ L R+ + + + L L Y ++H L+ +I+L + ++ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 611 GMARIFAKESLEENTEQVVGTIGYIPPE-----YATKGVYSTKSDVFSFGVLLLQIISGK 665
++ + + D ++ G+ +
Sbjct: 256 EHLVRDGASAVSPIGR-GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW----- 309
Query: 666 RLSMLCG 672
+ C
Sbjct: 310 ---IWCA 313
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 27/212 (12%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE--------FKNEVML 513
+ + + LG G G V + +A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 514 TAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGI 572
KL H +I++ F D+E+ ++ E M L FD + L +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 123
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVV 629
+ YL E IIHRDLK N+LL E KI+DFG ++I + SL +
Sbjct: 124 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 177
Query: 630 GTIGYIPPE---YATKGVYSTKSDVFSFGVLL 658
GT Y+ PE Y+ D +S GV+L
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN--------EVMLT 514
+R+ KLGEG YG VYK + E +A+K++ E + EV L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 515 AKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
+LQH N+I + + LI+EY L Y+ D + + K + +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIK--SFLYQLIN 143
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKP-----KISDFGMARIFAKESLEENTEQVV 629
G+ + +HRDLK N+LL + KI DFG+AR F + + T +++
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTHEII 199
Query: 630 GTIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
T+ Y PPE + YST D++S + +++ L G +E
Sbjct: 200 -TLWYRPPEILLGSRH--YSTSVDIWSIACIWAEMLMKTPL--FPGDSE 243
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 64/228 (28%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 461 AATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN-----EVMLT 514
+++ +F KLG G Y VYKG+ G +A+K++ S +G E+ L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57
Query: 515 AKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGIT- 573
+L+H N++R+ + L++E+M L Y+ D +++++
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYM-DSRTVGNTPRGLELNLVKYFQW 115
Query: 574 ---QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG 630
QGL + E I+HRDLK N+L+ + + K+ DFG+AR F + + +VV
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-VNTFSSEVV- 170
Query: 631 TIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
T+ Y P+ + YST D++S G +L ++I+GK L G N+
Sbjct: 171 TLWYRAPDVLMGSRT--YSTSIDIWSCGCILAEMITGKPL--FPGTND 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 27/221 (12%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVM----LT 514
+ E ++G G YG V K V P G+++AVK++ T + +E K +M +
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVM 75
Query: 515 AKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV------HI 568
+++ G + + E M + S D + + + I
Sbjct: 76 RSSDCPYIVQFYGALFREGDCWICMELM-STSFD----KFYKYVYSVLDDVIPEEILGKI 130
Query: 569 IEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQV 628
+ L +L L IIHRD+K SNILL + K+ DFG++ +
Sbjct: 131 TLATVKALNHL--KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD--- 185
Query: 629 VGTIGYIPPE----YATKGVYSTKSDVFSFGVLLLQIISGK 665
G Y+ PE A++ Y +SDV+S G+ L ++ +G+
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 36/221 (16%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
T+ + ++ +G G Y + + AVK + K+ EE E++L QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEILLRY-GQHPN 77
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR------VHIIEGITQG 575
+I + D + ++ E M L D I + +K ++ IT+
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILR-----QKFFSEREASAVLFTITKT 128
Query: 576 LLYLQEYSRLTIIHRDLKVSNILL----GEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
+ YL ++HRDLK SNIL G +I DFG A+ E T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYT 183
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
++ PE + Y D++S GVLL +ML G
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL--------YTMLTG 216
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 4e-22
Identities = 46/361 (12%), Positives = 95/361 (26%), Gaps = 90/361 (24%)
Query: 424 EEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKG 483
+++ + A++ +N P RV S LG+ +
Sbjct: 36 VRTTSEYMQSAADSLVSTSLWNTGQP-FRVESELGER--PRTLVRGTVLGQEDPYAYLEA 92
Query: 484 V-LPCGEVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQ--------------------- 518
GE V T ++ K EV+ L+
Sbjct: 93 TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152
Query: 519 ----HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLI-----LDWKKRVHII 569
+IRV D + Y +S + + L R+ +
Sbjct: 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 212
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
+ + L L Y ++H L+ +I+L + ++ F +
Sbjct: 213 LQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGARVVSS 263
Query: 630 GTIGYIPPEY-----------ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI----N 674
+ G+ PPE + + + D ++ G+++ + C
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW--------IWCADLPITK 315
Query: 675 ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSMLE 732
+ E++ + P + L L + DR L+
Sbjct: 316 DAALGG------------SEWIFRSCKNIPQPVRALLEGFL-------RYPKEDRLLPLQ 356
Query: 733 V 733
Sbjct: 357 A 357
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-22
Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE--FKNEVMLTAKLQH 519
TE + + +LG+G + V + V + G+ A ++ + + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLY 578
N++R+ + LI++ + L F+ I + H I+ I + +L+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 579 LQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
+ + ++HR+LK N+LL + K++DFG+A E ++ GT GY+
Sbjct: 126 CHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGYL 180
Query: 636 PPEYATKGVYSTKSDVFSFGVLL 658
PE K Y D+++ GV+L
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVIL 203
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 5e-22
Identities = 56/326 (17%), Positives = 111/326 (34%), Gaps = 55/326 (16%)
Query: 450 NLRVYSLADIEAATERFSIRNKLGEG--GYGPVYKGV-LPCGEVIAVKK--LSKTSTQGF 504
NL ++ + + +G+G V P GE + V++ L S +
Sbjct: 11 NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70
Query: 505 EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKS----LDCYLFDPIRKLIL 560
+ E+ ++ H N++ I E ++ +M S + + D + +L +
Sbjct: 71 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI 130
Query: 561 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620
+I++G+ + L Y+ +HR +K S+IL+ K +S
Sbjct: 131 -----AYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182
Query: 621 LEENT-----EQVVGTIGYIPPEYATKGV--YSTKSDVFSFGV----------------- 656
+ + V + ++ PE + + Y KSD++S G+
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
Query: 657 --LLLQIISGK--RLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRC 712
+LL+ ++G L I + + + G S N
Sbjct: 243 TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302
Query: 713 LE---------IALLCVQENPNDRPS 729
+ C+Q NP+ RPS
Sbjct: 303 HRTFSPHFHHFVE-QCLQRNPDARPS 327
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 28/214 (13%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGF---------EEFKNEVM 512
E + + LG G V + + P + AVK + T F E EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 513 LTAKL-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIE 570
+ K+ H N+I++ + L+++ M L FD + K+ L K+ I+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMR 131
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG 630
+ + + L + L I+HRDLK NILL + M K++DFG + E +V G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCG 185
Query: 631 TIGYIPPE------YATKGVYSTKSDVFSFGVLL 658
T Y+ PE Y + D++S GV++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVN 521
+ + ++ +G G V P E +A+K+++ + +E E+ ++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSL-----DCYLFDPIRKLILDWKKRVHIIEGITQGL 576
++ + +E L+ + + S+ + +LD I+ + +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA-----RIFAKESLEENTEQVVGT 631
YL + IHRD+K NILLGE +I+DFG++ + T VGT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVGT 189
Query: 632 IGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGK 665
++ PE + Y K+D++SFG+ +++ +G
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 27/249 (10%)
Query: 427 SAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGV-L 485
AK N TE F P + A + +++ ++ +G G V + V
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116
Query: 486 PCGEVIAVKKLSKTSTQG--------FEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERM 536
G AVK + T+ + E + E + ++ H ++I ++ S
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176
Query: 537 LIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVS 595
L+++ M L FD + K+ L K+ I+ + + + +L I+HRDLK
Sbjct: 177 LVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPE 229
Query: 596 NILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE------YATKGVYSTKS 649
NILL + M+ ++SDFG + E ++ GT GY+ PE T Y +
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEP---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 650 DVFSFGVLL 658
D+++ GV+L
Sbjct: 287 DLWACGVIL 295
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 38/225 (16%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTA------- 515
++ K+G+G +G V+K G+ +A+KK+ E K +TA
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 516 -KLQHVNLIRVLGFCIDSEERM--------LIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
L+H N++ ++ C L++++ L L + + K L K
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIK-- 127
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF---AKESLEE 623
+++ + GL Y+ I+HRD+K +N+L+ K++DFG+AR F
Sbjct: 128 RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 624 NTEQVVGTIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGK 665
T +VV T+ Y PPE Y D++ G ++ ++ +
Sbjct: 185 YTNRVV-TLWYRPPELLLGERD--YGPPIDLWGAGCIMAEMWTRS 226
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQ 518
E++ +GEG YG V K G ++A+KK ++ + K E+ L +L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLR 82
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H NL+ +L C + L++E++ + ++ L L ++ + I G+ +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQK--YLFQIINGIGF 139
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
++ IIHRD+K NIL+ ++ K+ DFG AR A E ++V T Y PE
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYDDEVA-TRWYRAPE 194
Query: 639 Y---ATKGVYSTKSDVFSFGVLLLQIISGK 665
K Y DV++ G L+ ++ G+
Sbjct: 195 LLVGDVK--YGKAVDVWAIGCLVTEMFMGE 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 25/221 (11%)
Query: 464 ERFSIRNKLGEGGYGPVYKG-VLPCGEVIAVKKLSKTSTQGFEEFKN-----EVMLTAKL 517
E + +KLGEG Y VYKG ++A+K++ +G EV L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
+H N++ + + L++EY+ +K L YL D + + K + + +GL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVK--LFLFQLLRGLA 114
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
Y ++HRDLK N+L+ E + K++DFG+AR + + +VV T+ Y PP
Sbjct: 115 YCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEVV-TLWYRPP 169
Query: 638 EY---ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
+ +T YST+ D++ G + ++ +G+ L G
Sbjct: 170 DILLGSTD--YSTQIDMWGVGCIFYEMATGRPL--FPGSTV 206
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 445 NRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQG 503
R++ + + +L D F + +G G YG VYKG + G++ A+K + +
Sbjct: 8 ARSLDEIDLSALRDPA---GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDE 63
Query: 504 FEEFKNEV-MLTAKLQHVNLIRVLG------FCIDSEERMLIYEYMPNKSL-DCYLFDPI 555
EE K E+ ML H N+ G ++ L+ E+ S+ D L
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNT 121
Query: 556 RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615
+ L + +I I +GL +L ++ +IHRD+K N+LL E + K+ DFG++
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 616 FAKESLEENTEQVVGTIGYIPPE-----YATKGVYSTKSDVFSFGVLLLQIISGK 665
+ NT +GT ++ PE Y KSD++S G+ +++ G
Sbjct: 179 LDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 43/224 (19%)
Query: 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKN-EVMLTAKLQHV 520
++ +G G +G VY+ L GE++A+KK+ + + FKN E+ + KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107
Query: 521 NLIRVLGFCIDSEERM------LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG--- 571
N++R+ F S E+ L+ +Y+P Y ++ + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVY------RVARHYSRAKQTLPVIYV 158
Query: 572 ------ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP-KISDFGMARIFAKESLEEN 624
+ + L Y+ I HRD+K N+LL K+ DFG A+ + E N
Sbjct: 159 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPN 213
Query: 625 TEQVVGTIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGK 665
+ + Y PE AT Y++ DV+S G +L +++ G+
Sbjct: 214 VSYIC-SRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQ 254
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQ 518
E++ K+GEG YG V+K G+++A+KK ++ K E+ + +L+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD--PVIKKIALREIRMLKQLK 60
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H NL+ +L L++EY + ++ L R + K I Q + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKS--ITWQTLQAVNF 117
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
+++ IHRD+K NIL+ + K+ DFG AR+ + ++V T Y PE
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP-SDYYDDEVA-TRWYRSPE 172
Query: 639 Y---ATKGVYSTKSDVFSFGVLLLQIISGK 665
T+ Y DV++ G + +++SG
Sbjct: 173 LLVGDTQ--YGPPVDVWAIGCVFAELLSGV 200
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 57/304 (18%), Positives = 103/304 (33%), Gaps = 77/304 (25%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKK--LSKTSTQGFEEFKNEVMLTAKL-Q 518
T F K+G G +G V+K V G + A+K+ + + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 519 HVNLIRVLGFCIDSEERMLIY-EYMPNKSLDCYLFDPIRKL-ILDWKKRVHIIEGITQGL 576
H +++R + ++ MLI EY SL + + R + + ++ + +GL
Sbjct: 70 HSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKP-------------------KISDFGMARIFA 617
Y+ S ++H D+K SNI + P KI D G
Sbjct: 129 RYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 618 KESLEENTEQVVGTIGYIPPE-YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 676
+ + G ++ E + K+D+F+ + ++ + L
Sbjct: 185 -----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP-------- 231
Query: 677 LSILEHAYELW-KGGKGV----------EFVDSFLDDRNSPCKLMRCLEIALLCVQENPN 725
+ W + +G EF + L + + +P
Sbjct: 232 -----RNGDQWHEIRQGRLPRIPQVLSQEFTE-LLK----------------VMIHPDPE 269
Query: 726 DRPS 729
RPS
Sbjct: 270 RRPS 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 463 TERFSIRNK-LGEGGYGPVYKGV-LPCGEVIAVK--KLSKTSTQGFEEFKNEVMLTAKLQ 518
+ + +K LG G + V + + G+ A K K + E +E+ + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 519 HV-NLIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPIRKLILDW---KKRVHIIEG 571
+I + ++ E +LI EY +F + + + +I+
Sbjct: 87 SCPRVINLHEVYENTSEIILILEY-------AAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQV 628
I +G+ YL + I+H DLK NILL KI DFGM+R ++
Sbjct: 140 ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA---CELREI 193
Query: 629 VGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658
+GT Y+ PE +T +D+++ G++
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
++ F + ++LG G VY+ + A+K L KT + + + E+ + +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCY---LFDPI-RKLILDWKKRVHIIEGITQGLL 577
+I++ E L+ E LFD I K + ++ I + +
Sbjct: 110 IIKLKEIFETPTEISLVLEL-------VTGGELFDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 578 YLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
YL E I+HRDLK N+L KI+DFG+++I + + V GT GY
Sbjct: 163 YLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGY 216
Query: 635 IPPEYATKGVYSTKSDVFSFGVLL 658
PE Y + D++S G++
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIIT 240
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-20
Identities = 50/223 (22%), Positives = 98/223 (43%), Gaps = 42/223 (18%)
Query: 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKN-EVMLTAKLQHVN 521
++ +G G +G V++ L + +A+KK+ + + FKN E+ + ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPN 93
Query: 522 LIRVLGFCIDSEERM------LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG---- 571
++ + F + ++ L+ EY+P Y + + K +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVY------RASRHYAKLKQTMPMLLIK 144
Query: 572 -----ITQGLLYLQEYSRLTIIHRDLKVSNILL-GEAMKPKISDFGMARIFAKESLEENT 625
+ + L Y+ + I HRD+K N+LL + K+ DFG A+I + E N
Sbjct: 145 LYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNV 199
Query: 626 EQVVGTIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGK 665
+ + Y PE AT Y+T D++S G ++ +++ G+
Sbjct: 200 SYIC-SRYYRAPELIFGATN--YTTNIDIWSTGCVMAELMQGQ 239
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 52/227 (22%), Positives = 83/227 (36%), Gaps = 45/227 (19%)
Query: 469 RNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVL 526
+ LGEG + V + L + AVK + K EV + + Q H N++ ++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 527 GFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVH--------IIEGITQGLLY 578
F + + L++E M S+ I K R H +++ + L +
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI----LSHIHK-------RRHFNELEASVVVQDVASALDF 126
Query: 579 LQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQ-----VVG 630
L I HRDLK NIL + KI DF + G
Sbjct: 127 LHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 631 TIGYIPPE-----YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
+ Y+ PE +Y + D++S GV+L I +L G
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-I-------LLSG 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 468 IRNKLGEGGYGPVYKGV---LPCGEVIAVKKLSKTSTQGFEEFK-NEVMLTAKLQHVNLI 523
K+G G YG VYK + A+K++ G E+ L +L+H N+I
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVI 81
Query: 524 RVLGFCIDSEER--MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG--------IT 573
+ + +R L+++Y D + + KK V + G I
Sbjct: 82 SLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP----KISDFGMARIFAK--ESLEENTEQ 627
G+ YL ++HRDLK +NIL+ KI+D G AR+F + L +
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 628 VVGTIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGK 665
VV T Y PE A Y+ D+++ G + ++++ +
Sbjct: 196 VV-TFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSE 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-20
Identities = 55/230 (23%), Positives = 113/230 (49%), Gaps = 34/230 (14%)
Query: 464 ERFSIRNKLGEGGYGPVYKG--VLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTA------ 515
+++ ++GEG YG V+K + G +A+K++ + + + L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 516 -----KLQHVNLIRVL----GFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKR 565
+H N++R+ D E ++ L++E++ ++ L YL D + + + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625
++ + +GL +L + ++HRDLK NIL+ + + K++DFG+ARI++ + T
Sbjct: 123 KDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALT 177
Query: 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
VV T+ Y PE + Y+T D++S G + ++ K L G ++
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--FRGSSD 224
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 30/231 (12%)
Query: 462 ATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTA----- 515
AT R+ ++G G YG VYK G +A+K + + + ++
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG---GGGGGGLPISTVREVA 63
Query: 516 ------KLQHVNLIRVLGFCIDSEER-----MLIYEYMPNKSLDCYLFDPIRKLILDWKK 564
+H N++R++ C S L++E++ ++ L YL D L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAET 121
Query: 565 RVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
++ +GL +L I+HRDLK NIL+ K++DFG+ARI++ +
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--AL 176
Query: 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
T VV T+ Y PE + Y+T D++S G + ++ K L CG +E
Sbjct: 177 TPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL--FCGNSE 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 58/283 (20%), Positives = 105/283 (37%), Gaps = 49/283 (17%)
Query: 469 RNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNLIRVL 526
+ LG G G V + G+ A+K L + + + EV +++ +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88
Query: 527 GFCIDSEERM----LIYEYMPNKSLDCYLFDPIRKLILDW---KKRVHIIEGITQGLLYL 579
+ +I E M L F I++ ++ I+ I + +L
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 580 QEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
I HRD+K N+L + K++DFG A+ + +L+ T Y+
Sbjct: 145 HS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTPYYVA 197
Query: 637 PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI-----NENLSILEHAYELWKGGK 691
PE Y D++S GV++ I +LCG N +I + G+
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMY-I-------LLCGFPPFYSNTGQAISPGMKRRIRLGQ 249
Query: 692 GVEFVDSFLDDRNSPCK-LMRCLEIALLCVQENPNDRPSMLEV 733
F + + + K L+R LL +P +R ++ +
Sbjct: 250 -YGFPNPEWSEVSEDAKQLIRL----LLKT--DPTERLTITQF 285
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 67/292 (22%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN------EVMLTAKL 517
++ + LG GG+G VY G+ + +A+K + K + E N EV+L K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 518 QHV--NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV------HII 569
+IR+L + + +LI E P D LFD I + + +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITE-----RGALQEELARSFF 155
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILL-GEAMKPKISDFGMARIFAKESLEENTEQV 628
+ + + + ++HRD+K NIL+ + K+ DFG + +
Sbjct: 156 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----F 208
Query: 629 VGTIGYIPPEYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCGIN---ENLSILEHAY 684
GT Y PPE+ Y + V+S G+LL M+CG + I+
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILL--------YDMVCGDIPFEHDEEIIRGQV 260
Query: 685 ELWKGGKGVEFVDSFLDDRNSP-CK--LMRCLEIALLCVQENPNDRPSMLEV 733
+ S C+ + CL + P+DRP+ E+
Sbjct: 261 F----------FRQRV----SSECQHLIRWCLAL-------RPSDRPTFEEI 291
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 70/293 (23%), Positives = 114/293 (38%), Gaps = 67/293 (22%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN------EV----ML 513
+ + LG+GG+G V+ G L +A+K + + G+ + EV +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 514 TAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV------H 567
A H +IR+L + E ML+ E P + D LFD I + K +
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITE-----KGPLGEGPSRC 143
Query: 568 IIEGITQGLLYLQEYSRLTIIHRDLKVSNILL-GEAMKPKISDFGMARIFAKESLEENTE 626
+ + + ++HRD+K NIL+ K+ DFG + E +
Sbjct: 144 FFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD--- 197
Query: 627 QVVGTIGYIPPEYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCGIN---ENLSILEH 682
GT Y PPE+ ++ Y + V+S G+LL M+CG + ILE
Sbjct: 198 -FDGTRVYSPPEWISRHQYHALPATVWSLGILL--------YDMVCGDIPFERDQEILEA 248
Query: 683 AYELWKGGKGVEFVDSFLDDRNSP--CKLMRCLEIALLCVQENPNDRPSMLEV 733
+ + SP C L+R C+ P+ RPS+ E+
Sbjct: 249 ELH----------FPAHV----SPDCCALIRR------CLAPKPSSRPSLEEI 281
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 40/215 (18%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGF 528
LGEG + K V + AVK +SK + E+ + H N++++
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 529 CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVH--------IIEGITQGLLYLQ 580
D L+ E + L F+ I KK+ H I+ + + ++
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERI-------KKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 581 EYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
+ + ++HRDLK N+L + ++ KI DFG AR+ ++ T T+ Y P
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
E + Y D++S GV+L ML G
Sbjct: 179 ELLNQNGYDESCDLWSLGVILY-T-------MLSG 205
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 49/230 (21%), Positives = 94/230 (40%), Gaps = 49/230 (21%)
Query: 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEE--FKN----EVMLTA 515
+RF + G+G +G V G G +A+KK+ ++ F+N + A
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRNRELQIMQDLA 74
Query: 516 KLQHVNLIRVLGFCIDSEER-------MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHI 568
L H N++++ + ER ++ EY+P + + ++ +R
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLH------RCCRNYYRRQVA 125
Query: 569 IEG---------ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFGMARIFAK 618
+ + + L S + + HRD+K N+L+ EA K+ DFG A+ +
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 619 ESLEENTEQVVGTIGYIPPEY---ATKGVYSTKSDVFSFGVLLLQIISGK 665
E N + + Y PE Y+T D++S G + +++ G+
Sbjct: 185 S--EPNVAYIC-SRYYRAPELIFGNQH--YTTAVDIWSVGCIFAEMMLGE 229
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
R++ + +GEG YG V +A+KK+S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 513 LTAKLQHVNLIRVLG-FCIDSEERM----LIYEYMPNKSLDCYLFDPIRKLILDWKKRVH 567
+ + +H N+I + + E+M ++ + M + L+ ++ L +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICY 132
Query: 568 IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--T 625
+ I +GL Y+ + ++HRDLK SN+LL KI DFG+AR+ + T
Sbjct: 133 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 626 EQVVGTIGYIPPEYA-TKGVYSTKSDVFSFGVLLLQIISGKRL 667
E V T Y PE Y+ D++S G +L +++S + +
Sbjct: 190 EYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 71/337 (21%), Positives = 129/337 (38%), Gaps = 59/337 (17%)
Query: 455 SLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEV 511
S AD + + + +G+G + V + G +A+K + KT + ++ EV
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREV 65
Query: 512 MLTAKLQHVNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIE 570
+ L H N+++ L I++E+ + LI EY + FD + R+ E
Sbjct: 66 RIMKILNHPNIVK-LFEVIETEKTLYLIMEYASGGEV----FDYLVA-----HGRMKEKE 115
Query: 571 G------ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
I + Y + I+HRDLK N+LL M KI+DFG + F +
Sbjct: 116 ARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172
Query: 625 TEQVVGTIGYIPPEYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCGI----NENLSI 679
G Y PE Y + DV+S GV+L +++ G +NL
Sbjct: 173 F---CGAPPYAAPELFQGKKYDGPEVDVWSLGVIL--------YTLVSGSLPFDGQNLKE 221
Query: 680 LEHAYELWKGGKGVEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEVSS-- 735
L + +G + ++ ++ C+ L R L + NP R ++ ++
Sbjct: 222 LRE-----RVLRGKYRIPFYM---STDCENLLKRFLVL-------NPIKRGTLEQIMKDR 266
Query: 736 -MLKNETTNINTPKKPAFSKQVDEIGIELLSTTNLEK 771
+ + P D+ I+++ +
Sbjct: 267 WINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQ 303
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEF----KNEVMLTAKLQHVNLIRVL 526
LGEG YG V + + AVK L K + K E+ L +L+H N+I+ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ-L 71
Query: 527 GFCIDSEERMLIY---EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG------ITQGLL 577
+ +EE+ +Y EY + + D + + KR + + + GL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE------KRFPVCQAHGYFCQLIDGLE 123
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
YL I+H+D+K N+LL KIS G+A + ++ G+ + PP
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 638 E-YATKGVYS-TKSDVFSFGVLLLQIISGK 665
E +S K D++S GV L I +G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 30/224 (13%)
Query: 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEE--FKN---------EV 511
++++ + G YG V GV G +A+K++ T + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 512 MLTAKLQHVNLIRVLG-FCIDSEERM----LIYEYMPNKSLDCYLFDPIR--KLILDWKK 564
L H N++ + F E M L+ E M L I ++++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQH 135
Query: 565 RVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
+ + I GL L E ++HRDL NILL + I DF +AR +
Sbjct: 136 IQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANK 190
Query: 625 TEQVVGTIGYIPPEY-ATKGVYSTKSDVFSFGVLLLQIISGKRL 667
T V Y PE ++ D++S G ++ ++ + K L
Sbjct: 191 THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 52/233 (22%), Positives = 99/233 (42%), Gaps = 46/233 (19%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
R+ LG GG G V+ V C + +A+KK+ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 513 LTAKLQHVNLIRVL----------GFCIDSEERM----LIYEYMPNKSLDCYLFDPIRKL 558
+ +L H N+++V + S + ++ EYM + L + + +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQG 115
Query: 559 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL-GEAMKPKISDFGMARIFA 617
L + + + +GL Y+ + ++HRDLK +N+ + E + KI DFG+ARI
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 618 KESLEEN--TEQVVGTIGYIPPE-YATKGVYSTKSDVFSFGVLLLQIISGKRL 667
+ +E +V T Y P + Y+ D+++ G + ++++GK L
Sbjct: 173 PHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 35/221 (15%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
+R+ +G G G V +A+KKLS+ F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 513 LTAKLQHVNLIRVL------GFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
L + H N+I +L + ++ L+ E M D L I+ + +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMS- 167
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
+++ + G+ +L IIHRDLK SNI++ KI DFG+AR T
Sbjct: 168 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTP 222
Query: 627 QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
VV T Y PE Y D++S G ++ +++ K L
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 262
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
+R+ +G G G V +A+KKLS+ F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 513 LTAKLQHVNLIRVLGFCI--DSEERM----LIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
L + H N+I +L S E ++ E M D L I+ + +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMS- 130
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
+++ + G+ +L IIHRDLK SNI++ KI DFG+AR T
Sbjct: 131 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTP 185
Query: 627 QVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
VV T Y PE Y D++S G ++ ++I G L
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL 225
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 59/216 (27%), Positives = 86/216 (39%), Gaps = 41/216 (18%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFC 529
LGEG YG V V E +AVK + E K E+ + L H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 530 IDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVH----------IIEGITQGLLY 578
L EY L FD I + ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEP-----DIGMPEPDAQRFFHQLMAGV------ 118
Query: 579 LQEYS-RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
Y + I HRD+K N+LL E KISDFG+A +F + E ++ GT+ Y+ P
Sbjct: 119 --VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 638 EYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCG 672
E + + DV+S G++L +ML G
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL--------TAMLAG 204
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 20/211 (9%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--------STQGFEEFKNEVMLTA 515
++S + LG G +G V+ V + + VK + K + E+ + +
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 516 KLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQ 574
+++H N+I+VL +++ M LF I R LD +I +
Sbjct: 85 RVEHANIIKVLDI-FENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
+ YL+ IIHRD+K NI++ E K+ DFG A + L GTI Y
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTIEY 195
Query: 635 IPPEYATKGVYS-TKSDVFSFGVLLLQIISG 664
PE Y + +++S GV L ++
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 35/214 (16%)
Query: 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGF 528
LG G G V + E A+K L + + EV L + +++R++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 529 CIDSEERM----LIYEYMPNKSLDCYLFDPIRKLILDW---KKRVHIIEGITQGLLYLQE 581
+ ++ E + L F I+ ++ I++ I + + YL
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 582 YSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
+ I HRD+K N+L K++DFG A+ + T Y+ PE
Sbjct: 180 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPE 233
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
Y D++S GV++ I +LCG
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMY-I-------LLCG 259
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
+ + +G G YG V + GE +A+KKLS+ F++ E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75
Query: 513 LTAKLQHVNLIRVLGFCIDSEERM------LIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
L +QH N+I +L + L+ +M L + + K +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQ- 129
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
+++ + +GL Y+ ++HRDLK N+ + E + KI DFG+AR E T
Sbjct: 130 YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTG 182
Query: 627 QVVGTIGYIPPEYA-TKGVYSTKSDVFSFGVLLLQIISGKRL 667
VV T Y PE + Y+ D++S G ++ ++++GK L
Sbjct: 183 YVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 63/253 (24%), Positives = 94/253 (37%), Gaps = 37/253 (14%)
Query: 430 ASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVY----KGVL 485
+ + + P R D F LGEG + V
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELAT- 54
Query: 486 PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LIYEY 541
A+K L K E + ++L H ++ L F +E++ Y
Sbjct: 55 --SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK-LYFTFQDDEKLYFGLSY 111
Query: 542 MPNKSLDCYLFDPIRKL--ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599
N L IRK+ + R + E I L YL IIHRDLK NILL
Sbjct: 112 AKNGEL----LKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILL 163
Query: 600 GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLL 659
E M +I+DFG A++ + ES + VGT Y+ PE T+ SD+++ G ++
Sbjct: 164 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 223
Query: 660 QIISGKRLSMLCG 672
Q ++ G
Sbjct: 224 Q--------LVAG 228
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 7e-17
Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 33/180 (18%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
+ +G+ +L + IHRDL NILL E KI DFG+AR + ++ + V
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253
Query: 632 IGYIP-----PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSML--CGINENLSILEHAY 684
+P PE VY+ +SDV+SFGVLL +I S L G+ +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---LGASPYPGVKIDEEFCRR-- 308
Query: 685 ELWKGGKGVEFVDSFLDD-RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743
L +G + + + ++ + L C P+ RP+ E+ L N
Sbjct: 309 -LKEGTR--------MRAPDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 35/160 (21%), Positives = 59/160 (36%), Gaps = 19/160 (11%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTSTQG-FEEFKNEV-MLTA 515
+R + LG G +G V + +AVK L + +T +E+ +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 516 KLQHVNLIRVLGFCID-SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
H+N++ +LG C M+I E+ +L YL KR + T+
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614
G + Q + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 37/222 (16%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
+ +G G YG V V G +A+KKL + F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76
Query: 513 LTAKLQHVNLIRVLGFCIDSEERM------LIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
L ++H N+I +L E L+ +M L ++ L +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQ 131
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
++ + +GL Y+ IIHRDLK N+ + E + KI DFG+AR E T
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTG 184
Query: 627 QVVGTIGYIPPEYA-TKGVYSTKSDVFSFGVLLLQIISGKRL 667
VV T Y PE Y+ D++S G ++ ++I+GK L
Sbjct: 185 YVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 59/216 (27%), Positives = 86/216 (39%), Gaps = 41/216 (18%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFC 529
LGEG YG V V E +AVK + E K E+ + L H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 530 IDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVH----------IIEGITQGLLY 578
L EY L FD I + ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEP-----DIGMPEPDAQRFFHQLMAGV------ 118
Query: 579 LQEYS-RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
Y + I HRD+K N+LL E KISDFG+A +F + E ++ GT+ Y+ P
Sbjct: 119 --VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 638 EYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCG 672
E + + DV+S G++L +ML G
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL--------TAMLAG 204
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 42/230 (18%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
+ F +++ LGEG YG V P GE++A+KK+ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 513 LTAKLQHVNLIRVLG-FCIDSEERM----LIYEYMPNKSLDCYLFDPIRKLILDWKKRVH 567
+ +H N+I + DS E +I E M L I +L +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQY 116
Query: 568 IIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--- 624
I + + L + +IHRDLK SN+L+ K+ DFG+ARI + + + +
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 625 ------TEQVVGTIGYIPPEY-ATKGVYSTKSDVFSFGVLLLQIISGKRL 667
E V T Y PE T YS DV+S G +L ++ + +
Sbjct: 174 GQQSGMVEFVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 466 FSIRNKLGEGGYGPVYKG-VLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAK----LQHV 520
FS+ +G GG+G VY G++ A+K L K + K L L V
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM----KQGETLALNERIMLSLV 246
Query: 521 NLIRV-----LGFCIDSEERM-LIYEYMPNKSLDCYL-----FDPIRKLILDWKKRVHII 569
+ + + + +++ I + M L +L F R +
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAA 299
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
E I GL ++ +++RDLK +NILL E +ISD G+A + ++ V
Sbjct: 300 E-IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASV 351
Query: 630 GTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGK 665
GT GY+ PE KGV Y + +D FS G +L +++ G
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-16
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 472 LGEGGYGPVY----KGVLPCGEVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIR 524
LG+GG+G V + G++ A KKL K +G NE + K+ ++
Sbjct: 192 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 525 VLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
L + ++++ + L+ M L +++ + + + + E I GL L
Sbjct: 249 -LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR-- 304
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE-ENTEQVVGTIGYIPPEYATK 642
I++RDLK NILL + +ISD G+A E + + VGT+GY+ PE
Sbjct: 305 -ERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 643 GVYSTKSDVFSFGVLLLQIISGK 665
Y+ D ++ G LL ++I+G+
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HV 520
+ + + KLG G Y V++ + + E + VK L + + K E+ + L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 521 NLIRVLGFCIDSEERM--LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHI---IEGITQG 575
N+I + D R L++E++ N + L I + I +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQL----YQTLTDY-----DIRFYMYEILKA 142
Query: 576 LLYLQEYSRLTIIHRDLKVSNILL-GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
L Y +S I+HRD+K N+++ E K ++ D+G+A + +E +V + +
Sbjct: 143 LDYC--HSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVA-SRYF 196
Query: 635 IPPE----YATKGVYSTKSDVFSFGVLLLQIISGKR 666
PE Y Y D++S G +L +I K
Sbjct: 197 KGPELLVDYQM---YDYSLDMWSLGCMLASMIFRKE 229
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 51/223 (22%), Positives = 83/223 (37%), Gaps = 49/223 (21%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKT-----------------STQGFEEFKNEVML 513
+G+G YG V A+K LSK + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 514 TA---------KLQHVNLIR---VLGFCIDSEERMLIY---EYMPNKSLDCYLFDPIRKL 558
KL H N+++ V +D +Y E + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV----LDDPNEDHLYMVFELVNQGPV----MEVPTLK 132
Query: 559 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618
L + + + +G+ YL IIHRD+K SN+L+GE KI+DFG++ F
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 619 ESLEENTEQVVGTIGYIPPE--YATKGVYS-TKSDVFSFGVLL 658
+ VGT ++ PE T+ ++S DV++ GV L
Sbjct: 190 S--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
ER+ + +G G YG V G +AVKKLS+ F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 513 LTAKLQHVNLIRVLGFCIDSEERM------LIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
L ++H N+I +L + L+ M L + ++ L
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQ 135
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
+I I +GL Y+ IIHRDLK SN+ + E + KI DFG+AR A +E T
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTG 188
Query: 627 QVVGTIGYIPPEYA-TKGVYSTKSDVFSFGVLLLQIISGKRL 667
V T Y PE Y+ D++S G ++ ++++G+ L
Sbjct: 189 YVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 38/213 (17%)
Query: 472 LGEGGYGPVY----KGVLPCGEVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIR 524
LG GG+G V+ K G++ A KKL+K +G++ E + AK+ ++
Sbjct: 193 LGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 525 VLGFCIDSEERM-LIYEYMP---------NKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
L + +++ + L+ M N D F R + + I
Sbjct: 250 -LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTAQ-IVS 300
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTI 632
GL +L + II+RDLK N+LL + +ISD G+A E T+ GT
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA----VELKAGQTKTKGYAGTP 353
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK 665
G++ PE Y D F+ GV L ++I+ +
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 52/261 (19%), Positives = 103/261 (39%), Gaps = 75/261 (28%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN-EVMLTAKL 517
E +++++S+ LG G +G V + + G+ A+KK+ + +KN E+ + L
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVL 57
Query: 518 QHVNLIRVLGFCIDSEERM--------------------------------------LIY 539
HVN+I+++ + + + +I
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG---------ITQGLLYLQEYSRLTIIHR 590
EY+P + K++ + + I + + + ++ L I HR
Sbjct: 118 EYVP---DTLH------KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHR 165
Query: 591 DLKVSNILL-GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY---ATKGVYS 646
D+K N+L+ + K+ DFG A+ E + + + Y PE AT+ Y+
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYIC-SRFYRAPELMLGATE--YT 220
Query: 647 TKSDVFSFGVLLLQIISGKRL 667
D++S G + ++I GK L
Sbjct: 221 PSIDLWSIGCVFGELILGKPL 241
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 40/204 (19%), Positives = 75/204 (36%), Gaps = 35/204 (17%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
+R+ IR+ +G G YG V + V+A+KK+ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIA 104
Query: 513 LTAKLQHVNLIRVLG-FCIDSEERM----LIYEYMPNKSLDCYLFDPIRK---LILDWKK 564
+ +L H ++++VL E+ ++ E D R L K
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIK 159
Query: 565 RVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624
++ + G+ Y+ I+HRDLK +N L+ + K+ DFG+AR +
Sbjct: 160 --TLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 625 TEQVVGTIGYIPPEYATKGVYSTK 648
+ + +
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKR 238
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLG 527
LG G +G V G G +AVK L++ S + K E+ +H ++I+ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK-LY 77
Query: 528 FCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG------ITQGLLYLQ 580
I + ++ EY+ L FD I K RV +E I + Y
Sbjct: 78 QVISTPTDFFMVMEYVSGGEL----FDYICK-----HGRVEEMEARRLFQQILSAVDYCH 128
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
R ++HRDLK N+LL M KI+DFG++ + + + G+ Y PE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVI 182
Query: 641 TKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCG 672
+ +Y+ + D++S GV+L ++LCG
Sbjct: 183 SGRLYAGPEVDIWSCGVIL--------YALLCG 207
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 43/197 (21%), Positives = 76/197 (38%), Gaps = 31/197 (15%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
+ + I++ +G G YG VY + +A+KK+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREIT 77
Query: 513 LTAKLQHVNLIRVLG-FCIDSEERM----LIYEYMPNKSLDCYLFDPIRKLI-LDWKKRV 566
+ +L+ +IR+ D + ++ E D L + I L +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIK 132
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
I+ + G ++ E IIHRDLK +N LL + K+ DFG+AR E
Sbjct: 133 TILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 627 QVVGTIGYIPPEYATKG 643
+ P K
Sbjct: 190 DLEENEEPGPHNKNLKK 206
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 7e-14
Identities = 67/326 (20%), Positives = 127/326 (38%), Gaps = 78/326 (23%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLG 527
LG G +G V G G +AVK L++ S + + E+ +H ++I+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK--- 80
Query: 528 FCIDSEERMLIYEYMPNKSLDCY----------LFDPIRKLILDWKKRVHIIEG------ 571
+Y+ + S D + LFD I K R+ E
Sbjct: 81 ----------LYQVISTPS-DIFMVMEYVSGGELFDYICK-----NGRLDEKESRRLFQQ 124
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
I G+ Y R ++HRDLK N+LL M KI+DFG++ + + + G+
Sbjct: 125 ILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGS 178
Query: 632 IGYIPPEYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCGI----NENLSILEHAYEL 686
Y PE + +Y+ + D++S GV+L ++LCG ++++ L ++
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVIL--------YALLCGTLPFDDDHVPTL---FK- 226
Query: 687 WKGGKGVEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEVSS---MLKNET 741
K G+ + +L N L L++ +P R ++ ++ ++
Sbjct: 227 -KICDGIFYTPQYL---NPSVISLLKHMLQV-------DPMKRATIKDIREHEWFKQDLP 275
Query: 742 TNINTPKKPAFSKQVDEIGIELLSTT 767
+ S +D+ ++ +
Sbjct: 276 KYLFPEDPSYSSTMIDDEALKEVCEK 301
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 53/221 (23%)
Query: 472 LGEGGYGPVYKGV-LPCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLG 527
LGEG +G V + +A+K +S+ + + E+ L+H ++I+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK--- 73
Query: 528 FCIDSEERMLIYEYMPNKSLDCY---------LFDPIRKLILDWKKRVHIIEG------I 572
+Y+ + + D LFD I + KKR+ EG I
Sbjct: 74 ----------LYDVITTPT-DIVMVIEYAGGELFDYIVE-----KKRMTEDEGRRFFQQI 117
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
+ Y R I+HRDLK N+LL + + KI+DFG++ I + + + G+
Sbjct: 118 ICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSP 171
Query: 633 GYIPPEYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCG 672
Y PE +Y+ + DV+S G++L ML G
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVL--------YVMLVG 204
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 48/238 (20%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKN---------EVM 512
++ + KLG+G YG V+K + GEV+AVKK+ F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 513 LTAKLQ-HVNLIRVLGFCI--DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHII 569
+ +L H N++ +L + + L+++YM + L IR IL+ + +++
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVV 115
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
+ + + YL ++HRD+K SNILL K++DFG++R F N +
Sbjct: 116 YQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 630 GTIGYIPP--------EY-ATK-----------GVYSTKSDVFSFGVLLLQIISGKRL 667
+Y AT+ Y+ D++S G +L +I+ GK +
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 20/209 (9%), Positives = 56/209 (26%), Gaps = 47/209 (22%)
Query: 465 RFSIRNKLGEGGYGPVYKG---VLPCGEVIAVKKL--SKTSTQGF-EEFKNEVMLTAKLQ 518
R+ + G ++ L +A+ + +E + + +++
Sbjct: 32 RYRLLIFHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
+ RVL +++ E++ SL + ++ +
Sbjct: 90 KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAA-- 142
Query: 579 LQEYS-RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
+ + R + S + +S G V+ +P
Sbjct: 143 --DAAHRAGVALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPD 178
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGKR 666
+ + D+ G L ++ +
Sbjct: 179 A-------NPQDDIRGIGASLYALLVNRW 200
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 47/224 (20%), Positives = 79/224 (35%), Gaps = 62/224 (27%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVN 521
+ LG G G V + E A+K L + + EV L + Q +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 72
Query: 522 LIRVLGFCIDSEERM----LIYEYMPNKSLDCY---LFDPIRKLILDW---KKRVHIIEG 571
++R++ + ++ E LF I+ ++ I++
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMEC-------LDGGELFSRIQDRGDQAFTEREASEIMKS 125
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAKESLEENTEQV 628
I + + YL + I HRD+K N+L K++DFG FAKE+ E
Sbjct: 126 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG----FAKETTGEK---- 174
Query: 629 VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
Y D++S GV++ I +LCG
Sbjct: 175 ----------------YDKSCDMWSLGVIMY-I-------LLCG 194
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
+R+ +G G +G E++AVK + + + E + E++ L+H N+
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNI 78
Query: 523 IRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVH----------IIEG 571
+R I + + +I EY L ++ I R ++ G
Sbjct: 79 VR-FKEVILTPTHLAIIMEYASGGEL----YERICN-----AGRFSEDEARFFFQQLLSG 128
Query: 572 ITQGLLYLQEYS-RLTIIHRDLKVSNILLGEAMKP--KISDFGMARIFAKESLEENTEQV 628
+ Y + I HRDLK+ N LL + P KI DFG ++ S ++T
Sbjct: 129 V--------SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 177
Query: 629 VGTIGYIPPEYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCG 672
VGT YI PE + Y +DV+S GV L ML G
Sbjct: 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTL--------YVMLVG 214
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 466 FSIRNKLGEGGYGPVY----KGVLPCGEVIAVKKLSKTSTQGFEEFKN---EVMLTAKLQ 518
F I +G+G +G V ++ A+K ++K E +N E+ + L+
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 519 HVNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEG------ 571
H L+ L + EE M ++ + + L +L ++ VH E
Sbjct: 74 HPFLVN-LWYSFQDEEDMFMVVDLLLGGDLRYHL-----------QQNVHFKEETVKLFI 121
Query: 572 --ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
+ L YLQ IIHRD+K NILL E I+DF +A + +E+ +
Sbjct: 122 CELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMA 175
Query: 630 GTIGYIPPE-YATKGV--YSTKSDVFSFGVLLLQIISGKR 666
GT Y+ PE ++++ YS D +S GV +++ G+R
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 5e-12
Identities = 29/198 (14%), Positives = 61/198 (30%), Gaps = 46/198 (23%)
Query: 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST--------QGFEEFKNEVML 513
TE+ K+GEG +G V++ + +A+K ++ + FEE E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 514 TAKLQ---------HVNLIRVLGFCI----DSEERMLIYEYMPNKSLDCY---------- 550
+ +L I + + +++ +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 551 ------------LFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598
+ +R + I+ +T L + L HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 599 LGEAMKPKISDFGMARIF 616
L + K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSS 212
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 63/273 (23%), Positives = 103/273 (37%), Gaps = 49/273 (17%)
Query: 420 LNLIEEDSAKASNTRANNETE----AGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEG 475
L + ++ + R N E A F V +R+ D F I +G G
Sbjct: 34 LICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRL-HRED-------FEILKVIGRG 85
Query: 476 GYGPVY----KGVLPCGEVIAVKKLSKTSTQGFEE---FKNEVMLTAKLQHVNLIRVLGF 528
+G V K +V A+K L+K E F+ E + + L +
Sbjct: 86 AFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT-LHY 141
Query: 529 CIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587
+ + L+ +Y L L +L + R ++ E + + + + L
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAE-MVIAIDSVHQ---LHY 196
Query: 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ---VVGTIGYIPPE-----Y 639
+HRD+K NIL+ +++DFG + +E+ T Q VGT YI PE
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGS----CLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
KG Y + D +S GV + + ML G
Sbjct: 253 GGKGRYGPECDWWSLGVCMYE--------MLYG 277
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 47/219 (21%)
Query: 472 LGEGGYGPVY----KGVLPCGEVIAVKKLSKTSTQGFEEFKNEV--MLTAK--LQHVN-- 521
LG+G +G V K G A+K L K K+EV LT LQ+
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVA----KDEVAHTLTENRVLQNSRHP 208
Query: 522 LIRVLGFCIDSEERM-LIYEYMPNKSL-----DCYLFDPIRKLILDWKKRVHIIEGITQG 575
+ L + + +R+ + EY L +F R R + E I
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAE-IVSA 260
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTIG 633
L YL +S +++RDLK+ N++L + KI+DFG+ KE +++ + GT
Sbjct: 261 LDYL--HSEKNVVYRDLKLENLMLDKDGHIKITDFGL----CKEGIKDGATMKTFCGTPE 314
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
Y+ PE Y D + GV++ + M+CG
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYE--------MMCG 345
|
| >1edt_A Endo-beta-N-acetylglucosaminidase H, endo H; hydrolase (glucosidase); 1.90A {Streptomyces plicatus} SCOP: c.1.8.5 PDB: 1c90_A 1c8x_A 1c91_A 1c3f_A 1c92_A 1c8y_A 1c93_A Length = 271 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 38/291 (13%), Positives = 80/291 (27%), Gaps = 43/291 (14%)
Query: 20 PAKAKPWIRVGYLNLSEVS-------TISGINYDLFTHLICSSADIN--STTYQLSLSLP 70
+ V Y+ ++ S T++ + F + +A+IN + T L
Sbjct: 3 APVKQGPTSVAYVEVNNNSMLNVGKYTLADGGGNAFDVAVIFAANINYDTGTKTAYLHFN 62
Query: 71 SDENQIAKFADT--VKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIA 128
+ ++ A T + I +LS+ + + + +F
Sbjct: 63 ENVQRVLDNAVTQIRPLQQQGIKVLLSVLGN---HQGAGFANFPSQQAASAFAKQLSDAV 119
Query: 129 RLYGFRGLDFAWTAPN------TSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTA 182
YG G+DF + + L R + K +I
Sbjct: 120 AKYGLDGVDFDDEYAEYGNNGTAQPNDSSFVHLVTALR---ANMPDK--------IISLY 168
Query: 183 RFRYSPPANSYLLNSIQRNLNWI-HAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQ 241
+ SY + ++ + ++ P A + I +
Sbjct: 169 NIGPAASRLSYGGVDVSDKFDYAWNPYYGTWQVPGIALPKAQLSPAAVEIGRTSRSTVAD 228
Query: 242 VLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLV 292
+ + ++ G + Y + D +A LY S V
Sbjct: 229 LARRTVDEG-----------YGVYLTYNLDGGDRTADVSAFTRELYGSEAV 268
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 49/225 (21%), Positives = 78/225 (34%), Gaps = 39/225 (17%)
Query: 466 FSIRNKLGEGGYGPVY----KGVLPCGEVIAVKKLSKTSTQGFEE---FKNEVMLTAKLQ 518
F I +G G + V K G+V A+K ++K E F+ E +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 519 H---VNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
L F E + L+ EY L L ++ + R ++ E I
Sbjct: 120 RRWITQLH----FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAE-IVM 173
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
+ + +HRD+K NILL +++DFG + + VGT Y
Sbjct: 174 AIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDY 229
Query: 635 IPPE-------YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
+ PE G Y + D ++ GV + M G
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYE--------MFYG 266
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 69/279 (24%), Positives = 100/279 (35%), Gaps = 58/279 (20%)
Query: 414 YNQMKRLNLIEEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLG 473
N+ R + + N N L D F+ LG
Sbjct: 298 GNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-------FNFLMVLG 350
Query: 474 EGGYGPV----YKGVLPCGEVIAVKKLSKTSTQGFEEFKNEV--------MLTAKLQHVN 521
+G +G V KG E+ AVK L K ++V +L +
Sbjct: 351 KGSFGKVMLSERKGT---DELYAVKILKKDVVIQ----DDDVECTMVEKRVLALPGKPPF 403
Query: 522 LIRVLGFCIDSEERM-LIYEYMPNKSL-----DCYLFDPIRKLILDWKKRVHIIEGITQG 575
L + L C + +R+ + EY+ L F + E I G
Sbjct: 404 LTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-IAIG 454
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTIG 633
L +LQ II+RDLK+ N++L KI+DFGM KE++ + T+ GT
Sbjct: 455 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM----CKENIWDGVTTKTFCGTPD 507
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
YI PE Y D ++FGVLL + ML G
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYE--------MLAG 538
|
| >3n12_A Chitinase A, chinctu2; zinc atoms, complex, hydrolase; 1.20A {Bacillus cereus} PDB: 3n11_A 3n15_A* 3n13_A* 3n17_A* 3n18_A* 3n1a_A* Length = 333 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 46/295 (15%), Positives = 91/295 (30%), Gaps = 30/295 (10%)
Query: 30 GYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPS 89
G + L +VS +D ++ + +T + S +D + + + +K K
Sbjct: 21 GIIKLKDVSP----KWD-VINVSFGETGGDRSTVEFSPVYGTDADFKSDIS-YLKSKG-- 72
Query: 90 ITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDM 149
+LSIG ++ +++ + FI+S + YGF G+D +
Sbjct: 73 KKVVLSIGGQNG------VVLLPDNAAKDRFINSIQSLIDKYGFDGIDIDLESGIYLNGN 126
Query: 150 FNIGLLFDEWRIA--ATKLDAKNSTRQQSLLILTA--RFRYSPPANSYLLNSIQRNLNWI 205
+I + + + +L+ Y S + L I
Sbjct: 127 DTNFKNPTTPQIVNLISAIRTISD-HYGPDFLLSMAPETAYVQGGYSAYGSIWGAYLPII 185
Query: 206 HAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYG- 264
+ V + GS G + +Q AD L+ P G
Sbjct: 186 YGVKDKL------TYIHVQHYNAGSGIGMDGNNYNQ--GTADYEVAMADMLLHGFPVGGN 237
Query: 265 --YAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYE 317
+ ++ + IG AA A G ++ ++K + V
Sbjct: 238 ANNIFPALRSDQVMIGLPAAPAAAPSGGYISPTEMKKALNYIIKGVPFGGKYKLS 292
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 46/219 (21%)
Query: 472 LGEGGYGPVY----KGVLPCGEVIAVKKLSKTSTQGFEEFKNEV-MLTAK--LQHVN--- 521
LG+G +G V+ ++ A+K L K + + ++ V + L VN
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV----RDRVRTKMERDILVEVNHPF 87
Query: 522 LIRVLGFCIDSEERM-LIYEYMPNKSL-----DCYLFDPIRKLILDWKKRVHIIEGITQG 575
+++ L + +E ++ LI +++ L +F + ++ E +
Sbjct: 88 IVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-------KFYLAE-LALA 138
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTIG 633
L +L L II+RDLK NILL E K++DFG+ +KES++ GT+
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSFCGTVE 191
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
Y+ PE + ++ +D +SFGVL+ + ML G
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFE--------MLTG 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 54/261 (20%), Positives = 91/261 (34%), Gaps = 46/261 (17%)
Query: 424 EEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVY-- 481
+ ++ E P+ L F LG G +G V
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGRVMLV 60
Query: 482 --KGVLPCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536
K G A+K L K + E NE + + L+++ D+
Sbjct: 61 KHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 537 LIYEYMPNKSLDCYL-----FDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 591
++ EY+ + +L F R + + I YL L +I+RD
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHA-------RFYAAQ-IVLTFEYLHS---LDLIYRD 166
Query: 592 LKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDV 651
LK N+L+ + +++DFG FAK ++ T + GT + PE Y+ D
Sbjct: 167 LKPENLLIDQQGYIQVTDFG----FAKR-VKGRTWTLCGTPEALAPEIILSKGYNKAVDW 221
Query: 652 FSFGVLLLQIISGKRLSMLCG 672
++ GVL+ + M G
Sbjct: 222 WALGVLIYE--------MAAG 234
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 64/258 (24%), Positives = 97/258 (37%), Gaps = 64/258 (24%)
Query: 438 ETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVY----KGVLPCGEVIAV 493
E+ V + + + F LG+G +G V K G++ AV
Sbjct: 4 ESSKEGNGIGVNSSNRLGIDN-------FEFIRVLGKGSFGKVMLARVKET---GDLYAV 53
Query: 494 KKLSKTSTQGFEEFKNEV--------MLTAKLQH---VNLIRVLGFCIDSEERM-LIYEY 541
K L K ++V +L+ H L C + +R+ + E+
Sbjct: 54 KVLKKDVILQ----DDDVECTMTEKRILSLARNHPFLTQLF----CCFQTPDRLFFVMEF 105
Query: 542 MPNKSL-----DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSN 596
+ L FD R R + E I L++L + II+RDLK+ N
Sbjct: 106 VNGGDLMFHIQKSRRFDEARA-------RFYAAE-IISALMFLHD---KGIIYRDLKLDN 154
Query: 597 ILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTIGYIPPEYATKGVYSTKSDVFSF 654
+LL K++DFGM KE + T GT YI PE + +Y D ++
Sbjct: 155 VLLDHEGHCKLADFGM----CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAM 210
Query: 655 GVLLLQIISGKRLSMLCG 672
GVLL + MLCG
Sbjct: 211 GVLLYE--------MLCG 220
|
| >2y8v_A CHIC, class III chitinase, putative; afchic, hydrolase; 1.99A {Aspergillus fumigatus} Length = 290 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 31/221 (14%), Positives = 64/221 (28%), Gaps = 31/221 (14%)
Query: 43 INYDLFTHLICSSADINSTTYQLSLSL--PSDENQIAKFADTVKKKNPSITTILSIGQGK 100
N TH+I ++ +N ++L+ P E +A+ K + + +G
Sbjct: 37 KNNTGVTHIIIAAFHLNEDPGHITLNDDPPDHEMYNPLWAEVPVLKRSGVKVMGMLGGA- 95
Query: 101 DTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWR 160
Y + + + + + + R + GLD + + L D +
Sbjct: 96 --AQGSYRCLDGDQEKFERYYQPLLAMVRRHQLDGLDLDVEEEMSLPGIIR---LIDRLK 150
Query: 161 IAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNF 220
I+T P + LL N + +
Sbjct: 151 -----------LDLGDDFIITLA-----PVAAALLG----IGNLSGFDYRQLEQQRGSKI 190
Query: 221 TAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLP 261
+ A Y ++ A + +G S ++V L
Sbjct: 191 SWYNAQFYNGWG---LAEDPRMYAAIVAQGWSPQRVVYGLL 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 3e-10
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 17/103 (16%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVV 629
I+ L +L + II+RDLK NI+L K++DFG+ KES+ + T
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL----CKESIHDGTVTHTFC 182
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
GTI Y+ PE + ++ D +S G L+ ML G
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYD--------MLTG 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 35/103 (33%), Positives = 46/103 (44%), Gaps = 17/103 (16%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVV 629
I L YL L I++RDLK NILL ++DFG+ KE++E N T
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL----CKENIEHNSTTSTFC 200
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
GT Y+ PE K Y D + G +L + ML G
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE--------MLYG 235
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 48/219 (21%)
Query: 472 LGEGGYGPV----YKGVLPCGEVIAVKKLSKTSTQGFEEFKNEV--MLTAK--LQHVN-- 521
LG+G +G V K G A+K L K K+EV +T LQ+
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIA----KDEVAHTVTESRVLQNTRHP 65
Query: 522 LIRVLGFCIDSEERM-LIYEYMPNKSL-----DCYLFDPIRKLILDWKKRVHIIEGITQG 575
+ L + + +R+ + EY L +F R R + E I
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RFYGAE-IVSA 117
Query: 576 LLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTIG 633
L YL +++RD+K+ N++L + KI+DFG+ KE + + + GT
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL----CKEGISDGATMKTFCGTPE 170
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
Y+ PE Y D + GV++ + M+CG
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYE--------MMCG 201
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 38/103 (36%), Positives = 51/103 (49%), Gaps = 17/103 (16%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVV 629
I GL +LQ II+RDLK+ N++L KI+DFGM KE++ + T+
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM----CKENIWDGVTTKTFC 182
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
GT YI PE Y D ++FGVLL + ML G
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE--------MLAG 217
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 57/224 (25%)
Query: 472 LGEGGYGPV----YKGVLPCGEVIAVKKLSKTSTQGFEEFKNEV--------MLTAKLQH 519
LG+G +G V +K + A+K L K ++V +L+ +H
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLM----DDDVECTMVEKRVLSLAWEH 77
Query: 520 ---VNLIRVLGFCIDSEERM-LIYEYMPNKSL-----DCYLFDPIRKLILDWKKRVHIIE 570
++ ++E + + EY+ L C+ FD R + E
Sbjct: 78 PFLTHMF----CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TFYAAE 126
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQV 628
I GL +L I++RDLK+ NILL + KI+DFGM KE++ + T
Sbjct: 127 -IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM----CKENMLGDAKTNTF 178
Query: 629 VGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
GT YI PE Y+ D +SFGVLL + ML G
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE--------MLIG 214
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 35/103 (33%), Positives = 47/103 (45%), Gaps = 17/103 (16%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVV 629
I+ L YL E II+RDLK+ N+LL K++D+GM KE L T
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFC 171
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
GT YI PE Y D ++ GVL+ + M+ G
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFE--------MMAG 206
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 60/272 (22%), Positives = 89/272 (32%), Gaps = 64/272 (23%)
Query: 424 EEDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGEGGYGPVY-- 481
A + E EA + + L D F + +G G Y V
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQD-------FDLLRVIGRGSYAKVLLV 71
Query: 482 --KGVLPCGEVIAVKKLSKTSTQGFEEFKNEV--------MLTAKLQH---VNLIRVLGF 528
K + A++ + K ++ + H V L
Sbjct: 72 RLKKT---DRIYAMRVVKKELVND----DEDIDWVQTEKHVFEQASNHPFLVGLH----S 120
Query: 529 CIDSEERM-LIYEYMPNKSL-----DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
C +E R+ + EY+ L R + E I+ L YL E
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-ISLALNYLHE- 171
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN--TEQVVGTIGYIPPEYA 640
II+RDLK+ N+LL K++D+GM KE L T GT YI PE
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
Y D ++ GVL+ + M+ G
Sbjct: 226 RGEDYGFSVDWWALGVLMFE--------MMAG 249
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 40/223 (17%)
Query: 466 FSIRNKLGEGGYGPVY----KGVLPCGEVIAVKKLSKTSTQGFEE---FKNEVMLTAKLQ 518
+ + +G G +G V K +V A+K LSK + F E + A
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 519 HVNLIRVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKK-RVHIIEGITQGL 576
+++ L + + + ++ EYMP L + + + K R + E + L
Sbjct: 128 SPWVVQ-LFYAFQDDRYLYMVMEYMPGGDL----VNLMSNYDVPEKWARFYTAE-VVLAL 181
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ---VVGTIG 633
+ + IHRD+K N+LL ++ K++DFG + +E + VGT
Sbjct: 182 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG----TCMKMNKEGMVRCDTAVGTPD 234
Query: 634 YIPPE----YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
YI PE G Y + D +S GV L + ML G
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYE--------MLVG 269
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 4e-09
Identities = 61/449 (13%), Positives = 132/449 (29%), Gaps = 97/449 (21%)
Query: 372 KDSITSASVD-----KDEHSSNRRLSIALISTAAAALTLLLG-CCAYKYN-QMKRLNLIE 424
K ++ +D KD S RL L+S + + Y M +
Sbjct: 43 KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK--T 100
Query: 425 EDSAKASNTRANNETEAGDFNRNVPNLRVYSLADIEAATERFSIRNKLGE---GGYGPVY 481
E + TR E +N N Y+++ ++ + +R L E +
Sbjct: 101 EQRQPSMMTRMYIEQRDRLYNDNQV-FAKYNVSRLQPYLK---LRQALLELRPAKNVLID 156
Query: 482 KGVLPCGE-VIAVKKLSKTSTQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERM--- 536
GVL G+ +A+ Q + ++ L L C E +
Sbjct: 157 -GVLGSGKTWVALDVCLSYKVQ--CKMDFKIFWLN-----------LKNCNSPETVLEML 202
Query: 537 --LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHII---EGITQGLLYLQE---------- 581
L+Y+ PN + I+ I + + + + LL L
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF 262
Query: 582 --YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT-IGYIPPE 638
++ + R +V++ L D + + ++ + + +P E
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLDH-HSMTLTPDEVKSLLLKYLDCRPQDLPRE 321
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698
L II + + + L+ ++ ++ K ++S
Sbjct: 322 -VLTT-----------NPRRLSII-AESIR------DGLATWDN-WKHVNCDKLTTIIES 361
Query: 699 FLDDRNSPCKLMRCLE-IALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQVD 757
L+ P + + + +++ P + S++ + V
Sbjct: 362 SLNVLE-PAEYRKMFDRLSVF-----PPSAHIPTILLSLIWFDVI----------KSDVM 405
Query: 758 EIGIELLSTTNLEK------CSAYDVSFS 780
+ +L + +EK S +
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIYLE 434
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 5e-07
Identities = 94/668 (14%), Positives = 174/668 (26%), Gaps = 187/668 (27%)
Query: 157 DEWRIAATK------LDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTA 210
D + +K + +K++ L T + ++ ++ N ++
Sbjct: 40 DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL----- 94
Query: 211 SYYEPVSTNFTAP--PAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWT 268
P+ T P +Y R K + R KL L
Sbjct: 95 --MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL-------L 145
Query: 269 LVKPEDNGI--GAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTV 326
++P N + G +G + + + V + +
Sbjct: 146 ELRPAKNVLIDGVLGSG----KTWVA---------------LDVCLSYKVQCK-MDFKIF 185
Query: 327 WFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAAAQKDSITSASVDKDEHS 386
W + + +L I + +HS
Sbjct: 186 WLNL-------------------KNC------NSPETVLEMLQKLLYQIDPNWTSRSDHS 220
Query: 387 SNRRLSIALISTAAAALTLLLGCCAYKYNQMKRLNLIEEDSAKASNTRANNETEAGDFNR 446
SN +L I + A L LL K + L+ + N FN
Sbjct: 221 SNIKLRI---HSIQAELRRLL-----KSKPYENCLLVLLN--------VQNAKAWNAFNL 264
Query: 447 NVPNL---RVYSLADIEAATERFSIRNKLGEGGYGPVY-KGVLPCGEVIAVK--KLSKTS 500
+ L R + D +A I P K +L + + + L +
Sbjct: 265 SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL--LKYLDCRPQDLPREV 322
Query: 501 TQGF--------EEFKNEVMLTAKLQHVN---LIRVLGFCID----SEERMLIYEYMPNK 545
E ++ + +HVN L ++ ++ +E R + ++
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM-FD----- 376
Query: 546 SLDCYLFD-----PIRKLILDWKKRVHI-IEGITQGL----LYLQEYSRLTI----IHRD 591
+F P L L W + + + L L ++ TI I+ +
Sbjct: 377 --RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE 434
Query: 592 LKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDV 651
LKV + + + + + F + L Y
Sbjct: 435 LKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD-----QYF---------------- 473
Query: 652 FSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMR 711
+S I H + + F FLD R
Sbjct: 474 YSH------------------------IGHHLKNIEHPERMTLFRMVFLD--------FR 501
Query: 712 CLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQVDEIGIELLST--TNL 769
LE + N S+L LK I P + + V+ I ++ L NL
Sbjct: 502 FLEQKIRHDSTAWNASGSILNTLQQLKFYKPYI-CDNDPKYERLVNAI-LDFLPKIEENL 559
Query: 770 EKCSAYDV 777
D+
Sbjct: 560 ICSKYTDL 567
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 7e-04
Identities = 59/387 (15%), Positives = 107/387 (27%), Gaps = 151/387 (39%)
Query: 6 ISIIFHTLLYSEL---HPAKAKPWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTT 62
+SII +E A W V N D T +I SS +
Sbjct: 330 LSII------AESIRDGLATWDNWKHV--------------NCDKLTTIIESSLN----- 364
Query: 63 YQLSLSLPSDENQ-----IAKFADTVKKKNPSITT-ILSIGQGKDTNYSIYSSMVRNSSH 116
L E + ++ F + I T +LS+ + +V N H
Sbjct: 365 -----VLEPAEYRKMFDRLSVFPPSAH-----IPTILLSLIWFDVIKSDV--MVVVNKLH 412
Query: 117 RKSFID-----SSIRIARLYGFRGLDFAWTAPNTST------DMFNIGLLFDEWRIAATK 165
+ S ++ S+I I +Y L+ N D +NI FD +
Sbjct: 413 KYSLVEKQPKESTISIPSIY----LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
Query: 166 LDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPA 225
LD Y + I H + E ++ F
Sbjct: 469 LD------------------------QYFYSHIGH-----HLKNIEHPERMTL-FR---- 494
Query: 226 ALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPA 285
++ ++E+ + D AW + +
Sbjct: 495 MVFLDFR-------------FLEQKIRHD---------STAWN---------ASGSILNT 523
Query: 286 LYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKE 345
L L YK +I P + + N+ + F + + + +K
Sbjct: 524 LQQ--LKFYKP---YICDNDPKYERLVNAILD---F-----------LPKIEENLICSKY 564
Query: 346 KRLLGYYAWQVSF-DDHDWLLSQAAAQ 371
LL +++ + + + +A Q
Sbjct: 565 TDLL-----RIALMAEDEAIFEEAHKQ 586
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 31/107 (28%), Positives = 49/107 (45%), Gaps = 22/107 (20%)
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN---TEQV 628
I L +L + L II+RD+K+ NILL ++DFG+ +KE + +
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL----SKEFVADETERAYDF 220
Query: 629 VGTIGYIPPE---YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
GTI Y+ P+ G + D +S GVL+ + +L G
Sbjct: 221 CGTIEYMAPDIVRGGDSG-HDKAVDWWSLGVLMYE--------LLTG 258
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 466 FSIRNKLGEGGYGPVY----KGVLPCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQ 518
F I LG G +G V+ + G A+K L K + E +E ++ + +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-----FDPIRKLILDWKKRVHIIEGIT 573
H +IR+ G D+++ +I +Y+ L L F + + E +
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAE-VC 116
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIG 633
L YL II+RDLK NILL + KI+DFG FAK + + T + GT
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFG----FAKY-VPDVTYTLCGTPD 168
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672
YI PE + Y+ D +SFG+L+ + ML G
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYE--------MLAG 199
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 48/226 (21%), Positives = 92/226 (40%), Gaps = 34/226 (15%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
R+ + KLG G + V+ + +A+K + + E ++E+ L LQ VN
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKL---LQRVNDA 75
Query: 524 RVLGFCIDSEE---RMLIYEYMPNKSLD--CYLFDPIRKLILDWKKR-------VHIIEG 571
++L + + +F+ + + +L K+ + ++
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 572 ITQ----GLLYLQEYSRLTIIHRDLKVSNILLGEAMKP------KISDFGMARIFAKESL 621
I++ GL Y+ + R IIH D+K N+L+ P KI+D G A
Sbjct: 136 ISKQLLLGLDYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----WY 188
Query: 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
+E+ + T Y PE + +D++S L+ ++I+G L
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 54/275 (19%), Positives = 95/275 (34%), Gaps = 88/275 (32%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
R+ + KLG G + V+ + + +A+K + K++ E +E+ L +++ +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 522 -------LIRVLG--FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR------- 565
++ L F I N + C +F+ + +L W +
Sbjct: 95 PNDPNREMVVQLLDDFKISG----------VNGTHICMVFEVLGHHLLKWIIKSNYQGLP 144
Query: 566 ----VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG--------------------- 600
II+ + QGL YL ++ IIH D+K NILL
Sbjct: 145 LPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 601 ----------------------------EAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
E +K KI+D G A K E + T
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTR 257
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
Y E Y+T +D++S + ++ +G L
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 36/158 (22%), Positives = 68/158 (43%), Gaps = 13/158 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
R+ + K+G G +G +Y G + GE +A+K + + E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66
Query: 523 I-RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
I + + + +++ E + SL+ RK L K + + + + + Y+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHS 123
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPK---ISDFGMARIF 616
+ IHRD+K N L+G K I DFG+A+ +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 38/224 (16%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV- 520
+R+ I + +G+G +G V K E +A+K + K + + EV L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 521 -----NLIRVLGF-------CIDSEERML---IYEYMPNKSLDCYLFDPIRKLILDWKKR 565
++ + C+ E ML +Y+ + N + + RK
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVSLNLTRK-------- 161
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP--KISDFGMARIFAKESLEE 623
+ + LL+L L+IIH DLK NILL + KI DFG + +
Sbjct: 162 --FAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-----GQ 213
Query: 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
Q + + Y PE Y D++S G +L+++ +G+ L
Sbjct: 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 25/176 (14%), Positives = 62/176 (35%), Gaps = 29/176 (16%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV---------LPCGEVIAVKKLSKTSTQGFEEFK------ 508
++ +++ G +Y+ P + ++K L + F E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 509 -----NEVMLTAKLQHVNLIRVLGFCIDSEE-RMLIYEYMPNKSLDCYLFDPIRKLILDW 562
N+ + + +GF + ++ R L+ + +SL D K +L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLSE 158
Query: 563 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKI--SDFGMARIF 616
+ + + + L +L E +H ++ NI + + ++ + +G A +
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >1nar_A Narbonin; plant SEED protein; 1.80A {Vicia narbonensis} SCOP: c.1.8.5 Length = 290 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 35/265 (13%), Positives = 70/265 (26%), Gaps = 49/265 (18%)
Query: 32 LNLSEVSTISGINYDLFTHLICS-----SADINSTTYQLSLSLPSDENQIAKFADTVKKK 86
L + T L H I + T S + K + +K++
Sbjct: 16 TTLHDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEKVKN-LKRR 74
Query: 87 NPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYG------FRGLDFAW 140
+P + ++SIG G + + + +S I + Y G+D +
Sbjct: 75 HPEVKVVISIG-G--RGVNTPFDPAEENVWVSNAKESLKLIIQKYSDDSGNLIDGIDIHY 131
Query: 141 TAPNTSTDMFN-IGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQ 199
+ +G L E + + L I S +S+
Sbjct: 132 EHIRSDEPFATLMGQLITELK------------KDDDLNINVVSIAPSENNSSHYQKLYN 179
Query: 200 RNLNWIHAVTASYY---EPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKL 256
++I+ V + +PVST+ +E+ K+
Sbjct: 180 AKKDYINWVDYQFSNQQKPVSTDDAFVEIF------------------KSLEKDYHPHKV 221
Query: 257 VMCLPFYGYAWTLVKPEDNGIGAAA 281
+ K +
Sbjct: 222 LPGFSTDPLDTKHNKITRDIFIGGC 246
|
| >2ebn_A Endo-beta-N-acetylglucosaminidase F1; hydrolase(glucosidase); 2.00A {Elizabethkingia meningoseptica} SCOP: c.1.8.5 Length = 289 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 37/228 (16%), Positives = 75/228 (32%), Gaps = 31/228 (13%)
Query: 39 TISGINYDLFTHLICSSADIN--STTYQLSLSLPSDENQIAKFADTVKK--KNPSITTIL 94
T+ L ++ SA+IN + ++ +S + + K ++ I IL
Sbjct: 30 TLKNSGKPLVDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQDKGIKVIL 89
Query: 95 SIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTST------- 147
SI D S +++ +++ K+F LY G+ F T
Sbjct: 90 SILGNHDR--SGIANL--STARAKAFAQELKNTCDLYNLDGVFFDDEYSAYQTPPPSGFV 145
Query: 148 --DMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWI 205
L E + + K L+ + R S + + +++
Sbjct: 146 TPSNNAAARLAYETK---QAMPNK-------LVTVYVYSRTSSFPTAVDGVNAGSYVDYA 195
Query: 206 HAVTASYYEPVSTNFTAPPAALYGSISGRFAR---STDQVLKAWIERG 250
Y+ +TN+ + S F + +T Q L+ + +G
Sbjct: 196 IHDYGGSYDL-ATNYPGLAKSGMVMSSQEFNQGRYATAQALRNIVTKG 242
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 37/158 (23%), Positives = 71/158 (44%), Gaps = 13/158 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
+F + K+G G +G +Y G + E +A+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64
Query: 523 I-RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
I V F ++ + +L+ + + SL+ RKL L K + + + + + ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHS 121
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPK---ISDFGMARIF 616
S +HRD+K N L+G + I DFG+A+ +
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3ebv_A Chinitase A; chitinase A, CHIA, glycosidase, structural genomics, unknown function, hydrolase, PSI-2, protein structure initiative; 1.50A {Streptomyces coelicolor} Length = 302 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 44/225 (19%), Positives = 73/225 (32%), Gaps = 31/225 (13%)
Query: 48 FTHLICSSADINST----TYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTN 103
+ + + AD +T T+ L + AD K+ I+S+G G+
Sbjct: 30 YDIIAVAFADATTTPGAVTFNLDSAGLGGYTVDQFKADVRAKQAAGKKVIISVG-GEKGT 88
Query: 104 YSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAA 163
S+ SS + +F +S + R YGF G+D T M A
Sbjct: 89 VSVNSS-----ASATNFANSVYSVMREYGFDGVDIDLENGLNPTYMTQ----------AL 133
Query: 164 TKLDAKNSTRQQSLLILTA--RFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFT 221
L AK +ILT + + + + V YY S
Sbjct: 134 RALSAKAGPD----MILTMAPQTIDMQSTQGGYFQTALNVKDILTVVNMQYYN--SGTML 187
Query: 222 APPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYA 266
+Y + F + +E GL+ ++ + LP A
Sbjct: 188 GCDGKVYAQGTVDFL---TALACIQLEGGLAPSQVGLGLPASTRA 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 36/159 (22%), Positives = 62/159 (38%), Gaps = 15/159 (9%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
F + K+G G +G + G L E +A+K S + E +L + I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 524 -RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
+V F + ++ E + SL+ R L K V +I Q + ++
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL---KTVLMI--AIQLISRMEYV 121
Query: 583 SRLTIIHRDLKVSNILLGEAMKPK-----ISDFGMARIF 616
+I+RD+K N L+G I DF +A+ +
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3ian_A Chitinase; structural genomics, hydrolase, glycosidase, PSI-2, protein structure initiative; 1.75A {Lactococcus lactis subsp} Length = 321 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 35/247 (14%), Positives = 68/247 (27%), Gaps = 22/247 (8%)
Query: 28 RVGYLNLSEVSTISGINYDLFTHLICSSADI--NSTTYQLSLSLPSDENQIAKFADTVKK 85
+ GY S + + + S T +D A + K
Sbjct: 19 KDGYKGGSSADFNLSSTQEGYNVINVSFMKTPEGQTLPTFKPYNKTDTEFRA---EISKL 75
Query: 86 KNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT 145
+ ++++G G D + + S F++ IR+ YGF GLD
Sbjct: 76 NAEGKSVLIALG-GADAHIEL------KKSQESDFVNEIIRLVDTYGFDGLDIDLEQAAI 128
Query: 146 STDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLL--NSIQRNLN 203
+ D + ++ + F Y + Y N++ +
Sbjct: 129 EAADNQTVI----PSALKKVKDHYRKDGKNFMITMAPEFPYLTSSGKYAPYINNLDSYYD 184
Query: 204 WIHA----VTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMC 259
+I+ + N + + + V + A K V+
Sbjct: 185 FINPQYYNQGGDGFWDSDLNMWISQSNDEKKEDFLYGLTQRLVTGTDGFIKIPASKFVIG 244
Query: 260 LPFYGYA 266
LP A
Sbjct: 245 LPSNNDA 251
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 35/160 (21%), Positives = 68/160 (42%), Gaps = 15/160 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
+ + ++GEG +G +++G L + +A+K + S + ++E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67
Query: 523 I-RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
I V F + +L+ + + SL+ L RK + K V + Q L +Q
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSV---KTVAMA--AKQMLARVQS 121
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPK-----ISDFGMARIF 616
++++RD+K N L+G + DFGM + +
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 29/174 (16%), Positives = 62/174 (35%), Gaps = 30/174 (17%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKL---SKTSTQGFEEFK-----------N 509
++ + K+G GG+G +Y E A + + + F E K
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 510 EVMLTAKLQHVNLIRVLGF----CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR 565
+ + +L ++ + G R ++ E + L +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKK---ST 152
Query: 566 V-HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKI--SDFGMARIF 616
V + + L Y+ E +H D+K +N+LLG ++ +D+G++ +
Sbjct: 153 VLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 48/224 (21%), Positives = 86/224 (38%), Gaps = 40/224 (17%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV- 520
R+ + +G+G +G V K + +A+K + + + + E+ + L+
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQD 154
Query: 521 -----NLIRVLGF-------CIDSEERML---IYEYMPNKSLDCYLFDPIRKLILDWKKR 565
N+I +L C+ E +L +YE + + +RK
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVRK-------- 204
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP--KISDFGMARIFAKESLEE 623
I Q L L + IIH DLK NILL + + K+ DFG + +
Sbjct: 205 --FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQ 254
Query: 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL 667
+ + Y PE Y D++S G +L ++++G L
Sbjct: 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 33/176 (18%), Positives = 65/176 (36%), Gaps = 31/176 (17%)
Query: 465 RFSIRNKLGEGGYGPVYKGVLPCGEVIAVK-----KLSKTST-QGFEEFK---------- 508
+ + +G+GG+G +Y + E + K+ + F E K
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 509 -NEVMLTAKLQHVNLIRVLGF----CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWK 563
+ + T KL+++ + + G R +I + L ++
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR--- 151
Query: 564 KRV-HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKI--SDFGMARIF 616
K V + I L Y+ E+ +H D+K SN+LL ++ D+G+A +
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 785 | |||
| 3aqu_A | 356 | AT4G19810; stress response, TIM barrel, hydrolase, | 100.0 | |
| 3alf_A | 353 | Chitinase, class V; hydrolase; 1.20A {Nicotiana ta | 100.0 | |
| 4ay1_A | 365 | Chitinase-3-like protein 2; chilectin, lectin, chi | 100.0 | |
| 3fy1_A | 395 | Amcase, TSA1902, acidic mammalian chitinase; struc | 100.0 | |
| 1vf8_A | 377 | YM1, secretory protein; chitinase, CHI-lectin, str | 100.0 | |
| 1wb0_A | 445 | Chitinase 1, chitotriosidase 1; cyclopentapeptide | 100.0 | |
| 2pi6_A | 361 | Chitinase-3-like protein 1; complex, signaling pro | 100.0 | |
| 1itx_A | 419 | Chitinase A1, glycosyl hydrolase; alpha-beta (TIM) | 100.0 | |
| 3qok_A | 420 | Putative chitinase II; structural genomics, PSI-bi | 100.0 | |
| 3g6m_A | 406 | Chitinase, crchi1; inhibitor, caffeine, glycosidas | 100.0 | |
| 1kfw_A | 435 | Chitinase B; TIM barrel, hydrolase; 1.74A {Arthrob | 100.0 | |
| 1ll7_A | 392 | Chitinase 1; beta-alpha barrel, hydrolase; 2.00A { | 100.0 | |
| 1w9p_A | 433 | Chitinase; peptide inhibitors, argifin, argadin, g | 100.0 | |
| 1goi_A | 499 | Chitinase B; chitin degradation, hydrolase, glycos | 100.0 | |
| 1jnd_A | 420 | Imaginal DISC growth factor-2; IDGF, chitinase, in | 100.0 | |
| 1edq_A | 540 | Chitinase A; beta-alpha (TIM) barrel, hydrolase; 1 | 100.0 | |
| 3arx_A | 584 | Chitinase A; TIM barrel, inhibitor complex, glycos | 100.0 | |
| 3oa5_A | 574 | CHI1; TIM barrel, hydrolase; HET: 2PE; 1.74A {Yers | 100.0 | |
| 3cz8_A | 319 | Putative sporulation-specific glycosylase YDHD; st | 100.0 | |
| 3bxw_B | 393 | Chitinase domain-containing protein 1; TIM barrel, | 100.0 | |
| 3fnd_A | 312 | Chitinase; TIM-barrel, structural genomics, PSI-2, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1nar_A | 290 | Narbonin; plant SEED protein; 1.80A {Vicia narbone | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3sim_A | 275 | Protein, family 18 chitinase; family 18 plant chit | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3n12_A | 333 | Chitinase A, chinctu2; zinc atoms, complex, hydrol | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y8v_A | 290 | CHIC, class III chitinase, putative; afchic, hydro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4axn_A | 328 | Chitinase C1; hydrolase; 1.68A {Serratia marcescen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3ebv_A | 302 | Chinitase A; chitinase A, CHIA, glycosidase, struc | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3ian_A | 321 | Chitinase; structural genomics, hydrolase, glycosi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4ac1_X | 283 | Endo-N-acetyl-beta-D-glucosaminidase; hydrolase, g | 99.98 | |
| 2hvm_A | 273 | Hevamine; hydrolase, chitinase/lysozyme; 1.80A {He | 99.97 | |
| 2uy2_A | 294 | Endochitinase; carbohydrate metabolism, polysaccha | 99.96 | |
| 2gsj_A | 271 | Protein PPL-2; mimosoideae, chimerolectin, endochi | 99.96 | |
| 1edt_A | 271 | Endo-beta-N-acetylglucosaminidase H, endo H; hydro | 99.96 | |
| 1eok_A | 290 | Endo-beta-N-acetylglucosaminidase F3; alpha/beta-b | 99.95 | |
| 1cnv_A | 299 | Concanavalin B; plant chitinase, chitin binding pr | 99.95 | |
| 2xtk_A | 310 | CHIA1, class III chitinase CHIA1; hydrolase, GH18; | 99.94 | |
| 2ebn_A | 289 | Endo-beta-N-acetylglucosaminidase F1; hydrolase(gl | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1ta3_A | 274 | XIP-1, xylanase inhibitor protein I; beta alpha ba | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3poh_A | 451 | Endo-beta-N-acetylglucosaminidase F1; TIM barrel, | 99.83 | |
| 3mu7_A | 273 | XAIP-II, xylanase and alpha-amylase inhibitor prot | 99.83 | |
| 2dsk_A | 311 | Chitinase; catalytic domain, active domain, crysta | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.76 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.46 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.69 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.68 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.52 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.42 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.35 | |
| 2vtf_A | 626 | Endo-beta-N-acetylglucosaminidase; hydrolase, fami | 97.31 | |
| 2w91_A | 653 | Endo-beta-N-acetylglucosaminidase D; hydrolase, N- | 97.18 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.11 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.68 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.44 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.47 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.17 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 85.65 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.74 |
| >3aqu_A AT4G19810; stress response, TIM barrel, hydrolase, chitin; HET: FLC; 2.01A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-67 Score=565.57 Aligned_cols=338 Identities=37% Similarity=0.690 Sum_probs=294.8
Q ss_pred CcEEEEEecCCCCCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCCCc
Q 003932 25 PWIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNY 104 (785)
Q Consensus 25 ~~~~vgY~~~~~~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~ 104 (785)
.++++|||.+...+++++||+++||||+|+|+.++++++.+.+.+. ++..+.+++..+|++||++|||+|||||+. ++
T Consensus 3 ~~~~~gY~~~~~~~~~~~i~~~~~THi~yaF~~i~~~~~~v~~~~~-~~~~~~~~~~~lk~~~~~lkvllsiGGw~~-~~ 80 (356)
T 3aqu_A 3 TVVKASYWFPASEFPVTDIDSSLFTHLFCAFADLNSQTNQVTVSSA-NQPKFSTFTQTVQRRNPSVKTLLSIGGGIA-DK 80 (356)
T ss_dssp CCEEEEEECGGGCCCGGGSCGGGCSEEEEEEEEEETTTTEEECCTT-THHHHHHHHHHHTTTCTTCEEEEEEECTTS-CH
T ss_pred ceEEEEEEeCCCCCCHHHCCcccCCEEEEEEEEecCCCCEEEeCCc-cHHHHHHHHHHHHhhCCCceEEEEECCCCC-Cc
Confidence 4689999944457899999999999999999999998778887654 345677787889999999999999999864 34
Q ss_pred ccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeec
Q 003932 105 SIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARF 184 (785)
Q Consensus 105 ~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~ 184 (785)
..|+.+++++++|++||+|+++++++|||||||||||||++++|++||+.|+++||++|++.+... .+.+..+++++++
T Consensus 81 ~~f~~~~~~~~~r~~fi~siv~~~~~~~fDGiDiDwE~p~~~~d~~n~~~ll~eLr~~l~~~~~~~-g~~~~~Ls~av~~ 159 (356)
T 3aqu_A 81 TAYASMASNPTSRKSFIDSSIRVARSYGFHGLDLDWEYPSSATEMTNFGTLLREWRSAVVAEASSS-GKPRLLLAAAVFY 159 (356)
T ss_dssp HHHHHHHHSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHHHHHHHHHHHHHHHHHHHH-CSCCCEEEEEEES
T ss_pred chHHHHhcCHHHHHHHHHHHHHHHHHhCCCeEEEEEeecCChhHHHHHHHHHHHHHHHHHHhhhhc-CCCceEEEEeccC
Confidence 569999999999999999999999999999999999999878899999999999999998754322 2234566666665
Q ss_pred ccCCCCccccHHHHHhccceeeeeeccCCCc-cCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeeccccc
Q 003932 185 RYSPPANSYLLNSIQRNLNWIHAVTASYYEP-VSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFY 263 (785)
Q Consensus 185 ~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~-~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~KlvlGip~Y 263 (785)
.+......|++++|.+++||||||+||+||+ |+ ..+||+|||+.... ...+++.+|++|+++|+|++||+||||||
T Consensus 160 ~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~~w~-~~~g~~apl~~~~~--~~~~v~~~v~~~~~~gvp~~KlvlGip~Y 236 (356)
T 3aqu_A 160 SNNYYSVLYPVSAVASSLDWVNLMAYDFYGPGWS-RVTGPPAALFDPSN--AGPSGDAGTRSWIQAGLPAKKAVLGFPYY 236 (356)
T ss_dssp SSEETTEECCHHHHHHHCSEEEEECCCCCCTTTC-SBCCCTTCSCCTTC--SSCCHHHHHHHHHHTTCCGGGEEEEEESE
T ss_pred CchhhhccCCHHHHhhhccEEEEEeeecccCCCC-CCcCCCCcCCCCCC--CCccHHHHHHHHHHcCCCHHHEEEEeccc
Confidence 4333345799999999999999999999998 86 56999999996543 25699999999999999999999999999
Q ss_pred cceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHHHHHhhh
Q 003932 264 GYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYA 343 (785)
Q Consensus 264 G~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~~K~~~~ 343 (785)
||+|+++++.++++++|..|+++.++|.++|.+||+.+...+ ++..||+.+.+||.+++++||+|||++|++.|++||
T Consensus 237 Gr~~~~~~~~~~~~~~p~~g~~~~~~g~~~y~ei~~~l~~~g--~~~~~D~~~~~~y~y~~~~~v~ydd~~Si~~K~~~~ 314 (356)
T 3aqu_A 237 GYAWRLTNANSHSYYAPTTGAAISPDGSIGYGQIRKFIVDNG--ATTVYNSTVVGDYCYAGTNWIGYDDNQSIVTKVRYA 314 (356)
T ss_dssp EEEEEESCTTCCSTTCBEEEECSSTTCEEEHHHHHHHHHHHT--CEEEEETTTTEEEEEETTEEEEECCHHHHHHHHHHH
T ss_pred eeeeEecCCcCCCCCCCCCCCCCCCCCeeeHHHHHHHHhcCC--CeEEEchhhceEEEEeCCEEEEeCCHHHHHHHHHHH
Confidence 999999998889999999998888899999999999877544 899999999999999899999999999999999999
Q ss_pred cccCccceEeeeccccchhhhhhhhhhc
Q 003932 344 KEKRLLGYYAWQVSFDDHDWLLSQAAAQ 371 (785)
Q Consensus 344 ~~~glgG~~~W~l~~Dd~~~~l~~~~~~ 371 (785)
+++||||+|+|++++|| +|.|++++..
T Consensus 315 ~~~gLgGv~~W~l~~Dd-~~~ll~a~~~ 341 (356)
T 3aqu_A 315 KQRGLLGYFSWHVGADD-NSGLSRAASQ 341 (356)
T ss_dssp HHTTCCEEEEECGGGSS-TTHHHHHHHH
T ss_pred HhCCCCeEEEEeccCCC-CchHHHHHHH
Confidence 99999999999999988 6778787754
|
| >3alf_A Chitinase, class V; hydrolase; 1.20A {Nicotiana tabacum} PDB: 3alg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-67 Score=564.88 Aligned_cols=337 Identities=38% Similarity=0.689 Sum_probs=292.1
Q ss_pred cEEEEEecCCCCCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCCCcc
Q 003932 26 WIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNYS 105 (785)
Q Consensus 26 ~~~vgY~~~~~~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~ 105 (785)
++++|||.+...+++++||+++||||+|+|+.++++++.+.+.+. +...+.++++.+|++||++|||+|||||+. ++.
T Consensus 3 ~~~~gY~~~~~~~~~~~i~~~~~THi~yaF~~i~~~~~~v~~~~~-~~~~~~~~~~~lk~~~~~lkvllsiGG~~~-~~~ 80 (353)
T 3alf_A 3 NVKGGYWFKDSGLALNNIDSTLFTHLFCAFADLNPQLNQLIISPE-NQDSFRQFTSTVQRKNPSVKTFLSIAGGRA-NST 80 (353)
T ss_dssp CEEEEEEEGGGCCCGGGCCGGGCSEEEEEEEEEETTTTEEECCHH-HHHHHHHHHHHHHHHCTTCEEEEEEECTTS-CHH
T ss_pred ceEEEEEecCCCCCHhHCCcccCCEEEEEEEEeeCCCCEEEeCCc-cHHHHHHHHHHHHhhCCCCeEEEEECCCCC-Cch
Confidence 588999955567899999999999999999999998778877632 345677777789999999999999999864 345
Q ss_pred cchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecc
Q 003932 106 IYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFR 185 (785)
Q Consensus 106 ~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~ 185 (785)
.|+.+++++++|++||+|+++++++|||||||||||||++++|+++|+.||++||++|++.+... .+....+++++++.
T Consensus 81 ~f~~~~~~~~~r~~fi~siv~~~~~~~fDGiDiDwE~p~~~~d~~n~~~ll~eLr~~l~~~~~~~-~~~~~~Ls~a~~~~ 159 (353)
T 3alf_A 81 AYGIMARQPNSRKSFIDSSIRLARQLGFHGLDLDWEYPLSAADMTNLGTLLNEWRTAINTEARNS-GRAALLLTAAVSNS 159 (353)
T ss_dssp HHHHHHHSHHHHHHHHHHHHHHHHHHTCSEEEEECCCCCSHHHHHHHHHHHHHHHHHHHHHHHHH-CSCCCEEEEEEESS
T ss_pred hHHHHhcCHHHHHHHHHHHHHHHHHcCCCeEEEEeeecCChhHHHHHHHHHHHHHHHHHHhhhhc-CCCceEEEEecccC
Confidence 69999999999999999999999999999999999999878899999999999999998754322 22345666666644
Q ss_pred cCCCCccccHHHHHhccceeeeeeccCCCc-cCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCceeecccccc
Q 003932 186 YSPPANSYLLNSIQRNLNWIHAVTASYYEP-VSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYG 264 (785)
Q Consensus 186 ~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~-~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~KlvlGip~YG 264 (785)
+......|++++|.+++||||||+||+||+ |+...+||+|||+.... ..+++.+|++|+++|+|++||+|||||||
T Consensus 160 ~~~~~~~~d~~~l~~~vD~invMtYD~~g~~w~~~~~g~~a~l~~~~~---~~~~~~~v~~~~~~gvp~~KlvlGip~YG 236 (353)
T 3alf_A 160 PRVNGLNYPVESLARNLDWINLMAYDFYGPNWSPSQTNSHAQLFDPVN---HVSGSDGINAWIQAGVPTKKLVLGIPFYG 236 (353)
T ss_dssp SEETTEECCHHHHHHHCSEEEEECCCSSCTTTSTTBCCCSSCSCCTTT---CCSHHHHHHHHHHTTCCGGGEEEEEESEE
T ss_pred chhhhcCCCHHHHhhhccEEEEEEeeccCCCCCCCCCCCCCcCcCCCC---CccHHHHHHHHHHcCCChHHEEEEeCCce
Confidence 333345799999999999999999999998 87567999999996432 46899999999999999999999999999
Q ss_pred ceeeecCCCCCCCCCCCCCC---ccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHHHHHh
Q 003932 265 YAWTLVKPEDNGIGAAAAGP---ALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIA 341 (785)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~g~---~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~~K~~ 341 (785)
|.|+++++.++++++|..|+ ++.++|.++|.+||+.+...+ ++..||+.+.+||.+++++||+|||++|++.|++
T Consensus 237 r~~~~~~~~~~~~~~~~~g~~~~~~~~~g~~~y~ei~~~~~~~g--~~~~~D~~~~~~y~y~~~~~v~ydd~~Si~~K~~ 314 (353)
T 3alf_A 237 YAWRLVNANIHGLRAPAAGKSNVGAVDDGSMTYNRIRDYIVESR--ATTVYNATIVGDYCYSGSNWISYDDTQTVRNKVN 314 (353)
T ss_dssp EEEEESCTTCCSTTCBEEEECTTSCTTTCEEEHHHHHHHHHHHT--CEEEEETTTTEEEEEETTEEEEECCHHHHHHHHH
T ss_pred eeeeccCCcCCCCCCCCCCCCCCCCCCCCeEcHHHHHHHHhhCC--CeEEEccccceEEEEeCCEEEEcCCHHHHHHHHH
Confidence 99999998888998887776 667789999999999877544 8999999999999998999999999999999999
Q ss_pred hhcccCccceEeeeccccchhhhhhhhhhc
Q 003932 342 YAKEKRLLGYYAWQVSFDDHDWLLSQAAAQ 371 (785)
Q Consensus 342 ~~~~~glgG~~~W~l~~Dd~~~~l~~~~~~ 371 (785)
||+++||||+|+|++++|| +|.|++++..
T Consensus 315 ~~~~~gLgGv~~W~l~~Dd-~~~ll~a~~~ 343 (353)
T 3alf_A 315 YVKGRGLLGYFAWHVAGDQ-NWGLSRTASQ 343 (353)
T ss_dssp HHHHTTCSEEEEECGGGSS-TTHHHHHHHH
T ss_pred HHHhCCCCEEEEEeccCCC-CchHHHHHHH
Confidence 9999999999999999987 6778787754
|
| >4ay1_A Chitinase-3-like protein 2; chilectin, lectin, chitooligosaccharide, pseudochitinase, HY; HET: NAG; 1.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-67 Score=569.45 Aligned_cols=328 Identities=27% Similarity=0.402 Sum_probs=274.7
Q ss_pred cEEEEEecCCC-------CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecC
Q 003932 26 WIRVGYLNLSE-------VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98 (785)
Q Consensus 26 ~~~vgY~~~~~-------~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG 98 (785)
+++||||++|. .+.+++||+++||||+|+|+.+++++ +...+.. +..+.+.+..+|++||++|||+||||
T Consensus 2 ~rvV~Yy~~W~~~r~~~~~~~~~~i~~~~~THi~yaFa~i~~~~--~~~~~~~-~~~~~~~~~~lK~~~p~lKvllSiGG 78 (365)
T 4ay1_A 2 YKLVCYFTNWSQDRQEPGKFTPENIDPFLCSHLIYSFASIENNK--VIIKDKS-EVMLYQTINSLKTKNPKLKILLSIGG 78 (365)
T ss_dssp CEEEEEEESGGGGSCTTSCCCGGGCCTTTCSEEEEEEEEEETTE--EECCCTT-HHHHHHHHHHHHHHCTTCEEEEEEEE
T ss_pred eEEEEEECCccccCCCCCCCChhHCCcccCCEEEEEeEEecCCe--eEECCcc-HHHHHHHHHHHHHHCCCCEEEEEEeC
Confidence 58999999884 36799999999999999999999886 3333333 34445556669999999999999999
Q ss_pred CCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeE
Q 003932 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLL 178 (785)
Q Consensus 99 ~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~ 178 (785)
|+. ++..|+.+++++++|++||+|+++|+++||||||||||||| ...++.+|+.|+++||++|++... ...+....+
T Consensus 79 w~~-~s~~Fs~~~~~~~~R~~Fi~siv~~~~~~~fDGiDiDWEyP-~~~d~~~~~~ll~elr~~~~~~~~-~~~~~~~~l 155 (365)
T 4ay1_A 79 YLF-GSKGFHPMVDSSTSRLEFINSIILFLRNHNFDGLDVSWIYP-DQKENTHFTVLIHELAEAFQKDFT-KSTKERLLL 155 (365)
T ss_dssp TTT-TTGGGTTGGGSHHHHHHHHHHHHHHHHHTTCCEEEEEESCC-HHHHHHHHHHHHHHHHHHHHHHHH-TCSSCCCEE
T ss_pred CCC-CCchHHHHHcCHHHHHHHHHHHHHHHHhcCCceEEEeeecC-CcccccccHHHHHHHHHHHHHHHh-hhccCceEE
Confidence 875 23459999999999999999999999999999999999999 457889999999999999876432 223345556
Q ss_pred EEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCC-CCCCCCCCCCCCCCCC---CCCHHHHHHHHHHcCCCCC
Q 003932 179 ILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTN-FTAPPAALYGSISGRF---ARSTDQVLKAWIERGLSAD 254 (785)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~-~~g~~apl~~~~~~~~---~~~~~~~v~~~~~~gvp~~ 254 (785)
++++++........|++++|.++||||||||||+||+|+.+ .+||+|||+..+.+.. ..+++.+|++|+++|+|++
T Consensus 156 t~a~~~~~~~~~~~~d~~~i~~~vD~inlMtYD~~g~w~~~~~tg~~apL~~~~~~~~~~~~~~v~~av~~~~~~gvp~~ 235 (365)
T 4ay1_A 156 TAGVSAGRQMIDNSYQVEKLAKDLDFINLLSFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYWIHKGMPSE 235 (365)
T ss_dssp EEEEECCHHHHHHHCCHHHHHHHCSEEEEECCCSSCTTCSSCBCCCSSCSSCCTTCCGGGGGSSHHHHHHHHHHTTCCGG
T ss_pred EeecCCChhhhhhhcchhhhhhcccEEEEEcccccCcccCCCcCCCCCCCCCCccccCccccccHHHHHHHHHHcCCCHH
Confidence 66665544333457999999999999999999999999854 6899999998765432 4589999999999999999
Q ss_pred ceeeccccccceeeecCCCCCCC----CCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEe
Q 003932 255 KLVMCLPFYGYAWTLVKPEDNGI----GAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGF 330 (785)
Q Consensus 255 KlvlGip~YG~~~~~~~~~~~~~----~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~y 330 (785)
||+||||||||+|+++++.+... +....|+.+.+.|.++|.|+|+.+. +....|+..+.+||.+++++||+|
T Consensus 236 KlvlGip~YGr~~~~~~~~~~~~~~~~~~~~~g~~t~~~g~~~y~e~~~~~~----~~~~~~~~~~~~~y~~~~~~~vsy 311 (365)
T 4ay1_A 236 KVVMGIPTYGHSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLK----GAKITRLQDQQVPYAVKGNQWVGY 311 (365)
T ss_dssp GEEEEEESEEEEEEESSSCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHT----TCEEEECTTTCCEEEEETTEEEEC
T ss_pred HeeeccCccceeeeecCCCCCCCCcccCCCCCccccccCCeeeHHHHHHHhc----CCceEEecCCeeEEEEECCEEEEe
Confidence 99999999999999987654321 2234567788999999999999765 256778888899999999999999
Q ss_pred CCHHHHHHHHhhhcccCccceEeeeccccchhh
Q 003932 331 DDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDW 363 (785)
Q Consensus 331 dd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~~ 363 (785)
||++|+++|++||+++||||+|+|+|++||...
T Consensus 312 dd~~Si~~K~~y~~~~~LgGv~~W~l~~DD~~G 344 (365)
T 4ay1_A 312 DDVKSMETKVQFLKNLNLGGAMIWSIDMDDFTG 344 (365)
T ss_dssp CCHHHHHHHHHHHHHTTCSEEEEECGGGSCTTS
T ss_pred CCHHHHHHHHHHHHhcCCCEEEEEeCCCcCCCC
Confidence 999999999999999999999999999999654
|
| >3fy1_A Amcase, TSA1902, acidic mammalian chitinase; structure, crystallography, asthma,inhibitor, chitin degradation, methylallosamidin; HET: NA1 NAA AMI; 1.70A {Homo sapiens} PDB: 3fxy_A* 3rm4_A* 3rm8_A* 3rm9_A* 3rme_A* 2ybt_A* 2ybu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-66 Score=565.23 Aligned_cols=328 Identities=26% Similarity=0.439 Sum_probs=278.9
Q ss_pred cEEEEEecCCCC-------CCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecC
Q 003932 26 WIRVGYLNLSEV-------STISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98 (785)
Q Consensus 26 ~~~vgY~~~~~~-------~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG 98 (785)
+++||||++|.. +.+++||+++||||+|+|+.++ ++ .+...+..+ ....+.+..+|++||++|||+||||
T Consensus 1 ~~~v~Yy~~W~~~r~~~~~~~~~~i~~~~~THi~yaFa~i~-~~-~i~~~~~~d-~~~~~~~~~lK~~~p~lKvllSiGG 77 (395)
T 3fy1_A 1 YQLTCYFTNWAQYRPGLGRFMPDDINPCLCTHLIYAFAGMQ-NN-EITTIEWND-VTLYQAFNGLKNKNSQLKTLLAIGG 77 (395)
T ss_dssp CEEEEEEETTGGGSCGGGCCCGGGSCTTTCSEEEEEEEEEE-TT-EEECCSTTH-HHHHHHHHHGGGSCTTCEEEEEEEC
T ss_pred CEEEEEECcccccCCCCCCCChhHCCcccCCEEEEEEEEee-CC-eeEeccccc-HHHHHHHHHHHHhCCCCEEEEEEcC
Confidence 478999999854 5799999999999999999999 54 666655434 3344445569999999999999999
Q ss_pred CCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCC----CCchhHHHHHHHHHHHhhhhhhhccccc
Q 003932 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTS----TDMFNIGLLFDEWRIAATKLDAKNSTRQ 174 (785)
Q Consensus 99 ~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~----~d~~~~~~ll~~lr~~l~~~~~~~~~~~ 174 (785)
|+. ++..|+.+++++++|++||+|+++++++|||||||||||||+.. +|+++|+.||++||++|++.+.. ..+.
T Consensus 78 w~~-~s~~f~~~~~~~~~R~~fi~siv~~l~~~gfDGiDiDwEyP~~~g~~~~d~~nf~~ll~eLr~~l~~~~~~-~~~~ 155 (395)
T 3fy1_A 78 WNF-GTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQ-INKP 155 (395)
T ss_dssp GGG-CSHHHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCTTSTTCCTTHHHHHHHHHHHHHHHHHHHHHH-HTSC
T ss_pred CCC-CCchhhHHhCCHHHHHHHHHHHHHHHHhcCCCeEEEEeEcCCCCCCChhHHHHHHHHHHHHHHHHHHhhhc-cCCC
Confidence 864 34569999999999999999999999999999999999999643 68999999999999999875432 2233
Q ss_pred ceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC---CCCHHHHHHHHHHcCC
Q 003932 175 QSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF---ARSTDQVLKAWIERGL 251 (785)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~---~~~~~~~v~~~~~~gv 251 (785)
...+++++++.......+|++++|.+++||||||+||+||+|+. .+||+|||+..+.+.. ..+++.+|++|+++|+
T Consensus 156 ~~~Lt~av~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~w~~-~~g~~apl~~~~~~~~~~~~~~v~~~v~~~~~~gv 234 (395)
T 3fy1_A 156 RLMVTAAVAAGISNIQSGYEIPQLSQYLDYIHVMTYDLHGSWEG-YTGENSPLYKYPTDTGSNAYLNVDYVMNYWKDNGA 234 (395)
T ss_dssp CCEEEEEECCSHHHHHHHCCHHHHHHHCSEEEECCCCCSCGGGS-BCCCSSCSSCCTTCCGGGGGCSHHHHHHHHHHTTC
T ss_pred ceEEEEEecCChhHhhcchhHHHHHhhcceeeeecccccCCCCC-CCCCCCcCcCCCCCccccccccHHHHHHHHHHcCC
Confidence 45666666554332334699999999999999999999999975 5999999998765543 2589999999999999
Q ss_pred CCCceeeccccccceeeecCCCCCCCCCCCC-----CCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCE
Q 003932 252 SADKLVMCLPFYGYAWTLVKPEDNGIGAAAA-----GPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTV 326 (785)
Q Consensus 252 p~~KlvlGip~YG~~~~~~~~~~~~~~~~~~-----g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~ 326 (785)
|++||+||||||||+|+++++.+++.|++.. |+.+.+.|.++|+|||..++. ++...||+.+++||++++++
T Consensus 235 p~~KlvlGip~YGr~~~~~~~~~~~~g~p~~g~~~~G~~t~~~G~~~y~ei~~~~~~---g~~~~~D~~~~~~y~~~~~~ 311 (395)
T 3fy1_A 235 PAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKN---GATQGWDAPQEVPYAYQGNV 311 (395)
T ss_dssp CGGGEEEEEESEEEEEEESSTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHHT---TCEEEEETTTTEEEEEETTE
T ss_pred CHHHEEEEeccccceeEecCCCCCCCCCcccCCCCCCcccCCCceeeHHHHHHHhcc---CCeEEEecccceEEEEECCE
Confidence 9999999999999999999888888887654 555778999999999987752 46889999999999999999
Q ss_pred EEEeCCHHHHHHHHhhhcccCccceEeeeccccchh
Q 003932 327 WFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362 (785)
Q Consensus 327 ~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~ 362 (785)
||+|||++|++.|++||+++||||+|+|+|++||..
T Consensus 312 ~v~ydd~~Si~~K~~~~~~~gLgG~~~W~ld~DD~~ 347 (395)
T 3fy1_A 312 WVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDDFT 347 (395)
T ss_dssp EEECCCHHHHHHHHHHHHHTTCSEEEEECGGGSCSS
T ss_pred EEEeCCHHHHHHHHHHHHhCCCCEEEEEccccCccC
Confidence 999999999999999999999999999999999853
|
| >1vf8_A YM1, secretory protein; chitinase, CHI-lectin, structural plasticity, functional versatility, immune system; 1.31A {Mus musculus} SCOP: c.1.8.5 d.26.3.1 PDB: 1e9l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-65 Score=553.67 Aligned_cols=328 Identities=25% Similarity=0.439 Sum_probs=277.9
Q ss_pred cEEEEEecCCC-------CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecC
Q 003932 26 WIRVGYLNLSE-------VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98 (785)
Q Consensus 26 ~~~vgY~~~~~-------~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG 98 (785)
+++||||++|. .+.+++||+++||||+|+|+.++++ .+.+.+ +.+.+..+.+..+|++||++|||+||||
T Consensus 1 ~~vv~Y~~~w~~~~~~~~~~~~~~i~~~~~Thi~~aF~~i~~~--~~~~~d-~~d~~~~~~~~~lk~~~~~lkvllsiGG 77 (377)
T 1vf8_A 1 YQLMCYYTSWAKDRPIEGSFKPGNIDPCLCTHLIYAFAGMQNN--EITYTH-EQDLRDYEALNGLKDKNTELKTLLAIGG 77 (377)
T ss_dssp CEEEEEEEGGGGGSCGGGCCCGGGSCTTTCSEEEEEEEEEETT--EEECSS-TTHHHHHHHHHHGGGTCTTCEEEEEEEC
T ss_pred CeEEEEECcchhcCCcCCCCChHHCCcccCCEEEEEeEeeccC--ceeecc-hhHHHHHHHHHHHHhhCCCCeEEEEECC
Confidence 46899999885 4579999999999999999999987 566665 4444434445569999999999999999
Q ss_pred CCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC----CCCchhHHHHHHHHHHHhhhhhhhccccc
Q 003932 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT----STDMFNIGLLFDEWRIAATKLDAKNSTRQ 174 (785)
Q Consensus 99 ~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~----~~d~~~~~~ll~~lr~~l~~~~~~~~~~~ 174 (785)
|+. ++..|+.+++++++|++||+++++++++|||||||||||||+. ++|+++|+.||++||++|+..+... .+.
T Consensus 78 ~~~-~s~~fs~~~~~~~~R~~fi~si~~~~~~~~fDGiDiDwEyp~~~g~~~~d~~n~~~ll~eLr~~l~~~~~~~-~~~ 155 (377)
T 1vf8_A 78 WKF-GPAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNLDWQYPGSRGSPPKDKHLFSVLVKEMRKAFEEESVEK-DIP 155 (377)
T ss_dssp TTT-CSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTHHHHHHHHHHHHHHHHHHHHHHHH-TSC
T ss_pred CCC-CCchHhHHhcCHHHHHHHHHHHHHHHHHcCCCeEEEeeeCCCcCCCCHHHHHHHHHHHHHHHHHHHhhhhcc-CCC
Confidence 864 3346999999999999999999999999999999999999953 4588999999999999998643322 233
Q ss_pred ceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC---CCCHHHHHHHHHHcCC
Q 003932 175 QSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF---ARSTDQVLKAWIERGL 251 (785)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~---~~~~~~~v~~~~~~gv 251 (785)
+..+++++++........|++++|.+++||||||+||+||+|+ ..+||+|||+..+.+.. ..+++.+|++|+++|+
T Consensus 156 ~~~Ls~a~~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~w~-~~~g~~apl~~~~~~~~~~~~~~v~~~v~~~~~~gv 234 (377)
T 1vf8_A 156 RLLLTSTGAGIIDVIKSGYKIPELSQSLDYIQVMTYDLHDPKD-GYTGENSPLYKSPYDIGKSADLNVDSIISYWKDHGA 234 (377)
T ss_dssp CCEEEEEECSSHHHHHHHCCHHHHHHHCSEEEECCCCCSCGGG-SBCCCSSCSSCCTTCCGGGGGCSHHHHHHHHHHTTC
T ss_pred ceEEEEEccCCHHHHhccCCHHHHHhhCcEEEEEeecccCCCC-CCCCCCCCCCCCCCCccccccccHHHHHHHHHHcCC
Confidence 5667776655433223468999999999999999999999987 56999999998765432 4589999999999999
Q ss_pred CCCceeeccccccceeeecCCCCCCCCCCCC-----CCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCE
Q 003932 252 SADKLVMCLPFYGYAWTLVKPEDNGIGAAAA-----GPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTV 326 (785)
Q Consensus 252 p~~KlvlGip~YG~~~~~~~~~~~~~~~~~~-----g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~ 326 (785)
|++||+||||||||+|+++++.+++.+++.. |+.+.++|.++|.|||+.+. .+++..||+.+++||.+++++
T Consensus 235 p~~KlvlGip~YGr~~~~~~~~~~~~g~p~~g~~~~g~~t~~~G~~~y~ei~~~~~---~g~~~~~D~~~~~~y~y~~~~ 311 (377)
T 1vf8_A 235 ASEKLIVGFPAYGHTFILSDPSKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFLN---EGATEVWDAPQEVPYAYQGNE 311 (377)
T ss_dssp CGGGEEEEEESEEEEEEESCTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHH---TTCEEEEETTTTEEEEEETTE
T ss_pred CHHHEEEEecccceeeEcccCCCCCCCCcCCCCCCCCCccCcCceecHHHHHHHHh---cCCeEEeccccceeEEEeCCE
Confidence 9999999999999999999887777777653 55677899999999998764 358999999999999998999
Q ss_pred EEEeCCHHHHHHHHhhhcccCccceEeeeccccchh
Q 003932 327 WFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362 (785)
Q Consensus 327 ~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~ 362 (785)
||+|||++|++.|++||+++||||+|+|+|++||..
T Consensus 312 ~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~ 347 (377)
T 1vf8_A 312 WVGYDNVRSFKLKAQWLKDNNLGGAVVWPLDMDDFS 347 (377)
T ss_dssp EEECCCHHHHHHHHHHHHHTTCCEEEEETGGGSCTT
T ss_pred EEEecCHHHHHHHHHHHHhCCCceEEEEeeecccCC
Confidence 999999999999999999999999999999999953
|
| >1wb0_A Chitinase 1, chitotriosidase 1; cyclopentapeptide inhibitors, chitinase inhibitors, carbohyd metabolism, chitin degradation, chitin-binding; HET: VR0 MEA; 1.65A {Homo sapiens} SCOP: c.1.8.5 d.26.3.1 PDB: 1waw_A* 1guv_A 1lg2_A 1lg1_A 1lq0_A 1hki_A* 1hkj_A* 1hkm_A* 1hkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-65 Score=560.16 Aligned_cols=324 Identities=26% Similarity=0.445 Sum_probs=276.7
Q ss_pred EEEEEecCCC-------CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCC
Q 003932 27 IRVGYLNLSE-------VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQG 99 (785)
Q Consensus 27 ~~vgY~~~~~-------~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~ 99 (785)
++||||++|. .+.+++||+++||||+|+|+.++++ .+...+ +.+.++.+.+..||++||++|||+|||||
T Consensus 2 kvv~Y~~~w~~~r~~~~~~~~~~i~~~~~THi~yaF~~i~~~--~~~~~d-~~d~~~~~~~~~lk~~~p~lKvllsiGGw 78 (445)
T 1wb0_A 2 KLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNH--QLSTTE-WNDETLYQEFNGLKKMNPKLKTLLAIGGW 78 (445)
T ss_dssp EEEEEEETTGGGSCGGGCCCGGGCCTTTCSEEEEEEEEEETT--EEECSS-TTHHHHHHHHHHGGGTCTTCEEEEEEECT
T ss_pred eEEEEECcccccCCCCCCCCHHHCCcccCCEEEEEEEeeccC--ceeecC-hhHHHHHHHHHHHHHhCCCCeEEEEECCC
Confidence 5899999985 3579999999999999999999987 566665 44444444556699999999999999998
Q ss_pred CCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC----CCCchhHHHHHHHHHHHhhhhhhhcccccc
Q 003932 100 KDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT----STDMFNIGLLFDEWRIAATKLDAKNSTRQQ 175 (785)
Q Consensus 100 ~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~----~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~ 175 (785)
+. ++..|+.+++++++|++||+++++++++|||||||||||||+. ++|+++|+.||++||++|++..... .+.+
T Consensus 79 ~~-~s~~fs~~~~~~~~R~~fi~siv~~l~~~gfDGiDiDwEyP~~~g~~~~d~~nf~~ll~eLr~~l~~~~~~~-~~~~ 156 (445)
T 1wb0_A 79 NF-GTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTS-GKER 156 (445)
T ss_dssp TT-CSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTTHHHHHHHHHHHHHHHHHHHHHHH-CSCC
T ss_pred CC-CCchHHHHHcCHHHHHHHHHHHHHHHHHcCCCeEEEeCccCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhcc-CCCc
Confidence 64 3446999999999999999999999999999999999999954 4689999999999999998653322 2335
Q ss_pred eeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC---CCCHHHHHHHHHHcCCC
Q 003932 176 SLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF---ARSTDQVLKAWIERGLS 252 (785)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~---~~~~~~~v~~~~~~gvp 252 (785)
+.+++++++........|++++|.+++||||||+||+||+|+ ..+||+|||+..+.+.. ..+++.+|++|+++|+|
T Consensus 157 ~~Ls~av~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~w~-~~~g~~apL~~~~~~~~~~~~~~v~~av~~~~~~gvp 235 (445)
T 1wb0_A 157 LLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWE-KVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTP 235 (445)
T ss_dssp CEEEEEECCCHHHHHHHCCHHHHHHHCSEEEECCCCSSCTTS-SBCCCSSCSSCCTTCCGGGGGCSHHHHHHHHHHTTCC
T ss_pred eEEEEEecCCHHHHHccCCHHHHHHhcceeeeeeeeccCCCc-CCCCCCCCCCCCCCCccccccccHHHHHHHHHHcCCC
Confidence 667776655433223468999999999999999999999987 56999999998765432 46899999999999999
Q ss_pred CCceeeccccccceeeecCCCCCCCCCCCC-----CCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEE
Q 003932 253 ADKLVMCLPFYGYAWTLVKPEDNGIGAAAA-----GPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVW 327 (785)
Q Consensus 253 ~~KlvlGip~YG~~~~~~~~~~~~~~~~~~-----g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~ 327 (785)
++||+||||||||+|+++++.+++++++.. |+.+.+.|.++|.|||+. .+++..||+.++.||.+++++|
T Consensus 236 ~~KlvlGip~YGr~~~~~~~~~~~~g~p~~g~~~~g~~t~~~G~~~y~ei~~~-----~g~~~~~D~~~~~~y~y~~~~~ 310 (445)
T 1wb0_A 236 ASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSW-----KGATKQRIQDQKVPYIFRDNQW 310 (445)
T ss_dssp GGGEEEEEESEEEEEEESCTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHTTC-----TTCEEEEETTTTEEEEEETTEE
T ss_pred hhHEEEEecccceeeEccCCCCCCCCCcccCCCCCCCccCcCCcccHHHHhhc-----CCcEEEeccccceeEEEeCCEE
Confidence 999999999999999999877777776653 556778999999999975 2589999999999999999999
Q ss_pred EEeCCHHHHHHHHhhhcccCccceEeeeccccch
Q 003932 328 FGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDH 361 (785)
Q Consensus 328 i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~ 361 (785)
|+|||++|++.|++||+++||||+|+|+|++||.
T Consensus 311 v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~ 344 (445)
T 1wb0_A 311 VGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDF 344 (445)
T ss_dssp EECCCHHHHHHHHHHHHHTTCCEEEEECGGGSCT
T ss_pred EEeCCHHHHHHHHHHHHHCCCceEEEeccccccc
Confidence 9999999999999999999999999999999995
|
| >2pi6_A Chitinase-3-like protein 1; complex, signaling protein; HET: NAG MAN; 1.65A {Ovis aries} SCOP: c.1.8.5 d.26.3.1 PDB: 2dpe_A* 1sr0_A* 1zl1_A* 1zbk_A* 2dsu_A* 2dsv_A* 2dsw_A* 2fdm_A* 2g41_A* 2g8z_A* 2dt1_A* 1zbv_A* 1zu8_A* 2aos_A* 2b31_A* 1zbw_A* 2dt0_A* 2dsz_A* 2dt2_A* 2dt3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-64 Score=546.13 Aligned_cols=323 Identities=24% Similarity=0.388 Sum_probs=275.9
Q ss_pred cEEEEEecCCCC-------CCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHH-HHHHHHHHHhcCCCceEEEEec
Q 003932 26 WIRVGYLNLSEV-------STISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQ-IAKFADTVKKKNPSITTILSIG 97 (785)
Q Consensus 26 ~~~vgY~~~~~~-------~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~k~~~p~lkv~~sig 97 (785)
+++||||++|.. +.+++||+++||||+|+|+.++ +| ++.+.+ +.+.. +.++ ..+|++||++|||+|||
T Consensus 1 ~~vvgY~~~w~~~~~~~~~~~~~~i~~~~~Thi~~af~~i~-~g-~~~~~~-~~d~~~~~~~-~~lk~~~p~lkvllsiG 76 (361)
T 2pi6_A 1 YKLICYYTSWSQYREGDGSCFPDAIDPFLCTHVIYTFANIS-NN-EIDTWE-WNDVTLYDTL-NTLKNRNPKLKTLLSVG 76 (361)
T ss_dssp CEEEEEEEGGGGGSSGGGCCCGGGSCTTTCSEEEEEEEEEE-TT-EEECCS-TTHHHHHHHH-HHHHHHCTTCEEEEEEE
T ss_pred CeEEEEECcccccCCCCCCCChHHCCcccCCEEEEEEEecc-CC-eEEecc-HHHHHHHHHH-HHHHhcCCCCeEEEEEC
Confidence 478999999853 6899999999999999999999 76 787776 43333 4444 45999999999999999
Q ss_pred CCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhccccccee
Q 003932 98 QGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSL 177 (785)
Q Consensus 98 G~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~ 177 (785)
||+. ++..|+.+++++++|++||+++++++++|||||||||||||+ ..|+++|+.|+++||++|++.+.... ++..
T Consensus 77 G~~~-~s~~f~~~~~~~~~r~~fi~si~~~~~~~~fDGiDiDwE~p~-~~d~~~~~~ll~eLr~~l~~~~~~~~--~~~~ 152 (361)
T 2pi6_A 77 GWNF-GPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG-RRDKRHLTTLVKEMKAEFIREAQAGT--EQLL 152 (361)
T ss_dssp TTTS-CHHHHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCC-GGGHHHHHHHHHHHHHHHHHHHTTSS--CCCE
T ss_pred CCCC-CchhHHHHhcCHHHHHHHHHHHHHHHHHcCCCeEEEeeecCC-chHHHHHHHHHHHHHHHHhhhhcccC--CceE
Confidence 9865 345699999999999999999999999999999999999995 46999999999999999987532221 3556
Q ss_pred EEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCC--CCCCCHHHHHHHHHHcCCCCCc
Q 003932 178 LILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISG--RFARSTDQVLKAWIERGLSADK 255 (785)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~--~~~~~~~~~v~~~~~~gvp~~K 255 (785)
+++++++........|++++|.+++||||+|+||+||+|+. .+||+|||+..+.+ ....+++.+|++|+++|+|++|
T Consensus 153 Ls~a~~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~w~~-~~g~~apl~~~~~~~~~~~~~v~~~v~~~~~~g~p~~K 231 (361)
T 2pi6_A 153 LSAAVSAGKIAIDRGYDIAQISRHLDFISLLTYDFHGAWRQ-TVGHHSPLFRGNEDASSRFSNADYAVSYMLRLGAPANK 231 (361)
T ss_dssp EEEEEECCHHHHHHHCCHHHHHHHCSEEEEETTCCSCTTCC-BCCCSSCSSCCSSSCSCTTSSHHHHHHHHHHTTCCGGG
T ss_pred EEEEecCCHHHHhccCCHHHHHhhccEEEEEeeeccCCCCC-CCCCCCCCCCCCCCccccCccHHHHHHHHHHcCCCHHH
Confidence 77777655432224689999999999999999999999864 69999999986543 2356899999999999999999
Q ss_pred eeeccccccceeeecCCCCCCCCCCCC-----CCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEe
Q 003932 256 LVMCLPFYGYAWTLVKPEDNGIGAAAA-----GPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGF 330 (785)
Q Consensus 256 lvlGip~YG~~~~~~~~~~~~~~~~~~-----g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~y 330 (785)
|+||||||||+|+++++ +++.+++.. |+.+.++|.++|.|||+.+. +++..||+.+++||.+++++||+|
T Consensus 232 lvlGip~YGr~~~~~~~-~~~~~~~~~g~~~~g~~t~~~g~~~y~ei~~~~~----g~~~~~D~~~~~~y~~~~~~~v~y 306 (361)
T 2pi6_A 232 LVMGIPTFGRSFTLASS-KTDVGAPVSGPGIPGRFTKEKGILAYYEICDFLH----GATTHRFRDQQVPYATKGNQWVAY 306 (361)
T ss_dssp EEEEEESEEEEEEESSS-CCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHTT----TCEEEEETTTTEEEEEETTEEEEC
T ss_pred EEEEecccceeeecCCC-CCCCCCcCCCCCCCCCcCCCCceeeHHHHHHHhc----CCEEEecccccceEEEECCEEEEe
Confidence 99999999999999877 677776654 55677899999999999753 489999999999999988999999
Q ss_pred CCHHHHHHHHhhhcccCccceEeeeccccchh
Q 003932 331 DDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362 (785)
Q Consensus 331 dd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~ 362 (785)
||++|++.|++||+++||||+|+|+|++||..
T Consensus 307 dd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~ 338 (361)
T 2pi6_A 307 DDQESVKNKARYLKNRQLAGAMVWALDLDDFR 338 (361)
T ss_dssp CCHHHHHHHHHHHHHTTCSEEEEECGGGSCSS
T ss_pred CCHHHHHHHHHHHHhCCCcEEEEEcccccccC
Confidence 99999999999999999999999999999853
|
| >1itx_A Chitinase A1, glycosyl hydrolase; alpha-beta (TIM) barrel; 1.10A {Bacillus circulans} SCOP: c.1.8.5 d.26.3.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-64 Score=554.89 Aligned_cols=339 Identities=24% Similarity=0.369 Sum_probs=273.3
Q ss_pred CCCCcEEEEEecCCCC----CCcCCCCCCCCceEEEEEEEeeCCc-----------------------------cEEecC
Q 003932 22 KAKPWIRVGYLNLSEV----STISGINYDLFTHLICSSADINSTT-----------------------------YQLSLS 68 (785)
Q Consensus 22 ~~~~~~~vgY~~~~~~----~~~~~i~~~~~Thi~~~f~~~~~~~-----------------------------~~~~~~ 68 (785)
..+.+++||||++|.. +.+++||+++||||+|+|+.++.+| +++.+.
T Consensus 8 ~~~~~~vvgY~~~W~~y~~~~~~~~i~~~~~THi~yaFa~i~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~ 87 (419)
T 1itx_A 8 AADSYKIVGYYPSWAAYGRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTIVLG 87 (419)
T ss_dssp GGGGCEEEEEEEGGGGTTTCCCGGGCCGGGCSEEEEEEEEECBTTEEEECCTTSSCCEEEECBCTTSCBCCCCTTCEEES
T ss_pred cCCCCEEEEEECchhhcCCCCChhhCCHhhCcEEEEEeecccccccccccccccccccccccccccccccccCCCceeec
Confidence 3456789999999853 6799999999999999999996432 133343
Q ss_pred CCccH---------------HHHHHHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCC
Q 003932 69 LPSDE---------------NQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGF 133 (785)
Q Consensus 69 ~~~~~---------------~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~ 133 (785)
++|.+ ..+.+ +..||++||++|||+|||||+.+. .|+.+++++++|++||+|+++++++|||
T Consensus 88 D~~~d~~~~~~~~~w~~~~~g~~~~-l~~lk~~~p~lKvllsiGGw~~s~--~fs~~~~~~~~R~~Fi~s~v~~l~~~~f 164 (419)
T 1itx_A 88 DPWIDTGKTFAGDTWDQPIAGNINQ-LNKLKQTNPNLKTIISVGGWTWSN--RFSDVAATAATREVFANSAVDFLRKYNF 164 (419)
T ss_dssp SHHHHHTSCCTTCCSSSSCCHHHHH-HHHHHHHSTTCEEEEEEECSSSCT--THHHHHTSHHHHHHHHHHHHHHHHHHTC
T ss_pred chhhhhhcccCccccchhhhHHHHH-HHHHHHhCCCCEEEEEEcCCCCcc--hhhHHhcCHHHHHHHHHHHHHHHHHcCC
Confidence 33222 12333 455999999999999999998654 4999999999999999999999999999
Q ss_pred ceeeeeccCCCC---------CCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccce
Q 003932 134 RGLDFAWTAPNT---------STDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNW 204 (785)
Q Consensus 134 DGiDiDwE~p~~---------~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~ 204 (785)
||||||||||+. ++|+++|+.||++||++|++.+... .+.+.+++++++... ....+++++|.+++||
T Consensus 165 DGiDiDwEyP~~~~~~g~~~~~~d~~nf~~ll~eLr~~l~~~~~~~--g~~~~Lt~a~~~~~~-~~~~~d~~~l~~~vD~ 241 (419)
T 1itx_A 165 DGVDLDWEYPVSGGLDGNSKRPEDKQNYTLLLSKIREKLDAAGAVD--GKKYLLTIASGASAT-YAANTELAKIAAIVDW 241 (419)
T ss_dssp SEEEEECSCSSSCSCTTSCCCTTHHHHHHHHHHHHHHHHHHHHHHH--TSCCEEEEEECCSHH-HHHTSCHHHHHHHSSE
T ss_pred CceEEeeecCCCCCCCCCCCChhHHHHHHHHHHHHHHHHHhhhccc--CCceEEEEeccCCHH-HhhcCCHHHHHHhhhe
Confidence 999999999953 5788999999999999998754321 224566666544321 2246899999999999
Q ss_pred eeeeeccCCCccCCCCCCCCCCCCCCCCC-------CCCCCHHHHHHHHHHcCCCCCceeeccccccceeeecCCCCCCC
Q 003932 205 IHAVTASYYEPVSTNFTAPPAALYGSISG-------RFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGI 277 (785)
Q Consensus 205 v~vm~yd~~~~~~~~~~g~~apl~~~~~~-------~~~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~ 277 (785)
||||+|||||+|+ ..+||+|||+..+.+ ....+++.+|++|++.|+|++||+||||||||+|+++++..++.
T Consensus 242 inlMtYD~~g~w~-~~~g~~apL~~~~~~~~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~w~~~~~~~~g~ 320 (419)
T 1itx_A 242 INIMTYDFNGAWQ-KISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLGVPFYGRGWDGCAQAGNGQ 320 (419)
T ss_dssp EEECCCCSSCTTS-SBCCCSSCSSCCHHHHHTTCTTTTTCSHHHHHHHHHHHTCCGGGEEEEEESEEEEEESCCSGGGGT
T ss_pred eeeecccccCCCC-CCCCCCCcCcCCCCccccCCcccccccHHHHHHHHHHcCCCchhEEEEecccccceeecCCCCCCC
Confidence 9999999999996 469999999975321 23569999999999999999999999999999999877655555
Q ss_pred CCCCCCC---ccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeec--CCEEEEeCCHHHHHHHHhhhcccCccceE
Q 003932 278 GAAAAGP---ALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFST--GTVWFGFDDVEAVRAKIAYAKEKRLLGYY 352 (785)
Q Consensus 278 ~~~~~g~---~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~--~~~~i~ydd~~Si~~K~~~~~~~glgG~~ 352 (785)
+.+..|+ ++.+.|.++|.+||..+.. ..++...||+.+++||+++ +++||+|||++|++.|++||+++||||+|
T Consensus 321 ~~~~~g~~~~G~~~~G~~~y~ei~~~~~~-~~g~~~~~D~~~~~~y~y~~~~~~~v~ydd~~Si~~K~~y~~~~gLgGv~ 399 (419)
T 1itx_A 321 YQTCTGGSSVGTWEAGSFDFYDLEANYIN-KNGYTRYWNDTAKVPYLYNASNKRFISYDDAESVGYKTAYIKSKGLGGAM 399 (419)
T ss_dssp TCBCSEECSCCSSSTTEEEHHHHHHHTTT-CTTEEEEEETTTTEEEEEETTTCCEEECCCHHHHHHHHHHHHHHTCCEEE
T ss_pred CCCCCCCCCCCcccCCeeeHHHHHHhhcc-cCCcEEEeccccccceEEeCCCCEEEEeCCHHHHHHHHHHHHhCCCCeEE
Confidence 5544432 4567899999999975322 2458999999999999864 57999999999999999999999999999
Q ss_pred eeeccccchhhhhhhhh
Q 003932 353 AWQVSFDDHDWLLSQAA 369 (785)
Q Consensus 353 ~W~l~~Dd~~~~l~~~~ 369 (785)
+|+|++|+.. .|++++
T Consensus 400 ~W~l~~D~~~-~Ll~ai 415 (419)
T 1itx_A 400 FWELSGDRNK-TLQNKL 415 (419)
T ss_dssp EECGGGCTTC-HHHHHH
T ss_pred EEeecCCCCc-HHHHHH
Confidence 9999999865 455655
|
| >3qok_A Putative chitinase II; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, glycosyl hydrolases family 18; 2.60A {Klebsiella pneumoniae subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-64 Score=556.04 Aligned_cols=333 Identities=23% Similarity=0.353 Sum_probs=270.7
Q ss_pred CCCCCCcEEEEEecCCCC------CCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHH-HHH------------HHH
Q 003932 20 PAKAKPWIRVGYLNLSEV------STISGINYDLFTHLICSSADINSTTYQLSLSLPSDEN-QIA------------KFA 80 (785)
Q Consensus 20 ~~~~~~~~~vgY~~~~~~------~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~-~~~------------~~~ 80 (785)
...++.+++||||.+|.. +.++++|+++||||+|+|+.++++| .+.+.+.+.+. .+. +.+
T Consensus 20 ~~~~~~~~vvgYy~~~~~~r~~~~~~~~~i~~~~~THi~~af~~i~~~g-~~~~~~~~~d~~~~~~~w~~~~~~~~~~~~ 98 (420)
T 3qok_A 20 ALSAQPLMSVGYFNGGGDVTAGPGGDIDKLDVRQITHLNYSFGLIYNDE-KDETNAALKDPAHLHEIWLSPKVQADLQKL 98 (420)
T ss_dssp -----CCEEEEEEECSCCSSSCSCCCGGGCCCTTCSEEEEEEEEECCCC-TTCCCGGGGCGGGTTSEECCHHHHHHHTTH
T ss_pred CccCCCCEEEEEEcCccccCCCCCCCcccCCcccceEEEEEeEEECCCC-cEEecCcccchhhhhhcccccchhhhHHHH
Confidence 345567899999998875 6899999999999999999999887 44443333221 111 124
Q ss_pred HHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCC---------CCCCchh
Q 003932 81 DTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPN---------TSTDMFN 151 (785)
Q Consensus 81 ~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~---------~~~d~~~ 151 (785)
..+|++||++|||+|||||+ +..|+.+++++++|++||+++++++++|||||||||||||+ .++|+++
T Consensus 99 ~~lk~~~p~lkvllsiGG~~---s~~f~~~~~~~~~r~~fi~si~~~~~~~gfDGiDiDwE~p~~~~~~~~~~~~~d~~~ 175 (420)
T 3qok_A 99 PALRKQNPDLKVLLSVGGWG---ARGFSGAAATAESRAVFIRSAQKIIQQYGLDGIDLDWEFPVNGAWGLVASQPADRDN 175 (420)
T ss_dssp HHHHHHCTTCEEEEEEECTT---CCCHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCTTTHHHHTSCCCTTHHHH
T ss_pred HHHHHhCCCCEEEEEECCCC---CcchhhhhCCHHHHHHHHHHHHHHHHhcCCCceEEEEeCCCCCCCCCCCCChhHHHH
Confidence 55899999999999999987 34599999999999999999999999999999999999995 3788999
Q ss_pred HHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCC
Q 003932 152 IGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSI 231 (785)
Q Consensus 152 ~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~ 231 (785)
|+.|+++||++|++ +..+++++++........|+++++.+++||||||+||+||+|+. |+|||+..+
T Consensus 176 ~~~ll~eLr~~l~~---------~~~Ls~a~~~~~~~~~~~~d~~~l~~~~D~inlMtYD~~g~w~~----~~apL~~~~ 242 (420)
T 3qok_A 176 FTALLKSLREAVGE---------QKLVTIAVGANAESPKSWVDVKAVAPVLNYINLMTYDMAYGTQY----FNSNLYDSS 242 (420)
T ss_dssp HHHHHHHHHHHHCS---------SSEEEEEECSCTHHHHHTSCHHHHGGGCSEEEECCCCCCCTTCC----CSSCSSCCS
T ss_pred HHHHHHHHHHHhCC---------CcEEEEEecCccccccccccHHHHHhhCCEEEEecccCCCCCCC----CCCcccCCC
Confidence 99999999999963 56677776654322145799999999999999999999999864 999999876
Q ss_pred C-----CCCCCCHHHHHHHHHHcCCCCCceeeccccccce----------eeecCCCCCCCCCCCCCCc-----------
Q 003932 232 S-----GRFARSTDQVLKAWIERGLSADKLVMCLPFYGYA----------WTLVKPEDNGIGAAAAGPA----------- 285 (785)
Q Consensus 232 ~-----~~~~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~----------~~~~~~~~~~~~~~~~g~~----------- 285 (785)
. .....+++.+|++|++.|+|++||+||||||||. |+++++..++.+++..|++
T Consensus 243 ~~~~~~~~~~~~~~~~v~~~~~~g~p~~KlvlGip~YGr~~~~~~~~~~~w~~~~~~~~g~~~~~~g~~~~~~~~~~G~~ 322 (420)
T 3qok_A 243 HWPTVAAADKYSADFVVNNYLAAGLKPSQMNLGIGFYGRVPKRAVEPGIDWTKADAQNNPVTQPYFGPQQIALFASLGYD 322 (420)
T ss_dssp SSCCCSGGGCCCHHHHHHHHHHHTCCGGGEEEEEESEEECCGGGTSCBCCTTSTTGGGSCSBCCCCCHHHHHHHHHTTCC
T ss_pred cccccCCcccccHHHHHHHHHHcCCCHHHeEEEecccccccccccccccceecCCcccCCCCCCccCCCCCCCCCCCCcc
Confidence 2 2235699999999999999999999999999999 9988776777777655432
Q ss_pred cccCccccHHHHHhhh-hhcCCCeEEEeccceeeeeeecCC----E--EEEeCCHHHHHHHHhhhcccCccceEeeeccc
Q 003932 286 LYDSGLVTYKKIKNHI-KTYGPDVQVMYNSTYEVNYFSTGT----V--WFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSF 358 (785)
Q Consensus 286 ~~~~g~~~y~~i~~~~-~~~~~~~~~~~d~~~~~~y~~~~~----~--~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~ 358 (785)
....|.++|.+||+.+ ...+..++..||+.+++||++..+ + ||+|||++|++.|++||+++||||+|+|++++
T Consensus 323 ~~~~g~~~y~ei~~~~~~~~g~~~~~~~D~~~~~~y~~~~~~~g~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~ 402 (420)
T 3qok_A 323 LSKDTYVKYNDIVGKLLNDPQKRFTEHWDDEAKVPWLSVQSAEGKPLFALSYENPRSVAIKADYIKAKGLAGAMFWEYGA 402 (420)
T ss_dssp TTTCCEEEHHHHHHHTTTCTTCCEEEEEETTTTEEEEEEECTTSCEEEEEECCCHHHHHHHHHHHHHHTCSEEEEECGGG
T ss_pred ccCCCccCHHHHHHHhhccCCCceEEEECccccccEEEeCCCCCccceEEEcCCHHHHHHHHHHHHhCCCcEEEEEcccc
Confidence 2345569999999863 433333899999999999996433 4 99999999999999999999999999999999
Q ss_pred cchhhhhhhhhh
Q 003932 359 DDHDWLLSQAAA 370 (785)
Q Consensus 359 Dd~~~~l~~~~~ 370 (785)
|| +..|++++.
T Consensus 403 Dd-~~~Ll~a~~ 413 (420)
T 3qok_A 403 DD-QNQLARQLA 413 (420)
T ss_dssp SS-TTHHHHHHH
T ss_pred CC-ccHHHHHHH
Confidence 99 445666664
|
| >3g6m_A Chitinase, crchi1; inhibitor, caffeine, glycosidase, hydrolas hydrolase inhibitor complex; HET: CFF; 1.65A {Bionectria ochroleuca} PDB: 3g6l_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-64 Score=548.28 Aligned_cols=337 Identities=23% Similarity=0.304 Sum_probs=277.9
Q ss_pred CCCCCCCcEEEEEecCCC----CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHH-----------------HHH
Q 003932 19 HPAKAKPWIRVGYLNLSE----VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDEN-----------------QIA 77 (785)
Q Consensus 19 ~~~~~~~~~~vgY~~~~~----~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~-----------------~~~ 77 (785)
.+..++.+++||||++|. .+.+++||+++||||+|+|+.++++| ++.+.+++.+. ...
T Consensus 14 ~~~~~~~~~~v~Y~~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~g-~v~~~d~~~d~~~~~~~~~~~~~~~~~~g~~ 92 (406)
T 3g6m_A 14 LSTRATGSINAVYFTNWGIYGRNFQPADLQASKILHVLYSFMNLRVDG-TVYSGDTYADLEKHYSDDSWNDIGTNAYGCV 92 (406)
T ss_dssp -----CCBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTS-CEEESCHHHHHTCCCTTCCSCCSSSCCCHHH
T ss_pred CCcCCCCCEEEEEEChhhccCCCCChhhCChhhCCEEEEEEEEECCCC-cEEecChhhhhhhcccccccccccchhhHHH
Confidence 344566789999999986 46899999999999999999999988 67666544332 123
Q ss_pred HHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHH
Q 003932 78 KFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFD 157 (785)
Q Consensus 78 ~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~ 157 (785)
+.+..+|++||++|||+|||||..+. .|+.+++++++|++||+++++++++|||||||||||||+.++|+++|+.|++
T Consensus 93 ~~~~~lk~~~~~lKvllsiGGw~~s~--~fs~~~~~~~~R~~fi~siv~~l~~~gfDGiDiDwE~p~~~~d~~n~~~ll~ 170 (406)
T 3g6m_A 93 KQLYKLKKANRSLKIMLSIGGWTWST--NFPAAASTEATRATFAKTAVEFMKDWGFDGIDVDWEYPASETDANNMVLLLQ 170 (406)
T ss_dssp HHHHHHHHHCTTCEEEEEEECSSSCT--THHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCeEEEEEcCCCCCc--hHHHHhCCHHHHHHHHHHHHHHHHHcCCcEEEEEEECCCccchhhHHHHHHH
Confidence 34445999999999999999987644 4999999999999999999999999999999999999987778999999999
Q ss_pred HHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC--
Q 003932 158 EWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF-- 235 (785)
Q Consensus 158 ~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~-- 235 (785)
+||++|++........++..+++++++.... ...|++++|.+++||||||+|||||+|+. .+||+|||++.+.++.
T Consensus 171 eLr~~l~~~~~~~~~~~~~~Lsia~p~~~~~-~~~~d~~~l~~~vD~inlMtYD~~g~w~~-~~g~~a~l~~~~~~~~~~ 248 (406)
T 3g6m_A 171 RVRQELDSYSATYANGYHFQLSIAAPAGPSH-YNVLKLAQLGSVLDNINLMAYDYAGSWDS-VSGHQTNLYPSTSNPSST 248 (406)
T ss_dssp HHHHHHHHHHHHHSTTCCCEEEEEEECSHHH-HTTSCHHHHHHHCSEEEEECCCCSSTTSS-SCCCSSCSSCCSSCGGGC
T ss_pred HHHHHHHHhhhhccCCCCeEEEEEecCCHHH-hccCCHHHHHhhCCEEEEEcccCCCCCCC-CCCCCCcccCCCCCCcCC
Confidence 9999998765443334466777777654322 24799999999999999999999999874 5999999998765432
Q ss_pred CCCHHHHHHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCC--CCccccCccccHHHHHhhhhhcCCCeEEEec
Q 003932 236 ARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAA--GPALYDSGLVTYKKIKNHIKTYGPDVQVMYN 313 (785)
Q Consensus 236 ~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~--g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d 313 (785)
.++++.+|++|++.|+|++||+||||||||.|++++ +.+++.. |+++.+.|.++|.+|++ .++...||
T Consensus 249 ~~~~~~~v~~~~~~g~p~~KlvlGip~YGr~~~~~~----~~g~~~~g~~~~t~~~g~~~y~~l~~------~g~~~~~D 318 (406)
T 3g6m_A 249 PFSTKAAVDAYIAAGVPASKIILGMPIYGRAFVGTD----GPGKPYSTIGEGSWESGIWDYKVLPK------AGATVITD 318 (406)
T ss_dssp SCCHHHHHHHHHHTTCCGGGEEEEEESEEEEEESCS----STTSCCSBCCCCSSBTTEEEGGGCSC------TTCEEEEE
T ss_pred chhHHHHHHHHHHcCCCHHHEEEEecccceeeecCC----CCCCCCcCCCCCcCcccceeHHHHHh------cCCeEEEe
Confidence 458999999999999999999999999999999753 3344433 34567889999998865 35889999
Q ss_pred cceeeeeeec--CCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchh-hhhhhhhh
Q 003932 314 STYEVNYFST--GTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD-WLLSQAAA 370 (785)
Q Consensus 314 ~~~~~~y~~~--~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~-~~l~~~~~ 370 (785)
+.+++||.++ +++||+|||++|++.|++||+++||||+|+|++++||.. +.|+.++.
T Consensus 319 ~~~~~~y~y~~~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~~~~Ll~a~~ 378 (406)
T 3g6m_A 319 SAAGATYSYDSSSRTMISYDTPDMVRTKVSYAKGLGLGGSMFWEASADKTGSDSLIGTAL 378 (406)
T ss_dssp TTTTEEEEEETTTTEEEECCCHHHHHHHHHHHHHHTCCEEEEECGGGCCSGGGCHHHHHH
T ss_pred cCcccceEEeCCCCEEEEeCCHHHHHHHHHHHHhCCCceEEEEecccCCCCchHHHHHHH
Confidence 9999999864 679999999999999999999999999999999999964 45666664
|
| >1kfw_A Chitinase B; TIM barrel, hydrolase; 1.74A {Arthrobacter SP} SCOP: c.1.8.5 d.26.3.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-64 Score=551.67 Aligned_cols=335 Identities=21% Similarity=0.281 Sum_probs=271.6
Q ss_pred CCCCcEEEEEecCCC----CCCcCCCC----CCCCceEEEEEEEeeC-CccEEecC---------------CCcc-----
Q 003932 22 KAKPWIRVGYLNLSE----VSTISGIN----YDLFTHLICSSADINS-TTYQLSLS---------------LPSD----- 72 (785)
Q Consensus 22 ~~~~~~~vgY~~~~~----~~~~~~i~----~~~~Thi~~~f~~~~~-~~~~~~~~---------------~~~~----- 72 (785)
..+.+++||||++|. .+.+++|| .++||||+|+|+.+++ ++ .+.+. ++|.
T Consensus 5 ~~~~~~vvgY~~~W~~y~~~~~~~~i~~~~~~~~~THi~yaFa~i~~~~g-~~~~~~~~~~~~~~~~~~~~D~~~d~~~~ 83 (435)
T 1kfw_A 5 TVNGYRNVGYFAQWGVYGRAFQAKQLDVSGTAKNLTHINYSFGNINNQTL-TCFMANKAQGTGPNGSDGAGDAWADFGMG 83 (435)
T ss_dssp SBTTBEEEEEEEGGGGSTTCCCHHHHHHTSCGGGCSEEEEEEECBCTTTC-SBCCCEECCCSSTTTTTTCEEHHHHHTCC
T ss_pred CCCCcEEEEEECchhhcCCCCChhhCCcccccccCCEEEEEEEeecCCCC-eEEeeccccccccccccccccchhhhhcc
Confidence 346789999999985 35788888 4599999999999998 54 43322 1111
Q ss_pred ------------------HHHHHHHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHc---
Q 003932 73 ------------------ENQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLY--- 131 (785)
Q Consensus 73 ------------------~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y--- 131 (785)
...+.+ +..||++||++|||+|||||..+ ..|+.|++++++|++||+|+++++++|
T Consensus 84 ~~~~~~~~g~~d~~~~~~~g~~~~-l~~lK~~~p~lKvllSiGGw~~s--~~fs~~~~~~~~R~~Fi~siv~~l~~~~l~ 160 (435)
T 1kfw_A 84 YAADKSVSGKADTWDQPLAGSFNQ-LKQLKAKNPKLKVMISLGGWTWS--KNFSKAAATEASRQKLVSSCIDLYIKGNLP 160 (435)
T ss_dssp CCTTTSSSSSCCCTTCSCCHHHHH-HHHHHTTCTTCEEEEEEECSSSC--TTHHHHTSSHHHHHHHHHHHHHHHTSCCEE
T ss_pred ccccccccccccccchhhHHHHHH-HHHHHHhCCCCEEEEEEcCCCCc--chhhHHhCCHHHHHHHHHHHHHHHHhhccc
Confidence 123444 44599999999999999999764 459999999999999999999999875
Q ss_pred -------------CCceeeeeccCCCCC-----------CCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccC
Q 003932 132 -------------GFRGLDFAWTAPNTS-----------TDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYS 187 (785)
Q Consensus 132 -------------~~DGiDiDwE~p~~~-----------~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~ 187 (785)
+|||||||||||+.. +|++||+.||++||++|++.+... .+++.+++++++...
T Consensus 161 ~~~~~g~~g~~~~~fDGiDiDwEyP~~~~g~~g~~~~p~~d~~nf~~ll~eLr~~l~~~~~~~--g~~~~Ls~Avp~~~~ 238 (435)
T 1kfw_A 161 NFEGRGGAGAAAGIFDGIDIDWEWPGTNSGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTN--NKKYVLSAFLPANPA 238 (435)
T ss_dssp EETTEEETTTTTTTCCEEEEECSCTTSSCSSTTCCCCTTTHHHHHHHHHHHHHHHHHHHHHHT--TCCCEEEEEECSSHH
T ss_pred ccccccccccccCCCCceEEeeeCCCCCCCCCCCCCCcHHHHHHHHHHHHHHHHhhhhhhccc--CCceEEEEEccCChh
Confidence 699999999999753 789999999999999998754332 235667776655432
Q ss_pred CCCcc-ccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHcCCCCCceeecccc
Q 003932 188 PPANS-YLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGR----FARSTDQVLKAWIERGLSADKLVMCLPF 262 (785)
Q Consensus 188 ~~~~~-~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~----~~~~~~~~v~~~~~~gvp~~KlvlGip~ 262 (785)
....+ |++++|.+++||||||+|||||+|+...+||+|||+..+.++ ...+++.+|++|+++|+|++||+|||||
T Consensus 239 ~~~~g~~d~~~l~~~vD~invMtYD~~g~w~~~~tg~~apL~~~~~~~~~~~~~~~v~~av~~~~~~gvp~~KlvlGip~ 318 (435)
T 1kfw_A 239 DIDAGGWDDPANFKSLDFGSIQGYDLHGAWNPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAGIDPKQLGLGLAA 318 (435)
T ss_dssp HHHHHTTTCGGGGGTCSEEEECCSCSSCTTSTTBCCCSSCSSCCTTCCSCGGGCCCHHHHHHHHHHTTCCGGGEEEEEES
T ss_pred hhccCcccHHHHHhhhheeeeeeecccCCCCCCCCCCCCcCCCCCCCcccccccccHHHHHHHHHHcCCCHHHEEEEecc
Confidence 11223 899999999999999999999999754599999999876543 3568999999999999999999999999
Q ss_pred ccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHHHHHhh
Q 003932 263 YGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAY 342 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~~K~~~ 342 (785)
|||+|+++++..++......++++.+.|+++|.+| . .+++..||+.+.++|.+++++||+|||++|++.|++|
T Consensus 319 YGr~w~~~~~~~~g~~~~~~~~~t~~~G~~~y~ei----~---~~~~~~~D~~~~~~y~y~~~~~vsydd~~Si~~K~~y 391 (435)
T 1kfw_A 319 YGRGWTGAKNVSPWGPATDGAPGTYETANEDYDKL----K---TLGTDHYDAATGSAWRYDGTQWWSYDNIATTKQKTDY 391 (435)
T ss_dssp EEEEEESCCCSSSSCBCSEECCCSSBTTEEEHHHH----T---TSSEEEEETTTTEEEEECSSCEEEECCHHHHHHHHHH
T ss_pred cceeeecCCCCCCCCCCCCCCCCCCcCCceeHHHh----c---CCCeEEEccccceeEEEECCEEEEecCHHHHHHHHHH
Confidence 99999998766554222234566788999999999 1 2368999999999999989999999999999999999
Q ss_pred hcccCccceEeeeccccchhhhhhhhhh
Q 003932 343 AKEKRLLGYYAWQVSFDDHDWLLSQAAA 370 (785)
Q Consensus 343 ~~~~glgG~~~W~l~~Dd~~~~l~~~~~ 370 (785)
|+++||||+|+|+|++ |.++.|++++.
T Consensus 392 ~~~~gLgGv~~W~l~~-D~~~~Ll~a~~ 418 (435)
T 1kfw_A 392 IVSKGLGGGMWWELSG-DRNGELVGAMS 418 (435)
T ss_dssp HHHTTCCEEEEECGGG-CTTCHHHHHHH
T ss_pred HHhCCCCEEEEEecCC-CCCchHHHHHH
Confidence 9999999999999999 55666767764
|
| >1ll7_A Chitinase 1; beta-alpha barrel, hydrolase; 2.00A {Coccidioides immitis} SCOP: c.1.8.5 d.26.3.1 PDB: 1d2k_A 1ll4_A* 1ll6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-63 Score=537.58 Aligned_cols=330 Identities=22% Similarity=0.352 Sum_probs=274.4
Q ss_pred CcEEEEEecCCCC----CCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccH------------------HHHHHHHHH
Q 003932 25 PWIRVGYLNLSEV----STISGINYDLFTHLICSSADINSTTYQLSLSLPSDE------------------NQIAKFADT 82 (785)
Q Consensus 25 ~~~~vgY~~~~~~----~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~ 82 (785)
++++||||++|.. +.+++||+++||||+|+|+.++++| ++.+.+++.+ ..+.+ +..
T Consensus 2 ~~~vvgY~~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~g-~v~~~d~~~d~~~~~~~~~w~~~~~~~~~~~~~-l~~ 79 (392)
T 1ll7_A 2 GFRSVVYFVNWAIYGRGHNPQDLKADQFTHILYAFANIRPSG-EVYLSDTWADTDKHYPGDKWDEPGNNVYGCIKQ-MYL 79 (392)
T ss_dssp CBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTS-CEEESCHHHHTTCCCTTCCSSCSSCCCCHHHHH-HHH
T ss_pred CcEEEEEECchhhcCCCCChhhCCcccCCEEEEEEEEECCCC-eEEecChhhhhhcccCCccccccchhhhHHHHH-HHH
Confidence 5789999999854 5799999999999999999999987 6666543322 12334 445
Q ss_pred HHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHH
Q 003932 83 VKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIA 162 (785)
Q Consensus 83 ~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~ 162 (785)
+|+++|++|||+|||||+.+ ..|+.+++++++|++||+++++++++|||||||||||||+.++|+++|+.||++||++
T Consensus 80 lk~~~~~lKvllsiGG~~~s--~~f~~~~~~~~~r~~fi~siv~~l~~~~fDGiDiDwE~p~~~~d~~~~~~ll~eLr~~ 157 (392)
T 1ll7_A 80 LKKNNRNLKTLLSIGGWTYS--PNFKTPASTEEGRKKFADTSLKLMKDLGFDGIDIDWQYPEDEKQANDFVLLLKACREA 157 (392)
T ss_dssp HHHHCTTCEEEEEEEHHHHG--GGSHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCeEEEEEeCCCCC--chHhHHhCCHHHHHHHHHHHHHHHHhcCCCcEEEEeeCCCChHHHHHHHHHHHHHHHH
Confidence 99999999999999998754 4599999999999999999999999999999999999998778999999999999999
Q ss_pred hhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC--CCCHH
Q 003932 163 ATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF--ARSTD 240 (785)
Q Consensus 163 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~--~~~~~ 240 (785)
|++.+......+++.+++++++... ....|++++|.+++||||||+||+||+|+ ..+||+|||++.+.++. .++++
T Consensus 158 l~~~~~~~~~~~~~~Ls~av~~~~~-~~~~~d~~~l~~~vD~inlMtYD~~g~w~-~~~g~~apl~~~~~~~~~~~~~v~ 235 (392)
T 1ll7_A 158 LDAYSAKHPNGKKFLLTIASPAGPQ-NYNKLKLAEMDKYLDFWNLMAYDFSGSWD-KVSGHMSNVFPSTTKPESTPFSSD 235 (392)
T ss_dssp HHHHHHTSTTSCCCEEEEEEECSHH-HHTTSCHHHHHTTCSEEEEECCCSSSTTS-SBCCCSSCSSCCSSCGGGCSCCHH
T ss_pred HHhhhhcccCCCceEEEEEecCCHH-HhccCCHHHHHHhhheeeEEeecccCCCC-CCCCCCCcCCCCCCCCccccccHH
Confidence 9876544334456777777765432 22368999999999999999999999987 46999999998765432 35899
Q ss_pred HHHHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCCCC--ccccCccccHHHHHhhhhhcCCCeEEEeccceee
Q 003932 241 QVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGP--ALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEV 318 (785)
Q Consensus 241 ~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~--~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~ 318 (785)
.+|++|++.|+|++||+||||||||.|++.+ +.+++..|+ ++.+.|.++|.+|++ .+++..||+.+.+
T Consensus 236 ~~v~~~~~~gvp~~KlvlGip~YGr~~~~~~----~~g~~~~g~~~g~~~~g~~~y~~l~~------~g~~~~~D~~~~~ 305 (392)
T 1ll7_A 236 KAVKDYIKAGVPANKIVLGMPLYGRAFASTD----GIGTSFNGVGGGSWENGVWDYKDMPQ------QGAQVTELEDIAA 305 (392)
T ss_dssp HHHHHHHHTTCCGGGEEEEEESEEEEECSCS----STTSBCCCCCCBSSSTTEEEGGGCSC------TTCEEEEETTTTE
T ss_pred HHHHHHHHcCCChhHEEEEecccceeeeccC----CCCCcCCCCCCCCCccccccHHHHhh------CCCeEEEecccce
Confidence 9999999999999999999999999998754 334444433 345778999988764 3588999999999
Q ss_pred eeee--cCCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchh-hhhhhhhh
Q 003932 319 NYFS--TGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD-WLLSQAAA 370 (785)
Q Consensus 319 ~y~~--~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~-~~l~~~~~ 370 (785)
||.+ .+++||+|||++|++.|++||+++||||+|+|+|++||.. +.|++++.
T Consensus 306 ~y~y~~~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~~~~Ll~a~~ 360 (392)
T 1ll7_A 306 SYSYDKNKRYLISYDTVKIAGKKAEYITKNGMGGGMWWESSSDKTGNESLVGTVV 360 (392)
T ss_dssp EEEEETTTTEEEECCCHHHHHHHHHHHHHTTCCEEEEECTTSCCCGGGCHHHHHH
T ss_pred eEEEECCCCEEEEeCCHHHHHHHHHHHHhCCCCeEEEEeecCCCCCcchHHHHHH
Confidence 9987 4789999999999999999999999999999999999953 56667664
|
| >1w9p_A Chitinase; peptide inhibitors, argifin, argadin, glycosidase, hydrolase; 1.7A {Aspergillus fumigatus} SCOP: c.1.8.5 d.26.3.1 PDB: 1w9u_A* 1w9v_A* 2a3a_A* 2a3b_A* 2a3c_A* 2a3e_A* 2iuz_A* 3ch9_A 3chc_A* 3chd_A* 3che_A* 3chf_A* 1wno_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-62 Score=538.27 Aligned_cols=333 Identities=20% Similarity=0.332 Sum_probs=275.0
Q ss_pred CCCcEEEEEecCCCC----CCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccH------------------HHHHHHH
Q 003932 23 AKPWIRVGYLNLSEV----STISGINYDLFTHLICSSADINSTTYQLSLSLPSDE------------------NQIAKFA 80 (785)
Q Consensus 23 ~~~~~~vgY~~~~~~----~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~------------------~~~~~~~ 80 (785)
.+.+++||||++|.. +.+++|+.++||||+|+|+.++++.+++.+.+++.+ ..+.++
T Consensus 40 ~~~~~vvgYy~~W~~y~r~~~~~~i~~~~~THI~yaF~~i~~~~g~v~~~d~~~d~~~~~~~~~w~~~~~~~~~~~~~l- 118 (433)
T 1w9p_A 40 SSGYRSVVYFVNWAIYGRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCIKQL- 118 (433)
T ss_dssp BCCBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTTCCEEESCHHHHHTCCCTTCCSSCCSSCCCHHHHHH-
T ss_pred CCCCEEEEEECchhhcCCCCChhHCCHhhCCEEEEEEEEecCCCCeeeecCchhhhhcccCCccccccchhhhHHHHHH-
Confidence 467899999998864 579999999999999999999984346766654322 123343
Q ss_pred HHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHH
Q 003932 81 DTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWR 160 (785)
Q Consensus 81 ~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr 160 (785)
..+|+++|++|||+|||||..+ ..|+.+++++++|++||+++++++++|||||||||||||++++|+++|+.|+++||
T Consensus 119 ~~lK~~~~~lKvllsiGGw~~s--~~fs~~~~~~~~R~~fi~siv~~l~~~gfDGIDiDwEyP~~~~d~~nf~~ll~eLr 196 (433)
T 1w9p_A 119 YLLKKQNRNLKVLLSIGGWTYS--PNFAPAASTDAGRKNFAKTAVKLLQDLGFDGLDIDWEYPENDQQANDFVLLLKEVR 196 (433)
T ss_dssp HHHHHHCTTCEEEEEEECTTTG--GGHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCEEEEEEeCCCCC--cchhhHhcCHHHHHHHHHHHHHHHHhcCcCceeEEEEeccChhHHHHHHHHHHHHH
Confidence 4599999999999999998764 45999999999999999999999999999999999999987788999999999999
Q ss_pred HHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC--CCC
Q 003932 161 IAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF--ARS 238 (785)
Q Consensus 161 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~--~~~ 238 (785)
++|++.+......+++.+++++++... ....|++++|.+++||||||+||+||+|+ ..+||+|||++.+.++. .++
T Consensus 197 ~~l~~~~~~~~~~~~~~Ls~avp~~~~-~~~~~d~~~l~~~vD~inlMtYD~~G~w~-~~~g~~apL~~~~~~~~~~~~~ 274 (433)
T 1w9p_A 197 TALDSYSAANAGGQHFLLTVASPAGPD-KIKVLHLKDMDQQLDFWNLMAYDYAGSFS-SLSGHQANVYNDTSNPLSTPFN 274 (433)
T ss_dssp HHHHHHHHHHSTTCCCEEEEEECCSHH-HHHHSCHHHHHTTCSEEEECCCCCSSTTS-SSCCCSSCSSCCTTCGGGCSCC
T ss_pred HHHHhhhhcccCCCceEEEEEccCCHH-HhhhCCHHHHHHhhheeeeeccccCCCCC-CCCCCCCcCCCCCCCCCCCccc
Confidence 999876544334456677777655332 22368999999999999999999999987 46999999997664432 458
Q ss_pred HHHHHHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCCCC--ccccCccccHHHHHhhhhhcCCCeEEEeccce
Q 003932 239 TDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGP--ALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTY 316 (785)
Q Consensus 239 ~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~--~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~ 316 (785)
++.+|++|++.|+|++||+||||||||.|++.+ +.|++..|+ ++.+.|.++|.+|++ .++...||+.+
T Consensus 275 v~~~v~~~~~~Gvp~~KlvlGip~YGr~w~~~~----~~g~~~~g~~~g~~~~g~~~y~~l~~------~g~~~~~D~~~ 344 (433)
T 1w9p_A 275 TQTALDLYRAGGVPANKIVLGMPLYGRSFANTD----GPGKPYNGVGQGSWENGVWDYKALPQ------AGATEHVLPDI 344 (433)
T ss_dssp HHHHHHHHHHTTCCGGGEEEEEESEEEEESSCS----STTSCCCCCCCCSSBTTEEEGGGCSC------TTCEEEEEGGG
T ss_pred HHHHHHHHHHcCCChhHEEEEecccceeeeccC----CCCCcccCCCCCCCccceeeHHHHHh------CCCEEEecccc
Confidence 999999999999999999999999999998754 234444333 346788999998764 35889999999
Q ss_pred eeeeee--cCCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchh-hhhhhhhh
Q 003932 317 EVNYFS--TGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD-WLLSQAAA 370 (785)
Q Consensus 317 ~~~y~~--~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~-~~l~~~~~ 370 (785)
..+|.+ .+++||+|||++|++.|++||+++||||+|+|++++||.+ +.|++++.
T Consensus 345 ~~~y~yd~~~~~~v~ydd~~Si~~K~~~~~~~gLgGv~~W~l~~Dd~~~~~Ll~ai~ 401 (433)
T 1w9p_A 345 MASYSYDATNKFLISYDNPQVANLKSGYIKSLGLGGAMWWDSSSDKTGSDSLITTVV 401 (433)
T ss_dssp TEEEEEETTTTEEEECCCHHHHHHHHHHHHHHTCCEEEEECGGGSCCGGGCHHHHHH
T ss_pred CcceEEECCCCEEEEcCCHHHHHHHHHHHHhCCCCEEEEEeccCCCCCcchHHHHHH
Confidence 999987 4789999999999999999999999999999999999953 56666664
|
| >1goi_A Chitinase B; chitin degradation, hydrolase, glycosidase; 1.45A {Serratia marcescens} SCOP: b.72.2.1 c.1.8.5 d.26.3.1 PDB: 1o6i_A* 1e6r_A* 1e15_A 1gpf_A* 1ur8_A* 1w1p_A* 1w1t_A* 1w1v_A* 1w1y_A* 1e6p_A 1e6n_A 1h0g_A* 1h0i_A* 1ogb_A 1ogg_A* 1e6z_A* 1ur9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-62 Score=549.09 Aligned_cols=343 Identities=23% Similarity=0.374 Sum_probs=282.0
Q ss_pred CCCcEEEEEec--C--------CC----CCCcCCCC---CCCCceEEEEEEEeeCCccEEecCCCccH----HHHHHHHH
Q 003932 23 AKPWIRVGYLN--L--------SE----VSTISGIN---YDLFTHLICSSADINSTTYQLSLSLPSDE----NQIAKFAD 81 (785)
Q Consensus 23 ~~~~~~vgY~~--~--------~~----~~~~~~i~---~~~~Thi~~~f~~~~~~~~~~~~~~~~~~----~~~~~~~~ 81 (785)
.+.+++||||+ + +. .+.+++|+ .++||||+|+|+.++++| .+.+.+++.+ ..+.+ +.
T Consensus 2 ~~~~~vvgYy~~~~~~w~~~~~~~~~~~~~~~~~i~~~q~~~~THi~yaF~~i~~~g-~~~~~~~~~d~~~~~~~~~-l~ 79 (499)
T 1goi_A 2 STRKAVIGYYFIPTNQINNYTETDTSVVPFPVSNITPAKAKQLTHINFSFLDINSNL-ECAWDPATNDAKARDVVNR-LT 79 (499)
T ss_dssp -CCCEEEEEEECCHHHHHTCCSSCTTTCSSCGGGSCHHHHHHCSEEEEEEEEECTTS-SEECCTTCCHHHHHHHHHH-HH
T ss_pred CCCCEEEEEEccCccccccccccCCccCcCCHhHCCCccccCCCEEEEEeEEECCCC-eEEecCcccchhhHHHHHH-HH
Confidence 35678999998 6 33 57899999 999999999999999887 6777654432 23444 44
Q ss_pred HHHhcCCCceEEEEecCCCCCC-----cccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHH
Q 003932 82 TVKKKNPSITTILSIGQGKDTN-----YSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLF 156 (785)
Q Consensus 82 ~~k~~~p~lkv~~sigG~~~~~-----~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll 156 (785)
.+|++||++|||+|||||..++ ...|+.+++++++|++||+++++++++|||||||||||||+ ++|+++|+.||
T Consensus 80 ~lk~~~p~lKvllSiGGw~~s~~~~~~~~~f~~~~~~~~~r~~fi~siv~~~~~~gfDGiDiDwE~p~-~~d~~~~~~ll 158 (499)
T 1goi_A 80 ALKAHNPSLRIMFSIGGWYYSNDLGVSHANYVNAVKTPASRAKFAQSCVRIMKDYGFDGVNIDWEYPQ-AAEVDGFIAAL 158 (499)
T ss_dssp HGGGGCTTCEEEEEEECHHHHSTTSTTHHHHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCC-HHHHHHHHHHH
T ss_pred HHHHhCCCCeEEEEECCCCCCCCcccccchhhHhhCCHHHHHHHHHHHHHHHHHcCCCeEEEecccCC-hhhHHHHHHHH
Confidence 5999999999999999985431 15699999999999999999999999999999999999995 68999999999
Q ss_pred HHHHHHhhhhhhhccc-ccceeEEEEeecccCCCCccc-cHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCC
Q 003932 157 DEWRIAATKLDAKNST-RQQSLLILTARFRYSPPANSY-LLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGR 234 (785)
Q Consensus 157 ~~lr~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~ 234 (785)
++||++|++.+..... ..++.+++++++........| ++++|.+++||||||+||+||+|+ ..+||+|||++.+.++
T Consensus 159 ~eLr~~l~~~~~~~g~~~~~~~Ls~a~~~~~~~~~~~y~d~~~l~~~vD~inlMtYD~~g~w~-~~tg~~apL~~~~~~~ 237 (499)
T 1goi_A 159 QEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVAPLDYINLMTYDLAGPWE-KVTNHQAALFGDAAGP 237 (499)
T ss_dssp HHHHHHHHHHHHHTTCTTSCCEEEEEEESSHHHHTTTGGGHHHHHTTCSEEEEECCCSSCTTS-SSCCCTTCSSBCTTSC
T ss_pred HHHHHHhhhhhhhcccccCceEEEEeccCCHHHHhhhhhhHHHHhhcCCEEEEEeeeccCCCC-CCCCCCCcCcCCCCCc
Confidence 9999999875432211 114567776655432222333 999999999999999999999986 4699999999765543
Q ss_pred -----------------------C--CCCHHHHHHHHHH-cCCCCCceeeccccccceeeecCCCCCCCCCCCCCCcc--
Q 003932 235 -----------------------F--ARSTDQVLKAWIE-RGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPAL-- 286 (785)
Q Consensus 235 -----------------------~--~~~~~~~v~~~~~-~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~-- 286 (785)
. ..+++.+|++|++ +|+|++||+||||||||.|+++++.+++++++..+|..
T Consensus 238 ~~~n~l~~~~~~~~~~~~~~~~~~~~~~~v~~av~~~~~~~Gvp~~KlvlGip~YGr~w~~~~~~~~g~~~~~~~~~~~~ 317 (499)
T 1goi_A 238 TFYNALREANLGWSWEELTRAFPSPFSLTVDAAVQQHLMMEGVPSAKIVMGVPFYGRAFKGVSGGNGGQYSSHSTPGEDP 317 (499)
T ss_dssp CBCCGGGGSSCCCCHHHHHHHCCSSBCCCHHHHHHHHHTSTTCCGGGEEEEEESEEEEEESCCSSSTTTTCCCCCCCCSS
T ss_pred cccccccccccccccccccccccccccccHHHHHHHHHHhcCCCHHHeEEEecccceeeEecCCCCCCCCCcccCCCCCc
Confidence 1 4589999999999 99999999999999999999998877777776655432
Q ss_pred -----------------ccCccccHHHHHhhhhhcCCCeEEEeccceeeeeee--cCCEEEEeCCHHHHHHHHhhhcccC
Q 003932 287 -----------------YDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFS--TGTVWFGFDDVEAVRAKIAYAKEKR 347 (785)
Q Consensus 287 -----------------~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~--~~~~~i~ydd~~Si~~K~~~~~~~g 347 (785)
.++|.++|.+||+.+.. ..+++..||+.+.+||++ ++++||+|||++|++.|++||+++|
T Consensus 318 ~~~~~~~~~g~~~c~~~~~~g~~~y~ei~~~~~~-~~g~~~~~D~~~~~~y~y~~~~~~~vsydd~~Si~~K~~y~~~~g 396 (499)
T 1goi_A 318 YPSTDYWLVGCEECVRDKDPRIASYRQLEQMLQG-NYGYQRLWNDKTKTPYLYHAQNGLFVTYDDAESFKYKAKYIKQQQ 396 (499)
T ss_dssp CSSSCCCSTTCHHHHHHTCTTEEEHHHHHHHHHT-TSSEEEEEETTTTEEEEEETTTTEEEECCCHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccCCCCcccHHHHHHhhhc-CCCceEEEccccceEEEEECCCCEEEEeeCHHHHHHHHHHHHhcC
Confidence 24568999999987653 246899999999999986 6789999999999999999999999
Q ss_pred ccceEeeeccccchhhhhhhhhh
Q 003932 348 LLGYYAWQVSFDDHDWLLSQAAA 370 (785)
Q Consensus 348 lgG~~~W~l~~Dd~~~~l~~~~~ 370 (785)
|||+|+|+|++||.+..|++++.
T Consensus 397 LgGv~~W~l~~Dd~~~~Ll~ai~ 419 (499)
T 1goi_A 397 LGGVMFWHLGQDNRNGDLLAALD 419 (499)
T ss_dssp CCEEEEECGGGSCTTCHHHHHHH
T ss_pred CCceEEEeeccCCCCchHHHHHH
Confidence 99999999999997666767664
|
| >1jnd_A Imaginal DISC growth factor-2; IDGF, chitinase, insulin recep heparin, hormone-growth factor complex; HET: NAG BMA MAN; 1.30A {Drosophila melanogaster} SCOP: c.1.8.5 d.26.3.1 PDB: 1jne_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-62 Score=539.84 Aligned_cols=327 Identities=21% Similarity=0.335 Sum_probs=265.5
Q ss_pred cEEEEEecCCC-------CCCcCCCC--CCCCceEEEEEEEeeCCccEEecCCCccH---HHHHHHHHHHHhcCCCceEE
Q 003932 26 WIRVGYLNLSE-------VSTISGIN--YDLFTHLICSSADINSTTYQLSLSLPSDE---NQIAKFADTVKKKNPSITTI 93 (785)
Q Consensus 26 ~~~vgY~~~~~-------~~~~~~i~--~~~~Thi~~~f~~~~~~~~~~~~~~~~~~---~~~~~~~~~~k~~~p~lkv~ 93 (785)
+++||||++|. .+.+++|| .++||||+|+|+.++++++++...+++.+ ..+.+ +..+|++||++|||
T Consensus 2 ~~vvgYy~~w~~~r~~~~~~~~~~i~~~~~~~THi~yaFa~i~~~~~~~~~~d~~~d~~~~~~~~-~~~lk~~~p~lKvl 80 (420)
T 1jnd_A 2 SNLVCYYDSSSYTREGLGKLLNPDLEIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSE-VTSLKRKYPHLKVL 80 (420)
T ss_dssp CEEEEEEEGGGGGCSSTTCCCHHHHHHHGGGCSEEEEEEEEECTTTCCEEETTHHHHTTTCHHHH-HHGGGGTSTTCEEE
T ss_pred CeEEEEEccchhcCCCCCCcCHhHcCCccccCCEEEEEEEEecCCCCEEEecCccchhhhHHHHH-HHHHHhhCCCceEE
Confidence 47899998875 35677887 47899999999999998767776644211 23444 44599999999999
Q ss_pred EEecCCCCC---CcccchhhhcChhhh-HHHHHHHHHHHHHcCCceeeeeccCCCCC-----------------------
Q 003932 94 LSIGQGKDT---NYSIYSSMVRNSSHR-KSFIDSSIRIARLYGFRGLDFAWTAPNTS----------------------- 146 (785)
Q Consensus 94 ~sigG~~~~---~~~~fs~~~~~~~~r-~~fi~si~~~~~~y~~DGiDiDwE~p~~~----------------------- 146 (785)
+|||||+.+ ++..|+.+++++++| ++||+|+++++++|||||||||||||+..
T Consensus 81 lsiGGw~~~~~~~s~~f~~~~~~~~~R~~~Fi~s~v~~~~~~gfDGiDiDwEyP~~~~~~~~g~~g~~~~~~~~~~~g~~ 160 (420)
T 1jnd_A 81 LSVGGDHDIDPDHPNKYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAYQFPKNKPRKVHGDLGLAWKSIKKLFTGDF 160 (420)
T ss_dssp EEEETTCCCCTTSTTHHHHHHTCCHHHHHHHHHHHHHHHHHTTCSEEEEECCCCCCCCCCC-------------------
T ss_pred EEeCCCcCCCCccchhhhHhhcChHHHHHHHHHHHHHHHHHcCCCceEEeeecCCccccccccccccccccccccccCCc
Confidence 999999763 245699999999999 99999999999999999999999999642
Q ss_pred -------CCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCC-
Q 003932 147 -------TDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVST- 218 (785)
Q Consensus 147 -------~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~- 218 (785)
+|++||+.||++||++|+.. ++.+++++++.. .....|++++|.+++||||||+||+||+|++
T Consensus 161 ~~~~~~~~d~~nf~~ll~eLr~~l~~~--------~~~Ls~av~~~~-~~~~~~d~~~l~~~vD~inlMtYD~~g~~~~~ 231 (420)
T 1jnd_A 161 IVDPHAALHKEQFTALVRDVKDSLRAD--------GFLLSLTVLPNV-NSTWYFDIPALNGLVDFVNLATFDFLTPARNP 231 (420)
T ss_dssp CCCTTHHHHHHHHHHHHHHHHHHHHTT--------TCEEEEEECTTC-CHHHHCCHHHHHTTCSEEEECCCCSSCTTTCT
T ss_pred ccccCChhHHHHHHHHHHHHHHHHhhc--------CcEEEEEEeCCc-chhhccCHHHHHhhCcEEEEeeeecCCCcCCC
Confidence 46899999999999999752 456666665432 2234689999999999999999999999974
Q ss_pred CCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHcCCCCCceeeccccccceeeecCCCCC--------CCCCCCCCCccc
Q 003932 219 NFTAPPAALYGSISG---RFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDN--------GIGAAAAGPALY 287 (785)
Q Consensus 219 ~~~g~~apl~~~~~~---~~~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~--------~~~~~~~g~~~~ 287 (785)
..+||+|||+..+.+ ....+++.+|++|+++|+|++||+||||||||+|++++..+. ..|....|+++.
T Consensus 232 ~~~g~~apl~~~~~~~~~~~~~~v~~~v~~~~~~gvp~~KlvlGip~YGr~w~~~~~~~~~g~~~~~~~~g~~~~g~~t~ 311 (420)
T 1jnd_A 232 EEADYSAPIYHPDGSKDRLAHLNADFQVEYWLSQGFPSNKINLGVATYGNAWKLTKDSGLEGVPVVPETSGPAPEGFQSQ 311 (420)
T ss_dssp TCBCCSSCSSCCTTSTTCCTTCSHHHHHHHHHHTTCCGGGEEEEEESEEEEEECCGGGCSCCSSCBCSCCSBCCCCTTTC
T ss_pred CccccCCcccCCccccCccccccHHHHHHHHHHcCCCHHHEEEEecccceeeEecCCCCCCCCCcccccCCCCCCCCCCC
Confidence 468999999986632 235689999999999999999999999999999998754321 122334466788
Q ss_pred cCccccHHHHHhhhhhcCC--------CeEEEeccce-eeeeee-------cCCEEEEeCCHHHHHHHHhhhcccCccce
Q 003932 288 DSGLVTYKKIKNHIKTYGP--------DVQVMYNSTY-EVNYFS-------TGTVWFGFDDVEAVRAKIAYAKEKRLLGY 351 (785)
Q Consensus 288 ~~g~~~y~~i~~~~~~~~~--------~~~~~~d~~~-~~~y~~-------~~~~~i~ydd~~Si~~K~~~~~~~glgG~ 351 (785)
++|.++|.|||+.+...+. .+...||+.. ..+|.+ .+++||+|||++|++.|++||+++||||+
T Consensus 312 ~~G~~~y~ei~~~~~~~~~~~~~g~~~~~~~~~D~~~~~~~y~y~~~d~~~~~~~wvsydd~~Si~~K~~y~~~~gLgGv 391 (420)
T 1jnd_A 312 KPGLLSYAEICGKLSNPQNQFLKGNESPLRRVSDPTKRFGGIAYRPVDGQITEGIWVSYDDPDSASNKAAYARVKNLGGV 391 (420)
T ss_dssp CTTEEEHHHHHHHBCCTTTTTCCGGGSCBEEECCTTCCSCEEEEECSBTTBCCCEEEEECCHHHHHHHHHHHHHTTCSEE
T ss_pred CCceeeHHHHHHhhcccCcccccccccceeEEechhhccceeEEEecccCCCCCEEEEcCCHHHHHHHHHHHHhCCCceE
Confidence 8999999999998764322 3678899864 456664 35899999999999999999999999999
Q ss_pred Eeeeccccchh
Q 003932 352 YAWQVSFDDHD 362 (785)
Q Consensus 352 ~~W~l~~Dd~~ 362 (785)
|+|+|++||..
T Consensus 392 ~~W~l~~Dd~~ 402 (420)
T 1jnd_A 392 ALFDLSYDDFR 402 (420)
T ss_dssp EEECGGGSCTT
T ss_pred EEEeeccCCCC
Confidence 99999999954
|
| >1edq_A Chitinase A; beta-alpha (TIM) barrel, hydrolase; 1.55A {Serratia marcescens} SCOP: b.1.18.2 c.1.8.5 d.26.3.1 PDB: 1ffq_A* 1ffr_A* 1ehn_A* 1ctn_A 1k9t_A* 1eib_A* 2wlz_A* 2wly_A* 2wm0_A* 2wk2_A* 1nh6_A* 1x6l_A 1rd6_A 1x6n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-62 Score=548.69 Aligned_cols=337 Identities=21% Similarity=0.317 Sum_probs=269.7
Q ss_pred CCcEEEEEecCCC----CCCcCCCCCCCCceEEEEEEEeeCC-------------------------ccEEecCCCccH-
Q 003932 24 KPWIRVGYLNLSE----VSTISGINYDLFTHLICSSADINST-------------------------TYQLSLSLPSDE- 73 (785)
Q Consensus 24 ~~~~~vgY~~~~~----~~~~~~i~~~~~Thi~~~f~~~~~~-------------------------~~~~~~~~~~~~- 73 (785)
+.++++|||++|. .+++++||+++||||+|+|+.++.+ .+++.+.++|.+
T Consensus 133 ~~~~v~~Y~~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~~~~n~~l~~~~g~~~~~~~~c~~~~~~~v~~~D~~ad~ 212 (540)
T 1edq_A 133 SGKVVGSYFVEWGVYGRNFTVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSCQGREDFKVSIHDPFAAL 212 (540)
T ss_dssp SSCEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEECBCCCTTTSGGGGGSTTHHHHHHHHTTTCCTTSBCCSCHHHHH
T ss_pred CCcEEEEEECcccccCCCCChhHCCHhhCCEEEEeeecccCcccccccccccccchhhhhcccccccCcceEecChhHhh
Confidence 5578899999985 4789999999999999999998641 123333332221
Q ss_pred --------------HHHHHHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcC-Cceeee
Q 003932 74 --------------NQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYG-FRGLDF 138 (785)
Q Consensus 74 --------------~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~-~DGiDi 138 (785)
......+..||++||++|||+|||||..+. .|+.| +++++|++||+|+++||++|| ||||||
T Consensus 213 ~~~~~g~~~~~~~~~g~~~~l~~lK~~~p~lKvllSiGGw~~s~--~F~~~-~~~~~R~~Fi~siv~~l~~yg~fDGIDI 289 (540)
T 1edq_A 213 QKAQKGVTAWDDPYKGNFGQLMALKQAHPDLKILPSIGGWTLSD--PFFFM-GDKVKRDRFVGSVKEFLQTWKFFDGVDI 289 (540)
T ss_dssp TSCBTTBCSTTCSSCHHHHHHHHHHHHCTTCEEEEEEECSSSCG--GGGGT-TSHHHHHHHHHHHHHHHHHCTTCCEEEE
T ss_pred ccccCCcccccccchhhHHHHHHHHHhCCCCeEEEEEeCCcCCC--cchhh-cCHHHHHHHHHHHHHHHHHcCCCceEEE
Confidence 112334456999999999999999998754 49987 699999999999999999999 999999
Q ss_pred eccCCC---------CCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeee
Q 003932 139 AWTAPN---------TSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVT 209 (785)
Q Consensus 139 DwE~p~---------~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~ 209 (785)
|||||+ +++|++||+.||++||++|++.+... .+++.+++++++... ....+++++|.+++||||||+
T Consensus 290 DWEyP~~~g~~~~~g~~~D~~nf~~ll~eLr~~l~~~~~~~--g~~~~LT~Av~a~~~-~~~~~d~~~l~~~vD~inlMt 366 (540)
T 1edq_A 290 DWEFPGGKGANPNLGSPQDGETYVLLMKELRAMLDQLSVET--GRKYELTSAISAGKD-KIDKVAYNVAQNSMDHIFLMS 366 (540)
T ss_dssp ECSCTTSCSSCTTCCCTTHHHHHHHHHHHHHHHHHHHHHHH--TCCCEEEEEEECSHH-HHTTSCHHHHGGGCSEEEEEC
T ss_pred EEEccccCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhcc--CCceEEEEEecCChh-HhhcccHHHHHhhccEEEEec
Confidence 999995 46789999999999999998754322 224566666654432 234688999999999999999
Q ss_pred ccCCCccCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHcCCCCCceeeccccccceeeecCCCCCC--CCCCCCCCc-
Q 003932 210 ASYYEPVSTNFTAPPAALYGSISGR-FARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNG--IGAAAAGPA- 285 (785)
Q Consensus 210 yd~~~~~~~~~~g~~apl~~~~~~~-~~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~--~~~~~~g~~- 285 (785)
|||||+|+...+||+|||++...++ ..++++.+|++|+++|+|++||+||||||||.|+++++...+ ...+..||.
T Consensus 367 YD~~G~W~~~~~G~~apLy~~~~~~~~~~~v~~av~~~~~~gvp~~KivlGip~YGr~w~~~~~~~~~~~~~g~~~G~~~ 446 (540)
T 1edq_A 367 YDFYGAFDLKNLGHQTALNAPAWKPDTAYTTVNGVNALLAQGVKPGKIVVGTAMYGRGWTGVNGYQNNIPFTGTATGPVK 446 (540)
T ss_dssp CCSSCTTCSSSCCCSSCSSCCTTCTTCSCCHHHHHHHHHHHTCCGGGEEEEEESEEEEEESCBSCSTTCGGGSBCSEECC
T ss_pred cccCCCCCCCCCCCcCCCCCCccCCCCCcCHHHHHHHHHHcCCCHHHEEEEeeccceeEeeccCCCCCCcccccCCCCcc
Confidence 9999999854599999999865432 356899999999999999999999999999999988753221 111222332
Q ss_pred -cccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeec--CCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchh
Q 003932 286 -LYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFST--GTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362 (785)
Q Consensus 286 -~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~--~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~ 362 (785)
+.+.|.++|++||+.+.. .+++..||+.+.+||+++ +++||+|||++|++.|++||+++||||+|+|+|++||.
T Consensus 447 Gt~e~G~~~y~ei~~~~~~--~g~~~~~D~~~~~~y~y~~~~~~~vsydd~~Si~~K~~y~k~~gLgGv~~W~l~~Dd~- 523 (540)
T 1edq_A 447 GTWENGIVDYRQIAGQFMS--GEWQYTYDATAEAPYVFKPSTGDLITFDDARSVQAKGKYVLDKQLGGLFSWEIDADNG- 523 (540)
T ss_dssp CSSBTTEEEHHHHHHHSSS--TTCEEEEETTTTEEEEEETTTTEEEECCCHHHHHHHHHHHHHHTCCEEEEECGGGCCS-
T ss_pred ccccCCcccHHHHHHHhhc--CCceEEECCccccceEEECCCCEEEEECCHHHHHHHHHHHHhCCCCEEEEEeccCCCH-
Confidence 467899999999997764 458999999999999865 47999999999999999999999999999999999973
Q ss_pred hhhhhhhh
Q 003932 363 WLLSQAAA 370 (785)
Q Consensus 363 ~~l~~~~~ 370 (785)
.|++++.
T Consensus 524 -~Ll~ai~ 530 (540)
T 1edq_A 524 -DILNSMN 530 (540)
T ss_dssp -HHHHHHH
T ss_pred -HHHHHHH
Confidence 3555553
|
| >3arx_A Chitinase A; TIM barrel, inhibitor complex, glycosidase, hydrolase, hydro hydrolase inhibitor complex; HET: POY; 1.16A {Vibrio harveyi} PDB: 3aro_A* 3arp_A* 3arr_A* 3arv_A* 3arw_A* 3arq_A* 3ary_A* 3arz_A* 3b8s_A 3b9e_A 3b9a_A* 3b9d_A 3as2_A* 3ars_A* 3art_A* 3as0_A* 3as1_A* 3aru_A* 3as3_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=548.63 Aligned_cols=339 Identities=21% Similarity=0.324 Sum_probs=268.0
Q ss_pred CCCcEEEEEecCCC----CCCcCCCCCCCCceEEEEEEEeeCC-----------------------ccEEecCCCccHH-
Q 003932 23 AKPWIRVGYLNLSE----VSTISGINYDLFTHLICSSADINST-----------------------TYQLSLSLPSDEN- 74 (785)
Q Consensus 23 ~~~~~~vgY~~~~~----~~~~~~i~~~~~Thi~~~f~~~~~~-----------------------~~~~~~~~~~~~~- 74 (785)
.+.++++|||.+|. .+.+++||.++||||+|+|+.++.+ .+++.+.++|.+.
T Consensus 135 ~~~~~v~~Y~~~W~~y~~~~~~~~i~~~~~THI~yaF~~i~~~~~~l~~~~~~~~~~~~~~c~~~~~~~v~~~D~~~d~~ 214 (584)
T 3arx_A 135 DPSIVMGTYFVEWGIYGRDYTVDNMPVDNLTHILYGFIPICGPNESVKSVGGNSFNALQTACRGVNDYEVVIHDPWAAYQ 214 (584)
T ss_dssp CTTSEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEECBSSCCGGGGGGCTTHHHHHHHHTTTCCTTCBCCSCHHHHHT
T ss_pred CCCcEEEEEECcccccCCCCChhHCCHhhCCEEEEEEEEecCCCccccccCccchhhhhhhcccCCCcceEecCchHhhh
Confidence 35578899999985 4789999999999999999998742 1133333332221
Q ss_pred ---------------HHHHHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcC-Cceeee
Q 003932 75 ---------------QIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYG-FRGLDF 138 (785)
Q Consensus 75 ---------------~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~-~DGiDi 138 (785)
.....+..||++||++|||+|||||..+. .|+.| +++++|++||+|+++||++|| ||||||
T Consensus 215 ~~~~~~g~~w~~~~~g~~~~l~~lK~~np~lKvllSiGGw~~s~--~F~~~-~~~~~R~~Fi~siv~~l~~yg~fDGIDI 291 (584)
T 3arx_A 215 KSFPQAGHEYSTPIKGNYAMLMALKQRNPDLKIIPSIGGWTLSD--PFYDF-VDKKNRDTFVASVKKFLKTWKFYDGVDI 291 (584)
T ss_dssp SCCGGGTCCTTCSSCHHHHHHHHHHHHCTTCEEEEEEEESSSCG--GGGGG-GSHHHHHHHHHHHHHHHHHCTTCCEEEE
T ss_pred hccccCCccccccccchHHHHHHHHHhCCCCEEEEEEcCCcCCc--chhhh-hCHHHHHHHHHHHHHHHHHcCCcceEee
Confidence 12334556999999999999999998754 49987 699999999999999999999 999999
Q ss_pred eccCCC---------CC-CCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeee
Q 003932 139 AWTAPN---------TS-TDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAV 208 (785)
Q Consensus 139 DwE~p~---------~~-~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm 208 (785)
|||||+ ++ +|+++|+.||++||++|++.+... .+.+.|++++++... ....+++++|.+++||||||
T Consensus 292 DWEyP~~~g~~~~~g~p~~D~~nf~~ll~eLr~~l~~~~~~~--g~~~~LT~Av~a~~~-~~~~~d~~~l~~~vD~inlM 368 (584)
T 3arx_A 292 DWEFPGGGGAAADKGDPVNDGPAYIALMRELRVMLDELEAET--GRTYELTSAIGVGYD-KIEDVDYADAVQYMDYIFAM 368 (584)
T ss_dssp EESCTTSCSSCTTCCCTTTHHHHHHHHHHHHHHHHHHHHHHH--SCCCEEEEEECCSHH-HHTTSCHHHHGGGCSEEEEC
T ss_pred cccCccccCCCCCCCCchHHHHHHHHHHHHHHHhHHhhhhcc--CCceEEEEEecCChH-HhhccCHHHHHhhCCEEEEe
Confidence 999995 23 388999999999999998754322 224566666654332 23468899999999999999
Q ss_pred eccCCCccCCCCCCCCCCCCCCCCCC------------------CCCCHHHHHHHHHHcCCCCCceeeccccccceeeec
Q 003932 209 TASYYEPVSTNFTAPPAALYGSISGR------------------FARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLV 270 (785)
Q Consensus 209 ~yd~~~~~~~~~~g~~apl~~~~~~~------------------~~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~ 270 (785)
+|||||+|+.. +||+|||++.+..+ ..++++.+|++|+++|+|++||+||||||||+|+++
T Consensus 369 tYD~hG~W~~~-tG~~apLy~~~~~~~~~c~~~~v~~~~~~~~~~~~~v~~av~~~~~~Gvp~~KivLGip~YGr~w~~~ 447 (584)
T 3arx_A 369 TYDFYGGWNNV-PGHQTALYCGSFMRPGQCDGGGVDENGEPYKGPAYTADNGIQLLLAQGVPANKLVLGTAMYGRGWEGV 447 (584)
T ss_dssp CCCSSCTTSSC-CCCSSCSSCCTTSCTTTTTSCSBCTTSCBCCSCCSCHHHHHHHHHHTTCCGGGEEEEEESEEEEEECC
T ss_pred cccccCCCCCC-cCCCCCCCCCCCCccccccccccccccccccccceeHHHHHHHHHHcCCCHHHEEEEEccccceeeec
Confidence 99999999754 99999999765322 246899999999999999999999999999999987
Q ss_pred CCC-CCCCCCCC----CCCcc-------ccCccccHHHHHhhhhhc----CCCeEEEeccceeeeeeec--CCEEEEeCC
Q 003932 271 KPE-DNGIGAAA----AGPAL-------YDSGLVTYKKIKNHIKTY----GPDVQVMYNSTYEVNYFST--GTVWFGFDD 332 (785)
Q Consensus 271 ~~~-~~~~~~~~----~g~~~-------~~~g~~~y~~i~~~~~~~----~~~~~~~~d~~~~~~y~~~--~~~~i~ydd 332 (785)
++. +.+.+++. .||.+ .+.|.++|++||+.+... ..++...||+.+.+||+++ +++||+|||
T Consensus 448 ~~~~~~~~~~~~~g~~~G~~~gt~~~~~~~~G~~~y~ei~~~~~~~~~~g~~g~~~~~D~~a~~py~y~~~~~~~vsyDd 527 (584)
T 3arx_A 448 TPDTLTDPNDPMTGTATGKLKGSTAQGVWEDGVIDYKGIKSFMLGANNTGINGFEYGYDAQAEAPWVWNRSTGELITFDD 527 (584)
T ss_dssp CGGGCSSTTCGGGSCCSEECCCCGGGTCSBTTEEEHHHHHHHTTTTTTSCCTTEEEEEETTTTEEEEEETTTTEEEECCC
T ss_pred ccccccCCCCccccCCCCCcCCccccccccCCceeHHHHHHHhhcccccccCCcEEEECCccceeEEEECCCCEEEEeCC
Confidence 532 12222222 22222 678999999999875432 1368999999999999865 579999999
Q ss_pred HHHHHHHHhhhcccCccceEeeeccccchhhhhhhhhh
Q 003932 333 VEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAAA 370 (785)
Q Consensus 333 ~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~~~l~~~~~ 370 (785)
++|++.|++||+++||||+|+|+|++||. .|++++.
T Consensus 528 ~~Si~~K~~y~k~~gLgGv~~W~l~~Dd~--~Ll~ai~ 563 (584)
T 3arx_A 528 HRSVLAKGNYAKSLGLAGLFSWEIDADNG--DILNAMH 563 (584)
T ss_dssp HHHHHHHHHHHHHHTCCEEEEECGGGCCS--HHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCEEEEEeccCCcH--HHHHHHH
Confidence 99999999999999999999999999973 3555553
|
| >3oa5_A CHI1; TIM barrel, hydrolase; HET: 2PE; 1.74A {Yersinia} PDB: 4a5q_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-61 Score=535.36 Aligned_cols=333 Identities=15% Similarity=0.198 Sum_probs=269.9
Q ss_pred CCCcEEEEEecCCCCC-----------------CcCCC---CCCCCceEEEEEEEeeCCc--------------------
Q 003932 23 AKPWIRVGYLNLSEVS-----------------TISGI---NYDLFTHLICSSADINSTT-------------------- 62 (785)
Q Consensus 23 ~~~~~~vgY~~~~~~~-----------------~~~~i---~~~~~Thi~~~f~~~~~~~-------------------- 62 (785)
.+.++++|||.+|..+ ++..| |+..||||+|+|+++..+.
T Consensus 97 ~~~~~v~~Y~~~W~~yd~r~~~~~~~~~~gr~~d~~~l~~~~p~~~t~ii~~F~~i~gd~~~g~~~~~i~~~~~~~~~d~ 176 (574)
T 3oa5_A 97 DDDFNVLCYFTDWSQYDPRIINKEIRDTGGRSADILRLNTPDGRPFKRLIYSFGGLIGDKKYSADGNASIAVRLGVATDP 176 (574)
T ss_dssp CSSCEEEEEEETTTTCCGGGTCSSCCSSCCCCCCGGGGCCSSSCSCSEEEEEEEEETTCTTTCTTTTHHHHHHHTSCSSH
T ss_pred CCCceEEEEEcchhhcccccccccccccCCCccCHhhhccCCCccccEEEEEEEeecCCcccCchHHHHHHHHhhhcccc
Confidence 4568899999998655 78888 8899999999999998765
Q ss_pred --------cEEecCCCccHHH--------------------------HHHHHHHHHhcCCCceEEEEecCCCCCCcccch
Q 003932 63 --------YQLSLSLPSDENQ--------------------------IAKFADTVKKKNPSITTILSIGQGKDTNYSIYS 108 (785)
Q Consensus 63 --------~~~~~~~~~~~~~--------------------------~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs 108 (785)
+++.+.++|.+.+ ....+..||++||++|||+|||||+.+. .|+
T Consensus 177 ~~~~~~~~g~v~~~D~wad~~~~~n~g~~~~~~~~~~~~~~~~~~~G~~~~l~~LK~~np~LKvllSIGGw~~S~--~Fs 254 (574)
T 3oa5_A 177 DDAIANHKGKTIPVDPDGAVLASINCGFTKWEAGDANERYNQEKAKGLLGGFRLLHEADKELEFSLSIGGWSMSG--LFS 254 (574)
T ss_dssp HHHHHHHTTCEEESCHHHHHTCCTTTTCCSCCCCCHHHHCSTTTCCHHHHHHHHHHHHCTTCEEEEEEECGGGCT--THH
T ss_pred cccccCcCCeEeecCchhhhcccccccccccccCCccccccCccchhHHHHHHHHHHHCCCCEEEEEECCCCCcc--hhH
Confidence 3555555543321 2355566999999999999999998754 499
Q ss_pred hhhcChhhhHHHHHHHHHHHHHcC-CceeeeeccCCC--------CCCCchhHHHHHHHHHHHhhhhhhhccccccee-E
Q 003932 109 SMVRNSSHRKSFIDSSIRIARLYG-FRGLDFAWTAPN--------TSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSL-L 178 (785)
Q Consensus 109 ~~~~~~~~r~~fi~si~~~~~~y~-~DGiDiDwE~p~--------~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~-~ 178 (785)
.+++++++|++||+|+++|+++|| |||||||||||+ +++|+++|+.||++||+++. .+.. +
T Consensus 255 ~~~s~~~~R~~Fi~siv~~l~~yg~fDGIDIDWEyP~~~g~~n~~~~~D~~nf~~LLkeLR~~~~---------~~~~~L 325 (574)
T 3oa5_A 255 EIAKDEILRTNFVEGIKDFFQRFPMFSHLDIDWEYPGSIGAGNPNSPDDGANFAILIQQITDAKI---------SNLKGI 325 (574)
T ss_dssp HHHHCHHHHHHHHHHHHHHHHHCTTCCEEEEECSCTTSCTTTCCCCTTHHHHHHHHHHHHHHTCC---------TTCCEE
T ss_pred HHhCCHHHHHHHHHHHHHHHHHcCCCceEEEEEEeccccccCCCCCHHHHHHHHHHHHHHHHhcc---------CCceEE
Confidence 999999999999999999999998 999999999996 56789999999999998432 2455 6
Q ss_pred EEEeecccCCCCccccHHHHH-hccceeeeeeccCCCccCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHH-cCCCCCc
Q 003932 179 ILTARFRYSPPANSYLLNSIQ-RNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGR-FARSTDQVLKAWIE-RGLSADK 255 (785)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~l~-~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~-~~~~~~~~v~~~~~-~gvp~~K 255 (785)
++++++... ....+++++|. +++||||||+|||||+|+. .+||+|||+..+.++ ..++++.+|++|++ +|+|++|
T Consensus 326 SiAvpa~~~-~~~~~d~~~l~~~~vD~InlMtYD~~G~W~~-~tG~~apL~~~~~d~~~~~svd~aV~~~l~~~GvP~~K 403 (574)
T 3oa5_A 326 SIASSADPA-KIDAANIPALMDAGVTGINLMTYDFFTLGDG-KLSHHTNIYRDPSDVYSKYSIDDAVTHLIDEKKVDPKA 403 (574)
T ss_dssp EEEECSSHH-HHHHHTHHHHHHTTCCEEEECCCCCCCTTSS-BCCCSSCSCCCTTCSSSCCCHHHHHHHHHHTTCCCGGG
T ss_pred EEEccCccc-cccccCHHHHHhhhCCEEEEEccccCCCCCC-CCCCCCCCCCCCCCccccccHHHHHHHHHHhcCCCHHH
Confidence 666655432 23458999986 5999999999999999975 699999999866543 35689999999999 9999999
Q ss_pred eeeccccccceeeecCCCCC-CCCCCCC--------CCccccCccccHHHHHhhhh-----hcCCCeEEEeccceeeeee
Q 003932 256 LVMCLPFYGYAWTLVKPEDN-GIGAAAA--------GPALYDSGLVTYKKIKNHIK-----TYGPDVQVMYNSTYEVNYF 321 (785)
Q Consensus 256 lvlGip~YG~~~~~~~~~~~-~~~~~~~--------g~~~~~~g~~~y~~i~~~~~-----~~~~~~~~~~d~~~~~~y~ 321 (785)
|+||||||||.|++++..+. +.++|.. ++++.+.|.++|.+||.... ....+++..||+.+++||+
T Consensus 404 LvLGip~YGR~w~~~~~~~~~~~~~p~~G~~~~~g~~~Gt~e~G~l~y~eI~~~~l~~~~~~~~~g~~~~wD~~a~~pY~ 483 (574)
T 3oa5_A 404 IFIGYAGYTRNAKNATITTSIPSEEALKGTYTDANQTLGSFEYSVLEWTDIICHYMDFEKGEGRNGYKLVHDKVAKADYL 483 (574)
T ss_dssp EEEEEESBCEEESSEEECCSSTTTSCCCEEESCCTTCCBSSBTTBCBHHHHHHHTEETTTTEESTTCEEEEETTTTEEEE
T ss_pred EEEEeCccceeeecCCCCcccccCCCCCCccccCCCCCCcccCCceeHHHHHHHhhhhhhhhccCCceEEEchhcCceEE
Confidence 99999999999998764332 1222221 24466789999999985432 1235689999999999999
Q ss_pred ec--CCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchhhhhhhhhh
Q 003932 322 ST--GTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAAA 370 (785)
Q Consensus 322 ~~--~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~~~l~~~~~ 370 (785)
++ +++||+|||++|++.|++||+++||||+|+|+|++| ++.|++++.
T Consensus 484 y~~~~~~~VsYDD~~Si~~K~~yak~~gLGGv~iW~ld~D--~g~LlnAi~ 532 (574)
T 3oa5_A 484 YSEATKVFISLDTPRSVRDKGRYVKDKGLGGLFIWSGDQD--NGILTNAAH 532 (574)
T ss_dssp ECTTTCCEEEECCHHHHHHHHHHHHHHTCCEEEEETGGGC--CSHHHHHHH
T ss_pred EECCCCEEEEeCCHHHHHHHHHHHHhcCCCEEEEEeccCC--cHHHHHHHH
Confidence 75 568999999999999999999999999999999999 445667664
|
| >3cz8_A Putative sporulation-specific glycosylase YDHD; structural genomics, uncharacterized protein, protein struct initiative, PSI-2; 2.20A {Bacillus subtilis subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=467.16 Aligned_cols=296 Identities=15% Similarity=0.239 Sum_probs=239.1
Q ss_pred CCcEEEEEecCCC---CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCC
Q 003932 24 KPWIRVGYLNLSE---VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGK 100 (785)
Q Consensus 24 ~~~~~vgY~~~~~---~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~ 100 (785)
....++|||.+|. .+...+.+.++||||+++|+.++++| .+..... +.. +++.+| ++++||++|||||+
T Consensus 6 ~~~~vvgYy~~w~~~~~~~~l~~~~~~lthi~~~~~~i~~~g-~l~~~~~--~~~---~~~~~~--~~~~kv~lsigg~~ 77 (319)
T 3cz8_A 6 YIAGTLSFYVLRNPDLDRELINDYAPYSSSISIFEYHIAPNG-DIANQLN--DAA---AIETTW--QRRVTPLATITNLT 77 (319)
T ss_dssp SCCEEEEEEEEECGGGC------CCCCCCEEEEEEEEBCTTS-CBCCCCS--CHH---HHHHHH--HTTCEEEEEEECEE
T ss_pred CCceEEEEEecCCCccCHHHHHHhhCCCCEEEEeEEEECCCC-CEecCcC--CHH---HHHHHH--HCCCeEEEEEecCC
Confidence 4468999999876 34444556889999999999999987 5554432 222 334344 35799999999875
Q ss_pred C--CCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeE
Q 003932 101 D--TNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLL 178 (785)
Q Consensus 101 ~--~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~ 178 (785)
. .++..|+.+++++++|++||+++++++++||||||||||||| .++|+++|+.|+++||++|++. ++.+
T Consensus 78 ~~~~~~~~~~~~~~~~~~r~~fi~si~~~~~~~gfDGiDiDwE~p-~~~d~~~~~~ll~eLr~~l~~~--------~~~L 148 (319)
T 3cz8_A 78 SGGFSTEIVHQVLNNPTARTNLVNNIYDLVSTRGYGGVTIDFEQV-SAADRDLFTGFLRQLRDRLQAG--------GYVL 148 (319)
T ss_dssp TTEECHHHHHHHHTCHHHHHHHHHHHHHHHHHHTCSEEEEECCSC-CGGGHHHHHHHHHHHHHHHHHT--------TCEE
T ss_pred CCCcCHHHHHHHHcCHHHHHHHHHHHHHHHHHhCCCeEEEeccCC-CHHHHHHHHHHHHHHHHHHhhc--------CcEE
Confidence 2 345578999999999999999999999999999999999999 4689999999999999999752 4567
Q ss_pred EEEeecccCC---CCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCCCc
Q 003932 179 ILTARFRYSP---PANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADK 255 (785)
Q Consensus 179 ~~~~~~~~~~---~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~~K 255 (785)
++++++.... ....|+++++.+++||||||+||++|+|. .+||+||++ +++.++++|++ ++|++|
T Consensus 149 s~av~~~~~~~~~~~~~~d~~~l~~~vD~i~vMtYD~~g~~~--~~g~~apl~---------~v~~~v~~~~~-~vp~~K 216 (319)
T 3cz8_A 149 TIAVPAKTSDNIPWLRGYDYGGIGAVVNYMFIMAYDWHHAGS--EPGPVAPIT---------EIRRTIEFTIA-QVPSRK 216 (319)
T ss_dssp EEEEECCSCSCCGGGTTCCHHHHHHHCSEEEEECCCSSCTTS--CSCCSSCHH---------HHHHHHHHHTT-TSCGGG
T ss_pred EEEecCCcccccchhcccCHHHHHhhCCEEEEEeeccCCCCC--CCCCCCChH---------HHHHHHHHHHh-cCCHHH
Confidence 7776655432 34679999999999999999999999874 489999987 78999999887 599999
Q ss_pred eeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeec----C-CEEEEe
Q 003932 256 LVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFST----G-TVWFGF 330 (785)
Q Consensus 256 lvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~----~-~~~i~y 330 (785)
|+||||||||.|++++.. |. ..|.++|.+||+.+...+ +...||+.+++||+.. + ++||+|
T Consensus 217 lvlGip~YGr~w~~~~~~----g~--------~~~~~~~~ei~~~~~~~g--~~~~~D~~~~~~y~~~~d~~g~~~~v~y 282 (319)
T 3cz8_A 217 IIIGVPLYGYDWIIPYQP----GT--------VASAISNQNAIERAMRYQ--APIQYSAEYQSPFFRYSDQQGRTHEVWF 282 (319)
T ss_dssp EEEECCSCEEEEESSCCT----TC--------CCEEECHHHHHHHHHHTT--CCCEEETTTTEEEEEEECTTSCEEEEEC
T ss_pred EEEEecCcCCcccccCCC----CC--------CCCccCHHHHHHHHHHcC--CeEEechhhCCcEEEEEcCCCCEEEEEe
Confidence 999999999999976421 11 157799999999877644 7889999999999842 3 379999
Q ss_pred CCHHHHHHHHhhhcccCccceEeeeccccchh
Q 003932 331 DDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362 (785)
Q Consensus 331 dd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~ 362 (785)
||++|++.|++||+++||||+|+|+|++||+.
T Consensus 283 dd~~Si~~K~~~~~~~~LgGv~~W~l~~dd~~ 314 (319)
T 3cz8_A 283 EGVRSMSRKMQIVREYRLQAIGAWQLTLAEGH 314 (319)
T ss_dssp CCHHHHHHHHHHHHHTTCSEEEEEEEEEC---
T ss_pred cCHHHHHHHHHHHHhcCCCeEEEEECCCCCcc
Confidence 99999999999999999999999999999854
|
| >3bxw_B Chitinase domain-containing protein 1; TIM barrel, lysosome, secreted, hydrolase; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=477.61 Aligned_cols=294 Identities=13% Similarity=0.186 Sum_probs=242.9
Q ss_pred CcEEEEEecCCCC--CCcCCCCCCCCceEEEEEEEeeCCc-cEEecCCCccHHHHHHHHHHHHhcCCCceEEE--EecCC
Q 003932 25 PWIRVGYLNLSEV--STISGINYDLFTHLICSSADINSTT-YQLSLSLPSDENQIAKFADTVKKKNPSITTIL--SIGQG 99 (785)
Q Consensus 25 ~~~~vgY~~~~~~--~~~~~i~~~~~Thi~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~--sigG~ 99 (785)
+.+++|||++|.. +.+.+++.++||||+|+|+.++++| +.+.+....+. . ...+..+|++||++||++ |||||
T Consensus 78 ~~~vvgY~~~W~~~~~~~~~~~~~~lThi~~af~~i~~~g~~~l~~~~~~d~-~-~~~~~~lk~~~~~lkvl~~isiGGw 155 (393)
T 3bxw_B 78 AGDVLGYVTPWNSHGYDVTKVFGSKFTQISPVWLQLKRRGREMFEVTGLHDV-D-QGWMRAVRKHAKGLHIVPRLLFEDW 155 (393)
T ss_dssp CSCEEEEEBTTBTHHHHHHHHHGGGCSEEEECCEEEEEEETTEEEEECGGGC-C-HHHHHHHHHHSSSCEECCEEEECSC
T ss_pred CCcEEEEECCccCCCCChhhcCHhhCCEEEEEEEEEecCCCceEEecCCCcc-C-HHHHHHHHhhCCCCEEEEEEeECCC
Confidence 4678999999975 6788899999999999999999987 45655432221 1 345566999999999995 88988
Q ss_pred CCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeee-ccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeE
Q 003932 100 KDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFA-WTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLL 178 (785)
Q Consensus 100 ~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiD-wE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~ 178 (785)
+. +.|+.+++++++|++||+++++++++||||||||| ||||+ ++|+++|+.|+++||++|++. +..+
T Consensus 156 ~~---~~f~~~~~~~~~R~~fi~siv~~~~~~gfDGidiDfWE~p~-~~d~~~~~~ll~eLr~~l~~~--------~~~L 223 (393)
T 3bxw_B 156 TY---DDFRNVLDSEDEIEELSKTVVQVAKNQHFDGFVVEVWNQLL-SQKRVGLIHMLTHLAEALHQA--------RLLA 223 (393)
T ss_dssp CH---HHHHHHHTCHHHHHHHHHHHHHHHHHHTCCEEEEECGGGCC-C-CHHHHHHHHHHHHHHHHHT--------TCEE
T ss_pred CH---HHHHHHhcCHHHHHHHHHHHHHHHHHhCCCCEEecccccCC-hhhHHHHHHHHHHHHHHHhhc--------CcEE
Confidence 63 36999999999999999999999999999999999 99995 689999999999999999752 4567
Q ss_pred EEEeecccCC------CCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCC
Q 003932 179 ILTARFRYSP------PANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLS 252 (785)
Q Consensus 179 ~~~~~~~~~~------~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp 252 (785)
++++++.... ....|++++|++++||||+|+||+||+ +.+||+|||+ +++.+|++|+++|+|
T Consensus 224 siav~~~~~~~~~~~~~~~~~d~~~l~~~vD~inlMtYD~~g~---~~~G~~apL~---------~v~~~v~~~~~~gvp 291 (393)
T 3bxw_B 224 LLVIPPAITPGTDQLGMFTHKEFEQLAPVLDGFSLMTYDYSTA---HQPGPNAPLS---------WVRACVQVLDPKSKW 291 (393)
T ss_dssp EEEECCSBCTTTSSBCSSCHHHHHHHTTTCSEEEECCCCCCBT---TBCCCSSCHH---------HHHHHHHHHSTTCSS
T ss_pred EEEEcccccccccccccccccCHHHHHhhccEEEEEeeecCCC---CCCCCcCCHH---------HHHHHHHHHHHcCCC
Confidence 7766655211 134689999999999999999999984 5699999998 799999999999999
Q ss_pred CCceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeee-e----cCCEE
Q 003932 253 ADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYF-S----TGTVW 327 (785)
Q Consensus 253 ~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~-~----~~~~~ 327 (785)
++||+||||||||.|++.++ .| ++.+ ...|.+||+. .++...||+.+++||+ + ++++|
T Consensus 292 ~~KivlGip~YGr~w~~~~~----~g----~~~t----~~~y~~i~~~-----~g~~~~~D~~~~~~~~~y~d~~~~~~~ 354 (393)
T 3bxw_B 292 RSKILLGLNFYGMDYATSKD----AR----EPVV----GARYIQTLKD-----HRPRMVWDSQASEHFFEYKKSRSGRHV 354 (393)
T ss_dssp GGGEEEEEESSEEEEETTTT----EE----EEEC----HHHHHHHHHH-----HCCBCEEETTTTEEEEEEEETTTEEEE
T ss_pred HHHEEEEecccccccccCCC----CC----CccC----HHHHHHHHHh-----cCCceEEccccCCceEEEEecCCCCEE
Confidence 99999999999999985431 11 2211 1367777764 2377899999998864 4 45799
Q ss_pred EEeCCHHHHHHHHhhhcccCccceEeeeccccchh
Q 003932 328 FGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362 (785)
Q Consensus 328 i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~ 362 (785)
|+|||++|++.|++||+++|| |+|+|++++||+.
T Consensus 355 v~ydd~~Si~~K~~~~~~~gL-Gv~~W~l~~d~~~ 388 (393)
T 3bxw_B 355 VFYPTLKSLQVRLELARELGV-GVSIWELGQGLDY 388 (393)
T ss_dssp EECCCHHHHHHHHHHHHHHTC-EEEEECTTSSCGG
T ss_pred EEeCCHHHHHHHHHHHHHcCC-EEEEEECCCCchh
Confidence 999999999999999999999 9999999999865
|
| >3fnd_A Chitinase; TIM-barrel, structural genomics, PSI-2, P structure initiative, NEW YORK SGX research center for STRU genomics, nysgxrc; 1.90A {Bacteroides thetaiotaomicron} PDB: 3co4_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=459.88 Aligned_cols=291 Identities=19% Similarity=0.266 Sum_probs=234.9
Q ss_pred CcEEEEEecCCCC--CC-cCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCC
Q 003932 25 PWIRVGYLNLSEV--ST-ISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKD 101 (785)
Q Consensus 25 ~~~~vgY~~~~~~--~~-~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~ 101 (785)
.+++||||++|+. .. +++||+++||||+|+|+.++++| .+.+.+ +...+.++++ |+++|++||++|||||.
T Consensus 3 ~krvvgY~~~~~~~~~~~~~~i~~~~~Thi~~af~~i~~~g-~~~~~~--~~~~~~~~~~--k~~~~~lkvllsiGG~~- 76 (312)
T 3fnd_A 3 LKVVIGYLALDDWEFESLFPTIEWKYLTHINASFARVKADG-TLNINP--VRKRIESVRE--TAHKHNVKILISLAKNS- 76 (312)
T ss_dssp CCEEEEEEETTCTTHHHHGGGCCGGGCSEEEEEEEEECTTS-CEECTT--TTTTHHHHHH--HHHHTTCEEEEEEEESS-
T ss_pred CceEEEEEeccccccCCChhhCCcccCCEEEEEEEEECCCC-eEEecC--cHHHHHHHHH--HHHcCCCEEEEEEcCCC-
Confidence 4689999987643 33 79999999999999999999987 555543 2334555554 67788999999999885
Q ss_pred CCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeecc-CCCCCCCchhHHHHHHHHHH-Hh-hhhhhhcccccceeE
Q 003932 102 TNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWT-APNTSTDMFNIGLLFDEWRI-AA-TKLDAKNSTRQQSLL 178 (785)
Q Consensus 102 ~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE-~p~~~~d~~~~~~ll~~lr~-~l-~~~~~~~~~~~~~~~ 178 (785)
++.|+.+++++++|++||+++++++++||||||||||| ||+. .++|+.|+++||+ +| +. .+..+
T Consensus 77 --~~~~~~~~~~~~~r~~fi~si~~~~~~~~~DGiDiDwE~~p~~---~~~~~~ll~eLr~~~l~~~--------~~~~l 143 (312)
T 3fnd_A 77 --PGEFTTAINDPKARKELIQQIIAFTKEYKLDGFDIDYEEYDNW---DKNFPSLLVFARGLYLAKE--------KNMLM 143 (312)
T ss_dssp --TTHHHHHHHSHHHHHHHHHHHHHHHHHTTCSEEEECCCCCTTH---HHHHHHHHHHHHHHHHHSC--------TTCEE
T ss_pred --CchhhHHhCCHHHHHHHHHHHHHHHHHcCCCeEEEeeeeCCCc---hHHHHHHHHHHHHHHhccc--------CCcEE
Confidence 23499999999999999999999999999999999999 9954 3899999999999 98 32 14556
Q ss_pred EEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH-HcCCCCCcee
Q 003932 179 ILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWI-ERGLSADKLV 257 (785)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~-~~gvp~~Klv 257 (785)
++++++. ...|+ .++.+++||||||+||+ |+|. ..+||+||++ +++.++++|+ ..|+|++||+
T Consensus 144 s~av~~~----~~~~~-~~~~~~~D~i~vm~YD~-g~~~-~~~g~~apl~---------~~~~~v~~~~~~~g~p~~Klv 207 (312)
T 3fnd_A 144 TCAVNSR----WLNYG-TEWEQYFDYINLMSYDR-GAFT-DKPVQHASYD---------DFVKDLKYWNEQCRASKSKIV 207 (312)
T ss_dssp EEEECCS----SSCCT-TTSGGGCSEEEECCCCT-TCSS-SSCCCSSCHH---------HHHHHHHHHHHTSCCCGGGEE
T ss_pred EEEecCC----ccccc-HHHHhhCCEEEEeeccC-CCCC-CCCCCCCchH---------HHHHHHHHHHHHcCCCHHHEE
Confidence 6665542 22455 67889999999999999 8885 5699999987 7899999999 8999999999
Q ss_pred eccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHH
Q 003932 258 MCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVR 337 (785)
Q Consensus 258 lGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~ 337 (785)
||||||||.|+++..+ .....|.++|.+||+..... .+..+++.||+|||++|++
T Consensus 208 lGip~YGr~w~~~~~g-----------~~~~~~~~~y~ei~~~~~~~--------------~~~~d~~~~v~ydd~~Si~ 262 (312)
T 3fnd_A 208 GGLPFYGYSWEESLQG-----------AVDDVRGIRYSGILKHLGNE--------------AADKDNIGKTYYNGRPTIA 262 (312)
T ss_dssp EEEESEEEECCGGGTT-----------SSCTTSEEEHHHHHHHHCGG--------------GGGCSEETTEECCCHHHHH
T ss_pred EEEcccCceeecCCCC-----------CCCCCCceeHHHHHHhcCCc--------------eEEecCCeEEEcCCHHHHH
Confidence 9999999999876421 12356789999999854211 1111233479999999999
Q ss_pred HHHhhhcccCccceEeeeccccch-hhhhhhhhhccccc
Q 003932 338 AKIAYAKEKRLLGYYAWQVSFDDH-DWLLSQAAAQKDSI 375 (785)
Q Consensus 338 ~K~~~~~~~glgG~~~W~l~~Dd~-~~~l~~~~~~~~~~ 375 (785)
.|++||+++||||+|+|++++||. +..|++++...+.+
T Consensus 263 ~K~~~~~~~gLgGv~~W~l~~Dd~~~~~Ll~ai~~v~~~ 301 (312)
T 3fnd_A 263 NKCKFIKENDYAGVMIWQLFQDAHNDNYDLKLINVVGRE 301 (312)
T ss_dssp HHHHHHHHTTCCEEEEECGGGSCCGGGGGGCHHHHHHHH
T ss_pred HHHHHHHhcCCcEEEEEeCcCCCCCCccHHHHHHHhhhh
Confidence 999999999999999999999996 57788888765443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=440.30 Aligned_cols=260 Identities=27% Similarity=0.451 Sum_probs=208.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
++|.+.++||+|+||.||+|++. +++.||||++........++|.+|+++|++++|||||+++|+|.+....+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999853 478899999988777777899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCce
Q 003932 538 IYEYMPNKSLDCYLFDPI------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP 605 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 605 (785)
|||||++|+|.++++... ....+++..++.|+.||++||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996532 1246899999999999999999999876 9999999999999999999
Q ss_pred eeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHH
Q 003932 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 606 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 684 (785)
||+|||+++.+............+||+.|||||++.+..++.++|||||||+||||+| |+.||......+ .+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~---- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AI---- 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HH----
Confidence 9999999987655443344455689999999999999999999999999999999999 899986432211 11
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.....+.... .+...+.++.+|+.+||+.||++|||++||++.|+....
T Consensus 271 ~~i~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DCITQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1122121111 122334578999999999999999999999999998643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=439.48 Aligned_cols=259 Identities=28% Similarity=0.479 Sum_probs=215.1
Q ss_pred cCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57889999999999999999853 477899999988777777889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCc----------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceee
Q 003932 538 IYEYMPNKSLDCYLFDPI----------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKI 607 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 607 (785)
|||||++|+|.++|+... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996432 2346999999999999999999999986 999999999999999999999
Q ss_pred ccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHH
Q 003932 608 SDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYEL 686 (785)
Q Consensus 608 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 686 (785)
+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||......+ . ...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~----~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V----IEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H----HHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHH
Confidence 99999987654433334445679999999999999999999999999999999999 899986432211 1 112
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
...+.... .+...+.++.+|+.+||+.||++|||++||.+.|++..
T Consensus 243 i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 243 ITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22222111 12234457899999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=433.43 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=212.9
Q ss_pred cCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
.++++.++||+|+||+||+|.+. +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+....+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45678899999999999999852 46789999997543 344578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC
Q 003932 537 LIYEYMPNKSLDCYLFDPI-------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM 603 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 603 (785)
||||||++|+|.++|.... ....+++..++.|+.||++||+|||+.+ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996432 1346899999999999999999999986 99999999999999999
Q ss_pred ceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHH
Q 003932 604 KPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEH 682 (785)
Q Consensus 604 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~ 682 (785)
++||+|||+++.+............+||+.|||||++.+..++.++|||||||+||||+| |+.||...... .
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-------~ 255 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------D 255 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-------H
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-------H
Confidence 999999999987655444444556789999999999999999999999999999999998 89998643221 1
Q ss_pred HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 683 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.......+.... .+..++..+.+|+.+||+.||++|||++||++.|+..
T Consensus 256 ~~~~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEMIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 122222222111 1223445789999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=422.17 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=205.4
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
..+++.+.++||+|+||+||+|++.. .||||+++.. .....+.|.+|+.++++++|||||+++++|.+ +.++|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34678899999999999999999753 5899998743 34556789999999999999999999999865 5689999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||++|+|.++|+.. ...+++..++.|+.||++||+|||+.+ ||||||||+||||++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999999643 345999999999999999999999976 999999999999999999999999999876544
Q ss_pred ccccccccccccCCcccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATK---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.........+||+.|||||++.+ ..|+.++|||||||+||||+||+.||...... .........+...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~--- 256 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYAS--- 256 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCC---
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCC---
Confidence 33344556789999999999864 45899999999999999999999999643221 1111222221111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
+.+ .......+..+.+|+.+||+.||++|||+.||++.|+.+...+
T Consensus 257 -p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 257 -PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp -CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred -CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 001 1112234457889999999999999999999999988764433
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=425.91 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=202.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|++++.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999995 57899999999764 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
||++|+|.++|... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999999542 3345789999999999999999999986 999999999999999999999999999876432
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+. .+........ ...
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~-~~~------- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISG-SFP------- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHT-CCC-------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcC-CCC-------
Confidence 1223456899999999999999999999999999999999999999964321 1111122221 110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......+.++.+|+.+||+.||++|||++|+++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011123457889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=424.25 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=207.9
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
+.|++.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5699999999999999999995 479999999997655455567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 99999998843 45899999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+ .. .......... +
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~----~~i~~~~~~~-----~-- 290 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AM----KMIRDNLPPR-----L-- 290 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHSSCCC-----C--
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH----HHHHcCCCCC-----C--
Confidence 23455789999999999999999999999999999999999999996432111 11 1111111000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......+.++.+|+.+||+.||++|||++|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223457889999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=419.39 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=208.5
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++++.||+|+||+||+|+. .+++.||||++.+.. ....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999995 578999999997542 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999953 456999999999999999999999987 999999999999999999999999999987654
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.........+||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+ +.. ..... . ..+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~---~i~~~-~-~~~---- 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFA---KIIKL-E-YDF---- 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHT-C-CCC----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHcC-C-CCC----
Confidence 44444566799999999999999999999999999999999999999996432211 111 11111 1 111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS 734 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 734 (785)
+...+.++.+|+.+||+.||++|||++|++
T Consensus 254 -----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 -----PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 112234788999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=419.02 Aligned_cols=255 Identities=18% Similarity=0.217 Sum_probs=206.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
+.|++.++||+|+||.||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+...++||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 5688889999999999999995 5789999999976432 246999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-ceeeccccceeeeccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFGMARIFAKESL 621 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 621 (785)
++|+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999953 346999999999999999999999886 99999999999999987 699999999998754322
Q ss_pred cc---ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 622 EE---NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 622 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. .....+||+.|||||++.+..++.++|||||||+||||+||+.||......+....+ ........
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~~~~---- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPPPIR---- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSCCGGG----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCCCCch----
Confidence 21 223468999999999999999999999999999999999999999754443322111 11111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
..++..+..+.+++.+||+.||++|||+.|+++.|......
T Consensus 277 ----~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 277 ----EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp ----GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 11122345788999999999999999999999988765443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=427.10 Aligned_cols=269 Identities=28% Similarity=0.401 Sum_probs=219.1
Q ss_pred cChHHHHHHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCC-CceeeE
Q 003932 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQH-VNLIRV 525 (785)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l 525 (785)
+...+++...++|++.+.||+|+||.||+|.+. .++.||||++.... ....+.|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 456677778899999999999999999999843 23679999997653 3456679999999999965 899999
Q ss_pred EEEEecC-CccEEEEEecCCCChhhhhcCCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEec
Q 003932 526 LGFCIDS-EERMLIYEYMPNKSLDCYLFDPIR-------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 591 (785)
Q Consensus 526 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 591 (785)
+|+|.+. ..+++|||||++|+|.++|+.... ...+++..++.++.||++||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 568999999999999999964321 345899999999999999999999986 99999
Q ss_pred ccCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcc
Q 003932 592 LKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSML 670 (785)
Q Consensus 592 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~ 670 (785)
|||+|||+++++.+||+|||+|+.+............+||+.|||||++.+..++.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654433334455789999999999999999999999999999999998 9999865
Q ss_pred cCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 671 CGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
....+ ........+.... .+...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus 291 ~~~~~------~~~~~i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKIDE------EFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCSH------HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 43222 1112222222111 1222345788999999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=425.51 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=208.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
+.|+++++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999995 479999999998765555667899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++|+|.+++. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 231 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 9999999884 335899999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ .. .......... +.
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~----~~i~~~~~~~-----~~- 368 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AM----KMIRDNLPPR-----LK- 368 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHSCCCC-----CS-
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH----HHHHcCCCCC-----Cc-
Confidence 23456789999999999999999999999999999999999999996432111 11 1111111000 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11123457889999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=401.39 Aligned_cols=246 Identities=25% Similarity=0.384 Sum_probs=197.0
Q ss_pred CcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec----CCccEEEE
Q 003932 467 SIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLIY 539 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 539 (785)
++.++||+|+||.||+|.. .++..||+|++... .....+.|.+|++++++++|||||++++++.+ ...++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999995 46889999999654 34456789999999999999999999999865 34579999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-CCceeeccccceeeecc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFGMARIFAK 618 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~ 618 (785)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999953 456899999999999999999999874 35999999999999984 79999999999975322
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
......+||+.|||||++.+ .|+.++|||||||+||||+||+.||..... ..........+.....++
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~~~~~~- 252 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFD- 252 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGGG-
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCCCCCCC-
Confidence 23345689999999999875 599999999999999999999999963221 111122222221111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ..+.++.+|+.+||+.||++|||++|+++
T Consensus 253 ---~----~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 ---K----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---G----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---c----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 12236889999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=401.51 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=190.0
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||+||+|+. .+++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 578999999997642 233567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899888853 346999999999999999999999986 999999999999999999999999999875433
Q ss_pred ccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
......+||+.|||||++.+..+ +.++|||||||++|||+||+.||...+.. .. .+....+.. .
T Consensus 166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~----~~~i~~~~~-~---- 230 (275)
T 3hyh_A 166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VL----FKNISNGVY-T---- 230 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCC-C----
T ss_pred ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHcCCC-C----
Confidence 23345789999999999998876 57999999999999999999999643211 11 111111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+...+.++.+|+.+||+.||++|||++|+++
T Consensus 231 -----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 -----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11122357889999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=409.50 Aligned_cols=268 Identities=21% Similarity=0.264 Sum_probs=201.6
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC----ccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 539 (785)
++|.+.++||+|+||+||+|++. |+.||||++...... ...+..|+..+.+++|||||+++++|.+.. .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 46888899999999999999985 899999999654322 122345666667889999999999998654 579999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-----SRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
|||++|+|.++|+. ..+++..+.+++.|+++||+|||+. +.++|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 4589999999999999999999986 24469999999999999999999999999998
Q ss_pred eecccccc--cccccccccCCcccccccCCC------CCCChhhHHHHHHHHHHHHcCCCCCcccCCCC--------ccc
Q 003932 615 IFAKESLE--ENTEQVVGTIGYIPPEYATKG------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINE--------NLS 678 (785)
Q Consensus 615 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~--------~~~ 678 (785)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||++|+....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 87543221 122346799999999999764 36789999999999999999988765332211 011
Q ss_pred HHHHHHHHHhCCccccccccccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 679 ILEHAYELWKGGKGVEFVDSFLDD-RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
..+........... .+.+.. ......+..+.+|+.+||+.||++||||.||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 12222222221111 111111 112345567899999999999999999999999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=408.16 Aligned_cols=242 Identities=21% Similarity=0.310 Sum_probs=193.2
Q ss_pred cCCCcceeeceeCcEEEEEEEe----CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
++|++++.||+|+||+||+|+. .+++.||+|++.+.. ......+.+|+++|++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999984 257899999997642 2223467889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|||||++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999953 446999999999999999999999986 9999999999999999999999999998654
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
... ......+||+.|||||++.+..++.++|||||||+||||+||+.||...+..+ .. ...... . ..
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~---~~i~~~-~-~~--- 244 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TM---TMILKA-K-LG--- 244 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHC-C-CC---
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HH---HHHHcC-C-CC---
Confidence 322 23445789999999999999999999999999999999999999996432211 11 111111 1 01
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSM 730 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 730 (785)
.+...+.++.+|+.+||+.||++|||+
T Consensus 245 ------~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 ------MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ------CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 112234578899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=397.88 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=189.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC--------
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-------- 533 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 533 (785)
.+|++++.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999995 478999999997543 344567899999999999999999999987544
Q ss_pred ----ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecc
Q 003932 534 ----ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISD 609 (785)
Q Consensus 534 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 609 (785)
.+++|||||++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976544455677788999999999999999986 99999999999999999999999
Q ss_pred ccceeeeccccccc----------ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccH
Q 003932 610 FGMARIFAKESLEE----------NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSI 679 (785)
Q Consensus 610 fg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~ 679 (785)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 99998765432211 1234579999999999999999999999999999999997 55311 111
Q ss_pred HHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 680 LEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.... ........... .......+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~-~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTL-TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11111110000 0112235678999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=380.43 Aligned_cols=285 Identities=36% Similarity=0.592 Sum_probs=245.1
Q ss_pred cChHHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC
Q 003932 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE 533 (785)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 533 (785)
+++.++...+++|++.+.||+|+||.||+|...+++.||+|++........+.+.+|+.++++++||||+++++++.+..
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44455566778999999999999999999998889999999998776667788999999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCcc-ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIR-KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999865332 335899999999999999999999986 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
++...............||..|+|||++.+..++.++|||||||++|||++|+.|+......+......+..........
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98754433333334456899999999998889999999999999999999999999876666666677666666555555
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
...++..+.....+..+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 6666666666667788889999999999999999999999999999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=394.89 Aligned_cols=267 Identities=21% Similarity=0.287 Sum_probs=203.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEec------CCc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID------SEE 534 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 534 (785)
++|++++.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999995 579999999997643 3445678899999999999999999998764 357
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
+|||||||. |+|.+++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999995 679888853 456999999999999999999999987 9999999999999999999999999998
Q ss_pred eeccccc--ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 615 IFAKESL--EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 615 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|++||...+..+ .............
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTPS 283 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCC
Confidence 7643321 2234457899999999998875 46999999999999999999999997543222 1221111111110
Q ss_pred ccc-----------ccccccCCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 003932 692 GVE-----------FVDSFLDDRN------SPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 740 (785)
Q Consensus 692 ~~~-----------~~~~~l~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 740 (785)
... .+........ .+....++.+|+.+||+.||++|||++|+++ .|.+.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 000 0000000000 0112346889999999999999999999986 45443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=380.18 Aligned_cols=197 Identities=26% Similarity=0.364 Sum_probs=169.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEe----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 537 (785)
.++|++.++||+|+||+||+|+. .+++.||+|++.+... ...+.+|+++|+.+ +||||+++++++.+.+..++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 46899999999999999999974 2468899999876543 35678899999988 69999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-Cceeeccccceeee
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDFGMARIF 616 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~~ 616 (785)
|||||++|+|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+..
T Consensus 98 vmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 98 AMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 999999999999882 3889999999999999999999987 9999999999999876 79999999999875
Q ss_pred cccccc--------------------------cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCc
Q 003932 617 AKESLE--------------------------ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSM 669 (785)
Q Consensus 617 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~ 669 (785)
...... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 432110 112345799999999999875 48999999999999999999999985
Q ss_pred c
Q 003932 670 L 670 (785)
Q Consensus 670 ~ 670 (785)
.
T Consensus 249 ~ 249 (361)
T 4f9c_A 249 K 249 (361)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=377.38 Aligned_cols=290 Identities=39% Similarity=0.661 Sum_probs=242.1
Q ss_pred CccccChHHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEE
Q 003932 450 NLRVYSLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGF 528 (785)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~ 528 (785)
.++.++..++....++|++.+.||+|+||.||+|...+++.||+|++..... .....+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4567899999999999999999999999999999987899999999976532 222368899999999999999999999
Q ss_pred EecCCccEEEEEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceee
Q 003932 529 CIDSEERMLIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKI 607 (785)
Q Consensus 529 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 607 (785)
+.+....++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999997543 3345899999999999999999999984445999999999999999999999
Q ss_pred ccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccC--CCCcccHHHHHHH
Q 003932 608 SDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG--INENLSILEHAYE 685 (785)
Q Consensus 608 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~--~~~~~~~~~~~~~ 685 (785)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........+...
T Consensus 176 ~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999998764332 222334569999999999988889999999999999999999999986321 2233344555544
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...........+..+........+..+.+++.+||+.||.+|||+.||++.|++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 4445555556666666667778888999999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=403.81 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=209.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++++.||+|+||.||+|+. .+|+.||+|++........+.+.+|+.+|++++||||+++++++.+...++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999995 57899999999887777777899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC--Cceeeccccceeeeccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA--MKPKISDFGMARIFAKE 619 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--~~~kl~Dfg~a~~~~~~ 619 (785)
|++|+|.++|.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998853 2345899999999999999999999987 9999999999999854 89999999999987543
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ .......... .+....
T Consensus 311 ---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-------~~~~i~~~~~-~~~~~~ 379 (573)
T 3uto_A 311 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDW-NMDDSA 379 (573)
T ss_dssp ---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCC-CCCSGG
T ss_pred ---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHhCCC-CCCccc
Confidence 23345689999999999999999999999999999999999999996432211 1111111110 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 380 -----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 -----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112347889999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=396.42 Aligned_cols=248 Identities=24% Similarity=0.282 Sum_probs=199.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHH---HHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEF---KNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
++|+++++||+|+||.||+|+. .+|+.||+|++.+.. ....... ..++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999995 479999999996532 1112223 34466777889999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
||||||+||+|..+|.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999953 456999999999999999999999886 999999999999999999999999999876
Q ss_pred cccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
... .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......+...+.. ......
T Consensus 343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~~----- 410 (689)
T 3v5w_A 343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMA----- 410 (689)
T ss_dssp SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHCC-----
T ss_pred CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCCC-----
Confidence 433 2345789999999999964 579999999999999999999999997544333211111 111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSS 735 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 735 (785)
...+...+.++.+|+.+||+.||.+|++ ++||++
T Consensus 411 ------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0111223457889999999999999998 677754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=352.40 Aligned_cols=284 Identities=36% Similarity=0.555 Sum_probs=230.2
Q ss_pred CccccChHHHHHHhcCCCcc------eeeceeCcEEEEEEEeCCCcEEEEEEcCCC----ChhhHHHHHHHHHHHHcCCC
Q 003932 450 NLRVYSLADIEAATERFSIR------NKLGEGGYGPVYKGVLPCGEVIAVKKLSKT----STQGFEEFKNEVMLTAKLQH 519 (785)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 519 (785)
....|++.++..++.+|... +.||+|+||.||+|... ++.||+|++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34568999999999998887 89999999999999874 789999998753 23345678999999999999
Q ss_pred CceeeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE
Q 003932 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599 (785)
Q Consensus 520 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 599 (785)
|||+++++++.+....++||||+++++|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999875545567999999999999999999999986 9999999999999
Q ss_pred cCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccH
Q 003932 600 GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSI 679 (785)
Q Consensus 600 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~ 679 (785)
+.++.+||+|||+++...............||..|+|||.+.+ .++.++||||||+++|+|++|+.|+...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999987654332223344678999999998875 488999999999999999999999976544333322
Q ss_pred HHHHHHHHhCCc-cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 680 LEHAYELWKGGK-GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 680 ~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
+.. ....... ....++..+ .......+..+.+++.+||+.||.+|||+.++++.|++..
T Consensus 246 ~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKE--EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHH--HHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHH--Hhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 221 1111111 122222222 2235566778999999999999999999999999999763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=358.76 Aligned_cols=269 Identities=24% Similarity=0.368 Sum_probs=206.8
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
....++|++.+.||+|+||.||+|... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 334578999999999999999999874 8889999997653 3445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|.+++........+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999976444445899999999999999999999874 239999999999999999999999999997643
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +............
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~~---- 258 (309)
T 3p86_A 191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKRL---- 258 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCCC----
T ss_pred ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCC----
Confidence 321 1233467999999999999999999999999999999999999998643211 1111111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTP 747 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 747 (785)
..+...+..+.+++.+||+.||.+|||+.|+++.|+.......+|
T Consensus 259 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 259 -----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 111223347889999999999999999999999999887654433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=353.75 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=207.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999994 57899999999766555567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence 999999999843 35889999999999999999999986 9999999999999999999999999998765432
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .
T Consensus 171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~--------~ 235 (297)
T 3fxz_A 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP--------E 235 (297)
T ss_dssp -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC--------C
T ss_pred -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC--------C
Confidence 2234467999999999999999999999999999999999999998643211 111111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0112223457889999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=357.23 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=212.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|.+.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35789999999999999999995 46899999999877777778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998642 345899999999999999999999986 99999999999999999999999999987643321
Q ss_pred cc------------ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcc--cHHHHHHHHH
Q 003932 622 EE------------NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--SILEHAYELW 687 (785)
Q Consensus 622 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~ 687 (785)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+......... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 11 111457999999999999999999999999999999999999987643322111 011111010
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
..+...+..+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 243 ---------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 ---------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01111223688899999999999999999999999886543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=365.02 Aligned_cols=260 Identities=26% Similarity=0.400 Sum_probs=212.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe--------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL--------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS 532 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 532 (785)
.++|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46899999999999999999984 235679999997653 34556789999999999 899999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIR-------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 599 (785)
...++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999864321 235889999999999999999999986 9999999999999
Q ss_pred cCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCccc
Q 003932 600 GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLS 678 (785)
Q Consensus 600 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 678 (785)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999987654433333444567889999999999999999999999999999999 999986543222
Q ss_pred HHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 679 ILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.. .....+... ..+...+..+.+++.+||+.||.+||++.|+++.|+++.
T Consensus 314 ~~----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 LF----KLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HH----HHHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 112221111 112223457889999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=359.87 Aligned_cols=270 Identities=23% Similarity=0.291 Sum_probs=209.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc----cEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE----RMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv 538 (785)
.++|++.++||+|+||.||+|+.. ++.||||++..... .......|+.++++++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999876 78999999975533 33455678999999999999999999987543 6999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-------CCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-------SRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ++.+|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999943 3489999999999999999999987 11249999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCC-----CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHH------
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL------ 680 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~------ 680 (785)
+++.+.............||+.|+|||++.+. .++.++|||||||++|||++|+.||............
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99887654433334456799999999999873 4567899999999999999999998754432222111
Q ss_pred ---HHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 681 ---EHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 681 ---~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
...............+... ......+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111111111111110 012234567999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.36 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=205.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++.+. .....+.+.+|+.++++++||||+++++++......++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999995 57999999998754 3455667889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999998853 345899999999999999999999986 999999999999999999999999999765432
Q ss_pred ccccccccccccCCcccccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
......+||+.|+|||++.+..++ .++|||||||++|||++|+.||...... +..........
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~------- 231 (328)
T 3fe3_A 168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVLRGKY------- 231 (328)
T ss_dssp ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-------
T ss_pred ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-------
Confidence 233456899999999999888765 7999999999999999999999643211 11111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
..+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111223468899999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.20 Aligned_cols=274 Identities=20% Similarity=0.269 Sum_probs=215.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC--ccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 539 (785)
++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57999999999999999999964 58999999997543 334567889999999999999999999988665 779999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE----cCCCceeeccccceee
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL----GEAMKPKISDFGMARI 615 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~Dfg~a~~ 615 (785)
||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976555555999999999999999999999986 9999999999999 7888899999999987
Q ss_pred ecccccccccccccccCCcccccccC--------CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYAT--------KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
..... ......||..|+|||++. +..++.++|||||||++|||++|+.||............. ....
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~ 240 (319)
T 4euu_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM--YKII 240 (319)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH--HHHH
T ss_pred cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH--HHHh
Confidence 65432 233457899999999886 5778999999999999999999999997544333222211 1111
Q ss_pred hCCc--ccccc------------ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 003932 688 KGGK--GVEFV------------DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNIN 745 (785)
Q Consensus 688 ~~~~--~~~~~------------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 745 (785)
.... ..... ...............+.+++.+||+.||++|||++|+++...+..-.-+
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~ 312 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC---
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCC
Confidence 1111 00000 0011123345667789999999999999999999999999987654333
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=355.55 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=209.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.++|++.+.||+|+||.||+|... .+..||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999963 3556999999765 34456679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998542 345899999999999999999999986 9999999999999999999999999998765
Q ss_pred ccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 618 KESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 618 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
..... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||......+ ..........
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~--- 272 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYR--- 272 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCC---
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCC---
Confidence 43211 12223456778999999998899999999999999999999 999986432211 1111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
.......+..+.+++.+||+.||.+|||+.||++.|+.....
T Consensus 273 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 ------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 111222345788999999999999999999999999987544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=365.68 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=209.8
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467899999999999999999965 78999999997653 334456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999853 2345889999999999999999999986 999999999999999999999999999875433
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
..........++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... ........+....
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~---- 335 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRLP---- 335 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCCC----
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC----
Confidence 22222222345778999999998889999999999999999998 99988643211 1112222221111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.+...+..+.+++.+||+.||++|||++++++.|++.
T Consensus 336 -----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 336 -----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1122345788999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=345.21 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=213.7
Q ss_pred ccChHHHHHHhcC----------CCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCc
Q 003932 453 VYSLADIEAATER----------FSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521 (785)
Q Consensus 453 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 521 (785)
.++.+++..+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3677777777654 777889999999999999965 79999999998766666778999999999999999
Q ss_pred eeeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC
Q 003932 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE 601 (785)
Q Consensus 522 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~ 601 (785)
|+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999998843 35899999999999999999999986 999999999999999
Q ss_pred CCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHH
Q 003932 602 AMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 681 (785)
Q Consensus 602 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~ 681 (785)
++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .+
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~ 248 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQ 248 (321)
T ss_dssp TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HH
T ss_pred CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HH
Confidence 9999999999998765432 123346799999999999999999999999999999999999999864321 11
Q ss_pred HHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 682 HAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
........ ..... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~-~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 AMKRLRDS-PPPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHS-SCCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcC-CCCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 10000 0111233478899999999999999999999873
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.34 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=207.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35799999999999999999995 46889999998543 334456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999853 346899999999999999999999986 99999999999999999999999999976543
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ............ .... .
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~-~~~~-~ 234 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSV-PNVT-T 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCC-CCHH-H
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccC-CCcc-h
Confidence 321 223345799999999999999999999999999999999999999864321 111222222211 1110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcccCCCC
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRP-SMLEVSSMLKNETTNIN 745 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~ 745 (785)
.. ....+..+.+++.+||+.||.+|| +++++.+.|+.......
T Consensus 235 ~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 235 DV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred hc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 01 112235788999999999999999 99999999998754433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.26 Aligned_cols=267 Identities=29% Similarity=0.422 Sum_probs=208.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--Ccc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 535 (785)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999983 36889999999887777778899999999999999999999998653 568
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 335899999999999999999999986 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCC--------C-CcccHHHHHHH
Q 003932 616 FAKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI--------N-ENLSILEHAYE 685 (785)
Q Consensus 616 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~--------~-~~~~~~~~~~~ 685 (785)
....... .......++..|+|||.+.+..++.++|||||||++|||++|..|+..... . ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6433211 122334577889999999999999999999999999999999988753210 0 00001111111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
...... ....+...+..+.+++.+||+.||++|||+.|+++.|+....+
T Consensus 244 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 244 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 111111 1111223345789999999999999999999999999986544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.75 Aligned_cols=262 Identities=28% Similarity=0.425 Sum_probs=213.3
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE 533 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 533 (785)
...++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3457899999999999999999984 24578999999764 3455678899999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCcc---------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecc
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIR---------------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 592 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 592 (785)
..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999864322 234889999999999999999999986 999999
Q ss_pred cCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCccc
Q 003932 593 KVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLC 671 (785)
Q Consensus 593 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~ 671 (785)
||+|||++.++.+||+|||+++...............+|..|+|||.+.+..++.++|||||||++|||++ |+.|+...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654433223334567889999999998889999999999999999999 99998644
Q ss_pred CCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 672 GINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.... .. ......... ......+..+.+++.+||+.||.+||++.|+++.|++..
T Consensus 257 ~~~~---~~----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 257 PPER---LF----NLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CGGG---HH----HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHH---HH----HHhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3222 11 112211111 111223457889999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=362.97 Aligned_cols=269 Identities=28% Similarity=0.414 Sum_probs=215.2
Q ss_pred cChHHHHHHhcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeE
Q 003932 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRV 525 (785)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l 525 (785)
+...+++...++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45566677789999999999999999999972 346789999997653 34456789999999999 79999999
Q ss_pred EEEEecCC-ccEEEEEecCCCChhhhhcCCcc------------------------------------------------
Q 003932 526 LGFCIDSE-ERMLIYEYMPNKSLDCYLFDPIR------------------------------------------------ 556 (785)
Q Consensus 526 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------ 556 (785)
++++.+.. ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 48999999999999999865432
Q ss_pred ---------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 557 ---------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 557 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999986 99999999999999999999999999987644333
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
........||..|+|||++.+..++.++|||||||++|||++ |+.|+......+. . ...........
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~---~~~~~~~~~~~------ 316 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F---CRRLKEGTRMR------ 316 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---H---HHHHHHTCCCC------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---H---HHHHHcCCCCC------
Confidence 333445678999999999999999999999999999999998 9999865432221 1 11111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.+......+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 317 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 317 ---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1112334788999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=340.93 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=210.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.++|++.+.||+|+||.||+|...++..||+|++..... ..+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 468999999999999999999988888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998542 345899999999999999999999986 999999999999999999999999999876543221
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ..... .......
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~-~~~~~~~-------- 224 (268)
T 3sxs_A 161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLK-VSQGHRL-------- 224 (268)
T ss_dssp -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH-HHTTCCC--------
T ss_pred -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHH-HHcCCCC--------
Confidence 2233456778999999998889999999999999999999 99998643211 11111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
..+...+..+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 -YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0111123478899999999999999999999999998743
|
| >1nar_A Narbonin; plant SEED protein; 1.80A {Vicia narbonensis} SCOP: c.1.8.5 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=342.30 Aligned_cols=211 Identities=13% Similarity=0.107 Sum_probs=167.3
Q ss_pred EEEEEe-cCCCCCCcCCCC------CCCCceEEEEEEEeeCCc---cEEecCCCccHHH-HHHHHHHHHhcCCCceEEEE
Q 003932 27 IRVGYL-NLSEVSTISGIN------YDLFTHLICSSADINSTT---YQLSLSLPSDENQ-IAKFADTVKKKNPSITTILS 95 (785)
Q Consensus 27 ~~vgY~-~~~~~~~~~~i~------~~~~Thi~~~f~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~k~~~p~lkv~~s 95 (785)
+-..|+ .+...+.+++|| +++||||+|+|+.++++. +...+.+.+++.. ..+.+..+|+++|++|||+|
T Consensus 4 ~~~~Y~g~~~~~~~~~di~~~~~~~~~~~THi~yaFa~~~~~~~~~~~g~~~~~~~d~~~~~~~~~~lk~~~~~~KvllS 83 (290)
T 1nar_A 4 IFREYIGVKPNSTTLHDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEKVKNLKRRHPEVKVVIS 83 (290)
T ss_dssp EEEEEESCCTTCCSCSSCCSTTCCCSSSEEEEEEEEEEEEECTTSCEEEEEEECSCHHHHSHHHHHHHHHHCTTCEEEEE
T ss_pred chheeeccCCCCCCHhHCCcccccCcccCcEEEEEeeeecCccccCCCceecccccccccCHHHHHHHHHHCCCceEEEE
Confidence 334577 556788999999 789999999999998730 0222334454443 24445669999999999999
Q ss_pred ecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcC------CceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhh
Q 003932 96 IGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYG------FRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAK 169 (785)
Q Consensus 96 igG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~------~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~ 169 (785)
||||..+. .|+. ++++++|++|++++++++++|| |||||||||||+ .| ++|+.|+++||++|++.+
T Consensus 84 iGG~~~s~--~fs~-~~~~~~r~~f~~s~~~~~~~~g~~~~~~fDGiDiDwE~p~--~d-~~~~~ll~~Lr~~l~~~~-- 155 (290)
T 1nar_A 84 IGGRGVNT--PFDP-AEENVWVSNAKESLKLIIQKYSDDSGNLIDGIDIHYEHIR--SD-EPFATLMGQLITELKKDD-- 155 (290)
T ss_dssp EEESSTTS--CBCB-SCHHHHHHHHHHHHHHHHHHSEETTEECCCEEEEEESCBC--SS-TTHHHHHHHHHHHHHHCT--
T ss_pred EECCCCCC--Ceec-cCCHHHHHHHHHHHHHHHHHhCCCcCCccceEEEeccCCC--Ch-HHHHHHHHHHHHHhhhcc--
Confidence 99997754 4887 6889999999999999999999 999999999984 35 999999999999997631
Q ss_pred cccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHc
Q 003932 170 NSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIER 249 (785)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~ 249 (785)
....+++++++... . ..++++.+.+++||||+|+|||||+|.+. .+++.++++|++.
T Consensus 156 ----~~~~l~a~vap~~~-~-~~~~~~~l~~~~D~i~vM~YD~~g~~~~~-----------------~~~~~~v~~~~~~ 212 (290)
T 1nar_A 156 ----DLNINVVSIAPSEN-N-SSHYQKLYNAKKDYINWVDYQFSNQQKPV-----------------STDDAFVEIFKSL 212 (290)
T ss_dssp ----TSCCCEEEECCCTT-T-HHHHHHHHHHHTTTCCEEEEEGGGCSSCC-----------------CSHHHHHHHHHHH
T ss_pred ----CceeEEEEeCCCcc-c-ccCcHHHHHHhCCEEEEEeecCCCCCCCC-----------------CCHHHHHHHHHHh
Confidence 11244444443322 2 67899999999999999999999988521 2789999999985
Q ss_pred C--CCCCceeeccccccceee
Q 003932 250 G--LSADKLVMCLPFYGYAWT 268 (785)
Q Consensus 250 g--vp~~KlvlGip~YG~~~~ 268 (785)
| +|++||+||+|+||+.|.
T Consensus 213 ~~gvp~~Ki~lGlp~yg~~~~ 233 (290)
T 1nar_A 213 EKDYHPHKVLPGFSTDPLDTK 233 (290)
T ss_dssp HHHSCTTCEEEEEECCHHHHH
T ss_pred ccCCCHHHEEEEEeccCCccc
Confidence 4 999999999999999983
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=352.13 Aligned_cols=248 Identities=19% Similarity=0.245 Sum_probs=204.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357999999999999999999954 6899999999754 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999988843 346899999999999999999999986 99999999999999999999999999976432
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ....... . .
T Consensus 158 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~---~~~i~~~-~-~----- 222 (337)
T 1o6l_A 158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L---FELILME-E-I----- 222 (337)
T ss_dssp T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHHC-C-C-----
T ss_pred C--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---H---HHHHHcC-C-C-----
Confidence 2 123445689999999999999999999999999999999999999986432111 1 1111111 1 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
..+...+..+.+++.+||+.||++|| +++|+++
T Consensus 223 ----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11122345788999999999999999 8999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=350.92 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=203.6
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 58999999999999999999954 789999999865432 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999998853 345899999999999999999999986 99999999999999999999999999987654433
Q ss_pred ccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ . ...+......
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~----~~~~~~~~~~------- 227 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKTY------- 227 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--H----HHHHHTTCTT-------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHHhccccc-------
Confidence 334455789999999999987765 7789999999999999999999965432211 1 1111111100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
..........+.+|+.+||+.||++|||+.|+++.
T Consensus 228 -~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00112234567899999999999999999999763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=343.57 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=209.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357999999999999999999987888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...... .
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 161 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-c
Confidence 99999999854 2345899999999999999999999986 9999999999999999999999999997654322 1
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... + ..........
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~-~~~~~~~~~~--------- 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------E-VVEDISTGFR--------- 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCC---------
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------H-HHHHHhcCcc---------
Confidence 12233456788999999998999999999999999999999 99998643211 1 1111111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
...+...+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 1111222457889999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.63 Aligned_cols=275 Identities=16% Similarity=0.195 Sum_probs=218.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35799999999999999999994 5789999999865432 24578899999999 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc-----eeeccccceee
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK-----PKISDFGMARI 615 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----~kl~Dfg~a~~ 615 (785)
|+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998542 335899999999999999999999886 999999999999987776 99999999988
Q ss_pred ecccccc-----cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 616 FAKESLE-----ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 616 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
....... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 12345679999999999999999999999999999999999999997654433322222221111111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCCcc
Q 003932 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSK 754 (785)
Q Consensus 691 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 754 (785)
.... +.. ..+..+.+++.+||+.||++||++++|++.|++............+.|
T Consensus 241 ~~~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 241 PLRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp CHHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred cHHH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 1000 011 123478899999999999999999999999999876665555554555
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=347.03 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=202.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36899999999999999999998889999999997543 2234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++ +|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9975 77777754 2345899999999999999999999986 9999999999999999999999999998754321
Q ss_pred cccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc--
Q 003932 621 LEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD-- 697 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 697 (785)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ..................
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGT
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhh
Confidence 22334578999999999876 5689999999999999999999999975544332 222222222111110000
Q ss_pred ----------cccCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 698 ----------SFLDDRN----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 698 ----------~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....... .+....++.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 0112347889999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=361.68 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=210.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999842 4678999999754 344556788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCc----cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC---ceeec
Q 003932 536 MLIYEYMPNKSLDCYLFDPI----RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM---KPKIS 608 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~ 608 (785)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986432 2245899999999999999999999986 99999999999999555 59999
Q ss_pred cccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHH
Q 003932 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |+.|+...... ......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-------~~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHH
Confidence 9999986544333333445678999999999999999999999999999999998 99998643211 111222
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
..+... ......+..+.+|+.+||+.||.+|||+.||++.|+....
T Consensus 300 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 300 TSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 222111 1112234478899999999999999999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=353.71 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=204.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChh------hHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQ------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|++.+.||+|+||.||+|... +++.||+|++.+.... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457999999999999999999954 6899999999764321 356789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC----ceeecccc
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM----KPKISDFG 611 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfg 611 (785)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999853 346899999999999999999999986 99999999999998777 79999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......+ .........
T Consensus 165 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-------~~~~i~~~~ 234 (361)
T 2yab_A 165 LAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITAVS 234 (361)
T ss_dssp SCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTC
T ss_pred CceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcC
Confidence 99876543 22345679999999999999999999999999999999999999996432111 111111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. .+..... ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~-~~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 Y-DFDEEFF-----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C-CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C-CCCchhc-----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000000 112346889999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.52 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=203.6
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
++|++.+.||+|+||.||+|... ++.||+|++.... ..+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 57899999999999999999976 7889999997543 4567899999999999999999999886 45899999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc-eeeccccceeeecccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK-PKISDFGMARIFAKESLE 622 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-~kl~Dfg~a~~~~~~~~~ 622 (785)
+|+|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976544456889999999999999999999955456999999999999998886 799999999764322
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
.....||..|+|||++.+..++.++|||||||++|||++|+.|+....... ....... ........
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~------- 225 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAV-HNGTRPPL------- 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHH-HTTCCCCC-------
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHH-hcCCCCCc-------
Confidence 233468999999999999999999999999999999999999986433221 1111111 11111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTP 747 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 747 (785)
....+..+.+++.+||+.||.+|||+.|+++.|+......+..
T Consensus 226 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 226 --IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp --BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred --ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 1122346889999999999999999999999998876554433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=359.34 Aligned_cols=263 Identities=26% Similarity=0.389 Sum_probs=214.3
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe--------CCCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEec
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL--------PCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID 531 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 531 (785)
..++|.+.+.||+|+||.||+|.. ..+..||+|++... .....+.+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 357899999999999999999984 22357999999765 344557789999999999 99999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIR-------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
....++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999864321 235899999999999999999999986 999999999999
Q ss_pred EcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcc
Q 003932 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENL 677 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~ 677 (785)
++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |+.|+.....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---- 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987654433333444567889999999999999999999999999999999 9999864321
Q ss_pred cHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
.........+.... ........+.+++.+||+.||++|||+.|+++.|++....
T Consensus 300 ---~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 300 ---EELFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp ---HHHHHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11222222222111 1122345788999999999999999999999999987543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=370.36 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=212.6
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
++...++|++.+.||+|+||.||+|...++..||||++.... ...+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 444567899999999999999999998888899999997654 34678999999999999999999999986 5678999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999643 2235888999999999999999999986 99999999999999999999999999987543
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
... .......++..|+|||++....++.++|||||||++|||++ |+.|+......+ .. .....+..
T Consensus 337 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~~~----- 403 (454)
T 1qcf_A 337 NEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VI----RALERGYR----- 403 (454)
T ss_dssp HHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH----HHHHHTCC-----
T ss_pred Cce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCC-----
Confidence 211 11223456788999999998899999999999999999999 999986432111 11 11111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
...+...+..+.+++.+||+.||++|||+++|++.|++....
T Consensus 404 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 404 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 011122345789999999999999999999999999997544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=354.26 Aligned_cols=266 Identities=27% Similarity=0.443 Sum_probs=214.1
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEec
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID 531 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 531 (785)
+....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445688999999999999999999964 34889999998653 3445678999999999999999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCcc---------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEe
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIR---------------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 590 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 590 (785)
....++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999864321 156899999999999999999999986 9999
Q ss_pred cccCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCc
Q 003932 591 DLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSM 669 (785)
Q Consensus 591 Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~ 669 (785)
||||+|||++.++.+||+|||+++...............+|..|+|||.+.+..++.++|||||||++|||++ |+.|+.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987644332233344568899999999998899999999999999999999 999986
Q ss_pred ccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 670 LCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
.... .........+.... .+...+..+.+++.+||+.||++||++.++++.|++....
T Consensus 279 ~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 279 GMAH-------EEVIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TSCH-------HHHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCh-------HHHHHHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 4321 11112222222111 1122345788999999999999999999999999987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=358.18 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=198.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
..+|++.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 458999999999999999999854 5678999999765 34455679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999642 345899999999999999999999986 9999999999999999999999999998765
Q ss_pred cccccc-ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 618 KESLEE-NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 618 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
...... ......++..|+|||++.+..++.++|||||||++|||++ |+.|+...... ........+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-------~~~~~i~~~~---- 267 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------DVIKAVDEGY---- 267 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-------HHHHHHHTTE----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC----
Confidence 332111 1222345778999999999999999999999999999998 99998643211 1111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
........+..+.+++.+||+.||++||++.||++.|+....
T Consensus 268 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 268 -----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp -----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 011122234578999999999999999999999999988654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.51 Aligned_cols=275 Identities=15% Similarity=0.141 Sum_probs=216.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+|.. .+++.||||++...... +.+.+|+.+++++ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35799999999999999999994 57899999998754332 4578999999999 99999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc-----eeeccccceee
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK-----PKISDFGMARI 615 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----~kl~Dfg~a~~ 615 (785)
|+ +++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998642 346899999999999999999999986 999999999999998887 99999999987
Q ss_pred eccccccc-----ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 616 FAKESLEE-----NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 616 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~- 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA- 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-
Confidence 65432211 124567999999999999999999999999999999999999999765443332222222111100
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCCccc
Q 003932 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQ 755 (785)
Q Consensus 691 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 755 (785)
.....+.. ..+ .+.+++..||+.||.+||++.+|.+.|++............+.|.
T Consensus 239 ----~~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 239 ----TPIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp ----SCHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred ----CCHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 00000001 112 788999999999999999999999999876655444443344444
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=353.21 Aligned_cols=265 Identities=27% Similarity=0.397 Sum_probs=211.5
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEec
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID 531 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 531 (785)
+...++|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34567899999999999999999985 245689999997542 33456789999999999 89999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCccc--------------------cCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEec
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIRK--------------------LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 591 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 591 (785)
....++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+.+ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 99999999999999999999653221 34789999999999999999999986 99999
Q ss_pred ccCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcc
Q 003932 592 LKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSML 670 (785)
Q Consensus 592 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~ 670 (785)
|||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999987654433223344567889999999998899999999999999999998 9999865
Q ss_pred cCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 671 CGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
...... ........... ..+...+..+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 278 ~~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 278 IPVDAN------FYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCCSHH------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCcHHH------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 432221 11122221111 1112234578899999999999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=353.82 Aligned_cols=264 Identities=24% Similarity=0.433 Sum_probs=195.4
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCC-Cc---EEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPC-GE---VIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
..++|++.+.||+|+||.||+|.... +. .||+|++... .....+.+.+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999998553 32 7999999765 344567899999999999999999999999877655
Q ss_pred ------EEEEEecCCCChhhhhcCCc---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCcee
Q 003932 536 ------MLIYEYMPNKSLDCYLFDPI---RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPK 606 (785)
Q Consensus 536 ------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 606 (785)
++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999885422 1225899999999999999999999986 99999999999999999999
Q ss_pred eccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHH
Q 003932 607 ISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 685 (785)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ ...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~---- 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN---- 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH----
Confidence 999999987654433333334557889999999999999999999999999999999 899986543222 111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
........ ......+..+.+++.+||+.||++|||+.++++.|++.....
T Consensus 251 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 YLIGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhcCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111111 112223457899999999999999999999999999876443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=351.43 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=200.5
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCc----EEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGE----VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
++|++.+.||+|+||.||+|+.. +++ .||+|.+... .....+.+.+|+.++++++||||++++++|.+. ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 57999999999999999999853 444 3688888654 234557899999999999999999999999875 4789
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999998642 345899999999999999999999986 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
............+|..|+|||.+.+..++.++|||||||++|||++ |+.||........ . ........
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----~~~~~~~~---- 237 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKGER---- 237 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTTCC----
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---H----HHHHcCCC----
Confidence 4433333334567889999999999999999999999999999999 9999865432221 1 11111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
..........+.+++.+||+.||.+||++.|+++.|+....
T Consensus 238 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11122234578899999999999999999999999977543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=367.28 Aligned_cols=265 Identities=26% Similarity=0.427 Sum_probs=209.0
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
+...++|++.+.||+|+||.||+|....+..||||++..... ..+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 344678999999999999999999988778899999976543 34678999999999999999999999876 6789999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999532 2345899999999999999999999986 999999999999999999999999999876433
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... + .......+...
T Consensus 334 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~~----- 400 (452)
T 1fmk_A 334 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRM----- 400 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCC-----
T ss_pred ce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCC-----
Confidence 21 12223456789999999998899999999999999999999 99998643211 1 11122221111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTP 747 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 747 (785)
..+...+..+.+++.+||+.||++|||+++|++.|+.........
T Consensus 401 ----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 401 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 112233457889999999999999999999999999986654443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.77 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=196.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh----hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST----QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|... ++.+|+|++..... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357899999999999999999976 88999999876432 2346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC--------CCceeeccc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE--------AMKPKISDF 610 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~--------~~~~kl~Df 610 (785)
|||+++++|.+++. ...+++..+..++.|+++||.|||+.+..+++||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999884 345899999999999999999999986555999999999999986 778999999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
|++....... .....||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...........
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCC
Confidence 9998654321 2245689999999999998999999999999999999999999864321 11111111111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 691 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.. .......+..+.+++.+||+.||.+|||+.|+++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 LA---------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC---------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 11112234578899999999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.99 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=204.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++.+.||+|+||.||+|... +++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 368999999999999999999954 68899999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC--CCceeeccccceeeeccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE--AMKPKISDFGMARIFAKE 619 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~--~~~~kl~Dfg~a~~~~~~ 619 (785)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999854 2345899999999999999999999986 999999999999987 789999999999876543
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ .. ......... .....
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~~~~~--~~~~~ 226 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II---ENIMNAEYT--FDEEA 226 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHHTCCC--CCHHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HH---HHHHcCCCC--CChhh
Confidence 2 2334678999999999999889999999999999999999999986432111 11 111111100 00000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ...+.++.+++.+||+.||.+|||+.|+++
T Consensus 227 ~-----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 F-----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 112347889999999999999999999987
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.31 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=204.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh------hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357999999999999999999954 689999999875432 1357789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC----ceeecccc
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM----KPKISDFG 611 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfg 611 (785)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999853 345899999999999999999999986 99999999999999887 89999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ .. .......
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~~~~~~- 233 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANVSAVN- 233 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHHTC-
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHHhcC-
Confidence 998764332 2334679999999999999999999999999999999999999986432111 11 1111110
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 -~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 -YEFEDEYF-----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CCCCHHHH-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCcCcccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00100000 112346889999999999999999999987
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=352.69 Aligned_cols=250 Identities=20% Similarity=0.311 Sum_probs=198.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 537 (785)
.++|+++++||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|..++.++ +||||+++++++.+....++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999954 68899999997642 22334578899999877 89999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999988853 346899999999999999999999986 9999999999999999999999999997532
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcc--cHHHHHHHHHhCCccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--SILEHAYELWKGGKGVEF 695 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 695 (785)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.. ..............
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 278 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 278 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence 22 12345578999999999999999999999999999999999999999654332211 11111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSM 730 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 730 (785)
...+......+.+|+.+||+.||.+||++
T Consensus 279 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 ------IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 01112234578899999999999999996
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=352.72 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=207.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++.+.||+|+||.||+|... +++.+|+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999954 6889999999877666667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC--CCceeeccccceeeeccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE--AMKPKISDFGMARIFAKE 619 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~--~~~~kl~Dfg~a~~~~~~ 619 (785)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998854 2345899999999999999999999986 999999999999974 578999999999876443
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... ..
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~--~~---- 269 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDW--EF---- 269 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCC--CC----
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC--CC----
Confidence 2 22345789999999999999999999999999999999999999864321 111111111110 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
........+..+.+++.+||+.||++|||+.|+++.
T Consensus 270 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111111234578899999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=339.24 Aligned_cols=264 Identities=25% Similarity=0.318 Sum_probs=200.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHc--CCCCceeeEEEEEecC----CccE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDS----EERM 536 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 536 (785)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999987 48999999986542 3455566666665 7999999999987643 4578
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-----SRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
+||||+++|+|.+++. ...+++..+..++.|++.||.|||.. ++.+|+||||||+|||++.++.+||+|||
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 9999999999999994 34589999999999999999999921 12359999999999999999999999999
Q ss_pred ceeeeccccccc--ccccccccCCcccccccCCC------CCCChhhHHHHHHHHHHHHcC----------CCCCcccCC
Q 003932 612 MARIFAKESLEE--NTEQVVGTIGYIPPEYATKG------VYSTKSDVFSFGVLLLQIISG----------KRLSMLCGI 673 (785)
Q Consensus 612 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvvl~elltG----------~~p~~~~~~ 673 (785)
+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 998765432221 12335799999999999876 455799999999999999999 777654332
Q ss_pred CCcccHHHHHHHHHhC-CccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 674 NENLSILEHAYELWKG-GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 674 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.... .......... ........ .......+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 239 ~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPS--FEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCC--HHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcc--hhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2211 1111121111 11111111 111234567899999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.86 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=207.4
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..++|++.+.||+|+||.||+|...++..||+|++...... .+++.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 35689999999999999999999888889999999765433 36789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999998642 345899999999999999999999986 99999999999999999999999999976543211
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ........
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~-~~~~~~~~-------- 239 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETA-EHIAQGLR-------- 239 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHH-HHHHTTCC--------
T ss_pred -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHH-HHHhcccC--------
Confidence 12233456788999999998899999999999999999998 99998643221 111 11111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
...+...+..+.+++.+||+.||.+|||++|+++.|++..
T Consensus 240 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 240 -LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 1111122347889999999999999999999999998753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=360.41 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=206.4
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC-ccEEEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLIYE 540 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 540 (785)
..++|++.+.||+|+||.||+|... ++.||||++.... ..+.+.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3567899999999999999999976 7899999997654 3467899999999999999999999987765 7899999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999643 2334789999999999999999999986 999999999999999999999999999864321
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+. .. ....+...
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~----~i~~~~~~------ 405 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----RVEKGYKM------ 405 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH----HHHTTCCC------
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCCCC------
Confidence 122356889999999999999999999999999999998 9999875443321 11 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
..+...+..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 406 ---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 406 ---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 112233457899999999999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.70 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=212.9
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCC
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE 533 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 533 (785)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 456899999999999999999984 356789999997653 34557789999999999 9999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCcc---------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIR---------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999864322 124899999999999999999999986 999999999999
Q ss_pred EcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcc
Q 003932 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENL 677 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~ 677 (785)
++.++.+||+|||+++...............+|..|+|||.+.+..++.++|||||||++|||++ |+.|+........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 99999999999999987654433223334567889999999998899999999999999999999 9999865432211
Q ss_pred cHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.. ....... ........+..+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 257 --~~---~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 257 --FY---KMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp --HH---HHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HH---HHhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 11 1111110 011112234578899999999999999999999999998653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.50 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=210.9
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe--------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEec
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL--------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID 531 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 531 (785)
..++|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 357899999999999999999985 246789999997653 34566789999999999 89999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIR-------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
....++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965321 234889999999999999999999986 999999999999
Q ss_pred EcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcc
Q 003932 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENL 677 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~ 677 (785)
++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |+.|+......+
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence 99999999999999987654433233344567889999999988889999999999999999999 999986432111
Q ss_pred cHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
........... ......+..+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 268 -----~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 268 -----LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp -----HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111111111 1112234578899999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=353.67 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=198.6
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 536 (785)
..++|++.+.||+|+||.||+|+. .+++.||+|++.+. .....+.+.+|..+++.+ +||||+++++++.+....+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 357899999999999999999995 46899999999754 223455678899999988 7999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999998853 345899999999999999999999986 999999999999999999999999999753
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . .........
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~---~~~i~~~~~----- 241 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---L---FEAILNDEV----- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHHCCC-----
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---H---HHHHHcCCC-----
Confidence 322 123445689999999999999899999999999999999999999996433211 1 111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSM------LEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 735 (785)
..+......+.+++.+||+.||.+||++ +|+++
T Consensus 242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111233468899999999999999998 67764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=350.34 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=203.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35799999999999999999995 468899999986532 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+.+|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999853 345899999999999999999999986 99999999999999999999999999987643
Q ss_pred cccccccccccccCCcccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATK---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
. ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. .... .
T Consensus 168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~~~-~---- 236 (384)
T 4fr4_A 168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---FETT-V---- 236 (384)
T ss_dssp T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH---HHHC-C----
T ss_pred C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hhhc-c----
Confidence 3 23445689999999999974 4589999999999999999999999975433322111111 1111 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS-MLEVSS 735 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 735 (785)
...+...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 237 ------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111223457889999999999999998 777764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=366.92 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=212.5
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
...+|++.+.||+|+||.||+|... ++..||||++..... ..+.+.+|+.++++++||||++++++|.+....++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 4567999999999999999999965 488999999976543 45789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999643 2345899999999999999999999986 9999999999999999999999999998764332
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
. .......++..|+|||++.+..++.++|||||||++|||++ |+.|+......+ .. ........
T Consensus 373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~------- 437 (495)
T 1opk_A 373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY----ELLEKDYR------- 437 (495)
T ss_dssp E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----HHHHTTCC-------
T ss_pred e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCC-------
Confidence 1 12233456789999999998899999999999999999999 999986543222 11 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
...+...+..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 438 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1112233457889999999999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=344.87 Aligned_cols=249 Identities=21% Similarity=0.328 Sum_probs=200.0
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 538 (785)
++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|..+++++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999964 6889999999764 334456688999999988 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999998853 345899999999999999999999986 99999999999999999999999999975332
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcc--cHHHHHHHHHhCCcccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--SILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 696 (785)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.. .............. .
T Consensus 163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-~--- 236 (345)
T 3a8x_A 163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-I--- 236 (345)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-C---
T ss_pred C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-C---
Confidence 2 12344568999999999999999999999999999999999999999654332211 11111111111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSM 730 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 730 (785)
..+...+..+.+++.+||+.||.+||++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1112234578899999999999999996
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.03 Aligned_cols=262 Identities=18% Similarity=0.235 Sum_probs=206.8
Q ss_pred hHHHHHHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEec
Q 003932 456 LADIEAATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCID 531 (785)
Q Consensus 456 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 531 (785)
+.++....++|++.++||+|+||.||+|+.. +++.||+|++.+... ...+.+.+|..++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4445556789999999999999999999965 578999999965321 122347889999999999999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
....++|||||++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999642 345899999999999999999999986 9999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 686 (785)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+ .....
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~~~i--- 293 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKI--- 293 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---HHHhh---
Confidence 9987644321 2233468999999999986 5678999999999999999999999997433221 11111
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPND--RPSMLEVSS 735 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 735 (785)
........+.. .....+..+.+|+.+||+.+|++ ||+++|+++
T Consensus 294 ~~~~~~~~~p~------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 294 MNHKERFQFPT------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HTHHHHCCCCS------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhccccccCCc------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11000001110 01112347889999999988888 999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=340.36 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=195.0
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh--------------------------hhHHHHHHHHHHHHc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST--------------------------QGFEEFKNEVMLTAK 516 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~ 516 (785)
++|++.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5799999999999999999985 4688999999865421 123468899999999
Q ss_pred CCCCceeeEEEEEec--CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccC
Q 003932 517 LQHVNLIRVLGFCID--SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKV 594 (785)
Q Consensus 517 l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp 594 (785)
++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||+.||.|||+.+ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999986 56789999999999998765 3346899999999999999999999986 99999999
Q ss_pred CCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCccc
Q 003932 595 SNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV---YSTKSDVFSFGVLLLQIISGKRLSMLC 671 (785)
Q Consensus 595 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltG~~p~~~~ 671 (785)
+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999998765332 1233457999999999998765 478899999999999999999998643
Q ss_pred CCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 672 GINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. .......... . .... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~------~~~~~~~~~~-~-~~~~-------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RI------MCLHSKIKSQ-A-LEFP-------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SH------HHHHHHHHHC-C-CCCC-------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cH------HHHHHHHhcc-c-CCCC-------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 1111111111 1 0000 01122347889999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=343.51 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=203.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999954 68999999997542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999853 345889999999999999999999886 99999999999999999999999999987532
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~--~----- 220 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAE--L----- 220 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCC--C-----
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC--C-----
Confidence 23346799999999999999999999999999999999999999864321 11111111111 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
..+......+.+++.+||+.||.+|| +++|+++
T Consensus 221 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01122334788999999999999999 8899874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=346.91 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=201.0
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|.+.+.||+|+||.||+|.. .+++.||+|++.+.. ......+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999995 578999999986432 122356889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+ +|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 7888888743 345899999999999999999999987 999999999999999999999999999765433
Q ss_pred ccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... .+..
T Consensus 162 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i~~ 222 (336)
T 3h4j_B 162 ---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KVNS 222 (336)
T ss_dssp ---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CCCS
T ss_pred ---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HHHc
Confidence 22345679999999999998876 789999999999999999999997543322111 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ....+...+..+.+++.+||+.||.+|||++|+++
T Consensus 223 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 223 C-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp S-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred C-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 00112223457889999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.48 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=200.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc------
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE------ 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 534 (785)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999965 78999999997543 3455778999999999999999999999865432
Q ss_pred ---------------------------------------------------cEEEEEecCCCChhhhhcCCccccCCCHH
Q 003932 535 ---------------------------------------------------RMLIYEYMPNKSLDCYLFDPIRKLILDWK 563 (785)
Q Consensus 535 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~ 563 (785)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999776555667788
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc----------cccccccccCC
Q 003932 564 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE----------ENTEQVVGTIG 633 (785)
Q Consensus 564 ~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~ 633 (785)
.+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999986 999999999999999999999999999886543211 12234579999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHH
Q 003932 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCL 713 (785)
Q Consensus 634 y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 713 (785)
|+|||++.+..++.++|||||||++|||++|..|+.. ... ........... .........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~-~~~~~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVR-IITDVRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHH-HHHHHHTTCCC---------HHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHH-HHHHhhccCCC---------cccccCChhHH
Confidence 9999999999999999999999999999998765421 011 11111111100 00122334678
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 003932 714 EIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 714 ~li~~cl~~dP~~RPs~~evl~ 735 (785)
+++.+||+.||++|||+.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=350.16 Aligned_cols=253 Identities=22% Similarity=0.348 Sum_probs=204.7
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999954 6899999999754 334556789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC---ceeeccccceee
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM---KPKISDFGMARI 615 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~Dfg~a~~ 615 (785)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999988853 345899999999999999999999986 99999999999998654 599999999987
Q ss_pred ecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... .....+.. ..
T Consensus 181 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~----~~i~~~~~-~~ 249 (362)
T 2bdw_A 181 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY----AQIKAGAY-DY 249 (362)
T ss_dssp CTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCC-CC
T ss_pred ecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhCCC-CC
Confidence 6432 2233467999999999999999999999999999999999999998643211 111 11111110 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
... .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Ccc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 011224578899999999999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=356.84 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=203.6
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
..++|++.+.||+|+||.||+|.. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 357899999999999999999985 578999999997653 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc---CCCceeeccccceee
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG---EAMKPKISDFGMARI 615 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~Dfg~a~~ 615 (785)
|||+++|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999988853 345899999999999999999999986 99999999999998 467899999999977
Q ss_pred ecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ . ......+.. ..
T Consensus 163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~----~~~i~~~~~-~~ 232 (444)
T 3soa_A 163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---L----YQQIKAGAY-DF 232 (444)
T ss_dssp CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H----HHHHHHTCC-CC
T ss_pred ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---H----HHHHHhCCC-CC
Confidence 54332 22334679999999999999999999999999999999999999986432111 1 111111110 11
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..+ .....+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 PSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Ccc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 110 01122457889999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=349.82 Aligned_cols=270 Identities=27% Similarity=0.433 Sum_probs=216.3
Q ss_pred cChHHHHHHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEE
Q 003932 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVL 526 (785)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 526 (785)
+..++++...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334455566789999999999999999999853 36789999997653 34456788999999999999999999
Q ss_pred EEEecCCccEEEEEecCCCChhhhhcCCcc-------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE
Q 003932 527 GFCIDSEERMLIYEYMPNKSLDCYLFDPIR-------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599 (785)
Q Consensus 527 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 599 (785)
+++.+....++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 999999999999999999999999854221 145789999999999999999999986 9999999999999
Q ss_pred cCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCccc
Q 003932 600 GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLS 678 (785)
Q Consensus 600 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 678 (785)
+.++.+||+|||+++...............+|..|+|||.+.+..++.++|||||||++|||++ |+.|+.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----- 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----
Confidence 9999999999999986644333233334567889999999998899999999999999999999 8888754321
Q ss_pred HHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 679 ILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.............. .....+..+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 247 --~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 --EQVLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11112222211111 112234578899999999999999999999999998743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.18 Aligned_cols=261 Identities=22% Similarity=0.312 Sum_probs=199.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.+.||+|+||.||+|+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47899999999999999999988899999999975432 2246788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 975 888887542 345889999999999999999999986 9999999999999999999999999987653221
Q ss_pred ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc------
Q 003932 622 EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE------ 694 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 694 (785)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .................
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhc
Confidence 122345789999999999764 5899999999999999999999998643221 12222222211111000
Q ss_pred --ccccccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 695 --FVDSFLD-------DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 695 --~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..+.... ..........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0001123457889999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=349.85 Aligned_cols=284 Identities=16% Similarity=0.195 Sum_probs=213.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCC------CcEEEEEEcCCCChhhHH-----------HHHHHHHHHHcCCCCceeeE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPC------GEVIAVKKLSKTSTQGFE-----------EFKNEVMLTAKLQHVNLIRV 525 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l 525 (785)
.++|++.+.||+|+||.||+|.... ++.||+|++......... .+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999998653 478999998765432111 23345666778899999999
Q ss_pred EEEEecC----CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-
Q 003932 526 LGFCIDS----EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG- 600 (785)
Q Consensus 526 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~- 600 (785)
++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998765 4589999999 9999999854 2346899999999999999999999986 99999999999999
Q ss_pred -CCCceeeccccceeeeccccccc-----ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCC
Q 003932 601 -EAMKPKISDFGMARIFAKESLEE-----NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN 674 (785)
Q Consensus 601 -~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~ 674 (785)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998765432211 123456999999999999999999999999999999999999999753322
Q ss_pred CcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCCcc
Q 003932 675 ENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSK 754 (785)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 754 (785)
.. .......... ......++..+... ..+.++.+++..||+.||.+||++.+|++.|++.......+....+.|
T Consensus 268 ~~--~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 268 PK--YVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp HH--HHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred HH--HHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 21 1111111111 11222233222211 123478899999999999999999999999998877666666566666
Q ss_pred cccc
Q 003932 755 QVDE 758 (785)
Q Consensus 755 ~~~~ 758 (785)
...+
T Consensus 342 ~~~~ 345 (364)
T 3op5_A 342 SVVE 345 (364)
T ss_dssp ----
T ss_pred Eecc
Confidence 5433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=343.03 Aligned_cols=268 Identities=25% Similarity=0.391 Sum_probs=212.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEe--cCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI--DSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 535 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35799999999999999999983 468899999998887777788999999999999999999999987 44568
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 8999999999999998542 335899999999999999999999986 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCC--------CcccHHHHHHHH
Q 003932 616 FAKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN--------ENLSILEHAYEL 686 (785)
Q Consensus 616 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~--------~~~~~~~~~~~~ 686 (785)
....... .......+|..|+|||++.+..++.++|||||||++|+|++|+.|+...... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433211 1233456788899999999888999999999999999999999987532110 111111122222
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
...+. ........+..+.+++.+||+.||++|||+.|+++.|+......
T Consensus 257 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 22211 11122334457899999999999999999999999999876544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.78 Aligned_cols=259 Identities=21% Similarity=0.274 Sum_probs=205.5
Q ss_pred HHHHHHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEEEEecC
Q 003932 457 ADIEAATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS 532 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 532 (785)
.++....++|++.++||+|+||.||+|+.. +++.||+|++.+... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344445678999999999999999999964 688999999865311 1223478899999999999999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998843 35889999999999999999999986 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHh
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK 688 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 688 (785)
++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+ ... ....
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~---~i~~ 287 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYS---KIMN 287 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHT
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---HHH---HHHh
Confidence 987654321 1234568999999999997765 7899999999999999999999997433211 111 1111
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003932 689 GGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPND--RPSMLEVSSM 736 (785)
Q Consensus 689 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 736 (785)
......+.. ....+..+.+|+.+||+.+|.+ ||+++||++.
T Consensus 288 ~~~~~~~p~-------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHCCCCT-------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccccCCC-------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000001110 0112347889999999999998 9999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.28 Aligned_cols=261 Identities=30% Similarity=0.461 Sum_probs=210.3
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
+...++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 33457899999999999999999998888899999997653 23567899999999999999999999986 45689999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999998542 2235899999999999999999999986 999999999999999999999999999876543
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... + ..........
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~~~~------ 228 (279)
T 1qpc_A 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------E-VIQNLERGYR------ 228 (279)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCC------
T ss_pred cc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------H-HHHHHhcccC------
Confidence 21 12233456889999999988889999999999999999999 89888643211 1 1111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
.......+..+.+++.+||+.||++|||+.++++.|++....
T Consensus 229 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 229 ---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 011122345788999999999999999999999999986543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.81 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=195.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+|+... .+|+|++... .....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4689999999999999999998653 5999998754 344567789999999999999999999965 4567899999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999998854 2345899999999999999999999986 9999999999999999999999999998654332
Q ss_pred cccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.........||..|+|||.+. +..++.++|||||||++|||++|+.||......+ ................
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcchh
Confidence 233344567999999999987 5678889999999999999999999986433211 1111111111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
......+..+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 249 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 -----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111223457899999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.02 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=202.1
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCc
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 534 (785)
....++|.+.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999964 68999999997542 23445678899998876 99999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999853 345899999999999999999999986 9999999999999999999999999997
Q ss_pred eecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ... ..... .
T Consensus 167 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~---~i~~~-~--- 234 (345)
T 1xjd_A 167 ENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH---SIRMD-N--- 234 (345)
T ss_dssp CCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHC-C---
T ss_pred hcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHH---HHHhC-C---
Confidence 64322 123445689999999999999999999999999999999999999986432211 111 11111 1
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSML-EVS 734 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 734 (785)
...+......+.+++.+||+.||++||++. |++
T Consensus 235 -------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 001112235788999999999999999998 664
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.63 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=202.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcE----EEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEV----IAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
++|++.+.||+|+||.||+|... +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57899999999999999999853 4443 7888875432 233346778999999999999999999986 467899
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998643 346888999999999999999999986 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
............+|..|+|||++.+..++.++|||||||++|||++ |+.||......+. ............
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~~~- 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLLEKGERLAQ- 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHHHTTCBCCC-
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCCCCCC-
Confidence 4433333445678889999999998999999999999999999999 9999875432221 111222111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
+......+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 239 --------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 239 --------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp --------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred --------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11122357789999999999999999999999987653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=346.54 Aligned_cols=244 Identities=20% Similarity=0.219 Sum_probs=202.9
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999954 68999999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999853 345899999999999999999999986 999999999999999999999999999875432
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... +.. .
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~-~~~-~----- 256 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVS-GKV-R----- 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCC-C-----
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHc-CCC-C-----
Confidence 2346799999999999999999999999999999999999999864321 111111111 110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 735 (785)
.+...+..+.+++.+||+.||.+||+ ++|+++
T Consensus 257 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11123457889999999999999998 888865
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.96 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=201.0
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999964 68999999997543 3344678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++ +|.+.+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence 9976 55444432 2346899999999999999999999986 999999999999999999999999999876432
Q ss_pred cccccccccccCCcccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc---
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV--- 696 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 696 (785)
........||..|+|||++.+.. ++.++|||||||++|||++|..|+.... ......................
T Consensus 155 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred -cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhhc
Confidence 12234457899999999998766 7999999999999999999988864322 1112222222222211110000
Q ss_pred ---c---------cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 ---D---------SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ---~---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+ ........+.....+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00000111223457889999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.44 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=203.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CC-------cEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CG-------EVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 534 (785)
.++|.+.+.||+|+||.||+|... ++ ..||+|++........+.+.+|+.++++++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357999999999999999999854 23 4799999987766677889999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc--------ee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK--------PK 606 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--------~k 606 (785)
.++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999642 334899999999999999999999986 999999999999998887 99
Q ss_pred eccccceeeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH
Q 003932 607 ISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 685 (785)
|+|||++..... .....||..|+|||++.+ ..++.++|||||||++|||++|..|+..... ... ...
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~-~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQR-KLQ 229 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHH-HHH
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHH-HHH
Confidence 999999864322 223457899999999987 6789999999999999999996554432111 111 111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTP 747 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 747 (785)
....... . +...+..+.+++.+||+.||++|||+.|+++.|++..++..++
T Consensus 230 ~~~~~~~--~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 230 FYEDRHQ--L---------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp HHHTTCC--C---------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred HhhccCC--C---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 1111110 0 0011235788999999999999999999999999987654443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=347.07 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=202.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-----hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45799999999999999999985 468999999985421 123567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc---eeeccccc
Q 003932 537 LIYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK---PKISDFGM 612 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Dfg~ 612 (785)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775422 2345899999999999999999999986 999999999999987655 99999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
+....... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... ......+..
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~----~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERL----FEGIIKGKY 249 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHH----HHHHHHTCC
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHH----HHHHHcCCC
Confidence 98765432 22344679999999999999999999999999999999999999986421 111 111111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ...... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 250 ~-~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K-MNPRQW-----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C-CCHHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-CCcccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 000000 012347889999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=336.47 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=195.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.++|++.+.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 468999999999999999999853 24579999987643 344567899999999999999999999984 567899
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999853 2345899999999999999999999986 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
..... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ... ........
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~----~i~~~~~~--- 236 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGERL--- 236 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCC---
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHH----HHHcCCCC---
Confidence 43211 2223456789999999998899999999999999999997 999986543222 111 11111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
......+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122345788999999999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=342.25 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=193.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe----CCCcEEEEEEcCCCC----hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 534 (785)
.++|++.+.||+|+||.||+|+. .+++.||+|++.+.. ......+.+|+.++++++||||+++++++.....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 478999999997652 2334567889999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999998853 345889999999999999999999986 9999999999999999999999999987
Q ss_pred eecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~--- 238 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCKL--- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCC---
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC---
Confidence 643221 2234467999999999999999999999999999999999999998643211 11111111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
..+......+.+++.+||+.||.+|| ++.|+++
T Consensus 239 --------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 --------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11122345788999999999999999 6778765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.93 Aligned_cols=264 Identities=27% Similarity=0.399 Sum_probs=211.2
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEeC-C-----CcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEe
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVLP-C-----GEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCI 530 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 530 (785)
++...++|.+.+.||+|+||.||+|... . ...||+|++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3344678999999999999999999853 2 2479999997653 34556789999999999 8999999999999
Q ss_pred cCCccEEEEEecCCCChhhhhcCCcc-----------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE
Q 003932 531 DSEERMLIYEYMPNKSLDCYLFDPIR-----------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL 599 (785)
Q Consensus 531 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 599 (785)
+....++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 99999999999999999999854221 235789999999999999999999986 9999999999999
Q ss_pred cCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCccc
Q 003932 600 GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLS 678 (785)
Q Consensus 600 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~ 678 (785)
+.++.+||+|||+++...............+|..|+|||.+.+..++.++|||||||++|||++ |..|+........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-- 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-- 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence 9999999999999987654332223334567889999999998899999999999999999998 8888864332221
Q ss_pred HHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 679 ILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
. ......... ...+...+..+.+++.+||+.||.+|||+.|+++.|++.
T Consensus 276 -~---~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 -F---YKLVKDGYQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -H---HHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -H---HHHHhcCCC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1 111111110 011112235788999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=334.51 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=209.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
.++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467899999999999999999988888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence 999999998542 345889999999999999999999986 9999999999999999999999999987654321 1
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... +.. .....+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~-~~i~~~~~--------- 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVV-EDISTGFR--------- 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH-HHHHTTCC---------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHH-HHHhcCCc---------
Confidence 12233457789999999998889999999999999999999 89888643211 111 11111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
...+...+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111122457889999999999999999999999998753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=333.59 Aligned_cols=276 Identities=18% Similarity=0.230 Sum_probs=215.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEE-ecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFC-IDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... +.+.+|+.++++++|++++..+..+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999995 67899999998655332 4688999999999988766655555 56677899999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE---cCCCceeeccccceeeec
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFA 617 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~ 617 (785)
|+ +++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999998532 345899999999999999999999986 9999999999999 488999999999998865
Q ss_pred cccccc-----ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 618 KESLEE-----NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 618 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence 432211 12446799999999999999999999999999999999999999986554443333333222111100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCCccc
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSKQ 755 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 755 (785)
...+.. ..+..+.+++.+||+.||++|||+.++++.|++.......+....+.|+
T Consensus 239 ----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 239 ----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp ----HHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred ----hHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 000111 1234788999999999999999999999999987766555554445554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.21 Aligned_cols=272 Identities=20% Similarity=0.270 Sum_probs=214.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC--ccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 538 (785)
.++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357999999999999999999964 58999999997543 234567789999999999999999999998765 67999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE----cCCCceeecccccee
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL----GEAMKPKISDFGMAR 614 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~Dfg~a~ 614 (785)
|||+++|+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976544455999999999999999999999986 9999999999999 778889999999998
Q ss_pred eecccccccccccccccCCcccccccCC--------CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATK--------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 686 (785)
...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.......... +.....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~ 239 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKI 239 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHH
Confidence 764432 2334679999999998865 457889999999999999999999997544332221 222222
Q ss_pred HhCCccc--ccc------------ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 687 WKGGKGV--EFV------------DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 687 ~~~~~~~--~~~------------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
....... ... ...............+.+++.+||+.||++||++.|+++.++....
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 2221110 000 0001122345667788999999999999999999999999887643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.92 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=206.6
Q ss_pred cCCCcceeeceeCcEEEEEEEe-----CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--Ccc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EER 535 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 535 (785)
++|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4689999999999999999983 468899999997543 34457789999999999999999999999876 668
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999853 2345899999999999999999999986 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccC--------CCCcccHHHHHHHH
Q 003932 616 FAKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG--------INENLSILEHAYEL 686 (785)
Q Consensus 616 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~--------~~~~~~~~~~~~~~ 686 (785)
....... .......||..|+|||.+.+..++.++|||||||++|||++|+.|+.... ..............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6543221 22334568888999999999999999999999999999999998754210 11111111122222
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...... ...+...+..+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 256 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 222111 111223345789999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=349.25 Aligned_cols=252 Identities=25% Similarity=0.285 Sum_probs=199.6
Q ss_pred CcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCCC
Q 003932 467 SIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
...+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3367899999999999985 568999999998876667788999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE--cCCCceeeccccceeeeccccccc
Q 003932 546 SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL--GEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 546 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 172 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 172 ELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp EEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred cHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 99888853 2345899999999999999999999986 9999999999999 567899999999998765432
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 703 (785)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.......... ......
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~--~~~~~~---- 311 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRW--DLEDEE---- 311 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC--CSCSGG----
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccC--CCChhh----
Confidence 233457999999999999999999999999999999999999998643221 11111111111 000100
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 003932 704 NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 739 (785)
Q Consensus 704 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 739 (785)
.......+.+++.+||+.||.+|||+.|+++ .|.+
T Consensus 312 -~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 312 -FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp -GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred -hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 1112357889999999999999999999987 5544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.73 Aligned_cols=270 Identities=16% Similarity=0.191 Sum_probs=204.4
Q ss_pred hcCCCcceeecee--CcEEEEEEEeC-CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEG--GYGPVYKGVLP-CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.++|++.+.||+| +||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999965 7899999999754 24445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998643 2245899999999999999999999986 9999999999999999999999999987653
Q ss_pred ccccc-----cccccccccCCcccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHH-HHHHHHhC
Q 003932 618 KESLE-----ENTEQVVGTIGYIPPEYATK--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE-HAYELWKG 689 (785)
Q Consensus 618 ~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~-~~~~~~~~ 689 (785)
..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||............. ........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 32111 11233478999999999988 579999999999999999999999997543322110000 00000000
Q ss_pred C-------------------ccccccc---c------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 690 G-------------------KGVEFVD---S------FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 690 ~-------------------~~~~~~~---~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
. ...+... . .............+.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 0000000 0 00000111223468899999999999999999999854
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=342.40 Aligned_cols=267 Identities=15% Similarity=0.174 Sum_probs=200.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCCChhh-----------HHHHHHHHHHHHcCCCCceeeEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKTSTQG-----------FEEFKNEVMLTAKLQHVNLIRVLG 527 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~ 527 (785)
.++|.+.+.||+|+||.||+|... ++..+|+|++....... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999964 57789999987653211 123567888999999999999999
Q ss_pred EEec----CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC
Q 003932 528 FCID----SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM 603 (785)
Q Consensus 528 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 603 (785)
++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 67899999999 99999998542 36899999999999999999999986 99999999999999887
Q ss_pred --ceeeccccceeeecccccc-----cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCc
Q 003932 604 --KPKISDFGMARIFAKESLE-----ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 676 (785)
Q Consensus 604 --~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~ 676 (785)
.+||+|||+++.+...... .......||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876543211 11234579999999999999999999999999999999999999996432211
Q ss_pred ccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 677 LSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.............. ...+..... ....+..+.+++.+||+.||++||++++|++.|++...
T Consensus 268 -~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 -VAVQTAKTNLLDEL-PQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -HHHHHHHHHHHHTT-THHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -HHHHHHHHhhcccc-cHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111111110 011111110 01223478899999999999999999999999998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.04 Aligned_cols=276 Identities=18% Similarity=0.229 Sum_probs=212.2
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEE-ecCCccEEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFC-IDSEERMLIY 539 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 539 (785)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... +.+.+|+.++++++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999995 57899999987554322 3578899999999988766666555 5667789999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE---cCCCceeeccccceeee
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIF 616 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~ 616 (785)
||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 345899999999999999999999986 9999999999999 78999999999999886
Q ss_pred cccccc-----cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 617 AKESLE-----ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 617 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543221 122346799999999999999999999999999999999999999986555444444333222111100
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCCcc
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSK 754 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 754 (785)
...+... .+..+.+++.+||+.||++|||++++++.|++.......+....+.|
T Consensus 239 -----~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 4hgt_A 239 -----IEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp -----HHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGG
T ss_pred -----hhhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccch
Confidence 0000011 13478899999999999999999999999999876655555444444
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=344.07 Aligned_cols=269 Identities=27% Similarity=0.403 Sum_probs=213.7
Q ss_pred ChHHHHHHhcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEE
Q 003932 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVL 526 (785)
Q Consensus 455 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~ 526 (785)
...++....++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 4445555678999999999999999999973 356889999997653 34456789999999999 799999999
Q ss_pred EEEecCC-ccEEEEEecCCCChhhhhcCCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecc
Q 003932 527 GFCIDSE-ERMLIYEYMPNKSLDCYLFDPIR-------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 592 (785)
Q Consensus 527 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 592 (785)
+++.... ..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987654 58999999999999999965332 123789999999999999999999986 999999
Q ss_pred cCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCccc
Q 003932 593 KVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLC 671 (785)
Q Consensus 593 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~ 671 (785)
||+||+++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |+.|+...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987644332223344567889999999999999999999999999999998 99998654
Q ss_pred CCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 672 GINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
...+. . ......+.... ........+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 255 ~~~~~---~---~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 255 KIDEE---F---CRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCSHH---H---HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHH---H---HHHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 32221 1 11111111111 11122347889999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=345.71 Aligned_cols=249 Identities=24% Similarity=0.290 Sum_probs=202.1
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 536 (785)
..++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999965 57889999997542 23456778899999988 8999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999853 345899999999999999999999986 999999999999999999999999999764
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. ...... . .
T Consensus 172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~---~~i~~~-~-~--- 238 (353)
T 2i0e_A 172 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF---QSIMEH-N-V--- 238 (353)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHC-C-C---
T ss_pred ccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HH---HHHHhC-C-C---
Confidence 322 123445689999999999999999999999999999999999999996432111 11 111111 1 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 735 (785)
..+...+..+.+++.+||+.||.+||+ ++|+++
T Consensus 239 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111223457889999999999999995 467754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.11 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=193.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++.+.||+|+||.||+++.. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999964 7899999999765332 35688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc--eeeccccceeeeccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK--PKISDFGMARIFAKE 619 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~~~~~ 619 (785)
+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998843 345899999999999999999999986 999999999999987765 999999998753222
Q ss_pred ccccccccccccCCcccccccCCCCCCCh-hhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTK-SDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......... ........... ...
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~~~~~~~~--~~~-- 242 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQRILSVKY--SIP-- 242 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHHHHHTTCC--CCC--
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHHHHhcCCC--CCC--
Confidence 22334579999999999988877665 899999999999999999997544332211 11111111110 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 -----~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 -----DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -----TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -----CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001123478899999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.52 Aligned_cols=266 Identities=22% Similarity=0.290 Sum_probs=207.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEe----cCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI----DSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~l 537 (785)
.++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999995 578999999997776777788999999999999999999999987 3347889
Q ss_pred EEEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 538 IYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999885421 2356899999999999999999999986 999999999999999999999999998765
Q ss_pred ccccccc-------ccccccccCCcccccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH
Q 003932 617 AKESLEE-------NTEQVVGTIGYIPPEYATKGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686 (785)
Q Consensus 617 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 686 (785)
....... ......||..|+|||.+.+.. ++.++|||||||++|||++|+.||........ .... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----A 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----H
Confidence 3211100 112345799999999987654 68999999999999999999999853211110 0110 0
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNIN 745 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 745 (785)
.... .........+..+.+++.+||+.||.+|||+.|+++.|+......+
T Consensus 260 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 260 VQNQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred hhcc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 1110 0001112234578999999999999999999999999998754433
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=335.69 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=210.3
Q ss_pred hcCCCcce-eeceeCcEEEEEEEeC---CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRN-KLGEGGYGPVYKGVLP---CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.++|.+.+ .||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35666776 9999999999999843 5788999999875 344567889999999999999999999999 4567899
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999853 3345899999999999999999999986 9999999999999999999999999998764
Q ss_pred ccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 618 KESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 618 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
..... .......+|..|+|||++.+..++.++|||||||++|||++ |+.|+......+ .......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~-- 232 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM-- 232 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC--
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcC--
Confidence 33221 12233456889999999988889999999999999999998 999986433211 11112221111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTP 747 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 747 (785)
..+...+..+.+++.+||+.||++||++.++++.|++.......+
T Consensus 233 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 233 -------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp -------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 112233457899999999999999999999999999875444333
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.33 Aligned_cols=254 Identities=24% Similarity=0.479 Sum_probs=201.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChh-------hHHHHHHHHHHHHcCCCCceeeEEEEEecCCc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQ-------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 534 (785)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36799999999999999999995 57899999999754321 1157889999999999999999999986544
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc-----eeecc
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK-----PKISD 609 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~-----~kl~D 609 (785)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888854 3346899999999999999999999874 23999999999999988776 99999
Q ss_pred ccceeeecccccccccccccccCCcccccccC--CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 610 FGMARIFAKESLEENTEQVVGTIGYIPPEYAT--KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 610 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
||+++.... ......||..|+|||.+. ...++.++|||||||++|||++|+.||....... ........
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIR 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHH
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHh
Confidence 999975322 233467899999999984 4557899999999999999999999996543222 11111111
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
..... .......+..+.+++.+||+.||.+|||++|+++.|++
T Consensus 244 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEGLR---------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSCCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCCC---------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11111 11122234578999999999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.30 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=189.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46799999999999999999995 468999999987543 2234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCc---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 541 YMPNKSLDCYLFDPI---RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|++ |+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 68988875321 1235889999999999999999999986 9999999999999999999999999998754
Q ss_pred ccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc---
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV--- 693 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 693 (785)
... .......||..|+|||++.+. .++.++|||||||++|||++|+.||......+ ...............
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhh
Confidence 321 223345789999999999764 68999999999999999999999986433221 112221211110000
Q ss_pred c-----cccccc------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 E-----FVDSFL------------DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 ~-----~~~~~l------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. .....+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 000000 00001112347889999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=369.45 Aligned_cols=264 Identities=27% Similarity=0.426 Sum_probs=212.9
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
++...++|++.+.||+|+||.||+|.+..+..||||++..... ..+.|.+|+++|++++|+||+++++++.+ ...++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 3445678999999999999999999988778899999976543 34679999999999999999999999876 678999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999532 2245889999999999999999999986 99999999999999999999999999976543
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
... .......++..|+|||++.+..++.++|||||||+||||++ |+.|+...... + .......+...
T Consensus 416 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~~---- 483 (535)
T 2h8h_A 416 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRM---- 483 (535)
T ss_dssp HHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------H-HHHHHHTTCCC----
T ss_pred Cce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCC----
Confidence 211 11223456789999999998899999999999999999999 89988643211 1 11222222111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNIN 745 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 745 (785)
......+..+.+|+.+||+.||++|||+++|++.|+.......
T Consensus 484 -----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 484 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 1112234578899999999999999999999999999865543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=343.88 Aligned_cols=265 Identities=26% Similarity=0.409 Sum_probs=199.9
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE 533 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 533 (785)
....++|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334678999999999999999999843 3458999999754 3445567899999999999999999999998755
Q ss_pred -----ccEEEEEecCCCChhhhhcCC---ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCce
Q 003932 534 -----ERMLIYEYMPNKSLDCYLFDP---IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP 605 (785)
Q Consensus 534 -----~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 605 (785)
..++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 349999999999999988432 13356899999999999999999999886 9999999999999999999
Q ss_pred eeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHH
Q 003932 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 606 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 684 (785)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... ...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~--- 260 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD--- 260 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH---
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH---
Confidence 9999999987654432233344567889999999999999999999999999999999 888886433221 111
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
....+... ......+..+.+++.+||+.||.+|||+.++++.|++....
T Consensus 261 -~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 261 -YLLHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp -HHHTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111 11122335788999999999999999999999999986543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.04 Aligned_cols=259 Identities=29% Similarity=0.451 Sum_probs=212.2
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
...++|++.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34678999999999999999999965 58889999997653 34578899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999998643 2345899999999999999999999987 999999999999999999999999999865433
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. .......+|..|+|||.+.+..++.++||||||+++|+|++ |+.|+....... ... ......
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~----~~~~~~------- 229 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDY------- 229 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTC-------
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhccC-------
Confidence 21 22334557889999999998899999999999999999999 998886543222 111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
........+..+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 230 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 230 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 11112223457889999999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=354.09 Aligned_cols=262 Identities=18% Similarity=0.227 Sum_probs=205.2
Q ss_pred ChHHHHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEe
Q 003932 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCI 530 (785)
Q Consensus 455 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 530 (785)
.+.++....++|++.+.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|..++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3444555678999999999999999999996 478999999997532 122345788999999999999999999999
Q ss_pred cCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 531 DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 531 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
+.+..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999998532 235899999999999999999999986 999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccC-------CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYAT-------KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA 683 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 683 (785)
|+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+. ....
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i 282 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---YGKI 282 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 99987654321 1233468999999999987 45689999999999999999999999964332111 1111
Q ss_pred HHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 003932 684 YELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDR---PSMLEVSS 735 (785)
Q Consensus 684 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 735 (785)
......... +.. ....+.++.+|+.+||+ +|.+| |+++|+++
T Consensus 283 ---~~~~~~~~~--p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 ---VHYKEHLSL--PLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ---HTHHHHCCC--C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ---HhcccCcCC--Ccc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 100000000 000 11223478899999999 99998 58999875
|
| >3sim_A Protein, family 18 chitinase; family 18 plant chitinase, TIM barrel, chitin binding, glyco hydrolase, hydrolase; 2.10A {Crocus vernus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=332.22 Aligned_cols=197 Identities=14% Similarity=0.188 Sum_probs=155.1
Q ss_pred CCCcCCCCCCC-CceEEEEEEEeeCCccEE-------ecCCCccHHHH-HHHHHHHHhcCCCceEEEEecCCCCCCcccc
Q 003932 37 VSTISGINYDL-FTHLICSSADINSTTYQL-------SLSLPSDENQI-AKFADTVKKKNPSITTILSIGQGKDTNYSIY 107 (785)
Q Consensus 37 ~~~~~~i~~~~-~Thi~~~f~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~k~~~p~lkv~~sigG~~~~~~~~f 107 (785)
.+..-+||+.+ ||||+|+|+ ++.++ .+ .+...|++..+ .+.+..+|++||++|||+|||||+.+.+..|
T Consensus 16 ~~~d~pid~~l~ctHliyaFa-i~~~~-~~~~~~~~g~~~~~w~~~~~~~~~~~~lK~~~~~lKvllSiGG~~~~~~~~~ 93 (275)
T 3sim_A 16 KFSDVPINPHITKFQFVLSFA-VDYTA-SSPHTSTNGKFNVFWDSSILGPDQISAIKSSHPNVRVAVSLGGASVGSNTVQ 93 (275)
T ss_dssp CGGGSCCCTTCSEEEEEEEEE-ESBCS-SSSCCBCTTCCEECSCTTTSCHHHHHHHHHHCTTEEEEEEEECSEETTEECC
T ss_pred CCccCCCCCCccccEEEEEEE-ecccC-ccccCCCCCccccccccccccHHHHHHHHHhCCCCEEEEEEcCCCCCCcchh
Confidence 44555678899 999999999 87543 22 11122333322 4555669999999999999999987655566
Q ss_pred hhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccC
Q 003932 108 SSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYS 187 (785)
Q Consensus 108 s~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~ 187 (785)
+.++++++.|++||+++++++++|||||||||||||+ ++|+++|+.|+++||++|++. .++++++.++.
T Consensus 94 ~~~~~~~~~r~~fi~si~~~l~~~gfDGiDiDwE~p~-~~d~~~~~~ll~eLr~~l~~~---------~~ls~a~~~p~- 162 (275)
T 3sim_A 94 FQAASVDSWVSNAVTSLTRIIQRYNLDGIDIDYEHFQ-NTDKNTFAECIGRLITTLKKN---------GVISFASISPF- 162 (275)
T ss_dssp CCCSCHHHHHHHHHHHHHHHHHHTTCCEEEEECCCCT-TSCHHHHHHHHHHHHHHHHHT---------TSCSEEEECCC-
T ss_pred hhhhcCHHHHHHHHHHHHHHHHHhCCCeEEEEeecCC-cccHHHHHHHHHHHHHHhccC---------CeEEEEEcCCh-
Confidence 8888899999999999999999999999999999995 579999999999999999752 23455544443
Q ss_pred CCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCC--CCCceeecccccc
Q 003932 188 PPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGL--SADKLVMCLPFYG 264 (785)
Q Consensus 188 ~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gv--p~~KlvlGip~YG 264 (785)
.....++++.+.+++||||+|+||+|+ |++. .+++.++++|++.|. |++||+||+|+++
T Consensus 163 ~~~~~~~~~~~~~~~D~i~vm~YD~~~-~~~~-----------------~~~~~~v~~~~~~g~~~p~~KlvlGlpa~~ 223 (275)
T 3sim_A 163 PSVDEYYLALFNEYKNAINHINYQFKA-YDSS-----------------TSVDKFLGYYNNAASKYKGGNVLISFSTGP 223 (275)
T ss_dssp GGGHHHHHHHHHHSGGGCCEEECCGGG-SCTT-----------------CCHHHHHHHHHHHHHHTTTSCEEEEEECSS
T ss_pred HHhhhccHHHHHHhCCEEEEEeccCCC-CCCC-----------------ccHHHHHHHHHHHhccCChhheEEEEeecC
Confidence 223345589999999999999999994 4311 178899999999887 9999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=343.97 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=200.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCc----EEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGE----VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
.++|++.+.||+|+||.||+|... +++ .|++|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357999999999999999999853 444 3578877543 3345678899999999999999999999998754 88
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998642 345899999999999999999999986 999999999999999999999999999876
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
.............+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+. . ........
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~----~~~~~~~~--- 237 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKGER--- 237 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTTCC---
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---H----HHHHcCCC---
Confidence 54433333334557889999999999999999999999999999999 9999865433221 1 11111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
.......+..+.+++.+||+.||.+||++.|+++.|+.....
T Consensus 238 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 238 ------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111222344788999999999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=345.34 Aligned_cols=261 Identities=23% Similarity=0.288 Sum_probs=201.9
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC-----ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT-----STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS 532 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 532 (785)
+....++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345577899999999999999999995 46889999998643 234557889999999999999999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCc-------------------------------------cccCCCHHHHHHHHHHHHHH
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPI-------------------------------------RKLILDWKKRVHIIEGITQG 575 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~ 575 (785)
...++||||+++|+|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 01224567788999999999
Q ss_pred HHHHhhcCCCCeEEecccCCCEEEcCCC--ceeeccccceeeeccccccc--ccccccccCCcccccccCC--CCCCChh
Q 003932 576 LLYLQEYSRLTIIHRDLKVSNILLGEAM--KPKISDFGMARIFAKESLEE--NTEQVVGTIGYIPPEYATK--GVYSTKS 649 (785)
Q Consensus 576 l~~LH~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~ 649 (785)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+....... ......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999986 99999999999998776 89999999998764322111 2344679999999999975 6789999
Q ss_pred hHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 003932 650 DVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS 729 (785)
Q Consensus 650 DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 729 (785)
|||||||++|||++|+.||...... +.............. + ........+.+++.+||+.||.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFEN--P-----NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTTS--G-----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccCC--c-----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999998643221 112222222111110 0 01112457889999999999999999
Q ss_pred HHHHHH
Q 003932 730 MLEVSS 735 (785)
Q Consensus 730 ~~evl~ 735 (785)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=341.22 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=196.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCC--CceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQH--VNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++++++| +||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4579999999999999999999888999999998754 34455778999999999976 9999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899999853 346889999999999999999999986 99999999999997 57899999999987654
Q ss_pred cccccccccccccCCcccccccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATK-----------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHh
Confidence 433223345679999999999864 678899999999999999999999985321 1222222222
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
....... .+......+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~---------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccC---------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 2111111 111123468899999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=353.40 Aligned_cols=251 Identities=22% Similarity=0.370 Sum_probs=206.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999964 78999999996542 123467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999853 345899999999999999999999886 999999999999999999999999999876443
Q ss_pred ccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... . ......+..
T Consensus 170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~----~~~i~~~~~------ 233 (476)
T 2y94_A 170 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---L----FKKICDGIF------ 233 (476)
T ss_dssp ---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---H----HHHHHTTCC------
T ss_pred ---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---H----HHHHhcCCc------
Confidence 22345679999999999998765 689999999999999999999986432211 1 111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 740 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 740 (785)
..+......+.+++.+||+.||.+|||+.|+++ .+.+.
T Consensus 234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 011112347889999999999999999999987 56554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=332.99 Aligned_cols=245 Identities=22% Similarity=0.241 Sum_probs=192.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.++||+|+||+||+|+.. +++.||||++.... .........|+..+.++ +||||++++++|.+....++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 468999999999999999999965 78999999986543 23334455566555554 999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 77888887542 345899999999999999999999986 99999999999999999999999999987543
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..............
T Consensus 210 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~~~--- 272 (311)
T 3p1a_A 210 A---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLPPE--- 272 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCCHH---
T ss_pred C---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCCcc---
Confidence 3 22334568999999999876 6899999999999999999997665321 01111211111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+ ....+..+.+++.+||+.||++|||++|+++
T Consensus 273 -~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 -F----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -H----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -c----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 0112357889999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.13 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=195.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc---
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--- 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 535 (785)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36899999999999999999995 578999999997653 33455788999999999999999999998766544
Q ss_pred -EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 536 -MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 536 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999853 345899999999999999999999986 9999999999999999999999999998
Q ss_pred eecccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 615 IFAKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 615 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC
Confidence 76443211 223345789999999999999999999999999999999999999864321 11112222211110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH-HHHHhcc
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV-SSMLKNE 740 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev-l~~L~~~ 740 (785)
..... ...+..+.+++.+||+.||.+||++.++ ...|...
T Consensus 239 ---~~~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 ---PSARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---HHHHS----TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---ccccc----CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00000 1123468899999999999999965554 4555544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=357.67 Aligned_cols=253 Identities=24% Similarity=0.292 Sum_probs=206.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|+. .+++.||+|++.+.. ......+.+|+.++++++||||+++++++.+....++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999996 478999999996532 22345678999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++|+|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999886532 334899999999999999999999986 99999999999999999999999999987643
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .....
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~---i~~~~------- 405 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VKEVP------- 405 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH---HHHCC-------
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH---hhccc-------
Confidence 32 233458999999999999999999999999999999999999999754432221111111 11110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
...+...+..+.+|+.+||+.||.+|| +++|+++
T Consensus 406 ---~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ---EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011122345788999999999999999 7788875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=338.54 Aligned_cols=249 Identities=21% Similarity=0.267 Sum_probs=179.4
Q ss_pred eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 470 NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
+.||+|+||.||+|... +++.||||++.+. ....+.+|+.+++++. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999964 6899999999653 3456788999999997 99999999999999999999999999999
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC---ceeeccccceeeecccccccc
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM---KPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 165 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP 165 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence 999854 346899999999999999999999986 99999999999998765 89999999998754332 22
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRN 704 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 704 (785)
....+||..|+|||++.+..++.++|||||||++|||++|+.||.....................+... .... .
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~-----~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-FEGE-----A 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-CCSH-----H
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-CCcc-----c
Confidence 344678999999999999999999999999999999999999997544332222222222222222110 0000 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 705 SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 705 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+..+.+|+.+||+.||.+|||++|+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0112457889999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=329.45 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=203.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467999999999999999999954 5778999999876555677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE---cCCCceeeccccceeeecc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~ 618 (785)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999988853 345899999999999999999999986 9999999999999 7889999999999987654
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.|+...... +........ .. .....
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~-~~-~~~~~ 229 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREG-TF-TFPEK 229 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-CC-CCCHH
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC-CC-CCCch
Confidence 32 23345789999999998765 899999999999999999999998643211 111111111 10 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~-----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 DW-----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hh-----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 012347889999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=329.11 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=205.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999964 6899999998643 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999998853 345899999999999999999999986 9999999999999999999999999998765433
Q ss_pred cccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.........||..|+|||.+.+..+ +.++||||||+++|||++|+.||........ . ...+...... .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~~--~--- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKTY--L--- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--H----HHHHHTTCTT--S---
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHhhhcccc--c---
Confidence 3333445678999999999988765 7799999999999999999999965432211 1 1111111100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011123447889999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=334.25 Aligned_cols=260 Identities=26% Similarity=0.347 Sum_probs=205.2
Q ss_pred CCcceeeceeCcEEEEEEEe-----CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccEE
Q 003932 466 FSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERML 537 (785)
Q Consensus 466 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 537 (785)
|++++.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999999863 268899999998653 34566789999999999999999999999874 56789
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999843 34899999999999999999999986 9999999999999999999999999998865
Q ss_pred ccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCC--------CcccHHHHHHHHHh
Q 003932 618 KESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN--------ENLSILEHAYELWK 688 (785)
Q Consensus 618 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~--------~~~~~~~~~~~~~~ 688 (785)
..... .......+|..|+|||.+.+..++.++|||||||++|||++|+.|+...... ..............
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 43211 1233456788899999999988999999999999999999999987532110 00000111111111
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 689 GGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 689 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
... ........+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 266 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 266 RGE---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccc---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 11122233457899999999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.09 Aligned_cols=207 Identities=25% Similarity=0.288 Sum_probs=178.3
Q ss_pred cChHHHHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-----CCceeeEEE
Q 003932 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-----HVNLIRVLG 527 (785)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~ 527 (785)
+++.+.....++|.+.++||+|+||.||+|+. .+++.||||++... ....+.+..|+.+++++. ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 44444445568999999999999999999996 56889999999753 344466788999999986 999999999
Q ss_pred EEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC------
Q 003932 528 FCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE------ 601 (785)
Q Consensus 528 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~------ 601 (785)
++......++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 999999986432 234899999999999999999999986 999999999999975
Q ss_pred -------------------CCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHH
Q 003932 602 -------------------AMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQII 662 (785)
Q Consensus 602 -------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ell 662 (785)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 78999999999986432 223467899999999999999999999999999999999
Q ss_pred cCCCCCccc
Q 003932 663 SGKRLSMLC 671 (785)
Q Consensus 663 tG~~p~~~~ 671 (785)
+|+.||...
T Consensus 254 ~g~~pf~~~ 262 (360)
T 3llt_A 254 TGSLLFRTH 262 (360)
T ss_dssp HSSCSCCCS
T ss_pred HCCCCCCCC
Confidence 999999653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.81 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=188.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467999999999999999999965 57899999997653 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---CCceeeccccceeeecc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---AMKPKISDFGMARIFAK 618 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg~a~~~~~ 618 (785)
+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999998853 345899999999999999999999986 999999999999975 88999999999987543
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ........... ....+
T Consensus 204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~-~~~~~ 273 (349)
T 2w4o_A 204 Q---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY-YFISP 273 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC-CCCTT
T ss_pred c---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC-ccCCc
Confidence 2 12334678999999999999999999999999999999999999986432211 11111111111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 274 -----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 -----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11123457889999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=345.08 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=197.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCC--CCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|....++.||||++... .....+.+.+|+.++++++ ||||+++++++......++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999877999999998654 3445678899999999996 59999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 668899999854 336888899999999999999999886 99999999999995 57999999999987654
Q ss_pred cccccccccccccCCcccccccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATK-----------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHh
Confidence 332223345679999999999865 368899999999999999999999986321 1122222222
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
....... .+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 282 ~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CccccCC---------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 2211111 111123468899999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=329.67 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=203.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999985 46889999998654 3445567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc---eeeccccceeee
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK---PKISDFGMARIF 616 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Dfg~a~~~ 616 (785)
||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888743 345899999999999999999999986 999999999999986655 999999999876
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+....... .. ........ ...
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~----~~~~~~~~-~~~ 227 (284)
T 3kk8_A 159 NDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LY----AQIKAGAY-DYP 227 (284)
T ss_dssp CSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHTCC-CCC
T ss_pred ccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HH----HHHHhccc-cCC
Confidence 433 22334678999999999999999999999999999999999999986432111 11 11111110 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 01122347889999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.06 Aligned_cols=264 Identities=23% Similarity=0.304 Sum_probs=198.1
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999964 589999999865532 335668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999888743 345899999999999999999999986 9999999999999999999999999998764322
Q ss_pred cccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH--------HHHHhCCc
Q 003932 621 LEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGK 691 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 691 (785)
.......||..|+|||.+.+ ..++.++|||||||++|+|++|+.|+......+....+... ...+....
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22334578999999999876 56899999999999999999999998654322211111100 00111111
Q ss_pred cccccc-cccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVEFVD-SFLDDRN-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~~~~-~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...... +...... .+..+..+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000000 0122346889999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.10 Aligned_cols=247 Identities=27% Similarity=0.387 Sum_probs=199.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999854 57789999986532 22345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999998853 345899999999999999999999876 99999999999999999999999999865432
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+......+ .. .......
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~------- 223 (279)
T 3fdn_A 162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TY-KRISRVE------- 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHHTC-------
T ss_pred c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HH-HHHHhCC-------
Confidence 2 2234578999999999999999999999999999999999999986432111 11 1111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
...+......+.+++.+||+.||.+|||+.|+++.
T Consensus 224 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111233478899999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.33 Aligned_cols=264 Identities=26% Similarity=0.369 Sum_probs=192.3
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCC--cc
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSE--ER 535 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 535 (785)
..++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999985 57899999998654 3445567889999999997 999999999997544 68
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++|||||+ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 688888743 45889999999999999999999986 99999999999999999999999999987
Q ss_pred ecccc-------------------cccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCC
Q 003932 616 FAKES-------------------LEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675 (785)
Q Consensus 616 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~ 675 (785)
+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 54311 0112234579999999999987 678999999999999999999999997543221
Q ss_pred cccHHHHHHHHHhCCccccc-----------c----------ccccCC------------CCCHHHHHHHHHHHHHcccc
Q 003932 676 NLSILEHAYELWKGGKGVEF-----------V----------DSFLDD------------RNSPCKLMRCLEIALLCVQE 722 (785)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~-----------~----------~~~l~~------------~~~~~~~~~l~~li~~cl~~ 722 (785)
................. + ...... .........+.+|+.+||+.
T Consensus 239 ---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 239 ---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp ---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred ---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 11111111111100000 0 000000 00001234688999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003932 723 NPNDRPSMLEVSSM 736 (785)
Q Consensus 723 dP~~RPs~~evl~~ 736 (785)
||++|||++|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.38 Aligned_cols=271 Identities=25% Similarity=0.324 Sum_probs=202.3
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC--CCCceeeEEEEEecC----
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL--QHVNLIRVLGFCIDS---- 532 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~---- 532 (785)
.....++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445678999999999999999999976 8999999986442 23445555665554 899999999999877
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEecccCCCEEEcCCCceee
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-----SRLTIIHRDLKVSNILLGEAMKPKI 607 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl 607 (785)
...++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +..+|+||||||+|||++.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 678999999999999999843 3589999999999999999999987 1224999999999999999999999
Q ss_pred ccccceeeeccccccc--ccccccccCCcccccccCCCCCCCh------hhHHHHHHHHHHHHcC----------CCCCc
Q 003932 608 SDFGMARIFAKESLEE--NTEQVVGTIGYIPPEYATKGVYSTK------SDVFSFGVLLLQIISG----------KRLSM 669 (785)
Q Consensus 608 ~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvvl~elltG----------~~p~~ 669 (785)
+|||+++.+....... ......||..|+|||++.+...+.+ +|||||||++|||++| +.|+.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998764332211 1234579999999999988766654 9999999999999999 55554
Q ss_pred ccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 670 LCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
....... ................... ........+..+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 264 ~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 264 DLVPSDP--SYEDMREIVCIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTSCSSC--CHHHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCCC--chhhhHHHHhhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 3222211 1111111111111100000 000122566789999999999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.26 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=205.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC--CccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 538 (785)
.++|++.+.||+|+||.||+|+.. ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357899999999999999999986 889999999765 344556799999999999999999999999877 788999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ .+++||||||+|||++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~-- 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF-- 163 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT--
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee--
Confidence 9999999999999653 2335899999999999999999999863 24999999999999999999999998886532
Q ss_pred cccccccccccccCCcccccccCCCCCCC---hhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYST---KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
......||+.|+|||.+.+..++. ++|||||||++|||++|+.|+..... ..............
T Consensus 164 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~-- 230 (271)
T 3kmu_A 164 -----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRP-- 230 (271)
T ss_dssp -----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCC--
T ss_pred -----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCC--
Confidence 122356899999999998765544 89999999999999999999864321 11112222222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
..+...+..+.+++.+||+.||++|||++|+++.|++..
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 231 -------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112223457889999999999999999999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.97 Aligned_cols=265 Identities=29% Similarity=0.417 Sum_probs=209.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC--cc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-----PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 535 (785)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45789999999999999999983 368899999998877677788999999999999999999999987654 78
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998542 345899999999999999999999986 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccC--------CCCc-ccHHHHHHH
Q 003932 616 FAKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG--------INEN-LSILEHAYE 685 (785)
Q Consensus 616 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~--------~~~~-~~~~~~~~~ 685 (785)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.|+.... .... .........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543221 11233457788999999998889999999999999999999998875321 0000 000111111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
....... ...+...+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus 275 ~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 275 LLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111 1112223457899999999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=333.13 Aligned_cols=261 Identities=23% Similarity=0.358 Sum_probs=203.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCC----CcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEe-cCCccE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPC----GEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCI-DSEERM 536 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 536 (785)
..+|++.+.||+|+||.||+|.... ...+|+|.+... .....+.+.+|+.++++++||||+++++++. .....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568899999999999999998532 235899998764 3445677899999999999999999999865 456789
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999964 2345789999999999999999999986 999999999999999999999999999876
Q ss_pred cccccc--cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 617 AKESLE--ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG-KRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 617 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
...... .......+|..|+|||.+.+..++.++||||||+++|||++| .+|+......+ ... . .......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~---~-~~~~~~~ 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV---Y-LLQGRRL 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH---H-HHTTCCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH---H-HhcCCCC
Confidence 443221 122335678899999999999999999999999999999995 45554332222 111 1 1111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
..+...+..+.+++.+||+.||++|||++|+++.|+......
T Consensus 252 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 252 ---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 011122347889999999999999999999999999875443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.26 Aligned_cols=261 Identities=24% Similarity=0.377 Sum_probs=196.8
Q ss_pred cCCCcceeeceeCcEEEEEEEeC--CC--cEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec-CCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP--CG--EVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 537 (785)
..|.+.+.||+|+||.||+|... ++ ..||+|.+... .....+.+.+|+.++++++||||++++++|.. ....++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999853 22 46899998754 34556789999999999999999999998764 457899
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999964 2345788999999999999999999986 9999999999999999999999999998764
Q ss_pred cccccc--ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 618 KESLEE--NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 618 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
...... ......+|..|+|||.+.+..++.++|||||||++|||++ |.+|+......+ .... ...+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~~~~~~- 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGRRL- 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HHTTCCC-
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HHcCCCC-
Confidence 332111 1233457889999999999999999999999999999999 666765433322 1111 1111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNIN 745 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 745 (785)
..+...+..+.+++.+||+.||++|||+.|+++.|+.......
T Consensus 316 --------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 316 --------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0112234578899999999999999999999999998765443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.54 Aligned_cols=270 Identities=24% Similarity=0.322 Sum_probs=197.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHH--HHcCCCCceeeEEEEEec-----CCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVML--TAKLQHVNLIRVLGFCID-----SEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 535 (785)
.++|++.+.||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999987 489999999965432 334444444 445899999999986542 2356
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEEecccCCCEEEcCCCceeecc
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS------RLTIIHRDLKVSNILLGEAMKPKISD 609 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dikp~Nill~~~~~~kl~D 609 (785)
++||||+++|+|.+++.. ...++..+..++.||++||.|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 899999999999999843 33588999999999999999999871 11499999999999999999999999
Q ss_pred ccceeeeccccc------ccccccccccCCcccccccCC-------CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCc
Q 003932 610 FGMARIFAKESL------EENTEQVVGTIGYIPPEYATK-------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 676 (785)
Q Consensus 610 fg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~ 676 (785)
||+++.+..... ........||..|+|||++.+ ..++.++|||||||++|||++|..|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987653321 112234579999999999987 4567799999999999999999877654322211
Q ss_pred cc-H----------HHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 677 LS-I----------LEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 677 ~~-~----------~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.. . ................+... .......+..+.+++.+||+.||++|||++|+++.|++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11 0 11111111111111111100 01123356679999999999999999999999999988653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=338.60 Aligned_cols=268 Identities=24% Similarity=0.358 Sum_probs=197.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhh-HHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.++++++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999964 78999999997543221 12345799999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 97 5888887542 345889999999999999999999986 9999999999999999999999999998654321
Q ss_pred ccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc---ccc
Q 003932 622 EENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE---FVD 697 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 697 (785)
.......||..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ................ ...
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhc
Confidence 22334578999999999877 568999999999999999999999996543222 2222222221111000 000
Q ss_pred c------ccCC---C----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccC
Q 003932 698 S------FLDD---R----NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNETT 742 (785)
Q Consensus 698 ~------~l~~---~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~ 742 (785)
. .... . ..+.....+.+|+.+||+.||++|||++|+++ .+.+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0 0000 0 00112346789999999999999999999987 4555443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=353.69 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=206.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 357899999999999999999964 68999999997542 23346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 539 YEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|||+++|+|..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999886533 2446899999999999999999999986 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~~~~------ 410 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLEQAV------ 410 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHHCCC------
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhhccc------
Confidence 432 1233458999999999999999999999999999999999999999754332211 111111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSM-----LEVSS 735 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 735 (785)
..+...+..+.+++.+||+.||.+||++ +++++
T Consensus 411 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1112234578899999999999999975 56653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.07 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=203.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh------hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999954 689999999875432 1357789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC----ceeecccc
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM----KPKISDFG 611 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfg 611 (785)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999853 345889999999999999999999986 99999999999999888 79999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... +.. .......
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~-~~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETL-ANITSVS 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHH-HHHHTTC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHH-HHHHhcc
Confidence 998765431 233457899999999999999999999999999999999999998643211 111 1111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ....... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~-~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y-DFDEEFF-----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C-CCCHHHH-----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c-ccChhhh-----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0000000 112346889999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.85 Aligned_cols=252 Identities=19% Similarity=0.255 Sum_probs=191.1
Q ss_pred cCCCcc-eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHH-cCCCCceeeEEEEEec----CCccE
Q 003932 464 ERFSIR-NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTA-KLQHVNLIRVLGFCID----SEERM 536 (785)
Q Consensus 464 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~ 536 (785)
++|.+. +.||+|+||.||+|... +++.||||++... ..+.+|+.++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 467666 78999999999999954 6889999999643 35677888774 4589999999998865 56789
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---CCceeeccccce
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---AMKPKISDFGMA 613 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg~a 613 (785)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999653 2345899999999999999999999986 999999999999997 789999999999
Q ss_pred eeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.................. +. .
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---~~-~ 284 (400)
T 1nxk_A 212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQ-Y 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH---TC-C
T ss_pred cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc---Cc-c
Confidence 875432 2234567899999999999999999999999999999999999999754433221111111111 10 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.... ........++.+|+.+||+.||++|||+.|+++.
T Consensus 285 ~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 EFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0100 0011234578899999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=357.98 Aligned_cols=248 Identities=19% Similarity=0.240 Sum_probs=193.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++.+. .......+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999995 56899999999753 233445678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999988843 3468999999999999999999998 65 9999999999999999999999999997533
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ........
T Consensus 301 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i~~~~~------ 366 (446)
T 4ejn_A 301 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF---ELILMEEI------ 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCC------
T ss_pred CC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HH---HHHHhCCC------
Confidence 22 122345689999999999999999999999999999999999999996432111 11 11111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
..+......+.+|+.+||+.||.+|| +++|+++
T Consensus 367 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11122335788999999999999999 9999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.75 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=202.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.++|.+.+.||+|+||.||+|... .+..||+|++... .....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 468999999999999999999843 2346999999865 34456788999999999999999999999864 46789
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999854 2345889999999999999999999986 9999999999999999999999999998654
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+ ..... ......
T Consensus 165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~~~~--- 233 (281)
T 3cc6_A 165 DEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKGDRL--- 233 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHTCCC---
T ss_pred cccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcCCCC---
Confidence 3321 12233456889999999998899999999999999999998 999986433222 11111 111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
......+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 01112234788999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=333.68 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=200.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++......++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999995 57899999999753 344566789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 539 YEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999885422 2455889999999999999999999986 9999999999999999999999999988654
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...... ...........
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~~~~~-- 258 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-KKIEQCDYPPL-- 258 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHH-HHHHTTCSCCC--
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHH-HHhhcccCCCC--
Confidence 321 122345689999999999999999999999999999999999999864321 111111 11111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
.....+..+.+++.+||+.||.+|||+.++++.|++....
T Consensus 259 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 259 ------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp ------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1112344788999999999999999999999999886543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.11 Aligned_cols=262 Identities=19% Similarity=0.228 Sum_probs=199.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999954 68899999997542 23346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999853 345899999999999999999999986 99999999999999999999999999977543
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ............. ..
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~--~~- 255 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPR--PS- 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCC--GG-
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCC--cc-
Confidence 321 122345689999999999999999999999999999999999999864221 1111111111100 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcccCCCC
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRP-SMLEVSSMLKNETTNIN 745 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~ 745 (785)
.. .+..+..+.+++.+||+.||++|| +++++++.|++......
T Consensus 256 ~~----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 256 TV----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp GT----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred cc----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 01 112234688999999999999999 99999999998765443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=331.87 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=204.4
Q ss_pred CCCcceeeceeCcEEEEEEEeC-C---CcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc-EEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLP-C---GEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLI 538 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 538 (785)
.|.+.++||+|+||.||+|... + +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4667799999999999999842 2 2379999997643 34567889999999999999999999999876655 999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+.+|+|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999864 2345789999999999999999999986 99999999999999999999999999986543
Q ss_pred ccc--ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 619 ESL--EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 619 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... ........+|..|+|||.+.+..++.++|||||||++|||++|..|+...... ..... ........
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~----~~~~~~~~--- 247 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTH----FLAQGRRL--- 247 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHH----HHHTTCCC---
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHH----HhhcCCCC---
Confidence 321 12233456789999999999999999999999999999999966654322111 11111 11111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
......+..+.+++.+||+.||.+|||++++++.|++....+
T Consensus 248 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 248 ------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 111122347889999999999999999999999999875444
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=340.54 Aligned_cols=255 Identities=15% Similarity=0.129 Sum_probs=206.3
Q ss_pred HHhcCCCcceeeceeCcEEEEEEE------eCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC---CCceeeEEEEEec
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGV------LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCID 531 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 531 (785)
...++|.+.+.||+|+||.||+|. ..+++.||+|++..... .++..|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 45688999999976543 46677888888776 9999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCc--cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC--------
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPI--RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-------- 601 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-------- 601 (785)
.+..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999985421 2456999999999999999999999876 999999999999998
Q ss_pred ---CCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCccc
Q 003932 602 ---AMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS 678 (785)
Q Consensus 602 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~ 678 (785)
++.+||+|||+++.+............+||..|+|||++.+..++.++|||||||++|||++|+.|+.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999987653333334455679999999999999999999999999999999999999985432211
Q ss_pred HHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhcccC
Q 003932 679 ILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDR-PSMLEVSSMLKNETT 742 (785)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~ 742 (785)
..+...+.... ....+.+++..|++.+|.+| |+++++.+.|++...
T Consensus 293 ---------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 ---------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ---------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 01111111111 23467789999999999999 588888888887643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.99 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=203.5
Q ss_pred hcCCCcce-eeceeCcEEEEEEEe---CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 463 TERFSIRN-KLGEGGYGPVYKGVL---PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 463 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
.++|.+.+ .||+|+||.||+|.. ..++.||||++.... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 999999999999953 346889999997653 23356789999999999999999999999 566789
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999854 345889999999999999999999986 999999999999999999999999999876
Q ss_pred cccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 617 AKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 617 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ............
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~- 239 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERM- 239 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCC-
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC-
Confidence 443211 11223346788999999988889999999999999999999 99998643221 111222222111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
..+...+..+.+++.+||+.||.+||++.++++.|++..
T Consensus 240 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 240 --------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223457899999999999999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.40 Aligned_cols=245 Identities=20% Similarity=0.238 Sum_probs=190.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHH-HHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVML-TAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999964 68899999997643 2233455667666 467899999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998853 345889999999999999999999986 9999999999999999999999999987532
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +......... ..
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~--~~--- 257 (373)
T 2r5t_A 191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKP--LQ--- 257 (373)
T ss_dssp CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHSC--CC---
T ss_pred cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhcc--cC---
Confidence 22 12344578999999999999999999999999999999999999998643211 1111111111 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLE 732 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 732 (785)
........+.+|+.+||+.||.+||++.+
T Consensus 258 ------~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 ------LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ------CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ------CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11122347889999999999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=338.04 Aligned_cols=258 Identities=25% Similarity=0.425 Sum_probs=201.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCC-----CcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPC-----GEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
..+|.+.+.||+|+||.||+|.... +..||+|++.... ......+.+|+.++++++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3578888999999999999998542 2459999997653 344567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999854 2346899999999999999999999986 999999999999999999999999999876
Q ss_pred ccccccc-ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 617 AKESLEE-NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 617 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
....... ......+|..|+|||.+.+..++.++|||||||++|||++ |+.|+...... ........+...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~~- 269 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGFRL- 269 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCC-
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHCCCcC-
Confidence 4332111 1222346788999999999999999999999999999999 99998643211 111122221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
......+..+.+++.+||+.||++||++.++++.|++..
T Consensus 270 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 270 --------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223457889999999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=339.15 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=199.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+|... +++.||+|++.+.... ..+|++++.++ +||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 567999999999999999999954 6889999999765432 34678888777 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC----Cceeeccccceeee
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA----MKPKISDFGMARIF 616 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~~kl~Dfg~a~~~ 616 (785)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999998853 345899999999999999999999986 9999999999998543 35999999999876
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............ .....+.. .
T Consensus 171 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~-~-- 241 (342)
T 2qr7_A 171 RAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKF-S-- 241 (342)
T ss_dssp BCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCC-C--
T ss_pred cCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCc-c--
Confidence 4432 2234567899999999998888999999999999999999999999743222211111 11111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+........+..+.+|+.+||+.||++|||+.|+++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111223457889999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=332.07 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=204.7
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEec---------
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--------- 531 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 531 (785)
...+|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999965 78999999997654 346789999999999999999998854
Q ss_pred -------CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc
Q 003932 532 -------SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK 604 (785)
Q Consensus 532 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 604 (785)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34578999999999999998643 2346899999999999999999999986 999999999999999999
Q ss_pred eeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHH
Q 003932 605 PKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 605 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 684 (785)
+||+|||++....... ......||..|+|||.+.+..++.++||||||+++|||++|..|+... ....
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~ 228 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFF 228 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHH
Confidence 9999999998765432 223456899999999999999999999999999999999999876421 1111
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCC
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNIN 745 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 745 (785)
....... + ....+..+.+++.+||+.||.+|||+.|+++.|+.......
T Consensus 229 ~~~~~~~--------~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 229 TDLRDGI--------I----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHHTTC--------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHhhccc--------c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1111111 1 11123467899999999999999999999999998754433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=339.40 Aligned_cols=261 Identities=29% Similarity=0.447 Sum_probs=205.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999983 24678999999754 344556788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCcc----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---CCceeec
Q 003932 536 MLIYEYMPNKSLDCYLFDPIR----KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---AMKPKIS 608 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~ 608 (785)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999965321 245889999999999999999999986 999999999999984 4569999
Q ss_pred cccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHH
Q 003932 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
|||++................+|..|+|||.+.+..++.++|||||||++|||++ |+.|+...... ......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------HHHHHH
Confidence 9999976544333333344567899999999988899999999999999999998 88888643211 111222
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
...... ......+..+.+++.+||+.||.+||++.|+++.|+....
T Consensus 259 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 259 TSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 221111 1112234578899999999999999999999999987643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.34 Aligned_cols=247 Identities=30% Similarity=0.405 Sum_probs=199.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35689999999999999999995 578999999997542 23446788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+. |+|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 677777643 2346899999999999999999999986 99999999999999999999999999976432
Q ss_pred cccccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
.....||+.|+|||++. ...++.++|||||||++|||++|+.|+..... ............. .
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~~-~- 272 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP-A- 272 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-C-
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCC-C-
Confidence 23457899999999884 56789999999999999999999999864321 1122222222111 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
+ .....+..+.+++.+||+.||++|||++++++.
T Consensus 273 ----~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 ----L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----C---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 111223468899999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.84 Aligned_cols=275 Identities=14% Similarity=0.171 Sum_probs=210.7
Q ss_pred cCCCcceeeceeCcEEEEEEEeCC---------CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceee----------
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPC---------GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIR---------- 524 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 524 (785)
++|.+.+.||+|+||.||+|.... ++.||+|++... +.+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 689999999999999999999653 788999998754 35788999999999999887
Q ss_pred -----EEEEEec-CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 525 -----VLGFCID-SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 525 -----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6677765 67889999999 99999999643 2356999999999999999999999986 999999999999
Q ss_pred EcCCC--ceeeccccceeeecccccc-----cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCccc
Q 003932 599 LGEAM--KPKISDFGMARIFAKESLE-----ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLC 671 (785)
Q Consensus 599 l~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~ 671 (785)
++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876543211 1123457999999999999999999999999999999999999999754
Q ss_pred CCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCC
Q 003932 672 GINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPA 751 (785)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 751 (785)
.... ..+......+... ...+...... ....+..+.+++.+||+.||++|||++++++.|++.......+....
T Consensus 272 ~~~~--~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 345 (352)
T 2jii_A 272 LPNT--EDIMKQKQKFVDK-PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP 345 (352)
T ss_dssp TTCH--HHHHHHHHHHHHS-CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred CcCH--HHHHHHHHhccCC-hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence 3221 1111111111111 1111111100 01123578899999999999999999999999998876555444433
Q ss_pred Ccc
Q 003932 752 FSK 754 (785)
Q Consensus 752 ~~~ 754 (785)
+.|
T Consensus 346 ~dw 348 (352)
T 2jii_A 346 IGL 348 (352)
T ss_dssp CCC
T ss_pred ccC
Confidence 443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.06 Aligned_cols=268 Identities=22% Similarity=0.240 Sum_probs=195.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEEEe--------cC
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCI--------DS 532 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~ 532 (785)
..+|++.++||+|+||.||+|+. .+++.||+|++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 46899999999999999999995 478999999997776666778899999999996 999999999984 33
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
...++||||+. |+|.+++........+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45789999995 789888865434556999999999999999999999863 2499999999999999999999999999
Q ss_pred eeeeccccccc----------ccccccccCCccccccc---CCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccH
Q 003932 613 ARIFAKESLEE----------NTEQVVGTIGYIPPEYA---TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSI 679 (785)
Q Consensus 613 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~ 679 (785)
++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.|+.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98764322111 11234689999999998 56678999999999999999999999985322111
Q ss_pred HHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCC
Q 003932 680 LEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPA 751 (785)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 751 (785)
.... .............+.+++.+||+.||.+|||+.|+++.|+......+.+.+..
T Consensus 261 ------~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~ 317 (337)
T 3ll6_A 261 ------IVNG---------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP 317 (337)
T ss_dssp --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred ------hhcC---------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCcc
Confidence 0000 00000111112357789999999999999999999999998765544444443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=337.76 Aligned_cols=259 Identities=28% Similarity=0.410 Sum_probs=204.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcE--EEEEEcCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEV--IAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 538 (785)
++|++.+.||+|+||.||+|+.. ++.. +|+|++... .....+.+.+|+.+++++ +||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57999999999999999999853 5554 499988753 233455788999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCce
Q 003932 539 YEYMPNKSLDCYLFDPI-------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP 605 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 605 (785)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986532 2346899999999999999999999986 9999999999999999999
Q ss_pred eeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHH
Q 003932 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 606 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 684 (785)
||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY 251 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHH
Confidence 99999998743221 12233456889999999988889999999999999999998 99998643211 111
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
.....+. ........+..+.+++.+||+.||.+|||+.|+++.|++.....
T Consensus 252 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 252 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111 01112223457889999999999999999999999998865443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=327.71 Aligned_cols=249 Identities=28% Similarity=0.432 Sum_probs=182.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999995 578999999986432 12346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998642 346899999999999999999999986 99999999999999999999999999987643
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.......... ..... +.
T Consensus 165 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------~~~~~---~~ 229 (278)
T 3cok_A 165 PH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------KVVLA---DY 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSS---CC
T ss_pred CC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------HHhhc---cc
Confidence 22 12234568999999999999889999999999999999999999986543222110 00000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..+...+..+.+++.+||+.||++|||++++++
T Consensus 230 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 ----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111223457889999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=340.92 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=202.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEe----CCCcEEEEEEcCCCC----hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCC
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTS----TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE 533 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 533 (785)
.++|++.+.||+|+||.||+|+. .+++.||||++.+.. ....+.+.+|+.+++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999986 468999999987532 12334567899999999 6999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999853 345899999999999999999999986 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCcccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATK--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
+.+.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ........
T Consensus 207 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~~- 282 (355)
T 1vzo_A 207 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSE- 282 (355)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHCC-
T ss_pred eecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhccC-
Confidence 8764332 122344679999999999986 34789999999999999999999999754433322111 11111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSSML 737 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 737 (785)
...+......+.+|+.+||+.||++|| +++|+++..
T Consensus 283 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011122334688999999999999999 999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.16 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=196.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|.+.+.||+|+||.||+|.. .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35799999999999999999995 468899999987543 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE---cCCCceeeccccceeee
Q 003932 541 YMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIF 616 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~ 616 (785)
|+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999998885422 2356899999999999999999999986 9999999999999 45678999999999765
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... .......||..|+|||.+. ..++.++|||||||++|||++|+.||...... ...............
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~- 246 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAV- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC-
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccccc-
Confidence 432 2233457899999999886 46899999999999999999999998643211 111111111110000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. .......+.+++.+||+.||++|||+.|+++
T Consensus 247 ----~---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ----E---CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----c---cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0012346889999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.22 Aligned_cols=263 Identities=26% Similarity=0.367 Sum_probs=197.5
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-----hhhHHHHHHHHHHHHcC---CCCceeeEEEEEecC
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-----TQGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDS 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 532 (785)
..++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999995 578999999986432 11123556777777666 599999999999875
Q ss_pred C-----ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceee
Q 003932 533 E-----ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKI 607 (785)
Q Consensus 533 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 607 (785)
. ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999996 69999886532 234899999999999999999999987 999999999999999999999
Q ss_pred ccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 608 SDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 608 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .........
T Consensus 162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHH
T ss_pred eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence 999999765322 22345678999999999999999999999999999999999999986433221 222222222
Q ss_pred hCCccccc------cccccCCC--C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 688 KGGKGVEF------VDSFLDDR--N-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 688 ~~~~~~~~------~~~~l~~~--~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........ ....+... . .+.....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11110000 00000000 0 0112357889999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=350.29 Aligned_cols=259 Identities=22% Similarity=0.240 Sum_probs=194.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC------
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ 533 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 533 (785)
.++|++++.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999984 46899999999764 3445667889999999999999999999997553
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 469999999765 555552 23889999999999999999999986 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc--
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK-- 691 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 691 (785)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+ .............
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence 875432 23345689999999999999999999999999999999999999996533211 1111111111000
Q ss_pred -----------------c-c-----cccccccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 692 -----------------G-V-----EFVDSFLDDRN---SPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 692 -----------------~-~-----~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
. . ..+...+.... .......+.+|+.+||+.||++|||++|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0 00000000000 01124578999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=330.86 Aligned_cols=274 Identities=21% Similarity=0.267 Sum_probs=209.3
Q ss_pred ChHHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHc--CCCCceeeEEEEEecC
Q 003932 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDS 532 (785)
Q Consensus 455 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 532 (785)
++.-.....++|.+.+.||+|+||.||+|+.. ++.||+|++... ....+.+|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 33444556789999999999999999999985 899999999643 33567788888887 7999999999999877
Q ss_pred C----ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEecccCCCEEEcCCC
Q 003932 533 E----ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-----SRLTIIHRDLKVSNILLGEAM 603 (785)
Q Consensus 533 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dikp~Nill~~~~ 603 (785)
. ..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||.. +..+|+||||||+|||++.++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred CCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 6 78999999999999999843 3589999999999999999999931 122599999999999999999
Q ss_pred ceeeccccceeeeccccccc--ccccccccCCcccccccCCCC------CCChhhHHHHHHHHHHHHcC----------C
Q 003932 604 KPKISDFGMARIFAKESLEE--NTEQVVGTIGYIPPEYATKGV------YSTKSDVFSFGVLLLQIISG----------K 665 (785)
Q Consensus 604 ~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvvl~elltG----------~ 665 (785)
.+||+|||++.......... ......||..|+|||++.+.. ++.++|||||||++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999998765432211 234457999999999998762 34689999999999999999 5
Q ss_pred CCCcccCCCCcccHHHHHHHHHhCCcc-ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 666 RLSMLCGINENLSILEHAYELWKGGKG-VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 666 ~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.|+........ . ............. ..... ..........+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 265 ~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 265 LPYYDLVPSDP-S-VEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CTTTTTSCSSC-C-HHHHHHHHTTSCCCCCCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccccCcCcc-c-HHHHHHHHHHHHhCCCCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 66654322211 1 1112222211111 11111 01123456789999999999999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=329.24 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=204.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|.+.+.||+|+||.||+|... +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999964 6789999998654 234556788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988743 346899999999999999999999986 99999999999999999999999999987643
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... +.... ......
T Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~~~------ 232 (294)
T 2rku_A 168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLR-IKKNEY------ 232 (294)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHTTCC------
T ss_pred Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HhhccC------
Confidence 22 2233457899999999999999999999999999999999999998643211 11111 111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..+......+.+++.+||+.||++|||++|+++
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 011122346889999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=339.48 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=201.2
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHHcCCCCceeeEEEEEecC
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST--------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 532 (785)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999984 5789999999976531 1233567899999999999999999999999
Q ss_pred CccEEEEEecCCC-ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 533 EERMLIYEYMPNK-SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 533 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
...++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99988853 345899999999999999999999986 9999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
+++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 998765432 2334679999999999998876 7899999999999999999999853211
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 691 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
...... ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ----~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0011123478899999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.21 Aligned_cols=260 Identities=21% Similarity=0.262 Sum_probs=197.5
Q ss_pred cCCCcc-eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIR-NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|.+. +.||+|+||.||+|.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467774 7899999999999994 47899999999876655667889999999885 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc---eeeccccceeeec
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK---PKISDFGMARIFA 617 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Dfg~a~~~~ 617 (785)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999853 345899999999999999999999986 999999999999998776 9999999987653
Q ss_pred cccc-----ccccccccccCCcccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccH--------
Q 003932 618 KESL-----EENTEQVVGTIGYIPPEYATK-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSI-------- 679 (785)
Q Consensus 618 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~-------- 679 (785)
.... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||......+....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223569999999999875 4588999999999999999999999975443221000
Q ss_pred HHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 680 LEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
............. ....... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~i~~~~~-~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKY-EFPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCC-CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCc-ccCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0111111111110 0100000 012347889999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=336.21 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=206.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|.+.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999954 5789999998654 334556788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998743 346899999999999999999999986 99999999999999999999999999987643
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
.. .......||..|+|||++.+..++.++|||||||++|||++|+.|+...... +..........
T Consensus 194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~------- 258 (335)
T 2owb_A 194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEY------- 258 (335)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC-------
T ss_pred Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhcCCC-------
Confidence 22 2233467899999999999999999999999999999999999998643211 11111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 739 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 739 (785)
..+......+.+++.+||+.||++|||+.|+++ .+.+
T Consensus 259 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 259 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 011122346889999999999999999999986 4544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=364.63 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=202.9
Q ss_pred cCCCcce-eeceeCcEEEEEEEeC---CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRN-KLGEGGYGPVYKGVLP---CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
+++.+.+ .||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||++++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4455555 7999999999999853 46679999998653 3456789999999999999999999999976 568999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999854 2446899999999999999999999986 99999999999999999999999999986543
Q ss_pred ccc-ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 619 ESL-EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 619 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ .......+....
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~-- 559 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME-- 559 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCCC--
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCC--
Confidence 211 111222345689999999998999999999999999999998 999987543221 112222222111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
.+...+..+.+|+.+||+.||++||++.+|++.|+.....
T Consensus 560 -------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 560 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1222345789999999999999999999999999886533
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=331.68 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=203.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|.+.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 468999999999999999999954 7899999999876554556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE---cCCCceeeccccceeeecc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~ 618 (785)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999988843 345889999999999999999999986 9999999999999 7889999999999875432
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. ......||..|+|||.+.+..++.++|||||||++|||++|+.|+...... ... .....+.. ..
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~----~~i~~~~~-~~--- 226 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF----EKIKEGYY-EF--- 226 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHCCC-CC---
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcCCC-CC---
Confidence 2 223456899999999999999999999999999999999999998643211 111 11111110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 739 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 739 (785)
........+..+.+++.+||+.||++|||+.|+++ .+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 227 --ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp --CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred --CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 01111223457889999999999999999999986 4544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.91 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=205.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.+.|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35799999999999999999985 468899999997543 3456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998843 45899999999999999999999986 9999999999999999999999999998765432
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......... ... .+
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~-----~~ 239 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFLIPKN-NPP-----TL 239 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCC-----CC
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHHhhcC-CCC-----CC
Confidence 1233457899999999999999999999999999999999999998643211 111111111 110 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 240 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11223468899999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.21 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=197.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-CccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 541 (785)
.++|++.+.||+|+||.||+|... ++.||+|++.... ..+.+.+|+.++++++||||+++++++... ...++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467999999999999999999875 8899999997653 346789999999999999999999997654 478999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999998542 2234788999999999999999999986 999999999999999999999999998764322
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ .. .....+..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~-------- 232 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYK-------- 232 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTCC--------
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCCC--------
Confidence 223457889999999998899999999999999999998 999986443221 11 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.......+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 233 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 -MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111122345788999999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.76 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=199.5
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
+|....+||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++......++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355556999999999999995 5688999999987666666789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-CCceeeccccceeeecccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
+++|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 9999999865444455778999999999999999999986 999999999999987 8999999999998754321
Q ss_pred cccccccccCCcccccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 623 ENTEQVVGTIGYIPPEYATKGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......|+..|+|||++.+.. ++.++||||||+++|||++|+.|+........ ......... .
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~-----------~ 243 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGMFK-----------V 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHHHC-----------C
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhcccc-----------c
Confidence 2233457899999999987653 78999999999999999999999864332110 000101110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+...+..+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01112223457889999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.99 Aligned_cols=263 Identities=24% Similarity=0.313 Sum_probs=193.1
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999984 4789999999975532 224567799999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-----CCCceeeccccc
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG-----EAMKPKISDFGM 612 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-----~~~~~kl~Dfg~ 612 (785)
||||++ |+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 599888853 345899999999999999999999986 99999999999994 555699999999
Q ss_pred eeeecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
++...... .......||..|+|||++.+. .++.++|||||||++|||++|+.||...... ..............
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCC
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCc
Confidence 97654221 223345689999999999875 4899999999999999999999998643221 11222222111111
Q ss_pred ccccc---------cc--ccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVEFV---------DS--FLDDRN-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~~~---------~~--~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..... .. ...... .......+.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00 000000 0012357889999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.20 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=204.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999964 67889999986532 123457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999998853 345889999999999999999999886 999999999999999999999999998765332
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...... .....
T Consensus 168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~-~~~~~------- 229 (284)
T 2vgo_A 168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRI-VNVDL------- 229 (284)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH-HTTCC-------
T ss_pred ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHH-hcccc-------
Confidence 223457899999999999999999999999999999999999998643211 111111 11110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 740 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 740 (785)
..+...+..+.+++.+||+.||.+||++.|+++ .++..
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 111223347889999999999999999999986 55544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.91 Aligned_cols=264 Identities=18% Similarity=0.257 Sum_probs=208.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC-CceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.++||+|+||.||+|.. .+++.||||++...... .++..|+++++.++| +++..+..++......++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36799999999999999999995 57899999988654332 357889999999977 566667777777888999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE---cCCCceeeccccceeeec
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARIFA 617 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~ 617 (785)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 345899999999999999999999986 9999999999999 688999999999998875
Q ss_pred cccccc-----ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 618 KESLEE-----NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 618 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
...... ......||..|+|||++.+..++.++|||||||+||||++|+.||...........+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT-- 235 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS--
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc--
Confidence 433211 1235679999999999999999999999999999999999999997654443333332222211110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCC
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 743 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 743 (785)
.+.... . ..+.++.+++..||+.+|++||++.+|++.|++....
T Consensus 236 --~~~~l~-~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 236 --SIEALC-R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp --CHHHHH-T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --cHHHHh-c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 111000 1 1134788999999999999999999999999886443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=340.27 Aligned_cols=199 Identities=24% Similarity=0.387 Sum_probs=166.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-----Cc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 534 (785)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 35899999999999999999995 46889999999764 334556789999999999999999999999766 56
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 699988853 345899999999999999999999986 9999999999999999999999999998
Q ss_pred eecccccc--------------------cccccccccCCccccccc-CCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 003932 615 IFAKESLE--------------------ENTEQVVGTIGYIPPEYA-TKGVYSTKSDVFSFGVLLLQIISGKRLS 668 (785)
Q Consensus 615 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltG~~p~ 668 (785)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76533211 123556899999999986 5567999999999999999999865554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.58 Aligned_cols=260 Identities=23% Similarity=0.283 Sum_probs=196.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC------
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ 533 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 533 (785)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 36799999999999999999995 57899999999654 3344567889999999999999999999997653
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899988843 45889999999999999999999986 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
+.... ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ............ .
T Consensus 176 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~-~ 246 (367)
T 1cm8_A 176 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTP-P 246 (367)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCC-C
T ss_pred ccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCC-C
Confidence 87532 2334578999999999877 679999999999999999999999986433211 111111111100 0
Q ss_pred ccc-------------------cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 003932 693 VEF-------------------VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 740 (785)
Q Consensus 693 ~~~-------------------~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 740 (785)
.+. ....+. ...+.....+.+|+.+||+.||.+|||+.|+++ .+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000 000000 001122357889999999999999999999988 45554
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=328.12 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=200.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh------hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999965 689999999875421 2357889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC----ceeecccc
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM----KPKISDFG 611 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfg 611 (785)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999853 346899999999999999999999986 99999999999998877 89999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
++....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.|+...... . .........
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------E-TLTNISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------H-HHHHhHhcc
Confidence 998764321 223456899999999999999999999999999999999999998643211 1 111111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ....... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 228 ~-~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 Y-DFDEEYF-----SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C-CCCHHHH-----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-CCcchhc-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 0000000 112346889999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=339.24 Aligned_cols=263 Identities=23% Similarity=0.278 Sum_probs=202.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999964 6889999999765 34455678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999853 34588999999999999999999985 5 999999999999999999999999998754322
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH----------------
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA---------------- 683 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~---------------- 683 (785)
......||..|+|||++.+..++.++|||||||++|||++|+.||......+........
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 233457899999999999999999999999999999999999998643321100000000
Q ss_pred -------HHHHhCCccccccccc----cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 684 -------YELWKGGKGVEFVDSF----LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 684 -------~~~~~~~~~~~~~~~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..........+..+.. .........+..+.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000000000 000111123447889999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=333.36 Aligned_cols=265 Identities=24% Similarity=0.299 Sum_probs=196.5
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhh-----HHHHHHHHHHHHcCCCCceeeEEEEEecCCc
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQG-----FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 534 (785)
...++|++.+.||+|+||.||+|... +++.||+|++....... .+.+.+|+.++++++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999964 68999999997542211 2357899999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++||||+++ +|..++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999976 88887754 2345788899999999999999999987 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
.+.... .......||+.|+|||++.+. .++.++|||||||++|||++|.+|+..... .................
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChh
Confidence 654321 223446789999999999764 488999999999999999999998864322 11222222221111111
Q ss_pred ccc------ccccCC---CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 694 EFV------DSFLDD---RNS-----PCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 694 ~~~------~~~l~~---~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
... +..... ..+ ......+.+++.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000000 000 1123578999999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.23 Aligned_cols=264 Identities=26% Similarity=0.369 Sum_probs=198.0
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57999999999999999999964 58999999986543 3334567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999887643 345899999999999999999999986 9999999999999999999999999998654322
Q ss_pred cccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHH--------HHHHHhCCc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGGK 691 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~ 691 (785)
.......||..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.. ....+....
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 223345789999999999875 689999999999999999999999865332211110000 000011100
Q ss_pred c-ccccccccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 G-VEFVDSFLDDRNS-----PCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~-~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. .....+.+..... +..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000001111111 122457899999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.25 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=202.6
Q ss_pred HHHHhcCCCcc-eeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCC
Q 003932 459 IEAATERFSIR-NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE 533 (785)
Q Consensus 459 ~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 533 (785)
.+...++|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++ +||||+++++++.+..
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34456678887 89999999999999954 68999999987642 33456789999999999 5699999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---CCceeeccc
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---AMKPKISDF 610 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Df 610 (785)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999988543 2356899999999999999999999986 999999999999997 789999999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .........
T Consensus 179 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~ 249 (327)
T 3lm5_A 179 GMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNISQVN 249 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC
T ss_pred ccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHhcc
Confidence 9998764331 2334679999999999999999999999999999999999999986432211 111111110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 691 KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 691 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
. .. ...........+.+++.+||+.||.+|||++|+++.
T Consensus 250 ~--~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 V--DY-----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C--CC-----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c--cc-----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 00 011112234578899999999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=330.14 Aligned_cols=259 Identities=25% Similarity=0.305 Sum_probs=203.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec--CCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 537 (785)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357999999999999999999964 6899999999754 34456678999999999999999999998854 567899
Q ss_pred EEEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 538 IYEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYS--RLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ..+++||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986432 2345899999999999999999999975 1349999999999999999999999999987
Q ss_pred eecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... + .......+....
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------E-LAGKIREGKFRR 235 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCCC
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------H-HHHHHhhccccc
Confidence 654321 1123356899999999999989999999999999999999999998643211 1 111111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.+...+..+.+++.+||+.||.+|||+.|+++.+..
T Consensus 236 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111234578899999999999999999999987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.78 Aligned_cols=245 Identities=21% Similarity=0.317 Sum_probs=197.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 568999999999999999999965 7899999998764 233456788899999999 999999999999999999999
Q ss_pred EEecCCCChhhhhcCCcc-ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC---------------
Q 003932 539 YEYMPNKSLDCYLFDPIR-KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA--------------- 602 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--------------- 602 (785)
|||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999864321 255899999999999999999999986 9999999999999844
Q ss_pred ----CceeeccccceeeecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcc
Q 003932 603 ----MKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 677 (785)
Q Consensus 603 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~ 677 (785)
..+||+|||++...... ....||..|+|||.+.+. .++.++|||||||++|||++|.+++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence 47999999999875432 224589999999999876 5668999999999999999998765321
Q ss_pred cHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. ......+.... .+...+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~----~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 DQ----WHEIRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HH----HHHHHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hH----HHHHHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 01 11112211111 11122357889999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.75 Aligned_cols=242 Identities=15% Similarity=0.174 Sum_probs=188.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC---ChhhHHHHHHHH---HHHHcCCCCceeeEE-------EE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT---STQGFEEFKNEV---MLTAKLQHVNLIRVL-------GF 528 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 528 (785)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ ..+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999995 56899999999743 344567889999 455556899999988 66
Q ss_pred EecCC-----------------ccEEEEEecCCCChhhhhcCCcc----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 003932 529 CIDSE-----------------ERMLIYEYMPNKSLDCYLFDPIR----KLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587 (785)
Q Consensus 529 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 587 (785)
+.+.+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 55443 278999999 6899999864211 122445888899999999999999986 9
Q ss_pred EEecccCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCC-----------CCCChhhHHHHHH
Q 003932 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG-----------VYSTKSDVFSFGV 656 (785)
Q Consensus 588 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGv 656 (785)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986322 2334567 999999999887 8999999999999
Q ss_pred HHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 657 LLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 657 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
++|||++|+.||.......... .+ ... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~----------------~~---~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE----------------WI---FRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSG----------------GG---GSS--CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchh----------------hh---hhh--ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999986433222111 00 000 0112347889999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=351.93 Aligned_cols=250 Identities=27% Similarity=0.342 Sum_probs=197.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.++|++.+.||+|+||.||+|+.. ++..+|+|++.+.. ......+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999964 68899999997643 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC---Cceeeccccceeee
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA---MKPKISDFGMARIF 616 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfg~a~~~ 616 (785)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999888743 345899999999999999999999986 9999999999999764 45999999999876
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||......+ . . .....+.. ...
T Consensus 190 ~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~---~-~~i~~~~~-~~~ 257 (494)
T 3lij_A 190 ENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---I---L-RKVEKGKY-TFD 257 (494)
T ss_dssp BTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H-HHHHHTCC-CCC
T ss_pred CCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---H---H-HHHHhCCC-CCC
Confidence 543 2234467999999999987 468999999999999999999999996433211 1 1 11111110 010
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+.. ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1100 112346889999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=327.20 Aligned_cols=256 Identities=20% Similarity=0.278 Sum_probs=199.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEEEec--CCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCID--SEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36899999999999999999984 578999999997543 357889999999997 9999999999987 5678999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-ceeeccccceeeec
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFGMARIFA 617 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~ 617 (785)
|||+++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988873 2788999999999999999999986 99999999999999776 89999999998764
Q ss_pred ccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH---------H
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL---------W 687 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~---------~ 687 (785)
... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.|+...... .......... .
T Consensus 183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHH
T ss_pred CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHH
Confidence 432 2334578999999999987 66899999999999999999999998532211 1111111000 0
Q ss_pred hCC--------------ccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 688 KGG--------------KGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 688 ~~~--------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
... .....................+.+|+.+||+.||.+|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000011111111122223567899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=345.50 Aligned_cols=194 Identities=24% Similarity=0.403 Sum_probs=153.6
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-----Ccc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EER 535 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 535 (785)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 5899999999999999999985 47899999999764 344566789999999999999999999998543 568
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+ +++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999998 5789888853 345899999999999999999999986 99999999999999999999999999987
Q ss_pred ecccccc-------------------------cccccccccCCccccccc-CCCCCCChhhHHHHHHHHHHHHcC
Q 003932 616 FAKESLE-------------------------ENTEQVVGTIGYIPPEYA-TKGVYSTKSDVFSFGVLLLQIISG 664 (785)
Q Consensus 616 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvvl~elltG 664 (785)
....... ......+||+.|+|||++ .+..++.++|||||||+||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6422110 123345789999999976 556799999999999999999994
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.46 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=203.2
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh--------hhHHHHHHHHHHHHcC-CCCceeeEEEE
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST--------QGFEEFKNEVMLTAKL-QHVNLIRVLGF 528 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~ 528 (785)
.....++|++.+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999964 789999999875431 1245678899999999 89999999999
Q ss_pred EecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeec
Q 003932 529 CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKIS 608 (785)
Q Consensus 529 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 608 (785)
+......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999853 346899999999999999999999986 9999999999999999999999
Q ss_pred cccceeeecccccccccccccccCCcccccccCC------CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHH
Q 003932 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATK------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH 682 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 682 (785)
|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...
T Consensus 243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~ 313 (365)
T 2y7j_A 243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILM 313 (365)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHH
T ss_pred ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHH
Confidence 999998765432 2344679999999998853 3588999999999999999999999864221 111
Q ss_pred HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 683 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. .....+.. ....+... ..+..+.+++.+||+.||++|||+.|+++
T Consensus 314 ~-~~i~~~~~-~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 L-RMIMEGQY-QFSSPEWD-----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H-HHHHHTCC-CCCHHHHS-----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-HHHHhCCC-CCCCcccc-----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 11111110 00000000 11346889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=341.15 Aligned_cols=253 Identities=24% Similarity=0.314 Sum_probs=191.0
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--------hhhHHHHHHHHHHHHcCCCCceeeEEEEEec
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID 531 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 531 (785)
...++|.+.+.||+|+||.||+|.. .+++.||+|++.+.. ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3467899999999999999999985 468899999986532 1122347899999999999999999999754
Q ss_pred CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC---ceeec
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM---KPKIS 608 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl~ 608 (785)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 557999999999999988853 345899999999999999999999986 99999999999997544 59999
Q ss_pred cccceeeecccccccccccccccCCcccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH
Q 003932 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATK---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 685 (785)
|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....
T Consensus 285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~---- 355 (419)
T 3i6u_A 285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD---- 355 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH----
T ss_pred ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH----
Confidence 99999875432 22345679999999999864 567889999999999999999999996433222 1111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+... ...... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 356 ~i~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 QITSGKYN-FIPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTCCC-CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCC-CCchhh-----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111110 000000 012347889999999999999999999986
|
| >3n12_A Chitinase A, chinctu2; zinc atoms, complex, hydrolase; 1.20A {Bacillus cereus} PDB: 3n11_A 3n15_A* 3n13_A* 3n17_A* 3n18_A* 3n1a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=322.41 Aligned_cols=218 Identities=16% Similarity=0.213 Sum_probs=162.3
Q ss_pred CCCcEEEEEecCCCC----CCcCCCCCCCCceEEEEEEEeeCCccEEecCCCc-cHHHHHHHHHHHHhcCCCceEEEEec
Q 003932 23 AKPWIRVGYLNLSEV----STISGINYDLFTHLICSSADINSTTYQLSLSLPS-DENQIAKFADTVKKKNPSITTILSIG 97 (785)
Q Consensus 23 ~~~~~~vgY~~~~~~----~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~k~~~p~lkv~~sig 97 (785)
...+++||||.+|.. +.+++|+..+ |||+|+|+.++.++..+.+.... .+..+.+.+..+|++ ++|||+|||
T Consensus 4 ~~~~~vvgYy~~~~~~~~~~~~~~i~~~l-thi~~aF~~~~~~~~~~~~~~~~~~~~~~~~~i~~~k~~--g~kvllsiG 80 (333)
T 3n12_A 4 LGSKLLVGYWHNFDNGTGIIKLKDVSPKW-DVINVSFGETGGDRSTVEFSPVYGTDADFKSDISYLKSK--GKKVVLSIG 80 (333)
T ss_dssp CCSSEEEEEEESSCSSSCCCCGGGSCTTC-SEEEEEEEEECTTSCSEECCCSSSCHHHHHHHHHHHHHT--TCEEEEEEE
T ss_pred CCCCEEEEEECcccCCCCccCHHHCCCCC-cEEEEEEEEecCCCCeEEecCCccchHHHHHHHHHHHhC--CCeEEEEec
Confidence 345789999998864 6899998765 99999999999887556554322 355666777778887 599999999
Q ss_pred CCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC---------CCCchhHHHHHHHHHHHhhhhhh
Q 003932 98 QGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT---------STDMFNIGLLFDEWRIAATKLDA 168 (785)
Q Consensus 98 G~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~---------~~d~~~~~~ll~~lr~~l~~~~~ 168 (785)
||. ++.+++++++|++||+++++++++|||||||||||||+. ++|+++|+.|+++||++|++.+
T Consensus 81 G~~------~s~~~~~~~~r~~fi~si~~~~~~~gfDGiDiDwE~p~~~~~~d~~~~~~d~~~~~~ll~eLr~~l~~~g- 153 (333)
T 3n12_A 81 GQN------GVVLLPDNAAKDRFINSIQSLIDKYGFDGIDIDLESGIYLNGNDTNFKNPTTPQIVNLISAIRTISDHYG- 153 (333)
T ss_dssp STT------CCCCCCSHHHHHHHHHHHHHHHHHHCCSEEEEECCTTCCBCTTCCCTTSCCCHHHHHHHHHHHHHHHHHC-
T ss_pred CCC------CccccCCHHHHHHHHHHHHHHHHHcCCCeEEEeccCCCCCCCCCcCCCcccHHHHHHHHHHHHHHHHhcC-
Confidence 885 347899999999999999999999999999999999842 2367799999999999997642
Q ss_pred hcccccceeEEEEeecccCC--------CCccc--cHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCC
Q 003932 169 KNSTRQQSLLILTARFRYSP--------PANSY--LLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARS 238 (785)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~ 238 (785)
+...+++++..+... ....| +++++.+++||||||+||+||.|. .+|++.+-. ...
T Consensus 154 -----~~~~lT~Ap~~~~~~~~~~~y~~~~~~y~~d~~~i~~~lD~invMtYD~hg~~g--~~g~~~~~~-------~~~ 219 (333)
T 3n12_A 154 -----PDFLLSMAPETAYVQGGYSAYGSIWGAYLPIIYGVKDKLTYIHVQHYNAGSGIG--MDGNNYNQG-------TAD 219 (333)
T ss_dssp -----TTCEEEECCBGGGTGGGGTCCBBTBTTTHHHHHHTTTTCCEEEEECSSCCEEEC--TTSCEEETT-------SHH
T ss_pred -----CCEEEEEccCcccccccccccccccchhHHHHHHHhcccCEEEeeeecCCCcCC--CCCcccccC-------cch
Confidence 245555554333211 11345 889999999999999999998763 344432210 011
Q ss_pred HHHHHHHHHHcC-------------CCCCceeecccccc
Q 003932 239 TDQVLKAWIERG-------------LSADKLVMCLPFYG 264 (785)
Q Consensus 239 ~~~~v~~~~~~g-------------vp~~KlvlGip~YG 264 (785)
...++..++..| +|++||+||+|..+
T Consensus 220 ~~~a~~~~l~~g~~~~g~~~~~~~~ip~~KlvlGlPa~~ 258 (333)
T 3n12_A 220 YEVAMADMLLHGFPVGGNANNIFPALRSDQVMIGLPAAP 258 (333)
T ss_dssp HHHHHHHHHHHEEEETTEEEEEEECCCGGGEEEEEESSG
T ss_pred HHHHHHHHHHhcccccCcccccccccCHHHeeeccccCC
Confidence 223444445544 99999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=332.26 Aligned_cols=265 Identities=22% Similarity=0.345 Sum_probs=186.4
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3457899999999999999999985 468899999987543 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCC-----ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 539 YEYMPNKSLDCYLFDP-----IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
|||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988531 12345899999999999999999999986 999999999999999999999999998
Q ss_pred eeeccccc---ccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhC
Q 003932 614 RIFAKESL---EENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG 689 (785)
Q Consensus 614 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 689 (785)
........ ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+....... ... .....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~~~~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLM---LTLQN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHH---HHhcc
Confidence 76543211 112234578999999999876 568999999999999999999999986543222 111 11111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 690 GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 690 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. ................+..+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SC-CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CC-CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 1110000001111122347889999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.33 Aligned_cols=252 Identities=21% Similarity=0.369 Sum_probs=198.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++.+.||+|+||.||+|... +++.+|+|++........+.+.+|+.++++++||||+++++++......++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999965 5889999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999988853 2345899999999999999999999986 999999999999999999999999987543221
Q ss_pred ccccccccccCCccccccc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 622 EENTEQVVGTIGYIPPEYA-----TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
........||..|+|||++ .+..++.++|||||||++|||++|+.|+..... ............. ..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~-~~- 242 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPP-TL- 242 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-CC-
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCCc-cc-
Confidence 1122345789999999988 467789999999999999999999999864321 1111111111111 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 ------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011223457889999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=340.97 Aligned_cols=199 Identities=22% Similarity=0.259 Sum_probs=170.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC------CCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL------QHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 535 (785)
..+|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45799999999999999999985 46899999999764 33345677888888776 577999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc--eeeccccce
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK--PKISDFGMA 613 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a 613 (785)
++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999995 68888885432 234899999999999999999999986 999999999999999887 999999999
Q ss_pred eeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccC
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 672 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~ 672 (785)
+.... ......||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 76432 2334678999999999999999999999999999999999999986543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=324.36 Aligned_cols=256 Identities=23% Similarity=0.266 Sum_probs=200.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC----hhhHHHHHHHHHHHHcCCCCceeeEEEEEe--cCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCI--DSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 535 (785)
.++|.+.+.||+|+||.||+|.. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999995 468899999997542 234567899999999999999999999985 44578
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 66666432 2446899999999999999999999986 99999999999999999999999999987
Q ss_pred ecccccccccccccccCCcccccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
..............||..|+|||++.+.. ++.++|||||||++|||++|+.|+..... .. ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YK-LFENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HH-HHHHHhcCCC-
Confidence 65433333334567899999999998654 47899999999999999999999864321 11 1111111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 740 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 740 (785)
.........+.+++.+||+.||.+|||++|+++ .+++.
T Consensus 231 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 ---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 011122347889999999999999999999986 45554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.09 Aligned_cols=264 Identities=19% Similarity=0.299 Sum_probs=199.1
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecC--------
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-------- 532 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 532 (785)
++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999996 5789999999865432 2245678999999999999999999998863
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
...++||||+++ +|...+... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999975 676666432 245899999999999999999999986 99999999999999999999999999
Q ss_pred eeeeccccc--ccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhC
Q 003932 613 ARIFAKESL--EENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG 689 (785)
Q Consensus 613 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 689 (785)
++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+....... ...........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~ 247 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGS 247 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Confidence 987653221 122344578999999999876 458999999999999999999999987533222 11111111111
Q ss_pred Cccc---c-----cccc--ccC-CCCCH-HH------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 690 GKGV---E-----FVDS--FLD-DRNSP-CK------LMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 690 ~~~~---~-----~~~~--~l~-~~~~~-~~------~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.... . .... ... ..... .. ...+.+|+.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1100 0 0000 000 00000 01 2357899999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.27 Aligned_cols=248 Identities=21% Similarity=0.346 Sum_probs=194.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357999999999999999999965 78999999986532 23345788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999853 345889999999999999999999987 99999999999999999999999999876543
Q ss_pred cccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.. ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.|+...... ...........
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~----- 228 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGVF----- 228 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC-----
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCcc-----
Confidence 21 2234568999999999988765 68999999999999999999998643211 11111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
..+......+.+++.+||+.||++|||+.|+++.
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111123468899999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.63 Aligned_cols=260 Identities=18% Similarity=0.273 Sum_probs=194.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc------cEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE------RML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l 537 (785)
.+|.+.+.||+|+||.||+|+...+..+|+|++...... ..+|+++++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 579999999999999999999876777999988654321 2469999999999999999999865433 789
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-CCCceeeccccceeee
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG-EAMKPKISDFGMARIF 616 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~~ 616 (785)
||||++++.+............+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987655443322223456899999999999999999999986 99999999999999 7999999999999876
Q ss_pred cccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc---
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG--- 692 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 692 (785)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ..............
T Consensus 193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 193 IAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHH
T ss_pred cCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence 4332 23345789999999998765 58999999999999999999999997533221 11111111111000
Q ss_pred ----cccccccc---CCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 693 ----VEFVDSFL---DDR-----NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 693 ----~~~~~~~l---~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.......+ ... .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000 000 111133578999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=351.14 Aligned_cols=250 Identities=28% Similarity=0.346 Sum_probs=199.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh-------------hhHHHHHHHHHHHHcCCCCceeeEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST-------------QGFEEFKNEVMLTAKLQHVNLIRVLGF 528 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 528 (785)
.++|.+.++||+|+||.||+|... +++.||+|++.+... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 578999999999999999999954 688999999875421 234678899999999999999999999
Q ss_pred EecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC---ce
Q 003932 529 CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM---KP 605 (785)
Q Consensus 529 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~ 605 (785)
+.+....++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999888843 345899999999999999999999986 99999999999998776 69
Q ss_pred eeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH
Q 003932 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 606 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 685 (785)
||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+ .. .
T Consensus 189 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~----~ 257 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---II----K 257 (504)
T ss_dssp EECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----H
T ss_pred EEEECCCCEEcCCC---CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH----H
Confidence 99999999876543 22344679999999999874 68999999999999999999999996433211 11 1
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....+... ...... ...+..+.+++.+||+.||.+|||++|+++
T Consensus 258 ~i~~~~~~-~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 KVEKGKYY-FDFNDW-----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHCCCC-CCHHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHcCCCC-CCcccc-----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111100 000000 012347889999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=352.19 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=202.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
.++|++.+.||+|+||.||+|... +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999964 78999999986542 33467889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE---cCCCceeeccccceee
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL---GEAMKPKISDFGMARI 615 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~ 615 (785)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999988853 345899999999999999999999986 9999999999999 5678999999999976
Q ss_pred ecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
+... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+ . .............
T Consensus 179 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~---~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 179 FEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---I---LKKVEKGKYTFEL 248 (484)
T ss_dssp BCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHHCCCCCCS
T ss_pred cccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---H---HHHHHcCCCCCCC
Confidence 5433 22334579999999999876 68999999999999999999999996432211 1 1111111111000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. .....+..+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 P-------QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp G-------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 01123457889999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=332.72 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=183.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------C
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------E 533 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 533 (785)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36899999999999999999984 57899999999754 334556788999999999999999999998754 5
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
..++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7899888743 45899999999999999999999986 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
+.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...............
T Consensus 180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 180 RHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCH
T ss_pred ccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 86432 2334678999999999887 67899999999999999999999998653321 122222121111100
Q ss_pred -----------ccccccccC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 693 -----------VEFVDSFLD-DRNS-----PCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 693 -----------~~~~~~~l~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
...+..... .... +.....+.+|+.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000 0000 0113468899999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.98 Aligned_cols=269 Identities=22% Similarity=0.309 Sum_probs=198.6
Q ss_pred ChHHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh-----------hhHHHHHHHHHHHHcCCCCcee
Q 003932 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST-----------QGFEEFKNEVMLTAKLQHVNLI 523 (785)
Q Consensus 455 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv 523 (785)
...++....++|.+.+.||+|+||.||+|....++.||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35667778899999999999999999999988899999999865321 2236789999999999999999
Q ss_pred eEEEEEec-----CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 524 RVLGFCID-----SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 524 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
++++++.. ....++||||+. |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 99999854 235799999997 678777753 3346899999999999999999999986 999999999999
Q ss_pred EcCCCceeeccccceeeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcc
Q 003932 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 677 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~ 677 (785)
++.++.+||+|||+++..... .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 999999999999999754332 22334578999999999887 678999999999999999999999986533211
Q ss_pred cHHHHHHHHHhCCccc-----------cccccccCCCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 678 SILEHAYELWKGGKGV-----------EFVDSFLDDRN-------SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 678 ~~~~~~~~~~~~~~~~-----------~~~~~~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
............... ......+.... .+.....+.+|+.+||+.||.+|||+.|+++
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111111111000 00000000000 0112346889999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=360.49 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=197.4
Q ss_pred eeeceeCcEEEEEEEe---CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVL---PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
+.||+|+||.||+|.+ ..++.||||++.... ....+++.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 346789999997642 3446789999999999999999999999964 568899999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc-cc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL-EE 623 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~ 623 (785)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999953 345899999999999999999999986 99999999999999999999999999987543221 11
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......+|..|+|||++.+..++.++|||||||++|||++ |+.||...... ........+....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~~~-------- 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMG-------- 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC--------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC--------
Confidence 2233456789999999999999999999999999999998 99998643221 1122222222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.+...+..+.+|+.+||+.||++||++.+|++.|++..
T Consensus 593 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 593 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12223457899999999999999999999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=350.42 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=202.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.++|++.+.||+|+||.||+|... +++.||||++.+.. ......+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999954 78999999986431 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc---CCCceeeccccceeee
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG---EAMKPKISDFGMARIF 616 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~Dfg~a~~~ 616 (785)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999888843 345899999999999999999999986 99999999999995 4567999999999765
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+ ...............
T Consensus 175 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 175 QQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKYAFDLP 244 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCCSCSG
T ss_pred CCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCCCc
Confidence 432 22334579999999999876 58999999999999999999999986432211 111111111100000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 740 (785)
.....+..+.+++.+||+.||.+|||+.|+++. +++.
T Consensus 245 -------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 245 -------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp -------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred -------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 011224578899999999999999999999873 4443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.47 Aligned_cols=253 Identities=10% Similarity=0.039 Sum_probs=180.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---hhHHHHHHHH---HHHHcCCCCceeeEE-------EE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---QGFEEFKNEV---MLTAKLQHVNLIRVL-------GF 528 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 528 (785)
..+|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+ ..++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 34689999999999999999995 4789999999987542 3445677785 45555 799988855 34
Q ss_pred EecC-----------------CccEEEEEecCCCChhhhhcCCccccCCCHHHH------HHHHHHHHHHHHHHhhcCCC
Q 003932 529 CIDS-----------------EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR------VHIIEGITQGLLYLQEYSRL 585 (785)
Q Consensus 529 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~ 585 (785)
+... ...++||||++ |+|.+++... ...+++..+ ..++.||+.||+|||+.+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 3322 23799999998 8999999643 223445555 778899999999999986
Q ss_pred CeEEecccCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCC--CCCCChhhHHHHHHHHHHHHc
Q 003932 586 TIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK--GVYSTKSDVFSFGVLLLQIIS 663 (785)
Q Consensus 586 ~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~ellt 663 (785)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999999999999999999999999875322 113456799999999987 679999999999999999999
Q ss_pred CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 664 GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 664 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
|+.||......... .+.....................+..+.+|+.+||+.||++|||+.|+++
T Consensus 289 g~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKG--------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTT--------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCccccc--------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999754322110 00000000000001111111233457899999999999999999999964
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.63 Aligned_cols=262 Identities=22% Similarity=0.296 Sum_probs=200.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-----Ccc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 535 (785)
..+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 35899999999999999999985 468899999997543 34456788999999999999999999998754 368
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+. |+|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 58988874 335899999999999999999999986 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 616 FAKESLE-ENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 616 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ..............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHH
Confidence 6543221 12344679999999998654 4589999999999999999999999975443332 22221111111000
Q ss_pred -----------cccccccCC-CC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 -----------EFVDSFLDD-RN-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 -----------~~~~~~l~~-~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......... .. .+.....+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 00 0112346889999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.26 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=197.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec----CCccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 536 (785)
+.|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3578889999999999999985 46788999998753 34556778999999999999999999998865 34589
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-CCCceeeccccceee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG-EAMKPKISDFGMARI 615 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~ 615 (785)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999853 355889999999999999999999874 2499999999999998 789999999999865
Q ss_pred ecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
.... ......||+.|+|||.+.+ .++.++|||||||++|+|++|+.|+...... .........+.....
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS 250 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG
T ss_pred cccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccc
Confidence 3322 2234568999999998874 5899999999999999999999998643211 111122222111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 251 ~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 FD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC--------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 111246889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.79 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=199.6
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
..++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999964 58999999997643 33678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999998852 2446899999999999999999999986 9999999999999999999999999998764332
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ............ ...
T Consensus 180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~~----- 245 (314)
T 3com_A 180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTNPP-PTF----- 245 (314)
T ss_dssp --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCC-----
T ss_pred --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCC-ccc-----
Confidence 123345789999999999999999999999999999999999999864321 111111111111 000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......+..+.+++.+||+.||.+|||+.++++
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011223457889999999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=322.90 Aligned_cols=251 Identities=23% Similarity=0.296 Sum_probs=201.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---------hhhHHHHHHHHHHHHcCC-CCceeeEEEEEec
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---------TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCID 531 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 531 (785)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999964 68999999987543 123456789999999995 9999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999853 346899999999999999999999986 9999999999999999999999999
Q ss_pred ceeeecccccccccccccccCCcccccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYAT------KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 685 (785)
++....... ......|+..|+|||++. ...++.++||||||+++|||++|+.|+..... ......
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~ 240 (298)
T 1phk_A 170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRM 240 (298)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHH
Confidence 998764332 233457899999999884 45688999999999999999999999864321 111111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...... ... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~--~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGNY--QFG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTCC--CCC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCCc--ccC-----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111110 000 0111223457899999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.66 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=196.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC--CCc--EEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP--CGE--VIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 535 (785)
.++|++.+.||+|+||.||+|... +++ .||+|++... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999842 233 6899998754 2345678899999999999999999999998654 8
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999988542 345889999999999999999999986 99999999999999999999999999987
Q ss_pred ecccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 616 FAKESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 616 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... +............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCCC
Confidence 6543221 12233457888999999988889999999999999999999 99998643211 1111111111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
......+..+.+++.+||+.||.+|||+.++++.|++..
T Consensus 245 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 ---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 111223457899999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.09 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=195.6
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHHcCCCCceeeEEEEEecC
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST--------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS 532 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 532 (785)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 356899999999999999999995 4688999999875421 2233578999999999999999999998765
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc---eeecc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK---PKISD 609 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~D 609 (785)
. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999998853 346899999999999999999999986 999999999999987664 99999
Q ss_pred ccceeeecccccccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH
Q 003932 610 FGMARIFAKESLEENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686 (785)
Q Consensus 610 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 686 (785)
||+++...... ......||..|+|||++. ...++.++|||||||++|+|++|+.||........ .....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~--- 232 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI--- 232 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH---
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH---
Confidence 99998764321 223456899999999873 56789999999999999999999999875433221 11111
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..+.. ....... ...+..+.+++.+||+.||++||++.|+++
T Consensus 233 -~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 -TSGKY-NFIPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHTCC-CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HhCcc-ccCchhh-----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11110 0000000 012347889999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.55 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=186.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hh-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .. ..+.+.++...++.++||||+++++++.+....++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999995 578999999997653 22 2233445556678889999999999999999999999
Q ss_pred EecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 540 EYMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 540 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||++ |+|.+++... .....+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5887776432 1345689999999999999999999997 6 9999999999999999999999999998754
Q ss_pred ccccccccccccccCCccccccc----CCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYA----TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.|+..... ...............
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPSPQ 233 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCCCC
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCCCC
Confidence 331 22334689999999996 556789999999999999999999999864221 111122222221110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 ---------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111123447889999999999999999999987
|
| >2y8v_A CHIC, class III chitinase, putative; afchic, hydrolase; 1.99A {Aspergillus fumigatus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=317.58 Aligned_cols=209 Identities=13% Similarity=0.107 Sum_probs=154.1
Q ss_pred CCCcEEEEEecCCCC----C---CcCCCCCCCCceEEEEEEEeeCCccEEecCCCccH----HHHHHHHHHHHhcCCCce
Q 003932 23 AKPWIRVGYLNLSEV----S---TISGINYDLFTHLICSSADINSTTYQLSLSLPSDE----NQIAKFADTVKKKNPSIT 91 (785)
Q Consensus 23 ~~~~~~vgY~~~~~~----~---~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~----~~~~~~~~~~k~~~p~lk 91 (785)
.+.+++||||.+|.. + .+++++.++||||+|+|+.++++++++.+.+..+. ..+.+.++.+|+++ +|
T Consensus 10 ~~~~~vv~Y~~~~~~~~g~~~~~~~~~i~~~~~Thii~af~~i~~~~g~~~~~~~~~~~~~~~~~~~~i~~~k~~g--~k 87 (290)
T 2y8v_A 10 PEHRRVICYHQTLCPNRGDYVSVLPLVKNNTGVTHIIIAAFHLNEDPGHITLNDDPPDHEMYNPLWAEVPVLKRSG--VK 87 (290)
T ss_dssp CCCSEEEEEECCCSGGGCSCCCCTHHHHTTCCCCEEEEEEEEECSSTTCEEETTBCTTSGGGHHHHHHHHHHHHTT--CE
T ss_pred CCCCeEEEEECCEeCCCCceeecChhhcCCccCcEEEEEEEEecCCCCceeecCCCcccchHHHHHHHHHHHHHCC--CE
Confidence 356789999988852 3 55678999999999999999987557877754322 34566677788775 99
Q ss_pred EEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcc
Q 003932 92 TILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNS 171 (785)
Q Consensus 92 v~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~ 171 (785)
||+|||||.. ++ |+.+++++++|++|++++++++++|||||||||||||+ ++++|+.|+++||++|.+
T Consensus 88 vllSiGG~~~-~~--fs~~~~~~~~r~~f~~s~~~~~~~~~~DGiDiDwE~p~---~~~~~~~ll~~Lr~~~~~------ 155 (290)
T 2y8v_A 88 VMGMLGGAAQ-GS--YRCLDGDQEKFERYYQPLLAMVRRHQLDGLDLDVEEEM---SLPGIIRLIDRLKLDLGD------ 155 (290)
T ss_dssp EEEEEECSST-TT--TGGGSSCHHHHHHHHHHHHHHHHHHTCSEEEEECCSCB---CHHHHHHHHHHHHHHHCT------
T ss_pred EEEEECCCCC-CC--chhccCCHHHHHHHHHHHHHHHHHhCCCeEEEcccccc---hHHHHHHHHHHHHHHhCC------
Confidence 9999999853 33 99999999999999999999999999999999999994 589999999999998854
Q ss_pred cccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCC---CCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q 003932 172 TRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVST---NFTAPPAALYGSISGRFARSTDQVLKAWIE 248 (785)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~---~~~g~~apl~~~~~~~~~~~~~~~v~~~~~ 248 (785)
+..+++++..+. ++|++++|+|||++.|.. ...++++++|....... + ...+++|+.
T Consensus 156 ---~~~lt~A~~~~~--------------~~d~~~~~~yD~~~~~~~~~~~~d~~~~~~Y~~~~~~~--~-~~~~~~~~~ 215 (290)
T 2y8v_A 156 ---DFIITLAPVAAA--------------LLGIGNLSGFDYRQLEQQRGSKISWYNAQFYNGWGLAE--D-PRMYAAIVA 215 (290)
T ss_dssp ---TSEEEECCBGGG--------------GGTSCCSSBSCHHHHHHHHGGGCCEEEEECCTTSCCTT--C-THHHHHHHH
T ss_pred ---CEEEEecccccc--------------ccCccccccccHHHHHhhcccccceeeecccCCCCCCC--C-chHHHHHHH
Confidence 445555444321 344445555554444331 13344444444322111 1 246889999
Q ss_pred cCCCCCceeeccccccc
Q 003932 249 RGLSADKLVMCLPFYGY 265 (785)
Q Consensus 249 ~gvp~~KlvlGip~YG~ 265 (785)
+|+|++||+||+|+|..
T Consensus 216 ~g~p~~KivlGlp~~~~ 232 (290)
T 2y8v_A 216 QGWSPQRVVYGLLTNPG 232 (290)
T ss_dssp TTCCGGGEEEEEESSGG
T ss_pred cCCCHHHEEEeccCCCC
Confidence 99999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.73 Aligned_cols=257 Identities=23% Similarity=0.251 Sum_probs=190.0
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC------c
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------E 534 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 534 (785)
++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 5899999999999999999985 46889999999753 3344567889999999999999999999997654 6
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7999999974 7777763 23888999999999999999999986 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH---------
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE--------- 685 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------- 685 (785)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+ .......
T Consensus 176 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 176 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEF 249 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHHH
T ss_pred ccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence 65432 12334678999999999999999999999999999999999999986433211 1111000
Q ss_pred ----------HHhCCccc------cccccccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 686 ----------LWKGGKGV------EFVDSFLDDRN---SPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 686 ----------~~~~~~~~------~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........ ........... .......+.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000 00000000000 1122567899999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.29 Aligned_cols=262 Identities=20% Similarity=0.270 Sum_probs=194.8
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------ 532 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 532 (785)
+...++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999985 5789999999865432 224799999999999999999998543
Q ss_pred --------------------------------CccEEEEEecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHH
Q 003932 533 --------------------------------EERMLIYEYMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYL 579 (785)
Q Consensus 533 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~L 579 (785)
...++||||++ |+|.+.+... .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999998 5877776432 2345689999999999999999999
Q ss_pred hhcCCCCeEEecccCCCEEEc-CCCceeeccccceeeecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHH
Q 003932 580 QEYSRLTIIHRDLKVSNILLG-EAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVL 657 (785)
Q Consensus 580 H~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvv 657 (785)
|+.+ |+||||||+|||++ .++.+||+|||+++.+.... ......||..|+|||++.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9886 99999999999998 68899999999998764332 23345789999999998875 48999999999999
Q ss_pred HHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc----------ccccccccCCC-----CCHHHHHHHHHHHHHcccc
Q 003932 658 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKG----------VEFVDSFLDDR-----NSPCKLMRCLEIALLCVQE 722 (785)
Q Consensus 658 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~ 722 (785)
+|||++|+.||......+ .............. .+..-+.+... .+...+..+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999987533221 11111111111100 00000000000 1112344688999999999
Q ss_pred CCCCCCCHHHHHH
Q 003932 723 NPNDRPSMLEVSS 735 (785)
Q Consensus 723 dP~~RPs~~evl~ 735 (785)
||.+|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999974
|
| >4axn_A Chitinase C1; hydrolase; 1.68A {Serratia marcescens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.05 Aligned_cols=227 Identities=12% Similarity=0.166 Sum_probs=161.3
Q ss_pred CCCCCCcEEEEEecCCCC-------------CCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhc
Q 003932 20 PAKAKPWIRVGYLNLSEV-------------STISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKK 86 (785)
Q Consensus 20 ~~~~~~~~~vgY~~~~~~-------------~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~ 86 (785)
+.....+++||||++|.. .++++|+ ..||||+|+|+.++.+. .+... ...+.++.+.++.+|++
T Consensus 19 p~~~~~~~~vgY~~~w~~~~~~~~~~~~~~~~~l~~i~-~~~~~i~~aF~~~~~~~-~~~~~-~~~~~~~~~~i~~~~~~ 95 (328)
T 4axn_A 19 PSIANKKILMGFWHNWAAGASDGYQQGQFANMNLTDIP-TEYNVVAVAFMKGQGIP-TFKPY-NLSDTEFRRQVGVLNSQ 95 (328)
T ss_dssp CCCTTSCEEEEEEESSCCCSSCSTTSCBCCCCCGGGSC-TTCCEEEEEEEBCSSSC-BCCCS-SSCHHHHHHHHHHHHHT
T ss_pred CCCCCCeEEEEEeCcccccCCCCccCCcCCCCchhhCC-CCCCEEEEEEEccCCCc-eeccC-CCCHHHHHHHHHHHHHC
Confidence 333456788999998852 2456665 56999999999887654 33332 33466777888878876
Q ss_pred CCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC--CCCchhHHHHHHHHHHHhh
Q 003932 87 NPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT--STDMFNIGLLFDEWRIAAT 164 (785)
Q Consensus 87 ~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~--~~d~~~~~~ll~~lr~~l~ 164 (785)
++|||+|||||..+ +..+++.|++|++++++++++|||||||||||||.. .++..+|..++++|++.+.
T Consensus 96 --g~kvllSiGG~~~~-------~~~~~~~r~~F~~s~~~~l~~ygfDGiDiDwE~p~~~~~~~~~~~~~~l~~l~~~~~ 166 (328)
T 4axn_A 96 --GRAVLISLGGADAH-------IELKTGDEDKLKDEIIRLVEVYGFDGLDIDLEQAAIGAANNKTVLPAALKKVKDHYA 166 (328)
T ss_dssp --TCEEEEEEEETTCC-------CCCCTTCHHHHHHHHHHHHHHHCCCEEEEEECTTTTTSTTHHHHHHHHHHHHHHHHH
T ss_pred --CCEEEEEeCCCCCC-------ccCChHHHHHHHHHHHHHHHHhCCCeEEEecccCCCCCcchHHHHHHHHHHHHHHHH
Confidence 59999999998642 355678899999999999999999999999999953 3456778888888887776
Q ss_pred hhhhhcccccceeEEEEeecccCCCCccc--cHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHH
Q 003932 165 KLDAKNSTRQQSLLILTARFRYSPPANSY--LLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQV 242 (785)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~ 242 (785)
+. .+.+.+++++..+.......| ++.++.+++||||+|+||+++.|.. .++++++++..............
T Consensus 167 ~~------g~~~~lt~Ap~~~~~~~~~~y~~~~~~~~~~~D~invm~Yd~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T 4axn_A 167 AQ------GKNFIISMAPEFPYLRTNGTYLDYINALEGYYDFIAPQYYNQGGDGIW-VDELNAWITQNNDAMKEDFLYYL 239 (328)
T ss_dssp TT------TCCCEEEECCBGGGGBTTCTTHHHHHHTTTTCCEECCBCSSCTTCEEE-ETTTTEEEETTCSTTHHHHHHHH
T ss_pred hc------CCceEEEEcccccccCCCcchhhHHHHhhccccEEeeecccCCCcccC-CCCcccccccCCcccchhHHHHH
Confidence 53 224555555444333333333 3678899999999999999998863 47888888754432211111112
Q ss_pred HHHHH-----HcCCCCCceeeccccccc
Q 003932 243 LKAWI-----ERGLSADKLVMCLPFYGY 265 (785)
Q Consensus 243 v~~~~-----~~gvp~~KlvlGip~YG~ 265 (785)
...+. ..|+|++||+||+|+|+.
T Consensus 240 ~~~~~~~~~~~~g~p~~KivlGlPa~~~ 267 (328)
T 4axn_A 240 TESLVTGTRGYAKIPAAKFVIGLPSNND 267 (328)
T ss_dssp HHHHHHTCTTBCCCCGGGBEEEEESSTT
T ss_pred HHHHHHHHhhhcCCChhceEEeeccccC
Confidence 22222 259999999999998864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=359.80 Aligned_cols=249 Identities=24% Similarity=0.283 Sum_probs=203.4
Q ss_pred HhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 536 (785)
..++|+++++||+|+||.||+|+. .+++.||||++.+.. ....+.+..|..++..+ +||+|+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999995 468899999997531 23345678899999987 7999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999853 345899999999999999999999986 999999999999999999999999999864
Q ss_pred cccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. + ......... .
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~-~--- 559 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------E-LFQSIMEHN-V--- 559 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHSSC-C---
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------H-HHHHHHhCC-C---
Confidence 3221 2344578999999999999999999999999999999999999999643221 1 111111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSM-----LEVSS 735 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 735 (785)
..+.....++.+|+.+||+.||++||++ +||++
T Consensus 560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1112234578899999999999999998 77754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.93 Aligned_cols=262 Identities=22% Similarity=0.236 Sum_probs=201.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC--------CCceeeEEEEEe---
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ--------HVNLIRVLGFCI--- 530 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 530 (785)
.++|++.++||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999984 56889999999754 344567889999999885 788999999987
Q ss_pred -cCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEEecccCCCEEEcCCC-----
Q 003932 531 -DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKVSNILLGEAM----- 603 (785)
Q Consensus 531 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~----- 603 (785)
+....++||||+ +++|.+.+... ....+++..+..++.||+.||.|||+. + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556889999999 55665555332 224589999999999999999999997 5 99999999999999775
Q ss_pred --------------------------------------------ceeeccccceeeecccccccccccccccCCcccccc
Q 003932 604 --------------------------------------------KPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639 (785)
Q Consensus 604 --------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 639 (785)
.+||+|||+++..... .....||..|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999875432 334578999999999
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHH---HHHHHHhCC--------c-ccccccc-----c---
Q 003932 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE---HAYELWKGG--------K-GVEFVDS-----F--- 699 (785)
Q Consensus 640 ~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~---~~~~~~~~~--------~-~~~~~~~-----~--- 699 (785)
+.+..++.++|||||||++|||++|+.||......+...... ......... . ...+... .
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997654433221111 111111110 0 0000000 0
Q ss_pred -----------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 700 -----------LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 700 -----------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
-...........+.+|+.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001124556678999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.29 Aligned_cols=275 Identities=22% Similarity=0.338 Sum_probs=200.9
Q ss_pred HHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc
Q 003932 457 ADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 534 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 534 (785)
.++....++|++.+.||+|+||.||+|.... .+|+|++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3334446789999999999999999998763 48999987542 2233457789999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++ ++.+||+|||+++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 99999999999999998542 345888999999999999999999986 99999999999998 6799999999987
Q ss_pred eecccc---cccccccccccCCcccccccCC---------CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHH
Q 003932 615 IFAKES---LEENTEQVVGTIGYIPPEYATK---------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH 682 (785)
Q Consensus 615 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 682 (785)
...... .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.|+...... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~- 250 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------A- 250 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------H-
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-
Confidence 653211 1122234568999999999875 34788999999999999999999998643211 1
Q ss_pred HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCCcc
Q 003932 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSK 754 (785)
Q Consensus 683 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 754 (785)
.......+....... ...+..+.+++.+||+.||.+|||+.++++.|++..........|...|
T Consensus 251 ~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 251 IIWQMGTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp HHHHHHTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred HHHHhccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 111111111111110 0122368899999999999999999999999999876555444444333
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.37 Aligned_cols=257 Identities=22% Similarity=0.344 Sum_probs=203.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChh-----------------hHHHHHHHHHHHHcCCCCceeeE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQ-----------------GFEEFKNEVMLTAKLQHVNLIRV 525 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l 525 (785)
.++|.+.+.||+|+||.||+|.. +++.||+|++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999998 7999999998643211 12788999999999999999999
Q ss_pred EEEEecCCccEEEEEecCCCChhhh------hcCCccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEEecccCCCEE
Q 003932 526 LGFCIDSEERMLIYEYMPNKSLDCY------LFDPIRKLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 526 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nil 598 (785)
++++.+.+..++||||+++++|.++ +... ....+++..+..++.|++.||.|||+ .+ ++||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 4321 24568999999999999999999998 65 999999999999
Q ss_pred EcCCCceeeccccceeeecccccccccccccccCCcccccccCCC-CCCC-hhhHHHHHHHHHHHHcCCCCCcccCCCCc
Q 003932 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG-VYST-KSDVFSFGVLLLQIISGKRLSMLCGINEN 676 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvvl~elltG~~p~~~~~~~~~ 676 (785)
++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++|||||||++|||++|+.|+.......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 999999999999999875433 23445789999999999887 6666 9999999999999999999987543211
Q ss_pred ccHHHHHHHHHhCCcccccccc---ccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 677 LSILEHAYELWKGGKGVEFVDS---FLD-------DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~---~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........... ..... ... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 260 -----~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 -----ELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -----HHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11112222211 11100 000 0000223457899999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.82 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=191.8
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------CccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 536 (785)
.+|++.+.||+|+||.||+|+.. +++.||||++..... ...+|++++++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999964 689999999865432 234699999999999999999998542 1367
Q ss_pred EEEEecCCCChhhhhcCC-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-Cceeecccccee
Q 003932 537 LIYEYMPNKSLDCYLFDP-IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDFGMAR 614 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~ 614 (785)
+||||+++ +|.+.+... .....+++..+..++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999976 555554321 23456899999999999999999999876 9999999999999955 678999999998
Q ss_pred eecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC---
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG--- 690 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 690 (785)
.+.... ......||..|+|||++.+. .++.++|||||||++|||++|+.||......+ .+..........
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 764332 22345789999999998765 79999999999999999999999987533211 111111111110
Q ss_pred -------ccccccccccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 691 -------KGVEFVDSFLDDR-----NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 691 -------~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...++..+.+... ..+.....+.+|+.+||+.||.+|||+.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0001100001000 11122457899999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.51 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=197.7
Q ss_pred HHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCC--CCceeeEEEEEecCC
Q 003932 458 DIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSE 533 (785)
Q Consensus 458 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 533 (785)
.+....++|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++++++ |+||+++++++....
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 334456789999999999999999999888999999998654 3445678899999999997 599999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
..++||| +.+++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||+++ +.+||+|||++
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccc
Confidence 9999999 668899999853 346889999999999999999999986 999999999999965 89999999999
Q ss_pred eeecccccccccccccccCCcccccccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHH
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATK-----------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH 682 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 682 (785)
................||..|+|||.+.+ ..++.++|||||||++|||++|+.|+.... .....
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~ 248 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISK 248 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-----HHHHH
Confidence 87654332222344578999999999876 468889999999999999999999985322 11222
Q ss_pred HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 683 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
............ ........+.+++.+||+.||.+||++.|+++
T Consensus 249 ~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 249 LHAIIDPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHCTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhcccccC---------CcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 222222111111 11112347889999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=330.39 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=196.4
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEec-----
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID----- 531 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 531 (785)
+....++|++.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 334567899999999999999999996 4789999999875432 346788999999998 89999999999976
Q ss_pred -CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 532 -SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 532 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeC
Confidence 45789999999999999998643 2346889999999999999999999986 999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHH
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 685 (785)
|++....... .......||..|+|||++. +..++.++|||||||++|+|++|+.|+..... ......
T Consensus 174 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~ 245 (326)
T 2x7f_A 174 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFL 245 (326)
T ss_dssp TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH
T ss_pred cCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHH
Confidence 9987654321 1223457899999999987 56689999999999999999999999854321 111111
Q ss_pred HHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 686 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...... ... .....+..+.+++.+||+.||.+||++.|+++
T Consensus 246 ~~~~~~-~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPRNPA-PRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHSCC-CCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhcCcc-ccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 000 01122347889999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.19 Aligned_cols=266 Identities=23% Similarity=0.304 Sum_probs=195.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEe-----------
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI----------- 530 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 530 (785)
.++|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 358999999999999999999965 58999999998777777788999999999999999999999874
Q ss_pred ---cCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-CCCcee
Q 003932 531 ---DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG-EAMKPK 606 (785)
Q Consensus 531 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~k 606 (785)
+....++||||++ |+|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3457899999997 69998884 345889999999999999999999986 99999999999997 567999
Q ss_pred eccccceeeeccccc-ccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHH
Q 003932 607 ISDFGMARIFAKESL-EENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 684 (785)
|+|||+++....... ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 999999987643211 112334567999999998865 678999999999999999999999986543211 111111
Q ss_pred HHHhCC----------ccccccccccC-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 003932 685 ELWKGG----------KGVEFVDSFLD-DRN-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 739 (785)
Q Consensus 685 ~~~~~~----------~~~~~~~~~l~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 739 (785)
...... ........... ... .+..+..+.+++.+||+.||++|||++|+++ .++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 100000 00000000000 000 0112457899999999999999999999976 4554
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.15 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=199.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-----Ccc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 535 (785)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 358999999999999999999954 68999999997543 34456788999999999999999999998754 678
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999996 689888743 45899999999999999999999986 99999999999999999999999999987
Q ss_pred eccccccc--------ccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH
Q 003932 616 FAKESLEE--------NTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686 (785)
Q Consensus 616 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 686 (785)
........ ......||..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHH
Confidence 65322111 1223578999999998754 678999999999999999999999986543211 11111111
Q ss_pred HhCCcccc------------ccccccC-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 003932 687 WKGGKGVE------------FVDSFLD-DRN-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 740 (785)
Q Consensus 687 ~~~~~~~~------------~~~~~l~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 740 (785)
........ ....... ... .+..+..+.+++.+||+.||++|||+.|+++ .|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 11100000 0000000 000 0122357889999999999999999999987 45443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.24 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=201.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCC------ceeeEEEEEecCCc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL--PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV------NLIRVLGFCIDSEE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 534 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.+++.++|+ +++++++++.....
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35899999999999999999985 36889999999754 34456788999999988665 49999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-------------
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE------------- 601 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~------------- 601 (785)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999888543 2235889999999999999999999986 999999999999987
Q ss_pred ------CCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCC
Q 003932 602 ------AMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675 (785)
Q Consensus 602 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~ 675 (785)
++.+||+|||+++.... ......||..|+|||++.+..++.++|||||||++|||++|+.|+......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 67899999999986432 2234578999999999999999999999999999999999999987543222
Q ss_pred cccHHHHHHHHHhCC--------ccccccc---------------------cc-cCCCCCHHHHHHHHHHHHHccccCCC
Q 003932 676 NLSILEHAYELWKGG--------KGVEFVD---------------------SF-LDDRNSPCKLMRCLEIALLCVQENPN 725 (785)
Q Consensus 676 ~~~~~~~~~~~~~~~--------~~~~~~~---------------------~~-l~~~~~~~~~~~l~~li~~cl~~dP~ 725 (785)
....+. ...... ....... .. -...........+.+++.+||+.||.
T Consensus 242 ~~~~~~---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 242 HLAMME---RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHH---HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHH---HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 111111 111000 0000000 00 00111234567899999999999999
Q ss_pred CCCCHHHHHH
Q 003932 726 DRPSMLEVSS 735 (785)
Q Consensus 726 ~RPs~~evl~ 735 (785)
+|||+.|+++
T Consensus 319 ~Rpt~~ell~ 328 (339)
T 1z57_A 319 KRITLREALK 328 (339)
T ss_dssp TSCCHHHHTT
T ss_pred cccCHHHHhc
Confidence 9999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=355.52 Aligned_cols=260 Identities=23% Similarity=0.377 Sum_probs=204.9
Q ss_pred HHHHHhcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC
Q 003932 458 DIEAATERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS 532 (785)
Q Consensus 458 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 532 (785)
+.+...++|++.+.||+|+||.||+|... .+..||+|++... .....+.+.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 33445678999999999999999999853 2567999998764 3344567899999999999999999999985 4
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 578999999999999999853 2345899999999999999999999986 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+ ... . ...+.
T Consensus 538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~---~-i~~~~ 609 (656)
T 2j0j_A 538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---R-IENGE 609 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---H-HHHTC
T ss_pred CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---H-HHcCC
Confidence 987643321 12223456789999999998899999999999999999997 999986432211 111 1 11111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.. ..+...+..+.+++.+||+.||.+|||+.|+++.|++.
T Consensus 610 ~~---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 RL---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 11122345788999999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.41 Aligned_cols=267 Identities=21% Similarity=0.292 Sum_probs=183.0
Q ss_pred cCCCc-ceeeceeCcEEEEEEEeC---CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEec--CCccEE
Q 003932 464 ERFSI-RNKLGEGGYGPVYKGVLP---CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERML 537 (785)
Q Consensus 464 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 537 (785)
+.|++ .++||+|+||.||+|+.. +++.||+|++...... ..+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34665 468999999999999954 5788999999765332 467899999999999999999999954 668899
Q ss_pred EEEecCCCChhhhhcCCc------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE----cCCCceee
Q 003932 538 IYEYMPNKSLDCYLFDPI------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL----GEAMKPKI 607 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl 607 (785)
||||+. ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 57777664211 1234899999999999999999999986 9999999999999 77889999
Q ss_pred ccccceeeeccccc-ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCC------cccH
Q 003932 608 SDFGMARIFAKESL-EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINE------NLSI 679 (785)
Q Consensus 608 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~------~~~~ 679 (785)
+|||+++.+..... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987643211 1223446789999999999874 58999999999999999999999996443210 1112
Q ss_pred HHHHHHHHhCCccccccc----------------cccCCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 680 LEHAYELWKGGKGVEFVD----------------SFLDDR--------NSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~----------------~~l~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+................. ...... ........+.+|+.+||+.||.+|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 222222221111000000 000000 00001336789999999999999999999987
Q ss_pred H
Q 003932 736 M 736 (785)
Q Consensus 736 ~ 736 (785)
.
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.81 Aligned_cols=273 Identities=19% Similarity=0.233 Sum_probs=190.9
Q ss_pred HHHHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc-
Q 003932 457 ADIEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE- 534 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 534 (785)
.......++|++.+.||+|+||.||+|+. .+++.||||++..... ......+|+..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34556678999999999999999999996 4689999999865432 22355678888888999999999999975443
Q ss_pred ------cEEEEEecCCCChhhhhcC-CccccCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEEecccCCCEEEcC-CCc
Q 003932 535 ------RMLIYEYMPNKSLDCYLFD-PIRKLILDWKKRVHIIEGITQGLLYLQ--EYSRLTIIHRDLKVSNILLGE-AMK 604 (785)
Q Consensus 535 ------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~Dikp~Nill~~-~~~ 604 (785)
.++||||++++ |...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 78999999864 4333321 123456889999999999999999999 654 999999999999996 899
Q ss_pred eeeccccceeeecccccccccccccccCCcccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH
Q 003932 605 PKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA 683 (785)
Q Consensus 605 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 683 (785)
+||+|||+++...... ......||..|+|||++.+.. ++.++|||||||++|||++|+.||....... .....
T Consensus 171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~ 244 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEI 244 (360)
T ss_dssp EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHH
Confidence 9999999998764332 233457899999999987654 8999999999999999999999987543221 11111
Q ss_pred HHHHhCC------------cccccccc------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 003932 684 YELWKGG------------KGVEFVDS------FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNE 740 (785)
Q Consensus 684 ~~~~~~~------------~~~~~~~~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 740 (785)
.+..... ........ .............+.+|+.+||+.||.+|||+.|+++. +++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 1111100 00000000 00011112235679999999999999999999999863 4443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.70 Aligned_cols=200 Identities=24% Similarity=0.313 Sum_probs=169.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CC-----ceeeEEEEEecCCcc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HV-----NLIRVLGFCIDSEER 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~ 535 (785)
.++|++.+.||+|+||.||+|... +++.||||++... .....++..|+.+++.++ |+ +|+++++++......
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 578999999999999999999854 6889999999754 334466778888888874 44 499999999999999
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc--CCCceeeccccce
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG--EAMKPKISDFGMA 613 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Dfg~a 613 (785)
++||||+. ++|.+++.... ...+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999996 59998886432 23589999999999999999999963 23599999999999995 5788999999999
Q ss_pred eeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCccc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLC 671 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~ 671 (785)
+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 87532 233467899999999999999999999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=324.78 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=195.2
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCcc----
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER---- 535 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 535 (785)
.++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 36899999999999999999985 46899999999764 333456788999999999999999999999877655
Q ss_pred --EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 536 --MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 536 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68877762 23889999999999999999999986 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ............ .
T Consensus 192 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~-~ 262 (371)
T 4exu_A 192 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVP-G 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC-C
T ss_pred ccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC-c
Confidence 86432 2334578999999999987 678999999999999999999999996433211 111111111100 0
Q ss_pred cccc------------ccccCCC-C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 693 VEFV------------DSFLDDR-N-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 693 ~~~~------------~~~l~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.+.. ....... . .+.....+.+|+.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 0000000 0 01124578999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=320.43 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=198.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEe--CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcC---CCCceeeEEEEEe-----
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL--PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKL---QHVNLIRVLGFCI----- 530 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----- 530 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 46899999999999999999996 468899999986432 11123455677666655 8999999999987
Q ss_pred cCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 531 DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 531 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
.....++||||+. |+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999997 69998885432 234899999999999999999999986 999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
|+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... .............
T Consensus 165 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~ 238 (326)
T 1blx_A 165 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLP 238 (326)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCC
T ss_pred cccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCC
Confidence 999865432 2234467899999999999999999999999999999999999998643321 1222222211111
Q ss_pred cccccc------ccccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 691 KGVEFV------DSFLD-------DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 691 ~~~~~~------~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...... ..... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00000 0011223457889999999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.15 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=201.6
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344678999999999999999999964 68899999986532 334678899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC---Cceeeccccce
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA---MKPKISDFGMA 613 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfg~a 613 (785)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999888743 345899999999999999999999986 9999999999999754 46999999998
Q ss_pred eeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
...... .......||..|+|||.+.+. ++.++||||||+++|+|++|+.|+...... +............
T Consensus 172 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQN---TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAF 241 (287)
T ss_dssp GTBCCC---SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC
T ss_pred eeecCC---CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCCC
Confidence 765432 122344689999999998764 899999999999999999999998643211 1111111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.. +. ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~--~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DL--PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CS--GG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc--hh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 00 0112347889999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.69 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=177.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHH-HHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 36789999999999999999996 478999999997653 333445556665 677789999999999999999999999
Q ss_pred EecCCCChhhhhcCC--ccccCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 540 EYMPNKSLDCYLFDP--IRKLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 540 e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 777766421 1245689999999999999999999997 6 999999999999999999999999999765
Q ss_pred cccccccccccccccCCccccccc----CCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYA----TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
.... ......||..|+|||++ .+..++.++|||||||++|||++|+.|+....... ......
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~-- 242 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---------DQLTQV-- 242 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCC--
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---------HHHHHH--
Confidence 4321 22234689999999998 45678999999999999999999999986432110 000000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.......+...........+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000001111111223457889999999999999999999965
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=318.64 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=191.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEec----------
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID---------- 531 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 531 (785)
.++|++.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46799999999999999999995 47899999999653 3445778999999999999999999998865
Q ss_pred ---CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeec
Q 003932 532 ---SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKIS 608 (785)
Q Consensus 532 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 608 (785)
....++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3467899999999999999964 2345788899999999999999999986 9999999999999999999999
Q ss_pred cccceeeeccccc------------ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCC
Q 003932 609 DFGMARIFAKESL------------EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675 (785)
Q Consensus 609 Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~ 675 (785)
|||++........ ........||..|+|||.+.+. .++.++|||||||++|||++ |+...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence 9999976542210 1122345689999999999865 68999999999999999998 33210
Q ss_pred cccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 676 NLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..... ......... .. +........+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 -~~~~~-~~~~~~~~~-~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 -MERVN-ILKKLRSVS-IE-----FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHH-HHHHHHSTT-CC-----CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhHHH-HHHhccccc-cc-----cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 01111 111121111 01 111122333456889999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=319.93 Aligned_cols=258 Identities=17% Similarity=0.223 Sum_probs=175.4
Q ss_pred hcCCCcce-eeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEec----CCccE
Q 003932 463 TERFSIRN-KLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERM 536 (785)
Q Consensus 463 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 536 (785)
.++|.+.+ .||+|+||.||+|... +++.||+|++.... ....+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45788855 6999999999999965 68999999996542 122223344566799999999999875 44589
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---CCceeeccccce
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---AMKPKISDFGMA 613 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg~a 613 (785)
+||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999996532 346899999999999999999999986 999999999999986 455999999999
Q ss_pred eeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. ....... .
T Consensus 179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~-~ 250 (336)
T 3fhr_A 179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLGQ-Y 250 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhccc-c
Confidence 865432 2334578999999999988889999999999999999999999986543222111000 0000000 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNET 741 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 741 (785)
. .........+..+.+++.+||+.||.+|||+.|+++ .+++..
T Consensus 251 ~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 251 G-----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp C-----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred c-----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0 000111123457889999999999999999999998 666543
|
| >3ebv_A Chinitase A; chitinase A, CHIA, glycosidase, structural genomics, unknown function, hydrolase, PSI-2, protein structure initiative; 1.50A {Streptomyces coelicolor} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=302.27 Aligned_cols=210 Identities=17% Similarity=0.212 Sum_probs=155.9
Q ss_pred CCcEEEEEecCCC----CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCC------ccHHHHHHHHHHHHhcCCCceEE
Q 003932 24 KPWIRVGYLNLSE----VSTISGINYDLFTHLICSSADINSTTYQLSLSLP------SDENQIAKFADTVKKKNPSITTI 93 (785)
Q Consensus 24 ~~~~~vgY~~~~~----~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~------~~~~~~~~~~~~~k~~~p~lkv~ 93 (785)
..+++||||.+|. .+++++|| ++||||+|+|+.++++.+.+.+... .....+.+.++.+| ++++|||
T Consensus 3 ~~~~vvgY~~~w~~~~~~~~~~~i~-~~~thi~~aFa~~~~~~G~i~~~~~~~~~~~~~~~~~~~~i~~~~--~~g~kvl 79 (302)
T 3ebv_A 3 LKHAVTGYWQNFNNGATVQKISDVP-SAYDIIAVAFADATTTPGAVTFNLDSAGLGGYTVDQFKADVRAKQ--AAGKKVI 79 (302)
T ss_dssp CSSEEEEEEESSCSSSCCCCGGGSC-TTCSEEEEEEEEECSSTTCEECCCCTTTTTSCCHHHHHHHHHHHH--HTTCEEE
T ss_pred CCceEEEEEccccCCCCCCCHHHcC-CCCCEEEEEEEEEECCCCeEEEeeccccccccCHHHHHHHHHHHH--cCCCEEE
Confidence 4578999999876 35799998 8999999999999874335554322 13456666666555 4579999
Q ss_pred EEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccc
Q 003932 94 LSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTR 173 (785)
Q Consensus 94 ~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~ 173 (785)
+|||||.. +.++++++.|++|++++++++++|||||||||||||. +..+|..||++||+++..
T Consensus 80 lsiGG~~~------s~~~~~~~~r~~f~~~~~~~~~~~~~DGiDiD~E~p~---~~~~~~~~l~~l~~~~g~-------- 142 (302)
T 3ebv_A 80 ISVGGEKG------TVSVNSSASATNFANSVYSVMREYGFDGVDIDLENGL---NPTYMTQALRALSAKAGP-------- 142 (302)
T ss_dssp EEEEETTC------CCCCCSHHHHHHHHHHHHHHHHHHTCCEEEEEECSCC---CHHHHHHHHHHHHHHHCT--------
T ss_pred EEEECCCC------CcccCCHHHHHHHHHHHHHHHHHhCCCeEEEeccccc---CHHHHHHHHHHHHHhcCC--------
Confidence 99999853 3458899999999999999999999999999999984 567899999999988732
Q ss_pred cceeEEEEeecccCC-CCccccHHHH--HhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHH---HHH
Q 003932 174 QQSLLILTARFRYSP-PANSYLLNSI--QRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLK---AWI 247 (785)
Q Consensus 174 ~~~~~~~~~~~~~~~-~~~~~~~~~l--~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~---~~~ 247 (785)
+..+++++..+... ....|....+ .+++||||+|+||. |+| +++++++|... +.+..+. .++
T Consensus 143 -~~~lt~Ap~~~~~~~~~~~y~~~~~~~~~~lD~vnvq~Yd~-g~~----~~c~~~~y~~~------~~~~~~~~a~~~~ 210 (302)
T 3ebv_A 143 -DMILTMAPQTIDMQSTQGGYFQTALNVKDILTVVNMQYYNS-GTM----LGCDGKVYAQG------TVDFLTALACIQL 210 (302)
T ss_dssp -TCEEEECCBGGGSSSTTSHHHHHHHHTGGGCCEEEEECSSC-CCE----ECTTSCEECTT------SHHHHHHHHHHHH
T ss_pred -CEEEEEeeccccccccchhHHHHHHHhcCcceEEEeecccC-CCc----CCCCccccCCC------CccHHHHHHHHHH
Confidence 45555554443211 2234543433 57999999999996 555 77888887532 2333322 345
Q ss_pred HcCCCCCceeeccccccc
Q 003932 248 ERGLSADKLVMCLPFYGY 265 (785)
Q Consensus 248 ~~gvp~~KlvlGip~YG~ 265 (785)
..|+|++||+||+|+|..
T Consensus 211 ~~gvp~~KIvlGlPa~~~ 228 (302)
T 3ebv_A 211 EGGLAPSQVGLGLPASTR 228 (302)
T ss_dssp TTTCCGGGEEEEEESSTT
T ss_pred hcCCCHHHEEEecccCCC
Confidence 679999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=324.23 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=194.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc------
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE------ 534 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 534 (785)
++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5799999999999999999995 468999999997642 3345678899999999999999999999987654
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 68877763 23889999999999999999999986 9999999999999999999999999987
Q ss_pred eecccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc-
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG- 692 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 692 (785)
..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ..............
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTE 246 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 64322 234578999999999887 678999999999999999999999987543211 11111111100000
Q ss_pred -----------------ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 -----------------VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 -----------------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.......+ ....+.....+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 0011223457899999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=324.95 Aligned_cols=262 Identities=18% Similarity=0.214 Sum_probs=198.6
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-----------CCceeeEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-----------HVNLIRVLGFCI 530 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 530 (785)
.++|.+.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35899999999999999999995 57899999999754 334567888999998876 899999999987
Q ss_pred cCC----ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEEecccCCCEEEc-----
Q 003932 531 DSE----ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKVSNILLG----- 600 (785)
Q Consensus 531 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dikp~Nill~----- 600 (785)
... ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 554 789999999 899999886432 34489999999999999999999997 6 99999999999995
Q ss_pred -CCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCccc-
Q 003932 601 -EAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS- 678 (785)
Q Consensus 601 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~- 678 (785)
..+.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4448999999999875432 234578999999999999999999999999999999999999997543222111
Q ss_pred --HHHHHHHHHhCCc------------------cccccc--------c--ccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003932 679 --ILEHAYELWKGGK------------------GVEFVD--------S--FLDDRNSPCKLMRCLEIALLCVQENPNDRP 728 (785)
Q Consensus 679 --~~~~~~~~~~~~~------------------~~~~~~--------~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 728 (785)
............. ....+. . .............+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 1111111111000 000000 0 001123456677899999999999999999
Q ss_pred CHHHHHH
Q 003932 729 SMLEVSS 735 (785)
Q Consensus 729 s~~evl~ 735 (785)
|++|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=318.48 Aligned_cols=244 Identities=25% Similarity=0.376 Sum_probs=190.1
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChh------hHHHHHHHHHHHHcC----CCCceeeEEE
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQ------GFEEFKNEVMLTAKL----QHVNLIRVLG 527 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~ 527 (785)
.+...++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999985 46889999999765321 223456789998888 8999999999
Q ss_pred EEecCCccEEEEEe-cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-CCCce
Q 003932 528 FCIDSEERMLIYEY-MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG-EAMKP 605 (785)
Q Consensus 528 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~ 605 (785)
++...+..++|+|+ +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999853 345899999999999999999999986 99999999999999 88999
Q ss_pred eeccccceeeecccccccccccccccCCcccccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHH
Q 003932 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 684 (785)
Q Consensus 606 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~ 684 (785)
||+|||+++..... ......|+..|+|||++.+..+. .++|||||||++|||++|+.|+....
T Consensus 180 kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------ 243 (312)
T 2iwi_A 180 KLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------ 243 (312)
T ss_dssp EECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------
Confidence 99999999876543 22345689999999998876664 58999999999999999999985310
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...... . .........+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~--~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 EILEAE--L---------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHTC--C---------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhhhc--c---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001100 0 011123347889999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.25 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=197.9
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CC-cEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCc------eeeEEEEEecCCc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CG-EVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN------LIRVLGFCIDSEE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 534 (785)
.++|++.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|+.++++++|++ ++.+.+++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 368999999999999999999853 34 68999999754 344567888999999987665 8999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEE---------------
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILL--------------- 599 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill--------------- 599 (785)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 66666666432 2245899999999999999999999886 9999999999999
Q ss_pred ----cCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCC
Q 003932 600 ----GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675 (785)
Q Consensus 600 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~ 675 (785)
+.++.+||+|||+++.... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 6788999999999986432 2234578999999999999999999999999999999999999997543222
Q ss_pred cccHHHHHHHHHhCC--------ccccc-ccc---------------------ccCCCCCHHHHHHHHHHHHHccccCCC
Q 003932 676 NLSILEHAYELWKGG--------KGVEF-VDS---------------------FLDDRNSPCKLMRCLEIALLCVQENPN 725 (785)
Q Consensus 676 ~~~~~~~~~~~~~~~--------~~~~~-~~~---------------------~l~~~~~~~~~~~l~~li~~cl~~dP~ 725 (785)
. ........... ..... ... .............+.+|+.+||+.||+
T Consensus 247 ~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 247 H---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp H---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred H---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 1 11111111100 00000 000 000011223456789999999999999
Q ss_pred CCCCHHHHHH
Q 003932 726 DRPSMLEVSS 735 (785)
Q Consensus 726 ~RPs~~evl~ 735 (785)
+|||+.|+++
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.08 Aligned_cols=252 Identities=22% Similarity=0.247 Sum_probs=186.0
Q ss_pred CCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEecC
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+....++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 45566889999999998776667999999998653 235678899999876 89999999999999999999999995
Q ss_pred CCChhhhhcCCcccc----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC-------------Ccee
Q 003932 544 NKSLDCYLFDPIRKL----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-------------MKPK 606 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-------------~~~k 606 (785)
|+|.+++....... ..++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999986532211 1123345789999999999999986 9999999999999754 4899
Q ss_pred eccccceeeecccccc--cccccccccCCcccccccCC-------CCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCc
Q 003932 607 ISDFGMARIFAKESLE--ENTEQVVGTIGYIPPEYATK-------GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINEN 676 (785)
Q Consensus 607 l~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~ 676 (785)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.|+.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999886543211 12234679999999999976 568999999999999999999 899985322111
Q ss_pred ccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 677 LSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.......... ..+........+.++.+++.+||+.||.+|||+.|+++
T Consensus 248 -------~~i~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -------SNIIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -------HHHHHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHhcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111111 01112223455678999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.28 Aligned_cols=243 Identities=24% Similarity=0.398 Sum_probs=197.0
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChh------hHHHHHHHHHHHHcCC--CCceeeEEEEEe
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQ------GFEEFKNEVMLTAKLQ--HVNLIRVLGFCI 530 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 530 (785)
....++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34457899999999999999999984 57899999998654211 2234677999999996 599999999999
Q ss_pred cCCccEEEEEecCC-CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-CCCceeec
Q 003932 531 DSEERMLIYEYMPN-KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG-EAMKPKIS 608 (785)
Q Consensus 531 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~ 608 (785)
..+..++|+|++.+ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999976 899998853 346899999999999999999999986 99999999999999 78999999
Q ss_pred cccceeeecccccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHH
Q 003932 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW 687 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 687 (785)
|||+++..... ......||..|+|||++.+..+ +.++|||||||++|||++|+.|+.... ...
T Consensus 193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~ 256 (320)
T 3a99_A 193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII 256 (320)
T ss_dssp CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH
T ss_pred eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhh
Confidence 99999876432 2234568999999999987665 678999999999999999999985321 011
Q ss_pred hCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 688 KGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 688 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.... .... ..+..+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~-------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 257 RGQV-------FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HCCC-------CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccc-------cccc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 0111 12347889999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=310.34 Aligned_cols=251 Identities=21% Similarity=0.313 Sum_probs=178.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh-h-hHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST-Q-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
.++|++.+.||+|+||.||+|... +++.||+|++..... . ..+.+.++..+++.++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999964 689999999976532 2 2233445556788889999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
||+ ++.+..+... ....+++..+..++.|+++||.|||+. + ++||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4555544422 234589999999999999999999985 5 99999999999999999999999999976543
Q ss_pred cccccccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
.. ......||..|+|||++. ...++.++|||||||++|||++|+.|+..... ..+.......... .
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~-~ 248 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQEEP-P 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHSCC-C
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhccCC-C
Confidence 21 223456899999999984 45688999999999999999999999864321 1111112222111 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
... . ....+..+.+++.+||+.||.+||++.|+++
T Consensus 249 ~~~-----~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLP-----G--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCC-----S--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCC-----c--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000 0 0112347889999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=337.71 Aligned_cols=264 Identities=25% Similarity=0.296 Sum_probs=198.0
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec------CCc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID------SEE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 534 (785)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 46899999999999999999985 46889999999764 44556778999999999999999999999765 667
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCc---eeecccc
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMK---PKISDFG 611 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~---~kl~Dfg 611 (785)
.++||||+++|+|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976554456888999999999999999999986 999999999999997765 8999999
Q ss_pred ceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCccc-HH-HHHHHH-Hh
Q 003932 612 MARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS-IL-EHAYEL-WK 688 (785)
Q Consensus 612 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~-~~-~~~~~~-~~ 688 (785)
++....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.......... .. ...... ..
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 998754332 2344678999999999999999999999999999999999999986431100000 00 000000 00
Q ss_pred CCcc---cccccc-ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003932 689 GGKG---VEFVDS-FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLE 732 (785)
Q Consensus 689 ~~~~---~~~~~~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 732 (785)
.... ..+... ..........+..+.+++.+||+.||++|||+.|
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000 000000 0011233446678999999999999999999966
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=323.14 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=185.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..+|.+.++||+|+||+|+.....+++.||||++...... .+.+|+.+++++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3568899999999999976555566899999999764332 356799999999 799999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-----CCceeeccccceeee
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-----AMKPKISDFGMARIF 616 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-----~~~~kl~Dfg~a~~~ 616 (785)
+. |+|.+++.... .......+..++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 69999886532 22344456789999999999999986 999999999999953 335789999999876
Q ss_pred ccccc-ccccccccccCCcccccccC---CCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 617 AKESL-EENTEQVVGTIGYIPPEYAT---KGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 617 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
..... ........||+.|+|||++. ...++.++|||||||++|||++ |+.|+...... . ........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~-~~~~~~~~ 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------Q-ANILLGAC 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------H-HHHHTTCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------H-HHHHhccC
Confidence 53321 12233467999999999997 4567889999999999999999 88888532110 0 11111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11111 112234556889999999999999999999983
|
| >3ian_A Chitinase; structural genomics, hydrolase, glycosidase, PSI-2, protein structure initiative; 1.75A {Lactococcus lactis subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.72 Aligned_cols=218 Identities=13% Similarity=0.182 Sum_probs=154.9
Q ss_pred CCcEEEEEecCCCC-------------CCcCCCCCCCCceEEEEEEEeeCCccEEecCC-CccHHHHHHHHHHHHhcCCC
Q 003932 24 KPWIRVGYLNLSEV-------------STISGINYDLFTHLICSSADINSTTYQLSLSL-PSDENQIAKFADTVKKKNPS 89 (785)
Q Consensus 24 ~~~~~vgY~~~~~~-------------~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~k~~~p~ 89 (785)
+.+++||||.+|.. +++++||+. ||||+|+|+.++++++.+.+.. ...+..+.+.+..+|+++
T Consensus 3 ~~~~~vgYy~~w~~~~~~gyr~g~~~~~~~~~i~~~-~thv~~aFa~i~~~~g~~~~~~~~~~~~~~~~~i~~~k~~g-- 79 (321)
T 3ian_A 3 LDKVLVGYWHNWKSTGKDGYKGGSSADFNLSSTQEG-YNVINVSFMKTPEGQTLPTFKPYNKTDTEFRAEISKLNAEG-- 79 (321)
T ss_dssp CCBEEEEEEESSCCCSSCSTTSCBCCCCCGGGCCTT-CSEEEEEEEBCCTTCCSCBCCCSSSCHHHHHHHHHHHHHTT--
T ss_pred CCcEEEEEECcccccccccccCCccCccCHHHCCCC-CCEEEEEEEEecCCCCeEEecCCcccchhHHHHHHHHHHCC--
Confidence 56799999998865 478999988 7899999999985443444331 233556777777788875
Q ss_pred ceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC--CCCchhHHHHHHHHHHHhhhhh
Q 003932 90 ITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT--STDMFNIGLLFDEWRIAATKLD 167 (785)
Q Consensus 90 lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~--~~d~~~~~~ll~~lr~~l~~~~ 167 (785)
+|||+|||||..+ + ..+++.|++||+++++++++|||||||||||||.. ++++++|..||++||+++++.
T Consensus 80 ~kvllsiGG~~~~----~---~~~~~~r~~f~~~~~~~~~~~g~DGiDiD~E~p~~~~~~~~~~~~~~l~~lr~~~~~~- 151 (321)
T 3ian_A 80 KSVLIALGGADAH----I---ELKKSQESDFVNEIIRLVDTYGFDGLDIDLEQAAIEAADNQTVIPSALKKVKDHYRKD- 151 (321)
T ss_dssp CEEEEEEEETTCC----C---CCCGGGHHHHHHHHHHHHHHHCCCEEEEEECHHHHTSTTHHHHHHHHHHHHHHHHHTT-
T ss_pred CEEEEEeccCCCC----c---ccChHHHHHHHHHHHHHHHHhCCCeEEEecccCCcccccCHHHHHHHHHHHHHHHhhc-
Confidence 9999999998643 2 23567899999999999999999999999999953 467889999999999988652
Q ss_pred hhcccccceeEEEEeecccCCCCcccc--HHHHHhccceeeeeeccCCC--ccCCCCCCCCCCCCCCCCCCC--CCCHHH
Q 003932 168 AKNSTRQQSLLILTARFRYSPPANSYL--LNSIQRNLNWIHAVTASYYE--PVSTNFTAPPAALYGSISGRF--ARSTDQ 241 (785)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~D~v~vm~yd~~~--~~~~~~~g~~apl~~~~~~~~--~~~~~~ 241 (785)
.+...+++++..+.......|+ ++++..++||||||+||+++ .|... +. ++......+. .+.. .
T Consensus 152 -----g~~~~LT~Ap~~~~~~~~~~y~~~i~~l~~~~D~invm~YD~~~~g~~~~~-~~---~~~~~~~~~~~~~f~~-~ 221 (321)
T 3ian_A 152 -----GKNFMITMAPEFPYLTSSGKYAPYINNLDSYYDFINPQYYNQGGDGFWDSD-LN---MWISQSNDEKKEDFLY-G 221 (321)
T ss_dssp -----TCCCEEEECCBGGGCBTTSTTHHHHHHTTTTCCEECCBCSSCTTCEEEETT-TT---EEEETTCSTTHHHHHH-H
T ss_pred -----cCCEEEEEcccCccccccchHHHHHHHHhCCEeEEEEccCCCCCCCCcccc-cc---hhhccCCCccccchhH-H
Confidence 2244555554433322334566 78889999999999999964 33321 11 2222111111 1112 2
Q ss_pred HHHHHHHc-----CCCCCceeecccc
Q 003932 242 VLKAWIER-----GLSADKLVMCLPF 262 (785)
Q Consensus 242 ~v~~~~~~-----gvp~~KlvlGip~ 262 (785)
....+++. |+|++||+||+|.
T Consensus 222 ~~~~~l~~~~~~~~iP~~KlvlGlPa 247 (321)
T 3ian_A 222 LTQRLVTGTDGFIKIPASKFVIGLPS 247 (321)
T ss_dssp HHHHHHHTCTTBCCCCGGGBEEEEES
T ss_pred HHHHHHhccccccCCChHHEEEeccc
Confidence 23446664 8999999999997
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=339.13 Aligned_cols=238 Identities=19% Similarity=0.284 Sum_probs=191.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC--CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc-----
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP--CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE----- 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 534 (785)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999964 5899999998754 33455678899999999999999999999987665
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.++||||+++++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 5899999999999999999999986 9999999999999986 99999999998
Q ss_pred eecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+........
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------ 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------------
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc------------------
Confidence 75432 3457999999999987654 8899999999999999999887653211100
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhc
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS-MLEVSSMLKN 739 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~ 739 (785)
............+.+++.+||+.||.+||+ ++++...|..
T Consensus 285 -----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 -----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000011112346889999999999999995 5666655543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.96 Aligned_cols=229 Identities=10% Similarity=0.049 Sum_probs=182.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+..+.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999964 58999999998653 334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++++|.+++.. . .......+++.|++.||+|||+.+ |+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999843 1 345578889999999999999986 9999999999999999999998543
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
|++| ++.++|||||||++|||++|+.||............ .......
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~~~ 221 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAGQ 221 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTTSC
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhccC
Confidence 3333 688999999999999999999999754432211000 0000000
Q ss_pred cC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 700 LD--DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 700 l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.. .......+..+.+++.+||+.||++| |+.|+++.|++...
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00 00011223478899999999999999 99999999998654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=295.99 Aligned_cols=232 Identities=19% Similarity=0.232 Sum_probs=179.1
Q ss_pred cCCCcc-eeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHH-HcCCCCceeeEEEEEec----CCccE
Q 003932 464 ERFSIR-NKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLT-AKLQHVNLIRVLGFCID----SEERM 536 (785)
Q Consensus 464 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 536 (785)
++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567777 7899999999999995 57899999999643 3567788887 56699999999999876 66789
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---CCceeeccccce
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---AMKPKISDFGMA 613 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg~a 613 (785)
+||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998653 2335899999999999999999999986 999999999999998 789999999998
Q ss_pred eeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
.... +..++.++|||||||++|||++|+.||........ . .. ..
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~-~~-~~ 211 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------S-PG-MK 211 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CC-SC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------h-HH-HH
Confidence 6532 23467899999999999999999999864322110 0 00 00
Q ss_pred cccccccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 003932 694 EFVDSFLDDRNS----PCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNET 741 (785)
Q Consensus 694 ~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 741 (785)
..+... ..... ...+..+.+++.+||+.||.+|||+.|+++ .+.+..
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 212 TRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 000000 00011 112457899999999999999999999987 455543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=317.25 Aligned_cols=241 Identities=15% Similarity=0.156 Sum_probs=178.5
Q ss_pred hcCCCcceeeceeCcEEEEEEE-eCCCcEEEEEEcCCCCh---hhHHHHHHHHHHHHcCCC-Cce----------e----
Q 003932 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTST---QGFEEFKNEVMLTAKLQH-VNL----------I---- 523 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni----------v---- 523 (785)
..+|...+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+.+++.++| +|. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3467888999999999999999 55789999999874322 235678999999999987 211 1
Q ss_pred -------eEEEEEec-----CCccEEEEEecCCCChhhhhcC----CccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 003932 524 -------RVLGFCID-----SEERMLIYEYMPNKSLDCYLFD----PIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTI 587 (785)
Q Consensus 524 -------~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 587 (785)
.+..++.. ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111111 12356666655 7899888841 112345788899999999999999999986 9
Q ss_pred EEecccCCCEEEcCCCceeeccccceeeecccccccccccccccCCccccccc----------CCCCCCChhhHHHHHHH
Q 003932 588 IHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA----------TKGVYSTKSDVFSFGVL 657 (785)
Q Consensus 588 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvv 657 (785)
+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998864322 344567 999999999 66678899999999999
Q ss_pred HHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003932 658 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS 734 (785)
Q Consensus 658 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 734 (785)
+|||++|+.||......+.. ...+... ...+..+.+|+.+||+.||++||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~~~-------------------~~~~~~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGS-------------------EWIFRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCS-------------------GGGGSSC--CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhhH-------------------HHHHhhc--ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999998643322211 1111111 01235788999999999999999976663
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.17 Aligned_cols=241 Identities=16% Similarity=0.130 Sum_probs=183.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCC--------hhhHHHHHHHHHHHHcCC---------CCceeeE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTS--------TQGFEEFKNEVMLTAKLQ---------HVNLIRV 525 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 525 (785)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 58999999997542 223467889999988885 8888888
Q ss_pred EEEEe------------------------------cCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHH
Q 003932 526 LGFCI------------------------------DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575 (785)
Q Consensus 526 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 575 (785)
.+++. +....++||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 77643 26789999999999977666632 458999999999999999
Q ss_pred HHHHh-hcCCCCeEEecccCCCEEEcCCC--------------------ceeeccccceeeecccccccccccccccCCc
Q 003932 576 LLYLQ-EYSRLTIIHRDLKVSNILLGEAM--------------------KPKISDFGMARIFAKESLEENTEQVVGTIGY 634 (785)
Q Consensus 576 l~~LH-~~~~~~ivH~Dikp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 634 (785)
|.||| +.+ |+||||||+|||++.++ .+||+|||+++..... ..+||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 786 99999999999999887 8999999999876432 34799999
Q ss_pred ccccccCCCCCCChhhHHHHHHH-HHHHHcCCCCCcccCCCCcccHHHHHH-HHHhCCccccccccccCCCCCHHHHHHH
Q 003932 635 IPPEYATKGVYSTKSDVFSFGVL-LLQIISGKRLSMLCGINENLSILEHAY-ELWKGGKGVEFVDSFLDDRNSPCKLMRC 712 (785)
Q Consensus 635 ~aPE~~~~~~~~~~~DvwSlGvv-l~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l 712 (785)
+|||++.+.. +.++|||||+++ .+++++|..|+.... ...... ......... ...........+.++
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhccC----cccchhhhhhcCHHH
Confidence 9999998776 899999998777 777888988874210 000011 111110000 000001122456789
Q ss_pred HHHHHHccccCCCCCCCHHHHH
Q 003932 713 LEIALLCVQENPNDRPSMLEVS 734 (785)
Q Consensus 713 ~~li~~cl~~dP~~RPs~~evl 734 (785)
.+|+.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999976 999988
|
| >4ac1_X Endo-N-acetyl-beta-D-glucosaminidase; hydrolase, glycoside hydrolase family 18, deglycosylation; HET: NAG; 1.30A {Hypocrea jecorina} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-31 Score=274.39 Aligned_cols=201 Identities=14% Similarity=0.131 Sum_probs=148.9
Q ss_pred cEEEEEecCCCCC--------CcCCCCCCCCceEEEEEEEeeCCccEEecCCCc--c--HHHHHHHHHHHHhcCCCceEE
Q 003932 26 WIRVGYLNLSEVS--------TISGINYDLFTHLICSSADINSTTYQLSLSLPS--D--ENQIAKFADTVKKKNPSITTI 93 (785)
Q Consensus 26 ~~~vgY~~~~~~~--------~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~k~~~p~lkv~ 93 (785)
.++||||..|... ++..+|...||||+|+|++++++| .+.+.+.. + ...+.+.++++|++ ++|||
T Consensus 3 pR~i~Yy~t~~~~~~~~~~~~p~~~~p~~~~THi~~af~~~~~~g-~i~~~d~~p~~~~~~~l~~~i~~~q~~--g~Kvl 79 (283)
T 4ac1_X 3 PRLIVYFQTTHDSSNRPISMLPLITEKGIALTHLIVCSFHINQGG-VVHLNDFPPDDPHFYTLWNETITMKQA--GVKVM 79 (283)
T ss_dssp SEEEEEECCCBCTTSCBCCSTHHHHSSSCCCCEEEEEEEECCTTS-CCEETTBCTTSGGGHHHHHHHHHHHHT--TCEEE
T ss_pred CeEEEEEeccccCCCCccccCCcccCCCCCccEEEEEEEEECCCC-eEEECCCCccchHHHHHHHHHHHHHcC--CCEEE
Confidence 3789999877432 344556778999999999999988 55554322 1 13444555555544 69999
Q ss_pred EEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccc
Q 003932 94 LSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTR 173 (785)
Q Consensus 94 ~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~ 173 (785)
+|||||+.+....++...+++++|++|++++++++++|+||||||||||| .+.++|..|+++||+.|.+
T Consensus 80 lsiGG~~~g~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~dG~D~d~e~~---~~~~~~~~li~~Lr~~~g~-------- 148 (283)
T 4ac1_X 80 GMVGGAAPGSFNTQTLDSPDSATFEHYYGQLRDAIVNFQLEGMDLDVEQP---MSQQGIDRLIARLRADFGP-------- 148 (283)
T ss_dssp EEEETTSSCSSSTTTTTCSSHHHHHHHHHHHHHHHHHTTCSEEEEECCSC---BCHHHHHHHHHHHHHHHCT--------
T ss_pred EEEcCCCCCCCcccccccccHHHHHHHHHHHHHHHHHcCCCceEeecccC---CCHHHHHHHHHHHHHHcCC--------
Confidence 99999976555567778889999999999999999999999999999999 3567999999999998854
Q ss_pred cceeEEEEeecccC---CCCccccHH----HHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q 003932 174 QQSLLILTARFRYS---PPANSYLLN----SIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAW 246 (785)
Q Consensus 174 ~~~~~~~~~~~~~~---~~~~~~~~~----~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~ 246 (785)
.+.+++++..+.. ....++++. .....+||+|+|.||..+.+.+ ..+++.+
T Consensus 149 -~~~lT~Ap~~~~~~~~~~~~~~~~~~l~~~~~~~~D~vnvQfYn~~~~~~~---------------------~~~~~~~ 206 (283)
T 4ac1_X 149 -DFLITLAPVASALEDSSNLSGFSYTALQQTQGNDIDWYNTQFYSGFGSMAD---------------------TSDYDRI 206 (283)
T ss_dssp -TSEEEECCBGGGGTTSCCSSBSCHHHHHHHHGGGCCEEEEECCTTSCCSSS---------------------SHHHHHH
T ss_pred -CceEEEccccccccccccccchhHHHHHHhhcccccEEEecCCCCCCCcCC---------------------HHHHHHH
Confidence 5555555433321 112233433 3457899999999997554321 2356678
Q ss_pred HHcCCCCCceeecccc
Q 003932 247 IERGLSADKLVMCLPF 262 (785)
Q Consensus 247 ~~~gvp~~KlvlGip~ 262 (785)
+.+|+|++||+||+|.
T Consensus 207 ~~~g~p~~KivlGlpa 222 (283)
T 4ac1_X 207 VANGFAPAKVVAGQLT 222 (283)
T ss_dssp HHTTCCGGGEEEEEES
T ss_pred HHhCCCcccEEEEeec
Confidence 8999999999999984
|
| >2hvm_A Hevamine; hydrolase, chitinase/lysozyme; 1.80A {Hevea brasiliensis} SCOP: c.1.8.5 PDB: 1hvq_A* 1llo_A 1kr0_A* 1kr1_A* 1kqy_A* 1kqz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=263.82 Aligned_cols=200 Identities=13% Similarity=0.128 Sum_probs=139.1
Q ss_pred EEEEEec-CCCCCCcC-CCCCCCCceEEEEEEEeeCCcc--EEecCCCc-----cHHHHHHHHHHHHhcCCCceEEEEec
Q 003932 27 IRVGYLN-LSEVSTIS-GINYDLFTHLICSSADINSTTY--QLSLSLPS-----DENQIAKFADTVKKKNPSITTILSIG 97 (785)
Q Consensus 27 ~~vgY~~-~~~~~~~~-~i~~~~~Thi~~~f~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~k~~~p~lkv~~sig 97 (785)
.+++||- +.....+. ..+.++||||+|||+.+..+|. .+.+.... ....+...++.+| ++++|||+|||
T Consensus 2 ~iavYWg~n~~~~~L~~~c~~~~~t~i~~AF~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~i~~~q--~~g~KVllSiG 79 (273)
T 2hvm_A 2 GIAIYWGQNGNEGTLTQTCSTRKYSYVNIAFLNKFGNGQTPQINLAGHCNPAAGGCTIVSNGIRSCQ--IQGIKVMLSLG 79 (273)
T ss_dssp EEEEEESSCGGGCCHHHHHHTSCCSEEEEEEEEECSTTCCCEECCGGGCCCGGGTTTTHHHHHHHHH--HTTCEEEEEEE
T ss_pred CEEEEcCCCCCCCchHhhcCCCCCCEEEEEEEEEeCCCceeeeeecCCCCcccccHHHHHHHHHHHH--cCCCEEEEEeC
Confidence 3678993 33222222 2346789999999999987752 23332111 1123445555444 46899999999
Q ss_pred CCCCCCcccchhhhcChhhhHHHHHHH----------HHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhh
Q 003932 98 QGKDTNYSIYSSMVRNSSHRKSFIDSS----------IRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLD 167 (785)
Q Consensus 98 G~~~~~~~~fs~~~~~~~~r~~fi~si----------~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~ 167 (785)
||++ + |+ +++++.|++|++++ ++++++|+|||||||||||. .++|..|+++||+.+.+
T Consensus 80 G~~g--~--~~--~~s~~~~~~fa~~~~~~f~~g~s~~~~~~~~~~DGiDiDwE~p~----~~~~~~l~~~Lr~~~~~-- 147 (273)
T 2hvm_A 80 GGIG--S--YT--LASQADAKNVADYLWNNFLGGKSSSRPLGDAVLDGIDFDIEHGS----TLYWDDLARYLSAYSKQ-- 147 (273)
T ss_dssp CSSC--C--CC--CCSHHHHHHHHHHHHHHTSSSCCSCCTTCSCCCSEEEEECCSSC----CSSHHHHHHHHHHGGGG--
T ss_pred CCCC--c--cC--CCCHHHHHHHHHHHHHHhcCCchhhhHHHHcCCceEEeeccCCC----chhHHHHHHHHHHHHhc--
Confidence 9863 3 66 67899999999998 77899999999999999995 47899999999987642
Q ss_pred hhcccccceeEEEEeecccCCCCccccHHHH-HhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q 003932 168 AKNSTRQQSLLILTARFRYSPPANSYLLNSI-QRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAW 246 (785)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~ 246 (785)
.++..+++++..+. ...|....+ ..++||||+|+||+++.... ++ . ..++..+++.|
T Consensus 148 -----g~~~~LT~A~~~~~---~~~~~~~~l~~~~~D~invm~Yd~~~~~~~--~~---~---------~~~~~~~~~~w 205 (273)
T 2hvm_A 148 -----GKKVYLTAAPQCPF---PDRYLGTALNTGLFDYVWVQFYNNPPCQYS--SG---N---------INNIINSWNRW 205 (273)
T ss_dssp -----SSCCEEEECCBSSS---SCTTTHHHHHTTCCSEEEEECSSCGGGSCB--TT---B---------CHHHHHHHHHH
T ss_pred -----CCCeEEEECCCCCC---cchhHHHHHhcccCCEEEEeccCCCCCcCC--CC---C---------HHHHHHHHHHH
Confidence 22445555443322 234555566 47999999999998742100 00 0 11456788889
Q ss_pred HHcCCCCCceeeccccc
Q 003932 247 IERGLSADKLVMCLPFY 263 (785)
Q Consensus 247 ~~~gvp~~KlvlGip~Y 263 (785)
++ |+|++||+||+|++
T Consensus 206 ~~-g~p~~KlvlGlp~~ 221 (273)
T 2hvm_A 206 TT-SINAGKIFLGLPAA 221 (273)
T ss_dssp HH-HCCCSEEEEEEESS
T ss_pred Hh-cCCcccEEEEEecC
Confidence 87 89999999999997
|
| >2uy2_A Endochitinase; carbohydrate metabolism, polysaccharide degradation, glycopr chitin-binding, chitin degradation, CAZY, hydrolase; 1.60A {Saccharomyces cerevisiae} PDB: 2uy3_A* 2uy4_A* 2uy5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=260.20 Aligned_cols=201 Identities=15% Similarity=0.136 Sum_probs=142.6
Q ss_pred CCcEEEEEecC---CCCCCcCCC-CCCCCceEEEEEEEeeCCccEEecCCCc---------cHHHHHHHHHHHHhcCCCc
Q 003932 24 KPWIRVGYLNL---SEVSTISGI-NYDLFTHLICSSADINSTTYQLSLSLPS---------DENQIAKFADTVKKKNPSI 90 (785)
Q Consensus 24 ~~~~~vgY~~~---~~~~~~~~i-~~~~~Thi~~~f~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~k~~~p~l 90 (785)
+...+++||.. ....+++++ +.++||||+|||+.+.+++ .+.+.+.. ....+...++.+|++ ++
T Consensus 4 ~~~~v~~Ywgqn~~~~~~~L~~~c~~~~~t~v~~AF~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~i~~~q~~--g~ 80 (294)
T 2uy2_A 4 ANTNIAVYWGQNSAGTQESLATYCESSDADIFLLSFLNQFPTL-GLNFANACSDTFSDGLLHCTQIAEDIETCQSL--GK 80 (294)
T ss_dssp CCCEEEEEESSCTTSCCCCHHHHHTSSSCSEEEEEEEEEBTTT-EECCGGGCCCBCTTSCBCCHHHHHHHHHHHHT--TC
T ss_pred CCCCEEEEcCCCCCCCCCCHHHhCCCCCCCEEEEeeEEecCCC-eEEecCcCCCCCCCcccchHHHHHHHHHHHHC--CC
Confidence 34578999974 345577776 6789999999999998875 56665320 123455555555554 79
Q ss_pred eEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHH--------HHHcC---CceeeeeccCCCCCCCchhHHHHHHHH
Q 003932 91 TTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRI--------ARLYG---FRGLDFAWTAPNTSTDMFNIGLLFDEW 159 (785)
Q Consensus 91 kv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~--------~~~y~---~DGiDiDwE~p~~~~d~~~~~~ll~~l 159 (785)
|||+|||||+++-. +++++.|++|+++++++ +++|| |||||||||||. ..+|..|+++|
T Consensus 81 KVllSiGG~~g~~~------~~s~~~~~~fa~s~~~~f~~~~~~~~r~~g~~~~DGiDiD~E~p~----~~~~~~L~~~L 150 (294)
T 2uy2_A 81 KVLLSLGGASGSYL------FSDDSQAETFAQTLWDTFGEGTGASERPFDSAVVDGFDFDIENNN----EVGYSALATKL 150 (294)
T ss_dssp EEEEEEECSCCCBC------CSSHHHHHHHHHHHHHHHSSCCSCCCCTTTTCCCSEEEEECCSSC----CTTHHHHHHHH
T ss_pred EEEEEeCCCCCCCc------CCCHHHHHHHHHHHHHHhcccccccccccCcccccceEEecccCC----cccHHHHHHHH
Confidence 99999999874322 46889999999999987 57788 999999999994 57999999999
Q ss_pred HHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHH-HhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCC
Q 003932 160 RIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSI-QRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARS 238 (785)
Q Consensus 160 r~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~ 238 (785)
|+.+++. .+++++++++..+.. ...+. ..| ..++||||+|+||+. .+ .++ .++
T Consensus 151 r~~~~~~------g~~~~LTaAp~~~~~--~~~~~-~~l~~~~~D~invq~Yd~~---~~----~~~----------~~~ 204 (294)
T 2uy2_A 151 RTLFAEG------TKQYYLSAAPQCPYP--DASVG-DLLENADIDFAFIQFYNNY---CS----VSG----------QFN 204 (294)
T ss_dssp HHHHTTS------SSCCEEEECCBSSSS--CTTTH-HHHHHSCCSEEEEECSSST---TS----TTS----------SCC
T ss_pred HHHHhhc------CCceEEEECCCcccc--hhhhH-HHHhcCCcCeEEeecccCC---CC----CCC----------CcC
Confidence 9998641 224555554433321 11222 334 689999999999972 11 111 124
Q ss_pred HHHHHHHHHHc--CCCCCceeecccccc
Q 003932 239 TDQVLKAWIER--GLSADKLVMCLPFYG 264 (785)
Q Consensus 239 ~~~~v~~~~~~--gvp~~KlvlGip~YG 264 (785)
++ +...|++. |+|++||+||+|++.
T Consensus 205 ~~-~~~~~~~~~~g~p~~KivlGlPa~~ 231 (294)
T 2uy2_A 205 WD-TWLTYAQTVSPNKNIKLFLGLPGSA 231 (294)
T ss_dssp HH-HHHHHHHHTCSSTTCEEEEEEESST
T ss_pred HH-HHHHHHHhcCCCCchhEEEeccCCc
Confidence 44 47778875 799999999999963
|
| >2gsj_A Protein PPL-2; mimosoideae, chimerolectin, endochitinase, glycosyl hydrolase family 18, equilibrium sedimentation, X-RAY; 1.73A {Parkia platycephala} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=258.21 Aligned_cols=199 Identities=15% Similarity=0.133 Sum_probs=137.1
Q ss_pred EEEEEecC-CCCCCcC-CCCCCCCceEEEEEEEeeCCcc--EEecCCCcc-----HHHHHHHHHHHHhcCCCceEEEEec
Q 003932 27 IRVGYLNL-SEVSTIS-GINYDLFTHLICSSADINSTTY--QLSLSLPSD-----ENQIAKFADTVKKKNPSITTILSIG 97 (785)
Q Consensus 27 ~~vgY~~~-~~~~~~~-~i~~~~~Thi~~~f~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~k~~~p~lkv~~sig 97 (785)
.+++||-. ....++. ..+.++||||+|||+.+..+|. .+.+....+ ...+...++.+| ++++|||+|||
T Consensus 2 ~i~~YWg~n~~~~~L~~~c~~~~~t~i~~AF~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~i~~lq--~~g~KVllSiG 79 (271)
T 2gsj_A 2 GIVVYWGQNGGEGTLTSTCESGLYQIVNIAFLSQFGGGRRPQINLAGHCDPANNGCRTVSDGIRACQ--RRGIKVMLSIG 79 (271)
T ss_dssp EEEEEESSCTTSCCHHHHHHTSCCSEEEEEEEEEBSTTCCCEECCGGGCCTGGGTTTTHHHHHHHHH--TTTCEEEEEEE
T ss_pred CEEEEeCCCCCCCChHHhccCCCCCEEEEEEEEecCCCCCcCccccccCCCccccHHHHHHHHHHHH--hCCCEEEEEeC
Confidence 47889943 2222222 2246789999999999987653 343331111 123445555455 56899999999
Q ss_pred CCCCCCcccchhhhcChhhhHHHHHHH----------HHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhh
Q 003932 98 QGKDTNYSIYSSMVRNSSHRKSFIDSS----------IRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLD 167 (785)
Q Consensus 98 G~~~~~~~~fs~~~~~~~~r~~fi~si----------~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~ 167 (785)
||++ + |+ +++++.|++|++++ ++++++|+|||||||||||+ ++|..|+++||+.++.
T Consensus 80 G~~g--s--~~--~~s~~~~~~fa~s~~~~f~~~~s~~~~~~~~~~DGiDiDwE~p~-----~~~~~l~~~Lr~~~~~-- 146 (271)
T 2gsj_A 80 GGAG--S--YS--LSSVQDARSVADYIWNNFLGGRSSSRPLGDAVLDGVDFDIEHGG-----AYYDALARRLSEHNRG-- 146 (271)
T ss_dssp CSSS--C--BC--CCSHHHHHHHHHHHHHHHSSSCCTTCTTCSCCCSEEEEECCSCC-----TTHHHHHHHHHGGGGS--
T ss_pred CCCC--c--ee--cCCHHHHHHHHHHHHHHhcCCcchhhhHHHcCCceEEEeecCch-----HHHHHHHHHHHHHhhc--
Confidence 9864 2 54 57889999999999 56789999999999999995 7999999999987642
Q ss_pred hhcccccceeEEEEeecccCCCCccccHHHH-HhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q 003932 168 AKNSTRQQSLLILTARFRYSPPANSYLLNSI-QRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAW 246 (785)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~ 246 (785)
.++.++++++..+ ....+....+ ..++||||+|+||+++. . +.... ..++..+++.|
T Consensus 147 -----g~~~~LTaAp~~~---~~~~~~~~~~~~~~~D~invm~Yd~~~~---~--------~~~~~---~~~~~~~~~~w 204 (271)
T 2gsj_A 147 -----GKKVFLSAAPQCP---FPDQSLNKALSTGLFDYVWVQFYNNPQC---E--------FNSGN---PSNFRNSWNKW 204 (271)
T ss_dssp -----SSCCEEEECCBSS---SSCTTTHHHHHTSCCSEEEEECSSCTTT---S--------CCTTC---THHHHHHHHHH
T ss_pred -----CCCeEEEEeccCC---cchhhHHHHHhhccCCeEEEEcccCCCc---c--------CCCCc---hhHHHHHHHHH
Confidence 2244455443332 2234555555 47999999999997531 0 00000 11567889999
Q ss_pred HHcCCCCCceeecccccc
Q 003932 247 IERGLSADKLVMCLPFYG 264 (785)
Q Consensus 247 ~~~gvp~~KlvlGip~YG 264 (785)
++ |+|+ ||+||+|++-
T Consensus 205 ~~-~~p~-Kl~lGlp~~~ 220 (271)
T 2gsj_A 205 TS-SFNA-KFYVGLPASP 220 (271)
T ss_dssp HH-HCSS-EEEEEEESSG
T ss_pred Hh-cCCC-cEEEeccCCc
Confidence 98 7999 9999999964
|
| >1edt_A Endo-beta-N-acetylglucosaminidase H, endo H; hydrolase (glucosidase); 1.90A {Streptomyces plicatus} SCOP: c.1.8.5 PDB: 1c90_A 1c8x_A 1c91_A 1c3f_A 1c92_A 1c8y_A 1c93_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=260.25 Aligned_cols=175 Identities=15% Similarity=0.178 Sum_probs=128.7
Q ss_pred CCcEEEEEecCCC-------CCCcC-CCCCCCCceEEEEEEEeeCCc--cEEecCCCccHH-HH---HHHHHHHHhcCCC
Q 003932 24 KPWIRVGYLNLSE-------VSTIS-GINYDLFTHLICSSADINSTT--YQLSLSLPSDEN-QI---AKFADTVKKKNPS 89 (785)
Q Consensus 24 ~~~~~vgY~~~~~-------~~~~~-~i~~~~~Thi~~~f~~~~~~~--~~~~~~~~~~~~-~~---~~~~~~~k~~~p~ 89 (785)
..+++||||..|. .+.++ +||+.+||||+|+ +.++.++ +...+....+.. .. .+.++.+ ++|+
T Consensus 7 ~~~~~vcY~~~~~~~~~~~g~~~~~~di~~~~~thiiya-a~i~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~g 83 (271)
T 1edt_A 7 QGPTSVAYVEVNNNSMLNVGKYTLADGGGNAFDVAVIFA-ANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPL--QQQG 83 (271)
T ss_dssp CSCEEEEEEETTTSCGGGGGGEEETTTCSBSCSEEEEEE-EEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHH--HHTT
T ss_pred CCCEEEEEEeccceeccCCceeeecccCCccccEEEEee-cccCCCccccceEEEeCcchhhhhhhHHHHHHHH--hcCC
Confidence 4578999997432 34688 8999999999999 8887653 223222111111 11 1222223 4578
Q ss_pred ceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC------CCCchhHHHHHHHHHHHh
Q 003932 90 ITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT------STDMFNIGLLFDEWRIAA 163 (785)
Q Consensus 90 lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~------~~d~~~~~~ll~~lr~~l 163 (785)
+|||+|||||+.+. .|+.+. ++++|++||+++++++++|+|||||||||||+. ..|+++|+.|+++||++|
T Consensus 84 ~KvllsiGG~~~~~--~~~~l~-s~~~r~~f~~s~~~~~~~~~fDGiDiDwE~p~~~~~g~~~~d~~~~~~ll~eLr~~l 160 (271)
T 1edt_A 84 IKVLLSVLGNHQGA--GFANFP-SQQAASAFAKQLSDAVAKYGLDGVDFDDEYAEYGNNGTAQPNDSSFVHLVTALRANM 160 (271)
T ss_dssp CEEEEEEEECTTSC--CTTCCS-SHHHHHHHHHHHHHHHHHHTCCEEEEECSSCCTTGGGCCCCCSSHHHHHHHHHHHHC
T ss_pred CEEEEEECCCCCCC--CceecC-CHHHHHHHHHHHHHHHHHhCCCeEEEecccCCCCCCCCCCCCHHHHHHHHHHHHHHC
Confidence 99999999987543 387765 899999999999999999999999999999952 247899999999999998
Q ss_pred hhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCC
Q 003932 164 TKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVST 218 (785)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~ 218 (785)
+ ...+++++.++ ......|+++++.+++||+ +||+||+|..
T Consensus 161 ~----------~~~Ls~a~~~~-~~~~~~yd~~~~~~~lD~i---~~d~yg~w~~ 201 (271)
T 1edt_A 161 P----------DKIISLYNIGP-AASRLSYGGVDVSDKFDYA---WNPYYGTWQV 201 (271)
T ss_dssp T----------TSEEEEESCHH-HHTCCEETTEECGGGCSEE---ECCSTTEECC
T ss_pred C----------CCEEEEEecCC-cchhccCCHHHHHhhCCEE---EEcccCCCCC
Confidence 3 34555555432 2233578999999999998 7888888864
|
| >1eok_A Endo-beta-N-acetylglucosaminidase F3; alpha/beta-barrel, hydrolase; 1.80A {Elizabethkingia meningoseptica} SCOP: c.1.8.5 PDB: 1eom_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=250.91 Aligned_cols=200 Identities=10% Similarity=0.069 Sum_probs=133.8
Q ss_pred CCcEEEEEecCC---CCCCcCCCCCCCCceEEEEEEE-eeCCccEEecCCCc--c------HHHHHHHHHHHHhcCCCce
Q 003932 24 KPWIRVGYLNLS---EVSTISGINYDLFTHLICSSAD-INSTTYQLSLSLPS--D------ENQIAKFADTVKKKNPSIT 91 (785)
Q Consensus 24 ~~~~~vgY~~~~---~~~~~~~i~~~~~Thi~~~f~~-~~~~~~~~~~~~~~--~------~~~~~~~~~~~k~~~p~lk 91 (785)
+.++++|||.+. ..+.+++|| ..++||++ |+. +..++ .+.+.... . -..+.+.++.+| ++++|
T Consensus 7 ~~~~vv~Y~~~~~~~~~~~l~~i~-~~~~~i~~-F~~~~~~~g-~~~~~p~~~~~~~~~~~~~~~~~~i~~~q--~~g~K 81 (290)
T 1eok_A 7 SNGVCIAYYITDGRNPTFKLKDIP-DKVDMVIL-FGLKYWSLQ-DTTKLPGGTGMMGSFKSYKDLDTQIRSLQ--SRGIK 81 (290)
T ss_dssp -CCEEEEEEECSCSSTTSCGGGCC-TTCCEEEE-ESSCHHHHH-CTTSSCTTSGGGTTCSSHHHHHHHHHHHH--TTTCE
T ss_pred CCCEEEEEEecCCCCCcccHhHCC-CCCCEEEE-ccccCCCCC-cceeCCCCcccccccccHHHHHHHHHHHH--hCCCE
Confidence 457899999642 345789998 45667776 763 22222 33321111 0 133445555455 56799
Q ss_pred EEEEecCCCCCCcccchhh-hcChhhhHHHHHHHHH-HHHHcCCceeeeeccCCCC---------------------CCC
Q 003932 92 TILSIGQGKDTNYSIYSSM-VRNSSHRKSFIDSSIR-IARLYGFRGLDFAWTAPNT---------------------STD 148 (785)
Q Consensus 92 v~~sigG~~~~~~~~fs~~-~~~~~~r~~fi~si~~-~~~~y~~DGiDiDwE~p~~---------------------~~d 148 (785)
||+|||| +..|+.+ +++.++|++|++++++ ++++|||||||||||||+. +.+
T Consensus 82 VllSIGG-----~~~~~~~~~~~~~~r~~fa~s~~~~~l~~yg~DGiDiDwEy~~~~~~~~~~~pg~~~~g~~~~~~~~~ 156 (290)
T 1eok_A 82 VLQNIDD-----DVSWQSSKPGGFASAAAYGDAIKSIVIDKWKLDGISLDIEHSGAKPNPIPTFPGYAATGYNGWYSGSM 156 (290)
T ss_dssp EEEEEEC-----CGGGGSSSGGGSSSHHHHHHHHHHHHTTTTCCCEEEEECCCCCCCCSSCCCCCCHHHHSCSSCCTTSC
T ss_pred EEEEeCC-----CcCCCCccccchhHHHHHHHHHHHHHHHhcCCCcEEEecCCCCcccccccccccccccccccccCcch
Confidence 9999997 2247777 7777899999999999 9999999999999999854 122
Q ss_pred --chhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCC
Q 003932 149 --MFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAA 226 (785)
Q Consensus 149 --~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~ap 226 (785)
.++|..||++||+++... ......++++... .......+++++.+++||||+|+||+++.
T Consensus 157 ~~~~~~~~~l~el~~~~~~~-----a~~~~~l~i~~~~--~~y~~~~~~~~~~~~lD~invm~Yd~~~~----------- 218 (290)
T 1eok_A 157 AATPAFLNVISELTKYFGTT-----APNNKQLQIASGI--DVYAWNKIMENFRNNFNYIQLQSYGANVS----------- 218 (290)
T ss_dssp CCCHHHHHHHHHHTTTSSTT-----SSSCCEEEEEECT--TSTTHHHHHHHHTTTCSEEEECCTTCCHH-----------
T ss_pred HHHHHHHHHHHHHHHHhCCC-----CCCceEEEecCCc--ccccchHHHHHHhhccCEEEEecCCCCCc-----------
Confidence 579999999999776432 1123344433321 11111225778999999999999997541
Q ss_pred CCCCCCCCCCCCHHHHHHHHH--HcCCCCCceeeccccc
Q 003932 227 LYGSISGRFARSTDQVLKAWI--ERGLSADKLVMCLPFY 263 (785)
Q Consensus 227 l~~~~~~~~~~~~~~~v~~~~--~~gvp~~KlvlGip~Y 263 (785)
.....++ |. ..|+|++||+||+|+|
T Consensus 219 -----------~~~~~~~-~~~~~~g~p~~Ki~lG~Pa~ 245 (290)
T 1eok_A 219 -----------RTQLMMN-YATGTNKIPASKMVFGAYAE 245 (290)
T ss_dssp -----------HHHHHHH-HHHHTSCCCGGGEEEEECTT
T ss_pred -----------HHHHHHH-HhhccCCCCHHHEEeccccC
Confidence 2233344 52 1699999999999998
|
| >1cnv_A Concanavalin B; plant chitinase, chitin binding protein, SEED protein; 1.65A {Canavalia ensiformis} SCOP: c.1.8.5 | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-28 Score=248.26 Aligned_cols=204 Identities=15% Similarity=0.147 Sum_probs=138.7
Q ss_pred EEEEEecCCCCCCcCC-CCCCCCceEEEEEEEeeCCc---cEEecCCCcc------HHHHHHHHHHHHhcCCCceEEEEe
Q 003932 27 IRVGYLNLSEVSTISG-INYDLFTHLICSSADINSTT---YQLSLSLPSD------ENQIAKFADTVKKKNPSITTILSI 96 (785)
Q Consensus 27 ~~vgY~~~~~~~~~~~-i~~~~~Thi~~~f~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~k~~~p~lkv~~si 96 (785)
.+++||.+...-.+.. -+.+.||||+++|+.+..+| ..+.+....+ ...+...++.+|++ ++|||+||
T Consensus 6 ~i~~YWg~~~~g~L~~~c~~~~~~~V~~aF~~~~~~G~~~p~~~l~~~~~~~~~~~~~~~~~~Ik~~q~~--g~KVllSi 83 (299)
T 1cnv_A 6 EIAVYWGQREDGLLRDTCKTNNYKIVFISFLDKFGCEIRKPELELEGVCGPSVGNPCSFLESQIKECQRM--GVKVFLAL 83 (299)
T ss_dssp EEEEEECSGGGCCHHHHHHTCCCSEEEEEEECEECTTCSSCCCCBTTTBBTTTTBCGGGGHHHHHHHHHT--TCEEEEEE
T ss_pred cEEEEcCCCCCCCcccccCCCCCCEEEEEEEEecCCCCcchhhhhcccCCcccCcchHhHHHHHHHHHhC--CCEEEEEe
Confidence 5899996621111111 13567999999999987665 1233332211 24456666655654 79999999
Q ss_pred cCCCCCCcccchhhhcChhhhHHHHHHHH---------HHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhh
Q 003932 97 GQGKDTNYSIYSSMVRNSSHRKSFIDSSI---------RIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLD 167 (785)
Q Consensus 97 gG~~~~~~~~fs~~~~~~~~r~~fi~si~---------~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~ 167 (785)
|||+++ |+ +++++.|++|++++. +++.+|+|||||||||||.+ .++|..|+++||+.+...
T Consensus 84 GG~~gs----~~--~~s~~~~~~fa~~~~~~f~~g~~~~~~~~~~~DGiDiD~E~~~~---~~~~~~L~~~Lr~~~~~~- 153 (299)
T 1cnv_A 84 GGPKGT----YS--ACSADYAKDLAEYLHTYFLSERREGPLGKVALDGIHFDIQKPVD---ELNWDNLLEELYQIKDVY- 153 (299)
T ss_dssp ECSSSE----EC--CCSHHHHHHHHHHHHHHHBSSSSCBTTBSCBCSEEEEECSSCSC---STTHHHHHHHHHHHHHHH-
T ss_pred cCCccc----cc--cCCHHHHHHHHHHHHHHhcCccccchHHhcCCceEEeeccCCCc---hhHHHHHHHHHHHhhhhc-
Confidence 998743 43 678999999999994 88999999999999999953 389999999999866431
Q ss_pred hhcccccceeEEEEeecccCCCCccccHHHH-HhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q 003932 168 AKNSTRQQSLLILTARFRYSPPANSYLLNSI-QRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAW 246 (785)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~ 246 (785)
.+++++++++..+. ...+....+ ..++||||+|.||..+ .+.++ .. ..++..+++.|
T Consensus 154 -----g~~~~LTaAp~~~~---~~~~~~~~~~~~~lD~invq~Yn~~~------c~~~~----g~----~~~~~~a~~~w 211 (299)
T 1cnv_A 154 -----QSTFLLSAAPGCLS---PDEYLDNAIQTRHFDYIFVRFYNDRS------CQYST----GN----IQRIRNAWLSW 211 (299)
T ss_dssp -----TCCCEEEECCBSSS---SCTTTHHHHTTTCCSEEEEECSSCTT------TSCBT----TB----CHHHHHHHHHH
T ss_pred -----CCCeEEEEeccCCC---cchhHHHHHhcCCcCEEEEEeecCCC------cCCCC----CC----hhhHHHHHHHH
Confidence 22445555444332 223333334 6899999999999631 11110 00 01457889999
Q ss_pred HHcCC-CCCceeecccccc
Q 003932 247 IERGL-SADKLVMCLPFYG 264 (785)
Q Consensus 247 ~~~gv-p~~KlvlGip~YG 264 (785)
++.+. |++||+||+|++.
T Consensus 212 ~~~~~~p~~Kl~lGlPa~~ 230 (299)
T 1cnv_A 212 TKSVYPRDKNLFLELPASQ 230 (299)
T ss_dssp HHHSSSCSSCEEEEEESSG
T ss_pred HHhCCCCcccEEEEecCCc
Confidence 99764 9999999999964
|
| >2xtk_A CHIA1, class III chitinase CHIA1; hydrolase, GH18; HET: AZM; 2.00A {Aspergillus fumigatus} PDB: 2xuc_A 2xvp_A 2xvn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=242.39 Aligned_cols=208 Identities=14% Similarity=0.082 Sum_probs=141.4
Q ss_pred EEEEEecC-CCCCCcCCC-CCCCCceEEEEEEEeeCCcc-----EEecC-----------CC------ccHHHHHHHHHH
Q 003932 27 IRVGYLNL-SEVSTISGI-NYDLFTHLICSSADINSTTY-----QLSLS-----------LP------SDENQIAKFADT 82 (785)
Q Consensus 27 ~~vgY~~~-~~~~~~~~i-~~~~~Thi~~~f~~~~~~~~-----~~~~~-----------~~------~~~~~~~~~~~~ 82 (785)
.+++||-. ....++++. +...+++|++||+.+..+++ .+.+. +. ..-..+...++.
T Consensus 3 ~i~vYWGq~~~~~~L~~~c~~~~ydii~laF~~~~~~~~~~~~P~~n~~~~c~~~~~~~~~g~~t~~l~~c~~l~~~I~~ 82 (310)
T 2xtk_A 3 NLAIYWGQGPNQLRLSHFCQETSLDIINIGFINYFPDMSPGHWPGSNFGNQCDGSVYVTNDGVVTKLLSGCHQIMEDIPI 82 (310)
T ss_dssp EEEEEESCCTTCCCHHHHHTCTTCSEEEEEEEEECTTTSGGGSCEECCTTCSCSCEEECTTCCEEEEESCCHHHHHHHHH
T ss_pred CEEEEECCCCCCCChHHhcCCCCccEEEEeeeeccCCCCCCCCccceeccccCccccccCCCcccccccCcHhHHHHHHH
Confidence 47889954 344566666 34579999999998865421 12221 10 012567777776
Q ss_pred HHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHH----------HHHHcC---CceeeeeccCCCCCCCc
Q 003932 83 VKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIR----------IARLYG---FRGLDFAWTAPNTSTDM 149 (785)
Q Consensus 83 ~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~----------~~~~y~---~DGiDiDwE~p~~~~d~ 149 (785)
+|++ ++|||+|||||+.+. ++ +++++.|++|++++++ +++.|| |||||||||||. .
T Consensus 83 ~q~~--g~KVllSiGG~~~~~---~~--~~s~~~r~~fa~s~~~~f~~~~~~~~~~r~~g~~~fDGiDiDwE~p~----~ 151 (310)
T 2xtk_A 83 CQAA--GKKVLLSIGGAYPPD---QS--ILSEDSAVAFATFLWGAFGPVAEGWEGPRPFGDVVVDGFDFDIEHNG----G 151 (310)
T ss_dssp HHHT--TCEEEEEEEESSCSC---CC--CCCHHHHHHHHHHHHHHHSSCCTTCCSCCTTTTCCCSEEEEEECSSC----C
T ss_pred HHhC--CCEEEEEeCCCcCCc---cc--cCCHHHHHHHHHHHHHHhcCcccccccccccCCcccceEEEeecCCC----c
Confidence 7765 699999999987632 22 4688999999999986 588899 999999999994 4
Q ss_pred hhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHH-hccceeeeeeccCCCccCCCCCCCCCCCC
Q 003932 150 FNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQ-RNLNWIHAVTASYYEPVSTNFTAPPAALY 228 (785)
Q Consensus 150 ~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~D~v~vm~yd~~~~~~~~~~g~~apl~ 228 (785)
++|..|+++||+.|++. ..++.++++++..+ ....+....|. .++||||+|+||+++- . ...+
T Consensus 152 ~~~~~L~~~Lr~~~~~~-----~~~~~~LTaAp~~~---~~~~~~~~~l~~~~lD~invq~Yd~~~~-~-------~~~~ 215 (310)
T 2xtk_A 152 FGYATMVNTFRQYFNQV-----PERKFYLSAAPQCI---IPDAQLSDAIFNAAFDFIWIQYYNTAAC-S-------AKSF 215 (310)
T ss_dssp TTHHHHHHHHHHHHHTC-----TTSCCEEEECCBSS---SSCTTTHHHHHHSCCSEEEEECSSCTTT-C-------THHH
T ss_pred hhHHHHHHHHHHhhccc-----cCCCeEEEeCCcCC---CcchHHHHHHHhCCCCceeeeeccCCCC-C-------cccc
Confidence 68999999999998642 12244555544332 22345667785 6999999999998531 1 0000
Q ss_pred CCCCCCCCCCHHHHHHHHHHc-CCCCCceeeccccc
Q 003932 229 GSISGRFARSTDQVLKAWIER-GLSADKLVMCLPFY 263 (785)
Q Consensus 229 ~~~~~~~~~~~~~~v~~~~~~-gvp~~KlvlGip~Y 263 (785)
.. .....++++.. ..|+.. |+|++||+||+|++
T Consensus 216 ~~-~~~~~~~~~~~-~~~~~~~~~p~~KlvlGlPa~ 249 (310)
T 2xtk_A 216 ID-TSLGTFNFDAW-VTVLKASASKDAKLYVGLPAS 249 (310)
T ss_dssp HS-TTSCCCCHHHH-HHHHTTSTTTTCEEEEEEESS
T ss_pred cc-CccccccHHHH-HHHHHhcCCCchhEEEeecCC
Confidence 00 00112366654 467765 58999999999996
|
| >2ebn_A Endo-beta-N-acetylglucosaminidase F1; hydrolase(glucosidase); 2.00A {Elizabethkingia meningoseptica} SCOP: c.1.8.5 | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-26 Score=228.91 Aligned_cols=196 Identities=16% Similarity=0.111 Sum_probs=138.0
Q ss_pred CCcEEEEEecCCC-------CCCc-CCCCCCCCceEEEEEEEeeCC--ccEEecCCCccH----HHHHHHHHHHHhcCCC
Q 003932 24 KPWIRVGYLNLSE-------VSTI-SGINYDLFTHLICSSADINST--TYQLSLSLPSDE----NQIAKFADTVKKKNPS 89 (785)
Q Consensus 24 ~~~~~vgY~~~~~-------~~~~-~~i~~~~~Thi~~~f~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~k~~~p~ 89 (785)
...++|+|+..|. .+.+ +++++. ||||+++|+.++.+ ++.+.+....+. ....+.++.+|++ +
T Consensus 8 ~~~kvVcY~~~~~~~p~~~g~f~l~~~~~p~-~d~vi~~fa~in~d~~~g~~~l~~n~~~~~~~~~~~~~i~~lq~~--g 84 (289)
T 2ebn_A 8 ANIKLFSFTEVNDTNPLNNLNFTLKNSGKPL-VDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQDK--G 84 (289)
T ss_dssp CSCEEEEEEETTTCCGGGGGGEEETTTCCBS-CCEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHHT--T
T ss_pred CCCEEEEEEEecCCCCCcCceEEeccCCCCc-eeEEEEEEEecccCCCCCeeEEecCccccccccchHHHHHHHHhC--C
Confidence 4568999997652 3446 677664 99999999988643 235544422221 1124555657644 6
Q ss_pred ceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC---------CCCchhHHHHHHHHH
Q 003932 90 ITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT---------STDMFNIGLLFDEWR 160 (785)
Q Consensus 90 lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~---------~~d~~~~~~ll~~lr 160 (785)
+|||+|||||+.... |+.+. ++.|++||+++++++++|||||||||||||+. ..|+++|+.|+++||
T Consensus 85 lKVllSIGG~~~~~g--~~~l~--~~~r~~Fa~sv~~~v~~ygfDGiDiDwEyp~~~~~g~~g~~~~d~~n~~~Ll~eLR 160 (289)
T 2ebn_A 85 IKVILSILGNHDRSG--IANLS--TARAKAFAQELKNTCDLYNLDGVFFDDEYSAYQTPPPSGFVTPSNNAAARLAYETK 160 (289)
T ss_dssp CEEEEEEECCSSSCC--TTCBC--HHHHHHHHHHHHHHHHHHTCCEEEEECCSCCCCSSCCTTBCCCCHHHHHHHHHHHH
T ss_pred CEEEEEeCCCCCCCC--eecCC--HHHHHHHHHHHHHHHHHhCCCcEEEeeecCCCCccCCCCCCCccHHHHHHHHHHHH
Confidence 999999998654333 66554 78999999999999999999999999999732 127899999999999
Q ss_pred HHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHH
Q 003932 161 IAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTD 240 (785)
Q Consensus 161 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~ 240 (785)
++|. .+++++++..+.......++++++++++||+.. +| |.|++. .. |.
T Consensus 161 ~~l~----------~klLT~Av~g~~~~~~~~~d~~~~~~ylDy~~~-~Y---g~~~~~-~~---~~------------- 209 (289)
T 2ebn_A 161 QAMP----------NKLVTVYVYSRTSSFPTAVDGVNAGSYVDYAIH-DY---GGSYDL-AT---NY------------- 209 (289)
T ss_dssp HHCT----------TSEEEEEESGGGSCCCSCBTTBCGGGTCSEEEE-CT---TCCSCC-TT---TS-------------
T ss_pred HHCC----------CCEEEEEecCCccccccccCHHHHHhcCCEEEe-cc---cCcccC-CC---cC-------------
Confidence 9983 345666665444433678999999999999876 46 444310 11 11
Q ss_pred HHHHHHHHcCCCCCceeeccccccc
Q 003932 241 QVLKAWIERGLSADKLVMCLPFYGY 265 (785)
Q Consensus 241 ~~v~~~~~~gvp~~KlvlGip~YG~ 265 (785)
.|+|++|+..+-+.+++
T Consensus 210 --------~g~~~~~~~~~~~~~~~ 226 (289)
T 2ebn_A 210 --------PGLAKSGMVMSSQEFNQ 226 (289)
T ss_dssp --------TTCCGGGEEEEEEETTT
T ss_pred --------CCCChhceecceeEecC
Confidence 37899998877666654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=273.19 Aligned_cols=184 Identities=16% Similarity=0.120 Sum_probs=129.7
Q ss_pred eeceeCcEEEEEEE-eCCCcEEEEEEcCCCC----------hhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEE
Q 003932 471 KLGEGGYGPVYKGV-LPCGEVIAVKKLSKTS----------TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 471 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 538 (785)
..+.|+.|.+..++ .-.|+.+++|++.+.. ....++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35566666666554 3357889999997542 23345799999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||++|++|.++|.. ...++.. +|+.||+.||+|||+++ ||||||||+|||+++++++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999954 3345553 58899999999999987 99999999999999999999999999987643
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCC
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~ 666 (785)
.. ......+||+.|||||++.+. +..++|+||+|+++++|.+|..
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 32 233457899999999999764 5678999999999988876643
|
| >1ta3_A XIP-1, xylanase inhibitor protein I; beta alpha barrel (XIP-I), beta alpha barrel (xylanase), HYD inhibitor-hydrolase complex; HET: NAG; 1.70A {Triticum aestivum} SCOP: c.1.8.5 PDB: 1om0_A* 1te1_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-23 Score=212.22 Aligned_cols=203 Identities=13% Similarity=0.058 Sum_probs=130.9
Q ss_pred cEEEEEec-CCCCCCcCCC-CCCCCceEEEEEEEeeC-Ccc-EEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCC
Q 003932 26 WIRVGYLN-LSEVSTISGI-NYDLFTHLICSSADINS-TTY-QLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKD 101 (785)
Q Consensus 26 ~~~vgY~~-~~~~~~~~~i-~~~~~Thi~~~f~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~ 101 (785)
..+++||- +....++... +.+.+|||+++|+.+.+ +|. .+.+... ...++...++.++++ ++|||+|||||.+
T Consensus 6 ~~i~~YWGqn~~~~~L~~~c~~~~~~~V~~AF~~~~~~~G~~~~d~~g~-~~~~~~~~I~~cq~~--g~kVlLSiGG~~g 82 (274)
T 1ta3_A 6 GQVTVFWGRNKAEGSLREACDSGMYTMVTMSFLDVFGANGKYHLDLSGH-DLSSVGADIKHCQSK--GVPVSLSIGGYGT 82 (274)
T ss_dssp CCEEEEESSCGGGCCHHHHHHTTCCSEEEEEEEEEBSSSSCCEECCTTC-CGGGHHHHHHHHHHT--TCCEEEEEEESSS
T ss_pred CcEEEEeCCCCCCCchHhhcccCCCcEEEEccEeecCCCCceeeccCCC-ChHHHHHHHHHHHhC--CCEEEEecCCCcC
Confidence 35788994 3333334433 25689999999999887 441 2222211 223455666655544 6999999999875
Q ss_pred CCcccchhhhcChhhhHHHHHHHHHHH------------HHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhh
Q 003932 102 TNYSIYSSMVRNSSHRKSFIDSSIRIA------------RLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAK 169 (785)
Q Consensus 102 ~~~~~fs~~~~~~~~r~~fi~si~~~~------------~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~ 169 (785)
+-+ +.+++.+++|++++.+.. .+++|||||||||+|. +..+|..|+++||+.+.+..
T Consensus 83 s~~------l~s~~~a~~fa~~l~~~f~~g~~~~~~r~~g~~~lDGiDiD~E~~~---~~~~~~~L~~~Lr~~~~~~~-- 151 (274)
T 1ta3_A 83 GYS------LPSNRSALDLFDHLWNSYFGGSKPSVPRPFGDAWLDGVDLFLEHGT---PADRYDVLALELAKHNIRGG-- 151 (274)
T ss_dssp CBC------CCSHHHHHHHHHHHHHHHSSCCCTTSCCTTTTCCCSEEEEEESSCC---TTCCHHHHHHHHHTTCCSSS--
T ss_pred ccc------cCCHHHHHHHHHHHHHHhcCcccccccccHhhcCcCeEEEeccCCC---CchhHHHHHHHHHHHHhhcc--
Confidence 433 456788999999998764 4567999999999983 56799999999997664211
Q ss_pred cccccceeEEEEeecccCCCCccccHHHH-HhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q 003932 170 NSTRQQSLLILTARFRYSPPANSYLLNSI-QRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIE 248 (785)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~ 248 (785)
..+++++++++..+.. ...+.-..+ ..++||||+|.||- ++ ++.. .. ....+++.|++
T Consensus 152 --~g~~~~LTaAPq~p~~--~d~~~~~~l~~~~~D~v~vqfYdn-n~------~c~~--~~--------~~~~~~~~w~~ 210 (274)
T 1ta3_A 152 --PGKPLHLTATVRCGYP--PAAHVGRALATGIFERVHVRTYES-DK------WCNQ--NL--------GWEGSWDKWTA 210 (274)
T ss_dssp --SSCCCEEEEEECSSSS--CCHHHHHHHTTSCCCEEEEECSSC-CT------TSBT--TB--------BHHHHHHHHHH
T ss_pred --CCCCEEEEECCcCCCC--CChhHHHHHhcCCCCeEEeeeecC-CC------CCcc--cc--------ccHHHHHHHHh
Confidence 1234555555433322 122222222 46899999999940 11 1110 00 12347778887
Q ss_pred cCCCCCceeecccccc
Q 003932 249 RGLSADKLVMCLPFYG 264 (785)
Q Consensus 249 ~gvp~~KlvlGip~YG 264 (785)
++|++||+||+|++.
T Consensus 211 -~~p~~Ki~lGlPa~~ 225 (274)
T 1ta3_A 211 -AYPATRFYVGLTADD 225 (274)
T ss_dssp -HCTTSEEEEEEECCT
T ss_pred -cCCcccEEEeeecCc
Confidence 699999999999964
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-25 Score=248.25 Aligned_cols=185 Identities=17% Similarity=0.173 Sum_probs=144.1
Q ss_pred CcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh--------hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 467 SIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST--------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
...++||+|+||.||+|... ++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 34578999999999999654 67888888654321 1234588999999999999999666666677888999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
|||+++++|.+++.. +..++.|+++||.|||+.+ |+||||||+|||++. ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999853 4589999999999999986 999999999999999 999999999998754
Q ss_pred ccccc-----ccccccccCCcccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCC
Q 003932 619 ESLEE-----NTEQVVGTIGYIPPEYATK--GVYSTKSDVFSFGVLLLQIISGKRLS 668 (785)
Q Consensus 619 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvvl~elltG~~p~ 668 (785)
..... ......||+.|||||++.. ..|+..+|+||..+-..+-+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32111 1235689999999999987 56788899999999888888777654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.2e-22 Score=204.67 Aligned_cols=152 Identities=19% Similarity=0.098 Sum_probs=120.1
Q ss_pred HHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh------------------hhHHHHHHHHHHHHcCC
Q 003932 457 ADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST------------------QGFEEFKNEVMLTAKLQ 518 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 518 (785)
..+......|.+.+.||+|+||.||+|...+++.||+|+++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344444566778899999999999999997799999999965321 13456889999999998
Q ss_pred CCceeeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 519 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||
T Consensus 163 ~---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 G---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred C---CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 44444433 356799999999999987 421 123469999999999999886 999999999999
Q ss_pred EcCCCceeeccccceeeecccccccccccccccCCcccccccC
Q 003932 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT 641 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 641 (785)
++ ++.+||+|||+++. +..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99 99999999999864 23578898774
|
| >3poh_A Endo-beta-N-acetylglucosaminidase F1; TIM barrel, structural genomics, joint center for structural genomics, JCSG; 1.55A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.9e-20 Score=195.97 Aligned_cols=164 Identities=9% Similarity=0.112 Sum_probs=120.8
Q ss_pred CcEEEEEecCC-------CCCCcCCCCCCCCceEEEEEEEee--CCccEEecCCCccHH-HH---HHHHHHHHhcCCCce
Q 003932 25 PWIRVGYLNLS-------EVSTISGINYDLFTHLICSSADIN--STTYQLSLSLPSDEN-QI---AKFADTVKKKNPSIT 91 (785)
Q Consensus 25 ~~~~vgY~~~~-------~~~~~~~i~~~~~Thi~~~f~~~~--~~~~~~~~~~~~~~~-~~---~~~~~~~k~~~p~lk 91 (785)
...+++|..-. ..|.++. --...+|++++.+.|+ +.+++..+....+.. .+ .++++.++++ ++|
T Consensus 167 ~~~~~~y~evn~~npln~~~y~l~~-~~~~~d~v~lfaanin~d~~~~~~~l~~n~~~~~~L~~~~~~v~~lq~~--glK 243 (451)
T 3poh_A 167 VMQGYLFFEVNDVNPLNTLSFQLEN-GKLLWDVVVLFAANINYDAEAGRPRVQCNPNVQYLLDNNETLLQPLRRR--GVK 243 (451)
T ss_dssp CCEEEEEEETTTCCGGGGGGCBBTT-SCBSCSEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHHT--TCE
T ss_pred CceEEEEEEeCCCCccccceeEecC-CCceeeEEEEeeeecCCCcccCeEEEEcCCchHHhhhChHHHHHHHHHC--CCE
Confidence 35778888432 2334432 1237899999999998 434565555444433 22 4666777776 499
Q ss_pred EEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCC---------CCchhHHHHHHHHHHH
Q 003932 92 TILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTS---------TDMFNIGLLFDEWRIA 162 (785)
Q Consensus 92 v~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~---------~d~~~~~~ll~~lr~~ 162 (785)
|++|||||+.... |+.+ +++.|++|++++++++++|||||||||||||+.. .+.++|+.|+++||++
T Consensus 244 VllSIgGg~~~~g--f~~l--s~~~r~~Fa~~v~~~v~~yglDGIDiDwEYp~~~~~g~~~~~~~d~~nf~~Ll~eLR~~ 319 (451)
T 3poh_A 244 VLLGLLGNHDITG--LAQL--SEQGAKDFAREVAQYCKAYNLDGVNYDDEYSNSPDLSNPSLTNPSTAAAARLCYETKQA 319 (451)
T ss_dssp EEEEEECCSSSCC--TTCB--CHHHHHHHHHHHHHHHHHTTCCEEEEECCSCCCCCTTSTTBCSCCHHHHHHHHHHHHHH
T ss_pred EEEEECcCCCCCC--cccC--CHHHHHHHHHHHHHHHHHhCCCcEEEeccCCCCCCCCCCCcCCCCHHHHHHHHHHHHHh
Confidence 9999987655433 7776 7899999999999999999999999999999532 4789999999999999
Q ss_pred hhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceee
Q 003932 163 ATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIH 206 (785)
Q Consensus 163 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~ 206 (785)
|+ .+++++++.... .....++..++.+++||+.
T Consensus 320 lp----------~kllT~A~~g~~-~~~~~~d~~~~~~ylDy~~ 352 (451)
T 3poh_A 320 MP----------DKLVTVFDWGQM-YGVATVDGVDAKEWIDIVV 352 (451)
T ss_dssp CT----------TSEEEEECCTTS-SCCCEETTEEGGGTCCEEE
T ss_pred CC----------CCEEEEEeccCc-ccccccChhhHhhhceeee
Confidence 84 344555554443 3567899999999999976
|
| >3mu7_A XAIP-II, xylanase and alpha-amylase inhibitor protein; TIM barell, amylase/xylanase inhibitory protein, hydrolase I; 1.29A {Scadoxus multiflorus} SCOP: c.1.8.0 PDB: 3o9n_A 3oih_A* 3hu7_A 3m7s_A* 3d5h_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=8.2e-20 Score=182.87 Aligned_cols=198 Identities=15% Similarity=0.122 Sum_probs=130.0
Q ss_pred EEEEEecCCC-CCCcCCC-CCCCCceEEEEEEEeeCCcc--EEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCC
Q 003932 27 IRVGYLNLSE-VSTISGI-NYDLFTHLICSSADINSTTY--QLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDT 102 (785)
Q Consensus 27 ~~vgY~~~~~-~~~~~~i-~~~~~Thi~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~ 102 (785)
.++.||-... .-+++.. +...+++|+++|+....+|. .+.+.. ..+.++...++.++++ ++|||+||||+..+
T Consensus 4 ~iavYWGqn~~~~~L~~~C~~~~y~~v~laFl~~~g~g~~p~~nl~~-~c~~~l~~dI~~cQ~~--G~kVlLSiGG~~g~ 80 (273)
T 3mu7_A 4 DIAVYWGQSFDERSLEATCDSGNYAYVIIGFLNTFGGGQTPALDISG-HSPKGLEPQIKHCQSK--NVKVLLSIGGPAGP 80 (273)
T ss_dssp CEEEEECSCTTSCCHHHHHHTSCCSEEEEEEEEEBSTTCCCEECSTT-CCTTTHHHHHHHHHHT--TCEEEEEEEESSCS
T ss_pred CEEEECCCCCCCCCHHHHhcCCCCCEEEEEeEeccCCCCCccccccc-cchHHHHHHHHHHHHC--CCEEEEEeccCCCc
Confidence 3567884322 2233322 24579999999998876652 455543 2346777888877766 59999999988643
Q ss_pred CcccchhhhcChhhhHHHHHHHHHHH----------HHcC---CceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhh
Q 003932 103 NYSIYSSMVRNSSHRKSFIDSSIRIA----------RLYG---FRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAK 169 (785)
Q Consensus 103 ~~~~fs~~~~~~~~r~~fi~si~~~~----------~~y~---~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~ 169 (785)
-+ +.+++.+++|++++.+.. +.+| |||||||||+|. .++|..|+++||+.++.
T Consensus 81 ~~------l~s~~~a~~fa~~l~~~f~p~~~g~~~~rp~g~~~lDGiD~D~E~~~----~~~~~~l~~~Lr~~~~~---- 146 (273)
T 3mu7_A 81 YS------LDSRNDANDLAVYLHKNFLLPPAGTSESRPFGNAVLDGIDFHIEHGG----PSQYQLLANILSSFRLS---- 146 (273)
T ss_dssp BC------CCSHHHHHHHHHHHHHHHTSCCCSSCCCCTTTTCCCSEEEEEECSSC----STTHHHHHHHHHHHHTT----
T ss_pred ee------cCCHHHHHHHHHHHHHHhccccCCCcccccccccccCceEeecccCC----chhHHHHHHHHHHHhcc----
Confidence 22 677888999999999865 4455 999999999994 36899999999987732
Q ss_pred cccccceeEEEEeecccCCCCccccHHHH-HhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q 003932 170 NSTRQQSLLILTARFRYSPPANSYLLNSI-QRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIE 248 (785)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~ 248 (785)
.++.++++++..+. ...+.-..| ...+|||++|.||-.+ +.. ... . ......+...|..
T Consensus 147 ---g~~~~LTaAPqcp~---pd~~l~~~l~~~~~D~v~vQfYNn~~--------C~~--~~~-~---~~~f~~~w~~w~~ 206 (273)
T 3mu7_A 147 ---GSEFALTAAPQCVY---PDPNLGTVINSATFDAIWVQFYNNPQ--------CSY--SAS-N---ASALMNAWKEWSM 206 (273)
T ss_dssp ---SSCCEEEECCBSSS---SCTTTHHHHHTTCCSEEEEECSSCGG--------GSC--BTT-B---CHHHHHHHHHHHH
T ss_pred ---CCceEEEEcccCCC---cchhHHHHhhcCcccEEEEEeccCCC--------ccc--ccC-C---hhHHHHHHHHHHh
Confidence 12444444433332 223433344 3689999999998311 100 000 0 0122345566764
Q ss_pred cCCCCCceeecccc
Q 003932 249 RGLSADKLVMCLPF 262 (785)
Q Consensus 249 ~gvp~~KlvlGip~ 262 (785)
++|+.||+||+|.
T Consensus 207 -~~p~~Kv~lGlPA 219 (273)
T 3mu7_A 207 -KARTDKVFLGFPA 219 (273)
T ss_dssp -HCCSSCEEEEEES
T ss_pred -cCCcceEEEEeec
Confidence 7999999999986
|
| >2dsk_A Chitinase; catalytic domain, active domain, crystalline CHIT barrel, hydrolase; 1.50A {Pyrococcus furiosus} PDB: 3a4w_A* 3a4x_A* 3afb_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=190.44 Aligned_cols=152 Identities=11% Similarity=0.042 Sum_probs=98.5
Q ss_pred CCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHH
Q 003932 44 NYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDS 123 (785)
Q Consensus 44 ~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~s 123 (785)
....++|++++|+.....+.............+...++.+|++ ++||++|||||.++. ++.+.+.+++|+++
T Consensus 31 ~~~g~~~v~lAFl~~~~g~c~p~w~g~~~~~~~~~~I~~~q~~--G~kVllSiGGa~Gs~------~~~s~~~~~~~a~~ 102 (311)
T 2dsk_A 31 KLTGTKYFTLAFILYSSVYNGPAWAGSIPLEKFVDEVRELREI--GGEVIIAFGGAVGPY------LCQQASTPEQLAEW 102 (311)
T ss_dssp HHHSCSEEEEEEEEEETTTTEEEETTTBCGGGGHHHHHHHHTT--TCEEEEEEEESSCCC------HHHHCSSHHHHHHH
T ss_pred HhcCCCEEEEEEEeccCCCCcccCCCCCchHHHHHHHHHHHHC--CCeEEEEecCCCCcc------ccccccCHHHHHHH
Confidence 3457999999999864333333333221224456677777766 599999999886542 35566788999999
Q ss_pred HHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCC-CCccc-cHHH---H
Q 003932 124 SIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSP-PANSY-LLNS---I 198 (785)
Q Consensus 124 i~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~---l 198 (785)
..+++++|+|||||||||++.. .+.+...|+.|+++. ++..++++.++.+.. ...+. -+.. .
T Consensus 103 ~~~~i~~ygldGIDfDiE~~~~---~d~~~~aL~~l~~~~----------p~~~vs~TL~~~p~gl~~~g~~~l~~a~~~ 169 (311)
T 2dsk_A 103 YIKVIDTYNATYLDFDIEAGID---ADKLADALLIVQRER----------PWVKFSFTLPSDPGIGLAGGYGIIETMAKK 169 (311)
T ss_dssp HHHHHHHHTCSEEEEEECSCCC---HHHHHHHHHHHHHHS----------TTCEEEEEEEEETTTEESTHHHHHHHHHHH
T ss_pred HHHHHHHhCCCcEEEeccCCcc---HHHHHHHHHHHHhhC----------CCcEEEEEeccCCCCCCcchHHHHHHHHHc
Confidence 9999999999999999999943 235555566655332 133344443332211 11111 1222 3
Q ss_pred HhccceeeeeeccCCCcc
Q 003932 199 QRNLNWIHAVTASYYEPV 216 (785)
Q Consensus 199 ~~~~D~v~vm~yd~~~~~ 216 (785)
...+|+||||+|||++.+
T Consensus 170 g~~ld~VniM~~Df~~~~ 187 (311)
T 2dsk_A 170 GVRVDRVNPMTMDYYWTP 187 (311)
T ss_dssp TCCCCEEEEECCCCSSSC
T ss_pred CccccEEEEEeeccCCCC
Confidence 336899999999998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=7.3e-18 Score=173.08 Aligned_cols=137 Identities=18% Similarity=0.175 Sum_probs=105.2
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcE--EEEEEcCCCChh------------------------hHHHHHHHHHHHHcC
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEV--IAVKKLSKTSTQ------------------------GFEEFKNEVMLTAKL 517 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 517 (785)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999997 67888 999987543111 113578899999999
Q ss_pred CCCce--eeEEEEEecCCccEEEEEecCC-C----ChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEE
Q 003932 518 QHVNL--IRVLGFCIDSEERMLIYEYMPN-K----SLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ-EYSRLTIIH 589 (785)
Q Consensus 518 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH 589 (785)
.|+++ ..++.+ ...+|||||+.+ | +|.++... .++.....++.|++.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88754 444442 367899999942 4 55544321 223456789999999999999 776 999
Q ss_pred ecccCCCEEEcCCCceeeccccceeee
Q 003932 590 RDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 590 ~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=4.6e-15 Score=157.93 Aligned_cols=135 Identities=14% Similarity=0.135 Sum_probs=100.1
Q ss_pred CCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh--------------hhHH--------HHHHHHHHHHcCCCCce
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST--------------QGFE--------EFKNEVMLTAKLQHVNL 522 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~ni 522 (785)
-|.+.+.||+|++|.||+|...+|+.||||+++.... .... ...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3899999999999999999988899999998753210 0000 12356777777755443
Q ss_pred --eeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc
Q 003932 523 --IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG 600 (785)
Q Consensus 523 --v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~ 600 (785)
...+.+ ...+|||||+++++|..+... .....++.|++.+|.+||..+ ||||||||.|||++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 223332 234799999999988655421 123467899999999999886 99999999999998
Q ss_pred CCCc----------eeeccccceee
Q 003932 601 EAMK----------PKISDFGMARI 615 (785)
Q Consensus 601 ~~~~----------~kl~Dfg~a~~ 615 (785)
+++. +.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 8773 88999997764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=3.3e-11 Score=123.71 Aligned_cols=148 Identities=18% Similarity=0.116 Sum_probs=114.9
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEE
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 537 (785)
+......|.+...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+.++++++.+....++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3444567888899999999999999865 6789999986532122245788999999884 6778889999988888999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS---------------------------------- 583 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------- 583 (785)
||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999999765311 1223467889999999999821
Q ss_pred ----------------------CCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 584 ----------------------RLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 584 ----------------------~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998765667999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.03 E-value=3.7e-10 Score=115.61 Aligned_cols=137 Identities=15% Similarity=0.169 Sum_probs=100.5
Q ss_pred CCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCc--eeeEEEEEecCCccEEEEEec
Q 003932 465 RFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN--LIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~ 542 (785)
++.+..+.+.|..+.||++...+|+.+++|+..... ...+..|+.+++.+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 444433334566799999987777889999976542 245678999988885444 556888888777889999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS--------------------------------------- 583 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 583 (785)
+|.+|. ... .+ ...++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999884 211 11 1256777888888888643
Q ss_pred ----------------CCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 584 ----------------RLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 584 ----------------~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=8.2e-09 Score=111.01 Aligned_cols=143 Identities=15% Similarity=0.268 Sum_probs=107.5
Q ss_pred cceeeceeCcEEEEEEEeCCCcEEEEEEcC--CCC-hhhHHHHHHHHHHHHcCC--CCceeeEEEEEecC---CccEEEE
Q 003932 468 IRNKLGEGGYGPVYKGVLPCGEVIAVKKLS--KTS-TQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDS---EERMLIY 539 (785)
Q Consensus 468 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 539 (785)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +..+.+++.++.+. ...++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999999876 4678889876 322 122346788999999886 45678899988776 3489999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS------------------------------------ 583 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 583 (785)
||++|..+.+.. ...++...+..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874322 123667788889999999999999731
Q ss_pred -------------------CCCeEEecccCCCEEEcCCCc--eeeccccceeee
Q 003932 584 -------------------RLTIIHRDLKVSNILLGEAMK--PKISDFGMARIF 616 (785)
Q Consensus 584 -------------------~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~~ 616 (785)
...++|||+++.|||++.++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997753 689999998763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.76 E-value=7.9e-09 Score=108.34 Aligned_cols=183 Identities=19% Similarity=0.172 Sum_probs=121.6
Q ss_pred ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcC-CCCc--eeeEEEEEecCC---ccEEEEEec
Q 003932 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVN--LIRVLGFCIDSE---ERMLIYEYM 542 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~ 542 (785)
.+.++.|....||+.. ..+++|+.... .....+.+|..+++.+ .+.. +.+++....... ..++||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 45888986432 3446788999999887 3332 445555544333 357899999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS--------------------------------------- 583 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 583 (785)
+|.+|..... ..++..++..++.++++.|+.||...
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998865331 23566777788888888888888621
Q ss_pred ----------------CCCeEEecccCCCEEEcC--CCceeeccccceeeecccccccccccccccCCc---ccccccCC
Q 003932 584 ----------------RLTIIHRDLKVSNILLGE--AMKPKISDFGMARIFAKESLEENTEQVVGTIGY---IPPEYATK 642 (785)
Q Consensus 584 ----------------~~~ivH~Dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 642 (785)
...++|+|++|.||++++ ...+.|+||+.+....+... ....... ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHH
Confidence 235899999999999998 55678999999876432110 0000011 12221110
Q ss_pred -----CC---------CCChhhHHHHHHHHHHHHcCCCCC
Q 003932 643 -----GV---------YSTKSDVFSFGVLLLQIISGKRLS 668 (785)
Q Consensus 643 -----~~---------~~~~~DvwSlGvvl~elltG~~p~ 668 (785)
+. .....+.|+++.++|.+.+|..++
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 112368999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=5.8e-06 Score=86.40 Aligned_cols=137 Identities=20% Similarity=0.162 Sum_probs=94.6
Q ss_pred ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCC---ceeeEEEEEe-cCCccEEEEEecCC
Q 003932 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV---NLIRVLGFCI-DSEERMLIYEYMPN 544 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 544 (785)
.+.++.|....||+. +..+++|+.. .......+..|..+|+.+.+. .+.+++.++. .....++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 367888999999987 5668888853 233456788999999998642 3566777664 34567899999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY------------------------------------------ 582 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 582 (785)
.+|...... .++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888653211 123344444555555555555532
Q ss_pred ---------------CCCCeEEecccCCCEEEcC---CCc-eeeccccceeee
Q 003932 583 ---------------SRLTIIHRDLKVSNILLGE---AMK-PKISDFGMARIF 616 (785)
Q Consensus 583 ---------------~~~~ivH~Dikp~Nill~~---~~~-~kl~Dfg~a~~~ 616 (785)
.+..++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 455 489999988764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.1e-06 Score=84.53 Aligned_cols=136 Identities=16% Similarity=0.170 Sum_probs=96.2
Q ss_pred eeeceeCcE-EEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEEEEecCCCC
Q 003932 470 NKLGEGGYG-PVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLIYEYMPNKS 546 (785)
Q Consensus 470 ~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 546 (785)
+.+..|..+ .||+.... ++..+++|+-... ....+..|...|+.+. +-.+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556554 68987754 4567889986432 3456788999988774 4457788899988889999999999988
Q ss_pred hhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 003932 547 LDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS------------------------------------------- 583 (785)
Q Consensus 547 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 583 (785)
+.+..... ......++.+++..|..||...
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 76654211 1122345566666666666421
Q ss_pred ------------CCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 584 ------------RLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 584 ------------~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999877777999998865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=5.5e-06 Score=88.64 Aligned_cols=81 Identities=6% Similarity=-0.011 Sum_probs=56.1
Q ss_pred ceee-ceeCcEEEEEEEeC-------CCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCC-C--CceeeEEEEEecC--
Q 003932 469 RNKL-GEGGYGPVYKGVLP-------CGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQ-H--VNLIRVLGFCIDS-- 532 (785)
Q Consensus 469 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 532 (785)
.+.| +.|....+|+.... +++.+++|+..... ......+..|..+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88989999988754 25678899875432 101135677888888774 2 3567788887655
Q ss_pred -CccEEEEEecCCCChhh
Q 003932 533 -EERMLIYEYMPNKSLDC 549 (785)
Q Consensus 533 -~~~~lv~e~~~~gsL~~ 549 (785)
...++|||+++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.69 E-value=7.3e-05 Score=79.20 Aligned_cols=141 Identities=13% Similarity=0.208 Sum_probs=79.1
Q ss_pred eeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-----CCceeeEE-E--EEecCCccEEEEEe
Q 003932 470 NKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-----HVNLIRVL-G--FCIDSEERMLIYEY 541 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~ 541 (785)
+.|+.|..+.||+....++ .+++|+.... . ..+..|..+++.|. .|.++... | +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987654 5899998752 2 23334555554442 24333310 0 11234567899999
Q ss_pred cCCCChhh--------------hhcCCcc----c-------cCCCHHHH-------------------------------
Q 003932 542 MPNKSLDC--------------YLFDPIR----K-------LILDWKKR------------------------------- 565 (785)
Q Consensus 542 ~~~gsL~~--------------~l~~~~~----~-------~~l~~~~~------------------------------- 565 (785)
++|.++.. .+|.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876530 0111000 0 01122211
Q ss_pred HHHHHHHHHHHHHHhh----------cCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 566 VHIIEGITQGLLYLQE----------YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 566 ~~i~~~i~~~l~~LH~----------~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
..+...+..++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666653 1245699999999999998888999999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00011 Score=79.62 Aligned_cols=75 Identities=13% Similarity=0.134 Sum_probs=49.4
Q ss_pred ceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCCh-------hhHHHHHHHHHHHHcCCC--C-ceeeEEEEEecCCccEE
Q 003932 469 RNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTST-------QGFEEFKNEVMLTAKLQH--V-NLIRVLGFCIDSEERML 537 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 537 (785)
.+.||.|..+.||++... +++.+++|....... ...+.+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 467899998653211 122345778888887632 3 34456654 3456789
Q ss_pred EEEecCCC
Q 003932 538 IYEYMPNK 545 (785)
Q Consensus 538 v~e~~~~g 545 (785)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00036 Score=71.88 Aligned_cols=80 Identities=19% Similarity=0.202 Sum_probs=59.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC---CceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH---VNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e 540 (785)
....-.+.+|.|..+.||+....+|+.+++|+...........+..|...|+.|.. -.+.+++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34556688999999999999999999999999765544334467889998888742 2345555542 3579999
Q ss_pred ecCCCCh
Q 003932 541 YMPNKSL 547 (785)
Q Consensus 541 ~~~~gsL 547 (785)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00091 Score=69.44 Aligned_cols=138 Identities=17% Similarity=0.111 Sum_probs=91.6
Q ss_pred ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC---CCceeeEEEEEecCCccEEEEEecCCC
Q 003932 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLIYEYMPNK 545 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 545 (785)
.+.|+.|....+|+.... +..+++|+.... ....+..|...|+.|. ...+.+++.++......++|||++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 467999999999999865 667889987543 3456788988888873 356888888888778899999999988
Q ss_pred Chhh-----------hhcCCcc-------------------ccCCCHHHHH---HHHH----------------HHH-HH
Q 003932 546 SLDC-----------YLFDPIR-------------------KLILDWKKRV---HIIE----------------GIT-QG 575 (785)
Q Consensus 546 sL~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~~----------------~i~-~~ 575 (785)
.+.. .|+.... .-.-+|.... ++.. .++ ..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1121110 0012454322 1111 111 11
Q ss_pred HHHHhh-cCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 576 LLYLQE-YSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 576 l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
...|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223321 2245799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00074 Score=73.72 Aligned_cols=78 Identities=9% Similarity=0.086 Sum_probs=50.1
Q ss_pred CCCeEEecccCCCEEEcCCCceeeccccceeeecccccccccccccc--cCCcccccccCCCC---CCChhhHHHHHHHH
Q 003932 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVG--TIGYIPPEYATKGV---YSTKSDVFSFGVLL 658 (785)
Q Consensus 584 ~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwSlGvvl 658 (785)
...++|+|++|.|||++.++ ++|+||+.+..-.+... ...... ...|++|+...... .....++.+....+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45799999999999999876 99999999876432110 000111 23466766554221 12245666888888
Q ss_pred HHHHcCC
Q 003932 659 LQIISGK 665 (785)
Q Consensus 659 ~elltG~ 665 (785)
|+.+++.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887753
|
| >2vtf_A Endo-beta-N-acetylglucosaminidase; hydrolase, family 85, glycosidase, carbohydrat binding; HET: B3P PGE; 1.79A {Arthrobacter protophormiae} PDB: 3fhq_A* 3fha_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00033 Score=78.66 Aligned_cols=154 Identities=10% Similarity=0.064 Sum_probs=96.3
Q ss_pred HHHHHhcCCCceEEEEec-CCCCCC--cccchhhh-cChhhhHHHHHHHHHHHHHcCCceeeeeccCC-CCCCCchhHHH
Q 003932 80 ADTVKKKNPSITTILSIG-QGKDTN--YSIYSSMV-RNSSHRKSFIDSSIRIARLYGFRGLDFAWTAP-NTSTDMFNIGL 154 (785)
Q Consensus 80 ~~~~k~~~p~lkv~~sig-G~~~~~--~~~fs~~~-~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p-~~~~d~~~~~~ 154 (785)
+.++|++ ++||+=.+. .|...+ ......++ .++..|..+|+.++++++.|||||+.||+|.+ ...++.+++..
T Consensus 115 idaAHrn--GV~VlGt~~fe~~~~gg~~~~~~~lL~~~~~~~~~~a~kLv~~a~~yGFDGw~IN~E~~~~~~~~~~~l~~ 192 (626)
T 2vtf_A 115 IDASHRN--GVPILGNVFFPPTVYGGQLEWLEQMLEQEEDGSFPLADKLLEVADYYGFDGWFINQQTEGADEGTAEAMQA 192 (626)
T ss_dssp HHHHHHT--TCCEEEEEEECCGGGTCCHHHHHHHTCCCTTCCCHHHHHHHHHHHHHTCCEEEEEECCTTCCHHHHHHHHH
T ss_pred HHHHHHc--CCEEEEEEecCcccCCcHHHHHHHHhccCccchHHHHHHHHHHHHHhCCCceEEeeccccCCHHHHHHHHH
Confidence 3446666 599985443 121111 13356777 67778889999999999999999999999975 34567889999
Q ss_pred HHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCC----
Q 003932 155 LFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGS---- 230 (785)
Q Consensus 155 ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~---- 230 (785)
|+++|++.... +..+ =+..-|+++-.-.|.+.....+.+....
T Consensus 193 F~~~L~~~~~~---------~~~v------------------------~WYDs~t~~G~l~wQn~Ln~~N~~ff~~~~~~ 239 (626)
T 2vtf_A 193 FLVYLQEQKPE---------GMHI------------------------MWYDSMIDTGAIAWQNHLTDRNKMYLQNGSTR 239 (626)
T ss_dssp HHHHHHHHSCT---------TCEE------------------------EEESCBCTTSCBCCCSSCCTTTGGGTEETTEE
T ss_pred HHHHHHHhCCC---------CcEE------------------------EEeeccccCCCEeeccccCHHHHHHHhccCCC
Confidence 99999865421 1111 1111222222223444444445544443
Q ss_pred -CCCCC-CC---CHHHHHHHHHHcCCCCCceeeccccccceee
Q 003932 231 -ISGRF-AR---STDQVLKAWIERGLSADKLVMCLPFYGYAWT 268 (785)
Q Consensus 231 -~~~~~-~~---~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~ 268 (785)
++... .+ .++..++.....|.++..|.+||=..||++.
T Consensus 240 v~D~~FlNY~W~~l~~S~~~A~~~g~~~~dvy~GiDv~grg~~ 282 (626)
T 2vtf_A 240 VADSMFLNFWWRDQRQSNELAQALGRSPYDLYAGVDVEARGTS 282 (626)
T ss_dssp CCSEEEECSCCSCCHHHHHHHHHTTCCGGGEEEEEECTTTGGG
T ss_pred ccceEEEccCCCChHHHHHHHHHhCCCHHHEEEEEEEecCccC
Confidence 21110 11 3456666666789999999999999998763
|
| >2w91_A Endo-beta-N-acetylglucosaminidase D; hydrolase, N-glycan, secreted, oxazoline, NAG-thiazoline, substrate-participation; 1.40A {Streptococcus pneumoniae} PDB: 2w92_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00054 Score=77.28 Aligned_cols=157 Identities=10% Similarity=0.077 Sum_probs=101.7
Q ss_pred HHHHHhcCCCceEEEEec-CCCCCC--cccchhhh-cChhhhHHHHHHHHHHHHHcCCceeeeeccCC--CCCCCchhHH
Q 003932 80 ADTVKKKNPSITTILSIG-QGKDTN--YSIYSSMV-RNSSHRKSFIDSSIRIARLYGFRGLDFAWTAP--NTSTDMFNIG 153 (785)
Q Consensus 80 ~~~~k~~~p~lkv~~sig-G~~~~~--~~~fs~~~-~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p--~~~~d~~~~~ 153 (785)
+.++|++ +++|+-.|- .|...+ ......++ .+++.|..+|+.++++++.|||||+.||+|.+ ...++.+++.
T Consensus 107 idaAHrn--GV~VlGT~~fe~~~~~~~~~~~~~lL~~~~~~~~~~a~kLv~la~~yGFDGw~IN~E~~~~~~~~~~~~l~ 184 (653)
T 2w91_A 107 IDAGHRN--GVPVYGTLFFNWSNSIADQERFAEALKQDADGSFPIARKLVDMAKYYGYDGYFINQETTGDLVKPLGEKMR 184 (653)
T ss_dssp HHHHHHT--TCCEEEEEEEEEECCHHHHHHHHHHTCCCTTSCCHHHHHHHHHHHHHTCCEEEEEEEECSTTTGGGHHHHH
T ss_pred HHHHHHC--CCEEEEEEecCcccCCcHHHHHHHHhccCccchHHHHHHHHHHHHHhCCCceEEeecccCCCCHHHHHHHH
Confidence 3446666 599985442 111111 12356777 67888899999999999999999999999975 3567889999
Q ss_pred HHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCC-
Q 003932 154 LLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSIS- 232 (785)
Q Consensus 154 ~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~- 232 (785)
.|+++|++.++... ... .+=+..-|+++-.-.|.+.....+.+.+....
T Consensus 185 ~F~~~L~~~~~~~~------~~~------------------------~v~WYDs~t~~G~l~wQn~Ln~~N~~ff~~~~~ 234 (653)
T 2w91_A 185 QFMLYSKEYAAKVN------HPI------------------------KYSWYDAMTYNYGRYHQDGLGEYNYQFMQPEGD 234 (653)
T ss_dssp HHHHHHHHHHHHTT------CCC------------------------EEEEESCBCSSSSBCCCSSSCTTTGGGTCCBTT
T ss_pred HHHHHHHHHHhccC------CCc------------------------EEEEeeccccCCcEeecccccHhHHHHHhccCC
Confidence 99999998875410 000 11122233333333466666777777766522
Q ss_pred -----CCC-CC-----CHHHHHHHHHHcCCCCCceeecccccc-ceee
Q 003932 233 -----GRF-AR-----STDQVLKAWIERGLSADKLVMCLPFYG-YAWT 268 (785)
Q Consensus 233 -----~~~-~~-----~~~~~v~~~~~~gvp~~KlvlGip~YG-~~~~ 268 (785)
... .+ .....++.....|.++..|.+||=..| ++|.
T Consensus 235 ~~~~D~~FlNY~W~~~~l~~S~~~A~~~g~~~~dvy~GiDV~gggg~~ 282 (653)
T 2w91_A 235 KVPADNFFANFNWDKAKNDYTIATANWIGRNPYDVFAGLELQQGGSYK 282 (653)
T ss_dssp BCSCSEEEECSCCCHHHHHHHHHHHHHHTCCGGGEEEEEEHHHHTGGG
T ss_pred CcccceEEEecCCCcchHHHHHHHHHHhCCCHHHEEEEEEEecCCCCC
Confidence 111 11 334555555566889999999999888 6553
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00092 Score=69.98 Aligned_cols=159 Identities=14% Similarity=0.073 Sum_probs=86.7
Q ss_pred cChHHHHHHhcCCCc-----ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCc--eeeEE
Q 003932 454 YSLADIEAATERFSI-----RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN--LIRVL 526 (785)
Q Consensus 454 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 526 (785)
++.+++.....+|.+ .+.|+.|....+|+....++ .+++|+...... .+.+..|..+++.+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence 445556555556654 34567788899999987655 578998875311 124456777766653212 22332
Q ss_pred EE------EecCCccEEEEEecCCCChhhh--------------hcCCcc---cc---CC---CHHHHHH----------
Q 003932 527 GF------CIDSEERMLIYEYMPNKSLDCY--------------LFDPIR---KL---IL---DWKKRVH---------- 567 (785)
Q Consensus 527 ~~------~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~---~~---~l---~~~~~~~---------- 567 (785)
.. ....+..++++++++|..+... ++.... .. .. .|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1123456899999988664210 111000 00 01 1221100
Q ss_pred --HHHHHHHHHHHHhhc----CCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 568 --IIEGITQGLLYLQEY----SRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 568 --i~~~i~~~l~~LH~~----~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
+...+...+..++.. .+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001134445555532 234699999999999999876668999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0022 Score=68.45 Aligned_cols=141 Identities=17% Similarity=0.182 Sum_probs=82.7
Q ss_pred eeeceeCcEEEEEEEeC--------CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCccEEEEE
Q 003932 470 NKLGEGGYGPVYKGVLP--------CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 540 (785)
+.|..|-...+|++... +++.+++|+.... ........+|..+++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 56777888889998864 2478999986442 223456678988888774 2223566766643 39999
Q ss_pred ecCCCChhhh-h----------------cCCc--cccCC--CHHHHHHHHHHHHH-------------------HHHHH-
Q 003932 541 YMPNKSLDCY-L----------------FDPI--RKLIL--DWKKRVHIIEGITQ-------------------GLLYL- 579 (785)
Q Consensus 541 ~~~~gsL~~~-l----------------~~~~--~~~~l--~~~~~~~i~~~i~~-------------------~l~~L- 579 (785)
|++|.+|..- + |... -.... -+.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 1 1110 01111 13344444433321 12333
Q ss_pred ---hhc-CCCCeEEecccCCCEEEcCC----Cceeeccccceee
Q 003932 580 ---QEY-SRLTIIHRDLKVSNILLGEA----MKPKISDFGMARI 615 (785)
Q Consensus 580 ---H~~-~~~~ivH~Dikp~Nill~~~----~~~kl~Dfg~a~~ 615 (785)
... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 23469999999999999876 7899999998865
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0011 Score=72.47 Aligned_cols=72 Identities=15% Similarity=0.223 Sum_probs=49.4
Q ss_pred eeeceeCcEEEEEEEeCC--------CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCce-eeEEEEEecCCccEEEEE
Q 003932 470 NKLGEGGYGPVYKGVLPC--------GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 540 (785)
+.|+.|-...+|++...+ ++.+++|+...... .+.+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 578888899999998652 47899998854211 1345578888887743333 566766532 38999
Q ss_pred ecCCCCh
Q 003932 541 YMPNKSL 547 (785)
Q Consensus 541 ~~~~gsL 547 (785)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987555
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0039 Score=65.49 Aligned_cols=142 Identities=13% Similarity=0.100 Sum_probs=72.2
Q ss_pred eeeceeCcEE-EEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC--CceeeEEEEEecCCccEEEEEecCCCC
Q 003932 470 NKLGEGGYGP-VYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH--VNLIRVLGFCIDSEERMLIYEYMPNKS 546 (785)
Q Consensus 470 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 546 (785)
+.|+.|.... +|+....+++.+++|....... +.+..|+.+++.+.. -.+.+++.+..+ .-+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence 3465555444 6676654466777887644321 223456666665532 235566665433 3378999997766
Q ss_pred hhhhhcC---------------------Ccc--ccCCCHHHHH-------H-------------HHHHHHHHHHHHh---
Q 003932 547 LDCYLFD---------------------PIR--KLILDWKKRV-------H-------------IIEGITQGLLYLQ--- 580 (785)
Q Consensus 547 L~~~l~~---------------------~~~--~~~l~~~~~~-------~-------------i~~~i~~~l~~LH--- 580 (785)
+.+.+.. ... ...++..... . ....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 5433211 000 0111111100 0 0011112222221
Q ss_pred hcCCCCeEEecccCCCEEEcCC----Cceeeccccceeee
Q 003932 581 EYSRLTIIHRDLKVSNILLGEA----MKPKISDFGMARIF 616 (785)
Q Consensus 581 ~~~~~~ivH~Dikp~Nill~~~----~~~kl~Dfg~a~~~ 616 (785)
......++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1134569999999999999874 67899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0047 Score=67.72 Aligned_cols=74 Identities=14% Similarity=0.074 Sum_probs=48.5
Q ss_pred eeeceeCcEEEEEEEeCC-CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCce-eeEEEEEecCCccEEEEEecCCCCh
Q 003932 470 NKLGEGGYGPVYKGVLPC-GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
+.|+.|-...+|++...+ +..+++|+........ -....|..+++.|...++ .++++.+. -.+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCccC
Confidence 678889899999998764 4788899875432111 112578888888865444 56777663 2369999988665
Q ss_pred h
Q 003932 548 D 548 (785)
Q Consensus 548 ~ 548 (785)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0019 Score=66.87 Aligned_cols=139 Identities=12% Similarity=0.113 Sum_probs=75.7
Q ss_pred ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCce-eeEEEEEecCCccEEEEEec-CCCC
Q 003932 469 RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLIYEYM-PNKS 546 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 546 (785)
.+.|+.|....+|+. +.+++|+....... .....+|...++.+...++ .++++++ .+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 578999999999998 45788887653211 1123457777766632222 4555543 44467899999 6655
Q ss_pred hhhh------------------hcCCcc--ccCCCH-HHHHHHHH--------------HHHHHH----HHHhh-cCCCC
Q 003932 547 LDCY------------------LFDPIR--KLILDW-KKRVHIIE--------------GITQGL----LYLQE-YSRLT 586 (785)
Q Consensus 547 L~~~------------------l~~~~~--~~~l~~-~~~~~i~~--------------~i~~~l----~~LH~-~~~~~ 586 (785)
|... +|.... ...... .....+.. .+.+.+ ..|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5320 011000 000011 11111100 011111 11111 12345
Q ss_pred eEEecccCCCEEEcCCCceeeccccceeee
Q 003932 587 IIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 587 ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
++|+|+.+.||+ ..++.+.|+||..+..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56678899999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0098 Score=62.18 Aligned_cols=158 Identities=13% Similarity=0.105 Sum_probs=87.6
Q ss_pred cChHHHHHHhcCCCc-----ceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCC--ceeeEE
Q 003932 454 YSLADIEAATERFSI-----RNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV--NLIRVL 526 (785)
Q Consensus 454 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~ 526 (785)
.+.+++......|.+ ...|+ |....||+....+|+.+++|+.+.... ..+.+..|..+++.+... .+++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeeccee
Confidence 344555444444432 34576 888899998876677899999864321 234566777777766322 233343
Q ss_pred EE-----EecCCccEEEEEecCCCChhh----h----------hcCC------ccccCCCHHHH----HHH---------
Q 003932 527 GF-----CIDSEERMLIYEYMPNKSLDC----Y----------LFDP------IRKLILDWKKR----VHI--------- 568 (785)
Q Consensus 527 ~~-----~~~~~~~~lv~e~~~~gsL~~----~----------l~~~------~~~~~l~~~~~----~~i--------- 568 (785)
.. ....+..+++|++++|.++.. . ++.. ......++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 111334578999998865431 0 1110 00111222111 000
Q ss_pred ------HHHHHHHHHHHhhc----CCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 569 ------IEGITQGLLYLQEY----SRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 569 ------~~~i~~~l~~LH~~----~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
...+...+..+... .+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 234589999999999999 4 899999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0054 Score=65.46 Aligned_cols=73 Identities=11% Similarity=0.081 Sum_probs=43.9
Q ss_pred eeeceeCcEEEEEEEeCC---------CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCc-eeeEEEEEecCCccEEEE
Q 003932 470 NKLGEGGYGPVYKGVLPC---------GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 539 (785)
+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...+ ..++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 567888888999988653 267888987653221 112356777777764333 34566544 247899
Q ss_pred EecCCCCh
Q 003932 540 EYMPNKSL 547 (785)
Q Consensus 540 e~~~~gsL 547 (785)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.19 E-value=0.022 Score=54.54 Aligned_cols=100 Identities=10% Similarity=0.006 Sum_probs=64.7
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccccc
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEEN 624 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 624 (785)
-||.+.|.. ...++++.+++.++.|.+..|.-+-... .+ ..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 367888753 4567999999999999999887762211 11 1233457899999999988774 1110
Q ss_pred cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcC
Q 003932 625 TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISG 664 (785)
Q Consensus 625 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG 664 (785)
.....+.|||... ...+.+.=|||||+++|.-+--
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123566888764 3457889999999999998863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.11 E-value=0.019 Score=60.36 Aligned_cols=33 Identities=21% Similarity=0.406 Sum_probs=28.8
Q ss_pred CCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 584 ~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
...++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998888999999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.47 E-value=0.15 Score=54.94 Aligned_cols=74 Identities=15% Similarity=0.116 Sum_probs=48.4
Q ss_pred ceeeceeCcEEEEEEEeCC--------CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCc-eeeEEEEEecCCccEEEE
Q 003932 469 RNKLGEGGYGPVYKGVLPC--------GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 539 (785)
.+.|..|-...+|+..... ++.+++|+....... .-...+|..+++.+...+ ..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4678788889999998653 578999987543221 112356777777764222 345555432 37899
Q ss_pred EecCCCCh
Q 003932 540 EYMPNKSL 547 (785)
Q Consensus 540 e~~~~gsL 547 (785)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.17 E-value=0.29 Score=52.55 Aligned_cols=30 Identities=33% Similarity=0.437 Sum_probs=25.7
Q ss_pred CeEEecccCCCEEE------cCCCceeeccccceee
Q 003932 586 TIIHRDLKVSNILL------GEAMKPKISDFGMARI 615 (785)
Q Consensus 586 ~ivH~Dikp~Nill------~~~~~~kl~Dfg~a~~ 615 (785)
.++|+|+.+.|||+ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567799999999875
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A | Back alignment and structure |
|---|
Probab=85.65 E-value=1.3 Score=51.25 Aligned_cols=157 Identities=10% Similarity=0.052 Sum_probs=87.7
Q ss_pred HHHHHHhcCCCceEEEEec-CCCCCCc--ccchh-hhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCC--CchhH
Q 003932 79 FADTVKKKNPSITTILSIG-QGKDTNY--SIYSS-MVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTST--DMFNI 152 (785)
Q Consensus 79 ~~~~~k~~~p~lkv~~sig-G~~~~~~--~~fs~-~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~--d~~~~ 152 (785)
.+.++|++ +|||+=.|- .|..... ..|.. +..++.....+++.++++++.|||||.=|+-|..+... ...++
T Consensus 257 winaAHrn--GV~VLGT~i~ew~~~~~~~~~~~~~L~~d~~g~~~~A~KLveiAkyyGFDGWlINiE~~~~~~~~~~~~l 334 (937)
T 3gdb_A 257 VIDAGHRN--GVPVYGTLFFNWSNSIADQERFAEALKQDADGSFPIARKLVDMAKYYGYDGYFINQETTGDLVKPLGEKM 334 (937)
T ss_dssp HHHHHHHT--TCCEEEEEEEEEECCHHHHHHHHHHTCCCTTSCCHHHHHHHHHHHHHTCCEEEEEEEECSTTTGGGHHHH
T ss_pred HHHHHHhc--CCeEEEEEecCcccchhhHHHHHHHhccCccchhHHHHHHHHHHHHcCcCceEeccccccccchhhHHHH
Confidence 34456766 599985553 1222111 12333 33566667799999999999999999999999875422 23556
Q ss_pred HHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCC--
Q 003932 153 GLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGS-- 230 (785)
Q Consensus 153 ~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~-- 230 (785)
..|++.+++..++.+ .... +=|..-|++|..-.|.+.....+.+++..
T Consensus 335 ~~Fl~yl~e~~~~v~------~~~~------------------------ViWYDSvt~~G~l~wQN~Ln~~N~~Ff~~~~ 384 (937)
T 3gdb_A 335 RQFMLYSKEYAAKVN------HPIK------------------------YSWYDAMTYNYGRYHQDGLGEYNYQFMQPEG 384 (937)
T ss_dssp HHHHHHHHHHHHHTT------CCCE------------------------EEEESCBCSSSSBCCCSSSCTTTGGGGCCBT
T ss_pred HHHHHHHHHHHhhcC------CCeE------------------------EEEeccccCCCCeeeccchhhHHHHHHhccc
Confidence 666666664433211 0100 11122223332223444445555554431
Q ss_pred ----CCCCC-CC-C----HHHHHHHHHHcCCCCCceeecccccccee
Q 003932 231 ----ISGRF-AR-S----TDQVLKAWIERGLSADKLVMCLPFYGYAW 267 (785)
Q Consensus 231 ----~~~~~-~~-~----~~~~v~~~~~~gvp~~KlvlGip~YG~~~ 267 (785)
++... .+ | .+..++.....|.++..|.+||=.+|++.
T Consensus 385 ~~~~~DgiFlNY~W~~~~L~~S~~~Ak~lGr~~~DVY~GIDV~g~G~ 431 (937)
T 3gdb_A 385 DKVPADNFFANFNWDKAKNDYTIATANWIGRNPYDVFAGLELQQGGS 431 (937)
T ss_dssp TBCSCSEEEECSCCCHHHHHHHHHHHHHHTCCGGGEEEEEEHHHHTG
T ss_pred cccccceeEEecCCCccchHHHHHHHHHhCCCHHHEEEEEEEECCCc
Confidence 11110 11 1 23345555567999999999999988763
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.74 E-value=6.6 Score=37.42 Aligned_cols=116 Identities=9% Similarity=0.049 Sum_probs=78.0
Q ss_pred CCCceeeEEEEEecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCE
Q 003932 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNI 597 (785)
Q Consensus 518 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Ni 597 (785)
.||++++. .+..+.+.+.+.++. ..+...+- .-..++...+++++.+|+....+++. -+|--|.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDI--NDNHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECC--CTTSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEc--CcccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 68888876 455555655555543 33332222 12347788999999999887765553 37888999999
Q ss_pred EEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCc
Q 003932 598 LLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSM 669 (785)
Q Consensus 598 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~ 669 (785)
+++.++.+++.-.|+-.. ++|. ..+...=.-.+=|++..+++++..|.
T Consensus 111 ~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999998776322 1222 12333445567888999999987764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 785 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-34 | |
| d1goia2 | 356 | c.1.8.5 (A:3-291,A:380-446) Chitinase B, catalytic | 1e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d1vf8a1 | 302 | c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin | 4e-28 | |
| d1vf8a1 | 302 | c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin | 1e-04 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-28 | |
| d1w9pa1 | 333 | c.1.8.5 (A:39-298,A:361-433) Chitinase 1 {Aspergil | 1e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d2pi6a1 | 292 | c.1.8.5 (A:1-239,A:308-361) Signal processing prot | 4e-27 | |
| d2pi6a1 | 292 | c.1.8.5 (A:1-239,A:308-361) Signal processing prot | 6e-06 | |
| d1ll7a1 | 330 | c.1.8.5 (A:36-292,A:355-427) Chitinase 1 {Fungus ( | 5e-27 | |
| d1wb0a1 | 297 | c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Huma | 1e-26 | |
| d1wb0a1 | 297 | c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Huma | 2e-05 | |
| d1edqa2 | 358 | c.1.8.5 (A:133-443,A:517-563) Chitinase A, catalyt | 2e-26 | |
| d1jnda1 | 327 | c.1.8.5 (A:2-278,A:371-420) Imaginal disc growth f | 1e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 | |
| d1kfwa1 | 374 | c.1.8.5 (A:10-327,A:389-444) Psychrophilic chitina | 3e-19 | |
| d1itxa1 | 347 | c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillu | 3e-18 | |
| d1itxa1 | 347 | c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillu | 1e-07 | |
| d1nara_ | 289 | c.1.8.5 (A:) Seed storage protein {Vicia narbonens | 1e-14 | |
| d1edta_ | 265 | c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {St | 1e-13 | |
| d2ebna_ | 285 | c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Fl | 3e-13 | |
| d1vf8a2 | 70 | d.26.3.1 (A:246-315) Chitinase-like lectin ym1 {Mo | 6e-09 | |
| d2hvma_ | 273 | c.1.8.5 (A:) Hevamine A (chitinase/lysozyme) {Para | 2e-07 | |
| d1itxa2 | 72 | d.26.3.1 (A:338-409) Chitinase A1 {Bacillus circul | 5e-07 | |
| d1wb0a2 | 68 | d.26.3.1 (A:267-336) Chitotriosidase {Human (Homo | 2e-06 | |
| d1edqa3 | 73 | d.26.3.1 (A:444-516) Chitinase A {Serratia marcesc | 3e-06 | |
| d1eoka_ | 282 | c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Fl | 3e-06 | |
| d1kfwa2 | 61 | d.26.3.1 (A:328-388) Psychrophilic chitinase B {Ar | 1e-05 | |
| d2pi6a2 | 68 | d.26.3.1 (A:240-307) Signal processing protein (SP | 1e-05 | |
| d1ta3a_ | 274 | c.1.8.5 (A:) Xylanase inhibitor protein I, XIP-I { | 8e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 3e-69
Identities = 74/294 (25%), Positives = 142/294 (48%), Gaps = 22/294 (7%)
Query: 458 DIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL 517
D E + ++ ++G G +G VYKG + + ++ + Q + FKNEV + K
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
+HVN++ +G+ + + ++ ++ SL +L + + K + I QG+
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMD 118
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
YL S IIHRDLK +NI L E + KI DFG+A + ++ S EQ+ G+I ++ P
Sbjct: 119 YLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 638 EYAT---KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694
E K YS +SDV++FG++L ++++G+ N++ + + G
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP------YSNINNRDQIIFMVGRG---- 225
Query: 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPK 748
++ L S C + C+++ ++RP ++ + ++ ++ PK
Sbjct: 226 YLSPDLSKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIELLARSL--PK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-63
Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 22/276 (7%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
E + +LG G +G V+ G +AVK L + S + F E L +LQH L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
R+ E +I EYM N SL +L P + L K + + I +G+ +++E +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG 643
IHRDL+ +NIL+ + + KI+DFG+AR+ +++ E I + PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 644 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703
++ KSDV+SFG+LL +I++ R+ N + + + G + D+ ++
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCPEE- 238
Query: 704 NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
++ LC +E P DRP+ + S+L++
Sbjct: 239 --------LYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-62
Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
+ ++G G +G V+ G + +A+K + + E+F E + KL H L+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
++ G C++ L++E+M + L YL ++ + + + + + +G+ YL+E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG 643
+IHRDL N L+GE K+SDFGM R + ++ + + PE +
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177
Query: 644 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703
YS+KSDV+SFGVL+ ++ S ++ N + + G L
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------VEDISTGFRLYKPRLAST 229
Query: 704 NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738
+I C +E P DRP+ + L
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 3e-61
Identities = 71/313 (22%), Positives = 128/313 (40%), Gaps = 46/313 (14%)
Query: 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVLPC------GEVIAVKKLSKTSTQGFE-EF 507
L +E +GEG +G V++ P ++AVK L + ++ + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 508 KNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLI-------- 559
+ E L A+ + N++++LG C + L++EYM L+ +L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 560 -------------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPK 606
L +++ I + G+ YL E +HRDL N L+GE M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180
Query: 607 ISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
I+DFG++R + I ++PPE Y+T+SDV+++GV+L +I S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 667 LSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPND 726
+E + + G + ++ + + LC + P D
Sbjct: 241 QPYYGMAHEEV------IYYVRDGNILACPENCPLE---------LYNLMRLCWSKLPAD 285
Query: 727 RPSMLEVSSMLKN 739
RPS + +L+
Sbjct: 286 RPSFCSIHRILQR 298
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-60
Identities = 59/298 (19%), Positives = 122/298 (40%), Gaps = 28/298 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
++ +G+G +G V++G GE +AVK S + + + E+ T L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENIL 60
Query: 524 RVLGFCIDSE----ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
+ + L+ +Y + S LFD + + + + + + GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 580 QE-----YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF--AKESLEENTEQVVGTI 632
+ I HRDLK NIL+ + I+D G+A A ++++ VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 633 GYIPPEYATKGV------YSTKSDVFSFGVLLLQIISGKRLSMLCGINE----NLSILEH 682
Y+ PE + ++D+++ G++ +I + + + +L +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCL-EIALLCVQENPNDRPSMLEVSSMLKN 739
+ E + + + + +R C+ +R + +I C N R + L + L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 7e-60
Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 22/288 (7%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
E + KLG+G +G V+ G +A+K L T E F E + KL+H L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
++ + E ++ EYM SL +L K + + V + I G+ Y++ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN 133
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG 643
+HRDL+ +NIL+GE + K++DFG+AR+ I + PE A G
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 644 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703
++ KSDV+SFG+LL ++ + R+ +N + + + G + +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPECPES- 242
Query: 704 NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPA 751
++ C ++ P +RP+ + + L++ T+ +P
Sbjct: 243 --------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-59
Identities = 62/276 (22%), Positives = 115/276 (41%), Gaps = 22/276 (7%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
+ + +LG G +G V G +A+K + + S +EF E + L H L+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
++ G C +I EYM N L YL + + ++ + + + + + + YL+
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE--- 117
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKG 643
+HRDL N L+ + K+SDFG++R + + + + PPE
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176
Query: 644 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703
+S+KSD+++FGVL+ +I S + YE + + E + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 704 NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ I C E ++RP+ + S + +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 4e-59
Identities = 63/304 (20%), Positives = 115/304 (37%), Gaps = 38/304 (12%)
Query: 459 IEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGF-EEFKNEVMLTAK 516
+E + F ++LG G G V+K P G V+A K + + E+ + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
++ G E + E+M SLD L R + + + + +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
YL + I+HRD+K SNIL+ + K+ DFG++ + VGT Y+
Sbjct: 118 TYL--REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMS 171
Query: 637 PEYATKGVYSTKSDVFSFGVLLLQIISGKR---------LSMLCGINENLSILEHAYELW 687
PE YS +SD++S G+ L+++ G+ L ++ G E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 688 KGGKGVEFVDSFLDDRNSPCKLMR------------------CLEIALLCVQENPNDRPS 729
G+ + + +L+ + C+ +NP +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 730 MLEV 733
+ ++
Sbjct: 292 LKQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 6e-59
Identities = 79/281 (28%), Positives = 131/281 (46%), Gaps = 22/281 (7%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ 518
E ++++KLG G YG VY+GV +AVK L + + + EEF E + +++
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIK 71
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H NL+++LG C +I E+M +L YL + + + +++ I+ + Y
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEY 130
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
L + IHRDL N L+GE K++DFG++R+ ++ + I + PE
Sbjct: 131 L---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPE 186
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698
+S KSDV++FGVLL +I + GI+ L YEL + +E +
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-PYPGID-----LSQVYELLEKDYRMERPEG 240
Query: 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ E+ C Q NP+DRPS E+ +
Sbjct: 241 CPEK---------VYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 9e-59
Identities = 66/277 (23%), Positives = 121/277 (43%), Gaps = 28/277 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
+ + +G+G +G V G G +AVK + +T + F E + +L+H NL+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 524 RVLGFCIDSEERM-LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
++LG ++ + + ++ EYM SL YL R +L + + + + YL+
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 583 SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATK 642
+ +HRDL N+L+ E K+SDFG+ + + + + PE +
Sbjct: 123 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALRE 174
Query: 643 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702
+STKSDV+SFG+LL +I S R+ +++ + G ++ D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCPPA 228
Query: 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
E+ C + RPS L++ L++
Sbjct: 229 ---------VYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 8e-58
Identities = 68/306 (22%), Positives = 119/306 (38%), Gaps = 43/306 (14%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTSTQGF-EEFKNEVMLTAK 516
R S LG G +G V + +AVK L ++ E +E+ + +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 517 L-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLI---------------L 560
L H+N++ +LG C ++I EY L +L I L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 561 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620
D + + + +G+ +L IHRDL NILL KI DFG+AR +S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 680
+ ++ PE VY+ +SDV+S+G+ L ++ S + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----PGMPVD 254
Query: 681 EHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK-- 738
Y++ K G + + + +I C +P RP+ ++ +++
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 739 -NETTN 743
+E+TN
Sbjct: 306 ISESTN 311
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (498), Expect = 2e-57
Identities = 71/315 (22%), Positives = 131/315 (41%), Gaps = 43/315 (13%)
Query: 454 YSLADIEAATERFS---------IRNKLGEGGYGPVYKGVLPC----GEVIAVKKLSKTS 500
++ D A F+ I +G G +G V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 501 T-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLI 559
T + +F +E + + H N+I + G S M+I E+M N SLD +L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 560 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619
+ V ++ GI G+ YL + + +HRDL NIL+ + K+SDFG++R +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 620 SLEENTEQVVG---TIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 676
+ + +G I + PE +++ SDV+S+G+++ +++S
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------- 233
Query: 677 LSILEHAYELWKGGKGVEFVDSFLDDRNSPCKL---MRCLEIALLCVQENPNDRPSMLEV 733
+ + +++ D P + ++ L C Q++ N RP ++
Sbjct: 234 ----------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 734 SSMLKNETTNINTPK 748
+ L N N+ K
Sbjct: 284 VNTLDKMIRNPNSLK 298
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-57
Identities = 62/283 (21%), Positives = 116/283 (40%), Gaps = 27/283 (9%)
Query: 462 ATERFSIRN-KLGEGGYGPVYKGVLPC---GEVIAVKKLSKTSTQGF-EEFKNEVMLTAK 516
+ I + +LG G +G V +GV +A+K L + + + EE E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
L + ++R++G C +E ML+ E L +L ++ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF-AKESLEENTEQVVGTIGYI 635
YL+E + +HRDL N+LL KISDFG+++ A +S + +
Sbjct: 123 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695
PE +S++SDV+S+GV + + +S + + + GK +E
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGKRMEC 233
Query: 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738
+ + C DRP L V ++
Sbjct: 234 PPECPPE---------LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 7e-56
Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 34/278 (12%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQ 518
+ FS ++G G +G VY + EV+A+KK+S + Q +++ EV KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H N I+ G + L+ EY + D + K L + + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
L ++ +IHRD+K NILL E K+ DFG A I A VGT ++ PE
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPE 181
Query: 639 YA---TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695
+G Y K DV+S G+ +++ K N++ + Y + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP------LFNMNAMSALYHIAQNES---- 231
Query: 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
+ S C+Q+ P DRP+ +
Sbjct: 232 -PALQSGHWSE----YFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 7e-56
Identities = 78/302 (25%), Positives = 129/302 (42%), Gaps = 32/302 (10%)
Query: 453 VYSLADIEAATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTSTQGF-E 505
VY + E A E+ ++ +LG+G +G VY+GV +A+K +++ ++
Sbjct: 9 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 68
Query: 506 EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLI------ 559
EF NE + + +++R+LG + ++I E M L YL +
Sbjct: 69 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128
Query: 560 -LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618
K + + I G+ YL +HRDL N ++ E KI DFGM R +
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185
Query: 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS 678
+ + + ++ PE GV++T SDV+SFGV+L +I + NE +
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV- 244
Query: 679 ILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738
G ++ D+ D E+ +C Q NP RPS LE+ S +K
Sbjct: 245 -----LRFVMEGGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSIK 290
Query: 739 NE 740
E
Sbjct: 291 EE 292
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-55
Identities = 69/305 (22%), Positives = 118/305 (38%), Gaps = 45/305 (14%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTSTQGF-EEFKNEVMLTAK 516
E LG G +G V +AVK L + + E +E+ + +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 517 L-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKL----------------- 558
L H N++ +LG C S LI+EY L YL K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 559 ---ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615
+L ++ + + +G+ +L+ S +HRDL N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 616 FAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 675
+S + ++ PE +G+Y+ KSDV+S+G+LL +I S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY-----P 268
Query: 676 NLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735
+ + + Y+L + G ++ ++ I C + RPS ++S
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEE---------IYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 736 MLKNE 740
L +
Sbjct: 320 FLGCQ 324
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 63/283 (22%), Positives = 118/283 (41%), Gaps = 29/283 (10%)
Query: 464 ERFSIRNK-LGEGGYGPVYKGVLP---CGEVIAVKKLSKTSTQG--FEEFKNEVMLTAKL 517
+ ++ +K LG G +G V KG + +AVK L + +E E + +L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 518 QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
+ ++R++G C ++E ML+ E L+ YL + K + ++ ++ G+
Sbjct: 66 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMK 121
Query: 578 YLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE-SLEENTEQVVGTIGYIP 636
YL+ +HRDL N+LL KISDFG+++ + + + + +
Sbjct: 122 YLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 637 PEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696
PE +S+KSDV+SFGVL+ + S + + + + G+ +
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGCP 232
Query: 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ ++ LC + +RP V L+N
Sbjct: 233 AGCPRE---------MYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 7e-55
Identities = 79/312 (25%), Positives = 129/312 (41%), Gaps = 43/312 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP---CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKL-Q 518
++ +GEG +G V K + A+K++ + S +F E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYL-------------FDPIRKLILDWKKR 565
H N+I +LG C L EY P+ +L +L L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENT 625
+H + +G+ YL + IHRDL NIL+GE KI+DFG++R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 626 EQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 685
+ ++ E VY+T SDV+S+GVLL +I+S CG+ YE
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-CGMTC-----AELYE 237
Query: 686 LWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV----SSMLKNET 741
G +E + D+ ++ C +E P +RPS ++ + ML+
Sbjct: 238 KLPQGYRLEKPLNCDDE---------VYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 742 TNINTPKKPAFS 753
T +NT F+
Sbjct: 289 TYVNTTLYEKFT 300
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 8e-55
Identities = 61/294 (20%), Positives = 116/294 (39%), Gaps = 30/294 (10%)
Query: 455 SLADIEAATERFSIR--NKLGEGGYGPVYKGVLPC----GEVIAVKKLSKTSTQGF-EEF 507
++ + + +G G +G VY G L AVK L++ + G +F
Sbjct: 16 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 508 KNEVMLTAKLQHVNLIRVLGFCIDSEER-MLIYEYMPNKSLDCYLFDPIRKLILDWKKRV 566
E ++ H N++ +LG C+ SE +++ YM + L ++ + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135
Query: 567 HIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE 626
+ ++ + +HRDL N +L E K++DFG+AR + +
Sbjct: 136 GLQVAK-----GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190
Query: 627 Q--VVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 684
+ + ++ E ++TKSDV+SFGVLL ++++ +++ +
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITV 245
Query: 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738
L +G + L P E+ L C RPS E+ S +
Sbjct: 246 YLLQGRR-------LLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 9e-55
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 23/273 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVN 521
E + + LGEG YG V V E +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
+++ G + + L EY L + + + + G++YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA- 640
+ I HRD+K N+LL E KISDFG+A +F + E ++ GT+ Y+ PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700
+ ++ DV+S G++L +++G+ +++ WK K +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGEL--PWDQPSDSCQEYSD----WKEKKTYLNPWKKI 232
Query: 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
D L + + ENP+ R ++ ++
Sbjct: 233 DS--------APLALLHKILVENPSARITIPDI 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-54
Identities = 64/286 (22%), Positives = 122/286 (42%), Gaps = 27/286 (9%)
Query: 460 EAATERFSIRNKLGEGGYGPVYKGVLPCGE-----VIAVKKLSKTSTQGF-EEFKNEVML 513
E + + +G G +G VYKG+L +A+K L T+ +F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 514 TAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGIT 573
+ H N+IR+ G + M+I EYM N +LD +L + + + V ++ GI
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIA 120
Query: 574 QGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQ-VVGTI 632
G+ Y + + +HRDL NIL+ + K+SDFG++R+ + T I
Sbjct: 121 AGMKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692
+ PE + +++ SDV+SFG+++ ++++ N +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--------------- 222
Query: 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738
++ ++ ++ + C Q+ RP ++ S+L
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 7e-54
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 26/278 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHV 520
E + + +G G YG K G+++ K+L S + +EV L +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 521 NLIRVLGFCIDSEERML--IYEYMPNKSLDCYLFDPIR-KLILDWKKRVHIIEGITQGLL 577
N++R ID L + EY L + + + LD + + ++ +T L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 578 YL--QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYI 635
+ T++HRDLK +N+ L K+ DFG+ARI ++ + VGT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695
PE + Y+ KSD++S G LL ++ + ++ + + GK
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQ-----KELAGKIREGKFRRI 234
Query: 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
+ D+ EI + RPS+ E+
Sbjct: 235 PYRYSDE---------LNEIITRMLNLKDYHRPSVEEI 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 8e-54
Identities = 55/277 (19%), Positives = 112/277 (40%), Gaps = 27/277 (9%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
+ + I +LG+G +G VYK + A K + S + E++ E+ + A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
++++L ++ E+ ++D + + R L + + + L YL +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD 128
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA- 640
IIHRDLK NIL K++DFG++ + + + +GT ++ PE
Sbjct: 129 NK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVM 183
Query: 641 ----TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696
Y K+DV+S G+ L+++ + + L+ + ++ K
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELNPMRVLLKIAKSEPPTLAQ 237
Query: 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
S + C+++N + R + ++
Sbjct: 238 PSRWSS--------NFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 7e-53
Identities = 60/272 (22%), Positives = 117/272 (43%), Gaps = 24/272 (8%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN 521
++++ K+G+G G VY + + G+ +A+++++ E NE+++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
++ L + +E ++ EY+ S L D + + +D + + Q L +L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT 641
+IHRD+K NILLG K++DFG E + +VGT ++ PE T
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVT 189
Query: 642 KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701
+ Y K D++S G++ +++I G+ N + L Y + G L
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP------YLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
+ C+ + R S E+
Sbjct: 244 A--------IFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 7e-53
Identities = 66/283 (23%), Positives = 109/283 (38%), Gaps = 28/283 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPC----GEVIAVKKLSK---TSTQGFEEFKNEVMLTAK 516
+ + KLG+G +G V +G +AVK L + + ++F EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
L H NLIR+ G + +M + E P SL L +L R + +G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK-ESLEENTEQVVGTIGYI 635
YL+ IHRDL N+LL KI DFG+ R + + E +
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695
PE +S SD + FGV L ++ + + L+ + +++ K G+ +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW-----IGLNGSQILHKIDKEGERLPR 236
Query: 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738
+ D + + C P DRP+ + + L
Sbjct: 237 PEDCPQD---------IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-53
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 35/276 (12%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT---STQGFEEFKNEVMLTAKLQH 519
E F I LG+G +G VY ++A+K L K + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
N++R+ G+ D+ LI EY P ++ L + D ++ I + L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
+IHRD+K N+LLG A + KI+DFG ++ + + GT+ Y+PPE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 175
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699
++ K D++S GVL + + GK ++ E
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP-------------------PFEANTYQETYKRI 216
Query: 700 LDDRNSPCKLM--RCLEIALLCVQENPNDRPSMLEV 733
+ + ++ ++ NP+ RP + EV
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 31/276 (11%)
Query: 466 FSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNL 522
++G G + VYKG+ +A +L + + FK E + LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 523 IRVLGFCIDSEER----MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
+R + + +L+ E M + +L YL R ++ K I +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 579 LQEYSRLTIIHRDLKVSNILL-GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPP 637
L + IIHRDLK NI + G KI D G+A + + V+GT ++ P
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAP 182
Query: 638 EYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697
E + Y DV++FG+ +L++ + + I K
Sbjct: 183 EMY-EEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVK--------P 231
Query: 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
+ D P EI C+++N ++R S+ ++
Sbjct: 232 ASFDKVAIP----EVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-52
Identities = 63/279 (22%), Positives = 120/279 (43%), Gaps = 27/279 (9%)
Query: 466 FSIRNKLGEGGYGPVYKGVLP-----CGEVIAVKKLSK-TSTQGFEEFKNEVMLTAKLQH 519
F LG G +G VYKG+ +A+K+L + TS + +E +E + A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
++ R+LG C+ LI + MP L Y+ + K + + ++ I +G+ YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
++ ++HRDL N+L+ KI+DFG+A++ E E + E I ++ E
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699
+Y+ +SDV+S+GV + ++++ Y+ + ++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKG 229
Query: 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738
P + I + C + + RP E+
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-51
Identities = 53/281 (18%), Positives = 109/281 (38%), Gaps = 27/281 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQ 518
ER + +GEG +G V++G+ +A+K ++ E+F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H ++++++G + +I E L +L L D + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAY 123
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
L+ +HRD+ N+L+ K+ DFG++R ++S + I ++ PE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE 179
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698
+++ SDV+ FGV + +I+ N ++ + G+ + +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPN 233
Query: 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
+ C +P+ RP E+ + L
Sbjct: 234 CPPT---------LYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 74/298 (24%), Positives = 115/298 (38%), Gaps = 39/298 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV------LPCGEVIAVKKLSKTSTQG-FEEFKNEV-MLTA 515
+R + LG G +G V + +AVK L + +T +E+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 516 KLQHVNLIRVLGFCIDSEER-MLIYEYMPNKSLDCYLF-------------DPIRKLILD 561
H+N++ +LG C M+I E+ +L YL + + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 562 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621
+ + + +G+ +L IHRDL NILL E KI DFG+AR K+
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 681
+ ++ PE VY+ +SDV+SFGVLL +I S + I E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDE 244
Query: 682 HAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
K G + D + + L C P+ RP+ E+ L N
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 9e-50
Identities = 69/299 (23%), Positives = 117/299 (39%), Gaps = 41/299 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP--------CGEVIAVKKLSKTSTQ-GFEEFKNEVMLT 514
+R + LGEG +G V +AVK L +T+ + +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 515 AKL-QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLI-------------L 560
+ +H N+I +LG C +I EY +L YL + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 561 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620
K V + +G+ YL IHRDL N+L+ E KI+DFG+AR
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 680
+ T + ++ PE +Y+ +SDV+SFGVLL +I + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPV- 243
Query: 681 EHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
E ++L K G ++ + ++ + C P+ RP+ ++ L
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 2e-48
Identities = 62/275 (22%), Positives = 101/275 (36%), Gaps = 29/275 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQH 519
E F LGEG + V L A+K L K E + ++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
+++ D E+ Y N L Y+ D + + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTA---EIVSAL 121
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
+ IIHRDLK NILL E M +I+DFG A++ + ES + VGT Y+ PE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS-ILEHAYELWKGGKGVEFVDS 698
T+ SD+++ G ++ Q+++G I++ Y+ + +F
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE-----KFFPK 236
Query: 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
D + + L + + R E+
Sbjct: 237 ARD------LVEKLLVL-------DATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (438), Expect = 2e-48
Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 28/275 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
+ + I +LG G +G V++ G A K + E + E+ + L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
+ + D E ++IYE+M L + D K + + V + + +GL ++ E
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 143
Query: 583 SRLTIIHRDLKVSNILLG--EAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
+ +H DLK NI+ + + K+ DFG+ +++ + GT + PE A
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVA 197
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700
+D++S GVL ++SG G N++ ++ W DS
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWN------MDDSAF 249
Query: 701 DDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV 733
+ K + + L +PN R ++ +
Sbjct: 250 SGISEDGKDFIRKLLLA-------DPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (424), Expect = 2e-46
Identities = 56/275 (20%), Positives = 108/275 (39%), Gaps = 28/275 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
+ + I +LG G +G V++ V G V K ++ KNE+ + +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
I + D E +LI E++ L + + + ++ + +GL ++ E
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 583 SRLTIIHRDLKVSNILL--GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
+I+H D+K NI+ +A KI DFG+A + + + T + PE
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700
+ +D+++ GVL ++SG G ++ ++ W EF +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDW------EFDEDAF 252
Query: 701 DDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV 733
+ K + L+ P R ++ +
Sbjct: 253 SSVSPEAKDFIKNLLQK-------EPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (412), Expect = 2e-45
Identities = 58/306 (18%), Positives = 120/306 (39%), Gaps = 34/306 (11%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHV 520
+ + R+ LG G + V +++A+K ++K + +G E +NE+ + K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 521 NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
N++ + LI + + L + + K + +I + + YL
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
+ + + + L E K ISDFG++++ S+ GT GY+ PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700
+ YS D +S GV+ ++ G + + + ++ K EF +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPF------YDENDAKLFEQILKA--EYEFDSPYW 233
Query: 701 DDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV---------SSMLKNETTNINTPKK 749
DD + K + +E +P R + + +++ KN +++ K
Sbjct: 234 DDISDSAKDFIRHLMEK-------DPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIK 286
Query: 750 PAFSKQ 755
F+K
Sbjct: 287 KNFAKS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-45
Identities = 64/325 (19%), Positives = 124/325 (38%), Gaps = 26/325 (8%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHV 520
R++ + +GEG YG V +A+KK+S Q + + E+ + + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 521 NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
N+I + + Y+ + L+ ++ L + + I +GL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTE-QVVGTIGYIPPEY 639
++HRDLK SN+LL KI DFG+AR+ + + V T Y PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 640 ATKGVYSTKS-DVFSFGVLLLQIISGKR--------------LSMLCGINENLSILEHAY 684
TKS D++S G +L +++S + L +L ++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM-----LKN 739
+ + + +R P + L++ + NP+ R + + + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 740 ETTNINTPKKPAFSKQVDEIGIELL 764
+ F ++D++ E L
Sbjct: 304 PSDEPIAEAPFKFDMELDDLPKEKL 328
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (404), Expect = 1e-44
Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 29/285 (10%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQ 518
++R+ + LG GG V+ L +AVK L + + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 519 HVNLIRVLGFCIDSEER----MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
H ++ V ++ EY+ +L + + K+ + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE-SLEENTEQVVGTIG 633
L + + IIHRD+K +NI++ K+ DFG+AR A + T V+GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693
Y+ PE A +SDV+S G +L ++++G+ S + AY+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVAYQHVREDP-- 231
Query: 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRP-SMLEVSSML 737
S + S + L + +NP +R + E+ + L
Sbjct: 232 -IPPSARHEGLSA----DLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-44
Identities = 55/299 (18%), Positives = 108/299 (36%), Gaps = 31/299 (10%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
E++ I LG G +G V++ V + K + T K E+ + +H N+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNI 63
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
+ + EE ++I+E++ + + L+ ++ V + + + L +L +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 583 SRLTIIHRDLKVSNILLG--EAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
+ I H D++ NI+ + KI +FG AR +N + Y PE
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVH 175
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700
V ST +D++S G L+ ++SG + E + F +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP--FLAETN-----QQIIENIMNAEY-TFDEEAF 227
Query: 701 DDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV--SSMLKNETTNINTPKKPAFSKQ 755
+ + + R L R + E LK + ++T +
Sbjct: 228 KEISIEAMDFVDRLLVK-------ERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHR 279
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 4e-42
Identities = 50/284 (17%), Positives = 94/284 (33%), Gaps = 25/284 (8%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
R+ + K+G G +G +Y G + GE +A+K + + E + +Q I
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGI 65
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
+ +C + ++ + SL+ RK K + + + + + Y+
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHS-- 121
Query: 584 RLTIIHRDLKVSNIL---LGEAMKPKISDFGMARIFAKESLEEN-----TEQVVGTIGYI 635
IHRD+K N L + I DFG+A+ + ++ + + GT Y
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 636 PPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695
S + D+ S G +L+ G E E K +
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKMST 235
Query: 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739
L C +D+P + + +N
Sbjct: 236 PIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (383), Expect = 9e-42
Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 43/289 (14%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGF---------EEFKNEVML 513
E + + LG G V + + P + AVK + T F E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 514 TAKLQ-HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGI 572
K+ H N+I++ + L+++ M L YL K+ L K+ I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
+ + L + L I+HRDLK NILL + M K++DFG + E +V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTP 173
Query: 633 GYIPPEYAT------KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686
Y+ PE Y + D++S GV++ +++G + + +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------FWHRKQMLMLRMI 227
Query: 687 WKGGKGVEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV 733
G +F DD + K + R L + P R + E
Sbjct: 228 MSG--NYQFGSPEWDDYSDTVKDLVSRFLVV-------QPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (384), Expect = 2e-41
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 454 YSLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK---TSTQGFEEFKN 509
YSL D F I LG G +G V+ G A+K L K + E +
Sbjct: 1 YSLQD-------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 510 EVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHII 569
E ++ + + H +IR+ G D+++ +I +Y+ L L R K +
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 570 EGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVV 629
L L+ II+RDLK NILL + KI+DFG A+ + + T +
Sbjct: 114 ------CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYTLC 162
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR 666
GT YI PE + Y+ D +SFG+L+ ++++G
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (380), Expect = 3e-41
Identities = 43/295 (14%), Positives = 96/295 (32%), Gaps = 27/295 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL 522
+ + ++GEG +G +++G L + +A+K + S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 523 IRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY 582
I + + ++ + SL+ L RK K + + + + E
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKF--SVKTVAMAAKQMLARVQSIHEK 120
Query: 583 SRLTIIHRDLKVSNILLGEAMKP-----KISDFGMARIFAKESLEEN-----TEQVVGTI 632
S +++RD+K N L+G + DFGM + + +++ + + GT
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 633 GYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692
Y+ S + D+ + G + + + G + + YE K
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ----GLKAATNKQKYERIGEKKQ 233
Query: 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTP 747
+ + + P + + +NT
Sbjct: 234 STPLRELCAGFPEEFY-----KYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (385), Expect = 4e-41
Identities = 64/279 (22%), Positives = 106/279 (37%), Gaps = 32/279 (11%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQG------FEEFKNEVMLTAK 516
FS+ +G GG+G VY G++ A+K L K + + + L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 517 LQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
++ + ++ I + M L +L + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
++ +++RDLK +NILL E +ISD G+A F+K+ VGT GY+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 637 PEYATKGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695
PE KGV Y + +D FS G +L +++ G + I + VE
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-----VEL 228
Query: 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVS 734
DSF + + +Q + N R L
Sbjct: 229 PDSFSPE---------LRSLLEGLLQRDVNRRLGCLGRG 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-41
Identities = 62/294 (21%), Positives = 117/294 (39%), Gaps = 40/294 (13%)
Query: 453 VYSLADIEAATERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGF------E 505
V+ +++ + + +LG G + V K G A K + K T+ E
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 506 EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKR 565
+ + EV + ++QH N+I + + + +LI E + L + K L ++
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF---LAEKESLTEEEA 115
Query: 566 VHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP----KISDFGMARIFAKESL 621
++ I L + L I H DLK NI+L + P KI DFG+A +
Sbjct: 116 TEFLKQI---LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 681
+ + GT ++ PE ++D++S GV+ ++SG + E L+ +
Sbjct: 173 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229
Query: 682 HAYELWKGGKGVEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV 733
EF D + + ++ K + R L ++P R ++ +
Sbjct: 230 A--------VNYEFEDEYFSNTSALAKDFIRRLL-------VKDPKKRMTIQDS 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (376), Expect = 9e-41
Identities = 59/284 (20%), Positives = 112/284 (39%), Gaps = 21/284 (7%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKL--SKTSTQGFEEFKNEVMLTAKLQHVN 521
E++ K+GEG YG VYK GE A+KK+ K E+ + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 522 LIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE 581
++++ + +L++E++ + L+ + + G+ Y +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 582 YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYAT 641
++HRDLK N+L+ + KI+DFG+AR F + ++V P
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMG 174
Query: 642 KGVYSTKSDVFSFGVLLLQIISGKRL-------SMLCGINENL-----SILEHAYELWKG 689
YST D++S G + ++++G L L I L + EL K
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 690 GKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
+ + +++ ++ +PN R + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-40
Identities = 63/274 (22%), Positives = 100/274 (36%), Gaps = 34/274 (12%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK---TSTQGFEEFKNEV-MLTAKLQ 518
E F + LG+G +G V+ + A+K L K E E +L+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 519 HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
H L + E + EY+ L ++ + D + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
L I++RDLK+ NILL + KI+DFGM + + NT GT YI PE
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698
Y+ D +SFGVLL +++ G+ + G E S
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS-------------------PFHGQDEEELFHS 214
Query: 699 FLDDRNSPCKLM--RCLEIALLCVQENPNDRPSM 730
D + + ++ + P R +
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGV 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 62/292 (21%), Positives = 118/292 (40%), Gaps = 26/292 (8%)
Query: 462 ATERFSIRNKLGEGGYGPVYKG--VLPCGEVIAVKKLSKTSTQG--FEEFKNEVMLTAKL 517
A +++ ++GEG YG V+K + G +A+K++ + + EV + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 518 ---QHVNLIRVLGFCIDSEERMLIYEYMPNKSLDC---YLFDPIRKLILDWKKRVHIIEG 571
+H N++R+ C S + + +D D + + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 572 ITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGT 631
+ +GL +L + ++HRDLK NIL+ + + K++DFG+ARI++ + VV T
Sbjct: 125 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVT 178
Query: 632 IGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS-----ILEHAYEL 686
+ Y PE + Y+T D++S G + ++ K L + L I E
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALL-----CVQENPNDRPSMLEV 733
W + K + ++ C+ NP R S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 50/299 (16%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE------FKNEVMLTAKL 517
++ + LG GG+G VY G+ + +A+K + K + E EV+L K+
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 518 Q--HVNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQG 575
+IR+L + + +LI E + L + + +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEA 122
Query: 576 LLYLQEYSRLTIIHRDLKVSNILL-GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
+ + ++HRD+K NIL+ + K+ DFG + + GT Y
Sbjct: 123 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVY 175
Query: 635 IPPEY-ATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693
PPE+ + + V+S G+LL ++ G ++ + +
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI-------------------PFEHDEEI 216
Query: 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV-------SSMLKNETTNIN 745
F R S C + C+ P+DRP+ E+ +L ET I+
Sbjct: 217 IRGQVFFRQRVSS----ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-40
Identities = 64/285 (22%), Positives = 109/285 (38%), Gaps = 21/285 (7%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHV 520
E F K+GEG YG VYK GEV+A+KK+ + E+ L +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 521 NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
N++++L + L++E++ + + L K Q L L
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-----QLLQGLA 116
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
++HRDLK N+L+ K++DFG+AR F T +VV P
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILL 175
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL-----SILEHAYELWKGGKGV-E 694
YST D++S G + ++++ + L + L ++ +W G + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 695 FVDSFLDDRNSPCKLMR------CLEIALLCVQENPNDRPSMLEV 733
+ SF + + + +PN R S
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-39
Identities = 63/282 (22%), Positives = 109/282 (38%), Gaps = 26/282 (9%)
Query: 470 NKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEE-----FKNEVMLTAKLQHVNLI 523
+ LGEG + VYK +++A+KK+ ++ E+ L +L H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 524 RVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS 583
+L L++++M D + L+L + QGL YL ++
Sbjct: 64 GLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 584 RLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA-TK 642
I+HRDLK +N+LL E K++DFG+A+ F V T Y PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175
Query: 643 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS-ILEHAY----ELWKGGKGVEFVD 697
+Y D+++ G +L +++ + L+ I E E W +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 698 SFLDDRNSPCKLM------RCLEIALLCVQENPNDRPSMLEV 733
+F P + L++ NP R + +
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 53/299 (17%), Positives = 115/299 (38%), Gaps = 35/299 (11%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQG--FEEFKNEVMLTAKLQHV 520
++ K+G+G +G V+K G+ +A+KK+ + + E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 521 NLIRVLGFCIDSEERM--------LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGI 572
N++ ++ C L++++ + ++ + +++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF--AKESLEENTEQVVG 630
GL Y+ I+HRD+K +N+L+ K++DFG+AR F AK S V
Sbjct: 127 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 631 TIGYIPPE-YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY----- 684
T+ Y PPE + Y D++ G ++ ++ + + L+++
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALL----------CVQENPNDRPSMLEV 733
E+W E + + K+ L+ + + +P R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 57/289 (19%), Positives = 106/289 (36%), Gaps = 29/289 (10%)
Query: 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
++ +G G +G VY+ L GE++A+KK+ + E+ + KL H N++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 524 RVLGFCIDSEERM------LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLL 577
R+ F S E+ L+ +Y+P K L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 578 YLQEYSRLTIIHRDLKVSNILL-GEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIP 636
Y+ I HRD+K N+LL + K+ DFG A+ + + + P
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAP 191
Query: 637 PEYATKGVYSTKSDVFSFGVLLLQIISGKRL-------SMLCGINENL-----SILEHAY 684
Y++ DV+S G +L +++ G+ + L I + L +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
+ K + P + + ++ P R + LE
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 5e-38
Identities = 55/288 (19%), Positives = 107/288 (37%), Gaps = 27/288 (9%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHV 520
+++ K+GEG YG V+K E++A+K++ E+ L +L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 521 NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQ 580
N++R+ ++ L++E+ + + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 581 EYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYA 640
++HRDLK N+L+ + K+++FG+AR F + +VV P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLF 174
Query: 641 TKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700
+YST D++S G + ++ + R L N+ L+ + L ++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR--PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 701 DDRNSPCKLMR---------------CLEIALLCVQENPNDRPSMLEV 733
P + ++ ++ NP R S E
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 3e-36
Identities = 54/282 (19%), Positives = 106/282 (37%), Gaps = 35/282 (12%)
Query: 464 ERFSIRNK-LGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHV 520
+ + + ++ LG G G V + E A+K L + + EV L + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 521 NLIRVLGFCIDSEER----MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGL 576
+++R++ + +++ E + L + D + ++ I++ I + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAI 124
Query: 577 LYLQEYSRLTIIHRDLKVSNILLGEAMKP---KISDFGMARIFAKESLEENTEQVVGTIG 633
YL + I HRD+K N+L K++DFG A+ + T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPY 178
Query: 634 YIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693
Y+ PE Y D++S GV++ ++ G N L+I + G+
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQ-Y 234
Query: 694 EFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSMLEV 733
EF + + + K + L + P R ++ E
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLL-------KTEPTQRMTITEF 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-35
Identities = 58/316 (18%), Positives = 114/316 (36%), Gaps = 27/316 (8%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHV 520
+ +G G YG V V G +A+KKL + S + E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 521 NLIRVLGFCIDSEERMLIYE-YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
N+I +L E + Y+ + L ++ L + ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
IIHRDLK N+ + E + KI DFG+AR E T VV P
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVI 190
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRL--------SMLCGINENLSILEHAYELWKGGK 691
Y+ D++S G ++ ++I+GK L + + + + + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 692 GVEFVDSFLDDRNSPCKLMR------CLEIALLCVQENPNDRPSMLEV--SSMLKNETTN 743
++ + + + + + + R + E ++
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 744 INTPKKPAFSKQVDEI 759
+ P+ + D++
Sbjct: 311 EDEPQVQKYDDSFDDV 326
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 40/207 (19%), Positives = 78/207 (37%), Gaps = 12/207 (5%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQH 519
F LG+G +G V G A+K L K + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
L + + + EY L +L R+ + ++ + + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
+ +++RD+K+ N++L + KI+DFG+ + + + GT Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKR 666
Y D + GV++ +++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1goia2 c.1.8.5 (A:3-291,A:380-446) Chitinase B, catalytic domain {Serratia marcescens [TaxId: 615]} Length = 356 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase B, catalytic domain species: Serratia marcescens [TaxId: 615]
Score = 133 bits (335), Expect = 1e-34
Identities = 63/343 (18%), Positives = 117/343 (34%), Gaps = 55/343 (16%)
Query: 36 EVSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFAD---TVKKKNPSITT 92
VS I+ TH+ S DINS + +++ + + +K NPS+
Sbjct: 30 PVSNITPAKAKQLTHINFSFLDINSNLE-CAWDPATNDAKARDVVNRLTALKAHNPSLRI 88
Query: 93 ILSIG-----QGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTST 147
+ SIG +++ Y + V+ + R F S +RI + YGF G++ W +
Sbjct: 89 MFSIGGWYYSNDLGVSHANYVNAVKTPASRAKFAQSCVRIMKDYGFDGVNIDWE-YPQAA 147
Query: 148 DMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYL--LNSIQRNLNWI 205
++ E R + + + + A + + Y L I L++I
Sbjct: 148 EVDGFIAALQEIRTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVAPLDYI 207
Query: 206 HAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGY 265
+ +T P T AAL+G +G + G+
Sbjct: 208 NLMTYDLAGPWE-KVTNHQAALFGDAAGP------------------TFYNALREANLGW 248
Query: 266 AWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGT 325
+W + + A ++ H+ G +
Sbjct: 249 SWEELTRAFPSPFSLTVDAA-----------VQQHLMMEGV-------------PSAKIV 284
Query: 326 VWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQA 368
+ FDD E+ + K Y K+++L G W + D+ + L A
Sbjct: 285 MGVPFDDAESFKYKAKYIKQQQLGGVMFWHLGQDNRNGDLLAA 327
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 2e-32
Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 15/208 (7%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQH 519
++F LG G +G V G A+K L K + E NE + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 520 VNLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
L+++ D+ ++ EY+ + +L R I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 580 QEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEY 639
L +I+RDLK N+L+ + +++DFG A+ + T + GT + PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209
Query: 640 ATKGVYSTKSDVFSFGVLLLQIISGKRL 667
Y+ D ++ GVL+ ++ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-32
Identities = 57/280 (20%), Positives = 113/280 (40%), Gaps = 35/280 (12%)
Query: 464 ERFSIRNKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTS----TQGFEEFKNEVMLTA 515
E F + LG G YG V+ G++ A+K L K + + E + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 516 KLQHV-NLIRVLGFCIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
++ L+ + + LI +Y+ L +L R + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
+L L+ +L II+RD+K+ NILL ++DFG+++ F + E GTI Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEY 196
Query: 635 IPPEYATKGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692
+ P+ G + D +S GVL+ ++++G + G + + + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------RI 248
Query: 693 VEFVDSFLDDRNSPCK--LMRCLEIALLCVQENPNDRPSM 730
++ + + ++ K + R L ++P R
Sbjct: 249 LKSEPPYPQEMSALAKDLIQRLL-------MKDPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 120 bits (302), Expect = 2e-30
Identities = 55/296 (18%), Positives = 109/296 (36%), Gaps = 40/296 (13%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVN 521
+ + + KLG G Y V++ + + E + VK L ++ K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 522 LIRVLGFCIDSEERM--LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYL 579
+I + D R L++E++ N L + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 580 QEYSRLTIIHRDLKVSNILLG-EAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
+ I+HRD+K N+++ E K ++ D+G+A + +E +V P
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPEL 200
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGK--------------RLSMLCG-------INENL 677
+Y D++S G +L +I K R++ + G I++
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEV 733
L+ + G + + F+ N L+ ++ + R + E
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-30
Identities = 61/289 (21%), Positives = 107/289 (37%), Gaps = 25/289 (8%)
Query: 463 TERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQH 519
ER+ + +G G YG V G +AVKKLS+ S + E+ L ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 520 VNLIRVLGFCIDSEERMLI-YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLY 578
N+I +L + Y+ + L + ++ L +I I +GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 579 LQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPE 638
+ IHRDLK SN+ + E + KI DFG+AR E T V P
Sbjct: 137 IHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 189
Query: 639 YATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-----YELWKGGKGV 693
Y+ D++S G ++ ++++G+ L + L ++ EL K
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 694 EFVDSFLDDRNSPCKLMR---------CLEIALLCVQENPNDRPSMLEV 733
+ P +++ + + + R + +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1vf8a1 c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin ym1, saccharide binding domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 302 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase-like lectin ym1, saccharide binding domain species: Mouse (Mus musculus) [TaxId: 10090]
Score = 113 bits (283), Expect = 4e-28
Identities = 60/253 (23%), Positives = 108/253 (42%), Gaps = 16/253 (6%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98
I+ L THLI + A + + ++ + D +K KN + T+L+IG
Sbjct: 21 KPGNIDPCLCTHLIYAFAGMQNNE--ITYTHEQDLRDYEALNG-LKDKNTELKTLLAIGG 77
Query: 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAP----NTSTDMFNIGL 154
+ +S+MV +R+ FI S IR R Y F GL+ W P + D +
Sbjct: 78 -WKFGPAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNLDWQYPGSRGSPPKDKHLFSV 136
Query: 155 LFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYE 214
L E R A + ++ + LL T + Y + + ++L++I +T ++
Sbjct: 137 LVKEMR-KAFEEESVEKDIPRLLLTSTGAGIIDVIKSGYKIPELSQSLDYIQVMTYDLHD 195
Query: 215 PVSTNFTAPPAALYGS---ISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGY-AWTLV 270
P +T + LY S I + D ++ W + G +++KL++ P ++ L
Sbjct: 196 P-KDGYTGENSPLYKSPYDIGKSADLNVDSIISYWKDHGAASEKLIVGFPADNVRSFKLK 254
Query: 271 K--PEDNGIGAAA 281
+DN +G A
Sbjct: 255 AQWLKDNNLGGAV 267
|
| >d1vf8a1 c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin ym1, saccharide binding domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 302 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase-like lectin ym1, saccharide binding domain species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.5 bits (99), Expect = 1e-04
Identities = 13/65 (20%), Positives = 22/65 (33%), Gaps = 7/65 (10%)
Query: 304 YGPDVQVMYNSTYEVNYFSTGTV-------WFGFDDVEAVRAKIAYAKEKRLLGYYAWQV 356
Y N ++Y+ F D+V + + K + K+ L G W +
Sbjct: 212 YDIGKSADLNVDSIISYWKDHGAASEKLIVGFPADNVRSFKLKAQWLKDNNLGGAVVWPL 271
Query: 357 SFDDH 361
DD
Sbjct: 272 DMDDF 276
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 7e-28
Identities = 68/333 (20%), Positives = 119/333 (35%), Gaps = 50/333 (15%)
Query: 464 ERFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHV 520
+R+ +G G G V +A+KKLS+ + + E++L + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 521 NLIRVLGFCI------DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQ 574
N+I +L + ++ L+ E M + D ++ +++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 575 GLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGY 634
G+ +L IIHRDLK SNI++ KI DFG+AR V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYY 184
Query: 635 IPPEYATKGVYSTKSDVFSFGVLLLQIISGKRL-------SMLCGINENL---------- 677
PE Y D++S G ++ +++ K L + E L
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 678 ------SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALL--CVQENPNDRPS 729
+ +E+ + F DS + KL LL + +P R S
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 730 MLEVSSM----LKNETTNINTPKKPAFSKQVDE 758
+ + + + + P + KQ+DE
Sbjct: 305 VDDALQHPYINVWYDPAEVEAPPPQIYDKQLDE 337
|
| >d1w9pa1 c.1.8.5 (A:39-298,A:361-433) Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]} Length = 333 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase 1 species: Aspergillus fumigatus [TaxId: 5085]
Score = 112 bits (281), Expect = 1e-27
Identities = 50/264 (18%), Positives = 102/264 (38%), Gaps = 26/264 (9%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADT---------------- 82
+ + TH++ + A++ T ++ ++ + + D+
Sbjct: 22 NPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCIKQLY 81
Query: 83 -VKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWT 141
+KK+N ++ +LSIG + ++ + RK+F +++++ + GF GLD W
Sbjct: 82 LLKKQNRNLKVLLSIGGWTYS--PNFAPAASTDAGRKNFAKTAVKLLQDLGFDGLDIDWE 139
Query: 142 APNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRN 201
P + LL E R A A N+ Q LL + + L + +
Sbjct: 140 YPENDQQANDFVLLLKEVRTALDSYSAANAGGQHFLLTVASPAGPDK-IKVLHLKDMDQQ 198
Query: 202 LNWIHAVTASYYEPVSTNFTAPPAALYGSIS--GRFARSTDQVLKAWIERGLSADKLVMC 259
L++ + + Y S + + A +Y S +T L + G+ A+K+V+
Sbjct: 199 LDFWNLMAYDYAGSFS-SLSGHQANVYNDTSNPLSTPFNTQTALDLYRAGGVPANKIVLG 257
Query: 260 LPFYGYAWTLVKPE---DNGIGAA 280
+P +K G+G A
Sbjct: 258 MPLDNPQVANLKSGYIKSLGLGGA 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 3e-27
Identities = 55/315 (17%), Positives = 108/315 (34%), Gaps = 49/315 (15%)
Query: 465 RFSIRNKLGEGGYGPVYKGV-LPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI 523
R+ + KLG G + V+ + +A+K + E ++E+ L ++ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNT 72
Query: 524 RVLGFCIDSEERMLIY--EYMPNKSLDCYLFDPIRKLILDWKKR-----------VHIIE 570
+ + ++L + PN +F+ + + +L K+ I +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 571 GITQGLLYLQEYSRLTIIHRDLKVSNILLGEA-MKPKISDFGMARIFAKESLEENTEQVV 629
+ GL Y+ + R IIH D+K N+L+ + +A + +E+ +
Sbjct: 133 QLLLGLDYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 630 GTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH------- 682
T Y PE + +D++S L+ ++I+G L + +H
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 683 -----AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLE-----------------IALL-- 718
+Y L G F +S RN LE L
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 719 CVQENPNDRPSMLEV 733
+Q +P R +
Sbjct: 311 MLQLDPRKRADAGGL 325
|
| >d2pi6a1 c.1.8.5 (A:1-239,A:308-361) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Signal processing protein (SPC-40, MGP-40) species: Sheep (Ovis aries) [TaxId: 9940]
Score = 109 bits (274), Expect = 4e-27
Identities = 48/227 (21%), Positives = 90/227 (39%), Gaps = 10/227 (4%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98
I+ L TH+I + A+I++ + ++ + +T+K +NP + T+LS+G
Sbjct: 21 FPDAIDPFLCTHVIYTFANISNNEID---TWEWNDVTLYDTLNTLKNRNPKLKTLLSVGG 77
Query: 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDE 158
+S + + R++FI S R +GF GLD AW P L+ +
Sbjct: 78 WNF-GPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPGRRDKRHLTTLVKEM 136
Query: 159 WRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVST 218
+ A S + + Y + I R+L++I +T ++
Sbjct: 137 KAEFIREAQAGTEQLLLSAAVSAGKIAID---RGYDIAQISRHLDFISLLTYDFHGAWR- 192
Query: 219 NFTAPPAALYGSISGRFAR--STDQVLKAWIERGLSADKLVMCLPFY 263
+ L+ +R + D + + G A+KLVM +P
Sbjct: 193 QTVGHHSPLFRGNEDASSRFSNADYAVSYMLRLGAPANKLVMGIPTD 239
|
| >d2pi6a1 c.1.8.5 (A:1-239,A:308-361) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Signal processing protein (SPC-40, MGP-40) species: Sheep (Ovis aries) [TaxId: 9940]
Score = 46.7 bits (110), Expect = 6e-06
Identities = 16/58 (27%), Positives = 23/58 (39%), Gaps = 7/58 (12%)
Query: 311 MYNSTYEVNYFSTGTV-------WFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDH 361
N+ Y V+Y DD E+V+ K Y K ++L G W + DD
Sbjct: 212 FSNADYAVSYMLRLGAPANKLVMGIPTDDQESVKNKARYLKNRQLAGAMVWALDLDDF 269
|
| >d1ll7a1 c.1.8.5 (A:36-292,A:355-427) Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: 5501]} Length = 330 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase 1 species: Fungus (Coccidioides immitis) [TaxId: 5501]
Score = 110 bits (276), Expect = 5e-27
Identities = 52/263 (19%), Positives = 103/263 (39%), Gaps = 25/263 (9%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFAD----------------T 82
+ D FTH++ + A+I + +D ++
Sbjct: 20 NPQDLKADQFTHILYAFANIRPSGEVYLSDTWADTDKHYPGDKWDEPGNNVYGCIKQMYL 79
Query: 83 VKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTA 142
+KK N ++ T+LSIG + + RK F D+S+++ + GF G+D W
Sbjct: 80 LKKNNRNLKTLLSIGGWTY--SPNFKTPASTEEGRKKFADTSLKLMKDLGFDGIDIDWQY 137
Query: 143 PNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNL 202
P + LL R A AK+ ++ LL + + N L + + L
Sbjct: 138 PEDEKQANDFVLLLKACREALDAYSAKHPNGKKFLLTIASPAGPQN-YNKLKLAEMDKYL 196
Query: 203 NWIHAVTASYYEPVSTNFTAPPAALYGSISGRFAR--STDQVLKAWIERGLSADKLVMCL 260
++ + + + + + ++ S + + S+D+ +K +I+ G+ A+K+V+ +
Sbjct: 197 DFWNLMAYDFSGSWD-KVSGHMSNVFPSTTKPESTPFSSDKAVKDYIKAGVPANKIVLGM 255
Query: 261 PFYGYAWTLVKPE---DNGIGAA 280
P K E NG+G
Sbjct: 256 PLDTVKIAGKKAEYITKNGMGGG 278
|
| >d1wb0a1 c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]} Length = 297 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitotriosidase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-26
Identities = 56/230 (24%), Positives = 111/230 (48%), Gaps = 11/230 (4%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98
++ L THLI + A + + +QLS + +DE +F +KK NP + T+L+IG
Sbjct: 21 LPKDLDPSLCTHLIYAFAGMTN--HQLSTTEWNDETLYQEFNG-LKKMNPKLKTLLAIG- 76
Query: 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT----STDMFNIGL 154
G + ++ MV +++R++F++S+IR R Y F GLD W P + + D
Sbjct: 77 GWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTT 136
Query: 155 LFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYE 214
L + A + +A+ S +++ LL + Y ++ I +NL++++ + ++
Sbjct: 137 LVQDLA-NAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHG 195
Query: 215 PVS--TNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPF 262
T +P + + D ++ W+++G A KL++ +P
Sbjct: 196 SWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPT 245
|
| >d1wb0a1 c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]} Length = 297 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitotriosidase species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 2e-05
Identities = 15/58 (25%), Positives = 22/58 (37%), Gaps = 7/58 (12%)
Query: 312 YNSTYEVNYFSTGTV-------WFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD 362
N V + DDVE+ + K++Y K+K L G W + DD
Sbjct: 220 LNVDAAVQQWLQKGTPASKLILGMPTDDVESFKTKVSYLKQKGLGGAMVWALDLDDFA 277
|
| >d1edqa2 c.1.8.5 (A:133-443,A:517-563) Chitinase A, catalytic domain {Serratia marcescens [TaxId: 615]} Length = 358 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase A, catalytic domain species: Serratia marcescens [TaxId: 615]
Score = 109 bits (272), Expect = 2e-26
Identities = 48/305 (15%), Positives = 84/305 (27%), Gaps = 59/305 (19%)
Query: 39 TISGINYDLFTHLICSSADINSTTY-------------QLSLSLPSDENQIAKFAD---- 81
T+ I THL+ I L S E+ D
Sbjct: 43 TVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSCQGREDFKVSIHDPFAA 102
Query: 82 -----------------------TVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRK 118
+K+ +P + + SIG S + + R
Sbjct: 103 LQKAQKGVTAWDDPYKGNFGQLMALKQAHPDLKILPSIGGW---TLSDPFFFMGDKVKRD 159
Query: 119 SFIDSSIRIARLYG-FRGLDFAWTAPNTS---------TDMFNIGLLFDEWRIAATKLDA 168
F+ S + + F G+D W P D LL E R LD
Sbjct: 160 RFVGSVKEFLQTWKFFDGVDIDWEFPGGKGANPNLGSPQDGETYVLLMKELRAM---LDQ 216
Query: 169 KNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALY 228
+ + + +A + N Q +++ I ++ +Y AL
Sbjct: 217 LSVETGRKYELTSAISAGKDKIDKVAYNVAQNSMDHIFLMSYDFYGAFDLKNLGHQTALN 276
Query: 229 GSISGR-FARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKP--EDNGIGAAAAGPA 285
A +T + A + +G+ K+V+ + D +G +
Sbjct: 277 APAWKPDTAYTTVNGVNALLAQGVKPGKIVVGTAMDARSVQAKGKYVLDKQLGGLFSWEI 336
Query: 286 LYDSG 290
D+G
Sbjct: 337 DADNG 341
|
| >d1jnda1 c.1.8.5 (A:2-278,A:371-420) Imaginal disc growth factor-2 {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 327 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Imaginal disc growth factor-2 species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 103 bits (257), Expect = 1e-24
Identities = 43/251 (17%), Positives = 96/251 (38%), Gaps = 31/251 (12%)
Query: 43 INYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFAD--TVKKKNPSITTILSIGQGK 100
I +HL+ A + Q + + +F++ ++K+K P + +LS+G
Sbjct: 27 IALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSEVTSLKRKYPHLKVLLSVGGDH 86
Query: 101 DTNY---SIYSSMVRNSSHRK-SFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGL-- 154
D + + Y ++ R+ FI S+ + + YGF GLD A+ P + L
Sbjct: 87 DIDPDHPNKYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAYQFPKNKPRKVHGDLGL 146
Query: 155 ---LFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLL---------------- 195
+ +D + ++ L + S A+ +LL
Sbjct: 147 AWKSIKKLFTGDFIVDPHAALHKEQFTALVRDVKDSLRADGFLLSLTVLPNVNSTWYFDI 206
Query: 196 NSIQRNLNWIHAVTASYY----EPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGL 251
++ +++++ T + P +++AP GS + D ++ W+ +G
Sbjct: 207 PALNGLVDFVNLATFDFLTPARNPEEADYSAPIYHPDGSKDRLAHLNADFQVEYWLSQGF 266
Query: 252 SADKLVMCLPF 262
++K+ + +
Sbjct: 267 PSNKINLGVAT 277
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.5 bits (229), Expect = 4e-22
Identities = 38/201 (18%), Positives = 67/201 (33%), Gaps = 33/201 (16%)
Query: 467 SIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST----------QGFEEFKNEVMLTAK 516
+I +GEG V+ VK T G F + +A+
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 517 LQHVNLIRVLGFCI----DSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGI 572
+ L ++ G + E ++ E + K L + +++ I
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV----------RVENPDEVLDMI 112
Query: 573 TQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTI 632
+ + I+H DL N+L+ E I DF + +E E E+ V I
Sbjct: 113 LEEVAKFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNI 168
Query: 633 GYIPPEYATKGVYSTKSDVFS 653
Y ++ Y T+ D+ S
Sbjct: 169 ----ITYFSRT-YRTEKDINS 184
|
| >d1kfwa1 c.1.8.5 (A:10-327,A:389-444) Psychrophilic chitinase B {Arthrobacter sp., tad20 [TaxId: 1667]} Length = 374 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Psychrophilic chitinase B species: Arthrobacter sp., tad20 [TaxId: 1667]
Score = 88.4 bits (218), Expect = 3e-19
Identities = 52/309 (16%), Positives = 93/309 (30%), Gaps = 78/309 (25%)
Query: 43 INYDLFTHLICSSADINSTTYQLSLSLPSDENQIA-------KFADT------------- 82
TH+ S +IN+ T ++ + +AD
Sbjct: 34 GTAKNLTHINYSFGNINNQTLTCFMANKAQGTGPNGSDGAGDAWADFGMGYAADKSVSGK 93
Query: 83 -----------------VKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSI 125
+K KNP + ++S+G T +S + R+ + S I
Sbjct: 94 ADTWDQPLAGSFNQLKQLKAKNPKLKVMISLGGW--TWSKNFSKAAATEASRQKLVSSCI 151
Query: 126 RIARLYG----------------FRGLDFAW-----------TAPNTSTDMFNIGLLFDE 158
+ F G+D W +T D N L E
Sbjct: 152 DLYIKGNLPNFEGRGGAGAAAGIFDGIDIDWEWPGTNSGLAGNGVDTVNDRANFKALLAE 211
Query: 159 WRIAATKLDAKNSTRQQSLLILTA--RFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPV 216
+R LDA ST + ++ A + + ++L++ +
Sbjct: 212 FRKQ---LDAYGSTNNKKYVLSAFLPANPADIDAGGWDDPANFKSLDFGSIQGYDLHGAW 268
Query: 217 STNFTAPPAALYGSISGRFAR----STDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKP 272
+ T A LY + A S D+ +K ++ G+ +L + L A T K
Sbjct: 269 NPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAGIDPKQLGLGLAADNIATTKQKT 328
Query: 273 E---DNGIG 278
+ G+G
Sbjct: 329 DYIVSKGLG 337
|
| >d1itxa1 c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillus circulans [TaxId: 1397]} Length = 347 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase A1 species: Bacillus circulans [TaxId: 1397]
Score = 84.9 bits (209), Expect = 3e-18
Identities = 53/282 (18%), Positives = 96/282 (34%), Gaps = 63/282 (22%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFAD----------------- 81
++ I+ TH+ + ADI + +
Sbjct: 29 NVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTIVLGD 88
Query: 82 --------------------------TVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSS 115
+K+ NP++ TI+S+G +N +S + ++
Sbjct: 89 PWIDTGKTFAGDTWDQPIAGNINQLNKLKQTNPNLKTIISVGGWTWSNR--FSDVAATAA 146
Query: 116 HRKSFIDSSIRIARLYGFRGLDFAWTA---------PNTSTDMFNIGLLFDEWRIAATKL 166
R+ F +S++ R Y F G+D W D N LL + R KL
Sbjct: 147 TREVFANSAVDFLRKYNFDGVDLDWEYPVSGGLDGNSKRPEDKQNYTLLLSKIR---EKL 203
Query: 167 DAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVS--TNFTAP- 223
DA + + L+ A + A + L I ++WI+ +T + + AP
Sbjct: 204 DAAGAVDGKKYLLTIASGASATYAANTELAKIAAIVDWINIMTYDFNGAWQKISAHNAPL 263
Query: 224 ---PAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPF 262
PAA + + + ++ G+ A KLV+ +PF
Sbjct: 264 NYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLGVPF 305
|
| >d1itxa1 c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillus circulans [TaxId: 1397]} Length = 347 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase A1 species: Bacillus circulans [TaxId: 1397]
Score = 52.2 bits (124), Expect = 1e-07
Identities = 19/66 (28%), Positives = 26/66 (39%), Gaps = 7/66 (10%)
Query: 312 YNSTYEVNYFSTGTV-------WFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWL 364
+N V FDD E+V K AY K K L G W++S D + L
Sbjct: 280 FNVAAGAQGHLDAGVPAAKLVLGVPFDDAESVGYKTAYIKSKGLGGAMFWELSGDRNKTL 339
Query: 365 LSQAAA 370
++ A
Sbjct: 340 QNKLKA 345
|
| >d1nara_ c.1.8.5 (A:) Seed storage protein {Vicia narbonensis, Narbonin [TaxId: 3912]} Length = 289 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Seed storage protein species: Vicia narbonensis, Narbonin [TaxId: 3912]
Score = 73.2 bits (179), Expect = 1e-14
Identities = 31/242 (12%), Positives = 63/242 (26%), Gaps = 27/242 (11%)
Query: 43 INYD-LFTHLICSSA-----DINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSI 96
IN + L H I A + T S + K + +K+++P + ++SI
Sbjct: 26 INTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEKVKN-LKRRHPEVKVVISI 84
Query: 97 GQGKDTNY---SIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIG 153
G + + V N+ I G+D +
Sbjct: 85 GGRGVNTPFDPAEENVWVSNAKESLKLIIQKYSDDSGNLIDGIDIHYEHIR---SDEPFA 141
Query: 154 LLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYY 213
L + T+L + L I S +S+ ++I+ V +
Sbjct: 142 TLMGQLI---TELKKDD-----DLNINVVSIAPSENNSSHYQKLYNAKKDYINWVDYQFS 193
Query: 214 EPVS--TNFTAPPAALYGSISG----RFARSTDQVLKAWIERGLSADKLVMCLPFYGYAW 267
+ A + ++ D + +
Sbjct: 194 NQQKPVSTDDAFVEIFKSLEKDYHPHKVLPGFSTDPLDTKHNKITRDIFIGGCTRLVQTF 253
Query: 268 TL 269
+L
Sbjct: 254 SL 255
|
| >d1edta_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Streptomyces plicatus, endoglycosidase H [TaxId: 1922]} Length = 265 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Streptomyces plicatus, endoglycosidase H [TaxId: 1922]
Score = 69.7 bits (170), Expect = 1e-13
Identities = 40/264 (15%), Positives = 67/264 (25%), Gaps = 34/264 (12%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDEN----QIAKFADTVKKKNPSITTIL 94
T++ + F + +A+IN T + L +EN + I +L
Sbjct: 24 TLADGGGNAFDVAVIFAANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPLQQQGIKVLL 83
Query: 95 SIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPN------TSTD 148
S+ + + + +F YG G+DF +
Sbjct: 84 SVLGN---HQGAGFANFPSQQAASAFAKQLSDAVAKYGLDGVDFDDEYAEYGNNGTAQPN 140
Query: 149 MFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAV 208
+ L R +I PA S L +
Sbjct: 141 DSSFVHLVTALR-----------ANMPDKIISLY---NIGPAASRLSYGGVDVSDKFDYA 186
Query: 209 TASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWT 268
YY A P A + R++ L+ + Y +
Sbjct: 187 WNPYYGTWQVPGIALPKAQLSPAAVEIGRTSR-----STVADLARRTVDEGYGVYLT-YN 240
Query: 269 LVKPEDNGIGAAAAGPALYDSGLV 292
L D +A LY S V
Sbjct: 241 L-DGGDRTADVSAFTRELYGSEAV 263
|
| >d2ebna_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]
Score = 69.0 bits (168), Expect = 3e-13
Identities = 42/295 (14%), Positives = 85/295 (28%), Gaps = 41/295 (13%)
Query: 39 TISGINYDLFTHLICSSADINSTTYQLSLSLPSDEN---QIAKFADTVKK-KNPSITTIL 94
T+ L ++ SA+IN + + ++ N + A +K ++ I IL
Sbjct: 26 TLKNSGKPLVDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQDKGIKVIL 85
Query: 95 SIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGL 154
SI D S +++ +++ K+F LY G+ F G
Sbjct: 86 SILGNHDR--SGIANL--STARAKAFAQELKNTCDLYNLDGVFFDDEYS-AYQTPPPSGF 140
Query: 155 LFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYY- 213
+ AA L+ + R S + +++ Y
Sbjct: 141 VTPSNNAAARLAYETKQAMPNKLVTVYVYSRTSSFPTAV---DGVNAGSYVDYAIHDYGG 197
Query: 214 -EPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKP 272
++TN+ + S F + + + + GY
Sbjct: 198 SYDLATNYPGLAKSGMVMSSQEFNQGR------YATAQALRNIVT-----KGYGG----- 241
Query: 273 EDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVW 327
+ I A + + SG + K+ + +Y + W
Sbjct: 242 --HMIFAMDPNRSNFTSGQLPALKL---------IAKELYGDELVYSNTPYSKDW 285
|
| >d1vf8a2 d.26.3.1 (A:246-315) Chitinase-like lectin ym1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 70 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase-like lectin ym1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 51.0 bits (122), Expect = 6e-09
Identities = 18/73 (24%), Positives = 30/73 (41%), Gaps = 8/73 (10%)
Query: 263 YGYAWTLVKPEDNGIGAAAAGPAL-----YDSGLVTYKKIKNHIKTYGPDVQVMYNSTYE 317
YG+ + L P GIGA +SGL+ Y ++ + ++++ E
Sbjct: 1 YGHTFILSDPSKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFLNEG---ATEVWDAPQE 57
Query: 318 VNYFSTGTVWFGF 330
V Y G W G+
Sbjct: 58 VPYAYQGNEWVGY 70
|
| >d2hvma_ c.1.8.5 (A:) Hevamine A (chitinase/lysozyme) {Para rubber tree (Hevea brasiliensis) [TaxId: 3981]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Hevamine A (chitinase/lysozyme) species: Para rubber tree (Hevea brasiliensis) [TaxId: 3981]
Score = 50.9 bits (121), Expect = 2e-07
Identities = 41/273 (15%), Positives = 79/273 (28%), Gaps = 55/273 (20%)
Query: 43 INYDLFTHLICSSADI--NSTTYQLSLS---LPSDENQIAKFADTVKKKNPSITTILSIG 97
+ ++++ + + N T Q++L+ P+ + I +LS+G
Sbjct: 20 CSTRKYSYVNIAFLNKFGNGQTPQINLAGHCNPAAGGCTIVSNGIRSCQIQGIKVMLSLG 79
Query: 98 QGKDTNYSIYS-----SMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNI 152
G +Y++ S ++ + SS R G+DF +T
Sbjct: 80 -GGIGSYTLASQADAKNVADYLWNNFLGGKSSSRPLGDAVLDGIDFDIEHGST------- 131
Query: 153 GLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASY 212
W A L A + ++ L + + LN+ + W+
Sbjct: 132 ----LYWDDLARYLSAYSKQGKKVYLTAAPQCPFPDRYLGTALNTGLFDYVWVQFYNNPP 187
Query: 213 YEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKP 272
+ S N + ++A K+ + LP
Sbjct: 188 CQYSSGNINNIINSWN-----------------RWTTSINAGKIFLGLPAAP-------- 222
Query: 273 EDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYG 305
AA +G Y V +I IK
Sbjct: 223 -----EAAGSG---YVPPDVLISRILPEIKKSP 247
|
| >d1itxa2 d.26.3.1 (A:338-409) Chitinase A1 {Bacillus circulans [TaxId: 1397]} Length = 72 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase A1 species: Bacillus circulans [TaxId: 1397]
Score = 45.4 bits (107), Expect = 5e-07
Identities = 11/73 (15%), Positives = 24/73 (32%), Gaps = 6/73 (8%)
Query: 263 YGYAWTLVKPEDNGIGAAAAGPA---LYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVN 319
YG W NG G + +++G + ++ + +N T +V
Sbjct: 1 YGRGWDGCAQAGNGQYQTCTGGSSVGTWEAGSFDFYDLEANYIN-KNGYTRYWNDTAKVP 59
Query: 320 YFSTGT--VWFGF 330
Y + + +
Sbjct: 60 YLYNASNKRFISY 72
|
| >d1wb0a2 d.26.3.1 (A:267-336) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]} Length = 68 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitotriosidase species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (103), Expect = 2e-06
Identities = 16/73 (21%), Positives = 26/73 (35%), Gaps = 10/73 (13%)
Query: 263 YGYAWTLVKPEDNGIGAAAAGPAL-----YDSGLVTYKKIKNHIKTYGPDVQVMYNSTYE 317
YG ++TL D +GA A G + G++ Y ++ + +
Sbjct: 1 YGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKG-----ATKQRIQDQK 55
Query: 318 VNYFSTGTVWFGF 330
V Y W GF
Sbjct: 56 VPYIFRDNQWVGF 68
|
| >d1edqa3 d.26.3.1 (A:444-516) Chitinase A {Serratia marcescens [TaxId: 615]} Length = 73 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase A species: Serratia marcescens [TaxId: 615]
Score = 43.5 bits (102), Expect = 3e-06
Identities = 19/75 (25%), Positives = 29/75 (38%), Gaps = 8/75 (10%)
Query: 263 YGYAWTLVKPEDNGIG----AAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEV 318
YG WT V N I A +++G+V Y++I + Q Y++T E
Sbjct: 1 YGRGWTGVNGYQNNIPFTGTATGPVKGTWENGIVDYRQIAGQFM--SGEWQYTYDATAEA 58
Query: 319 NYFSTGT--VWFGFD 331
Y + FD
Sbjct: 59 PYVFKPSTGDLITFD 73
|
| >d1eoka_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]} Length = 282 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]
Score = 47.5 bits (112), Expect = 3e-06
Identities = 30/290 (10%), Positives = 70/290 (24%), Gaps = 31/290 (10%)
Query: 26 WIRVGYLNLSEVSTISGINYDLFTHLICSSADINSTTYQLSLS--LPSDENQIAKFADTV 83
R L ++ D+ + TT + + S ++
Sbjct: 11 DGRNPTFKLKDIP----DKVDMVILFGLKYWSLQDTTKLPGGTGMMGSFKSYKDLDTQIR 66
Query: 84 KKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSI-RIARLYGFRGLDFAWTA 142
++ I + +I SS + ++ D+ + + G+
Sbjct: 67 SLQSRGIKVLQNIDDDVSW----QSSKPGGFASAAAYGDAIKSIVIDKWKLDGISLDIEH 122
Query: 143 PNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNL 202
+ + + + + L + + + +Q
Sbjct: 123 SGAKPNPIPTFPGYAATGYNG--WYSGSMAATPAFLNVISELTKYFGTTAPNNKQLQIAS 180
Query: 203 NWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIE--RGLSADKLVMCL 260
E NF YG+ S Q++ + + A K+V
Sbjct: 181 GIDVYAWNKIMENFRNNFNYIQLQSYGANV-----SRTQLMMNYATGTNKIPASKMVFGA 235
Query: 261 PFYGYAWTLV-------KPEDNGIGAAAAGPALYDSGLVTY-KKIKNHIK 302
G P G + V+Y +++ +K
Sbjct: 236 YAEGGTNQANDVEVAKWTPTQGAKGGMMIYTYNSN---VSYANAVRDAVK 282
|
| >d1kfwa2 d.26.3.1 (A:328-388) Psychrophilic chitinase B {Arthrobacter sp., tad20 [TaxId: 1667]} Length = 61 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Psychrophilic chitinase B species: Arthrobacter sp., tad20 [TaxId: 1667]
Score = 41.4 bits (97), Expect = 1e-05
Identities = 15/68 (22%), Positives = 24/68 (35%), Gaps = 7/68 (10%)
Query: 263 YGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFS 322
YG WT K A P Y++ Y K+K + Y++ +
Sbjct: 1 YGRGWTGAKNVSPWGPATDGAPGTYETANEDYDKLKTLGTDH-------YDAATGSAWRY 53
Query: 323 TGTVWFGF 330
GT W+ +
Sbjct: 54 DGTQWWSY 61
|
| >d2pi6a2 d.26.3.1 (A:240-307) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]} Length = 68 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Signal processing protein (SPC-40, MGP-40) species: Sheep (Ovis aries) [TaxId: 9940]
Score = 41.3 bits (97), Expect = 1e-05
Identities = 14/73 (19%), Positives = 29/73 (39%), Gaps = 10/73 (13%)
Query: 263 YGYAWTLVKPEDNGIGAAAAGPAL-----YDSGLVTYKKIKNHIKTYGPDVQVMYNSTYE 317
+G ++TL +GA +GP + + G++ Y +I + + +
Sbjct: 1 FGRSFTLASS-KTDVGAPVSGPGIPGRFTKEKGILAYYEICDFLHGAT----THRFRDQQ 55
Query: 318 VNYFSTGTVWFGF 330
V Y + G W +
Sbjct: 56 VPYATKGNQWVAY 68
|
| >d1ta3a_ c.1.8.5 (A:) Xylanase inhibitor protein I, XIP-I {Wheat (Triticum aestivum) [TaxId: 4565]} Length = 274 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Xylanase inhibitor protein I, XIP-I species: Wheat (Triticum aestivum) [TaxId: 4565]
Score = 42.8 bits (100), Expect = 8e-05
Identities = 41/242 (16%), Positives = 73/242 (30%), Gaps = 41/242 (16%)
Query: 43 INYDLFTHLICSSADI--NSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQGK 100
+ ++T + S D+ + Y L LS D + + AD ++ + LSIG G
Sbjct: 25 CDSGMYTMVTMSFLDVFGANGKYHLDLS-GHDLSSVG--ADIKHCQSKGVPVSLSIG-GY 80
Query: 101 DTNYSIYSSMVRN-------SSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIG 153
T YS+ S+ +S+ S R G+D +
Sbjct: 81 GTGYSLPSNRSALDLFDHLWNSYFGGSKPSVPRPFGDAWLDGVDLFLEHGTPAD---RYD 137
Query: 154 LLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNL-NWIHAVTASY 212
+L E + L LTA R P +++ ++ + +H T
Sbjct: 138 VLALELAKHNIRGGPGKP------LHLTATVRCGYPPAAHVGRALATGIFERVHVRTYES 191
Query: 213 YEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKP 272
+ GS W A + + L + V P
Sbjct: 192 D-----KWCNQNLGWEGS------------WDKWT-AAYPATRFYVGLTADDKSHQWVHP 233
Query: 273 ED 274
++
Sbjct: 234 KN 235
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 785 | |||
| d1w9pa1 | 333 | Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]} | 100.0 | |
| d1kfwa1 | 374 | Psychrophilic chitinase B {Arthrobacter sp., tad20 | 100.0 | |
| d1edqa2 | 358 | Chitinase A, catalytic domain {Serratia marcescens | 100.0 | |
| d1itxa1 | 347 | Chitinase A1 {Bacillus circulans [TaxId: 1397]} | 100.0 | |
| d2pi6a1 | 292 | Signal processing protein (SPC-40, MGP-40) {Sheep | 100.0 | |
| d1wb0a1 | 297 | Chitotriosidase {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ll7a1 | 330 | Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: | 100.0 | |
| d1vf8a1 | 302 | Chitinase-like lectin ym1, saccharide binding doma | 100.0 | |
| d1jnda1 | 327 | Imaginal disc growth factor-2 {Fruit fly (Drosophi | 100.0 | |
| d1goia2 | 356 | Chitinase B, catalytic domain {Serratia marcescens | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nara_ | 289 | Seed storage protein {Vicia narbonensis, Narbonin | 100.0 | |
| d2hvma_ | 273 | Hevamine A (chitinase/lysozyme) {Para rubber tree | 99.96 | |
| d1edta_ | 265 | Endo-beta-N-acetylglucosaminidase {Streptomyces pl | 99.95 | |
| d2ebna_ | 285 | Endo-beta-N-acetylglucosaminidase {Flavobacterium | 99.94 | |
| d1ta3a_ | 274 | Xylanase inhibitor protein I, XIP-I {Wheat (Tritic | 99.92 | |
| d1cnva_ | 283 | Seed storage protein {Jack bean (Canavalia ensifor | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1eoka_ | 282 | Endo-beta-N-acetylglucosaminidase {Flavobacterium | 99.78 | |
| d1vf8a2 | 70 | Chitinase-like lectin ym1 {Mouse (Mus musculus) [T | 99.19 | |
| d1wb0a2 | 68 | Chitotriosidase {Human (Homo sapiens) [TaxId: 9606 | 99.09 | |
| d2pi6a2 | 68 | Signal processing protein (SPC-40, MGP-40) {Sheep | 99.02 | |
| d1kfwa2 | 61 | Psychrophilic chitinase B {Arthrobacter sp., tad20 | 98.79 | |
| d1itxa2 | 72 | Chitinase A1 {Bacillus circulans [TaxId: 1397]} | 98.77 | |
| d1edqa3 | 73 | Chitinase A {Serratia marcescens [TaxId: 615]} | 98.73 | |
| d1jnda2 | 92 | Imaginal disc growth factor-2 {Fruit fly (Drosophi | 98.5 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d1w9pa2 | 62 | Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]} | 97.84 | |
| d1goia3 | 88 | Chitinase B {Serratia marcescens [TaxId: 615]} | 97.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d1ll7a2 | 62 | Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: | 97.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.33 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.47 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.34 | |
| d2bhua3 | 420 | Glycosyltrehalose trehalohydrolase, central domain | 82.41 |
| >d1w9pa1 c.1.8.5 (A:39-298,A:361-433) Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase 1 species: Aspergillus fumigatus [TaxId: 5085]
Probab=100.00 E-value=2.4e-55 Score=464.14 Aligned_cols=276 Identities=21% Similarity=0.286 Sum_probs=232.0
Q ss_pred CCCcEEEEEecCCC----CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHH-----------------HHHHHHH
Q 003932 23 AKPWIRVGYLNLSE----VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDEN-----------------QIAKFAD 81 (785)
Q Consensus 23 ~~~~~~vgY~~~~~----~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~ 81 (785)
++++++||||++|. .+++++||+++||||+|+|+.++++++.+...+++.+. ...+.+.
T Consensus 2 ~~g~kvv~Yy~~W~~y~~~~~~~~i~~~~~THI~yaFa~i~~~~g~~~~~d~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (333)
T d1w9pa1 2 SSGYRSVVYFVNWAIYGRNHNPQDLPVERLTHVLYAFANVRPETGEVYMTDSWADIEKHYPGDSWSDTGNNVYGCIKQLY 81 (333)
T ss_dssp BCCBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTTCCEEESCHHHHHTCCCTTCCSSCCSSCCCHHHHHHH
T ss_pred CCCCEEEEEECcccccCCCCChhHCCcccCCeEEEeeEEecCCCCeEEecChHHhhccccCCccccccccchhhHHHHHH
Confidence 46789999999883 46899999999999999999999988888877654332 1233445
Q ss_pred HHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHH
Q 003932 82 TVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRI 161 (785)
Q Consensus 82 ~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~ 161 (785)
.+|++||++|||+|||||+.+. .|+.+++++++|++||+++++|+++|+|||||||||||+..++..+|+.|+++||+
T Consensus 82 ~lk~~~p~lKvllSiGGw~~s~--~f~~~~~~~~~R~~Fi~siv~~l~~y~fDGiDiDWE~p~~~~~~~~~~~llkelr~ 159 (333)
T d1w9pa1 82 LLKKQNRNLKVLLSIGGWTYSP--NFAPAASTDAGRKNFAKTAVKLLQDLGFDGLDIDWEYPENDQQANDFVLLLKEVRT 159 (333)
T ss_dssp HHHHHCTTCEEEEEEECTTTGG--GHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHHHHHHHHHHH
T ss_pred HHHhccCCceEEEEEeCCcCCC--cccccccCHHHHHHHHHHHHHHHHHhcCCceeeeeeecccccccchHHHHHHHHHH
Confidence 5999999999999999987644 49999999999999999999999999999999999999887888999999999999
Q ss_pred HhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCC--CCCCH
Q 003932 162 AATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGR--FARST 239 (785)
Q Consensus 162 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~--~~~~~ 239 (785)
+|+.............+++++++... ....++++++.++|||||||+|||+|+|. +.+||+|||+.....+ ..+++
T Consensus 160 ~L~~~~~~~~~~~~~~ls~a~~~~~~-~~~~~d~~~i~~~vD~invMtYD~~g~~~-~~tg~~aply~~~~~~~~~~~nv 237 (333)
T d1w9pa1 160 ALDSYSAANAGGQHFLLTVASPAGPD-KIKVLHLKDMDQQLDFWNLMAYDYAGSFS-SLSGHQANVYNDTSNPLSTPFNT 237 (333)
T ss_dssp HHHHHHHHHSTTCCCEEEEEECCSHH-HHHHSCHHHHHTTCSEEEECCCCCSSTTS-SSCCCSSCSSCCTTCGGGCSCCH
T ss_pred HHHhhhhhhccCCceEEEEEccCChh-hhhccchHHHhhcCCeEEEeeeccCCCCC-CCCCCCccccCCCCCCccCCccH
Confidence 99876655555556666666654332 23468999999999999999999999986 4699999999865443 24689
Q ss_pred HHHHHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeee
Q 003932 240 DQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVN 319 (785)
Q Consensus 240 ~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~ 319 (785)
+.+|++|+++|+|++||||||||||+.|
T Consensus 238 ~~av~~~~~~Gvp~~KlvlGiPfyg~~~---------------------------------------------------- 265 (333)
T d1w9pa1 238 QTALDLYRAGGVPANKIVLGMPLDNPQV---------------------------------------------------- 265 (333)
T ss_dssp HHHHHHHHHTTCCGGGEEEEEESCCHHH----------------------------------------------------
T ss_pred HHHHHHHHHCCCCHHHeEEEeCCCchHH----------------------------------------------------
Confidence 9999999999999999999999998754
Q ss_pred eeecCCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchh-hhhhhhhh
Q 003932 320 YFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD-WLLSQAAA 370 (785)
Q Consensus 320 y~~~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~-~~l~~~~~ 370 (785)
++.|+.|++++||||+|+|++++|... ..|..++.
T Consensus 266 ----------------~~~k~~y~~~~~lgG~m~We~~~D~~~~~sl~~a~~ 301 (333)
T d1w9pa1 266 ----------------ANLKSGYIKSLGLGGAMWWDSSSDKTGSDSLITTVV 301 (333)
T ss_dssp ----------------HHHHHHHHHHHTCCEEEEECGGGSCCGGGCHHHHHH
T ss_pred ----------------HHHhHHHHHhCCCceEEEEeccCCCCCCchHHHHHH
Confidence 566999999999999999999999743 44555554
|
| >d1kfwa1 c.1.8.5 (A:10-327,A:389-444) Psychrophilic chitinase B {Arthrobacter sp., tad20 [TaxId: 1667]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Psychrophilic chitinase B species: Arthrobacter sp., tad20 [TaxId: 1667]
Probab=100.00 E-value=8.3e-55 Score=463.57 Aligned_cols=278 Identities=20% Similarity=0.254 Sum_probs=226.5
Q ss_pred CCCCCCcEEEEEecCCCCC----C----cCCCCCCCCceEEEEEEEeeCCccEEecCC---------------C------
Q 003932 20 PAKAKPWIRVGYLNLSEVS----T----ISGINYDLFTHLICSSADINSTTYQLSLSL---------------P------ 70 (785)
Q Consensus 20 ~~~~~~~~~vgY~~~~~~~----~----~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~---------------~------ 70 (785)
.+...++++||||++|..+ . +.++++++||||+|||+.|++++..+...+ +
T Consensus 3 ~~~~~g~rvvgYy~~W~~y~r~~~~~~l~~~i~~~~lTHi~YAFa~i~~~~~~~~~~~~~~~~~~~g~~~~~d~~~d~~~ 82 (374)
T d1kfwa1 3 TSTVNGYRNVGYFAQWGVYGRAFQAKQLDVSGTAKNLTHINYSFGNINNQTLTCFMANKAQGTGPNGSDGAGDAWADFGM 82 (374)
T ss_dssp BSSBTTBEEEEEEEGGGGSTTCCCHHHHHHTSCGGGCSEEEEEEECBCTTTCSBCCCEECCCSSTTTTTTCEEHHHHHTC
T ss_pred CCCCCCCEEEEEECcceecCCCCChhhCcCCCChhhCCEEEEeeeeecCCcceeeccccccccCCCCccccCcchhhhcc
Confidence 4566789999999998533 2 477888999999999999998764332110 0
Q ss_pred -----------------ccHHHHHHHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcC-
Q 003932 71 -----------------SDENQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYG- 132 (785)
Q Consensus 71 -----------------~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~- 132 (785)
.....+.++ ..||++||++|||+|||||+.+.. |+.+++++++|++||+|+++|+++|+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~l-~~lK~~~p~lKvllSiGGw~~s~~--F~~~a~~~~~R~~Fi~s~v~~~~~~~l 159 (374)
T d1kfwa1 83 GYAADKSVSGKADTWDQPLAGSFNQL-KQLKAKNPKLKVMISLGGWTWSKN--FSKAAATEASRQKLVSSCIDLYIKGNL 159 (374)
T ss_dssp CCCTTTSSSSSCCCTTCSCCHHHHHH-HHHHTTCTTCEEEEEEECSSSCTT--HHHHTSSHHHHHHHHHHHHHHHTSCCE
T ss_pred ccccccccccccccccccchhhHHHH-HHHHhhCCCCeEEEEEeCCCCCCc--cchhhcCHHHHHHHHHHHHHHHHHcCC
Confidence 011234444 559999999999999999986554 99999999999999999999999999
Q ss_pred ---------------CceeeeeccCCCC-----------CCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeeccc
Q 003932 133 ---------------FRGLDFAWTAPNT-----------STDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRY 186 (785)
Q Consensus 133 ---------------~DGiDiDwE~p~~-----------~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~ 186 (785)
|||||||||||+. ++|++||+.|+++||++|+..+... ++...++++++...
T Consensus 160 ~~~~~~~~~~~~~~~FDGiDiDWEyP~~~~~~~~~~~~~~~D~~nf~~Ll~eLR~~ld~~~~~~--~k~~~Ls~A~~~~~ 237 (374)
T d1kfwa1 160 PNFEGRGGAGAAAGIFDGIDIDWEWPGTNSGLAGNGVDTVNDRANFKALLAEFRKQLDAYGSTN--NKKYVLSAFLPANP 237 (374)
T ss_dssp EEETTEEETTTTTTTCCEEEEECSCTTSSCSSTTCCCCTTTHHHHHHHHHHHHHHHHHHHHHHT--TCCCEEEEEECSSH
T ss_pred cccccccccccccccccccceeeeecccccCCCCCCCCChhHHHHHHHHHHHHHHHHHHHhccc--CceEEEEEEecccc
Confidence 8999999999953 4678999999999999998765332 23455666654433
Q ss_pred CCC-CccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC----CCCHHHHHHHHHHcCCCCCceeeccc
Q 003932 187 SPP-ANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF----ARSTDQVLKAWIERGLSADKLVMCLP 261 (785)
Q Consensus 187 ~~~-~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~----~~~~~~~v~~~~~~gvp~~KlvlGip 261 (785)
... ...|+.+++.++|||||||+|||||+|....+||+||||+.+.++. .++++.+|++|+++|+|++||+||||
T Consensus 238 ~~~~~~~~d~~~i~~~vD~invMtYD~~G~w~~~~tg~~apLy~~~~~~~~~~~~~svd~aV~~~~~~Gvp~~KlvlGip 317 (374)
T d1kfwa1 238 ADIDAGGWDDPANFKSLDFGSIQGYDLHGAWNPTLTGHQANLYDDPADPRAPSKKFSADKAVKKYLAAGIDPKQLGLGLA 317 (374)
T ss_dssp HHHHHHTTTCGGGGGTCSEEEECCSCSSCTTSTTBCCCSSCSSCCTTCCSCGGGCCCHHHHHHHHHHTTCCGGGEEEEEE
T ss_pred ccccccCcchhhhhceeEEEEEEecccccCCCCCCCCccCcCCCCCCCCCCCCCCeeHHHHHHHHHHCCCCHHHeEEEec
Confidence 221 2358899999999999999999999998888999999998765543 45899999999999999999999976
Q ss_pred cccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHHHHHh
Q 003932 262 FYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIA 341 (785)
Q Consensus 262 ~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~~K~~ 341 (785)
||+++|++.|++
T Consensus 318 --------------------------------------------------------------------yd~~~si~~K~~ 329 (374)
T d1kfwa1 318 --------------------------------------------------------------------ADNIATTKQKTD 329 (374)
T ss_dssp --------------------------------------------------------------------SCCHHHHHHHHH
T ss_pred --------------------------------------------------------------------CCCHHHHHHHHH
Confidence 788999999999
Q ss_pred hhcccCccceEeeeccccchhhhhhhhhhc
Q 003932 342 YAKEKRLLGYYAWQVSFDDHDWLLSQAAAQ 371 (785)
Q Consensus 342 ~~~~~glgG~~~W~l~~Dd~~~~l~~~~~~ 371 (785)
||+++||||+|+|++++|+. ..|++++..
T Consensus 330 y~~~~glgG~m~W~~~~D~~-g~Ll~a~~~ 358 (374)
T d1kfwa1 330 YIVSKGLGGGMWWELSGDRN-GELVGAMSD 358 (374)
T ss_dssp HHHHTTCCEEEEECGGGCTT-CHHHHHHHH
T ss_pred HHHhcCCceEEEEEccCCCC-CcHHHHHHH
Confidence 99999999999999999985 467777754
|
| >d1edqa2 c.1.8.5 (A:133-443,A:517-563) Chitinase A, catalytic domain {Serratia marcescens [TaxId: 615]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase A, catalytic domain species: Serratia marcescens [TaxId: 615]
Probab=100.00 E-value=1.8e-54 Score=458.82 Aligned_cols=276 Identities=19% Similarity=0.270 Sum_probs=220.8
Q ss_pred CCCCCcEEEEEecCCC----CCCcCCCCCCCCceEEEEEEEeeCCcc-------------------------EEecCCCc
Q 003932 21 AKAKPWIRVGYLNLSE----VSTISGINYDLFTHLICSSADINSTTY-------------------------QLSLSLPS 71 (785)
Q Consensus 21 ~~~~~~~~vgY~~~~~----~~~~~~i~~~~~Thi~~~f~~~~~~~~-------------------------~~~~~~~~ 71 (785)
...+.++++|||++|. .+.+++||+++||||+|||+.++++++ .+...+++
T Consensus 21 ~~~~~~~v~~Yy~~W~~y~~~~~~~~I~~~~~THi~YAFa~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 100 (358)
T d1edqa2 21 KQNSGKVVGSYFVEWGVYGRNFTVDKIPAQNLTHLLYGFIPICGGNGINDSLKEIEGSFQALQRSCQGREDFKVSIHDPF 100 (358)
T ss_dssp CCCSSCEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEECBCCCTTTSGGGGGSTTHHHHHHHHTTTCCTTSBCCSCHH
T ss_pred CCCCCCEEEEEeCcccccCCCCChhhCCHhHCCeEEEeeEEecCCCCcccccccccccccccccccccCCCcceeecCch
Confidence 3445689999999983 578999999999999999999987653 11221111
Q ss_pred cH----------------HHHHHHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcC-Cc
Q 003932 72 DE----------------NQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYG-FR 134 (785)
Q Consensus 72 ~~----------------~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~-~D 134 (785)
.+ ..+.++ .+||+++|++|||+|||||+.++. |+ +++++++|++||+|+++||++|+ ||
T Consensus 101 ~~~~~~~~~~~~~~~~~~g~~~~~-~~LK~~~p~lKvllSiGGw~~s~~--~~-~~a~~~~R~~Fi~svv~~l~~y~~fD 176 (358)
T d1edqa2 101 AALQKAQKGVTAWDDPYKGNFGQL-MALKQAHPDLKILPSIGGWTLSDP--FF-FMGDKVKRDRFVGSVKEFLQTWKFFD 176 (358)
T ss_dssp HHHTSCBTTBCSTTCSSCHHHHHH-HHHHHHCTTCEEEEEEECSSSCGG--GG-GTTSHHHHHHHHHHHHHHHHHCTTCC
T ss_pred hhhhccccCccccccccccHHHHH-HHHHHhCCCCeEEEEEECCCCCCC--cc-cccCHHHHHHHHHHHHHHHHHhccCC
Confidence 11 134455 459999999999999999877554 54 68899999999999999999999 99
Q ss_pred eeeeeccCCC---------CCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhcccee
Q 003932 135 GLDFAWTAPN---------TSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWI 205 (785)
Q Consensus 135 GiDiDwE~p~---------~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v 205 (785)
|||||||||+ +++|++||+.||++||++|+..+.... ....+++++..... ....++++++.+++|||
T Consensus 177 GIDIDWEyP~~~g~~~~~~~~~D~~nf~~Ll~eLR~~l~~~~~~~~--~~~~ls~a~~~~~~-~~~~~~~~~l~~~vD~i 253 (358)
T d1edqa2 177 GVDIDWEFPGGKGANPNLGSPQDGETYVLLMKELRAMLDQLSVETG--RKYELTSAISAGKD-KIDKVAYNVAQNSMDHI 253 (358)
T ss_dssp EEEEECSCTTSCSSCTTCCCTTHHHHHHHHHHHHHHHHHHHHHHHT--CCCEEEEEEECSHH-HHTTSCHHHHGGGCSEE
T ss_pred cccceeeecccccCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhhcC--CccceeeeecCchh-hhhhhhHHHHhhcCCEE
Confidence 9999999994 467899999999999999987643322 24445555544332 33568999999999999
Q ss_pred eeeeccCCCccCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCCCC
Q 003932 206 HAVTASYYEPVSTNFTAPPAALYGSISGRF-ARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGP 284 (785)
Q Consensus 206 ~vm~yd~~~~~~~~~~g~~apl~~~~~~~~-~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~ 284 (785)
|||+|||||+|+...+||++++++....+. ..+++.+|++|+++|+|++|||||||||||
T Consensus 254 nlMtYD~~G~w~~~~~g~~t~l~~~~~~~~~~~~v~~~v~~~~~~Gvp~~KlvlGip~YGR------------------- 314 (358)
T d1edqa2 254 FLMSYDFYGAFDLKNLGHQTALNAPAWKPDTAYTTVNGVNALLAQGVKPGKIVVGTAMDAR------------------- 314 (358)
T ss_dssp EEECCCSSCTTCSSSCCCSSCSSCCTTCTTCSCCHHHHHHHHHHHTCCGGGEEEEEESCHH-------------------
T ss_pred EEeeccccCCCCCCCCCCCCCCCCCccCCCCcccHHHHHHHHHHCCCCHHHeEEEeCccHH-------------------
Confidence 999999999998778999999987654433 569999999999999999999999999996
Q ss_pred ccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchhhh
Q 003932 285 ALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWL 364 (785)
Q Consensus 285 ~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~~~ 364 (785)
|++.|++|++++||||+|+|++++||.+ +
T Consensus 315 --------------------------------------------------s~~~K~~y~~~~~lgG~~~W~~~~D~g~-l 343 (358)
T d1edqa2 315 --------------------------------------------------SVQAKGKYVLDKQLGGLFSWEIDADNGD-I 343 (358)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHTCCEEEEECGGGCCSH-H
T ss_pred --------------------------------------------------HHHHHHHHHhcCCCceEEEEeccCCccH-H
Confidence 4578999999999999999999999743 4
Q ss_pred hhhhhhccc
Q 003932 365 LSQAAAQKD 373 (785)
Q Consensus 365 l~~~~~~~~ 373 (785)
+..+.+.++
T Consensus 344 l~a~~~~l~ 352 (358)
T d1edqa2 344 LNSMNASLG 352 (358)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHhcC
Confidence 444434443
|
| >d1itxa1 c.1.8.5 (A:33-337,A:410-451) Chitinase A1 {Bacillus circulans [TaxId: 1397]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase A1 species: Bacillus circulans [TaxId: 1397]
Probab=100.00 E-value=1.5e-54 Score=461.32 Aligned_cols=274 Identities=26% Similarity=0.372 Sum_probs=222.2
Q ss_pred CCCCCcEEEEEecCCC----CCCcCCCCCCCCceEEEEEEEeeCCccE-----------------------------Eec
Q 003932 21 AKAKPWIRVGYLNLSE----VSTISGINYDLFTHLICSSADINSTTYQ-----------------------------LSL 67 (785)
Q Consensus 21 ~~~~~~~~vgY~~~~~----~~~~~~i~~~~~Thi~~~f~~~~~~~~~-----------------------------~~~ 67 (785)
..+.++++||||++|. .+.+++||+++||||+|||+.++.++.. +..
T Consensus 7 ~a~~~~rvv~Yy~~W~~y~~~~~~~~i~~~~~THi~yaF~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (347)
T d1itxa1 7 EAADSYKIVGYYPSWAAYGRNYNVADIDPTKVTHINYAFADICWNGIHGNPDPSGPNPVTWTCQNEKSQTINVPNGTIVL 86 (347)
T ss_dssp CGGGGCEEEEEEEGGGGTTTCCCGGGCCGGGCSEEEEEEEEECBTTEEEECCTTSSCCEEEECBCTTSCBCCCCTTCEEE
T ss_pred CCCCCCEEEEEECcccccCCCCChhHCCHhhCCeEEEeeEeecCCcccccCcccccccccccccccccccccCCCceEEe
Confidence 3456789999999984 4689999999999999999999876522 111
Q ss_pred CCCccH---------------HHHHHHHHHHHhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcC
Q 003932 68 SLPSDE---------------NQIAKFADTVKKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYG 132 (785)
Q Consensus 68 ~~~~~~---------------~~~~~~~~~~k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~ 132 (785)
.+++.+ ..+.++ ..||+++|++|||+|||||+.+.. |+.+++++++|++||+++++|+++||
T Consensus 87 ~d~~~d~~~~~~~~~~~~~~~g~~~~~-~~lK~~~p~lKvllSiGGw~~s~~--Fs~~~~~~~~R~~Fi~siv~~l~~~~ 163 (347)
T d1itxa1 87 GDPWIDTGKTFAGDTWDQPIAGNINQL-NKLKQTNPNLKTIISVGGWTWSNR--FSDVAATAATREVFANSAVDFLRKYN 163 (347)
T ss_dssp SSHHHHHTSCCTTCCSSSSCCHHHHHH-HHHHHHSTTCEEEEEEECSSSCTT--HHHHHTSHHHHHHHHHHHHHHHHHHT
T ss_pred cCchhhhccccccccccccchhHHHHH-HHHHHhCCCCEEEEEEcCCCCCcc--hhhhhcCHHHHHHHHHHHHHHHHHhC
Confidence 212111 124444 459999999999999999987554 99999999999999999999999999
Q ss_pred CceeeeeccCCC---------CCCCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccc
Q 003932 133 FRGLDFAWTAPN---------TSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLN 203 (785)
Q Consensus 133 ~DGiDiDwE~p~---------~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D 203 (785)
|||||||||||+ .++|+++|+.|+++||++|+..+.... ....+++++... ......|+++++.+++|
T Consensus 164 fDGIDiDWE~P~~~g~~~~~~~~~d~~nf~~ll~eLr~~l~~~~~~~~--~~~~ls~a~~~~-~~~~~~~d~~~i~~~vD 240 (347)
T d1itxa1 164 FDGVDLDWEYPVSGGLDGNSKRPEDKQNYTLLLSKIREKLDAAGAVDG--KKYLLTIASGAS-ATYAANTELAKIAAIVD 240 (347)
T ss_dssp CSEEEEECSCSSSCSCTTSCCCTTHHHHHHHHHHHHHHHHHHHHHHHT--SCCEEEEEECCS-HHHHHTSCHHHHHHHSS
T ss_pred CCcEEEecccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhhcC--Cccceeecccch-hhhhhhccHHHHhhccC
Confidence 999999999984 456889999999999999987543322 234455555433 22335689999999999
Q ss_pred eeeeeeccCCCccCCCCCCCCCCCCCCC-------CCCCCCCHHHHHHHHHHcCCCCCceeeccccccceeeecCCCCCC
Q 003932 204 WIHAVTASYYEPVSTNFTAPPAALYGSI-------SGRFARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNG 276 (785)
Q Consensus 204 ~v~vm~yd~~~~~~~~~~g~~apl~~~~-------~~~~~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~ 276 (785)
|||||+|||||+|. +.+||+|||+..+ .....++++.+|++|+++|+|++|||||||
T Consensus 241 ~vnvMtYD~~g~w~-~~~g~~apL~~~~~~~~~~~~~~~~~~v~~~v~~~~~~G~p~~KlvlGip--------------- 304 (347)
T d1itxa1 241 WINIMTYDFNGAWQ-KISAHNAPLNYDPAASAAGVPDANTFNVAAGAQGHLDAGVPAAKLVLGVP--------------- 304 (347)
T ss_dssp EEEECCCCSSCTTS-SBCCCSSCSSCCHHHHHTTCTTTTTCSHHHHHHHHHHHTCCGGGEEEEEE---------------
T ss_pred EEEeeeccccCCCC-CcccccCCCcCCcccccccCCCCCceeHHHHHHHHHHCCCCHHHeEEEec---------------
Confidence 99999999999987 4699999998542 122356899999999999999999999987
Q ss_pred CCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHHHHHhhhcccCccceEeeec
Q 003932 277 IGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQV 356 (785)
Q Consensus 277 ~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l 356 (785)
|||++||+.|++||+++||||+|+|++
T Consensus 305 -----------------------------------------------------fd~~~si~~K~~y~k~~~LgGvmiW~l 331 (347)
T d1itxa1 305 -----------------------------------------------------FDDAESVGYKTAYIKSKGLGGAMFWEL 331 (347)
T ss_dssp -----------------------------------------------------SCCHHHHHHHHHHHHHHTCCEEEEECG
T ss_pred -----------------------------------------------------cCCHHHHHHHHHHHHhCCCCEEEEEEe
Confidence 699999999999999999999999999
Q ss_pred cccchhhhhhhhhh
Q 003932 357 SFDDHDWLLSQAAA 370 (785)
Q Consensus 357 ~~Dd~~~~l~~~~~ 370 (785)
++||.. .|++++.
T Consensus 332 ~~Dd~~-~L~~a~~ 344 (347)
T d1itxa1 332 SGDRNK-TLQNKLK 344 (347)
T ss_dssp GGCTTC-HHHHHHH
T ss_pred cCCCCc-HHHHHHH
Confidence 999854 5666653
|
| >d2pi6a1 c.1.8.5 (A:1-239,A:308-361) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Signal processing protein (SPC-40, MGP-40) species: Sheep (Ovis aries) [TaxId: 9940]
Probab=100.00 E-value=3e-54 Score=449.85 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=219.2
Q ss_pred cEEEEEecCCC-------CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecC
Q 003932 26 WIRVGYLNLSE-------VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98 (785)
Q Consensus 26 ~~~vgY~~~~~-------~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG 98 (785)
+++||||++|. .+.+++||+++||||+|+|+.+++++ +... .+.+....+.+.++|+++|++|||+||||
T Consensus 1 ~kvv~Yy~~w~~~r~~~~~~~~~~i~~~~~THiiyafa~i~~~~--~~~~-~~~~~~~~~~~~~lk~~~~~lKvllSvGG 77 (292)
T d2pi6a1 1 YKLICYYTSWSQYREGDGSCFPDAIDPFLCTHVIYTFANISNNE--IDTW-EWNDVTLYDTLNTLKNRNPKLKTLLSVGG 77 (292)
T ss_dssp CEEEEEEEGGGGGSSGGGCCCGGGSCTTTCSEEEEEEEEEETTE--EECC-STTHHHHHHHHHHHHHHCTTCEEEEEEET
T ss_pred CeEEEEEccccccCCCCCCCChhHCCcccCCEEEEEEEEecCCC--ceec-ccccHHHHHHHHHHHhhCCCceEEEEEec
Confidence 47899998874 35799999999999999999999876 2333 23444555556679999999999999999
Q ss_pred CCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccccceeE
Q 003932 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTRQQSLL 178 (785)
Q Consensus 99 ~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~ 178 (785)
|+. ++..|+.+++++++|++||+|+++++++|+|||||||||||+ ..++.+|+.|++++|++|.+.... ......+
T Consensus 78 ~~~-~~~~fs~~~~~~~~r~~fi~si~~~l~~~~fDGiDiDwE~p~-~~~~~~~~~l~~~lr~~l~~~~~~--~~~~~~~ 153 (292)
T d2pi6a1 78 WNF-GPERFSKIASKTQSRRTFIKSVPPFLRTHGFDGLDLAWLYPG-RRDKRHLTTLVKEMKAEFIREAQA--GTEQLLL 153 (292)
T ss_dssp TTS-CHHHHHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCC-GGGHHHHHHHHHHHHHHHHHHHTT--SSCCCEE
T ss_pred ccc-CchHHHHHhccHHHHHHHHHHHHHHHHhcCCCeEEEeccccc-cccccccchhHHHHHHHHHHHHhc--cCCCcce
Confidence 865 345699999999999999999999999999999999999994 578899999999999999764322 2223445
Q ss_pred EEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC--CCCHHHHHHHHHHcCCCCCce
Q 003932 179 ILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF--ARSTDQVLKAWIERGLSADKL 256 (785)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~--~~~~~~~v~~~~~~gvp~~Kl 256 (785)
+++++.........|++.++.+++||||+|+||++|+|. ..+||+|||+.....+. ..+++.+|++|+++|+|++||
T Consensus 154 s~~~~~~~~~~~~~~~~~~l~~~vD~invMtYD~~g~~~-~~~g~~apL~~~~~~~~~~~~~v~~~v~~~~~~Gvp~~Kl 232 (292)
T d2pi6a1 154 SAAVSAGKIAIDRGYDIAQISRHLDFISLLTYDFHGAWR-QTVGHHSPLFRGNEDASSRFSNADYAVSYMLRLGAPANKL 232 (292)
T ss_dssp EEEEECCHHHHHHHCCHHHHHHHCSEEEEETTCCSCTTC-CBCCCSSCSSCCSSSCSCTTSSHHHHHHHHHHTTCCGGGE
T ss_pred ecccCchhhHHhccccHHHHHhhCCEEEEecccccCCCC-CccccCCCCCCCCcccCcCCccHHHHHHHHHHCCCCHHHe
Confidence 555444433334579999999999999999999999987 56999999997665443 358999999999999999999
Q ss_pred eeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHH
Q 003932 257 VMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAV 336 (785)
Q Consensus 257 vlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si 336 (785)
+|||| |||++|+
T Consensus 233 vlGip--------------------------------------------------------------------ydd~~Si 244 (292)
T d2pi6a1 233 VMGIP--------------------------------------------------------------------TDDQESV 244 (292)
T ss_dssp EEEEE--------------------------------------------------------------------SCCHHHH
T ss_pred EEEec--------------------------------------------------------------------CCCHHHH
Confidence 99986 6999999
Q ss_pred HHHHhhhcccCccceEeeeccccchhh
Q 003932 337 RAKIAYAKEKRLLGYYAWQVSFDDHDW 363 (785)
Q Consensus 337 ~~K~~~~~~~glgG~~~W~l~~Dd~~~ 363 (785)
+.|++||+++||||+|+|++++||...
T Consensus 245 ~~K~~~~~~~~lgGv~iW~l~~DD~~G 271 (292)
T d2pi6a1 245 KNKARYLKNRQLAGAMVWALDLDDFRG 271 (292)
T ss_dssp HHHHHHHHHTTCSEEEEECGGGSCSSS
T ss_pred HHHHHHHHHCCCceEEEEecccccCCC
Confidence 999999999999999999999999654
|
| >d1wb0a1 c.1.8.5 (A:22-266,A:337-388) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitotriosidase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=448.14 Aligned_cols=263 Identities=25% Similarity=0.416 Sum_probs=219.8
Q ss_pred EEEEEecCCC-------CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecCC
Q 003932 27 IRVGYLNLSE-------VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQG 99 (785)
Q Consensus 27 ~~vgY~~~~~-------~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG~ 99 (785)
++||||++|. .+.+++||+++||||+|+|+.+++++ .... ++++..+...+.++|+++|++|||+|||||
T Consensus 2 kvvcYy~~w~~~~~~~~~~~~~~i~~~~~THi~yaf~~~~~~~--~~~~-~~~~~~~~~~~~~lk~~~p~lKvllSiGG~ 78 (297)
T d1wb0a1 2 KLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQ--LSTT-EWNDETLYQEFNGLKKMNPKLKTLLAIGGW 78 (297)
T ss_dssp EEEEEEETTGGGSCGGGCCCGGGCCTTTCSEEEEEEEEEETTE--EECS-STTHHHHHHHHHHGGGTCTTCEEEEEEECT
T ss_pred eEEEEECcCcccCCCCCCCChhHCCcccCCEEEEEEEEccCCc--cccC-CcccHHHHHHHHHHHHhCCCCeEEEEEecc
Confidence 6899999873 35799999999999999999998875 3333 445555555566799999999999999998
Q ss_pred CCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC----CCCchhHHHHHHHHHHHhhhhhhhcccccc
Q 003932 100 KDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT----STDMFNIGLLFDEWRIAATKLDAKNSTRQQ 175 (785)
Q Consensus 100 ~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~----~~d~~~~~~ll~~lr~~l~~~~~~~~~~~~ 175 (785)
+. ++..|+.+++++++|++||+++++++++|||||||||||||+. +.|+.+|+.|+++||++|+...... .+..
T Consensus 79 ~~-~~~~fs~~~~~~~~R~~Fi~siv~~l~~y~fDGiDiDWE~p~~~~~~~~d~~n~~~l~~~Lr~~l~~~~~~~-~~~~ 156 (297)
T d1wb0a1 79 NF-GTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTS-GKER 156 (297)
T ss_dssp TT-CSHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTTHHHHHHHHHHHHHHHHHHHHHHH-CSCC
T ss_pred cc-ccchHHHHhhhhHHHHHHHHHHHHHHHHcCCCceeEEEEeccccCCChHHHHHHHHHHHHHHHHHhhhhhhc-CCCc
Confidence 65 3445999999999999999999999999999999999999953 4689999999999999998754322 2233
Q ss_pred eeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHcCCC
Q 003932 176 SLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGR---FARSTDQVLKAWIERGLS 252 (785)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~---~~~~~~~~v~~~~~~gvp 252 (785)
..+++++++........|++.++.+++||||+|+||++|+|+ +.+|+++|||+..... ..++++.+|++|+++|+|
T Consensus 157 ~~~s~~~~~~~~~~~~~~~~~~i~~~vD~invmtYD~~g~~~-~~tg~~aply~~~~~~~~~~~~~~d~~v~~~~~~G~p 235 (297)
T d1wb0a1 157 LLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWE-KVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTP 235 (297)
T ss_dssp CEEEEEECCCHHHHHHHCCHHHHHHHCSEEEECCCCSSCTTS-SBCCCSSCSSCCTTCCGGGGGCSHHHHHHHHHHTTCC
T ss_pred eeEEEEccCchhHhhhccCHHHHHhhCCEEEEEecccCCCCC-CCCCCCCcCCCCccccCCCCCCCHHHHHHHHHHcCCC
Confidence 445555443332233578999999999999999999999986 4699999999866543 256899999999999999
Q ss_pred CCceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCC
Q 003932 253 ADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDD 332 (785)
Q Consensus 253 ~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd 332 (785)
++||+|||| |||
T Consensus 236 ~~KlvlGip--------------------------------------------------------------------yd~ 247 (297)
T d1wb0a1 236 ASKLILGMP--------------------------------------------------------------------TDD 247 (297)
T ss_dssp GGGEEEEEE--------------------------------------------------------------------SCC
T ss_pred HHHeEEEec--------------------------------------------------------------------cCC
Confidence 999999986 699
Q ss_pred HHHHHHHHhhhcccCccceEeeeccccchhh
Q 003932 333 VEAVRAKIAYAKEKRLLGYYAWQVSFDDHDW 363 (785)
Q Consensus 333 ~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~~ 363 (785)
++|++.|++|++++||||+|+|++++||...
T Consensus 248 ~~si~~K~~~~~~~glgGv~~W~l~~DD~~G 278 (297)
T d1wb0a1 248 VESFKTKVSYLKQKGLGGAMVWALDLDDFAG 278 (297)
T ss_dssp HHHHHHHHHHHHHTTCCEEEEECGGGSCTTC
T ss_pred HHHHHHHHHHHHhcCCceEEEEeCccccCCC
Confidence 9999999999999999999999999999654
|
| >d1ll7a1 c.1.8.5 (A:36-292,A:355-427) Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: 5501]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase 1 species: Fungus (Coccidioides immitis) [TaxId: 5501]
Probab=100.00 E-value=6.7e-54 Score=453.40 Aligned_cols=273 Identities=21% Similarity=0.302 Sum_probs=226.6
Q ss_pred CcEEEEEecCCC----CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccH-----------------HHHHHHHHHH
Q 003932 25 PWIRVGYLNLSE----VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDE-----------------NQIAKFADTV 83 (785)
Q Consensus 25 ~~~~vgY~~~~~----~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~ 83 (785)
++++||||++|. .+.+++||+++||||+|||+.++++| .+...+++.+ ....+.+..+
T Consensus 2 g~kvv~Yy~~W~~y~~~~~~~~i~~~~~THi~yaFa~i~~~g-~~~~~d~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~l 80 (330)
T d1ll7a1 2 GFRSVVYFVNWAIYGRGHNPQDLKADQFTHILYAFANIRPSG-EVYLSDTWADTDKHYPGDKWDEPGNNVYGCIKQMYLL 80 (330)
T ss_dssp CBEEEEEEEGGGGSTTCCCGGGSCGGGCSEEEEEEEEECTTS-CEEESCHHHHTTCCCTTCCSSCSSCCCCHHHHHHHHH
T ss_pred CcEEEEEECcccccCCCCChhHCCcccCceeEEeeEEECCCC-CEEecChhHhhcccCCccccccccchhhHHHHHHHHH
Confidence 578999999873 46899999999999999999999987 5655543222 1223444559
Q ss_pred HhcCCCceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHh
Q 003932 84 KKKNPSITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAA 163 (785)
Q Consensus 84 k~~~p~lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l 163 (785)
|++||+||||+|||||+.+ ..|+.+++++++|++||+++++++++|+|||||||||||++.++..+|..|+++||++|
T Consensus 81 k~~~p~lKvllSvGGw~~s--~~f~~~~~~~~~R~~Fi~siv~~l~~y~fDGIDiDWE~p~~~~~~~~~~~~l~~lr~~l 158 (330)
T d1ll7a1 81 KKNNRNLKTLLSIGGWTYS--PNFKTPASTEEGRKKFADTSLKLMKDLGFDGIDIDWQYPEDEKQANDFVLLLKACREAL 158 (330)
T ss_dssp HHHCTTCEEEEEEEHHHHG--GGSHHHHTSHHHHHHHHHHHHHHHHHHTCSEEEEECSCCCSHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCCCeEEEEEeCCCCC--CCchhhhcCHHHHHHHHHHHHHHHHHhcccccceEEEeeccccccccHHHHHHHHHHHH
Confidence 9999999999999998754 44999999999999999999999999999999999999988888899999999999999
Q ss_pred hhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC--CCCHHH
Q 003932 164 TKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF--ARSTDQ 241 (785)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~--~~~~~~ 241 (785)
+.+.......+...++++++.... ....++++++.+++||||||+||++|.|. ..+||++||++.+..+. ..+++.
T Consensus 159 ~~~~~~~~~g~~~~lt~a~~~~~~-~~~~~~~~~l~~~vD~invmtYD~~g~w~-~~tg~~s~l~~~~~~~~~~~~sv~~ 236 (330)
T d1ll7a1 159 DAYSAKHPNGKKFLLTIASPAGPQ-NYNKLKLAEMDKYLDFWNLMAYDFSGSWD-KVSGHMSNVFPSTTKPESTPFSSDK 236 (330)
T ss_dssp HHHHHTSTTSCCCEEEEEEECSHH-HHTTSCHHHHHTTCSEEEEECCCSSSTTS-SBCCCSSCSSCCSSCGGGCSCCHHH
T ss_pred HHHHHHhhcCCceeEEEeccCChH-hhccccHHHHhhcCCEEEEEEeeccCCCC-CCCCcCcccCCCcCCCCCCCccHHH
Confidence 876655444555666666654332 23478999999999999999999999986 56999999997665433 459999
Q ss_pred HHHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeee
Q 003932 242 VLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYF 321 (785)
Q Consensus 242 ~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~ 321 (785)
+|++|+++|+|++||+||||||||.|.
T Consensus 237 av~~~~~~Gvp~~KlvlGiP~ygr~~~----------------------------------------------------- 263 (330)
T d1ll7a1 237 AVKDYIKAGVPANKIVLGMPLDTVKIA----------------------------------------------------- 263 (330)
T ss_dssp HHHHHHHTTCCGGGEEEEEESCCHHHH-----------------------------------------------------
T ss_pred HHHHHHHCCCCHHHeEEEecCCCchhh-----------------------------------------------------
Confidence 999999999999999999999999873
Q ss_pred ecCCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchh-hhhhhhhh
Q 003932 322 STGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHD-WLLSQAAA 370 (785)
Q Consensus 322 ~~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~-~~l~~~~~ 370 (785)
..|++|++++|+||+|+|++++|... ..|..+..
T Consensus 264 ---------------~~k~~~~~~~g~gG~m~We~~~D~~g~~sl~~a~~ 298 (330)
T d1ll7a1 264 ---------------GKKAEYITKNGMGGGMWWESSSDKTGNESLVGTVV 298 (330)
T ss_dssp ---------------HHHHHHHHHTTCCEEEEECTTSCCCGGGCHHHHHH
T ss_pred ---------------hhhhHhHhhcCCCceEEEeeccCCCCCcccccccc
Confidence 34999999999999999999999743 44444443
|
| >d1vf8a1 c.1.8.5 (A:1-245,A:316-372) Chitinase-like lectin ym1, saccharide binding domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase-like lectin ym1, saccharide binding domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-53 Score=444.54 Aligned_cols=264 Identities=24% Similarity=0.383 Sum_probs=218.0
Q ss_pred cEEEEEecCCC-------CCCcCCCCCCCCceEEEEEEEeeCCccEEecCCCccHHHHHHHHHHHHhcCCCceEEEEecC
Q 003932 26 WIRVGYLNLSE-------VSTISGINYDLFTHLICSSADINSTTYQLSLSLPSDENQIAKFADTVKKKNPSITTILSIGQ 98 (785)
Q Consensus 26 ~~~vgY~~~~~-------~~~~~~i~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~sigG 98 (785)
+++||||++|. .+++++||+++||||+|+|+.+++++ +.+..+.+...+.++ ..+|+++|++||++||||
T Consensus 1 ~kvvcYy~~w~~~r~~~~~~~~~~i~~~~cTHiiyaf~~i~~~~--~~~~~~~~~~~~~~~-~~lk~~~p~lKvllSiGG 77 (302)
T d1vf8a1 1 YQLMCYYTSWAKDRPIEGSFKPGNIDPCLCTHLIYAFAGMQNNE--ITYTHEQDLRDYEAL-NGLKDKNTELKTLLAIGG 77 (302)
T ss_dssp CEEEEEEEGGGGGSCGGGCCCGGGSCTTTCSEEEEEEEEEETTE--EECSSTTHHHHHHHH-HHGGGTCTTCEEEEEEEC
T ss_pred CeEEEEECcccccCCCCCCCChhHCCcccCcEEEEEEEEecCCc--eEEcCcccHHHHHHH-HHHHHhCCCcEEEEEEec
Confidence 47999998873 46899999999999999999999875 444444444555544 459999999999999999
Q ss_pred CCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCC----CCCCchhHHHHHHHHHHHhhhhhhhccccc
Q 003932 99 GKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPN----TSTDMFNIGLLFDEWRIAATKLDAKNSTRQ 174 (785)
Q Consensus 99 ~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~----~~~d~~~~~~ll~~lr~~l~~~~~~~~~~~ 174 (785)
|+.+ +..|+.+++++++|++||+++++++++|||||||||||||+ .++|++||+.|+++||++|+........ .
T Consensus 78 ~~~~-~~~fs~~~~~~~~R~~fi~si~~~l~~~~fDGIDIDWE~p~~~~~~~~d~~n~~~ll~elr~~l~~~~~~~~~-~ 155 (302)
T d1vf8a1 78 WKFG-PAPFSAMVSTPQNRQIFIQSVIRFLRQYNFDGLNLDWQYPGSRGSPPKDKHLFSVLVKEMRKAFEEESVEKDI-P 155 (302)
T ss_dssp TTTC-SHHHHHHHTSHHHHHHHHHHHHHHHHHTTCCEEEEECSCTTSTTCCTHHHHHHHHHHHHHHHHHHHHHHHHTS-C
T ss_pred CCCC-CcchHHHhcchHHHHHHHHHHHHHHHHhCCCeeeeeeeecccccccchhHhHHHHHHHHHHHHHHHhhhhcCC-C
Confidence 8754 34599999999999999999999999999999999999995 3567899999999999999875433222 2
Q ss_pred ceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCC---CCCHHHHHHHHHHcCC
Q 003932 175 QSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRF---ARSTDQVLKAWIERGL 251 (785)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~---~~~~~~~v~~~~~~gv 251 (785)
...++.++.+........|+++++.+++||||+|+||++|+|. +.+|++|||++.+.+.. ..+++.+|++|+++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~yd~~~~~~~vD~inlmtYD~~g~~~-~~tg~~apl~~~~~~~~~~~~~~v~~~v~~~~~~Gv 234 (302)
T d1vf8a1 156 RLLLTSTGAGIIDVIKSGYKIPELSQSLDYIQVMTYDLHDPKD-GYTGENSPLYKSPYDIGKSADLNVDSIISYWKDHGA 234 (302)
T ss_dssp CCEEEEEECSSHHHHHHHCCHHHHHHHCSEEEECCCCCSCGGG-SBCCCSSCSSCCTTCCGGGGGCSHHHHHHHHHHTTC
T ss_pred ceeeeecccchhhhhhhcCcchhhccccCeeeeeccccCCCCC-CCCCCCCCCCCCCCCCCCCCCccHHHHHHHHHHcCC
Confidence 2333333333222234568999999999999999999999986 56999999998765432 4689999999999999
Q ss_pred CCCceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeC
Q 003932 252 SADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFD 331 (785)
Q Consensus 252 p~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~yd 331 (785)
|++||+||||+||
T Consensus 235 p~~KlvlGip~~g------------------------------------------------------------------- 247 (302)
T d1vf8a1 235 ASEKLIVGFPADN------------------------------------------------------------------- 247 (302)
T ss_dssp CGGGEEEEEESCC-------------------------------------------------------------------
T ss_pred CHHHeEEEEecCC-------------------------------------------------------------------
Confidence 9999999999764
Q ss_pred CHHHHHHHHhhhcccCccceEeeeccccchhh
Q 003932 332 DVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDW 363 (785)
Q Consensus 332 d~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~~ 363 (785)
++|++.|++|++++||||+|+|++|+||...
T Consensus 248 -~rs~~~K~~~~~~~~lgGv~~W~~d~DDf~G 278 (302)
T d1vf8a1 248 -VRSFKLKAQWLKDNNLGGAVVWPLDMDDFSG 278 (302)
T ss_dssp -HHHHHHHHHHHHHTTCCEEEEETGGGSCTTS
T ss_pred -hHHHHHHHHHHHhCCCeeEEEeccccCCCCC
Confidence 6899999999999999999999999999654
|
| >d1jnda1 c.1.8.5 (A:2-278,A:371-420) Imaginal disc growth factor-2 {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Imaginal disc growth factor-2 species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=100.00 E-value=5.9e-52 Score=439.04 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=212.3
Q ss_pred EEEEEecCCC-------CCCcCCC--CCCCCceEEEEEEEeeCCccEEecCCCccH---HHHHHHHHHHHhcCCCceEEE
Q 003932 27 IRVGYLNLSE-------VSTISGI--NYDLFTHLICSSADINSTTYQLSLSLPSDE---NQIAKFADTVKKKNPSITTIL 94 (785)
Q Consensus 27 ~~vgY~~~~~-------~~~~~~i--~~~~~Thi~~~f~~~~~~~~~~~~~~~~~~---~~~~~~~~~~k~~~p~lkv~~ 94 (785)
.+||||++|. .+.+.+| +.++||||+|+|+.+++++..+...+++.+ ..+.++ .++|++||++|+++
T Consensus 2 ~ivcYy~~ws~~r~g~~~~~~~~id~~~~~cTHiiyafa~i~~~~~~~~~~d~~~d~~~~~~~~~-~~lk~~~p~lKvll 80 (327)
T d1jnda1 2 NLVCYYDSSSYTREGLGKLLNPDLEIALQFCSHLVYGYAGLRGENLQAYSMNENLDIYKHQFSEV-TSLKRKYPHLKVLL 80 (327)
T ss_dssp EEEEEEEGGGGGCSSTTCCCHHHHHHHGGGCSEEEEEEEEECTTTCCEEETTHHHHTTTCHHHHH-HGGGGTSTTCEEEE
T ss_pred eEEEEECCCcccCCCCCCcCHhhcCCCcccCCeEEEEEEEecCCCCEEEecCchhhhhHHHHHHH-HHHHHhCCCCeEEE
Confidence 5899999884 3456655 567799999999999998877776655433 234444 45999999999999
Q ss_pred EecCCCCCC----cccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCC------------------------
Q 003932 95 SIGQGKDTN----YSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTS------------------------ 146 (785)
Q Consensus 95 sigG~~~~~----~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~------------------------ 146 (785)
|||||+.++ +..|+.+++++++|++||+|+++|+++|+|||||||||||+..
T Consensus 81 SiGGw~~~~~~~~~~~~~~~~~~~~rr~~Fi~svv~~l~~~~fDGIDiDWEyP~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (327)
T d1jnda1 81 SVGGDHDIDPDHPNKYIDLLEGEKVRQIGFIRSAYELVKTYGFDGLDLAYQFPKNKPRKVHGDLGLAWKSIKKLFTGDFI 160 (327)
T ss_dssp EEETTCCCCTTSTTHHHHHHTCCHHHHHHHHHHHHHHHHHTTCSEEEEECCCCCCCCCCC-------------------C
T ss_pred EEECCCCCCCCcccchhHHHhCCHHHHHHHHHHHHHHHHHCCCCceEEEeeccCCCCcccccccchhhhhhhhccccccc
Confidence 999987543 3357777888888899999999999999999999999999642
Q ss_pred ------CCchhHHHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccC-CC
Q 003932 147 ------TDMFNIGLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVS-TN 219 (785)
Q Consensus 147 ------~d~~~~~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~-~~ 219 (785)
.++++|+.|++++|+++... .+.+++++.+. ......|+++++.+++||||+|+|||+|+|. ..
T Consensus 161 ~~~~~~~d~~~~~~l~~elr~~l~~~--------~~~ls~a~~~~-~~~~~~~d~~~l~~~vD~vnlmtYD~~g~~~~~~ 231 (327)
T d1jnda1 161 VDPHAALHKEQFTALVRDVKDSLRAD--------GFLLSLTVLPN-VNSTWYFDIPALNGLVDFVNLATFDFLTPARNPE 231 (327)
T ss_dssp CCTTHHHHHHHHHHHHHHHHHHHHTT--------TCEEEEEECTT-CCHHHHCCHHHHHTTCSEEEECCCCSSCTTTCTT
T ss_pred cccccHHHHHHHHHHHHHHHHhhccC--------CceEEEEecCC-hHHhhcccHHHHhhhhhhHhhhhhhhcCccccCC
Confidence 24679999999999998752 44555555433 2233578999999999999999999999885 45
Q ss_pred CCCCCCCCCCCCCCCC---CCCHHHHHHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHH
Q 003932 220 FTAPPAALYGSISGRF---ARSTDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKK 296 (785)
Q Consensus 220 ~~g~~apl~~~~~~~~---~~~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~ 296 (785)
.+|++|||++...... ..+++.+|++|+++|+|++||++|||
T Consensus 232 ~~g~~apL~~~~~~~~~~~~~~~d~~v~~~~~~G~p~~Kl~lGi~----------------------------------- 276 (327)
T d1jnda1 232 EADYSAPIYHPDGSKDRLAHLNADFQVEYWLSQGFPSNKINLGVA----------------------------------- 276 (327)
T ss_dssp CBCCSSCSSCCTTSTTCCTTCSHHHHHHHHHHTTCCGGGEEEEEE-----------------------------------
T ss_pred cccccCCCCCCCCCCCcccCccHHHHHHHHHHcCCCHHHeEEEEc-----------------------------------
Confidence 7999999997654432 45899999999999999999999865
Q ss_pred HHhhhhhcCCCeEEEeccceeeeeeecCCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchhh
Q 003932 297 IKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDW 363 (785)
Q Consensus 297 i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~~ 363 (785)
|||++||+.|++|++++||||+|+|++++||+..
T Consensus 277 ---------------------------------ydd~~Si~~K~~~~~~~~lgGv~~W~l~~DDf~G 310 (327)
T d1jnda1 277 ---------------------------------TDDPDSASNKAAYARVKNLGGVALFDLSYDDFRG 310 (327)
T ss_dssp ---------------------------------SCCHHHHHHHHHHHHHTTCSEEEEECGGGSCTTC
T ss_pred ---------------------------------CCCHHHHHHHHHHHHhcCCCEEEEEeccCCCCCC
Confidence 8999999999999999999999999999999654
|
| >d1goia2 c.1.8.5 (A:3-291,A:380-446) Chitinase B, catalytic domain {Serratia marcescens [TaxId: 615]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Chitinase B, catalytic domain species: Serratia marcescens [TaxId: 615]
Probab=100.00 E-value=1e-50 Score=435.19 Aligned_cols=303 Identities=21% Similarity=0.244 Sum_probs=228.1
Q ss_pred CcEEEEEec-------CCC-------CCCcCCCCC---CCCceEEEEEEEeeCCccEEecCCCccHH---HHHHHHHHHH
Q 003932 25 PWIRVGYLN-------LSE-------VSTISGINY---DLFTHLICSSADINSTTYQLSLSLPSDEN---QIAKFADTVK 84 (785)
Q Consensus 25 ~~~~vgY~~-------~~~-------~~~~~~i~~---~~~Thi~~~f~~~~~~~~~~~~~~~~~~~---~~~~~~~~~k 84 (785)
.+.+||||. ++. .+++++|+. ++||||+|+|+.++++| .+.+.....+. .+.+.+..||
T Consensus 2 ~~~~~~yy~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~lTHi~yaFa~i~~~g-~~~~~~~~~~~~~~~~~~~~~~lK 80 (356)
T d1goia2 2 RKAVIGYYFIPTNQINNYTETDTSVVPFPVSNITPAKAKQLTHINFSFLDINSNL-ECAWDPATNDAKARDVVNRLTALK 80 (356)
T ss_dssp CCEEEEEEECCHHHHHTCCSSCTTTCSSCGGGSCHHHHHHCSEEEEEEEEECTTS-SEECCTTCCHHHHHHHHHHHHHGG
T ss_pred CcEEEEEEeCCccCcCcccccCCccCCcChhcCCcchHhhCCeEEEEEEEECCCc-cEEecCCccchHHHHHHHHHHHHH
Confidence 367899993 332 345666654 67899999999999998 45554444433 2345556699
Q ss_pred hcCCCceEEEEecCCCCCC-----cccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHH
Q 003932 85 KKNPSITTILSIGQGKDTN-----YSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEW 159 (785)
Q Consensus 85 ~~~p~lkv~~sigG~~~~~-----~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~l 159 (785)
++||+||||+|||||+.++ ...|+.+++++++|++||+++++|+++||||||||||||| ..+++.+|+.|++++
T Consensus 81 ~~~p~lKvllSiGGW~~s~~~~~~~~~fs~~~~~~~~R~~Fi~siv~~l~~ygfDGIDIDWE~P-~~~~~~~~~~l~~el 159 (356)
T d1goia2 81 AHNPSLRIMFSIGGWYYSNDLGVSHANYVNAVKTPASRAKFAQSCVRIMKDYGFDGVNIDWEYP-QAAEVDGFIAALQEI 159 (356)
T ss_dssp GGCTTCEEEEEEECHHHHSTTSTTHHHHHHHTSSHHHHHHHHHHHHHHHHHHTCSEEEEECSCC-CHHHHHHHHHHHHHH
T ss_pred HHCCCCeEEEEEcCCcCCCCCcccccchHHHhCCHHHHHHHHHHHHHHHHHhCCCceeeeeccc-cccccccchhHHHHH
Confidence 9999999999999986432 3479999999999999999999999999999999999999 457889999999999
Q ss_pred HHHhhhhhhhcccc-cceeEEEEeecccCC-CCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCC
Q 003932 160 RIAATKLDAKNSTR-QQSLLILTARFRYSP-PANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFAR 237 (785)
Q Consensus 160 r~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~ 237 (785)
|.+++.+....... ....++++++..... ....+++++|.++|||||||+|||||+|+ +.+||+|||++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~ls~a~~~~~~~~~~~~~d~~~l~~~vD~invMtYD~~g~w~-~~tg~~spLy~~------- 231 (356)
T d1goia2 160 RTLLNQQTITDGRQALPYQLTIAGAGGAFFLSRYYSKLAQIVAPLDYINLMTYDLAGPWE-KVTNHQAALFGD------- 231 (356)
T ss_dssp HHHHHHHHHHTTCTTSCCEEEEEEESSHHHHTTTGGGHHHHHTTCSEEEEECCCSSCTTS-SSCCCTTCSSBC-------
T ss_pred HHHHHHHHHHhccccccceeEEeccCCHHHHhhhhhHHHHhhcccCeeEEEeecccCCCC-CCCCCCCcccCC-------
Confidence 99987764333222 233455555443322 23456899999999999999999999987 469999999863
Q ss_pred CHHHHHHHHHHcCCCCCceeeccccccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEecccee
Q 003932 238 STDQVLKAWIERGLSADKLVMCLPFYGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYE 317 (785)
Q Consensus 238 ~~~~~v~~~~~~gvp~~KlvlGip~YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~ 317 (785)
.+.|..+.++|+++||+.|.......++. +..++...... |.....
T Consensus 232 -----------~~~p~~~~~~~~~~~G~~~~~~~~~~~~~------------~~~~~~~~~~~-----------~~~~~~ 277 (356)
T d1goia2 232 -----------AAGPTFYNALREANLGWSWEELTRAFPSP------------FSLTVDAAVQQ-----------HLMMEG 277 (356)
T ss_dssp -----------TTSCCBCCGGGGSSCCCCHHHHHHHCCSS------------BCCCHHHHHHH-----------HHTSTT
T ss_pred -----------CCCChhhccccccccccChhhcccccCCC------------cceeccHHHHH-----------HHHhcC
Confidence 25788999999999999997543222211 11222222211 111112
Q ss_pred eeeeecCCEEEEeCCHHHHHHHHhhhcccCccceEeeeccccchhhhhhhhhhcc
Q 003932 318 VNYFSTGTVWFGFDDVEAVRAKIAYAKEKRLLGYYAWQVSFDDHDWLLSQAAAQK 372 (785)
Q Consensus 318 ~~y~~~~~~~i~ydd~~Si~~K~~~~~~~glgG~~~W~l~~Dd~~~~l~~~~~~~ 372 (785)
.|+ .+..+||+|||++||+.|++||+++||||+|+|+|++||.++.|++|+...
T Consensus 278 ~p~-~~~~~~vsydd~~Si~~K~~y~~~~~LgGv~iW~l~~Dd~~gsLl~ai~~~ 331 (356)
T d1goia2 278 VPS-AKIVMGVPFDDAESFKYKAKYIKQQQLGGVMFWHLGQDNRNGDLLAALDRY 331 (356)
T ss_dssp CCG-GGEEEEEESCCHHHHHHHHHHHHHTTCCEEEEECGGGSCTTCHHHHHHHHH
T ss_pred CCc-cceeEEeccCCHHHHHHHHHHHHhCCCCEEEEEecCCCCCCcHHHHHHHHh
Confidence 233 234589999999999999999999999999999999999999999998643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=412.47 Aligned_cols=264 Identities=27% Similarity=0.410 Sum_probs=204.7
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
..++|++.+.||+|+||+||+|+.+ ..||||+++.. .....+.|.+|+.++++++||||+++++++.+ ...++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 3568999999999999999999865 35999999754 34566789999999999999999999999764 5689999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999998642 345899999999999999999999986 999999999999999999999999999876544
Q ss_pred ccccccccccccCCcccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATK---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
..........||+.|||||++.+ ..++.++|||||||+||||+||+.||....... . .......+......
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~---~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---Q---IIFMVGRGYLSPDL 231 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---H---HHHHHHHTSCCCCG
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---H---HHHHHhcCCCCCcc
Confidence 33334456789999999999865 358999999999999999999999986432211 1 11111111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNI 744 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 744 (785)
. ......+..+.+|+.+||+.||++|||++||++.|+....++
T Consensus 232 ~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 S-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp G-----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred h-----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 0 011223457889999999999999999999999998765443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=404.45 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=204.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999995 4789999999976532 3345689999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++++||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999853 346999999999999999999999986 99999999999999999999999999998755443
Q ss_pred ccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......+||+.|||||++.+..+ +.++|||||||++|||++|+.||....... ... .........
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~----~~~~~~~~~------- 225 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEY----SDWKEKKTY------- 225 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHH----HHHHTTCTT-------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHH----HHHhcCCCC-------
Confidence 444556789999999999988876 578999999999999999999996433221 111 111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.......+.++.+|+.+||+.||++|||++|+++
T Consensus 226 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111122357789999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=404.00 Aligned_cols=255 Identities=26% Similarity=0.446 Sum_probs=199.2
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
++|++.+.||+|+||+||+|++.+++.||||+++.... ..++|.+|++++++++||||++++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 57889999999999999999988888999999976543 34689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence 9999998864 3356889999999999999999999986 99999999999999999999999999987654322 2
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDR 703 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 703 (785)
......||..|+|||++.+..++.++|||||||++|||+|+..|+.... ....... ....+.. ..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~----~i~~~~~---------~~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVE----DISTGFR---------LY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHH----HHHHTCC---------CC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHH----HHHhcCC---------CC
Confidence 2334578999999999999999999999999999999999544433211 1111111 1111111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 704 NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 704 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.+...+.++.+|+.+||+.||++|||++||++.|+++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1122345789999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=404.82 Aligned_cols=259 Identities=30% Similarity=0.472 Sum_probs=209.2
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
...++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 3456899999999999999999999888899999997654 334679999999999999999999998864 56799999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+++|+|.+++... ....+++..++.++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++.+....
T Consensus 88 y~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999887543 2345899999999999999999999986 9999999999999999999999999999875432
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
. .......||+.|+|||++.+..++.++|||||||++|||+||..|+..... . .........+....
T Consensus 164 ~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~----~~~~~~i~~~~~~~------ 230 (272)
T d1qpca_ 164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--N----PEVIQNLERGYRMV------ 230 (272)
T ss_dssp E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--H----HHHHHHHHTTCCCC------
T ss_pred c-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--H----HHHHHHHHhcCCCC------
Confidence 2 223446789999999999999999999999999999999997655432211 1 11112222221111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.+...+.++.+|+.+||+.||++|||++||++.|++..
T Consensus 231 ---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 ---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11223457889999999999999999999999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=402.35 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=207.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999995 578999999997665555678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 99999988742 35899999999999999999999986 9999999999999999999999999998865432
Q ss_pred cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 623 ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........... . .
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~-------~ 236 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-E-------L 236 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-C-------C
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-C-------C
Confidence 2334567999999999999999999999999999999999999999643211 111111111110 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223457889999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=398.67 Aligned_cols=245 Identities=28% Similarity=0.407 Sum_probs=204.5
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++.+.||+|+||+||+|+. .+++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4699999999999999999996 468899999986532 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999853 346899999999999999999999986 999999999999999999999999999765432
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
......||+.|+|||++.+..++.++|||||||+||||++|+.||......+ ..........
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~------- 221 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF------- 221 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC-------
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 2334679999999999999999999999999999999999999996432111 1111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111223457889999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-49 Score=408.50 Aligned_cols=262 Identities=29% Similarity=0.441 Sum_probs=213.9
Q ss_pred HHHHhcCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 459 IEAATERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 459 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
++...++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|+++|++++||||++++++|.+.+..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3444678999999999999999999964 68899999997654 345789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
|||||++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++...
T Consensus 91 v~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999998643 3456899999999999999999999986 9999999999999999999999999998764
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.... .......|++.|+|||++.+..++.++|||||||++|||++|..|+..... ..........+...
T Consensus 167 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~------~~~~~~~i~~~~~~---- 235 (287)
T d1opja_ 167 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKDYRM---- 235 (287)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHTTCCC----
T ss_pred CCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch------HHHHHHHHhcCCCC----
Confidence 4322 223345689999999999999999999999999999999997776542211 11112222222111
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
..+...+.++.+|+.+||+.||++|||++||++.|+...
T Consensus 236 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 236 -----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112233457899999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=393.32 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=211.5
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecC
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMP 543 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 543 (785)
++|++.++||+|+||+||+|+.++++.||||++++... ..++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57899999999999999999998888999999986543 34689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccccc
Q 003932 544 NKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLEE 623 (785)
Q Consensus 544 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 623 (785)
+|+|..++.. ....+++..+.+++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..... .
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence 9999988754 3446889999999999999999999986 99999999999999999999999999987654322 2
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......||..|+|||.+.+..++.++|||||||++|||+| |+.||......+ .......+....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~~~-------- 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRLY-------- 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCCC--------
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCCCC--------
Confidence 3334678999999999999999999999999999999998 898886433211 112222221111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 739 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 739 (785)
.+...+.++.+|+.+||+.||++|||++||++.|.+
T Consensus 222 -~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 -RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 112233578999999999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=399.41 Aligned_cols=254 Identities=26% Similarity=0.330 Sum_probs=194.9
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEec--CCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 538 (785)
++|++.+.||+|+||+||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999985 578999999987653 4455678999999999999999999999875 3568999
Q ss_pred EEecCCCChhhhhcCCc-cccCCCHHHHHHHHHHHHHHHHHHhhcCC--CCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 539 YEYMPNKSLDCYLFDPI-RKLILDWKKRVHIIEGITQGLLYLQEYSR--LTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
||||++|+|.+++.... ....+++..++.++.||+.||.|||+.+. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999985432 24569999999999999999999998652 3599999999999999999999999999987
Q ss_pred ecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 616 FAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 616 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .......+.....
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~~~ 234 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRI 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCCC
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCCC
Confidence 64332 22345689999999999999999999999999999999999999986432211 1111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
+...+.++.+|+.+||+.||++|||++|+++
T Consensus 235 ---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1123347889999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-48 Score=405.34 Aligned_cols=258 Identities=25% Similarity=0.396 Sum_probs=199.0
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CC---cEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CG---EVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
++|++.++||+|+||+||+|... ++ ..||||++... .....+.|.+|+.+|++++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 46778899999999999999864 22 36899998764 445567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
||||++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998854 2346899999999999999999999986 99999999999999999999999999987654
Q ss_pred cccccc---cccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 619 ESLEEN---TEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 619 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
...... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ .......+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~-- 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINAIEQDYR-- 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC--
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC--
Confidence 322211 223457899999999999999999999999999999998 899986432211 1111222111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
...+...+..+.+|+.+||+.||++|||+.||++.|++...
T Consensus 252 -------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 -------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11122344578999999999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=399.30 Aligned_cols=251 Identities=21% Similarity=0.325 Sum_probs=206.9
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
+.|++++.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999995 578999999998776666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 99999998753 2345899999999999999999999986 9999999999999999999999999998754321
Q ss_pred cccccccccCCcccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 623 ENTEQVVGTIGYIPPEYAT-----KGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 623 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||......+ ... ....... ..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~---~i~~~~~-~~--- 234 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL---KIAKSEP-PT--- 234 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHHSCC-CC---
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHcCCC-CC---
Confidence 2234567999999999984 4568999999999999999999999996543322 111 1111111 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 235 ----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ----LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111223457889999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=401.20 Aligned_cols=267 Identities=26% Similarity=0.434 Sum_probs=209.5
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
..++|++.+.||+|+||.||+|+.++++.||||++.... ...+.|.+|+.++++++|||||+++++|.+ +..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 356899999999999999999998888889999997553 345789999999999999999999999854 568999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++|+|..++... ....+++..++.++.||++||+|||+.+ |+||||||+||||+.++++||+|||+++.+.....
T Consensus 93 ~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 93 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999888542 2345899999999999999999999986 99999999999999999999999999987643322
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccccC
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLD 701 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 701 (785)
.......||+.|+|||++.+..++.++|||||||++|||++|..|+..... . .........+...
T Consensus 169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~-~~~~~~i~~~~~~-------- 233 (285)
T d1fmka3 169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----N-REVLDQVERGYRM-------- 233 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----H-HHHHHHHHTTCCC--------
T ss_pred -eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----H-HHHHHHHHhcCCC--------
Confidence 223345789999999999999999999999999999999997666543221 1 1111222222111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 003932 702 DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKP 750 (785)
Q Consensus 702 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~ 750 (785)
......+.++.+++.+||+.||++|||+++|+++|+....+...+..|
T Consensus 234 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 234 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred -CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 112233457899999999999999999999999999987766554444
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=394.32 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=207.9
Q ss_pred cCCCccee-eceeCcEEEEEEEeC---CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNK-LGEGGYGPVYKGVLP---CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 538 (785)
++|.+.+. ||+|+||.||+|... ++..||||++... .....++|.+|+++|++++|||||+++++|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 46777774 999999999999753 4557999999765 34556789999999999999999999999865 568999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
||||++|+|.+++.. .+..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998753 3346899999999999999999999986 99999999999999999999999999998754
Q ss_pred cccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 619 ESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 619 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ .......+...+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~-- 232 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME-- 232 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCC--
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC--
Confidence 3222 22334568999999999999999999999999999999998 899986433211 112222222221
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.++..+.++.+|+.+||+.||++|||+.+|++.|+...
T Consensus 233 -------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 233 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp -------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12233457889999999999999999999999998643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=399.98 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=202.5
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++++.||+|+||+||+|+. .+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999995 578999999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999874 3456899999999999999999999986 999999999999999999999999999987544
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+ . ........ ..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~----~~~i~~~~-~~----- 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---I----FQKIIKLE-YD----- 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHTTC-CC-----
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---H----HHHHHcCC-CC-----
Confidence 33334455689999999999999999999999999999999999999996432111 1 11111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+...+.++.+|+.+||+.||++|||++|+++
T Consensus 229 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11122347889999999999999999999743
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=403.93 Aligned_cols=260 Identities=27% Similarity=0.389 Sum_probs=207.9
Q ss_pred HHhcCCCcceeeceeCcEEEEEEEeCC-C-----cEEEEEEcCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecC
Q 003932 461 AATERFSIRNKLGEGGYGPVYKGVLPC-G-----EVIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS 532 (785)
Q Consensus 461 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 532 (785)
...++|++.++||+|+||+||+|+... + ..||+|++... .......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 345789999999999999999998532 2 36899998654 333446788999999998 899999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCcc--------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIR--------------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 592 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 592 (785)
+..++|||||++|+|.++|..... ...+++..++.++.||++||+|||+.+ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999965321 235899999999999999999999986 999999
Q ss_pred cCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCccc
Q 003932 593 KVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLC 671 (785)
Q Consensus 593 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~ 671 (785)
||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987655433333445678999999999999999999999999999999998 89998654
Q ss_pred CCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 003932 672 GINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 738 (785)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 738 (785)
..... .......+... ..+...+.++.+|+.+||+.||++|||++||++.|.
T Consensus 271 ~~~~~------~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDAN------FYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHH------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHH------HHHHHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 33221 11222222111 112223457899999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=400.83 Aligned_cols=263 Identities=23% Similarity=0.295 Sum_probs=204.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.++|+++++||+|+||+||+|+. .+++.||+|+++... ....+.+.+|+.+|++++|||||+++++|.+....++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46899999999999999999995 578999999997653 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||++|+|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++++||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999853 34589999999999999999999974 5 999999999999999999999999999865432
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH----------------
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA---------------- 683 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~---------------- 683 (785)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+........
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 234568999999999999999999999999999999999999999754322110000000
Q ss_pred ---HHHHhCC----ccccccccccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 684 ---YELWKGG----KGVEFVDSFLD----DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 684 ---~~~~~~~----~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....... ...+..+.... .......+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000 00000000000 0001112357889999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=392.61 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=200.7
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCC-----cEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCG-----EVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
..|++.++||+|+||.||+|.+... ..||||++.... .....+|.+|+.++++++|||||+++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688889999999999999985432 469999997643 3445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+.++++.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887753 3346899999999999999999999986 9999999999999999999999999998765
Q ss_pred ccccc-cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLE-ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
..... .......||+.|+|||++.+..++.++|||||||++|||++|..|+..... . .........+..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~----~~~~~~i~~~~~---- 231 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--N----HEVMKAINDGFR---- 231 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--H----HHHHHHHHTTCC----
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--H----HHHHHHHhccCC----
Confidence 43221 122345689999999999999999999999999999999997666542211 1 111222222211
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
...+...+..+.+|+.+||+.||++|||+.||++.|+....
T Consensus 232 -----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11122234578999999999999999999999999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=391.33 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=198.5
Q ss_pred eeeceeCcEEEEEEEeC---CCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEecCC
Q 003932 470 NKLGEGGYGPVYKGVLP---CGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYMPN 544 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 544 (785)
++||+|+||+||+|.+. .++.||||+++... ....+++.+|+++|++++||||++++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999853 35689999997542 3345679999999999999999999999865 467899999999
Q ss_pred CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc-c
Q 003932 545 KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE-E 623 (785)
Q Consensus 545 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 623 (785)
|+|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999853 345899999999999999999999986 999999999999999999999999999876543222 2
Q ss_pred ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCccccccccccCC
Q 003932 624 NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFLDD 702 (785)
Q Consensus 624 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 702 (785)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... ........+....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~~~-------- 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMG-------- 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC--------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-------HHHHHHHcCCCCC--------
Confidence 2334578999999999999999999999999999999998 89998643211 1122222222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 703 RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 703 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.+...+.++.+|+.+||+.||++|||+++|++.|+..
T Consensus 231 -~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1122345788999999999999999999999988764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-46 Score=400.25 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=209.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++++.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999995 57899999999887777778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc--CCCceeeccccceeeeccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG--EAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Dfg~a~~~~~~ 619 (785)
|++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999998854 2345899999999999999999999986 99999999999996 4678999999999876543
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.......||+.|||||++.+..++.++|||||||++|||++|+.||...+..+ .. ......... ..
T Consensus 180 ---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~---~~i~~~~~~--~~--- 245 (350)
T d1koaa2 180 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TL---RNVKSCDWN--MD--- 245 (350)
T ss_dssp ---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHTCCC--SC---
T ss_pred ---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCCCC--CC---
Confidence 23345689999999999999999999999999999999999999986432111 11 111111110 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.......+.++.+|+.+||+.||++|||++|+++.
T Consensus 246 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 --DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111223578899999999999999999999884
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-46 Score=399.70 Aligned_cols=259 Identities=23% Similarity=0.298 Sum_probs=211.9
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEYM 542 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 542 (785)
++|++++.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++||||+++++++.+....++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999995 579999999998776666678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc--CCCceeeccccceeeecccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG--EAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Dfg~a~~~~~~~ 620 (785)
++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 99999887743 2345899999999999999999999986 99999999999998 6789999999999886543
Q ss_pred cccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ . ......... ..
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~---~~~i~~~~~--~~----- 247 (352)
T d1koba_ 183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---T---LQNVKRCDW--EF----- 247 (352)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---H---HHHHHHCCC--CC-----
T ss_pred --CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCCC--CC-----
Confidence 23344678999999999999999999999999999999999999996432111 1 111111110 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcccCC
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNETTN 743 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~ 743 (785)
........+.++.+|+.+||+.||.+|||++|+++. |++...+
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 111112234578899999999999999999999873 6554333
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=382.25 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=196.0
Q ss_pred CcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec----CCccEEEE
Q 003932 467 SIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLIY 539 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 539 (785)
++.++||+|+||+||+|+. .+++.||+|++... .....+.+.+|+++|++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5667899999999999995 46889999998654 34556779999999999999999999999865 34578999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc-CCCceeeccccceeeecc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG-EAMKPKISDFGMARIFAK 618 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~ 618 (785)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999853 346899999999999999999999874 3599999999999997 578999999999975332
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
......+||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ....+....+.....++
T Consensus 168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~~- 235 (270)
T d1t4ha_ 168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD- 235 (270)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG-
T ss_pred ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcccC-
Confidence 22345689999999999875 5999999999999999999999998632211 11122222221111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
. ..+.++.+|+.+||+.||++|||++|+++
T Consensus 236 ---~----~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 ---K----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---G----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---c----cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 12336889999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-47 Score=396.59 Aligned_cols=265 Identities=26% Similarity=0.438 Sum_probs=212.9
Q ss_pred HHHHHHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEE
Q 003932 457 ADIEAATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFC 529 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 529 (785)
.+++...++|++.+.||+|+||+||+|+.. +++.||||++.... ....++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344556778999999999999999999853 35789999997653 34456799999999999999999999999
Q ss_pred ecCCccEEEEEecCCCChhhhhcCCc---------------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 003932 530 IDSEERMLIYEYMPNKSLDCYLFDPI---------------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTII 588 (785)
Q Consensus 530 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 588 (785)
......+++|||+++|+|.++++... ....+++..++.++.|++.||+|||+.+ +|
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999985321 1234889999999999999999999986 99
Q ss_pred EecccCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCC-CC
Q 003932 589 HRDLKVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK-RL 667 (785)
Q Consensus 589 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~-~p 667 (785)
||||||+|||++.++.+||+|||+++.+.............||+.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998765443334444567899999999999999999999999999999999986 45
Q ss_pred CcccCCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 668 SMLCGINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
+......+ . ......+..... +...+.++.+|+.+||+.||++||||.||+++|++.
T Consensus 243 ~~~~~~~e---~----~~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYGMAHEE---V----IYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTSCHHH---H----HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCHHH---H----HHHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 54322111 1 122222222111 122335788999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=394.83 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=189.7
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
.+.|++.+.||+|+||+||+|+. .+++.||||++.+... ...+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45799999999999999999995 4689999999976532 233567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc---CCCceeeccccceeeec
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG---EAMKPKISDFGMARIFA 617 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~Dfg~a~~~~ 617 (785)
||++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999853 346999999999999999999999986 99999999999995 57899999999998754
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 697 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (785)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.......... ..
T Consensus 162 ~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~--~~-- 228 (307)
T d1a06a_ 162 PG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAEY--EF-- 228 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTCC--CC--
T ss_pred CC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccCC--CC--
Confidence 33 2234567999999999999999999999999999999999999999643211 11111111111 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 698 SFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 698 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.....+..+.++.+|+.+||+.||++|||++|+++
T Consensus 229 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 ---DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111223457889999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-46 Score=393.09 Aligned_cols=249 Identities=29% Similarity=0.408 Sum_probs=202.9
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
+.|+.++.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4599999999999999999995 578899999997653 234467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999976653 3356899999999999999999999986 99999999999999999999999999976432
Q ss_pred ccccccccccccCCcccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATK---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.......... ...
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~-~~~- 234 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES-PAL- 234 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCC-
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC-CCC-
Confidence 234679999999999864 4589999999999999999999999864321 111222222211 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 739 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 739 (785)
.....+..+.+|+.+||+.||++|||++|+++ .+.+
T Consensus 235 -------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 11122457889999999999999999999986 4544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=381.88 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=198.5
Q ss_pred hcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-CccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 541 (785)
.++|++.+.||+|+||.||+|+.. |+.||||++++.. ..+.+.+|++++++++||||++++|+|.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 357889999999999999999986 7889999997653 346799999999999999999999998654 568999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+++|+|.++|... ....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999999643 2335899999999999999999999986 999999999999999999999999999864322
Q ss_pred ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 622 EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
.....+|..|+|||++.+..++.++|||||||++|||+| |++|+......+ .... ...+...
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~~~~------- 219 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKM------- 219 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTTCCC-------
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCC-------
Confidence 233567899999999999999999999999999999998 677765432222 2211 2222111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
..+...+.++.+|+.+||+.||++|||+.|+++.|++.
T Consensus 220 --~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 220 --DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 12222345788999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=386.95 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=204.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC------hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
++|++++.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+....+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999995 578999999986532 123578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC----ceeeccccc
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM----KPKISDFGM 612 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfg~ 612 (785)
+|||||++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999853 346999999999999999999999986 99999999999998776 599999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..........
T Consensus 164 a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNY 233 (293)
T ss_dssp CEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCC
T ss_pred hhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcCC
Confidence 9876433 22344678999999999999999999999999999999999999996432111 1111111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
....... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 234 -~~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 -EFEDEYF-----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CCCHHHH-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCCchhc-----CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 112346889999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-45 Score=386.63 Aligned_cols=244 Identities=25% Similarity=0.327 Sum_probs=203.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++++.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4699999999999999999995 568999999996532 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999988884 3445788888999999999999999886 999999999999999999999999999876432
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+ ..........
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~~~~-------- 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAEL-------- 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCCC--------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHHHHcCCC--------
Confidence 335689999999999999999999999999999999999999996432211 1111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
..++..+.++.+++.+||+.||.+|| |++|+++
T Consensus 219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11122335788999999999999996 8999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=385.00 Aligned_cols=255 Identities=22% Similarity=0.369 Sum_probs=197.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEeC----CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVLP----CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.++|++.+.||+|+||.||+|++. .+..||||++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 568999999999999999999853 24568999987543 444567999999999999999999999986 467899
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
||||+++|+|..++.. ....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988753 3446899999999999999999999986 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
.... .......||+.|+|||.+.+..++.++|||||||++|||++ |++|+......+ ... ....+....
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~----~i~~~~~~~-- 229 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGERLP-- 229 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCCC--
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCCCC--
Confidence 4322 22344568999999999999999999999999999999998 888886543322 111 112222111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.++..+..+.+|+.+||+.||++|||++||++.|+..
T Consensus 230 -------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 230 -------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1222345789999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=389.14 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=200.7
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCc----EEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGE----VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 537 (785)
.+|+++++||+|+||+||+|... +|+ .||+|++... .....+++.+|+.++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 36999999999999999999853 443 5899988654 344567899999999999999999999999864 5678
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
++||+.+|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888754 3456899999999999999999999986 9999999999999999999999999998765
Q ss_pred ccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccccc
Q 003932 618 KESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFV 696 (785)
Q Consensus 618 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (785)
............||+.|+|||++.++.++.++|||||||++|||+| |+.|+......+ ... ....+..
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~~---- 231 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER---- 231 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTCC----
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCC----
Confidence 4433333444578999999999999999999999999999999998 788876443222 111 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 697 DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 697 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...++..+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 111223345789999999999999999999999988765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=388.83 Aligned_cols=247 Identities=19% Similarity=0.256 Sum_probs=205.2
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++++.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999995 579999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
|||++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999998853 446889999999999999999999986 999999999999999999999999999865432
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+ + ........ ..
T Consensus 159 --~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~----~~~i~~~~-~~----- 223 (337)
T d1o6la_ 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L----FELILMEE-IR----- 223 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCC-CC-----
T ss_pred --CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---H----HHHHhcCC-CC-----
Confidence 123445789999999999999999999999999999999999999997533211 1 11111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 735 (785)
.+...+.++.+|+.+||+.||.+||+ ++|+++
T Consensus 224 ----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11223447889999999999999995 788876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=384.47 Aligned_cols=268 Identities=27% Similarity=0.375 Sum_probs=203.2
Q ss_pred ChHHHHHHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEE
Q 003932 455 SLADIEAATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVL 526 (785)
Q Consensus 455 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~ 526 (785)
....++...++|++.++||+|+||.||+|... +++.||||++... .....+.+.+|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34455555678999999999999999999842 3468999999754 344456677888877776 689999999
Q ss_pred EEEecC-CccEEEEEecCCCChhhhhcCCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecc
Q 003932 527 GFCIDS-EERMLIYEYMPNKSLDCYLFDPIR-------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 592 (785)
Q Consensus 527 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 592 (785)
+++... ...++|||||++|+|.+++..... ...+++..+..++.||++||.|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 998765 468999999999999999864321 345899999999999999999999986 999999
Q ss_pred cCCCEEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCC-CCCccc
Q 003932 593 KVSNILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK-RLSMLC 671 (785)
Q Consensus 593 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~-~p~~~~ 671 (785)
||+||||++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +|+...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765544333445568999999999999999999999999999999999975 466433
Q ss_pred CCCCcccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 672 GINENLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
...+ . .......+..... +...+.++.+++.+||+.||++|||++||++.|++.
T Consensus 241 ~~~~---~---~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 241 KIDE---E---FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCSH---H---HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHH---H---HHHHHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2221 1 1111222211111 122344788999999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=379.90 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=196.8
Q ss_pred cCCCcceeeceeCcEEEEEEEeC--CC--cEEEEEEcCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP--CG--EVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
++|++.+.||+|+||.||+|+.. ++ ..||||++.+. .....+.|.+|+.++++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57999999999999999999843 22 36899998754 23445689999999999999999999999975 4678
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999988754 3445999999999999999999999976 999999999999999999999999999987
Q ss_pred ccccccc-ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 617 AKESLEE-NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 617 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
....... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...... +........+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCCCC
Confidence 5443222 2334567889999999999999999999999999999998 89998643221 11122222221111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.+...+..+.+|+.+||+.||++|||++||.+.|++.
T Consensus 236 ---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 ---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122335788999999999999999999999999863
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=384.99 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=212.7
Q ss_pred HHHhcCCCcceeeceeCcEEEEEEEe------CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEec
Q 003932 460 EAATERFSIRNKLGEGGYGPVYKGVL------PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID 531 (785)
Q Consensus 460 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 531 (785)
+...++|++.++||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +||||++++++|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 34457899999999999999999974 346789999997653 44556789999999999 69999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCc---------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCC
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPI---------------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSN 596 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~N 596 (785)
....++|||||++|+|.++++... ....+++..+..++.||++||+|||+++ ++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence 999999999999999999986432 2235889999999999999999999986 9999999999
Q ss_pred EEEcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCC
Q 003932 597 ILLGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINE 675 (785)
Q Consensus 597 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~ 675 (785)
||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |++|+......+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987655443344455789999999999999999999999999999999999 455554332221
Q ss_pred cccHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 676 NLSILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
. + ......+. ....+...+..+.+|+.+||+.||++|||++||+++|++..
T Consensus 256 ~---~---~~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 256 K---F---YKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp H---H---HHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---H---HHHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1 1 11111111 11112223457899999999999999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=384.67 Aligned_cols=265 Identities=28% Similarity=0.413 Sum_probs=214.6
Q ss_pred HHHHHhcCCCcceeeceeCcEEEEEEEeC------CCcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEe
Q 003932 458 DIEAATERFSIRNKLGEGGYGPVYKGVLP------CGEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCI 530 (785)
Q Consensus 458 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 530 (785)
+++...++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|++++++++||||++++++|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34444678999999999999999999853 3578999999764 3445567899999999999999999999999
Q ss_pred cCCccEEEEEecCCCChhhhhcCCc-------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC
Q 003932 531 DSEERMLIYEYMPNKSLDCYLFDPI-------RKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM 603 (785)
Q Consensus 531 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 603 (785)
.....++||||+++|+|.+++.... ....+++..+.+++.|+++||.|||+.+ |+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 9999999999999999999885321 2234789999999999999999999986 99999999999999999
Q ss_pred ceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCC-CCCcccCCCCcccHHHH
Q 003932 604 KPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEH 682 (785)
Q Consensus 604 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~ 682 (785)
++||+|||+++.+.............||+.|+|||.+.+..++.++|||||||++|||+||. .|+.... ..+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~ 244 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQV 244 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHH
Confidence 99999999998765544444445567899999999999999999999999999999999986 5553321 1111
Q ss_pred HHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 683 AYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 683 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
......+..... +...+..+.+++.+||+.||++|||++||++.|++..
T Consensus 245 -~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 245 -LRFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp -HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -HHHHHhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 122222222111 1123357999999999999999999999999999863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-44 Score=372.00 Aligned_cols=250 Identities=24% Similarity=0.299 Sum_probs=203.3
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---------hhHHHHHHHHHHHHcCC-CCceeeEEEEEecC
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---------QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDS 532 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 532 (785)
++|++.+.||+|+||+||+|+. .+++.||||++.+... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5899999999999999999995 5789999999876431 12345789999999997 99999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccc
Q 003932 533 EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGM 612 (785)
Q Consensus 533 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 612 (785)
+..++|||||++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999953 446899999999999999999999986 99999999999999999999999999
Q ss_pred eeeecccccccccccccccCCcccccccCC------CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATK------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 686 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 686 (785)
++.+.... ......||..|+|||.+.+ ..++.++||||+||+||||++|+.||......+ .....
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~~~~i 227 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMI 227 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------HHHHH
Confidence 98865432 2344679999999998853 347889999999999999999999997432111 11111
Q ss_pred HhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 687 WKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 687 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
...... . ........+.++.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~~--~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNYQ--F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCCC--C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCCC--C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111110 0 11112233457899999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=381.31 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=209.3
Q ss_pred HhcCCCcceeeceeCcEEEEEEEeC--------CCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEEEEec
Q 003932 462 ATERFSIRNKLGEGGYGPVYKGVLP--------CGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID 531 (785)
Q Consensus 462 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 531 (785)
..++|++++.||+|+||.||+|+.. .+..||||++.+.. .....++.+|...+.++ +||||++++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3568999999999999999999842 12479999997754 34457788898888888 89999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEE
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIR-------------KLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNIL 598 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 598 (785)
....++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 9999999999999999999964321 245899999999999999999999987 999999999999
Q ss_pred EcCCCceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCcccCCCCcc
Q 003932 599 LGEAMKPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENL 677 (785)
Q Consensus 599 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~ 677 (785)
++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |++|+.....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---- 243 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 243 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence 99999999999999998766554445556779999999999999999999999999999999998 6777753321
Q ss_pred cHHHHHHHHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 678 SILEHAYELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
......+..+..... +...+.++.+|+.+||+.||++|||+.||++.|+++.
T Consensus 244 ---~~~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 ---EELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ---HHHHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 122233333322221 1123357899999999999999999999999998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-44 Score=375.73 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=200.6
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCc----c
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE----R 535 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 535 (785)
++|++.+.||+|+||.||+|+. .+++.||||++.+.. ....+.+.+|++++++++||||+++++++..... .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5799999999999999999995 579999999997643 3445678999999999999999999999876543 7
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
++||||+++++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++..+|+|||.+..
T Consensus 87 ~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999988743 446899999999999999999999886 99999999999999999999999999876
Q ss_pred eccccc-ccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc
Q 003932 616 FAKESL-EENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 694 (785)
Q Consensus 616 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (785)
...... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+............
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~- 233 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP- 233 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC-
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC-
Confidence 543221 2234456899999999999999999999999999999999999999864321 12222222222111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcc
Q 003932 695 FVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRP-SMLEVSSMLKNE 740 (785)
Q Consensus 695 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~ 740 (785)
.... ....+..+.+++.+||+.||++|| |++++++.|.+.
T Consensus 234 --~~~~----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 --PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp --GGGT----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --Cchh----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0011 111234788999999999999999 899998888754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-44 Score=382.62 Aligned_cols=244 Identities=20% Similarity=0.222 Sum_probs=203.6
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 539 (785)
++|++++.||+|+||.||+|+. .+|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4799999999999999999995 579999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKE 619 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 619 (785)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999988853 346899999999999999999999986 999999999999999999999999999876432
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..... ............
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~-------- 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKV-------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCCC--------
Confidence 3346899999999999999999999999999999999999999964321 111111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRP-----SMLEVSS 735 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 735 (785)
..+...+.++.+++.+||+.||.+|+ |++|+++
T Consensus 256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11122344788999999999999994 8999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=376.80 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=200.0
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC----ccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 539 (785)
++|.+.+.||+|+||.||+|+.. |+.||||++...... ......|+..+.+++||||++++++|.+.. ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 46788899999999999999975 889999998654221 122334555556789999999999998654 578999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEY-----SRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
|||++|+|.++|.. ..+++..+++++.|++.||.|||+. +..+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 3589999999999999999999974 24579999999999999999999999999999
Q ss_pred eecccccc--cccccccccCCcccccccCCCC------CCChhhHHHHHHHHHHHHcCCCCCcccCCCCc--------cc
Q 003932 615 IFAKESLE--ENTEQVVGTIGYIPPEYATKGV------YSTKSDVFSFGVLLLQIISGKRLSMLCGINEN--------LS 678 (785)
Q Consensus 615 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~--------~~ 678 (785)
........ .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 87543221 1234567999999999987643 57799999999999999999987654322110 11
Q ss_pred HHHHHHHHHhCCccccccccccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 003932 679 ILEHAYELWKGGKGVEFVDSFLDD-RNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 740 (785)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 740 (785)
.............. .+.+.. .........+.+|+.+||+.||++|||+.||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11222222221111 111111 11223456789999999999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=377.60 Aligned_cols=256 Identities=20% Similarity=0.278 Sum_probs=206.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.++|++++.||+|+||+||+|.. .+++.||+|++..... ....+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 36899999999999999999995 4788999999977643 345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCC--Cceeeccccceeeeccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEA--MKPKISDFGMARIFAKE 619 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~--~~~kl~Dfg~a~~~~~~ 619 (785)
|++|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999998542 335899999999999999999999986 9999999999999854 58999999999876432
Q ss_pred ccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccccccc
Q 003932 620 SLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSF 699 (785)
Q Consensus 620 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (785)
.......+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+ . ......... .+....
T Consensus 158 ---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~---~~~i~~~~~--~~~~~~ 226 (321)
T d1tkia_ 158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---I---IENIMNAEY--TFDEEA 226 (321)
T ss_dssp ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHHTCC--CCCHHH
T ss_pred ---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCCC--CCChhh
Confidence 22344678999999999999999999999999999999999999996433211 1 111111110 000000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 003932 700 LDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 740 (785)
Q Consensus 700 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 740 (785)
. +..+.++.+|+.+||+.||++|||++|+++ .+++.
T Consensus 227 ~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 227 F-----KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp H-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred c-----cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0 012346889999999999999999999987 45443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=381.06 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=203.4
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCc--EEEEEEcCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGE--VIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 538 (785)
++|++.++||+|+||.||+|++. ++. .||||++... .....+.+.+|+++|+++ +||||++++++|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57899999999999999999964 444 4788887644 334556799999999998 799999999999999999999
Q ss_pred EEecCCCChhhhhcCC-------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCce
Q 003932 539 YEYMPNKSLDCYLFDP-------------IRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKP 605 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 605 (785)
|||+++|+|.++|+.. .....+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 23456999999999999999999999986 9999999999999999999
Q ss_pred eeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCC-CCcccCCCCcccHHHHHH
Q 003932 606 KISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKR-LSMLCGINENLSILEHAY 684 (785)
Q Consensus 606 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~-p~~~~~~~~~~~~~~~~~ 684 (785)
||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|.. |+..... ....
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-------~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELY 236 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHH
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-------HHHH
Confidence 99999999864332 12234568999999999999999999999999999999999765 5543221 1111
Q ss_pred HHHhCCccccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 685 ELWKGGKGVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 685 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.....+.. ...+...+.++.+|+.+||+.||++||||+||++.|++...
T Consensus 237 ~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 237 EKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22222111 11122334578999999999999999999999999988653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.9e-44 Score=382.90 Aligned_cols=248 Identities=24% Similarity=0.288 Sum_probs=198.2
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh---hhHHHH---HHHHHHHHcCCCCceeeEEEEEecCCccE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST---QGFEEF---KNEVMLTAKLQHVNLIRVLGFCIDSEERM 536 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 536 (785)
++|++.++||+|+||.||+|+. .+|+.||||++.+... .....+ .+|+.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999995 4789999999864321 112223 34577778889999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeee
Q 003932 537 LIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIF 616 (785)
Q Consensus 537 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 616 (785)
+|||||++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999853 445889999999999999999999986 999999999999999999999999999876
Q ss_pred cccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccccc
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 695 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 695 (785)
... .....+||+.|+|||++.. ..++.++|||||||+||||+||+.||......+.. ........ ...
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~~-~~~-- 226 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT-MAV-- 226 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----HHHHHSSS-CCC--
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhccc-CCC--
Confidence 543 2344679999999999875 56899999999999999999999999754433211 11111110 000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003932 696 VDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSS 735 (785)
Q Consensus 696 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 735 (785)
..+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 227 -------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 -------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111123447889999999999999999 688864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=375.40 Aligned_cols=262 Identities=23% Similarity=0.258 Sum_probs=197.6
Q ss_pred cceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhh-----HHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 468 IRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQG-----FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 468 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
.+++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999995 468999999997543221 23588999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+.++++..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 99888776653 3455888899999999999999999986 9999999999999999999999999997654332
Q ss_pred ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc--
Q 003932 622 EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS-- 698 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 698 (785)
......+||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ......+...........+.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTS
T ss_pred -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhc
Confidence 223346799999999988754 57999999999999999999999986433222 22222222211110000000
Q ss_pred -----ccCC--CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 003932 699 -----FLDD--RNS-----PCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 740 (785)
Q Consensus 699 -----~l~~--~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 740 (785)
.... ... +.....+.+|+.+||+.||++|||++|+++ .|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000 000 112357899999999999999999999997 46654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=376.62 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=202.4
Q ss_pred ceeeceeCcEEEEEEEeCC----CcEEEEEEcCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-CccEEEEEec
Q 003932 469 RNKLGEGGYGPVYKGVLPC----GEVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLIYEYM 542 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 542 (785)
.++||+|+||+||+|++.. ...||||++.+. .....++|.+|++++++++||||++++|+|... ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999998542 236899999753 555667899999999999999999999998754 5789999999
Q ss_pred CCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccccc
Q 003932 543 PNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESLE 622 (785)
Q Consensus 543 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 622 (785)
++|+|.+++.. .....++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998864 3445778889999999999999999886 999999999999999999999999999876543222
Q ss_pred c--ccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccccc
Q 003932 623 E--NTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSFL 700 (785)
Q Consensus 623 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 700 (785)
. ......||..|+|||.+.+..++.++||||||+++|||+||+.|+....... ... .....+....
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~----~~i~~g~~~~------ 254 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DIT----VYLLQGRRLL------ 254 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH----HHHHTTCCCC------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHH----HHHHcCCCCC------
Confidence 1 2233568999999999999999999999999999999999888765322111 111 1112222111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccC
Q 003932 701 DDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 742 (785)
Q Consensus 701 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 742 (785)
.+...+..+.+|+.+||+.||++||++.||++.|++...
T Consensus 255 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 255 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112234578899999999999999999999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=377.72 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=197.4
Q ss_pred hcCCCcce-eeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHc-CCCCceeeEEEEEec----CCcc
Q 003932 463 TERFSIRN-KLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAK-LQHVNLIRVLGFCID----SEER 535 (785)
Q Consensus 463 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 535 (785)
.++|.+.+ .||+|+||.||+|+. .+++.||||++++. ..+.+|+.++.+ ++||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788875 599999999999995 57899999998653 456789988655 589999999999865 3568
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC---CCceeeccccc
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE---AMKPKISDFGM 612 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg~ 612 (785)
++|||||++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999653 2345899999999999999999999986 999999999999985 56799999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
++..... ......+||+.|+|||++.+..++.++|||||||+||||+||+.||............ ........
T Consensus 161 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~- 233 (335)
T d2ozaa1 161 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQ- 233 (335)
T ss_dssp CEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS-
T ss_pred eeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCC-
Confidence 9876543 2334568999999999999999999999999999999999999999754433221111 00000000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..+ ........+.++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 YEF-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSC-----CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 00011123457899999999999999999999988
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=379.21 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=200.6
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC---hhhHHHHHHHHHHHH-cCCCCceeeEEEEEecCCccEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS---TQGFEEFKNEVMLTA-KLQHVNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 538 (785)
++|++++.||+|+||+||+|+. .+++.||||++.+.. ....+.+..|..++. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999995 478999999997532 233455666776655 68999999999999999999999
Q ss_pred EEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecc
Q 003932 539 YEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAK 618 (785)
Q Consensus 539 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 618 (785)
||||++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999853 345889999999999999999999986 99999999999999999999999999986543
Q ss_pred cccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccccc
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 698 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 698 (785)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..........
T Consensus 156 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~------ 220 (320)
T d1xjda_ 156 G--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP------ 220 (320)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------
T ss_pred c--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC------
Confidence 2 223345689999999999999999999999999999999999999996432211 1111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003932 699 FLDDRNSPCKLMRCLEIALLCVQENPNDRPSML-EVSS 735 (785)
Q Consensus 699 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 735 (785)
..+...+.++.+|+.+||+.||++|||+. |+++
T Consensus 221 ----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11112245788999999999999999996 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=370.22 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=201.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|+++++||+|+||+||+|+. .+++.||||++..... ...+++.+|++++++++||||+++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999995 5789999999965432 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
|+.++.+. ++.. .....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~- 155 (298)
T d1gz8a_ 82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155 (298)
T ss_dssp CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-
T ss_pred ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC-
Confidence 99765444 3322 13445899999999999999999999986 999999999999999999999999999865432
Q ss_pred cccccccccccCCcccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc---c--
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV---E-- 694 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 694 (785)
........||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..+ ............... .
T Consensus 156 -~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 -VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp -SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred -cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhccccc
Confidence 22344567999999999887765 5789999999999999999999996432211 111111111111100 0
Q ss_pred -ccc--cccCCC--C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 003932 695 -FVD--SFLDDR--N-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNE 740 (785)
Q Consensus 695 -~~~--~~l~~~--~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 740 (785)
..+ ...... . .+....++.+|+.+||+.||++|||++|+++. |++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000 000000 0 01123578899999999999999999999984 6654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-43 Score=366.82 Aligned_cols=261 Identities=21% Similarity=0.315 Sum_probs=200.3
Q ss_pred cCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|+++++||+|+||+||+|+..+++.||||++..... ...+.+.+|+.+|++++||||+++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999988899999999976532 2356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeeccccc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKESL 621 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 621 (785)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 98877766653 3456999999999999999999999986 9999999999999999999999999998754332
Q ss_pred ccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccccc----
Q 003932 622 EENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV---- 696 (785)
Q Consensus 622 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 696 (785)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+ ..................
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhh
Confidence 223345689999999998765 56899999999999999999999996433211 122221211111000000
Q ss_pred ----ccccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 697 ----DSFLD-------DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 697 ----~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..... ..........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0011122357889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=363.02 Aligned_cols=239 Identities=24% Similarity=0.402 Sum_probs=193.8
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCCh------hhHHHHHHHHHHHHcCC--CCceeeEEEEEecCCc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTST------QGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEE 534 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 534 (785)
++|++.++||+|+||+||+|+. .+++.||||++.+... .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999995 5789999999865321 11234668999999986 8999999999999999
Q ss_pred cEEEEEecCC-CChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-CCceeeccccc
Q 003932 535 RMLIYEYMPN-KSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-AMKPKISDFGM 612 (785)
Q Consensus 535 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~ 612 (785)
.++||||+.+ +++.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 56766663 3456899999999999999999999986 999999999999985 47999999999
Q ss_pred eeeecccccccccccccccCCcccccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 613 ARIFAKESLEENTEQVVGTIGYIPPEYATKGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 613 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .......
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~ 221 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV 221 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC
T ss_pred ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhccc
Confidence 9875432 2345679999999999987765 567999999999999999999985311 1111110
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
.+... .+.++.+|+.+||+.||++|||++|+++
T Consensus 222 -------~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111 2347889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=364.26 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=195.3
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CC-CcEEEEEEcCCCC--hhhHHHHHHHHHHHHcC---CCCceeeEEEEEec----
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PC-GEVIAVKKLSKTS--TQGFEEFKNEVMLTAKL---QHVNLIRVLGFCID---- 531 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 531 (785)
.++|++++.||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999995 34 6779999986432 11223455677766655 89999999999853
Q ss_pred -CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccc
Q 003932 532 -SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDF 610 (785)
Q Consensus 532 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 610 (785)
....+++|||+.++++...... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 3467899999998877544432 3456889999999999999999999986 999999999999999999999999
Q ss_pred cceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCC
Q 003932 611 GMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG 690 (785)
Q Consensus 611 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 690 (785)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ............
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCC
Confidence 998764332 23455789999999999999999999999999999999999999996433221 111111211111
Q ss_pred ccccc------cccccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 691 KGVEF------VDSFLD-------DRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 691 ~~~~~------~~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
..... ...... ..........+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 000000 0011122356889999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=363.77 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=193.4
Q ss_pred CCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCceeeEEEEEecC------CccEE
Q 003932 465 RFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERML 537 (785)
Q Consensus 465 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 537 (785)
+|+.+++||+|+||+||+|+. .+++.||||++.+... ...+|+++|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588889999999999999995 4789999999976532 234799999999999999999998543 34789
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-ceeeccccceeee
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFGMARIF 616 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~ 616 (785)
|||||+++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655444432234556999999999999999999999876 99999999999999775 8999999999876
Q ss_pred cccccccccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHh-------
Q 003932 617 AKESLEENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK------- 688 (785)
Q Consensus 617 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~------- 688 (785)
... .......||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. .....+...
T Consensus 174 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~---l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTREQI 247 (350)
T ss_dssp CTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCCCHHHH
T ss_pred cCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH---HHHHHHHhCCChHHhh
Confidence 443 22344679999999998775 5689999999999999999999999965432221 111111110
Q ss_pred ----CCc-ccccc---ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 689 ----GGK-GVEFV---DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 689 ----~~~-~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
... ...+. ...............+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000 000000111223457889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-41 Score=351.40 Aligned_cols=274 Identities=17% Similarity=0.201 Sum_probs=211.8
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC-CceeeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.+.||+|+||+||+|+. .+++.||||++..... .+.+.+|++.++.+.| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 5899999999999999999995 4689999999865432 2356788999999965 8999999999999999999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcC-----CCceeeccccceeee
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGE-----AMKPKISDFGMARIF 616 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-----~~~~kl~Dfg~a~~~ 616 (785)
+ +++|.+++.. ....++...+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+
T Consensus 83 ~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9 7899888753 2345899999999999999999999886 999999999999974 578999999999987
Q ss_pred cccccc-----cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCc
Q 003932 617 AKESLE-----ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK 691 (785)
Q Consensus 617 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 691 (785)
...... ......+||+.|||||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 543221 123346799999999999999999999999999999999999999975544433322222211111110
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCCcc
Q 003932 692 GVEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNINTPKKPAFSK 754 (785)
Q Consensus 692 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 754 (785)
..+ +... .+.++.+++..|++.+|++||+++.+.+.|++............|.|
T Consensus 237 ~~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 237 LRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp HHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred hHH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 000 1111 23468889999999999999999999998887654444433333443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-41 Score=359.54 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=195.1
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC------
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ 533 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 533 (785)
.++|++++.||+|+||+||+|.. .+|+.||||++.+. .....+.+.+|+++|++++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35899999999999999999995 57999999999754 3344567889999999999999999999997654
Q ss_pred ccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccce
Q 003932 534 ERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMA 613 (785)
Q Consensus 534 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 613 (785)
..++||||+ +.+|..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 567766653 345999999999999999999999986 999999999999999999999999999
Q ss_pred eeecccccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhC---
Q 003932 614 RIFAKESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG--- 689 (785)
Q Consensus 614 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 689 (785)
+..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.|+......+. ..........
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPA 240 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH---HHHHHhccCCCcH
Confidence 875432 3456799999999998764 578999999999999999999999865432111 1111110000
Q ss_pred -----Ccc----------ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhccc
Q 003932 690 -----GKG----------VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 741 (785)
Q Consensus 690 -----~~~----------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 741 (785)
... .+.....+. .........+.+|+.+||+.||++|||++|+++. |++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000 000000000 0011123467899999999999999999999984 66543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-41 Score=358.24 Aligned_cols=267 Identities=22% Similarity=0.276 Sum_probs=198.7
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCC----ccEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERML 537 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 537 (785)
.+|++++.||+|+||+||+|+. .+++.||||++.+.. ....+.+.+|+.+|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4799999999999999999984 579999999997653 445567899999999999999999999987553 2355
Q ss_pred EEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeec
Q 003932 538 IYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFA 617 (785)
Q Consensus 538 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 617 (785)
+++|+.+|+|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 6677789999999843 35899999999999999999999986 9999999999999999999999999998765
Q ss_pred ccccc-cccccccccCCcccccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc--
Q 003932 618 KESLE-ENTEQVVGTIGYIPPEYATK-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV-- 693 (785)
Q Consensus 618 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 693 (785)
..... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+ ...............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDL 237 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChhhh
Confidence 43222 22345679999999999855 457899999999999999999999986433211 111111111110000
Q ss_pred ---------cccccccCCC-C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 003932 694 ---------EFVDSFLDDR-N-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNE 740 (785)
Q Consensus 694 ---------~~~~~~l~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 740 (785)
.......... . .+....++.+|+.+||+.||++|||++|+++. |+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0000000000 0 01112368899999999999999999999974 5543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=357.41 Aligned_cols=265 Identities=18% Similarity=0.263 Sum_probs=196.4
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec--------
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-------- 531 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 531 (785)
.++|++++.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999995 57999999998654 23344678899999999999999999999865
Q ss_pred CCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccc
Q 003932 532 SEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFG 611 (785)
Q Consensus 532 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 611 (785)
....++||||+.++++..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 346789999998887765542 3345888999999999999999999986 9999999999999999999999999
Q ss_pred ceeeecccccc--cccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHh
Q 003932 612 MARIFAKESLE--ENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK 688 (785)
Q Consensus 612 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 688 (785)
+++.+...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH---HHHHHHHhcC
Confidence 99876533221 223345799999999998765 68999999999999999999999986432211 1122222221
Q ss_pred CCcc--ccc---------cccccCCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 689 GGKG--VEF---------VDSFLDDRNSPC-------KLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 689 ~~~~--~~~---------~~~~l~~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
.... ... ............ ....+.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1100 000 000000001111 12356789999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-41 Score=353.65 Aligned_cols=261 Identities=18% Similarity=0.221 Sum_probs=197.8
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCce-eeEEEEEecCCccEEEEEe
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLIYEY 541 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 541 (785)
++|++.+.||+|+||.||+|+. .+++.||||++...... +++..|++++++++|+|+ +.+..+..+....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4799999999999999999995 56899999998764332 457889999999987765 5555666777888999999
Q ss_pred cCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEc---CCCceeeccccceeeecc
Q 003932 542 MPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLG---EAMKPKISDFGMARIFAK 618 (785)
Q Consensus 542 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~Dfg~a~~~~~ 618 (785)
+ +++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5566555532 2346899999999999999999999987 99999999999986 455799999999998754
Q ss_pred cccc-----cccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCccc
Q 003932 619 ESLE-----ENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV 693 (785)
Q Consensus 619 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (785)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC--
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC--
Confidence 3221 123456799999999999999999999999999999999999999976554443332222211110000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 003932 694 EFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 741 (785)
Q Consensus 694 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 741 (785)
.+.+.. ..+.++.+++..||+.+|++||+++++.+.|+...
T Consensus 237 ---~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 ---IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ---HHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ---hhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 001111 12346889999999999999999999998888653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-41 Score=353.78 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=201.5
Q ss_pred cCCCcceeeceeCcEEEEEEEe----CCCcEEEEEEcCCCC----hhhHHHHHHHHHHHHcCCC-CceeeEEEEEecCCc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL----PCGEVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEE 534 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 534 (785)
++|++++.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999984 257899999987532 2234567889999999976 899999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.+++|||+.+|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999998853 345778889999999999999999986 9999999999999999999999999998
Q ss_pred eecccccccccccccccCCcccccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 692 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (785)
.+..... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+.... ... .
T Consensus 178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~~-~- 252 (322)
T d1vzoa_ 178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKS-E- 252 (322)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHC-C-
T ss_pred hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--ccC-C-
Confidence 7654322 223446799999999999765 46889999999999999999999997655444333222211 111 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003932 693 VEFVDSFLDDRNSPCKLMRCLEIALLCVQENPNDRPS-----MLEVSS 735 (785)
Q Consensus 693 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 735 (785)
...+...+.++.+++.+||+.||++||| ++|+++
T Consensus 253 ---------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0111223457899999999999999994 788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=344.78 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=205.8
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecCCccEEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLIYE 540 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 540 (785)
++|+++++||+|+||+||+|+. .+++.||||+++... ....+++.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 578999999986543 3446788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeeccccceeeecccc
Q 003932 541 YMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMARIFAKES 620 (785)
Q Consensus 541 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 620 (785)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998877743 345789999999999999999999986 9999999999999999999999999998765432
Q ss_pred cccccccccccCCcccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcccc-----
Q 003932 621 LEENTEQVVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE----- 694 (785)
Q Consensus 621 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 694 (785)
.......++..|+|||.+.+.. ++.++|||||||++|||++|+.|+.... ....................
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhhhhh
Confidence 2233345788999999987765 6899999999999999999999875322 11122222222222111000
Q ss_pred -cccc---------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 003932 695 -FVDS---------FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 739 (785)
Q Consensus 695 -~~~~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 739 (785)
..+. .............+.+|+.+||+.||++|||++|+++ .|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0000 0000111223457889999999999999999999986 4544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.6e-40 Score=349.03 Aligned_cols=255 Identities=20% Similarity=0.281 Sum_probs=196.4
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecC--CccEEEE
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDS--EERMLIY 539 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 539 (785)
++|+++++||+|+||+||+|+. .+++.||||++.+.. .+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5899999999999999999995 578999999997643 357889999999995 99999999998743 5689999
Q ss_pred EecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC-ceeeccccceeeecc
Q 003932 540 EYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM-KPKISDFGMARIFAK 618 (785)
Q Consensus 540 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~ 618 (785)
||+.+++|..+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 24889999999999999999999987 99999999999998655 699999999987654
Q ss_pred cccccccccccccCCcccccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHH---------Hh
Q 003932 619 ESLEENTEQVVGTIGYIPPEYATKG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL---------WK 688 (785)
Q Consensus 619 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~---------~~ 688 (785)
. .......+|..|+|||.+.+. .++.++||||+||+++||++|+.|+....... ......... ..
T Consensus 183 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 183 G---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp T---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHH
T ss_pred C---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhhh
Confidence 3 233456789999999998775 47999999999999999999999986433211 111111000 00
Q ss_pred ---CCcccccc-----------ccccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003932 689 ---GGKGVEFV-----------DSFLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLEVSS 735 (785)
Q Consensus 689 ---~~~~~~~~-----------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 735 (785)
........ ..............++.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 001111111223457889999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=348.32 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=197.8
Q ss_pred hcCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEEEEecC-----Cc
Q 003932 463 TERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EE 534 (785)
Q Consensus 463 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 534 (785)
.++|+++++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45899999999999999999994 579999999997653 34456788999999999999999999998643 34
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4677888899999998843 35899999999999999999999987 9999999999999999999999999987
Q ss_pred eecccccccccccccccCCcccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHHHHHHhCCcc-
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG- 692 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 692 (785)
.... ......||..|+|||.+.+.. ++.++|||||||++|+|++|+.||....... ..............
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAE 241 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHH
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChH
Confidence 6432 234467899999999877654 6899999999999999999999986432211 11111111100000
Q ss_pred ------c----cccccccCCC-C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccC
Q 003932 693 ------V----EFVDSFLDDR-N-----SPCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNETT 742 (785)
Q Consensus 693 ------~----~~~~~~l~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~ 742 (785)
. .......... . .......+.+|+.+||+.||++|||++|+++ .|.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 0 0000000000 0 0112346789999999999999999999998 5665433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=347.33 Aligned_cols=261 Identities=21% Similarity=0.236 Sum_probs=188.8
Q ss_pred cCCCcceeeceeCcEEEEEEEeC-CCcEEEEEEcCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEEEEec------CCc
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID------SEE 534 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 534 (785)
++|+++++||+|+||+||+|+.. +|+.||||++.+. .......+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999954 6999999999754 34445678899999999999999999999864 357
Q ss_pred cEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeecccccee
Q 003932 535 RMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKISDFGMAR 614 (785)
Q Consensus 535 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 614 (785)
.|+||||+.++.+. .+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999766554 332 24789999999999999999999987 9999999999999999999999999988
Q ss_pred eecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHH-------------
Q 003932 615 IFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE------------- 681 (785)
Q Consensus 615 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~------------- 681 (785)
..... ......++|+.|+|||++.+..++.++||||+||+++||++|+.||...+.......+.
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 65432 23445678999999999999999999999999999999999999986432111110000
Q ss_pred ---HHHHHHhCCcc------ccccccccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003932 682 ---HAYELWKGGKG------VEFVDSFLDDR---NSPCKLMRCLEIALLCVQENPNDRPSMLEVSSM 736 (785)
Q Consensus 682 ---~~~~~~~~~~~------~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 736 (785)
........... ........... ........+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000010000 00000001111 112345678999999999999999999999853
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-35 Score=315.20 Aligned_cols=268 Identities=18% Similarity=0.184 Sum_probs=193.2
Q ss_pred cCCCcceeeceeCcEEEEEEEe-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-----------CCceeeEEEEEec
Q 003932 464 ERFSIRNKLGEGGYGPVYKGVL-PCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-----------HVNLIRVLGFCID 531 (785)
Q Consensus 464 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 531 (785)
.+|+++++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999995 579999999997653 23456788998888775 5789999988764
Q ss_pred C--CccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCC------
Q 003932 532 S--EERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAM------ 603 (785)
Q Consensus 532 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~------ 603 (785)
. ...+++++++..+..............+++..+..++.||+.||.|||+.. +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 3 456677777766654433333334566889999999999999999999832 599999999999998665
Q ss_pred ceeeccccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCcccCCCCcccHHHHH
Q 003932 604 KPKISDFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA 683 (785)
Q Consensus 604 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 683 (785)
.++++|||.+..... .....+||+.|+|||++.+..++.++||||+||+++||++|+.||...............
T Consensus 170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 399999999976432 234567999999999999999999999999999999999999998754332222111111
Q ss_pred ---HHHHhC------------------Ccccccccc----------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003932 684 ---YELWKG------------------GKGVEFVDS----------FLDDRNSPCKLMRCLEIALLCVQENPNDRPSMLE 732 (785)
Q Consensus 684 ---~~~~~~------------------~~~~~~~~~----------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 732 (785)
...+.. ......+.. .............+.+|+.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111100 000000000 0012234556678999999999999999999999
Q ss_pred HHHH--Hhc
Q 003932 733 VSSM--LKN 739 (785)
Q Consensus 733 vl~~--L~~ 739 (785)
+++. |++
T Consensus 325 ~L~Hp~f~~ 333 (362)
T d1q8ya_ 325 LVNHPWLKD 333 (362)
T ss_dssp HHTCGGGTT
T ss_pred HhcCcccCC
Confidence 9873 554
|
| >d1nara_ c.1.8.5 (A:) Seed storage protein {Vicia narbonensis, Narbonin [TaxId: 3912]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Seed storage protein species: Vicia narbonensis, Narbonin [TaxId: 3912]
Probab=100.00 E-value=1.4e-33 Score=290.21 Aligned_cols=215 Identities=13% Similarity=0.069 Sum_probs=155.6
Q ss_pred EEEEEecC-CCCCCcCCCCCCCC------ceEEEEEEEeeCCc---cEEecCCCccH-HHHHHHHHHHHhcCCCceEEEE
Q 003932 27 IRVGYLNL-SEVSTISGINYDLF------THLICSSADINSTT---YQLSLSLPSDE-NQIAKFADTVKKKNPSITTILS 95 (785)
Q Consensus 27 ~~vgY~~~-~~~~~~~~i~~~~~------Thi~~~f~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~k~~~p~lkv~~s 95 (785)
+.-.||-. ....+++++|.+.+ ||++|+|+....++ ....+...++. ....+.++.+|++||++|||+|
T Consensus 4 ~~r~Y~g~~~~~~~~~d~p~~~~~~~~~~~h~i~aFa~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~lK~~~~~~KvllS 83 (289)
T d1nara_ 4 IFREYIGVKPNSTTLHDFPTEIINTETLEFHYILGFAIESYYESGKGTGTFEESWDVELFGPEKVKNLKRRHPEVKVVIS 83 (289)
T ss_dssp EEEEEESCCTTCCSCSSCCSTTCCCSSSEEEEEEEEEEEEECTTSCEEEEEEECSCHHHHSHHHHHHHHHHCTTCEEEEE
T ss_pred chhhhcCCCCCCCccccCChhhcCCCceEEEEEEecccccCCCCCCCCCeeccccccccccHHHHHHHHHHCCCCeEEEE
Confidence 44567732 23345666665544 49999999544221 12223333443 3335667779999999999999
Q ss_pred ecCCCCCCc---ccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhccc
Q 003932 96 IGQGKDTNY---SIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNST 172 (785)
Q Consensus 96 igG~~~~~~---~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~ 172 (785)
||||+.+.. ..++.++++...|.+|+.++++++++|+|||||||||||+ +.++|..|+++||++|++..
T Consensus 84 iGG~~~~~~f~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~DGiDiDwE~p~---~~~~~~~ll~~Lr~~l~~~~----- 155 (289)
T d1nara_ 84 IGGRGVNTPFDPAEENVWVSNAKESLKLIIQKYSDDSGNLIDGIDIHYEHIR---SDEPFATLMGQLITELKKDD----- 155 (289)
T ss_dssp EEESSTTSCBCBSCHHHHHHHHHHHHHHHHHHSEETTEECCCEEEEEESCBC---SSTTHHHHHHHHHHHHHHCT-----
T ss_pred ecCCCCCCccChhhhHHHHhCHHHHHHHHHHHHHHHHhcCCCceeeeeeecC---CHHHHHHHHHHHHHHHhhCC-----
Confidence 999987543 2467889999999999999999999999999999999994 55789999999999997521
Q ss_pred ccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCC
Q 003932 173 RQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLS 252 (785)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp 252 (785)
...+++++.++ ......++++.+.+++|||++|+|||||.|.. .+|++++++ ..+.|. .|+|
T Consensus 156 --~~~~~~~~~ap-~~~~~~~~~~~~~~~~D~in~m~ydfyg~w~~-~~g~~~~~~-------------~~~~~~-~~~p 217 (289)
T d1nara_ 156 --DLNINVVSIAP-SENNSSHYQKLYNAKKDYINWVDYQFSNQQKP-VSTDDAFVE-------------IFKSLE-KDYH 217 (289)
T ss_dssp --TSCCCEEEECC-CTTTHHHHHHHHHHHTTTCCEEEEEGGGCSSC-CCSHHHHHH-------------HHHHHH-HHSC
T ss_pred --CcEEEEEEecC-cCccccchHHHHHhhCCEEEEEEEeccCCCCC-CCChhHHHH-------------HHHHhh-cCCC
Confidence 22233332222 23345667888999999999999999999864 477666542 334444 4799
Q ss_pred CCceeecccccccee
Q 003932 253 ADKLVMCLPFYGYAW 267 (785)
Q Consensus 253 ~~KlvlGip~YG~~~ 267 (785)
++||+||+|+++..+
T Consensus 218 ~~Kv~lG~pa~~~~~ 232 (289)
T d1nara_ 218 PHKVLPGFSTDPLDT 232 (289)
T ss_dssp TTCEEEEEECCHHHH
T ss_pred hhheEEeeecchhhh
Confidence 999999999988766
|
| >d2hvma_ c.1.8.5 (A:) Hevamine A (chitinase/lysozyme) {Para rubber tree (Hevea brasiliensis) [TaxId: 3981]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Hevamine A (chitinase/lysozyme) species: Para rubber tree (Hevea brasiliensis) [TaxId: 3981]
Probab=99.96 E-value=7.6e-30 Score=261.46 Aligned_cols=210 Identities=11% Similarity=0.008 Sum_probs=136.6
Q ss_pred EEEEEecC-CCCCCcCC-CCCCCCceEEEEEEEeeCCccEEecCCC-------ccHHHHHHHHHHHHhcCCCceEEEEec
Q 003932 27 IRVGYLNL-SEVSTISG-INYDLFTHLICSSADINSTTYQLSLSLP-------SDENQIAKFADTVKKKNPSITTILSIG 97 (785)
Q Consensus 27 ~~vgY~~~-~~~~~~~~-i~~~~~Thi~~~f~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~k~~~p~lkv~~sig 97 (785)
.+++||-. .....+.. .+.+.||||++||+.+.++++....... ....++...++.+|++ ++|||+|||
T Consensus 2 ~~~~YWg~~~~~~~l~~~c~~~~~~~I~laF~~~~~~g~~~~~~~~~~~~~~~~~~~~l~~~I~~~q~~--g~KVllSiG 79 (273)
T d2hvma_ 2 GIAIYWGQNGNEGTLTQTCSTRKYSYVNIAFLNKFGNGQTPQINLAGHCNPAAGGCTIVSNGIRSCQIQ--GIKVMLSLG 79 (273)
T ss_dssp EEEEEESSCGGGCCHHHHHHTSCCSEEEEEEEEECSTTCCCEECCGGGCCCGGGTTTTHHHHHHHHHHT--TCEEEEEEE
T ss_pred CEEEEcCCCCCCCchHHHcCCCCCCEEEEEEEeEECCCCeeeccccccCCCccCchhhHHHHHHHHHhC--CCEEEEEEe
Confidence 47889833 22333433 3456899999999998887643332210 1124466666656654 699999999
Q ss_pred CCCCCCc----ccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcccc
Q 003932 98 QGKDTNY----SIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNSTR 173 (785)
Q Consensus 98 G~~~~~~----~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~~~ 173 (785)
||+.... ..+..++.+...|..|++++++++.+|+|||||||||+|.. .+|..|+++||+.++.-
T Consensus 80 G~~~~~~~~s~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~DGiDiD~E~~~~----~~~~~li~~Lr~~~~~~------- 148 (273)
T d2hvma_ 80 GGIGSYTLASQADAKNVADYLWNNFLGGKSSSRPLGDAVLDGIDFDIEHGST----LYWDDLARYLSAYSKQG------- 148 (273)
T ss_dssp CSSCCCCCCSHHHHHHHHHHHHHHTSSSCCSCCTTCSCCCSEEEEECCSSCC----SSHHHHHHHHHHGGGGS-------
T ss_pred cCCCCccccCHHHHHHHHHhHHHHhccchhhhhhhhcccccceeeccccCcc----hhHHHHHHHHHhhhccC-------
Confidence 9875422 12334555555666666667778999999999999999943 57999999999877541
Q ss_pred cceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCCCC
Q 003932 174 QQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGLSA 253 (785)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gvp~ 253 (785)
+..++++++... .....+.......++||||+|+||+++.|... .+.. .......+|. .|+|+
T Consensus 149 -~~~~it~ap~~~-~~~~~~~~~~~~~~~D~invq~Yn~~~~~~~~-~~~~-------------~~~~~~~~~~-~g~~~ 211 (273)
T d2hvma_ 149 -KKVYLTAAPQCP-FPDRYLGTALNTGLFDYVWVQFYNNPPCQYSS-GNIN-------------NIINSWNRWT-TSINA 211 (273)
T ss_dssp -SCCEEEECCBSS-SSCTTTHHHHHTTCCSEEEEECSSCGGGSCBT-TBCH-------------HHHHHHHHHH-HHCCC
T ss_pred -CeEEEEeccccc-cchhhhHHHhhcCcccEEEEEeecCCCccccc-cchh-------------HHHHHHHHHh-hcCCc
Confidence 223333333322 22333333444688999999999998876421 1110 2233344444 58999
Q ss_pred Cceeeccccccce
Q 003932 254 DKLVMCLPFYGYA 266 (785)
Q Consensus 254 ~KlvlGip~YG~~ 266 (785)
+||+||+|+|++.
T Consensus 212 ~KivlGlp~~~~~ 224 (273)
T d2hvma_ 212 GKIFLGLPAAPEA 224 (273)
T ss_dssp SEEEEEEESSGGG
T ss_pred ccEEEEEecCCCC
Confidence 9999999999864
|
| >d1edta_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Streptomyces plicatus, endoglycosidase H [TaxId: 1922]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Streptomyces plicatus, endoglycosidase H [TaxId: 1922]
Probab=99.95 E-value=2.3e-28 Score=246.63 Aligned_cols=175 Identities=14% Similarity=0.143 Sum_probs=128.0
Q ss_pred CcEEEEEecCCC-------CCCcCCCCCCCCceEEEEEEEeeCCc--cEEecCCCccH-H---HHHHHHHHHHhcCCCce
Q 003932 25 PWIRVGYLNLSE-------VSTISGINYDLFTHLICSSADINSTT--YQLSLSLPSDE-N---QIAKFADTVKKKNPSIT 91 (785)
Q Consensus 25 ~~~~vgY~~~~~-------~~~~~~i~~~~~Thi~~~f~~~~~~~--~~~~~~~~~~~-~---~~~~~~~~~k~~~p~lk 91 (785)
+.+.|+|+..|+ .+.+++++...||||+++|+.++.|+ ....+....+. . .....++.+|+ +++|
T Consensus 3 ~p~~v~y~~~~~~~~~n~g~y~~~~~~~~~~d~v~~~~a~i~~d~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~--~g~K 80 (265)
T d1edta_ 3 GPTSVAYVEVNNNSMLNVGKYTLADGGGNAFDVAVIFAANINYDTGTKTAYLHFNENVQRVLDNAVTQIRPLQQ--QGIK 80 (265)
T ss_dssp SCEEEEEEETTTSCGGGGGGEEETTTCSBSCSEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHH--TTCE
T ss_pred CCEEEEEEEeccccCCcCCeeeeccCCCcceeEEEEeeeecccCCCCCeeEEecCcchhhhhhhHHHHHHHHHh--CCCE
Confidence 567899997654 35788899999999999999887543 23322222211 1 22344444555 4699
Q ss_pred EEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCC------CCCCchhHHHHHHHHHHHhhh
Q 003932 92 TILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPN------TSTDMFNIGLLFDEWRIAATK 165 (785)
Q Consensus 92 v~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~------~~~d~~~~~~ll~~lr~~l~~ 165 (785)
|++|||||+.+.. |+.+ ++++.|++||+++++++++|||||||||||||+ ...++++|+.|+++||++|..
T Consensus 81 vllsiGG~~~~~~--f~~~-~s~~~~~~Fa~~~~~~~~~~~~DGiDiD~Eyp~~~~~~~~~~d~~~~~~ll~~lR~~l~~ 157 (265)
T d1edta_ 81 VLLSVLGNHQGAG--FANF-PSQQAASAFAKQLSDAVAKYGLDGVDFDDEYAEYGNNGTAQPNDSSFVHLVTALRANMPD 157 (265)
T ss_dssp EEEEEEECTTSCC--TTCC-SSHHHHHHHHHHHHHHHHHHTCCEEEEECSSCCTTGGGCCCCCSSHHHHHHHHHHHHCTT
T ss_pred EEEEEccCcCCCC--ceec-CCHHHHHHHHHHHHHHHHhcCCCceEeccccCcccCCCCCcccHHHHHHHHHHHHHhhhh
Confidence 9999999876544 8875 478999999999999999999999999999994 456889999999999999853
Q ss_pred hhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCC
Q 003932 166 LDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVST 218 (785)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~ 218 (785)
.++++++ +........++.. ...|||++|+||+||+|+.
T Consensus 158 ----------~~is~a~-~~~~~~~~~~~~~---~~~d~id~m~YD~~g~w~~ 196 (265)
T d1edta_ 158 ----------KIISLYN-IGPAASRLSYGGV---DVSDKFDYAWNPYYGTWQV 196 (265)
T ss_dssp ----------SEEEEES-CHHHHTCCEETTE---ECGGGCSEEECCSTTEECC
T ss_pred ----------cEEEEEe-cCChhhhcCcCHh---HhcCeEEEEeccCCCcCCC
Confidence 3344443 3333334445543 4568888999999999964
|
| >d2ebna_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Flavobacterium meningosepticum, endoglycosidase F1 [TaxId: 238]
Probab=99.94 E-value=3.5e-28 Score=249.79 Aligned_cols=177 Identities=16% Similarity=0.125 Sum_probs=130.3
Q ss_pred CCCcEEEEEecCCC-------CCCcCCCCCCCCceEEEEEEEeeCCcc--EEecCCCccHH----HHHHHHHHHHhcCCC
Q 003932 23 AKPWIRVGYLNLSE-------VSTISGINYDLFTHLICSSADINSTTY--QLSLSLPSDEN----QIAKFADTVKKKNPS 89 (785)
Q Consensus 23 ~~~~~~vgY~~~~~-------~~~~~~i~~~~~Thi~~~f~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~k~~~p~ 89 (785)
....+.++|+.-+. .+.+++++..+|||++++|+.++.|+. ...+.....-. .....++.+++ ++
T Consensus 3 ~~~~~~~~y~~~~~~n~~n~~~~~~~~~~~~~~d~v~~~~a~i~~d~~~~~~~~~~~~~~~~~~~~~~~~i~~~q~--~g 80 (285)
T d2ebna_ 3 KANIKLFSFTEVNDTNPLNNLNFTLKNSGKPLVDMVVLFSANINYDAANDKVFVSNNPNVQHLLTNRAKYLKPLQD--KG 80 (285)
T ss_dssp CCSCEEEEEEETTTCCGGGGGGEEETTTCCBSCCEEEEEEEEEEEETTTTEEEEECCHHHHHHHHTHHHHTHHHHH--TT
T ss_pred cCCceEEEEEEccCCCccccccceeecCCCCcccEEEEEeeeccCCcCCceeeeccCcchhhhhhhHHHHHHHHHh--CC
Confidence 34567899996443 456888998999999999999986543 23222111111 12344444554 46
Q ss_pred ceEEEEecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCC---------CCCchhHHHHHHHHH
Q 003932 90 ITTILSIGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNT---------STDMFNIGLLFDEWR 160 (785)
Q Consensus 90 lkv~~sigG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~---------~~d~~~~~~ll~~lr 160 (785)
+||++|||||..+.. |+.+ +++.|++|++++++++++|||||||||||||.. ..++++|..|++|||
T Consensus 81 ~KvllsigG~~~~~~--~~~~--~~~~~~~F~~~~~~~~~~y~lDGiDiD~Ey~~~~~~~~~~~~~~~~~~~~~li~eLr 156 (285)
T d2ebna_ 81 IKVILSILGNHDRSG--IANL--STARAKAFAQELKNTCDLYNLDGVFFDDEYSAYQTPPPSGFVTPSNNAAARLAYETK 156 (285)
T ss_dssp CEEEEEEECCSSSCC--TTCB--CHHHHHHHHHHHHHHHHHHTCCEEEEECCSCCCCSSCCTTBCCCCHHHHHHHHHHHH
T ss_pred CEEEEEeccCCCCcc--cccC--CHHHHHHHHHHHHHHHHHcCCcEEeccccCccccCCCccccCcchHHHHHHHHHHHH
Confidence 999999999865443 7765 778999999999999999999999999999842 358899999999999
Q ss_pred HHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCC
Q 003932 161 IAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVST 218 (785)
Q Consensus 161 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~ 218 (785)
++|+ ...+++++..........++ ..+++|+|++|+||+||+|..
T Consensus 157 ~~~~----------~~~lt~a~~~~~~~~~~~~~---~~~~~d~id~m~Yd~~g~w~~ 201 (285)
T d2ebna_ 157 QAMP----------NKLVTVYVYSRTSSFPTAVD---GVNAGSYVDYAIHDYGGSYDL 201 (285)
T ss_dssp HHCT----------TSEEEEEESGGGSCCCSCBT---TBCGGGTCSEEEECTTCCSCC
T ss_pred HHCC----------CCeEEEEEecccccccccch---HHHHhhheeEEeecccCccCC
Confidence 9985 34566666655544444443 456799999999999999864
|
| >d1ta3a_ c.1.8.5 (A:) Xylanase inhibitor protein I, XIP-I {Wheat (Triticum aestivum) [TaxId: 4565]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Xylanase inhibitor protein I, XIP-I species: Wheat (Triticum aestivum) [TaxId: 4565]
Probab=99.92 E-value=1.7e-25 Score=228.26 Aligned_cols=202 Identities=13% Similarity=0.063 Sum_probs=129.8
Q ss_pred EEEEEecC-CCCCCcCCC-CCCCCceEEEEEEEeeCCccEEecCC-CccHHHHHHHHHHHHhcCCCceEEEEecCCCCCC
Q 003932 27 IRVGYLNL-SEVSTISGI-NYDLFTHLICSSADINSTTYQLSLSL-PSDENQIAKFADTVKKKNPSITTILSIGQGKDTN 103 (785)
Q Consensus 27 ~~vgY~~~-~~~~~~~~i-~~~~~Thi~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~k~~~p~lkv~~sigG~~~~~ 103 (785)
.+++||-. .....+.+. +.+.+|||+++|+.+..+++...+.. ..+..++...++.+|++ ++|||+|||||+...
T Consensus 7 ~i~~YWGq~~~~~~L~~~c~~~~~~~I~laF~~~~~~~~~~~~~~~~~~~~~~~~~I~~~q~~--g~KVllSiGG~~~~~ 84 (274)
T d1ta3a_ 7 QVTVFWGRNKAEGSLREACDSGMYTMVTMSFLDVFGANGKYHLDLSGHDLSSVGADIKHCQSK--GVPVSLSIGGYGTGY 84 (274)
T ss_dssp CEEEEESSCGGGCCHHHHHHTTCCSEEEEEEEEEBSSSSCCEECCTTCCGGGHHHHHHHHHHT--TCCEEEEEEESSSCB
T ss_pred cEEEEcCCCCCCCChHHHcCCCCCCEEEEEEEEEcCCCCeeeccCCCCChhHHHHHHHHHHhC--CCEEEEEEcCCCCCc
Confidence 57889932 223344443 34679999999999876654433332 22245566666656655 699999999987543
Q ss_pred cccchhhhcChhhhHHHH------------HHHHHHHHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhhhhcc
Q 003932 104 YSIYSSMVRNSSHRKSFI------------DSSIRIARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLDAKNS 171 (785)
Q Consensus 104 ~~~fs~~~~~~~~r~~fi------------~si~~~~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~~~~~ 171 (785)
. |. +....+.|+ .++++++.+|+|||||||||+|. +..++..|+++||+.+++..
T Consensus 85 ~--~~----~~~~~~~~a~~l~~~~~~~~~~s~~~~~~~~~~DGiDiD~E~~~---~~~~~~~li~~Lr~~~~~~~---- 151 (274)
T d1ta3a_ 85 S--LP----SNRSALDLFDHLWNSYFGGSKPSVPRPFGDAWLDGVDLFLEHGT---PADRYDVLALELAKHNIRGG---- 151 (274)
T ss_dssp C--CC----SHHHHHHHHHHHHHHHSSCCCTTSCCTTTTCCCSEEEEEESSCC---TTCCHHHHHHHHHTTCCSSS----
T ss_pred c--cc----chhHHHHHHHHHHHhhcccchhhHHHHhhccceeeEEeccccCC---CcchHHHHHHHHHHHHhhcc----
Confidence 3 32 233333444 45677899999999999999994 45679999999998765421
Q ss_pred cccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHcCC
Q 003932 172 TRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWIERGL 251 (785)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~~~gv 251 (785)
.. ...++.+++..+..............++|+|++|.||.++.+... .....+++.|.+ |+
T Consensus 152 ~~-~~~litaAp~~~~~~~~~~~~~~~~~~fD~i~vq~Yn~~~~~~~~-----------------~~~~~s~~~w~~-~~ 212 (274)
T d1ta3a_ 152 PG-KPLHLTATVRCGYPPAAHVGRALATGIFERVHVRTYESDKWCNQN-----------------LGWEGSWDKWTA-AY 212 (274)
T ss_dssp SS-CCCEEEEEECSSSSCCHHHHHHHTTSCCCEEEEECSSCCTTSBTT-----------------BBHHHHHHHHHH-HC
T ss_pred CC-CceEEEecccCccCchhhhhhhhhccccceEEEEEecCCCCCCCC-----------------hHHHHHHHHHHh-cC
Confidence 11 223333333332222222222333457899999999976543211 144667888875 89
Q ss_pred CCCceeecccc
Q 003932 252 SADKLVMCLPF 262 (785)
Q Consensus 252 p~~KlvlGip~ 262 (785)
|++||+||+|+
T Consensus 213 p~~Ki~lGlPa 223 (274)
T d1ta3a_ 213 PATRFYVGLTA 223 (274)
T ss_dssp TTSEEEEEEEC
T ss_pred CCceEEEeecc
Confidence 99999999996
|
| >d1cnva_ c.1.8.5 (A:) Seed storage protein {Jack bean (Canavalia ensiformis), Concanavalin B [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Seed storage protein species: Jack bean (Canavalia ensiformis), Concanavalin B [TaxId: 3823]
Probab=99.91 E-value=1e-24 Score=223.63 Aligned_cols=207 Identities=13% Similarity=0.039 Sum_probs=130.5
Q ss_pred EEEEEecCCCCCCcCCC-CCCCCceEEEEEEEeeCCcc---EEecCC------CccHHHHHHHHHHHHhcCCCceEEEEe
Q 003932 27 IRVGYLNLSEVSTISGI-NYDLFTHLICSSADINSTTY---QLSLSL------PSDENQIAKFADTVKKKNPSITTILSI 96 (785)
Q Consensus 27 ~~vgY~~~~~~~~~~~i-~~~~~Thi~~~f~~~~~~~~---~~~~~~------~~~~~~~~~~~~~~k~~~p~lkv~~si 96 (785)
.++.||-.+..-.+... +...+|||+++|+....++. .+.+.. .....++.+.++.+|++ ++|||+||
T Consensus 6 ~v~vYWgq~~~g~L~~~c~~~~~diI~laF~~~~~~~~~~p~~n~~~~~~~~~~~~~~~l~~dI~~~q~~--G~KVllSl 83 (283)
T d1cnva_ 6 EIAVYWGQREDGLLRDTCKTNNYKIVFISFLDKFGCEIRKPELELEGVCGPSVGNPCSFLESQIKECQRM--GVKVFLAL 83 (283)
T ss_dssp EEEEEECSGGGCCHHHHHHTCCCSEEEEEEECEECTTCSSCCCCBTTTBBTTTTBCGGGGHHHHHHHHHT--TCEEEEEE
T ss_pred CEEEECCCCCCCCHHHHccCCCCCEEEEEEEeeeCCCCCCcceecccCCCcccCCchHHHHHHHHHHHhC--CCEEEEEe
Confidence 56669954432234443 23579999999997665432 122211 11235566777767766 69999999
Q ss_pred cCCCCCCcccchhhhcChhhhHHHHHHHHHH---------HHHcCCceeeeeccCCCCCCCchhHHHHHHHHHHHhhhhh
Q 003932 97 GQGKDTNYSIYSSMVRNSSHRKSFIDSSIRI---------ARLYGFRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKLD 167 (785)
Q Consensus 97 gG~~~~~~~~fs~~~~~~~~r~~fi~si~~~---------~~~y~~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~~ 167 (785)
|||+.... +.+....+.|++++.+. +.+|+|||||||||+|.......+|..+++++|..+.+
T Consensus 84 GG~~~~~~------~~~~~~a~~fa~~~~~~~~~~~~~~~~~~~~lDGiDiD~E~p~~~~~~~~~~~~l~~l~~~~~~-- 155 (283)
T d1cnva_ 84 GGPKGTYS------ACSADYAKDLAEYLHTYFLSERREGPLGKVALDGIHFDIQKPVDELNWDNLLEELYQIKDVYQS-- 155 (283)
T ss_dssp ECSSSEEC------CCSHHHHHHHHHHHHHHHBSSSSCBTTBSCBCSEEEEECSSCSCSTTHHHHHHHHHHHHHHHTC--
T ss_pred cCCCCCcc------cccHHHHHHHHHHHHHhhcCccccccccccccCcccccccCCCCcccHHHHHHHHHHHHHhcCC--
Confidence 99865322 44566778899988665 68899999999999997666677788888777766543
Q ss_pred hhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 003932 168 AKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSISGRFARSTDQVLKAWI 247 (785)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~~~~~~~~~~~v~~~~ 247 (785)
.+++++++..+ .+ ...+.......++|||++|.||.++.+. ++... ....+.......
T Consensus 156 -------~~~it~AP~~~-~~-d~~~~~~~~~~~~D~i~vq~Yn~~~~~~-----~~~~~--------~~~~~~~~~~~~ 213 (283)
T d1cnva_ 156 -------TFLLSAAPGCL-SP-DEYLDNAIQTRHFDYIFVRFYNDRSCQY-----STGNI--------QRIRNAWLSWTK 213 (283)
T ss_dssp -------CCEEEECCBSS-SS-CTTTHHHHTTTCCSEEEEECSSCTTTSC-----BTTBC--------HHHHHHHHHHHH
T ss_pred -------CeEEEeccCCc-cC-chhhHHHhhcccccEEEEEeccCCcccC-----CCccH--------HHHHHHHHHHHH
Confidence 44444433222 21 1222222234689999999999754332 11111 112333333334
Q ss_pred HcCCCCCceeeccccccc
Q 003932 248 ERGLSADKLVMCLPFYGY 265 (785)
Q Consensus 248 ~~gvp~~KlvlGip~YG~ 265 (785)
..+.|++|+++|+|++..
T Consensus 214 ~~~~~~~k~~lGlp~~~~ 231 (283)
T d1cnva_ 214 SVYPRDKNLFLELPASQA 231 (283)
T ss_dssp HSSSCSSCEEEEEESSGG
T ss_pred hcCCCccceEEEecCCCc
Confidence 567999999999998754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.1e-21 Score=189.69 Aligned_cols=169 Identities=21% Similarity=0.191 Sum_probs=120.3
Q ss_pred CcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCCh------------------hhHHHHHHHHHHHHcCCCCceeeEEEE
Q 003932 467 SIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTST------------------QGFEEFKNEVMLTAKLQHVNLIRVLGF 528 (785)
Q Consensus 467 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 528 (785)
.+.++||+|+||+||+|...+|+.||||+++.... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999988899999998753210 112234568889999999999998866
Q ss_pred EecCCccEEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEEecccCCCEEEcCCCceeec
Q 003932 529 CIDSEERMLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKVSNILLGEAMKPKIS 608 (785)
Q Consensus 529 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 608 (785)
. ..+++|||+++..+..+ +......++.|+++++.|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 34799999988765432 22334678999999999999986 9999999999999965 58999
Q ss_pred cccceeeecccccccccccccccCCcccccccCCCCCCChhhHHHHHHHH
Q 003932 609 DFGMARIFAKESLEENTEQVVGTIGYIPPEYATKGVYSTKSDVFSFGVLL 658 (785)
Q Consensus 609 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvvl 658 (785)
|||+|............. ..... -.|.+ ...|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~l~---rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE---RDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHH---HHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH---HHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 999997654321111000 00000 01111 35578899999986544
|
| >d1eoka_ c.1.8.5 (A:) Endo-beta-N-acetylglucosaminidase {Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Type II chitinase domain: Endo-beta-N-acetylglucosaminidase species: Flavobacterium meningosepticum, endoglycosidase F3 [TaxId: 238]
Probab=99.78 E-value=2.7e-19 Score=184.08 Aligned_cols=204 Identities=10% Similarity=0.021 Sum_probs=129.7
Q ss_pred EEEEEecCCC---CCCcCCCCCCCCceEEEEEEEee--CCc------cEEecCCCccHHHHHHHHHHHHhcCCCceEEEE
Q 003932 27 IRVGYLNLSE---VSTISGINYDLFTHLICSSADIN--STT------YQLSLSLPSDENQIAKFADTVKKKNPSITTILS 95 (785)
Q Consensus 27 ~~vgY~~~~~---~~~~~~i~~~~~Thi~~~f~~~~--~~~------~~~~~~~~~~~~~~~~~~~~~k~~~p~lkv~~s 95 (785)
++|+||..|. ...++++| +.++.|+++|+... ++. ..+... ......+...++.++++ ++||++|
T Consensus 3 ~~~~y~~~~~~~~~~~l~~~p-~~~d~v~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~q~~--g~kVllS 78 (282)
T d1eoka_ 3 VCIAYYITDGRNPTFKLKDIP-DKVDMVILFGLKYWSLQDTTKLPGGTGMMGS-FKSYKDLDTQIRSLQSR--GIKVLQN 78 (282)
T ss_dssp EEEEEEECSCSSTTSCGGGCC-TTCCEEEEESSCHHHHHCTTSSCTTSGGGTT-CSSHHHHHHHHHHHHTT--TCEEEEE
T ss_pred eEEEEEeccCCCCceeeccCC-CCCCEEEEEccccccccccccccCCcceeec-ccchhHHHHHHHHHhhc--CceEEEE
Confidence 6899997764 45788885 66899999887542 111 111111 12345566777767766 5999999
Q ss_pred ecCCCCCCcccchhhhcChhhhHHHHHHHHHHHHHcCCceeeeeccCCCCCC-----------------------CchhH
Q 003932 96 IGQGKDTNYSIYSSMVRNSSHRKSFIDSSIRIARLYGFRGLDFAWTAPNTST-----------------------DMFNI 152 (785)
Q Consensus 96 igG~~~~~~~~fs~~~~~~~~r~~fi~si~~~~~~y~~DGiDiDwE~p~~~~-----------------------d~~~~ 152 (785)
|||+..... + ....+.+.++.+.+++.+++.+|||||||||||+|.... ...+|
T Consensus 79 iGG~~~~~~--~-~~~~~~~~~~~~~~~~~~~i~~yglDGiDiD~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
T d1eoka_ 79 IDDDVSWQS--S-KPGGFASAAAYGDAIKSIVIDKWKLDGISLDIEHSGAKPNPIPTFPGYAATGYNGWYSGSMAATPAF 155 (282)
T ss_dssp EECCGGGGS--S-SGGGSSSHHHHHHHHHHHHTTTTCCCEEEEECCCCCCCCSSCCCCCCHHHHSCSSCCTTSCCCCHHH
T ss_pred EecCCCCCc--c-CCccHHHHHHHHHHHHHHHHHHhCCCceeecccCCcccCCchhhhhhhhhhhhhhhhhcccccchhc
Confidence 998754322 2 234455667788888889999999999999999985322 22456
Q ss_pred HHHHHHHHHHhhhhhhhcccccceeEEEEeecccCCCCccccHHHHHhccceeeeeeccCCCccCCCCCCCCCCCCCCCC
Q 003932 153 GLLFDEWRIAATKLDAKNSTRQQSLLILTARFRYSPPANSYLLNSIQRNLNWIHAVTASYYEPVSTNFTAPPAALYGSIS 232 (785)
Q Consensus 153 ~~ll~~lr~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~D~v~vm~yd~~~~~~~~~~g~~apl~~~~~ 232 (785)
..++.+++..+... .......... ...........+..+...+||+++|+|+..+.+
T Consensus 156 ~~~~a~l~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~v~~q~Y~~~~~~---------------- 212 (282)
T d1eoka_ 156 LNVISELTKYFGTT------APNNKQLQIA-SGIDVYAWNKIMENFRNNFNYIQLQSYGANVSR---------------- 212 (282)
T ss_dssp HHHHHHHTTTSSTT------SSSCCEEEEE-ECTTSTTHHHHHHHHTTTCSEEEECCTTCCHHH----------------
T ss_pred chhHHHHHHhhccc------cCcceEEEee-cCccccccccchhccccccceeeeeeecccCCc----------------
Confidence 66666666554321 1111122222 122222233456778899999999999854322
Q ss_pred CCCCCCHHHHHHHHH--HcCCCCCceeecccccccee
Q 003932 233 GRFARSTDQVLKAWI--ERGLSADKLVMCLPFYGYAW 267 (785)
Q Consensus 233 ~~~~~~~~~~v~~~~--~~gvp~~KlvlGip~YG~~~ 267 (785)
...+..|. ..++|++|+++|+|+++...
T Consensus 213 -------~~~~~~~~~~~~~~pa~k~~~G~~~~~~~~ 242 (282)
T d1eoka_ 213 -------TQLMMNYATGTNKIPASKMVFGAYAEGGTN 242 (282)
T ss_dssp -------HHHHHHHHHHTSCCCGGGEEEEECTTTCSC
T ss_pred -------hhhHHhhhhccCCCCccceEeeecCCCCcc
Confidence 22333343 35899999999999876533
|
| >d1vf8a2 d.26.3.1 (A:246-315) Chitinase-like lectin ym1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase-like lectin ym1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.19 E-value=1e-11 Score=95.53 Aligned_cols=65 Identities=28% Similarity=0.600 Sum_probs=57.9
Q ss_pred ccceeeecCCCCCCCCCCCCC-----CccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEe
Q 003932 263 YGYAWTLVKPEDNGIGAAAAG-----PALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGF 330 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~~~g-----~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~y 330 (785)
|||+|+|.++.++++|+|..| +.+.++|.++|.|||+.++. +++..||+.+.+||++++++||+|
T Consensus 1 YGRs~tL~~~~~~~~gap~~g~g~~G~~t~~~G~l~y~EIc~~~~~---~~~~~~D~~~~~~y~~~~~qWisY 70 (70)
T d1vf8a2 1 YGHTFILSDPSKTGIGAPTISTGPPGKYTDESGLLAYYEVCTFLNE---GATEVWDAPQEVPYAYQGNEWVGY 70 (70)
T ss_dssp EEEEEEESCTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHHHT---TCEEEEETTTTEEEEEETTEEEEC
T ss_pred CCCceECCCCccCCCCCccccCCCCCCccCCCCeEeHHHHHHHHhC---CCeEEEeCCCCccEEEECCEEEeC
Confidence 899999999999999987654 45788999999999998763 478899999999999999999998
|
| >d1wb0a2 d.26.3.1 (A:267-336) Chitotriosidase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitotriosidase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=4e-11 Score=91.66 Aligned_cols=63 Identities=27% Similarity=0.534 Sum_probs=55.9
Q ss_pred ccceeeecCCCCCCCCCCCCC-----CccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEe
Q 003932 263 YGYAWTLVKPEDNGIGAAAAG-----PALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGF 330 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~~~g-----~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~y 330 (785)
|||+|+|.++.++++|+|..| +.+.++|.++|.|||+.. .++..||+.+.+||++++++||+|
T Consensus 1 YGrs~tL~~~~~~~~gap~~Gpg~~G~~T~~~G~l~y~EIc~~~-----~~~~~~d~~~~~py~~~~~qWisY 68 (68)
T d1wb0a2 1 YGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWK-----GATKQRIQDQKVPYIFRDNQWVGF 68 (68)
T ss_dssp EEEEEEESCTTCCSTTCBEEEECCCCTTTCCTTEEEHHHHTTCT-----TCEEEEETTTTEEEEEETTEEEEC
T ss_pred CCcceEcCCCCCCCCCCccccCCCCCCccCCCeeEEhHHhhhhc-----CCcEEEeccccccEEEECCEEEeC
Confidence 899999999999999987654 457789999999999863 378899999999999999999998
|
| >d2pi6a2 d.26.3.1 (A:240-307) Signal processing protein (SPC-40, MGP-40) {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Signal processing protein (SPC-40, MGP-40) species: Sheep (Ovis aries) [TaxId: 9940]
Probab=99.02 E-value=1.4e-10 Score=88.35 Aligned_cols=63 Identities=21% Similarity=0.489 Sum_probs=54.1
Q ss_pred ccceeeecCCCCCCCCCCCC-----CCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEe
Q 003932 263 YGYAWTLVKPEDNGIGAAAA-----GPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGF 330 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~~~-----g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~y 330 (785)
|||+|+|.++ ++++|+|.. ||.+.++|.++|+|||+.++. +.+.||..+.+||.+++++||+|
T Consensus 1 YGRsftL~~~-~~~~g~p~~Gpg~~G~~T~~~G~lay~EIc~~~~~----~~~~~d~~~~~pyay~g~qWi~Y 68 (68)
T d2pi6a2 1 FGRSFTLASS-KTDVGAPVSGPGIPGRFTKEKGILAYYEICDFLHG----ATTHRFRDQQVPYATKGNQWVAY 68 (68)
T ss_dssp EEEEEEESSS-CCSTTCBEEEECCCCTTTCCTTEEEHHHHHHHTTT----CEEEEETTTTEEEEEETTEEEEC
T ss_pred CCCceEcCCC-CCCCCCccccCCCCCCccCCCceEEHHHHHHHHhC----CcEEEecCccccEEEECCEEEcC
Confidence 8999999985 578888754 556789999999999998753 56789999999999999999998
|
| >d1kfwa2 d.26.3.1 (A:328-388) Psychrophilic chitinase B {Arthrobacter sp., tad20 [TaxId: 1667]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Psychrophilic chitinase B species: Arthrobacter sp., tad20 [TaxId: 1667]
Probab=98.79 E-value=2.2e-09 Score=79.35 Aligned_cols=61 Identities=25% Similarity=0.425 Sum_probs=49.2
Q ss_pred ccceeeecCCCCCCCCCCCCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeecCCEEEEe
Q 003932 263 YGYAWTLVKPEDNGIGAAAAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFSTGTVWFGF 330 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~~~~~i~y 330 (785)
|||+|+++.....+..+...++++.++|+++|++||+ ++++.||+.++.||.+++++||+|
T Consensus 1 YGRgwt~v~~~g~~~~a~g~~~gt~e~G~~~Y~~l~~-------~~~~~~D~~a~a~Y~y~g~~wisY 61 (61)
T d1kfwa2 1 YGRGWTGAKNVSPWGPATDGAPGTYETANEDYDKLKT-------LGTDHYDAATGSAWRYDGTQWWSY 61 (61)
T ss_dssp EEEEEESCCCSSSSCBCSEECCCSSBTTEEEHHHHTT-------SSEEEEETTTTEEEEECSSCEEEE
T ss_pred CCcccccCcCCCccccccCCCCCcccchhhhHHhhcC-------CCEEEeeCCCcEeEEEeCCEEEeC
Confidence 8999998754333333334456688999999999973 478999999999999999999998
|
| >d1itxa2 d.26.3.1 (A:338-409) Chitinase A1 {Bacillus circulans [TaxId: 1397]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase A1 species: Bacillus circulans [TaxId: 1397]
Probab=98.77 E-value=2.1e-09 Score=83.15 Aligned_cols=67 Identities=16% Similarity=0.376 Sum_probs=56.6
Q ss_pred ccceeeecCCCCCCCCCCCCCC---ccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeec--CCEEEEe
Q 003932 263 YGYAWTLVKPEDNGIGAAAAGP---ALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFST--GTVWFGF 330 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~~~g~---~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~--~~~~i~y 330 (785)
|||+|+++++..++++++..++ ++.++|+++|+|||+.+.. ..++++.||+.+++||+++ +++||+|
T Consensus 1 YGR~w~~v~~~~~g~~~~~~g~~~~G~~e~G~~~Y~ei~~~~~~-~~g~~~~~D~~a~apY~y~~~~~~~isY 72 (72)
T d1itxa2 1 YGRGWDGCAQAGNGQYQTCTGGSSVGTWEAGSFDFYDLEANYIN-KNGYTRYWNDTAKVPYLYNASNKRFISY 72 (72)
T ss_dssp EEEEEESCCSGGGGTTCBCSEECSCCSSSTTEEEHHHHHHHTTT-CTTEEEEEETTTTEEEEEETTTCCEEEC
T ss_pred CCCceeCCCCCCCCCCCcccCCCCCCccccccChHHHHHHHhcc-CCCCEEEEcCCCccceEEeCCCCeEEeC
Confidence 8999999999888888877654 3558899999999998654 3579999999999999965 5699998
|
| >d1edqa3 d.26.3.1 (A:444-516) Chitinase A {Serratia marcescens [TaxId: 615]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase A species: Serratia marcescens [TaxId: 615]
Probab=98.73 E-value=5.3e-09 Score=81.10 Aligned_cols=67 Identities=27% Similarity=0.452 Sum_probs=54.7
Q ss_pred ccceeeecCCCCCCCCCC----CCCCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeec--CCEEEEeC
Q 003932 263 YGYAWTLVKPEDNGIGAA----AAGPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFST--GTVWFGFD 331 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~----~~g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~--~~~~i~yd 331 (785)
|||+|+++++..++.+.. ..++++.++|+++|++||+.+.. .++++.||+.+++||+++ +++||+||
T Consensus 1 YGRgw~~v~~~~~g~~~~~~~~~~~~gt~e~G~~~Y~~l~~~~~~--~g~~~~wD~~a~apY~Y~~~~~~~isYD 73 (73)
T d1edqa3 1 YGRGWTGVNGYQNNIPFTGTATGPVKGTWENGIVDYRQIAGQFMS--GEWQYTYDATAEAPYVFKPSTGDLITFD 73 (73)
T ss_dssp EEEEEESCBSCSTTCGGGSBCSEECCCSSBTTEEEHHHHHHHSSS--TTCEEEEETTTTEEEEEETTTTEEEECC
T ss_pred CCCcccCCCCCCCCccccccCCCCcCcccccchhHHHHHHHHhcc--CCeeEEEeccccccEEEeCCCCeEEeCC
Confidence 899999998776665432 23456789999999999998764 469999999999999975 56899998
|
| >d1jnda2 d.26.3.1 (A:279-370) Imaginal disc growth factor-2 {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Imaginal disc growth factor-2 species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.50 E-value=7e-08 Score=76.88 Aligned_cols=68 Identities=22% Similarity=0.403 Sum_probs=49.4
Q ss_pred ccceeeecCCCCC---CCC-----CCCCCCccccCccccHHHHHhhhhhcCCC--------eEEEeccceee-eeee---
Q 003932 263 YGYAWTLVKPEDN---GIG-----AAAAGPALYDSGLVTYKKIKNHIKTYGPD--------VQVMYNSTYEV-NYFS--- 322 (785)
Q Consensus 263 YG~~~~~~~~~~~---~~~-----~~~~g~~~~~~g~~~y~~i~~~~~~~~~~--------~~~~~d~~~~~-~y~~--- 322 (785)
|||+|+|.++++. +++ ....|+.+.++|+++|+|||+.+...+.. .++.+|..... ||++
T Consensus 1 YGRsftL~~~s~~~~~~~~~~~~g~g~~G~~t~~~G~lsy~EIC~~l~~~~~~~~~~~~a~lrrV~D~~~~~g~YAyr~~ 80 (92)
T d1jnda2 1 YGNAWKLTKDSGLEGVPVVPETSGPAPEGFQSQKPGLLSYAEICGKLSNPQNQFLKGNESPLRRVSDPTKRFGGIAYRPV 80 (92)
T ss_dssp EEEEEECCGGGCSCCSSCBCSCCSBCCCCTTTCCTTEEEHHHHHHHBCCTTTTTCCGGGSCBEEECCTTCCSCEEEEECS
T ss_pred CCCCeEcCCCCCCCCCCCCCcccCCCCCCcccCCcceEEHHHHHHHhccCCcceeecccCceeEecCcccceeeeEEecc
Confidence 8999999765432 233 34567788999999999999998765422 35566766554 7875
Q ss_pred ----cCCEEEEe
Q 003932 323 ----TGTVWFGF 330 (785)
Q Consensus 323 ----~~~~~i~y 330 (785)
.+++||+|
T Consensus 81 d~~~~~~qWVsY 92 (92)
T d1jnda2 81 DGQITEGIWVSY 92 (92)
T ss_dssp BTTBCCCEEEEE
T ss_pred cCCCcCCEeecC
Confidence 47899998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=1.7e-07 Score=93.20 Aligned_cols=150 Identities=17% Similarity=0.130 Sum_probs=103.9
Q ss_pred HHHHHHhcCCCcceeeceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCC-CCceeeEEEEEecCCcc
Q 003932 457 ADIEAATERFSIRNKLGEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEER 535 (785)
Q Consensus 457 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 535 (785)
.++....+.|++.+..+.++.+.||+.... ++.+++|+...........+.+|...++.+. +--+.+++.++.+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 456666778887777666666899998755 5567888876544333345677888877663 44467788888888889
Q ss_pred EEEEEecCCCChhhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 003932 536 MLIYEYMPNKSLDCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQEYS-------------------------------- 583 (785)
Q Consensus 536 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 583 (785)
++||+++++.++....... .....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999998886544211 112234555556666666421
Q ss_pred ------------------------CCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 584 ------------------------RLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 584 ------------------------~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876667999998765
|
| >d1w9pa2 d.26.3.1 (A:299-360) Chitinase 1 {Aspergillus fumigatus [TaxId: 5085]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase 1 species: Aspergillus fumigatus [TaxId: 5085]
Probab=97.84 E-value=6.2e-06 Score=60.29 Aligned_cols=58 Identities=16% Similarity=0.327 Sum_probs=45.0
Q ss_pred ccceeeecCCCCCCCCCCCC--CCccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeec--CCEEEEe
Q 003932 263 YGYAWTLVKPEDNGIGAAAA--GPALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFST--GTVWFGF 330 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~~~--g~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~--~~~~i~y 330 (785)
|||+|+.++ +++.+.. ++++.++|+++|++|.. +++.+.||+.++.+|+++ .+.||||
T Consensus 1 YGRgf~gv~----g~~q~~~g~~~Gt~e~Gv~dYk~L~~------~G~~~~~D~~a~aay~Yd~~~~~~isY 62 (62)
T d1w9pa2 1 YGRSFANTD----GPGKPYNGVGQGSWENGVWDYKALPQ------AGATEHVLPDIMASYSYDATNKFLISY 62 (62)
T ss_dssp EEEEESSCS----STTSCCCCCCCCSSBTTEEEGGGCSC------TTCEEEEEGGGTEEEEEETTTTEEEEC
T ss_pred CCccccCCC----CCCCccccccCCCcccceEEHHHcCc------CCceEEEcCCceEEEEEeCCCCeEeeC
Confidence 899998764 4444443 44578999999998853 468999999999999864 5689998
|
| >d1goia3 d.26.3.1 (A:292-379) Chitinase B {Serratia marcescens [TaxId: 615]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase B species: Serratia marcescens [TaxId: 615]
Probab=97.84 E-value=1.3e-05 Score=63.55 Aligned_cols=67 Identities=16% Similarity=0.361 Sum_probs=51.6
Q ss_pred ccceeeecCCCCCCCCCCCCCCc-------------------cccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeec
Q 003932 263 YGYAWTLVKPEDNGIGAAAAGPA-------------------LYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFST 323 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~~~g~~-------------------~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~ 323 (785)
|||.|+.+.+..++...+..++. ..+.|...|.+|.+.+.. ..++++.||+.+++||+.+
T Consensus 1 YgRGW~gV~~~~nGl~q~~~~~~~g~~~~~~~~~~~~~~g~~~~e~G~~~y~~l~~~~~~-~~Gy~~~~D~~AkApylyn 79 (88)
T d1goia3 1 YGRAFKGVSGGNGGQYSSHSTPGEDPYPSTDYWLVGCEECVRDKDPRIASYRQLEQMLQG-NYGYQRLWNDKTKTPYLYH 79 (88)
T ss_dssp EEEEEESCCSSSTTTTCCCCCCCCSSCSSSCCCSTTCHHHHHHTCTTEEEHHHHHHHHHT-TSSEEEEEETTTTEEEEEE
T ss_pred CCCcccCCCCCCCCccccccCCCCCcccccCcccccccccccccccccccHHHHHHhhcc-CCCcEEEeCcCcccceEEe
Confidence 89999999887777655444332 136788999999875432 3569999999999999964
Q ss_pred --CCEEEEe
Q 003932 324 --GTVWFGF 330 (785)
Q Consensus 324 --~~~~i~y 330 (785)
++.||||
T Consensus 80 ~~~g~fiSY 88 (88)
T d1goia3 80 AQNGLFVTY 88 (88)
T ss_dssp TTTTEEEEC
T ss_pred CCCCeEeeC
Confidence 6789998
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=2.1e-05 Score=77.14 Aligned_cols=131 Identities=18% Similarity=0.171 Sum_probs=86.9
Q ss_pred eeceeC-cEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCC--CceeeEEEEEecCCccEEEEEecCCCCh
Q 003932 471 KLGEGG-YGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH--VNLIRVLGFCIDSEERMLIYEYMPNKSL 547 (785)
Q Consensus 471 ~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 547 (785)
.+..|. .+.||+...+++..+++|....... ..+..|...++.+.. -.+.+++.++.+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 445554 3689999888788889998765433 245677777776632 3466788888888889999999998776
Q ss_pred hhhhcCCccccCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------------
Q 003932 548 DCYLFDPIRKLILDWKKRVHIIEGITQGLLYLQE---------------------------------------------- 581 (785)
Q Consensus 548 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---------------------------------------------- 581 (785)
.+.. ... ...+.++++.|.-||.
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 010 1112223333333332
Q ss_pred -----c----CCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 582 -----Y----SRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 582 -----~----~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
. .+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 122379999999999999876678999998764
|
| >d1ll7a2 d.26.3.1 (A:293-354) Chitinase 1 {Fungus (Coccidioides immitis) [TaxId: 5501]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: FKBP-like superfamily: Chitinase insertion domain family: Chitinase insertion domain domain: Chitinase 1 species: Fungus (Coccidioides immitis) [TaxId: 5501]
Probab=97.78 E-value=8.3e-06 Score=59.47 Aligned_cols=58 Identities=22% Similarity=0.413 Sum_probs=45.2
Q ss_pred ccceeeecCCCCCCCCCCCCC--CccccCccccHHHHHhhhhhcCCCeEEEeccceeeeeeec--CCEEEEe
Q 003932 263 YGYAWTLVKPEDNGIGAAAAG--PALYDSGLVTYKKIKNHIKTYGPDVQVMYNSTYEVNYFST--GTVWFGF 330 (785)
Q Consensus 263 YG~~~~~~~~~~~~~~~~~~g--~~~~~~g~~~y~~i~~~~~~~~~~~~~~~d~~~~~~y~~~--~~~~i~y 330 (785)
|||+|+.++ +++.+..| +++.+.|++.|++|.. +++++.||+.++.+|+++ .+.||||
T Consensus 1 YGRgf~gv~----G~~q~~~G~~~Gt~e~Gv~dYk~L~~------~g~~~~~D~~a~A~y~yd~~~~~fiSY 62 (62)
T d1ll7a2 1 YGRAFASTD----GIGTSFNGVGGGSWENGVWDYKDMPQ------QGAQVTELEDIAASYSYDKNKRYLISY 62 (62)
T ss_dssp EEEEECSCS----STTSBCCCCCCBSSSTTEEEGGGCSC------TTCEEEEETTTTEEEEEETTTTEEEEC
T ss_pred CCcccCCCC----CCCCcCcCCCCCcccccEEEHHHCCC------CCceEEEcCCceEEEEEeCCCCeEeeC
Confidence 899998764 45555443 4567899999998743 468999999999999864 5689998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.33 E-value=0.00027 Score=73.71 Aligned_cols=76 Identities=14% Similarity=0.170 Sum_probs=48.4
Q ss_pred eeeceeCcEEEEEEEeC-CCcEEEEEEcCCC-------ChhhHHHHHHHHHHHHcC-CC--CceeeEEEEEecCCccEEE
Q 003932 470 NKLGEGGYGPVYKGVLP-CGEVIAVKKLSKT-------STQGFEEFKNEVMLTAKL-QH--VNLIRVLGFCIDSEERMLI 538 (785)
Q Consensus 470 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~lv 538 (785)
+.||.|....||++... +++.++||.-... -....++...|.+.|+.+ .+ ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 57899999999999864 4678999975421 011223345677777665 22 345666654 45667899
Q ss_pred EEecCCCCh
Q 003932 539 YEYMPNKSL 547 (785)
Q Consensus 539 ~e~~~~gsL 547 (785)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.47 E-value=0.0031 Score=65.42 Aligned_cols=73 Identities=14% Similarity=0.170 Sum_probs=50.1
Q ss_pred ceeeceeCcEEEEEEEeCC--------CcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCc-eeeEEEEEecCCccEEEE
Q 003932 469 RNKLGEGGYGPVYKGVLPC--------GEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLIY 539 (785)
Q Consensus 469 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 539 (785)
++.|+.|-.-.+|++...+ .+.|++++...... .....+|..+++.+.-.+ ..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3678889999999998543 35677777653322 234567888888774334 3567777643 6899
Q ss_pred EecCCCCh
Q 003932 540 EYMPNKSL 547 (785)
Q Consensus 540 e~~~~gsL 547 (785)
||+++.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.44 E-value=0.0044 Score=61.99 Aligned_cols=159 Identities=13% Similarity=-0.018 Sum_probs=81.9
Q ss_pred cChHHHHHHhcCCCcceee-----ceeCcEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCcee--eEE
Q 003932 454 YSLADIEAATERFSIRNKL-----GEGGYGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI--RVL 526 (785)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~ 526 (785)
.+.+|++....+|.+.+.. ..|---+.|+...++|+ +++|+...... .+++..|++++..|...++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 4567788888888875443 45666888999887665 89999865322 13445566666665322221 111
Q ss_pred E------EEecCCccEEEEEecCCCChhhhh--------------c------CCccccC------------------CCH
Q 003932 527 G------FCIDSEERMLIYEYMPNKSLDCYL--------------F------DPIRKLI------------------LDW 562 (785)
Q Consensus 527 ~------~~~~~~~~~lv~e~~~~gsL~~~l--------------~------~~~~~~~------------------l~~ 562 (785)
. +..-......++.++.+......- + ....... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 0 011123445566666554331110 0 0000000 000
Q ss_pred HHHHHHHHHHHHHHHHHhh-cCCCCeEEecccCCCEEEcCCCceeeccccceee
Q 003932 563 KKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 563 ~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
......+..+...+...+. .-+.++||+|+.+.||+++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1111122222222222221 1234699999999999999887778999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.34 E-value=0.0029 Score=63.76 Aligned_cols=136 Identities=13% Similarity=0.116 Sum_probs=77.2
Q ss_pred cEEEEEEEeCCCcEEEEEEcCCCChhhHHHHHHHHHHHHcCCCCce--eeEEE-----EEecCCccEEEEEecCCCChhh
Q 003932 477 YGPVYKGVLPCGEVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL--IRVLG-----FCIDSEERMLIYEYMPNKSLDC 549 (785)
Q Consensus 477 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~~ 549 (785)
-..||++..++|+.+++|+.+.... ..+++..|...+..|...++ +..+. .+......+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 4689999998899999999876432 34667788888877743222 11111 1123455778899987654321
Q ss_pred h-----------h---cC------CccccCCCHH-------------------HHHHHHHHHHHHHHHHhh----cCCCC
Q 003932 550 Y-----------L---FD------PIRKLILDWK-------------------KRVHIIEGITQGLLYLQE----YSRLT 586 (785)
Q Consensus 550 ~-----------l---~~------~~~~~~l~~~-------------------~~~~i~~~i~~~l~~LH~----~~~~~ 586 (785)
. + +. ...+...+.. ....+...+.+.+..+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 0 00 0011111111 111122222233333332 22346
Q ss_pred eEEecccCCCEEEcCCCceeeccccceee
Q 003932 587 IIHRDLKVSNILLGEAMKPKISDFGMARI 615 (785)
Q Consensus 587 ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 615 (785)
+||+|+.+.|||++++ ..++||+-++.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998864
|
| >d2bhua3 c.1.8.1 (A:111-530) Glycosyltrehalose trehalohydrolase, central domain {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: TIM beta/alpha-barrel superfamily: (Trans)glycosidases family: Amylase, catalytic domain domain: Glycosyltrehalose trehalohydrolase, central domain species: Deinococcus radiodurans [TaxId: 1299]
Probab=82.41 E-value=3 Score=41.99 Aligned_cols=90 Identities=16% Similarity=0.147 Sum_probs=59.8
Q ss_pred cHHHHHHHHHHHHhcCCCceEEEEec-CCCCCCcccchh------------------hhcChhhhHHHHHHHHHHHHHcC
Q 003932 72 DENQIAKFADTVKKKNPSITTILSIG-QGKDTNYSIYSS------------------MVRNSSHRKSFIDSSIRIARLYG 132 (785)
Q Consensus 72 ~~~~~~~~~~~~k~~~p~lkv~~sig-G~~~~~~~~fs~------------------~~~~~~~r~~fi~si~~~~~~y~ 132 (785)
+.+++..+++++|+++ +||++=+- .....+...|.. -..+++.|+.+++++.-|++++|
T Consensus 81 ~~~d~~~lv~~aH~~g--i~VilD~V~NH~~~~~~~~~~~~~~~~~~~~~~~~~~dlN~~np~v~~~~~~~~~~Wl~~~G 158 (420)
T d2bhua3 81 RPEDLMALVDAAHRLG--LGVFLDVVYNHFGPSGNYLSSYAPSYFTDRFSSAWGMGLDYAEPHMRRYVTGNARMWLRDYH 158 (420)
T ss_dssp CHHHHHHHHHHHHHTT--CEEEEEECCSCCCSSSCCHHHHCGGGEEEEEECSSSEEECTTSHHHHHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHhcc--ccccccccccccCCCCccccccccccccccccccccccccccChHHHHHHHHHhheeeeccc
Confidence 3567999999999885 99998764 011111111111 14678999999999999999999
Q ss_pred CceeeeeccCCCCCCCchhHHHHHHHHHHHhhhh
Q 003932 133 FRGLDFAWTAPNTSTDMFNIGLLFDEWRIAATKL 166 (785)
Q Consensus 133 ~DGiDiDwE~p~~~~d~~~~~~ll~~lr~~l~~~ 166 (785)
+||+-||--.--..+.. ..++++++++++..
T Consensus 159 VDGfR~D~~~~l~~~~~---~~~~~~~~~~~~~~ 189 (420)
T d2bhua3 159 FDGLRLDATPYMTDDSE---THILTELAQEIHEL 189 (420)
T ss_dssp CSEEEETTGGGCCCCSS---SCHHHHHHHHHHTT
T ss_pred ccEEEEeeeeeeccccc---cccHHHHHHHHHhh
Confidence 99999996421111111 23577788777653
|